id	sid	tid	token	lemma	pos
cord-015365-iqdi99pd	1	1	key	key	JJ
cord-015365-iqdi99pd	1	2	:	:	:
cord-015365-iqdi99pd	1	3	cord-015365-iqdi99pd	cord-015365-iqdi99pd	JJ
cord-015365-iqdi99pd	1	4	authors	author	NNS
cord-015365-iqdi99pd	1	5	:	:	:
cord-015365-iqdi99pd	2	1	nan	nan	NNP
cord-015365-iqdi99pd	2	2	title	title	NN
cord-015365-iqdi99pd	2	3	:	:	:
cord-015365-iqdi99pd	2	4	25th	25th	JJ
cord-015365-iqdi99pd	2	5	Annual	Annual	NNP
cord-015365-iqdi99pd	2	6	Meeting	Meeting	NNP
cord-015365-iqdi99pd	2	7	of	of	IN
cord-015365-iqdi99pd	2	8	the	the	DT
cord-015365-iqdi99pd	2	9	Austrian	Austrian	NNP
cord-015365-iqdi99pd	2	10	Society	Society	NNP
cord-015365-iqdi99pd	2	11	of	of	IN
cord-015365-iqdi99pd	2	12	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	2	13	,	,	,
cord-015365-iqdi99pd	2	14	Transfusion	Transfusion	NNP
cord-015365-iqdi99pd	2	15	and	and	CC
cord-015365-iqdi99pd	2	16	Genetics	Genetics	NNP
cord-015365-iqdi99pd	2	17	Graz	Graz	NNP
cord-015365-iqdi99pd	2	18	,	,	,
cord-015365-iqdi99pd	2	19	October	October	NNP
cord-015365-iqdi99pd	2	20	19–21	19–21	CD
cord-015365-iqdi99pd	2	21	,	,	,
cord-015365-iqdi99pd	2	22	2011	2011	CD
cord-015365-iqdi99pd	2	23	date	date	NN
cord-015365-iqdi99pd	2	24	:	:	:
cord-015365-iqdi99pd	3	1	2011	2011	CD
cord-015365-iqdi99pd	3	2	journal	journal	NNP
cord-015365-iqdi99pd	3	3	:	:	:
cord-015365-iqdi99pd	4	1	Eur	Eur	NNP
cord-015365-iqdi99pd	4	2	Surg	Surg	NNP
cord-015365-iqdi99pd	4	3	DOI	DOI	NNP
cord-015365-iqdi99pd	5	1	:	:	:
cord-015365-iqdi99pd	5	2	10.1007	10.1007	CD
cord-015365-iqdi99pd	5	3	/	/	SYM
cord-015365-iqdi99pd	5	4	s10353	s10353	CD
cord-015365-iqdi99pd	5	5	-	-	HYPH
cord-015365-iqdi99pd	5	6	011	011	CD
cord-015365-iqdi99pd	5	7	-	-	HYPH
cord-015365-iqdi99pd	5	8	0041-z	0041-z	NN
cord-015365-iqdi99pd	5	9	sha	sha	NNP
cord-015365-iqdi99pd	5	10	:	:	:
cord-015365-iqdi99pd	6	1	5fcaa5b826f3255958984041b5e25f3549b12ae7	5fcaa5b826f3255958984041b5e25f3549b12ae7	XX
cord-015365-iqdi99pd	7	1	doc_id	doc_id	CD
cord-015365-iqdi99pd	7	2	:	:	:
cord-015365-iqdi99pd	8	1	15365	15365	CD
cord-015365-iqdi99pd	8	2	cord_uid	cord_uid	NNS
cord-015365-iqdi99pd	8	3	:	:	:
cord-015365-iqdi99pd	8	4	iqdi99pd	iqdi99pd	XX
cord-015365-iqdi99pd	8	5	nan	nan	NNP
cord-015365-iqdi99pd	8	6	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	8	7	.	.	.
cord-015365-iqdi99pd	9	1	Parvovirus	Parvovirus	NNP
cord-015365-iqdi99pd	9	2	B19	B19	NNP
cord-015365-iqdi99pd	9	3	(	(	-LRB-
cord-015365-iqdi99pd	9	4	PVB19	pvb19	NN
cord-015365-iqdi99pd	9	5	)	)	-RRB-
cord-015365-iqdi99pd	9	6	als	als	NNP
cord-015365-iqdi99pd	10	1	Ursache	Ursache	NNP
cord-015365-iqdi99pd	10	2	einer	einer	NNP
cord-015365-iqdi99pd	10	3	schweren	schweren	NNP
cord-015365-iqdi99pd	10	4	aplastischen	aplastischen	NNP
cord-015365-iqdi99pd	10	5	Anämie	Anämie	NNP
cord-015365-iqdi99pd	10	6	(	(	-LRB-
cord-015365-iqdi99pd	10	7	SAA	SAA	NNP
cord-015365-iqdi99pd	10	8	)	)	-RRB-
cord-015365-iqdi99pd	10	9	oder	oder	NNP
cord-015365-iqdi99pd	10	10	eines	eines	NNP
cord-015365-iqdi99pd	11	1	myelodysplastischen	myelodysplastischen	NNP
cord-015365-iqdi99pd	11	2	Syndroms	Syndroms	NNP
cord-015365-iqdi99pd	11	3	(	(	-LRB-
cord-015365-iqdi99pd	11	4	MDS	MDS	NNP
cord-015365-iqdi99pd	11	5	)	)	-RRB-
cord-015365-iqdi99pd	11	6	ist	ist	NNP
cord-015365-iqdi99pd	11	7	bisher	bisher	NNP
cord-015365-iqdi99pd	11	8	erst	erst	NNP
cord-015365-iqdi99pd	11	9	selten	selten	NNP
cord-015365-iqdi99pd	11	10	beschrieben	beschrieben	NNP
cord-015365-iqdi99pd	11	11	.	.	.
cord-015365-iqdi99pd	12	1	Es	Es	NNP
cord-015365-iqdi99pd	12	2	existieren	existieren	NNP
cord-015365-iqdi99pd	12	3	auch	auch	NNP
cord-015365-iqdi99pd	12	4	kaum	kaum	NNP
cord-015365-iqdi99pd	13	1	Berichte	Berichte	NNP
cord-015365-iqdi99pd	14	1	über	über	NNP
cord-015365-iqdi99pd	14	2	Stammzell	Stammzell	NNP
cord-015365-iqdi99pd	14	3	-	-	HYPH
cord-015365-iqdi99pd	14	4	Transplantationen	Transplantationen	NNP
cord-015365-iqdi99pd	14	5	(	(	-LRB-
cord-015365-iqdi99pd	14	6	SCT	SCT	NNP
cord-015365-iqdi99pd	14	7	)	)	-RRB-
cord-015365-iqdi99pd	14	8	bei	bei	NNP
cord-015365-iqdi99pd	14	9	diesen	diesen	NNP
cord-015365-iqdi99pd	14	10	Krankheitsbildern	Krankheitsbildern	NNP
cord-015365-iqdi99pd	14	11	.	.	.
cord-015365-iqdi99pd	15	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	15	2	.	.	.
cord-015365-iqdi99pd	16	1	Bei	Bei	NNP
cord-015365-iqdi99pd	16	2	6	6	CD
cord-015365-iqdi99pd	17	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	17	2	mit	mit	NNP
cord-015365-iqdi99pd	17	3	SAA	SAA	NNP
cord-015365-iqdi99pd	17	4	(	(	-LRB-
cord-015365-iqdi99pd	17	5	n	n	NN
cord-015365-iqdi99pd	17	6	¼	¼	NNP
cord-015365-iqdi99pd	17	7	4	4	CD
cord-015365-iqdi99pd	17	8	)	)	-RRB-
cord-015365-iqdi99pd	18	1	oder	oder	NNP
cord-015365-iqdi99pd	18	2	MDS	MDS	NNP
cord-015365-iqdi99pd	18	3	(	(	-LRB-
cord-015365-iqdi99pd	18	4	n	n	NN
cord-015365-iqdi99pd	18	5	¼	¼	NNP
cord-015365-iqdi99pd	18	6	2	2	CD
cord-015365-iqdi99pd	18	7	)	)	-RRB-
cord-015365-iqdi99pd	18	8	wurde	wurde	NNP
cord-015365-iqdi99pd	18	9	bei	bei	NNP
cord-015365-iqdi99pd	18	10	Diagnosestellung	Diagnosestellung	NNP
cord-015365-iqdi99pd	18	11	eine	eine	JJ
cord-015365-iqdi99pd	18	12	frische	frische	JJ
cord-015365-iqdi99pd	18	13	Infektion	Infektion	NNP
cord-015365-iqdi99pd	18	14	mit	mit	NNP
cord-015365-iqdi99pd	18	15	PVB19	PVB19	NNP
cord-015365-iqdi99pd	18	16	mittels	mittels	NNP
cord-015365-iqdi99pd	18	17	positivem	positivem	NNP
cord-015365-iqdi99pd	18	18	Nachweis	Nachweis	NNP
cord-015365-iqdi99pd	18	19	von	von	NNP
cord-015365-iqdi99pd	18	20	IgM	IgM	NNP
cord-015365-iqdi99pd	18	21	,	,	,
cord-015365-iqdi99pd	18	22	IgG	IgG	NNP
cord-015365-iqdi99pd	18	23	und	und	IN
cord-015365-iqdi99pd	18	24	PCR	PCR	NNP
cord-015365-iqdi99pd	18	25	nachgewiesen	nachgewiesen	NNP
cord-015365-iqdi99pd	18	26	.	.	.
cord-015365-iqdi99pd	19	1	Alle	Alle	NNP
cord-015365-iqdi99pd	19	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	19	3	erhielten	erhielten	XX
cord-015365-iqdi99pd	19	4	eine	eine	NNP
cord-015365-iqdi99pd	20	1	SCT	SCT	NNP
cord-015365-iqdi99pd	20	2	unter	unter	NNP
cord-015365-iqdi99pd	20	3	dem	dem	JJ
cord-015365-iqdi99pd	20	4	Schutz	Schutz	NNP
cord-015365-iqdi99pd	20	5	repetitiver	repetitiver	NNP
cord-015365-iqdi99pd	21	1	intravenöser	intravenöser	NNP
cord-015365-iqdi99pd	21	2	Immunglobulin	Immunglobulin	NNP
cord-015365-iqdi99pd	21	3	(	(	-LRB-
cord-015365-iqdi99pd	21	4	IVIG)-Gaben	ivig)-gaben	NN
cord-015365-iqdi99pd	21	5	.	.	.
cord-015365-iqdi99pd	22	1	Das	Das	NNP
cord-015365-iqdi99pd	22	2	virologische	virologische	NN
cord-015365-iqdi99pd	22	3	Monitoring	Monitoring	NNP
cord-015365-iqdi99pd	22	4	mittels	mittels	FW
cord-015365-iqdi99pd	22	5	PCR	PCR	NNP
cord-015365-iqdi99pd	22	6	erfolgte	erfolgte	NN
cord-015365-iqdi99pd	22	7	in	in	IN
cord-015365-iqdi99pd	22	8	5	5	CD
cord-015365-iqdi99pd	22	9	von	von	NNP
cord-015365-iqdi99pd	22	10	6	6	CD
cord-015365-iqdi99pd	22	11	Fällen	Fällen	NNP
cord-015365-iqdi99pd	22	12	in	in	IN
cord-015365-iqdi99pd	22	13	der	der	NNP
cord-015365-iqdi99pd	22	14	Akutphase	Akutphase	NNP
cord-015365-iqdi99pd	22	15	wöchentlich	wöchentlich	NNP
cord-015365-iqdi99pd	22	16	,	,	,
cord-015365-iqdi99pd	22	17	danach	danach	NNP
cord-015365-iqdi99pd	22	18	monatlich	monatlich	NNP
cord-015365-iqdi99pd	23	1	bis	bis	NNP
cord-015365-iqdi99pd	23	2	zur	zur	NNP
cord-015365-iqdi99pd	23	3	hämatologischen	hämatologischen	NNP
cord-015365-iqdi99pd	23	4	Rekonstituierung	Rekonstituierung	NNP
cord-015365-iqdi99pd	23	5	.	.	.
cord-015365-iqdi99pd	24	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	24	2	.	.	.
cord-015365-iqdi99pd	25	1	Die	die	VBP
cord-015365-iqdi99pd	25	2	4	4	CD
cord-015365-iqdi99pd	25	3	Patienten	Patienten	NNP
cord-015365-iqdi99pd	25	4	mit	mit	NNP
cord-015365-iqdi99pd	25	5	SAA	SAA	NNP
cord-015365-iqdi99pd	25	6	erhielten	erhielten	NN
cord-015365-iqdi99pd	26	1	Knochenmark	Knochenmark	NNP
cord-015365-iqdi99pd	26	2	eines	eines	NNP
cord-015365-iqdi99pd	26	3	HLA	HLA	NNP
cord-015365-iqdi99pd	26	4	-	-	HYPH
cord-015365-iqdi99pd	26	5	identen	identen	NNP
cord-015365-iqdi99pd	26	6	Geschwister	Geschwister	NNP
cord-015365-iqdi99pd	26	7	-	-	HYPH
cord-015365-iqdi99pd	26	8	Spenders	Spenders	NNPS
cord-015365-iqdi99pd	26	9	(	(	-LRB-
cord-015365-iqdi99pd	26	10	n	n	CC
cord-015365-iqdi99pd	26	11	¼	¼	NNP
cord-015365-iqdi99pd	26	12	3	3	CD
cord-015365-iqdi99pd	26	13	)	)	-RRB-
cord-015365-iqdi99pd	27	1	oder	oder	NNP
cord-015365-iqdi99pd	27	2	HLA	HLA	NNP
cord-015365-iqdi99pd	27	3	-	-	HYPH
cord-015365-iqdi99pd	27	4	idente	idente	NNP
cord-015365-iqdi99pd	27	5	hochgereinigte	hochgereinigte	NN
cord-015365-iqdi99pd	27	6	,	,	,
cord-015365-iqdi99pd	27	7	periphere	periphere	NNP
cord-015365-iqdi99pd	27	8	Stammzellen	Stammzellen	NNP
cord-015365-iqdi99pd	27	9	eines	eines	NNPS
cord-015365-iqdi99pd	27	10	unverwandten	unverwandten	NNP
cord-015365-iqdi99pd	27	11	Spenders	Spenders	NNPS
cord-015365-iqdi99pd	27	12	(	(	-LRB-
cord-015365-iqdi99pd	27	13	n	n	CC
cord-015365-iqdi99pd	27	14	¼	¼	NNP
cord-015365-iqdi99pd	27	15	1	1	CD
cord-015365-iqdi99pd	27	16	)	)	-RRB-
cord-015365-iqdi99pd	27	17	.	.	.
cord-015365-iqdi99pd	28	1	Ein	Ein	NNP
cord-015365-iqdi99pd	28	2	Patient	Patient	NNP
cord-015365-iqdi99pd	28	3	entwickelte	entwickelte	NNP
cord-015365-iqdi99pd	28	4	nach	nach	NNP
cord-015365-iqdi99pd	28	5	SCT	SCT	NNP
cord-015365-iqdi99pd	28	6	eine	eine	NNP
cord-015365-iqdi99pd	28	7	chronische	chronische	NNP
cord-015365-iqdi99pd	28	8	,	,	,
cord-015365-iqdi99pd	28	9	hypoplastische	hypoplastische	NNP
cord-015365-iqdi99pd	28	10	Anämie	Anämie	NNP
cord-015365-iqdi99pd	28	11	,	,	,
cord-015365-iqdi99pd	28	12	die	die	VB
cord-015365-iqdi99pd	28	13	bis	bis	NNP
cord-015365-iqdi99pd	28	14	zur	zur	XX
cord-015365-iqdi99pd	29	1	vollständigen	vollständigen	NNP
cord-015365-iqdi99pd	29	2	Blutbild	Blutbild	NNP
cord-015365-iqdi99pd	29	3	-	-	HYPH
cord-015365-iqdi99pd	29	4	Regeneration	Regeneration	NNP
cord-015365-iqdi99pd	29	5	am	be	VBP
cord-015365-iqdi99pd	29	6	Tag	tag	NN
cord-015365-iqdi99pd	29	7	186	186	CD
cord-015365-iqdi99pd	29	8	andauerte	andauerte	NNS
cord-015365-iqdi99pd	29	9	.	.	.
cord-015365-iqdi99pd	30	1	Der	Der	NNP
cord-015365-iqdi99pd	30	2	Posttransplantations	Posttransplantations	NNP
cord-015365-iqdi99pd	30	3	-	-	HYPH
cord-015365-iqdi99pd	30	4	Verlauf	Verlauf	NNP
cord-015365-iqdi99pd	30	5	der	der	NNP
cord-015365-iqdi99pd	30	6	ü	ü	NN
cord-015365-iqdi99pd	30	7	brigen	brigen	NNP
cord-015365-iqdi99pd	30	8	3	3	CD
cord-015365-iqdi99pd	31	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	31	2	war	war	NN
cord-015365-iqdi99pd	31	3	komplikationslos	komplikationslos	NNP
cord-015365-iqdi99pd	31	4	mit	mit	NNP
cord-015365-iqdi99pd	31	5	einem	einem	NNP
cord-015365-iqdi99pd	31	6	Leukozyten	Leukozyten	NNP
cord-015365-iqdi99pd	31	7	-	-	HYPH
cord-015365-iqdi99pd	31	8	Engraftment	Engraftment	NNP
cord-015365-iqdi99pd	31	9	nach	nach	NNP
cord-015365-iqdi99pd	31	10	8	8	CD
cord-015365-iqdi99pd	32	1	-31	-31	NFP
cord-015365-iqdi99pd	32	2	Tagen	Tagen	NNP
cord-015365-iqdi99pd	32	3	und	und	NNP
cord-015365-iqdi99pd	32	4	einer	einer	NNP
cord-015365-iqdi99pd	33	1	hämatologischen	hämatologischen	NNP
cord-015365-iqdi99pd	33	2	Rekonstituierung	Rekonstituierung	NNP
cord-015365-iqdi99pd	33	3	nach	nach	NNP
cord-015365-iqdi99pd	33	4	36	36	CD
cord-015365-iqdi99pd	33	5	-	-	SYM
cord-015365-iqdi99pd	33	6	112	112	CD
cord-015365-iqdi99pd	33	7	Tagen	Tagen	NNP
cord-015365-iqdi99pd	33	8	.	.	.
cord-015365-iqdi99pd	34	1	Die	die	VB
cord-015365-iqdi99pd	34	2	2	2	CD
cord-015365-iqdi99pd	35	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	35	2	mit	mit	NNP
cord-015365-iqdi99pd	35	3	MDS	MDS	NNP
cord-015365-iqdi99pd	35	4	wurden	wurden	NNS
cord-015365-iqdi99pd	35	5	nach	nach	NNP
cord-015365-iqdi99pd	35	6	Konditionierung	Konditionierung	NNP
cord-015365-iqdi99pd	35	7	mit	mit	NNP
cord-015365-iqdi99pd	35	8	Thiotepa	Thiotepa	NNP
cord-015365-iqdi99pd	35	9	,	,	,
cord-015365-iqdi99pd	35	10	Fludarabin	Fludarabin	NNP
cord-015365-iqdi99pd	35	11	und	und	IN
cord-015365-iqdi99pd	35	12	ATG	ATG	NNP
cord-015365-iqdi99pd	35	13	einer	einer	NNP
cord-015365-iqdi99pd	35	14	SCT	SCT	NNP
cord-015365-iqdi99pd	35	15	mit	mit	NNP
cord-015365-iqdi99pd	35	16	unverwandten	unverwandten	NNP
cord-015365-iqdi99pd	35	17	Spendern	Spendern	NNP
cord-015365-iqdi99pd	35	18	(	(	-LRB-
cord-015365-iqdi99pd	35	19	1x	1x	JJ
cord-015365-iqdi99pd	35	20	Knochenmark	Knochenmark	NNP
cord-015365-iqdi99pd	35	21	,	,	,
cord-015365-iqdi99pd	36	1	1x	1x	NNP
cord-015365-iqdi99pd	36	2	periphere	periphere	NNP
cord-015365-iqdi99pd	36	3	hochgereinigte	hochgereinigte	NNP
cord-015365-iqdi99pd	37	1	Stammzellen	Stammzellen	NNP
cord-015365-iqdi99pd	37	2	)	)	-RRB-
cord-015365-iqdi99pd	37	3	unterzogen	unterzogen	NNP
cord-015365-iqdi99pd	37	4	.	.	.
cord-015365-iqdi99pd	38	1	Nach	Nach	NNP
cord-015365-iqdi99pd	38	2	zögerlichem	zögerlichem	NNP
cord-015365-iqdi99pd	38	3	Leukozyten	Leukozyten	NNP
cord-015365-iqdi99pd	38	4	-	-	HYPH
cord-015365-iqdi99pd	38	5	Engraftment	Engraftment	NNP
cord-015365-iqdi99pd	38	6	dauerte	dauerte	NNS
cord-015365-iqdi99pd	39	1	es	es	NNP
cord-015365-iqdi99pd	39	2	1260	1260	CD
cord-015365-iqdi99pd	39	3	bzw	bzw	NNP
cord-015365-iqdi99pd	39	4	.	.	.
cord-015365-iqdi99pd	40	1	119	119	CD
cord-015365-iqdi99pd	40	2	Tage	tage	NN
cord-015365-iqdi99pd	40	3	bis	bis	NN
cord-015365-iqdi99pd	40	4	zur	zur	NNP
cord-015365-iqdi99pd	40	5	Blutbild	Blutbild	NNP
cord-015365-iqdi99pd	40	6	-	-	HYPH
cord-015365-iqdi99pd	40	7	Normalisierung	Normalisierung	NNP
cord-015365-iqdi99pd	41	1	,	,	,
cord-015365-iqdi99pd	41	2	PVB19	PVB19	NNP
cord-015365-iqdi99pd	41	3	wurde	wurde	NNP
cord-015365-iqdi99pd	41	4	in	in	IN
cord-015365-iqdi99pd	41	5	der	der	NNP
cord-015365-iqdi99pd	41	6	PCR	PCR	NNP
cord-015365-iqdi99pd	41	7	bis	bis	NN
cord-015365-iqdi99pd	41	8	zum	zum	NN
cord-015365-iqdi99pd	41	9	Tag	tag	NN
cord-015365-iqdi99pd	41	10	686	686	CD
cord-015365-iqdi99pd	41	11	bzw	bzw	NN
cord-015365-iqdi99pd	41	12	.	.	.
cord-015365-iqdi99pd	42	1	139	139	CD
cord-015365-iqdi99pd	42	2	nachgewiesen	nachgewiesen	NNP
cord-015365-iqdi99pd	42	3	.	.	.
cord-015365-iqdi99pd	43	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	43	2	.	.	.
cord-015365-iqdi99pd	44	1	Eine	Eine	NNP
cord-015365-iqdi99pd	44	2	erfolgreiche	erfolgreiche	NN
cord-015365-iqdi99pd	44	3	SCT	SCT	NNP
cord-015365-iqdi99pd	44	4	bei	bei	NNP
cord-015365-iqdi99pd	44	5	diesen	diesen	NNP
cord-015365-iqdi99pd	45	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	45	2	ist	ist	NN
cord-015365-iqdi99pd	45	3	möglich	möglich	NNP
cord-015365-iqdi99pd	45	4	,	,	,
cord-015365-iqdi99pd	45	5	sofern	sofern	NNP
cord-015365-iqdi99pd	45	6	eine	eine	NNP
cord-015365-iqdi99pd	45	7	engmaschige	engmaschige	NNP
cord-015365-iqdi99pd	45	8	Monitorisierung	Monitorisierung	NNP
cord-015365-iqdi99pd	45	9	der	der	NNP
cord-015365-iqdi99pd	45	10	PVB19-PCR	pvb19-pcr	FW
cord-015365-iqdi99pd	45	11	und	und	IN
cord-015365-iqdi99pd	46	1	eine	eine	NNP
cord-015365-iqdi99pd	46	2	konsequente	konsequente	NNP
cord-015365-iqdi99pd	46	3	repetitive	repetitive	JJ
cord-015365-iqdi99pd	46	4	IVIG	IVIG	NNP
cord-015365-iqdi99pd	46	5	-	-	HYPH
cord-015365-iqdi99pd	46	6	Therapie	Therapie	NNP
cord-015365-iqdi99pd	46	7	erfolgen	erfolgen	NN
cord-015365-iqdi99pd	46	8	.	.	.
cord-015365-iqdi99pd	47	1	Der	Der	NNP
cord-015365-iqdi99pd	47	2	Transplantationsverlauf	Transplantationsverlauf	NNP
cord-015365-iqdi99pd	47	3	kann	kann	NNP
cord-015365-iqdi99pd	47	4	durch	durch	NNP
cord-015365-iqdi99pd	47	5	ein	ein	FW
cord-015365-iqdi99pd	47	6	zögerliches	zögerliches	NNP
cord-015365-iqdi99pd	47	7	Engraftment	Engraftment	NNP
cord-015365-iqdi99pd	47	8	und	und	XX
cord-015365-iqdi99pd	48	1	eine	eine	NNP
cord-015365-iqdi99pd	48	2	prolongierte	prolongierte	NNP
cord-015365-iqdi99pd	48	3	"	"	``
cord-015365-iqdi99pd	48	4	poor	poor	JJ
cord-015365-iqdi99pd	48	5	graft	graft	NN
cord-015365-iqdi99pd	48	6	function	function	NN
cord-015365-iqdi99pd	48	7	"	"	``
cord-015365-iqdi99pd	48	8	kompliziert	kompliziert	NNP
cord-015365-iqdi99pd	48	9	werden	werden	NNP
cord-015365-iqdi99pd	48	10	.	.	.
cord-015365-iqdi99pd	49	1	Retrospective	retrospective	JJ
cord-015365-iqdi99pd	49	2	study	study	NN
cord-015365-iqdi99pd	49	3	to	to	TO
cord-015365-iqdi99pd	49	4	test	test	VB
cord-015365-iqdi99pd	49	5	ferritin	ferritin	NN
cord-015365-iqdi99pd	49	6	serum	serum	NN
cord-015365-iqdi99pd	49	7	levels	level	NNS
cord-015365-iqdi99pd	49	8	as	as	IN
cord-015365-iqdi99pd	49	9	biomarker	biomarker	NN
cord-015365-iqdi99pd	49	10	for	for	IN
cord-015365-iqdi99pd	49	11	graft	graft	NN
cord-015365-iqdi99pd	49	12	-	-	HYPH
cord-015365-iqdi99pd	49	13	versus	versus	IN
cord-015365-iqdi99pd	49	14	-	-	HYPH
cord-015365-iqdi99pd	49	15	host	host	NN
cord-015365-iqdi99pd	49	16	disease	disease	NN
cord-015365-iqdi99pd	49	17	-	-	HYPH
cord-015365-iqdi99pd	49	18	associated	associate	VBN
cord-015365-iqdi99pd	49	19	non	non	JJ
cord-015365-iqdi99pd	49	20	-	-	JJ
cord-015365-iqdi99pd	49	21	infectious	infectious	JJ
cord-015365-iqdi99pd	49	22	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	49	23	reaction	reaction	NN
cord-015365-iqdi99pd	49	24	in	in	IN
cord-015365-iqdi99pd	49	25	117	117	CD
cord-015365-iqdi99pd	49	26	children	child	NNS
cord-015365-iqdi99pd	49	27	after	after	IN
cord-015365-iqdi99pd	49	28	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	49	29	stem	stem	NN
cord-015365-iqdi99pd	49	30	cell	cell	NN
cord-015365-iqdi99pd	49	31	transplantation	transplantation	NN
cord-015365-iqdi99pd	49	32	Background	Background	NNP
cord-015365-iqdi99pd	49	33	.	.	.
cord-015365-iqdi99pd	50	1	Myelodysplastic	myelodysplastic	JJ
cord-015365-iqdi99pd	50	2	syndromes	syndrome	NNS
cord-015365-iqdi99pd	50	3	(	(	-LRB-
cord-015365-iqdi99pd	50	4	MDS	MDS	NNP
cord-015365-iqdi99pd	50	5	)	)	-RRB-
cord-015365-iqdi99pd	50	6	are	be	VBP
cord-015365-iqdi99pd	50	7	a	a	DT
cord-015365-iqdi99pd	50	8	heterogeneous	heterogeneous	JJ
cord-015365-iqdi99pd	50	9	group	group	NN
cord-015365-iqdi99pd	50	10	of	of	IN
cord-015365-iqdi99pd	50	11	stem	stem	NN
cord-015365-iqdi99pd	50	12	cell	cell	NN
cord-015365-iqdi99pd	50	13	disorders	disorder	NNS
cord-015365-iqdi99pd	50	14	characterized	characterize	VBN
cord-015365-iqdi99pd	50	15	by	by	IN
cord-015365-iqdi99pd	50	16	bone	bone	NN
cord-015365-iqdi99pd	50	17	marrow	marrow	NN
cord-015365-iqdi99pd	50	18	dysplasia	dysplasia	NN
cord-015365-iqdi99pd	50	19	,	,	,
cord-015365-iqdi99pd	50	20	peripheral	peripheral	JJ
cord-015365-iqdi99pd	50	21	cytopenia	cytopenia	NNS
cord-015365-iqdi99pd	50	22	,	,	,
cord-015365-iqdi99pd	50	23	and	and	CC
cord-015365-iqdi99pd	50	24	an	an	DT
cord-015365-iqdi99pd	50	25	enhanced	enhanced	JJ
cord-015365-iqdi99pd	50	26	risk	risk	NN
cord-015365-iqdi99pd	50	27	to	to	TO
cord-015365-iqdi99pd	50	28	transform	transform	VB
cord-015365-iqdi99pd	50	29	to	to	IN
cord-015365-iqdi99pd	50	30	acute	acute	JJ
cord-015365-iqdi99pd	50	31	myeloid	myeloid	NN
cord-015365-iqdi99pd	50	32	leukemia	leukemia	NN
cord-015365-iqdi99pd	50	33	(	(	-LRB-
cord-015365-iqdi99pd	50	34	AML	AML	NNP
cord-015365-iqdi99pd	50	35	)	)	-RRB-
cord-015365-iqdi99pd	50	36	.	.	.
cord-015365-iqdi99pd	51	1	In	in	IN
cord-015365-iqdi99pd	51	2	most	most	JJS
cord-015365-iqdi99pd	51	3	patients	patient	NNS
cord-015365-iqdi99pd	51	4	,	,	,
cord-015365-iqdi99pd	51	5	treatment	treatment	NN
cord-015365-iqdi99pd	51	6	options	option	NNS
cord-015365-iqdi99pd	51	7	are	be	VBP
cord-015365-iqdi99pd	51	8	limited	limit	VBN
cord-015365-iqdi99pd	51	9	to	to	IN
cord-015365-iqdi99pd	51	10	supportive	supportive	JJ
cord-015365-iqdi99pd	51	11	care	care	NN
cord-015365-iqdi99pd	51	12	and	and	CC
cord-015365-iqdi99pd	51	13	palliative	palliative	JJ
cord-015365-iqdi99pd	51	14	cytoreduction	cytoreduction	NN
cord-015365-iqdi99pd	51	15	.	.	.
cord-015365-iqdi99pd	52	1	However	however	RB
cord-015365-iqdi99pd	52	2	,	,	,
cord-015365-iqdi99pd	52	3	in	in	IN
cord-015365-iqdi99pd	52	4	a	a	DT
cord-015365-iqdi99pd	52	5	group	group	NN
cord-015365-iqdi99pd	52	6	of	of	IN
cord-015365-iqdi99pd	52	7	patients	patient	NNS
cord-015365-iqdi99pd	52	8	,	,	,
cord-015365-iqdi99pd	52	9	intensive	intensive	JJ
cord-015365-iqdi99pd	52	10	therapy	therapy	NN
cord-015365-iqdi99pd	52	11	can	can	MD
cord-015365-iqdi99pd	52	12	be	be	VB
cord-015365-iqdi99pd	52	13	offered	offer	VBN
cord-015365-iqdi99pd	52	14	.	.	.
cord-015365-iqdi99pd	53	1	The	the	DT
cord-015365-iqdi99pd	53	2	only	only	RB
cord-015365-iqdi99pd	53	3	established	establish	VBN
cord-015365-iqdi99pd	53	4	curative	curative	JJ
cord-015365-iqdi99pd	53	5	treatment	treatment	NN
cord-015365-iqdi99pd	53	6	approach	approach	NN
cord-015365-iqdi99pd	53	7	for	for	IN
cord-015365-iqdi99pd	53	8	these	these	DT
cord-015365-iqdi99pd	53	9	patients	patient	NNS
cord-015365-iqdi99pd	53	10	is	be	VBZ
cord-015365-iqdi99pd	53	11	haematopoietic	haematopoietic	JJ
cord-015365-iqdi99pd	53	12	stem	stem	NN
cord-015365-iqdi99pd	53	13	cell	cell	NN
cord-015365-iqdi99pd	53	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	53	15	(	(	-LRB-
cord-015365-iqdi99pd	53	16	SCT	SCT	NNP
cord-015365-iqdi99pd	53	17	)	)	-RRB-
cord-015365-iqdi99pd	53	18	.	.	.
cord-015365-iqdi99pd	54	1	Methods	method	NNS
cord-015365-iqdi99pd	54	2	.	.	.
cord-015365-iqdi99pd	55	1	In	in	IN
cord-015365-iqdi99pd	55	2	the	the	DT
cord-015365-iqdi99pd	55	3	present	present	JJ
cord-015365-iqdi99pd	55	4	study	study	NN
cord-015365-iqdi99pd	55	5	,	,	,
cord-015365-iqdi99pd	55	6	we	-PRON-	PRP
cord-015365-iqdi99pd	55	7	retrospectively	retrospectively	RB
cord-015365-iqdi99pd	55	8	analyzed	analyze	VBD
cord-015365-iqdi99pd	55	9	a	a	DT
cord-015365-iqdi99pd	55	10	cohort	cohort	NN
cord-015365-iqdi99pd	55	11	of	of	IN
cord-015365-iqdi99pd	55	12	60	60	CD
cord-015365-iqdi99pd	55	13	adult	adult	NN
cord-015365-iqdi99pd	55	14	patients	patient	NNS
cord-015365-iqdi99pd	55	15	(	(	-LRB-
cord-015365-iqdi99pd	55	16	33	33	CD
cord-015365-iqdi99pd	55	17	males	male	NNS
cord-015365-iqdi99pd	55	18	,	,	,
cord-015365-iqdi99pd	55	19	27	27	CD
cord-015365-iqdi99pd	55	20	females	female	NNS
cord-015365-iqdi99pd	55	21	)	)	-RRB-
cord-015365-iqdi99pd	55	22	with	with	IN
cord-015365-iqdi99pd	55	23	MDS	MDS	NNP
cord-015365-iqdi99pd	55	24	(	(	-LRB-
cord-015365-iqdi99pd	55	25	n	n	NN
cord-015365-iqdi99pd	55	26	¼	¼	NNP
cord-015365-iqdi99pd	55	27	28	28	CD
cord-015365-iqdi99pd	55	28	)	)	-RRB-
cord-015365-iqdi99pd	55	29	or	or	CC
cord-015365-iqdi99pd	55	30	MDS	MDS	NNP
cord-015365-iqdi99pd	55	31	transforming	transform	VBG
cord-015365-iqdi99pd	55	32	into	into	IN
cord-015365-iqdi99pd	55	33	secondary	secondary	JJ
cord-015365-iqdi99pd	55	34	AML	AML	NNP
cord-015365-iqdi99pd	55	35	(	(	-LRB-
cord-015365-iqdi99pd	55	36	n	n	NN
cord-015365-iqdi99pd	55	37	¼	¼	NNP
cord-015365-iqdi99pd	55	38	33	33	CD
cord-015365-iqdi99pd	55	39	)	)	-RRB-
cord-015365-iqdi99pd	55	40	,	,	,
cord-015365-iqdi99pd	55	41	who	who	WP
cord-015365-iqdi99pd	55	42	underwent	undergo	VBD
cord-015365-iqdi99pd	55	43	SCT	SCT	NNP
cord-015365-iqdi99pd	55	44	at	at	IN
cord-015365-iqdi99pd	55	45	our	-PRON-	PRP$
cord-015365-iqdi99pd	55	46	institution	institution	NN
cord-015365-iqdi99pd	55	47	between	between	IN
cord-015365-iqdi99pd	55	48	1988	1988	CD
cord-015365-iqdi99pd	55	49	and	and	CC
cord-015365-iqdi99pd	55	50	2010	2010	CD
cord-015365-iqdi99pd	55	51	.	.	.
cord-015365-iqdi99pd	56	1	Fifty	fifty	CD
cord-015365-iqdi99pd	56	2	-	-	HYPH
cord-015365-iqdi99pd	56	3	one	one	CD
cord-015365-iqdi99pd	56	4	patients	patient	NNS
cord-015365-iqdi99pd	56	5	had	have	VBD
cord-015365-iqdi99pd	56	6	an	an	DT
cord-015365-iqdi99pd	56	7	HLA	HLA	NNP
cord-015365-iqdi99pd	56	8	-	-	HYPH
cord-015365-iqdi99pd	56	9	identical	identical	JJ
cord-015365-iqdi99pd	56	10	related	related	JJ
cord-015365-iqdi99pd	56	11	transplant	transplant	NN
cord-015365-iqdi99pd	56	12	donor	donor	NN
cord-015365-iqdi99pd	56	13	,	,	,
cord-015365-iqdi99pd	56	14	and	and	CC
cord-015365-iqdi99pd	56	15	9	9	CD
cord-015365-iqdi99pd	56	16	had	have	VBD
cord-015365-iqdi99pd	56	17	an	an	DT
cord-015365-iqdi99pd	56	18	HLA	HLA	NNP
cord-015365-iqdi99pd	56	19	-	-	HYPH
cord-015365-iqdi99pd	56	20	matched	match	VBN
cord-015365-iqdi99pd	56	21	unrelated	unrelated	JJ
cord-015365-iqdi99pd	56	22	donor	donor	NN
cord-015365-iqdi99pd	56	23	.	.	.
cord-015365-iqdi99pd	57	1	The	the	DT
cord-015365-iqdi99pd	57	2	median	median	JJ
cord-015365-iqdi99pd	57	3	age	age	NN
cord-015365-iqdi99pd	57	4	at	at	IN
cord-015365-iqdi99pd	57	5	time	time	NN
cord-015365-iqdi99pd	57	6	of	of	IN
cord-015365-iqdi99pd	57	7	SCT	SCT	NNP
cord-015365-iqdi99pd	57	8	was	be	VBD
cord-015365-iqdi99pd	57	9	44	44	CD
cord-015365-iqdi99pd	57	10	years	year	NNS
cord-015365-iqdi99pd	58	1	(	(	-LRB-
cord-015365-iqdi99pd	58	2	range	range	NN
cord-015365-iqdi99pd	58	3	:	:	:
cord-015365-iqdi99pd	58	4	18	18	CD
cord-015365-iqdi99pd	58	5	to	to	TO
cord-015365-iqdi99pd	58	6	68	68	CD
cord-015365-iqdi99pd	58	7	years	year	NNS
cord-015365-iqdi99pd	58	8	)	)	-RRB-
cord-015365-iqdi99pd	58	9	.	.	.
cord-015365-iqdi99pd	59	1	According	accord	VBG
cord-015365-iqdi99pd	59	2	to	to	IN
cord-015365-iqdi99pd	59	3	the	the	DT
cord-015365-iqdi99pd	59	4	WHO	who	WP
cord-015365-iqdi99pd	59	5	classification	classification	NN
cord-015365-iqdi99pd	59	6	,	,	,
cord-015365-iqdi99pd	59	7	4	4	CD
cord-015365-iqdi99pd	59	8	patients	patient	NNS
cord-015365-iqdi99pd	59	9	had	have	VBD
cord-015365-iqdi99pd	59	10	RA	RA	NNP
cord-015365-iqdi99pd	59	11	,	,	,
cord-015365-iqdi99pd	59	12	1	1	CD
cord-015365-iqdi99pd	59	13	RARS	rar	NNS
cord-015365-iqdi99pd	59	14	,	,	,
cord-015365-iqdi99pd	59	15	3	3	CD
cord-015365-iqdi99pd	59	16	RCMD	RCMD	NNS
cord-015365-iqdi99pd	59	17	,	,	,
cord-015365-iqdi99pd	59	18	1	1	CD
cord-015365-iqdi99pd	59	19	RCMD	rcmd	NN
cord-015365-iqdi99pd	59	20	-	-	HYPH
cord-015365-iqdi99pd	59	21	RS	RS	NNP
cord-015365-iqdi99pd	59	22	,	,	,
cord-015365-iqdi99pd	59	23	6	6	CD
cord-015365-iqdi99pd	59	24	RAEB-1	RAEB-1	NNP
cord-015365-iqdi99pd	59	25	,	,	,
cord-015365-iqdi99pd	59	26	12	12	CD
cord-015365-iqdi99pd	59	27	RAEB-2	RAEB-2	NNS
cord-015365-iqdi99pd	59	28	,	,	,
cord-015365-iqdi99pd	59	29	1	1	CD
cord-015365-iqdi99pd	59	30	CMML	CMML	NNP
cord-015365-iqdi99pd	59	31	,	,	,
cord-015365-iqdi99pd	59	32	and	and	CC
cord-015365-iqdi99pd	59	33	32	32	CD
cord-015365-iqdi99pd	59	34	had	have	VBD
cord-015365-iqdi99pd	59	35	AML	AML	NNP
cord-015365-iqdi99pd	59	36	following	follow	VBG
cord-015365-iqdi99pd	59	37	RAEB	RAEB	NNP
cord-015365-iqdi99pd	59	38	at	at	IN
cord-015365-iqdi99pd	59	39	SCT	SCT	NNP
cord-015365-iqdi99pd	59	40	.	.	.
cord-015365-iqdi99pd	60	1	Conditioning	conditioning	NN
cord-015365-iqdi99pd	60	2	consisted	consist	VBD
cord-015365-iqdi99pd	60	3	of	of	IN
cord-015365-iqdi99pd	60	4	chemotherapy	chemotherapy	NN
cord-015365-iqdi99pd	60	5	plus	plus	CC
cord-015365-iqdi99pd	60	6	total	total	JJ
cord-015365-iqdi99pd	60	7	body	body	NN
cord-015365-iqdi99pd	60	8	irradiation	irradiation	NN
cord-015365-iqdi99pd	60	9	(	(	-LRB-
cord-015365-iqdi99pd	60	10	55/60	55/60	CD
cord-015365-iqdi99pd	60	11	patients	patient	NNS
cord-015365-iqdi99pd	60	12	)	)	-RRB-
cord-015365-iqdi99pd	60	13	or	or	CC
cord-015365-iqdi99pd	60	14	chemotherapy	chemotherapy	NN
cord-015365-iqdi99pd	60	15	alone	alone	JJ
cord-015365-iqdi99pd	60	16	(	(	-LRB-
cord-015365-iqdi99pd	60	17	5/60	5/60	CD
cord-015365-iqdi99pd	60	18	patients	patient	NNS
cord-015365-iqdi99pd	60	19	)	)	-RRB-
cord-015365-iqdi99pd	60	20	.	.	.
cord-015365-iqdi99pd	61	1	Graft	graft	NN
cord-015365-iqdi99pd	61	2	versus	versus	IN
cord-015365-iqdi99pd	61	3	host	host	NN
cord-015365-iqdi99pd	61	4	disease	disease	NN
cord-015365-iqdi99pd	61	5	(	(	-LRB-
cord-015365-iqdi99pd	61	6	GvHD	GvHD	NNP
cord-015365-iqdi99pd	61	7	)	)	-RRB-
cord-015365-iqdi99pd	61	8	prophylaxis	prophylaxis	NN
cord-015365-iqdi99pd	61	9	consisted	consist	VBD
cord-015365-iqdi99pd	61	10	of	of	IN
cord-015365-iqdi99pd	61	11	a	a	DT
cord-015365-iqdi99pd	61	12	combination	combination	NN
cord-015365-iqdi99pd	61	13	of	of	IN
cord-015365-iqdi99pd	61	14	low	low	JJ
cord-015365-iqdi99pd	61	15	-	-	HYPH
cord-015365-iqdi99pd	61	16	dose	dose	NN
cord-015365-iqdi99pd	61	17	methotrexate	methotrexate	NNP
cord-015365-iqdi99pd	61	18	and	and	CC
cord-015365-iqdi99pd	61	19	cyclosporine	cyclosporine	NNP
cord-015365-iqdi99pd	61	20	A	A	NNP
cord-015365-iqdi99pd	61	21	(	(	-LRB-
cord-015365-iqdi99pd	61	22	37/60	37/60	CD
cord-015365-iqdi99pd	61	23	patients	patient	NNS
cord-015365-iqdi99pd	61	24	)	)	-RRB-
cord-015365-iqdi99pd	61	25	or	or	CC
cord-015365-iqdi99pd	61	26	cyclosporine	cyclosporine	NNP
cord-015365-iqdi99pd	61	27	A	A	NNP
cord-015365-iqdi99pd	61	28	plus	plus	CC
cord-015365-iqdi99pd	61	29	mycophenolat	mycophenolat	NNP
cord-015365-iqdi99pd	61	30	mofetil	mofetil	NNP
cord-015365-iqdi99pd	61	31	(	(	-LRB-
cord-015365-iqdi99pd	61	32	23/60	23/60	CD
cord-015365-iqdi99pd	61	33	patients	patient	NNS
cord-015365-iqdi99pd	61	34	)	)	-RRB-
cord-015365-iqdi99pd	61	35	.	.	.
cord-015365-iqdi99pd	62	1	Results	result	NNS
cord-015365-iqdi99pd	62	2	.	.	.
cord-015365-iqdi99pd	63	1	Patients	patient	NNS
cord-015365-iqdi99pd	63	2	were	be	VBD
cord-015365-iqdi99pd	63	3	followed	follow	VBN
cord-015365-iqdi99pd	63	4	up	up	RP
cord-015365-iqdi99pd	63	5	with	with	IN
cord-015365-iqdi99pd	63	6	a	a	DT
cord-015365-iqdi99pd	63	7	median	median	JJ
cord-015365-iqdi99pd	63	8	observation	observation	NN
cord-015365-iqdi99pd	63	9	time	time	NN
cord-015365-iqdi99pd	63	10	of	of	IN
cord-015365-iqdi99pd	63	11	16	16	CD
cord-015365-iqdi99pd	63	12	months	month	NNS
cord-015365-iqdi99pd	63	13	(	(	-LRB-
cord-015365-iqdi99pd	63	14	range	range	NN
cord-015365-iqdi99pd	63	15	:	:	:
cord-015365-iqdi99pd	63	16	1	1	CD
cord-015365-iqdi99pd	63	17	-	-	SYM
cord-015365-iqdi99pd	63	18	218	218	CD
cord-015365-iqdi99pd	63	19	)	)	-RRB-
cord-015365-iqdi99pd	63	20	.	.	.
cord-015365-iqdi99pd	64	1	Currently	currently	RB
cord-015365-iqdi99pd	64	2	,	,	,
cord-015365-iqdi99pd	64	3	34	34	CD
cord-015365-iqdi99pd	64	4	patients	patient	NNS
cord-015365-iqdi99pd	64	5	(	(	-LRB-
cord-015365-iqdi99pd	64	6	57	57	CD
cord-015365-iqdi99pd	64	7	%	%	NN
cord-015365-iqdi99pd	64	8	)	)	-RRB-
cord-015365-iqdi99pd	64	9	are	be	VBP
cord-015365-iqdi99pd	64	10	alive	alive	JJ
cord-015365-iqdi99pd	64	11	.	.	.
cord-015365-iqdi99pd	65	1	Of	of	IN
cord-015365-iqdi99pd	65	2	the	the	DT
cord-015365-iqdi99pd	65	3	26	26	CD
cord-015365-iqdi99pd	65	4	patients	patient	NNS
cord-015365-iqdi99pd	65	5	who	who	WP
cord-015365-iqdi99pd	65	6	died	die	VBD
cord-015365-iqdi99pd	65	7	,	,	,
cord-015365-iqdi99pd	65	8	post	post	JJ
cord-015365-iqdi99pd	65	9	-	-	NN
cord-015365-iqdi99pd	65	10	transplantation	transplantation	JJ
cord-015365-iqdi99pd	65	11	relapse	relapse	NN
cord-015365-iqdi99pd	65	12	occurred	occur	VBD
cord-015365-iqdi99pd	65	13	in	in	IN
cord-015365-iqdi99pd	65	14	12	12	CD
cord-015365-iqdi99pd	65	15	patients	patient	NNS
cord-015365-iqdi99pd	65	16	,	,	,
cord-015365-iqdi99pd	65	17	and	and	CC
cord-015365-iqdi99pd	65	18	14	14	CD
cord-015365-iqdi99pd	65	19	patients	patient	NNS
cord-015365-iqdi99pd	65	20	died	die	VBD
cord-015365-iqdi99pd	65	21	of	of	IN
cord-015365-iqdi99pd	65	22	treatment	treatment	NN
cord-015365-iqdi99pd	65	23	-	-	HYPH
cord-015365-iqdi99pd	65	24	related	relate	VBN
cord-015365-iqdi99pd	65	25	causes	cause	NNS
cord-015365-iqdi99pd	65	26	(	(	-LRB-
cord-015365-iqdi99pd	65	27	multi	multi	JJ
cord-015365-iqdi99pd	65	28	-	-	JJ
cord-015365-iqdi99pd	65	29	organ	organ	JJ
cord-015365-iqdi99pd	65	30	failure	failure	NN
cord-015365-iqdi99pd	65	31	,	,	,
cord-015365-iqdi99pd	65	32	n	n	NN
cord-015365-iqdi99pd	65	33	¼	¼	NNP
cord-015365-iqdi99pd	65	34	7	7	CD
cord-015365-iqdi99pd	65	35	;	;	:
cord-015365-iqdi99pd	65	36	sepsis	sepsis	NN
cord-015365-iqdi99pd	65	37	,	,	,
cord-015365-iqdi99pd	65	38	n	n	NN
cord-015365-iqdi99pd	65	39	¼	¼	NNP
cord-015365-iqdi99pd	65	40	4	4	CD
cord-015365-iqdi99pd	65	41	;	;	:
cord-015365-iqdi99pd	65	42	haemorrhage	haemorrhage	NN
cord-015365-iqdi99pd	65	43	,	,	,
cord-015365-iqdi99pd	65	44	n	n	NN
cord-015365-iqdi99pd	65	45	¼	¼	NNP
cord-015365-iqdi99pd	65	46	3	3	CD
cord-015365-iqdi99pd	65	47	)	)	-RRB-
cord-015365-iqdi99pd	65	48	.	.	.
cord-015365-iqdi99pd	66	1	In	in	IN
cord-015365-iqdi99pd	66	2	multivariate	multivariate	JJ
cord-015365-iqdi99pd	66	3	analysis	analysis	NN
cord-015365-iqdi99pd	66	4	we	-PRON-	PRP
cord-015365-iqdi99pd	66	5	identified	identify	VBD
cord-015365-iqdi99pd	66	6	pre	pre	JJ
cord-015365-iqdi99pd	66	7	-	-	JJ
cord-015365-iqdi99pd	66	8	transplantation	transplantation	JJ
cord-015365-iqdi99pd	66	9	ferritin	ferritin	NN
cord-015365-iqdi99pd	66	10	as	as	IN
cord-015365-iqdi99pd	66	11	a	a	DT
cord-015365-iqdi99pd	66	12	significant	significant	JJ
cord-015365-iqdi99pd	66	13	adverse	adverse	JJ
cord-015365-iqdi99pd	66	14	prognostic	prognostic	JJ
cord-015365-iqdi99pd	66	15	variable	variable	NN
cord-015365-iqdi99pd	66	16	for	for	IN
cord-015365-iqdi99pd	66	17	survival	survival	NN
cord-015365-iqdi99pd	66	18	in	in	IN
cord-015365-iqdi99pd	66	19	our	-PRON-	PRP$
cord-015365-iqdi99pd	66	20	MDS	MDS	NNP
cord-015365-iqdi99pd	66	21	patients	patient	NNS
cord-015365-iqdi99pd	66	22	.	.	.
cord-015365-iqdi99pd	67	1	In	in	IN
cord-015365-iqdi99pd	67	2	contrast	contrast	NN
cord-015365-iqdi99pd	67	3	,	,	,
cord-015365-iqdi99pd	67	4	the	the	DT
cord-015365-iqdi99pd	67	5	overall	overall	JJ
cord-015365-iqdi99pd	67	6	outcome	outcome	NN
cord-015365-iqdi99pd	67	7	after	after	IN
cord-015365-iqdi99pd	67	8	SCT	SCT	NNP
cord-015365-iqdi99pd	67	9	was	be	VBD
cord-015365-iqdi99pd	67	10	independent	independent	JJ
cord-015365-iqdi99pd	67	11	of	of	IN
cord-015365-iqdi99pd	67	12	IPSS	IPSS	NNP
cord-015365-iqdi99pd	67	13	risk	risk	NN
cord-015365-iqdi99pd	67	14	categories	category	NNS
cord-015365-iqdi99pd	67	15	or	or	CC
cord-015365-iqdi99pd	67	16	the	the	DT
cord-015365-iqdi99pd	67	17	WHO	who	WP
cord-015365-iqdi99pd	67	18	classification	classification	NN
cord-015365-iqdi99pd	67	19	.	.	.
cord-015365-iqdi99pd	68	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	68	2	.	.	.
cord-015365-iqdi99pd	69	1	Based	base	VBN
cord-015365-iqdi99pd	69	2	on	on	IN
cord-015365-iqdi99pd	69	3	these	these	DT
cord-015365-iqdi99pd	69	4	data	datum	NNS
cord-015365-iqdi99pd	69	5	and	and	CC
cord-015365-iqdi99pd	69	6	similar	similar	JJ
cord-015365-iqdi99pd	69	7	published	publish	VBN
cord-015365-iqdi99pd	69	8	data	datum	NNS
cord-015365-iqdi99pd	69	9	we	-PRON-	PRP
cord-015365-iqdi99pd	69	10	recommend	recommend	VBP
cord-015365-iqdi99pd	69	11	to	to	TO
cord-015365-iqdi99pd	69	12	select	select	VB
cord-015365-iqdi99pd	69	13	patients	patient	NNS
cord-015365-iqdi99pd	69	14	with	with	IN
cord-015365-iqdi99pd	69	15	MDS	MDS	NNP
cord-015365-iqdi99pd	69	16	or	or	CC
cord-015365-iqdi99pd	69	17	sAML	saml	NN
cord-015365-iqdi99pd	69	18	for	for	IN
cord-015365-iqdi99pd	69	19	SCT	SCT	NNP
cord-015365-iqdi99pd	69	20	who	who	WP
cord-015365-iqdi99pd	69	21	are	be	VBP
cord-015365-iqdi99pd	69	22	considered	consider	VBN
cord-015365-iqdi99pd	69	23	candidates	candidate	NNS
cord-015365-iqdi99pd	69	24	for	for	IN
cord-015365-iqdi99pd	69	25	SCT	SCT	NNP
cord-015365-iqdi99pd	69	26	according	accord	VBG
cord-015365-iqdi99pd	69	27	to	to	IN
cord-015365-iqdi99pd	69	28	the	the	DT
cord-015365-iqdi99pd	69	29	presence	presence	NN
cord-015365-iqdi99pd	69	30	of	of	IN
cord-015365-iqdi99pd	69	31	pre	pre	JJ
cord-015365-iqdi99pd	69	32	-	-	JJ
cord-015365-iqdi99pd	69	33	transplantation	transplantation	JJ
cord-015365-iqdi99pd	69	34	iron	iron	NN
cord-015365-iqdi99pd	69	35	-	-	HYPH
cord-015365-iqdi99pd	69	36	overload	overload	NN
cord-015365-iqdi99pd	69	37	.	.	.
cord-015365-iqdi99pd	70	1	Significantly	significantly	RB
cord-015365-iqdi99pd	70	2	worse	bad	JJR
cord-015365-iqdi99pd	70	3	survival	survival	NN
cord-015365-iqdi99pd	70	4	of	of	IN
cord-015365-iqdi99pd	70	5	patients	patient	NNS
cord-015365-iqdi99pd	70	6	with	with	IN
cord-015365-iqdi99pd	70	7	chronic	chronic	JJ
cord-015365-iqdi99pd	70	8	graft	graft	NN
cord-015365-iqdi99pd	70	9	-	-	HYPH
cord-015365-iqdi99pd	70	10	versus	versus	IN
cord-015365-iqdi99pd	70	11	-	-	HYPH
cord-015365-iqdi99pd	70	12	host	host	NN
cord-015365-iqdi99pd	70	13	disease	disease	NN
cord-015365-iqdi99pd	70	14	(	(	-LRB-
cord-015365-iqdi99pd	70	15	cGVHD	cGVHD	NNP
cord-015365-iqdi99pd	70	16	)	)	-RRB-
cord-015365-iqdi99pd	70	17	defined	define	VBN
cord-015365-iqdi99pd	70	18	according	accord	VBG
cord-015365-iqdi99pd	70	19	to	to	IN
cord-015365-iqdi99pd	70	20	the	the	DT
cord-015365-iqdi99pd	70	21	National	National	NNP
cord-015365-iqdi99pd	70	22	Institutes	Institutes	NNPS
cord-015365-iqdi99pd	70	23	of	of	IN
cord-015365-iqdi99pd	70	24	Health	Health	NNP
cord-015365-iqdi99pd	70	25	(	(	-LRB-
cord-015365-iqdi99pd	70	26	NIH	NIH	NNP
cord-015365-iqdi99pd	70	27	)	)	-RRB-
cord-015365-iqdi99pd	70	28	consensus	consensus	NN
cord-015365-iqdi99pd	70	29	criteria	criterion	NNS
cord-015365-iqdi99pd	70	30	and	and	CC
cord-015365-iqdi99pd	70	31	thrombocytopenia	thrombocytopenia	NN
cord-015365-iqdi99pd	70	32	data	datum	NNS
cord-015365-iqdi99pd	70	33	and	and	CC
cord-015365-iqdi99pd	70	34	expert	expert	JJ
cord-015365-iqdi99pd	70	35	opinion	opinion	NN
cord-015365-iqdi99pd	70	36	.	.	.
cord-015365-iqdi99pd	71	1	For	for	IN
cord-015365-iqdi99pd	71	2	both	both	DT
cord-015365-iqdi99pd	71	3	acute	acute	JJ
cord-015365-iqdi99pd	71	4	as	as	RB
cord-015365-iqdi99pd	71	5	well	well	RB
cord-015365-iqdi99pd	71	6	as	as	IN
cord-015365-iqdi99pd	71	7	cGVHD	cgvhd	JJ
cord-015365-iqdi99pd	71	8	new	new	JJ
cord-015365-iqdi99pd	71	9	definitions	definition	NNS
cord-015365-iqdi99pd	71	10	were	be	VBD
cord-015365-iqdi99pd	71	11	proposed	propose	VBN
cord-015365-iqdi99pd	71	12	.	.	.
cord-015365-iqdi99pd	72	1	We	-PRON-	PRP
cord-015365-iqdi99pd	72	2	performed	perform	VBD
cord-015365-iqdi99pd	72	3	a	a	DT
cord-015365-iqdi99pd	72	4	prospective	prospective	JJ
cord-015365-iqdi99pd	72	5	study	study	NN
cord-015365-iqdi99pd	72	6	on	on	IN
cord-015365-iqdi99pd	72	7	all	all	DT
cord-015365-iqdi99pd	72	8	consecutive	consecutive	JJ
cord-015365-iqdi99pd	72	9	patients	patient	NNS
cord-015365-iqdi99pd	72	10	undergoing	undergo	VBG
cord-015365-iqdi99pd	72	11	allogeneic	allogeneic	IN
cord-015365-iqdi99pd	72	12	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	72	13	stem	stem	NN
cord-015365-iqdi99pd	72	14	cell	cell	NN
cord-015365-iqdi99pd	72	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	72	16	(	(	-LRB-
cord-015365-iqdi99pd	72	17	HCT	HCT	NNP
cord-015365-iqdi99pd	72	18	)	)	-RRB-
cord-015365-iqdi99pd	72	19	since	since	IN
cord-015365-iqdi99pd	72	20	2005	2005	CD
cord-015365-iqdi99pd	72	21	to	to	TO
cord-015365-iqdi99pd	72	22	assess	assess	VB
cord-015365-iqdi99pd	72	23	the	the	DT
cord-015365-iqdi99pd	72	24	prognostic	prognostic	JJ
cord-015365-iqdi99pd	72	25	impact	impact	NN
cord-015365-iqdi99pd	72	26	of	of	IN
cord-015365-iqdi99pd	72	27	the	the	DT
cord-015365-iqdi99pd	72	28	new	new	JJ
cord-015365-iqdi99pd	72	29	cGVHD	cgvhd	NN
cord-015365-iqdi99pd	72	30	staging	stage	VBG
cord-015365-iqdi99pd	72	31	criteria	criterion	NNS
cord-015365-iqdi99pd	72	32	.	.	.
cord-015365-iqdi99pd	73	1	Methods	method	NNS
cord-015365-iqdi99pd	73	2	.	.	.
cord-015365-iqdi99pd	74	1	One	one	CD
cord-015365-iqdi99pd	74	2	hundred	hundred	CD
cord-015365-iqdi99pd	74	3	seventy	seventy	CD
cord-015365-iqdi99pd	74	4	-	-	HYPH
cord-015365-iqdi99pd	74	5	eight	eight	CD
cord-015365-iqdi99pd	74	6	patients	patient	NNS
cord-015365-iqdi99pd	74	7	(	(	-LRB-
cord-015365-iqdi99pd	74	8	85	85	CD
cord-015365-iqdi99pd	74	9	males	male	NNS
cord-015365-iqdi99pd	74	10	,	,	,
cord-015365-iqdi99pd	74	11	93	93	CD
cord-015365-iqdi99pd	74	12	females	female	NNS
cord-015365-iqdi99pd	74	13	)	)	-RRB-
cord-015365-iqdi99pd	74	14	with	with	IN
cord-015365-iqdi99pd	74	15	a	a	DT
cord-015365-iqdi99pd	74	16	median	median	JJ
cord-015365-iqdi99pd	74	17	age	age	NN
cord-015365-iqdi99pd	74	18	of	of	IN
cord-015365-iqdi99pd	74	19	40	40	CD
cord-015365-iqdi99pd	74	20	years	year	NNS
cord-015365-iqdi99pd	74	21	alive	alive	JJ
cord-015365-iqdi99pd	74	22	on	on	IN
cord-015365-iqdi99pd	74	23	day	day	NN
cord-015365-iqdi99pd	74	24	þ	þ	NNP
cord-015365-iqdi99pd	74	25	100	100	CD
cord-015365-iqdi99pd	74	26	after	after	IN
cord-015365-iqdi99pd	74	27	HCT	HCT	NNP
cord-015365-iqdi99pd	74	28	with	with	IN
cord-015365-iqdi99pd	74	29	myeloablative	myeloablative	NNP
cord-015365-iqdi99pd	74	30	(	(	-LRB-
cord-015365-iqdi99pd	74	31	n	n	NNP
cord-015365-iqdi99pd	74	32	¼	¼	NNP
cord-015365-iqdi99pd	74	33	110	110	CD
cord-015365-iqdi99pd	74	34	)	)	-RRB-
cord-015365-iqdi99pd	74	35	or	or	CC
cord-015365-iqdi99pd	74	36	reduced	reduce	VBN
cord-015365-iqdi99pd	74	37	-	-	HYPH
cord-015365-iqdi99pd	74	38	intensity	intensity	NN
cord-015365-iqdi99pd	74	39	(	(	-LRB-
cord-015365-iqdi99pd	74	40	n	n	NN
cord-015365-iqdi99pd	74	41	¼	¼	NNP
cord-015365-iqdi99pd	74	42	68	68	CD
cord-015365-iqdi99pd	74	43	)	)	-RRB-
cord-015365-iqdi99pd	74	44	conditioning	conditioning	NN
cord-015365-iqdi99pd	74	45	and	and	CC
cord-015365-iqdi99pd	74	46	a	a	DT
cord-015365-iqdi99pd	74	47	related	related	JJ
cord-015365-iqdi99pd	74	48	(	(	-LRB-
cord-015365-iqdi99pd	74	49	n	n	NN
cord-015365-iqdi99pd	74	50	¼	¼	NNP
cord-015365-iqdi99pd	74	51	37	37	CD
cord-015365-iqdi99pd	74	52	)	)	-RRB-
cord-015365-iqdi99pd	74	53	or	or	CC
cord-015365-iqdi99pd	74	54	unrelated	unrelated	JJ
cord-015365-iqdi99pd	74	55	(	(	-LRB-
cord-015365-iqdi99pd	74	56	n	n	NNP
cord-015365-iqdi99pd	74	57	¼	¼	NNP
cord-015365-iqdi99pd	74	58	141	141	CD
cord-015365-iqdi99pd	74	59	)	)	-RRB-
cord-015365-iqdi99pd	74	60	stem	stem	NN
cord-015365-iqdi99pd	74	61	cell	cell	NN
cord-015365-iqdi99pd	74	62	donor	donor	NN
cord-015365-iqdi99pd	74	63	were	be	VBD
cord-015365-iqdi99pd	74	64	enrolled	enrol	VBN
cord-015365-iqdi99pd	74	65	into	into	IN
cord-015365-iqdi99pd	74	66	the	the	DT
cord-015365-iqdi99pd	74	67	study	study	NN
cord-015365-iqdi99pd	74	68	.	.	.
cord-015365-iqdi99pd	75	1	Starting	start	VBG
cord-015365-iqdi99pd	75	2	on	on	IN
cord-015365-iqdi99pd	75	3	day	day	NN
cord-015365-iqdi99pd	75	4	þ	þ	CD
cord-015365-iqdi99pd	75	5	100	100	CD
cord-015365-iqdi99pd	75	6	after	after	IN
cord-015365-iqdi99pd	75	7	HCT	HCT	NNP
cord-015365-iqdi99pd	75	8	all	all	DT
cord-015365-iqdi99pd	75	9	patients	patient	NNS
cord-015365-iqdi99pd	75	10	were	be	VBD
cord-015365-iqdi99pd	75	11	assessed	assess	VBN
cord-015365-iqdi99pd	75	12	clinically	clinically	RB
cord-015365-iqdi99pd	75	13	every	every	DT
cord-015365-iqdi99pd	75	14	3	3	CD
cord-015365-iqdi99pd	75	15	months	month	NNS
cord-015365-iqdi99pd	75	16	in	in	IN
cord-015365-iqdi99pd	75	17	the	the	DT
cord-015365-iqdi99pd	75	18	outpatient	outpatient	NN
cord-015365-iqdi99pd	75	19	clinic	clinic	NN
cord-015365-iqdi99pd	75	20	for	for	IN
cord-015365-iqdi99pd	75	21	cGVHD	cGVHD	NNP
cord-015365-iqdi99pd	75	22	activity	activity	NN
cord-015365-iqdi99pd	75	23	according	accord	VBG
cord-015365-iqdi99pd	75	24	to	to	IN
cord-015365-iqdi99pd	75	25	the	the	DT
cord-015365-iqdi99pd	75	26	NIH	NIH	NNP
cord-015365-iqdi99pd	75	27	consensus	consensus	NN
cord-015365-iqdi99pd	75	28	criteria	criterion	NNS
cord-015365-iqdi99pd	75	29	(	(	-LRB-
cord-015365-iqdi99pd	75	30	Filipovich	Filipovich	NNP
cord-015365-iqdi99pd	75	31	AH	AH	NNP
cord-015365-iqdi99pd	75	32	et	et	FW
cord-015365-iqdi99pd	75	33	al	al	NNP
cord-015365-iqdi99pd	75	34	,	,	,
cord-015365-iqdi99pd	75	35	BBMT	BBMT	NNP
cord-015365-iqdi99pd	75	36	2005	2005	CD
cord-015365-iqdi99pd	75	37	;	;	:
cord-015365-iqdi99pd	75	38	11:945	11:945	CD
cord-015365-iqdi99pd	75	39	-	-	SYM
cord-015365-iqdi99pd	75	40	956	956	CD
cord-015365-iqdi99pd	75	41	)	)	-RRB-
cord-015365-iqdi99pd	75	42	.	.	.
cord-015365-iqdi99pd	76	1	Results	result	NNS
cord-015365-iqdi99pd	76	2	.	.	.
cord-015365-iqdi99pd	77	1	One	one	CD
cord-015365-iqdi99pd	77	2	hundred	hundred	CD
cord-015365-iqdi99pd	77	3	twenty	twenty	CD
cord-015365-iqdi99pd	77	4	-	-	HYPH
cord-015365-iqdi99pd	77	5	six	six	CD
cord-015365-iqdi99pd	77	6	(	(	-LRB-
cord-015365-iqdi99pd	77	7	71	71	CD
cord-015365-iqdi99pd	77	8	%	%	NN
cord-015365-iqdi99pd	77	9	)	)	-RRB-
cord-015365-iqdi99pd	77	10	patients	patient	NNS
cord-015365-iqdi99pd	77	11	experienced	experience	VBD
cord-015365-iqdi99pd	77	12	acute	acute	JJ
cord-015365-iqdi99pd	77	13	GVHD	GVHD	NNP
cord-015365-iqdi99pd	77	14	grades	grade	NNS
cord-015365-iqdi99pd	77	15	I	-PRON-	PRP
cord-015365-iqdi99pd	77	16	to	to	IN
cord-015365-iqdi99pd	77	17	IV	IV	NNP
cord-015365-iqdi99pd	77	18	including	include	VBG
cord-015365-iqdi99pd	77	19	11	11	CD
cord-015365-iqdi99pd	77	20	with	with	IN
cord-015365-iqdi99pd	77	21	recurrent	recurrent	JJ
cord-015365-iqdi99pd	77	22	,	,	,
cord-015365-iqdi99pd	77	23	11	11	CD
cord-015365-iqdi99pd	77	24	with	with	IN
cord-015365-iqdi99pd	77	25	persistent	persistent	JJ
cord-015365-iqdi99pd	77	26	,	,	,
cord-015365-iqdi99pd	77	27	and	and	CC
cord-015365-iqdi99pd	77	28	10	10	CD
cord-015365-iqdi99pd	77	29	with	with	IN
cord-015365-iqdi99pd	77	30	late	late	JJ
cord-015365-iqdi99pd	77	31	-	-	HYPH
cord-015365-iqdi99pd	77	32	onset	onset	NN
cord-015365-iqdi99pd	77	33	acute	acute	JJ
cord-015365-iqdi99pd	77	34	GVHD	GVHD	NNP
cord-015365-iqdi99pd	77	35	after	after	IN
cord-015365-iqdi99pd	77	36	a	a	DT
cord-015365-iqdi99pd	77	37	median	median	NN
cord-015365-iqdi99pd	77	38	of	of	IN
cord-015365-iqdi99pd	77	39	18	18	CD
cord-015365-iqdi99pd	78	1	(	(	-LRB-
cord-015365-iqdi99pd	78	2	range	range	NN
cord-015365-iqdi99pd	78	3	,	,	,
cord-015365-iqdi99pd	78	4	9	9	CD
cord-015365-iqdi99pd	78	5	-	-	SYM
cord-015365-iqdi99pd	78	6	120	120	CD
cord-015365-iqdi99pd	78	7	)	)	-RRB-
cord-015365-iqdi99pd	78	8	days	day	NNS
cord-015365-iqdi99pd	78	9	after	after	IN
cord-015365-iqdi99pd	78	10	HCT	HCT	NNP
cord-015365-iqdi99pd	78	11	.	.	.
cord-015365-iqdi99pd	79	1	One	one	CD
cord-015365-iqdi99pd	79	2	hundred	hundred	CD
cord-015365-iqdi99pd	79	3	-	-	HYPH
cord-015365-iqdi99pd	79	4	fifteen	fifteen	CD
cord-015365-iqdi99pd	79	5	patients	patient	NNS
cord-015365-iqdi99pd	79	6	(	(	-LRB-
cord-015365-iqdi99pd	79	7	65	65	CD
cord-015365-iqdi99pd	79	8	%	%	NN
cord-015365-iqdi99pd	79	9	)	)	-RRB-
cord-015365-iqdi99pd	79	10	experienced	experience	VBD
cord-015365-iqdi99pd	79	11	cGVHD	cgvhd	NN
cord-015365-iqdi99pd	79	12	after	after	IN
cord-015365-iqdi99pd	79	13	a	a	DT
cord-015365-iqdi99pd	79	14	median	median	NN
cord-015365-iqdi99pd	79	15	of	of	IN
cord-015365-iqdi99pd	79	16	151	151	CD
cord-015365-iqdi99pd	79	17	(	(	-LRB-
cord-015365-iqdi99pd	79	18	range	range	NN
cord-015365-iqdi99pd	79	19	,	,	,
cord-015365-iqdi99pd	79	20	82	82	CD
cord-015365-iqdi99pd	79	21	-	-	SYM
cord-015365-iqdi99pd	79	22	510	510	CD
cord-015365-iqdi99pd	79	23	)	)	-RRB-
cord-015365-iqdi99pd	79	24	days	day	NNS
cord-015365-iqdi99pd	79	25	after	after	IN
cord-015365-iqdi99pd	79	26	HCT	HCT	NNP
cord-015365-iqdi99pd	79	27	.	.	.
cord-015365-iqdi99pd	80	1	Eighty	eighty	CD
cord-015365-iqdi99pd	80	2	-	-	HYPH
cord-015365-iqdi99pd	80	3	nine	nine	CD
cord-015365-iqdi99pd	80	4	patients	patient	NNS
cord-015365-iqdi99pd	80	5	(	(	-LRB-
cord-015365-iqdi99pd	80	6	77	77	CD
cord-015365-iqdi99pd	80	7	%	%	NN
cord-015365-iqdi99pd	80	8	)	)	-RRB-
cord-015365-iqdi99pd	80	9	had	have	VBD
cord-015365-iqdi99pd	80	10	classic	classic	JJ
cord-015365-iqdi99pd	80	11	cGVHD	cgvhd	NN
cord-015365-iqdi99pd	80	12	and	and	CC
cord-015365-iqdi99pd	80	13	26	26	CD
cord-015365-iqdi99pd	80	14	(	(	-LRB-
cord-015365-iqdi99pd	80	15	23	23	CD
cord-015365-iqdi99pd	80	16	%	%	NN
cord-015365-iqdi99pd	80	17	)	)	-RRB-
cord-015365-iqdi99pd	81	1	overlap	overlap	NNP
cord-015365-iqdi99pd	81	2	syndrome	syndrome	NN
cord-015365-iqdi99pd	81	3	.	.	.
cord-015365-iqdi99pd	82	1	Probability	probability	NN
cord-015365-iqdi99pd	82	2	of	of	IN
cord-015365-iqdi99pd	82	3	overall	overall	JJ
cord-015365-iqdi99pd	82	4	survival	survival	NN
cord-015365-iqdi99pd	82	5	(	(	-LRB-
cord-015365-iqdi99pd	82	6	OS	OS	NNP
cord-015365-iqdi99pd	82	7	)	)	-RRB-
cord-015365-iqdi99pd	82	8	at	at	IN
cord-015365-iqdi99pd	82	9	3	3	CD
cord-015365-iqdi99pd	82	10	years	year	NNS
cord-015365-iqdi99pd	82	11	for	for	IN
cord-015365-iqdi99pd	82	12	late	late	JJ
cord-015365-iqdi99pd	82	13	-	-	HYPH
cord-015365-iqdi99pd	82	14	acute	acute	JJ
cord-015365-iqdi99pd	82	15	GVHD	GVHD	NNP
cord-015365-iqdi99pd	82	16	,	,	,
cord-015365-iqdi99pd	82	17	chronic	chronic	JJ
cord-015365-iqdi99pd	82	18	classic	classic	JJ
cord-015365-iqdi99pd	82	19	and	and	CC
cord-015365-iqdi99pd	82	20	overlap	overlap	VB
cord-015365-iqdi99pd	82	21	cGVHD	cGVHD	NNP
cord-015365-iqdi99pd	82	22	were	be	VBD
cord-015365-iqdi99pd	82	23	69	69	CD
cord-015365-iqdi99pd	82	24	%	%	NN
cord-015365-iqdi99pd	82	25	,	,	,
cord-015365-iqdi99pd	82	26	83	83	CD
cord-015365-iqdi99pd	82	27	%	%	NN
cord-015365-iqdi99pd	82	28	,	,	,
cord-015365-iqdi99pd	82	29	and	and	CC
cord-015365-iqdi99pd	82	30	73	73	CD
cord-015365-iqdi99pd	82	31	%	%	NN
cord-015365-iqdi99pd	82	32	.	.	.
cord-015365-iqdi99pd	83	1	Three	three	CD
cord-015365-iqdi99pd	83	2	-	-	HYPH
cord-015365-iqdi99pd	83	3	year	year	NN
cord-015365-iqdi99pd	83	4	OS	os	NN
cord-015365-iqdi99pd	83	5	for	for	IN
cord-015365-iqdi99pd	83	6	mild	mild	JJ
cord-015365-iqdi99pd	83	7	,	,	,
cord-015365-iqdi99pd	83	8	moderate	moderate	JJ
cord-015365-iqdi99pd	83	9	and	and	CC
cord-015365-iqdi99pd	83	10	severe	severe	JJ
cord-015365-iqdi99pd	83	11	cGVHD	cgvhd	NN
cord-015365-iqdi99pd	84	1	at	at	IN
cord-015365-iqdi99pd	84	2	onset	onset	NN
cord-015365-iqdi99pd	84	3	were	be	VBD
cord-015365-iqdi99pd	84	4	93	93	CD
cord-015365-iqdi99pd	84	5	%	%	NN
cord-015365-iqdi99pd	84	6	,	,	,
cord-015365-iqdi99pd	84	7	79	79	CD
cord-015365-iqdi99pd	84	8	%	%	NN
cord-015365-iqdi99pd	84	9	,	,	,
cord-015365-iqdi99pd	84	10	and	and	CC
cord-015365-iqdi99pd	84	11	62.5	62.5	CD
cord-015365-iqdi99pd	84	12	%	%	NN
cord-015365-iqdi99pd	84	13	and	and	CC
cord-015365-iqdi99pd	84	14	significantly	significantly	RB
cord-015365-iqdi99pd	84	15	different	different	JJ
cord-015365-iqdi99pd	84	16	between	between	IN
cord-015365-iqdi99pd	84	17	mild	mild	JJ
cord-015365-iqdi99pd	84	18	and	and	CC
cord-015365-iqdi99pd	84	19	severe	severe	JJ
cord-015365-iqdi99pd	84	20	(	(	-LRB-
cord-015365-iqdi99pd	84	21	p	p	NN
cord-015365-iqdi99pd	84	22	¼	¼	CD
cord-015365-iqdi99pd	84	23	0.007	0.007	CD
cord-015365-iqdi99pd	84	24	)	)	-RRB-
cord-015365-iqdi99pd	84	25	.	.	.
cord-015365-iqdi99pd	85	1	Patients	patient	NNS
cord-015365-iqdi99pd	85	2	with	with	IN
cord-015365-iqdi99pd	85	3	progressive	progressive	JJ
cord-015365-iqdi99pd	85	4	onset	onset	NN
cord-015365-iqdi99pd	85	5	type	type	NN
cord-015365-iqdi99pd	85	6	of	of	IN
cord-015365-iqdi99pd	85	7	cGVHD	cGVHD	NNP
cord-015365-iqdi99pd	85	8	had	have	VBD
cord-015365-iqdi99pd	85	9	significantly	significantly	RB
cord-015365-iqdi99pd	85	10	worse	bad	JJR
cord-015365-iqdi99pd	85	11	three	three	CD
cord-015365-iqdi99pd	85	12	-	-	HYPH
cord-015365-iqdi99pd	85	13	year	year	NN
cord-015365-iqdi99pd	85	14	survival	survival	NN
cord-015365-iqdi99pd	85	15	compared	compare	VBN
cord-015365-iqdi99pd	85	16	to	to	IN
cord-015365-iqdi99pd	85	17	de	de	NNP
cord-015365-iqdi99pd	85	18	novo	novo	NNP
cord-015365-iqdi99pd	85	19	and	and	CC
cord-015365-iqdi99pd	85	20	quiescent	quiescent	JJ
cord-015365-iqdi99pd	85	21	(	(	-LRB-
cord-015365-iqdi99pd	85	22	54.5	54.5	CD
cord-015365-iqdi99pd	85	23	%	%	NN
cord-015365-iqdi99pd	85	24	vs.	vs.	CC
cord-015365-iqdi99pd	85	25	89.5	89.5	CD
cord-015365-iqdi99pd	85	26	%	%	NN
cord-015365-iqdi99pd	85	27	,	,	,
cord-015365-iqdi99pd	85	28	84	84	CD
cord-015365-iqdi99pd	85	29	%	%	NN
cord-015365-iqdi99pd	85	30	,	,	,
cord-015365-iqdi99pd	85	31	p	p	NN
cord-015365-iqdi99pd	85	32	<	<	XX
cord-015365-iqdi99pd	85	33	0.01	0.01	CD
cord-015365-iqdi99pd	85	34	)	)	-RRB-
cord-015365-iqdi99pd	85	35	.	.	.
cord-015365-iqdi99pd	86	1	Three	three	CD
cord-015365-iqdi99pd	86	2	-	-	HYPH
cord-015365-iqdi99pd	86	3	year	year	NN
cord-015365-iqdi99pd	86	4	OS	OS	NNP
cord-015365-iqdi99pd	86	5	was	be	VBD
cord-015365-iqdi99pd	86	6	also	also	RB
cord-015365-iqdi99pd	86	7	significantly	significantly	RB
cord-015365-iqdi99pd	86	8	worse	bad	JJR
cord-015365-iqdi99pd	86	9	in	in	IN
cord-015365-iqdi99pd	86	10	patients	patient	NNS
cord-015365-iqdi99pd	86	11	with	with	IN
cord-015365-iqdi99pd	86	12	platelet	platelet	NN
cord-015365-iqdi99pd	86	13	counts	count	VBZ
cord-015365-iqdi99pd	86	14	below	below	IN
cord-015365-iqdi99pd	86	15	100	100	CD
cord-015365-iqdi99pd	86	16	G	g	NN
cord-015365-iqdi99pd	86	17	/	/	SYM
cord-015365-iqdi99pd	86	18	l	l	NN
cord-015365-iqdi99pd	86	19	at	at	IN
cord-015365-iqdi99pd	86	20	onset	onset	NN
cord-015365-iqdi99pd	86	21	of	of	IN
cord-015365-iqdi99pd	86	22	cGVHD	cGVHD	NNP
cord-015365-iqdi99pd	86	23	(	(	-LRB-
cord-015365-iqdi99pd	86	24	35	35	CD
cord-015365-iqdi99pd	86	25	%	%	NN
cord-015365-iqdi99pd	86	26	vs.	vs.	NN
cord-015365-iqdi99pd	86	27	86	86	CD
cord-015365-iqdi99pd	86	28	%	%	NN
cord-015365-iqdi99pd	86	29	,	,	,
cord-015365-iqdi99pd	86	30	p	p	NN
cord-015365-iqdi99pd	86	31	<	<	XX
cord-015365-iqdi99pd	86	32	0.0001	0.0001	CD
cord-015365-iqdi99pd	86	33	)	)	-RRB-
cord-015365-iqdi99pd	86	34	.	.	.
cord-015365-iqdi99pd	87	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	87	2	.	.	.
cord-015365-iqdi99pd	88	1	This	this	DT
cord-015365-iqdi99pd	88	2	prospective	prospective	JJ
cord-015365-iqdi99pd	88	3	analysis	analysis	NN
cord-015365-iqdi99pd	88	4	supports	support	VBZ
cord-015365-iqdi99pd	88	5	the	the	DT
cord-015365-iqdi99pd	88	6	importance	importance	NN
cord-015365-iqdi99pd	88	7	of	of	IN
cord-015365-iqdi99pd	88	8	distinguishing	distinguish	VBG
cord-015365-iqdi99pd	88	9	late	late	JJ
cord-015365-iqdi99pd	88	10	-	-	HYPH
cord-015365-iqdi99pd	88	11	acute	acute	JJ
cord-015365-iqdi99pd	88	12	GVHD	GVHD	NNP
cord-015365-iqdi99pd	88	13	from	from	IN
cord-015365-iqdi99pd	88	14	cGVHD	cGVHD	NNP
cord-015365-iqdi99pd	88	15	and	and	CC
cord-015365-iqdi99pd	88	16	indicates	indicate	VBZ
cord-015365-iqdi99pd	88	17	a	a	DT
cord-015365-iqdi99pd	88	18	prognostic	prognostic	JJ
cord-015365-iqdi99pd	88	19	value	value	NN
cord-015365-iqdi99pd	88	20	of	of	IN
cord-015365-iqdi99pd	88	21	thrombocytopenia	thrombocytopenia	NN
cord-015365-iqdi99pd	88	22	and	and	CC
cord-015365-iqdi99pd	88	23	progressive	progressive	JJ
cord-015365-iqdi99pd	88	24	onset	onset	NN
cord-015365-iqdi99pd	88	25	type	type	NN
cord-015365-iqdi99pd	88	26	of	of	IN
cord-015365-iqdi99pd	88	27	cGVHD	cgvhd	NN
cord-015365-iqdi99pd	88	28	for	for	IN
cord-015365-iqdi99pd	88	29	HCT	hct	NN
cord-015365-iqdi99pd	88	30	outcomes	outcome	NNS
cord-015365-iqdi99pd	88	31	.	.	.
cord-015365-iqdi99pd	89	1	Current	current	JJ
cord-015365-iqdi99pd	89	2	concepts	concept	NNS
cord-015365-iqdi99pd	89	3	suggest	suggest	VBP
cord-015365-iqdi99pd	89	4	a	a	DT
cord-015365-iqdi99pd	89	5	major	major	JJ
cord-015365-iqdi99pd	89	6	role	role	NN
cord-015365-iqdi99pd	89	7	for	for	IN
cord-015365-iqdi99pd	89	8	innate	innate	JJ
cord-015365-iqdi99pd	89	9	immunity	immunity	NN
cord-015365-iqdi99pd	89	10	in	in	IN
cord-015365-iqdi99pd	89	11	the	the	DT
cord-015365-iqdi99pd	89	12	initiation	initiation	NN
cord-015365-iqdi99pd	89	13	of	of	IN
cord-015365-iqdi99pd	89	14	acute	acute	JJ
cord-015365-iqdi99pd	89	15	graft	graft	NN
cord-015365-iqdi99pd	89	16	-	-	HYPH
cord-015365-iqdi99pd	89	17	vs.-host	vs.-host	NN
cord-015365-iqdi99pd	89	18	-	-	HYPH
cord-015365-iqdi99pd	89	19	disease	disease	NN
cord-015365-iqdi99pd	89	20	(	(	-LRB-
cord-015365-iqdi99pd	89	21	aGvHD	agvhd	NN
cord-015365-iqdi99pd	89	22	)	)	-RRB-
cord-015365-iqdi99pd	89	23	as	as	RB
cord-015365-iqdi99pd	89	24	well	well	RB
cord-015365-iqdi99pd	89	25	as	as	IN
cord-015365-iqdi99pd	89	26	in	in	IN
cord-015365-iqdi99pd	89	27	Crohn	Crohn	NNP
cord-015365-iqdi99pd	89	28	's	's	POS
cord-015365-iqdi99pd	89	29	disease	disease	NN
cord-015365-iqdi99pd	89	30	.	.	.
cord-015365-iqdi99pd	90	1	Identical	identical	JJ
cord-015365-iqdi99pd	90	2	single	single	JJ
cord-015365-iqdi99pd	90	3	nucleotide	nucleotide	JJ
cord-015365-iqdi99pd	90	4	polymorphisms	polymorphism	NNS
cord-015365-iqdi99pd	90	5	(	(	-LRB-
cord-015365-iqdi99pd	90	6	SNP	SNP	NNP
cord-015365-iqdi99pd	90	7	)	)	-RRB-
cord-015365-iqdi99pd	90	8	have	have	VBP
cord-015365-iqdi99pd	90	9	been	be	VBN
cord-015365-iqdi99pd	90	10	described	describe	VBN
cord-015365-iqdi99pd	90	11	as	as	IN
cord-015365-iqdi99pd	90	12	risk	risk	NN
cord-015365-iqdi99pd	90	13	factors	factor	NNS
cord-015365-iqdi99pd	90	14	for	for	IN
cord-015365-iqdi99pd	90	15	both	both	DT
cord-015365-iqdi99pd	90	16	diseases	disease	NNS
cord-015365-iqdi99pd	90	17	.	.	.
cord-015365-iqdi99pd	91	1	Recently	recently	RB
cord-015365-iqdi99pd	91	2	,	,	,
cord-015365-iqdi99pd	91	3	the	the	DT
cord-015365-iqdi99pd	91	4	noncoding	noncoding	NNP
cord-015365-iqdi99pd	91	5	C	C	NNP
cord-015365-iqdi99pd	91	6	/	/	SYM
cord-015365-iqdi99pd	91	7	T	t	NN
cord-015365-iqdi99pd	91	8	polymorphism	polymorphism	NN
cord-015365-iqdi99pd	91	9	rs2274910	rs2274910	NN
cord-015365-iqdi99pd	91	10	in	in	IN
cord-015365-iqdi99pd	91	11	intron	intron	NN
cord-015365-iqdi99pd	91	12	3	3	CD
cord-015365-iqdi99pd	91	13	of	of	IN
cord-015365-iqdi99pd	91	14	the	the	DT
cord-015365-iqdi99pd	91	15	intelectin	intelectin	NNP
cord-015365-iqdi99pd	91	16	1	1	CD
cord-015365-iqdi99pd	91	17	(	(	-LRB-
cord-015365-iqdi99pd	91	18	ITLN1	ITLN1	NNP
cord-015365-iqdi99pd	91	19	)	)	-RRB-
cord-015365-iqdi99pd	91	20	gene	gene	NN
cord-015365-iqdi99pd	91	21	(	(	-LRB-
cord-015365-iqdi99pd	91	22	human	human	JJ
cord-015365-iqdi99pd	91	23	lactoferrin	lactoferrin	NNP
cord-015365-iqdi99pd	91	24	receptor	receptor	NN
cord-015365-iqdi99pd	91	25	)	)	-RRB-
cord-015365-iqdi99pd	91	26	has	have	VBZ
cord-015365-iqdi99pd	91	27	been	be	VBN
cord-015365-iqdi99pd	91	28	associated	associate	VBN
cord-015365-iqdi99pd	91	29	with	with	IN
cord-015365-iqdi99pd	91	30	Crohn	Crohn	NNP
cord-015365-iqdi99pd	91	31	's	's	POS
cord-015365-iqdi99pd	91	32	disease	disease	NN
cord-015365-iqdi99pd	91	33	.	.	.
cord-015365-iqdi99pd	92	1	We	-PRON-	PRP
cord-015365-iqdi99pd	92	2	retrospectively	retrospectively	RB
cord-015365-iqdi99pd	92	3	typed	type	VBD
cord-015365-iqdi99pd	92	4	this	this	DT
cord-015365-iqdi99pd	92	5	polymorphism	polymorphism	NN
cord-015365-iqdi99pd	92	6	in	in	IN
cord-015365-iqdi99pd	92	7	AML	AML	NNP
cord-015365-iqdi99pd	92	8	patients	patient	NNS
cord-015365-iqdi99pd	92	9	and	and	CC
cord-015365-iqdi99pd	92	10	their	-PRON-	PRP$
cord-015365-iqdi99pd	92	11	donors	donor	NNS
cord-015365-iqdi99pd	92	12	.	.	.
cord-015365-iqdi99pd	93	1	A	a	DT
cord-015365-iqdi99pd	93	2	pilot	pilot	NN
cord-015365-iqdi99pd	93	3	study	study	NN
cord-015365-iqdi99pd	93	4	of	of	IN
cord-015365-iqdi99pd	93	5	19	19	CD
cord-015365-iqdi99pd	93	6	patients	patient	NNS
cord-015365-iqdi99pd	93	7	in	in	IN
cord-015365-iqdi99pd	93	8	CR1	CR1	NNP
cord-015365-iqdi99pd	93	9	transplanted	transplant	VBD
cord-015365-iqdi99pd	93	10	from	from	IN
cord-015365-iqdi99pd	93	11	HLA	HLA	NNP
cord-015365-iqdi99pd	93	12	identical	identical	JJ
cord-015365-iqdi99pd	93	13	sibling	sibling	NN
cord-015365-iqdi99pd	93	14	donors	donor	NNS
cord-015365-iqdi99pd	93	15	after	after	IN
cord-015365-iqdi99pd	93	16	myeloablative	myeloablative	NNP
cord-015365-iqdi99pd	93	17	conditioning	conditioning	NNP
cord-015365-iqdi99pd	93	18	was	be	VBD
cord-015365-iqdi99pd	93	19	confirmed	confirm	VBN
cord-015365-iqdi99pd	93	20	in	in	IN
cord-015365-iqdi99pd	93	21	a	a	DT
cord-015365-iqdi99pd	93	22	second	second	JJ
cord-015365-iqdi99pd	93	23	cohort	cohort	NN
cord-015365-iqdi99pd	93	24	including	include	VBG
cord-015365-iqdi99pd	93	25	40	40	CD
cord-015365-iqdi99pd	93	26	other	other	JJ
cord-015365-iqdi99pd	93	27	AML	AML	NNP
cord-015365-iqdi99pd	93	28	patients	patient	NNS
cord-015365-iqdi99pd	93	29	.	.	.
cord-015365-iqdi99pd	94	1	A	a	DT
cord-015365-iqdi99pd	94	2	total	total	NN
cord-015365-iqdi99pd	94	3	of	of	IN
cord-015365-iqdi99pd	94	4	59	59	CD
cord-015365-iqdi99pd	94	5	consecutive	consecutive	JJ
cord-015365-iqdi99pd	94	6	patients	patient	NNS
cord-015365-iqdi99pd	94	7	(	(	-LRB-
cord-015365-iqdi99pd	94	8	median	median	JJ
cord-015365-iqdi99pd	94	9	age	age	NN
cord-015365-iqdi99pd	94	10	43	43	CD
cord-015365-iqdi99pd	94	11	yrs	yr	NNS
cord-015365-iqdi99pd	94	12	(	(	-LRB-
cord-015365-iqdi99pd	94	13	18	18	CD
cord-015365-iqdi99pd	94	14	-	-	SYM
cord-015365-iqdi99pd	94	15	63	63	CD
cord-015365-iqdi99pd	94	16	)	)	-RRB-
cord-015365-iqdi99pd	94	17	;	;	:
cord-015365-iqdi99pd	94	18	25/34	25/34	CD
cord-015365-iqdi99pd	94	19	CR1	CR1	NNP
cord-015365-iqdi99pd	94	20	/	/	SYM
cord-015365-iqdi99pd	94	21	advanced	advanced	JJ
cord-015365-iqdi99pd	94	22	disease	disease	NN
cord-015365-iqdi99pd	94	23	;	;	:
cord-015365-iqdi99pd	94	24	40	40	CD
cord-015365-iqdi99pd	94	25	myeloablative	myeloablative	JJ
cord-015365-iqdi99pd	94	26	and	and	CC
cord-015365-iqdi99pd	94	27	19	19	CD
cord-015365-iqdi99pd	94	28	reduced	reduce	VBN
cord-015365-iqdi99pd	94	29	intensity	intensity	NN
cord-015365-iqdi99pd	94	30	conditioning	conditioning	NN
cord-015365-iqdi99pd	94	31	;	;	:
cord-015365-iqdi99pd	94	32	54	54	CD
cord-015365-iqdi99pd	94	33	peripheral	peripheral	JJ
cord-015365-iqdi99pd	94	34	stem	stem	NN
cord-015365-iqdi99pd	94	35	cells	cell	NNS
cord-015365-iqdi99pd	94	36	)	)	-RRB-
cord-015365-iqdi99pd	94	37	were	be	VBD
cord-015365-iqdi99pd	94	38	tested	test	VBN
cord-015365-iqdi99pd	94	39	.	.	.
cord-015365-iqdi99pd	95	1	T	T	NNP
cord-015365-iqdi99pd	95	2	-	-	HYPH
cord-015365-iqdi99pd	95	3	alleles	allele	NNS
cord-015365-iqdi99pd	95	4	were	be	VBD
cord-015365-iqdi99pd	95	5	found	find	VBN
cord-015365-iqdi99pd	95	6	at	at	IN
cord-015365-iqdi99pd	95	7	a	a	DT
cord-015365-iqdi99pd	95	8	frequency	frequency	NN
cord-015365-iqdi99pd	95	9	of	of	IN
cord-015365-iqdi99pd	95	10	28.8	28.8	CD
cord-015365-iqdi99pd	95	11	%	%	NN
cord-015365-iqdi99pd	95	12	in	in	IN
cord-015365-iqdi99pd	95	13	recipients	recipient	NNS
cord-015365-iqdi99pd	95	14	and	and	CC
cord-015365-iqdi99pd	95	15	29.7	29.7	CD
cord-015365-iqdi99pd	95	16	%	%	NN
cord-015365-iqdi99pd	95	17	in	in	IN
cord-015365-iqdi99pd	95	18	donors	donor	NNS
cord-015365-iqdi99pd	95	19	.	.	.
cord-015365-iqdi99pd	96	1	50.8	50.8	CD
cord-015365-iqdi99pd	96	2	%	%	NN
cord-015365-iqdi99pd	96	3	of	of	IN
cord-015365-iqdi99pd	96	4	patients	patient	NNS
cord-015365-iqdi99pd	96	5	had	have	VBD
cord-015365-iqdi99pd	96	6	a	a	DT
cord-015365-iqdi99pd	96	7	CC	CC	NNP
cord-015365-iqdi99pd	96	8	genotype	genotype	NN
cord-015365-iqdi99pd	96	9	.	.	.
cord-015365-iqdi99pd	97	1	In	in	IN
cord-015365-iqdi99pd	97	2	the	the	DT
cord-015365-iqdi99pd	97	3	pilot	pilot	NN
cord-015365-iqdi99pd	97	4	study	study	NN
cord-015365-iqdi99pd	97	5	,	,	,
cord-015365-iqdi99pd	97	6	2	2	CD
cord-015365-iqdi99pd	97	7	out	out	IN
cord-015365-iqdi99pd	97	8	of	of	IN
cord-015365-iqdi99pd	97	9	12	12	CD
cord-015365-iqdi99pd	97	10	patients	patient	NNS
cord-015365-iqdi99pd	97	11	with	with	IN
cord-015365-iqdi99pd	97	12	a	a	DT
cord-015365-iqdi99pd	97	13	CC	cc	NN
cord-015365-iqdi99pd	97	14	genotype	genotype	NN
cord-015365-iqdi99pd	97	15	versus	versus	IN
cord-015365-iqdi99pd	97	16	5	5	CD
cord-015365-iqdi99pd	97	17	out	out	IN
cord-015365-iqdi99pd	97	18	of	of	IN
cord-015365-iqdi99pd	97	19	7	7	CD
cord-015365-iqdi99pd	97	20	patients	patient	NNS
cord-015365-iqdi99pd	97	21	with	with	IN
cord-015365-iqdi99pd	97	22	a	a	DT
cord-015365-iqdi99pd	97	23	T	t	NN
cord-015365-iqdi99pd	97	24	-	-	HYPH
cord-015365-iqdi99pd	97	25	allele	allele	NN
cord-015365-iqdi99pd	97	26	had	have	VBD
cord-015365-iqdi99pd	97	27	acute	acute	JJ
cord-015365-iqdi99pd	97	28	intestinal	intestinal	JJ
cord-015365-iqdi99pd	97	29	aGvHD	aGvHD	.
cord-015365-iqdi99pd	97	30	(	(	-LRB-
cord-015365-iqdi99pd	97	31	p	p	NN
cord-015365-iqdi99pd	97	32	¼	¼	NNP
cord-015365-iqdi99pd	97	33	0.045	0.045	CD
cord-015365-iqdi99pd	97	34	)	)	-RRB-
cord-015365-iqdi99pd	97	35	.	.	.
cord-015365-iqdi99pd	98	1	These	these	DT
cord-015365-iqdi99pd	98	2	results	result	NNS
cord-015365-iqdi99pd	98	3	were	be	VBD
cord-015365-iqdi99pd	98	4	confirmed	confirm	VBN
cord-015365-iqdi99pd	98	5	in	in	IN
cord-015365-iqdi99pd	98	6	a	a	DT
cord-015365-iqdi99pd	98	7	second	second	JJ
cord-015365-iqdi99pd	98	8	cohort	cohort	NN
cord-015365-iqdi99pd	98	9	.	.	.
cord-015365-iqdi99pd	99	1	Acute	acute	JJ
cord-015365-iqdi99pd	99	2	intestinal	intestinal	JJ
cord-015365-iqdi99pd	99	3	GvHD	gvhd	NN
cord-015365-iqdi99pd	99	4	was	be	VBD
cord-015365-iqdi99pd	99	5	found	find	VBN
cord-015365-iqdi99pd	99	6	in	in	IN
cord-015365-iqdi99pd	99	7	3/18	3/18	CD
cord-015365-iqdi99pd	99	8	patients	patient	NNS
cord-015365-iqdi99pd	99	9	(	(	-LRB-
cord-015365-iqdi99pd	99	10	16.7	16.7	CD
cord-015365-iqdi99pd	99	11	%	%	NN
cord-015365-iqdi99pd	99	12	)	)	-RRB-
cord-015365-iqdi99pd	99	13	with	with	IN
cord-015365-iqdi99pd	99	14	a	a	DT
cord-015365-iqdi99pd	99	15	CC	cc	NN
cord-015365-iqdi99pd	99	16	genotype	genotype	NN
cord-015365-iqdi99pd	99	17	and	and	CC
cord-015365-iqdi99pd	99	18	12/	12/	CD
cord-015365-iqdi99pd	99	19	22	22	CD
cord-015365-iqdi99pd	99	20	patients	patient	NNS
cord-015365-iqdi99pd	99	21	(	(	-LRB-
cord-015365-iqdi99pd	99	22	54.5	54.5	CD
cord-015365-iqdi99pd	99	23	%	%	NN
cord-015365-iqdi99pd	99	24	)	)	-RRB-
cord-015365-iqdi99pd	99	25	with	with	IN
cord-015365-iqdi99pd	99	26	a	a	DT
cord-015365-iqdi99pd	99	27	T	t	NN
cord-015365-iqdi99pd	99	28	-	-	HYPH
cord-015365-iqdi99pd	99	29	allele	allele	NN
cord-015365-iqdi99pd	99	30	(	(	-LRB-
cord-015365-iqdi99pd	99	31	p	p	NN
cord-015365-iqdi99pd	99	32	¼	¼	CD
cord-015365-iqdi99pd	99	33	0.014	0.014	CD
cord-015365-iqdi99pd	99	34	)	)	-RRB-
cord-015365-iqdi99pd	99	35	.	.	.
cord-015365-iqdi99pd	100	1	In	in	IN
cord-015365-iqdi99pd	100	2	a	a	DT
cord-015365-iqdi99pd	100	3	combined	combined	JJ
cord-015365-iqdi99pd	100	4	analysis	analysis	NN
cord-015365-iqdi99pd	100	5	(	(	-LRB-
cord-015365-iqdi99pd	100	6	n	n	NN
cord-015365-iqdi99pd	100	7	¼	¼	NNP
cord-015365-iqdi99pd	100	8	59	59	CD
cord-015365-iqdi99pd	100	9	)	)	-RRB-
cord-015365-iqdi99pd	100	10	we	-PRON-	PRP
cord-015365-iqdi99pd	100	11	found	find	VBD
cord-015365-iqdi99pd	100	12	intestinal	intestinal	JJ
cord-015365-iqdi99pd	100	13	aGvHD	agvhd	NN
cord-015365-iqdi99pd	100	14	in	in	IN
cord-015365-iqdi99pd	100	15	58.6	58.6	CD
cord-015365-iqdi99pd	100	16	%	%	NN
cord-015365-iqdi99pd	100	17	of	of	IN
cord-015365-iqdi99pd	100	18	patients	patient	NNS
cord-015365-iqdi99pd	100	19	with	with	IN
cord-015365-iqdi99pd	100	20	a	a	DT
cord-015365-iqdi99pd	100	21	T	t	NN
cord-015365-iqdi99pd	100	22	-	-	HYPH
cord-015365-iqdi99pd	100	23	allele	allele	NN
cord-015365-iqdi99pd	100	24	versus	versus	IN
cord-015365-iqdi99pd	100	25	16.7	16.7	CD
cord-015365-iqdi99pd	100	26	%	%	NN
cord-015365-iqdi99pd	100	27	of	of	IN
cord-015365-iqdi99pd	100	28	patients	patient	NNS
cord-015365-iqdi99pd	100	29	with	with	IN
cord-015365-iqdi99pd	100	30	a	a	DT
cord-015365-iqdi99pd	100	31	CC	cc	NN
cord-015365-iqdi99pd	100	32	genotype	genotype	NN
cord-015365-iqdi99pd	100	33	(	(	-LRB-
cord-015365-iqdi99pd	100	34	p	p	NN
cord-015365-iqdi99pd	100	35	<	<	XX
cord-015365-iqdi99pd	100	36	0.001	0.001	CD
cord-015365-iqdi99pd	100	37	)	)	-RRB-
cord-015365-iqdi99pd	100	38	.	.	.
cord-015365-iqdi99pd	101	1	The	the	DT
cord-015365-iqdi99pd	101	2	lower	low	JJR
cord-015365-iqdi99pd	101	3	incidence	incidence	NN
cord-015365-iqdi99pd	101	4	of	of	IN
cord-015365-iqdi99pd	101	5	aGvHD	agvhd	NN
cord-015365-iqdi99pd	101	6	grades	grade	NNS
cord-015365-iqdi99pd	101	7	II	II	NNP
cord-015365-iqdi99pd	101	8	-	-	HYPH
cord-015365-iqdi99pd	101	9	IV	IV	NNP
cord-015365-iqdi99pd	101	10	in	in	IN
cord-015365-iqdi99pd	101	11	patients	patient	NNS
cord-015365-iqdi99pd	101	12	with	with	IN
cord-015365-iqdi99pd	101	13	a	a	DT
cord-015365-iqdi99pd	101	14	CC	cc	NN
cord-015365-iqdi99pd	101	15	genotype	genotype	NN
cord-015365-iqdi99pd	101	16	(	(	-LRB-
cord-015365-iqdi99pd	101	17	p	p	NN
cord-015365-iqdi99pd	101	18	¼	¼	NNP
cord-015365-iqdi99pd	101	19	0.019	0.019	CD
cord-015365-iqdi99pd	101	20	)	)	-RRB-
cord-015365-iqdi99pd	101	21	was	be	VBD
cord-015365-iqdi99pd	101	22	only	only	RB
cord-015365-iqdi99pd	101	23	due	due	JJ
cord-015365-iqdi99pd	101	24	to	to	IN
cord-015365-iqdi99pd	101	25	less	less	RBR
cord-015365-iqdi99pd	101	26	intestinal	intestinal	JJ
cord-015365-iqdi99pd	101	27	aGvHD	agvhd	NN
cord-015365-iqdi99pd	101	28	while	while	IN
cord-015365-iqdi99pd	101	29	no	no	DT
cord-015365-iqdi99pd	101	30	difference	difference	NN
cord-015365-iqdi99pd	101	31	was	be	VBD
cord-015365-iqdi99pd	101	32	found	find	VBN
cord-015365-iqdi99pd	101	33	with	with	IN
cord-015365-iqdi99pd	101	34	regard	regard	NN
cord-015365-iqdi99pd	101	35	to	to	IN
cord-015365-iqdi99pd	101	36	skin	skin	NN
cord-015365-iqdi99pd	101	37	or	or	CC
cord-015365-iqdi99pd	101	38	liver	liver	NN
cord-015365-iqdi99pd	101	39	aGvHD	agvhd	NN
cord-015365-iqdi99pd	101	40	.	.	.
cord-015365-iqdi99pd	102	1	We	-PRON-	PRP
cord-015365-iqdi99pd	102	2	did	do	VBD
cord-015365-iqdi99pd	102	3	not	not	RB
cord-015365-iqdi99pd	102	4	see	see	VB
cord-015365-iqdi99pd	102	5	any	any	DT
cord-015365-iqdi99pd	102	6	association	association	NN
cord-015365-iqdi99pd	102	7	between	between	IN
cord-015365-iqdi99pd	102	8	donor	donor	NN
cord-015365-iqdi99pd	102	9	genotypes	genotype	NNS
cord-015365-iqdi99pd	102	10	and	and	CC
cord-015365-iqdi99pd	102	11	aGvHD	agvhd	NN
cord-015365-iqdi99pd	102	12	.	.	.
cord-015365-iqdi99pd	103	1	The	the	DT
cord-015365-iqdi99pd	103	2	strong	strong	JJ
cord-015365-iqdi99pd	103	3	association	association	NN
cord-015365-iqdi99pd	103	4	(	(	-LRB-
cord-015365-iqdi99pd	103	5	RR	RR	NNP
cord-015365-iqdi99pd	103	6	3.52	3.52	CD
cord-015365-iqdi99pd	103	7	;	;	:
cord-015365-iqdi99pd	103	8	95	95	CD
cord-015365-iqdi99pd	103	9	%	%	NN
cord-015365-iqdi99pd	103	10	CI	CI	NNP
cord-015365-iqdi99pd	103	11	1.5	1.5	CD
cord-015365-iqdi99pd	103	12	-	-	HYPH
cord-015365-iqdi99pd	103	13	8.2	8.2	CD
cord-015365-iqdi99pd	103	14	)	)	-RRB-
cord-015365-iqdi99pd	103	15	between	between	IN
cord-015365-iqdi99pd	103	16	this	this	DT
cord-015365-iqdi99pd	103	17	SNP	SNP	NNP
cord-015365-iqdi99pd	103	18	and	and	CC
cord-015365-iqdi99pd	103	19	the	the	DT
cord-015365-iqdi99pd	103	20	incidence	incidence	NN
cord-015365-iqdi99pd	103	21	of	of	IN
cord-015365-iqdi99pd	103	22	intestinal	intestinal	JJ
cord-015365-iqdi99pd	103	23	aGvHD	agvhd	NN
cord-015365-iqdi99pd	103	24	is	be	VBZ
cord-015365-iqdi99pd	103	25	in	in	IN
cord-015365-iqdi99pd	103	26	accordance	accordance	NN
cord-015365-iqdi99pd	103	27	with	with	IN
cord-015365-iqdi99pd	103	28	reports	report	NNS
cord-015365-iqdi99pd	103	29	about	about	IN
cord-015365-iqdi99pd	103	30	SNPs	SNPs	NNPS
cord-015365-iqdi99pd	103	31	in	in	IN
cord-015365-iqdi99pd	103	32	other	other	JJ
cord-015365-iqdi99pd	103	33	genes	gene	NNS
cord-015365-iqdi99pd	103	34	associated	associate	VBN
cord-015365-iqdi99pd	103	35	with	with	IN
cord-015365-iqdi99pd	103	36	both	both	DT
cord-015365-iqdi99pd	103	37	aGvHD	agvhd	NN
cord-015365-iqdi99pd	103	38	and	and	CC
cord-015365-iqdi99pd	103	39	Crohn	Crohn	NNP
cord-015365-iqdi99pd	103	40	's	's	POS
cord-015365-iqdi99pd	103	41	disease	disease	NN
cord-015365-iqdi99pd	103	42	.	.	.
cord-015365-iqdi99pd	104	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	104	2	results	result	NNS
cord-015365-iqdi99pd	104	3	further	further	RB
cord-015365-iqdi99pd	104	4	support	support	VBP
cord-015365-iqdi99pd	104	5	the	the	DT
cord-015365-iqdi99pd	104	6	concept	concept	NN
cord-015365-iqdi99pd	104	7	of	of	IN
cord-015365-iqdi99pd	104	8	the	the	DT
cord-015365-iqdi99pd	104	9	importance	importance	NN
cord-015365-iqdi99pd	104	10	of	of	IN
cord-015365-iqdi99pd	104	11	the	the	DT
cord-015365-iqdi99pd	104	12	gut	gut	NN
cord-015365-iqdi99pd	104	13	associated	associate	VBN
cord-015365-iqdi99pd	104	14	innate	innate	JJ
cord-015365-iqdi99pd	104	15	immune	immune	JJ
cord-015365-iqdi99pd	104	16	system	system	NN
cord-015365-iqdi99pd	104	17	in	in	IN
cord-015365-iqdi99pd	104	18	the	the	DT
cord-015365-iqdi99pd	104	19	initiation	initiation	NN
cord-015365-iqdi99pd	104	20	of	of	IN
cord-015365-iqdi99pd	104	21	aGvHD	agvhd	NN
cord-015365-iqdi99pd	104	22	.	.	.
cord-015365-iqdi99pd	105	1	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	105	2	.	.	.
cord-015365-iqdi99pd	106	1	Klinische	Klinische	NNP
cord-015365-iqdi99pd	106	2	Studien	Studien	NNP
cord-015365-iqdi99pd	106	3	zeigen	zeigen	NNP
cord-015365-iqdi99pd	106	4	,	,	,
cord-015365-iqdi99pd	106	5	dass	dass	NNP
cord-015365-iqdi99pd	106	6	sich	sich	NNP
cord-015365-iqdi99pd	106	7	Minorhistokompatibilitätsantigen	Minorhistokompatibilitätsantigen	NNP
cord-015365-iqdi99pd	106	8	(	(	-LRB-
cord-015365-iqdi99pd	106	9	mHag)-spezifische	mHag)-spezifische	``
cord-015365-iqdi99pd	106	10	Spender	Spender	NNP
cord-015365-iqdi99pd	106	11	T	T	NNP
cord-015365-iqdi99pd	106	12	-	-	HYPH
cord-015365-iqdi99pd	106	13	Zellen	Zellen	NNP
cord-015365-iqdi99pd	106	14	positiv	positiv	JJ
cord-015365-iqdi99pd	106	15	in	in	IN
cord-015365-iqdi99pd	106	16	der	der	NNP
cord-015365-iqdi99pd	106	17	Therapie	Therapie	NNP
cord-015365-iqdi99pd	106	18	eines	eine	NNS
cord-015365-iqdi99pd	107	1	leukämischen	leukämischen	NNP
cord-015365-iqdi99pd	107	2	Relapses	Relapses	NNP
cord-015365-iqdi99pd	107	3	nach	nach	VBP
cord-015365-iqdi99pd	107	4	HLAidenter	HLAidenter	NNP
cord-015365-iqdi99pd	108	1	hämatopoetischer	hämatopoetischer	NNP
cord-015365-iqdi99pd	108	2	Stammzelltransplantation	Stammzelltransplantation	NNP
cord-015365-iqdi99pd	108	3	(	(	-LRB-
cord-015365-iqdi99pd	108	4	SZT	SZT	NNP
cord-015365-iqdi99pd	108	5	)	)	-RRB-
cord-015365-iqdi99pd	108	6	auswirken	auswirken	VBN
cord-015365-iqdi99pd	108	7	.	.	.
cord-015365-iqdi99pd	109	1	Der	Der	NNP
cord-015365-iqdi99pd	109	2	prädiktive	prädiktive	NNP
cord-015365-iqdi99pd	110	1	Wert	wert	UH
cord-015365-iqdi99pd	110	2	der	der	NNP
cord-015365-iqdi99pd	110	3	mHag	mHag	NNP
cord-015365-iqdi99pd	110	4	-	-	HYPH
cord-015365-iqdi99pd	110	5	Typisierung	Typisierung	NNP
cord-015365-iqdi99pd	110	6	für	für	IN
cord-015365-iqdi99pd	110	7	das	das	NNP
cord-015365-iqdi99pd	110	8	Auftreten	Auftreten	NNP
cord-015365-iqdi99pd	110	9	eines	eines	NNP
cord-015365-iqdi99pd	110	10	Graft	graft	NN
cord-015365-iqdi99pd	110	11	-	-	HYPH
cord-015365-iqdi99pd	110	12	versus	versus	NN
cord-015365-iqdi99pd	110	13	-	-	HYPH
cord-015365-iqdi99pd	110	14	Leukämie	Leukämie	NNP
cord-015365-iqdi99pd	110	15	Effektes	Effektes	NNP
cord-015365-iqdi99pd	111	1	oder	oder	NNP
cord-015365-iqdi99pd	111	2	von	von	NNP
cord-015365-iqdi99pd	111	3	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	111	4	nach	nach	NNP
cord-015365-iqdi99pd	111	5	SZT	SZT	NNP
cord-015365-iqdi99pd	111	6	ist	ist	FW
cord-015365-iqdi99pd	111	7	jedoch	jedoch	NN
cord-015365-iqdi99pd	111	8	nach	nach	NN
cord-015365-iqdi99pd	111	9	wie	wie	NN
cord-015365-iqdi99pd	111	10	vor	vor	NNP
cord-015365-iqdi99pd	111	11	umstritten	umstritten	NNP
cord-015365-iqdi99pd	111	12	.	.	.
cord-015365-iqdi99pd	112	1	Auch	Auch	NNP
cord-015365-iqdi99pd	112	2	Langzeitstudien	Langzeitstudien	NNP
cord-015365-iqdi99pd	113	1	über	über	NNP
cord-015365-iqdi99pd	113	2	den	den	NNP
cord-015365-iqdi99pd	113	3	Einfluss	Einfluss	NNP
cord-015365-iqdi99pd	113	4	von	von	NNP
cord-015365-iqdi99pd	113	5	mHag	mHag	NNP
cord-015365-iqdi99pd	113	6	-	-	HYPH
cord-015365-iqdi99pd	113	7	Mismatches	mismatch	NNS
cord-015365-iqdi99pd	113	8	auf	auf	NNP
cord-015365-iqdi99pd	113	9	das	das	NNP
cord-015365-iqdi99pd	113	10	Ü	ü	NN
cord-015365-iqdi99pd	113	11	berleben	berleben	NNP
cord-015365-iqdi99pd	113	12	der	der	NNP
cord-015365-iqdi99pd	113	13	Patienten	Patienten	NNP
cord-015365-iqdi99pd	113	14	fehlen	fehlen	XX
cord-015365-iqdi99pd	113	15	.	.	.
cord-015365-iqdi99pd	114	1	Deshalb	Deshalb	NNP
cord-015365-iqdi99pd	114	2	haben	haben	NNP
cord-015365-iqdi99pd	114	3	wir	wir	NNP
cord-015365-iqdi99pd	114	4	in	in	IN
cord-015365-iqdi99pd	114	5	der	der	NNP
cord-015365-iqdi99pd	114	6	vorliegenden	vorliegenden	NNP
cord-015365-iqdi99pd	114	7	Studie	Studie	NNP
cord-015365-iqdi99pd	114	8	Unterschiede	Unterschiede	NNP
cord-015365-iqdi99pd	114	9	in	in	IN
cord-015365-iqdi99pd	114	10	zehn	zehn	NNP
cord-015365-iqdi99pd	114	11	verschiedenen	verschiedenen	NNP
cord-015365-iqdi99pd	114	12	mHag	mHag	VBZ
cord-015365-iqdi99pd	114	13	in	in	IN
cord-015365-iqdi99pd	114	14	insgesamt	insgesamt	NNP
cord-015365-iqdi99pd	114	15	217	217	CD
cord-015365-iqdi99pd	114	16	Patienten	Patienten	NNP
cord-015365-iqdi99pd	115	1	und	und	IN
cord-015365-iqdi99pd	115	2	ihren	ihren	NNP
cord-015365-iqdi99pd	116	1	HLA	HLA	NNP
cord-015365-iqdi99pd	116	2	-	-	HYPH
cord-015365-iqdi99pd	116	3	identen	identen	NNP
cord-015365-iqdi99pd	116	4	Familienoder	Familienoder	NNP
cord-015365-iqdi99pd	116	5	Fremdspendern	Fremdspendern	NNP
cord-015365-iqdi99pd	116	6	untersucht	untersucht	NN
cord-015365-iqdi99pd	116	7	und	und	NNP
cord-015365-iqdi99pd	116	8	sie	sie	NNP
cord-015365-iqdi99pd	116	9	mit	mit	NNP
cord-015365-iqdi99pd	116	10	Ü	Ü	NNP
cord-015365-iqdi99pd	116	11	berleben	berleben	NNP
cord-015365-iqdi99pd	116	12	und	und	DT
cord-015365-iqdi99pd	116	13	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	116	14	nach	nach	NN
cord-015365-iqdi99pd	116	15	allogener	allogener	JJ
cord-015365-iqdi99pd	116	16	SZT	SZT	NNP
cord-015365-iqdi99pd	116	17	korreliert	korreliert	NNP
cord-015365-iqdi99pd	116	18	.	.	.
cord-015365-iqdi99pd	117	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	117	2	.	.	.
cord-015365-iqdi99pd	118	1	Die	die	VB
cord-015365-iqdi99pd	118	2	Bestimmung	Bestimmung	NNP
cord-015365-iqdi99pd	118	3	der	der	NNP
cord-015365-iqdi99pd	118	4	mHag	mHag	NNP
cord-015365-iqdi99pd	118	5	wurde	wurde	NN
cord-015365-iqdi99pd	118	6	mittels	mittels	NNP
cord-015365-iqdi99pd	118	7	Allelspezifischer	Allelspezifischer	NNP
cord-015365-iqdi99pd	118	8	Polymerase	Polymerase	NNP
cord-015365-iqdi99pd	118	9	-	-	HYPH
cord-015365-iqdi99pd	118	10	Kettenreaktion	Kettenreaktion	NNP
cord-015365-iqdi99pd	118	11	mit	mit	NNP
cord-015365-iqdi99pd	118	12	Hilfe	Hilfe	NNP
cord-015365-iqdi99pd	118	13	eines	eine	NNS
cord-015365-iqdi99pd	118	14	kommerziell	kommerziell	NNP
cord-015365-iqdi99pd	118	15	erhältlichen	erhältlichen	NNP
cord-015365-iqdi99pd	118	16	mHag	mHag	NNP
cord-015365-iqdi99pd	118	17	-	-	HYPH
cord-015365-iqdi99pd	118	18	Typisierungskits	Typisierungskits	NNP
cord-015365-iqdi99pd	118	19	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	118	20	.	.	.
cord-015365-iqdi99pd	119	1	Die	die	VB
cord-015365-iqdi99pd	119	2	Wahrscheinlichkeit	Wahrscheinlichkeit	NNP
cord-015365-iqdi99pd	119	3	des	des	NNP
cord-015365-iqdi99pd	119	4	Ü	ü	NN
cord-015365-iqdi99pd	119	5	berlebens	berlebens	NNP
cord-015365-iqdi99pd	120	1	(	(	-LRB-
cord-015365-iqdi99pd	120	2	bis	bis	NNP
cord-015365-iqdi99pd	120	3	zu	zu	NNP
cord-015365-iqdi99pd	120	4	22	22	CD
cord-015365-iqdi99pd	121	1	Jahre	Jahre	NNP
cord-015365-iqdi99pd	121	2	nach	nach	NNP
cord-015365-iqdi99pd	121	3	SZT	SZT	NNP
cord-015365-iqdi99pd	121	4	)	)	-RRB-
cord-015365-iqdi99pd	122	1	wurde	wurde	NNP
cord-015365-iqdi99pd	122	2	mittels	mittels	NNP
cord-015365-iqdi99pd	122	3	Kaplan	Kaplan	NNP
cord-015365-iqdi99pd	122	4	-	-	HYPH
cord-015365-iqdi99pd	122	5	Meier	Meier	NNP
cord-015365-iqdi99pd	122	6	Ü	Ü	NNP
cord-015365-iqdi99pd	122	7	berlebensanalyse	berlebensanalyse	NNP
cord-015365-iqdi99pd	122	8	,	,	,
cord-015365-iqdi99pd	122	9	die	die	VB
cord-015365-iqdi99pd	122	10	Komplikationsraten	Komplikationsraten	NNP
cord-015365-iqdi99pd	122	11	mittels	mittel	NNS
cord-015365-iqdi99pd	122	12	Cumulativer	Cumulativer	NNP
cord-015365-iqdi99pd	122	13	Inzidenz	Inzidenz	NNP
cord-015365-iqdi99pd	122	14	berechnet	berechnet	NN
cord-015365-iqdi99pd	122	15	.	.	.
cord-015365-iqdi99pd	123	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	123	2	.	.	.
cord-015365-iqdi99pd	124	1	Von	Von	NNP
cord-015365-iqdi99pd	124	2	den	den	NNP
cord-015365-iqdi99pd	124	3	217	217	CD
cord-015365-iqdi99pd	125	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	125	2	/	/	SYM
cord-015365-iqdi99pd	125	3	Spenderkombinationen	Spenderkombinationen	NNP
cord-015365-iqdi99pd	125	4	wiesen	wiesen	VBD
cord-015365-iqdi99pd	125	5	119	119	CD
cord-015365-iqdi99pd	125	6	keinen	keinen	NNP
cord-015365-iqdi99pd	125	7	mHag	mHag	NNP
cord-015365-iqdi99pd	125	8	-	-	HYPH
cord-015365-iqdi99pd	125	9	Mismatch	mismatch	NN
cord-015365-iqdi99pd	125	10	,	,	,
cord-015365-iqdi99pd	125	11	67	67	CD
cord-015365-iqdi99pd	125	12	einen	einen	NNP
cord-015365-iqdi99pd	125	13	mHag	mHag	NNP
cord-015365-iqdi99pd	125	14	-	-	HYPH
cord-015365-iqdi99pd	125	15	Mismatch	mismatch	NN
cord-015365-iqdi99pd	125	16	und	und	XX
cord-015365-iqdi99pd	126	1	31	31	CD
cord-015365-iqdi99pd	126	2	zwei	zwei	NNP
cord-015365-iqdi99pd	126	3	oder	oder	NNP
cord-015365-iqdi99pd	126	4	mehrere	mehrere	NNP
cord-015365-iqdi99pd	126	5	mHag	mHag	NNP
cord-015365-iqdi99pd	126	6	-	-	HYPH
cord-015365-iqdi99pd	126	7	Mismatches	mismatch	NNS
cord-015365-iqdi99pd	126	8	auf	auf	NNS
cord-015365-iqdi99pd	126	9	.	.	.
cord-015365-iqdi99pd	127	1	Sämtliche	Sämtliche	NNP
cord-015365-iqdi99pd	127	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	127	3	mit	mit	XX
cord-015365-iqdi99pd	128	1	einem	einem	NNP
cord-015365-iqdi99pd	128	2	HA-1-	HA-1-	NNP
cord-015365-iqdi99pd	128	3	,	,	,
cord-015365-iqdi99pd	128	4	HA-2-	HA-2-	NNP
cord-015365-iqdi99pd	128	5	,	,	,
cord-015365-iqdi99pd	128	6	HA-8-(HLA	HA-8-(HLA	NNP
cord-015365-iqdi99pd	128	7	-	-	HYPH
cord-015365-iqdi99pd	128	8	A2-restringiert	a2-restringiert	JJ
cord-015365-iqdi99pd	128	9	)	)	-RRB-
cord-015365-iqdi99pd	129	1	oder	oder	NNP
cord-015365-iqdi99pd	129	2	HA-3-(HLA	HA-3-(HLA	NNP
cord-015365-iqdi99pd	129	3	-	-	HYPH
cord-015365-iqdi99pd	129	4	A1-restringiert	A1-restringiert	NNP
cord-015365-iqdi99pd	129	5	)	)	-RRB-
cord-015365-iqdi99pd	130	1	Mismatch	mismatch	NN
cord-015365-iqdi99pd	130	2	zeigten	zeigten	NNP
cord-015365-iqdi99pd	131	1	eine	eine	NNP
cord-015365-iqdi99pd	131	2	geringere	geringere	NNP
cord-015365-iqdi99pd	131	3	Rezidivrate	Rezidivrate	NNP
cord-015365-iqdi99pd	131	4	als	als	NNP
cord-015365-iqdi99pd	131	5	Patienten	Patienten	NNP
cord-015365-iqdi99pd	131	6	ohne	ohne	NNP
cord-015365-iqdi99pd	131	7	den	den	NNP
cord-015365-iqdi99pd	131	8	entsprechenden	entsprechenden	NNP
cord-015365-iqdi99pd	131	9	mHag	mHag	NNP
cord-015365-iqdi99pd	131	10	-	-	HYPH
cord-015365-iqdi99pd	131	11	Mismatch	mismatch	NN
cord-015365-iqdi99pd	131	12	.	.	.
cord-015365-iqdi99pd	132	1	Ein	Ein	NNP
cord-015365-iqdi99pd	132	2	HA-2-und	HA-2-und	NNP
cord-015365-iqdi99pd	132	3	ein	ein	NN
cord-015365-iqdi99pd	133	1	HA-3-Mismatch	HA-3-Mismatch	NNP
cord-015365-iqdi99pd	133	2	waren	waren	NNP
cord-015365-iqdi99pd	133	3	jedoch	jedoch	NNP
cord-015365-iqdi99pd	134	1	mit	mit	NNP
cord-015365-iqdi99pd	134	2	einer	einer	NNP
cord-015365-iqdi99pd	134	3	erhöhten	erhöhten	VBN
cord-015365-iqdi99pd	134	4	Inzidenz	Inzidenz	NNP
cord-015365-iqdi99pd	135	1	an	an	DT
cord-015365-iqdi99pd	135	2	akuter	akuter	NN
cord-015365-iqdi99pd	135	3	GvHD	GvHD	NNP
cord-015365-iqdi99pd	135	4	und	und	IN
cord-015365-iqdi99pd	136	1	daher	daher	NNP
cord-015365-iqdi99pd	136	2	mit	mit	NNP
cord-015365-iqdi99pd	136	3	einer	einer	NNP
cord-015365-iqdi99pd	136	4	geringeren	geringeren	NNP
cord-015365-iqdi99pd	136	5	Ü	Ü	NNP
cord-015365-iqdi99pd	136	6	berlebensrate	berlebensrate	NNP
cord-015365-iqdi99pd	136	7	verbunden	verbunden	NNP
cord-015365-iqdi99pd	136	8	.	.	.
cord-015365-iqdi99pd	137	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	137	2	/	/	,
cord-015365-iqdi99pd	137	3	Spenderkombinationen	Spenderkombinationen	NNP
cord-015365-iqdi99pd	137	4	mit	mit	NNP
cord-015365-iqdi99pd	138	1	einem	einem	NNP
cord-015365-iqdi99pd	138	2	HY	HY	NNP
cord-015365-iqdi99pd	138	3	-	-	HYPH
cord-015365-iqdi99pd	138	4	Mismatch	Mismatch	NNP
cord-015365-iqdi99pd	138	5	profitierten	profitierten	NNP
cord-015365-iqdi99pd	138	6	mit	mit	NNP
cord-015365-iqdi99pd	138	7	einem	einem	NNP
cord-015365-iqdi99pd	138	8	leichten	leichten	NNP
cord-015365-iqdi99pd	138	9	Ü	Ü	NNP
cord-015365-iqdi99pd	138	10	berlebensvorteil	berlebensvorteil	NNP
cord-015365-iqdi99pd	138	11	(	(	-LRB-
cord-015365-iqdi99pd	138	12	48	48	CD
cord-015365-iqdi99pd	138	13	%	%	NN
cord-015365-iqdi99pd	138	14	vs.	vs.	IN
cord-015365-iqdi99pd	138	15	40	40	CD
cord-015365-iqdi99pd	138	16	%	%	NN
cord-015365-iqdi99pd	138	17	)	)	-RRB-
cord-015365-iqdi99pd	138	18	.	.	.
cord-015365-iqdi99pd	139	1	Interessanterweise	Interessanterweise	NNP
cord-015365-iqdi99pd	139	2	wirkten	wirkten	NN
cord-015365-iqdi99pd	139	3	sich	sich	NNP
cord-015365-iqdi99pd	139	4	mehrere	mehrere	NNP
cord-015365-iqdi99pd	139	5	mHag	mHag	NNP
cord-015365-iqdi99pd	139	6	-	-	HYPH
cord-015365-iqdi99pd	139	7	Mismatches	mismatch	NNS
cord-015365-iqdi99pd	139	8	positiv	positiv	JJ
cord-015365-iqdi99pd	139	9	auf	auf	NNS
cord-015365-iqdi99pd	139	10	das	das	NNP
cord-015365-iqdi99pd	139	11	Langzeitüberleben	Langzeitüberleben	NNP
cord-015365-iqdi99pd	139	12	aus	aus	NNP
cord-015365-iqdi99pd	139	13	.	.	.
cord-015365-iqdi99pd	140	1	Vier	Vier	NNP
cord-015365-iqdi99pd	140	2	Jahre	Jahre	NNP
cord-015365-iqdi99pd	140	3	nach	nach	NN
cord-015365-iqdi99pd	140	4	SZT	SZT	NNP
cord-015365-iqdi99pd	140	5	betrug	betrug	NNP
cord-015365-iqdi99pd	140	6	das	das	NNP
cord-015365-iqdi99pd	140	7	Gesamtüberleben	Gesamtüberleben	NNP
cord-015365-iqdi99pd	140	8	von	von	NNP
cord-015365-iqdi99pd	140	9	Patienten	Patienten	NNP
cord-015365-iqdi99pd	140	10	ohne	ohne	NNP
cord-015365-iqdi99pd	140	11	Mismatch	Mismatch	NNP
cord-015365-iqdi99pd	140	12	44	44	CD
cord-015365-iqdi99pd	140	13	%	%	NN
cord-015365-iqdi99pd	140	14	,	,	,
cord-015365-iqdi99pd	140	15	von	von	NNP
cord-015365-iqdi99pd	140	16	Patienten	Patienten	NNP
cord-015365-iqdi99pd	140	17	mit	mit	NNP
cord-015365-iqdi99pd	140	18	einem	einem	NNP
cord-015365-iqdi99pd	140	19	Mismatch	Mismatch	NNP
cord-015365-iqdi99pd	140	20	43	43	CD
cord-015365-iqdi99pd	140	21	%	%	NN
cord-015365-iqdi99pd	140	22	,	,	,
cord-015365-iqdi99pd	141	1	von	von	NNP
cord-015365-iqdi99pd	141	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	141	3	mit	mit	NNP
cord-015365-iqdi99pd	141	4	2	2	CD
cord-015365-iqdi99pd	141	5	Mismatches	mismatch	NNS
cord-015365-iqdi99pd	141	6	55	55	CD
cord-015365-iqdi99pd	141	7	%	%	NN
cord-015365-iqdi99pd	142	1	und	und	NNP
cord-015365-iqdi99pd	143	1	von	von	NNP
cord-015365-iqdi99pd	143	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	143	3	mit	mit	NNP
cord-015365-iqdi99pd	143	4	3	3	CD
cord-015365-iqdi99pd	143	5	Mismatches	mismatch	NNS
cord-015365-iqdi99pd	143	6	75	75	CD
cord-015365-iqdi99pd	143	7	%	%	NN
cord-015365-iqdi99pd	144	1	(	(	-LRB-
cord-015365-iqdi99pd	144	2	allerdings	allerdings	NNP
cord-015365-iqdi99pd	144	3	nur	nur	NNP
cord-015365-iqdi99pd	144	4	8	8	CD
cord-015365-iqdi99pd	144	5	Patienten	Patienten	NNP
cord-015365-iqdi99pd	144	6	)	)	-RRB-
cord-015365-iqdi99pd	144	7	.	.	.
cord-015365-iqdi99pd	145	1	In	in	IN
cord-015365-iqdi99pd	145	2	Ü	Ü	NNP
cord-015365-iqdi99pd	145	3	bereinstimmung	bereinstimmung	NNP
cord-015365-iqdi99pd	145	4	mit	mit	NNP
cord-015365-iqdi99pd	145	5	diesem	diesem	NNP
cord-015365-iqdi99pd	145	6	Ergebnis	Ergebnis	NNP
cord-015365-iqdi99pd	145	7	betrug	betrug	NNP
cord-015365-iqdi99pd	145	8	die	die	VB
cord-015365-iqdi99pd	145	9	Inzidenz	Inzidenz	NNP
cord-015365-iqdi99pd	145	10	der	der	NNP
cord-015365-iqdi99pd	145	11	Nonrelapse	Nonrelapse	NNP
cord-015365-iqdi99pd	146	1	-Mortalität	-Mortalität	:
cord-015365-iqdi99pd	146	2	von	von	NNP
cord-015365-iqdi99pd	146	3	Patienten	Patienten	NNP
cord-015365-iqdi99pd	146	4	ohne	ohne	NNP
cord-015365-iqdi99pd	146	5	Mismatch	Mismatch	NNP
cord-015365-iqdi99pd	146	6	50	50	CD
cord-015365-iqdi99pd	146	7	%	%	NN
cord-015365-iqdi99pd	146	8	,	,	,
cord-015365-iqdi99pd	146	9	von	von	NNP
cord-015365-iqdi99pd	146	10	Patienten	Patienten	NNP
cord-015365-iqdi99pd	146	11	mit	mit	NNP
cord-015365-iqdi99pd	146	12	einem	einem	NNP
cord-015365-iqdi99pd	146	13	Mismatch	Mismatch	NNP
cord-015365-iqdi99pd	146	14	54	54	CD
cord-015365-iqdi99pd	146	15	%	%	NN
cord-015365-iqdi99pd	146	16	und	und	IN
cord-015365-iqdi99pd	146	17	von	von	NNP
cord-015365-iqdi99pd	146	18	Patienten	Patienten	NNP
cord-015365-iqdi99pd	146	19	mit	mit	NNP
cord-015365-iqdi99pd	146	20	zwei	zwei	NNP
cord-015365-iqdi99pd	146	21	bzw	bzw	NNP
cord-015365-iqdi99pd	146	22	.	.	.
cord-015365-iqdi99pd	147	1	drei	drei	NNP
cord-015365-iqdi99pd	147	2	Mismatches	Mismatches	NNP
cord-015365-iqdi99pd	147	3	36	36	CD
cord-015365-iqdi99pd	147	4	%	%	NN
cord-015365-iqdi99pd	147	5	bzw	bzw	NNP
cord-015365-iqdi99pd	147	6	.	.	.
cord-015365-iqdi99pd	148	1	14	14	CD
cord-015365-iqdi99pd	148	2	%	%	NN
cord-015365-iqdi99pd	148	3	.	.	.
cord-015365-iqdi99pd	149	1	Eine	Eine	NNP
cord-015365-iqdi99pd	149	2	Erklärung	Erklärung	NNP
cord-015365-iqdi99pd	150	1	für	für	NNP
cord-015365-iqdi99pd	150	2	dieses	dieses	NNP
cord-015365-iqdi99pd	150	3	Ergebnis	Ergebnis	NNP
cord-015365-iqdi99pd	150	4	könnte	könnte	NNP
cord-015365-iqdi99pd	150	5	der	der	NNP
cord-015365-iqdi99pd	150	6	Graft	Graft	NNP
cord-015365-iqdi99pd	150	7	-	-	HYPH
cord-015365-iqdi99pd	150	8	versus	versus	NN
cord-015365-iqdi99pd	150	9	-	-	HYPH
cord-015365-iqdi99pd	150	10	Leukämie	Leukämie	NNP
cord-015365-iqdi99pd	150	11	Effekt	Effekt	NNP
cord-015365-iqdi99pd	150	12	sein	sein	NNP
cord-015365-iqdi99pd	150	13	,	,	,
cord-015365-iqdi99pd	150	14	der	der	NNP
cord-015365-iqdi99pd	150	15	durch	durch	NNP
cord-015365-iqdi99pd	150	16	die	die	NNP
cord-015365-iqdi99pd	151	1	erhöhte	erhöhte	NNP
cord-015365-iqdi99pd	151	2	Anzahl	Anzahl	NNP
cord-015365-iqdi99pd	151	3	an	an	DT
cord-015365-iqdi99pd	151	4	Spender	Spender	NNP
cord-015365-iqdi99pd	151	5	T	T	NNP
cord-015365-iqdi99pd	151	6	-	-	HYPH
cord-015365-iqdi99pd	151	7	Zellen	Zellen	NNP
cord-015365-iqdi99pd	151	8	induziert	induziert	NN
cord-015365-iqdi99pd	151	9	wird	wird	NNP
cord-015365-iqdi99pd	151	10	,	,	,
cord-015365-iqdi99pd	151	11	die	die	VB
cord-015365-iqdi99pd	152	1	verschiedene	verschiedene	NNP
cord-015365-iqdi99pd	152	2	hämatopoetisch	hämatopoetisch	NNP
cord-015365-iqdi99pd	152	3	-	-	HYPH
cord-015365-iqdi99pd	152	4	restringierte	restringierte	NNP
cord-015365-iqdi99pd	152	5	mHag	mHag	NNP
cord-015365-iqdi99pd	152	6	auf	auf	NNP
cord-015365-iqdi99pd	152	7	den	den	NNP
cord-015365-iqdi99pd	152	8	residuellen	residuellen	NNP
cord-015365-iqdi99pd	152	9	Leukämiezellen	Leukämiezellen	NNP
cord-015365-iqdi99pd	152	10	des	des	NNP
cord-015365-iqdi99pd	152	11	Patienten	Patienten	NNP
cord-015365-iqdi99pd	152	12	erkennen	erkennen	NNP
cord-015365-iqdi99pd	152	13	und	und	IN
cord-015365-iqdi99pd	153	1	diese	diese	NNP
cord-015365-iqdi99pd	153	2	zerstören	zerstören	NNP
cord-015365-iqdi99pd	153	3	.	.	.
cord-015365-iqdi99pd	154	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	154	2	.	.	.
cord-015365-iqdi99pd	155	1	Die	die	VB
cord-015365-iqdi99pd	155	2	Bestimmung	Bestimmung	NNP
cord-015365-iqdi99pd	155	3	von	von	NNP
cord-015365-iqdi99pd	155	4	mHag	mHag	NNP
cord-015365-iqdi99pd	155	5	in	in	IN
cord-015365-iqdi99pd	156	1	Patient	patient	JJ
cord-015365-iqdi99pd	156	2	und	und	IN
cord-015365-iqdi99pd	156	3	Spender	spender	NN
cord-015365-iqdi99pd	156	4	vor	vor	NNP
cord-015365-iqdi99pd	156	5	der	der	NNP
cord-015365-iqdi99pd	156	6	SZT	SZT	NNP
cord-015365-iqdi99pd	156	7	wäre	wäre	NNP
cord-015365-iqdi99pd	156	8	eine	eine	NNP
cord-015365-iqdi99pd	156	9	sinnvolle	sinnvolle	NN
cord-015365-iqdi99pd	157	1	Maßnahme	Maßnahme	NNP
cord-015365-iqdi99pd	157	2	zur	zur	NNP
cord-015365-iqdi99pd	157	3	zusätzlichen	zusätzlichen	NNP
cord-015365-iqdi99pd	157	4	Risikoabschätzung	Risikoabschätzung	NNP
cord-015365-iqdi99pd	157	5	von	von	NNP
cord-015365-iqdi99pd	157	6	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	157	7	,	,	,
cord-015365-iqdi99pd	157	8	vor	vor	NNP
cord-015365-iqdi99pd	157	9	allem	allem	FW
cord-015365-iqdi99pd	157	10	aber	aber	NNP
cord-015365-iqdi99pd	157	11	Ü	ü	NN
cord-015365-iqdi99pd	157	12	berleben	berleben	NN
cord-015365-iqdi99pd	157	13	nach	nach	NNP
cord-015365-iqdi99pd	157	14	SZT	SZT	NNP
cord-015365-iqdi99pd	157	15	.	.	.
cord-015365-iqdi99pd	157	16	"	"	''
cord-015365-iqdi99pd	158	1	Stuhltransplantation	Stuhltransplantation	NNP
cord-015365-iqdi99pd	158	2	"	"	``
cord-015365-iqdi99pd	158	3	als	als	NN
cord-015365-iqdi99pd	158	4	erfolgreiche	erfolgreiche	NNP
cord-015365-iqdi99pd	158	5	Therapie	Therapie	NNP
cord-015365-iqdi99pd	158	6	bei	bei	NNP
cord-015365-iqdi99pd	158	7	schwerer	schwerer	NN
cord-015365-iqdi99pd	158	8	idiopathischer	idiopathischer	NN
cord-015365-iqdi99pd	158	9	Enterocolitis	Enterocolitis	NNP
cord-015365-iqdi99pd	158	10	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	158	11	.	.	.
cord-015365-iqdi99pd	159	1	Die	die	VB
cord-015365-iqdi99pd	159	2	normale	normale	FW
cord-015365-iqdi99pd	159	3	humane	humane	JJ
cord-015365-iqdi99pd	159	4	Darmflora	Darmflora	NNP
cord-015365-iqdi99pd	159	5	umfasst	umfasst	NNP
cord-015365-iqdi99pd	159	6	etwa	etwa	NNP
cord-015365-iqdi99pd	159	7	100	100	CD
cord-015365-iqdi99pd	159	8	Billionen	Billionen	NNP
cord-015365-iqdi99pd	159	9	Bakterien	Bakterien	NNP
cord-015365-iqdi99pd	159	10	,	,	,
cord-015365-iqdi99pd	159	11	von	von	NNP
cord-015365-iqdi99pd	159	12	denen	denen	NNP
cord-015365-iqdi99pd	159	13	der	der	NNP
cord-015365-iqdi99pd	159	14	Großteil	Großteil	NNP
cord-015365-iqdi99pd	159	15	mit	mit	VBD
cord-015365-iqdi99pd	159	16	konventionellen	konventionellen	NNP
cord-015365-iqdi99pd	159	17	Methoden	Methoden	NNP
cord-015365-iqdi99pd	159	18	nicht	nicht	NNP
cord-015365-iqdi99pd	159	19	kultivierbar	kultivierbar	NNP
cord-015365-iqdi99pd	159	20	ist	ist	NN
cord-015365-iqdi99pd	159	21	.	.	.
cord-015365-iqdi99pd	160	1	Störungen	Störungen	NNP
cord-015365-iqdi99pd	160	2	in	in	IN
cord-015365-iqdi99pd	160	3	der	der	NNP
cord-015365-iqdi99pd	160	4	Zusammensetzung	Zusammensetzung	NNP
cord-015365-iqdi99pd	160	5	der	der	NNP
cord-015365-iqdi99pd	160	6	Darmflora	Darmflora	NNP
cord-015365-iqdi99pd	160	7	scheinen	scheinen	NNP
cord-015365-iqdi99pd	160	8	bei	bei	NNP
cord-015365-iqdi99pd	160	9	der	der	NNP
cord-015365-iqdi99pd	160	10	Entstehung	Entstehung	NNP
cord-015365-iqdi99pd	160	11	von	von	NNP
cord-015365-iqdi99pd	160	12	Darmentzündungen	Darmentzündungen	NNP
cord-015365-iqdi99pd	160	13	und	und	XX
cord-015365-iqdi99pd	161	1	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	161	2	eine	eine	NNP
cord-015365-iqdi99pd	161	3	wichtige	wichtige	NN
cord-015365-iqdi99pd	161	4	Rolle	Rolle	NNP
cord-015365-iqdi99pd	161	5	zu	zu	NNP
cord-015365-iqdi99pd	161	6	spielen	spielen	NNP
cord-015365-iqdi99pd	161	7	.	.	.
cord-015365-iqdi99pd	162	1	Die	die	VB
cord-015365-iqdi99pd	162	2	fäkale	fäkale	NNP
cord-015365-iqdi99pd	163	1	Bakterientherapie	Bakterientherapie	NNP
cord-015365-iqdi99pd	163	2	(	(	-LRB-
cord-015365-iqdi99pd	163	3	Stuhltransplantation	Stuhltransplantation	NNP
cord-015365-iqdi99pd	163	4	)	)	-RRB-
cord-015365-iqdi99pd	163	5	zielt	zielt	NNP
cord-015365-iqdi99pd	164	1	auf	auf	NNP
cord-015365-iqdi99pd	164	2	die	die	VBP
cord-015365-iqdi99pd	165	1	Wiederherstellung	Wiederherstellung	NNP
cord-015365-iqdi99pd	165	2	einer	einer	NNP
cord-015365-iqdi99pd	166	1	gestörten	gestörten	NNP
cord-015365-iqdi99pd	166	2	Darmflora	Darmflora	NNP
cord-015365-iqdi99pd	166	3	durch	durch	NNP
cord-015365-iqdi99pd	166	4	Ü	Ü	NNP
cord-015365-iqdi99pd	166	5	bertragung	bertragung	NNP
cord-015365-iqdi99pd	166	6	von	von	NNP
cord-015365-iqdi99pd	166	7	Stuhl	Stuhl	NNP
cord-015365-iqdi99pd	166	8	eines	eines	NNP
cord-015365-iqdi99pd	166	9	Gesunden	Gesunden	NNP
cord-015365-iqdi99pd	166	10	in	in	IN
cord-015365-iqdi99pd	166	11	den	den	NNP
cord-015365-iqdi99pd	166	12	Darm	Darm	NNP
cord-015365-iqdi99pd	166	13	eines	eine	NNS
cord-015365-iqdi99pd	166	14	Erkrankten	Erkrankten	NNP
cord-015365-iqdi99pd	166	15	.	.	.
cord-015365-iqdi99pd	167	1	Diese	Diese	NNP
cord-015365-iqdi99pd	167	2	Therapie	Therapie	NNP
cord-015365-iqdi99pd	167	3	wird	wird	NNP
cord-015365-iqdi99pd	167	4	erfolgreich	erfolgreich	JJ
cord-015365-iqdi99pd	167	5	bei	bei	NNP
cord-015365-iqdi99pd	167	6	therapierefraktären	therapierefraktären	NNP
cord-015365-iqdi99pd	167	7	Clostridium	Clostridium	NNP
cord-015365-iqdi99pd	167	8	difficile	difficile	NN
cord-015365-iqdi99pd	167	9	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	167	10	eingesetzt	eingesetzt	VBD
cord-015365-iqdi99pd	167	11	.	.	.
cord-015365-iqdi99pd	168	1	Fallbericht	Fallbericht	NNP
cord-015365-iqdi99pd	168	2	und	und	IN
cord-015365-iqdi99pd	168	3	Methodik	Methodik	NNP
cord-015365-iqdi99pd	168	4	.	.	.
cord-015365-iqdi99pd	169	1	Eine	Eine	NNP
cord-015365-iqdi99pd	170	1	16-jährige	16-jährige	CD
cord-015365-iqdi99pd	170	2	Patientin	Patientin	NNP
cord-015365-iqdi99pd	170	3	wurde	wurde	VBD
cord-015365-iqdi99pd	170	4	aufgrund	aufgrund	NNP
cord-015365-iqdi99pd	170	5	eines	eines	NNP
cord-015365-iqdi99pd	170	6	Schädelhirntraumas	Schädelhirntraumas	NNP
cord-015365-iqdi99pd	170	7	intensivmedizinisch	intensivmedizinisch	NNP
cord-015365-iqdi99pd	170	8	behandelt	behandelt	NNP
cord-015365-iqdi99pd	170	9	.	.	.
cord-015365-iqdi99pd	171	1	Unter	Unter	NNP
cord-015365-iqdi99pd	171	2	einer	einer	NNP
cord-015365-iqdi99pd	171	3	mehrfachen	mehrfachen	NNP
cord-015365-iqdi99pd	171	4	,	,	,
cord-015365-iqdi99pd	171	5	antibiotischen	antibiotischen	NNP
cord-015365-iqdi99pd	171	6	Therapie	Therapie	NNP
cord-015365-iqdi99pd	171	7	in	in	IN
cord-015365-iqdi99pd	171	8	Kombination	Kombination	NNP
cord-015365-iqdi99pd	171	9	mit	mit	NNP
cord-015365-iqdi99pd	171	10	Steroiden	Steroiden	NNP
cord-015365-iqdi99pd	171	11	entwickelte	entwickelte	NNP
cord-015365-iqdi99pd	171	12	die	die	VBP
cord-015365-iqdi99pd	171	13	Patientin	Patientin	NNP
cord-015365-iqdi99pd	171	14	eine	eine	NNP
cord-015365-iqdi99pd	171	15	schwere	schwere	NN
cord-015365-iqdi99pd	171	16	Enterocolitis	Enterocolitis	NNP
cord-015365-iqdi99pd	171	17	mit	mit	NNP
cord-015365-iqdi99pd	171	18	ausgeprägter	ausgeprägter	NNP
cord-015365-iqdi99pd	171	19	Diarrhoe	Diarrhoe	NNP
cord-015365-iqdi99pd	172	1	(	(	-LRB-
cord-015365-iqdi99pd	172	2	bis	bis	NNP
cord-015365-iqdi99pd	172	3	zu	zu	NNP
cord-015365-iqdi99pd	172	4	7	7	CD
cord-015365-iqdi99pd	172	5	Litern	Litern	NNP
cord-015365-iqdi99pd	172	6	Stuhl	Stuhl	NNP
cord-015365-iqdi99pd	172	7	pro	pro	JJ
cord-015365-iqdi99pd	172	8	Tag	tag	NN
cord-015365-iqdi99pd	172	9	)	)	-RRB-
cord-015365-iqdi99pd	172	10	.	.	.
cord-015365-iqdi99pd	173	1	Die	die	VB
cord-015365-iqdi99pd	173	2	histologischen	histologischen	NN
cord-015365-iqdi99pd	173	3	und	und	IN
cord-015365-iqdi99pd	173	4	endoskopischen	endoskopischen	NNP
cord-015365-iqdi99pd	173	5	Befunde	Befunde	NNP
cord-015365-iqdi99pd	173	6	der	der	NNP
cord-015365-iqdi99pd	173	7	Darmentzündung	Darmentzündung	NNP
cord-015365-iqdi99pd	173	8	zeigte	zeigte	NN
cord-015365-iqdi99pd	173	9	das	das	NNP
cord-015365-iqdi99pd	173	10	Bild	Bild	NNP
cord-015365-iqdi99pd	173	11	einer	einer	NNP
cord-015365-iqdi99pd	173	12	Graft	Graft	NNP
cord-015365-iqdi99pd	173	13	versus	versus	IN
cord-015365-iqdi99pd	173	14	Host	Host	NNP
cord-015365-iqdi99pd	173	15	Disease	Disease	NNP
cord-015365-iqdi99pd	173	16	(	(	-LRB-
cord-015365-iqdi99pd	173	17	GvHD	GvHD	NNP
cord-015365-iqdi99pd	173	18	)	)	-RRB-
cord-015365-iqdi99pd	173	19	artigen	artigen	NNP
cord-015365-iqdi99pd	173	20	Entzündung	Entzündung	NNP
cord-015365-iqdi99pd	173	21	.	.	.
cord-015365-iqdi99pd	174	1	Eine	Eine	NNP
cord-015365-iqdi99pd	174	2	Abklärung	Abklärung	NNP
cord-015365-iqdi99pd	174	3	auf	auf	NNP
cord-015365-iqdi99pd	174	4	mögliche	mögliche	NN
cord-015365-iqdi99pd	174	5	Ursachen	Ursachen	NNP
cord-015365-iqdi99pd	175	1	insbesondere	insbesondere	NNP
cord-015365-iqdi99pd	175	2	auf	auf	NNP
cord-015365-iqdi99pd	175	3	infektiöse	infektiöse	NNP
cord-015365-iqdi99pd	175	4	Erreger	Erreger	NNP
cord-015365-iqdi99pd	175	5	blieb	blieb	NNP
cord-015365-iqdi99pd	176	1	negativ	negativ	NNP
cord-015365-iqdi99pd	176	2	.	.	.
cord-015365-iqdi99pd	177	1	I	-PRON-	PRP
cord-015365-iqdi99pd	177	2	m	be	VBP
cord-015365-iqdi99pd	177	3	Verlauf	Verlauf	NNP
cord-015365-iqdi99pd	177	4	nach	nach	NNP
cord-015365-iqdi99pd	177	5	8	8	CD
cord-015365-iqdi99pd	178	1	Wochen	Wochen	NNP
cord-015365-iqdi99pd	178	2	kam	kam	NNP
cord-015365-iqdi99pd	179	1	es	es	XX
cord-015365-iqdi99pd	179	2	zu	zu	NNP
cord-015365-iqdi99pd	179	3	einer	einer	NNP
cord-015365-iqdi99pd	179	4	spontanen	spontanen	NNP
cord-015365-iqdi99pd	180	1	Besserung	Besserung	NNP
cord-015365-iqdi99pd	180	2	der	der	NNP
cord-015365-iqdi99pd	180	3	Entzündung	Entzündung	NNP
cord-015365-iqdi99pd	181	1	i	-PRON-	PRP
cord-015365-iqdi99pd	181	2	m	be	VBP
cord-015365-iqdi99pd	181	3	Dünndarm	Dünndarm	NNP
cord-015365-iqdi99pd	182	1	,	,	,
cord-015365-iqdi99pd	182	2	i	-PRON-	PRP
cord-015365-iqdi99pd	182	3	m	be	VBP
cord-015365-iqdi99pd	182	4	Dickdarm	Dickdarm	NNP
cord-015365-iqdi99pd	182	5	persistierte	persistierte	NNS
cord-015365-iqdi99pd	182	6	jedoch	jedoch	NNP
cord-015365-iqdi99pd	182	7	die	die	VBP
cord-015365-iqdi99pd	182	8	schwere	schwere	NNP
cord-015365-iqdi99pd	182	9	Colitis	Colitis	NNP
cord-015365-iqdi99pd	182	10	.	.	.
cord-015365-iqdi99pd	183	1	In	in	IN
cord-015365-iqdi99pd	183	2	den	den	NNP
cord-015365-iqdi99pd	183	3	histologischen	histologischen	JJ
cord-015365-iqdi99pd	183	4	Proben	Proben	NNP
cord-015365-iqdi99pd	183	5	aus	aus	NNP
cord-015365-iqdi99pd	183	6	dem	dem	NNP
cord-015365-iqdi99pd	183	7	Colon	colon	NN
cord-015365-iqdi99pd	183	8	zeigte	zeigte	NN
cord-015365-iqdi99pd	183	9	sich	sich	NNP
cord-015365-iqdi99pd	183	10	ein	ein	NNP
cord-015365-iqdi99pd	183	11	fast	fast	JJ
cord-015365-iqdi99pd	183	12	kompletter	kompletter	NNP
cord-015365-iqdi99pd	183	13	Verlust	Verlust	NNP
cord-015365-iqdi99pd	183	14	des	des	NNP
cord-015365-iqdi99pd	183	15	Epithels	Epithels	NNPS
cord-015365-iqdi99pd	183	16	.	.	.
cord-015365-iqdi99pd	184	1	Als	Als	NNP
cord-015365-iqdi99pd	184	2	Ursache	Ursache	NNP
cord-015365-iqdi99pd	184	3	der	der	NN
cord-015365-iqdi99pd	184	4	Colitis	Colitis	NNP
cord-015365-iqdi99pd	184	5	wurde	wurde	NN
cord-015365-iqdi99pd	184	6	eine	eine	NNP
cord-015365-iqdi99pd	184	7	Störung	Störung	NNP
cord-015365-iqdi99pd	184	8	der	der	NNP
cord-015365-iqdi99pd	184	9	Darmflora	Darmflora	NNP
cord-015365-iqdi99pd	184	10	durch	durch	NNP
cord-015365-iqdi99pd	184	11	die	die	NN
cord-015365-iqdi99pd	184	12	antibiotische	antibiotische	NN
cord-015365-iqdi99pd	185	1	Therapie	Therapie	NNP
cord-015365-iqdi99pd	185	2	angenommen	angenommen	NNP
cord-015365-iqdi99pd	185	3	und	und	IN
cord-015365-iqdi99pd	185	4	deshalb	deshalb	NNP
cord-015365-iqdi99pd	185	5	bei	bei	NNP
cord-015365-iqdi99pd	185	6	der	der	NNP
cord-015365-iqdi99pd	185	7	Patientin	Patientin	NNP
cord-015365-iqdi99pd	185	8	eine	eine	NNP
cord-015365-iqdi99pd	185	9	Stuhltransplantation	Stuhltransplantation	NNP
cord-015365-iqdi99pd	185	10	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	185	11	.	.	.
cord-015365-iqdi99pd	186	1	Als	Als	NNP
cord-015365-iqdi99pd	186	2	Stuhlspender	Stuhlspender	NNP
cord-015365-iqdi99pd	186	3	wurde	wurde	NNP
cord-015365-iqdi99pd	186	4	die	die	VBP
cord-015365-iqdi99pd	186	5	gesunde	gesunde	NNP
cord-015365-iqdi99pd	186	6	Mutter	Mutter	NNP
cord-015365-iqdi99pd	186	7	der	der	NNP
cord-015365-iqdi99pd	186	8	Patientin	Patientin	NNP
cord-015365-iqdi99pd	186	9	herangezogen	herangezogen	NNP
cord-015365-iqdi99pd	186	10	,	,	,
cord-015365-iqdi99pd	186	11	diese	diese	NNP
cord-015365-iqdi99pd	186	12	wurde	wurde	NNP
cord-015365-iqdi99pd	186	13	zuvor	zuvor	NNP
cord-015365-iqdi99pd	186	14	auf	auf	NNP
cord-015365-iqdi99pd	186	15	übertragbare	übertragbare	NN
cord-015365-iqdi99pd	186	16	Infektionskrankheiten	Infektionskrankheiten	NNP
cord-015365-iqdi99pd	186	17	getestet	getestet	NNP
cord-015365-iqdi99pd	186	18	.	.	.
cord-015365-iqdi99pd	187	1	Der	Der	NNP
cord-015365-iqdi99pd	187	2	Stuhl	Stuhl	NNP
cord-015365-iqdi99pd	187	3	wurde	wurde	NN
cord-015365-iqdi99pd	187	4	mit	mit	NNP
cord-015365-iqdi99pd	187	5	Kochsalzlösung	Kochsalzlösung	NNP
cord-015365-iqdi99pd	187	6	verflüssigt	verflüssigt	NNP
cord-015365-iqdi99pd	188	1	und	und	NNP
cord-015365-iqdi99pd	188	2	filtriert	filtriert	NNP
cord-015365-iqdi99pd	188	3	.	.	.
cord-015365-iqdi99pd	189	1	I	-PRON-	PRP
cord-015365-iqdi99pd	189	2	m	be	VBP
cord-015365-iqdi99pd	189	3	Anschluss	Anschluss	NNP
cord-015365-iqdi99pd	189	4	wurde	wurde	NN
cord-015365-iqdi99pd	189	5	bei	bei	NNP
cord-015365-iqdi99pd	189	6	der	der	NNP
cord-015365-iqdi99pd	189	7	Patientin	Patientin	NNP
cord-015365-iqdi99pd	189	8	eine	eine	NNP
cord-015365-iqdi99pd	189	9	Coloskopie	Coloskopie	NNP
cord-015365-iqdi99pd	189	10	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	189	11	und	und	IN
cord-015365-iqdi99pd	189	12	insgesamt	insgesamt	NNP
cord-015365-iqdi99pd	190	1	400	400	CD
cord-015365-iqdi99pd	190	2	ml	ml	NN
cord-015365-iqdi99pd	190	3	des	des	FW
cord-015365-iqdi99pd	190	4	flüssigen	flüssigen	NNP
cord-015365-iqdi99pd	190	5	Spenderstuhls	Spenderstuhls	NNP
cord-015365-iqdi99pd	190	6	in	in	IN
cord-015365-iqdi99pd	190	7	das	das	NNP
cord-015365-iqdi99pd	190	8	Ileum	Ileum	NNP
cord-015365-iqdi99pd	190	9	und	und	IN
cord-015365-iqdi99pd	190	10	Colon	Colon	NNP
cord-015365-iqdi99pd	190	11	appliziert	appliziert	NN
cord-015365-iqdi99pd	190	12	.	.	.
cord-015365-iqdi99pd	191	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	191	2	.	.	.
cord-015365-iqdi99pd	192	1	Die	die	VB
cord-015365-iqdi99pd	192	2	Stuhltransplantation	Stuhltransplantation	NNP
cord-015365-iqdi99pd	192	3	führte	führte	NN
cord-015365-iqdi99pd	192	4	bei	bei	NNP
cord-015365-iqdi99pd	192	5	der	der	NNP
cord-015365-iqdi99pd	192	6	Patientin	Patientin	NNP
cord-015365-iqdi99pd	192	7	in	in	IN
cord-015365-iqdi99pd	192	8	der	der	NNP
cord-015365-iqdi99pd	192	9	endoskopischen	endoskopischen	NNP
cord-015365-iqdi99pd	192	10	Kontrolle	Kontrolle	NNP
cord-015365-iqdi99pd	192	11	nach	nach	NNP
cord-015365-iqdi99pd	192	12	1	1	CD
cord-015365-iqdi99pd	192	13	Woche	Woche	NNP
cord-015365-iqdi99pd	192	14	zu	zu	NNP
cord-015365-iqdi99pd	192	15	einer	einer	NNP
cord-015365-iqdi99pd	192	16	rapiden	rapiden	NNP
cord-015365-iqdi99pd	193	1	Besserung	Besserung	NNP
cord-015365-iqdi99pd	193	2	vor	vor	NNP
cord-015365-iqdi99pd	193	3	allem	allem	NNP
cord-015365-iqdi99pd	193	4	des	des	FW
cord-015365-iqdi99pd	193	5	histologischen	histologischen	NNP
cord-015365-iqdi99pd	193	6	Befundes	Befundes	NNP
cord-015365-iqdi99pd	193	7	.	.	.
cord-015365-iqdi99pd	194	1	Ebenso	Ebenso	NNP
cord-015365-iqdi99pd	194	2	kam	kam	NNP
cord-015365-iqdi99pd	194	3	es	es	XX
cord-015365-iqdi99pd	194	4	zu	zu	NNP
cord-015365-iqdi99pd	194	5	einem	einem	NNP
cord-015365-iqdi99pd	194	6	schrittweisen	schrittweisen	NNP
cord-015365-iqdi99pd	195	1	Rückgang	Rückgang	NNP
cord-015365-iqdi99pd	195	2	des	des	NNP
cord-015365-iqdi99pd	195	3	Stuhlvolumens	Stuhlvolumens	NNP
cord-015365-iqdi99pd	195	4	mit	mit	NNP
cord-015365-iqdi99pd	195	5	Normalisierung	Normalisierung	NNP
cord-015365-iqdi99pd	195	6	der	der	NNP
cord-015365-iqdi99pd	195	7	Stuhlfrequenz	Stuhlfrequenz	NNP
cord-015365-iqdi99pd	195	8	nach	nach	NN
cord-015365-iqdi99pd	195	9	6	6	CD
cord-015365-iqdi99pd	195	10	Wochen	Wochen	NNP
cord-015365-iqdi99pd	195	11	.	.	.
cord-015365-iqdi99pd	196	1	In	in	IN
cord-015365-iqdi99pd	196	2	der	der	NNP
cord-015365-iqdi99pd	196	3	Kontrolle	Kontrolle	NNP
cord-015365-iqdi99pd	196	4	nach	nach	NN
cord-015365-iqdi99pd	196	5	2	2	CD
cord-015365-iqdi99pd	196	6	Monaten	Monaten	NNP
cord-015365-iqdi99pd	196	7	war	war	NN
cord-015365-iqdi99pd	196	8	der	der	NN
cord-015365-iqdi99pd	196	9	endoskopische	endoskopische	VBN
cord-015365-iqdi99pd	196	10	und	und	DT
cord-015365-iqdi99pd	197	1	histologische	histologische	NNP
cord-015365-iqdi99pd	197	2	Befund	Befund	NNP
cord-015365-iqdi99pd	197	3	i	-PRON-	PRP
cord-015365-iqdi99pd	197	4	m	be	VBP
cord-015365-iqdi99pd	197	5	Colon	Colon	NNP
cord-015365-iqdi99pd	197	6	normal	normal	JJ
cord-015365-iqdi99pd	197	7	.	.	.
cord-015365-iqdi99pd	198	1	I	-PRON-	PRP
cord-015365-iqdi99pd	198	2	m	be	VBP
cord-015365-iqdi99pd	199	1	weiteren	weiteren	NNP
cord-015365-iqdi99pd	199	2	Beobachtungszeitraum	Beobachtungszeitraum	NNP
cord-015365-iqdi99pd	199	3	nach	nach	NNP
cord-015365-iqdi99pd	199	4	5	5	CD
cord-015365-iqdi99pd	199	5	Monaten	Monaten	NNP
cord-015365-iqdi99pd	199	6	ist	ist	NN
cord-015365-iqdi99pd	199	7	es	es	XX
cord-015365-iqdi99pd	199	8	zu	zu	NNP
cord-015365-iqdi99pd	199	9	keiner	keiner	NNP
cord-015365-iqdi99pd	200	1	neuerlichen	neuerlichen	NNP
cord-015365-iqdi99pd	200	2	Reaktivierung	Reaktivierung	NNP
cord-015365-iqdi99pd	200	3	der	der	NNP
cord-015365-iqdi99pd	200	4	idiopathischen	idiopathischen	NNP
cord-015365-iqdi99pd	201	1	Enterocolitis	Enterocolitis	NNP
cord-015365-iqdi99pd	201	2	gekommen	gekommen	NNP
cord-015365-iqdi99pd	201	3	.	.	.
cord-015365-iqdi99pd	202	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	202	2	.	.	.
cord-015365-iqdi99pd	203	1	Die	die	VB
cord-015365-iqdi99pd	203	2	GvHD	GvHD	NNP
cord-015365-iqdi99pd	203	3	-	-	HYPH
cord-015365-iqdi99pd	203	4	artige	artige	NNP
cord-015365-iqdi99pd	203	5	idiopathische	idiopathische	NNP
cord-015365-iqdi99pd	204	1	Enterocolitis	Enterocolitis	NNP
cord-015365-iqdi99pd	204	2	nach	nach	NNP
cord-015365-iqdi99pd	204	3	Antibiotikatherapie	Antibiotikatherapie	NNP
cord-015365-iqdi99pd	204	4	scheint	scheint	NNP
cord-015365-iqdi99pd	205	1	durch	durch	NNP
cord-015365-iqdi99pd	205	2	eine	eine	NNP
cord-015365-iqdi99pd	205	3	persistierende	persistierende	NNP
cord-015365-iqdi99pd	205	4	Störung	Störung	NNP
cord-015365-iqdi99pd	205	5	der	der	NNP
cord-015365-iqdi99pd	205	6	Darmflora	Darmflora	NNP
cord-015365-iqdi99pd	205	7	mitbedingt	mitbedingt	NNP
cord-015365-iqdi99pd	205	8	zu	zu	NNP
cord-015365-iqdi99pd	205	9	sein	sein	NNP
cord-015365-iqdi99pd	205	10	.	.	.
cord-015365-iqdi99pd	206	1	Die	die	VB
cord-015365-iqdi99pd	206	2	Stuhltransplantation	Stuhltransplantation	NNP
cord-015365-iqdi99pd	206	3	war	war	NN
cord-015365-iqdi99pd	206	4	bei	bei	NN
cord-015365-iqdi99pd	206	5	der	der	NNP
cord-015365-iqdi99pd	206	6	beschriebenen	beschriebenen	NNP
cord-015365-iqdi99pd	207	1	Patientin	Patientin	NNP
cord-015365-iqdi99pd	207	2	mit	mit	NNP
cord-015365-iqdi99pd	207	3	diesem	diesem	NNP
cord-015365-iqdi99pd	207	4	schweren	schweren	VBZ
cord-015365-iqdi99pd	207	5	Krankheitsbild	Krankheitsbild	NNP
cord-015365-iqdi99pd	207	6	eine	eine	FW
cord-015365-iqdi99pd	207	7	sehr	sehr	NNP
cord-015365-iqdi99pd	207	8	effektive	effektive	NNP
cord-015365-iqdi99pd	207	9	Therapiemaßnahme	Therapiemaßnahme	NNP
cord-015365-iqdi99pd	207	10	.	.	.
cord-015365-iqdi99pd	208	1	Tissue	tissue	NN
cord-015365-iqdi99pd	208	2	specific	specific	JJ
cord-015365-iqdi99pd	208	3	epigenetic	epigenetic	JJ
cord-015365-iqdi99pd	208	4	memory	memory	NN
cord-015365-iqdi99pd	208	5	:	:	:
cord-015365-iqdi99pd	209	1	differentiation	differentiation	NN
cord-015365-iqdi99pd	209	2	capacity	capacity	NN
cord-015365-iqdi99pd	209	3	of	of	IN
cord-015365-iqdi99pd	209	4	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	209	5	stem	stem	NN
cord-015365-iqdi99pd	209	6	cell	cell	NN
cord-015365-iqdi99pd	209	7	is	be	VBZ
cord-015365-iqdi99pd	209	8	restricted	restrict	VBN
cord-015365-iqdi99pd	209	9	to	to	IN
cord-015365-iqdi99pd	209	10	their	-PRON-	PRP$
cord-015365-iqdi99pd	209	11	tissue	tissue	NN
cord-015365-iqdi99pd	209	12	of	of	IN
cord-015365-iqdi99pd	209	13	origin	origin	NN
cord-015365-iqdi99pd	209	14	Human	human	JJ
cord-015365-iqdi99pd	209	15	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	209	16	stem	stem	NN
cord-015365-iqdi99pd	209	17	and	and	CC
cord-015365-iqdi99pd	209	18	progenitor	progenitor	NN
cord-015365-iqdi99pd	209	19	cells	cell	NNS
cord-015365-iqdi99pd	209	20	(	(	-LRB-
cord-015365-iqdi99pd	209	21	MSPCs	mspc	NNS
cord-015365-iqdi99pd	209	22	)	)	-RRB-
cord-015365-iqdi99pd	209	23	are	be	VBP
cord-015365-iqdi99pd	209	24	currently	currently	RB
cord-015365-iqdi99pd	209	25	evaluated	evaluate	VBN
cord-015365-iqdi99pd	209	26	in	in	IN
cord-015365-iqdi99pd	209	27	clinical	clinical	JJ
cord-015365-iqdi99pd	209	28	trials	trial	NNS
cord-015365-iqdi99pd	209	29	for	for	IN
cord-015365-iqdi99pd	209	30	bone	bone	NN
cord-015365-iqdi99pd	209	31	and	and	CC
cord-015365-iqdi99pd	209	32	marrow	marrow	NN
cord-015365-iqdi99pd	209	33	regeneration	regeneration	NN
cord-015365-iqdi99pd	209	34	and	and	CC
cord-015365-iqdi99pd	209	35	their	-PRON-	PRP$
cord-015365-iqdi99pd	209	36	immune	immune	JJ
cord-015365-iqdi99pd	209	37	modulation	modulation	NN
cord-015365-iqdi99pd	209	38	potential	potential	NN
cord-015365-iqdi99pd	209	39	.	.	.
cord-015365-iqdi99pd	210	1	MSPCs	mspc	NNS
cord-015365-iqdi99pd	210	2	from	from	IN
cord-015365-iqdi99pd	210	3	virtually	virtually	RB
cord-015365-iqdi99pd	210	4	all	all	DT
cord-015365-iqdi99pd	210	5	tissues	tissue	NNS
cord-015365-iqdi99pd	210	6	appear	appear	VBP
cord-015365-iqdi99pd	210	7	indistinguishable	indistinguishable	JJ
cord-015365-iqdi99pd	210	8	regarding	regard	VBG
cord-015365-iqdi99pd	210	9	immunephenotype	immunephenotype	NN
cord-015365-iqdi99pd	210	10	and	and	CC
cord-015365-iqdi99pd	210	11	multipotent	multipotent	JJ
cord-015365-iqdi99pd	210	12	differentiation	differentiation	NN
cord-015365-iqdi99pd	210	13	capacity	capacity	NN
cord-015365-iqdi99pd	210	14	in	in	IN
cord-015365-iqdi99pd	210	15	vitro	vitro	FW
cord-015365-iqdi99pd	210	16	.	.	.
cord-015365-iqdi99pd	211	1	Improvements	improvement	NNS
cord-015365-iqdi99pd	211	2	of	of	IN
cord-015365-iqdi99pd	211	3	limited	limited	JJ
cord-015365-iqdi99pd	211	4	clinical	clinical	JJ
cord-015365-iqdi99pd	211	5	efficiency	efficiency	NN
cord-015365-iqdi99pd	211	6	are	be	VBP
cord-015365-iqdi99pd	211	7	hampered	hamper	VBN
cord-015365-iqdi99pd	211	8	by	by	IN
cord-015365-iqdi99pd	211	9	a	a	DT
cord-015365-iqdi99pd	211	10	lack	lack	NN
cord-015365-iqdi99pd	211	11	of	of	IN
cord-015365-iqdi99pd	211	12	understanding	understand	VBG
cord-015365-iqdi99pd	211	13	MSPC	MSPC	NNP
cord-015365-iqdi99pd	211	14	functionality	functionality	NN
cord-015365-iqdi99pd	211	15	in	in	IN
cord-015365-iqdi99pd	211	16	vivo	vivo	NNP
cord-015365-iqdi99pd	211	17	.	.	.
cord-015365-iqdi99pd	212	1	Here	here	RB
cord-015365-iqdi99pd	212	2	we	-PRON-	PRP
cord-015365-iqdi99pd	212	3	demonstrate	demonstrate	VBP
cord-015365-iqdi99pd	212	4	that	that	IN
cord-015365-iqdi99pd	212	5	the	the	DT
cord-015365-iqdi99pd	212	6	capacity	capacity	NN
cord-015365-iqdi99pd	212	7	of	of	IN
cord-015365-iqdi99pd	212	8	in	in	IN
cord-015365-iqdi99pd	212	9	vivo	vivo	FW
cord-015365-iqdi99pd	212	10	endochondral	endochondral	JJ
cord-015365-iqdi99pd	212	11	bone	bone	NN
cord-015365-iqdi99pd	212	12	formation	formation	NN
cord-015365-iqdi99pd	212	13	followed	follow	VBN
cord-015365-iqdi99pd	212	14	by	by	IN
cord-015365-iqdi99pd	212	15	infiltration	infiltration	NN
cord-015365-iqdi99pd	212	16	of	of	IN
cord-015365-iqdi99pd	212	17	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	212	18	components	component	NNS
cord-015365-iqdi99pd	212	19	can	can	MD
cord-015365-iqdi99pd	212	20	be	be	VB
cord-015365-iqdi99pd	212	21	used	use	VBN
cord-015365-iqdi99pd	212	22	as	as	IN
cord-015365-iqdi99pd	212	23	a	a	DT
cord-015365-iqdi99pd	212	24	surrogate	surrogate	NN
cord-015365-iqdi99pd	212	25	to	to	TO
cord-015365-iqdi99pd	212	26	determine	determine	VB
cord-015365-iqdi99pd	212	27	in	in	IN
cord-015365-iqdi99pd	212	28	vivo	vivo	NNP
cord-015365-iqdi99pd	212	29	MSPC	MSPC	NNP
cord-015365-iqdi99pd	212	30	-	-	HYPH
cord-015365-iqdi99pd	212	31	multipotentiality	multipotentiality	NN
cord-015365-iqdi99pd	212	32	.	.	.
cord-015365-iqdi99pd	213	1	MSPCs	mspc	NNS
cord-015365-iqdi99pd	213	2	from	from	IN
cord-015365-iqdi99pd	213	3	bone	bone	NN
cord-015365-iqdi99pd	213	4	marrow	marrow	NN
cord-015365-iqdi99pd	213	5	(	(	-LRB-
cord-015365-iqdi99pd	213	6	BM	BM	NNP
cord-015365-iqdi99pd	213	7	)	)	-RRB-
cord-015365-iqdi99pd	213	8	,	,	,
cord-015365-iqdi99pd	213	9	adipose	adipose	JJ
cord-015365-iqdi99pd	213	10	tissue	tissue	NN
cord-015365-iqdi99pd	213	11	(	(	-LRB-
cord-015365-iqdi99pd	213	12	AT	at	IN
cord-015365-iqdi99pd	213	13	)	)	-RRB-
cord-015365-iqdi99pd	213	14	and	and	CC
cord-015365-iqdi99pd	213	15	umbilical	umbilical	JJ
cord-015365-iqdi99pd	213	16	cord	cord	NN
cord-015365-iqdi99pd	213	17	(	(	-LRB-
cord-015365-iqdi99pd	213	18	UC	UC	NNP
cord-015365-iqdi99pd	213	19	)	)	-RRB-
cord-015365-iqdi99pd	213	20	have	have	VBP
cord-015365-iqdi99pd	213	21	been	be	VBN
cord-015365-iqdi99pd	213	22	isolated	isolate	VBN
cord-015365-iqdi99pd	213	23	.	.	.
cord-015365-iqdi99pd	214	1	Comparative	comparative	JJ
cord-015365-iqdi99pd	214	2	analysis	analysis	NN
cord-015365-iqdi99pd	214	3	of	of	IN
cord-015365-iqdi99pd	214	4	immune	immune	JJ
cord-015365-iqdi99pd	214	5	-	-	HYPH
cord-015365-iqdi99pd	214	6	phenotype	phenotype	NN
cord-015365-iqdi99pd	214	7	,	,	,
cord-015365-iqdi99pd	214	8	adipo-	adipo-	RB
cord-015365-iqdi99pd	214	9	,	,	,
cord-015365-iqdi99pd	214	10	chondro	chondro	NN
cord-015365-iqdi99pd	214	11	-	-	:
cord-015365-iqdi99pd	214	12	and	and	CC
cord-015365-iqdi99pd	214	13	osteogenic	osteogenic	JJ
cord-015365-iqdi99pd	214	14	differentiation	differentiation	NN
cord-015365-iqdi99pd	214	15	potential	potential	NN
cord-015365-iqdi99pd	214	16	in	in	IN
cord-015365-iqdi99pd	214	17	vitro	vitro	FW
cord-015365-iqdi99pd	214	18	as	as	RB
cord-015365-iqdi99pd	214	19	well	well	RB
cord-015365-iqdi99pd	214	20	as	as	IN
cord-015365-iqdi99pd	214	21	expression	expression	NN
cord-015365-iqdi99pd	214	22	analysis	analysis	NN
cord-015365-iqdi99pd	214	23	of	of	IN
cord-015365-iqdi99pd	214	24	key	key	JJ
cord-015365-iqdi99pd	214	25	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	214	26	lineage	lineage	NN
cord-015365-iqdi99pd	214	27	genes	gene	NNS
cord-015365-iqdi99pd	214	28	were	be	VBD
cord-015365-iqdi99pd	214	29	performed	perform	VBN
cord-015365-iqdi99pd	214	30	.	.	.
cord-015365-iqdi99pd	215	1	Epigenetic	epigenetic	JJ
cord-015365-iqdi99pd	215	2	profiling	profiling	NN
cord-015365-iqdi99pd	215	3	of	of	IN
cord-015365-iqdi99pd	215	4	MSPCs	mspc	NNS
cord-015365-iqdi99pd	215	5	was	be	VBD
cord-015365-iqdi99pd	215	6	done	do	VBN
cord-015365-iqdi99pd	215	7	using	use	VBG
cord-015365-iqdi99pd	215	8	a	a	DT
cord-015365-iqdi99pd	215	9	methylation	methylation	NN
cord-015365-iqdi99pd	215	10	array	array	NN
cord-015365-iqdi99pd	215	11	.	.	.
cord-015365-iqdi99pd	216	1	In	in	IN
cord-015365-iqdi99pd	216	2	vivo	vivo	NN
cord-015365-iqdi99pd	216	3	differentiation	differentiation	NN
cord-015365-iqdi99pd	216	4	capacity	capacity	NN
cord-015365-iqdi99pd	216	5	was	be	VBD
cord-015365-iqdi99pd	216	6	tested	test	VBN
cord-015365-iqdi99pd	216	7	by	by	IN
cord-015365-iqdi99pd	216	8	transplanting	transplant	VBG
cord-015365-iqdi99pd	216	9	MSPCs	mspc	NNS
cord-015365-iqdi99pd	216	10	subcutaneously	subcutaneously	RB
cord-015365-iqdi99pd	216	11	into	into	IN
cord-015365-iqdi99pd	216	12	immune	immune	NN
cord-015365-iqdi99pd	216	13	-	-	HYPH
cord-015365-iqdi99pd	216	14	compromised	compromise	VBN
cord-015365-iqdi99pd	216	15	mice	mouse	NNS
cord-015365-iqdi99pd	216	16	.	.	.
cord-015365-iqdi99pd	217	1	The	the	DT
cord-015365-iqdi99pd	217	2	developmental	developmental	JJ
cord-015365-iqdi99pd	217	3	sequence	sequence	NN
cord-015365-iqdi99pd	217	4	of	of	IN
cord-015365-iqdi99pd	217	5	chondrogenic	chondrogenic	NNP
cord-015365-iqdi99pd	217	6	and	and	CC
cord-015365-iqdi99pd	217	7	osteogenic	osteogenic	JJ
cord-015365-iqdi99pd	217	8	as	as	IN
cord-015365-iqdi99pd	217	9	compared	compare	VBN
cord-015365-iqdi99pd	217	10	to	to	IN
cord-015365-iqdi99pd	217	11	perivascular	perivascular	JJ
cord-015365-iqdi99pd	217	12	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	217	13	tissue	tissue	NN
cord-015365-iqdi99pd	217	14	formation	formation	NN
cord-015365-iqdi99pd	217	15	was	be	VBD
cord-015365-iqdi99pd	217	16	analyzed	analyze	VBN
cord-015365-iqdi99pd	217	17	.	.	.
cord-015365-iqdi99pd	218	1	Formation	formation	NN
cord-015365-iqdi99pd	218	2	of	of	IN
cord-015365-iqdi99pd	218	3	a	a	DT
cord-015365-iqdi99pd	218	4	marrow	marrow	NN
cord-015365-iqdi99pd	218	5	niche	niche	NN
cord-015365-iqdi99pd	218	6	with	with	IN
cord-015365-iqdi99pd	218	7	establishment	establishment	NN
cord-015365-iqdi99pd	218	8	of	of	IN
cord-015365-iqdi99pd	218	9	the	the	DT
cord-015365-iqdi99pd	218	10	complete	complete	JJ
cord-015365-iqdi99pd	218	11	host	host	NN
cord-015365-iqdi99pd	218	12	hematopoiesis	hematopoiesis	NN
cord-015365-iqdi99pd	218	13	was	be	VBD
cord-015365-iqdi99pd	218	14	studied	study	VBN
cord-015365-iqdi99pd	218	15	.	.	.
cord-015365-iqdi99pd	219	1	Secondary	secondary	JJ
cord-015365-iqdi99pd	219	2	transplants	transplant	NNS
cord-015365-iqdi99pd	219	3	of	of	IN
cord-015365-iqdi99pd	219	4	MSPCs	mspc	NNS
cord-015365-iqdi99pd	219	5	were	be	VBD
cord-015365-iqdi99pd	219	6	performed	perform	VBN
cord-015365-iqdi99pd	219	7	and	and	CC
cord-015365-iqdi99pd	219	8	analyzed	analyze	VBN
cord-015365-iqdi99pd	219	9	equally	equally	RB
cord-015365-iqdi99pd	219	10	.	.	.
cord-015365-iqdi99pd	220	1	MSPCs	mspc	NNS
cord-015365-iqdi99pd	220	2	from	from	IN
cord-015365-iqdi99pd	220	3	all	all	DT
cord-015365-iqdi99pd	220	4	tissues	tissue	NNS
cord-015365-iqdi99pd	220	5	analyzed	analyze	VBD
cord-015365-iqdi99pd	220	6	show	show	VBP
cord-015365-iqdi99pd	220	7	an	an	DT
cord-015365-iqdi99pd	220	8	almost	almost	RB
cord-015365-iqdi99pd	220	9	identical	identical	JJ
cord-015365-iqdi99pd	220	10	immune	immune	JJ
cord-015365-iqdi99pd	220	11	-	-	HYPH
cord-015365-iqdi99pd	220	12	phenotype	phenotype	NN
cord-015365-iqdi99pd	220	13	using	use	VBG
cord-015365-iqdi99pd	220	14	a	a	DT
cord-015365-iqdi99pd	220	15	MSPC	MSPC	NNP
cord-015365-iqdi99pd	220	16	marker	marker	NN
cord-015365-iqdi99pd	220	17	profile	profile	NN
cord-015365-iqdi99pd	220	18	.	.	.
cord-015365-iqdi99pd	221	1	Osteo	Osteo	NNP
cord-015365-iqdi99pd	221	2	-	-	HYPH
cord-015365-iqdi99pd	221	3	and	and	CC
cord-015365-iqdi99pd	221	4	adipogenic	adipogenic	JJ
cord-015365-iqdi99pd	221	5	differentiation	differentiation	NN
cord-015365-iqdi99pd	221	6	potential	potential	NN
cord-015365-iqdi99pd	221	7	in	in	IN
cord-015365-iqdi99pd	221	8	vitro	vitro	FW
cord-015365-iqdi99pd	221	9	as	as	RB
cord-015365-iqdi99pd	221	10	well	well	RB
cord-015365-iqdi99pd	221	11	as	as	IN
cord-015365-iqdi99pd	221	12	gene	gene	NN
cord-015365-iqdi99pd	221	13	expression	expression	NN
cord-015365-iqdi99pd	221	14	can	can	MD
cord-015365-iqdi99pd	221	15	not	not	RB
cord-015365-iqdi99pd	221	16	distinguish	distinguish	VB
cord-015365-iqdi99pd	221	17	tissuespecific	tissuespecific	JJ
cord-015365-iqdi99pd	221	18	MSPCs	mspc	NNS
cord-015365-iqdi99pd	221	19	.	.	.
cord-015365-iqdi99pd	222	1	MSPCs	mspc	NNS
cord-015365-iqdi99pd	222	2	from	from	IN
cord-015365-iqdi99pd	222	3	all	all	DT
cord-015365-iqdi99pd	222	4	tissues	tissue	NNS
cord-015365-iqdi99pd	222	5	except	except	IN
cord-015365-iqdi99pd	222	6	BM	BM	NNP
cord-015365-iqdi99pd	222	7	lack	lack	NN
cord-015365-iqdi99pd	222	8	in	in	IN
cord-015365-iqdi99pd	222	9	vitro	vitro	FW
cord-015365-iqdi99pd	222	10	chondrogenic	chondrogenic	JJ
cord-015365-iqdi99pd	222	11	differentiation	differentiation	NN
cord-015365-iqdi99pd	222	12	potential	potential	NN
cord-015365-iqdi99pd	222	13	using	use	VBG
cord-015365-iqdi99pd	222	14	stringent	stringent	JJ
cord-015365-iqdi99pd	222	15	3D	3d	JJ
cord-015365-iqdi99pd	222	16	-	-	HYPH
cord-015365-iqdi99pd	222	17	chon	chon	NNP
cord-015365-iqdi99pd	222	18	-	-	HYPH
cord-015365-iqdi99pd	222	19	drogenesis	drogenesis	NNP
cord-015365-iqdi99pd	222	20	assays	assay	NNS
cord-015365-iqdi99pd	222	21	followed	follow	VBN
cord-015365-iqdi99pd	222	22	by	by	IN
cord-015365-iqdi99pd	222	23	appropriate	appropriate	JJ
cord-015365-iqdi99pd	222	24	histological	histological	JJ
cord-015365-iqdi99pd	222	25	staining	staining	NN
cord-015365-iqdi99pd	222	26	.	.	.
cord-015365-iqdi99pd	223	1	In	in	IN
cord-015365-iqdi99pd	223	2	vivo	vivo	NN
cord-015365-iqdi99pd	223	3	studies	study	NNS
cord-015365-iqdi99pd	223	4	could	could	MD
cord-015365-iqdi99pd	223	5	strengthen	strengthen	VB
cord-015365-iqdi99pd	223	6	these	these	DT
cord-015365-iqdi99pd	223	7	findings	finding	NNS
cord-015365-iqdi99pd	223	8	,	,	,
cord-015365-iqdi99pd	223	9	because	because	IN
cord-015365-iqdi99pd	223	10	only	only	RB
cord-015365-iqdi99pd	223	11	BMderived	BMderived	NNP
cord-015365-iqdi99pd	223	12	MSPCs	MSPCs	NNPS
cord-015365-iqdi99pd	223	13	were	be	VBD
cord-015365-iqdi99pd	223	14	able	able	JJ
cord-015365-iqdi99pd	223	15	to	to	TO
cord-015365-iqdi99pd	223	16	generate	generate	VB
cord-015365-iqdi99pd	223	17	bone	bone	NN
cord-015365-iqdi99pd	223	18	through	through	IN
cord-015365-iqdi99pd	223	19	an	an	DT
cord-015365-iqdi99pd	223	20	endochondral	endochondral	JJ
cord-015365-iqdi99pd	223	21	ossification	ossification	NN
cord-015365-iqdi99pd	223	22	process	process	NN
cord-015365-iqdi99pd	223	23	with	with	IN
cord-015365-iqdi99pd	223	24	subsequent	subsequent	JJ
cord-015365-iqdi99pd	223	25	invasion	invasion	NN
cord-015365-iqdi99pd	223	26	of	of	IN
cord-015365-iqdi99pd	223	27	mouse	mouse	NN
cord-015365-iqdi99pd	223	28	marrow	marrow	NN
cord-015365-iqdi99pd	223	29	.	.	.
cord-015365-iqdi99pd	224	1	These	these	DT
cord-015365-iqdi99pd	224	2	results	result	NNS
cord-015365-iqdi99pd	224	3	correlate	correlate	VBP
cord-015365-iqdi99pd	224	4	with	with	IN
cord-015365-iqdi99pd	224	5	the	the	DT
cord-015365-iqdi99pd	224	6	epigenetic	epigenetic	JJ
cord-015365-iqdi99pd	224	7	status	status	NN
cord-015365-iqdi99pd	224	8	of	of	IN
cord-015365-iqdi99pd	224	9	the	the	DT
cord-015365-iqdi99pd	224	10	cells	cell	NNS
cord-015365-iqdi99pd	224	11	since	since	IN
cord-015365-iqdi99pd	224	12	BM	bm	NN
cord-015365-iqdi99pd	224	13	-	-	HYPH
cord-015365-iqdi99pd	224	14	derived	derive	VBN
cord-015365-iqdi99pd	224	15	MSPCs	mspc	NNS
cord-015365-iqdi99pd	224	16	cluster	cluster	NN
cord-015365-iqdi99pd	224	17	separately	separately	RB
cord-015365-iqdi99pd	224	18	in	in	IN
cord-015365-iqdi99pd	224	19	principalcomponent	principalcomponent	NN
cord-015365-iqdi99pd	224	20	-	-	HYPH
cord-015365-iqdi99pd	224	21	analysis	analysis	NN
cord-015365-iqdi99pd	224	22	(	(	-LRB-
cord-015365-iqdi99pd	224	23	PCA	PCA	NNP
cord-015365-iqdi99pd	224	24	)	)	-RRB-
cord-015365-iqdi99pd	224	25	,	,	,
cord-015365-iqdi99pd	224	26	whereas	whereas	IN
cord-015365-iqdi99pd	224	27	MSPCs	mspc	NNS
cord-015365-iqdi99pd	224	28	from	from	IN
cord-015365-iqdi99pd	224	29	all	all	DT
cord-015365-iqdi99pd	224	30	other	other	JJ
cord-015365-iqdi99pd	224	31	tissues	tissue	NNS
cord-015365-iqdi99pd	224	32	cluster	cluster	VB
cord-015365-iqdi99pd	224	33	together	together	RB
cord-015365-iqdi99pd	224	34	.	.	.
cord-015365-iqdi99pd	225	1	BM	BM	NNP
cord-015365-iqdi99pd	225	2	was	be	VBD
cord-015365-iqdi99pd	225	3	the	the	DT
cord-015365-iqdi99pd	225	4	only	only	JJ
cord-015365-iqdi99pd	225	5	tissue	tissue	NN
cord-015365-iqdi99pd	225	6	containing	contain	VBG
cord-015365-iqdi99pd	225	7	MSPCs	mspc	NNS
cord-015365-iqdi99pd	225	8	with	with	IN
cord-015365-iqdi99pd	225	9	multipotent	multipotent	JJ
cord-015365-iqdi99pd	225	10	differentiation	differentiation	NN
cord-015365-iqdi99pd	225	11	capacity	capacity	NN
cord-015365-iqdi99pd	225	12	.	.	.
cord-015365-iqdi99pd	226	1	This	this	DT
cord-015365-iqdi99pd	226	2	is	be	VBZ
cord-015365-iqdi99pd	226	3	reflected	reflect	VBN
cord-015365-iqdi99pd	226	4	by	by	IN
cord-015365-iqdi99pd	226	5	a	a	DT
cord-015365-iqdi99pd	226	6	BMspecific	BMspecific	NNP
cord-015365-iqdi99pd	226	7	epigenetic	epigenetic	JJ
cord-015365-iqdi99pd	226	8	profile	profile	NN
cord-015365-iqdi99pd	226	9	that	that	WDT
cord-015365-iqdi99pd	226	10	differs	differ	VBZ
cord-015365-iqdi99pd	226	11	from	from	IN
cord-015365-iqdi99pd	226	12	all	all	DT
cord-015365-iqdi99pd	226	13	other	other	JJ
cord-015365-iqdi99pd	226	14	tissues	tissue	NNS
cord-015365-iqdi99pd	226	15	analyzed	analyze	VBN
cord-015365-iqdi99pd	226	16	.	.	.
cord-015365-iqdi99pd	227	1	Since	since	IN
cord-015365-iqdi99pd	227	2	cartilage	cartilage	NN
cord-015365-iqdi99pd	227	3	formation	formation	NN
cord-015365-iqdi99pd	227	4	is	be	VBZ
cord-015365-iqdi99pd	227	5	an	an	DT
cord-015365-iqdi99pd	227	6	essential	essential	JJ
cord-015365-iqdi99pd	227	7	developmental	developmental	JJ
cord-015365-iqdi99pd	227	8	process	process	NN
cord-015365-iqdi99pd	227	9	important	important	JJ
cord-015365-iqdi99pd	227	10	for	for	IN
cord-015365-iqdi99pd	227	11	bone	bone	NN
cord-015365-iqdi99pd	227	12	generation	generation	NN
cord-015365-iqdi99pd	227	13	and	and	CC
cord-015365-iqdi99pd	227	14	hematopoiesis	hematopoiesis	NN
cord-015365-iqdi99pd	227	15	attraction	attraction	NN
cord-015365-iqdi99pd	227	16	,	,	,
cord-015365-iqdi99pd	227	17	an	an	DT
cord-015365-iqdi99pd	227	18	epigenetic	epigenetic	JJ
cord-015365-iqdi99pd	227	19	predisposition	predisposition	NN
cord-015365-iqdi99pd	227	20	of	of	IN
cord-015365-iqdi99pd	227	21	BM	BM	NNP
cord-015365-iqdi99pd	227	22	-	-	HYPH
cord-015365-iqdi99pd	227	23	MSPCs	mspc	NNS
cord-015365-iqdi99pd	227	24	to	to	TO
cord-015365-iqdi99pd	227	25	undergo	undergo	VB
cord-015365-iqdi99pd	227	26	endochondral	endochondral	JJ
cord-015365-iqdi99pd	227	27	ossification	ossification	NN
cord-015365-iqdi99pd	227	28	makes	make	VBZ
cord-015365-iqdi99pd	227	29	these	these	DT
cord-015365-iqdi99pd	227	30	cells	cell	NNS
cord-015365-iqdi99pd	227	31	unique	unique	JJ
cord-015365-iqdi99pd	227	32	for	for	IN
cord-015365-iqdi99pd	227	33	bone	bone	NN
cord-015365-iqdi99pd	227	34	and	and	CC
cord-015365-iqdi99pd	227	35	marrow	marrow	NN
cord-015365-iqdi99pd	227	36	regeneration	regeneration	NN
cord-015365-iqdi99pd	227	37	purposes	purpose	NNS
cord-015365-iqdi99pd	227	38	.	.	.
cord-015365-iqdi99pd	228	1	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	228	2	.	.	.
cord-015365-iqdi99pd	229	1	Die	die	VB
cord-015365-iqdi99pd	230	1	Hemmung	Hemmung	NNP
cord-015365-iqdi99pd	230	2	des	des	NNP
cord-015365-iqdi99pd	230	3	Renin	Renin	NNP
cord-015365-iqdi99pd	230	4	-	-	HYPH
cord-015365-iqdi99pd	230	5	Angiotensin	Angiotensin	NNP
cord-015365-iqdi99pd	230	6	-	-	HYPH
cord-015365-iqdi99pd	230	7	Systems	Systems	NNP
cord-015365-iqdi99pd	230	8	(	(	-LRB-
cord-015365-iqdi99pd	230	9	RAS	RAS	NNP
cord-015365-iqdi99pd	230	10	)	)	-RRB-
cord-015365-iqdi99pd	230	11	entweder	entweder	NNP
cord-015365-iqdi99pd	230	12	mit	mit	NNP
cord-015365-iqdi99pd	230	13	ACE	ACE	NNP
cord-015365-iqdi99pd	230	14	-	-	HYPH
cord-015365-iqdi99pd	230	15	Hemmern	Hemmern	NNP
cord-015365-iqdi99pd	230	16	oder	oder	NNP
cord-015365-iqdi99pd	230	17	mit	mit	NNP
cord-015365-iqdi99pd	230	18	Angiotensin	Angiotensin	NNP
cord-015365-iqdi99pd	230	19	-	-	HYPH
cord-015365-iqdi99pd	230	20	Rezeptor	Rezeptor	NNP
cord-015365-iqdi99pd	230	21	-	-	HYPH
cord-015365-iqdi99pd	230	22	Blockern	Blockern	NNP
cord-015365-iqdi99pd	230	23	(	(	-LRB-
cord-015365-iqdi99pd	230	24	ARB	ARB	NNP
cord-015365-iqdi99pd	230	25	)	)	-RRB-
cord-015365-iqdi99pd	230	26	verlangsamt	verlangsamt	NNP
cord-015365-iqdi99pd	230	27	die	die	VBP
cord-015365-iqdi99pd	231	1	Progression	progression	NN
cord-015365-iqdi99pd	231	2	unterschiedlicher	unterschiedlicher	NN
cord-015365-iqdi99pd	231	3	chronischer	chronischer	NNP
cord-015365-iqdi99pd	232	1	Nierenerkrankungen	Nierenerkrankungen	NNP
cord-015365-iqdi99pd	232	2	und	und	IN
cord-015365-iqdi99pd	232	3	der	der	NNP
cord-015365-iqdi99pd	232	4	chronischen	chronischen	NNP
cord-015365-iqdi99pd	232	5	Transplantatdysfunktion	Transplantatdysfunktion	NNP
cord-015365-iqdi99pd	232	6	.	.	.
cord-015365-iqdi99pd	233	1	RAS	RAS	NNP
cord-015365-iqdi99pd	233	2	-	-	HYPH
cord-015365-iqdi99pd	233	3	Blockierung	Blockierung	NNP
cord-015365-iqdi99pd	233	4	kann	kann	NNP
cord-015365-iqdi99pd	234	1	auch	auch	NNP
cord-015365-iqdi99pd	234	2	durch	durch	NNP
cord-015365-iqdi99pd	235	1	eine	eine	NNP
cord-015365-iqdi99pd	235	2	direkte	direkte	NNP
cord-015365-iqdi99pd	235	3	Renin	Renin	NNP
cord-015365-iqdi99pd	235	4	-	-	HYPH
cord-015365-iqdi99pd	235	5	Inhibierung	Inhibierung	NNP
cord-015365-iqdi99pd	235	6	erreicht	erreicht	NN
cord-015365-iqdi99pd	235	7	werden	werden	NNP
cord-015365-iqdi99pd	236	1	,	,	,
cord-015365-iqdi99pd	236	2	die	die	VB
cord-015365-iqdi99pd	236	3	aber	aber	NNP
cord-015365-iqdi99pd	236	4	infolge	infolge	NNP
cord-015365-iqdi99pd	236	5	einer	einer	NNP
cord-015365-iqdi99pd	236	6	verminderten	verminderten	NNP
cord-015365-iqdi99pd	236	7	Produktion	Produktion	NNP
cord-015365-iqdi99pd	236	8	der	der	NN
cord-015365-iqdi99pd	236	9	protektiven	protektiven	NNP
cord-015365-iqdi99pd	237	1	Angiotensin	angiotensin	NN
cord-015365-iqdi99pd	237	2	II	II	NNP
cord-015365-iqdi99pd	238	1	-Spaltprodukte	-Spaltprodukte	:
cord-015365-iqdi99pd	238	2	wie	wie	NNP
cord-015365-iqdi99pd	238	3	z.	z.	NNP
cord-015365-iqdi99pd	238	4	B.	B.	NNP
cord-015365-iqdi99pd	238	5	Angiotensin	Angiotensin	NNP
cord-015365-iqdi99pd	238	6	(	(	-LRB-
cord-015365-iqdi99pd	238	7	Ang)(1	Ang)(1	NNP
cord-015365-iqdi99pd	238	8	-	-	HYPH
cord-015365-iqdi99pd	238	9	7	7	CD
cord-015365-iqdi99pd	238	10	)	)	-RRB-
cord-015365-iqdi99pd	238	11	zusätzliche	zusätzliche	NNP
cord-015365-iqdi99pd	238	12	Effekte	Effekte	NNP
cord-015365-iqdi99pd	238	13	haben	haben	NNP
cord-015365-iqdi99pd	238	14	kann	kann	NNP
cord-015365-iqdi99pd	238	15	.	.	.
cord-015365-iqdi99pd	239	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	239	2	.	.	.
cord-015365-iqdi99pd	240	1	I	-PRON-	PRP
cord-015365-iqdi99pd	241	1	m	m	NNP
cord-015365-iqdi99pd	241	2	Fischer	Fischer	NNP
cord-015365-iqdi99pd	241	3	-	-	HYPH
cord-015365-iqdi99pd	241	4	Lewis	Lewis	NNP
cord-015365-iqdi99pd	241	5	Nierentransplantationsmodell	Nierentransplantationsmodell	NNP
cord-015365-iqdi99pd	241	6	der	der	NNP
cord-015365-iqdi99pd	241	7	Ratte	Ratte	NNP
cord-015365-iqdi99pd	241	8	wurde	wurde	NN
cord-015365-iqdi99pd	241	9	der	der	NNP
cord-015365-iqdi99pd	241	10	Effekt	Effekt	NNP
cord-015365-iqdi99pd	241	11	von	von	NNP
cord-015365-iqdi99pd	241	12	Aliskiren	Aliskiren	NNP
cord-015365-iqdi99pd	241	13	(	(	-LRB-
cord-015365-iqdi99pd	241	14	10	10	CD
cord-015365-iqdi99pd	241	15	mg	mg	NNP
cord-015365-iqdi99pd	241	16	/	/	SYM
cord-015365-iqdi99pd	241	17	kg	kg	NNP
cord-015365-iqdi99pd	241	18	/	/	SYM
cord-015365-iqdi99pd	241	19	Tag	tag	NN
cord-015365-iqdi99pd	241	20	)	)	-RRB-
cord-015365-iqdi99pd	241	21	auf	auf	NN
cord-015365-iqdi99pd	241	22	die	die	VBP
cord-015365-iqdi99pd	242	1	Entstehung	Entstehung	NNP
cord-015365-iqdi99pd	242	2	der	der	NNP
cord-015365-iqdi99pd	243	1	chronischen	chronischen	NNP
cord-015365-iqdi99pd	243	2	Transplantatdysfunktion	Transplantatdysfunktion	NNP
cord-015365-iqdi99pd	244	1	i	i	PRP
cord-015365-iqdi99pd	245	1	m	m	NNP
cord-015365-iqdi99pd	245	2	Vergleich	Vergleich	NNP
cord-015365-iqdi99pd	246	1	zu	zu	NNP
cord-015365-iqdi99pd	247	1	einer	einer	NNP
cord-015365-iqdi99pd	247	2	Behandlung	Behandlung	NNP
cord-015365-iqdi99pd	247	3	mit	mit	NNP
cord-015365-iqdi99pd	247	4	Vehikel	Vehikel	NNP
cord-015365-iqdi99pd	247	5	oder	oder	NNP
cord-015365-iqdi99pd	247	6	mit	mit	NNP
cord-015365-iqdi99pd	247	7	dem	dem	NNP
cord-015365-iqdi99pd	247	8	ARB	ARB	NNP
cord-015365-iqdi99pd	247	9	Candesartan	Candesartan	NNP
cord-015365-iqdi99pd	247	10	als	als	NN
cord-015365-iqdi99pd	247	11	bekannter	bekannter	NN
cord-015365-iqdi99pd	247	12	Hemmer	Hemmer	NNP
cord-015365-iqdi99pd	247	13	der	der	NNP
cord-015365-iqdi99pd	247	14	chronischen	chronischen	NNP
cord-015365-iqdi99pd	247	15	Transplantatdysfunktion	Transplantatdysfunktion	NNP
cord-015365-iqdi99pd	247	16	untersucht	untersucht	NN
cord-015365-iqdi99pd	247	17	.	.	.
cord-015365-iqdi99pd	248	1	Analysiert	Analysiert	NNP
cord-015365-iqdi99pd	248	2	wurden	wurden	NNS
cord-015365-iqdi99pd	248	3	die	die	VBP
cord-015365-iqdi99pd	249	1	Histologie	Histologie	NNP
cord-015365-iqdi99pd	249	2	der	der	VB
cord-015365-iqdi99pd	249	3	Niere	Niere	NNP
cord-015365-iqdi99pd	250	1	und	und	NNP
cord-015365-iqdi99pd	250	2	der	der	NNP
cord-015365-iqdi99pd	250	3	Verlauf	Verlauf	NNP
cord-015365-iqdi99pd	250	4	der	der	NNP
cord-015365-iqdi99pd	250	5	Proteinurie	Proteinurie	NNP
cord-015365-iqdi99pd	250	6	,	,	,
cord-015365-iqdi99pd	250	7	der	der	NNP
cord-015365-iqdi99pd	250	8	Serum	Serum	NNP
cord-015365-iqdi99pd	250	9	-	-	HYPH
cord-015365-iqdi99pd	250	10	Spiegel	Spiegel	NNP
cord-015365-iqdi99pd	250	11	von	von	NNP
cord-015365-iqdi99pd	250	12	Ang	Ang	NNP
cord-015365-iqdi99pd	250	13	(	(	-LRB-
cord-015365-iqdi99pd	250	14	1	1	CD
cord-015365-iqdi99pd	250	15	-	-	SYM
cord-015365-iqdi99pd	250	16	7	7	CD
cord-015365-iqdi99pd	250	17	)	)	-RRB-
cord-015365-iqdi99pd	250	18	und	und	NNP
cord-015365-iqdi99pd	250	19	der	der	NNP
cord-015365-iqdi99pd	250	20	Spiegel	Spiegel	NNP
cord-015365-iqdi99pd	250	21	von	von	NNP
cord-015365-iqdi99pd	250	22	Angiotensinogen	Angiotensinogen	NNP
cord-015365-iqdi99pd	251	1	i	-PRON-	PRP
cord-015365-iqdi99pd	251	2	m	be	VBP
cord-015365-iqdi99pd	251	3	Harn	Harn	NNP
cord-015365-iqdi99pd	251	4	als	als	NNP
cord-015365-iqdi99pd	251	5	Indikator	Indikator	NNP
cord-015365-iqdi99pd	251	6	für	für	NNS
cord-015365-iqdi99pd	251	7	die	die	VBP
cord-015365-iqdi99pd	251	8	intrarenale	intrarenale	NNP
cord-015365-iqdi99pd	251	9	RAS	RAS	NNP
cord-015365-iqdi99pd	251	10	-	-	HYPH
cord-015365-iqdi99pd	251	11	Aktivität	Aktivität	NNP
cord-015365-iqdi99pd	251	12	.	.	.
cord-015365-iqdi99pd	252	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	252	2	.	.	.
cord-015365-iqdi99pd	253	1	I	-PRON-	PRP
cord-015365-iqdi99pd	254	1	m	m	LS
cord-015365-iqdi99pd	254	2	Gegensatz	Gegensatz	NNP
cord-015365-iqdi99pd	254	3	zu	zu	NNP
cord-015365-iqdi99pd	254	4	Candesartan	Candesartan	NNP
cord-015365-iqdi99pd	254	5	verminderte	verminderte	NN
cord-015365-iqdi99pd	254	6	Aliskiren	Aliskiren	NNP
cord-015365-iqdi99pd	254	7	weder	weder	NNP
cord-015365-iqdi99pd	254	8	die	die	VB
cord-015365-iqdi99pd	254	9	klinischen	klinischen	NNP
cord-015365-iqdi99pd	254	10	(	(	-LRB-
cord-015365-iqdi99pd	255	1	Proteinurie	Proteinurie	NNP
cord-015365-iqdi99pd	255	2	,	,	,
cord-015365-iqdi99pd	255	3	Kreatinin	Kreatinin	NNP
cord-015365-iqdi99pd	255	4	-	-	HYPH
cord-015365-iqdi99pd	255	5	Clearence	Clearence	NNP
cord-015365-iqdi99pd	255	6	)	)	-RRB-
cord-015365-iqdi99pd	255	7	noch	noch	NNP
cord-015365-iqdi99pd	255	8	die	die	NNP
cord-015365-iqdi99pd	256	1	histologischen	histologischen	NNP
cord-015365-iqdi99pd	256	2	Zeichen	Zeichen	NNP
cord-015365-iqdi99pd	256	3	(	(	-LRB-
cord-015365-iqdi99pd	256	4	Glomerulosclerose	Glomerulosclerose	NNP
cord-015365-iqdi99pd	256	5	,	,	,
cord-015365-iqdi99pd	256	6	interstitielle	interstitielle	NNP
cord-015365-iqdi99pd	256	7	Fibrose	Fibrose	NNP
cord-015365-iqdi99pd	256	8	,	,	,
cord-015365-iqdi99pd	256	9	Makrophagen	Makrophagen	NNP
cord-015365-iqdi99pd	256	10	-	-	HYPH
cord-015365-iqdi99pd	256	11	Infiltration	Infiltration	NNP
cord-015365-iqdi99pd	256	12	)	)	-RRB-
cord-015365-iqdi99pd	256	13	der	der	NNP
cord-015365-iqdi99pd	256	14	chronischen	chronischen	NNP
cord-015365-iqdi99pd	256	15	Transplantatdysfunktion	Transplantatdysfunktion	NNP
cord-015365-iqdi99pd	256	16	.	.	.
cord-015365-iqdi99pd	257	1	Candesartan	Candesartan	NNP
cord-015365-iqdi99pd	257	2	verbesserte	verbesserte	NNP
cord-015365-iqdi99pd	258	1	i	i	PRP
cord-015365-iqdi99pd	259	1	m	m	NNP
cord-015365-iqdi99pd	259	2	Vergleich	Vergleich	NNP
cord-015365-iqdi99pd	260	1	zu	zu	NNP
cord-015365-iqdi99pd	261	1	Vehikel	Vehikel	NNP
cord-015365-iqdi99pd	261	2	-	-	HYPH
cord-015365-iqdi99pd	261	3	und	und	NNP
cord-015365-iqdi99pd	262	1	Aliskiren	Aliskiren	NNP
cord-015365-iqdi99pd	262	2	-	-	HYPH
cord-015365-iqdi99pd	262	3	behandelten	behandelten	NNP
cord-015365-iqdi99pd	262	4	Gruppen	Gruppen	NNP
cord-015365-iqdi99pd	262	5	sowohl	sowohl	NNP
cord-015365-iqdi99pd	262	6	die	die	VBP
cord-015365-iqdi99pd	262	7	Proteinurie	Proteinurie	NNP
cord-015365-iqdi99pd	262	8	als	als	NN
cord-015365-iqdi99pd	262	9	auch	auch	JJ
cord-015365-iqdi99pd	262	10	den	den	NNP
cord-015365-iqdi99pd	262	11	Histologieschaden	Histologieschaden	NNP
cord-015365-iqdi99pd	262	12	.	.	.
cord-015365-iqdi99pd	263	1	Die	die	VB
cord-015365-iqdi99pd	263	2	mit	mit	NNP
cord-015365-iqdi99pd	263	3	Aliskiren	Aliskiren	NNP
cord-015365-iqdi99pd	263	4	behandelten	behandelten	NNP
cord-015365-iqdi99pd	263	5	Ratten	Ratten	NNP
cord-015365-iqdi99pd	263	6	zeigten	zeigten	NNP
cord-015365-iqdi99pd	264	1	einen	einen	NNP
cord-015365-iqdi99pd	264	2	verminderten	verminderten	NNP
cord-015365-iqdi99pd	264	3	Serum	Serum	NNP
cord-015365-iqdi99pd	264	4	-	-	HYPH
cord-015365-iqdi99pd	264	5	Spiegel	Spiegel	NNP
cord-015365-iqdi99pd	264	6	des	des	FW
cord-015365-iqdi99pd	264	7	protektiven	protektiven	NNP
cord-015365-iqdi99pd	264	8	Ang(1	Ang(1	NNP
cord-015365-iqdi99pd	264	9	-	-	HYPH
cord-015365-iqdi99pd	264	10	7	7	NNP
cord-015365-iqdi99pd	264	11	)	)	-RRB-
cord-015365-iqdi99pd	264	12	und	und	RB
cord-015365-iqdi99pd	265	1	einen	einen	NNP
cord-015365-iqdi99pd	265	2	höheren	höheren	NNP
cord-015365-iqdi99pd	265	3	Harn	Harn	NNP
cord-015365-iqdi99pd	265	4	-	-	HYPH
cord-015365-iqdi99pd	265	5	Angiotensinogen	Angiotensinogen	NNP
cord-015365-iqdi99pd	265	6	-	-	HYPH
cord-015365-iqdi99pd	265	7	Spiegel	Spiegel	NNP
cord-015365-iqdi99pd	266	1	i	-PRON-	PRP
cord-015365-iqdi99pd	266	2	m	be	VBP
cord-015365-iqdi99pd	266	3	Vergleich	Vergleich	NNP
cord-015365-iqdi99pd	266	4	zu	zu	NNP
cord-015365-iqdi99pd	266	5	den	den	NNP
cord-015365-iqdi99pd	266	6	mit	mit	NNP
cord-015365-iqdi99pd	266	7	Candesartan	Candesartan	NNP
cord-015365-iqdi99pd	266	8	behandelten	behandelten	NNP
cord-015365-iqdi99pd	266	9	Tieren	Tieren	NNP
cord-015365-iqdi99pd	266	10	.	.	.
cord-015365-iqdi99pd	267	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	267	2	.	.	.
cord-015365-iqdi99pd	268	1	Der	Der	NNP
cord-015365-iqdi99pd	268	2	Renin	Renin	NNP
cord-015365-iqdi99pd	268	3	-	-	HYPH
cord-015365-iqdi99pd	268	4	Blocker	Blocker	NNP
cord-015365-iqdi99pd	268	5	Aliskiren	Aliskiren	NNP
cord-015365-iqdi99pd	268	6	verminderte	verminderte	NN
cord-015365-iqdi99pd	268	7	das	das	NNP
cord-015365-iqdi99pd	268	8	Fortschreiten	Fortschreiten	NNP
cord-015365-iqdi99pd	268	9	der	der	NNP
cord-015365-iqdi99pd	268	10	chronischen	chronischen	FW
cord-015365-iqdi99pd	268	11	Transplantatdysfunktion	Transplantatdysfunktion	NNP
cord-015365-iqdi99pd	268	12	nicht	nicht	NNP
cord-015365-iqdi99pd	268	13	.	.	.
cord-015365-iqdi99pd	269	1	Der	Der	NNP
cord-015365-iqdi99pd	269	2	fehlende	fehlende	NNP
cord-015365-iqdi99pd	269	3	Schutzeffekt	Schutzeffekt	NNP
cord-015365-iqdi99pd	269	4	hängt	hängt	NNP
cord-015365-iqdi99pd	269	5	wahrscheinlich	wahrscheinlich	NNP
cord-015365-iqdi99pd	269	6	entweder	entweder	NNP
cord-015365-iqdi99pd	269	7	mit	mit	NNP
cord-015365-iqdi99pd	269	8	der	der	NNP
cord-015365-iqdi99pd	269	9	verminderten	verminderten	NNP
cord-015365-iqdi99pd	269	10	Produktion	Produktion	NNP
cord-015365-iqdi99pd	269	11	des	des	FW
cord-015365-iqdi99pd	269	12	protektiven	protektiven	NN
cord-015365-iqdi99pd	270	1	Ang(1	Ang(1	NNP
cord-015365-iqdi99pd	270	2	-	-	HYPH
cord-015365-iqdi99pd	270	3	7	7	CD
cord-015365-iqdi99pd	270	4	)	)	-RRB-
cord-015365-iqdi99pd	271	1	oder	oder	NNP
cord-015365-iqdi99pd	271	2	mit	mit	NNP
cord-015365-iqdi99pd	271	3	einer	einer	NNP
cord-015365-iqdi99pd	271	4	ineffektiven	ineffektiven	NNP
cord-015365-iqdi99pd	271	5	intrarenalen	intrarenalen	NNP
cord-015365-iqdi99pd	271	6	RAS	RAS	NNP
cord-015365-iqdi99pd	271	7	-	-	HYPH
cord-015365-iqdi99pd	271	8	Blockierung	Blockierung	NNP
cord-015365-iqdi99pd	271	9	zusammen	zusammen	NNP
cord-015365-iqdi99pd	271	10	.	.	.
cord-015365-iqdi99pd	272	1	Kein	Kein	NNP
cord-015365-iqdi99pd	272	2	Unterschied	Unterschied	NNP
cord-015365-iqdi99pd	272	3	i	-PRON-	PRP
cord-015365-iqdi99pd	272	4	m	be	VBP
cord-015365-iqdi99pd	272	5	Gehalt	Gehalt	NNP
cord-015365-iqdi99pd	273	1	an	an	DT
cord-015365-iqdi99pd	273	2	energiereichen	energiereichen	NNP
cord-015365-iqdi99pd	273	3	Phosphaten	Phosphaten	NNP
cord-015365-iqdi99pd	273	4	in	in	IN
cord-015365-iqdi99pd	273	5	Organen	Organen	NNP
cord-015365-iqdi99pd	273	6	von	von	NNP
cord-015365-iqdi99pd	273	7	Lebendspendern	Lebendspendern	NNP
cord-015365-iqdi99pd	273	8	,	,	,
cord-015365-iqdi99pd	273	9	hirntoten	hirntoten	VBN
cord-015365-iqdi99pd	273	10	Spendern	Spendern	NNP
cord-015365-iqdi99pd	273	11	und	und	IN
cord-015365-iqdi99pd	273	12	"	"	``
cord-015365-iqdi99pd	273	13	non	non	JJ
cord-015365-iqdi99pd	273	14	-	-	JJ
cord-015365-iqdi99pd	273	15	heartbeating	heartbeating	JJ
cord-015365-iqdi99pd	273	16	"	"	``
cord-015365-iqdi99pd	273	17	Spendern	Spendern	NNP
cord-015365-iqdi99pd	273	18	i	-PRON-	PRP
cord-015365-iqdi99pd	273	19	m	be	VBP
cord-015365-iqdi99pd	273	20	Tiermodell	Tiermodell	NNP
cord-015365-iqdi99pd	273	21	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	273	22	.	.	.
cord-015365-iqdi99pd	274	1	Zusammenfassend	Zusammenfassend	NNP
cord-015365-iqdi99pd	274	2	sind	sind	NN
cord-015365-iqdi99pd	274	3	unterschiedliche	unterschiedliche	NN
cord-015365-iqdi99pd	275	1	miRNA	miRNA	NNP
cord-015365-iqdi99pd	275	2	-	-	HYPH
cord-015365-iqdi99pd	275	3	Signaturen	Signaturen	NNP
cord-015365-iqdi99pd	275	4	mit	mit	NNP
cord-015365-iqdi99pd	275	5	zellulärer	zellulärer	NNP
cord-015365-iqdi99pd	275	6	oder	oder	NNP
cord-015365-iqdi99pd	275	7	humoraler	humoraler	NNP
cord-015365-iqdi99pd	275	8	Abstoßung	Abstoßung	NNP
cord-015365-iqdi99pd	275	9	sowie	sowie	NNP
cord-015365-iqdi99pd	275	10	DGF	DGF	NNP
cord-015365-iqdi99pd	275	11	assoziiert	assoziiert	NNP
cord-015365-iqdi99pd	275	12	.	.	.
cord-015365-iqdi99pd	276	1	Die	die	VB
cord-015365-iqdi99pd	276	2	identifizierten	identifizierten	NNP
cord-015365-iqdi99pd	276	3	miRNAs	miRNAs	NNP
cord-015365-iqdi99pd	276	4	und	und	IN
cord-015365-iqdi99pd	276	5	Target	Target	NNP
cord-015365-iqdi99pd	276	6	-	-	HYPH
cord-015365-iqdi99pd	276	7	Gene	Gene	NNP
cord-015365-iqdi99pd	276	8	werden	werden	NNP
cord-015365-iqdi99pd	276	9	neue	neue	NNP
cord-015365-iqdi99pd	277	1	Sichtweisen	Sichtweisen	NNP
cord-015365-iqdi99pd	277	2	auf	auf	NNP
cord-015365-iqdi99pd	277	3	die	die	NNP
cord-015365-iqdi99pd	277	4	molekulare	molekulare	NNP
cord-015365-iqdi99pd	278	1	Regulation	regulation	NN
cord-015365-iqdi99pd	278	2	von	von	NNP
cord-015365-iqdi99pd	278	3	Transplantatabstoßung	Transplantatabstoßung	NNP
cord-015365-iqdi99pd	278	4	und	und	IN
cord-015365-iqdi99pd	278	5	Transplantatversagen	Transplantatversagen	NNP
cord-015365-iqdi99pd	278	6	erlauben	erlauben	NN
cord-015365-iqdi99pd	278	7	und	und	XX
cord-015365-iqdi99pd	278	8	so	so	RB
cord-015365-iqdi99pd	279	1	den	den	NNP
cord-015365-iqdi99pd	279	2	Weg	Weg	NNP
cord-015365-iqdi99pd	279	3	für	für	IN
cord-015365-iqdi99pd	279	4	neue	neue	NNP
cord-015365-iqdi99pd	279	5	Therapieansätze	Therapieansätze	NNP
cord-015365-iqdi99pd	279	6	ebnen	ebnen	NNP
cord-015365-iqdi99pd	279	7	.	.	.
cord-015365-iqdi99pd	280	1	Darüber	Darüber	NNP
cord-015365-iqdi99pd	280	2	hinaus	hinaus	NNP
cord-015365-iqdi99pd	280	3	könnten	könnten	RB
cord-015365-iqdi99pd	280	4	die	die	VBP
cord-015365-iqdi99pd	280	5	identifizierten	identifizierten	NNP
cord-015365-iqdi99pd	280	6	miRNAs	miRNAs	NNP
cord-015365-iqdi99pd	281	1	und	und	NNP
cord-015365-iqdi99pd	281	2	Target	Target	NNP
cord-015365-iqdi99pd	281	3	-	-	HYPH
cord-015365-iqdi99pd	281	4	Proteine	Proteine	NNP
cord-015365-iqdi99pd	281	5	in	in	IN
cord-015365-iqdi99pd	281	6	Zukunft	Zukunft	NNP
cord-015365-iqdi99pd	281	7	als	als	CD
cord-015365-iqdi99pd	281	8	neue	neue	NNP
cord-015365-iqdi99pd	281	9	diagnostische	diagnostische	IN
cord-015365-iqdi99pd	281	10	Marker	Marker	NNP
cord-015365-iqdi99pd	281	11	eingesetzt	eingesetzt	VBD
cord-015365-iqdi99pd	281	12	werden	werden	NNP
cord-015365-iqdi99pd	281	13	.	.	.
cord-015365-iqdi99pd	282	1	Correlation	correlation	NN
cord-015365-iqdi99pd	282	2	of	of	IN
cord-015365-iqdi99pd	282	3	recipient	recipient	NN
cord-015365-iqdi99pd	282	4	factors	factor	NNS
cord-015365-iqdi99pd	282	5	with	with	IN
cord-015365-iqdi99pd	282	6	the	the	DT
cord-015365-iqdi99pd	282	7	course	course	NN
cord-015365-iqdi99pd	282	8	of	of	IN
cord-015365-iqdi99pd	282	9	lymphocytes	lymphocyte	NNS
cord-015365-iqdi99pd	282	10	after	after	IN
cord-015365-iqdi99pd	282	11	alemtuzumab	alemtuzumab	JJ
cord-015365-iqdi99pd	282	12	induction	induction	NN
cord-015365-iqdi99pd	282	13	in	in	IN
cord-015365-iqdi99pd	282	14	renal	renal	JJ
cord-015365-iqdi99pd	282	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	282	16	Background	background	NN
cord-015365-iqdi99pd	282	17	.	.	.
cord-015365-iqdi99pd	283	1	Alemtuzumab	Alemtuzumab	NNP
cord-015365-iqdi99pd	283	2	,	,	,
cord-015365-iqdi99pd	283	3	an	an	DT
cord-015365-iqdi99pd	283	4	anti	anti	JJ
cord-015365-iqdi99pd	283	5	-	-	JJ
cord-015365-iqdi99pd	283	6	CD52	cd52	JJ
cord-015365-iqdi99pd	283	7	T	t	NN
cord-015365-iqdi99pd	283	8	-	-	HYPH
cord-015365-iqdi99pd	283	9	cell	cell	NN
cord-015365-iqdi99pd	283	10	and	and	CC
cord-015365-iqdi99pd	283	11	B	b	NN
cord-015365-iqdi99pd	283	12	-	-	HYPH
cord-015365-iqdi99pd	283	13	cell	cell	NN
cord-015365-iqdi99pd	283	14	depleting	deplete	VBG
cord-015365-iqdi99pd	283	15	monoclonal	monoclonal	JJ
cord-015365-iqdi99pd	283	16	antibody	antibody	NN
cord-015365-iqdi99pd	283	17	,	,	,
cord-015365-iqdi99pd	283	18	used	use	VBN
cord-015365-iqdi99pd	283	19	as	as	IN
cord-015365-iqdi99pd	283	20	induction	induction	NN
cord-015365-iqdi99pd	283	21	therapy	therapy	NN
cord-015365-iqdi99pd	283	22	in	in	IN
cord-015365-iqdi99pd	283	23	renal	renal	JJ
cord-015365-iqdi99pd	283	24	transplantation	transplantation	NN
cord-015365-iqdi99pd	283	25	(	(	-LRB-
cord-015365-iqdi99pd	283	26	KTs	kts	NN
cord-015365-iqdi99pd	283	27	)	)	-RRB-
cord-015365-iqdi99pd	283	28	.	.	.
cord-015365-iqdi99pd	284	1	The	the	DT
cord-015365-iqdi99pd	284	2	recovery	recovery	NN
cord-015365-iqdi99pd	284	3	of	of	IN
cord-015365-iqdi99pd	284	4	lymphocytes	lymphocyte	NNS
cord-015365-iqdi99pd	284	5	after	after	IN
cord-015365-iqdi99pd	284	6	alemtuzumab	alemtuzumab	JJ
cord-015365-iqdi99pd	284	7	induction	induction	NN
cord-015365-iqdi99pd	284	8	has	have	VBZ
cord-015365-iqdi99pd	284	9	been	be	VBN
cord-015365-iqdi99pd	284	10	investigated	investigate	VBN
cord-015365-iqdi99pd	284	11	in	in	IN
cord-015365-iqdi99pd	284	12	a	a	DT
cord-015365-iqdi99pd	284	13	number	number	NN
cord-015365-iqdi99pd	284	14	of	of	IN
cord-015365-iqdi99pd	284	15	trials	trial	NNS
cord-015365-iqdi99pd	284	16	,	,	,
cord-015365-iqdi99pd	284	17	however	however	RB
cord-015365-iqdi99pd	284	18	,	,	,
cord-015365-iqdi99pd	284	19	the	the	DT
cord-015365-iqdi99pd	284	20	clinical	clinical	JJ
cord-015365-iqdi99pd	284	21	course	course	NN
cord-015365-iqdi99pd	284	22	after	after	IN
cord-015365-iqdi99pd	284	23	KTx	KTx	NNS
cord-015365-iqdi99pd	284	24	has	have	VBZ
cord-015365-iqdi99pd	284	25	not	not	RB
cord-015365-iqdi99pd	284	26	been	be	VBN
cord-015365-iqdi99pd	284	27	correlated	correlate	VBN
cord-015365-iqdi99pd	284	28	with	with	IN
cord-015365-iqdi99pd	284	29	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	284	30	recovery	recovery	NN
cord-015365-iqdi99pd	284	31	.	.	.
cord-015365-iqdi99pd	285	1	Herein	herein	RB
cord-015365-iqdi99pd	285	2	,	,	,
cord-015365-iqdi99pd	285	3	we	-PRON-	PRP
cord-015365-iqdi99pd	285	4	correlate	correlate	VBP
cord-015365-iqdi99pd	285	5	the	the	DT
cord-015365-iqdi99pd	285	6	outcome	outcome	NN
cord-015365-iqdi99pd	285	7	as	as	RB
cord-015365-iqdi99pd	285	8	well	well	RB
cord-015365-iqdi99pd	285	9	as	as	IN
cord-015365-iqdi99pd	285	10	recipient	recipient	NN
cord-015365-iqdi99pd	285	11	factors	factor	NNS
cord-015365-iqdi99pd	285	12	with	with	IN
cord-015365-iqdi99pd	285	13	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	285	14	recovery	recovery	NN
cord-015365-iqdi99pd	285	15	after	after	IN
cord-015365-iqdi99pd	285	16	induction	induction	NN
cord-015365-iqdi99pd	285	17	with	with	IN
cord-015365-iqdi99pd	285	18	alemtuzumab	alemtuzumab	NNS
cord-015365-iqdi99pd	285	19	.	.	.
cord-015365-iqdi99pd	286	1	Methods	method	NNS
cord-015365-iqdi99pd	286	2	.	.	.
cord-015365-iqdi99pd	287	1	Single	single	JJ
cord-015365-iqdi99pd	287	2	center	center	NN
cord-015365-iqdi99pd	287	3	retrospective	retrospective	JJ
cord-015365-iqdi99pd	287	4	analysis	analysis	NN
cord-015365-iqdi99pd	287	5	of	of	IN
cord-015365-iqdi99pd	287	6	225	225	CD
cord-015365-iqdi99pd	287	7	patients	patient	NNS
cord-015365-iqdi99pd	287	8	/	/	SYM
cord-015365-iqdi99pd	287	9	consecutive	consecutive	JJ
cord-015365-iqdi99pd	287	10	kidney	kidney	NN
cord-015365-iqdi99pd	287	11	transplantations	transplantation	NNS
cord-015365-iqdi99pd	287	12	between	between	IN
cord-015365-iqdi99pd	287	13	01/	01/	CD
cord-015365-iqdi99pd	287	14	2004	2004	CD
cord-015365-iqdi99pd	287	15	and	and	CC
cord-015365-iqdi99pd	287	16	12/2010	12/2010	CD
cord-015365-iqdi99pd	287	17	which	which	WDT
cord-015365-iqdi99pd	287	18	received	receive	VBD
cord-015365-iqdi99pd	287	19	alemtuzumab	alemtuzumab	NNP
cord-015365-iqdi99pd	287	20	as	as	IN
cord-015365-iqdi99pd	287	21	induction	induction	NN
cord-015365-iqdi99pd	287	22	agent	agent	NN
cord-015365-iqdi99pd	287	23	(	(	-LRB-
cord-015365-iqdi99pd	287	24	one	one	CD
cord-015365-iqdi99pd	287	25	dose	dose	NN
cord-015365-iqdi99pd	287	26	of	of	IN
cord-015365-iqdi99pd	287	27	30	30	CD
cord-015365-iqdi99pd	287	28	mg	mg	NN
cord-015365-iqdi99pd	287	29	)	)	-RRB-
cord-015365-iqdi99pd	287	30	.	.	.
cord-015365-iqdi99pd	288	1	Patients	patient	NNS
cord-015365-iqdi99pd	288	2	were	be	VBD
cord-015365-iqdi99pd	288	3	devided	devide	VBN
cord-015365-iqdi99pd	288	4	into	into	IN
cord-015365-iqdi99pd	288	5	4	4	CD
cord-015365-iqdi99pd	288	6	groups	group	NNS
cord-015365-iqdi99pd	288	7	according	accord	VBG
cord-015365-iqdi99pd	288	8	to	to	IN
cord-015365-iqdi99pd	288	9	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	288	10	recovery	recovery	NN
cord-015365-iqdi99pd	288	11	at	at	IN
cord-015365-iqdi99pd	288	12	4	4	CD
cord-015365-iqdi99pd	288	13	points	point	NNS
cord-015365-iqdi99pd	288	14	of	of	IN
cord-015365-iqdi99pd	288	15	time	time	NN
cord-015365-iqdi99pd	288	16	(	(	-LRB-
cord-015365-iqdi99pd	288	17	pre	pre	NNP
cord-015365-iqdi99pd	288	18	-	-	NNP
cord-015365-iqdi99pd	288	19	Tx	Tx	NNP
cord-015365-iqdi99pd	288	20	,	,	,
cord-015365-iqdi99pd	288	21	1	1	CD
cord-015365-iqdi99pd	288	22	-	-	SYM
cord-015365-iqdi99pd	288	23	3	3	CD
cord-015365-iqdi99pd	288	24	weeks	week	NNS
cord-015365-iqdi99pd	288	25	post	post	NN
cord-015365-iqdi99pd	288	26	-	-	NNP
cord-015365-iqdi99pd	288	27	Tx	Tx	NNP
cord-015365-iqdi99pd	288	28	,	,	,
cord-015365-iqdi99pd	288	29	3	3	CD
cord-015365-iqdi99pd	288	30	weeks-3	weeks-3	NNP
cord-015365-iqdi99pd	288	31	months	month	NNS
cord-015365-iqdi99pd	288	32	post	post	NNP
cord-015365-iqdi99pd	288	33	-	-	NNP
cord-015365-iqdi99pd	288	34	Tx	Tx	NNP
cord-015365-iqdi99pd	288	35	and	and	CC
cord-015365-iqdi99pd	288	36	3	3	CD
cord-015365-iqdi99pd	288	37	-	-	SYM
cord-015365-iqdi99pd	288	38	6	6	CD
cord-015365-iqdi99pd	288	39	months	month	NNS
cord-015365-iqdi99pd	288	40	after	after	IN
cord-015365-iqdi99pd	288	41	KTx	KTx	NNS
cord-015365-iqdi99pd	288	42	)	)	-RRB-
cord-015365-iqdi99pd	288	43	.	.	.
cord-015365-iqdi99pd	289	1	The	the	DT
cord-015365-iqdi99pd	289	2	relevance	relevance	NN
cord-015365-iqdi99pd	289	3	of	of	IN
cord-015365-iqdi99pd	289	4	recipient	recipient	NN
cord-015365-iqdi99pd	289	5	-	-	HYPH
cord-015365-iqdi99pd	289	6	characteristics	characteristic	NNS
cord-015365-iqdi99pd	289	7	was	be	VBD
cord-015365-iqdi99pd	289	8	analyzed	analyze	VBN
cord-015365-iqdi99pd	289	9	.	.	.
cord-015365-iqdi99pd	290	1	Delayed	delay	VBN
cord-015365-iqdi99pd	290	2	kidney	kidney	NN
cord-015365-iqdi99pd	290	3	graft	graft	NN
cord-015365-iqdi99pd	290	4	function	function	NN
cord-015365-iqdi99pd	290	5	(	(	-LRB-
cord-015365-iqdi99pd	290	6	DGF	DGF	NNP
cord-015365-iqdi99pd	290	7	)	)	-RRB-
cord-015365-iqdi99pd	290	8	was	be	VBD
cord-015365-iqdi99pd	290	9	defined	define	VBN
cord-015365-iqdi99pd	290	10	as	as	IN
cord-015365-iqdi99pd	290	11	requirement	requirement	NN
cord-015365-iqdi99pd	290	12	for	for	IN
cord-015365-iqdi99pd	290	13	more	more	JJR
cord-015365-iqdi99pd	290	14	than	than	IN
cord-015365-iqdi99pd	290	15	one	one	CD
cord-015365-iqdi99pd	290	16	dialysis	dialysis	NN
cord-015365-iqdi99pd	290	17	within	within	IN
cord-015365-iqdi99pd	290	18	the	the	DT
cord-015365-iqdi99pd	290	19	first	first	JJ
cord-015365-iqdi99pd	290	20	week	week	NN
cord-015365-iqdi99pd	290	21	after	after	IN
cord-015365-iqdi99pd	290	22	KTx	KTx	NNS
cord-015365-iqdi99pd	290	23	.	.	.
cord-015365-iqdi99pd	291	1	Statistical	statistical	JJ
cord-015365-iqdi99pd	291	2	analysis	analysis	NN
cord-015365-iqdi99pd	291	3	was	be	VBD
cord-015365-iqdi99pd	291	4	performed	perform	VBN
cord-015365-iqdi99pd	291	5	with	with	IN
cord-015365-iqdi99pd	291	6	SPSS	SPSS	NNP
cord-015365-iqdi99pd	291	7	17.0	17.0	CD
cord-015365-iqdi99pd	291	8	software	software	NN
cord-015365-iqdi99pd	291	9	(	(	-LRB-
cord-015365-iqdi99pd	291	10	SPSS	SPSS	NNP
cord-015365-iqdi99pd	291	11	Inc.	Inc.	NNP
cord-015365-iqdi99pd	291	12	,	,	,
cord-015365-iqdi99pd	291	13	Chicago	Chicago	NNP
cord-015365-iqdi99pd	291	14	,	,	,
cord-015365-iqdi99pd	291	15	IL	IL	NNP
cord-015365-iqdi99pd	291	16	,	,	,
cord-015365-iqdi99pd	291	17	USA	USA	NNP
cord-015365-iqdi99pd	291	18	)	)	-RRB-
cord-015365-iqdi99pd	291	19	.	.	.
cord-015365-iqdi99pd	292	1	Analysis	analysis	NN
cord-015365-iqdi99pd	292	2	of	of	IN
cord-015365-iqdi99pd	292	3	variance	variance	NN
cord-015365-iqdi99pd	292	4	for	for	IN
cord-015365-iqdi99pd	292	5	repeated	repeat	VBN
cord-015365-iqdi99pd	292	6	measurements	measurement	NNS
cord-015365-iqdi99pd	292	7	with	with	IN
cord-015365-iqdi99pd	292	8	measurement	measurement	NN
cord-015365-iqdi99pd	292	9	time	time	NN
cord-015365-iqdi99pd	292	10	as	as	IN
cord-015365-iqdi99pd	292	11	withinsubject	withinsubject	NN
cord-015365-iqdi99pd	292	12	factor	factor	NN
cord-015365-iqdi99pd	292	13	and	and	CC
cord-015365-iqdi99pd	292	14	with	with	IN
cord-015365-iqdi99pd	292	15	age	age	NN
cord-015365-iqdi99pd	292	16	,	,	,
cord-015365-iqdi99pd	292	17	CMV	CMV	NNP
cord-015365-iqdi99pd	292	18	status	status	NN
cord-015365-iqdi99pd	292	19	,	,	,
cord-015365-iqdi99pd	292	20	DGF	dgf	NN
cord-015365-iqdi99pd	292	21	status	status	NN
cord-015365-iqdi99pd	292	22	as	as	IN
cord-015365-iqdi99pd	292	23	between	between	IN
cord-015365-iqdi99pd	292	24	subject	subject	JJ
cord-015365-iqdi99pd	292	25	factors	factor	NNS
cord-015365-iqdi99pd	292	26	were	be	VBD
cord-015365-iqdi99pd	292	27	performed	perform	VBN
cord-015365-iqdi99pd	292	28	.	.	.
cord-015365-iqdi99pd	293	1	Results	result	NNS
cord-015365-iqdi99pd	293	2	.	.	.
cord-015365-iqdi99pd	294	1	Median	median	JJ
cord-015365-iqdi99pd	294	2	age	age	NN
cord-015365-iqdi99pd	294	3	of	of	IN
cord-015365-iqdi99pd	294	4	all	all	DT
cord-015365-iqdi99pd	294	5	recipients	recipient	NNS
cord-015365-iqdi99pd	294	6	was	be	VBD
cord-015365-iqdi99pd	294	7	49.63	49.63	CD
cord-015365-iqdi99pd	294	8	years	year	NNS
cord-015365-iqdi99pd	294	9	,	,	,
cord-015365-iqdi99pd	294	10	65.33	65.33	CD
cord-015365-iqdi99pd	294	11	%	%	NN
cord-015365-iqdi99pd	294	12	were	be	VBD
cord-015365-iqdi99pd	294	13	male	male	JJ
cord-015365-iqdi99pd	294	14	.	.	.
cord-015365-iqdi99pd	295	1	Mean	mean	JJ
cord-015365-iqdi99pd	295	2	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	295	3	counts	count	NNS
cord-015365-iqdi99pd	295	4	were	be	VBD
cord-015365-iqdi99pd	295	5	22.8	22.8	CD
cord-015365-iqdi99pd	295	6	AE	AE	NNP
cord-015365-iqdi99pd	295	7	9.41	9.41	CD
cord-015365-iqdi99pd	295	8	%	%	NN
cord-015365-iqdi99pd	295	9	pre	pre	JJ
cord-015365-iqdi99pd	295	10	-	-	NNP
cord-015365-iqdi99pd	295	11	Tx	Tx	NNP
cord-015365-iqdi99pd	295	12	,	,	,
cord-015365-iqdi99pd	295	13	2.61	2.61	CD
cord-015365-iqdi99pd	295	14	AE	AE	NNP
cord-015365-iqdi99pd	295	15	3.11	3.11	CD
cord-015365-iqdi99pd	295	16	%	%	NN
cord-015365-iqdi99pd	295	17	between	between	IN
cord-015365-iqdi99pd	295	18	week	week	NN
cord-015365-iqdi99pd	295	19	1	1	CD
cord-015365-iqdi99pd	295	20	and	and	CC
cord-015365-iqdi99pd	295	21	3	3	CD
cord-015365-iqdi99pd	295	22	,	,	,
cord-015365-iqdi99pd	295	23	6.98	6.98	CD
cord-015365-iqdi99pd	295	24	AE	AE	NNP
cord-015365-iqdi99pd	295	25	6.7	6.7	CD
cord-015365-iqdi99pd	295	26	%	%	NN
cord-015365-iqdi99pd	295	27	between	between	IN
cord-015365-iqdi99pd	295	28	3	3	CD
cord-015365-iqdi99pd	295	29	weeks	week	NNS
cord-015365-iqdi99pd	295	30	and	and	CC
cord-015365-iqdi99pd	295	31	3	3	CD
cord-015365-iqdi99pd	295	32	months	month	NNS
cord-015365-iqdi99pd	295	33	after	after	IN
cord-015365-iqdi99pd	295	34	Tx	Tx	NNP
cord-015365-iqdi99pd	295	35	and	and	CC
cord-015365-iqdi99pd	295	36	18.20	18.20	CD
cord-015365-iqdi99pd	295	37	AE	AE	NNP
cord-015365-iqdi99pd	295	38	11.48	11.48	CD
cord-015365-iqdi99pd	295	39	%	%	NN
cord-015365-iqdi99pd	295	40	at	at	IN
cord-015365-iqdi99pd	295	41	later	later	JJ
cord-015365-iqdi99pd	295	42	time	time	NN
cord-015365-iqdi99pd	295	43	points	point	NNS
cord-015365-iqdi99pd	295	44	.	.	.
cord-015365-iqdi99pd	296	1	Among	among	IN
cord-015365-iqdi99pd	296	2	all	all	DT
cord-015365-iqdi99pd	296	3	factors	factor	NNS
cord-015365-iqdi99pd	296	4	analyzed	analyze	VBN
cord-015365-iqdi99pd	296	5	,	,	,
cord-015365-iqdi99pd	296	6	DGF	DGF	NNP
cord-015365-iqdi99pd	296	7	,	,	,
cord-015365-iqdi99pd	296	8	CMV	CMV	NNP
cord-015365-iqdi99pd	296	9	status	status	NN
cord-015365-iqdi99pd	296	10	and	and	CC
cord-015365-iqdi99pd	296	11	age	age	NN
cord-015365-iqdi99pd	296	12	showed	show	VBD
cord-015365-iqdi99pd	296	13	a	a	DT
cord-015365-iqdi99pd	296	14	significant	significant	JJ
cord-015365-iqdi99pd	296	15	correlation	correlation	NN
cord-015365-iqdi99pd	296	16	with	with	IN
cord-015365-iqdi99pd	296	17	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	296	18	counts	count	NNS
cord-015365-iqdi99pd	296	19	.	.	.
cord-015365-iqdi99pd	297	1	DGF	DGF	NNP
cord-015365-iqdi99pd	297	2	occurred	occur	VBD
cord-015365-iqdi99pd	297	3	in	in	IN
cord-015365-iqdi99pd	297	4	27.56	27.56	CD
cord-015365-iqdi99pd	297	5	%	%	NN
cord-015365-iqdi99pd	297	6	of	of	IN
cord-015365-iqdi99pd	297	7	the	the	DT
cord-015365-iqdi99pd	297	8	recipients	recipient	NNS
cord-015365-iqdi99pd	297	9	.	.	.
cord-015365-iqdi99pd	298	1	The	the	DT
cord-015365-iqdi99pd	298	2	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	298	3	-	-	HYPH
cord-015365-iqdi99pd	298	4	counts	count	NNS
cord-015365-iqdi99pd	298	5	in	in	IN
cord-015365-iqdi99pd	298	6	the	the	DT
cord-015365-iqdi99pd	298	7	DGFgroup	dgfgroup	NN
cord-015365-iqdi99pd	298	8	were	be	VBD
cord-015365-iqdi99pd	298	9	significantly	significantly	RB
cord-015365-iqdi99pd	298	10	higher	high	JJR
cord-015365-iqdi99pd	298	11	,	,	,
cord-015365-iqdi99pd	298	12	10.7	10.7	CD
cord-015365-iqdi99pd	298	13	%	%	NN
cord-015365-iqdi99pd	298	14	vs.	vs.	IN
cord-015365-iqdi99pd	298	15	13.13	13.13	CD
cord-015365-iqdi99pd	298	16	%	%	NN
cord-015365-iqdi99pd	299	1	(	(	-LRB-
cord-015365-iqdi99pd	299	2	p	p	NN
cord-015365-iqdi99pd	299	3	¼	¼	CD
cord-015365-iqdi99pd	299	4	0.036	0.036	CD
cord-015365-iqdi99pd	299	5	)	)	-RRB-
cord-015365-iqdi99pd	300	1	post	post	NNP
cord-015365-iqdi99pd	300	2	-	-	NNP
cord-015365-iqdi99pd	300	3	Tx	Tx	NNP
cord-015365-iqdi99pd	300	4	.	.	.
cord-015365-iqdi99pd	301	1	CMV	CMV	NNP
cord-015365-iqdi99pd	301	2	-	-	HYPH
cord-015365-iqdi99pd	301	3	status	status	NN
cord-015365-iqdi99pd	301	4	of	of	IN
cord-015365-iqdi99pd	301	5	the	the	DT
cord-015365-iqdi99pd	301	6	recipient	recipient	NN
cord-015365-iqdi99pd	301	7	influences	influence	VBZ
cord-015365-iqdi99pd	301	8	the	the	DT
cord-015365-iqdi99pd	301	9	quantity	quantity	NN
cord-015365-iqdi99pd	301	10	of	of	IN
cord-015365-iqdi99pd	301	11	lymphocytes	lymphocytes	FW
cord-015365-iqdi99pd	301	12	pre	pre	NNP
cord-015365-iqdi99pd	301	13	-	-	NNP
cord-015365-iqdi99pd	301	14	Tx	Tx	NNP
cord-015365-iqdi99pd	301	15	significantly	significantly	RB
cord-015365-iqdi99pd	301	16	(	(	-LRB-
cord-015365-iqdi99pd	301	17	p	p	NN
cord-015365-iqdi99pd	301	18	¼	¼	CD
cord-015365-iqdi99pd	301	19	0.009	0.009	CD
cord-015365-iqdi99pd	301	20	)	)	-RRB-
cord-015365-iqdi99pd	301	21	.	.	.
cord-015365-iqdi99pd	302	1	Age	age	NN
cord-015365-iqdi99pd	302	2	showed	show	VBD
cord-015365-iqdi99pd	302	3	a	a	DT
cord-015365-iqdi99pd	302	4	significantly	significantly	JJ
cord-015365-iqdi99pd	302	5	influence	influence	NN
cord-015365-iqdi99pd	302	6	on	on	IN
cord-015365-iqdi99pd	302	7	the	the	DT
cord-015365-iqdi99pd	302	8	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	302	9	count	count	NN
cord-015365-iqdi99pd	302	10	3	3	CD
cord-015365-iqdi99pd	302	11	months	month	NNS
cord-015365-iqdi99pd	302	12	post	post	NNP
cord-015365-iqdi99pd	302	13	-	-	NNP
cord-015365-iqdi99pd	302	14	Tx	Tx	NNP
cord-015365-iqdi99pd	302	15	(	(	-LRB-
cord-015365-iqdi99pd	302	16	p	p	NN
cord-015365-iqdi99pd	302	17	¼	¼	CD
cord-015365-iqdi99pd	302	18	0.032	0.032	CD
cord-015365-iqdi99pd	302	19	)	)	-RRB-
cord-015365-iqdi99pd	302	20	.	.	.
cord-015365-iqdi99pd	303	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	303	2	.	.	.
cord-015365-iqdi99pd	304	1	CMV	CMV	NNP
cord-015365-iqdi99pd	304	2	-	-	HYPH
cord-015365-iqdi99pd	304	3	status	status	NN
cord-015365-iqdi99pd	304	4	and	and	CC
cord-015365-iqdi99pd	304	5	age	age	NN
cord-015365-iqdi99pd	304	6	have	have	VBP
cord-015365-iqdi99pd	304	7	a	a	DT
cord-015365-iqdi99pd	304	8	significant	significant	JJ
cord-015365-iqdi99pd	304	9	impact	impact	NN
cord-015365-iqdi99pd	304	10	on	on	IN
cord-015365-iqdi99pd	304	11	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	304	12	recovery	recovery	NN
cord-015365-iqdi99pd	304	13	after	after	IN
cord-015365-iqdi99pd	304	14	alemtuzumab	alemtuzumab	NNP
cord-015365-iqdi99pd	304	15	induction	induction	NN
cord-015365-iqdi99pd	304	16	therapy	therapy	NN
cord-015365-iqdi99pd	304	17	.	.	.
cord-015365-iqdi99pd	305	1	Lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	305	2	counts	count	VBZ
cord-015365-iqdi99pd	305	3	early	early	RB
cord-015365-iqdi99pd	305	4	after	after	IN
cord-015365-iqdi99pd	305	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	305	6	represent	represent	VBP
cord-015365-iqdi99pd	305	7	a	a	DT
cord-015365-iqdi99pd	305	8	prognostic	prognostic	JJ
cord-015365-iqdi99pd	305	9	factor	factor	NN
cord-015365-iqdi99pd	305	10	for	for	IN
cord-015365-iqdi99pd	305	11	kidney	kidney	NN
cord-015365-iqdi99pd	305	12	function	function	NN
cord-015365-iqdi99pd	305	13	early	early	RB
cord-015365-iqdi99pd	305	14	after	after	IN
cord-015365-iqdi99pd	305	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	305	16	.	.	.
cord-015365-iqdi99pd	306	1	A	a	DT
cord-015365-iqdi99pd	306	2	detailed	detailed	JJ
cord-015365-iqdi99pd	306	3	analysis	analysis	NN
cord-015365-iqdi99pd	306	4	of	of	IN
cord-015365-iqdi99pd	306	5	phenotype	phenotype	NN
cord-015365-iqdi99pd	306	6	and	and	CC
cord-015365-iqdi99pd	306	7	function	function	NN
cord-015365-iqdi99pd	306	8	of	of	IN
cord-015365-iqdi99pd	306	9	lymphocytes	lymphocyte	NNS
cord-015365-iqdi99pd	306	10	after	after	IN
cord-015365-iqdi99pd	306	11	alemtuzumab	alemtuzumab	NNP
cord-015365-iqdi99pd	306	12	induction	induction	NN
cord-015365-iqdi99pd	306	13	together	together	RB
cord-015365-iqdi99pd	306	14	with	with	IN
cord-015365-iqdi99pd	306	15	a	a	DT
cord-015365-iqdi99pd	306	16	correlation	correlation	NN
cord-015365-iqdi99pd	306	17	with	with	IN
cord-015365-iqdi99pd	306	18	the	the	DT
cord-015365-iqdi99pd	306	19	clinical	clinical	JJ
cord-015365-iqdi99pd	306	20	course	course	NN
cord-015365-iqdi99pd	306	21	is	be	VBZ
cord-015365-iqdi99pd	306	22	warranted	warrant	VBN
cord-015365-iqdi99pd	306	23	.	.	.
cord-015365-iqdi99pd	307	1	Belatacept	Belatacept	NNP
cord-015365-iqdi99pd	307	2	-	-	HYPH
cord-015365-iqdi99pd	307	3	based	base	VBN
cord-015365-iqdi99pd	307	4	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	307	5	in	in	IN
cord-015365-iqdi99pd	307	6	de	de	NNP
cord-015365-iqdi99pd	307	7	novo	novo	NNP
cord-015365-iqdi99pd	307	8	liver	liver	NN
cord-015365-iqdi99pd	307	9	transplant	transplant	NN
cord-015365-iqdi99pd	307	10	recipients	recipient	NNS
cord-015365-iqdi99pd	307	11	:	:	:
cord-015365-iqdi99pd	307	12	1-year	1-year	CD
cord-015365-iqdi99pd	307	13	experience	experience	NN
cord-015365-iqdi99pd	307	14	from	from	IN
cord-015365-iqdi99pd	307	15	a	a	DT
cord-015365-iqdi99pd	307	16	phase	phase	NN
cord-015365-iqdi99pd	307	17	II	ii	CD
cord-015365-iqdi99pd	307	18	study	study	NN
cord-015365-iqdi99pd	307	19	Background	Background	NNP
cord-015365-iqdi99pd	307	20	.	.	.
cord-015365-iqdi99pd	308	1	Calcineurin	Calcineurin	NNP
cord-015365-iqdi99pd	308	2	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	308	3	contribute	contribute	VBP
cord-015365-iqdi99pd	308	4	to	to	IN
cord-015365-iqdi99pd	308	5	substantial	substantial	JJ
cord-015365-iqdi99pd	308	6	toxicities	toxicity	NNS
cord-015365-iqdi99pd	308	7	in	in	IN
cord-015365-iqdi99pd	308	8	liver	liver	NN
cord-015365-iqdi99pd	308	9	transplant	transplant	NN
cord-015365-iqdi99pd	308	10	(	(	-LRB-
cord-015365-iqdi99pd	308	11	LT	LT	NNP
cord-015365-iqdi99pd	308	12	)	)	-RRB-
cord-015365-iqdi99pd	308	13	patients	patient	NNS
cord-015365-iqdi99pd	308	14	that	that	WDT
cord-015365-iqdi99pd	308	15	can	can	MD
cord-015365-iqdi99pd	308	16	lead	lead	VB
cord-015365-iqdi99pd	308	17	to	to	IN
cord-015365-iqdi99pd	308	18	renal	renal	JJ
cord-015365-iqdi99pd	308	19	dysfunction	dysfunction	NN
cord-015365-iqdi99pd	308	20	/	/	SYM
cord-015365-iqdi99pd	308	21	failure	failure	NN
cord-015365-iqdi99pd	308	22	and	and	CC
cord-015365-iqdi99pd	308	23	cardiovascular	cardiovascular	JJ
cord-015365-iqdi99pd	308	24	(	(	-LRB-
cord-015365-iqdi99pd	308	25	CV	cv	NN
cord-015365-iqdi99pd	308	26	)	)	-RRB-
cord-015365-iqdi99pd	308	27	disease	disease	NN
cord-015365-iqdi99pd	308	28	.	.	.
cord-015365-iqdi99pd	309	1	This	this	DT
cord-015365-iqdi99pd	309	2	phase	phase	NN
cord-015365-iqdi99pd	309	3	II	ii	CD
cord-015365-iqdi99pd	309	4	study	study	NN
cord-015365-iqdi99pd	309	5	evaluated	evaluate	VBD
cord-015365-iqdi99pd	309	6	belatacept	belatacept	NN
cord-015365-iqdi99pd	309	7	versus	versus	IN
cord-015365-iqdi99pd	309	8	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	309	9	(	(	-LRB-
cord-015365-iqdi99pd	309	10	Tac	Tac	NNP
cord-015365-iqdi99pd	309	11	)	)	-RRB-
cord-015365-iqdi99pd	309	12	in	in	IN
cord-015365-iqdi99pd	309	13	de	de	NNP
cord-015365-iqdi99pd	309	14	novo	novo	NNP
cord-015365-iqdi99pd	309	15	LT	LT	NNP
cord-015365-iqdi99pd	309	16	recipients	recipient	NNS
cord-015365-iqdi99pd	309	17	.	.	.
cord-015365-iqdi99pd	310	1	Methods	method	NNS
cord-015365-iqdi99pd	310	2	.	.	.
cord-015365-iqdi99pd	311	1	250	250	CD
cord-015365-iqdi99pd	311	2	LT	LT	NNP
cord-015365-iqdi99pd	311	3	recipients	recipient	NNS
cord-015365-iqdi99pd	311	4	were	be	VBD
cord-015365-iqdi99pd	311	5	randomized	randomize	VBN
cord-015365-iqdi99pd	311	6	to	to	IN
cord-015365-iqdi99pd	311	7	belataceptbased	belataceptbased	JJ
cord-015365-iqdi99pd	311	8	(	(	-LRB-
cord-015365-iqdi99pd	311	9	high	high	JJ
cord-015365-iqdi99pd	311	10	dose	dose	NN
cord-015365-iqdi99pd	311	11	[	[	-LRB-
cord-015365-iqdi99pd	311	12	HD	hd	NN
cord-015365-iqdi99pd	311	13	]	]	-RRB-
cord-015365-iqdi99pd	311	14	or	or	CC
cord-015365-iqdi99pd	311	15	low	low	JJ
cord-015365-iqdi99pd	311	16	dose	dose	NN
cord-015365-iqdi99pd	311	17	[	[	-LRB-
cord-015365-iqdi99pd	311	18	LD	LD	NNP
cord-015365-iqdi99pd	311	19	]	]	-RRB-
cord-015365-iqdi99pd	311	20	)	)	-RRB-
cord-015365-iqdi99pd	311	21	or	or	CC
cord-015365-iqdi99pd	311	22	Tac	Tac	NNP
cord-015365-iqdi99pd	311	23	-	-	HYPH
cord-015365-iqdi99pd	311	24	based	base	VBN
cord-015365-iqdi99pd	311	25	regimens	regimen	NNS
cord-015365-iqdi99pd	311	26	.	.	.
cord-015365-iqdi99pd	312	1	All	all	DT
cord-015365-iqdi99pd	312	2	patients	patient	NNS
cord-015365-iqdi99pd	312	3	received	receive	VBD
cord-015365-iqdi99pd	312	4	steroids	steroid	NNS
cord-015365-iqdi99pd	312	5	for	for	IN
cord-015365-iqdi99pd	312	6	the	the	DT
cord-015365-iqdi99pd	312	7	first	first	JJ
cord-015365-iqdi99pd	312	8	3	3	CD
cord-015365-iqdi99pd	312	9	months	month	NNS
cord-015365-iqdi99pd	312	10	.	.	.
cord-015365-iqdi99pd	313	1	Results	result	NNS
cord-015365-iqdi99pd	313	2	.	.	.
cord-015365-iqdi99pd	314	1	Demographic	demographic	JJ
cord-015365-iqdi99pd	314	2	characteristics	characteristic	NNS
cord-015365-iqdi99pd	314	3	were	be	VBD
cord-015365-iqdi99pd	314	4	similar	similar	JJ
cord-015365-iqdi99pd	314	5	among	among	IN
cord-015365-iqdi99pd	314	6	groups	group	NNS
cord-015365-iqdi99pd	314	7	;	;	:
cord-015365-iqdi99pd	314	8	46	46	CD
cord-015365-iqdi99pd	314	9	%	%	NN
cord-015365-iqdi99pd	314	10	of	of	IN
cord-015365-iqdi99pd	314	11	patients	patient	NNS
cord-015365-iqdi99pd	314	12	were	be	VBD
cord-015365-iqdi99pd	314	13	HCV	HCV	NNP
cord-015365-iqdi99pd	314	14	positive	positive	JJ
cord-015365-iqdi99pd	314	15	.	.	.
cord-015365-iqdi99pd	315	1	The	the	DT
cord-015365-iqdi99pd	315	2	primary	primary	JJ
cord-015365-iqdi99pd	315	3	endpoint	endpoint	NN
cord-015365-iqdi99pd	315	4	(	(	-LRB-
cord-015365-iqdi99pd	315	5	composite	composite	NN
cord-015365-iqdi99pd	315	6	of	of	IN
cord-015365-iqdi99pd	315	7	acute	acute	JJ
cord-015365-iqdi99pd	315	8	rejection	rejection	NN
cord-015365-iqdi99pd	315	9	[	[	-LRB-
cord-015365-iqdi99pd	315	10	AR	AR	NNP
cord-015365-iqdi99pd	315	11	]	]	-RRB-
cord-015365-iqdi99pd	315	12	,	,	,
cord-015365-iqdi99pd	315	13	graft	graft	NN
cord-015365-iqdi99pd	315	14	loss	loss	NN
cord-015365-iqdi99pd	315	15	[	[	-LRB-
cord-015365-iqdi99pd	315	16	GL	GL	NNP
cord-015365-iqdi99pd	315	17	]	]	-RRB-
cord-015365-iqdi99pd	315	18	,	,	,
cord-015365-iqdi99pd	315	19	and	and	CC
cord-015365-iqdi99pd	315	20	death	death	NN
cord-015365-iqdi99pd	315	21	by	by	IN
cord-015365-iqdi99pd	315	22	month	month	NN
cord-015365-iqdi99pd	315	23	6	6	CD
cord-015365-iqdi99pd	315	24	)	)	-RRB-
cord-015365-iqdi99pd	315	25	occurred	occur	VBD
cord-015365-iqdi99pd	315	26	more	more	RBR
cord-015365-iqdi99pd	315	27	frequently	frequently	RB
cord-015365-iqdi99pd	315	28	in	in	IN
cord-015365-iqdi99pd	315	29	belatacept	belatacept	NN
cord-015365-iqdi99pd	315	30	groups	group	NNS
cord-015365-iqdi99pd	315	31	.	.	.
cord-015365-iqdi99pd	316	1	By	by	IN
cord-015365-iqdi99pd	316	2	year	year	NN
cord-015365-iqdi99pd	316	3	1	1	CD
cord-015365-iqdi99pd	316	4	,	,	,
cord-015365-iqdi99pd	316	5	more	more	JJR
cord-015365-iqdi99pd	316	6	deaths	death	NNS
cord-015365-iqdi99pd	316	7	and	and	CC
cord-015365-iqdi99pd	316	8	GL	GL	NNP
cord-015365-iqdi99pd	316	9	occurred	occur	VBD
cord-015365-iqdi99pd	316	10	with	with	IN
cord-015365-iqdi99pd	316	11	belatacept	belatacept	NN
cord-015365-iqdi99pd	316	12	LD	LD	NNP
cord-015365-iqdi99pd	316	13	vs.	vs.	IN
cord-015365-iqdi99pd	316	14	other	other	JJ
cord-015365-iqdi99pd	316	15	groups	group	NNS
cord-015365-iqdi99pd	316	16	.	.	.
cord-015365-iqdi99pd	317	1	Causes	cause	NNS
cord-015365-iqdi99pd	317	2	of	of	IN
cord-015365-iqdi99pd	317	3	early	early	JJ
cord-015365-iqdi99pd	317	4	(	(	-LRB-
cord-015365-iqdi99pd	317	5	by	by	IN
cord-015365-iqdi99pd	317	6	6	6	CD
cord-015365-iqdi99pd	317	7	weeks	week	NNS
cord-015365-iqdi99pd	317	8	)	)	-RRB-
cord-015365-iqdi99pd	318	1	death	death	NN
cord-015365-iqdi99pd	318	2	and	and	CC
cord-015365-iqdi99pd	318	3	GL	GL	NNP
cord-015365-iqdi99pd	318	4	were	be	VBD
cord-015365-iqdi99pd	318	5	mostly	mostly	RB
cord-015365-iqdi99pd	318	6	due	due	JJ
cord-015365-iqdi99pd	318	7	to	to	IN
cord-015365-iqdi99pd	318	8	postoperative	postoperative	JJ
cord-015365-iqdi99pd	318	9	complications	complication	NNS
cord-015365-iqdi99pd	318	10	;	;	.
cord-015365-iqdi99pd	319	1	thereafter	thereafter	RB
cord-015365-iqdi99pd	319	2	causes	cause	NNS
cord-015365-iqdi99pd	319	3	included	include	VBD
cord-015365-iqdi99pd	319	4	sepsis	sepsis	NN
cord-015365-iqdi99pd	319	5	,	,	,
cord-015365-iqdi99pd	319	6	PTLD	PTLD	NNP
cord-015365-iqdi99pd	319	7	,	,	,
cord-015365-iqdi99pd	319	8	and	and	CC
cord-015365-iqdi99pd	319	9	multi	multi	JJ
cord-015365-iqdi99pd	319	10	-	-	JJ
cord-015365-iqdi99pd	319	11	organ	organ	JJ
cord-015365-iqdi99pd	319	12	failure	failure	NN
cord-015365-iqdi99pd	319	13	.	.	.
cord-015365-iqdi99pd	320	1	AR	AR	NNP
cord-015365-iqdi99pd	320	2	was	be	VBD
cord-015365-iqdi99pd	320	3	more	more	RBR
cord-015365-iqdi99pd	320	4	common	common	JJ
cord-015365-iqdi99pd	320	5	with	with	IN
cord-015365-iqdi99pd	320	6	belatacept	belatacept	NN
cord-015365-iqdi99pd	320	7	-	-	HYPH
cord-015365-iqdi99pd	320	8	based	base	VBN
cord-015365-iqdi99pd	320	9	regimens	regimen	NNS
cord-015365-iqdi99pd	320	10	compared	compare	VBN
cord-015365-iqdi99pd	320	11	to	to	IN
cord-015365-iqdi99pd	320	12	Tac	Tac	NNP
cord-015365-iqdi99pd	320	13	þ	þ	NNP
cord-015365-iqdi99pd	320	14	MMF	mmf	NN
cord-015365-iqdi99pd	320	15	.	.	.
cord-015365-iqdi99pd	321	1	By	by	IN
cord-015365-iqdi99pd	321	2	1	1	CD
cord-015365-iqdi99pd	321	3	year	year	NN
cord-015365-iqdi99pd	321	4	,	,	,
cord-015365-iqdi99pd	321	5	mean	mean	JJ
cord-015365-iqdi99pd	321	6	cGFR	cGFR	NNP
cord-015365-iqdi99pd	321	7	was	be	VBD
cord-015365-iqdi99pd	321	8	15	15	CD
cord-015365-iqdi99pd	321	9	-	-	SYM
cord-015365-iqdi99pd	321	10	34	34	CD
cord-015365-iqdi99pd	321	11	mL	ml	NN
cord-015365-iqdi99pd	321	12	/	/	SYM
cord-015365-iqdi99pd	321	13	min	min	NN
cord-015365-iqdi99pd	321	14	higher	higher	RBR
cord-015365-iqdi99pd	321	15	in	in	IN
cord-015365-iqdi99pd	321	16	belatacept	belatacept	NN
cord-015365-iqdi99pd	321	17	vs.	vs.	FW
cord-015365-iqdi99pd	321	18	Tac	Tac	NNP
cord-015365-iqdi99pd	321	19	groups	group	NNS
cord-015365-iqdi99pd	321	20	.	.	.
cord-015365-iqdi99pd	322	1	Lower	low	JJR
cord-015365-iqdi99pd	322	2	blood	blood	NN
cord-015365-iqdi99pd	322	3	pressure	pressure	NN
cord-015365-iqdi99pd	322	4	and	and	CC
cord-015365-iqdi99pd	322	5	less	less	JJR
cord-015365-iqdi99pd	322	6	neurotoxicity	neurotoxicity	NN
cord-015365-iqdi99pd	322	7	were	be	VBD
cord-015365-iqdi99pd	322	8	observed	observe	VBN
cord-015365-iqdi99pd	322	9	with	with	IN
cord-015365-iqdi99pd	322	10	belatacept	belatacept	NN
cord-015365-iqdi99pd	322	11	treatment	treatment	NN
cord-015365-iqdi99pd	322	12	.	.	.
cord-015365-iqdi99pd	323	1	2	2	LS
cord-015365-iqdi99pd	323	2	PTLD	PTLD	NNP
cord-015365-iqdi99pd	323	3	cases	case	NNS
cord-015365-iqdi99pd	323	4	and	and	CC
cord-015365-iqdi99pd	323	5	1	1	CD
cord-015365-iqdi99pd	323	6	PML	PML	NNP
cord-015365-iqdi99pd	323	7	case	case	NN
cord-015365-iqdi99pd	323	8	(	(	-LRB-
cord-015365-iqdi99pd	323	9	HD	HD	NNP
cord-015365-iqdi99pd	323	10	group	group	NN
cord-015365-iqdi99pd	323	11	)	)	-RRB-
cord-015365-iqdi99pd	323	12	occurred	occur	VBD
cord-015365-iqdi99pd	323	13	in	in	IN
cord-015365-iqdi99pd	323	14	the	the	DT
cord-015365-iqdi99pd	323	15	belatacept	belatacept	NN
cord-015365-iqdi99pd	323	16	groups	group	NNS
cord-015365-iqdi99pd	323	17	.	.	.
cord-015365-iqdi99pd	324	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	324	2	.	.	.
cord-015365-iqdi99pd	325	1	Belatacept	Belatacept	NNP
cord-015365-iqdi99pd	325	2	HD	HD	NNP
cord-015365-iqdi99pd	325	3	group	group	NN
cord-015365-iqdi99pd	325	4	had	have	VBD
cord-015365-iqdi99pd	325	5	comparable	comparable	JJ
cord-015365-iqdi99pd	325	6	efficacy	efficacy	NN
cord-015365-iqdi99pd	325	7	relative	relative	JJ
cord-015365-iqdi99pd	325	8	to	to	IN
cord-015365-iqdi99pd	325	9	Tac	Tac	NNP
cord-015365-iqdi99pd	325	10	alone	alone	RB
cord-015365-iqdi99pd	325	11	but	but	CC
cord-015365-iqdi99pd	325	12	was	be	VBD
cord-015365-iqdi99pd	325	13	less	less	RBR
cord-015365-iqdi99pd	325	14	effective	effective	JJ
cord-015365-iqdi99pd	325	15	compared	compare	VBN
cord-015365-iqdi99pd	325	16	to	to	IN
cord-015365-iqdi99pd	325	17	Tac	Tac	NNP
cord-015365-iqdi99pd	325	18	þ	þ	NNP
cord-015365-iqdi99pd	325	19	MMF	mmf	NN
cord-015365-iqdi99pd	325	20	.	.	.
cord-015365-iqdi99pd	326	1	Belatacept	Belatacept	NNP
cord-015365-iqdi99pd	326	2	LD	LD	NNP
cord-015365-iqdi99pd	326	3	group	group	NN
cord-015365-iqdi99pd	326	4	was	be	VBD
cord-015365-iqdi99pd	326	5	less	less	RBR
cord-015365-iqdi99pd	326	6	effective	effective	JJ
cord-015365-iqdi99pd	326	7	with	with	IN
cord-015365-iqdi99pd	326	8	more	more	JJR
cord-015365-iqdi99pd	326	9	deaths	death	NNS
cord-015365-iqdi99pd	326	10	and	and	CC
cord-015365-iqdi99pd	326	11	GL	GL	NNP
cord-015365-iqdi99pd	326	12	observed	observe	VBD
cord-015365-iqdi99pd	326	13	compared	compare	VBD
cord-015365-iqdi99pd	326	14	to	to	IN
cord-015365-iqdi99pd	326	15	both	both	CC
cord-015365-iqdi99pd	326	16	Tac	Tac	NNP
cord-015365-iqdi99pd	326	17	-	-	HYPH
cord-015365-iqdi99pd	326	18	based	base	VBN
cord-015365-iqdi99pd	326	19	groups	group	NNS
cord-015365-iqdi99pd	326	20	.	.	.
cord-015365-iqdi99pd	327	1	Belatacept	Belatacept	NNP
cord-015365-iqdi99pd	327	2	provided	provide	VBD
cord-015365-iqdi99pd	327	3	improved	improved	JJ
cord-015365-iqdi99pd	327	4	renal	renal	JJ
cord-015365-iqdi99pd	327	5	function	function	NN
cord-015365-iqdi99pd	327	6	with	with	IN
cord-015365-iqdi99pd	327	7	less	less	JJR
cord-015365-iqdi99pd	327	8	CV	cv	NN
cord-015365-iqdi99pd	327	9	/	/	SYM
cord-015365-iqdi99pd	327	10	metabolic	metabolic	JJ
cord-015365-iqdi99pd	327	11	and	and	CC
cord-015365-iqdi99pd	327	12	neurotoxicities	neurotoxicitie	NNS
cord-015365-iqdi99pd	327	13	vs.	vs.	IN
cord-015365-iqdi99pd	327	14	Tac	Tac	NNP
cord-015365-iqdi99pd	327	15	-	-	HYPH
cord-015365-iqdi99pd	327	16	based	base	VBN
cord-015365-iqdi99pd	327	17	regimens	regimen	NNS
cord-015365-iqdi99pd	327	18	.	.	.
cord-015365-iqdi99pd	328	1	PTLD	PTLD	NNP
cord-015365-iqdi99pd	328	2	and	and	CC
cord-015365-iqdi99pd	328	3	PML	PML	NNP
cord-015365-iqdi99pd	328	4	were	be	VBD
cord-015365-iqdi99pd	328	5	observed	observe	VBN
cord-015365-iqdi99pd	328	6	with	with	IN
cord-015365-iqdi99pd	328	7	belatacept	belatacept	NN
cord-015365-iqdi99pd	328	8	.	.	.
cord-015365-iqdi99pd	329	1	The	the	DT
cord-015365-iqdi99pd	329	2	optimal	optimal	JJ
cord-015365-iqdi99pd	329	3	dose	dose	NN
cord-015365-iqdi99pd	329	4	/	/	SYM
cord-015365-iqdi99pd	329	5	regimen	regimen	NN
cord-015365-iqdi99pd	329	6	of	of	IN
cord-015365-iqdi99pd	329	7	belatacept	belatacept	NN
cord-015365-iqdi99pd	329	8	in	in	IN
cord-015365-iqdi99pd	329	9	LT	LT	NNP
cord-015365-iqdi99pd	329	10	is	be	VBZ
cord-015365-iqdi99pd	329	11	yet	yet	RB
cord-015365-iqdi99pd	329	12	to	to	TO
cord-015365-iqdi99pd	329	13	be	be	VB
cord-015365-iqdi99pd	329	14	determined	determine	VBN
cord-015365-iqdi99pd	329	15	.	.	.
cord-015365-iqdi99pd	330	1	CMV	CMV	NNP
cord-015365-iqdi99pd	330	2	late	late	JJ
cord-015365-iqdi99pd	330	3	phase	phase	NN
cord-015365-iqdi99pd	330	4	-	-	HYPH
cord-015365-iqdi99pd	330	5	induced	induce	VBN
cord-015365-iqdi99pd	330	6	mTOR	mTOR	NNP
cord-015365-iqdi99pd	330	7	activation	activation	NN
cord-015365-iqdi99pd	330	8	is	be	VBZ
cord-015365-iqdi99pd	330	9	essential	essential	JJ
cord-015365-iqdi99pd	330	10	for	for	IN
cord-015365-iqdi99pd	330	11	efficient	efficient	JJ
cord-015365-iqdi99pd	330	12	virus	virus	NN
cord-015365-iqdi99pd	330	13	replication	replication	NN
cord-015365-iqdi99pd	330	14	in	in	IN
cord-015365-iqdi99pd	330	15	human	human	JJ
cord-015365-iqdi99pd	330	16	M2-polarized	m2-polarize	VBN
cord-015365-iqdi99pd	330	17	macrophages	macrophage	NNS
cord-015365-iqdi99pd	330	18	Human	Human	NNP
cord-015365-iqdi99pd	330	19	Cytomegalovirus	Cytomegalovirus	NNP
cord-015365-iqdi99pd	330	20	(	(	-LRB-
cord-015365-iqdi99pd	330	21	CMV	CMV	NNP
cord-015365-iqdi99pd	330	22	)	)	-RRB-
cord-015365-iqdi99pd	330	23	remains	remain	VBZ
cord-015365-iqdi99pd	330	24	one	one	CD
cord-015365-iqdi99pd	330	25	of	of	IN
cord-015365-iqdi99pd	330	26	the	the	DT
cord-015365-iqdi99pd	330	27	most	most	RBS
cord-015365-iqdi99pd	330	28	important	important	JJ
cord-015365-iqdi99pd	330	29	pathogens	pathogen	NNS
cord-015365-iqdi99pd	330	30	following	follow	VBG
cord-015365-iqdi99pd	330	31	solid	solid	JJ
cord-015365-iqdi99pd	330	32	-	-	HYPH
cord-015365-iqdi99pd	330	33	organ	organ	NN
cord-015365-iqdi99pd	330	34	transplantation	transplantation	NN
cord-015365-iqdi99pd	330	35	,	,	,
cord-015365-iqdi99pd	330	36	potentially	potentially	RB
cord-015365-iqdi99pd	330	37	leading	lead	VBG
cord-015365-iqdi99pd	330	38	to	to	IN
cord-015365-iqdi99pd	330	39	CMV	CMV	NNP
cord-015365-iqdi99pd	330	40	disease	disease	NN
cord-015365-iqdi99pd	330	41	,	,	,
cord-015365-iqdi99pd	330	42	allograft	allograft	NN
cord-015365-iqdi99pd	330	43	dysfunction	dysfunction	NN
cord-015365-iqdi99pd	330	44	,	,	,
cord-015365-iqdi99pd	330	45	acute	acute	JJ
cord-015365-iqdi99pd	330	46	and	and	CC
cord-015365-iqdi99pd	330	47	chronic	chronic	JJ
cord-015365-iqdi99pd	330	48	rejection	rejection	NN
cord-015365-iqdi99pd	330	49	and	and	CC
cord-015365-iqdi99pd	330	50	opportunistic	opportunistic	JJ
cord-015365-iqdi99pd	330	51	infections	infection	NNS
cord-015365-iqdi99pd	330	52	.	.	.
cord-015365-iqdi99pd	331	1	Mounting	mount	VBG
cord-015365-iqdi99pd	331	2	evidence	evidence	NN
cord-015365-iqdi99pd	331	3	indicates	indicate	VBZ
cord-015365-iqdi99pd	331	4	that	that	IN
cord-015365-iqdi99pd	331	5	mammalian	mammalian	JJ
cord-015365-iqdi99pd	331	6	target	target	NN
cord-015365-iqdi99pd	331	7	of	of	IN
cord-015365-iqdi99pd	331	8	rapamycin	rapamycin	NNP
cord-015365-iqdi99pd	331	9	(	(	-LRB-
cord-015365-iqdi99pd	331	10	mTOR	mTOR	NNP
cord-015365-iqdi99pd	331	11	)	)	-RRB-
cord-015365-iqdi99pd	331	12	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	331	13	may	may	MD
cord-015365-iqdi99pd	331	14	decrease	decrease	VB
cord-015365-iqdi99pd	331	15	the	the	DT
cord-015365-iqdi99pd	331	16	incidence	incidence	NN
cord-015365-iqdi99pd	331	17	of	of	IN
cord-015365-iqdi99pd	331	18	CMV	CMV	NNP
cord-015365-iqdi99pd	331	19	infection	infection	NN
cord-015365-iqdi99pd	331	20	in	in	IN
cord-015365-iqdi99pd	331	21	renal	renal	JJ
cord-015365-iqdi99pd	331	22	transplant	transplant	NN
cord-015365-iqdi99pd	331	23	recipients	recipient	NNS
cord-015365-iqdi99pd	331	24	.	.	.
cord-015365-iqdi99pd	332	1	Here	here	RB
cord-015365-iqdi99pd	332	2	we	-PRON-	PRP
cord-015365-iqdi99pd	332	3	aimed	aim	VBD
cord-015365-iqdi99pd	332	4	to	to	TO
cord-015365-iqdi99pd	332	5	elucidate	elucidate	VB
cord-015365-iqdi99pd	332	6	the	the	DT
cord-015365-iqdi99pd	332	7	molecular	molecular	JJ
cord-015365-iqdi99pd	332	8	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	332	9	of	of	IN
cord-015365-iqdi99pd	332	10	this	this	DT
cord-015365-iqdi99pd	332	11	effect	effect	NN
cord-015365-iqdi99pd	332	12	by	by	IN
cord-015365-iqdi99pd	332	13	employing	employ	VBG
cord-015365-iqdi99pd	332	14	a	a	DT
cord-015365-iqdi99pd	332	15	human	human	JJ
cord-015365-iqdi99pd	332	16	CMV	CMV	NNP
cord-015365-iqdi99pd	332	17	(	(	-LRB-
cord-015365-iqdi99pd	332	18	HCMV	HCMV	NNP
cord-015365-iqdi99pd	332	19	)	)	-RRB-
cord-015365-iqdi99pd	332	20	infection	infection	NN
cord-015365-iqdi99pd	332	21	model	model	NN
cord-015365-iqdi99pd	332	22	in	in	IN
cord-015365-iqdi99pd	332	23	human	human	JJ
cord-015365-iqdi99pd	332	24	macrophages	macrophage	NNS
cord-015365-iqdi99pd	332	25	,	,	,
cord-015365-iqdi99pd	332	26	since	since	IN
cord-015365-iqdi99pd	332	27	myeloid	myeloid	JJ
cord-015365-iqdi99pd	332	28	cells	cell	NNS
cord-015365-iqdi99pd	332	29	are	be	VBP
cord-015365-iqdi99pd	332	30	the	the	DT
cord-015365-iqdi99pd	332	31	principal	principal	NN
cord-015365-iqdi99pd	332	32	in	in	IN
cord-015365-iqdi99pd	332	33	vivo	vivo	NN
cord-015365-iqdi99pd	332	34	targets	target	NNS
cord-015365-iqdi99pd	332	35	of	of	IN
cord-015365-iqdi99pd	332	36	HCMV	HCMV	NNP
cord-015365-iqdi99pd	332	37	and	and	CC
cord-015365-iqdi99pd	332	38	the	the	DT
cord-015365-iqdi99pd	332	39	major	major	JJ
cord-015365-iqdi99pd	332	40	viral	viral	JJ
cord-015365-iqdi99pd	332	41	source	source	NN
cord-015365-iqdi99pd	332	42	during	during	IN
cord-015365-iqdi99pd	332	43	early	early	JJ
cord-015365-iqdi99pd	332	44	CMV	CMV	NNP
cord-015365-iqdi99pd	332	45	disease	disease	NN
cord-015365-iqdi99pd	332	46	.	.	.
cord-015365-iqdi99pd	333	1	Here	here	RB
cord-015365-iqdi99pd	333	2	we	-PRON-	PRP
cord-015365-iqdi99pd	333	3	demonstrate	demonstrate	VBP
cord-015365-iqdi99pd	333	4	that	that	DT
cord-015365-iqdi99pd	333	5	polarization	polarization	NN
cord-015365-iqdi99pd	333	6	of	of	IN
cord-015365-iqdi99pd	333	7	macrophages	macrophage	NNS
cord-015365-iqdi99pd	333	8	into	into	IN
cord-015365-iqdi99pd	333	9	M1	M1	NNP
cord-015365-iqdi99pd	333	10	and	and	CC
cord-015365-iqdi99pd	333	11	M2	M2	NNP
cord-015365-iqdi99pd	333	12	macrophages	macrophage	NNS
cord-015365-iqdi99pd	333	13	resulted	result	VBD
cord-015365-iqdi99pd	333	14	in	in	IN
cord-015365-iqdi99pd	333	15	highly	highly	RB
cord-015365-iqdi99pd	333	16	divergent	divergent	JJ
cord-015365-iqdi99pd	333	17	host	host	NN
cord-015365-iqdi99pd	333	18	cell	cell	NN
cord-015365-iqdi99pd	333	19	permissiveness	permissiveness	NN
cord-015365-iqdi99pd	333	20	for	for	IN
cord-015365-iqdi99pd	333	21	HCMV	HCMV	NNP
cord-015365-iqdi99pd	333	22	with	with	IN
cord-015365-iqdi99pd	333	23	optimal	optimal	JJ
cord-015365-iqdi99pd	333	24	infection	infection	NN
cord-015365-iqdi99pd	333	25	susceptibility	susceptibility	NN
cord-015365-iqdi99pd	333	26	in	in	IN
cord-015365-iqdi99pd	333	27	M2	M2	NNP
cord-015365-iqdi99pd	333	28	versus	versus	IN
cord-015365-iqdi99pd	333	29	M1	M1	NNP
cord-015365-iqdi99pd	333	30	macrophages	macrophage	NNS
cord-015365-iqdi99pd	333	31	.	.	.
cord-015365-iqdi99pd	334	1	Employing	employ	VBG
cord-015365-iqdi99pd	334	2	an	an	DT
cord-015365-iqdi99pd	334	3	ultra	ultra	JJ
cord-015365-iqdi99pd	334	4	-	-	JJ
cord-015365-iqdi99pd	334	5	high	high	JJ
cord-015365-iqdi99pd	334	6	purified	purify	VBN
cord-015365-iqdi99pd	334	7	HCMV	HCMV	NNP
cord-015365-iqdi99pd	334	8	stock	stock	NN
cord-015365-iqdi99pd	334	9	(	(	-LRB-
cord-015365-iqdi99pd	334	10	TB-40	TB-40	NNP
cord-015365-iqdi99pd	334	11	/	/	SYM
cord-015365-iqdi99pd	334	12	E	e	NN
cord-015365-iqdi99pd	334	13	)	)	-RRB-
cord-015365-iqdi99pd	334	14	selective	selective	JJ
cord-015365-iqdi99pd	334	15	rapamycinindependent	rapamycinindependent	JJ
cord-015365-iqdi99pd	334	16	induction	induction	NN
cord-015365-iqdi99pd	334	17	of	of	IN
cord-015365-iqdi99pd	334	18	IFN	IFN	NNP
cord-015365-iqdi99pd	334	19	-	-	HYPH
cord-015365-iqdi99pd	334	20	transcripts	transcript	NNS
cord-015365-iqdi99pd	334	21	,	,	,
cord-015365-iqdi99pd	334	22	but	but	CC
cord-015365-iqdi99pd	334	23	no	no	DT
cord-015365-iqdi99pd	334	24	proinflammatory	proinflammatory	JJ
cord-015365-iqdi99pd	334	25	cytokines	cytokine	NNS
cord-015365-iqdi99pd	334	26	or	or	CC
cord-015365-iqdi99pd	334	27	early	early	JJ
cord-015365-iqdi99pd	334	28	signalling	signal	VBG
cord-015365-iqdi99pd	334	29	events	event	NNS
cord-015365-iqdi99pd	334	30	including	include	VBG
cord-015365-iqdi99pd	334	31	MAPK	MAPK	NNP
cord-015365-iqdi99pd	334	32	and	and	CC
cord-015365-iqdi99pd	334	33	mTOR	mTOR	NNP
cord-015365-iqdi99pd	334	34	signalling	signalling	NN
cord-015365-iqdi99pd	334	35	could	could	MD
cord-015365-iqdi99pd	334	36	be	be	VB
cord-015365-iqdi99pd	334	37	detected	detect	VBN
cord-015365-iqdi99pd	334	38	.	.	.
cord-015365-iqdi99pd	335	1	Assessment	assessment	NN
cord-015365-iqdi99pd	335	2	of	of	IN
cord-015365-iqdi99pd	335	3	viral	viral	JJ
cord-015365-iqdi99pd	335	4	gene	gene	NN
cord-015365-iqdi99pd	335	5	expression	expression	NN
cord-015365-iqdi99pd	335	6	and	and	CC
cord-015365-iqdi99pd	335	7	mTORC1	mtorc1	CD
cord-015365-iqdi99pd	335	8	activity	activity	NN
cord-015365-iqdi99pd	335	9	during	during	IN
cord-015365-iqdi99pd	335	10	the	the	DT
cord-015365-iqdi99pd	335	11	course	course	NN
cord-015365-iqdi99pd	335	12	of	of	IN
cord-015365-iqdi99pd	335	13	macrophage	macrophage	NN
cord-015365-iqdi99pd	335	14	infection	infection	NN
cord-015365-iqdi99pd	335	15	revealed	reveal	VBD
cord-015365-iqdi99pd	335	16	that	that	IN
cord-015365-iqdi99pd	335	17	rapamycin	rapamycin	NNS
cord-015365-iqdi99pd	335	18	significantly	significantly	RB
cord-015365-iqdi99pd	335	19	suppressed	suppress	VBD
cord-015365-iqdi99pd	335	20	CMV	CMV	NNP
cord-015365-iqdi99pd	335	21	replication	replication	NN
cord-015365-iqdi99pd	335	22	3	3	CD
cord-015365-iqdi99pd	335	23	and	and	CC
cord-015365-iqdi99pd	335	24	5	5	CD
cord-015365-iqdi99pd	335	25	days	day	NNS
cord-015365-iqdi99pd	335	26	post	post	NN
cord-015365-iqdi99pd	335	27	infection	infection	NN
cord-015365-iqdi99pd	335	28	,	,	,
cord-015365-iqdi99pd	335	29	while	while	IN
cord-015365-iqdi99pd	335	30	CMV	CMV	NNP
cord-015365-iqdi99pd	335	31	proliferation	proliferation	NN
cord-015365-iqdi99pd	335	32	in	in	IN
cord-015365-iqdi99pd	335	33	fibroblasts	fibroblast	NNS
cord-015365-iqdi99pd	335	34	was	be	VBD
cord-015365-iqdi99pd	335	35	largely	largely	RB
cord-015365-iqdi99pd	335	36	unaffected	unaffected	JJ
cord-015365-iqdi99pd	335	37	by	by	IN
cord-015365-iqdi99pd	335	38	mTOR	mtor	NN
cord-015365-iqdi99pd	335	39	-	-	HYPH
cord-015365-iqdi99pd	335	40	blockade	blockade	NN
cord-015365-iqdi99pd	335	41	.	.	.
cord-015365-iqdi99pd	336	1	Analysis	analysis	NN
cord-015365-iqdi99pd	336	2	of	of	IN
cord-015365-iqdi99pd	336	3	mTORC1	mTORC1	NNP
cord-015365-iqdi99pd	336	4	activation	activation	NN
cord-015365-iqdi99pd	336	5	and	and	CC
cord-015365-iqdi99pd	336	6	late	late	JJ
cord-015365-iqdi99pd	336	7	phase	phase	NN
cord-015365-iqdi99pd	336	8	viral	viral	JJ
cord-015365-iqdi99pd	336	9	proteins	protein	NNS
cord-015365-iqdi99pd	336	10	including	include	VBG
cord-015365-iqdi99pd	336	11	pUL-44	pul-44	NN
cord-015365-iqdi99pd	336	12	and	and	CC
cord-015365-iqdi99pd	336	13	pp65	pp65	RB
cord-015365-iqdi99pd	336	14	signified	signify	VBD
cord-015365-iqdi99pd	336	15	an	an	DT
cord-015365-iqdi99pd	336	16	exquisite	exquisite	JJ
cord-015365-iqdi99pd	336	17	mTORC1	mtorc1	JJ
cord-015365-iqdi99pd	336	18	dependency	dependency	NN
cord-015365-iqdi99pd	336	19	of	of	IN
cord-015365-iqdi99pd	336	20	protein	protein	NN
cord-015365-iqdi99pd	336	21	synthesis	synthesis	NN
cord-015365-iqdi99pd	336	22	during	during	IN
cord-015365-iqdi99pd	336	23	the	the	DT
cord-015365-iqdi99pd	336	24	late	late	JJ
cord-015365-iqdi99pd	336	25	phases	phase	NNS
cord-015365-iqdi99pd	336	26	of	of	IN
cord-015365-iqdi99pd	336	27	viral	viral	JJ
cord-015365-iqdi99pd	336	28	replication	replication	NN
cord-015365-iqdi99pd	336	29	.	.	.
cord-015365-iqdi99pd	337	1	Collectively	collectively	RB
cord-015365-iqdi99pd	337	2	,	,	,
cord-015365-iqdi99pd	337	3	these	these	DT
cord-015365-iqdi99pd	337	4	data	datum	NNS
cord-015365-iqdi99pd	337	5	indicate	indicate	VBP
cord-015365-iqdi99pd	337	6	that	that	IN
cord-015365-iqdi99pd	337	7	mTORC1	mTORC1	NNP
cord-015365-iqdi99pd	337	8	is	be	VBZ
cord-015365-iqdi99pd	337	9	essential	essential	JJ
cord-015365-iqdi99pd	337	10	for	for	IN
cord-015365-iqdi99pd	337	11	virus	virus	NN
cord-015365-iqdi99pd	337	12	replication	replication	NN
cord-015365-iqdi99pd	337	13	during	during	IN
cord-015365-iqdi99pd	337	14	late	late	JJ
cord-015365-iqdi99pd	337	15	phases	phase	NNS
cord-015365-iqdi99pd	337	16	of	of	IN
cord-015365-iqdi99pd	337	17	the	the	DT
cord-015365-iqdi99pd	337	18	viral	viral	JJ
cord-015365-iqdi99pd	337	19	cycle	cycle	NN
cord-015365-iqdi99pd	337	20	in	in	IN
cord-015365-iqdi99pd	337	21	myeloid	myeloid	JJ
cord-015365-iqdi99pd	337	22	cells	cell	NNS
cord-015365-iqdi99pd	337	23	which	which	WDT
cord-015365-iqdi99pd	337	24	might	may	MD
cord-015365-iqdi99pd	337	25	explain	explain	VB
cord-015365-iqdi99pd	337	26	the	the	DT
cord-015365-iqdi99pd	337	27	potent	potent	JJ
cord-015365-iqdi99pd	337	28	anti	anti	JJ
cord-015365-iqdi99pd	337	29	-	-	JJ
cord-015365-iqdi99pd	337	30	CMV	cmv	JJ
cord-015365-iqdi99pd	337	31	effects	effect	NNS
cord-015365-iqdi99pd	337	32	of	of	IN
cord-015365-iqdi99pd	337	33	mTOR	mTOR	NNP
cord-015365-iqdi99pd	337	34	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	337	35	after	after	IN
cord-015365-iqdi99pd	337	36	organ	organ	NN
cord-015365-iqdi99pd	337	37	transplantation	transplantation	NN
cord-015365-iqdi99pd	337	38	.	.	.
cord-015365-iqdi99pd	338	1	Background	background	NN
cord-015365-iqdi99pd	338	2	.	.	.
cord-015365-iqdi99pd	339	1	Brain	brain	NN
cord-015365-iqdi99pd	339	2	death	death	NN
cord-015365-iqdi99pd	339	3	(	(	-LRB-
cord-015365-iqdi99pd	339	4	BD	BD	NNP
cord-015365-iqdi99pd	339	5	)	)	-RRB-
cord-015365-iqdi99pd	339	6	triggers	trigger	VBZ
cord-015365-iqdi99pd	339	7	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	339	8	signals	signal	NNS
cord-015365-iqdi99pd	339	9	and	and	CC
cord-015365-iqdi99pd	339	10	graft	graft	NN
cord-015365-iqdi99pd	339	11	injury	injury	NN
cord-015365-iqdi99pd	339	12	.	.	.
cord-015365-iqdi99pd	340	1	Clinically	clinically	RB
cord-015365-iqdi99pd	340	2	,	,	,
cord-015365-iqdi99pd	340	3	reduced	reduce	VBN
cord-015365-iqdi99pd	340	4	organ	organ	NN
cord-015365-iqdi99pd	340	5	quality	quality	NN
cord-015365-iqdi99pd	340	6	as	as	IN
cord-015365-iqdi99pd	340	7	a	a	DT
cord-015365-iqdi99pd	340	8	result	result	NN
cord-015365-iqdi99pd	340	9	of	of	IN
cord-015365-iqdi99pd	340	10	brain	brain	NN
cord-015365-iqdi99pd	340	11	death	death	NN
cord-015365-iqdi99pd	340	12	contributes	contribute	VBZ
cord-015365-iqdi99pd	340	13	to	to	IN
cord-015365-iqdi99pd	340	14	inferior	inferior	JJ
cord-015365-iqdi99pd	340	15	graft	graft	NN
cord-015365-iqdi99pd	340	16	and	and	CC
cord-015365-iqdi99pd	340	17	patient	patient	JJ
cord-015365-iqdi99pd	340	18	survival	survival	NN
cord-015365-iqdi99pd	340	19	.	.	.
cord-015365-iqdi99pd	341	1	Regulatory	regulatory	JJ
cord-015365-iqdi99pd	341	2	T	t	NN
cord-015365-iqdi99pd	341	3	-	-	HYPH
cord-015365-iqdi99pd	341	4	cells	cell	NNS
cord-015365-iqdi99pd	341	5	are	be	VBP
cord-015365-iqdi99pd	341	6	primarily	primarily	RB
cord-015365-iqdi99pd	341	7	known	know	VBN
cord-015365-iqdi99pd	341	8	for	for	IN
cord-015365-iqdi99pd	341	9	their	-PRON-	PRP$
cord-015365-iqdi99pd	341	10	control	control	NN
cord-015365-iqdi99pd	341	11	of	of	IN
cord-015365-iqdi99pd	341	12	the	the	DT
cord-015365-iqdi99pd	341	13	immune	immune	JJ
cord-015365-iqdi99pd	341	14	response	response	NN
cord-015365-iqdi99pd	341	15	.	.	.
cord-015365-iqdi99pd	342	1	We	-PRON-	PRP
cord-015365-iqdi99pd	342	2	analyzed	analyze	VBD
cord-015365-iqdi99pd	342	3	CD25þ	CD25þ	NNP
cord-015365-iqdi99pd	342	4	/	/	SYM
cord-015365-iqdi99pd	342	5	FoxP3þ	FoxP3þ	NNP
cord-015365-iqdi99pd	342	6	T	t	NN
cord-015365-iqdi99pd	342	7	-	-	HYPH
cord-015365-iqdi99pd	342	8	cell	cell	NN
cord-015365-iqdi99pd	342	9	subpopulations	subpopulation	NNS
cord-015365-iqdi99pd	342	10	in	in	IN
cord-015365-iqdi99pd	342	11	recipients	recipient	NNS
cord-015365-iqdi99pd	342	12	of	of	IN
cord-015365-iqdi99pd	342	13	either	either	DT
cord-015365-iqdi99pd	342	14	brain	brain	NN
cord-015365-iqdi99pd	342	15	dead	dead	JJ
cord-015365-iqdi99pd	342	16	and	and	CC
cord-015365-iqdi99pd	342	17	native	native	JJ
cord-015365-iqdi99pd	342	18	donor	donor	NN
cord-015365-iqdi99pd	342	19	hearts	heart	NNS
cord-015365-iqdi99pd	342	20	.	.	.
cord-015365-iqdi99pd	343	1	To	to	TO
cord-015365-iqdi99pd	343	2	dissect	dissect	VB
cord-015365-iqdi99pd	343	3	the	the	DT
cord-015365-iqdi99pd	343	4	role	role	NN
cord-015365-iqdi99pd	343	5	of	of	IN
cord-015365-iqdi99pd	343	6	donor	donor	NN
cord-015365-iqdi99pd	343	7	immune	immune	NN
cord-015365-iqdi99pd	343	8	competent	competent	JJ
cord-015365-iqdi99pd	343	9	cells	cell	NNS
cord-015365-iqdi99pd	343	10	in	in	IN
cord-015365-iqdi99pd	343	11	communicating	communicate	VBG
cord-015365-iqdi99pd	343	12	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	343	13	signals	signal	NNS
cord-015365-iqdi99pd	343	14	following	follow	VBG
cord-015365-iqdi99pd	343	15	BD	BD	NNP
cord-015365-iqdi99pd	344	1	we	-PRON-	PRP
cord-015365-iqdi99pd	344	2	performed	perform	VBD
cord-015365-iqdi99pd	344	3	syngeneic	syngeneic	NNS
cord-015365-iqdi99pd	344	4	cardiac	cardiac	JJ
cord-015365-iqdi99pd	344	5	transplants	transplant	NNS
cord-015365-iqdi99pd	344	6	from	from	IN
cord-015365-iqdi99pd	344	7	wildtype	wildtype	NN
cord-015365-iqdi99pd	344	8	and	and	CC
cord-015365-iqdi99pd	344	9	immune	immune	JJ
cord-015365-iqdi99pd	344	10	deficient	deficient	JJ
cord-015365-iqdi99pd	344	11	donors	donor	NNS
cord-015365-iqdi99pd	344	12	.	.	.
cord-015365-iqdi99pd	345	1	Methods	method	NNS
cord-015365-iqdi99pd	345	2	.	.	.
cord-015365-iqdi99pd	346	1	Hearts	heart	NNS
cord-015365-iqdi99pd	346	2	from	from	IN
cord-015365-iqdi99pd	346	3	brain	brain	NN
cord-015365-iqdi99pd	346	4	dead	dead	JJ
cord-015365-iqdi99pd	346	5	wild	wild	JJ
cord-015365-iqdi99pd	346	6	type	type	NN
cord-015365-iqdi99pd	347	1	(	(	-LRB-
cord-015365-iqdi99pd	347	2	BD	BD	NNP
cord-015365-iqdi99pd	347	3	/	/	SYM
cord-015365-iqdi99pd	347	4	WT	WT	NNP
cord-015365-iqdi99pd	347	5	)	)	-RRB-
cord-015365-iqdi99pd	348	1	C57BL6	c57bl6	NN
cord-015365-iqdi99pd	348	2	mice	mouse	NNS
cord-015365-iqdi99pd	348	3	and	and	CC
cord-015365-iqdi99pd	348	4	Rag2	Rag2	NNP
cord-015365-iqdi99pd	348	5	/	/	SYM
cord-015365-iqdi99pd	348	6	double	double	JJ
cord-015365-iqdi99pd	348	7	knockout	knockout	NN
cord-015365-iqdi99pd	349	1	(	(	-LRB-
cord-015365-iqdi99pd	349	2	BD	BD	NNP
cord-015365-iqdi99pd	349	3	/	/	SYM
cord-015365-iqdi99pd	349	4	KO	KO	NNP
cord-015365-iqdi99pd	349	5	)	)	-RRB-
cord-015365-iqdi99pd	350	1	mice	mouse	NNS
cord-015365-iqdi99pd	350	2	were	be	VBD
cord-015365-iqdi99pd	350	3	procured	procure	VBN
cord-015365-iqdi99pd	350	4	3	3	CD
cord-015365-iqdi99pd	350	5	hrs	hrs	NN
cord-015365-iqdi99pd	350	6	following	follow	VBG
cord-015365-iqdi99pd	350	7	brain	brain	NN
cord-015365-iqdi99pd	350	8	death	death	NN
cord-015365-iqdi99pd	350	9	induction	induction	NN
cord-015365-iqdi99pd	350	10	and	and	CC
cord-015365-iqdi99pd	350	11	transplanted	transplant	VBD
cord-015365-iqdi99pd	350	12	into	into	IN
cord-015365-iqdi99pd	350	13	WT	WT	NNP
cord-015365-iqdi99pd	350	14	recipients	recipient	NNS
cord-015365-iqdi99pd	350	15	.	.	.
cord-015365-iqdi99pd	351	1	Hearts	heart	NNS
cord-015365-iqdi99pd	351	2	originating	originate	VBG
cord-015365-iqdi99pd	351	3	from	from	IN
cord-015365-iqdi99pd	351	4	native	native	JJ
cord-015365-iqdi99pd	351	5	C57BL6	C57BL6	NNP
cord-015365-iqdi99pd	351	6	mice	mouse	NNS
cord-015365-iqdi99pd	351	7	served	serve	VBD
cord-015365-iqdi99pd	351	8	as	as	IN
cord-015365-iqdi99pd	351	9	controls	control	NNS
cord-015365-iqdi99pd	351	10	.	.	.
cord-015365-iqdi99pd	352	1	By	by	IN
cord-015365-iqdi99pd	352	2	3	3	CD
cord-015365-iqdi99pd	352	3	days	day	NNS
cord-015365-iqdi99pd	352	4	,	,	,
cord-015365-iqdi99pd	352	5	T	t	NN
cord-015365-iqdi99pd	352	6	-	-	HYPH
cord-015365-iqdi99pd	352	7	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	352	8	subpopulations	subpopulation	NNS
cord-015365-iqdi99pd	352	9	(	(	-LRB-
cord-015365-iqdi99pd	352	10	CD4	CD4	NNP
cord-015365-iqdi99pd	352	11	,	,	,
cord-015365-iqdi99pd	352	12	CD8	CD8	NNP
cord-015365-iqdi99pd	352	13	,	,	,
cord-015365-iqdi99pd	352	14	CD4	CD4	NNP
cord-015365-iqdi99pd	352	15	/	/	SYM
cord-015365-iqdi99pd	352	16	CD25	CD25	NNP
cord-015365-iqdi99pd	352	17	/	/	SYM
cord-015365-iqdi99pd	352	18	FoxP3	FoxP3	NNP
cord-015365-iqdi99pd	352	19	)	)	-RRB-
cord-015365-iqdi99pd	352	20	were	be	VBD
cord-015365-iqdi99pd	352	21	assessed	assess	VBN
cord-015365-iqdi99pd	352	22	by	by	IN
cord-015365-iqdi99pd	352	23	flow	flow	NN
cord-015365-iqdi99pd	352	24	cytometry	cytometry	NN
cord-015365-iqdi99pd	352	25	and	and	CC
cord-015365-iqdi99pd	352	26	graft	graft	NN
cord-015365-iqdi99pd	352	27	-	-	HYPH
cord-015365-iqdi99pd	352	28	specific	specific	JJ
cord-015365-iqdi99pd	352	29	changes	change	NNS
cord-015365-iqdi99pd	352	30	were	be	VBD
cord-015365-iqdi99pd	352	31	assessed	assess	VBN
cord-015365-iqdi99pd	352	32	by	by	IN
cord-015365-iqdi99pd	352	33	IHC	IHC	NNP
cord-015365-iqdi99pd	352	34	and	and	CC
cord-015365-iqdi99pd	352	35	RT	RT	NNP
cord-015365-iqdi99pd	352	36	-	-	HYPH
cord-015365-iqdi99pd	352	37	PCR	PCR	NNP
cord-015365-iqdi99pd	352	38	.	.	.
cord-015365-iqdi99pd	353	1	Results	result	NNS
cord-015365-iqdi99pd	353	2	.	.	.
cord-015365-iqdi99pd	354	1	Blood	blood	NN
cord-015365-iqdi99pd	354	2	pressure	pressure	NN
cord-015365-iqdi99pd	354	3	remained	remain	VBD
cord-015365-iqdi99pd	354	4	stable	stable	JJ
cord-015365-iqdi99pd	354	5	following	follow	VBG
cord-015365-iqdi99pd	354	6	BD	BD	NNP
cord-015365-iqdi99pd	354	7	induction	induction	NN
cord-015365-iqdi99pd	354	8	and	and	CC
cord-015365-iqdi99pd	354	9	intragraft	intragraft	NN
cord-015365-iqdi99pd	354	10	cell	cell	NN
cord-015365-iqdi99pd	354	11	infiltration	infiltration	NN
cord-015365-iqdi99pd	354	12	was	be	VBD
cord-015365-iqdi99pd	354	13	comparable	comparable	JJ
cord-015365-iqdi99pd	354	14	in	in	IN
cord-015365-iqdi99pd	354	15	all	all	DT
cord-015365-iqdi99pd	354	16	groups	group	NNS
cord-015365-iqdi99pd	354	17	(	(	-LRB-
cord-015365-iqdi99pd	354	18	p	p	NNP
cord-015365-iqdi99pd	354	19	¼	¼	NNP
cord-015365-iqdi99pd	354	20	n.s	n.s	NNP
cord-015365-iqdi99pd	354	21	.	.	NNP
cord-015365-iqdi99pd	354	22	)	)	-RRB-
cord-015365-iqdi99pd	354	23	.	.	.
cord-015365-iqdi99pd	355	1	Cardiac	cardiac	JJ
cord-015365-iqdi99pd	355	2	isografts	isograft	NNS
cord-015365-iqdi99pd	355	3	from	from	IN
cord-015365-iqdi99pd	355	4	BD	BD	NNP
cord-015365-iqdi99pd	355	5	/	/	SYM
cord-015365-iqdi99pd	355	6	WT	WT	NNP
cord-015365-iqdi99pd	355	7	donors	donor	NNS
cord-015365-iqdi99pd	355	8	demonstrated	demonstrate	VBD
cord-015365-iqdi99pd	355	9	pronounced	pronounced	JJ
cord-015365-iqdi99pd	355	10	cellular	cellular	JJ
cord-015365-iqdi99pd	355	11	infiltrates	infiltrate	VBZ
cord-015365-iqdi99pd	355	12	;	;	:
cord-015365-iqdi99pd	355	13	only	only	RB
cord-015365-iqdi99pd	355	14	few	few	JJ
cord-015365-iqdi99pd	355	15	cells	cell	NNS
cord-015365-iqdi99pd	355	16	infiltrated	infiltrate	VBD
cord-015365-iqdi99pd	355	17	hearts	heart	NNS
cord-015365-iqdi99pd	355	18	from	from	IN
cord-015365-iqdi99pd	355	19	living	live	VBG
cord-015365-iqdi99pd	355	20	WT	WT	NNP
cord-015365-iqdi99pd	355	21	donors	donor	NNS
cord-015365-iqdi99pd	355	22	(	(	-LRB-
cord-015365-iqdi99pd	355	23	p	p	NN
cord-015365-iqdi99pd	355	24	¼	¼	CD
cord-015365-iqdi99pd	355	25	0.025	0.025	CD
cord-015365-iqdi99pd	355	26	)	)	-RRB-
cord-015365-iqdi99pd	355	27	.	.	.
cord-015365-iqdi99pd	356	1	Of	of	IN
cord-015365-iqdi99pd	356	2	note	note	NN
cord-015365-iqdi99pd	356	3	,	,	,
cord-015365-iqdi99pd	356	4	CD4	CD4	NNP
cord-015365-iqdi99pd	356	5	/	/	SYM
cord-015365-iqdi99pd	356	6	CD25	CD25	NNP
cord-015365-iqdi99pd	356	7	/	/	SYM
cord-015365-iqdi99pd	356	8	FoxP3	FoxP3	NNP
cord-015365-iqdi99pd	356	9	regulatory	regulatory	JJ
cord-015365-iqdi99pd	356	10	T	t	NN
cord-015365-iqdi99pd	356	11	-	-	HYPH
cord-015365-iqdi99pd	356	12	cells	cell	NNS
cord-015365-iqdi99pd	356	13	counts	count	NNS
cord-015365-iqdi99pd	356	14	were	be	VBD
cord-015365-iqdi99pd	356	15	significantly	significantly	RB
cord-015365-iqdi99pd	356	16	elevated	elevate	VBN
cord-015365-iqdi99pd	356	17	in	in	IN
cord-015365-iqdi99pd	356	18	recipients	recipient	NNS
cord-015365-iqdi99pd	356	19	of	of	IN
cord-015365-iqdi99pd	356	20	BD	BD	NNP
cord-015365-iqdi99pd	356	21	/	/	SYM
cord-015365-iqdi99pd	356	22	WT	WT	NNP
cord-015365-iqdi99pd	356	23	grafts	graft	NNS
cord-015365-iqdi99pd	356	24	(	(	-LRB-
cord-015365-iqdi99pd	356	25	p	p	NN
cord-015365-iqdi99pd	356	26	¼	¼	CD
cord-015365-iqdi99pd	356	27	0.04	0.04	CD
cord-015365-iqdi99pd	356	28	)	)	-RRB-
cord-015365-iqdi99pd	356	29	.	.	.
cord-015365-iqdi99pd	357	1	Recipients	recipient	NNS
cord-015365-iqdi99pd	357	2	of	of	IN
cord-015365-iqdi99pd	357	3	BD	BD	NNP
cord-015365-iqdi99pd	357	4	/	/	SYM
cord-015365-iqdi99pd	357	5	KO	KO	NNP
cord-015365-iqdi99pd	357	6	hearts	heart	NNS
cord-015365-iqdi99pd	357	7	featured	feature	VBD
cord-015365-iqdi99pd	357	8	reduced	reduce	VBN
cord-015365-iqdi99pd	357	9	CD4	CD4	NNP
cord-015365-iqdi99pd	357	10	þ	þ	NNP
cord-015365-iqdi99pd	357	11	T	t	NN
cord-015365-iqdi99pd	357	12	-	-	HYPH
cord-015365-iqdi99pd	357	13	cell	cell	NN
cord-015365-iqdi99pd	357	14	infiltrates	infiltrate	VBZ
cord-015365-iqdi99pd	357	15	,	,	,
cord-015365-iqdi99pd	357	16	but	but	CC
cord-015365-iqdi99pd	357	17	comparable	comparable	JJ
cord-015365-iqdi99pd	357	18	FoxP3	FoxP3	NNP
cord-015365-iqdi99pd	357	19	levels	level	NNS
cord-015365-iqdi99pd	357	20	(	(	-LRB-
cord-015365-iqdi99pd	357	21	p	p	NN
cord-015365-iqdi99pd	357	22	¼	¼	NNP
cord-015365-iqdi99pd	357	23	n.s	n.s	NNP
cord-015365-iqdi99pd	357	24	.	.	NNP
cord-015365-iqdi99pd	357	25	)	)	-RRB-
cord-015365-iqdi99pd	357	26	.	.	.
cord-015365-iqdi99pd	358	1	In	in	IN
cord-015365-iqdi99pd	358	2	contrast	contrast	NN
cord-015365-iqdi99pd	358	3	,	,	,
cord-015365-iqdi99pd	358	4	BD	BD	NNP
cord-015365-iqdi99pd	358	5	/	/	SYM
cord-015365-iqdi99pd	358	6	KO	KO	NNP
cord-015365-iqdi99pd	358	7	heart	heart	NN
cord-015365-iqdi99pd	358	8	recipients	recipient	NNS
cord-015365-iqdi99pd	358	9	showed	show	VBD
cord-015365-iqdi99pd	358	10	significantly	significantly	RB
cord-015365-iqdi99pd	358	11	lower	low	JJR
cord-015365-iqdi99pd	358	12	IL-6	IL-6	NNP
cord-015365-iqdi99pd	358	13	,	,	,
cord-015365-iqdi99pd	358	14	IFN-	IFN-	NNP
cord-015365-iqdi99pd	358	15	,	,	,
cord-015365-iqdi99pd	358	16	and	and	CC
cord-015365-iqdi99pd	358	17	TNF	TNF	NNP
cord-015365-iqdi99pd	358	18	--	--	:
cord-015365-iqdi99pd	358	19	levels	level	NNS
cord-015365-iqdi99pd	358	20	(	(	-LRB-
cord-015365-iqdi99pd	358	21	p	p	NN
cord-015365-iqdi99pd	358	22	¼	¼	CD
cord-015365-iqdi99pd	358	23	0.03	0.03	CD
cord-015365-iqdi99pd	358	24	,	,	,
cord-015365-iqdi99pd	358	25	0.005	0.005	CD
cord-015365-iqdi99pd	358	26	,	,	,
cord-015365-iqdi99pd	358	27	0.01	0.01	CD
cord-015365-iqdi99pd	358	28	)	)	-RRB-
cord-015365-iqdi99pd	358	29	.	.	.
cord-015365-iqdi99pd	359	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	359	2	.	.	.
cord-015365-iqdi99pd	360	1	Inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	360	2	events	event	NNS
cord-015365-iqdi99pd	360	3	after	after	IN
cord-015365-iqdi99pd	360	4	brain	brain	NN
cord-015365-iqdi99pd	360	5	death	death	NN
cord-015365-iqdi99pd	360	6	are	be	VBP
cord-015365-iqdi99pd	360	7	counterbalanced	counterbalance	VBN
cord-015365-iqdi99pd	360	8	by	by	IN
cord-015365-iqdi99pd	360	9	significantly	significantly	RB
cord-015365-iqdi99pd	360	10	elevated	elevate	VBN
cord-015365-iqdi99pd	360	11	rates	rate	NNS
cord-015365-iqdi99pd	360	12	of	of	IN
cord-015365-iqdi99pd	360	13	CD4	CD4	NNP
cord-015365-iqdi99pd	360	14	/	/	SYM
cord-015365-iqdi99pd	360	15	CD25/	CD25/	NNP
cord-015365-iqdi99pd	361	1	FoxP3	FoxP3	NNP
cord-015365-iqdi99pd	361	2	reg	reg	NN
cord-015365-iqdi99pd	361	3	.	.	.
cord-015365-iqdi99pd	362	1	T	t	NN
cord-015365-iqdi99pd	362	2	-	-	HYPH
cord-015365-iqdi99pd	362	3	cells	cell	NNS
cord-015365-iqdi99pd	362	4	.	.	.
cord-015365-iqdi99pd	363	1	Less	less	RBR
cord-015365-iqdi99pd	363	2	pronounced	pronounced	JJ
cord-015365-iqdi99pd	363	3	consequences	consequence	NNS
cord-015365-iqdi99pd	363	4	of	of	IN
cord-015365-iqdi99pd	363	5	brain	brain	NN
cord-015365-iqdi99pd	363	6	death	death	NN
cord-015365-iqdi99pd	363	7	in	in	IN
cord-015365-iqdi99pd	363	8	hearts	heart	NNS
cord-015365-iqdi99pd	363	9	originating	originate	VBG
cord-015365-iqdi99pd	363	10	from	from	IN
cord-015365-iqdi99pd	363	11	immune	immune	JJ
cord-015365-iqdi99pd	363	12	deficient	deficient	JJ
cord-015365-iqdi99pd	363	13	donors	donor	NNS
cord-015365-iqdi99pd	363	14	suggest	suggest	VBP
cord-015365-iqdi99pd	363	15	a	a	DT
cord-015365-iqdi99pd	363	16	critical	critical	JJ
cord-015365-iqdi99pd	363	17	role	role	NN
cord-015365-iqdi99pd	363	18	of	of	IN
cord-015365-iqdi99pd	363	19	immune	immune	JJ
cord-015365-iqdi99pd	363	20	competent	competent	JJ
cord-015365-iqdi99pd	363	21	cells	cell	NNS
cord-015365-iqdi99pd	363	22	in	in	IN
cord-015365-iqdi99pd	363	23	communicating	communicate	VBG
cord-015365-iqdi99pd	363	24	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	363	25	signals	signal	NNS
cord-015365-iqdi99pd	363	26	.	.	.
cord-015365-iqdi99pd	364	1	Lipocalin-2	Lipocalin-2	NNPS
cord-015365-iqdi99pd	364	2	as	as	IN
cord-015365-iqdi99pd	364	3	a	a	DT
cord-015365-iqdi99pd	364	4	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	364	5	agent	agent	NN
cord-015365-iqdi99pd	364	6	in	in	IN
cord-015365-iqdi99pd	364	7	chemotaxis	chemotaxis	NN
cord-015365-iqdi99pd	364	8	during	during	IN
cord-015365-iqdi99pd	364	9	ischemia	ischemia	NN
cord-015365-iqdi99pd	364	10	and	and	CC
cord-015365-iqdi99pd	364	11	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	364	12	injury	injury	NN
cord-015365-iqdi99pd	364	13	following	follow	VBG
cord-015365-iqdi99pd	364	14	solid	solid	JJ
cord-015365-iqdi99pd	364	15	organ	organ	NN
cord-015365-iqdi99pd	364	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	364	17	Background	Background	NNP
cord-015365-iqdi99pd	364	18	.	.	.
cord-015365-iqdi99pd	365	1	Neutrophil	Neutrophil	NNP
cord-015365-iqdi99pd	365	2	gelatinase	gelatinase	NN
cord-015365-iqdi99pd	365	3	-	-	HYPH
cord-015365-iqdi99pd	365	4	associated	associate	VBN
cord-015365-iqdi99pd	365	5	lipocalin	lipocalin	NN
cord-015365-iqdi99pd	366	1	(	(	-LRB-
cord-015365-iqdi99pd	366	2	NGAL	NGAL	NNP
cord-015365-iqdi99pd	366	3	/	/	SYM
cord-015365-iqdi99pd	366	4	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	366	5	)	)	-RRB-
cord-015365-iqdi99pd	366	6	expression	expression	NN
cord-015365-iqdi99pd	366	7	is	be	VBZ
cord-015365-iqdi99pd	366	8	associated	associate	VBN
cord-015365-iqdi99pd	366	9	with	with	IN
cord-015365-iqdi99pd	366	10	ischemia	ischemia	NN
cord-015365-iqdi99pd	366	11	/	/	SYM
cord-015365-iqdi99pd	366	12	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	366	13	injury	injury	NN
cord-015365-iqdi99pd	366	14	(	(	-LRB-
cord-015365-iqdi99pd	366	15	IRI	IRI	NNP
cord-015365-iqdi99pd	366	16	)	)	-RRB-
cord-015365-iqdi99pd	366	17	following	follow	VBG
cord-015365-iqdi99pd	366	18	transplantation	transplantation	NN
cord-015365-iqdi99pd	366	19	and	and	CC
cord-015365-iqdi99pd	366	20	correlates	correlate	VBZ
cord-015365-iqdi99pd	366	21	with	with	IN
cord-015365-iqdi99pd	366	22	polymorphonuclear	polymorphonuclear	JJ
cord-015365-iqdi99pd	366	23	cell	cell	NN
cord-015365-iqdi99pd	366	24	infiltration	infiltration	NN
cord-015365-iqdi99pd	366	25	.	.	.
cord-015365-iqdi99pd	367	1	To	to	TO
cord-015365-iqdi99pd	367	2	get	get	VB
cord-015365-iqdi99pd	367	3	insight	insight	NN
cord-015365-iqdi99pd	367	4	into	into	IN
cord-015365-iqdi99pd	367	5	the	the	DT
cord-015365-iqdi99pd	367	6	regulatory	regulatory	JJ
cord-015365-iqdi99pd	367	7	role	role	NN
cord-015365-iqdi99pd	367	8	of	of	IN
cord-015365-iqdi99pd	367	9	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	367	10	during	during	IN
cord-015365-iqdi99pd	367	11	IRI	IRI	NNP
cord-015365-iqdi99pd	367	12	the	the	DT
cord-015365-iqdi99pd	367	13	expression	expression	NN
cord-015365-iqdi99pd	367	14	of	of	IN
cord-015365-iqdi99pd	367	15	different	different	JJ
cord-015365-iqdi99pd	367	16	chemokines	chemokine	NNS
cord-015365-iqdi99pd	367	17	and	and	CC
cord-015365-iqdi99pd	367	18	adhesion	adhesion	NN
cord-015365-iqdi99pd	367	19	molecules	molecule	NNS
cord-015365-iqdi99pd	367	20	were	be	VBD
cord-015365-iqdi99pd	367	21	analyzed	analyze	VBN
cord-015365-iqdi99pd	367	22	in	in	IN
cord-015365-iqdi99pd	367	23	a	a	DT
cord-015365-iqdi99pd	367	24	murine	murine	JJ
cord-015365-iqdi99pd	367	25	heart	heart	NN
cord-015365-iqdi99pd	367	26	transplantation	transplantation	NN
cord-015365-iqdi99pd	367	27	model	model	NN
cord-015365-iqdi99pd	367	28	.	.	.
cord-015365-iqdi99pd	368	1	Methods	method	NNS
cord-015365-iqdi99pd	368	2	.	.	.
cord-015365-iqdi99pd	369	1	The	the	DT
cord-015365-iqdi99pd	369	2	murine	murine	JJ
cord-015365-iqdi99pd	369	3	heterotopic	heterotopic	NNP
cord-015365-iqdi99pd	369	4	heart	heart	NN
cord-015365-iqdi99pd	369	5	transplant	transplant	NN
cord-015365-iqdi99pd	369	6	model	model	NN
cord-015365-iqdi99pd	369	7	also	also	RB
cord-015365-iqdi99pd	369	8	implying	imply	VBG
cord-015365-iqdi99pd	369	9	exogenous	exogenous	JJ
cord-015365-iqdi99pd	369	10	i.p	i.p	NNP
cord-015365-iqdi99pd	369	11	.	.	NNP
cord-015365-iqdi99pd	369	12	application	application	NN
cord-015365-iqdi99pd	369	13	of	of	IN
cord-015365-iqdi99pd	369	14	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	369	15	was	be	VBD
cord-015365-iqdi99pd	369	16	used	use	VBN
cord-015365-iqdi99pd	369	17	for	for	IN
cord-015365-iqdi99pd	369	18	in	in	IN
cord-015365-iqdi99pd	369	19	vivo	vivo	NN
cord-015365-iqdi99pd	369	20	experiments	experiment	NNS
cord-015365-iqdi99pd	369	21	.	.	.
cord-015365-iqdi99pd	370	1	The	the	DT
cord-015365-iqdi99pd	370	2	mRNA	mRNA	NNP
cord-015365-iqdi99pd	370	3	expression	expression	NN
cord-015365-iqdi99pd	370	4	of	of	IN
cord-015365-iqdi99pd	370	5	the	the	DT
cord-015365-iqdi99pd	370	6	chemokines	chemokine	NNS
cord-015365-iqdi99pd	370	7	MIP-2	MIP-2	NNP
cord-015365-iqdi99pd	370	8	,	,	,
cord-015365-iqdi99pd	370	9	LIX	LIX	NNP
cord-015365-iqdi99pd	370	10	,	,	,
cord-015365-iqdi99pd	370	11	KC	KC	NNP
cord-015365-iqdi99pd	370	12	,	,	,
cord-015365-iqdi99pd	370	13	MCP-1	MCP-1	NNP
cord-015365-iqdi99pd	370	14	,	,	,
cord-015365-iqdi99pd	370	15	IL-6	IL-6	NNP
cord-015365-iqdi99pd	370	16	and	and	CC
cord-015365-iqdi99pd	370	17	CCL-6	CCL-6	NNP
cord-015365-iqdi99pd	370	18	and	and	CC
cord-015365-iqdi99pd	370	19	their	-PRON-	PRP$
cord-015365-iqdi99pd	370	20	receptors	receptor	NNS
cord-015365-iqdi99pd	370	21	CXCR2	CXCR2	NNS
cord-015365-iqdi99pd	370	22	and	and	CC
cord-015365-iqdi99pd	370	23	CCR2	CCR2	NNP
cord-015365-iqdi99pd	370	24	as	as	RB
cord-015365-iqdi99pd	370	25	well	well	RB
cord-015365-iqdi99pd	370	26	as	as	IN
cord-015365-iqdi99pd	370	27	ICAM-1	ICAM-1	NNP
cord-015365-iqdi99pd	370	28	was	be	VBD
cord-015365-iqdi99pd	370	29	analyzed	analyze	VBN
cord-015365-iqdi99pd	370	30	by	by	IN
cord-015365-iqdi99pd	370	31	qPCR	qPCR	NNP
cord-015365-iqdi99pd	370	32	.	.	.
cord-015365-iqdi99pd	371	1	Immunohistochemistry	Immunohistochemistry	NNP
cord-015365-iqdi99pd	371	2	was	be	VBD
cord-015365-iqdi99pd	371	3	performed	perform	VBN
cord-015365-iqdi99pd	371	4	in	in	IN
cord-015365-iqdi99pd	371	5	heart	heart	NN
cord-015365-iqdi99pd	371	6	sections	section	NNS
cord-015365-iqdi99pd	371	7	and	and	CC
cord-015365-iqdi99pd	371	8	correlated	correlate	VBN
cord-015365-iqdi99pd	371	9	with	with	IN
cord-015365-iqdi99pd	371	10	neutrophil	neutrophil	NN
cord-015365-iqdi99pd	371	11	infiltration	infiltration	NN
cord-015365-iqdi99pd	371	12	at	at	IN
cord-015365-iqdi99pd	371	13	various	various	JJ
cord-015365-iqdi99pd	371	14	time	time	NN
cord-015365-iqdi99pd	371	15	points	point	NNS
cord-015365-iqdi99pd	371	16	(	(	-LRB-
cord-015365-iqdi99pd	371	17	2	2	CD
cord-015365-iqdi99pd	371	18	,	,	,
cord-015365-iqdi99pd	371	19	12	12	CD
cord-015365-iqdi99pd	371	20	,	,	,
cord-015365-iqdi99pd	371	21	24	24	CD
cord-015365-iqdi99pd	371	22	and	and	CC
cord-015365-iqdi99pd	371	23	48	48	CD
cord-015365-iqdi99pd	371	24	h	h	NN
cord-015365-iqdi99pd	371	25	)	)	-RRB-
cord-015365-iqdi99pd	371	26	.	.	.
cord-015365-iqdi99pd	372	1	Results	result	NNS
cord-015365-iqdi99pd	372	2	.	.	.
cord-015365-iqdi99pd	373	1	Significant	significant	JJ
cord-015365-iqdi99pd	373	2	lower	low	JJR
cord-015365-iqdi99pd	373	3	granulocyte	granulocyte	NN
cord-015365-iqdi99pd	373	4	infiltration	infiltration	NN
cord-015365-iqdi99pd	373	5	and	and	CC
cord-015365-iqdi99pd	373	6	serum	serum	NN
cord-015365-iqdi99pd	373	7	creatinine	creatinine	NN
cord-015365-iqdi99pd	373	8	kinase	kinase	NN
cord-015365-iqdi99pd	373	9	levels	level	NNS
cord-015365-iqdi99pd	373	10	during	during	IN
cord-015365-iqdi99pd	373	11	IRI	IRI	NNP
cord-015365-iqdi99pd	373	12	were	be	VBD
cord-015365-iqdi99pd	373	13	observed	observe	VBN
cord-015365-iqdi99pd	373	14	in	in	IN
cord-015365-iqdi99pd	373	15	the	the	DT
cord-015365-iqdi99pd	373	16	Lcn-2-/transplants	lcn-2-/transplant	NNS
cord-015365-iqdi99pd	373	17	correlating	correlate	VBG
cord-015365-iqdi99pd	373	18	with	with	IN
cord-015365-iqdi99pd	373	19	a	a	DT
cord-015365-iqdi99pd	373	20	stable	stable	JJ
cord-015365-iqdi99pd	373	21	ICAM-1	icam-1	NN
cord-015365-iqdi99pd	373	22	expression	expression	NN
cord-015365-iqdi99pd	373	23	compared	compare	VBN
cord-015365-iqdi99pd	373	24	to	to	IN
cord-015365-iqdi99pd	373	25	the	the	DT
cord-015365-iqdi99pd	373	26	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	373	27	wt	wt	NN
cord-015365-iqdi99pd	373	28	setting	setting	NN
cord-015365-iqdi99pd	373	29	(	(	-LRB-
cord-015365-iqdi99pd	373	30	>	>	NFP
cord-015365-iqdi99pd	373	31	5fold	5fold	CD
cord-015365-iqdi99pd	373	32	expression	expression	NN
cord-015365-iqdi99pd	373	33	at	at	IN
cord-015365-iqdi99pd	373	34	2	2	CD
cord-015365-iqdi99pd	373	35	h	h	NN
cord-015365-iqdi99pd	373	36	of	of	IN
cord-015365-iqdi99pd	373	37	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	373	38	)	)	-RRB-
cord-015365-iqdi99pd	373	39	.	.	.
cord-015365-iqdi99pd	374	1	In	in	IN
cord-015365-iqdi99pd	374	2	the	the	DT
cord-015365-iqdi99pd	374	3	early	early	JJ
cord-015365-iqdi99pd	374	4	phase	phase	NN
cord-015365-iqdi99pd	374	5	of	of	IN
cord-015365-iqdi99pd	374	6	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	374	7	(	(	-LRB-
cord-015365-iqdi99pd	374	8	2	2	CD
cord-015365-iqdi99pd	374	9	h	h	NN
cord-015365-iqdi99pd	374	10	)	)	-RRB-
cord-015365-iqdi99pd	374	11	MCP-1	MCP-1	NNP
cord-015365-iqdi99pd	374	12	,	,	,
cord-015365-iqdi99pd	374	13	KC	KC	NNP
cord-015365-iqdi99pd	374	14	,	,	,
cord-015365-iqdi99pd	374	15	LIX	LIX	NNP
cord-015365-iqdi99pd	374	16	and	and	CC
cord-015365-iqdi99pd	374	17	MIP-2	MIP-2	NNP
cord-015365-iqdi99pd	374	18	showed	show	VBD
cord-015365-iqdi99pd	374	19	a	a	DT
cord-015365-iqdi99pd	374	20	lower	low	JJR
cord-015365-iqdi99pd	374	21	expression	expression	NN
cord-015365-iqdi99pd	374	22	pattern	pattern	NN
cord-015365-iqdi99pd	374	23	in	in	IN
cord-015365-iqdi99pd	374	24	the	the	DT
cord-015365-iqdi99pd	374	25	Lcn-2-/transplants	Lcn-2-/transplants	NNPS
cord-015365-iqdi99pd	374	26	with	with	IN
cord-015365-iqdi99pd	374	27	delayed	delay	VBN
cord-015365-iqdi99pd	374	28	upregulation	upregulation	NN
cord-015365-iqdi99pd	374	29	at	at	IN
cord-015365-iqdi99pd	374	30	12	12	CD
cord-015365-iqdi99pd	374	31	h	h	NN
cord-015365-iqdi99pd	374	32	(	(	-LRB-
cord-015365-iqdi99pd	374	33	LIX	LIX	NNP
cord-015365-iqdi99pd	374	34	,	,	,
cord-015365-iqdi99pd	374	35	MIP-2	MIP-2	NNP
cord-015365-iqdi99pd	374	36	)	)	-RRB-
cord-015365-iqdi99pd	374	37	.	.	.
cord-015365-iqdi99pd	375	1	After	after	IN
cord-015365-iqdi99pd	375	2	i.p	i.p	NNP
cord-015365-iqdi99pd	375	3	.	.	.
cord-015365-iqdi99pd	376	1	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	376	2	application	application	VB
cord-015365-iqdi99pd	376	3	no	no	DT
cord-015365-iqdi99pd	376	4	significant	significant	JJ
cord-015365-iqdi99pd	376	5	difference	difference	NN
cord-015365-iqdi99pd	376	6	in	in	IN
cord-015365-iqdi99pd	376	7	apoptosis	apoptosis	NN
cord-015365-iqdi99pd	376	8	was	be	VBD
cord-015365-iqdi99pd	376	9	observed	observe	VBN
cord-015365-iqdi99pd	376	10	.	.	.
cord-015365-iqdi99pd	377	1	The	the	DT
cord-015365-iqdi99pd	377	2	number	number	NN
cord-015365-iqdi99pd	377	3	of	of	IN
cord-015365-iqdi99pd	377	4	infiltrating	infiltrate	VBG
cord-015365-iqdi99pd	377	5	granulocytes	granulocyte	NNS
cord-015365-iqdi99pd	377	6	was	be	VBD
cord-015365-iqdi99pd	377	7	reduced	reduce	VBN
cord-015365-iqdi99pd	377	8	after	after	IN
cord-015365-iqdi99pd	377	9	application	application	NN
cord-015365-iqdi99pd	377	10	of	of	IN
cord-015365-iqdi99pd	377	11	the	the	DT
cord-015365-iqdi99pd	377	12	iron	iron	NN
cord-015365-iqdi99pd	377	13	-	-	HYPH
cord-015365-iqdi99pd	377	14	loaded	load	VBN
cord-015365-iqdi99pd	377	15	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	377	16	compared	compare	VBN
cord-015365-iqdi99pd	377	17	to	to	IN
cord-015365-iqdi99pd	377	18	iron	iron	NN
cord-015365-iqdi99pd	377	19	-	-	HYPH
cord-015365-iqdi99pd	377	20	free	free	JJ
cord-015365-iqdi99pd	377	21	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	377	22	.	.	.
cord-015365-iqdi99pd	377	23	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	377	24	.	.	.
cord-015365-iqdi99pd	378	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	378	2	data	data	NN
cord-015365-iqdi99pd	378	3	point	point	NN
cord-015365-iqdi99pd	378	4	to	to	IN
cord-015365-iqdi99pd	378	5	a	a	DT
cord-015365-iqdi99pd	378	6	possible	possible	JJ
cord-015365-iqdi99pd	378	7	chemotactic	chemotactic	JJ
cord-015365-iqdi99pd	378	8	role	role	NN
cord-015365-iqdi99pd	378	9	of	of	IN
cord-015365-iqdi99pd	378	10	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	378	11	which	which	WDT
cord-015365-iqdi99pd	378	12	may	may	MD
cord-015365-iqdi99pd	378	13	also	also	RB
cord-015365-iqdi99pd	378	14	affect	affect	VB
cord-015365-iqdi99pd	378	15	the	the	DT
cord-015365-iqdi99pd	378	16	expression	expression	NN
cord-015365-iqdi99pd	378	17	of	of	IN
cord-015365-iqdi99pd	378	18	particular	particular	JJ
cord-015365-iqdi99pd	378	19	chemokines	chemokine	NNS
cord-015365-iqdi99pd	378	20	in	in	IN
cord-015365-iqdi99pd	378	21	the	the	DT
cord-015365-iqdi99pd	378	22	early	early	JJ
cord-015365-iqdi99pd	378	23	phase	phase	NN
cord-015365-iqdi99pd	378	24	of	of	IN
cord-015365-iqdi99pd	378	25	IRI	IRI	NNP
cord-015365-iqdi99pd	378	26	.	.	.
cord-015365-iqdi99pd	379	1	The	the	DT
cord-015365-iqdi99pd	379	2	role	role	NN
cord-015365-iqdi99pd	379	3	of	of	IN
cord-015365-iqdi99pd	379	4	the	the	DT
cord-015365-iqdi99pd	379	5	iron	iron	NN
cord-015365-iqdi99pd	379	6	binding	binding	NN
cord-015365-iqdi99pd	379	7	capacity	capacity	NN
cord-015365-iqdi99pd	379	8	of	of	IN
cord-015365-iqdi99pd	379	9	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	379	10	in	in	IN
cord-015365-iqdi99pd	379	11	chemotaxis	chemotaxis	NN
cord-015365-iqdi99pd	379	12	during	during	IN
cord-015365-iqdi99pd	379	13	IRI	IRI	NNP
cord-015365-iqdi99pd	379	14	is	be	VBZ
cord-015365-iqdi99pd	379	15	still	still	RB
cord-015365-iqdi99pd	379	16	unknown	unknown	JJ
cord-015365-iqdi99pd	379	17	.	.	.
cord-015365-iqdi99pd	380	1	Understanding	understand	VBG
cord-015365-iqdi99pd	380	2	these	these	DT
cord-015365-iqdi99pd	380	3	regulatory	regulatory	JJ
cord-015365-iqdi99pd	380	4	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	380	5	will	will	MD
cord-015365-iqdi99pd	380	6	be	be	VB
cord-015365-iqdi99pd	380	7	crucial	crucial	JJ
cord-015365-iqdi99pd	380	8	to	to	TO
cord-015365-iqdi99pd	380	9	establish	establish	VB
cord-015365-iqdi99pd	380	10	treatment	treatment	NN
cord-015365-iqdi99pd	380	11	strategies	strategy	NNS
cord-015365-iqdi99pd	380	12	for	for	IN
cord-015365-iqdi99pd	380	13	IRI	IRI	NNP
cord-015365-iqdi99pd	380	14	during	during	IN
cord-015365-iqdi99pd	380	15	solid	solid	JJ
cord-015365-iqdi99pd	380	16	organ	organ	NN
cord-015365-iqdi99pd	380	17	transplantation	transplantation	NN
cord-015365-iqdi99pd	380	18	.	.	.
cord-015365-iqdi99pd	381	1	Glomeruläre	Glomeruläre	NNP
cord-015365-iqdi99pd	381	2	Effekte	Effekte	NNP
cord-015365-iqdi99pd	381	3	des	des	FW
cord-015365-iqdi99pd	381	4	mTOR	mTOR	NNP
cord-015365-iqdi99pd	381	5	-	-	HYPH
cord-015365-iqdi99pd	381	6	Inhibitors	Inhibitors	NNP
cord-015365-iqdi99pd	381	7	Rapamycin	Rapamycin	NNP
cord-015365-iqdi99pd	381	8	in	in	IN
cord-015365-iqdi99pd	381	9	der	der	NNP
cord-015365-iqdi99pd	381	10	nephrotoxischen	nephrotoxischen	NNP
cord-015365-iqdi99pd	381	11	Serumnephritis	Serumnephritis	NNP
cord-015365-iqdi99pd	381	12	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	381	13	.	.	.
cord-015365-iqdi99pd	382	1	Der	Der	NNP
cord-015365-iqdi99pd	382	2	mTOR	mTOR	NNP
cord-015365-iqdi99pd	382	3	Inihibitor	Inihibitor	NNP
cord-015365-iqdi99pd	382	4	Rapamycin	Rapamycin	NNP
cord-015365-iqdi99pd	382	5	ist	ist	NN
cord-015365-iqdi99pd	382	6	ein	ein	NNP
cord-015365-iqdi99pd	382	7	Immunosuppressivum	Immunosuppressivum	NNP
cord-015365-iqdi99pd	382	8	,	,	,
cord-015365-iqdi99pd	382	9	welches	welches	NNP
cord-015365-iqdi99pd	382	10	klinische	klinische	NNP
cord-015365-iqdi99pd	382	11	Anwendung	Anwendung	NNP
cord-015365-iqdi99pd	382	12	zur	zur	NNP
cord-015365-iqdi99pd	382	13	Prävention	Prävention	NNP
cord-015365-iqdi99pd	382	14	von	von	NNP
cord-015365-iqdi99pd	382	15	Abstossungsreaktionen	Abstossungsreaktionen	NNP
cord-015365-iqdi99pd	382	16	bei	bei	NNP
cord-015365-iqdi99pd	382	17	nierentransplantierten	nierentransplantierten	NNP
cord-015365-iqdi99pd	383	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	383	2	gefunden	gefunden	NN
cord-015365-iqdi99pd	383	3	hat	hat	NN
cord-015365-iqdi99pd	383	4	.	.	.
cord-015365-iqdi99pd	384	1	Einer	Einer	NNP
cord-015365-iqdi99pd	384	2	der	der	NNP
cord-015365-iqdi99pd	384	3	limitierenden	limitierenden	JJ
cord-015365-iqdi99pd	384	4	Faktoren	Faktoren	NNP
cord-015365-iqdi99pd	384	5	bei	bei	NNP
cord-015365-iqdi99pd	384	6	der	der	NNP
cord-015365-iqdi99pd	384	7	klinischen	klinischen	NNP
cord-015365-iqdi99pd	384	8	Anwendung	Anwendung	NNP
cord-015365-iqdi99pd	384	9	ist	ist	NN
cord-015365-iqdi99pd	384	10	das	das	FW
cord-015365-iqdi99pd	384	11	de	de	FW
cord-015365-iqdi99pd	384	12	novo	novo	NNP
cord-015365-iqdi99pd	384	13	Auftreten	Auftreten	NNP
cord-015365-iqdi99pd	384	14	von	von	NNP
cord-015365-iqdi99pd	384	15	Proteinurie	Proteinurie	NNP
cord-015365-iqdi99pd	384	16	.	.	.
cord-015365-iqdi99pd	385	1	Ziel	Ziel	NNP
cord-015365-iqdi99pd	385	2	der	der	NNP
cord-015365-iqdi99pd	385	3	Arbeit	Arbeit	NNP
cord-015365-iqdi99pd	385	4	war	war	NN
cord-015365-iqdi99pd	385	5	es	es	NNP
cord-015365-iqdi99pd	385	6	,	,	,
cord-015365-iqdi99pd	385	7	die	die	VB
cord-015365-iqdi99pd	385	8	glomerulären	glomerulären	NNP
cord-015365-iqdi99pd	385	9	Veränderungen	Veränderungen	NNP
cord-015365-iqdi99pd	385	10	der	der	NNP
cord-015365-iqdi99pd	385	11	Rapamycininduzierten	Rapamycininduzierten	NNP
cord-015365-iqdi99pd	385	12	Proteinurie	Proteinurie	NNP
cord-015365-iqdi99pd	385	13	in	in	IN
cord-015365-iqdi99pd	385	14	einem	einem	NNP
cord-015365-iqdi99pd	385	15	experimentellen	experimentellen	NNP
cord-015365-iqdi99pd	385	16	Modell	Modell	NNP
cord-015365-iqdi99pd	385	17	der	der	NNP
cord-015365-iqdi99pd	385	18	nephrotoxischen	nephrotoxischen	NNP
cord-015365-iqdi99pd	385	19	Serumnephritis	Serumnephritis	NNP
cord-015365-iqdi99pd	385	20	(	(	-LRB-
cord-015365-iqdi99pd	385	21	NTS	NTS	NNP
cord-015365-iqdi99pd	385	22	)	)	-RRB-
cord-015365-iqdi99pd	385	23	näher	näher	NNP
cord-015365-iqdi99pd	385	24	zu	zu	NNP
cord-015365-iqdi99pd	385	25	untersuchen	untersuchen	NNP
cord-015365-iqdi99pd	385	26	.	.	.
cord-015365-iqdi99pd	386	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	386	2	.	.	.
cord-015365-iqdi99pd	387	1	NTS	NTS	NNP
cord-015365-iqdi99pd	387	2	wurde	wurde	VBD
cord-015365-iqdi99pd	387	3	in	in	IN
cord-015365-iqdi99pd	387	4	C57BL/6	C57BL/6	NNP
cord-015365-iqdi99pd	387	5	Mäusen	Mäusen	NNP
cord-015365-iqdi99pd	387	6	induziert	induziert	NN
cord-015365-iqdi99pd	388	1	und	und	IN
cord-015365-iqdi99pd	388	2	die	die	VBP
cord-015365-iqdi99pd	388	3	Gabe	Gabe	NNP
cord-015365-iqdi99pd	388	4	von	von	NNP
cord-015365-iqdi99pd	388	5	Rapamycin	Rapamycin	NNP
cord-015365-iqdi99pd	388	6	in	in	IN
cord-015365-iqdi99pd	388	7	einer	einer	NNP
cord-015365-iqdi99pd	388	8	Dosis	Dosis	NNP
cord-015365-iqdi99pd	388	9	von	von	NNP
cord-015365-iqdi99pd	388	10	0,5	0,5	CD
cord-015365-iqdi99pd	389	1	mg	mg	NNP
cord-015365-iqdi99pd	389	2	/	/	SYM
cord-015365-iqdi99pd	389	3	kg	kg	NNP
cord-015365-iqdi99pd	389	4	14	14	CD
cord-015365-iqdi99pd	389	5	Tage	Tage	NNP
cord-015365-iqdi99pd	389	6	nach	nach	NNP
cord-015365-iqdi99pd	389	7	Induktion	Induktion	NNP
cord-015365-iqdi99pd	389	8	begonnen	begonnen	XX
cord-015365-iqdi99pd	389	9	.	.	.
cord-015365-iqdi99pd	390	1	Die	die	VB
cord-015365-iqdi99pd	390	2	Mäuse	Mäuse	NNP
cord-015365-iqdi99pd	390	3	wurden	wurden	NNS
cord-015365-iqdi99pd	390	4	am	be	VBP
cord-015365-iqdi99pd	390	5	Tag	tag	NN
cord-015365-iqdi99pd	390	6	35	35	CD
cord-015365-iqdi99pd	390	7	sakrifiziert	sakrifiziert	NN
cord-015365-iqdi99pd	390	8	und	und	NNP
cord-015365-iqdi99pd	391	1	Glomeruli	Glomeruli	NNP
cord-015365-iqdi99pd	391	2	zur	zur	NNP
cord-015365-iqdi99pd	391	3	Genexpressionsanalyse	Genexpressionsanalyse	NNP
cord-015365-iqdi99pd	391	4	isoliert	isoliert	NN
cord-015365-iqdi99pd	391	5	.	.	.
cord-015365-iqdi99pd	392	1	Außerdem	Außerdem	NNP
cord-015365-iqdi99pd	392	2	wurde	wurde	NNP
cord-015365-iqdi99pd	392	3	mittels	mittels	NNPS
cord-015365-iqdi99pd	392	4	Immunhistochemie	Immunhistochemie	NNP
cord-015365-iqdi99pd	392	5	die	die	VBP
cord-015365-iqdi99pd	392	6	glomeruläre	glomeruläre	NNP
cord-015365-iqdi99pd	392	7	Expression	Expression	NNP
cord-015365-iqdi99pd	392	8	von	von	NNP
cord-015365-iqdi99pd	392	9	T	T	NNP
cord-015365-iqdi99pd	392	10	-	-	HYPH
cord-015365-iqdi99pd	392	11	Zell-(CD4	Zell-(CD4	NNP
cord-015365-iqdi99pd	392	12	)	)	-RRB-
cord-015365-iqdi99pd	392	13	,	,	,
cord-015365-iqdi99pd	392	14	Makrophagen-(F4/80	Makrophagen-(F4/80	NNP
cord-015365-iqdi99pd	392	15	,	,	,
cord-015365-iqdi99pd	392	16	CD68	CD68	NNP
cord-015365-iqdi99pd	392	17	)	)	-RRB-
cord-015365-iqdi99pd	392	18	,	,	,
cord-015365-iqdi99pd	392	19	Podocyten-(Nephrin	Podocyten-(Nephrin	NNP
cord-015365-iqdi99pd	392	20	)	)	-RRB-
cord-015365-iqdi99pd	392	21	,	,	,
cord-015365-iqdi99pd	392	22	sowie	sowie	JJ
cord-015365-iqdi99pd	392	23	Endothelzellmarkern	Endothelzellmarkern	NNP
cord-015365-iqdi99pd	392	24	(	(	-LRB-
cord-015365-iqdi99pd	392	25	CD31	CD31	NNP
cord-015365-iqdi99pd	392	26	)	)	-RRB-
cord-015365-iqdi99pd	392	27	untersucht	untersucht	NNP
cord-015365-iqdi99pd	392	28	.	.	.
cord-015365-iqdi99pd	393	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	393	2	.	.	.
cord-015365-iqdi99pd	394	1	Mäuse	Mäuse	NNP
cord-015365-iqdi99pd	394	2	,	,	,
cord-015365-iqdi99pd	394	3	die	die	VBP
cord-015365-iqdi99pd	394	4	mit	mit	NNP
cord-015365-iqdi99pd	394	5	Rapamycin	Rapamycin	NNP
cord-015365-iqdi99pd	394	6	ab	ab	NN
cord-015365-iqdi99pd	394	7	Tag	Tag	NNP
cord-015365-iqdi99pd	394	8	14	14	CD
cord-015365-iqdi99pd	394	9	behandelt	behandelt	NNP
cord-015365-iqdi99pd	394	10	wurden	wurden	NNP
cord-015365-iqdi99pd	394	11	,	,	,
cord-015365-iqdi99pd	394	12	entwickelten	entwickelten	NNP
cord-015365-iqdi99pd	395	1	eine	eine	NNP
cord-015365-iqdi99pd	395	2	signifikant	signifikant	NNP
cord-015365-iqdi99pd	395	3	erhöhte	erhöhte	NNP
cord-015365-iqdi99pd	396	1	Proteinurie	Proteinurie	NNP
cord-015365-iqdi99pd	397	1	i	-PRON-	PRP
cord-015365-iqdi99pd	397	2	m	be	VBP
cord-015365-iqdi99pd	397	3	Vergleich	Vergleich	NNP
cord-015365-iqdi99pd	397	4	zu	zu	NNP
cord-015365-iqdi99pd	397	5	den	den	NNP
cord-015365-iqdi99pd	397	6	Kontrolltieren	Kontrolltieren	NNP
cord-015365-iqdi99pd	397	7	.	.	.
cord-015365-iqdi99pd	398	1	Dies	die	VBZ
cord-015365-iqdi99pd	398	2	war	war	NN
cord-015365-iqdi99pd	398	3	mit	mit	NNP
cord-015365-iqdi99pd	398	4	einer	einer	NNP
cord-015365-iqdi99pd	398	5	verstärkten	verstärkten	NNP
cord-015365-iqdi99pd	398	6	glomerulären	glomerulären	NNP
cord-015365-iqdi99pd	398	7	Infiltration	Infiltration	NNP
cord-015365-iqdi99pd	398	8	von	von	NNP
cord-015365-iqdi99pd	398	9	CD4-positiven	CD4-positiven	NNP
cord-015365-iqdi99pd	399	1	(	(	-LRB-
cord-015365-iqdi99pd	399	2	mittlere	mittlere	RB
cord-015365-iqdi99pd	399	3	intraglomeruläre	intraglomeruläre	RB
cord-015365-iqdi99pd	399	4	positive	positive	JJ
cord-015365-iqdi99pd	400	1	Zellen/50	zellen/50	CD
cord-015365-iqdi99pd	400	2	Glomeruli	Glomeruli	NNP
cord-015365-iqdi99pd	400	3	4,43	4,43	CD
cord-015365-iqdi99pd	400	4	AE	AE	NNP
cord-015365-iqdi99pd	400	5	0,68	0,68	CD
cord-015365-iqdi99pd	400	6	vs	vs	IN
cord-015365-iqdi99pd	400	7	2,23	2,23	CD
cord-015365-iqdi99pd	400	8	AE	AE	NNP
cord-015365-iqdi99pd	400	9	0,57	0,57	CD
cord-015365-iqdi99pd	400	10	;	;	.
cord-015365-iqdi99pd	401	1	p	p	NN
cord-015365-iqdi99pd	401	2	<	<	XX
cord-015365-iqdi99pd	401	3	0,05	0,05	NNP
cord-015365-iqdi99pd	401	4	)	)	-RRB-
cord-015365-iqdi99pd	401	5	,	,	,
cord-015365-iqdi99pd	401	6	F4/80-positiven	F4/80-positiven	NNP
cord-015365-iqdi99pd	401	7	(	(	-LRB-
cord-015365-iqdi99pd	401	8	8,2	8,2	CD
cord-015365-iqdi99pd	401	9	AE	AE	NNP
cord-015365-iqdi99pd	401	10	1,58	1,58	CD
cord-015365-iqdi99pd	401	11	vs.	vs.	IN
cord-015365-iqdi99pd	401	12	3,64	3,64	CD
cord-015365-iqdi99pd	401	13	AE	AE	NNP
cord-015365-iqdi99pd	401	14	0,74	0,74	CD
cord-015365-iqdi99pd	401	15	;	;	:
cord-015365-iqdi99pd	401	16	p	p	NN
cord-015365-iqdi99pd	401	17	<	<	XX
cord-015365-iqdi99pd	401	18	0,05	0,05	XX
cord-015365-iqdi99pd	401	19	)	)	-RRB-
cord-015365-iqdi99pd	402	1	und	und	IN
cord-015365-iqdi99pd	402	2	CD68-positiven	CD68-positiven	NNP
cord-015365-iqdi99pd	402	3	Zellen	Zellen	NNP
cord-015365-iqdi99pd	402	4	(	(	-LRB-
cord-015365-iqdi99pd	402	5	18,80	18,80	CD
cord-015365-iqdi99pd	402	6	AE	AE	NNP
cord-015365-iqdi99pd	402	7	3,05	3,05	NN
cord-015365-iqdi99pd	402	8	vs.	vs.	NN
cord-015365-iqdi99pd	402	9	9,15AE	9,15ae	CD
cord-015365-iqdi99pd	402	10	1,61	1,61	CD
cord-015365-iqdi99pd	402	11	;	;	:
cord-015365-iqdi99pd	402	12	p	p	NN
cord-015365-iqdi99pd	402	13	<	<	XX
cord-015365-iqdi99pd	402	14	0,05	0,05	NN
cord-015365-iqdi99pd	402	15	;	;	:
cord-015365-iqdi99pd	402	16	n	n	NN
cord-015365-iqdi99pd	402	17	¼	¼	NNP
cord-015365-iqdi99pd	402	18	13	13	CD
cord-015365-iqdi99pd	402	19	Rapamycin	Rapamycin	NNP
cord-015365-iqdi99pd	402	20	,	,	,
cord-015365-iqdi99pd	402	21	n	n	NN
cord-015365-iqdi99pd	402	22	¼	¼	CD
cord-015365-iqdi99pd	402	23	12	12	CD
cord-015365-iqdi99pd	402	24	Vehikel	Vehikel	NNP
cord-015365-iqdi99pd	402	25	)	)	-RRB-
cord-015365-iqdi99pd	402	26	assoziiert	assoziiert	NNP
cord-015365-iqdi99pd	402	27	.	.	.
cord-015365-iqdi99pd	403	1	Keine	Keine	NNP
cord-015365-iqdi99pd	403	2	Unterschiede	Unterschiede	NNP
cord-015365-iqdi99pd	403	3	fanden	fanden	NNP
cord-015365-iqdi99pd	403	4	sich	sich	NNP
cord-015365-iqdi99pd	403	5	in	in	IN
cord-015365-iqdi99pd	403	6	der	der	NNP
cord-015365-iqdi99pd	403	7	glomerulären	glomerulären	NNP
cord-015365-iqdi99pd	403	8	Färbung	Färbung	NNP
cord-015365-iqdi99pd	403	9	von	von	NNP
cord-015365-iqdi99pd	403	10	Nephrin	Nephrin	NNP
cord-015365-iqdi99pd	403	11	und	und	IN
cord-015365-iqdi99pd	403	12	CD31	CD31	NNP
cord-015365-iqdi99pd	403	13	.	.	.
cord-015365-iqdi99pd	404	1	Real	real	JJ
cord-015365-iqdi99pd	404	2	-	-	HYPH
cord-015365-iqdi99pd	404	3	time	time	NN
cord-015365-iqdi99pd	404	4	PCR	PCR	NNP
cord-015365-iqdi99pd	404	5	der	der	NN
cord-015365-iqdi99pd	404	6	aus	aus	NNP
cord-015365-iqdi99pd	404	7	Glomeruli	Glomeruli	NNP
cord-015365-iqdi99pd	404	8	gewonnenen	gewonnenen	NNP
cord-015365-iqdi99pd	404	9	RNA	RNA	NNP
cord-015365-iqdi99pd	404	10	zeigte	zeigte	NNP
cord-015365-iqdi99pd	404	11	,	,	,
cord-015365-iqdi99pd	404	12	dass	dass	NNP
cord-015365-iqdi99pd	404	13	die	die	VBP
cord-015365-iqdi99pd	405	1	Rapamycin	Rapamycin	NNP
cord-015365-iqdi99pd	405	2	-	-	HYPH
cord-015365-iqdi99pd	405	3	Behandlung	Behandlung	NNP
cord-015365-iqdi99pd	405	4	zu	zu	NNP
cord-015365-iqdi99pd	406	1	einer	einer	NNP
cord-015365-iqdi99pd	407	1	verstärkten	verstärkten	NNP
cord-015365-iqdi99pd	407	2	Expression	Expression	NNP
cord-015365-iqdi99pd	407	3	der	der	NN
cord-015365-iqdi99pd	407	4	proinflammatorischen	proinflammatorischen	NN
cord-015365-iqdi99pd	407	5	Zytokine	Zytokine	NNP
cord-015365-iqdi99pd	408	1	IL-6	IL-6	NNP
cord-015365-iqdi99pd	408	2	(	(	-LRB-
cord-015365-iqdi99pd	408	3	12,0	12,0	CD
cord-015365-iqdi99pd	408	4	AE	AE	NNP
cord-015365-iqdi99pd	408	5	5,2	5,2	CD
cord-015365-iqdi99pd	408	6	vs.	vs.	NN
cord-015365-iqdi99pd	408	7	1,0	1,0	CD
cord-015365-iqdi99pd	408	8	AE	AE	NNP
cord-015365-iqdi99pd	408	9	0,1	0,1	CD
cord-015365-iqdi99pd	408	10	;	;	:
cord-015365-iqdi99pd	408	11	p	p	NN
cord-015365-iqdi99pd	408	12	<	<	XX
cord-015365-iqdi99pd	408	13	0,05	0,05	XX
cord-015365-iqdi99pd	408	14	)	)	-RRB-
cord-015365-iqdi99pd	409	1	und	und	NNP
cord-015365-iqdi99pd	410	1	TNF-(3,4	TNF-(3,4	NNP
cord-015365-iqdi99pd	410	2	AE	AE	NNP
cord-015365-iqdi99pd	410	3	1,0	1,0	CD
cord-015365-iqdi99pd	410	4	vs.	vs.	NN
cord-015365-iqdi99pd	410	5	1,0AE	1,0ae	CD
cord-015365-iqdi99pd	410	6	0,1	0,1	CD
cord-015365-iqdi99pd	410	7	;	;	:
cord-015365-iqdi99pd	410	8	p	p	NN
cord-015365-iqdi99pd	410	9	<	<	XX
cord-015365-iqdi99pd	410	10	0,05	0,05	XX
cord-015365-iqdi99pd	410	11	)	)	-RRB-
cord-015365-iqdi99pd	411	1	führte	führte	NNP
cord-015365-iqdi99pd	411	2	,	,	,
cord-015365-iqdi99pd	411	3	während	während	NNP
cord-015365-iqdi99pd	411	4	sich	sich	NNP
cord-015365-iqdi99pd	411	5	hierbei	hierbei	NNP
cord-015365-iqdi99pd	411	6	keine	keine	NNP
cord-015365-iqdi99pd	411	7	Hinweise	Hinweise	NNP
cord-015365-iqdi99pd	411	8	auf	auf	NNP
cord-015365-iqdi99pd	411	9	eine	eine	NNP
cord-015365-iqdi99pd	411	10	Schädigung	Schädigung	NNP
cord-015365-iqdi99pd	411	11	der	der	NNP
cord-015365-iqdi99pd	411	12	Endothelzellen	Endothelzellen	NNP
cord-015365-iqdi99pd	411	13	ergab	ergab	NN
cord-015365-iqdi99pd	411	14	.	.	.
cord-015365-iqdi99pd	412	1	Außerdem	Außerdem	NNP
cord-015365-iqdi99pd	412	2	fand	fand	UH
cord-015365-iqdi99pd	412	3	sich	sich	NNP
cord-015365-iqdi99pd	412	4	eine	eine	NNP
cord-015365-iqdi99pd	412	5	gesteigerte	gesteigerte	NNPS
cord-015365-iqdi99pd	412	6	glomeruläre	glomeruläre	NNP
cord-015365-iqdi99pd	412	7	Expression	Expression	NNP
cord-015365-iqdi99pd	412	8	des	des	FW
cord-015365-iqdi99pd	412	9	Transkriptionsfaktors	Transkriptionsfaktors	NNP
cord-015365-iqdi99pd	413	1	Foxp3	Foxp3	NNP
cord-015365-iqdi99pd	413	2	.	.	.
cord-015365-iqdi99pd	414	1	Bei	Bei	NNP
cord-015365-iqdi99pd	414	2	TX	TX	NNP
cord-015365-iqdi99pd	414	3	-	-	HYPH
cord-015365-iqdi99pd	414	4	Patienten	Patienten	NNP
cord-015365-iqdi99pd	414	5	/	/	SYM
cord-015365-iqdi99pd	414	6	innen	innen	NNP
cord-015365-iqdi99pd	414	7	findet	findet	NNP
cord-015365-iqdi99pd	414	8	man	man	NN
cord-015365-iqdi99pd	415	1	eine	eine	NNP
cord-015365-iqdi99pd	415	2	bis	bis	NNP
cord-015365-iqdi99pd	415	3	zu	zu	NNP
cord-015365-iqdi99pd	415	4	200-fache	200-fache	CD
cord-015365-iqdi99pd	415	5	Erhöhung	Erhöhung	NNP
cord-015365-iqdi99pd	415	6	der	der	NNP
cord-015365-iqdi99pd	415	7	sog	sog	NNP
cord-015365-iqdi99pd	415	8	.	.	.
cord-015365-iqdi99pd	416	1	,	,	,
cord-015365-iqdi99pd	416	2	non	non	JJ
cord-015365-iqdi99pd	416	3	-	-	JJ
cord-015365-iqdi99pd	416	4	melanoma	melanoma	JJ
cord-015365-iqdi99pd	416	5	skin	skin	NN
cord-015365-iqdi99pd	416	6	cancer'-Gruppe	cancer'-Gruppe	NNS
cord-015365-iqdi99pd	416	7	und	und	NNP
cord-015365-iqdi99pd	416	8	eine	eine	NNP
cord-015365-iqdi99pd	416	9	5-fache	5-fache	CD
cord-015365-iqdi99pd	417	1	Steigerung	Steigerung	NNP
cord-015365-iqdi99pd	417	2	der	der	NNP
cord-015365-iqdi99pd	417	3	Melanom	Melanom	NNP
cord-015365-iqdi99pd	417	4	-	-	HYPH
cord-015365-iqdi99pd	417	5	Inzidenz	Inzidenz	NNP
cord-015365-iqdi99pd	418	1	i	-PRON-	PRP
cord-015365-iqdi99pd	418	2	m	be	VBP
cord-015365-iqdi99pd	419	1	Vergleich	Vergleich	NNP
cord-015365-iqdi99pd	419	2	zur	zur	NNP
cord-015365-iqdi99pd	419	3	Normalbevölkerung	Normalbevölkerung	NNP
cord-015365-iqdi99pd	419	4	.	.	.
cord-015365-iqdi99pd	420	1	Das	Das	NNP
cord-015365-iqdi99pd	420	2	klinische	klinische	NNP
cord-015365-iqdi99pd	421	1	Bild	Bild	NNP
cord-015365-iqdi99pd	421	2	dieser	dieser	NNP
cord-015365-iqdi99pd	422	1	Neoplasien	Neoplasien	NNP
cord-015365-iqdi99pd	422	2	ist	ist	NN
cord-015365-iqdi99pd	422	3	nicht	nicht	NNP
cord-015365-iqdi99pd	422	4	selten	selten	NNP
cord-015365-iqdi99pd	422	5	atypisch	atypisch	NNP
cord-015365-iqdi99pd	422	6	,	,	,
cord-015365-iqdi99pd	423	1	das	das	NNP
cord-015365-iqdi99pd	423	2	Verhalten	Verhalten	NNP
cord-015365-iqdi99pd	423	3	aggressiv	aggressiv	NNP
cord-015365-iqdi99pd	423	4	und	und	IN
cord-015365-iqdi99pd	423	5	die	die	VBP
cord-015365-iqdi99pd	423	6	Prognose	Prognose	NNP
cord-015365-iqdi99pd	423	7	ungünstig	ungünstig	NN
cord-015365-iqdi99pd	423	8	.	.	.
cord-015365-iqdi99pd	424	1	Die	die	VB
cord-015365-iqdi99pd	424	2	Intensität	Intensität	NNP
cord-015365-iqdi99pd	424	3	bzw	bzw	NNP
cord-015365-iqdi99pd	424	4	.	.	.
cord-015365-iqdi99pd	425	1	Dauer	Dauer	NNP
cord-015365-iqdi99pd	425	2	der	der	NN
cord-015365-iqdi99pd	425	3	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	426	1	und	und	NNP
cord-015365-iqdi99pd	426	2	die	die	VB
cord-015365-iqdi99pd	426	3	Wahl	Wahl	NNP
cord-015365-iqdi99pd	426	4	der	der	NNP
cord-015365-iqdi99pd	426	5	immunsuppressiven	immunsuppressiven	NNP
cord-015365-iqdi99pd	426	6	Medikamente	Medikamente	NNP
cord-015365-iqdi99pd	426	7	in	in	IN
cord-015365-iqdi99pd	426	8	Verbindung	Verbindung	NNP
cord-015365-iqdi99pd	426	9	mit	mit	NNP
cord-015365-iqdi99pd	426	10	der	der	NNP
cord-015365-iqdi99pd	426	11	aktuellen	aktuellen	NNP
cord-015365-iqdi99pd	426	12	und	und	IN
cord-015365-iqdi99pd	426	13	zurückliegenden	zurückliegenden	NNP
cord-015365-iqdi99pd	426	14	UV	UV	NNP
cord-015365-iqdi99pd	426	15	-	-	HYPH
cord-015365-iqdi99pd	426	16	Exposition	exposition	NN
cord-015365-iqdi99pd	426	17	korreliert	korreliert	NN
cord-015365-iqdi99pd	426	18	dabei	dabei	NNP
cord-015365-iqdi99pd	426	19	mit	mit	NNP
cord-015365-iqdi99pd	426	20	der	der	NNP
cord-015365-iqdi99pd	426	21	Tumorentstehung	Tumorentstehung	NNP
cord-015365-iqdi99pd	426	22	.	.	.
cord-015365-iqdi99pd	427	1	Besonders	Besonders	NNP
cord-015365-iqdi99pd	427	2	wichtig	wichtig	NNP
cord-015365-iqdi99pd	427	3	sind	sind	VBP
cord-015365-iqdi99pd	427	4	regelmäßige	regelmäßige	NNS
cord-015365-iqdi99pd	428	1	Nachsorge	Nachsorge	NNP
cord-015365-iqdi99pd	428	2	-	-	HYPH
cord-015365-iqdi99pd	428	3	Untersuchungen	Untersuchungen	NNP
cord-015365-iqdi99pd	428	4	post	post	NN
cord-015365-iqdi99pd	428	5	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	428	6	,	,	,
cord-015365-iqdi99pd	428	7	welche	welche	NNP
cord-015365-iqdi99pd	428	8	in	in	IN
cord-015365-iqdi99pd	428	9	speziellen	speziellen	NNP
cord-015365-iqdi99pd	428	10	dermatologischen	dermatologischen	NNP
cord-015365-iqdi99pd	428	11	Ambulanzen	Ambulanzen	NNP
cord-015365-iqdi99pd	428	12	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	428	13	werden	werden	NNP
cord-015365-iqdi99pd	428	14	sollten	sollten	NNP
cord-015365-iqdi99pd	428	15	.	.	.
cord-015365-iqdi99pd	429	1	Hierbei	Hierbei	NNP
cord-015365-iqdi99pd	429	2	stehen	stehen	NNP
cord-015365-iqdi99pd	429	3	heute	heute	NNP
cord-015365-iqdi99pd	429	4	moderne	moderne	NNP
cord-015365-iqdi99pd	429	5	Hauttumor	Hauttumor	NNP
cord-015365-iqdi99pd	429	6	-	-	HYPH
cord-015365-iqdi99pd	429	7	Therapieformen	Therapieformen	NNP
cord-015365-iqdi99pd	429	8	(	(	-LRB-
cord-015365-iqdi99pd	429	9	,	,	,
cord-015365-iqdi99pd	429	10	targeted	target	VBN
cord-015365-iqdi99pd	429	11	'	'	''
cord-015365-iqdi99pd	429	12	therapy	therapy	NN
cord-015365-iqdi99pd	429	13	und	und	IN
cord-015365-iqdi99pd	429	14	Immunmodulatoren	Immunmodulatoren	NNP
cord-015365-iqdi99pd	429	15	)	)	-RRB-
cord-015365-iqdi99pd	430	1	zur	zur	NNP
cord-015365-iqdi99pd	430	2	Verfügung	Verfügung	NNP
cord-015365-iqdi99pd	430	3	.	.	.
cord-015365-iqdi99pd	431	1	Background	background	NN
cord-015365-iqdi99pd	431	2	.	.	.
cord-015365-iqdi99pd	432	1	We	-PRON-	PRP
cord-015365-iqdi99pd	432	2	compared	compare	VBD
cord-015365-iqdi99pd	432	3	steady	steady	JJ
cord-015365-iqdi99pd	432	4	state	state	NN
cord-015365-iqdi99pd	432	5	pharmacokinetics	pharmacokinetic	NNS
cord-015365-iqdi99pd	432	6	of	of	IN
cord-015365-iqdi99pd	432	7	mycophenolate	mycophenolate	NNP
cord-015365-iqdi99pd	432	8	mofetil	mofetil	NNP
cord-015365-iqdi99pd	433	1	-Myfenax	-myfenax	RB
cord-015365-iqdi99pd	433	2	+	+	CC
cord-015365-iqdi99pd	434	1	(	(	-LRB-
cord-015365-iqdi99pd	434	2	Teva	Teva	NNP
cord-015365-iqdi99pd	434	3	)	)	-RRB-
cord-015365-iqdi99pd	434	4	and	and	CC
cord-015365-iqdi99pd	434	5	CellCept	CellCept	NNP
cord-015365-iqdi99pd	434	6	+	+	CC
cord-015365-iqdi99pd	434	7	(	(	-LRB-
cord-015365-iqdi99pd	434	8	Roche	Roche	NNP
cord-015365-iqdi99pd	434	9	)	)	-RRB-
cord-015365-iqdi99pd	435	1	-in	-in	:
cord-015365-iqdi99pd	435	2	stable	stable	JJ
cord-015365-iqdi99pd	435	3	kidney	kidney	NN
cord-015365-iqdi99pd	435	4	transplant	transplant	NN
cord-015365-iqdi99pd	435	5	recipients	recipient	NNS
cord-015365-iqdi99pd	435	6	(	(	-LRB-
cord-015365-iqdi99pd	435	7	KTR	KTR	NNP
cord-015365-iqdi99pd	435	8	)	)	-RRB-
cord-015365-iqdi99pd	435	9	.	.	.
cord-015365-iqdi99pd	436	1	Methods	method	NNS
cord-015365-iqdi99pd	436	2	.	.	.
cord-015365-iqdi99pd	437	1	This	this	DT
cord-015365-iqdi99pd	437	2	was	be	VBD
cord-015365-iqdi99pd	437	3	an	an	DT
cord-015365-iqdi99pd	437	4	international	international	JJ
cord-015365-iqdi99pd	437	5	,	,	,
cord-015365-iqdi99pd	437	6	multi	multi	JJ
cord-015365-iqdi99pd	437	7	-	-	JJ
cord-015365-iqdi99pd	437	8	centre	centre	JJ
cord-015365-iqdi99pd	437	9	,	,	,
cord-015365-iqdi99pd	437	10	randomized	randomized	JJ
cord-015365-iqdi99pd	437	11	,	,	,
cord-015365-iqdi99pd	437	12	open	open	JJ
cord-015365-iqdi99pd	437	13	-	-	HYPH
cord-015365-iqdi99pd	437	14	label	label	NN
cord-015365-iqdi99pd	437	15	,	,	,
cord-015365-iqdi99pd	437	16	two	two	CD
cord-015365-iqdi99pd	437	17	-	-	HYPH
cord-015365-iqdi99pd	437	18	treatment	treatment	NN
cord-015365-iqdi99pd	437	19	,	,	,
cord-015365-iqdi99pd	437	20	two	two	CD
cord-015365-iqdi99pd	437	21	-	-	HYPH
cord-015365-iqdi99pd	437	22	sequence	sequence	NN
cord-015365-iqdi99pd	437	23	crossover	crossover	NN
cord-015365-iqdi99pd	437	24	study	study	NN
cord-015365-iqdi99pd	437	25	with	with	IN
cord-015365-iqdi99pd	437	26	a	a	DT
cord-015365-iqdi99pd	437	27	3-months	3-months	CD
cord-015365-iqdi99pd	437	28	follow	follow	NN
cord-015365-iqdi99pd	437	29	-	-	HYPH
cord-015365-iqdi99pd	437	30	up	up	NN
cord-015365-iqdi99pd	437	31	.	.	.
cord-015365-iqdi99pd	438	1	We	-PRON-	PRP
cord-015365-iqdi99pd	438	2	included	include	VBD
cord-015365-iqdi99pd	438	3	KTRs	ktr	NNS
cord-015365-iqdi99pd	438	4	at	at	IN
cord-015365-iqdi99pd	438	5	least	least	RBS
cord-015365-iqdi99pd	438	6	12	12	CD
cord-015365-iqdi99pd	438	7	months	month	NNS
cord-015365-iqdi99pd	438	8	post	post	NN
cord-015365-iqdi99pd	438	9	-	-	NN
cord-015365-iqdi99pd	438	10	transplantation	transplantation	NN
cord-015365-iqdi99pd	438	11	with	with	IN
cord-015365-iqdi99pd	438	12	stable	stable	JJ
cord-015365-iqdi99pd	438	13	renal	renal	JJ
cord-015365-iqdi99pd	438	14	graft	graft	NN
cord-015365-iqdi99pd	438	15	function	function	NN
cord-015365-iqdi99pd	438	16	for	for	IN
cord-015365-iqdi99pd	438	17	at	at	RB
cord-015365-iqdi99pd	438	18	least	least	JJS
cord-015365-iqdi99pd	438	19	3	3	CD
cord-015365-iqdi99pd	438	20	months	month	NNS
cord-015365-iqdi99pd	438	21	.	.	.
cord-015365-iqdi99pd	439	1	The	the	DT
cord-015365-iqdi99pd	439	2	maintenance	maintenance	NN
cord-015365-iqdi99pd	439	3	treatment	treatment	NN
cord-015365-iqdi99pd	439	4	consisted	consist	VBD
cord-015365-iqdi99pd	439	5	of	of	IN
cord-015365-iqdi99pd	439	6	MMF	MMF	NNP
cord-015365-iqdi99pd	439	7	in	in	IN
cord-015365-iqdi99pd	439	8	combination	combination	NN
cord-015365-iqdi99pd	439	9	with	with	IN
cord-015365-iqdi99pd	439	10	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	439	11	with	with	IN
cord-015365-iqdi99pd	439	12	or	or	CC
cord-015365-iqdi99pd	439	13	without	without	IN
cord-015365-iqdi99pd	439	14	steroids	steroid	NNS
cord-015365-iqdi99pd	439	15	.	.	.
cord-015365-iqdi99pd	440	1	At	at	IN
cord-015365-iqdi99pd	440	2	the	the	DT
cord-015365-iqdi99pd	440	3	end	end	NN
cord-015365-iqdi99pd	440	4	of	of	IN
cord-015365-iqdi99pd	440	5	the	the	DT
cord-015365-iqdi99pd	440	6	two	two	CD
cord-015365-iqdi99pd	440	7	treatment	treatment	NN
cord-015365-iqdi99pd	440	8	periods	period	NNS
cord-015365-iqdi99pd	440	9	6-hour	6-hour	CD
cord-015365-iqdi99pd	440	10	or	or	CC
cord-015365-iqdi99pd	440	11	12-hour	12-hour	CD
cord-015365-iqdi99pd	440	12	pharmacokinetic	pharmacokinetic	JJ
cord-015365-iqdi99pd	440	13	studies	study	NNS
cord-015365-iqdi99pd	440	14	of	of	IN
cord-015365-iqdi99pd	440	15	mycophenolic	mycophenolic	NNP
cord-015365-iqdi99pd	440	16	acid	acid	NNP
cord-015365-iqdi99pd	440	17	(	(	-LRB-
cord-015365-iqdi99pd	440	18	MPA	MPA	NNP
cord-015365-iqdi99pd	440	19	)	)	-RRB-
cord-015365-iqdi99pd	440	20	were	be	VBD
cord-015365-iqdi99pd	440	21	performed	perform	VBN
cord-015365-iqdi99pd	440	22	.	.	.
cord-015365-iqdi99pd	441	1	Results	result	NNS
cord-015365-iqdi99pd	441	2	(	(	-LRB-
cord-015365-iqdi99pd	441	3	0	0	CD
cord-015365-iqdi99pd	441	4	-	-	HYPH
cord-015365-iqdi99pd	441	5	6h	6h	CD
cord-015365-iqdi99pd	441	6	)	)	-RRB-
cord-015365-iqdi99pd	441	7	,	,	,
cord-015365-iqdi99pd	441	8	and	and	CC
cord-015365-iqdi99pd	441	9	Cmin	Cmin	NNP
cord-015365-iqdi99pd	441	10	of	of	IN
cord-015365-iqdi99pd	441	11	MPA	MPA	NNP
cord-015365-iqdi99pd	441	12	were	be	VBD
cord-015365-iqdi99pd	441	13	within	within	IN
cord-015365-iqdi99pd	441	14	the	the	DT
cord-015365-iqdi99pd	441	15	bioequivalence	bioequivalence	NN
cord-015365-iqdi99pd	441	16	margins	margin	NNS
cord-015365-iqdi99pd	441	17	and	and	CC
cord-015365-iqdi99pd	441	18	Cmax	Cmax	NNP
cord-015365-iqdi99pd	441	19	was	be	VBD
cord-015365-iqdi99pd	441	20	marginally	marginally	RB
cord-015365-iqdi99pd	441	21	outside	outside	RB
cord-015365-iqdi99pd	441	22	of	of	IN
cord-015365-iqdi99pd	441	23	these	these	DT
cord-015365-iqdi99pd	441	24	margins	margin	NNS
cord-015365-iqdi99pd	441	25	in	in	IN
cord-015365-iqdi99pd	441	26	this	this	DT
cord-015365-iqdi99pd	441	27	set	set	NN
cord-015365-iqdi99pd	441	28	of	of	IN
cord-015365-iqdi99pd	441	29	patients	patient	NNS
cord-015365-iqdi99pd	441	30	.	.	.
cord-015365-iqdi99pd	442	1	The	the	DT
cord-015365-iqdi99pd	442	2	numbers	number	NNS
cord-015365-iqdi99pd	442	3	and	and	CC
cord-015365-iqdi99pd	442	4	types	type	NNS
cord-015365-iqdi99pd	442	5	of	of	IN
cord-015365-iqdi99pd	442	6	adverse	adverse	JJ
cord-015365-iqdi99pd	442	7	events	event	NNS
cord-015365-iqdi99pd	442	8	were	be	VBD
cord-015365-iqdi99pd	442	9	not	not	RB
cord-015365-iqdi99pd	442	10	different	different	JJ
cord-015365-iqdi99pd	442	11	between	between	IN
cord-015365-iqdi99pd	442	12	the	the	DT
cord-015365-iqdi99pd	442	13	two	two	CD
cord-015365-iqdi99pd	442	14	treatments	treatment	NNS
cord-015365-iqdi99pd	442	15	.	.	.
cord-015365-iqdi99pd	443	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	443	2	.	.	.
cord-015365-iqdi99pd	444	1	The	the	DT
cord-015365-iqdi99pd	444	2	steady	steady	JJ
cord-015365-iqdi99pd	444	3	state	state	NN
cord-015365-iqdi99pd	444	4	pharmacokinetics	pharmacokinetic	NNS
cord-015365-iqdi99pd	444	5	of	of	IN
cord-015365-iqdi99pd	444	6	MPA	MPA	NNP
cord-015365-iqdi99pd	444	7	as	as	RB
cord-015365-iqdi99pd	444	8	well	well	RB
cord-015365-iqdi99pd	444	9	as	as	IN
cord-015365-iqdi99pd	444	10	adverse	adverse	JJ
cord-015365-iqdi99pd	444	11	events	event	NNS
cord-015365-iqdi99pd	444	12	are	be	VBP
cord-015365-iqdi99pd	444	13	comparable	comparable	JJ
cord-015365-iqdi99pd	444	14	for	for	IN
cord-015365-iqdi99pd	444	15	Myfenax	Myfenax	NNP
cord-015365-iqdi99pd	444	16	and	and	CC
cord-015365-iqdi99pd	444	17	CellCept	CellCept	NNP
cord-015365-iqdi99pd	444	18	in	in	IN
cord-015365-iqdi99pd	444	19	Tacrolimus	Tacrolimus	NNP
cord-015365-iqdi99pd	444	20	treated	treat	VBD
cord-015365-iqdi99pd	444	21	stable	stable	JJ
cord-015365-iqdi99pd	444	22	kidney	kidney	NN
cord-015365-iqdi99pd	444	23	transplant	transplant	NN
cord-015365-iqdi99pd	444	24	recipients	recipient	NNS
cord-015365-iqdi99pd	444	25	.	.	.
cord-015365-iqdi99pd	445	1	Belatacept	Belatacept	NNP
cord-015365-iqdi99pd	445	2	in	in	IN
cord-015365-iqdi99pd	445	3	de	de	FW
cord-015365-iqdi99pd	445	4	novo	novo	JJ
cord-015365-iqdi99pd	445	5	kidney	kidney	NN
cord-015365-iqdi99pd	445	6	transplant	transplant	NN
cord-015365-iqdi99pd	445	7	recipients	recipient	NNS
cord-015365-iqdi99pd	445	8	-10-year	-10-year	NN
cord-015365-iqdi99pd	445	9	experience	experience	NN
cord-015365-iqdi99pd	445	10	in	in	IN
cord-015365-iqdi99pd	445	11	a	a	DT
cord-015365-iqdi99pd	445	12	single	single	JJ
cord-015365-iqdi99pd	445	13	center	center	NN
cord-015365-iqdi99pd	445	14	Background	background	NN
cord-015365-iqdi99pd	445	15	.	.	.
cord-015365-iqdi99pd	446	1	Belatacept	Belatacept	NNP
cord-015365-iqdi99pd	446	2	is	be	VBZ
cord-015365-iqdi99pd	446	3	a	a	DT
cord-015365-iqdi99pd	446	4	co	co	JJ
cord-015365-iqdi99pd	446	5	-	-	JJ
cord-015365-iqdi99pd	446	6	stimulation	stimulation	NN
cord-015365-iqdi99pd	446	7	blocker	blocker	NN
cord-015365-iqdi99pd	446	8	which	which	WDT
cord-015365-iqdi99pd	446	9	has	have	VBZ
cord-015365-iqdi99pd	446	10	recently	recently	RB
cord-015365-iqdi99pd	446	11	been	be	VBN
cord-015365-iqdi99pd	446	12	approved	approve	VBN
cord-015365-iqdi99pd	446	13	as	as	IN
cord-015365-iqdi99pd	446	14	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	446	15	therapy	therapy	NN
cord-015365-iqdi99pd	446	16	in	in	IN
cord-015365-iqdi99pd	446	17	renal	renal	JJ
cord-015365-iqdi99pd	446	18	transplant	transplant	NN
cord-015365-iqdi99pd	446	19	recipients	recipient	NNS
cord-015365-iqdi99pd	446	20	.	.	.
cord-015365-iqdi99pd	447	1	Here	here	RB
cord-015365-iqdi99pd	447	2	we	-PRON-	PRP
cord-015365-iqdi99pd	447	3	assess	assess	VBP
cord-015365-iqdi99pd	447	4	the	the	DT
cord-015365-iqdi99pd	447	5	outcome	outcome	NN
cord-015365-iqdi99pd	447	6	of	of	IN
cord-015365-iqdi99pd	447	7	patients	patient	NNS
cord-015365-iqdi99pd	447	8	that	that	WDT
cord-015365-iqdi99pd	447	9	have	have	VBP
cord-015365-iqdi99pd	447	10	been	be	VBN
cord-015365-iqdi99pd	447	11	treated	treat	VBN
cord-015365-iqdi99pd	447	12	with	with	IN
cord-015365-iqdi99pd	447	13	belatacept	belatacept	NN
cord-015365-iqdi99pd	447	14	for	for	IN
cord-015365-iqdi99pd	447	15	10	10	CD
cord-015365-iqdi99pd	447	16	years	year	NNS
cord-015365-iqdi99pd	447	17	after	after	IN
cord-015365-iqdi99pd	447	18	kidney	kidney	NN
cord-015365-iqdi99pd	447	19	transplantation	transplantation	NN
cord-015365-iqdi99pd	447	20	.	.	.
cord-015365-iqdi99pd	448	1	Methods	method	NNS
cord-015365-iqdi99pd	448	2	.	.	.
cord-015365-iqdi99pd	449	1	In	in	IN
cord-015365-iqdi99pd	449	2	our	-PRON-	PRP$
cord-015365-iqdi99pd	449	3	center	center	NN
cord-015365-iqdi99pd	449	4	,	,	,
cord-015365-iqdi99pd	449	5	22	22	CD
cord-015365-iqdi99pd	449	6	patients	patient	NNS
cord-015365-iqdi99pd	449	7	were	be	VBD
cord-015365-iqdi99pd	449	8	enrolled	enrol	VBN
cord-015365-iqdi99pd	449	9	in	in	IN
cord-015365-iqdi99pd	449	10	the	the	DT
cord-015365-iqdi99pd	449	11	phase	phase	NN
cord-015365-iqdi99pd	449	12	II	II	NNP
cord-015365-iqdi99pd	449	13	multi	multi	JJ
cord-015365-iqdi99pd	449	14	-	-	JJ
cord-015365-iqdi99pd	449	15	center	center	JJ
cord-015365-iqdi99pd	449	16	belatacept	belatacept	NN
cord-015365-iqdi99pd	449	17	trial	trial	NN
cord-015365-iqdi99pd	449	18	that	that	WDT
cord-015365-iqdi99pd	449	19	started	start	VBD
cord-015365-iqdi99pd	449	20	in	in	IN
cord-015365-iqdi99pd	449	21	2001	2001	CD
cord-015365-iqdi99pd	449	22	.	.	.
cord-015365-iqdi99pd	450	1	Patients	patient	NNS
cord-015365-iqdi99pd	450	2	were	be	VBD
cord-015365-iqdi99pd	450	3	randomly	randomly	RB
cord-015365-iqdi99pd	450	4	assigned	assign	VBN
cord-015365-iqdi99pd	450	5	to	to	IN
cord-015365-iqdi99pd	450	6	belatacept-(n	belatacept-(n	NNP
cord-015365-iqdi99pd	450	7	¼	¼	NNP
cord-015365-iqdi99pd	450	8	14	14	CD
cord-015365-iqdi99pd	450	9	)	)	-RRB-
cord-015365-iqdi99pd	450	10	or	or	CC
cord-015365-iqdi99pd	450	11	CyA-(n	CyA-(n	NNP
cord-015365-iqdi99pd	450	12	¼	¼	NNP
cord-015365-iqdi99pd	450	13	8)	8)	NNP
cord-015365-iqdi99pd	450	14	based	base	VBN
cord-015365-iqdi99pd	450	15	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	450	16	(	(	-LRB-
cord-015365-iqdi99pd	450	17	all	all	DT
cord-015365-iqdi99pd	450	18	patients	patient	NNS
cord-015365-iqdi99pd	450	19	received	receive	VBD
cord-015365-iqdi99pd	450	20	basiliximab	basiliximab	NNS
cord-015365-iqdi99pd	450	21	,	,	,
cord-015365-iqdi99pd	450	22	MMF	mmf	NN
cord-015365-iqdi99pd	450	23	and	and	CC
cord-015365-iqdi99pd	450	24	steroids	steroid	NNS
cord-015365-iqdi99pd	450	25	)	)	-RRB-
cord-015365-iqdi99pd	450	26	.	.	.
cord-015365-iqdi99pd	451	1	In	in	IN
cord-015365-iqdi99pd	451	2	this	this	DT
cord-015365-iqdi99pd	451	3	retrospective	retrospective	JJ
cord-015365-iqdi99pd	451	4	analysis	analysis	NN
cord-015365-iqdi99pd	451	5	we	-PRON-	PRP
cord-015365-iqdi99pd	451	6	report	report	VBP
cord-015365-iqdi99pd	451	7	the	the	DT
cord-015365-iqdi99pd	451	8	outcome	outcome	NN
cord-015365-iqdi99pd	451	9	of	of	IN
cord-015365-iqdi99pd	451	10	the	the	DT
cord-015365-iqdi99pd	451	11	belatacept	belatacept	NN
cord-015365-iqdi99pd	451	12	group	group	NN
cord-015365-iqdi99pd	451	13	as	as	IN
cord-015365-iqdi99pd	451	14	of	of	IN
cord-015365-iqdi99pd	451	15	June	June	NNP
cord-015365-iqdi99pd	451	16	2011	2011	CD
cord-015365-iqdi99pd	451	17	.	.	.
cord-015365-iqdi99pd	452	1	Patient	patient	JJ
cord-015365-iqdi99pd	452	2	and	and	CC
cord-015365-iqdi99pd	452	3	graft	graft	NN
cord-015365-iqdi99pd	452	4	survival	survival	NN
cord-015365-iqdi99pd	452	5	,	,	,
cord-015365-iqdi99pd	452	6	the	the	DT
cord-015365-iqdi99pd	452	7	incidence	incidence	NN
cord-015365-iqdi99pd	452	8	of	of	IN
cord-015365-iqdi99pd	452	9	acute	acute	JJ
cord-015365-iqdi99pd	452	10	rejection	rejection	NN
cord-015365-iqdi99pd	452	11	,	,	,
cord-015365-iqdi99pd	452	12	kidney	kidney	NN
cord-015365-iqdi99pd	452	13	function	function	NN
cord-015365-iqdi99pd	452	14	(	(	-LRB-
cord-015365-iqdi99pd	452	15	calculated	calculate	VBN
cord-015365-iqdi99pd	452	16	GFR	GFR	NNP
cord-015365-iqdi99pd	452	17	;	;	:
cord-015365-iqdi99pd	452	18	MDRD	MDRD	NNP
cord-015365-iqdi99pd	452	19	[	[	-LRB-
cord-015365-iqdi99pd	452	20	ml	ml	NN
cord-015365-iqdi99pd	452	21	/	/	SYM
cord-015365-iqdi99pd	452	22	min/1.73	min/1.73	JJ
cord-015365-iqdi99pd	452	23	m	m	CD
cord-015365-iqdi99pd	452	24	2	2	CD
cord-015365-iqdi99pd	452	25	]	]	-RRB-
cord-015365-iqdi99pd	452	26	)	)	-RRB-
cord-015365-iqdi99pd	452	27	and	and	CC
cord-015365-iqdi99pd	452	28	cardiovascular	cardiovascular	JJ
cord-015365-iqdi99pd	452	29	risk	risk	NN
cord-015365-iqdi99pd	452	30	profiles	profile	NNS
cord-015365-iqdi99pd	452	31	(	(	-LRB-
cord-015365-iqdi99pd	452	32	triglycerides	triglyceride	NNS
cord-015365-iqdi99pd	452	33	and	and	CC
cord-015365-iqdi99pd	452	34	cholesterol	cholesterol	NN
cord-015365-iqdi99pd	452	35	)	)	-RRB-
cord-015365-iqdi99pd	452	36	are	be	VBP
cord-015365-iqdi99pd	452	37	presented	present	VBN
cord-015365-iqdi99pd	452	38	.	.	.
cord-015365-iqdi99pd	453	1	Results	result	NNS
cord-015365-iqdi99pd	453	2	.	.	.
cord-015365-iqdi99pd	454	1	At	at	IN
cord-015365-iqdi99pd	454	2	an	an	DT
cord-015365-iqdi99pd	454	3	average	average	NN
cord-015365-iqdi99pd	454	4	of	of	IN
cord-015365-iqdi99pd	454	5	9.2	9.2	CD
cord-015365-iqdi99pd	454	6	(	(	-LRB-
cord-015365-iqdi99pd	454	7	8.5	8.5	CD
cord-015365-iqdi99pd	454	8	-	-	SYM
cord-015365-iqdi99pd	454	9	10.1	10.1	CD
cord-015365-iqdi99pd	454	10	)	)	-RRB-
cord-015365-iqdi99pd	454	11	years	year	NNS
cord-015365-iqdi99pd	454	12	after	after	IN
cord-015365-iqdi99pd	454	13	kidney	kidney	NN
cord-015365-iqdi99pd	454	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	454	15	9	9	CD
cord-015365-iqdi99pd	454	16	out	out	IN
cord-015365-iqdi99pd	454	17	of	of	IN
cord-015365-iqdi99pd	454	18	14	14	CD
cord-015365-iqdi99pd	454	19	belatacept	belatacept	NN
cord-015365-iqdi99pd	454	20	(	(	-LRB-
cord-015365-iqdi99pd	454	21	64	64	CD
cord-015365-iqdi99pd	454	22	%	%	NN
cord-015365-iqdi99pd	454	23	)	)	-RRB-
cord-015365-iqdi99pd	454	24	patients	patient	NNS
cord-015365-iqdi99pd	454	25	are	be	VBP
cord-015365-iqdi99pd	454	26	still	still	RB
cord-015365-iqdi99pd	454	27	on	on	IN
cord-015365-iqdi99pd	454	28	therapy	therapy	NN
cord-015365-iqdi99pd	454	29	.	.	.
cord-015365-iqdi99pd	455	1	Five	five	CD
cord-015365-iqdi99pd	455	2	patients	patient	NNS
cord-015365-iqdi99pd	455	3	discontinued	discontinue	VBD
cord-015365-iqdi99pd	455	4	the	the	DT
cord-015365-iqdi99pd	455	5	study	study	NN
cord-015365-iqdi99pd	455	6	:	:	:
cord-015365-iqdi99pd	455	7	1	1	CD
cord-015365-iqdi99pd	455	8	due	due	IN
cord-015365-iqdi99pd	455	9	to	to	IN
cord-015365-iqdi99pd	455	10	lack	lack	NN
cord-015365-iqdi99pd	455	11	of	of	IN
cord-015365-iqdi99pd	455	12	efficacy	efficacy	NN
cord-015365-iqdi99pd	455	13	(	(	-LRB-
cord-015365-iqdi99pd	455	14	ATG	ATG	NNP
cord-015365-iqdi99pd	455	15	-	-	HYPH
cord-015365-iqdi99pd	455	16	resistant	resistant	JJ
cord-015365-iqdi99pd	455	17	rejection	rejection	NN
cord-015365-iqdi99pd	455	18	)	)	-RRB-
cord-015365-iqdi99pd	455	19	,	,	,
cord-015365-iqdi99pd	455	20	1	1	CD
cord-015365-iqdi99pd	455	21	due	due	JJ
cord-015365-iqdi99pd	455	22	to	to	IN
cord-015365-iqdi99pd	455	23	PTLD	PTLD	NNP
cord-015365-iqdi99pd	455	24	,	,	,
cord-015365-iqdi99pd	455	25	1	1	CD
cord-015365-iqdi99pd	455	26	due	due	JJ
cord-015365-iqdi99pd	455	27	to	to	IN
cord-015365-iqdi99pd	455	28	pneumocystis	pneumocystis	NNP
cord-015365-iqdi99pd	455	29	carinii	carinii	FW
cord-015365-iqdi99pd	455	30	pneumonia	pneumonia	NN
cord-015365-iqdi99pd	455	31	and	and	CC
cord-015365-iqdi99pd	456	1	2	2	CD
cord-015365-iqdi99pd	456	2	patients	patient	NNS
cord-015365-iqdi99pd	456	3	withdrew	withdraw	VBD
cord-015365-iqdi99pd	456	4	consent	consent	NN
cord-015365-iqdi99pd	456	5	(	(	-LRB-
cord-015365-iqdi99pd	456	6	1	1	CD
cord-015365-iqdi99pd	456	7	and	and	CC
cord-015365-iqdi99pd	456	8	3.5	3.5	CD
cord-015365-iqdi99pd	456	9	years	year	NNS
cord-015365-iqdi99pd	456	10	after	after	IN
cord-015365-iqdi99pd	456	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	456	12	with	with	IN
cord-015365-iqdi99pd	456	13	a	a	DT
cord-015365-iqdi99pd	456	14	functioning	function	VBG
cord-015365-iqdi99pd	456	15	graft	graft	NN
cord-015365-iqdi99pd	456	16	;	;	:
cord-015365-iqdi99pd	456	17	GFR	gfr	NN
cord-015365-iqdi99pd	456	18	:	:	:
cord-015365-iqdi99pd	456	19	65.4	65.4	CD
cord-015365-iqdi99pd	456	20	and	and	CC
cord-015365-iqdi99pd	456	21	46.05	46.05	CD
cord-015365-iqdi99pd	456	22	ml	ml	NNS
cord-015365-iqdi99pd	456	23	/	/	SYM
cord-015365-iqdi99pd	456	24	min/1.73	min/1.73	VBN
cord-015365-iqdi99pd	456	25	2	2	CD
cord-015365-iqdi99pd	456	26	)	)	-RRB-
cord-015365-iqdi99pd	456	27	.	.	.
cord-015365-iqdi99pd	457	1	Three	three	CD
cord-015365-iqdi99pd	457	2	patients	patient	NNS
cord-015365-iqdi99pd	457	3	died	die	VBD
cord-015365-iqdi99pd	457	4	:	:	:
cord-015365-iqdi99pd	457	5	the	the	DT
cord-015365-iqdi99pd	457	6	patient	patient	NN
cord-015365-iqdi99pd	457	7	with	with	IN
cord-015365-iqdi99pd	457	8	PTLD	PTLD	NNP
cord-015365-iqdi99pd	457	9	and	and	CC
cord-015365-iqdi99pd	457	10	the	the	DT
cord-015365-iqdi99pd	457	11	patient	patient	NN
cord-015365-iqdi99pd	457	12	with	with	IN
cord-015365-iqdi99pd	457	13	pneumocystis	pneumocystis	NNP
cord-015365-iqdi99pd	457	14	carinii	carinii	FW
cord-015365-iqdi99pd	457	15	pneumonia	pneumonia	NN
cord-015365-iqdi99pd	457	16	shortly	shortly	RB
cord-015365-iqdi99pd	457	17	after	after	IN
cord-015365-iqdi99pd	457	18	discontinuation	discontinuation	NN
cord-015365-iqdi99pd	457	19	and	and	CC
cord-015365-iqdi99pd	457	20	the	the	DT
cord-015365-iqdi99pd	457	21	patient	patient	NN
cord-015365-iqdi99pd	457	22	with	with	IN
cord-015365-iqdi99pd	457	23	lack	lack	NN
cord-015365-iqdi99pd	457	24	of	of	IN
cord-015365-iqdi99pd	457	25	efficacy	efficacy	NN
cord-015365-iqdi99pd	457	26	6	6	CD
cord-015365-iqdi99pd	457	27	years	year	NNS
cord-015365-iqdi99pd	457	28	later	later	RB
cord-015365-iqdi99pd	457	29	due	due	JJ
cord-015365-iqdi99pd	457	30	to	to	IN
cord-015365-iqdi99pd	457	31	cardiac	cardiac	JJ
cord-015365-iqdi99pd	457	32	arrest	arrest	NN
cord-015365-iqdi99pd	457	33	.	.	.
cord-015365-iqdi99pd	458	1	Two	two	CD
cord-015365-iqdi99pd	458	2	patients	patient	NNS
cord-015365-iqdi99pd	458	3	developed	develop	VBD
cord-015365-iqdi99pd	458	4	biopsy	biopsy	NN
cord-015365-iqdi99pd	458	5	-	-	HYPH
cord-015365-iqdi99pd	458	6	proven	prove	VBN
cord-015365-iqdi99pd	458	7	acute	acute	JJ
cord-015365-iqdi99pd	458	8	rejection	rejection	NN
cord-015365-iqdi99pd	458	9	(	(	-LRB-
cord-015365-iqdi99pd	458	10	2/14	2/14	CD
cord-015365-iqdi99pd	458	11	;	;	:
cord-015365-iqdi99pd	458	12	14.3	14.3	CD
cord-015365-iqdi99pd	458	13	%	%	NN
cord-015365-iqdi99pd	458	14	)	)	-RRB-
cord-015365-iqdi99pd	458	15	(	(	-LRB-
cord-015365-iqdi99pd	458	16	BANFF	BANFF	NNP
cord-015365-iqdi99pd	458	17	IIa	IIa	NNP
cord-015365-iqdi99pd	458	18	,	,	,
cord-015365-iqdi99pd	458	19	BANFF	BANFF	NNP
cord-015365-iqdi99pd	458	20	IIb	IIb	NNP
cord-015365-iqdi99pd	458	21	)	)	-RRB-
cord-015365-iqdi99pd	458	22	.	.	.
cord-015365-iqdi99pd	459	1	In	in	IN
cord-015365-iqdi99pd	459	2	8	8	CD
cord-015365-iqdi99pd	459	3	out	out	IN
cord-015365-iqdi99pd	459	4	of	of	IN
cord-015365-iqdi99pd	459	5	9	9	CD
cord-015365-iqdi99pd	459	6	patients	patient	NNS
cord-015365-iqdi99pd	459	7	kidney	kidney	NN
cord-015365-iqdi99pd	459	8	function	function	NN
cord-015365-iqdi99pd	459	9	remained	remain	VBD
cord-015365-iqdi99pd	459	10	stable	stable	JJ
cord-015365-iqdi99pd	459	11	over	over	IN
cord-015365-iqdi99pd	459	12	time	time	NN
cord-015365-iqdi99pd	459	13	:	:	:
cord-015365-iqdi99pd	459	14	mean	mean	VB
cord-015365-iqdi99pd	459	15	GFR	GFR	NNP
cord-015365-iqdi99pd	459	16	12	12	CD
cord-015365-iqdi99pd	459	17	months	month	NNS
cord-015365-iqdi99pd	459	18	after	after	IN
cord-015365-iqdi99pd	459	19	kidney	kidney	NN
cord-015365-iqdi99pd	459	20	transplantation	transplantation	NN
cord-015365-iqdi99pd	459	21	59.64	59.64	CD
cord-015365-iqdi99pd	459	22	(	(	-LRB-
cord-015365-iqdi99pd	459	23	SD	SD	NNP
cord-015365-iqdi99pd	459	24	10.6	10.6	CD
cord-015365-iqdi99pd	459	25	)	)	-RRB-
cord-015365-iqdi99pd	459	26	,	,	,
cord-015365-iqdi99pd	459	27	mean	mean	VBP
cord-015365-iqdi99pd	459	28	eGFR	egfr	NN
cord-015365-iqdi99pd	460	1	at	at	IN
cord-015365-iqdi99pd	460	2	the	the	DT
cord-015365-iqdi99pd	460	3	time	time	NN
cord-015365-iqdi99pd	460	4	of	of	IN
cord-015365-iqdi99pd	460	5	the	the	DT
cord-015365-iqdi99pd	460	6	last	last	JJ
cord-015365-iqdi99pd	460	7	visit	visit	NN
cord-015365-iqdi99pd	460	8	:	:	:
cord-015365-iqdi99pd	460	9	59.32	59.32	CD
cord-015365-iqdi99pd	460	10	(	(	-LRB-
cord-015365-iqdi99pd	460	11	SD	SD	NNP
cord-015365-iqdi99pd	460	12	11.2	11.2	CD
cord-015365-iqdi99pd	460	13	)	)	-RRB-
cord-015365-iqdi99pd	460	14	.	.	.
cord-015365-iqdi99pd	461	1	One	one	CD
cord-015365-iqdi99pd	461	2	patient	patient	NN
cord-015365-iqdi99pd	461	3	had	have	VBD
cord-015365-iqdi99pd	461	4	an	an	DT
cord-015365-iqdi99pd	461	5	impaired	impaired	JJ
cord-015365-iqdi99pd	461	6	kidney	kidney	NN
cord-015365-iqdi99pd	461	7	function	function	NN
cord-015365-iqdi99pd	461	8	with	with	IN
cord-015365-iqdi99pd	461	9	a	a	DT
cord-015365-iqdi99pd	461	10	GFR	GFR	NNP
cord-015365-iqdi99pd	461	11	of	of	IN
cord-015365-iqdi99pd	461	12	45.03	45.03	CD
cord-015365-iqdi99pd	461	13	at	at	IN
cord-015365-iqdi99pd	461	14	the	the	DT
cord-015365-iqdi99pd	461	15	last	last	JJ
cord-015365-iqdi99pd	461	16	visit	visit	NN
cord-015365-iqdi99pd	461	17	(	(	-LRB-
cord-015365-iqdi99pd	461	18	GFR	GFR	NNP
cord-015365-iqdi99pd	461	19	at	at	IN
cord-015365-iqdi99pd	461	20	month	month	NN
cord-015365-iqdi99pd	461	21	12	12	CD
cord-015365-iqdi99pd	461	22	:	:	SYM
cord-015365-iqdi99pd	461	23	68	68	CD
cord-015365-iqdi99pd	461	24	)	)	-RRB-
cord-015365-iqdi99pd	461	25	.	.	.
cord-015365-iqdi99pd	462	1	Mean	mean	JJ
cord-015365-iqdi99pd	462	2	serum	serum	NN
cord-015365-iqdi99pd	462	3	triglycerides	triglyceride	NNS
cord-015365-iqdi99pd	462	4	and	and	CC
cord-015365-iqdi99pd	462	5	cholesterol	cholesterol	NN
cord-015365-iqdi99pd	462	6	at	at	IN
cord-015365-iqdi99pd	462	7	12	12	CD
cord-015365-iqdi99pd	462	8	months	month	NNS
cord-015365-iqdi99pd	462	9	after	after	IN
cord-015365-iqdi99pd	462	10	transplantation	transplantation	NN
cord-015365-iqdi99pd	462	11	were	be	VBD
cord-015365-iqdi99pd	462	12	167	167	CD
cord-015365-iqdi99pd	462	13	(	(	-LRB-
cord-015365-iqdi99pd	462	14	SD	SD	NNP
cord-015365-iqdi99pd	462	15	70	70	CD
cord-015365-iqdi99pd	462	16	)	)	-RRB-
cord-015365-iqdi99pd	462	17	and	and	CC
cord-015365-iqdi99pd	462	18	207	207	CD
cord-015365-iqdi99pd	462	19	(	(	-LRB-
cord-015365-iqdi99pd	462	20	SD	SD	NNP
cord-015365-iqdi99pd	462	21	34	34	CD
cord-015365-iqdi99pd	462	22	)	)	-RRB-
cord-015365-iqdi99pd	462	23	respectively	respectively	RB
cord-015365-iqdi99pd	462	24	,	,	,
cord-015365-iqdi99pd	462	25	and	and	CC
cord-015365-iqdi99pd	462	26	changed	change	VBD
cord-015365-iqdi99pd	462	27	little	little	JJ
cord-015365-iqdi99pd	462	28	over	over	IN
cord-015365-iqdi99pd	462	29	time	time	NN
cord-015365-iqdi99pd	462	30	(	(	-LRB-
cord-015365-iqdi99pd	462	31	mean	mean	VB
cord-015365-iqdi99pd	462	32	triglycerides	triglyceride	NNS
cord-015365-iqdi99pd	462	33	:	:	:
cord-015365-iqdi99pd	462	34	159	159	CD
cord-015365-iqdi99pd	462	35	(	(	-LRB-
cord-015365-iqdi99pd	462	36	SD	SD	NNP
cord-015365-iqdi99pd	462	37	44	44	CD
cord-015365-iqdi99pd	462	38	)	)	-RRB-
cord-015365-iqdi99pd	462	39	and	and	CC
cord-015365-iqdi99pd	462	40	cholesterol	cholesterol	NN
cord-015365-iqdi99pd	462	41	:	:	:
cord-015365-iqdi99pd	462	42	201	201	CD
cord-015365-iqdi99pd	462	43	(	(	-LRB-
cord-015365-iqdi99pd	462	44	SD	SD	NNP
cord-015365-iqdi99pd	462	45	44	44	CD
cord-015365-iqdi99pd	462	46	)	)	-RRB-
cord-015365-iqdi99pd	462	47	at	at	IN
cord-015365-iqdi99pd	462	48	the	the	DT
cord-015365-iqdi99pd	462	49	last	last	JJ
cord-015365-iqdi99pd	462	50	visit	visit	NN
cord-015365-iqdi99pd	462	51	)	)	-RRB-
cord-015365-iqdi99pd	462	52	.	.	.
cord-015365-iqdi99pd	463	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	463	2	.	.	.
cord-015365-iqdi99pd	464	1	In	in	IN
cord-015365-iqdi99pd	464	2	this	this	DT
cord-015365-iqdi99pd	464	3	selected	selected	JJ
cord-015365-iqdi99pd	464	4	group	group	NN
cord-015365-iqdi99pd	464	5	of	of	IN
cord-015365-iqdi99pd	464	6	patients	patient	NNS
cord-015365-iqdi99pd	464	7	enrolled	enrol	VBN
cord-015365-iqdi99pd	464	8	in	in	IN
cord-015365-iqdi99pd	464	9	a	a	DT
cord-015365-iqdi99pd	464	10	phase	phase	NN
cord-015365-iqdi99pd	464	11	II	II	NNP
cord-015365-iqdi99pd	464	12	trial	trial	NN
cord-015365-iqdi99pd	464	13	,	,	,
cord-015365-iqdi99pd	464	14	continuous	continuous	JJ
cord-015365-iqdi99pd	464	15	use	use	NN
cord-015365-iqdi99pd	464	16	of	of	IN
cord-015365-iqdi99pd	464	17	belatacept	belatacept	NN
cord-015365-iqdi99pd	464	18	therapy	therapy	NN
cord-015365-iqdi99pd	464	19	for	for	IN
cord-015365-iqdi99pd	464	20	10	10	CD
cord-015365-iqdi99pd	464	21	years	year	NNS
cord-015365-iqdi99pd	464	22	is	be	VBZ
cord-015365-iqdi99pd	464	23	associated	associate	VBN
cord-015365-iqdi99pd	464	24	with	with	IN
cord-015365-iqdi99pd	464	25	stable	stable	JJ
cord-015365-iqdi99pd	464	26	long	long	JJ
cord-015365-iqdi99pd	464	27	-	-	HYPH
cord-015365-iqdi99pd	464	28	term	term	NN
cord-015365-iqdi99pd	464	29	graft	graft	NN
cord-015365-iqdi99pd	464	30	function	function	NN
cord-015365-iqdi99pd	464	31	in	in	IN
cord-015365-iqdi99pd	464	32	a	a	DT
cord-015365-iqdi99pd	464	33	high	high	JJ
cord-015365-iqdi99pd	464	34	percentage	percentage	NN
cord-015365-iqdi99pd	464	35	of	of	IN
cord-015365-iqdi99pd	464	36	patients	patient	NNS
cord-015365-iqdi99pd	464	37	.	.	.
cord-015365-iqdi99pd	465	1	The	the	DT
cord-015365-iqdi99pd	465	2	Innsbruck	Innsbruck	NNP
cord-015365-iqdi99pd	465	3	Hand	Hand	NNP
cord-015365-iqdi99pd	465	4	Transplant	Transplant	NNP
cord-015365-iqdi99pd	465	5	Program	Program	NNP
cord-015365-iqdi99pd	465	6	:	:	:
cord-015365-iqdi99pd	465	7	update	update	VB
cord-015365-iqdi99pd	465	8	at	at	IN
cord-015365-iqdi99pd	465	9	11	11	CD
cord-015365-iqdi99pd	465	10	years	year	NNS
cord-015365-iqdi99pd	465	11	after	after	IN
cord-015365-iqdi99pd	465	12	the	the	DT
cord-015365-iqdi99pd	465	13	first	first	JJ
cord-015365-iqdi99pd	465	14	transplant	transplant	NN
cord-015365-iqdi99pd	465	15	Background	background	NN
cord-015365-iqdi99pd	465	16	.	.	.
cord-015365-iqdi99pd	466	1	We	-PRON-	PRP
cord-015365-iqdi99pd	466	2	describe	describe	VBP
cord-015365-iqdi99pd	466	3	here	here	RB
cord-015365-iqdi99pd	466	4	the	the	DT
cord-015365-iqdi99pd	466	5	outcome	outcome	NN
cord-015365-iqdi99pd	466	6	after	after	IN
cord-015365-iqdi99pd	466	7	two	two	CD
cord-015365-iqdi99pd	466	8	bilateral	bilateral	JJ
cord-015365-iqdi99pd	466	9	hand	hand	NN
cord-015365-iqdi99pd	466	10	,	,	,
cord-015365-iqdi99pd	466	11	one	one	CD
cord-015365-iqdi99pd	466	12	bilateral	bilateral	JJ
cord-015365-iqdi99pd	466	13	forearm	forearm	NN
cord-015365-iqdi99pd	466	14	and	and	CC
cord-015365-iqdi99pd	466	15	one	one	CD
cord-015365-iqdi99pd	466	16	unilateral	unilateral	JJ
cord-015365-iqdi99pd	466	17	hand	hand	NN
cord-015365-iqdi99pd	466	18	transplantation	transplantation	NN
cord-015365-iqdi99pd	466	19	at	at	IN
cord-015365-iqdi99pd	466	20	11/8/5	11/8/5	CD
cord-015365-iqdi99pd	466	21	and	and	CC
cord-015365-iqdi99pd	466	22	2	2	CD
cord-015365-iqdi99pd	466	23	years	year	NNS
cord-015365-iqdi99pd	466	24	after	after	IN
cord-015365-iqdi99pd	466	25	transplantation	transplantation	NN
cord-015365-iqdi99pd	466	26	.	.	.
cord-015365-iqdi99pd	467	1	Methods	method	NNS
cord-015365-iqdi99pd	467	2	.	.	.
cord-015365-iqdi99pd	468	1	Four	four	CD
cord-015365-iqdi99pd	468	2	patients	patient	NNS
cord-015365-iqdi99pd	468	3	received	receive	VBD
cord-015365-iqdi99pd	468	4	a	a	DT
cord-015365-iqdi99pd	468	5	bilateral	bilateral	JJ
cord-015365-iqdi99pd	468	6	hand	hand	NN
cord-015365-iqdi99pd	468	7	(	(	-LRB-
cord-015365-iqdi99pd	468	8	n	n	NN
cord-015365-iqdi99pd	468	9	¼	¼	NNP
cord-015365-iqdi99pd	468	10	2	2	CD
cord-015365-iqdi99pd	468	11	)	)	-RRB-
cord-015365-iqdi99pd	468	12	,	,	,
cord-015365-iqdi99pd	468	13	a	a	DT
cord-015365-iqdi99pd	468	14	bilateral	bilateral	JJ
cord-015365-iqdi99pd	468	15	forearm	forearm	NN
cord-015365-iqdi99pd	468	16	(	(	-LRB-
cord-015365-iqdi99pd	468	17	n	n	NN
cord-015365-iqdi99pd	468	18	¼	¼	NNP
cord-015365-iqdi99pd	468	19	1	1	CD
cord-015365-iqdi99pd	468	20	)	)	-RRB-
cord-015365-iqdi99pd	468	21	or	or	CC
cord-015365-iqdi99pd	468	22	a	a	DT
cord-015365-iqdi99pd	468	23	unilateral	unilateral	JJ
cord-015365-iqdi99pd	468	24	hand	hand	NN
cord-015365-iqdi99pd	468	25	transplant	transplant	NN
cord-015365-iqdi99pd	468	26	between	between	IN
cord-015365-iqdi99pd	468	27	March	March	NNP
cord-015365-iqdi99pd	468	28	2000	2000	CD
cord-015365-iqdi99pd	468	29	and	and	CC
cord-015365-iqdi99pd	468	30	July	July	NNP
cord-015365-iqdi99pd	468	31	2009	2009	CD
cord-015365-iqdi99pd	468	32	.	.	.
cord-015365-iqdi99pd	469	1	Induction	induction	NN
cord-015365-iqdi99pd	469	2	therapy	therapy	NN
cord-015365-iqdi99pd	469	3	with	with	IN
cord-015365-iqdi99pd	469	4	ATG	ATG	NNP
cord-015365-iqdi99pd	469	5	(	(	-LRB-
cord-015365-iqdi99pd	469	6	n	n	NN
cord-015365-iqdi99pd	469	7	¼	¼	NNP
cord-015365-iqdi99pd	469	8	2	2	CD
cord-015365-iqdi99pd	469	9	)	)	-RRB-
cord-015365-iqdi99pd	469	10	or	or	CC
cord-015365-iqdi99pd	469	11	alemtuzumab	alemtuzumab	NNP
cord-015365-iqdi99pd	469	12	(	(	-LRB-
cord-015365-iqdi99pd	469	13	n	n	NN
cord-015365-iqdi99pd	469	14	¼	¼	NNP
cord-015365-iqdi99pd	469	15	2	2	CD
cord-015365-iqdi99pd	469	16	)	)	-RRB-
cord-015365-iqdi99pd	469	17	was	be	VBD
cord-015365-iqdi99pd	469	18	followed	follow	VBN
cord-015365-iqdi99pd	469	19	by	by	IN
cord-015365-iqdi99pd	469	20	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	469	21	,	,	,
cord-015365-iqdi99pd	469	22	prednisolone	prednisolone	NN
cord-015365-iqdi99pd	469	23	,	,	,
cord-015365-iqdi99pd	470	1	MMF	MMF	NNP
cord-015365-iqdi99pd	470	2	(	(	-LRB-
cord-015365-iqdi99pd	470	3	n	n	NN
cord-015365-iqdi99pd	470	4	¼	¼	NNP
cord-015365-iqdi99pd	470	5	3	3	CD
cord-015365-iqdi99pd	470	6	)	)	-RRB-
cord-015365-iqdi99pd	470	7	or	or	CC
cord-015365-iqdi99pd	470	8	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	470	9	and	and	CC
cord-015365-iqdi99pd	470	10	MMF	MMF	NNP
cord-015365-iqdi99pd	470	11	(	(	-LRB-
cord-015365-iqdi99pd	470	12	n	n	NN
cord-015365-iqdi99pd	470	13	¼	¼	NNP
cord-015365-iqdi99pd	470	14	1	1	CD
cord-015365-iqdi99pd	470	15	)	)	-RRB-
cord-015365-iqdi99pd	470	16	maintenance	maintenance	NN
cord-015365-iqdi99pd	470	17	IS	be	VBZ
cord-015365-iqdi99pd	470	18	.	.	.
cord-015365-iqdi99pd	471	1	Later	later	RB
cord-015365-iqdi99pd	471	2	,	,	,
cord-015365-iqdi99pd	471	3	sirolimus	sirolimus	NNP
cord-015365-iqdi99pd	471	4	/	/	SYM
cord-015365-iqdi99pd	471	5	everolimus	everolimus	NNP
cord-015365-iqdi99pd	471	6	was	be	VBD
cord-015365-iqdi99pd	471	7	added	add	VBN
cord-015365-iqdi99pd	471	8	under	under	IN
cord-015365-iqdi99pd	471	9	simultaneous	simultaneous	JJ
cord-015365-iqdi99pd	471	10	withdrawal	withdrawal	NN
cord-015365-iqdi99pd	471	11	(	(	-LRB-
cord-015365-iqdi99pd	471	12	n	n	NN
cord-015365-iqdi99pd	471	13	¼	¼	NNP
cord-015365-iqdi99pd	471	14	2	2	CD
cord-015365-iqdi99pd	471	15	)	)	-RRB-
cord-015365-iqdi99pd	471	16	or	or	CC
cord-015365-iqdi99pd	471	17	dose	dose	JJ
cord-015365-iqdi99pd	471	18	reduction	reduction	NN
cord-015365-iqdi99pd	471	19	(	(	-LRB-
cord-015365-iqdi99pd	471	20	n	n	NN
cord-015365-iqdi99pd	471	21	¼	¼	NNP
cord-015365-iqdi99pd	471	22	1	1	CD
cord-015365-iqdi99pd	471	23	)	)	-RRB-
cord-015365-iqdi99pd	471	24	of	of	IN
cord-015365-iqdi99pd	471	25	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	471	26	(	(	-LRB-
cord-015365-iqdi99pd	471	27	n	n	NNP
cord-015365-iqdi99pd	471	28	¼	¼	NNP
cord-015365-iqdi99pd	471	29	1	1	CD
cord-015365-iqdi99pd	471	30	)	)	-RRB-
cord-015365-iqdi99pd	471	31	or	or	CC
cord-015365-iqdi99pd	471	32	MMF	MMF	NNP
cord-015365-iqdi99pd	471	33	(	(	-LRB-
cord-015365-iqdi99pd	471	34	n	n	NN
cord-015365-iqdi99pd	471	35	¼	¼	NNP
cord-015365-iqdi99pd	471	36	1	1	CD
cord-015365-iqdi99pd	471	37	)	)	-RRB-
cord-015365-iqdi99pd	471	38	.	.	.
cord-015365-iqdi99pd	472	1	Steroids	steroid	NNS
cord-015365-iqdi99pd	472	2	were	be	VBD
cord-015365-iqdi99pd	472	3	avoided	avoid	VBN
cord-015365-iqdi99pd	472	4	in	in	IN
cord-015365-iqdi99pd	472	5	one	one	CD
cord-015365-iqdi99pd	472	6	and	and	CC
cord-015365-iqdi99pd	472	7	withdrawn	withdraw	VBN
cord-015365-iqdi99pd	472	8	in	in	IN
cord-015365-iqdi99pd	472	9	two	two	CD
cord-015365-iqdi99pd	472	10	patients	patient	NNS
cord-015365-iqdi99pd	472	11	.	.	.
cord-015365-iqdi99pd	473	1	Results	result	NNS
cord-015365-iqdi99pd	473	2	.	.	.
cord-015365-iqdi99pd	474	1	Range	range	NN
cord-015365-iqdi99pd	474	2	of	of	IN
cord-015365-iqdi99pd	474	3	motion	motion	NN
cord-015365-iqdi99pd	474	4	reached	reach	VBD
cord-015365-iqdi99pd	474	5	up	up	IN
cord-015365-iqdi99pd	474	6	to	to	TO
cord-015365-iqdi99pd	474	7	70	70	CD
cord-015365-iqdi99pd	474	8	%	%	NN
cord-015365-iqdi99pd	474	9	of	of	IN
cord-015365-iqdi99pd	474	10	normal	normal	JJ
cord-015365-iqdi99pd	474	11	with	with	IN
cord-015365-iqdi99pd	474	12	a	a	DT
cord-015365-iqdi99pd	474	13	grip	grip	NN
cord-015365-iqdi99pd	474	14	strength	strength	NN
cord-015365-iqdi99pd	474	15	of	of	IN
cord-015365-iqdi99pd	474	16	2	2	CD
cord-015365-iqdi99pd	474	17	-	-	SYM
cord-015365-iqdi99pd	474	18	10	10	CD
cord-015365-iqdi99pd	474	19	kg	kg	NNS
cord-015365-iqdi99pd	474	20	.	.	.
cord-015365-iqdi99pd	475	1	Hand	hand	NN
cord-015365-iqdi99pd	475	2	function	function	NN
cord-015365-iqdi99pd	475	3	correlated	correlate	VBN
cord-015365-iqdi99pd	475	4	well	well	RB
cord-015365-iqdi99pd	475	5	with	with	IN
cord-015365-iqdi99pd	475	6	time	time	NN
cord-015365-iqdi99pd	475	7	after	after	IN
cord-015365-iqdi99pd	475	8	transplant	transplant	NN
cord-015365-iqdi99pd	475	9	and	and	CC
cord-015365-iqdi99pd	475	10	amputation	amputation	NN
cord-015365-iqdi99pd	475	11	level	level	NN
cord-015365-iqdi99pd	475	12	.	.	.
cord-015365-iqdi99pd	476	1	Intrinsic	intrinsic	JJ
cord-015365-iqdi99pd	476	2	hand	hand	NN
cord-015365-iqdi99pd	476	3	muscle	muscle	NN
cord-015365-iqdi99pd	476	4	function	function	NN
cord-015365-iqdi99pd	476	5	recovery	recovery	NN
cord-015365-iqdi99pd	476	6	and	and	CC
cord-015365-iqdi99pd	476	7	discriminative	discriminative	JJ
cord-015365-iqdi99pd	476	8	sensation	sensation	NN
cord-015365-iqdi99pd	476	9	were	be	VBD
cord-015365-iqdi99pd	476	10	observed	observe	VBN
cord-015365-iqdi99pd	476	11	in	in	IN
cord-015365-iqdi99pd	476	12	all	all	DT
cord-015365-iqdi99pd	476	13	patients	patient	NNS
cord-015365-iqdi99pd	476	14	.	.	.
cord-015365-iqdi99pd	477	1	Complications	complication	NNS
cord-015365-iqdi99pd	477	2	included	include	VBD
cord-015365-iqdi99pd	477	3	CMV	CMV	NNP
cord-015365-iqdi99pd	477	4	infection	infection	NN
cord-015365-iqdi99pd	477	5	,	,	,
cord-015365-iqdi99pd	477	6	fungal	fungal	JJ
cord-015365-iqdi99pd	477	7	infection	infection	NN
cord-015365-iqdi99pd	477	8	,	,	,
cord-015365-iqdi99pd	477	9	hypertension	hypertension	NN
cord-015365-iqdi99pd	477	10	,	,	,
cord-015365-iqdi99pd	477	11	hyperglycemia	hyperglycemia	NN
cord-015365-iqdi99pd	477	12	,	,	,
cord-015365-iqdi99pd	477	13	transient	transient	JJ
cord-015365-iqdi99pd	477	14	creatinine	creatinine	NN
cord-015365-iqdi99pd	477	15	increase	increase	NN
cord-015365-iqdi99pd	477	16	and	and	CC
cord-015365-iqdi99pd	477	17	headache	headache	NN
cord-015365-iqdi99pd	477	18	.	.	.
cord-015365-iqdi99pd	478	1	Three	three	CD
cord-015365-iqdi99pd	478	2	,	,	,
cord-015365-iqdi99pd	478	3	six	six	CD
cord-015365-iqdi99pd	478	4	,	,	,
cord-015365-iqdi99pd	478	5	four	four	CD
cord-015365-iqdi99pd	478	6	,	,	,
cord-015365-iqdi99pd	478	7	and	and	CC
cord-015365-iqdi99pd	479	1	one	one	CD
cord-015365-iqdi99pd	479	2	rejection	rejection	NN
cord-015365-iqdi99pd	479	3	episode	episode	NN
cord-015365-iqdi99pd	479	4	were	be	VBD
cord-015365-iqdi99pd	479	5	successfully	successfully	RB
cord-015365-iqdi99pd	479	6	treated	treat	VBN
cord-015365-iqdi99pd	479	7	with	with	IN
cord-015365-iqdi99pd	479	8	steroids	steroid	NNS
cord-015365-iqdi99pd	479	9	,	,	,
cord-015365-iqdi99pd	479	10	anti	anti	JJ
cord-015365-iqdi99pd	479	11	-	-	NNP
cord-015365-iqdi99pd	479	12	CD25	cd25	JJ
cord-015365-iqdi99pd	479	13	,	,	,
cord-015365-iqdi99pd	479	14	anti	anti	JJ
cord-015365-iqdi99pd	479	15	-	-	JJ
cord-015365-iqdi99pd	479	16	CD52	cd52	JJ
cord-015365-iqdi99pd	479	17	antibodies	antibody	NNS
cord-015365-iqdi99pd	479	18	and/or	and/or	CC
cord-015365-iqdi99pd	479	19	intensified	intensify	VBN
cord-015365-iqdi99pd	479	20	maintenance	maintenance	NN
cord-015365-iqdi99pd	479	21	IS	be	VBZ
cord-015365-iqdi99pd	479	22	.	.	.
cord-015365-iqdi99pd	480	1	Skin	skin	NN
cord-015365-iqdi99pd	480	2	histology	histology	NN
cord-015365-iqdi99pd	480	3	at	at	IN
cord-015365-iqdi99pd	480	4	current	current	JJ
cord-015365-iqdi99pd	480	5	shows	show	VBZ
cord-015365-iqdi99pd	480	6	no	no	DT
cord-015365-iqdi99pd	480	7	or	or	CC
cord-015365-iqdi99pd	480	8	mild	mild	JJ
cord-015365-iqdi99pd	480	9	perivascular	perivascular	JJ
cord-015365-iqdi99pd	480	10	lymphocytic	lymphocytic	JJ
cord-015365-iqdi99pd	480	11	infiltrates	infiltrate	VBZ
cord-015365-iqdi99pd	480	12	without	without	IN
cord-015365-iqdi99pd	480	13	signs	sign	NNS
cord-015365-iqdi99pd	480	14	of	of	IN
cord-015365-iqdi99pd	480	15	progression	progression	NN
cord-015365-iqdi99pd	480	16	.	.	.
cord-015365-iqdi99pd	481	1	Vessels	vessel	NNS
cord-015365-iqdi99pd	481	2	are	be	VBP
cord-015365-iqdi99pd	481	3	patent	patent	NN
cord-015365-iqdi99pd	481	4	without	without	IN
cord-015365-iqdi99pd	481	5	signs	sign	NNS
cord-015365-iqdi99pd	481	6	for	for	IN
cord-015365-iqdi99pd	481	7	luminal	luminal	JJ
cord-015365-iqdi99pd	481	8	narrowing	narrowing	NN
cord-015365-iqdi99pd	481	9	or	or	CC
cord-015365-iqdi99pd	481	10	intimal	intimal	JJ
cord-015365-iqdi99pd	481	11	proliferation	proliferation	NN
cord-015365-iqdi99pd	481	12	.	.	.
cord-015365-iqdi99pd	482	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	482	2	.	.	.
cord-015365-iqdi99pd	483	1	The	the	DT
cord-015365-iqdi99pd	483	2	overall	overall	JJ
cord-015365-iqdi99pd	483	3	functional	functional	JJ
cord-015365-iqdi99pd	483	4	outcome	outcome	NN
cord-015365-iqdi99pd	483	5	and	and	CC
cord-015365-iqdi99pd	483	6	patient	patient	JJ
cord-015365-iqdi99pd	483	7	satisfaction	satisfaction	NN
cord-015365-iqdi99pd	483	8	after	after	IN
cord-015365-iqdi99pd	483	9	bilateral	bilateral	JJ
cord-015365-iqdi99pd	483	10	hand	hand	NN
cord-015365-iqdi99pd	483	11	,	,	,
cord-015365-iqdi99pd	483	12	bilateral	bilateral	JJ
cord-015365-iqdi99pd	483	13	forearm	forearm	NN
cord-015365-iqdi99pd	483	14	and	and	CC
cord-015365-iqdi99pd	483	15	unilateral	unilateral	JJ
cord-015365-iqdi99pd	483	16	hand	hand	NN
cord-015365-iqdi99pd	483	17	transplantation	transplantation	NN
cord-015365-iqdi99pd	483	18	are	be	VBP
cord-015365-iqdi99pd	483	19	highly	highly	RB
cord-015365-iqdi99pd	483	20	encouraging	encouraging	JJ
cord-015365-iqdi99pd	483	21	.	.	.
cord-015365-iqdi99pd	484	1	All	all	DT
cord-015365-iqdi99pd	484	2	patients	patient	NNS
cord-015365-iqdi99pd	484	3	are	be	VBP
cord-015365-iqdi99pd	484	4	now	now	RB
cord-015365-iqdi99pd	484	5	free	free	JJ
cord-015365-iqdi99pd	484	6	of	of	IN
cord-015365-iqdi99pd	484	7	rejection	rejection	NN
cord-015365-iqdi99pd	484	8	with	with	IN
cord-015365-iqdi99pd	484	9	moderate	moderate	JJ
cord-015365-iqdi99pd	484	10	levels	level	NNS
cord-015365-iqdi99pd	484	11	of	of	IN
cord-015365-iqdi99pd	484	12	IS	is	NN
cord-015365-iqdi99pd	484	13	.	.	.
cord-015365-iqdi99pd	485	1	Renal	renal	JJ
cord-015365-iqdi99pd	485	2	function	function	NN
cord-015365-iqdi99pd	485	3	efficacy	efficacy	NN
cord-015365-iqdi99pd	485	4	measures	measure	NNS
cord-015365-iqdi99pd	485	5	following	follow	VBG
cord-015365-iqdi99pd	485	6	conversion	conversion	NN
cord-015365-iqdi99pd	485	7	from	from	IN
cord-015365-iqdi99pd	485	8	calcineurin	calcineurin	NNP
cord-015365-iqdi99pd	485	9	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	485	10	to	to	TO
cord-015365-iqdi99pd	485	11	sirolimus	sirolimus	VB
cord-015365-iqdi99pd	485	12	after	after	IN
cord-015365-iqdi99pd	485	13	cardiac	cardiac	JJ
cord-015365-iqdi99pd	485	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	485	15	in	in	IN
cord-015365-iqdi99pd	485	16	patients	patient	NNS
cord-015365-iqdi99pd	485	17	with	with	IN
cord-015365-iqdi99pd	485	18	renal	renal	JJ
cord-015365-iqdi99pd	485	19	insufficiency	insufficiency	NN
cord-015365-iqdi99pd	485	20	Methods	method	NNS
cord-015365-iqdi99pd	485	21	.	.	.
cord-015365-iqdi99pd	486	1	This	this	DT
cord-015365-iqdi99pd	486	2	was	be	VBD
cord-015365-iqdi99pd	486	3	a	a	DT
cord-015365-iqdi99pd	486	4	randomized	randomized	JJ
cord-015365-iqdi99pd	486	5	(	(	-LRB-
cord-015365-iqdi99pd	486	6	1:1	1:1	LS
cord-015365-iqdi99pd	486	7	)	)	-RRB-
cord-015365-iqdi99pd	486	8	,	,	,
cord-015365-iqdi99pd	486	9	comparative	comparative	JJ
cord-015365-iqdi99pd	486	10	,	,	,
cord-015365-iqdi99pd	486	11	multinational	multinational	JJ
cord-015365-iqdi99pd	486	12	,	,	,
cord-015365-iqdi99pd	486	13	phase	phase	NN
cord-015365-iqdi99pd	486	14	4	4	CD
cord-015365-iqdi99pd	486	15	study	study	NN
cord-015365-iqdi99pd	486	16	of	of	IN
cord-015365-iqdi99pd	486	17	patients	patient	NNS
cord-015365-iqdi99pd	486	18	1	1	CD
cord-015365-iqdi99pd	486	19	-	-	SYM
cord-015365-iqdi99pd	486	20	8	8	CD
cord-015365-iqdi99pd	486	21	years	year	NNS
cord-015365-iqdi99pd	486	22	posttransplant	posttransplant	NN
cord-015365-iqdi99pd	486	23	.	.	.
cord-015365-iqdi99pd	487	1	Patients	patient	NNS
cord-015365-iqdi99pd	487	2	on	on	IN
cord-015365-iqdi99pd	487	3	CNI	CNI	NNP
cord-015365-iqdi99pd	487	4	therapy	therapy	NN
cord-015365-iqdi99pd	487	5	with	with	IN
cord-015365-iqdi99pd	487	6	GFR	GFR	NNP
cord-015365-iqdi99pd	487	7	40	40	CD
cord-015365-iqdi99pd	487	8	-	-	SYM
cord-015365-iqdi99pd	487	9	90	90	CD
cord-015365-iqdi99pd	487	10	mL/	mL/	NNS
cord-015365-iqdi99pd	488	1	min/1.73	min/1.73	NNP
cord-015365-iqdi99pd	488	2	m	m	CD
cord-015365-iqdi99pd	488	3	2	2	CD
cord-015365-iqdi99pd	488	4	were	be	VBD
cord-015365-iqdi99pd	488	5	eligible	eligible	JJ
cord-015365-iqdi99pd	488	6	for	for	IN
cord-015365-iqdi99pd	488	7	inclusion	inclusion	NN
cord-015365-iqdi99pd	488	8	.	.	.
cord-015365-iqdi99pd	489	1	Exclusion	exclusion	NN
cord-015365-iqdi99pd	489	2	criteria	criterion	NNS
cord-015365-iqdi99pd	489	3	included	include	VBD
cord-015365-iqdi99pd	489	4	acute	acute	JJ
cord-015365-iqdi99pd	489	5	rejection	rejection	NN
cord-015365-iqdi99pd	489	6	(	(	-LRB-
cord-015365-iqdi99pd	489	7	AR	AR	NNP
cord-015365-iqdi99pd	489	8	)	)	-RRB-
cord-015365-iqdi99pd	489	9	within	within	IN
cord-015365-iqdi99pd	489	10	3	3	CD
cord-015365-iqdi99pd	489	11	mos	mos	NN
cord-015365-iqdi99pd	489	12	or	or	CC
cord-015365-iqdi99pd	489	13	proteinuria	proteinuria	NN
cord-015365-iqdi99pd	490	1	>	>	XX
cord-015365-iqdi99pd	491	1	500	500	CD
cord-015365-iqdi99pd	491	2	mg	mg	NNP
cord-015365-iqdi99pd	491	3	/	/	SYM
cord-015365-iqdi99pd	491	4	d	d	NN
cord-015365-iqdi99pd	491	5	.	.	.
cord-015365-iqdi99pd	492	1	Primary	primary	JJ
cord-015365-iqdi99pd	492	2	end	end	NN
cord-015365-iqdi99pd	492	3	point	point	NN
cord-015365-iqdi99pd	492	4	was	be	VBD
cord-015365-iqdi99pd	492	5	1-yr	1-yr	CD
cord-015365-iqdi99pd	492	6	change	change	NN
cord-015365-iqdi99pd	492	7	from	from	IN
cord-015365-iqdi99pd	492	8	baseline	baseline	NN
cord-015365-iqdi99pd	492	9	in	in	IN
cord-015365-iqdi99pd	492	10	creatinine	creatinine	NN
cord-015365-iqdi99pd	492	11	clearance	clearance	NN
cord-015365-iqdi99pd	492	12	(	(	-LRB-
cord-015365-iqdi99pd	492	13	CLcr	CLcr	NNP
cord-015365-iqdi99pd	492	14	)	)	-RRB-
cord-015365-iqdi99pd	492	15	.	.	.
cord-015365-iqdi99pd	493	1	Results	result	NNS
cord-015365-iqdi99pd	493	2	.	.	.
cord-015365-iqdi99pd	494	1	A	a	DT
cord-015365-iqdi99pd	494	2	total	total	NN
cord-015365-iqdi99pd	494	3	of	of	IN
cord-015365-iqdi99pd	494	4	114	114	CD
cord-015365-iqdi99pd	494	5	patients	patient	NNS
cord-015365-iqdi99pd	494	6	were	be	VBD
cord-015365-iqdi99pd	494	7	randomized	randomize	VBN
cord-015365-iqdi99pd	494	8	and	and	CC
cord-015365-iqdi99pd	494	9	treated	treat	VBN
cord-015365-iqdi99pd	494	10	(	(	-LRB-
cord-015365-iqdi99pd	494	11	SRL	SRL	NNP
cord-015365-iqdi99pd	494	12	57	57	CD
cord-015365-iqdi99pd	494	13	;	;	:
cord-015365-iqdi99pd	494	14	CNI	CNI	NNP
cord-015365-iqdi99pd	494	15	57	57	CD
cord-015365-iqdi99pd	494	16	)	)	-RRB-
cord-015365-iqdi99pd	494	17	;	;	:
cord-015365-iqdi99pd	494	18	mean	mean	VB
cord-015365-iqdi99pd	494	19	baseline	baseline	JJ
cord-015365-iqdi99pd	494	20	GFR	GFR	NNP
cord-015365-iqdi99pd	494	21	was	be	VBD
cord-015365-iqdi99pd	494	22	$	$	$
cord-015365-iqdi99pd	494	23	57	57	CD
cord-015365-iqdi99pd	494	24	mL/	mL/	NNS
cord-015365-iqdi99pd	494	25	min/1.73	min/1.73	NNP
cord-015365-iqdi99pd	494	26	m	m	CD
cord-015365-iqdi99pd	494	27	2	2	CD
cord-015365-iqdi99pd	494	28	.	.	.
cord-015365-iqdi99pd	495	1	In	in	IN
cord-015365-iqdi99pd	495	2	the	the	DT
cord-015365-iqdi99pd	495	3	ITT	ITT	NNP
cord-015365-iqdi99pd	495	4	LOCF	LOCF	NNP
cord-015365-iqdi99pd	495	5	analysis	analysis	NN
cord-015365-iqdi99pd	495	6	,	,	,
cord-015365-iqdi99pd	495	7	1-yr	1-yr	CD
cord-015365-iqdi99pd	495	8	adjusted	adjust	VBN
cord-015365-iqdi99pd	495	9	mean	mean	JJ
cord-015365-iqdi99pd	495	10	change	change	NN
cord-015365-iqdi99pd	495	11	from	from	IN
cord-015365-iqdi99pd	495	12	baseline	baseline	NN
cord-015365-iqdi99pd	495	13	in	in	IN
cord-015365-iqdi99pd	495	14	CLcr	CLcr	NNP
cord-015365-iqdi99pd	495	15	was	be	VBD
cord-015365-iqdi99pd	495	16	þ	þ	NNP
cord-015365-iqdi99pd	495	17	4.0	4.0	CD
cord-015365-iqdi99pd	495	18	and	and	CC
cord-015365-iqdi99pd	495	19	À1.2	À1.2	NNP
cord-015365-iqdi99pd	495	20	mL	mL	NNP
cord-015365-iqdi99pd	495	21	/	/	SYM
cord-015365-iqdi99pd	495	22	min/	min/	NNP
cord-015365-iqdi99pd	495	23	1.73	1.73	CD
cord-015365-iqdi99pd	495	24	m	m	NN
cord-015365-iqdi99pd	495	25	2	2	CD
cord-015365-iqdi99pd	495	26	for	for	IN
cord-015365-iqdi99pd	495	27	SRL	SRL	NNP
cord-015365-iqdi99pd	495	28	vs.	vs.	IN
cord-015365-iqdi99pd	495	29	CNI	CNI	NNP
cord-015365-iqdi99pd	495	30	,	,	,
cord-015365-iqdi99pd	495	31	respectively	respectively	RB
cord-015365-iqdi99pd	495	32	(	(	-LRB-
cord-015365-iqdi99pd	495	33	p	p	NN
cord-015365-iqdi99pd	495	34	<	<	XX
cord-015365-iqdi99pd	495	35	0.001	0.001	CD
cord-015365-iqdi99pd	495	36	)	)	-RRB-
cord-015365-iqdi99pd	495	37	;	;	:
cord-015365-iqdi99pd	495	38	for	for	IN
cord-015365-iqdi99pd	495	39	the	the	DT
cord-015365-iqdi99pd	495	40	OT	OT	NNP
cord-015365-iqdi99pd	495	41	analysis	analysis	NN
cord-015365-iqdi99pd	495	42	,	,	,
cord-015365-iqdi99pd	495	43	values	value	NNS
cord-015365-iqdi99pd	495	44	were	be	VBD
cord-015365-iqdi99pd	495	45	þ4.7	þ4.7	JJ
cord-015365-iqdi99pd	495	46	and	and	CC
cord-015365-iqdi99pd	495	47	À2.1	À2.1	NNP
cord-015365-iqdi99pd	495	48	,	,	,
cord-015365-iqdi99pd	495	49	respectively	respectively	RB
cord-015365-iqdi99pd	495	50	(	(	-LRB-
cord-015365-iqdi99pd	495	51	p	p	NN
cord-015365-iqdi99pd	495	52	<	<	XX
cord-015365-iqdi99pd	495	53	0.001	0.001	CD
cord-015365-iqdi99pd	495	54	)	)	-RRB-
cord-015365-iqdi99pd	495	55	.	.	.
cord-015365-iqdi99pd	496	1	AR	AR	NNP
cord-015365-iqdi99pd	496	2	rates	rate	NNS
cord-015365-iqdi99pd	496	3	were	be	VBD
cord-015365-iqdi99pd	496	4	numerically	numerically	RB
cord-015365-iqdi99pd	496	5	higher	high	JJR
cord-015365-iqdi99pd	496	6	in	in	IN
cord-015365-iqdi99pd	496	7	the	the	DT
cord-015365-iqdi99pd	496	8	SRL	SRL	NNP
cord-015365-iqdi99pd	496	9	group	group	NN
cord-015365-iqdi99pd	496	10	;	;	:
cord-015365-iqdi99pd	496	11	there	there	EX
cord-015365-iqdi99pd	496	12	was	be	VBD
cord-015365-iqdi99pd	496	13	1	1	CD
cord-015365-iqdi99pd	496	14	AR	AR	NNP
cord-015365-iqdi99pd	496	15	with	with	IN
cord-015365-iqdi99pd	496	16	hemodynamic	hemodynamic	JJ
cord-015365-iqdi99pd	496	17	compromise	compromise	NN
cord-015365-iqdi99pd	496	18	in	in	IN
cord-015365-iqdi99pd	496	19	each	each	DT
cord-015365-iqdi99pd	496	20	group	group	NN
cord-015365-iqdi99pd	496	21	.	.	.
cord-015365-iqdi99pd	497	1	A	a	DT
cord-015365-iqdi99pd	497	2	significantly	significantly	RB
cord-015365-iqdi99pd	497	3	higher	high	JJR
cord-015365-iqdi99pd	497	4	(	(	-LRB-
cord-015365-iqdi99pd	497	5	33.3	33.3	CD
cord-015365-iqdi99pd	497	6	%	%	NN
cord-015365-iqdi99pd	497	7	vs.	vs.	CC
cord-015365-iqdi99pd	497	8	0	0	CD
cord-015365-iqdi99pd	497	9	%	%	NN
cord-015365-iqdi99pd	497	10	;	;	:
cord-015365-iqdi99pd	497	11	p	p	NN
cord-015365-iqdi99pd	497	12	<	<	XX
cord-015365-iqdi99pd	497	13	0.001	0.001	CD
cord-015365-iqdi99pd	497	14	)	)	-RRB-
cord-015365-iqdi99pd	497	15	treatment	treatment	NN
cord-015365-iqdi99pd	497	16	discontinuation	discontinuation	NN
cord-015365-iqdi99pd	497	17	rate	rate	NN
cord-015365-iqdi99pd	497	18	due	due	IN
cord-015365-iqdi99pd	497	19	to	to	IN
cord-015365-iqdi99pd	497	20	AEs	AEs	NNP
cord-015365-iqdi99pd	497	21	was	be	VBD
cord-015365-iqdi99pd	497	22	seen	see	VBN
cord-015365-iqdi99pd	497	23	in	in	IN
cord-015365-iqdi99pd	497	24	the	the	DT
cord-015365-iqdi99pd	497	25	SRL	SRL	NNP
cord-015365-iqdi99pd	497	26	group	group	NN
cord-015365-iqdi99pd	497	27	.	.	.
cord-015365-iqdi99pd	498	1	Most	Most	JJS
cord-015365-iqdi99pd	498	2	common	common	JJ
cord-015365-iqdi99pd	498	3	treatment	treatment	NN
cord-015365-iqdi99pd	498	4	-	-	HYPH
cord-015365-iqdi99pd	498	5	emergent	emergent	JJ
cord-015365-iqdi99pd	498	6	AEs	ae	NNS
cord-015365-iqdi99pd	498	7	that	that	WDT
cord-015365-iqdi99pd	498	8	were	be	VBD
cord-015365-iqdi99pd	498	9	significantly	significantly	RB
cord-015365-iqdi99pd	498	10	higher	high	JJR
cord-015365-iqdi99pd	498	11	in	in	IN
cord-015365-iqdi99pd	498	12	the	the	DT
cord-015365-iqdi99pd	498	13	SRL	SRL	NNP
cord-015365-iqdi99pd	498	14	group	group	NN
cord-015365-iqdi99pd	498	15	were	be	VBD
cord-015365-iqdi99pd	498	16	diarrhea	diarrhea	JJ
cord-015365-iqdi99pd	498	17	(	(	-LRB-
cord-015365-iqdi99pd	498	18	28.1	28.1	CD
cord-015365-iqdi99pd	498	19	%	%	NN
cord-015365-iqdi99pd	498	20	)	)	-RRB-
cord-015365-iqdi99pd	498	21	,	,	,
cord-015365-iqdi99pd	498	22	rash	rash	JJ
cord-015365-iqdi99pd	498	23	(	(	-LRB-
cord-015365-iqdi99pd	498	24	28.1	28.1	CD
cord-015365-iqdi99pd	498	25	%	%	NN
cord-015365-iqdi99pd	498	26	)	)	-RRB-
cord-015365-iqdi99pd	498	27	and	and	CC
cord-015365-iqdi99pd	498	28	infections	infection	NNS
cord-015365-iqdi99pd	498	29	(	(	-LRB-
cord-015365-iqdi99pd	498	30	47.4	47.4	CD
cord-015365-iqdi99pd	498	31	%	%	NN
cord-015365-iqdi99pd	498	32	)	)	-RRB-
cord-015365-iqdi99pd	498	33	.	.	.
cord-015365-iqdi99pd	499	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	499	2	.	.	.
cord-015365-iqdi99pd	500	1	Conversion	conversion	NN
cord-015365-iqdi99pd	500	2	to	to	IN
cord-015365-iqdi99pd	500	3	SRL	SRL	NNP
cord-015365-iqdi99pd	500	4	from	from	IN
cord-015365-iqdi99pd	500	5	CNI	CNI	NNP
cord-015365-iqdi99pd	500	6	therapy	therapy	NN
cord-015365-iqdi99pd	500	7	resulted	result	VBD
cord-015365-iqdi99pd	500	8	in	in	IN
cord-015365-iqdi99pd	500	9	improved	improved	JJ
cord-015365-iqdi99pd	500	10	renal	renal	JJ
cord-015365-iqdi99pd	500	11	function	function	NN
cord-015365-iqdi99pd	500	12	in	in	IN
cord-015365-iqdi99pd	500	13	cardiac	cardiac	JJ
cord-015365-iqdi99pd	500	14	transplant	transplant	NN
cord-015365-iqdi99pd	500	15	recipients	recipient	NNS
cord-015365-iqdi99pd	500	16	with	with	IN
cord-015365-iqdi99pd	500	17	renal	renal	JJ
cord-015365-iqdi99pd	500	18	insufficiency	insufficiency	NN
cord-015365-iqdi99pd	500	19	,	,	,
cord-015365-iqdi99pd	500	20	but	but	CC
cord-015365-iqdi99pd	500	21	was	be	VBD
cord-015365-iqdi99pd	500	22	associated	associate	VBN
cord-015365-iqdi99pd	500	23	with	with	IN
cord-015365-iqdi99pd	500	24	an	an	DT
cord-015365-iqdi99pd	500	25	attendant	attendant	NN
cord-015365-iqdi99pd	500	26	AR	AR	NNP
cord-015365-iqdi99pd	500	27	risk	risk	NN
cord-015365-iqdi99pd	500	28	and	and	CC
cord-015365-iqdi99pd	500	29	higher	high	JJR
cord-015365-iqdi99pd	500	30	discontinuation	discontinuation	NN
cord-015365-iqdi99pd	500	31	rate	rate	NN
cord-015365-iqdi99pd	500	32	due	due	IN
cord-015365-iqdi99pd	500	33	to	to	IN
cord-015365-iqdi99pd	500	34	AEs	AEs	NNP
cord-015365-iqdi99pd	500	35	.	.	.
cord-015365-iqdi99pd	501	1	Background	background	NN
cord-015365-iqdi99pd	501	2	.	.	.
cord-015365-iqdi99pd	502	1	ATG	ATG	NNP
cord-015365-iqdi99pd	502	2	-	-	HYPH
cord-015365-iqdi99pd	502	3	induction	induction	NN
cord-015365-iqdi99pd	502	4	therapy	therapy	NN
cord-015365-iqdi99pd	502	5	after	after	IN
cord-015365-iqdi99pd	502	6	heart	heart	NN
cord-015365-iqdi99pd	502	7	transplantation	transplantation	NN
cord-015365-iqdi99pd	502	8	is	be	VBZ
cord-015365-iqdi99pd	502	9	still	still	RB
cord-015365-iqdi99pd	502	10	controversial	controversial	JJ
cord-015365-iqdi99pd	502	11	and	and	CC
cord-015365-iqdi99pd	502	12	used	use	VBN
cord-015365-iqdi99pd	502	13	only	only	RB
cord-015365-iqdi99pd	502	14	by	by	IN
cord-015365-iqdi99pd	502	15	less	less	JJR
cord-015365-iqdi99pd	502	16	than	than	IN
cord-015365-iqdi99pd	502	17	50	50	CD
cord-015365-iqdi99pd	502	18	%	%	NN
cord-015365-iqdi99pd	502	19	of	of	IN
cord-015365-iqdi99pd	502	20	centers	center	NNS
cord-015365-iqdi99pd	502	21	.	.	.
cord-015365-iqdi99pd	503	1	Moreover	moreover	RB
cord-015365-iqdi99pd	503	2	,	,	,
cord-015365-iqdi99pd	503	3	there	there	EX
cord-015365-iqdi99pd	503	4	exist	exist	VBP
cord-015365-iqdi99pd	503	5	no	no	DT
cord-015365-iqdi99pd	503	6	data	datum	NNS
cord-015365-iqdi99pd	503	7	about	about	IN
cord-015365-iqdi99pd	503	8	the	the	DT
cord-015365-iqdi99pd	503	9	optimal	optimal	JJ
cord-015365-iqdi99pd	503	10	dosage	dosage	NN
cord-015365-iqdi99pd	503	11	of	of	IN
cord-015365-iqdi99pd	503	12	ATG	ATG	NNP
cord-015365-iqdi99pd	503	13	-	-	HYPH
cord-015365-iqdi99pd	503	14	induction	induction	NN
cord-015365-iqdi99pd	503	15	.	.	.
cord-015365-iqdi99pd	504	1	The	the	DT
cord-015365-iqdi99pd	504	2	aim	aim	NN
cord-015365-iqdi99pd	504	3	of	of	IN
cord-015365-iqdi99pd	504	4	this	this	DT
cord-015365-iqdi99pd	504	5	study	study	NN
cord-015365-iqdi99pd	504	6	is	be	VBZ
cord-015365-iqdi99pd	504	7	to	to	TO
cord-015365-iqdi99pd	504	8	compare	compare	VB
cord-015365-iqdi99pd	504	9	different	different	JJ
cord-015365-iqdi99pd	504	10	doses	dose	NNS
cord-015365-iqdi99pd	504	11	of	of	IN
cord-015365-iqdi99pd	504	12	ATG	ATG	NNP
cord-015365-iqdi99pd	504	13	-	-	HYPH
cord-015365-iqdi99pd	504	14	induction	induction	NN
cord-015365-iqdi99pd	504	15	.	.	.
cord-015365-iqdi99pd	505	1	Methods	method	NNS
cord-015365-iqdi99pd	505	2	.	.	.
cord-015365-iqdi99pd	506	1	Between	between	IN
cord-015365-iqdi99pd	506	2	1996	1996	CD
cord-015365-iqdi99pd	506	3	and	and	CC
cord-015365-iqdi99pd	506	4	2009	2009	CD
cord-015365-iqdi99pd	506	5	586	586	CD
cord-015365-iqdi99pd	506	6	cardiac	cardiac	JJ
cord-015365-iqdi99pd	506	7	transplants	transplant	NNS
cord-015365-iqdi99pd	506	8	were	be	VBD
cord-015365-iqdi99pd	506	9	performed	perform	VBN
cord-015365-iqdi99pd	506	10	in	in	IN
cord-015365-iqdi99pd	506	11	our	-PRON-	PRP$
cord-015365-iqdi99pd	506	12	center	center	NN
cord-015365-iqdi99pd	506	13	.	.	.
cord-015365-iqdi99pd	507	1	523	523	CD
cord-015365-iqdi99pd	507	2	(	(	-LRB-
cord-015365-iqdi99pd	507	3	89	89	CD
cord-015365-iqdi99pd	507	4	%	%	NN
cord-015365-iqdi99pd	507	5	)	)	-RRB-
cord-015365-iqdi99pd	507	6	patients	patient	NNS
cord-015365-iqdi99pd	507	7	with	with	IN
cord-015365-iqdi99pd	507	8	full	full	JJ
cord-015365-iqdi99pd	507	9	data	data	NN
cord-015365-iqdi99pd	507	10	sets	set	NNS
cord-015365-iqdi99pd	507	11	were	be	VBD
cord-015365-iqdi99pd	507	12	included	include	VBN
cord-015365-iqdi99pd	507	13	in	in	IN
cord-015365-iqdi99pd	507	14	the	the	DT
cord-015365-iqdi99pd	507	15	analysis	analysis	NN
cord-015365-iqdi99pd	507	16	.	.	.
cord-015365-iqdi99pd	508	1	The	the	DT
cord-015365-iqdi99pd	508	2	median	median	JJ
cord-015365-iqdi99pd	508	3	age	age	NN
cord-015365-iqdi99pd	508	4	was	be	VBD
cord-015365-iqdi99pd	508	5	56	56	CD
cord-015365-iqdi99pd	508	6	years	year	NNS
cord-015365-iqdi99pd	508	7	,	,	,
cord-015365-iqdi99pd	508	8	21	21	CD
cord-015365-iqdi99pd	508	9	%	%	NN
cord-015365-iqdi99pd	508	10	(	(	-LRB-
cord-015365-iqdi99pd	508	11	n	n	NN
cord-015365-iqdi99pd	508	12	¼	¼	NNP
cord-015365-iqdi99pd	508	13	112	112	CD
cord-015365-iqdi99pd	508	14	)	)	-RRB-
cord-015365-iqdi99pd	508	15	were	be	VBD
cord-015365-iqdi99pd	508	16	female	female	JJ
cord-015365-iqdi99pd	508	17	.	.	.
cord-015365-iqdi99pd	509	1	The	the	DT
cord-015365-iqdi99pd	509	2	median	median	JJ
cord-015365-iqdi99pd	509	3	follow	follow	NN
cord-015365-iqdi99pd	509	4	-	-	HYPH
cord-015365-iqdi99pd	509	5	up	up	NN
cord-015365-iqdi99pd	509	6	-	-	HYPH
cord-015365-iqdi99pd	509	7	time	time	NN
cord-015365-iqdi99pd	509	8	was	be	VBD
cord-015365-iqdi99pd	509	9	98	98	CD
cord-015365-iqdi99pd	509	10	months	month	NNS
cord-015365-iqdi99pd	509	11	.	.	.
cord-015365-iqdi99pd	510	1	Patients	patient	NNS
cord-015365-iqdi99pd	510	2	were	be	VBD
cord-015365-iqdi99pd	510	3	divided	divide	VBN
cord-015365-iqdi99pd	510	4	into	into	IN
cord-015365-iqdi99pd	510	5	3	3	CD
cord-015365-iqdi99pd	510	6	different	different	JJ
cord-015365-iqdi99pd	510	7	groups	group	NNS
cord-015365-iqdi99pd	510	8	according	accord	VBG
cord-015365-iqdi99pd	510	9	to	to	IN
cord-015365-iqdi99pd	510	10	total	total	JJ
cord-015365-iqdi99pd	510	11	ATG	ATG	NNP
cord-015365-iqdi99pd	510	12	dose	dose	NN
cord-015365-iqdi99pd	510	13	:	:	:
cord-015365-iqdi99pd	510	14	Group	Group	NNP
cord-015365-iqdi99pd	510	15	A	A	NNP
cord-015365-iqdi99pd	510	16	:	:	:
cord-015365-iqdi99pd	510	17	¼	¼	CD
cord-015365-iqdi99pd	510	18	4.5	4.5	CD
cord-015365-iqdi99pd	510	19	mg	mg	NNP
cord-015365-iqdi99pd	510	20	/	/	SYM
cord-015365-iqdi99pd	510	21	kg	kg	NNP
cord-015365-iqdi99pd	510	22	vs.	vs.	IN
cord-015365-iqdi99pd	510	23	Group	Group	NNP
cord-015365-iqdi99pd	510	24	B	B	NNP
cord-015365-iqdi99pd	510	25	:	:	:
cord-015365-iqdi99pd	510	26	4.5	4.5	CD
cord-015365-iqdi99pd	510	27	-	-	SYM
cord-015365-iqdi99pd	510	28	7.5	7.5	CD
cord-015365-iqdi99pd	510	29	mg/	mg/	NN
cord-015365-iqdi99pd	510	30	kg	kg	NNP
cord-015365-iqdi99pd	510	31	vs.	vs.	IN
cord-015365-iqdi99pd	510	32	Group	Group	NNP
cord-015365-iqdi99pd	510	33	C	C	NNP
cord-015365-iqdi99pd	510	34	:	:	:
cord-015365-iqdi99pd	510	35	>	>	XX
cord-015365-iqdi99pd	510	36	7.5	7.5	CD
cord-015365-iqdi99pd	510	37	mg	mg	NNP
cord-015365-iqdi99pd	510	38	/	/	SYM
cord-015365-iqdi99pd	510	39	kg	kg	NN
cord-015365-iqdi99pd	510	40	.	.	.
cord-015365-iqdi99pd	511	1	Survival	survival	NN
cord-015365-iqdi99pd	511	2	,	,	,
cord-015365-iqdi99pd	511	3	incidence	incidence	NN
cord-015365-iqdi99pd	511	4	of	of	IN
cord-015365-iqdi99pd	511	5	rejection	rejection	NN
cord-015365-iqdi99pd	511	6	,	,	,
cord-015365-iqdi99pd	511	7	infection	infection	NN
cord-015365-iqdi99pd	511	8	,	,	,
cord-015365-iqdi99pd	511	9	graft	graft	NN
cord-015365-iqdi99pd	511	10	vasculopathy	vasculopathy	NNP
cord-015365-iqdi99pd	511	11	and	and	CC
cord-015365-iqdi99pd	511	12	cancer	cancer	NN
cord-015365-iqdi99pd	511	13	were	be	VBD
cord-015365-iqdi99pd	511	14	compared	compare	VBN
cord-015365-iqdi99pd	511	15	by	by	IN
cord-015365-iqdi99pd	511	16	Kaplan	Kaplan	NNP
cord-015365-iqdi99pd	511	17	-	-	HYPH
cord-015365-iqdi99pd	511	18	Meier	Meier	NNP
cord-015365-iqdi99pd	511	19	-	-	HYPH
cord-015365-iqdi99pd	511	20	analyses	analysis	NNS
cord-015365-iqdi99pd	511	21	(	(	-LRB-
cord-015365-iqdi99pd	511	22	log	log	NN
cord-015365-iqdi99pd	511	23	rank	rank	NN
cord-015365-iqdi99pd	511	24	test	test	NN
cord-015365-iqdi99pd	511	25	)	)	-RRB-
cord-015365-iqdi99pd	511	26	.	.	.
cord-015365-iqdi99pd	512	1	Results	result	NNS
cord-015365-iqdi99pd	512	2	.	.	.
cord-015365-iqdi99pd	513	1	There	there	EX
cord-015365-iqdi99pd	513	2	was	be	VBD
cord-015365-iqdi99pd	513	3	better	well	JJR
cord-015365-iqdi99pd	513	4	early	early	JJ
cord-015365-iqdi99pd	513	5	(	(	-LRB-
cord-015365-iqdi99pd	513	6	12	12	CD
cord-015365-iqdi99pd	513	7	m	m	NN
cord-015365-iqdi99pd	513	8	)	)	-RRB-
cord-015365-iqdi99pd	513	9	and	and	CC
cord-015365-iqdi99pd	513	10	late	late	JJ
cord-015365-iqdi99pd	513	11	(	(	-LRB-
cord-015365-iqdi99pd	513	12	150	150	CD
cord-015365-iqdi99pd	513	13	m	m	NN
cord-015365-iqdi99pd	513	14	)	)	-RRB-
cord-015365-iqdi99pd	513	15	survival	survival	NN
cord-015365-iqdi99pd	513	16	in	in	IN
cord-015365-iqdi99pd	513	17	Group	Group	NNP
cord-015365-iqdi99pd	513	18	B	B	NNP
cord-015365-iqdi99pd	513	19	(	(	-LRB-
cord-015365-iqdi99pd	513	20	A	a	NN
cord-015365-iqdi99pd	513	21	:	:	:
cord-015365-iqdi99pd	513	22	80	80	CD
cord-015365-iqdi99pd	513	23	%	%	NN
cord-015365-iqdi99pd	513	24	,	,	,
cord-015365-iqdi99pd	513	25	43	43	CD
cord-015365-iqdi99pd	513	26	%	%	NN
cord-015365-iqdi99pd	513	27	;	;	:
cord-015365-iqdi99pd	513	28	B	b	NN
cord-015365-iqdi99pd	513	29	:	:	:
cord-015365-iqdi99pd	513	30	90	90	CD
cord-015365-iqdi99pd	513	31	%	%	NN
cord-015365-iqdi99pd	513	32	,	,	,
cord-015365-iqdi99pd	513	33	65	65	CD
cord-015365-iqdi99pd	513	34	%	%	NN
cord-015365-iqdi99pd	513	35	;	;	:
cord-015365-iqdi99pd	513	36	C	c	NN
cord-015365-iqdi99pd	513	37	:	:	:
cord-015365-iqdi99pd	513	38	88	88	CD
cord-015365-iqdi99pd	513	39	%	%	NN
cord-015365-iqdi99pd	513	40	,	,	,
cord-015365-iqdi99pd	513	41	58	58	CD
cord-015365-iqdi99pd	513	42	%	%	NN
cord-015365-iqdi99pd	513	43	;	;	:
cord-015365-iqdi99pd	513	44	p	p	NN
cord-015365-iqdi99pd	513	45	¼	¼	NNP
cord-015365-iqdi99pd	513	46	n.s	n.s	NNP
cord-015365-iqdi99pd	513	47	.	.	NNP
cord-015365-iqdi99pd	513	48	)	)	-RRB-
cord-015365-iqdi99pd	513	49	,	,	,
cord-015365-iqdi99pd	513	50	however	however	RB
cord-015365-iqdi99pd	513	51	,	,	,
cord-015365-iqdi99pd	513	52	the	the	DT
cord-015365-iqdi99pd	513	53	difference	difference	NN
cord-015365-iqdi99pd	513	54	was	be	VBD
cord-015365-iqdi99pd	513	55	not	not	RB
cord-015365-iqdi99pd	513	56	significant	significant	JJ
cord-015365-iqdi99pd	513	57	.	.	.
cord-015365-iqdi99pd	514	1	Freedom	freedom	NN
cord-015365-iqdi99pd	514	2	from	from	IN
cord-015365-iqdi99pd	514	3	treated	treat	VBN
cord-015365-iqdi99pd	514	4	acute	acute	JJ
cord-015365-iqdi99pd	514	5	rejection	rejection	NN
cord-015365-iqdi99pd	514	6	was	be	VBD
cord-015365-iqdi99pd	514	7	better	well	JJR
cord-015365-iqdi99pd	514	8	in	in	IN
cord-015365-iqdi99pd	514	9	group	group	NN
cord-015365-iqdi99pd	514	10	B	b	NN
cord-015365-iqdi99pd	514	11	(	(	-LRB-
cord-015365-iqdi99pd	514	12	88	88	CD
cord-015365-iqdi99pd	514	13	%	%	NN
cord-015365-iqdi99pd	514	14	)	)	-RRB-
cord-015365-iqdi99pd	514	15	compared	compare	VBN
cord-015365-iqdi99pd	514	16	to	to	IN
cord-015365-iqdi99pd	514	17	A	a	NN
cord-015365-iqdi99pd	514	18	and	and	CC
cord-015365-iqdi99pd	514	19	C	C	NNP
cord-015365-iqdi99pd	514	20	(	(	-LRB-
cord-015365-iqdi99pd	514	21	79	79	CD
cord-015365-iqdi99pd	514	22	%	%	NN
cord-015365-iqdi99pd	514	23	,	,	,
cord-015365-iqdi99pd	514	24	80	80	CD
cord-015365-iqdi99pd	514	25	%	%	NN
cord-015365-iqdi99pd	514	26	,	,	,
cord-015365-iqdi99pd	514	27	p	p	NN
cord-015365-iqdi99pd	514	28	¼	¼	CD
cord-015365-iqdi99pd	514	29	0.08	0.08	CD
cord-015365-iqdi99pd	514	30	)	)	-RRB-
cord-015365-iqdi99pd	514	31	.	.	.
cord-015365-iqdi99pd	515	1	Signs	sign	NNS
cord-015365-iqdi99pd	515	2	of	of	IN
cord-015365-iqdi99pd	515	3	histological	histological	JJ
cord-015365-iqdi99pd	515	4	rejection	rejection	NN
cord-015365-iqdi99pd	515	5	were	be	VBD
cord-015365-iqdi99pd	515	6	significantly	significantly	RB
cord-015365-iqdi99pd	515	7	different	different	JJ
cord-015365-iqdi99pd	515	8	between	between	IN
cord-015365-iqdi99pd	515	9	the	the	DT
cord-015365-iqdi99pd	515	10	groups	group	NNS
cord-015365-iqdi99pd	515	11	(	(	-LRB-
cord-015365-iqdi99pd	515	12	A	a	NN
cord-015365-iqdi99pd	515	13	:	:	:
cord-015365-iqdi99pd	515	14	25	25	CD
cord-015365-iqdi99pd	515	15	%	%	NN
cord-015365-iqdi99pd	515	16	,	,	,
cord-015365-iqdi99pd	515	17	B	b	NN
cord-015365-iqdi99pd	515	18	:	:	:
cord-015365-iqdi99pd	515	19	18	18	CD
cord-015365-iqdi99pd	515	20	%	%	NN
cord-015365-iqdi99pd	515	21	,	,	,
cord-015365-iqdi99pd	515	22	C	c	NN
cord-015365-iqdi99pd	515	23	:	:	:
cord-015365-iqdi99pd	515	24	33	33	CD
cord-015365-iqdi99pd	515	25	%	%	NN
cord-015365-iqdi99pd	515	26	;	;	:
cord-015365-iqdi99pd	515	27	p	p	NN
cord-015365-iqdi99pd	515	28	¼	¼	CD
cord-015365-iqdi99pd	515	29	0.03	0.03	CD
cord-015365-iqdi99pd	515	30	)	)	-RRB-
cord-015365-iqdi99pd	515	31	.	.	.
cord-015365-iqdi99pd	516	1	Group	Group	NNP
cord-015365-iqdi99pd	516	2	B	B	NNP
cord-015365-iqdi99pd	516	3	had	have	VBD
cord-015365-iqdi99pd	516	4	the	the	DT
cord-015365-iqdi99pd	516	5	lowest	low	JJS
cord-015365-iqdi99pd	516	6	incidence	incidence	NN
cord-015365-iqdi99pd	516	7	of	of	IN
cord-015365-iqdi99pd	516	8	severe	severe	JJ
cord-015365-iqdi99pd	516	9	infection	infection	NN
cord-015365-iqdi99pd	516	10	(	(	-LRB-
cord-015365-iqdi99pd	516	11	A	a	NN
cord-015365-iqdi99pd	516	12	:	:	:
cord-015365-iqdi99pd	516	13	37	37	CD
cord-015365-iqdi99pd	516	14	%	%	NN
cord-015365-iqdi99pd	516	15	,	,	,
cord-015365-iqdi99pd	516	16	B	b	NN
cord-015365-iqdi99pd	516	17	:	:	:
cord-015365-iqdi99pd	516	18	21	21	CD
cord-015365-iqdi99pd	516	19	%	%	NN
cord-015365-iqdi99pd	516	20	,	,	,
cord-015365-iqdi99pd	516	21	C	c	NN
cord-015365-iqdi99pd	516	22	:	:	:
cord-015365-iqdi99pd	516	23	51	51	CD
cord-015365-iqdi99pd	516	24	%	%	NN
cord-015365-iqdi99pd	516	25	;	;	:
cord-015365-iqdi99pd	516	26	p	p	NN
cord-015365-iqdi99pd	516	27	<	<	XX
cord-015365-iqdi99pd	516	28	0.01	0.01	CD
cord-015365-iqdi99pd	516	29	)	)	-RRB-
cord-015365-iqdi99pd	516	30	.	.	.
cord-015365-iqdi99pd	517	1	CMV	CMV	NNP
cord-015365-iqdi99pd	517	2	infection	infection	NN
cord-015365-iqdi99pd	517	3	incidence	incidence	NN
cord-015365-iqdi99pd	517	4	was	be	VBD
cord-015365-iqdi99pd	517	5	higher	high	JJR
cord-015365-iqdi99pd	517	6	in	in	IN
cord-015365-iqdi99pd	517	7	group	group	NN
cord-015365-iqdi99pd	517	8	C	C	NNP
cord-015365-iqdi99pd	517	9	(	(	-LRB-
cord-015365-iqdi99pd	517	10	35	35	CD
cord-015365-iqdi99pd	517	11	%	%	NN
cord-015365-iqdi99pd	517	12	)	)	-RRB-
cord-015365-iqdi99pd	517	13	compared	compare	VBN
cord-015365-iqdi99pd	517	14	to	to	IN
cord-015365-iqdi99pd	517	15	groups	group	NNS
cord-015365-iqdi99pd	517	16	A	A	NNP
cord-015365-iqdi99pd	517	17	,	,	,
cord-015365-iqdi99pd	517	18	B	b	NN
cord-015365-iqdi99pd	517	19	(	(	-LRB-
cord-015365-iqdi99pd	517	20	20	20	CD
cord-015365-iqdi99pd	517	21	%	%	NN
cord-015365-iqdi99pd	517	22	,	,	,
cord-015365-iqdi99pd	517	23	23	23	CD
cord-015365-iqdi99pd	517	24	%	%	NN
cord-015365-iqdi99pd	517	25	;	;	:
cord-015365-iqdi99pd	517	26	p	p	NN
cord-015365-iqdi99pd	517	27	<	<	XX
cord-015365-iqdi99pd	517	28	0.01	0.01	CD
cord-015365-iqdi99pd	517	29	)	)	-RRB-
cord-015365-iqdi99pd	517	30	.	.	.
cord-015365-iqdi99pd	518	1	There	there	EX
cord-015365-iqdi99pd	518	2	was	be	VBD
cord-015365-iqdi99pd	518	3	no	no	DT
cord-015365-iqdi99pd	518	4	significant	significant	JJ
cord-015365-iqdi99pd	518	5	difference	difference	NN
cord-015365-iqdi99pd	518	6	in	in	IN
cord-015365-iqdi99pd	518	7	freedom	freedom	NN
cord-015365-iqdi99pd	518	8	from	from	IN
cord-015365-iqdi99pd	518	9	graft	graft	NN
cord-015365-iqdi99pd	518	10	vasculopathy	vasculopathy	NNP
cord-015365-iqdi99pd	518	11	between	between	IN
cord-015365-iqdi99pd	518	12	the	the	DT
cord-015365-iqdi99pd	518	13	groups	group	NNS
cord-015365-iqdi99pd	518	14	(	(	-LRB-
cord-015365-iqdi99pd	518	15	A	a	NN
cord-015365-iqdi99pd	518	16	:	:	:
cord-015365-iqdi99pd	518	17	91	91	CD
cord-015365-iqdi99pd	518	18	%	%	NN
cord-015365-iqdi99pd	518	19	,	,	,
cord-015365-iqdi99pd	518	20	B	b	NN
cord-015365-iqdi99pd	518	21	:	:	:
cord-015365-iqdi99pd	518	22	85	85	CD
cord-015365-iqdi99pd	518	23	%	%	NN
cord-015365-iqdi99pd	518	24	,	,	,
cord-015365-iqdi99pd	518	25	C	c	NN
cord-015365-iqdi99pd	518	26	:	:	:
cord-015365-iqdi99pd	518	27	79	79	CD
cord-015365-iqdi99pd	518	28	%	%	NN
cord-015365-iqdi99pd	518	29	;	;	:
cord-015365-iqdi99pd	518	30	p	p	NN
cord-015365-iqdi99pd	518	31	¼	¼	NNP
cord-015365-iqdi99pd	518	32	n.s	n.s	NNP
cord-015365-iqdi99pd	518	33	.	.	NNP
cord-015365-iqdi99pd	518	34	)	)	-RRB-
cord-015365-iqdi99pd	518	35	.	.	.
cord-015365-iqdi99pd	519	1	The	the	DT
cord-015365-iqdi99pd	519	2	incidence	incidence	NN
cord-015365-iqdi99pd	519	3	of	of	IN
cord-015365-iqdi99pd	519	4	cancer	cancer	NN
cord-015365-iqdi99pd	519	5	was	be	VBD
cord-015365-iqdi99pd	519	6	similar	similar	JJ
cord-015365-iqdi99pd	519	7	in	in	IN
cord-015365-iqdi99pd	519	8	all	all	DT
cord-015365-iqdi99pd	519	9	ATG	ATG	NNP
cord-015365-iqdi99pd	519	10	groups	group	NNS
cord-015365-iqdi99pd	519	11	(	(	-LRB-
cord-015365-iqdi99pd	519	12	A	a	NN
cord-015365-iqdi99pd	519	13	:	:	:
cord-015365-iqdi99pd	519	14	3	3	CD
cord-015365-iqdi99pd	519	15	%	%	NN
cord-015365-iqdi99pd	519	16	,	,	,
cord-015365-iqdi99pd	519	17	B	b	NN
cord-015365-iqdi99pd	519	18	:	:	:
cord-015365-iqdi99pd	519	19	7	7	CD
cord-015365-iqdi99pd	519	20	%	%	NN
cord-015365-iqdi99pd	519	21	,	,	,
cord-015365-iqdi99pd	519	22	C	c	NN
cord-015365-iqdi99pd	519	23	:	:	:
cord-015365-iqdi99pd	519	24	11	11	CD
cord-015365-iqdi99pd	519	25	%	%	NN
cord-015365-iqdi99pd	519	26	;	;	:
cord-015365-iqdi99pd	519	27	p	p	NN
cord-015365-iqdi99pd	519	28	¼	¼	NNP
cord-015365-iqdi99pd	519	29	n.s	n.s	NNP
cord-015365-iqdi99pd	519	30	.	.	NNP
cord-015365-iqdi99pd	519	31	)	)	-RRB-
cord-015365-iqdi99pd	519	32	.	.	.
cord-015365-iqdi99pd	520	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	520	2	.	.	.
cord-015365-iqdi99pd	521	1	Different	different	JJ
cord-015365-iqdi99pd	521	2	doses	dose	NNS
cord-015365-iqdi99pd	521	3	of	of	IN
cord-015365-iqdi99pd	521	4	ATG	ATG	NNP
cord-015365-iqdi99pd	521	5	-	-	HYPH
cord-015365-iqdi99pd	521	6	induction	induction	NN
cord-015365-iqdi99pd	521	7	seem	seem	VBP
cord-015365-iqdi99pd	521	8	to	to	TO
cord-015365-iqdi99pd	521	9	have	have	VB
cord-015365-iqdi99pd	521	10	a	a	DT
cord-015365-iqdi99pd	521	11	significant	significant	JJ
cord-015365-iqdi99pd	521	12	impact	impact	NN
cord-015365-iqdi99pd	521	13	on	on	IN
cord-015365-iqdi99pd	521	14	the	the	DT
cord-015365-iqdi99pd	521	15	outcome	outcome	NN
cord-015365-iqdi99pd	521	16	of	of	IN
cord-015365-iqdi99pd	521	17	heart	heart	NN
cord-015365-iqdi99pd	521	18	transplantation	transplantation	NN
cord-015365-iqdi99pd	521	19	.	.	.
cord-015365-iqdi99pd	522	1	There	there	EX
cord-015365-iqdi99pd	522	2	is	be	VBZ
cord-015365-iqdi99pd	522	3	a	a	DT
cord-015365-iqdi99pd	522	4	strong	strong	JJ
cord-015365-iqdi99pd	522	5	need	need	NN
cord-015365-iqdi99pd	522	6	for	for	IN
cord-015365-iqdi99pd	522	7	more	more	JJR
cord-015365-iqdi99pd	522	8	studies	study	NNS
cord-015365-iqdi99pd	522	9	on	on	IN
cord-015365-iqdi99pd	522	10	optimization	optimization	NN
cord-015365-iqdi99pd	522	11	of	of	IN
cord-015365-iqdi99pd	522	12	ATG	ATG	NNP
cord-015365-iqdi99pd	522	13	therapy	therapy	NN
cord-015365-iqdi99pd	522	14	.	.	.
cord-015365-iqdi99pd	523	1	Nighttime	nighttime	JJ
cord-015365-iqdi99pd	523	2	kidney	kidney	NN
cord-015365-iqdi99pd	523	3	transplantationa	transplantationa	NN
cord-015365-iqdi99pd	523	4	risk	risk	NN
cord-015365-iqdi99pd	523	5	or	or	CC
cord-015365-iqdi99pd	523	6	a	a	DT
cord-015365-iqdi99pd	523	7	need	need	NN
cord-015365-iqdi99pd	523	8	?	?	.
cord-015365-iqdi99pd	524	1	Background	background	NN
cord-015365-iqdi99pd	524	2	.	.	.
cord-015365-iqdi99pd	525	1	Kidney	kidney	NN
cord-015365-iqdi99pd	525	2	transplantation	transplantation	NN
cord-015365-iqdi99pd	525	3	is	be	VBZ
cord-015365-iqdi99pd	525	4	performed	perform	VBN
cord-015365-iqdi99pd	525	5	as	as	IN
cord-015365-iqdi99pd	525	6	emergency	emergency	NN
cord-015365-iqdi99pd	525	7	surgery	surgery	NN
cord-015365-iqdi99pd	525	8	also	also	RB
cord-015365-iqdi99pd	525	9	as	as	IN
cord-015365-iqdi99pd	525	10	a	a	DT
cord-015365-iqdi99pd	525	11	nighttime	nighttime	JJ
cord-015365-iqdi99pd	525	12	procedure	procedure	NN
cord-015365-iqdi99pd	525	13	to	to	TO
cord-015365-iqdi99pd	525	14	reduce	reduce	VB
cord-015365-iqdi99pd	525	15	cold	cold	JJ
cord-015365-iqdi99pd	525	16	ischemia	ischemia	NN
cord-015365-iqdi99pd	525	17	time	time	NN
cord-015365-iqdi99pd	525	18	und	und	RB
cord-015365-iqdi99pd	525	19	therefore	therefore	RB
cord-015365-iqdi99pd	525	20	improve	improve	VB
cord-015365-iqdi99pd	525	21	outcomes	outcome	NNS
cord-015365-iqdi99pd	525	22	after	after	IN
cord-015365-iqdi99pd	525	23	kidney	kidney	NN
cord-015365-iqdi99pd	525	24	transplantation	transplantation	NN
cord-015365-iqdi99pd	525	25	.	.	.
cord-015365-iqdi99pd	526	1	However	however	RB
cord-015365-iqdi99pd	526	2	,	,	,
cord-015365-iqdi99pd	526	3	surgical	surgical	JJ
cord-015365-iqdi99pd	526	4	procedures	procedure	NNS
cord-015365-iqdi99pd	526	5	performed	perform	VBN
cord-015365-iqdi99pd	526	6	during	during	IN
cord-015365-iqdi99pd	526	7	nighttime	nighttime	NN
cord-015365-iqdi99pd	526	8	in	in	IN
cord-015365-iqdi99pd	526	9	the	the	DT
cord-015365-iqdi99pd	526	10	context	context	NN
cord-015365-iqdi99pd	526	11	of	of	IN
cord-015365-iqdi99pd	526	12	24	24	CD
cord-015365-iqdi99pd	526	13	hour	hour	NN
cord-015365-iqdi99pd	526	14	shifts	shift	NNS
cord-015365-iqdi99pd	526	15	and	and	CC
cord-015365-iqdi99pd	526	16	sleep	sleep	NN
cord-015365-iqdi99pd	526	17	deprivation	deprivation	NN
cord-015365-iqdi99pd	526	18	have	have	VBP
cord-015365-iqdi99pd	526	19	been	be	VBN
cord-015365-iqdi99pd	526	20	associated	associate	VBN
cord-015365-iqdi99pd	526	21	with	with	IN
cord-015365-iqdi99pd	526	22	a	a	DT
cord-015365-iqdi99pd	526	23	higher	high	JJR
cord-015365-iqdi99pd	526	24	rate	rate	NN
cord-015365-iqdi99pd	526	25	of	of	IN
cord-015365-iqdi99pd	526	26	complications	complication	NNS
cord-015365-iqdi99pd	526	27	than	than	IN
cord-015365-iqdi99pd	526	28	elective	elective	JJ
cord-015365-iqdi99pd	526	29	surgery	surgery	NN
cord-015365-iqdi99pd	526	30	.	.	.
cord-015365-iqdi99pd	527	1	The	the	DT
cord-015365-iqdi99pd	527	2	aim	aim	NN
cord-015365-iqdi99pd	527	3	of	of	IN
cord-015365-iqdi99pd	527	4	this	this	DT
cord-015365-iqdi99pd	527	5	retrospective	retrospective	JJ
cord-015365-iqdi99pd	527	6	analysis	analysis	NN
cord-015365-iqdi99pd	527	7	is	be	VBZ
cord-015365-iqdi99pd	527	8	to	to	TO
cord-015365-iqdi99pd	527	9	determine	determine	VB
cord-015365-iqdi99pd	527	10	the	the	DT
cord-015365-iqdi99pd	527	11	impact	impact	NN
cord-015365-iqdi99pd	527	12	of	of	IN
cord-015365-iqdi99pd	527	13	nighttime	nighttime	JJ
cord-015365-iqdi99pd	527	14	surgery	surgery	NN
cord-015365-iqdi99pd	527	15	on	on	IN
cord-015365-iqdi99pd	527	16	the	the	DT
cord-015365-iqdi99pd	527	17	outcome	outcome	NN
cord-015365-iqdi99pd	527	18	after	after	IN
cord-015365-iqdi99pd	527	19	kidney	kidney	NN
cord-015365-iqdi99pd	527	20	transplantation	transplantation	NN
cord-015365-iqdi99pd	527	21	.	.	.
cord-015365-iqdi99pd	528	1	Methods	method	NNS
cord-015365-iqdi99pd	528	2	.	.	.
cord-015365-iqdi99pd	529	1	All	all	DT
cord-015365-iqdi99pd	529	2	kidney	kidney	NN
cord-015365-iqdi99pd	529	3	transplants	transplant	NNS
cord-015365-iqdi99pd	529	4	from	from	IN
cord-015365-iqdi99pd	529	5	cadaveric	cadaveric	JJ
cord-015365-iqdi99pd	529	6	donors	donor	NNS
cord-015365-iqdi99pd	529	7	performed	perform	VBN
cord-015365-iqdi99pd	529	8	at	at	IN
cord-015365-iqdi99pd	529	9	our	-PRON-	PRP$
cord-015365-iqdi99pd	529	10	center	center	NN
cord-015365-iqdi99pd	529	11	from	from	IN
cord-015365-iqdi99pd	529	12	January	January	NNP
cord-015365-iqdi99pd	529	13	2000	2000	CD
cord-015365-iqdi99pd	529	14	through	through	IN
cord-015365-iqdi99pd	529	15	January	January	NNP
cord-015365-iqdi99pd	529	16	2010	2010	CD
cord-015365-iqdi99pd	530	1	(	(	-LRB-
cord-015365-iqdi99pd	530	2	n	n	NNP
cord-015365-iqdi99pd	530	3	¼	¼	NNP
cord-015365-iqdi99pd	530	4	873	873	CD
cord-015365-iqdi99pd	530	5	)	)	-RRB-
cord-015365-iqdi99pd	530	6	were	be	VBD
cord-015365-iqdi99pd	530	7	included	include	VBN
cord-015365-iqdi99pd	530	8	in	in	IN
cord-015365-iqdi99pd	530	9	this	this	DT
cord-015365-iqdi99pd	530	10	retrospective	retrospective	JJ
cord-015365-iqdi99pd	530	11	study	study	NN
cord-015365-iqdi99pd	530	12	and	and	CC
cord-015365-iqdi99pd	530	13	grouped	grouped	VBP
cord-015365-iqdi99pd	530	14	according	accord	VBG
cord-015365-iqdi99pd	530	15	to	to	IN
cord-015365-iqdi99pd	530	16	the	the	DT
cord-015365-iqdi99pd	530	17	time	time	NN
cord-015365-iqdi99pd	530	18	of	of	IN
cord-015365-iqdi99pd	530	19	surgery	surgery	NN
cord-015365-iqdi99pd	530	20	:	:	:
cord-015365-iqdi99pd	530	21	daytime	daytime	NN
cord-015365-iqdi99pd	530	22	(	(	-LRB-
cord-015365-iqdi99pd	530	23	from	from	IN
cord-015365-iqdi99pd	530	24	8	8	CD
cord-015365-iqdi99pd	530	25	a.m.	a.m.	NN
cord-015365-iqdi99pd	530	26	to	to	IN
cord-015365-iqdi99pd	530	27	8	8	CD
cord-015365-iqdi99pd	530	28	p.m.	p.m.	NN
cord-015365-iqdi99pd	530	29	,	,	,
cord-015365-iqdi99pd	530	30	n	n	NN
cord-015365-iqdi99pd	530	31	¼	¼	NNP
cord-015365-iqdi99pd	530	32	608	608	CD
cord-015365-iqdi99pd	530	33	)	)	-RRB-
cord-015365-iqdi99pd	530	34	versus	versus	IN
cord-015365-iqdi99pd	530	35	nighttime	nighttime	NN
cord-015365-iqdi99pd	530	36	(	(	-LRB-
cord-015365-iqdi99pd	530	37	from	from	IN
cord-015365-iqdi99pd	530	38	8	8	CD
cord-015365-iqdi99pd	530	39	p.m.	p.m.	NN
cord-015365-iqdi99pd	530	40	to	to	IN
cord-015365-iqdi99pd	530	41	8	8	CD
cord-015365-iqdi99pd	530	42	a.m.	a.m.	NN
cord-015365-iqdi99pd	530	43	,	,	,
cord-015365-iqdi99pd	530	44	n	n	NN
cord-015365-iqdi99pd	530	45	¼	¼	NNP
cord-015365-iqdi99pd	530	46	265	265	CD
cord-015365-iqdi99pd	530	47	)	)	-RRB-
cord-015365-iqdi99pd	530	48	.	.	.
cord-015365-iqdi99pd	531	1	Statistical	statistical	JJ
cord-015365-iqdi99pd	531	2	analysis	analysis	NN
cord-015365-iqdi99pd	531	3	compared	compare	VBN
cord-015365-iqdi99pd	531	4	patient	patient	JJ
cord-015365-iqdi99pd	531	5	and	and	CC
cord-015365-iqdi99pd	531	6	graft	graft	NN
cord-015365-iqdi99pd	531	7	survival	survival	NN
cord-015365-iqdi99pd	531	8	in	in	IN
cord-015365-iqdi99pd	531	9	the	the	DT
cord-015365-iqdi99pd	531	10	two	two	CD
cord-015365-iqdi99pd	531	11	groups	group	NNS
cord-015365-iqdi99pd	531	12	,	,	,
cord-015365-iqdi99pd	531	13	rate	rate	NN
cord-015365-iqdi99pd	531	14	of	of	IN
cord-015365-iqdi99pd	531	15	delayed	delay	VBN
cord-015365-iqdi99pd	531	16	graft	graft	NN
cord-015365-iqdi99pd	531	17	function	function	NN
cord-015365-iqdi99pd	531	18	and	and	CC
cord-015365-iqdi99pd	531	19	acute	acute	JJ
cord-015365-iqdi99pd	531	20	rejection	rejection	NN
cord-015365-iqdi99pd	531	21	as	as	RB
cord-015365-iqdi99pd	531	22	well	well	RB
cord-015365-iqdi99pd	531	23	as	as	IN
cord-015365-iqdi99pd	531	24	surgical	surgical	JJ
cord-015365-iqdi99pd	531	25	complications	complication	NNS
cord-015365-iqdi99pd	531	26	.	.	.
cord-015365-iqdi99pd	532	1	Results	result	NNS
cord-015365-iqdi99pd	532	2	.	.	.
cord-015365-iqdi99pd	533	1	5-year	5-year	CD
cord-015365-iqdi99pd	533	2	patient	patient	NN
cord-015365-iqdi99pd	533	3	survival	survival	NN
cord-015365-iqdi99pd	533	4	rates	rate	NNS
cord-015365-iqdi99pd	533	5	of	of	IN
cord-015365-iqdi99pd	533	6	87	87	CD
cord-015365-iqdi99pd	533	7	%	%	NN
cord-015365-iqdi99pd	533	8	and	and	CC
cord-015365-iqdi99pd	533	9	85	85	CD
cord-015365-iqdi99pd	533	10	%	%	NN
cord-015365-iqdi99pd	533	11	and	and	CC
cord-015365-iqdi99pd	533	12	10-year	10-year	CD
cord-015365-iqdi99pd	533	13	patient	patient	JJ
cord-015365-iqdi99pd	533	14	survival	survival	NN
cord-015365-iqdi99pd	533	15	rates	rate	NNS
cord-015365-iqdi99pd	533	16	of	of	IN
cord-015365-iqdi99pd	533	17	73	73	CD
cord-015365-iqdi99pd	533	18	%	%	NN
cord-015365-iqdi99pd	533	19	and	and	CC
cord-015365-iqdi99pd	533	20	69	69	CD
cord-015365-iqdi99pd	533	21	%	%	NN
cord-015365-iqdi99pd	533	22	in	in	IN
cord-015365-iqdi99pd	533	23	daytime	daytime	JJ
cord-015365-iqdi99pd	533	24	and	and	CC
cord-015365-iqdi99pd	533	25	nighttime	nighttime	JJ
cord-015365-iqdi99pd	533	26	kidney	kidney	NN
cord-015365-iqdi99pd	533	27	transplants	transplant	NNS
cord-015365-iqdi99pd	533	28	did	do	VBD
cord-015365-iqdi99pd	533	29	not	not	RB
cord-015365-iqdi99pd	533	30	show	show	VB
cord-015365-iqdi99pd	533	31	any	any	DT
cord-015365-iqdi99pd	533	32	significant	significant	JJ
cord-015365-iqdi99pd	533	33	difference	difference	NN
cord-015365-iqdi99pd	533	34	.	.	.
cord-015365-iqdi99pd	534	1	Also	also	RB
cord-015365-iqdi99pd	534	2	,	,	,
cord-015365-iqdi99pd	534	3	graft	graft	NN
cord-015365-iqdi99pd	534	4	survival	survival	NN
cord-015365-iqdi99pd	534	5	at	at	IN
cord-015365-iqdi99pd	534	6	5	5	CD
cord-015365-iqdi99pd	534	7	and	and	CC
cord-015365-iqdi99pd	534	8	10	10	CD
cord-015365-iqdi99pd	534	9	years	year	NNS
cord-015365-iqdi99pd	534	10	did	do	VBD
cord-015365-iqdi99pd	534	11	not	not	RB
cord-015365-iqdi99pd	534	12	differ	differ	VB
cord-015365-iqdi99pd	534	13	significantly	significantly	RB
cord-015365-iqdi99pd	534	14	(	(	-LRB-
cord-015365-iqdi99pd	534	15	85	85	CD
cord-015365-iqdi99pd	534	16	%	%	NN
cord-015365-iqdi99pd	534	17	versus	versus	IN
cord-015365-iqdi99pd	534	18	85	85	CD
cord-015365-iqdi99pd	534	19	%	%	NN
cord-015365-iqdi99pd	534	20	and	and	CC
cord-015365-iqdi99pd	534	21	69	69	CD
cord-015365-iqdi99pd	534	22	%	%	NN
cord-015365-iqdi99pd	534	23	versus	versus	IN
cord-015365-iqdi99pd	534	24	60	60	CD
cord-015365-iqdi99pd	534	25	%	%	NN
cord-015365-iqdi99pd	534	26	)	)	-RRB-
cord-015365-iqdi99pd	534	27	in	in	IN
cord-015365-iqdi99pd	534	28	the	the	DT
cord-015365-iqdi99pd	534	29	two	two	CD
cord-015365-iqdi99pd	534	30	groups	group	NNS
cord-015365-iqdi99pd	534	31	.	.	.
cord-015365-iqdi99pd	535	1	Delayed	delay	VBN
cord-015365-iqdi99pd	535	2	graft	graft	NN
cord-015365-iqdi99pd	535	3	function	function	NN
cord-015365-iqdi99pd	535	4	occurred	occur	VBD
cord-015365-iqdi99pd	535	5	in	in	IN
cord-015365-iqdi99pd	535	6	31	31	CD
cord-015365-iqdi99pd	535	7	%	%	NN
cord-015365-iqdi99pd	535	8	of	of	IN
cord-015365-iqdi99pd	535	9	daytime	daytime	JJ
cord-015365-iqdi99pd	535	10	transplants	transplant	NNS
cord-015365-iqdi99pd	535	11	compared	compare	VBN
cord-015365-iqdi99pd	535	12	to	to	IN
cord-015365-iqdi99pd	535	13	37	37	CD
cord-015365-iqdi99pd	535	14	%	%	NN
cord-015365-iqdi99pd	535	15	of	of	IN
cord-015365-iqdi99pd	535	16	nighttime	nighttime	JJ
cord-015365-iqdi99pd	535	17	procedures	procedure	NNS
cord-015365-iqdi99pd	535	18	(	(	-LRB-
cord-015365-iqdi99pd	535	19	p	p	NN
cord-015365-iqdi99pd	535	20	¼	¼	CD
cord-015365-iqdi99pd	535	21	0.06	0.06	CD
cord-015365-iqdi99pd	535	22	)	)	-RRB-
cord-015365-iqdi99pd	535	23	.	.	.
cord-015365-iqdi99pd	536	1	Acute	acute	JJ
cord-015365-iqdi99pd	536	2	allograft	allograft	NN
cord-015365-iqdi99pd	536	3	rejection	rejection	NN
cord-015365-iqdi99pd	536	4	was	be	VBD
cord-015365-iqdi99pd	536	5	observed	observe	VBN
cord-015365-iqdi99pd	536	6	in	in	IN
cord-015365-iqdi99pd	536	7	23	23	CD
cord-015365-iqdi99pd	536	8	%	%	NN
cord-015365-iqdi99pd	536	9	of	of	IN
cord-015365-iqdi99pd	536	10	daytime	daytime	JJ
cord-015365-iqdi99pd	536	11	graft	graft	NN
cord-015365-iqdi99pd	536	12	recipients	recipient	NNS
cord-015365-iqdi99pd	536	13	compared	compare	VBN
cord-015365-iqdi99pd	536	14	to	to	IN
cord-015365-iqdi99pd	536	15	18	18	CD
cord-015365-iqdi99pd	536	16	%	%	NN
cord-015365-iqdi99pd	536	17	of	of	IN
cord-015365-iqdi99pd	536	18	nighttime	nighttime	JJ
cord-015365-iqdi99pd	536	19	graft	graft	NN
cord-015365-iqdi99pd	536	20	recipients	recipient	NNS
cord-015365-iqdi99pd	536	21	(	(	-LRB-
cord-015365-iqdi99pd	536	22	p	p	NN
cord-015365-iqdi99pd	536	23	¼	¼	CD
cord-015365-iqdi99pd	536	24	0.13	0.13	CD
cord-015365-iqdi99pd	536	25	)	)	-RRB-
cord-015365-iqdi99pd	536	26	.	.	.
cord-015365-iqdi99pd	537	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	537	2	,	,	,
cord-015365-iqdi99pd	537	3	nighttime	nighttime	JJ
cord-015365-iqdi99pd	537	4	procedures	procedure	NNS
cord-015365-iqdi99pd	537	5	were	be	VBD
cord-015365-iqdi99pd	537	6	associated	associate	VBN
cord-015365-iqdi99pd	537	7	with	with	IN
cord-015365-iqdi99pd	537	8	a	a	DT
cord-015365-iqdi99pd	537	9	23	23	CD
cord-015365-iqdi99pd	537	10	%	%	NN
cord-015365-iqdi99pd	537	11	risk	risk	NN
cord-015365-iqdi99pd	537	12	of	of	IN
cord-015365-iqdi99pd	537	13	surgical	surgical	JJ
cord-015365-iqdi99pd	537	14	complications	complication	NNS
cord-015365-iqdi99pd	537	15	which	which	WDT
cord-015365-iqdi99pd	537	16	was	be	VBD
cord-015365-iqdi99pd	537	17	not	not	RB
cord-015365-iqdi99pd	537	18	significantly	significantly	RB
cord-015365-iqdi99pd	537	19	different	different	JJ
cord-015365-iqdi99pd	537	20	from	from	IN
cord-015365-iqdi99pd	537	21	daytime	daytime	JJ
cord-015365-iqdi99pd	537	22	surgery	surgery	NN
cord-015365-iqdi99pd	537	23	(	(	-LRB-
cord-015365-iqdi99pd	537	24	22	22	CD
cord-015365-iqdi99pd	537	25	%	%	NN
cord-015365-iqdi99pd	537	26	,	,	,
cord-015365-iqdi99pd	537	27	p	p	NN
cord-015365-iqdi99pd	537	28	¼	¼	NNP
cord-015365-iqdi99pd	537	29	0.7	0.7	CD
cord-015365-iqdi99pd	537	30	)	)	-RRB-
cord-015365-iqdi99pd	537	31	.	.	.
cord-015365-iqdi99pd	538	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	538	2	.	.	.
cord-015365-iqdi99pd	539	1	Nighttime	nighttime	JJ
cord-015365-iqdi99pd	539	2	kidney	kidney	NN
cord-015365-iqdi99pd	539	3	transplants	transplant	NNS
cord-015365-iqdi99pd	539	4	are	be	VBP
cord-015365-iqdi99pd	539	5	not	not	RB
cord-015365-iqdi99pd	539	6	associated	associate	VBN
cord-015365-iqdi99pd	539	7	with	with	IN
cord-015365-iqdi99pd	539	8	a	a	DT
cord-015365-iqdi99pd	539	9	higher	high	JJR
cord-015365-iqdi99pd	539	10	surgical	surgical	JJ
cord-015365-iqdi99pd	539	11	complication	complication	NN
cord-015365-iqdi99pd	539	12	rate	rate	NN
cord-015365-iqdi99pd	539	13	than	than	IN
cord-015365-iqdi99pd	539	14	daytime	daytime	JJ
cord-015365-iqdi99pd	539	15	procedures	procedure	NNS
cord-015365-iqdi99pd	539	16	.	.	.
cord-015365-iqdi99pd	540	1	Nighttime	nighttime	JJ
cord-015365-iqdi99pd	540	2	kidney	kidney	NN
cord-015365-iqdi99pd	540	3	transplant	transplant	NN
cord-015365-iqdi99pd	540	4	procedures	procedure	NNS
cord-015365-iqdi99pd	540	5	have	have	VBP
cord-015365-iqdi99pd	540	6	the	the	DT
cord-015365-iqdi99pd	540	7	same	same	JJ
cord-015365-iqdi99pd	540	8	outcome	outcome	NN
cord-015365-iqdi99pd	540	9	as	as	IN
cord-015365-iqdi99pd	540	10	daytime	daytime	JJ
cord-015365-iqdi99pd	540	11	transplants	transplant	NNS
cord-015365-iqdi99pd	540	12	and	and	CC
cord-015365-iqdi99pd	540	13	are	be	VBP
cord-015365-iqdi99pd	540	14	necessary	necessary	JJ
cord-015365-iqdi99pd	540	15	to	to	TO
cord-015365-iqdi99pd	540	16	keep	keep	VB
cord-015365-iqdi99pd	540	17	cold	cold	JJ
cord-015365-iqdi99pd	540	18	ischemia	ischemia	NN
cord-015365-iqdi99pd	540	19	time	time	NN
cord-015365-iqdi99pd	540	20	as	as	RB
cord-015365-iqdi99pd	540	21	short	short	JJ
cord-015365-iqdi99pd	540	22	as	as	IN
cord-015365-iqdi99pd	540	23	possible	possible	JJ
cord-015365-iqdi99pd	540	24	.	.	.
cord-015365-iqdi99pd	541	1	Ursolic	Ursolic	NNP
cord-015365-iqdi99pd	541	2	acid	acid	VB
cord-015365-iqdi99pd	541	3	a	a	DT
cord-015365-iqdi99pd	541	4	constituent	constituent	NN
cord-015365-iqdi99pd	541	5	of	of	IN
cord-015365-iqdi99pd	541	6	Dwarf	Dwarf	NNP
cord-015365-iqdi99pd	541	7	Elder	Elder	NNP
cord-015365-iqdi99pd	541	8	(	(	-LRB-
cord-015365-iqdi99pd	541	9	Sambucus	Sambucus	NNP
cord-015365-iqdi99pd	541	10	ebulus	ebulus	NN
cord-015365-iqdi99pd	541	11	)	)	-RRB-
cord-015365-iqdi99pd	541	12	inhibits	inhibit	VBZ
cord-015365-iqdi99pd	541	13	surface	surface	NN
cord-015365-iqdi99pd	541	14	expression	expression	NN
cord-015365-iqdi99pd	541	15	of	of	IN
cord-015365-iqdi99pd	541	16	endothelial	endothelial	JJ
cord-015365-iqdi99pd	541	17	adhesion	adhesion	NN
cord-015365-iqdi99pd	541	18	molecules	molecule	NNS
cord-015365-iqdi99pd	541	19	and	and	CC
cord-015365-iqdi99pd	541	20	prevents	prevent	VBZ
cord-015365-iqdi99pd	541	21	intimal	intimal	JJ
cord-015365-iqdi99pd	541	22	hyperplasia	hyperplasia	NN
cord-015365-iqdi99pd	541	23	in	in	IN
cord-015365-iqdi99pd	541	24	an	an	DT
cord-015365-iqdi99pd	541	25	in	in	IN
cord-015365-iqdi99pd	541	26	vivo	vivo	NN
cord-015365-iqdi99pd	541	27	model	model	NN
cord-015365-iqdi99pd	541	28	for	for	IN
cord-015365-iqdi99pd	541	29	bypass	bypass	NN
cord-015365-iqdi99pd	541	30	surgery	surgery	NN
cord-015365-iqdi99pd	541	31	Background	background	NN
cord-015365-iqdi99pd	541	32	.	.	.
cord-015365-iqdi99pd	542	1	In	in	IN
cord-015365-iqdi99pd	542	2	a	a	DT
cord-015365-iqdi99pd	542	3	recent	recent	JJ
cord-015365-iqdi99pd	542	4	study	study	NN
cord-015365-iqdi99pd	542	5	for	for	IN
cord-015365-iqdi99pd	542	6	the	the	DT
cord-015365-iqdi99pd	542	7	identification	identification	NN
cord-015365-iqdi99pd	542	8	of	of	IN
cord-015365-iqdi99pd	542	9	compounds	compound	NNS
cord-015365-iqdi99pd	542	10	capable	capable	JJ
cord-015365-iqdi99pd	542	11	of	of	IN
cord-015365-iqdi99pd	542	12	inhibiting	inhibit	VBG
cord-015365-iqdi99pd	542	13	VCAM-1	VCAM-1	NNP
cord-015365-iqdi99pd	542	14	expression	expression	NN
cord-015365-iqdi99pd	542	15	we	-PRON-	PRP
cord-015365-iqdi99pd	542	16	isolated	isolate	VBD
cord-015365-iqdi99pd	542	17	ursolic	ursolic	JJ
cord-015365-iqdi99pd	542	18	acid	acid	NN
cord-015365-iqdi99pd	542	19	(	(	-LRB-
cord-015365-iqdi99pd	542	20	UA	UA	NNP
cord-015365-iqdi99pd	542	21	)	)	-RRB-
cord-015365-iqdi99pd	542	22	from	from	IN
cord-015365-iqdi99pd	542	23	extracts	extract	NNS
cord-015365-iqdi99pd	542	24	of	of	IN
cord-015365-iqdi99pd	542	25	Dwarf	Dwarf	NNP
cord-015365-iqdi99pd	542	26	Elder	Elder	NNP
cord-015365-iqdi99pd	542	27	.	.	.
cord-015365-iqdi99pd	543	1	Herein	herein	RB
cord-015365-iqdi99pd	543	2	,	,	,
cord-015365-iqdi99pd	543	3	we	-PRON-	PRP
cord-015365-iqdi99pd	543	4	analyse	analyse	VBP
cord-015365-iqdi99pd	543	5	the	the	DT
cord-015365-iqdi99pd	543	6	mechanism	mechanism	NN
cord-015365-iqdi99pd	543	7	of	of	IN
cord-015365-iqdi99pd	543	8	action	action	NN
cord-015365-iqdi99pd	543	9	and	and	CC
cord-015365-iqdi99pd	543	10	the	the	DT
cord-015365-iqdi99pd	543	11	in	in	IN
cord-015365-iqdi99pd	543	12	vivo	vivo	NN
cord-015365-iqdi99pd	543	13	applicability	applicability	NN
cord-015365-iqdi99pd	543	14	of	of	IN
cord-015365-iqdi99pd	543	15	the	the	DT
cord-015365-iqdi99pd	543	16	compound	compound	NN
cord-015365-iqdi99pd	543	17	in	in	IN
cord-015365-iqdi99pd	543	18	a	a	DT
cord-015365-iqdi99pd	543	19	setting	setting	NN
cord-015365-iqdi99pd	543	20	for	for	IN
cord-015365-iqdi99pd	543	21	venous	venous	JJ
cord-015365-iqdi99pd	543	22	bypass	bypass	NN
cord-015365-iqdi99pd	543	23	graft	graft	NN
cord-015365-iqdi99pd	543	24	intimal	intimal	JJ
cord-015365-iqdi99pd	543	25	hyperplasia	hyperplasia	NN
cord-015365-iqdi99pd	543	26	.	.	.
cord-015365-iqdi99pd	544	1	Methods	method	NNS
cord-015365-iqdi99pd	544	2	and	and	CC
cord-015365-iqdi99pd	544	3	Results	result	NNS
cord-015365-iqdi99pd	544	4	.	.	.
cord-015365-iqdi99pd	545	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	545	2	analyses	analysis	NNS
cord-015365-iqdi99pd	545	3	indicate	indicate	VBP
cord-015365-iqdi99pd	545	4	that	that	IN
cord-015365-iqdi99pd	545	5	UA	UA	NNP
cord-015365-iqdi99pd	545	6	does	do	VBZ
cord-015365-iqdi99pd	545	7	not	not	RB
cord-015365-iqdi99pd	545	8	interfere	interfere	VB
cord-015365-iqdi99pd	545	9	with	with	IN
cord-015365-iqdi99pd	545	10	the	the	DT
cord-015365-iqdi99pd	545	11	adhesion	adhesion	NN
cord-015365-iqdi99pd	545	12	molecule	molecule	NN
cord-015365-iqdi99pd	545	13	expression	expression	NN
cord-015365-iqdi99pd	545	14	pathway	pathway	NN
cord-015365-iqdi99pd	545	15	at	at	IN
cord-015365-iqdi99pd	545	16	or	or	CC
cord-015365-iqdi99pd	545	17	upstream	upstream	RB
cord-015365-iqdi99pd	545	18	of	of	IN
cord-015365-iqdi99pd	545	19	NFK	NFK	NNP
cord-015365-iqdi99pd	545	20	-	-	HYPH
cord-015365-iqdi99pd	545	21	B	B	NNP
cord-015365-iqdi99pd	545	22	,	,	,
cord-015365-iqdi99pd	545	23	as	as	IN
cord-015365-iqdi99pd	545	24	NFK	NFK	NNP
cord-015365-iqdi99pd	545	25	-	-	HYPH
cord-015365-iqdi99pd	545	26	B	b	NN
cord-015365-iqdi99pd	545	27	translocation	translocation	NN
cord-015365-iqdi99pd	545	28	and	and	CC
cord-015365-iqdi99pd	545	29	NFK	NFK	NNP
cord-015365-iqdi99pd	545	30	-	-	HYPH
cord-015365-iqdi99pd	545	31	B	b	NN
cord-015365-iqdi99pd	545	32	mediated	mediate	VBN
cord-015365-iqdi99pd	545	33	transcription	transcription	NN
cord-015365-iqdi99pd	545	34	were	be	VBD
cord-015365-iqdi99pd	545	35	not	not	RB
cord-015365-iqdi99pd	545	36	affected	affect	VBN
cord-015365-iqdi99pd	545	37	by	by	IN
cord-015365-iqdi99pd	545	38	UA	UA	NNP
cord-015365-iqdi99pd	545	39	.	.	.
cord-015365-iqdi99pd	546	1	However	however	RB
cord-015365-iqdi99pd	546	2	,	,	,
cord-015365-iqdi99pd	546	3	UA	UA	NNP
cord-015365-iqdi99pd	546	4	inhibited	inhibited	JJ
cord-015365-iqdi99pd	546	5	adhesion	adhesion	NN
cord-015365-iqdi99pd	546	6	molecule	molecule	NN
cord-015365-iqdi99pd	546	7	protein	protein	NN
cord-015365-iqdi99pd	546	8	synthesis	synthesis	NN
cord-015365-iqdi99pd	546	9	suggesting	suggest	VBG
cord-015365-iqdi99pd	546	10	an	an	DT
cord-015365-iqdi99pd	546	11	inference	inference	NN
cord-015365-iqdi99pd	546	12	with	with	IN
cord-015365-iqdi99pd	546	13	the	the	DT
cord-015365-iqdi99pd	546	14	translation	translation	NN
cord-015365-iqdi99pd	546	15	of	of	IN
cord-015365-iqdi99pd	546	16	adhesion	adhesion	NN
cord-015365-iqdi99pd	546	17	molecules	molecule	NNS
cord-015365-iqdi99pd	546	18	.	.	.
cord-015365-iqdi99pd	547	1	In	in	IN
cord-015365-iqdi99pd	547	2	an	an	DT
cord-015365-iqdi99pd	547	3	in	in	IN
cord-015365-iqdi99pd	547	4	-	-	HYPH
cord-015365-iqdi99pd	547	5	vivo	vivo	FW
cord-015365-iqdi99pd	547	6	rat	rat	NN
cord-015365-iqdi99pd	547	7	model	model	NN
cord-015365-iqdi99pd	547	8	for	for	IN
cord-015365-iqdi99pd	547	9	vein	vein	NN
cord-015365-iqdi99pd	547	10	graft	graft	NN
cord-015365-iqdi99pd	547	11	disease	disease	NN
cord-015365-iqdi99pd	547	12	,	,	,
cord-015365-iqdi99pd	547	13	UA	UA	NNP
cord-015365-iqdi99pd	547	14	-	-	HYPH
cord-015365-iqdi99pd	547	15	containing	contain	VBG
cord-015365-iqdi99pd	547	16	Sambucus	Sambucus	NNP
cord-015365-iqdi99pd	547	17	extracts	extract	NNS
cord-015365-iqdi99pd	547	18	inhibited	inhibit	VBD
cord-015365-iqdi99pd	547	19	endothelial	endothelial	JJ
cord-015365-iqdi99pd	547	20	VCAM-1	VCAM-1	NNP
cord-015365-iqdi99pd	547	21	expression	expression	NN
cord-015365-iqdi99pd	547	22	,	,	,
cord-015365-iqdi99pd	547	23	induced	induce	VBN
cord-015365-iqdi99pd	547	24	cell	cell	NN
cord-015365-iqdi99pd	547	25	death	death	NN
cord-015365-iqdi99pd	547	26	in	in	IN
cord-015365-iqdi99pd	547	27	smooth	smooth	JJ
cord-015365-iqdi99pd	547	28	muscle	muscle	NN
cord-015365-iqdi99pd	547	29	cells	cell	NNS
cord-015365-iqdi99pd	547	30	,	,	,
cord-015365-iqdi99pd	547	31	and	and	CC
cord-015365-iqdi99pd	547	32	inhibited	inhibit	VBN
cord-015365-iqdi99pd	547	33	intimal	intimal	JJ
cord-015365-iqdi99pd	547	34	hyperplasia	hyperplasia	NN
cord-015365-iqdi99pd	547	35	in	in	IN
cord-015365-iqdi99pd	547	36	a	a	DT
cord-015365-iqdi99pd	547	37	rat	rat	NN
cord-015365-iqdi99pd	547	38	model	model	NN
cord-015365-iqdi99pd	547	39	for	for	IN
cord-015365-iqdi99pd	547	40	venous	venous	JJ
cord-015365-iqdi99pd	547	41	bypass	bypass	NN
cord-015365-iqdi99pd	547	42	graft	graft	NN
cord-015365-iqdi99pd	547	43	disease	disease	NN
cord-015365-iqdi99pd	547	44	.	.	.
cord-015365-iqdi99pd	548	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	548	2	.	.	.
cord-015365-iqdi99pd	549	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	549	2	results	result	NNS
cord-015365-iqdi99pd	549	3	suggest	suggest	VBP
cord-015365-iqdi99pd	549	4	that	that	IN
cord-015365-iqdi99pd	549	5	the	the	DT
cord-015365-iqdi99pd	549	6	inhibition	inhibition	NN
cord-015365-iqdi99pd	549	7	of	of	IN
cord-015365-iqdi99pd	549	8	VCAM-1	VCAM-1	NNP
cord-015365-iqdi99pd	549	9	expression	expression	NN
cord-015365-iqdi99pd	549	10	constitutes	constitute	VBZ
cord-015365-iqdi99pd	549	11	a	a	DT
cord-015365-iqdi99pd	549	12	valuable	valuable	JJ
cord-015365-iqdi99pd	549	13	target	target	NN
cord-015365-iqdi99pd	549	14	for	for	IN
cord-015365-iqdi99pd	549	15	drug	drug	NN
cord-015365-iqdi99pd	549	16	discovery	discovery	NN
cord-015365-iqdi99pd	549	17	in	in	IN
cord-015365-iqdi99pd	549	18	the	the	DT
cord-015365-iqdi99pd	549	19	field	field	NN
cord-015365-iqdi99pd	549	20	of	of	IN
cord-015365-iqdi99pd	549	21	cardiovascular	cardiovascular	JJ
cord-015365-iqdi99pd	549	22	research	research	NN
cord-015365-iqdi99pd	549	23	.	.	.
cord-015365-iqdi99pd	550	1	UA	UA	NNP
cord-015365-iqdi99pd	550	2	may	may	MD
cord-015365-iqdi99pd	550	3	be	be	VB
cord-015365-iqdi99pd	550	4	an	an	DT
cord-015365-iqdi99pd	550	5	interesting	interesting	JJ
cord-015365-iqdi99pd	550	6	agent	agent	NN
cord-015365-iqdi99pd	550	7	in	in	IN
cord-015365-iqdi99pd	550	8	the	the	DT
cord-015365-iqdi99pd	550	9	prevention	prevention	NN
cord-015365-iqdi99pd	550	10	of	of	IN
cord-015365-iqdi99pd	550	11	vein	vein	NN
cord-015365-iqdi99pd	550	12	graft	graft	NN
cord-015365-iqdi99pd	550	13	disease	disease	NN
cord-015365-iqdi99pd	550	14	and	and	CC
cord-015365-iqdi99pd	550	15	graft	graft	NN
cord-015365-iqdi99pd	550	16	failure	failure	NN
cord-015365-iqdi99pd	550	17	.	.	.
cord-015365-iqdi99pd	551	1	The	the	DT
cord-015365-iqdi99pd	551	2	killer	killer	NN
cord-015365-iqdi99pd	551	3	-	-	HYPH
cord-015365-iqdi99pd	551	4	cell	cell	NN
cord-015365-iqdi99pd	551	5	immunoglobulin	immunoglobulin	NN
cord-015365-iqdi99pd	551	6	-	-	HYPH
cord-015365-iqdi99pd	551	7	like	like	JJ
cord-015365-iqdi99pd	551	8	receptor	receptor	NN
cord-015365-iqdi99pd	551	9	(	(	-LRB-
cord-015365-iqdi99pd	551	10	KIR	KIR	NNP
cord-015365-iqdi99pd	551	11	)	)	-RRB-
cord-015365-iqdi99pd	551	12	genotype	genotype	NN
cord-015365-iqdi99pd	551	13	correlates	correlate	VBZ
cord-015365-iqdi99pd	551	14	with	with	IN
cord-015365-iqdi99pd	551	15	acute	acute	JJ
cord-015365-iqdi99pd	551	16	kidney	kidney	NN
cord-015365-iqdi99pd	551	17	failure	failure	NN
cord-015365-iqdi99pd	551	18	in	in	IN
cord-015365-iqdi99pd	551	19	the	the	DT
cord-015365-iqdi99pd	551	20	early	early	JJ
cord-015365-iqdi99pd	551	21	post	post	JJ
cord-015365-iqdi99pd	551	22	-	-	JJ
cord-015365-iqdi99pd	551	23	liver	liver	JJ
cord-015365-iqdi99pd	551	24	transplantation	transplantation	NN
cord-015365-iqdi99pd	551	25	period	period	NN
cord-015365-iqdi99pd	552	1	Acute	acute	JJ
cord-015365-iqdi99pd	552	2	renal	renal	JJ
cord-015365-iqdi99pd	552	3	failure	failure	NN
cord-015365-iqdi99pd	552	4	(	(	-LRB-
cord-015365-iqdi99pd	552	5	ARF	ARF	NNP
cord-015365-iqdi99pd	552	6	)	)	-RRB-
cord-015365-iqdi99pd	552	7	is	be	VBZ
cord-015365-iqdi99pd	552	8	a	a	DT
cord-015365-iqdi99pd	552	9	major	major	JJ
cord-015365-iqdi99pd	552	10	complication	complication	NN
cord-015365-iqdi99pd	552	11	following	follow	VBG
cord-015365-iqdi99pd	552	12	liver	liver	NN
cord-015365-iqdi99pd	552	13	transplantation	transplantation	NN
cord-015365-iqdi99pd	552	14	(	(	-LRB-
cord-015365-iqdi99pd	552	15	LT	LT	NNP
cord-015365-iqdi99pd	552	16	)	)	-RRB-
cord-015365-iqdi99pd	552	17	leading	lead	VBG
cord-015365-iqdi99pd	552	18	up	up	RP
cord-015365-iqdi99pd	552	19	to	to	IN
cord-015365-iqdi99pd	552	20	chronic	chronic	JJ
cord-015365-iqdi99pd	552	21	end	end	NN
cord-015365-iqdi99pd	552	22	-	-	HYPH
cord-015365-iqdi99pd	552	23	stage	stage	NN
cord-015365-iqdi99pd	552	24	renal	renal	JJ
cord-015365-iqdi99pd	552	25	disease	disease	NN
cord-015365-iqdi99pd	552	26	.	.	.
cord-015365-iqdi99pd	553	1	The	the	DT
cord-015365-iqdi99pd	553	2	etiology	etiology	NN
cord-015365-iqdi99pd	553	3	of	of	IN
cord-015365-iqdi99pd	553	4	post	post	JJ
cord-015365-iqdi99pd	553	5	-	-	JJ
cord-015365-iqdi99pd	553	6	LT	LT	NNP
cord-015365-iqdi99pd	553	7	impairment	impairment	NN
cord-015365-iqdi99pd	553	8	is	be	VBZ
cord-015365-iqdi99pd	553	9	multifactorial	multifactorial	JJ
cord-015365-iqdi99pd	553	10	,	,	,
cord-015365-iqdi99pd	553	11	but	but	CC
cord-015365-iqdi99pd	553	12	it	-PRON-	PRP
cord-015365-iqdi99pd	553	13	is	be	VBZ
cord-015365-iqdi99pd	553	14	suggested	suggest	VBN
cord-015365-iqdi99pd	553	15	that	that	IN
cord-015365-iqdi99pd	553	16	e.g.	e.g.	RB
cord-015365-iqdi99pd	553	17	during	during	IN
cord-015365-iqdi99pd	553	18	ischemia	ischemia	NN
cord-015365-iqdi99pd	553	19	initial	initial	JJ
cord-015365-iqdi99pd	553	20	insults	insult	NNS
cord-015365-iqdi99pd	553	21	provoke	provoke	VBP
cord-015365-iqdi99pd	553	22	morphological	morphological	JJ
cord-015365-iqdi99pd	553	23	and	and	CC
cord-015365-iqdi99pd	553	24	functional	functional	JJ
cord-015365-iqdi99pd	553	25	changes	change	NNS
cord-015365-iqdi99pd	553	26	within	within	IN
cord-015365-iqdi99pd	553	27	the	the	DT
cord-015365-iqdi99pd	553	28	vascular	vascular	JJ
cord-015365-iqdi99pd	553	29	and	and	CC
cord-015365-iqdi99pd	553	30	tubular	tubular	JJ
cord-015365-iqdi99pd	553	31	epithelium	epithelium	NN
cord-015365-iqdi99pd	553	32	.	.	.
cord-015365-iqdi99pd	554	1	Because	because	IN
cord-015365-iqdi99pd	554	2	it	-PRON-	PRP
cord-015365-iqdi99pd	554	3	has	have	VBZ
cord-015365-iqdi99pd	554	4	been	be	VBN
cord-015365-iqdi99pd	554	5	demonstrated	demonstrate	VBN
cord-015365-iqdi99pd	554	6	that	that	IN
cord-015365-iqdi99pd	554	7	ischemic	ischemic	JJ
cord-015365-iqdi99pd	554	8	ARF	arf	NN
cord-015365-iqdi99pd	554	9	can	can	MD
cord-015365-iqdi99pd	554	10	occur	occur	VB
cord-015365-iqdi99pd	554	11	in	in	IN
cord-015365-iqdi99pd	554	12	the	the	DT
cord-015365-iqdi99pd	554	13	absence	absence	NN
cord-015365-iqdi99pd	554	14	of	of	IN
cord-015365-iqdi99pd	554	15	classical	classical	JJ
cord-015365-iqdi99pd	554	16	T	t	NN
cord-015365-iqdi99pd	554	17	cell	cell	NN
cord-015365-iqdi99pd	554	18	function	function	NN
cord-015365-iqdi99pd	554	19	and	and	CC
cord-015365-iqdi99pd	554	20	that	that	IN
cord-015365-iqdi99pd	554	21	natural	natural	JJ
cord-015365-iqdi99pd	554	22	killer	killer	NN
cord-015365-iqdi99pd	554	23	(	(	-LRB-
cord-015365-iqdi99pd	554	24	NK	NK	NNP
cord-015365-iqdi99pd	554	25	)	)	-RRB-
cord-015365-iqdi99pd	554	26	cells	cell	NNS
cord-015365-iqdi99pd	554	27	can	can	MD
cord-015365-iqdi99pd	554	28	kill	kill	VB
cord-015365-iqdi99pd	554	29	syngeneic	syngeneic	NNS
cord-015365-iqdi99pd	554	30	tubular	tubular	JJ
cord-015365-iqdi99pd	554	31	epithelial	epithelial	JJ
cord-015365-iqdi99pd	554	32	cells	cell	NNS
cord-015365-iqdi99pd	554	33	in	in	IN
cord-015365-iqdi99pd	554	34	vitro	vitro	FW
cord-015365-iqdi99pd	554	35	,	,	,
cord-015365-iqdi99pd	554	36	we	-PRON-	PRP
cord-015365-iqdi99pd	554	37	aimed	aim	VBD
cord-015365-iqdi99pd	554	38	to	to	TO
cord-015365-iqdi99pd	554	39	elucidate	elucidate	VB
cord-015365-iqdi99pd	554	40	the	the	DT
cord-015365-iqdi99pd	554	41	role	role	NN
cord-015365-iqdi99pd	554	42	of	of	IN
cord-015365-iqdi99pd	554	43	NK	NK	NNP
cord-015365-iqdi99pd	554	44	cells	cell	NNS
cord-015365-iqdi99pd	554	45	and	and	CC
cord-015365-iqdi99pd	554	46	their	-PRON-	PRP$
cord-015365-iqdi99pd	554	47	receptors	receptor	NNS
cord-015365-iqdi99pd	554	48	in	in	IN
cord-015365-iqdi99pd	554	49	the	the	DT
cord-015365-iqdi99pd	554	50	context	context	NN
cord-015365-iqdi99pd	554	51	of	of	IN
cord-015365-iqdi99pd	554	52	early	early	JJ
cord-015365-iqdi99pd	554	53	post	post	JJ
cord-015365-iqdi99pd	554	54	-	-	JJ
cord-015365-iqdi99pd	554	55	liver	liver	JJ
cord-015365-iqdi99pd	554	56	transplant	transplant	NN
cord-015365-iqdi99pd	554	57	ARI	ARI	NNP
cord-015365-iqdi99pd	554	58	and	and	CC
cord-015365-iqdi99pd	554	59	ARF	ARF	NNP
cord-015365-iqdi99pd	554	60	more	more	RBR
cord-015365-iqdi99pd	554	61	precisely	precisely	RB
cord-015365-iqdi99pd	554	62	.	.	.
cord-015365-iqdi99pd	555	1	Patients	patient	NNS
cord-015365-iqdi99pd	555	2	with	with	IN
cord-015365-iqdi99pd	555	3	impaired	impaired	JJ
cord-015365-iqdi99pd	555	4	kidney	kidney	NN
cord-015365-iqdi99pd	555	5	function	function	NN
cord-015365-iqdi99pd	555	6	(	(	-LRB-
cord-015365-iqdi99pd	555	7	serum	serum	NN
cord-015365-iqdi99pd	555	8	creatinine	creatinine	NN
cord-015365-iqdi99pd	555	9	>	>	XX
cord-015365-iqdi99pd	555	10	1.2	1.2	CD
cord-015365-iqdi99pd	555	11	mg	mg	NNP
cord-015365-iqdi99pd	555	12	/	/	SYM
cord-015365-iqdi99pd	555	13	dl	dl	NNP
cord-015365-iqdi99pd	555	14	,	,	,
cord-015365-iqdi99pd	555	15	n	n	NNP
cord-015365-iqdi99pd	555	16	¼	¼	NNP
cord-015365-iqdi99pd	555	17	13	13	CD
cord-015365-iqdi99pd	555	18	)	)	-RRB-
cord-015365-iqdi99pd	555	19	illustrated	illustrate	VBN
cord-015365-iqdi99pd	555	20	heightened	heighten	VBD
cord-015365-iqdi99pd	555	21	peripheral	peripheral	JJ
cord-015365-iqdi99pd	555	22	NK	NK	NNP
cord-015365-iqdi99pd	555	23	cell	cell	NN
cord-015365-iqdi99pd	555	24	frequencies	frequency	NNS
cord-015365-iqdi99pd	555	25	prior	prior	RB
cord-015365-iqdi99pd	555	26	to	to	IN
cord-015365-iqdi99pd	555	27	LT	LT	NNP
cord-015365-iqdi99pd	555	28	compared	compare	VBN
cord-015365-iqdi99pd	555	29	with	with	IN
cord-015365-iqdi99pd	555	30	patients	patient	NNS
cord-015365-iqdi99pd	555	31	showing	show	VBG
cord-015365-iqdi99pd	555	32	stable	stable	JJ
cord-015365-iqdi99pd	555	33	renal	renal	JJ
cord-015365-iqdi99pd	555	34	function	function	NN
cord-015365-iqdi99pd	555	35	(	(	-LRB-
cord-015365-iqdi99pd	555	36	n	n	NN
cord-015365-iqdi99pd	555	37	¼	¼	NNP
cord-015365-iqdi99pd	555	38	9	9	CD
cord-015365-iqdi99pd	555	39	)	)	-RRB-
cord-015365-iqdi99pd	555	40	(	(	-LRB-
cord-015365-iqdi99pd	555	41	17.22	17.22	CD
cord-015365-iqdi99pd	555	42	%	%	NN
cord-015365-iqdi99pd	555	43	AE	AE	NNP
cord-015365-iqdi99pd	555	44	10.56	10.56	CD
cord-015365-iqdi99pd	555	45	versus	versus	IN
cord-015365-iqdi99pd	555	46	12.98	12.98	CD
cord-015365-iqdi99pd	555	47	%	%	NN
cord-015365-iqdi99pd	555	48	AE	AE	NNP
cord-015365-iqdi99pd	555	49	9.09	9.09	CD
cord-015365-iqdi99pd	555	50	)	)	-RRB-
cord-015365-iqdi99pd	555	51	.	.	.
cord-015365-iqdi99pd	556	1	We	-PRON-	PRP
cord-015365-iqdi99pd	556	2	further	further	RB
cord-015365-iqdi99pd	556	3	tested	test	VBD
cord-015365-iqdi99pd	556	4	retrospectively	retrospectively	RB
cord-015365-iqdi99pd	556	5	89	89	CD
cord-015365-iqdi99pd	556	6	liver	liver	NN
cord-015365-iqdi99pd	556	7	transplant	transplant	NN
cord-015365-iqdi99pd	556	8	recipients	recipient	NNS
cord-015365-iqdi99pd	556	9	for	for	IN
cord-015365-iqdi99pd	556	10	their	-PRON-	PRP$
cord-015365-iqdi99pd	556	11	killer	killer	NN
cord-015365-iqdi99pd	556	12	-	-	HYPH
cord-015365-iqdi99pd	556	13	cell	cell	NN
cord-015365-iqdi99pd	556	14	immunoglobulin	immunoglobulin	NN
cord-015365-iqdi99pd	556	15	-	-	HYPH
cord-015365-iqdi99pd	556	16	like	like	JJ
cord-015365-iqdi99pd	556	17	receptor	receptor	NN
cord-015365-iqdi99pd	556	18	(	(	-LRB-
cord-015365-iqdi99pd	556	19	KIR	KIR	NNP
cord-015365-iqdi99pd	556	20	)	)	-RRB-
cord-015365-iqdi99pd	556	21	genotype	genotype	NN
cord-015365-iqdi99pd	556	22	and	and	CC
cord-015365-iqdi99pd	556	23	the	the	DT
cord-015365-iqdi99pd	556	24	risk	risk	NN
cord-015365-iqdi99pd	556	25	of	of	IN
cord-015365-iqdi99pd	556	26	ARI	ARI	NNP
cord-015365-iqdi99pd	556	27	/	/	SYM
cord-015365-iqdi99pd	556	28	ARF	ARF	NNP
cord-015365-iqdi99pd	556	29	.	.	.
cord-015365-iqdi99pd	557	1	During	during	IN
cord-015365-iqdi99pd	557	2	the	the	DT
cord-015365-iqdi99pd	557	3	first	first	JJ
cord-015365-iqdi99pd	557	4	week	week	NN
cord-015365-iqdi99pd	557	5	post	post	NN
cord-015365-iqdi99pd	557	6	-	-	NNP
cord-015365-iqdi99pd	557	7	LT	LT	NNP
cord-015365-iqdi99pd	557	8	,	,	,
cord-015365-iqdi99pd	557	9	ARI	ARI	NNP
cord-015365-iqdi99pd	557	10	occurred	occur	VBD
cord-015365-iqdi99pd	557	11	in	in	IN
cord-015365-iqdi99pd	557	12	12	12	CD
cord-015365-iqdi99pd	557	13	%	%	NN
cord-015365-iqdi99pd	557	14	and	and	CC
cord-015365-iqdi99pd	557	15	ARF	arf	NN
cord-015365-iqdi99pd	557	16	in	in	IN
cord-015365-iqdi99pd	557	17	22	22	CD
cord-015365-iqdi99pd	557	18	%	%	NN
cord-015365-iqdi99pd	557	19	of	of	IN
cord-015365-iqdi99pd	557	20	the	the	DT
cord-015365-iqdi99pd	557	21	patients	patient	NNS
cord-015365-iqdi99pd	557	22	.	.	.
cord-015365-iqdi99pd	558	1	ARI	ARI	NNP
cord-015365-iqdi99pd	558	2	was	be	VBD
cord-015365-iqdi99pd	558	3	a	a	DT
cord-015365-iqdi99pd	558	4	significant	significant	JJ
cord-015365-iqdi99pd	558	5	risk	risk	NN
cord-015365-iqdi99pd	558	6	factor	factor	NN
cord-015365-iqdi99pd	558	7	for	for	IN
cord-015365-iqdi99pd	558	8	acute	acute	JJ
cord-015365-iqdi99pd	558	9	rejection	rejection	NN
cord-015365-iqdi99pd	558	10	(	(	-LRB-
cord-015365-iqdi99pd	558	11	p	p	NN
cord-015365-iqdi99pd	558	12	¼	¼	CD
cord-015365-iqdi99pd	558	13	0.0009	0.0009	CD
cord-015365-iqdi99pd	558	14	)	)	-RRB-
cord-015365-iqdi99pd	558	15	and	and	CC
cord-015365-iqdi99pd	558	16	ARF	ARF	NNP
cord-015365-iqdi99pd	558	17	led	lead	VBD
cord-015365-iqdi99pd	558	18	to	to	IN
cord-015365-iqdi99pd	558	19	elevated	elevated	JJ
cord-015365-iqdi99pd	558	20	serum	serum	NN
cord-015365-iqdi99pd	558	21	creatinine	creatinine	NN
cord-015365-iqdi99pd	558	22	levels	level	NNS
cord-015365-iqdi99pd	558	23	(	(	-LRB-
cord-015365-iqdi99pd	558	24	>	>	NFP
cord-015365-iqdi99pd	558	25	1.2	1.2	CD
cord-015365-iqdi99pd	558	26	mg	mg	NNP
cord-015365-iqdi99pd	558	27	/	/	SYM
cord-015365-iqdi99pd	558	28	dl	dl	NNP
cord-015365-iqdi99pd	558	29	)	)	-RRB-
cord-015365-iqdi99pd	558	30	at	at	IN
cord-015365-iqdi99pd	558	31	the	the	DT
cord-015365-iqdi99pd	558	32	time	time	NN
cord-015365-iqdi99pd	558	33	of	of	IN
cord-015365-iqdi99pd	558	34	hospital	hospital	NN
cord-015365-iqdi99pd	558	35	discharge	discharge	NN
cord-015365-iqdi99pd	559	1	(	(	-LRB-
cord-015365-iqdi99pd	559	2	p	p	NN
cord-015365-iqdi99pd	559	3	¼	¼	CD
cord-015365-iqdi99pd	559	4	0.008	0.008	CD
cord-015365-iqdi99pd	559	5	)	)	-RRB-
cord-015365-iqdi99pd	559	6	.	.	.
cord-015365-iqdi99pd	560	1	Interestingly	interestingly	RB
cord-015365-iqdi99pd	560	2	,	,	,
cord-015365-iqdi99pd	560	3	significantly	significantly	RB
cord-015365-iqdi99pd	560	4	less	less	JJR
cord-015365-iqdi99pd	560	5	patients	patient	NNS
cord-015365-iqdi99pd	560	6	having	have	VBG
cord-015365-iqdi99pd	560	7	a	a	DT
cord-015365-iqdi99pd	560	8	homozygous	homozygous	JJ
cord-015365-iqdi99pd	560	9	KIR	KIR	NNP
cord-015365-iqdi99pd	560	10	haplotype	haplotype	NN
cord-015365-iqdi99pd	560	11	A	a	DT
cord-015365-iqdi99pd	561	1	/A	/A	NNP
cord-015365-iqdi99pd	562	1	(	(	-LRB-
cord-015365-iqdi99pd	562	2	char	char	NN
cord-015365-iqdi99pd	562	3	-	-	HYPH
cord-015365-iqdi99pd	562	4	acterized	acterize	VBN
cord-015365-iqdi99pd	562	5	by	by	IN
cord-015365-iqdi99pd	562	6	the	the	DT
cord-015365-iqdi99pd	562	7	presence	presence	NN
cord-015365-iqdi99pd	562	8	of	of	IN
cord-015365-iqdi99pd	562	9	only	only	RB
cord-015365-iqdi99pd	562	10	one	one	CD
cord-015365-iqdi99pd	562	11	activating	activate	VBG
cord-015365-iqdi99pd	562	12	KIR	KIR	NNP
cord-015365-iqdi99pd	562	13	gene	gene	NN
cord-015365-iqdi99pd	562	14	)	)	-RRB-
cord-015365-iqdi99pd	562	15	displayed	display	VBD
cord-015365-iqdi99pd	562	16	a	a	DT
cord-015365-iqdi99pd	562	17	stable	stable	JJ
cord-015365-iqdi99pd	562	18	early	early	JJ
cord-015365-iqdi99pd	562	19	postoperative	postoperative	JJ
cord-015365-iqdi99pd	562	20	kidney	kidney	NN
cord-015365-iqdi99pd	562	21	function	function	NN
cord-015365-iqdi99pd	562	22	,	,	,
cord-015365-iqdi99pd	562	23	compared	compare	VBN
cord-015365-iqdi99pd	562	24	to	to	IN
cord-015365-iqdi99pd	562	25	patients	patient	NNS
cord-015365-iqdi99pd	562	26	with	with	IN
cord-015365-iqdi99pd	562	27	a	a	DT
cord-015365-iqdi99pd	562	28	KIR	KIR	NNP
cord-015365-iqdi99pd	562	29	haplotype	haplotype	NN
cord-015365-iqdi99pd	562	30	B/	B/	NNP
cord-015365-iqdi99pd	563	1	x	x	LS
cord-015365-iqdi99pd	564	1	(	(	-LRB-
cord-015365-iqdi99pd	564	2	more	more	JJR
cord-015365-iqdi99pd	564	3	than	than	IN
cord-015365-iqdi99pd	564	4	one	one	CD
cord-015365-iqdi99pd	564	5	activating	activate	VBG
cord-015365-iqdi99pd	564	6	receptor	receptor	NN
cord-015365-iqdi99pd	564	7	)	)	-RRB-
cord-015365-iqdi99pd	565	1	(	(	-LRB-
cord-015365-iqdi99pd	565	2	p	p	NN
cord-015365-iqdi99pd	565	3	¼	¼	CD
cord-015365-iqdi99pd	565	4	0.025	0.025	CD
cord-015365-iqdi99pd	565	5	,	,	,
cord-015365-iqdi99pd	565	6	odds	odd	NNS
cord-015365-iqdi99pd	565	7	ratio	ratio	NN
cord-015365-iqdi99pd	565	8	2.3	2.3	CD
cord-015365-iqdi99pd	565	9	,	,	,
cord-015365-iqdi99pd	565	10	CI	CI	NNP
cord-015365-iqdi99pd	565	11	¼	¼	NNP
cord-015365-iqdi99pd	565	12	1.3	1.3	CD
cord-015365-iqdi99pd	565	13	-	-	SYM
cord-015365-iqdi99pd	565	14	3.9	3.9	CD
cord-015365-iqdi99pd	565	15	)	)	-RRB-
cord-015365-iqdi99pd	565	16	.	.	.
cord-015365-iqdi99pd	566	1	Moreover	moreover	RB
cord-015365-iqdi99pd	566	2	,	,	,
cord-015365-iqdi99pd	566	3	the	the	DT
cord-015365-iqdi99pd	566	4	absence	absence	NN
cord-015365-iqdi99pd	566	5	of	of	IN
cord-015365-iqdi99pd	566	6	KIR2DL2	KIR2DL2	NNP
cord-015365-iqdi99pd	566	7	/	/	SYM
cord-015365-iqdi99pd	566	8	DS2	DS2	NNP
cord-015365-iqdi99pd	566	9	genes	gene	NNS
cord-015365-iqdi99pd	566	10	significantly	significantly	RB
cord-015365-iqdi99pd	566	11	influenced	influence	VBD
cord-015365-iqdi99pd	566	12	the	the	DT
cord-015365-iqdi99pd	566	13	risk	risk	NN
cord-015365-iqdi99pd	566	14	of	of	IN
cord-015365-iqdi99pd	566	15	ARF	ARF	NNP
cord-015365-iqdi99pd	566	16	(	(	-LRB-
cord-015365-iqdi99pd	566	17	p	p	NN
cord-015365-iqdi99pd	566	18	¼	¼	CD
cord-015365-iqdi99pd	566	19	0.05	0.05	CD
cord-015365-iqdi99pd	566	20	)	)	-RRB-
cord-015365-iqdi99pd	566	21	.	.	.
cord-015365-iqdi99pd	567	1	A	a	DT
cord-015365-iqdi99pd	567	2	multivariate	multivariate	JJ
cord-015365-iqdi99pd	567	3	regression	regression	NN
cord-015365-iqdi99pd	567	4	model	model	NN
cord-015365-iqdi99pd	567	5	of	of	IN
cord-015365-iqdi99pd	567	6	clinical	clinical	JJ
cord-015365-iqdi99pd	567	7	and	and	CC
cord-015365-iqdi99pd	567	8	genomic	genomic	JJ
cord-015365-iqdi99pd	567	9	risk	risk	NN
cord-015365-iqdi99pd	567	10	factors	factor	NNS
cord-015365-iqdi99pd	567	11	for	for	IN
cord-015365-iqdi99pd	567	12	ARI	ARI	NNP
cord-015365-iqdi99pd	567	13	/	/	SYM
cord-015365-iqdi99pd	567	14	ARF	ARF	NNP
cord-015365-iqdi99pd	567	15	confirmed	confirm	VBD
cord-015365-iqdi99pd	567	16	a	a	DT
cord-015365-iqdi99pd	567	17	link	link	NN
cord-015365-iqdi99pd	567	18	between	between	IN
cord-015365-iqdi99pd	567	19	the	the	DT
cord-015365-iqdi99pd	567	20	KIR	KIR	NNP
cord-015365-iqdi99pd	567	21	haplotype	haplotype	NN
cord-015365-iqdi99pd	567	22	A	A	NNP
cord-015365-iqdi99pd	567	23	/	/	SYM
cord-015365-iqdi99pd	567	24	A	a	NN
cord-015365-iqdi99pd	567	25	and	and	CC
cord-015365-iqdi99pd	567	26	post	post	JJ
cord-015365-iqdi99pd	567	27	-	-	JJ
cord-015365-iqdi99pd	567	28	LT	lt	NN
cord-015365-iqdi99pd	567	29	acute	acute	JJ
cord-015365-iqdi99pd	567	30	renal	renal	JJ
cord-015365-iqdi99pd	567	31	failure	failure	NN
cord-015365-iqdi99pd	567	32	(	(	-LRB-
cord-015365-iqdi99pd	567	33	p	p	NN
cord-015365-iqdi99pd	567	34	¼	¼	CD
cord-015365-iqdi99pd	567	35	0.04	0.04	CD
cord-015365-iqdi99pd	567	36	)	)	-RRB-
cord-015365-iqdi99pd	567	37	.	.	.
cord-015365-iqdi99pd	568	1	In	in	IN
cord-015365-iqdi99pd	568	2	summary	summary	NN
cord-015365-iqdi99pd	568	3	,	,	,
cord-015365-iqdi99pd	568	4	we	-PRON-	PRP
cord-015365-iqdi99pd	568	5	observed	observe	VBD
cord-015365-iqdi99pd	568	6	a	a	DT
cord-015365-iqdi99pd	568	7	higher	high	JJR
cord-015365-iqdi99pd	568	8	percentage	percentage	NN
cord-015365-iqdi99pd	568	9	of	of	IN
cord-015365-iqdi99pd	568	10	NK	NK	NNP
cord-015365-iqdi99pd	568	11	cells	cell	NNS
cord-015365-iqdi99pd	568	12	prior	prior	RB
cord-015365-iqdi99pd	568	13	to	to	IN
cord-015365-iqdi99pd	568	14	LT	LT	NNP
cord-015365-iqdi99pd	568	15	in	in	IN
cord-015365-iqdi99pd	568	16	patients	patient	NNS
cord-015365-iqdi99pd	568	17	with	with	IN
cord-015365-iqdi99pd	568	18	impaired	impaired	JJ
cord-015365-iqdi99pd	568	19	renal	renal	JJ
cord-015365-iqdi99pd	568	20	function	function	NN
cord-015365-iqdi99pd	568	21	and	and	CC
cord-015365-iqdi99pd	568	22	identified	identify	VBD
cord-015365-iqdi99pd	568	23	the	the	DT
cord-015365-iqdi99pd	568	24	KIR	KIR	NNP
cord-015365-iqdi99pd	568	25	haplotype	haplotype	NN
cord-015365-iqdi99pd	568	26	A/	A/	NNP
cord-015365-iqdi99pd	568	27	A	A	NNP
cord-015365-iqdi99pd	568	28	as	as	IN
cord-015365-iqdi99pd	568	29	an	an	DT
cord-015365-iqdi99pd	568	30	independent	independent	JJ
cord-015365-iqdi99pd	568	31	genetic	genetic	JJ
cord-015365-iqdi99pd	568	32	risk	risk	NN
cord-015365-iqdi99pd	568	33	factor	factor	NN
cord-015365-iqdi99pd	568	34	for	for	IN
cord-015365-iqdi99pd	568	35	ARF	arf	NN
cord-015365-iqdi99pd	568	36	within	within	IN
cord-015365-iqdi99pd	568	37	the	the	DT
cord-015365-iqdi99pd	568	38	first	first	JJ
cord-015365-iqdi99pd	568	39	postoperative	postoperative	JJ
cord-015365-iqdi99pd	568	40	week	week	NN
cord-015365-iqdi99pd	568	41	.	.	.
cord-015365-iqdi99pd	569	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	569	2	data	datum	NNS
cord-015365-iqdi99pd	569	3	provide	provide	VBP
cord-015365-iqdi99pd	569	4	new	new	JJ
cord-015365-iqdi99pd	569	5	aspects	aspect	NNS
cord-015365-iqdi99pd	569	6	of	of	IN
cord-015365-iqdi99pd	569	7	an	an	DT
cord-015365-iqdi99pd	569	8	innate	innate	JJ
cord-015365-iqdi99pd	569	9	immune	immune	JJ
cord-015365-iqdi99pd	569	10	response	response	NN
cord-015365-iqdi99pd	569	11	within	within	IN
cord-015365-iqdi99pd	569	12	the	the	DT
cord-015365-iqdi99pd	569	13	setting	setting	NN
cord-015365-iqdi99pd	569	14	of	of	IN
cord-015365-iqdi99pd	569	15	post	post	JJ
cord-015365-iqdi99pd	569	16	-	-	JJ
cord-015365-iqdi99pd	569	17	LT	LT	NNP
cord-015365-iqdi99pd	569	18	kidney	kidney	NN
cord-015365-iqdi99pd	569	19	injury	injury	NN
cord-015365-iqdi99pd	569	20	and	and	CC
cord-015365-iqdi99pd	569	21	failure	failure	NN
cord-015365-iqdi99pd	569	22	.	.	.
cord-015365-iqdi99pd	570	1	Background	background	NN
cord-015365-iqdi99pd	570	2	.	.	.
cord-015365-iqdi99pd	571	1	New	new	JJ
cord-015365-iqdi99pd	571	2	-	-	HYPH
cord-015365-iqdi99pd	571	3	onset	onset	JJ
cord-015365-iqdi99pd	571	4	diabetes	diabetes	NN
cord-015365-iqdi99pd	571	5	after	after	IN
cord-015365-iqdi99pd	571	6	transplantation	transplantation	NN
cord-015365-iqdi99pd	571	7	(	(	-LRB-
cord-015365-iqdi99pd	571	8	NODAT	NODAT	NNP
cord-015365-iqdi99pd	571	9	)	)	-RRB-
cord-015365-iqdi99pd	571	10	is	be	VBZ
cord-015365-iqdi99pd	571	11	a	a	DT
cord-015365-iqdi99pd	571	12	serious	serious	JJ
cord-015365-iqdi99pd	571	13	complication	complication	NN
cord-015365-iqdi99pd	571	14	after	after	IN
cord-015365-iqdi99pd	571	15	kidney	kidney	NN
cord-015365-iqdi99pd	571	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	571	17	affecting	affect	VBG
cord-015365-iqdi99pd	571	18	graft	graft	NN
cord-015365-iqdi99pd	571	19	and	and	CC
cord-015365-iqdi99pd	571	20	patient	patient	JJ
cord-015365-iqdi99pd	571	21	survival	survival	NN
cord-015365-iqdi99pd	571	22	.	.	.
cord-015365-iqdi99pd	572	1	Currently	currently	RB
cord-015365-iqdi99pd	572	2	,	,	,
cord-015365-iqdi99pd	572	3	no	no	DT
cord-015365-iqdi99pd	572	4	guidelines	guideline	NNS
cord-015365-iqdi99pd	572	5	exist	exist	VBP
cord-015365-iqdi99pd	572	6	about	about	IN
cord-015365-iqdi99pd	572	7	the	the	DT
cord-015365-iqdi99pd	572	8	ideal	ideal	JJ
cord-015365-iqdi99pd	572	9	management	management	NN
cord-015365-iqdi99pd	572	10	of	of	IN
cord-015365-iqdi99pd	572	11	renal	renal	JJ
cord-015365-iqdi99pd	572	12	transplant	transplant	NN
cord-015365-iqdi99pd	572	13	patients	patient	NNS
cord-015365-iqdi99pd	572	14	with	with	IN
cord-015365-iqdi99pd	572	15	impaired	impaired	JJ
cord-015365-iqdi99pd	572	16	glucose	glucose	NN
cord-015365-iqdi99pd	572	17	tolerance	tolerance	NN
cord-015365-iqdi99pd	572	18	(	(	-LRB-
cord-015365-iqdi99pd	572	19	IGT	IGT	NNP
cord-015365-iqdi99pd	572	20	,	,	,
cord-015365-iqdi99pd	572	21	blood	blood	NN
cord-015365-iqdi99pd	572	22	glucose	glucose	NN
cord-015365-iqdi99pd	573	1	>	>	XX
cord-015365-iqdi99pd	574	1	140	140	CD
cord-015365-iqdi99pd	574	2	and	and	CC
cord-015365-iqdi99pd	574	3	<	<	XX
cord-015365-iqdi99pd	574	4	200	200	CD
cord-015365-iqdi99pd	574	5	mg	mg	NNP
cord-015365-iqdi99pd	574	6	/	/	SYM
cord-015365-iqdi99pd	574	7	dl	dl	NNP
cord-015365-iqdi99pd	574	8	)	)	-RRB-
cord-015365-iqdi99pd	574	9	who	who	WP
cord-015365-iqdi99pd	574	10	are	be	VBP
cord-015365-iqdi99pd	574	11	at	at	IN
cord-015365-iqdi99pd	574	12	highest	high	JJS
cord-015365-iqdi99pd	574	13	risk	risk	NN
cord-015365-iqdi99pd	574	14	for	for	IN
cord-015365-iqdi99pd	574	15	developing	develop	VBG
cord-015365-iqdi99pd	574	16	manifest	manifest	JJ
cord-015365-iqdi99pd	574	17	diabetes	diabete	NNS
cord-015365-iqdi99pd	574	18	.	.	.
cord-015365-iqdi99pd	575	1	Here	here	RB
cord-015365-iqdi99pd	575	2	,	,	,
cord-015365-iqdi99pd	575	3	we	-PRON-	PRP
cord-015365-iqdi99pd	575	4	studied	study	VBD
cord-015365-iqdi99pd	575	5	the	the	DT
cord-015365-iqdi99pd	575	6	efficacy	efficacy	NN
cord-015365-iqdi99pd	575	7	and	and	CC
cord-015365-iqdi99pd	575	8	safety	safety	NN
cord-015365-iqdi99pd	575	9	of	of	IN
cord-015365-iqdi99pd	575	10	vildagliptin	vildagliptin	NN
cord-015365-iqdi99pd	575	11	and	and	CC
cord-015365-iqdi99pd	575	12	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	575	13	in	in	IN
cord-015365-iqdi99pd	575	14	patients	patient	NNS
cord-015365-iqdi99pd	575	15	with	with	IN
cord-015365-iqdi99pd	575	16	IGT	IGT	NNP
cord-015365-iqdi99pd	575	17	after	after	IN
cord-015365-iqdi99pd	575	18	renal	renal	JJ
cord-015365-iqdi99pd	575	19	transplantation	transplantation	NN
cord-015365-iqdi99pd	575	20	.	.	.
cord-015365-iqdi99pd	576	1	Methods	method	NNS
cord-015365-iqdi99pd	576	2	.	.	.
cord-015365-iqdi99pd	577	1	After	after	IN
cord-015365-iqdi99pd	577	2	routine	routine	JJ
cord-015365-iqdi99pd	577	3	oral	oral	JJ
cord-015365-iqdi99pd	577	4	glucose	glucose	NN
cord-015365-iqdi99pd	577	5	tolerance	tolerance	NN
cord-015365-iqdi99pd	577	6	testing	testing	NN
cord-015365-iqdi99pd	577	7	(	(	-LRB-
cord-015365-iqdi99pd	577	8	OGTT	OGTT	NNP
cord-015365-iqdi99pd	577	9	)	)	-RRB-
cord-015365-iqdi99pd	577	10	in	in	IN
cord-015365-iqdi99pd	577	11	our	-PRON-	PRP$
cord-015365-iqdi99pd	577	12	center	center	NN
cord-015365-iqdi99pd	577	13	,	,	,
cord-015365-iqdi99pd	577	14	48	48	CD
cord-015365-iqdi99pd	577	15	stable	stable	JJ
cord-015365-iqdi99pd	577	16	renal	renal	JJ
cord-015365-iqdi99pd	577	17	transplant	transplant	NN
cord-015365-iqdi99pd	577	18	patients	patient	NNS
cord-015365-iqdi99pd	577	19	with	with	IN
cord-015365-iqdi99pd	577	20	IGT	IGT	NNP
cord-015365-iqdi99pd	577	21	were	be	VBD
cord-015365-iqdi99pd	577	22	recruited	recruit	VBN
cord-015365-iqdi99pd	577	23	in	in	IN
cord-015365-iqdi99pd	577	24	this	this	DT
cord-015365-iqdi99pd	577	25	double	double	JJ
cord-015365-iqdi99pd	577	26	blind	blind	JJ
cord-015365-iqdi99pd	577	27	,	,	,
cord-015365-iqdi99pd	577	28	prospective	prospective	JJ
cord-015365-iqdi99pd	577	29	study	study	NN
cord-015365-iqdi99pd	577	30	and	and	CC
cord-015365-iqdi99pd	577	31	randomized	randomized	JJ
cord-015365-iqdi99pd	577	32	1	1	CD
cord-015365-iqdi99pd	577	33	:	:	SYM
cord-015365-iqdi99pd	577	34	1	1	CD
cord-015365-iqdi99pd	577	35	:	:	SYM
cord-015365-iqdi99pd	577	36	1	1	CD
cord-015365-iqdi99pd	577	37	to	to	TO
cord-015365-iqdi99pd	577	38	receive	receive	VB
cord-015365-iqdi99pd	577	39	either	either	CC
cord-015365-iqdi99pd	577	40	50	50	CD
cord-015365-iqdi99pd	577	41	mg	mg	NNP
cord-015365-iqdi99pd	577	42	vildagliptin	vildagliptin	NNP
cord-015365-iqdi99pd	577	43	,	,	,
cord-015365-iqdi99pd	577	44	30	30	CD
cord-015365-iqdi99pd	577	45	mg	mg	NN
cord-015365-iqdi99pd	577	46	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	577	47	or	or	CC
cord-015365-iqdi99pd	577	48	placebo	placebo	NN
cord-015365-iqdi99pd	577	49	once	once	RB
cord-015365-iqdi99pd	577	50	daily	daily	RB
cord-015365-iqdi99pd	577	51	for	for	IN
cord-015365-iqdi99pd	577	52	3	3	CD
cord-015365-iqdi99pd	577	53	months	month	NNS
cord-015365-iqdi99pd	577	54	.	.	.
cord-015365-iqdi99pd	578	1	After	after	IN
cord-015365-iqdi99pd	578	2	treatment	treatment	NN
cord-015365-iqdi99pd	578	3	OGTTs	ogtt	NNS
cord-015365-iqdi99pd	578	4	were	be	VBD
cord-015365-iqdi99pd	578	5	performed	perform	VBN
cord-015365-iqdi99pd	578	6	and	and	CC
cord-015365-iqdi99pd	578	7	HbA1c	HbA1c	NNP
cord-015365-iqdi99pd	578	8	levels	level	NNS
cord-015365-iqdi99pd	578	9	along	along	IN
cord-015365-iqdi99pd	578	10	with	with	IN
cord-015365-iqdi99pd	578	11	body	body	NN
cord-015365-iqdi99pd	578	12	mass	mass	NN
cord-015365-iqdi99pd	578	13	index	index	NN
cord-015365-iqdi99pd	578	14	(	(	-LRB-
cord-015365-iqdi99pd	578	15	BMI	BMI	NNP
cord-015365-iqdi99pd	578	16	)	)	-RRB-
cord-015365-iqdi99pd	578	17	,	,	,
cord-015365-iqdi99pd	578	18	metabolic	metabolic	JJ
cord-015365-iqdi99pd	578	19	and	and	CC
cord-015365-iqdi99pd	578	20	safety	safety	NN
cord-015365-iqdi99pd	578	21	parameters	parameter	NNS
cord-015365-iqdi99pd	578	22	were	be	VBD
cord-015365-iqdi99pd	578	23	evaluated	evaluate	VBN
cord-015365-iqdi99pd	578	24	.	.	.
cord-015365-iqdi99pd	579	1	Results	result	NNS
cord-015365-iqdi99pd	579	2	.	.	.
cord-015365-iqdi99pd	580	1	So	so	RB
cord-015365-iqdi99pd	580	2	far	far	RB
cord-015365-iqdi99pd	580	3	45	45	CD
cord-015365-iqdi99pd	580	4	patients	patient	NNS
cord-015365-iqdi99pd	580	5	have	have	VBP
cord-015365-iqdi99pd	580	6	finished	finish	VBN
cord-015365-iqdi99pd	580	7	the	the	DT
cord-015365-iqdi99pd	580	8	study	study	NN
cord-015365-iqdi99pd	580	9	.	.	.
cord-015365-iqdi99pd	581	1	2	2	CD
cord-015365-iqdi99pd	581	2	hour	hour	NN
cord-015365-iqdi99pd	581	3	glucose	glucose	NN
cord-015365-iqdi99pd	581	4	values	value	NNS
cord-015365-iqdi99pd	581	5	improved	improve	VBN
cord-015365-iqdi99pd	581	6	in	in	IN
cord-015365-iqdi99pd	581	7	all	all	DT
cord-015365-iqdi99pd	581	8	three	three	CD
cord-015365-iqdi99pd	581	9	groups	group	NNS
cord-015365-iqdi99pd	581	10	with	with	IN
cord-015365-iqdi99pd	581	11	the	the	DT
cord-015365-iqdi99pd	581	12	greatest	great	JJS
cord-015365-iqdi99pd	581	13	mean	mean	JJ
cord-015365-iqdi99pd	581	14	improvement	improvement	NN
cord-015365-iqdi99pd	581	15	in	in	IN
cord-015365-iqdi99pd	581	16	the	the	DT
cord-015365-iqdi99pd	581	17	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	581	18	group	group	NN
cord-015365-iqdi99pd	581	19	.	.	.
cord-015365-iqdi99pd	582	1	Fasting	fast	VBG
cord-015365-iqdi99pd	582	2	glucose	glucose	NN
cord-015365-iqdi99pd	582	3	values	value	NNS
cord-015365-iqdi99pd	582	4	also	also	RB
cord-015365-iqdi99pd	582	5	showed	show	VBD
cord-015365-iqdi99pd	582	6	the	the	DT
cord-015365-iqdi99pd	582	7	strongest	strong	JJS
cord-015365-iqdi99pd	582	8	improvement	improvement	NN
cord-015365-iqdi99pd	582	9	in	in	IN
cord-015365-iqdi99pd	582	10	the	the	DT
cord-015365-iqdi99pd	582	11	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	582	12	group	group	NN
cord-015365-iqdi99pd	582	13	as	as	RB
cord-015365-iqdi99pd	582	14	well	well	RB
cord-015365-iqdi99pd	582	15	as	as	IN
cord-015365-iqdi99pd	582	16	HbA1c	HbA1c	NNP
cord-015365-iqdi99pd	582	17	(	(	-LRB-
cord-015365-iqdi99pd	582	18	vildagliptin	vildagliptin	NNP
cord-015365-iqdi99pd	582	19	:	:	:
cord-015365-iqdi99pd	582	20	0.079	0.079	CD
cord-015365-iqdi99pd	582	21	%	%	NN
cord-015365-iqdi99pd	582	22	AE	AE	NNP
cord-015365-iqdi99pd	582	23	0.249	0.249	CD
cord-015365-iqdi99pd	582	24	%	%	NN
cord-015365-iqdi99pd	582	25	,	,	,
cord-015365-iqdi99pd	582	26	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	582	27	:	:	:
cord-015365-iqdi99pd	582	28	À0.153	à0.153	CD
cord-015365-iqdi99pd	582	29	%	%	NN
cord-015365-iqdi99pd	582	30	AE	AE	NNP
cord-015365-iqdi99pd	582	31	0.318	0.318	CD
cord-015365-iqdi99pd	582	32	%	%	NN
cord-015365-iqdi99pd	582	33	,	,	,
cord-015365-iqdi99pd	582	34	placebo	placebo	NN
cord-015365-iqdi99pd	582	35	:	:	:
cord-015365-iqdi99pd	582	36	þ0.056	þ0.056	NNP
cord-015365-iqdi99pd	582	37	%	%	NN
cord-015365-iqdi99pd	582	38	AE	AE	NNP
cord-015365-iqdi99pd	582	39	0.294	0.294	CD
cord-015365-iqdi99pd	582	40	%	%	NN
cord-015365-iqdi99pd	582	41	)	)	-RRB-
cord-015365-iqdi99pd	582	42	.	.	.
cord-015365-iqdi99pd	583	1	BMI	BMI	NNP
cord-015365-iqdi99pd	583	2	increased	increase	VBD
cord-015365-iqdi99pd	583	3	in	in	IN
cord-015365-iqdi99pd	583	4	the	the	DT
cord-015365-iqdi99pd	583	5	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	583	6	group	group	NN
cord-015365-iqdi99pd	583	7	and	and	CC
cord-015365-iqdi99pd	583	8	decreased	decrease	VBD
cord-015365-iqdi99pd	583	9	in	in	IN
cord-015365-iqdi99pd	583	10	the	the	DT
cord-015365-iqdi99pd	583	11	vildagliptin	vildagliptin	NN
cord-015365-iqdi99pd	583	12	and	and	CC
cord-015365-iqdi99pd	583	13	placebo	placebo	NN
cord-015365-iqdi99pd	583	14	group	group	NN
cord-015365-iqdi99pd	583	15	.	.	.
cord-015365-iqdi99pd	584	1	The	the	DT
cord-015365-iqdi99pd	584	2	difference	difference	NN
cord-015365-iqdi99pd	584	3	in	in	IN
cord-015365-iqdi99pd	584	4	HbA1c	hba1c	NN
cord-015365-iqdi99pd	584	5	between	between	IN
cord-015365-iqdi99pd	584	6	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	584	7	and	and	CC
cord-015365-iqdi99pd	584	8	placebo	placebo	NN
cord-015365-iqdi99pd	584	9	reached	reach	VBD
cord-015365-iqdi99pd	584	10	marginal	marginal	JJ
cord-015365-iqdi99pd	584	11	statistical	statistical	JJ
cord-015365-iqdi99pd	584	12	significance	significance	NN
cord-015365-iqdi99pd	584	13	at	at	IN
cord-015365-iqdi99pd	584	14	p	p	NN
cord-015365-iqdi99pd	584	15	¼	¼	CD
cord-015365-iqdi99pd	584	16	0.05	0.05	CD
cord-015365-iqdi99pd	584	17	.	.	.
cord-015365-iqdi99pd	585	1	Safety	safety	NN
cord-015365-iqdi99pd	585	2	analysis	analysis	NN
cord-015365-iqdi99pd	585	3	showed	show	VBD
cord-015365-iqdi99pd	585	4	no	no	DT
cord-015365-iqdi99pd	585	5	significant	significant	JJ
cord-015365-iqdi99pd	585	6	influences	influence	NNS
cord-015365-iqdi99pd	585	7	on	on	IN
cord-015365-iqdi99pd	585	8	glomerular	glomerular	JJ
cord-015365-iqdi99pd	585	9	filtration	filtration	NN
cord-015365-iqdi99pd	585	10	rate	rate	NN
cord-015365-iqdi99pd	585	11	(	(	-LRB-
cord-015365-iqdi99pd	585	12	GFR	GFR	NNP
cord-015365-iqdi99pd	585	13	)	)	-RRB-
cord-015365-iqdi99pd	585	14	.	.	.
cord-015365-iqdi99pd	586	1	Pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	586	2	led	lead	VBD
cord-015365-iqdi99pd	586	3	to	to	IN
cord-015365-iqdi99pd	586	4	significant	significant	JJ
cord-015365-iqdi99pd	586	5	reductions	reduction	NNS
cord-015365-iqdi99pd	586	6	in	in	IN
cord-015365-iqdi99pd	586	7	GPT	GPT	NNP
cord-015365-iqdi99pd	586	8	and	and	CC
cord-015365-iqdi99pd	586	9	Gamma	Gamma	NNP
cord-015365-iqdi99pd	586	10	-	-	HYPH
cord-015365-iqdi99pd	586	11	GT	GT	NNP
cord-015365-iqdi99pd	586	12	as	as	RB
cord-015365-iqdi99pd	586	13	well	well	RB
cord-015365-iqdi99pd	586	14	as	as	IN
cord-015365-iqdi99pd	586	15	increases	increase	NNS
cord-015365-iqdi99pd	586	16	in	in	IN
cord-015365-iqdi99pd	586	17	HDL	HDL	NNP
cord-015365-iqdi99pd	586	18	.	.	.
cord-015365-iqdi99pd	587	1	Adverse	adverse	JJ
cord-015365-iqdi99pd	587	2	events	event	NNS
cord-015365-iqdi99pd	587	3	occurred	occur	VBD
cord-015365-iqdi99pd	587	4	at	at	IN
cord-015365-iqdi99pd	587	5	similar	similar	JJ
cord-015365-iqdi99pd	587	6	rate	rate	NN
cord-015365-iqdi99pd	587	7	in	in	IN
cord-015365-iqdi99pd	587	8	all	all	DT
cord-015365-iqdi99pd	587	9	three	three	CD
cord-015365-iqdi99pd	587	10	groups	group	NNS
cord-015365-iqdi99pd	587	11	and	and	CC
cord-015365-iqdi99pd	587	12	were	be	VBD
cord-015365-iqdi99pd	587	13	generally	generally	RB
cord-015365-iqdi99pd	587	14	mild	mild	JJ
cord-015365-iqdi99pd	587	15	and	and	CC
cord-015365-iqdi99pd	587	16	reversible	reversible	JJ
cord-015365-iqdi99pd	587	17	.	.	.
cord-015365-iqdi99pd	588	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	588	2	.	.	.
cord-015365-iqdi99pd	589	1	Vildagliptin	Vildagliptin	NNP
cord-015365-iqdi99pd	589	2	and	and	CC
cord-015365-iqdi99pd	589	3	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	589	4	are	be	VBP
cord-015365-iqdi99pd	589	5	both	both	DT
cord-015365-iqdi99pd	589	6	safe	safe	JJ
cord-015365-iqdi99pd	589	7	and	and	CC
cord-015365-iqdi99pd	589	8	effective	effective	JJ
cord-015365-iqdi99pd	589	9	in	in	IN
cord-015365-iqdi99pd	589	10	patients	patient	NNS
cord-015365-iqdi99pd	589	11	after	after	IN
cord-015365-iqdi99pd	589	12	renal	renal	JJ
cord-015365-iqdi99pd	589	13	transplantation	transplantation	NN
cord-015365-iqdi99pd	589	14	.	.	.
cord-015365-iqdi99pd	590	1	However	however	RB
cord-015365-iqdi99pd	590	2	,	,	,
cord-015365-iqdi99pd	590	3	only	only	RB
cord-015365-iqdi99pd	590	4	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	590	5	led	lead	VBD
cord-015365-iqdi99pd	590	6	to	to	IN
cord-015365-iqdi99pd	590	7	significant	significant	JJ
cord-015365-iqdi99pd	590	8	improvements	improvement	NNS
cord-015365-iqdi99pd	590	9	in	in	IN
cord-015365-iqdi99pd	590	10	glycemic	glycemic	NN
cord-015365-iqdi99pd	590	11	control	control	NN
cord-015365-iqdi99pd	590	12	.	.	.
cord-015365-iqdi99pd	591	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	591	2	,	,	,
cord-015365-iqdi99pd	591	3	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	591	4	led	lead	VBD
cord-015365-iqdi99pd	591	5	to	to	IN
cord-015365-iqdi99pd	591	6	improvements	improvement	NNS
cord-015365-iqdi99pd	591	7	in	in	IN
cord-015365-iqdi99pd	591	8	GFR	GFR	NNP
cord-015365-iqdi99pd	591	9	and	and	CC
cord-015365-iqdi99pd	591	10	lipid	lipid	NN
cord-015365-iqdi99pd	591	11	metabolism	metabolism	NN
cord-015365-iqdi99pd	591	12	besides	besides	IN
cord-015365-iqdi99pd	591	13	causing	cause	VBG
cord-015365-iqdi99pd	591	14	the	the	DT
cord-015365-iqdi99pd	591	15	largest	large	JJS
cord-015365-iqdi99pd	591	16	weight	weight	NN
cord-015365-iqdi99pd	591	17	gain	gain	NN
cord-015365-iqdi99pd	591	18	.	.	.
cord-015365-iqdi99pd	592	1	While	while	IN
cord-015365-iqdi99pd	592	2	further	further	JJ
cord-015365-iqdi99pd	592	3	studies	study	NNS
cord-015365-iqdi99pd	592	4	with	with	IN
cord-015365-iqdi99pd	592	5	longer	long	JJR
cord-015365-iqdi99pd	592	6	observation	observation	NN
cord-015365-iqdi99pd	592	7	periods	period	NNS
cord-015365-iqdi99pd	592	8	are	be	VBP
cord-015365-iqdi99pd	592	9	urgently	urgently	RB
cord-015365-iqdi99pd	592	10	required	require	VBN
cord-015365-iqdi99pd	592	11	,	,	,
cord-015365-iqdi99pd	592	12	pioglitazone	pioglitazone	NN
cord-015365-iqdi99pd	592	13	seems	seem	VBZ
cord-015365-iqdi99pd	592	14	to	to	TO
cord-015365-iqdi99pd	592	15	possess	possess	VB
cord-015365-iqdi99pd	592	16	efficient	efficient	JJ
cord-015365-iqdi99pd	592	17	beta	beta	JJ
cord-015365-iqdi99pd	592	18	-	-	HYPH
cord-015365-iqdi99pd	592	19	cell	cell	NN
cord-015365-iqdi99pd	592	20	protective	protective	JJ
cord-015365-iqdi99pd	592	21	potency	potency	NN
cord-015365-iqdi99pd	592	22	.	.	.
cord-015365-iqdi99pd	593	1	Clinical	clinical	JJ
cord-015365-iqdi99pd	593	2	relevance	relevance	NN
cord-015365-iqdi99pd	593	3	of	of	IN
cord-015365-iqdi99pd	593	4	preformed	preformed	JJ
cord-015365-iqdi99pd	593	5	complement	complement	NN
cord-015365-iqdi99pd	593	6	-	-	:
cord-015365-iqdi99pd	593	7	and	and	CC
cord-015365-iqdi99pd	593	8	non	non	JJ
cord-015365-iqdi99pd	593	9	-	-	JJ
cord-015365-iqdi99pd	593	10	complement	complement	JJ
cord-015365-iqdi99pd	593	11	-	-	HYPH
cord-015365-iqdi99pd	593	12	fixing	fix	VBG
cord-015365-iqdi99pd	593	13	HLA	HLA	NNP
cord-015365-iqdi99pd	593	14	alloreactivity	alloreactivity	NN
cord-015365-iqdi99pd	593	15	in	in	IN
cord-015365-iqdi99pd	593	16	cardiac	cardiac	JJ
cord-015365-iqdi99pd	593	17	transplantation	transplantation	NN
cord-015365-iqdi99pd	593	18	S.	S.	NNP
cord-015365-iqdi99pd	593	19	Mahr	Mahr	NNP
cord-015365-iqdi99pd	593	20	1	1	CD
cord-015365-iqdi99pd	593	21	,	,	,
cord-015365-iqdi99pd	593	22	M.	M.	NNP
cord-015365-iqdi99pd	593	23	Wahrmann	Wahrmann	NNP
cord-015365-iqdi99pd	593	24	2	2	CD
cord-015365-iqdi99pd	593	25	,	,	,
cord-015365-iqdi99pd	593	26	A.	A.	NNP
cord-015365-iqdi99pd	593	27	Zuckermann	Zuckermann	NNP
cord-015365-iqdi99pd	593	28	1	1	CD
cord-015365-iqdi99pd	593	29	,	,	,
cord-015365-iqdi99pd	593	30	G.	G.	NNP
cord-015365-iqdi99pd	593	31	Böhmig	Böhmig	NNP
cord-015365-iqdi99pd	593	32	2	2	CD
cord-015365-iqdi99pd	593	33	Background	Background	NNP
cord-015365-iqdi99pd	593	34	.	.	.
cord-015365-iqdi99pd	594	1	There	there	EX
cord-015365-iqdi99pd	594	2	is	be	VBZ
cord-015365-iqdi99pd	594	3	increasing	increase	VBG
cord-015365-iqdi99pd	594	4	evidence	evidence	NN
cord-015365-iqdi99pd	594	5	for	for	IN
cord-015365-iqdi99pd	594	6	a	a	DT
cord-015365-iqdi99pd	594	7	role	role	NN
cord-015365-iqdi99pd	594	8	of	of	IN
cord-015365-iqdi99pd	594	9	alloantibody	alloantibody	NN
cord-015365-iqdi99pd	594	10	-	-	HYPH
cord-015365-iqdi99pd	594	11	mediated	mediate	VBN
cord-015365-iqdi99pd	594	12	rejection	rejection	NN
cord-015365-iqdi99pd	594	13	in	in	IN
cord-015365-iqdi99pd	594	14	organ	organ	NN
cord-015365-iqdi99pd	594	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	594	16	.	.	.
cord-015365-iqdi99pd	595	1	Solid	solid	JJ
cord-015365-iqdi99pd	595	2	phase	phase	NN
cord-015365-iqdi99pd	595	3	HLA	HLA	NNP
cord-015365-iqdi99pd	595	4	antibody	antibody	NN
cord-015365-iqdi99pd	595	5	detection	detection	NN
cord-015365-iqdi99pd	595	6	using	use	VBG
cord-015365-iqdi99pd	595	7	bead	bead	NN
cord-015365-iqdi99pd	595	8	array	array	NN
cord-015365-iqdi99pd	595	9	technology	technology	NN
cord-015365-iqdi99pd	595	10	may	may	MD
cord-015365-iqdi99pd	595	11	help	help	VB
cord-015365-iqdi99pd	595	12	identify	identify	VB
cord-015365-iqdi99pd	595	13	patients	patient	NNS
cord-015365-iqdi99pd	595	14	at	at	IN
cord-015365-iqdi99pd	595	15	risk	risk	NN
cord-015365-iqdi99pd	595	16	of	of	IN
cord-015365-iqdi99pd	595	17	rejection	rejection	NN
cord-015365-iqdi99pd	595	18	and	and	CC
cord-015365-iqdi99pd	595	19	graft	graft	NN
cord-015365-iqdi99pd	595	20	loss	loss	NN
cord-015365-iqdi99pd	595	21	.	.	.
cord-015365-iqdi99pd	596	1	Methods	method	NNS
cord-015365-iqdi99pd	596	2	.	.	.
cord-015365-iqdi99pd	597	1	In	in	IN
cord-015365-iqdi99pd	597	2	this	this	DT
cord-015365-iqdi99pd	597	3	retrospective	retrospective	JJ
cord-015365-iqdi99pd	597	4	monocentric	monocentric	JJ
cord-015365-iqdi99pd	597	5	cohort	cohort	NN
cord-015365-iqdi99pd	597	6	study	study	NN
cord-015365-iqdi99pd	597	7	we	-PRON-	PRP
cord-015365-iqdi99pd	597	8	evaluated	evaluate	VBD
cord-015365-iqdi99pd	597	9	229	229	CD
cord-015365-iqdi99pd	597	10	consecutive	consecutive	JJ
cord-015365-iqdi99pd	597	11	heart	heart	NN
cord-015365-iqdi99pd	597	12	transplant	transplant	NN
cord-015365-iqdi99pd	597	13	recipients	recipient	NNS
cord-015365-iqdi99pd	597	14	(	(	-LRB-
cord-015365-iqdi99pd	597	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	597	16	between	between	IN
cord-015365-iqdi99pd	597	17	2000	2000	CD
cord-015365-iqdi99pd	597	18	and	and	CC
cord-015365-iqdi99pd	597	19	2006	2006	CD
cord-015365-iqdi99pd	597	20	;	;	:
cord-015365-iqdi99pd	597	21	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	597	22	:	:	:
cord-015365-iqdi99pd	597	23	ATG	ATG	NNP
cord-015365-iqdi99pd	597	24	induction	induction	NN
cord-015365-iqdi99pd	597	25	and	and	CC
cord-015365-iqdi99pd	597	26	calcineurin	calcineurin	JJ
cord-015365-iqdi99pd	597	27	inhibitor	inhibitor	NN
cord-015365-iqdi99pd	597	28	-	-	HYPH
cord-015365-iqdi99pd	597	29	based	base	VBN
cord-015365-iqdi99pd	597	30	maintenance	maintenance	NN
cord-015365-iqdi99pd	597	31	therapy	therapy	NN
cord-015365-iqdi99pd	597	32	)	)	-RRB-
cord-015365-iqdi99pd	597	33	for	for	IN
cord-015365-iqdi99pd	597	34	the	the	DT
cord-015365-iqdi99pd	597	35	presence	presence	NN
cord-015365-iqdi99pd	597	36	of	of	IN
cord-015365-iqdi99pd	597	37	preformed	preformed	JJ
cord-015365-iqdi99pd	597	38	(	(	-LRB-
cord-015365-iqdi99pd	597	39	complement	complement	NN
cord-015365-iqdi99pd	597	40	-	-	:
cord-015365-iqdi99pd	597	41	and	and	CC
cord-015365-iqdi99pd	597	42	non	non	JJ
cord-015365-iqdi99pd	597	43	-	-	JJ
cord-015365-iqdi99pd	597	44	complement	complement	NN
cord-015365-iqdi99pd	597	45	-	-	HYPH
cord-015365-iqdi99pd	597	46	fixing	fix	VBG
cord-015365-iqdi99pd	597	47	)	)	-RRB-
cord-015365-iqdi99pd	597	48	HLA	HLA	NNP
cord-015365-iqdi99pd	597	49	alloantibodies	alloantibody	NNS
cord-015365-iqdi99pd	597	50	.	.	.
cord-015365-iqdi99pd	598	1	Sera	Sera	NNP
cord-015365-iqdi99pd	598	2	obtained	obtain	VBD
cord-015365-iqdi99pd	598	3	immediately	immediately	RB
cord-015365-iqdi99pd	598	4	before	before	IN
cord-015365-iqdi99pd	598	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	598	6	were	be	VBD
cord-015365-iqdi99pd	598	7	screened	screen	VBN
cord-015365-iqdi99pd	598	8	by	by	IN
cord-015365-iqdi99pd	598	9	FlowPRA	FlowPRA	NNP
cord-015365-iqdi99pd	598	10	,	,	,
cord-015365-iqdi99pd	598	11	and	and	CC
cord-015365-iqdi99pd	598	12	test	test	NN
cord-015365-iqdi99pd	598	13	-	-	HYPH
cord-015365-iqdi99pd	598	14	positive	positive	JJ
cord-015365-iqdi99pd	598	15	sera	sera	NNP
cord-015365-iqdi99pd	598	16	were	be	VBD
cord-015365-iqdi99pd	598	17	subjected	subject	VBN
cord-015365-iqdi99pd	598	18	to	to	IN
cord-015365-iqdi99pd	598	19	Luminex	Luminex	NNP
cord-015365-iqdi99pd	598	20	-	-	HYPH
cord-015365-iqdi99pd	598	21	based	base	VBN
cord-015365-iqdi99pd	598	22	single	single	JJ
cord-015365-iqdi99pd	598	23	antigen	antigen	NN
cord-015365-iqdi99pd	598	24	testing	testing	NN
cord-015365-iqdi99pd	598	25	including	include	VBG
cord-015365-iqdi99pd	598	26	a	a	DT
cord-015365-iqdi99pd	598	27	test	test	NN
cord-015365-iqdi99pd	598	28	modification	modification	NN
cord-015365-iqdi99pd	598	29	for	for	IN
cord-015365-iqdi99pd	598	30	detection	detection	NN
cord-015365-iqdi99pd	598	31	of	of	IN
cord-015365-iqdi99pd	598	32	in	in	IN
cord-015365-iqdi99pd	598	33	vitro	vitro	FW
cord-015365-iqdi99pd	598	34	C4d	C4d	NNP
cord-015365-iqdi99pd	598	35	deposition	deposition	NN
cord-015365-iqdi99pd	598	36	.	.	.
cord-015365-iqdi99pd	599	1	Results	result	NNS
cord-015365-iqdi99pd	599	2	.	.	.
cord-015365-iqdi99pd	600	1	Seventeen	seventeen	CD
cord-015365-iqdi99pd	600	2	recipients	recipient	NNS
cord-015365-iqdi99pd	600	3	(	(	-LRB-
cord-015365-iqdi99pd	600	4	7.3	7.3	CD
cord-015365-iqdi99pd	600	5	%	%	NN
cord-015365-iqdi99pd	600	6	)	)	-RRB-
cord-015365-iqdi99pd	600	7	were	be	VBD
cord-015365-iqdi99pd	600	8	found	find	VBN
cord-015365-iqdi99pd	600	9	to	to	TO
cord-015365-iqdi99pd	600	10	have	have	VB
cord-015365-iqdi99pd	600	11	preformed	preform	VBN
cord-015365-iqdi99pd	600	12	IgG	igg	NN
cord-015365-iqdi99pd	600	13	type	type	NN
cord-015365-iqdi99pd	600	14	donor	donor	NN
cord-015365-iqdi99pd	600	15	-	-	HYPH
cord-015365-iqdi99pd	600	16	specific	specific	JJ
cord-015365-iqdi99pd	600	17	alloantibodies	alloantibody	NNS
cord-015365-iqdi99pd	600	18	(	(	-LRB-
cord-015365-iqdi99pd	600	19	DSA	DSA	NNP
cord-015365-iqdi99pd	600	20	)	)	-RRB-
cord-015365-iqdi99pd	600	21	,	,	,
cord-015365-iqdi99pd	600	22	five	five	CD
cord-015365-iqdi99pd	600	23	of	of	IN
cord-015365-iqdi99pd	600	24	them	-PRON-	PRP
cord-015365-iqdi99pd	600	25	with	with	IN
cord-015365-iqdi99pd	600	26	C4d	C4d	NNP
cord-015365-iqdi99pd	600	27	-	-	HYPH
cord-015365-iqdi99pd	600	28	fixing	fix	VBG
cord-015365-iqdi99pd	600	29	capability	capability	NN
cord-015365-iqdi99pd	600	30	.	.	.
cord-015365-iqdi99pd	601	1	The	the	DT
cord-015365-iqdi99pd	601	2	presence	presence	NN
cord-015365-iqdi99pd	601	3	of	of	IN
cord-015365-iqdi99pd	601	4	DSA	DSA	NNP
cord-015365-iqdi99pd	601	5	was	be	VBD
cord-015365-iqdi99pd	601	6	related	relate	VBN
cord-015365-iqdi99pd	601	7	to	to	IN
cord-015365-iqdi99pd	601	8	retransplantation	retransplantation	NN
cord-015365-iqdi99pd	601	9	and	and	CC
cord-015365-iqdi99pd	601	10	previous	previous	JJ
cord-015365-iqdi99pd	601	11	pregnancies	pregnancy	NNS
cord-015365-iqdi99pd	601	12	,	,	,
cord-015365-iqdi99pd	601	13	but	but	CC
cord-015365-iqdi99pd	601	14	not	not	RB
cord-015365-iqdi99pd	601	15	associated	associate	VBN
cord-015365-iqdi99pd	601	16	with	with	IN
cord-015365-iqdi99pd	601	17	prior	prior	JJ
cord-015365-iqdi99pd	601	18	implantation	implantation	NN
cord-015365-iqdi99pd	601	19	of	of	IN
cord-015365-iqdi99pd	601	20	a	a	DT
cord-015365-iqdi99pd	601	21	ventricular	ventricular	JJ
cord-015365-iqdi99pd	601	22	assist	assist	NN
cord-015365-iqdi99pd	601	23	device	device	NN
cord-015365-iqdi99pd	601	24	.	.	.
cord-015365-iqdi99pd	602	1	Evaluating	evaluate	VBG
cord-015365-iqdi99pd	602	2	clinical	clinical	JJ
cord-015365-iqdi99pd	602	3	endpoints	endpoint	NNS
cord-015365-iqdi99pd	602	4	,	,	,
cord-015365-iqdi99pd	602	5	we	-PRON-	PRP
cord-015365-iqdi99pd	602	6	found	find	VBD
cord-015365-iqdi99pd	602	7	an	an	DT
cord-015365-iqdi99pd	602	8	association	association	NN
cord-015365-iqdi99pd	602	9	between	between	IN
cord-015365-iqdi99pd	602	10	DSA	DSA	NNP
cord-015365-iqdi99pd	602	11	and	and	CC
cord-015365-iqdi99pd	602	12	acute	acute	JJ
cord-015365-iqdi99pd	602	13	rejection	rejection	NN
cord-015365-iqdi99pd	602	14	(	(	-LRB-
cord-015365-iqdi99pd	602	15	>	>	NFP
cord-015365-iqdi99pd	602	16	grade	grade	NN
cord-015365-iqdi99pd	602	17	1A	1a	NN
cord-015365-iqdi99pd	602	18	according	accord	VBG
cord-015365-iqdi99pd	602	19	to	to	IN
cord-015365-iqdi99pd	602	20	the	the	DT
cord-015365-iqdi99pd	602	21	ISHLT	ISHLT	NNP
cord-015365-iqdi99pd	602	22	1990	1990	CD
cord-015365-iqdi99pd	602	23	grading	grading	NN
cord-015365-iqdi99pd	602	24	system	system	NN
cord-015365-iqdi99pd	602	25	;	;	:
cord-015365-iqdi99pd	602	26	no	no	DT
cord-015365-iqdi99pd	602	27	DSA	DSA	NNP
cord-015365-iqdi99pd	602	28	:	:	:
cord-015365-iqdi99pd	602	29	17	17	CD
cord-015365-iqdi99pd	602	30	%	%	NN
cord-015365-iqdi99pd	602	31	;	;	,
cord-015365-iqdi99pd	602	32	[	[	-LRB-
cord-015365-iqdi99pd	602	33	IgG]DSA	igg]dsa	NN
cord-015365-iqdi99pd	602	34	:	:	:
cord-015365-iqdi99pd	602	35	33	33	CD
cord-015365-iqdi99pd	602	36	%	%	NN
cord-015365-iqdi99pd	602	37	;	;	.
cord-015365-iqdi99pd	603	1	[	[	-LRB-
cord-015365-iqdi99pd	603	2	IgG	IgG	NNP
cord-015365-iqdi99pd	603	3	/	/	SYM
cord-015365-iqdi99pd	603	4	C4d	C4d	NNP
cord-015365-iqdi99pd	603	5	]	]	-RRB-
cord-015365-iqdi99pd	603	6	DSA	DSA	NNP
cord-015365-iqdi99pd	603	7	:	:	:
cord-015365-iqdi99pd	603	8	60	60	CD
cord-015365-iqdi99pd	603	9	%	%	NN
cord-015365-iqdi99pd	603	10	)	)	-RRB-
cord-015365-iqdi99pd	603	11	.	.	.
cord-015365-iqdi99pd	604	1	However	however	RB
cord-015365-iqdi99pd	604	2	,	,	,
cord-015365-iqdi99pd	604	3	in	in	IN
cord-015365-iqdi99pd	604	4	our	-PRON-	PRP$
cord-015365-iqdi99pd	604	5	study	study	NN
cord-015365-iqdi99pd	604	6	cohort	cohort	NN
cord-015365-iqdi99pd	604	7	,	,	,
cord-015365-iqdi99pd	604	8	sensitization	sensitization	NN
cord-015365-iqdi99pd	604	9	had	have	VBD
cord-015365-iqdi99pd	604	10	no	no	DT
cord-015365-iqdi99pd	604	11	effect	effect	NN
cord-015365-iqdi99pd	604	12	on	on	IN
cord-015365-iqdi99pd	604	13	long	long	JJ
cord-015365-iqdi99pd	604	14	-	-	HYPH
cord-015365-iqdi99pd	604	15	term	term	NN
cord-015365-iqdi99pd	604	16	survival	survival	NN
cord-015365-iqdi99pd	604	17	rates	rate	NNS
cord-015365-iqdi99pd	604	18	(	(	-LRB-
cord-015365-iqdi99pd	604	19	5-year	5-year	CD
cord-015365-iqdi99pd	604	20	transplant	transplant	NN
cord-015365-iqdi99pd	604	21	survival	survival	NN
cord-015365-iqdi99pd	604	22	:	:	:
cord-015365-iqdi99pd	604	23	72	72	CD
cord-015365-iqdi99pd	604	24	%	%	NN
cord-015365-iqdi99pd	604	25	vs.	vs.	IN
cord-015365-iqdi99pd	604	26	92	92	CD
cord-015365-iqdi99pd	604	27	%	%	NN
cord-015365-iqdi99pd	604	28	vs.	vs.	CC
cord-015365-iqdi99pd	604	29	80	80	CD
cord-015365-iqdi99pd	604	30	%	%	NN
cord-015365-iqdi99pd	604	31	)	)	-RRB-
cord-015365-iqdi99pd	604	32	or	or	CC
cord-015365-iqdi99pd	604	33	rates	rate	NNS
cord-015365-iqdi99pd	604	34	of	of	IN
cord-015365-iqdi99pd	604	35	chronic	chronic	JJ
cord-015365-iqdi99pd	604	36	transplant	transplant	NN
cord-015365-iqdi99pd	604	37	vasculopathy	vasculopathy	NNP
cord-015365-iqdi99pd	604	38	(	(	-LRB-
cord-015365-iqdi99pd	604	39	20	20	CD
cord-015365-iqdi99pd	604	40	%	%	NN
cord-015365-iqdi99pd	604	41	vs.	vs.	CC
cord-015365-iqdi99pd	604	42	18	18	CD
cord-015365-iqdi99pd	604	43	%	%	NN
cord-015365-iqdi99pd	604	44	vs.	vs.	CC
cord-015365-iqdi99pd	604	45	20	20	CD
cord-015365-iqdi99pd	604	46	%	%	NN
cord-015365-iqdi99pd	604	47	)	)	-RRB-
cord-015365-iqdi99pd	604	48	.	.	.
cord-015365-iqdi99pd	605	1	Moreover	moreover	RB
cord-015365-iqdi99pd	605	2	,	,	,
cord-015365-iqdi99pd	605	3	none	none	NN
cord-015365-iqdi99pd	605	4	of	of	IN
cord-015365-iqdi99pd	605	5	the	the	DT
cord-015365-iqdi99pd	605	6	DSA	DSA	NNP
cord-015365-iqdi99pd	605	7	-	-	HYPH
cord-015365-iqdi99pd	605	8	positive	positive	JJ
cord-015365-iqdi99pd	605	9	patients	patient	NNS
cord-015365-iqdi99pd	605	10	was	be	VBD
cord-015365-iqdi99pd	605	11	in	in	IN
cord-015365-iqdi99pd	605	12	need	need	NN
cord-015365-iqdi99pd	605	13	of	of	IN
cord-015365-iqdi99pd	605	14	extracorporeal	extracorporeal	JJ
cord-015365-iqdi99pd	605	15	membrane	membrane	NN
cord-015365-iqdi99pd	605	16	oxygenation	oxygenation	NN
cord-015365-iqdi99pd	605	17	,	,	,
cord-015365-iqdi99pd	605	18	and	and	CC
cord-015365-iqdi99pd	605	19	the	the	DT
cord-015365-iqdi99pd	605	20	duration	duration	NN
cord-015365-iqdi99pd	605	21	of	of	IN
cord-015365-iqdi99pd	605	22	post	post	JJ
cord-015365-iqdi99pd	605	23	-	-	JJ
cord-015365-iqdi99pd	605	24	transplant	transplant	JJ
cord-015365-iqdi99pd	605	25	intensive	intensive	JJ
cord-015365-iqdi99pd	605	26	care	care	NN
cord-015365-iqdi99pd	605	27	did	do	VBD
cord-015365-iqdi99pd	605	28	not	not	RB
cord-015365-iqdi99pd	605	29	differ	differ	VB
cord-015365-iqdi99pd	605	30	between	between	IN
cord-015365-iqdi99pd	605	31	groups	group	NNS
cord-015365-iqdi99pd	605	32	.	.	.
cord-015365-iqdi99pd	606	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	606	2	.	.	.
cord-015365-iqdi99pd	607	1	In	in	IN
cord-015365-iqdi99pd	607	2	conclusion	conclusion	NN
cord-015365-iqdi99pd	607	3	,	,	,
cord-015365-iqdi99pd	607	4	our	-PRON-	PRP$
cord-015365-iqdi99pd	607	5	data	data	NN
cord-015365-iqdi99pd	607	6	point	point	NN
cord-015365-iqdi99pd	607	7	to	to	IN
cord-015365-iqdi99pd	607	8	a	a	DT
cord-015365-iqdi99pd	607	9	relationship	relationship	NN
cord-015365-iqdi99pd	607	10	between	between	IN
cord-015365-iqdi99pd	607	11	preformed	preformed	JJ
cord-015365-iqdi99pd	607	12	donor	donor	NN
cord-015365-iqdi99pd	607	13	-	-	HYPH
cord-015365-iqdi99pd	607	14	specific	specific	JJ
cord-015365-iqdi99pd	607	15	alloreactivity	alloreactivity	NN
cord-015365-iqdi99pd	607	16	and	and	CC
cord-015365-iqdi99pd	607	17	acute	acute	JJ
cord-015365-iqdi99pd	607	18	rejection	rejection	NN
cord-015365-iqdi99pd	607	19	.	.	.
cord-015365-iqdi99pd	608	1	However	however	RB
cord-015365-iqdi99pd	608	2	,	,	,
cord-015365-iqdi99pd	608	3	possibly	possibly	RB
cord-015365-iqdi99pd	608	4	as	as	IN
cord-015365-iqdi99pd	608	5	a	a	DT
cord-015365-iqdi99pd	608	6	result	result	NN
cord-015365-iqdi99pd	608	7	of	of	IN
cord-015365-iqdi99pd	608	8	our	-PRON-	PRP$
cord-015365-iqdi99pd	608	9	local	local	JJ
cord-015365-iqdi99pd	608	10	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	608	11	regimen	regimen	NN
cord-015365-iqdi99pd	608	12	,	,	,
cord-015365-iqdi99pd	608	13	which	which	WDT
cord-015365-iqdi99pd	608	14	also	also	RB
cord-015365-iqdi99pd	608	15	includes	include	VBZ
cord-015365-iqdi99pd	608	16	induction	induction	NN
cord-015365-iqdi99pd	608	17	therapy	therapy	NN
cord-015365-iqdi99pd	608	18	with	with	IN
cord-015365-iqdi99pd	608	19	a	a	DT
cord-015365-iqdi99pd	608	20	depleting	deplete	VBG
cord-015365-iqdi99pd	608	21	anti	anti	JJ
cord-015365-iqdi99pd	608	22	-	-	JJ
cord-015365-iqdi99pd	608	23	lymphocyte	lymphocyte	JJ
cord-015365-iqdi99pd	608	24	antibody	antibody	NN
cord-015365-iqdi99pd	608	25	,	,	,
cord-015365-iqdi99pd	608	26	such	such	JJ
cord-015365-iqdi99pd	608	27	reactivity	reactivity	NN
cord-015365-iqdi99pd	608	28	did	do	VBD
cord-015365-iqdi99pd	608	29	not	not	RB
cord-015365-iqdi99pd	608	30	influence	influence	VB
cord-015365-iqdi99pd	608	31	long	long	JJ
cord-015365-iqdi99pd	608	32	-	-	HYPH
cord-015365-iqdi99pd	608	33	term	term	NN
cord-015365-iqdi99pd	608	34	allograft	allograft	NN
cord-015365-iqdi99pd	608	35	outcomes	outcome	NNS
cord-015365-iqdi99pd	608	36	.	.	.
cord-015365-iqdi99pd	609	1	Background	background	NN
cord-015365-iqdi99pd	609	2	.	.	.
cord-015365-iqdi99pd	610	1	So	so	RB
cord-015365-iqdi99pd	610	2	far	far	RB
cord-015365-iqdi99pd	610	3	,	,	,
cord-015365-iqdi99pd	610	4	no	no	DT
cord-015365-iqdi99pd	610	5	data	data	NN
cord-015365-iqdi99pd	610	6	is	be	VBZ
cord-015365-iqdi99pd	610	7	available	available	JJ
cord-015365-iqdi99pd	610	8	on	on	IN
cord-015365-iqdi99pd	610	9	the	the	DT
cord-015365-iqdi99pd	610	10	use	use	NN
cord-015365-iqdi99pd	610	11	of	of	IN
cord-015365-iqdi99pd	610	12	everolimus	everolimus	NN
cord-015365-iqdi99pd	610	13	in	in	IN
cord-015365-iqdi99pd	610	14	pediatric	pediatric	JJ
cord-015365-iqdi99pd	610	15	cardiac	cardiac	JJ
cord-015365-iqdi99pd	610	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	610	17	.	.	.
cord-015365-iqdi99pd	611	1	We	-PRON-	PRP
cord-015365-iqdi99pd	611	2	present	present	VBP
cord-015365-iqdi99pd	611	3	the	the	DT
cord-015365-iqdi99pd	611	4	first	first	JJ
cord-015365-iqdi99pd	611	5	results	result	NNS
cord-015365-iqdi99pd	611	6	of	of	IN
cord-015365-iqdi99pd	611	7	everolimus	everolimus	NN
cord-015365-iqdi99pd	611	8	in	in	IN
cord-015365-iqdi99pd	611	9	pediatric	pediatric	JJ
cord-015365-iqdi99pd	611	10	heart	heart	NN
cord-015365-iqdi99pd	611	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	611	12	.	.	.
cord-015365-iqdi99pd	612	1	Methods	method	NNS
cord-015365-iqdi99pd	612	2	.	.	.
cord-015365-iqdi99pd	613	1	From	from	IN
cord-015365-iqdi99pd	613	2	2000	2000	CD
cord-015365-iqdi99pd	613	3	to	to	IN
cord-015365-iqdi99pd	613	4	2008	2008	CD
cord-015365-iqdi99pd	613	5	,	,	,
cord-015365-iqdi99pd	613	6	HTx	HTx	NNS
cord-015365-iqdi99pd	613	7	was	be	VBD
cord-015365-iqdi99pd	613	8	performed	perform	VBN
cord-015365-iqdi99pd	613	9	in	in	IN
cord-015365-iqdi99pd	613	10	86	86	CD
cord-015365-iqdi99pd	613	11	children	child	NNS
cord-015365-iqdi99pd	613	12	aged	age	VBN
cord-015365-iqdi99pd	613	13	below	below	IN
cord-015365-iqdi99pd	613	14	17	17	CD
cord-015365-iqdi99pd	613	15	years	year	NNS
cord-015365-iqdi99pd	613	16	.	.	.
cord-015365-iqdi99pd	614	1	52	52	CD
cord-015365-iqdi99pd	614	2	of	of	IN
cord-015365-iqdi99pd	614	3	these	these	DT
cord-015365-iqdi99pd	614	4	children	child	NNS
cord-015365-iqdi99pd	614	5	received	receive	VBD
cord-015365-iqdi99pd	614	6	continuously	continuously	RB
cord-015365-iqdi99pd	614	7	either	either	CC
cord-015365-iqdi99pd	614	8	mycophenolat	mycophenolat	NNP
cord-015365-iqdi99pd	614	9	mofetil	mofetil	NNP
cord-015365-iqdi99pd	614	10	(	(	-LRB-
cord-015365-iqdi99pd	614	11	MMF	MMF	NNP
cord-015365-iqdi99pd	614	12	)	)	-RRB-
cord-015365-iqdi99pd	615	1	(	(	-LRB-
cord-015365-iqdi99pd	615	2	Group	Group	NNP
cord-015365-iqdi99pd	615	3	A	A	NNP
cord-015365-iqdi99pd	615	4	,	,	,
cord-015365-iqdi99pd	615	5	n	n	NN
cord-015365-iqdi99pd	615	6	¼	¼	NNP
cord-015365-iqdi99pd	615	7	28	28	CD
cord-015365-iqdi99pd	615	8	)	)	-RRB-
cord-015365-iqdi99pd	615	9	with	with	IN
cord-015365-iqdi99pd	615	10	standard	standard	JJ
cord-015365-iqdi99pd	615	11	cyclosporine	cyclosporine	NN
cord-015365-iqdi99pd	615	12	A	a	NN
cord-015365-iqdi99pd	615	13	(	(	-LRB-
cord-015365-iqdi99pd	615	14	CsA	CsA	NNP
cord-015365-iqdi99pd	615	15	)	)	-RRB-
cord-015365-iqdi99pd	615	16	exposure	exposure	NN
cord-015365-iqdi99pd	615	17	or	or	CC
cord-015365-iqdi99pd	615	18	were	be	VBD
cord-015365-iqdi99pd	615	19	randomized	randomize	VBN
cord-015365-iqdi99pd	615	20	to	to	TO
cord-015365-iqdi99pd	615	21	receive	receive	VB
cord-015365-iqdi99pd	615	22	everolimus	everolimus	NNP
cord-015365-iqdi99pd	615	23	(	(	-LRB-
cord-015365-iqdi99pd	615	24	EVE	EVE	NNP
cord-015365-iqdi99pd	615	25	)	)	-RRB-
cord-015365-iqdi99pd	616	1	(	(	-LRB-
cord-015365-iqdi99pd	616	2	Group	Group	NNP
cord-015365-iqdi99pd	616	3	B	B	NNP
cord-015365-iqdi99pd	616	4	,	,	,
cord-015365-iqdi99pd	616	5	n	n	NN
cord-015365-iqdi99pd	616	6	¼	¼	NNP
cord-015365-iqdi99pd	616	7	24	24	CD
cord-015365-iqdi99pd	616	8	)	)	-RRB-
cord-015365-iqdi99pd	616	9	with	with	IN
cord-015365-iqdi99pd	616	10	reduced	reduce	VBN
cord-015365-iqdi99pd	616	11	CsA	csa	NN
cord-015365-iqdi99pd	616	12	exposure	exposure	NN
cord-015365-iqdi99pd	616	13	in	in	IN
cord-015365-iqdi99pd	616	14	combination	combination	NN
cord-015365-iqdi99pd	616	15	with	with	IN
cord-015365-iqdi99pd	616	16	steroids	steroid	NNS
cord-015365-iqdi99pd	616	17	.	.	.
cord-015365-iqdi99pd	617	1	During	during	IN
cord-015365-iqdi99pd	617	2	a	a	DT
cord-015365-iqdi99pd	617	3	follow	follow	NN
cord-015365-iqdi99pd	617	4	-	-	HYPH
cord-015365-iqdi99pd	617	5	up	up	NN
cord-015365-iqdi99pd	617	6	period	period	NN
cord-015365-iqdi99pd	617	7	of	of	IN
cord-015365-iqdi99pd	617	8	24	24	CD
cord-015365-iqdi99pd	617	9	months	month	NNS
cord-015365-iqdi99pd	617	10	,	,	,
cord-015365-iqdi99pd	617	11	efficacy	efficacy	NN
cord-015365-iqdi99pd	617	12	with	with	IN
cord-015365-iqdi99pd	617	13	regard	regard	NN
cord-015365-iqdi99pd	617	14	to	to	IN
cord-015365-iqdi99pd	617	15	acute	acute	JJ
cord-015365-iqdi99pd	617	16	rejection	rejection	NN
cord-015365-iqdi99pd	617	17	,	,	,
cord-015365-iqdi99pd	617	18	allograft	allograft	NN
cord-015365-iqdi99pd	617	19	vasculopathy	vasculopathy	NNP
cord-015365-iqdi99pd	617	20	and	and	CC
cord-015365-iqdi99pd	617	21	survival	survival	NN
cord-015365-iqdi99pd	617	22	as	as	RB
cord-015365-iqdi99pd	617	23	well	well	RB
cord-015365-iqdi99pd	617	24	as	as	IN
cord-015365-iqdi99pd	617	25	safety	safety	NN
cord-015365-iqdi99pd	617	26	with	with	IN
cord-015365-iqdi99pd	617	27	regard	regard	NN
cord-015365-iqdi99pd	617	28	to	to	IN
cord-015365-iqdi99pd	617	29	myelosuppression	myelosuppression	NN
cord-015365-iqdi99pd	617	30	,	,	,
cord-015365-iqdi99pd	617	31	infection	infection	NN
cord-015365-iqdi99pd	617	32	,	,	,
cord-015365-iqdi99pd	617	33	tumors	tumor	NNS
cord-015365-iqdi99pd	617	34	,	,	,
cord-015365-iqdi99pd	617	35	lipids	lipid	NNS
cord-015365-iqdi99pd	617	36	and	and	CC
cord-015365-iqdi99pd	617	37	body	body	NN
cord-015365-iqdi99pd	617	38	growth	growth	NN
cord-015365-iqdi99pd	617	39	was	be	VBD
cord-015365-iqdi99pd	617	40	studied	study	VBN
cord-015365-iqdi99pd	617	41	.	.	.
cord-015365-iqdi99pd	618	1	Results	result	NNS
cord-015365-iqdi99pd	618	2	.	.	.
cord-015365-iqdi99pd	619	1	Mean	mean	JJ
cord-015365-iqdi99pd	619	2	post	post	NNP
cord-015365-iqdi99pd	620	1	Htx	Htx	NNP
cord-015365-iqdi99pd	620	2	CsA	csa	NN
cord-015365-iqdi99pd	620	3	exposure	exposure	NN
cord-015365-iqdi99pd	620	4	was	be	VBD
cord-015365-iqdi99pd	620	5	significantly	significantly	RB
cord-015365-iqdi99pd	620	6	lower	low	JJR
cord-015365-iqdi99pd	620	7	in	in	IN
cord-015365-iqdi99pd	620	8	EVE	EVE	NNP
cord-015365-iqdi99pd	620	9	treated	treat	VBD
cord-015365-iqdi99pd	620	10	children	child	NNS
cord-015365-iqdi99pd	620	11	compared	compare	VBN
cord-015365-iqdi99pd	620	12	to	to	IN
cord-015365-iqdi99pd	620	13	MMF	MMF	NNP
cord-015365-iqdi99pd	620	14	at	at	IN
cord-015365-iqdi99pd	620	15	month	month	NN
cord-015365-iqdi99pd	620	16	6	6	CD
cord-015365-iqdi99pd	621	1	(	(	-LRB-
cord-015365-iqdi99pd	621	2	167	167	CD
cord-015365-iqdi99pd	621	3	ng	ng	NN
cord-015365-iqdi99pd	621	4	/	/	SYM
cord-015365-iqdi99pd	621	5	ml	ml	NN
cord-015365-iqdi99pd	622	1	versus	versus	IN
cord-015365-iqdi99pd	622	2	284	284	CD
cord-015365-iqdi99pd	622	3	ng	ng	NNP
cord-015365-iqdi99pd	622	4	/	/	SYM
cord-015365-iqdi99pd	622	5	ml	ml	NN
cord-015365-iqdi99pd	622	6	)	)	-RRB-
cord-015365-iqdi99pd	622	7	,	,	,
cord-015365-iqdi99pd	622	8	month	month	NN
cord-015365-iqdi99pd	622	9	12	12	CD
cord-015365-iqdi99pd	623	1	(	(	-LRB-
cord-015365-iqdi99pd	623	2	mean	mean	VB
cord-015365-iqdi99pd	623	3	134	134	CD
cord-015365-iqdi99pd	623	4	ng	ng	NN
cord-015365-iqdi99pd	623	5	/	/	SYM
cord-015365-iqdi99pd	623	6	ml	ml	NN
cord-015365-iqdi99pd	623	7	versus	versus	IN
cord-015365-iqdi99pd	623	8	235	235	CD
cord-015365-iqdi99pd	623	9	ng	ng	NN
cord-015365-iqdi99pd	623	10	/	/	SYM
cord-015365-iqdi99pd	623	11	ml	ml	NN
cord-015365-iqdi99pd	623	12	)	)	-RRB-
cord-015365-iqdi99pd	623	13	and	and	CC
cord-015365-iqdi99pd	623	14	month	month	NN
cord-015365-iqdi99pd	623	15	24	24	CD
cord-015365-iqdi99pd	623	16	(	(	-LRB-
cord-015365-iqdi99pd	623	17	79	79	CD
cord-015365-iqdi99pd	623	18	ng	ng	NN
cord-015365-iqdi99pd	623	19	/	/	SYM
cord-015365-iqdi99pd	623	20	ml	ml	NN
cord-015365-iqdi99pd	624	1	versus	versus	IN
cord-015365-iqdi99pd	624	2	76	76	CD
cord-015365-iqdi99pd	624	3	ng	ng	NNP
cord-015365-iqdi99pd	624	4	/	/	SYM
cord-015365-iqdi99pd	624	5	ml	ml	NN
cord-015365-iqdi99pd	624	6	)	)	-RRB-
cord-015365-iqdi99pd	624	7	.	.	.
cord-015365-iqdi99pd	625	1	Mean	mean	JJ
cord-015365-iqdi99pd	625	2	daily	daily	JJ
cord-015365-iqdi99pd	625	3	dose	dose	NN
cord-015365-iqdi99pd	625	4	of	of	IN
cord-015365-iqdi99pd	625	5	EVE	EVE	NNP
cord-015365-iqdi99pd	625	6	was	be	VBD
cord-015365-iqdi99pd	625	7	1.16	1.16	CD
cord-015365-iqdi99pd	625	8	AE	AE	NNP
cord-015365-iqdi99pd	625	9	0.56	0.56	CD
cord-015365-iqdi99pd	625	10	mg	mg	NNP
cord-015365-iqdi99pd	625	11	/	/	SYM
cord-015365-iqdi99pd	625	12	m	m	NNP
cord-015365-iqdi99pd	625	13	2	2	CD
cord-015365-iqdi99pd	625	14	body	body	NN
cord-015365-iqdi99pd	625	15	surface	surface	NN
cord-015365-iqdi99pd	625	16	area	area	NN
cord-015365-iqdi99pd	625	17	resulting	result	VBG
cord-015365-iqdi99pd	625	18	in	in	IN
cord-015365-iqdi99pd	625	19	trough	trough	NN
cord-015365-iqdi99pd	625	20	levels	level	NNS
cord-015365-iqdi99pd	625	21	of	of	IN
cord-015365-iqdi99pd	625	22	4.8	4.8	CD
cord-015365-iqdi99pd	625	23	AE	AE	NNP
cord-015365-iqdi99pd	625	24	1.3	1.3	CD
cord-015365-iqdi99pd	625	25	ng	ng	NN
cord-015365-iqdi99pd	625	26	/	/	SYM
cord-015365-iqdi99pd	625	27	ml	ml	NN
cord-015365-iqdi99pd	625	28	by	by	IN
cord-015365-iqdi99pd	625	29	24	24	CD
cord-015365-iqdi99pd	625	30	months	month	NNS
cord-015365-iqdi99pd	625	31	of	of	IN
cord-015365-iqdi99pd	625	32	follow	follow	NN
cord-015365-iqdi99pd	625	33	-	-	HYPH
cord-015365-iqdi99pd	625	34	up	up	NN
cord-015365-iqdi99pd	625	35	.	.	.
cord-015365-iqdi99pd	626	1	Two	two	CD
cord-015365-iqdi99pd	626	2	cases	case	NNS
cord-015365-iqdi99pd	626	3	in	in	IN
cord-015365-iqdi99pd	626	4	each	each	DT
cord-015365-iqdi99pd	626	5	group	group	NN
cord-015365-iqdi99pd	626	6	encountered	encounter	VBD
cord-015365-iqdi99pd	626	7	biopsyproven	biopsyproven	NN
cord-015365-iqdi99pd	626	8	acute	acute	JJ
cord-015365-iqdi99pd	626	9	rejection	rejection	NN
cord-015365-iqdi99pd	626	10	>	>	XX
cord-015365-iqdi99pd	626	11	grade	grade	NN
cord-015365-iqdi99pd	626	12	2R	2R	NNP
cord-015365-iqdi99pd	626	13	(	(	-LRB-
cord-015365-iqdi99pd	626	14	7	7	CD
cord-015365-iqdi99pd	626	15	%	%	NN
cord-015365-iqdi99pd	626	16	versus	versus	IN
cord-015365-iqdi99pd	626	17	8	8	CD
cord-015365-iqdi99pd	626	18	%	%	NN
cord-015365-iqdi99pd	626	19	;	;	:
cord-015365-iqdi99pd	626	20	p	p	NN
cord-015365-iqdi99pd	626	21	¼	¼	CD
cord-015365-iqdi99pd	626	22	0.043	0.043	CD
cord-015365-iqdi99pd	626	23	)	)	-RRB-
cord-015365-iqdi99pd	626	24	.	.	.
cord-015365-iqdi99pd	627	1	Cardiac	cardiac	JJ
cord-015365-iqdi99pd	627	2	allograft	allograft	NN
cord-015365-iqdi99pd	627	3	vasculopathy	vasculopathy	NNP
cord-015365-iqdi99pd	627	4	at	at	IN
cord-015365-iqdi99pd	627	5	month	month	NN
cord-015365-iqdi99pd	627	6	12	12	CD
cord-015365-iqdi99pd	627	7	was	be	VBD
cord-015365-iqdi99pd	627	8	detected	detect	VBN
cord-015365-iqdi99pd	627	9	in	in	IN
cord-015365-iqdi99pd	627	10	4	4	CD
cord-015365-iqdi99pd	627	11	children	child	NNS
cord-015365-iqdi99pd	627	12	(	(	-LRB-
cord-015365-iqdi99pd	627	13	16	16	CD
cord-015365-iqdi99pd	627	14	%	%	NN
cord-015365-iqdi99pd	627	15	)	)	-RRB-
cord-015365-iqdi99pd	627	16	with	with	IN
cord-015365-iqdi99pd	627	17	EVE	EVE	NNP
cord-015365-iqdi99pd	627	18	compared	compare	VBN
cord-015365-iqdi99pd	627	19	to	to	IN
cord-015365-iqdi99pd	627	20	18	18	CD
cord-015365-iqdi99pd	627	21	%	%	NN
cord-015365-iqdi99pd	627	22	in	in	IN
cord-015365-iqdi99pd	627	23	MMF	MMF	NNP
cord-015365-iqdi99pd	627	24	.	.	.
cord-015365-iqdi99pd	628	1	Kidney	kidney	NN
cord-015365-iqdi99pd	628	2	function	function	NN
cord-015365-iqdi99pd	628	3	deteriorated	deteriorate	VBD
cord-015365-iqdi99pd	628	4	in	in	IN
cord-015365-iqdi99pd	628	5	both	both	DT
cord-015365-iqdi99pd	628	6	groups	group	NNS
cord-015365-iqdi99pd	628	7	during	during	IN
cord-015365-iqdi99pd	628	8	the	the	DT
cord-015365-iqdi99pd	628	9	first	first	JJ
cord-015365-iqdi99pd	628	10	month	month	NN
cord-015365-iqdi99pd	628	11	,	,	,
cord-015365-iqdi99pd	628	12	recovering	recover	VBG
cord-015365-iqdi99pd	628	13	after	after	IN
cord-015365-iqdi99pd	628	14	24	24	CD
cord-015365-iqdi99pd	628	15	months	month	NNS
cord-015365-iqdi99pd	628	16	to	to	IN
cord-015365-iqdi99pd	628	17	a	a	DT
cord-015365-iqdi99pd	628	18	glomerular	glomerular	JJ
cord-015365-iqdi99pd	628	19	filtration	filtration	NN
cord-015365-iqdi99pd	628	20	rate	rate	NN
cord-015365-iqdi99pd	628	21	of	of	IN
cord-015365-iqdi99pd	628	22	95.1	95.1	CD
cord-015365-iqdi99pd	628	23	AE	AE	NNP
cord-015365-iqdi99pd	628	24	0.3	0.3	CD
cord-015365-iqdi99pd	628	25	ml	ml	NN
cord-015365-iqdi99pd	628	26	/	/	SYM
cord-015365-iqdi99pd	628	27	min	min	NN
cord-015365-iqdi99pd	628	28	/	/	SYM
cord-015365-iqdi99pd	628	29	sqm	sqm	NN
cord-015365-iqdi99pd	628	30	for	for	IN
cord-015365-iqdi99pd	628	31	EVE	EVE	NNP
cord-015365-iqdi99pd	628	32	versus	versus	IN
cord-015365-iqdi99pd	628	33	88.9	88.9	CD
cord-015365-iqdi99pd	628	34	AE	AE	NNP
cord-015365-iqdi99pd	628	35	5.2	5.2	CD
cord-015365-iqdi99pd	628	36	ml	ml	NNS
cord-015365-iqdi99pd	628	37	/	/	SYM
cord-015365-iqdi99pd	628	38	min	min	NN
cord-015365-iqdi99pd	628	39	/	/	SYM
cord-015365-iqdi99pd	628	40	sqm	sqm	NN
cord-015365-iqdi99pd	628	41	for	for	IN
cord-015365-iqdi99pd	628	42	MMF	MMF	NNP
cord-015365-iqdi99pd	628	43	.	.	.
cord-015365-iqdi99pd	629	1	Rates	rate	NNS
cord-015365-iqdi99pd	629	2	of	of	IN
cord-015365-iqdi99pd	629	3	myelosuppressive	myelosuppressive	NNP
cord-015365-iqdi99pd	629	4	disorders	disorder	NNS
cord-015365-iqdi99pd	629	5	(	(	-LRB-
cord-015365-iqdi99pd	629	6	anaemia	anaemia	NN
cord-015365-iqdi99pd	629	7	,	,	,
cord-015365-iqdi99pd	629	8	leukopenia	leukopenia	NN
cord-015365-iqdi99pd	629	9	,	,	,
cord-015365-iqdi99pd	629	10	thrombocytopenia	thrombocytopenia	NN
cord-015365-iqdi99pd	629	11	)	)	-RRB-
cord-015365-iqdi99pd	629	12	,	,	,
cord-015365-iqdi99pd	629	13	infections	infection	NNS
cord-015365-iqdi99pd	629	14	and	and	CC
cord-015365-iqdi99pd	629	15	hyperlipidaemia	hyperlipidaemia	NN
cord-015365-iqdi99pd	629	16	was	be	VBD
cord-015365-iqdi99pd	629	17	low	low	JJ
cord-015365-iqdi99pd	629	18	and	and	CC
cord-015365-iqdi99pd	629	19	comparable	comparable	JJ
cord-015365-iqdi99pd	629	20	in	in	IN
cord-015365-iqdi99pd	629	21	both	both	DT
cord-015365-iqdi99pd	629	22	groups	group	NNS
cord-015365-iqdi99pd	629	23	.	.	.
cord-015365-iqdi99pd	630	1	Children	child	NNS
cord-015365-iqdi99pd	630	2	with	with	IN
cord-015365-iqdi99pd	630	3	EVE	EVE	NNP
cord-015365-iqdi99pd	630	4	did	do	VBD
cord-015365-iqdi99pd	630	5	not	not	RB
cord-015365-iqdi99pd	630	6	encounter	encounter	VB
cord-015365-iqdi99pd	630	7	inferiority	inferiority	NN
cord-015365-iqdi99pd	630	8	in	in	IN
cord-015365-iqdi99pd	630	9	body	body	NN
cord-015365-iqdi99pd	630	10	growth	growth	NN
cord-015365-iqdi99pd	630	11	.	.	.
cord-015365-iqdi99pd	631	1	1	1	CD
cord-015365-iqdi99pd	631	2	child	child	NN
cord-015365-iqdi99pd	631	3	with	with	IN
cord-015365-iqdi99pd	631	4	EVE	EVE	NNP
cord-015365-iqdi99pd	631	5	died	die	VBD
cord-015365-iqdi99pd	631	6	following	follow	VBG
cord-015365-iqdi99pd	631	7	intractable	intractable	JJ
cord-015365-iqdi99pd	631	8	ventricular	ventricular	JJ
cord-015365-iqdi99pd	631	9	fibrillation	fibrillation	NN
cord-015365-iqdi99pd	631	10	during	during	IN
cord-015365-iqdi99pd	631	11	myocardial	myocardial	JJ
cord-015365-iqdi99pd	631	12	biopsy	biopsy	NN
cord-015365-iqdi99pd	631	13	compared	compare	VBN
cord-015365-iqdi99pd	631	14	to	to	IN
cord-015365-iqdi99pd	631	15	5	5	CD
cord-015365-iqdi99pd	631	16	children	child	NNS
cord-015365-iqdi99pd	631	17	with	with	IN
cord-015365-iqdi99pd	631	18	MMF	mmf	NN
cord-015365-iqdi99pd	631	19	(	(	-LRB-
cord-015365-iqdi99pd	631	20	2	2	CD
cord-015365-iqdi99pd	631	21	deaths	death	NNS
cord-015365-iqdi99pd	631	22	due	due	JJ
cord-015365-iqdi99pd	631	23	to	to	IN
cord-015365-iqdi99pd	631	24	allograft	allograft	NN
cord-015365-iqdi99pd	631	25	rejection	rejection	NN
cord-015365-iqdi99pd	631	26	)	)	-RRB-
cord-015365-iqdi99pd	631	27	.	.	.
cord-015365-iqdi99pd	632	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	632	2	.	.	.
cord-015365-iqdi99pd	633	1	Everolimus	Everolimus	NNP
cord-015365-iqdi99pd	633	2	with	with	IN
cord-015365-iqdi99pd	633	3	reduced	reduce	VBN
cord-015365-iqdi99pd	633	4	CsA	csa	NN
cord-015365-iqdi99pd	633	5	combined	combine	VBN
cord-015365-iqdi99pd	633	6	with	with	IN
cord-015365-iqdi99pd	633	7	steroids	steroid	NNS
cord-015365-iqdi99pd	633	8	in	in	IN
cord-015365-iqdi99pd	633	9	paedriatic	paedriatic	JJ
cord-015365-iqdi99pd	633	10	cardiac	cardiac	JJ
cord-015365-iqdi99pd	633	11	transplant	transplant	NN
cord-015365-iqdi99pd	633	12	recipients	recipient	NNS
cord-015365-iqdi99pd	633	13	enables	enable	VBZ
cord-015365-iqdi99pd	633	14	high	high	JJ
cord-015365-iqdi99pd	633	15	efficacy	efficacy	NN
cord-015365-iqdi99pd	633	16	and	and	CC
cord-015365-iqdi99pd	633	17	is	be	VBZ
cord-015365-iqdi99pd	633	18	comparatively	comparatively	RB
cord-015365-iqdi99pd	633	19	safe	safe	JJ
cord-015365-iqdi99pd	633	20	to	to	IN
cord-015365-iqdi99pd	633	21	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	633	22	with	with	IN
cord-015365-iqdi99pd	633	23	MMF	mmf	NN
cord-015365-iqdi99pd	633	24	and	and	CC
cord-015365-iqdi99pd	633	25	standard	standard	JJ
cord-015365-iqdi99pd	633	26	exposure	exposure	NN
cord-015365-iqdi99pd	633	27	of	of	IN
cord-015365-iqdi99pd	633	28	CsA.	CsA.	NNP
cord-015365-iqdi99pd	633	29	Transplantation	transplantation	NN
cord-015365-iqdi99pd	633	30	of	of	IN
cord-015365-iqdi99pd	633	31	a	a	DT
cord-015365-iqdi99pd	633	32	minor	minor	RB
cord-015365-iqdi99pd	633	33	-	-	HYPH
cord-015365-iqdi99pd	633	34	mismatched	mismatched	JJ
cord-015365-iqdi99pd	633	35	skin	skin	NN
cord-015365-iqdi99pd	633	36	graft	graft	NN
cord-015365-iqdi99pd	633	37	elicits	elicit	VBZ
cord-015365-iqdi99pd	633	38	a	a	DT
cord-015365-iqdi99pd	633	39	rapid	rapid	JJ
cord-015365-iqdi99pd	633	40	humoral	humoral	JJ
cord-015365-iqdi99pd	633	41	response	response	NN
cord-015365-iqdi99pd	633	42	including	include	VBG
cord-015365-iqdi99pd	633	43	the	the	DT
cord-015365-iqdi99pd	633	44	induction	induction	NN
cord-015365-iqdi99pd	633	45	of	of	IN
cord-015365-iqdi99pd	633	46	antigen	antigen	NN
cord-015365-iqdi99pd	633	47	-	-	HYPH
cord-015365-iqdi99pd	633	48	specific	specific	JJ
cord-015365-iqdi99pd	633	49	IgE	IgE	NNP
cord-015365-iqdi99pd	633	50	Background	Background	NNP
cord-015365-iqdi99pd	633	51	.	.	.
cord-015365-iqdi99pd	634	1	Sensitization	sensitization	NN
cord-015365-iqdi99pd	634	2	to	to	IN
cord-015365-iqdi99pd	634	3	major	major	JJ
cord-015365-iqdi99pd	634	4	and	and	CC
cord-015365-iqdi99pd	634	5	minor	minor	JJ
cord-015365-iqdi99pd	634	6	antigens	antigen	NNS
cord-015365-iqdi99pd	634	7	is	be	VBZ
cord-015365-iqdi99pd	634	8	a	a	DT
cord-015365-iqdi99pd	634	9	critical	critical	JJ
cord-015365-iqdi99pd	634	10	problem	problem	NN
cord-015365-iqdi99pd	634	11	in	in	IN
cord-015365-iqdi99pd	634	12	transplantation	transplantation	NN
cord-015365-iqdi99pd	634	13	medicine	medicine	NN
cord-015365-iqdi99pd	634	14	with	with	IN
cord-015365-iqdi99pd	634	15	antibodies	antibody	NNS
cord-015365-iqdi99pd	634	16	of	of	IN
cord-015365-iqdi99pd	634	17	IgM	IgM	NNP
cord-015365-iqdi99pd	634	18	,	,	,
cord-015365-iqdi99pd	634	19	IgA	IgA	NNP
cord-015365-iqdi99pd	634	20	and	and	CC
cord-015365-iqdi99pd	634	21	IgG	IgG	NNP
cord-015365-iqdi99pd	634	22	isotypes	isotypes	NNP
cord-015365-iqdi99pd	634	23	have	have	VBP
cord-015365-iqdi99pd	634	24	been	be	VBN
cord-015365-iqdi99pd	634	25	demonstrated	demonstrate	VBN
cord-015365-iqdi99pd	634	26	towards	towards	IN
cord-015365-iqdi99pd	634	27	major	major	JJ
cord-015365-iqdi99pd	634	28	(	(	-LRB-
cord-015365-iqdi99pd	634	29	i.e.	i.e.	FW
cord-015365-iqdi99pd	634	30	MHC	MHC	NNP
cord-015365-iqdi99pd	634	31	)	)	-RRB-
cord-015365-iqdi99pd	634	32	and	and	CC
cord-015365-iqdi99pd	634	33	minor	minor	JJ
cord-015365-iqdi99pd	634	34	(	(	-LRB-
cord-015365-iqdi99pd	634	35	i.e.	i.e.	FW
cord-015365-iqdi99pd	634	36	non	non	FW
cord-015365-iqdi99pd	634	37	-	-	JJ
cord-015365-iqdi99pd	634	38	MHC	MHC	NNP
cord-015365-iqdi99pd	634	39	)	)	-RRB-
cord-015365-iqdi99pd	634	40	antigens	antigen	NNS
cord-015365-iqdi99pd	634	41	.	.	.
cord-015365-iqdi99pd	635	1	In	in	IN
cord-015365-iqdi99pd	635	2	a	a	DT
cord-015365-iqdi99pd	635	3	new	new	JJ
cord-015365-iqdi99pd	635	4	transgenic	transgenic	JJ
cord-015365-iqdi99pd	635	5	mouse	mouse	NN
cord-015365-iqdi99pd	635	6	model	model	NN
cord-015365-iqdi99pd	635	7	we	-PRON-	PRP
cord-015365-iqdi99pd	635	8	investigated	investigate	VBD
cord-015365-iqdi99pd	635	9	humoral	humoral	JJ
cord-015365-iqdi99pd	635	10	antigenspecific	antigenspecific	JJ
cord-015365-iqdi99pd	635	11	responses	response	NNS
cord-015365-iqdi99pd	635	12	towards	towards	IN
cord-015365-iqdi99pd	635	13	a	a	DT
cord-015365-iqdi99pd	635	14	highly	highly	RB
cord-015365-iqdi99pd	635	15	immunogenic	immunogenic	JJ
cord-015365-iqdi99pd	635	16	non	non	JJ
cord-015365-iqdi99pd	635	17	-	-	JJ
cord-015365-iqdi99pd	635	18	MHC	mhc	JJ
cord-015365-iqdi99pd	635	19	antigen	antigen	NN
cord-015365-iqdi99pd	635	20	.	.	.
cord-015365-iqdi99pd	636	1	A	a	DT
cord-015365-iqdi99pd	636	2	transgenic	transgenic	JJ
cord-015365-iqdi99pd	636	3	mouse	mouse	NN
cord-015365-iqdi99pd	636	4	expressing	express	VBG
cord-015365-iqdi99pd	636	5	the	the	DT
cord-015365-iqdi99pd	636	6	well	well	RB
cord-015365-iqdi99pd	636	7	-	-	HYPH
cord-015365-iqdi99pd	636	8	characterized	characterize	VBN
cord-015365-iqdi99pd	636	9	major	major	JJ
cord-015365-iqdi99pd	636	10	grass	grass	NN
cord-015365-iqdi99pd	636	11	pollen	pollen	NN
cord-015365-iqdi99pd	636	12	allergen	allergen	NN
cord-015365-iqdi99pd	636	13	Phl	Phl	NNP
cord-015365-iqdi99pd	636	14	p	p	NNP
cord-015365-iqdi99pd	636	15	5	5	CD
cord-015365-iqdi99pd	636	16	ubiquitously	ubiquitously	RB
cord-015365-iqdi99pd	636	17	on	on	IN
cord-015365-iqdi99pd	636	18	the	the	DT
cord-015365-iqdi99pd	636	19	cell	cell	NN
cord-015365-iqdi99pd	636	20	surface	surface	NN
cord-015365-iqdi99pd	636	21	was	be	VBD
cord-015365-iqdi99pd	636	22	generated	generate	VBN
cord-015365-iqdi99pd	636	23	.	.	.
cord-015365-iqdi99pd	637	1	Methods	method	NNS
cord-015365-iqdi99pd	637	2	.	.	.
cord-015365-iqdi99pd	638	1	A	a	DT
cord-015365-iqdi99pd	638	2	Phl	Phl	NNP
cord-015365-iqdi99pd	638	3	p	p	NN
cord-015365-iqdi99pd	638	4	5-transgenic	5-transgenic	CD
cord-015365-iqdi99pd	638	5	Balb	Balb	NNP
cord-015365-iqdi99pd	638	6	/	/	SYM
cord-015365-iqdi99pd	638	7	c	c	NN
cord-015365-iqdi99pd	638	8	mouse	mouse	NN
cord-015365-iqdi99pd	638	9	was	be	VBD
cord-015365-iqdi99pd	638	10	generated	generate	VBN
cord-015365-iqdi99pd	638	11	by	by	IN
cord-015365-iqdi99pd	638	12	pronuclear	pronuclear	NN
cord-015365-iqdi99pd	638	13	injection	injection	NN
cord-015365-iqdi99pd	638	14	integrating	integrate	VBG
cord-015365-iqdi99pd	638	15	Phl	Phl	NNP
cord-015365-iqdi99pd	638	16	p	p	NNP
cord-015365-iqdi99pd	638	17	5	5	CD
cord-015365-iqdi99pd	638	18	(	(	-LRB-
cord-015365-iqdi99pd	638	19	and	and	CC
cord-015365-iqdi99pd	638	20	GFP	GFP	NNP
cord-015365-iqdi99pd	638	21	)	)	-RRB-
cord-015365-iqdi99pd	638	22	fused	fuse	VBD
cord-015365-iqdi99pd	638	23	to	to	IN
cord-015365-iqdi99pd	638	24	a	a	DT
cord-015365-iqdi99pd	638	25	leader	leader	NN
cord-015365-iqdi99pd	638	26	peptide	peptide	NN
cord-015365-iqdi99pd	638	27	and	and	CC
cord-015365-iqdi99pd	638	28	a	a	DT
cord-015365-iqdi99pd	638	29	transmembrane	transmembrane	NN
cord-015365-iqdi99pd	638	30	domain	domain	NN
cord-015365-iqdi99pd	638	31	.	.	.
cord-015365-iqdi99pd	639	1	Splenocytes	Splenocytes	NNP
cord-015365-iqdi99pd	639	2	(	(	-LRB-
cord-015365-iqdi99pd	639	3	2.5Â106	2.5â106	CD
cord-015365-iqdi99pd	639	4	per	per	IN
cord-015365-iqdi99pd	639	5	mouse	mouse	NN
cord-015365-iqdi99pd	639	6	)	)	-RRB-
cord-015365-iqdi99pd	639	7	,	,	,
cord-015365-iqdi99pd	639	8	cell	cell	NN
cord-015365-iqdi99pd	639	9	extracts	extract	NNS
cord-015365-iqdi99pd	639	10	containing	contain	VBG
cord-015365-iqdi99pd	639	11	mainly	mainly	RB
cord-015365-iqdi99pd	639	12	membrane	membrane	NN
cord-015365-iqdi99pd	639	13	proteins	protein	NNS
cord-015365-iqdi99pd	639	14	and	and	CC
cord-015365-iqdi99pd	639	15	recombinant	recombinant	JJ
cord-015365-iqdi99pd	640	1	(	(	-LRB-
cord-015365-iqdi99pd	640	2	r	r	NN
cord-015365-iqdi99pd	640	3	)	)	-RRB-
cord-015365-iqdi99pd	640	4	Phl	phl	NN
cord-015365-iqdi99pd	640	5	p	p	NN
cord-015365-iqdi99pd	640	6	5	5	CD
cord-015365-iqdi99pd	640	7	[	[	-LRB-
cord-015365-iqdi99pd	640	8	5	5	CD
cord-015365-iqdi99pd	640	9	mg	mg	NN
cord-015365-iqdi99pd	640	10	AE	AE	NNP
cord-015365-iqdi99pd	640	11	Al(OH)3	Al(OH)3	:
cord-015365-iqdi99pd	640	12	per	per	IN
cord-015365-iqdi99pd	640	13	mouse	mouse	NN
cord-015365-iqdi99pd	640	14	]	]	-RRB-
cord-015365-iqdi99pd	640	15	were	be	VBD
cord-015365-iqdi99pd	640	16	injected	inject	VBN
cord-015365-iqdi99pd	640	17	subcutaneously	subcutaneously	RB
cord-015365-iqdi99pd	640	18	into	into	IN
cord-015365-iqdi99pd	640	19	naïve	naïve	JJ
cord-015365-iqdi99pd	640	20	Balb	Balb	NNP
cord-015365-iqdi99pd	640	21	/	/	SYM
cord-015365-iqdi99pd	640	22	c	c	NN
cord-015365-iqdi99pd	640	23	mice	mouse	NNS
cord-015365-iqdi99pd	640	24	(	(	-LRB-
cord-015365-iqdi99pd	640	25	n	n	CC
cord-015365-iqdi99pd	640	26	¼	¼	NNP
cord-015365-iqdi99pd	640	27	8	8	CD
cord-015365-iqdi99pd	640	28	per	per	IN
cord-015365-iqdi99pd	640	29	group	group	NN
cord-015365-iqdi99pd	640	30	)	)	-RRB-
cord-015365-iqdi99pd	640	31	.	.	.
cord-015365-iqdi99pd	641	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	641	2	tail	tail	VB
cord-015365-iqdi99pd	641	3	skin	skin	NN
cord-015365-iqdi99pd	641	4	of	of	IN
cord-015365-iqdi99pd	641	5	Phl	Phl	NNP
cord-015365-iqdi99pd	641	6	p	p	NN
cord-015365-iqdi99pd	641	7	5-transgenic	5-transgenic	CD
cord-015365-iqdi99pd	641	8	mice	mouse	NNS
cord-015365-iqdi99pd	641	9	was	be	VBD
cord-015365-iqdi99pd	641	10	grafted	graft	VBN
cord-015365-iqdi99pd	641	11	onto	onto	IN
cord-015365-iqdi99pd	641	12	naïve	naïve	JJ
cord-015365-iqdi99pd	641	13	Balb	Balb	NNP
cord-015365-iqdi99pd	641	14	/	/	SYM
cord-015365-iqdi99pd	641	15	c	c	NNP
cord-015365-iqdi99pd	641	16	(	(	-LRB-
cord-015365-iqdi99pd	641	17	n	n	NNP
cord-015365-iqdi99pd	641	18	¼	¼	NNP
cord-015365-iqdi99pd	641	19	13	13	CD
cord-015365-iqdi99pd	641	20	in	in	IN
cord-015365-iqdi99pd	641	21	two	two	CD
cord-015365-iqdi99pd	641	22	independent	independent	JJ
cord-015365-iqdi99pd	641	23	experiments	experiment	NNS
cord-015365-iqdi99pd	641	24	)	)	-RRB-
cord-015365-iqdi99pd	641	25	.	.	.
cord-015365-iqdi99pd	642	1	The	the	DT
cord-015365-iqdi99pd	642	2	Phl	Phl	NNP
cord-015365-iqdi99pd	642	3	p	p	NN
cord-015365-iqdi99pd	642	4	5-specific	5-specific	CD
cord-015365-iqdi99pd	642	5	humoral	humoral	JJ
cord-015365-iqdi99pd	642	6	response	response	NN
cord-015365-iqdi99pd	642	7	was	be	VBD
cord-015365-iqdi99pd	642	8	determined	determine	VBN
cord-015365-iqdi99pd	642	9	in	in	IN
cord-015365-iqdi99pd	642	10	sera	sera	NNP
cord-015365-iqdi99pd	642	11	by	by	IN
cord-015365-iqdi99pd	642	12	ELISAs	elisa	NNS
cord-015365-iqdi99pd	642	13	and	and	CC
cord-015365-iqdi99pd	642	14	T	t	NN
cord-015365-iqdi99pd	642	15	-	-	HYPH
cord-015365-iqdi99pd	642	16	cell	cell	NN
cord-015365-iqdi99pd	642	17	proliferation	proliferation	NN
cord-015365-iqdi99pd	642	18	assays	assay	NNS
cord-015365-iqdi99pd	642	19	were	be	VBD
cord-015365-iqdi99pd	642	20	assessed	assess	VBN
cord-015365-iqdi99pd	642	21	.	.	.
cord-015365-iqdi99pd	643	1	Results	result	NNS
cord-015365-iqdi99pd	643	2	.	.	.
cord-015365-iqdi99pd	644	1	Surprisingly	surprisingly	RB
cord-015365-iqdi99pd	644	2	,	,	,
cord-015365-iqdi99pd	644	3	a	a	DT
cord-015365-iqdi99pd	644	4	prompt	prompt	JJ
cord-015365-iqdi99pd	644	5	rejection	rejection	NN
cord-015365-iqdi99pd	644	6	of	of	IN
cord-015365-iqdi99pd	644	7	Phl	Phl	NNP
cord-015365-iqdi99pd	644	8	p	p	NN
cord-015365-iqdi99pd	644	9	5-transgenic	5-transgenic	CD
cord-015365-iqdi99pd	644	10	skin	skin	NN
cord-015365-iqdi99pd	644	11	was	be	VBD
cord-015365-iqdi99pd	644	12	elicited	elicit	VBN
cord-015365-iqdi99pd	644	13	(	(	-LRB-
cord-015365-iqdi99pd	644	14	within	within	IN
cord-015365-iqdi99pd	644	15	8	8	CD
cord-015365-iqdi99pd	644	16	-	-	SYM
cord-015365-iqdi99pd	644	17	10	10	CD
cord-015365-iqdi99pd	644	18	days	day	NNS
cord-015365-iqdi99pd	644	19	)	)	-RRB-
cord-015365-iqdi99pd	644	20	,	,	,
cord-015365-iqdi99pd	644	21	accompanied	accompany	VBN
cord-015365-iqdi99pd	644	22	by	by	IN
cord-015365-iqdi99pd	644	23	a	a	DT
cord-015365-iqdi99pd	644	24	strong	strong	JJ
cord-015365-iqdi99pd	644	25	Phl	Phl	NNP
cord-015365-iqdi99pd	644	26	p	p	NN
cord-015365-iqdi99pd	644	27	5	5	CD
cord-015365-iqdi99pd	644	28	specific	specific	JJ
cord-015365-iqdi99pd	644	29	antibody	antibody	NN
cord-015365-iqdi99pd	644	30	response	response	NN
cord-015365-iqdi99pd	644	31	including	include	VBG
cord-015365-iqdi99pd	645	1	Phl	Phl	NNP
cord-015365-iqdi99pd	645	2	p	p	NN
cord-015365-iqdi99pd	645	3	5-specific	5-specific	CD
cord-015365-iqdi99pd	645	4	IgE.	ige.	NN
cord-015365-iqdi99pd	646	1	Additionally	additionally	RB
cord-015365-iqdi99pd	646	2	to	to	IN
cord-015365-iqdi99pd	646	3	the	the	DT
cord-015365-iqdi99pd	646	4	skin	skin	NN
cord-015365-iqdi99pd	646	5	grafted	graft	VBN
cord-015365-iqdi99pd	646	6	group	group	NN
cord-015365-iqdi99pd	646	7	,	,	,
cord-015365-iqdi99pd	646	8	mice	mouse	NNS
cord-015365-iqdi99pd	646	9	receiving	receive	VBG
cord-015365-iqdi99pd	646	10	splenocytes	splenocyte	NNS
cord-015365-iqdi99pd	646	11	or	or	CC
cord-015365-iqdi99pd	646	12	rPhl	rPhl	NNP
cord-015365-iqdi99pd	646	13	p	p	NN
cord-015365-iqdi99pd	646	14	5	5	CD
cord-015365-iqdi99pd	646	15	plus	plus	NN
cord-015365-iqdi99pd	646	16	adjuvant	adjuvant	NN
cord-015365-iqdi99pd	646	17	showed	show	VBD
cord-015365-iqdi99pd	646	18	a	a	DT
cord-015365-iqdi99pd	646	19	comparable	comparable	JJ
cord-015365-iqdi99pd	646	20	response	response	NN
cord-015365-iqdi99pd	646	21	in	in	IN
cord-015365-iqdi99pd	646	22	terms	term	NNS
cord-015365-iqdi99pd	646	23	of	of	IN
cord-015365-iqdi99pd	646	24	Phl	Phl	NNP
cord-015365-iqdi99pd	646	25	p	p	NNP
cord-015365-iqdi99pd	646	26	5-specific	5-specific	CD
cord-015365-iqdi99pd	646	27	IgE	IgE	NNP
cord-015365-iqdi99pd	646	28	throughout	throughout	IN
cord-015365-iqdi99pd	646	29	the	the	DT
cord-015365-iqdi99pd	646	30	whole	whole	JJ
cord-015365-iqdi99pd	646	31	follow	follow	NN
cord-015365-iqdi99pd	646	32	-	-	HYPH
cord-015365-iqdi99pd	646	33	up	up	NN
cord-015365-iqdi99pd	646	34	(	(	-LRB-
cord-015365-iqdi99pd	646	35	week	week	NN
cord-015365-iqdi99pd	646	36	1	1	CD
cord-015365-iqdi99pd	646	37	,	,	,
cord-015365-iqdi99pd	646	38	2	2	CD
cord-015365-iqdi99pd	646	39	,	,	,
cord-015365-iqdi99pd	646	40	3	3	CD
cord-015365-iqdi99pd	646	41	,	,	,
cord-015365-iqdi99pd	646	42	5	5	CD
cord-015365-iqdi99pd	646	43	,	,	,
cord-015365-iqdi99pd	646	44	7	7	CD
cord-015365-iqdi99pd	646	45	,	,	,
cord-015365-iqdi99pd	646	46	9	9	CD
cord-015365-iqdi99pd	646	47	,	,	,
cord-015365-iqdi99pd	646	48	11	11	CD
cord-015365-iqdi99pd	646	49	)	)	-RRB-
cord-015365-iqdi99pd	646	50	suggesting	suggest	VBG
cord-015365-iqdi99pd	646	51	an	an	DT
cord-015365-iqdi99pd	646	52	unusually	unusually	RB
cord-015365-iqdi99pd	646	53	strong	strong	JJ
cord-015365-iqdi99pd	646	54	immune	immune	JJ
cord-015365-iqdi99pd	646	55	response	response	NN
cord-015365-iqdi99pd	646	56	to	to	IN
cord-015365-iqdi99pd	646	57	cell	cell	NN
cord-015365-iqdi99pd	646	58	or	or	CC
cord-015365-iqdi99pd	646	59	tissue	tissue	NN
cord-015365-iqdi99pd	646	60	-	-	HYPH
cord-015365-iqdi99pd	646	61	bound	bind	VBN
cord-015365-iqdi99pd	646	62	Phl	Phl	NNP
cord-015365-iqdi99pd	646	63	p	p	NN
cord-015365-iqdi99pd	646	64	5	5	CD
cord-015365-iqdi99pd	646	65	.	.	.
cord-015365-iqdi99pd	647	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	647	2	Phl	Phl	NNP
cord-015365-iqdi99pd	647	3	p	p	NNP
cord-015365-iqdi99pd	647	4	5-specific	5-specific	CD
cord-015365-iqdi99pd	647	5	IgG	IgG	NNP
cord-015365-iqdi99pd	647	6	isotypes	isotypes	NNP
cord-015365-iqdi99pd	647	7	,	,	,
cord-015365-iqdi99pd	647	8	IgA	IgA	NNP
cord-015365-iqdi99pd	647	9	and	and	CC
cord-015365-iqdi99pd	647	10	IgM	IgM	NNP
cord-015365-iqdi99pd	647	11	were	be	VBD
cord-015365-iqdi99pd	647	12	induced	induce	VBN
cord-015365-iqdi99pd	647	13	.	.	.
cord-015365-iqdi99pd	648	1	Besides	besides	IN
cord-015365-iqdi99pd	648	2	splenocyte	splenocyte	NN
cord-015365-iqdi99pd	648	3	-	-	HYPH
cord-015365-iqdi99pd	648	4	proliferation	proliferation	NN
cord-015365-iqdi99pd	648	5	assays	assay	NNS
cord-015365-iqdi99pd	648	6	showed	show	VBD
cord-015365-iqdi99pd	648	7	Phl	Phl	NNP
cord-015365-iqdi99pd	648	8	p	p	NN
cord-015365-iqdi99pd	648	9	5	5	CD
cord-015365-iqdi99pd	648	10	specific	specific	JJ
cord-015365-iqdi99pd	648	11	T	t	NN
cord-015365-iqdi99pd	648	12	-	-	HYPH
cord-015365-iqdi99pd	648	13	cell	cell	NN
cord-015365-iqdi99pd	648	14	responses	response	NNS
cord-015365-iqdi99pd	648	15	in	in	IN
cord-015365-iqdi99pd	648	16	all	all	DT
cord-015365-iqdi99pd	648	17	groups	group	NNS
cord-015365-iqdi99pd	648	18	of	of	IN
cord-015365-iqdi99pd	648	19	mice	mouse	NNS
cord-015365-iqdi99pd	648	20	that	that	WDT
cord-015365-iqdi99pd	648	21	showed	show	VBD
cord-015365-iqdi99pd	648	22	strong	strong	JJ
cord-015365-iqdi99pd	648	23	humoral	humoral	JJ
cord-015365-iqdi99pd	648	24	responses	response	NNS
cord-015365-iqdi99pd	648	25	.	.	.
cord-015365-iqdi99pd	649	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	649	2	.	.	.
cord-015365-iqdi99pd	650	1	The	the	DT
cord-015365-iqdi99pd	650	2	high	high	JJ
cord-015365-iqdi99pd	650	3	immunogenicity	immunogenicity	NN
cord-015365-iqdi99pd	650	4	of	of	IN
cord-015365-iqdi99pd	650	5	tissue	tissue	NN
cord-015365-iqdi99pd	650	6	-	-	HYPH
cord-015365-iqdi99pd	650	7	bound	bind	VBN
cord-015365-iqdi99pd	650	8	Phl	Phl	NNP
cord-015365-iqdi99pd	650	9	p	p	NN
cord-015365-iqdi99pd	650	10	5	5	CD
cord-015365-iqdi99pd	650	11	may	may	MD
cord-015365-iqdi99pd	650	12	represent	represent	VB
cord-015365-iqdi99pd	650	13	a	a	DT
cord-015365-iqdi99pd	650	14	new	new	JJ
cord-015365-iqdi99pd	650	15	stringent	stringent	JJ
cord-015365-iqdi99pd	650	16	model	model	NN
cord-015365-iqdi99pd	650	17	for	for	IN
cord-015365-iqdi99pd	650	18	studying	study	VBG
cord-015365-iqdi99pd	650	19	humoral	humoral	JJ
cord-015365-iqdi99pd	650	20	responses	response	NNS
cord-015365-iqdi99pd	650	21	towards	towards	IN
cord-015365-iqdi99pd	650	22	non	non	JJ
cord-015365-iqdi99pd	650	23	-	-	JJ
cord-015365-iqdi99pd	650	24	MHC	MHC	NNP
cord-015365-iqdi99pd	650	25	antigens	antigen	NNS
cord-015365-iqdi99pd	650	26	.	.	.
cord-015365-iqdi99pd	651	1	Notably	notably	RB
cord-015365-iqdi99pd	651	2	,	,	,
cord-015365-iqdi99pd	651	3	the	the	DT
cord-015365-iqdi99pd	651	4	immune	immune	JJ
cord-015365-iqdi99pd	651	5	reaction	reaction	NN
cord-015365-iqdi99pd	651	6	included	include	VBD
cord-015365-iqdi99pd	651	7	a	a	DT
cord-015365-iqdi99pd	651	8	rapid	rapid	JJ
cord-015365-iqdi99pd	651	9	IgE	IgE	NNP
cord-015365-iqdi99pd	651	10	response	response	NN
cord-015365-iqdi99pd	651	11	in	in	IN
cord-015365-iqdi99pd	651	12	this	this	DT
cord-015365-iqdi99pd	651	13	model	model	NN
cord-015365-iqdi99pd	651	14	.	.	.
cord-015365-iqdi99pd	652	1	The	the	DT
cord-015365-iqdi99pd	652	2	influence	influence	NN
cord-015365-iqdi99pd	652	3	of	of	IN
cord-015365-iqdi99pd	652	4	recipient	recipient	NN
cord-015365-iqdi99pd	652	5	age	age	NN
cord-015365-iqdi99pd	652	6	on	on	IN
cord-015365-iqdi99pd	652	7	chimerism	chimerism	NN
cord-015365-iqdi99pd	652	8	-	-	HYPH
cord-015365-iqdi99pd	652	9	based	base	VBN
cord-015365-iqdi99pd	652	10	tolerance	tolerance	NN
cord-015365-iqdi99pd	652	11	induction	induction	NN
cord-015365-iqdi99pd	652	12	K.	K.	NNP
cord-015365-iqdi99pd	652	13	Hock	Hock	NNP
cord-015365-iqdi99pd	652	14	1,2	1,2	CD
cord-015365-iqdi99pd	652	15	,	,	,
cord-015365-iqdi99pd	652	16	R.	R.	NNP
cord-015365-iqdi99pd	652	17	Oberhuber	Oberhuber	NNP
cord-015365-iqdi99pd	652	18	2,3	2,3	CD
cord-015365-iqdi99pd	652	19	,	,	,
cord-015365-iqdi99pd	652	20	Y.-L.	Y.-L.	NNP
cord-015365-iqdi99pd	652	21	Lee	Lee	NNP
cord-015365-iqdi99pd	652	22	2	2	CD
cord-015365-iqdi99pd	652	23	,	,	,
cord-015365-iqdi99pd	652	24	T.	T.	NNP
cord-015365-iqdi99pd	652	25	Wekerle	Wekerle	NNP
cord-015365-iqdi99pd	652	26	1	1	CD
cord-015365-iqdi99pd	652	27	,	,	,
cord-015365-iqdi99pd	652	28	S.	S.	NNP
cord-015365-iqdi99pd	652	29	G.	G.	NNP
cord-015365-iqdi99pd	652	30	Tullius	Tullius	NNP
cord-015365-iqdi99pd	652	31	2	2	CD
cord-015365-iqdi99pd	652	32	Background	Background	NNP
cord-015365-iqdi99pd	652	33	.	.	.
cord-015365-iqdi99pd	653	1	Immune	immune	JJ
cord-015365-iqdi99pd	653	2	senescence	senescence	NN
cord-015365-iqdi99pd	653	3	substantially	substantially	RB
cord-015365-iqdi99pd	653	4	alters	alter	VBZ
cord-015365-iqdi99pd	653	5	alloreactivity	alloreactivity	NN
cord-015365-iqdi99pd	653	6	.	.	.
cord-015365-iqdi99pd	654	1	Higher	high	JJR
cord-015365-iqdi99pd	654	2	frequencies	frequency	NNS
cord-015365-iqdi99pd	654	3	of	of	IN
cord-015365-iqdi99pd	654	4	memory	memory	NN
cord-015365-iqdi99pd	654	5	T	t	NN
cord-015365-iqdi99pd	654	6	cells	cell	NNS
cord-015365-iqdi99pd	654	7	(	(	-LRB-
cord-015365-iqdi99pd	654	8	Tmem	Tmem	NNP
cord-015365-iqdi99pd	654	9	)	)	-RRB-
cord-015365-iqdi99pd	654	10	found	find	VBD
cord-015365-iqdi99pd	654	11	in	in	IN
cord-015365-iqdi99pd	654	12	older	old	JJR
cord-015365-iqdi99pd	654	13	recipients	recipient	NNS
cord-015365-iqdi99pd	654	14	are	be	VBP
cord-015365-iqdi99pd	654	15	considered	consider	VBN
cord-015365-iqdi99pd	654	16	a	a	DT
cord-015365-iqdi99pd	654	17	substantial	substantial	JJ
cord-015365-iqdi99pd	654	18	barrier	barrier	NN
cord-015365-iqdi99pd	654	19	to	to	IN
cord-015365-iqdi99pd	654	20	tolerance	tolerance	NN
cord-015365-iqdi99pd	654	21	induction	induction	NN
cord-015365-iqdi99pd	654	22	.	.	.
cord-015365-iqdi99pd	655	1	Tolerance	tolerance	NN
cord-015365-iqdi99pd	655	2	induction	induction	NN
cord-015365-iqdi99pd	655	3	through	through	IN
cord-015365-iqdi99pd	655	4	mixed	mixed	JJ
cord-015365-iqdi99pd	655	5	chimerism	chimerism	NN
cord-015365-iqdi99pd	655	6	holds	hold	VBZ
cord-015365-iqdi99pd	655	7	promise	promise	NN
cord-015365-iqdi99pd	655	8	for	for	IN
cord-015365-iqdi99pd	655	9	clinical	clinical	JJ
cord-015365-iqdi99pd	655	10	translation	translation	NN
cord-015365-iqdi99pd	655	11	but	but	CC
cord-015365-iqdi99pd	655	12	has	have	VBZ
cord-015365-iqdi99pd	655	13	only	only	RB
cord-015365-iqdi99pd	655	14	been	be	VBN
cord-015365-iqdi99pd	655	15	investigated	investigate	VBN
cord-015365-iqdi99pd	655	16	in	in	IN
cord-015365-iqdi99pd	655	17	young	young	JJ
cord-015365-iqdi99pd	655	18	recipients	recipient	NNS
cord-015365-iqdi99pd	655	19	so	so	RB
cord-015365-iqdi99pd	655	20	far	far	RB
cord-015365-iqdi99pd	655	21	.	.	.
cord-015365-iqdi99pd	656	1	As	as	IN
cord-015365-iqdi99pd	656	2	the	the	DT
cord-015365-iqdi99pd	656	3	average	average	JJ
cord-015365-iqdi99pd	656	4	recipient	recipient	NN
cord-015365-iqdi99pd	656	5	age	age	NN
cord-015365-iqdi99pd	656	6	has	have	VBZ
cord-015365-iqdi99pd	656	7	increased	increase	VBN
cord-015365-iqdi99pd	656	8	substantially	substantially	RB
cord-015365-iqdi99pd	656	9	in	in	IN
cord-015365-iqdi99pd	656	10	clinical	clinical	JJ
cord-015365-iqdi99pd	656	11	organ	organ	NN
cord-015365-iqdi99pd	656	12	transplantation	transplantation	NN
cord-015365-iqdi99pd	656	13	,	,	,
cord-015365-iqdi99pd	656	14	we	-PRON-	PRP
cord-015365-iqdi99pd	656	15	investigated	investigate	VBD
cord-015365-iqdi99pd	656	16	the	the	DT
cord-015365-iqdi99pd	656	17	consequences	consequence	NNS
cord-015365-iqdi99pd	656	18	of	of	IN
cord-015365-iqdi99pd	656	19	recipient	recipient	NN
cord-015365-iqdi99pd	656	20	age	age	NN
cord-015365-iqdi99pd	656	21	on	on	IN
cord-015365-iqdi99pd	656	22	the	the	DT
cord-015365-iqdi99pd	656	23	outcome	outcome	NN
cord-015365-iqdi99pd	656	24	of	of	IN
cord-015365-iqdi99pd	656	25	costimulation	costimulation	NN
cord-015365-iqdi99pd	656	26	blockade	blockade	NN
cord-015365-iqdi99pd	656	27	based	base	VBN
cord-015365-iqdi99pd	656	28	allogeneic	allogeneic	IN
cord-015365-iqdi99pd	656	29	bone	bone	NN
cord-015365-iqdi99pd	656	30	marrow	marrow	NN
cord-015365-iqdi99pd	656	31	transplantation	transplantation	NN
cord-015365-iqdi99pd	656	32	(	(	-LRB-
cord-015365-iqdi99pd	656	33	BMT	BMT	NNP
cord-015365-iqdi99pd	656	34	)	)	-RRB-
cord-015365-iqdi99pd	656	35	for	for	IN
cord-015365-iqdi99pd	656	36	the	the	DT
cord-015365-iqdi99pd	656	37	purpose	purpose	NN
cord-015365-iqdi99pd	656	38	of	of	IN
cord-015365-iqdi99pd	656	39	mixed	mixed	JJ
cord-015365-iqdi99pd	656	40	chimerism	chimerism	NN
cord-015365-iqdi99pd	656	41	and	and	CC
cord-015365-iqdi99pd	656	42	tolerance	tolerance	NN
cord-015365-iqdi99pd	656	43	induction	induction	NN
cord-015365-iqdi99pd	656	44	.	.	.
cord-015365-iqdi99pd	657	1	Methods	method	NNS
cord-015365-iqdi99pd	657	2	.	.	.
cord-015365-iqdi99pd	658	1	Young	young	JJ
cord-015365-iqdi99pd	658	2	(	(	-LRB-
cord-015365-iqdi99pd	658	3	2	2	CD
cord-015365-iqdi99pd	658	4	months	month	NNS
cord-015365-iqdi99pd	658	5	;	;	:
cord-015365-iqdi99pd	658	6	weighing	weigh	VBG
cord-015365-iqdi99pd	658	7	approx	approx	NN
cord-015365-iqdi99pd	658	8	.	.	.
cord-015365-iqdi99pd	659	1	20	20	CD
cord-015365-iqdi99pd	659	2	grams	gram	NNS
cord-015365-iqdi99pd	659	3	)	)	-RRB-
cord-015365-iqdi99pd	659	4	and	and	CC
cord-015365-iqdi99pd	659	5	old	old	JJ
cord-015365-iqdi99pd	659	6	(	(	-LRB-
cord-015365-iqdi99pd	659	7	12	12	CD
cord-015365-iqdi99pd	659	8	months	month	NNS
cord-015365-iqdi99pd	659	9	;	;	:
cord-015365-iqdi99pd	659	10	25	25	CD
cord-015365-iqdi99pd	659	11	g	g	NN
cord-015365-iqdi99pd	659	12	)	)	-RRB-
cord-015365-iqdi99pd	659	13	recipients	recipient	NNS
cord-015365-iqdi99pd	659	14	(	(	-LRB-
cord-015365-iqdi99pd	659	15	C57BL/6	C57BL/6	NNP
cord-015365-iqdi99pd	659	16	)	)	-RRB-
cord-015365-iqdi99pd	659	17	were	be	VBD
cord-015365-iqdi99pd	659	18	treated	treat	VBN
cord-015365-iqdi99pd	659	19	with	with	IN
cord-015365-iqdi99pd	659	20	3	3	CD
cord-015365-iqdi99pd	659	21	or	or	CC
cord-015365-iqdi99pd	659	22	1	1	CD
cord-015365-iqdi99pd	659	23	Gy	Gy	NNP
cord-015365-iqdi99pd	659	24	total	total	JJ
cord-015365-iqdi99pd	659	25	body	body	NN
cord-015365-iqdi99pd	659	26	irradiation	irradiation	NN
cord-015365-iqdi99pd	659	27	(	(	-LRB-
cord-015365-iqdi99pd	659	28	TBI	TBI	NNP
cord-015365-iqdi99pd	659	29	,	,	,
cord-015365-iqdi99pd	659	30	d-1	d-1	NNP
cord-015365-iqdi99pd	659	31	)	)	-RRB-
cord-015365-iqdi99pd	659	32	and	and	CC
cord-015365-iqdi99pd	659	33	received	receive	VBD
cord-015365-iqdi99pd	659	34	adjusted	adjust	VBN
cord-015365-iqdi99pd	659	35	to	to	IN
cord-015365-iqdi99pd	659	36	the	the	DT
cord-015365-iqdi99pd	659	37	body	body	NN
cord-015365-iqdi99pd	659	38	weight	weight	NN
cord-015365-iqdi99pd	659	39	20Â10	20Â10	NNP
cord-015365-iqdi99pd	659	40	6	6	CD
cord-015365-iqdi99pd	659	41	and	and	CC
cord-015365-iqdi99pd	659	42	25Â10	25â10	CD
cord-015365-iqdi99pd	660	1	6	6	CD
cord-015365-iqdi99pd	660	2	un	un	NNP
cord-015365-iqdi99pd	660	3	-	-	HYPH
cord-015365-iqdi99pd	660	4	separated	separate	VBN
cord-015365-iqdi99pd	660	5	Balb	Balb	NNP
cord-015365-iqdi99pd	660	6	/	/	SYM
cord-015365-iqdi99pd	660	7	c	c	NN
cord-015365-iqdi99pd	660	8	BM	BM	NNP
cord-015365-iqdi99pd	660	9	cells	cell	NNS
cord-015365-iqdi99pd	660	10	(	(	-LRB-
cord-015365-iqdi99pd	660	11	d0	d0	NNP
cord-015365-iqdi99pd	660	12	)	)	-RRB-
cord-015365-iqdi99pd	660	13	and	and	CC
cord-015365-iqdi99pd	660	14	co	co	JJ
cord-015365-iqdi99pd	660	15	-	-	JJ
cord-015365-iqdi99pd	660	16	stimulatory	stimulatory	JJ
cord-015365-iqdi99pd	660	17	blockade	blockade	NN
cord-015365-iqdi99pd	660	18	with	with	IN
cord-015365-iqdi99pd	660	19	anti	anti	JJ
cord-015365-iqdi99pd	660	20	-	-	JJ
cord-015365-iqdi99pd	660	21	CD154	cd154	CD
cord-015365-iqdi99pd	660	22	mAb	mAb	NNS
cord-015365-iqdi99pd	660	23	(	(	-LRB-
cord-015365-iqdi99pd	660	24	d0	d0	NNP
cord-015365-iqdi99pd	660	25	)	)	-RRB-
cord-015365-iqdi99pd	660	26	and	and	CC
cord-015365-iqdi99pd	660	27	CTLA4Ig	CTLA4Ig	NNP
cord-015365-iqdi99pd	661	1	(	(	-LRB-
cord-015365-iqdi99pd	661	2	d	d	NN
cord-015365-iqdi99pd	661	3	þ	þ	NNP
cord-015365-iqdi99pd	661	4	2	2	CD
cord-015365-iqdi99pd	661	5	)	)	-RRB-
cord-015365-iqdi99pd	661	6	was	be	VBD
cord-015365-iqdi99pd	661	7	administered	administer	VBN
cord-015365-iqdi99pd	661	8	.	.	.
cord-015365-iqdi99pd	662	1	Lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	662	2	subsets	subset	NNS
cord-015365-iqdi99pd	662	3	and	and	CC
cord-015365-iqdi99pd	662	4	cytokine	cytokine	NN
cord-015365-iqdi99pd	662	5	production	production	NN
cord-015365-iqdi99pd	662	6	were	be	VBD
cord-015365-iqdi99pd	662	7	compared	compare	VBN
cord-015365-iqdi99pd	662	8	between	between	IN
cord-015365-iqdi99pd	662	9	young	young	JJ
cord-015365-iqdi99pd	662	10	and	and	CC
cord-015365-iqdi99pd	662	11	old	old	JJ
cord-015365-iqdi99pd	662	12	naïve	naïve	JJ
cord-015365-iqdi99pd	662	13	mice	mouse	NNS
cord-015365-iqdi99pd	662	14	and	and	CC
cord-015365-iqdi99pd	662	15	multilineage	multilineage	NN
cord-015365-iqdi99pd	662	16	chimerism	chimerism	NN
cord-015365-iqdi99pd	662	17	was	be	VBD
cord-015365-iqdi99pd	662	18	followed	follow	VBN
cord-015365-iqdi99pd	662	19	by	by	IN
cord-015365-iqdi99pd	662	20	flow	flow	NN
cord-015365-iqdi99pd	662	21	cytometry	cytometry	NN
cord-015365-iqdi99pd	662	22	.	.	.
cord-015365-iqdi99pd	663	1	Results	result	NNS
cord-015365-iqdi99pd	663	2	.	.	.
cord-015365-iqdi99pd	664	1	Old	old	JJ
cord-015365-iqdi99pd	664	2	mice	mouse	NNS
cord-015365-iqdi99pd	664	3	contain	contain	VBP
cord-015365-iqdi99pd	664	4	significantly	significantly	RB
cord-015365-iqdi99pd	664	5	more	more	JJR
cord-015365-iqdi99pd	664	6	CD4	CD4	NNP
cord-015365-iqdi99pd	664	7	(	(	-LRB-
cord-015365-iqdi99pd	664	8	p	p	NN
cord-015365-iqdi99pd	664	9	<	<	XX
cord-015365-iqdi99pd	664	10	0.05	0.05	CD
cord-015365-iqdi99pd	664	11	)	)	-RRB-
cord-015365-iqdi99pd	664	12	and	and	CC
cord-015365-iqdi99pd	664	13	CD8	CD8	NNP
cord-015365-iqdi99pd	664	14	(	(	-LRB-
cord-015365-iqdi99pd	664	15	p	p	NN
cord-015365-iqdi99pd	664	16	<	<	XX
cord-015365-iqdi99pd	664	17	0.001	0.001	CD
cord-015365-iqdi99pd	664	18	)	)	-RRB-
cord-015365-iqdi99pd	664	19	memory	memory	NN
cord-015365-iqdi99pd	664	20	T	T	NNP
cord-015365-iqdi99pd	664	21	cells	cell	NNS
cord-015365-iqdi99pd	664	22	(	(	-LRB-
cord-015365-iqdi99pd	664	23	CD44highCD62Llow	cd44highcd62llow	NN
cord-015365-iqdi99pd	664	24	)	)	-RRB-
cord-015365-iqdi99pd	664	25	,	,	,
cord-015365-iqdi99pd	664	26	early	early	RB
cord-015365-iqdi99pd	664	27	activated	activate	VBN
cord-015365-iqdi99pd	664	28	CD4	CD4	NNP
cord-015365-iqdi99pd	664	29	T	T	NNP
cord-015365-iqdi99pd	664	30	cells	cell	NNS
cord-015365-iqdi99pd	665	1	(	(	-LRB-
cord-015365-iqdi99pd	665	2	CD4	CD4	NNP
cord-015365-iqdi99pd	665	3	þ	þ	NNP
cord-015365-iqdi99pd	665	4	CD69	CD69	NNP
cord-015365-iqdi99pd	665	5	þ	þ	NNP
cord-015365-iqdi99pd	665	6	;	;	:
cord-015365-iqdi99pd	665	7	p	p	NN
cord-015365-iqdi99pd	665	8	<	<	XX
cord-015365-iqdi99pd	665	9	0.01	0.01	CD
cord-015365-iqdi99pd	665	10	)	)	-RRB-
cord-015365-iqdi99pd	665	11	,	,	,
cord-015365-iqdi99pd	665	12	less	less	JJR
cord-015365-iqdi99pd	665	13	CD4	CD4	NNP
cord-015365-iqdi99pd	665	14	and	and	CC
cord-015365-iqdi99pd	665	15	CD8	CD8	NNP
cord-015365-iqdi99pd	665	16	T	T	NNP
cord-015365-iqdi99pd	665	17	cells	cell	NNS
cord-015365-iqdi99pd	665	18	and	and	CC
cord-015365-iqdi99pd	665	19	comparable	comparable	JJ
cord-015365-iqdi99pd	665	20	amounts	amount	NNS
cord-015365-iqdi99pd	665	21	of	of	IN
cord-015365-iqdi99pd	665	22	regulatory	regulatory	JJ
cord-015365-iqdi99pd	665	23	T	t	NN
cord-015365-iqdi99pd	665	24	cells	cell	NNS
cord-015365-iqdi99pd	665	25	(	(	-LRB-
cord-015365-iqdi99pd	665	26	Tregs	Tregs	NNP
cord-015365-iqdi99pd	665	27	;	;	:
cord-015365-iqdi99pd	666	1	CD4	CD4	NNP
cord-015365-iqdi99pd	666	2	þ	þ	NNP
cord-015365-iqdi99pd	667	1	CD25	CD25	NNP
cord-015365-iqdi99pd	667	2	þ	þ	CD
cord-015365-iqdi99pd	667	3	FoxP3þ	FoxP3þ	NNP
cord-015365-iqdi99pd	667	4	;	;	:
cord-015365-iqdi99pd	668	1	p	p	NNP
cord-015365-iqdi99pd	668	2	¼	¼	NNP
cord-015365-iqdi99pd	668	3	n.s	n.s	NNP
cord-015365-iqdi99pd	668	4	.	.	.
cord-015365-iqdi99pd	669	1	vs.	vs.	FW
cord-015365-iqdi99pd	669	2	young	young	JJ
cord-015365-iqdi99pd	669	3	animals	animal	NNS
cord-015365-iqdi99pd	669	4	)	)	-RRB-
cord-015365-iqdi99pd	669	5	.	.	.
cord-015365-iqdi99pd	670	1	Moreover	moreover	RB
cord-015365-iqdi99pd	670	2	,	,	,
cord-015365-iqdi99pd	670	3	older	old	JJR
cord-015365-iqdi99pd	670	4	CD4	CD4	NNP
cord-015365-iqdi99pd	670	5	and	and	CC
cord-015365-iqdi99pd	670	6	CD8	CD8	NNP
cord-015365-iqdi99pd	670	7	T	T	NNP
cord-015365-iqdi99pd	670	8	cells	cell	NNS
cord-015365-iqdi99pd	670	9	release	release	VBP
cord-015365-iqdi99pd	670	10	more	more	JJR
cord-015365-iqdi99pd	670	11	IFN-(CD4	IFN-(CD4	NNP
cord-015365-iqdi99pd	670	12	:	:	:
cord-015365-iqdi99pd	670	13	p	p	NN
cord-015365-iqdi99pd	670	14	<	<	XX
cord-015365-iqdi99pd	670	15	0.05	0.05	CD
cord-015365-iqdi99pd	670	16	)	)	-RRB-
cord-015365-iqdi99pd	670	17	,	,	,
cord-015365-iqdi99pd	670	18	IL-2	IL-2	NNP
cord-015365-iqdi99pd	670	19	(	(	-LRB-
cord-015365-iqdi99pd	670	20	not	not	RB
cord-015365-iqdi99pd	670	21	CD8	CD8	NNP
cord-015365-iqdi99pd	670	22	T	T	NNP
cord-015365-iqdi99pd	670	23	cells	cell	NNS
cord-015365-iqdi99pd	670	24	)	)	-RRB-
cord-015365-iqdi99pd	670	25	,	,	,
cord-015365-iqdi99pd	670	26	IL-6	IL-6	NNP
cord-015365-iqdi99pd	670	27	(	(	-LRB-
cord-015365-iqdi99pd	670	28	CD4	CD4	NNP
cord-015365-iqdi99pd	670	29	:	:	:
cord-015365-iqdi99pd	670	30	p	p	NN
cord-015365-iqdi99pd	670	31	<	<	XX
cord-015365-iqdi99pd	670	32	0.05	0.05	CD
cord-015365-iqdi99pd	670	33	)	)	-RRB-
cord-015365-iqdi99pd	670	34	,	,	,
cord-015365-iqdi99pd	670	35	IL-10	IL-10	NNP
cord-015365-iqdi99pd	670	36	and	and	CC
cord-015365-iqdi99pd	670	37	TNF-	TNF-	NNP
cord-015365-iqdi99pd	670	38	.	.	.
cord-015365-iqdi99pd	670	39	Chimerism	chimerism	NN
cord-015365-iqdi99pd	670	40	developed	develop	VBD
cord-015365-iqdi99pd	670	41	earlier	early	RBR
cord-015365-iqdi99pd	670	42	in	in	IN
cord-015365-iqdi99pd	670	43	old	old	JJ
cord-015365-iqdi99pd	670	44	recipients	recipient	NNS
cord-015365-iqdi99pd	670	45	:	:	:
cord-015365-iqdi99pd	670	46	within	within	IN
cord-015365-iqdi99pd	670	47	one	one	CD
cord-015365-iqdi99pd	670	48	week	week	NN
cord-015365-iqdi99pd	670	49	most	most	RBS
cord-015365-iqdi99pd	670	50	older	old	JJR
cord-015365-iqdi99pd	670	51	recipients	recipient	NNS
cord-015365-iqdi99pd	670	52	became	become	VBD
cord-015365-iqdi99pd	670	53	chimeric	chimeric	JJ
cord-015365-iqdi99pd	670	54	following	follow	VBG
cord-015365-iqdi99pd	670	55	an	an	DT
cord-015365-iqdi99pd	670	56	irradiation	irradiation	NN
cord-015365-iqdi99pd	670	57	with	with	IN
cord-015365-iqdi99pd	670	58	3	3	CD
cord-015365-iqdi99pd	670	59	Gy	Gy	NNP
cord-015365-iqdi99pd	670	60	TBI	TBI	NNP
cord-015365-iqdi99pd	670	61	and	and	CC
cord-015365-iqdi99pd	670	62	co	co	JJ
cord-015365-iqdi99pd	670	63	-	-	JJ
cord-015365-iqdi99pd	670	64	stimulatory	stimulatory	JJ
cord-015365-iqdi99pd	670	65	blockade	blockade	NN
cord-015365-iqdi99pd	670	66	(	(	-LRB-
cord-015365-iqdi99pd	670	67	17/18	17/18	CD
cord-015365-iqdi99pd	670	68	vs.	vs.	IN
cord-015365-iqdi99pd	670	69	9/18	9/18	CD
cord-015365-iqdi99pd	670	70	chimeras	chimera	NNS
cord-015365-iqdi99pd	670	71	,	,	,
cord-015365-iqdi99pd	670	72	d	d	NNP
cord-015365-iqdi99pd	670	73	þ	þ	NNP
cord-015365-iqdi99pd	670	74	7	7	CD
cord-015365-iqdi99pd	670	75	and	and	CC
cord-015365-iqdi99pd	670	76	16/17	16/17	CD
cord-015365-iqdi99pd	670	77	vs.	vs.	IN
cord-015365-iqdi99pd	670	78	12/17	12/17	CD
cord-015365-iqdi99pd	670	79	,	,	,
cord-015365-iqdi99pd	670	80	d	d	NNP
cord-015365-iqdi99pd	670	81	þ	þ	NNP
cord-015365-iqdi99pd	670	82	14	14	CD
cord-015365-iqdi99pd	670	83	)	)	-RRB-
cord-015365-iqdi99pd	670	84	.	.	.
cord-015365-iqdi99pd	671	1	Old	old	JJ
cord-015365-iqdi99pd	671	2	recipients	recipient	NNS
cord-015365-iqdi99pd	671	3	became	become	VBD
cord-015365-iqdi99pd	671	4	even	even	RB
cord-015365-iqdi99pd	671	5	chimeric	chimeric	JJ
cord-015365-iqdi99pd	671	6	with	with	IN
cord-015365-iqdi99pd	671	7	a	a	DT
cord-015365-iqdi99pd	671	8	reduction	reduction	NN
cord-015365-iqdi99pd	671	9	of	of	IN
cord-015365-iqdi99pd	671	10	the	the	DT
cord-015365-iqdi99pd	671	11	total	total	JJ
cord-015365-iqdi99pd	671	12	body	body	NN
cord-015365-iqdi99pd	671	13	irradiation	irradiation	NN
cord-015365-iqdi99pd	671	14	to	to	IN
cord-015365-iqdi99pd	671	15	1	1	CD
cord-015365-iqdi99pd	671	16	Gy	Gy	NNP
cord-015365-iqdi99pd	671	17	.	.	.
cord-015365-iqdi99pd	672	1	In	in	IN
cord-015365-iqdi99pd	672	2	sharp	sharp	JJ
cord-015365-iqdi99pd	672	3	contrast	contrast	NN
cord-015365-iqdi99pd	672	4	,	,	,
cord-015365-iqdi99pd	672	5	none	none	NN
cord-015365-iqdi99pd	672	6	of	of	IN
cord-015365-iqdi99pd	672	7	the	the	DT
cord-015365-iqdi99pd	672	8	young	young	JJ
cord-015365-iqdi99pd	672	9	recipients	recipient	NNS
cord-015365-iqdi99pd	672	10	became	become	VBD
cord-015365-iqdi99pd	672	11	chimeric	chimeric	JJ
cord-015365-iqdi99pd	672	12	under	under	IN
cord-015365-iqdi99pd	672	13	those	those	DT
cord-015365-iqdi99pd	672	14	conditions	condition	NNS
cord-015365-iqdi99pd	672	15	(	(	-LRB-
cord-015365-iqdi99pd	672	16	4/8	4/8	CD
cord-015365-iqdi99pd	672	17	vs.	vs.	IN
cord-015365-iqdi99pd	672	18	0/8	0/8	CD
cord-015365-iqdi99pd	672	19	chimeras	chimera	NNS
cord-015365-iqdi99pd	672	20	in	in	IN
cord-015365-iqdi99pd	672	21	young	young	JJ
cord-015365-iqdi99pd	672	22	recipient	recipient	NN
cord-015365-iqdi99pd	672	23	,	,	,
cord-015365-iqdi99pd	672	24	p	p	NN
cord-015365-iqdi99pd	672	25	<	<	XX
cord-015365-iqdi99pd	672	26	0.05	0.05	CD
cord-015365-iqdi99pd	672	27	,	,	,
cord-015365-iqdi99pd	672	28	d	d	NNP
cord-015365-iqdi99pd	672	29	þ	þ	NNP
cord-015365-iqdi99pd	672	30	30	30	CD
cord-015365-iqdi99pd	672	31	)	)	-RRB-
cord-015365-iqdi99pd	672	32	.	.	.
cord-015365-iqdi99pd	673	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	673	2	.	.	.
cord-015365-iqdi99pd	674	1	Recipient	recipient	NN
cord-015365-iqdi99pd	674	2	age	age	NN
cord-015365-iqdi99pd	674	3	is	be	VBZ
cord-015365-iqdi99pd	674	4	linked	link	VBN
cord-015365-iqdi99pd	674	5	to	to	IN
cord-015365-iqdi99pd	674	6	a	a	DT
cord-015365-iqdi99pd	674	7	faster	fast	JJR
cord-015365-iqdi99pd	674	8	donor	donor	NN
cord-015365-iqdi99pd	674	9	BM	bm	NN
cord-015365-iqdi99pd	674	10	engraftment	engraftment	NN
cord-015365-iqdi99pd	674	11	and	and	CC
cord-015365-iqdi99pd	674	12	chimerism	chimerism	NN
cord-015365-iqdi99pd	674	13	.	.	.
cord-015365-iqdi99pd	675	1	Moreover	moreover	RB
cord-015365-iqdi99pd	675	2	,	,	,
cord-015365-iqdi99pd	675	3	chimerism	chimerism	NN
cord-015365-iqdi99pd	675	4	is	be	VBZ
cord-015365-iqdi99pd	675	5	attainable	attainable	JJ
cord-015365-iqdi99pd	675	6	with	with	IN
cord-015365-iqdi99pd	675	7	a	a	DT
cord-015365-iqdi99pd	675	8	lower	low	JJR
cord-015365-iqdi99pd	675	9	dose	dose	NN
cord-015365-iqdi99pd	675	10	of	of	IN
cord-015365-iqdi99pd	675	11	irradiation	irradiation	NN
cord-015365-iqdi99pd	675	12	.	.	.
cord-015365-iqdi99pd	676	1	Those	those	DT
cord-015365-iqdi99pd	676	2	results	result	NNS
cord-015365-iqdi99pd	676	3	support	support	VBP
cord-015365-iqdi99pd	676	4	the	the	DT
cord-015365-iqdi99pd	676	5	clinical	clinical	JJ
cord-015365-iqdi99pd	676	6	relevance	relevance	NN
cord-015365-iqdi99pd	676	7	of	of	IN
cord-015365-iqdi99pd	676	8	the	the	DT
cord-015365-iqdi99pd	676	9	chimerism	chimerism	NN
cord-015365-iqdi99pd	676	10	strategy	strategy	NN
cord-015365-iqdi99pd	676	11	for	for	IN
cord-015365-iqdi99pd	676	12	tolerance	tolerance	NN
cord-015365-iqdi99pd	676	13	induction	induction	NN
cord-015365-iqdi99pd	676	14	.	.	.
cord-015365-iqdi99pd	677	1	Background	background	NN
cord-015365-iqdi99pd	677	2	.	.	.
cord-015365-iqdi99pd	678	1	In	in	IN
cord-015365-iqdi99pd	678	2	allogeneic	allogeneic	NN
cord-015365-iqdi99pd	678	3	bone	bone	NN
cord-015365-iqdi99pd	678	4	marrow	marrow	NN
cord-015365-iqdi99pd	678	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	678	6	(	(	-LRB-
cord-015365-iqdi99pd	678	7	BMT	BMT	NNP
cord-015365-iqdi99pd	678	8	)	)	-RRB-
cord-015365-iqdi99pd	678	9	donor	donor	NN
cord-015365-iqdi99pd	678	10	T	t	NN
cord-015365-iqdi99pd	678	11	cells	cell	NNS
cord-015365-iqdi99pd	678	12	have	have	VBP
cord-015365-iqdi99pd	678	13	pleiotropic	pleiotropic	JJ
cord-015365-iqdi99pd	678	14	effects	effect	NNS
cord-015365-iqdi99pd	678	15	.	.	.
cord-015365-iqdi99pd	679	1	Surprisingly	surprisingly	RB
cord-015365-iqdi99pd	679	2	,	,	,
cord-015365-iqdi99pd	679	3	cotransplanting	cotransplante	VBG
cord-015365-iqdi99pd	679	4	high	high	JJ
cord-015365-iqdi99pd	679	5	doses	dose	NNS
cord-015365-iqdi99pd	679	6	of	of	IN
cord-015365-iqdi99pd	679	7	donor	donor	NN
cord-015365-iqdi99pd	679	8	T	t	NN
cord-015365-iqdi99pd	679	9	cells	cell	NNS
cord-015365-iqdi99pd	679	10	with	with	IN
cord-015365-iqdi99pd	679	11	donor	donor	NN
cord-015365-iqdi99pd	679	12	BM	bm	NN
cord-015365-iqdi99pd	679	13	causes	cause	VBZ
cord-015365-iqdi99pd	679	14	rejection	rejection	NN
cord-015365-iqdi99pd	679	15	of	of	IN
cord-015365-iqdi99pd	679	16	donor	donor	NN
cord-015365-iqdi99pd	679	17	BM	BM	NNP
cord-015365-iqdi99pd	679	18	despite	despite	IN
cord-015365-iqdi99pd	679	19	costimulation	costimulation	NN
cord-015365-iqdi99pd	679	20	blockade	blockade	NN
cord-015365-iqdi99pd	679	21	.	.	.
cord-015365-iqdi99pd	680	1	Therefore	therefore	RB
cord-015365-iqdi99pd	680	2	,	,	,
cord-015365-iqdi99pd	680	3	in	in	IN
cord-015365-iqdi99pd	680	4	the	the	DT
cord-015365-iqdi99pd	680	5	present	present	JJ
cord-015365-iqdi99pd	680	6	study	study	NN
cord-015365-iqdi99pd	680	7	we	-PRON-	PRP
cord-015365-iqdi99pd	680	8	investigate	investigate	VBP
cord-015365-iqdi99pd	680	9	the	the	DT
cord-015365-iqdi99pd	680	10	molecular	molecular	JJ
cord-015365-iqdi99pd	680	11	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	680	12	responsible	responsible	JJ
cord-015365-iqdi99pd	680	13	for	for	IN
cord-015365-iqdi99pd	680	14	this	this	DT
cord-015365-iqdi99pd	680	15	seemingly	seemingly	RB
cord-015365-iqdi99pd	680	16	paradoxical	paradoxical	JJ
cord-015365-iqdi99pd	680	17	phenomenon	phenomenon	NN
cord-015365-iqdi99pd	680	18	.	.	.
cord-015365-iqdi99pd	681	1	Methods	method	NNS
cord-015365-iqdi99pd	681	2	.	.	.
cord-015365-iqdi99pd	682	1	Recipients	recipient	NNS
cord-015365-iqdi99pd	682	2	(	(	-LRB-
cord-015365-iqdi99pd	682	3	C57BL/6	C57BL/6	NNP
cord-015365-iqdi99pd	682	4	)	)	-RRB-
cord-015365-iqdi99pd	682	5	were	be	VBD
cord-015365-iqdi99pd	682	6	treated	treat	VBN
cord-015365-iqdi99pd	682	7	with	with	IN
cord-015365-iqdi99pd	682	8	3	3	CD
cord-015365-iqdi99pd	682	9	Gy	Gy	NNP
cord-015365-iqdi99pd	682	10	TBI	TBI	NNP
cord-015365-iqdi99pd	682	11	(	(	-LRB-
cord-015365-iqdi99pd	682	12	d-1	d-1	NNP
cord-015365-iqdi99pd	682	13	)	)	-RRB-
cord-015365-iqdi99pd	682	14	and	and	CC
cord-015365-iqdi99pd	682	15	received	receive	VBD
cord-015365-iqdi99pd	682	16	approximately	approximately	RB
cord-015365-iqdi99pd	682	17	20Â106	20â106	CD
cord-015365-iqdi99pd	682	18	unseparated	unseparated	JJ
cord-015365-iqdi99pd	682	19	Balb	Balb	NNP
cord-015365-iqdi99pd	682	20	/	/	SYM
cord-015365-iqdi99pd	682	21	c	c	NN
cord-015365-iqdi99pd	682	22	BM	BM	NNP
cord-015365-iqdi99pd	682	23	cells	cell	NNS
cord-015365-iqdi99pd	682	24	(	(	-LRB-
cord-015365-iqdi99pd	682	25	d0	d0	NNP
cord-015365-iqdi99pd	682	26	)	)	-RRB-
cord-015365-iqdi99pd	682	27	and	and	CC
cord-015365-iqdi99pd	682	28	costimulation	costimulation	NN
cord-015365-iqdi99pd	682	29	blockers	blocker	NNS
cord-015365-iqdi99pd	682	30	anti	anti	NNP
cord-015365-iqdi99pd	682	31	-	-	JJ
cord-015365-iqdi99pd	682	32	CD154	CD154	NNP
cord-015365-iqdi99pd	682	33	mAb	mAb	NNS
cord-015365-iqdi99pd	682	34	(	(	-LRB-
cord-015365-iqdi99pd	682	35	d0	d0	NNP
cord-015365-iqdi99pd	682	36	)	)	-RRB-
cord-015365-iqdi99pd	682	37	and	and	CC
cord-015365-iqdi99pd	682	38	CTLA4Ig	CTLA4Ig	NNP
cord-015365-iqdi99pd	682	39	(	(	-LRB-
cord-015365-iqdi99pd	682	40	d	d	NN
cord-015365-iqdi99pd	682	41	þ	þ	NNP
cord-015365-iqdi99pd	682	42	2	2	CD
cord-015365-iqdi99pd	682	43	)	)	-RRB-
cord-015365-iqdi99pd	682	44	.	.	.
cord-015365-iqdi99pd	683	1	30Â10	30â10	CD
cord-015365-iqdi99pd	683	2	6	6	CD
cord-015365-iqdi99pd	684	1	Balb	Balb	NNP
cord-015365-iqdi99pd	684	2	/	/	SYM
cord-015365-iqdi99pd	684	3	c	c	NN
cord-015365-iqdi99pd	684	4	,	,	,
cord-015365-iqdi99pd	684	5	CB6F1	CB6F1	NNP
cord-015365-iqdi99pd	684	6	(	(	-LRB-
cord-015365-iqdi99pd	684	7	Balb	Balb	NNP
cord-015365-iqdi99pd	684	8	/	/	SYM
cord-015365-iqdi99pd	684	9	cÂB6	cÂB6	NNP
cord-015365-iqdi99pd	684	10	)	)	-RRB-
cord-015365-iqdi99pd	684	11	,	,	,
cord-015365-iqdi99pd	684	12	irradiated	irradiate	VBN
cord-015365-iqdi99pd	685	1	Balb	Balb	NNP
cord-015365-iqdi99pd	685	2	/	/	SYM
cord-015365-iqdi99pd	685	3	c	c	NN
cord-015365-iqdi99pd	685	4	or	or	CC
cord-015365-iqdi99pd	685	5	C3H	c3h	IN
cord-015365-iqdi99pd	685	6	CD4	CD4	NNP
cord-015365-iqdi99pd	685	7	T	T	NNP
cord-015365-iqdi99pd	685	8	cells	cell	NNS
cord-015365-iqdi99pd	685	9	(	(	-LRB-
cord-015365-iqdi99pd	685	10	isolated	isolate	VBN
cord-015365-iqdi99pd	685	11	by	by	IN
cord-015365-iqdi99pd	685	12	MACS	mac	NNS
cord-015365-iqdi99pd	685	13	)	)	-RRB-
cord-015365-iqdi99pd	685	14	were	be	VBD
cord-015365-iqdi99pd	685	15	co	co	VBN
cord-015365-iqdi99pd	685	16	-	-	VBN
cord-015365-iqdi99pd	685	17	transplanted	transplant	VBN
cord-015365-iqdi99pd	685	18	in	in	IN
cord-015365-iqdi99pd	685	19	addition	addition	NN
cord-015365-iqdi99pd	685	20	.	.	.
cord-015365-iqdi99pd	686	1	Groups	group	NNS
cord-015365-iqdi99pd	686	2	either	either	CC
cord-015365-iqdi99pd	686	3	received	receive	VBD
cord-015365-iqdi99pd	686	4	anti	anti	JJ
cord-015365-iqdi99pd	686	5	-	-	NNP
cord-015365-iqdi99pd	686	6	IL-6	il-6	JJ
cord-015365-iqdi99pd	686	7	,	,	,
cord-015365-iqdi99pd	686	8	anti	anti	JJ
cord-015365-iqdi99pd	686	9	-	-	JJ
cord-015365-iqdi99pd	686	10	IFN-	ifn-	JJ
cord-015365-iqdi99pd	686	11	,	,	,
cord-015365-iqdi99pd	686	12	anti	anti	JJ
cord-015365-iqdi99pd	686	13	-	-	JJ
cord-015365-iqdi99pd	686	14	LFA1	lfa1	JJ
cord-015365-iqdi99pd	686	15	mAb	mAb	NNS
cord-015365-iqdi99pd	686	16	or	or	CC
cord-015365-iqdi99pd	686	17	rapamycin	rapamycin	NNS
cord-015365-iqdi99pd	686	18	.	.	.
cord-015365-iqdi99pd	687	1	Multilineage	multilineage	NN
cord-015365-iqdi99pd	687	2	chimerism	chimerism	NN
cord-015365-iqdi99pd	687	3	was	be	VBD
cord-015365-iqdi99pd	687	4	followed	follow	VBN
cord-015365-iqdi99pd	687	5	by	by	IN
cord-015365-iqdi99pd	687	6	flow	flow	NN
cord-015365-iqdi99pd	687	7	cytometry	cytometry	NN
cord-015365-iqdi99pd	687	8	and	and	CC
cord-015365-iqdi99pd	687	9	cytokine	cytokine	NN
cord-015365-iqdi99pd	687	10	release	release	NN
cord-015365-iqdi99pd	687	11	was	be	VBD
cord-015365-iqdi99pd	687	12	analyzed	analyze	VBN
cord-015365-iqdi99pd	687	13	.	.	.
cord-015365-iqdi99pd	688	1	Results	result	NNS
cord-015365-iqdi99pd	688	2	.	.	.
cord-015365-iqdi99pd	689	1	Co	co	NN
cord-015365-iqdi99pd	689	2	-	-	NN
cord-015365-iqdi99pd	689	3	transplantation	transplantation	NN
cord-015365-iqdi99pd	689	4	of	of	IN
cord-015365-iqdi99pd	689	5	30Â10	30â10	CD
cord-015365-iqdi99pd	689	6	6	6	CD
cord-015365-iqdi99pd	689	7	CD4	CD4	NNP
cord-015365-iqdi99pd	689	8	T	T	NNP
cord-015365-iqdi99pd	689	9	cells	cell	NNS
cord-015365-iqdi99pd	689	10	but	but	CC
cord-015365-iqdi99pd	689	11	not	not	RB
cord-015365-iqdi99pd	689	12	CD8	CD8	NNP
cord-015365-iqdi99pd	689	13	T	T	NNP
cord-015365-iqdi99pd	689	14	cells	cell	NNS
cord-015365-iqdi99pd	689	15	triggered	trigger	VBD
cord-015365-iqdi99pd	689	16	rapid	rapid	JJ
cord-015365-iqdi99pd	689	17	BM	BM	NNP
cord-015365-iqdi99pd	689	18	rejection	rejection	NN
cord-015365-iqdi99pd	689	19	of	of	IN
cord-015365-iqdi99pd	689	20	donor	donor	NN
cord-015365-iqdi99pd	689	21	BM	BM	NNP
cord-015365-iqdi99pd	689	22	under	under	IN
cord-015365-iqdi99pd	689	23	costimulation	costimulation	NN
cord-015365-iqdi99pd	689	24	blockade	blockade	NN
cord-015365-iqdi99pd	689	25	within	within	IN
cord-015365-iqdi99pd	689	26	one	one	CD
cord-015365-iqdi99pd	689	27	week	week	NN
cord-015365-iqdi99pd	689	28	in	in	IN
cord-015365-iqdi99pd	689	29	an	an	DT
cord-015365-iqdi99pd	689	30	otherwise	otherwise	RB
cord-015365-iqdi99pd	689	31	successful	successful	JJ
cord-015365-iqdi99pd	689	32	protocol	protocol	NN
cord-015365-iqdi99pd	689	33	(	(	-LRB-
cord-015365-iqdi99pd	689	34	0/13	0/13	CD
cord-015365-iqdi99pd	689	35	vs.	vs.	IN
cord-015365-iqdi99pd	689	36	17/20	17/20	CD
cord-015365-iqdi99pd	689	37	chimeras	chimera	NNS
cord-015365-iqdi99pd	689	38	,	,	,
cord-015365-iqdi99pd	689	39	p	p	NN
cord-015365-iqdi99pd	689	40	<	<	XX
cord-015365-iqdi99pd	689	41	0.001	0.001	CD
cord-015365-iqdi99pd	689	42	)	)	-RRB-
cord-015365-iqdi99pd	689	43	.	.	.
cord-015365-iqdi99pd	690	1	The	the	DT
cord-015365-iqdi99pd	690	2	levels	level	NNS
cord-015365-iqdi99pd	690	3	of	of	IN
cord-015365-iqdi99pd	690	4	IL-6	IL-6	NNP
cord-015365-iqdi99pd	690	5	,	,	,
cord-015365-iqdi99pd	690	6	IFN-	IFN-	NNP
cord-015365-iqdi99pd	690	7	,	,	,
cord-015365-iqdi99pd	690	8	IL-17A	il-17a	NN
cord-015365-iqdi99pd	690	9	(	(	-LRB-
cord-015365-iqdi99pd	690	10	p	p	NN
cord-015365-iqdi99pd	690	11	<	<	XX
cord-015365-iqdi99pd	690	12	0.05	0.05	CD
cord-015365-iqdi99pd	690	13	)	)	-RRB-
cord-015365-iqdi99pd	690	14	and	and	CC
cord-015365-iqdi99pd	690	15	TGF	TGF	NNP
cord-015365-iqdi99pd	690	16	-	-	,
cord-015365-iqdi99pd	690	17	were	be	VBD
cord-015365-iqdi99pd	690	18	found	find	VBN
cord-015365-iqdi99pd	690	19	to	to	TO
cord-015365-iqdi99pd	690	20	be	be	VB
cord-015365-iqdi99pd	690	21	higher	high	JJR
cord-015365-iqdi99pd	690	22	in	in	IN
cord-015365-iqdi99pd	690	23	mice	mouse	NNS
cord-015365-iqdi99pd	690	24	treated	treat	VBN
cord-015365-iqdi99pd	690	25	with	with	IN
cord-015365-iqdi99pd	690	26	additional	additional	JJ
cord-015365-iqdi99pd	690	27	donor	donor	NN
cord-015365-iqdi99pd	690	28	T	t	NN
cord-015365-iqdi99pd	690	29	cells	cell	NNS
cord-015365-iqdi99pd	690	30	.	.	.
cord-015365-iqdi99pd	691	1	The	the	DT
cord-015365-iqdi99pd	691	2	neutralization	neutralization	NN
cord-015365-iqdi99pd	691	3	of	of	IN
cord-015365-iqdi99pd	691	4	IL-6	IL-6	NNP
cord-015365-iqdi99pd	691	5	,	,	,
cord-015365-iqdi99pd	691	6	but	but	CC
cord-015365-iqdi99pd	691	7	not	not	RB
cord-015365-iqdi99pd	691	8	of	of	IN
cord-015365-iqdi99pd	691	9	IFN	IFN	NNP
cord-015365-iqdi99pd	691	10	-	-	HYPH
cord-015365-iqdi99pd	691	11	resulted	result	VBD
cord-015365-iqdi99pd	691	12	in	in	IN
cord-015365-iqdi99pd	691	13	a	a	DT
cord-015365-iqdi99pd	691	14	significantly	significantly	RB
cord-015365-iqdi99pd	691	15	higher	high	JJR
cord-015365-iqdi99pd	691	16	rate	rate	NN
cord-015365-iqdi99pd	691	17	of	of	IN
cord-015365-iqdi99pd	691	18	chimerism	chimerism	NN
cord-015365-iqdi99pd	691	19	induction	induction	NN
cord-015365-iqdi99pd	691	20	compared	compare	VBN
cord-015365-iqdi99pd	691	21	to	to	IN
cord-015365-iqdi99pd	691	22	controls	control	NNS
cord-015365-iqdi99pd	691	23	(	(	-LRB-
cord-015365-iqdi99pd	691	24	5/7	5/7	CD
cord-015365-iqdi99pd	691	25	vs.	vs.	IN
cord-015365-iqdi99pd	691	26	0/5	0/5	CD
cord-015365-iqdi99pd	691	27	chimeras	chimera	NNS
cord-015365-iqdi99pd	691	28	;	;	:
cord-015365-iqdi99pd	691	29	p	p	NN
cord-015365-iqdi99pd	691	30	<	<	XX
cord-015365-iqdi99pd	691	31	0.05	0.05	CD
cord-015365-iqdi99pd	691	32	)	)	-RRB-
cord-015365-iqdi99pd	691	33	.	.	.
cord-015365-iqdi99pd	692	1	The	the	DT
cord-015365-iqdi99pd	692	2	injection	injection	NN
cord-015365-iqdi99pd	692	3	of	of	IN
cord-015365-iqdi99pd	692	4	CB6F1	CB6F1	NNP
cord-015365-iqdi99pd	692	5	or	or	CC
cord-015365-iqdi99pd	692	6	irradiated	irradiate	VBN
cord-015365-iqdi99pd	692	7	Balb	Balb	NNP
cord-015365-iqdi99pd	692	8	/	/	SYM
cord-015365-iqdi99pd	692	9	c	c	NN
cord-015365-iqdi99pd	692	10	CD4	CD4	NNP
cord-015365-iqdi99pd	692	11	T	T	NNP
cord-015365-iqdi99pd	692	12	cells	cell	NNS
cord-015365-iqdi99pd	692	13	did	do	VBD
cord-015365-iqdi99pd	692	14	not	not	RB
cord-015365-iqdi99pd	692	15	abrogate	abrogate	VB
cord-015365-iqdi99pd	692	16	chimerism	chimerism	NN
cord-015365-iqdi99pd	692	17	(	(	-LRB-
cord-015365-iqdi99pd	692	18	5/6	5/6	CD
cord-015365-iqdi99pd	692	19	and	and	CC
cord-015365-iqdi99pd	692	20	4/5	4/5	CD
cord-015365-iqdi99pd	692	21	vs.	vs.	NN
cord-015365-iqdi99pd	692	22	0/4	0/4	CD
cord-015365-iqdi99pd	692	23	chimeras	chimera	NNS
cord-015365-iqdi99pd	692	24	with	with	IN
cord-015365-iqdi99pd	692	25	Balb	Balb	NNP
cord-015365-iqdi99pd	692	26	/	/	SYM
cord-015365-iqdi99pd	692	27	c	c	NN
cord-015365-iqdi99pd	692	28	T	t	NN
cord-015365-iqdi99pd	692	29	cells	cell	NNS
cord-015365-iqdi99pd	692	30	;	;	:
cord-015365-iqdi99pd	692	31	p	p	NN
cord-015365-iqdi99pd	692	32	<	<	XX
cord-015365-iqdi99pd	692	33	0.05	0.05	CD
cord-015365-iqdi99pd	692	34	)	)	-RRB-
cord-015365-iqdi99pd	692	35	,	,	,
cord-015365-iqdi99pd	692	36	whereas	whereas	IN
cord-015365-iqdi99pd	692	37	C3H	c3h	CD
cord-015365-iqdi99pd	692	38	CD4	CD4	NNP
cord-015365-iqdi99pd	692	39	T	T	NNP
cord-015365-iqdi99pd	692	40	cells	cell	NNS
cord-015365-iqdi99pd	692	41	induced	induce	VBN
cord-015365-iqdi99pd	692	42	BM	BM	NNP
cord-015365-iqdi99pd	692	43	rejection	rejection	NN
cord-015365-iqdi99pd	692	44	(	(	-LRB-
cord-015365-iqdi99pd	692	45	0/5	0/5	CD
cord-015365-iqdi99pd	692	46	vs.	vs.	NN
cord-015365-iqdi99pd	692	47	9/9	9/9	CD
cord-015365-iqdi99pd	692	48	chimeras	chimera	NNS
cord-015365-iqdi99pd	692	49	BMT	BMT	NNP
cord-015365-iqdi99pd	692	50	,	,	,
cord-015365-iqdi99pd	692	51	p	p	NN
cord-015365-iqdi99pd	692	52	<	<	XX
cord-015365-iqdi99pd	692	53	0.001	0.001	CD
cord-015365-iqdi99pd	692	54	)	)	-RRB-
cord-015365-iqdi99pd	692	55	.	.	.
cord-015365-iqdi99pd	693	1	The	the	DT
cord-015365-iqdi99pd	693	2	additional	additional	JJ
cord-015365-iqdi99pd	693	3	treatment	treatment	NN
cord-015365-iqdi99pd	693	4	with	with	IN
cord-015365-iqdi99pd	693	5	rapamycin	rapamycin	NN
cord-015365-iqdi99pd	693	6	or	or	CC
cord-015365-iqdi99pd	693	7	anti	anti	JJ
cord-015365-iqdi99pd	693	8	-	-	JJ
cord-015365-iqdi99pd	693	9	LFA1	LFA1	NNP
cord-015365-iqdi99pd	693	10	overcame	overcome	VBD
cord-015365-iqdi99pd	693	11	the	the	DT
cord-015365-iqdi99pd	693	12	negative	negative	JJ
cord-015365-iqdi99pd	693	13	effect	effect	NN
cord-015365-iqdi99pd	693	14	of	of	IN
cord-015365-iqdi99pd	693	15	donor	donor	NN
cord-015365-iqdi99pd	693	16	T	t	NN
cord-015365-iqdi99pd	693	17	cell	cell	NN
cord-015365-iqdi99pd	693	18	injection	injection	NN
cord-015365-iqdi99pd	693	19	(	(	-LRB-
cord-015365-iqdi99pd	693	20	5/5	5/5	CD
cord-015365-iqdi99pd	693	21	and	and	CC
cord-015365-iqdi99pd	693	22	6/6	6/6	CD
cord-015365-iqdi99pd	693	23	vs.	vs.	IN
cord-015365-iqdi99pd	693	24	0/4	0/4	CD
cord-015365-iqdi99pd	693	25	chimeras	chimera	NNS
cord-015365-iqdi99pd	693	26	;	;	:
cord-015365-iqdi99pd	693	27	p	p	NN
cord-015365-iqdi99pd	693	28	<	<	XX
cord-015365-iqdi99pd	693	29	0.01	0.01	CD
cord-015365-iqdi99pd	693	30	)	)	-RRB-
cord-015365-iqdi99pd	693	31	.	.	.
cord-015365-iqdi99pd	694	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	694	2	.	.	.
cord-015365-iqdi99pd	695	1	The	the	DT
cord-015365-iqdi99pd	695	2	abrogation	abrogation	NN
cord-015365-iqdi99pd	695	3	of	of	IN
cord-015365-iqdi99pd	695	4	BM	BM	NNP
cord-015365-iqdi99pd	695	5	engraftment	engraftment	NN
cord-015365-iqdi99pd	695	6	through	through	IN
cord-015365-iqdi99pd	695	7	cotransplantation	cotransplantation	NN
cord-015365-iqdi99pd	695	8	of	of	IN
cord-015365-iqdi99pd	695	9	donor	donor	NN
cord-015365-iqdi99pd	695	10	CD4	CD4	NNP
cord-015365-iqdi99pd	695	11	T	T	NNP
cord-015365-iqdi99pd	695	12	cells	cell	NNS
cord-015365-iqdi99pd	695	13	involves	involve	VBZ
cord-015365-iqdi99pd	695	14	IL-6	IL-6	NNP
cord-015365-iqdi99pd	695	15	,	,	,
cord-015365-iqdi99pd	695	16	requires	require	VBZ
cord-015365-iqdi99pd	695	17	proliferative	proliferative	JJ
cord-015365-iqdi99pd	695	18	capacity	capacity	NN
cord-015365-iqdi99pd	695	19	of	of	IN
cord-015365-iqdi99pd	695	20	the	the	DT
cord-015365-iqdi99pd	695	21	co	co	NN
cord-015365-iqdi99pd	695	22	-	-	JJ
cord-015365-iqdi99pd	695	23	transplanted	transplanted	JJ
cord-015365-iqdi99pd	695	24	T	T	NNP
cord-015365-iqdi99pd	695	25	cells	cell	NNS
cord-015365-iqdi99pd	695	26	and	and	CC
cord-015365-iqdi99pd	695	27	needs	need	VBZ
cord-015365-iqdi99pd	695	28	to	to	TO
cord-015365-iqdi99pd	695	29	recognize	recognize	VB
cord-015365-iqdi99pd	695	30	the	the	DT
cord-015365-iqdi99pd	695	31	recipient	recipient	NN
cord-015365-iqdi99pd	695	32	as	as	IN
cord-015365-iqdi99pd	695	33	allogeneic	allogeneic	NN
cord-015365-iqdi99pd	695	34	.	.	.
cord-015365-iqdi99pd	696	1	Neutralisation	Neutralisation	NNP
cord-015365-iqdi99pd	696	2	of	of	IN
cord-015365-iqdi99pd	696	3	IL-6	IL-6	NNP
cord-015365-iqdi99pd	696	4	,	,	,
cord-015365-iqdi99pd	696	5	rapamycin	rapamycin	NN
cord-015365-iqdi99pd	696	6	and	and	CC
cord-015365-iqdi99pd	696	7	anti	anti	JJ
cord-015365-iqdi99pd	696	8	-	-	JJ
cord-015365-iqdi99pd	696	9	LFA1	LFA1	NNP
cord-015365-iqdi99pd	696	10	overcome	overcome	VB
cord-015365-iqdi99pd	696	11	the	the	DT
cord-015365-iqdi99pd	696	12	effect	effect	NN
cord-015365-iqdi99pd	696	13	of	of	IN
cord-015365-iqdi99pd	696	14	co	co	JJ
cord-015365-iqdi99pd	696	15	-	-	JJ
cord-015365-iqdi99pd	696	16	transplanted	transplanted	JJ
cord-015365-iqdi99pd	696	17	donor	donor	NN
cord-015365-iqdi99pd	696	18	CD4	CD4	NNP
cord-015365-iqdi99pd	696	19	T	T	NNP
cord-015365-iqdi99pd	696	20	cells	cell	NNS
cord-015365-iqdi99pd	696	21	and	and	CC
cord-015365-iqdi99pd	696	22	offer	offer	VBP
cord-015365-iqdi99pd	696	23	potential	potential	JJ
cord-015365-iqdi99pd	696	24	targets	target	NNS
cord-015365-iqdi99pd	696	25	for	for	IN
cord-015365-iqdi99pd	696	26	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	696	27	intervention	intervention	NN
cord-015365-iqdi99pd	696	28	in	in	IN
cord-015365-iqdi99pd	696	29	costimulation	costimulation	NN
cord-015365-iqdi99pd	696	30	blockade	blockade	NN
cord-015365-iqdi99pd	696	31	-	-	HYPH
cord-015365-iqdi99pd	696	32	resistant	resistant	JJ
cord-015365-iqdi99pd	696	33	rejection	rejection	NN
cord-015365-iqdi99pd	696	34	.	.	.
cord-015365-iqdi99pd	696	35	 	 	_SP
cord-015365-iqdi99pd	697	1	Background	background	NN
cord-015365-iqdi99pd	697	2	.	.	.
cord-015365-iqdi99pd	698	1	Mixed	mixed	JJ
cord-015365-iqdi99pd	698	2	chimerism	chimerism	NN
cord-015365-iqdi99pd	698	3	is	be	VBZ
cord-015365-iqdi99pd	698	4	an	an	DT
cord-015365-iqdi99pd	698	5	effective	effective	JJ
cord-015365-iqdi99pd	698	6	strategy	strategy	NN
cord-015365-iqdi99pd	698	7	for	for	IN
cord-015365-iqdi99pd	698	8	the	the	DT
cord-015365-iqdi99pd	698	9	induction	induction	NN
cord-015365-iqdi99pd	698	10	of	of	IN
cord-015365-iqdi99pd	698	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	698	12	tolerance	tolerance	NN
cord-015365-iqdi99pd	698	13	,	,	,
cord-015365-iqdi99pd	698	14	however	however	RB
cord-015365-iqdi99pd	698	15	,	,	,
cord-015365-iqdi99pd	698	16	translation	translation	NN
cord-015365-iqdi99pd	698	17	from	from	IN
cord-015365-iqdi99pd	698	18	murine	murine	JJ
cord-015365-iqdi99pd	698	19	models	model	NNS
cord-015365-iqdi99pd	698	20	to	to	IN
cord-015365-iqdi99pd	698	21	the	the	DT
cord-015365-iqdi99pd	698	22	clinical	clinical	JJ
cord-015365-iqdi99pd	698	23	setting	setting	NN
cord-015365-iqdi99pd	698	24	is	be	VBZ
cord-015365-iqdi99pd	698	25	challenging	challenging	JJ
cord-015365-iqdi99pd	698	26	.	.	.
cord-015365-iqdi99pd	699	1	One	one	CD
cord-015365-iqdi99pd	699	2	hurdle	hurdle	NN
cord-015365-iqdi99pd	699	3	is	be	VBZ
cord-015365-iqdi99pd	699	4	the	the	DT
cord-015365-iqdi99pd	699	5	high	high	JJ
cord-015365-iqdi99pd	699	6	frequency	frequency	NN
cord-015365-iqdi99pd	699	7	of	of	IN
cord-015365-iqdi99pd	699	8	alloreactive	alloreactive	JJ
cord-015365-iqdi99pd	699	9	memory	memory	NN
cord-015365-iqdi99pd	699	10	T	T	NNP
cord-015365-iqdi99pd	699	11	-	-	HYPH
cord-015365-iqdi99pd	699	12	cells	cell	NNS
cord-015365-iqdi99pd	699	13	(	(	-LRB-
cord-015365-iqdi99pd	699	14	Tmem	Tmem	NNP
cord-015365-iqdi99pd	699	15	)	)	-RRB-
cord-015365-iqdi99pd	699	16	found	find	VBN
cord-015365-iqdi99pd	699	17	in	in	IN
cord-015365-iqdi99pd	699	18	the	the	DT
cord-015365-iqdi99pd	699	19	(	(	-LRB-
cord-015365-iqdi99pd	699	20	pre)clinical	pre)clinical	JJ
cord-015365-iqdi99pd	699	21	setting	setting	NN
cord-015365-iqdi99pd	699	22	,	,	,
cord-015365-iqdi99pd	699	23	which	which	WDT
cord-015365-iqdi99pd	699	24	is	be	VBZ
cord-015365-iqdi99pd	699	25	not	not	RB
cord-015365-iqdi99pd	699	26	present	present	JJ
cord-015365-iqdi99pd	699	27	to	to	IN
cord-015365-iqdi99pd	699	28	a	a	DT
cord-015365-iqdi99pd	699	29	similar	similar	JJ
cord-015365-iqdi99pd	699	30	degree	degree	NN
cord-015365-iqdi99pd	699	31	in	in	IN
cord-015365-iqdi99pd	699	32	mouse	mouse	NN
cord-015365-iqdi99pd	699	33	models	model	NNS
cord-015365-iqdi99pd	699	34	.	.	.
cord-015365-iqdi99pd	700	1	To	to	TO
cord-015365-iqdi99pd	700	2	better	well	RBR
cord-015365-iqdi99pd	700	3	model	model	VB
cord-015365-iqdi99pd	700	4	this	this	DT
cord-015365-iqdi99pd	700	5	clinical	clinical	JJ
cord-015365-iqdi99pd	700	6	reality	reality	NN
cord-015365-iqdi99pd	700	7	,	,	,
cord-015365-iqdi99pd	700	8	we	-PRON-	PRP
cord-015365-iqdi99pd	700	9	have	have	VBP
cord-015365-iqdi99pd	700	10	developed	develop	VBN
cord-015365-iqdi99pd	700	11	a	a	DT
cord-015365-iqdi99pd	700	12	murine	murine	JJ
cord-015365-iqdi99pd	700	13	model	model	NN
cord-015365-iqdi99pd	700	14	in	in	IN
cord-015365-iqdi99pd	700	15	which	which	WDT
cord-015365-iqdi99pd	700	16	the	the	DT
cord-015365-iqdi99pd	700	17	transfer	transfer	NN
cord-015365-iqdi99pd	700	18	of	of	IN
cord-015365-iqdi99pd	700	19	3Â10	3â10	CD
cord-015365-iqdi99pd	700	20	7	7	CD
cord-015365-iqdi99pd	700	21	T	t	NN
cord-015365-iqdi99pd	700	22	-	-	HYPH
cord-015365-iqdi99pd	700	23	cells	cell	NNS
cord-015365-iqdi99pd	700	24	from	from	IN
cord-015365-iqdi99pd	700	25	sensitized	sensitize	VBN
cord-015365-iqdi99pd	700	26	mice	mouse	NNS
cord-015365-iqdi99pd	700	27	inhibits	inhibit	VBZ
cord-015365-iqdi99pd	700	28	the	the	DT
cord-015365-iqdi99pd	700	29	induction	induction	NN
cord-015365-iqdi99pd	700	30	of	of	IN
cord-015365-iqdi99pd	700	31	chimerism	chimerism	NN
cord-015365-iqdi99pd	700	32	and	and	CC
cord-015365-iqdi99pd	700	33	tolerance	tolerance	NN
cord-015365-iqdi99pd	700	34	in	in	IN
cord-015365-iqdi99pd	700	35	a	a	DT
cord-015365-iqdi99pd	700	36	well	well	RB
cord-015365-iqdi99pd	700	37	-	-	HYPH
cord-015365-iqdi99pd	700	38	characterized	characterize	VBN
cord-015365-iqdi99pd	700	39	costimulation	costimulation	NN
cord-015365-iqdi99pd	700	40	blockade	blockade	NN
cord-015365-iqdi99pd	700	41	-	-	HYPH
cord-015365-iqdi99pd	700	42	based	base	VBN
cord-015365-iqdi99pd	700	43	bone	bone	NN
cord-015365-iqdi99pd	700	44	marrow	marrow	NN
cord-015365-iqdi99pd	700	45	transplantation	transplantation	NN
cord-015365-iqdi99pd	700	46	(	(	-LRB-
cord-015365-iqdi99pd	700	47	BMT	BMT	NNP
cord-015365-iqdi99pd	700	48	)	)	-RRB-
cord-015365-iqdi99pd	700	49	model	model	NN
cord-015365-iqdi99pd	700	50	.	.	.
cord-015365-iqdi99pd	701	1	Here	here	RB
cord-015365-iqdi99pd	701	2	,	,	,
cord-015365-iqdi99pd	701	3	we	-PRON-	PRP
cord-015365-iqdi99pd	701	4	evaluated	evaluate	VBD
cord-015365-iqdi99pd	701	5	whether	whether	IN
cord-015365-iqdi99pd	701	6	treatment	treatment	NN
cord-015365-iqdi99pd	701	7	with	with	IN
cord-015365-iqdi99pd	701	8	clinically	clinically	RB
cord-015365-iqdi99pd	701	9	approved	approve	VBN
cord-015365-iqdi99pd	701	10	drugs	drug	NNS
cord-015365-iqdi99pd	701	11	(	(	-LRB-
cord-015365-iqdi99pd	701	12	rapamycin	rapamycin	NNS
cord-015365-iqdi99pd	701	13	,	,	,
cord-015365-iqdi99pd	701	14	anti	anti	JJ
cord-015365-iqdi99pd	701	15	-	-	JJ
cord-015365-iqdi99pd	701	16	LFA-1mAb	lfa-1mab	JJ
cord-015365-iqdi99pd	701	17	)	)	-RRB-
cord-015365-iqdi99pd	701	18	can	can	MD
cord-015365-iqdi99pd	701	19	overcome	overcome	VB
cord-015365-iqdi99pd	701	20	costimulationresistant	costimulationresistant	NN
cord-015365-iqdi99pd	701	21	rejection	rejection	NN
cord-015365-iqdi99pd	701	22	triggered	trigger	VBN
cord-015365-iqdi99pd	701	23	by	by	IN
cord-015365-iqdi99pd	701	24	memory	memory	NN
cord-015365-iqdi99pd	701	25	cells	cell	NNS
cord-015365-iqdi99pd	701	26	and	and	CC
cord-015365-iqdi99pd	701	27	tried	try	VBD
cord-015365-iqdi99pd	701	28	to	to	TO
cord-015365-iqdi99pd	701	29	gain	gain	VB
cord-015365-iqdi99pd	701	30	insight	insight	NN
cord-015365-iqdi99pd	701	31	into	into	IN
cord-015365-iqdi99pd	701	32	the	the	DT
cord-015365-iqdi99pd	701	33	underlying	underlie	VBG
cord-015365-iqdi99pd	701	34	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	701	35	.	.	.
cord-015365-iqdi99pd	702	1	Methods	method	NNS
cord-015365-iqdi99pd	702	2	.	.	.
cord-015365-iqdi99pd	703	1	T	T	NNP
cord-015365-iqdi99pd	703	2	-	-	HYPH
cord-015365-iqdi99pd	703	3	cells	cell	NNS
cord-015365-iqdi99pd	703	4	sensitized	sensitize	VBN
cord-015365-iqdi99pd	703	5	towards	towards	IN
cord-015365-iqdi99pd	703	6	donor	donor	NN
cord-015365-iqdi99pd	703	7	(	(	-LRB-
cord-015365-iqdi99pd	703	8	3Â10	3â10	CD
cord-015365-iqdi99pd	703	9	7	7	CD
cord-015365-iqdi99pd	703	10	Tmemenriched	Tmemenriched	NNP
cord-015365-iqdi99pd	703	11	T	t	NN
cord-015365-iqdi99pd	703	12	-	-	HYPH
cord-015365-iqdi99pd	703	13	cells	cell	NNS
cord-015365-iqdi99pd	703	14	)	)	-RRB-
cord-015365-iqdi99pd	703	15	were	be	VBD
cord-015365-iqdi99pd	703	16	adoptively	adoptively	RB
cord-015365-iqdi99pd	703	17	transferred	transfer	VBN
cord-015365-iqdi99pd	703	18	into	into	IN
cord-015365-iqdi99pd	703	19	groups	group	NNS
cord-015365-iqdi99pd	703	20	of	of	IN
cord-015365-iqdi99pd	703	21	naïve	naïve	JJ
cord-015365-iqdi99pd	703	22	B6	b6	NN
cord-015365-iqdi99pd	703	23	mice	mouse	NNS
cord-015365-iqdi99pd	703	24	prior	prior	RB
cord-015365-iqdi99pd	703	25	to	to	IN
cord-015365-iqdi99pd	703	26	BMT	BMT	NNP
cord-015365-iqdi99pd	703	27	(	(	-LRB-
cord-015365-iqdi99pd	703	28	d-7	d-7	NNS
cord-015365-iqdi99pd	703	29	)	)	-RRB-
cord-015365-iqdi99pd	703	30	.	.	.
cord-015365-iqdi99pd	704	1	BMT	BMT	NNP
cord-015365-iqdi99pd	704	2	recipients	recipient	NNS
cord-015365-iqdi99pd	704	3	received	receive	VBD
cord-015365-iqdi99pd	704	4	1Gy	1gy	JJ
cord-015365-iqdi99pd	704	5	total	total	JJ
cord-015365-iqdi99pd	704	6	body	body	NN
cord-015365-iqdi99pd	704	7	irradiation	irradiation	NN
cord-015365-iqdi99pd	704	8	(	(	-LRB-
cord-015365-iqdi99pd	704	9	d-1	d-1	NNP
cord-015365-iqdi99pd	704	10	)	)	-RRB-
cord-015365-iqdi99pd	704	11	,	,	,
cord-015365-iqdi99pd	704	12	20Â10	20â10	CD
cord-015365-iqdi99pd	704	13	6	6	CD
cord-015365-iqdi99pd	704	14	fully	fully	RB
cord-015365-iqdi99pd	704	15	mismatched	mismatch	VBN
cord-015365-iqdi99pd	704	16	Balb	Balb	NNP
cord-015365-iqdi99pd	704	17	/	/	SYM
cord-015365-iqdi99pd	704	18	c	c	NN
cord-015365-iqdi99pd	704	19	bone	bone	NN
cord-015365-iqdi99pd	704	20	marrow	marrow	NN
cord-015365-iqdi99pd	704	21	cells	cell	NNS
cord-015365-iqdi99pd	704	22	(	(	-LRB-
cord-015365-iqdi99pd	704	23	d0	d0	NNP
cord-015365-iqdi99pd	704	24	)	)	-RRB-
cord-015365-iqdi99pd	704	25	and	and	CC
cord-015365-iqdi99pd	704	26	costimulation	costimulation	NN
cord-015365-iqdi99pd	704	27	-	-	HYPH
cord-015365-iqdi99pd	704	28	blockade	blockade	NN
cord-015365-iqdi99pd	704	29	consisting	consisting	NN
cord-015365-iqdi99pd	704	30	of	of	IN
cord-015365-iqdi99pd	704	31	anti	anti	JJ
cord-015365-iqdi99pd	704	32	-	-	JJ
cord-015365-iqdi99pd	704	33	CD154mAb	cd154mab	JJ
cord-015365-iqdi99pd	704	34	(	(	-LRB-
cord-015365-iqdi99pd	704	35	1	1	CD
cord-015365-iqdi99pd	704	36	mg	mg	NN
cord-015365-iqdi99pd	704	37	,	,	,
cord-015365-iqdi99pd	704	38	d0	d0	NNP
cord-015365-iqdi99pd	704	39	)	)	-RRB-
cord-015365-iqdi99pd	704	40	and	and	CC
cord-015365-iqdi99pd	704	41	CTLA4Ig	CTLA4Ig	NNP
cord-015365-iqdi99pd	704	42	(	(	-LRB-
cord-015365-iqdi99pd	704	43	0.5	0.5	CD
cord-015365-iqdi99pd	704	44	mg	mg	NNP
cord-015365-iqdi99pd	704	45	,	,	,
cord-015365-iqdi99pd	704	46	d	d	NNP
cord-015365-iqdi99pd	704	47	þ	þ	NNP
cord-015365-iqdi99pd	704	48	2	2	CD
cord-015365-iqdi99pd	704	49	)	)	-RRB-
cord-015365-iqdi99pd	704	50	.	.	.
cord-015365-iqdi99pd	705	1	Groups	group	NNS
cord-015365-iqdi99pd	705	2	additionally	additionally	RB
cord-015365-iqdi99pd	705	3	received	receive	VBD
cord-015365-iqdi99pd	705	4	rapamycin	rapamycin	NNS
cord-015365-iqdi99pd	705	5	(	(	-LRB-
cord-015365-iqdi99pd	705	6	0.1	0.1	CD
cord-015365-iqdi99pd	705	7	mg	mg	NNP
cord-015365-iqdi99pd	705	8	/	/	SYM
cord-015365-iqdi99pd	705	9	d	d	XX
cord-015365-iqdi99pd	705	10	,	,	,
cord-015365-iqdi99pd	705	11	d-1/0/2	d-1/0/2	NNP
cord-015365-iqdi99pd	705	12	)	)	-RRB-
cord-015365-iqdi99pd	705	13	or	or	CC
cord-015365-iqdi99pd	705	14	anti	anti	JJ
cord-015365-iqdi99pd	705	15	-	-	JJ
cord-015365-iqdi99pd	705	16	LFA-1mAb	lfa-1mab	JJ
cord-015365-iqdi99pd	705	17	(	(	-LRB-
cord-015365-iqdi99pd	705	18	0.1	0.1	CD
cord-015365-iqdi99pd	705	19	mg	mg	NNP
cord-015365-iqdi99pd	705	20	/	/	SYM
cord-015365-iqdi99pd	705	21	d	d	NNP
cord-015365-iqdi99pd	705	22	,	,	,
cord-015365-iqdi99pd	705	23	d-1/2	d-1/2	NNP
cord-015365-iqdi99pd	705	24	)	)	-RRB-
cord-015365-iqdi99pd	705	25	.	.	.
cord-015365-iqdi99pd	706	1	Multilineage	multilineage	NN
cord-015365-iqdi99pd	706	2	chimerism	chimerism	NN
cord-015365-iqdi99pd	706	3	and	and	CC
cord-015365-iqdi99pd	706	4	deletion	deletion	NN
cord-015365-iqdi99pd	706	5	of	of	IN
cord-015365-iqdi99pd	706	6	donor	donor	NN
cord-015365-iqdi99pd	706	7	-	-	HYPH
cord-015365-iqdi99pd	706	8	reactive	reactive	JJ
cord-015365-iqdi99pd	706	9	T	t	NN
cord-015365-iqdi99pd	706	10	-	-	HYPH
cord-015365-iqdi99pd	706	11	cells	cell	NNS
cord-015365-iqdi99pd	706	12	were	be	VBD
cord-015365-iqdi99pd	706	13	followed	follow	VBN
cord-015365-iqdi99pd	706	14	by	by	IN
cord-015365-iqdi99pd	706	15	flow	flow	NN
cord-015365-iqdi99pd	706	16	-	-	HYPH
cord-015365-iqdi99pd	706	17	cytometry	cytometry	NN
cord-015365-iqdi99pd	706	18	and	and	CC
cord-015365-iqdi99pd	706	19	in	in	IN
cord-015365-iqdi99pd	706	20	vitro	vitro	FW
cord-015365-iqdi99pd	706	21	tolerance	tolerance	NN
cord-015365-iqdi99pd	706	22	was	be	VBD
cord-015365-iqdi99pd	706	23	assessed	assess	VBN
cord-015365-iqdi99pd	706	24	by	by	IN
cord-015365-iqdi99pd	706	25	MLR	MLR	NNP
cord-015365-iqdi99pd	706	26	.	.	.
cord-015365-iqdi99pd	707	1	Transferred	transfer	VBN
cord-015365-iqdi99pd	707	2	T	T	NNP
cord-015365-iqdi99pd	707	3	-	-	HYPH
cord-015365-iqdi99pd	707	4	cells	cell	NNS
cord-015365-iqdi99pd	707	5	were	be	VBD
cord-015365-iqdi99pd	707	6	followed	follow	VBN
cord-015365-iqdi99pd	707	7	in	in	IN
cord-015365-iqdi99pd	707	8	vivo	vivo	NN
cord-015365-iqdi99pd	707	9	using	use	VBG
cord-015365-iqdi99pd	707	10	CD45.1/2	cd45.1/2	NN
cord-015365-iqdi99pd	707	11	alleles	allele	NNS
cord-015365-iqdi99pd	707	12	as	as	IN
cord-015365-iqdi99pd	707	13	congeneic	congeneic	JJ
cord-015365-iqdi99pd	707	14	markers	marker	NNS
cord-015365-iqdi99pd	707	15	in	in	IN
cord-015365-iqdi99pd	707	16	peripheral	peripheral	JJ
cord-015365-iqdi99pd	707	17	blood	blood	NN
cord-015365-iqdi99pd	707	18	(	(	-LRB-
cord-015365-iqdi99pd	707	19	d-2/12	d-2/12	NNP
cord-015365-iqdi99pd	707	20	)	)	-RRB-
cord-015365-iqdi99pd	707	21	and	and	CC
cord-015365-iqdi99pd	707	22	lymphoid	lymphoid	JJ
cord-015365-iqdi99pd	707	23	organs	organ	NNS
cord-015365-iqdi99pd	707	24	(	(	-LRB-
cord-015365-iqdi99pd	707	25	d7	d7	NNP
cord-015365-iqdi99pd	707	26	)	)	-RRB-
cord-015365-iqdi99pd	707	27	.	.	.
cord-015365-iqdi99pd	708	1	IFNgamma	ifngamma	JJ
cord-015365-iqdi99pd	708	2	-	-	HYPH
cord-015365-iqdi99pd	708	3	production	production	NN
cord-015365-iqdi99pd	708	4	upon	upon	IN
cord-015365-iqdi99pd	708	5	stimulation	stimulation	NN
cord-015365-iqdi99pd	708	6	with	with	IN
cord-015365-iqdi99pd	708	7	donor	donor	NN
cord-015365-iqdi99pd	708	8	antigen	antigen	NN
cord-015365-iqdi99pd	708	9	was	be	VBD
cord-015365-iqdi99pd	708	10	measured	measure	VBN
cord-015365-iqdi99pd	708	11	by	by	IN
cord-015365-iqdi99pd	708	12	ELISPOT	ELISPOT	NNP
cord-015365-iqdi99pd	708	13	and	and	CC
cord-015365-iqdi99pd	708	14	intracellular	intracellular	JJ
cord-015365-iqdi99pd	708	15	flow	flow	NN
cord-015365-iqdi99pd	708	16	-	-	HYPH
cord-015365-iqdi99pd	708	17	cytometry	cytometry	NN
cord-015365-iqdi99pd	708	18	.	.	.
cord-015365-iqdi99pd	709	1	Results	result	NNS
cord-015365-iqdi99pd	709	2	.	.	.
cord-015365-iqdi99pd	710	1	Rapamycin	Rapamycin	NNP
cord-015365-iqdi99pd	710	2	and	and	CC
cord-015365-iqdi99pd	710	3	anti	anti	NNP
cord-015365-iqdi99pd	710	4	-	-	NN
cord-015365-iqdi99pd	710	5	LFA-1	LFA-1	NNP
cord-015365-iqdi99pd	710	6	were	be	VBD
cord-015365-iqdi99pd	710	7	able	able	JJ
cord-015365-iqdi99pd	710	8	to	to	TO
cord-015365-iqdi99pd	710	9	overcome	overcome	VB
cord-015365-iqdi99pd	710	10	costimulation	costimulation	NN
cord-015365-iqdi99pd	710	11	-	-	HYPH
cord-015365-iqdi99pd	710	12	blockade	blockade	NN
cord-015365-iqdi99pd	710	13	resistant	resistant	JJ
cord-015365-iqdi99pd	710	14	rejection	rejection	NN
cord-015365-iqdi99pd	710	15	and	and	CC
cord-015365-iqdi99pd	710	16	induced	induce	VBN
cord-015365-iqdi99pd	710	17	stable	stable	JJ
cord-015365-iqdi99pd	710	18	multi	multi	JJ
cord-015365-iqdi99pd	710	19	-	-	JJ
cord-015365-iqdi99pd	710	20	lineage	lineage	JJ
cord-015365-iqdi99pd	710	21	chimerism	chimerism	NN
cord-015365-iqdi99pd	710	22	in	in	IN
cord-015365-iqdi99pd	710	23	pre	pre	JJ
cord-015365-iqdi99pd	710	24	-	-	JJ
cord-015365-iqdi99pd	710	25	sensitized	sensitize	VBN
cord-015365-iqdi99pd	710	26	recipients	recipient	NNS
cord-015365-iqdi99pd	710	27	(	(	-LRB-
cord-015365-iqdi99pd	710	28	0/7	0/7	CD
cord-015365-iqdi99pd	710	29	control	control	NN
cord-015365-iqdi99pd	710	30	vs.	vs.	IN
cord-015365-iqdi99pd	710	31	7/7	7/7	CD
cord-015365-iqdi99pd	710	32	rapa	rapa	NN
cord-015365-iqdi99pd	710	33	,	,	,
cord-015365-iqdi99pd	710	34	p	p	NN
cord-015365-iqdi99pd	710	35	<	<	XX
cord-015365-iqdi99pd	710	36	0.001	0.001	CD
cord-015365-iqdi99pd	710	37	;	;	:
cord-015365-iqdi99pd	710	38	3/7	3/7	CD
cord-015365-iqdi99pd	710	39	anti	anti	NNP
cord-015365-iqdi99pd	710	40	-	-	NNP
cord-015365-iqdi99pd	710	41	LFA-1	LFA-1	NNP
cord-015365-iqdi99pd	710	42	,	,	,
cord-015365-iqdi99pd	710	43	p	p	NN
cord-015365-iqdi99pd	710	44	¼	¼	CD
cord-015365-iqdi99pd	710	45	0.2	0.2	CD
cord-015365-iqdi99pd	710	46	;	;	:
cord-015365-iqdi99pd	710	47	representative	representative	NN
cord-015365-iqdi99pd	710	48	for	for	IN
cord-015365-iqdi99pd	710	49	multiple	multiple	JJ
cord-015365-iqdi99pd	710	50	experiments	experiment	NNS
cord-015365-iqdi99pd	710	51	)	)	-RRB-
cord-015365-iqdi99pd	710	52	.	.	.
cord-015365-iqdi99pd	711	1	Chimeras	chimera	NNS
cord-015365-iqdi99pd	711	2	showed	show	VBD
cord-015365-iqdi99pd	711	3	central	central	JJ
cord-015365-iqdi99pd	711	4	and	and	CC
cord-015365-iqdi99pd	711	5	peripheral	peripheral	JJ
cord-015365-iqdi99pd	711	6	deletion	deletion	NN
cord-015365-iqdi99pd	711	7	of	of	IN
cord-015365-iqdi99pd	711	8	donor	donor	NN
cord-015365-iqdi99pd	711	9	-	-	HYPH
cord-015365-iqdi99pd	711	10	reactive	reactive	JJ
cord-015365-iqdi99pd	711	11	T	t	NN
cord-015365-iqdi99pd	711	12	-	-	HYPH
cord-015365-iqdi99pd	711	13	cells	cell	NNS
cord-015365-iqdi99pd	711	14	and	and	CC
cord-015365-iqdi99pd	711	15	donor	donor	NN
cord-015365-iqdi99pd	711	16	-	-	HYPH
cord-015365-iqdi99pd	711	17	specific	specific	JJ
cord-015365-iqdi99pd	711	18	hyporesponsiveness	hyporesponsiveness	NN
cord-015365-iqdi99pd	711	19	in	in	IN
cord-015365-iqdi99pd	711	20	vitro	vitro	FW
cord-015365-iqdi99pd	711	21	.	.	.
cord-015365-iqdi99pd	712	1	The	the	DT
cord-015365-iqdi99pd	712	2	frequency	frequency	NN
cord-015365-iqdi99pd	712	3	of	of	IN
cord-015365-iqdi99pd	712	4	transferred	transfer	VBN
cord-015365-iqdi99pd	712	5	T	T	NNP
cord-015365-iqdi99pd	712	6	-	-	HYPH
cord-015365-iqdi99pd	712	7	cells	cell	NNS
cord-015365-iqdi99pd	712	8	decreased	decrease	VBD
cord-015365-iqdi99pd	712	9	over	over	IN
cord-015365-iqdi99pd	712	10	time	time	NN
cord-015365-iqdi99pd	712	11	,	,	,
cord-015365-iqdi99pd	712	12	but	but	CC
cord-015365-iqdi99pd	712	13	less	less	RBR
cord-015365-iqdi99pd	712	14	so	so	RB
cord-015365-iqdi99pd	712	15	in	in	IN
cord-015365-iqdi99pd	712	16	the	the	DT
cord-015365-iqdi99pd	712	17	rapamycin	rapamycin	NN
cord-015365-iqdi99pd	712	18	-	-	HYPH
cord-015365-iqdi99pd	712	19	treated	treat	VBN
cord-015365-iqdi99pd	712	20	group	group	NN
cord-015365-iqdi99pd	712	21	.	.	.
cord-015365-iqdi99pd	713	1	IFNgamma	IFNgamma	NNP
cord-015365-iqdi99pd	713	2	-	-	HYPH
cord-015365-iqdi99pd	713	3	production	production	NN
cord-015365-iqdi99pd	713	4	was	be	VBD
cord-015365-iqdi99pd	713	5	reduced	reduce	VBN
cord-015365-iqdi99pd	713	6	by	by	IN
cord-015365-iqdi99pd	713	7	rapa	rapa	NN
cord-015365-iqdi99pd	713	8	or	or	CC
cord-015365-iqdi99pd	713	9	anti	anti	NNP
cord-015365-iqdi99pd	713	10	-	-	NNP
cord-015365-iqdi99pd	713	11	LFA-1	LFA-1	NNP
cord-015365-iqdi99pd	713	12	treatment	treatment	NN
cord-015365-iqdi99pd	713	13	.	.	.
cord-015365-iqdi99pd	714	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	714	2	.	.	.
cord-015365-iqdi99pd	715	1	Rapamycin	Rapamycin	NNP
cord-015365-iqdi99pd	715	2	and	and	CC
cord-015365-iqdi99pd	715	3	anti	anti	NNP
cord-015365-iqdi99pd	715	4	-	-	NN
cord-015365-iqdi99pd	715	5	LFA-1	LFA-1	NNP
cord-015365-iqdi99pd	715	6	overcome	overcome	VB
cord-015365-iqdi99pd	715	7	the	the	DT
cord-015365-iqdi99pd	715	8	additional	additional	JJ
cord-015365-iqdi99pd	715	9	T	t	NN
cord-015365-iqdi99pd	715	10	-	-	HYPH
cord-015365-iqdi99pd	715	11	memory	memory	NN
cord-015365-iqdi99pd	715	12	-	-	HYPH
cord-015365-iqdi99pd	715	13	cell	cell	NN
cord-015365-iqdi99pd	715	14	barrier	barrier	NN
cord-015365-iqdi99pd	715	15	for	for	IN
cord-015365-iqdi99pd	715	16	tolerance	tolerance	NN
cord-015365-iqdi99pd	715	17	induction	induction	NN
cord-015365-iqdi99pd	715	18	,	,	,
cord-015365-iqdi99pd	715	19	although	although	IN
cord-015365-iqdi99pd	715	20	rapamycin	rapamycin	NNP
cord-015365-iqdi99pd	715	21	seems	seem	VBZ
cord-015365-iqdi99pd	715	22	to	to	TO
cord-015365-iqdi99pd	715	23	be	be	VB
cord-015365-iqdi99pd	715	24	more	more	RBR
cord-015365-iqdi99pd	715	25	potent	potent	JJ
cord-015365-iqdi99pd	715	26	in	in	IN
cord-015365-iqdi99pd	715	27	Tmem	Tmem	NNP
cord-015365-iqdi99pd	715	28	tolerization	tolerization	NN
cord-015365-iqdi99pd	715	29	in	in	IN
cord-015365-iqdi99pd	715	30	this	this	DT
cord-015365-iqdi99pd	715	31	model	model	NN
cord-015365-iqdi99pd	715	32	.	.	.
cord-015365-iqdi99pd	716	1	The	the	DT
cord-015365-iqdi99pd	716	2	trend	trend	NN
cord-015365-iqdi99pd	716	3	that	that	DT
cord-015365-iqdi99pd	716	4	elimination	elimination	NN
cord-015365-iqdi99pd	716	5	of	of	IN
cord-015365-iqdi99pd	716	6	Tmem	Tmem	NNP
cord-015365-iqdi99pd	716	7	is	be	VBZ
cord-015365-iqdi99pd	716	8	lower	low	JJR
cord-015365-iqdi99pd	716	9	in	in	IN
cord-015365-iqdi99pd	716	10	the	the	DT
cord-015365-iqdi99pd	716	11	rapamycin	rapamycin	NN
cord-015365-iqdi99pd	716	12	-	-	HYPH
cord-015365-iqdi99pd	716	13	treated	treat	VBN
cord-015365-iqdi99pd	716	14	group	group	NN
cord-015365-iqdi99pd	716	15	and	and	CC
cord-015365-iqdi99pd	716	16	central	central	JJ
cord-015365-iqdi99pd	716	17	deletion	deletion	NN
cord-015365-iqdi99pd	716	18	is	be	VBZ
cord-015365-iqdi99pd	716	19	more	more	RBR
cord-015365-iqdi99pd	716	20	pronounced	pronounced	JJ
cord-015365-iqdi99pd	716	21	early	early	RB
cord-015365-iqdi99pd	716	22	after	after	IN
cord-015365-iqdi99pd	716	23	BMT	BMT	NNP
cord-015365-iqdi99pd	716	24	suggests	suggest	VBZ
cord-015365-iqdi99pd	716	25	different	different	JJ
cord-015365-iqdi99pd	716	26	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	716	27	for	for	IN
cord-015365-iqdi99pd	716	28	Tmem	Tmem	NNP
cord-015365-iqdi99pd	716	29	tolerization	tolerization	NN
cord-015365-iqdi99pd	716	30	.	.	.
cord-015365-iqdi99pd	717	1	Lunchsymposium	Lunchsymposium	NNP
cord-015365-iqdi99pd	717	2	Virusinfektionen	Virusinfektionen	NNP
cord-015365-iqdi99pd	717	3	in	in	IN
cord-015365-iqdi99pd	717	4	der	der	NNP
cord-015365-iqdi99pd	717	5	Organ	Organ	NNP
cord-015365-iqdi99pd	717	6	-	-	HYPH
cord-015365-iqdi99pd	717	7	und	und	NNP
cord-015365-iqdi99pd	717	8	Stammzelltransplantation	Stammzelltransplantation	NNP
cord-015365-iqdi99pd	717	9	035	035	CD
cord-015365-iqdi99pd	718	1	Diagnostik	Diagnostik	NNP
cord-015365-iqdi99pd	718	2	von	von	NNP
cord-015365-iqdi99pd	718	3	Virusinfektionen	Virusinfektionen	NNP
cord-015365-iqdi99pd	718	4	in	in	IN
cord-015365-iqdi99pd	718	5	Transplantationspatienten	Transplantationspatienten	NNP
cord-015365-iqdi99pd	718	6	Patienten	Patienten	NNP
cord-015365-iqdi99pd	719	1	nach	nach	NNP
cord-015365-iqdi99pd	720	1	Organ	organ	NN
cord-015365-iqdi99pd	720	2	-	-	HYPH
cord-015365-iqdi99pd	720	3	oder	oder	NNP
cord-015365-iqdi99pd	720	4	Knochenmarkstransplantationen	Knochenmarkstransplantationen	NNP
cord-015365-iqdi99pd	720	5	werden	werden	NNP
cord-015365-iqdi99pd	720	6	immunsuppressiv	immunsuppressiv	NNP
cord-015365-iqdi99pd	720	7	behandelt	behandelt	NNP
cord-015365-iqdi99pd	721	1	und	und	NNP
cord-015365-iqdi99pd	721	2	weisen	weisen	NNP
cord-015365-iqdi99pd	721	3	daher	daher	NNP
cord-015365-iqdi99pd	721	4	ein	ein	NNP
cord-015365-iqdi99pd	721	5	anderes	anderes	NNP
cord-015365-iqdi99pd	721	6	Spektrum	Spektrum	NNP
cord-015365-iqdi99pd	721	7	von	von	NNP
cord-015365-iqdi99pd	721	8	potentiell	potentiell	NNP
cord-015365-iqdi99pd	721	9	gefährlichen	gefährlichen	NNP
cord-015365-iqdi99pd	722	1	Virusinfektionen	Virusinfektionen	NNP
cord-015365-iqdi99pd	722	2	auf	auf	NNP
cord-015365-iqdi99pd	722	3	als	als	NN
cord-015365-iqdi99pd	722	4	immunkompetente	immunkompetente	JJ
cord-015365-iqdi99pd	722	5	Personen	Personen	NNP
cord-015365-iqdi99pd	722	6	.	.	.
cord-015365-iqdi99pd	723	1	Vor	Vor	NNP
cord-015365-iqdi99pd	723	2	allem	allem	NNP
cord-015365-iqdi99pd	723	3	Viren	Viren	NNP
cord-015365-iqdi99pd	723	4	,	,	,
cord-015365-iqdi99pd	723	5	die	die	VBP
cord-015365-iqdi99pd	723	6	i	-PRON-	PRP
cord-015365-iqdi99pd	723	7	m	be	VBP
cord-015365-iqdi99pd	723	8	normalen	normalen	NNP
cord-015365-iqdi99pd	723	9	Wirt	Wirt	NNP
cord-015365-iqdi99pd	723	10	nur	nur	NNP
cord-015365-iqdi99pd	723	11	leichte	leichte	NNP
cord-015365-iqdi99pd	723	12	oder	oder	NNP
cord-015365-iqdi99pd	723	13	asymptomatische	asymptomatische	NNP
cord-015365-iqdi99pd	724	1	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	724	2	verursachen	verursachen	NNP
cord-015365-iqdi99pd	725	1	und	und	IN
cord-015365-iqdi99pd	725	2	latent	latent	JJ
cord-015365-iqdi99pd	726	1	i	-PRON-	PRP
cord-015365-iqdi99pd	726	2	m	be	VBP
cord-015365-iqdi99pd	726	3	Organismus	Organismus	NNP
cord-015365-iqdi99pd	726	4	verbleiben	verbleiben	NN
cord-015365-iqdi99pd	726	5	,	,	,
cord-015365-iqdi99pd	726	6	wie	wie	NNP
cord-015365-iqdi99pd	726	7	Herpesviren	Herpesviren	NNP
cord-015365-iqdi99pd	726	8	(	(	-LRB-
cord-015365-iqdi99pd	726	9	Zytomegalievirus	Zytomegalievirus	NNP
cord-015365-iqdi99pd	726	10	,	,	,
cord-015365-iqdi99pd	726	11	Epstein	Epstein	NNP
cord-015365-iqdi99pd	726	12	-	-	HYPH
cord-015365-iqdi99pd	726	13	Barr	Barr	NNP
cord-015365-iqdi99pd	726	14	Virus	Virus	NNP
cord-015365-iqdi99pd	726	15	etc	etc	NN
cord-015365-iqdi99pd	726	16	.	.	.
cord-015365-iqdi99pd	726	17	)	)	-RRB-
cord-015365-iqdi99pd	727	1	oder	oder	NNP
cord-015365-iqdi99pd	727	2	auch	auch	NNP
cord-015365-iqdi99pd	727	3	Polyomaviren	Polyomaviren	NNP
cord-015365-iqdi99pd	727	4	(	(	-LRB-
cord-015365-iqdi99pd	727	5	BK-	BK-	NNP
cord-015365-iqdi99pd	727	6	,	,	,
cord-015365-iqdi99pd	727	7	JC	JC	NNP
cord-015365-iqdi99pd	727	8	-	-	HYPH
cord-015365-iqdi99pd	727	9	Virus	Virus	NNP
cord-015365-iqdi99pd	727	10	)	)	-RRB-
cord-015365-iqdi99pd	727	11	,	,	.
cord-015365-iqdi99pd	728	1	können	können	UH
cord-015365-iqdi99pd	728	2	unter	unter	NNP
cord-015365-iqdi99pd	728	3	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	728	4	hoch	hoch	NNP
cord-015365-iqdi99pd	728	5	replizieren	replizieren	NNP
cord-015365-iqdi99pd	729	1	und	und	IN
cord-015365-iqdi99pd	729	2	zu	zu	NNP
cord-015365-iqdi99pd	729	3	schweren	schweren	NNP
cord-015365-iqdi99pd	729	4	und	und	XX
cord-015365-iqdi99pd	730	1	potentiell	potentiell	NNP
cord-015365-iqdi99pd	730	2	tödlichen	tödlichen	NNP
cord-015365-iqdi99pd	730	3	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	730	4	führen	führen	NNP
cord-015365-iqdi99pd	730	5	.	.	.
cord-015365-iqdi99pd	731	1	Um	um	UH
cord-015365-iqdi99pd	732	1	schwere	schwere	NNP
cord-015365-iqdi99pd	732	2	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	732	3	oder	oder	NNP
cord-015365-iqdi99pd	732	4	Reaktivierungen	Reaktivierungen	NNP
cord-015365-iqdi99pd	732	5	durch	durch	NNP
cord-015365-iqdi99pd	732	6	verschiedene	verschiedene	NN
cord-015365-iqdi99pd	732	7	Viren	Viren	NNP
cord-015365-iqdi99pd	732	8	zu	zu	NNP
cord-015365-iqdi99pd	732	9	verhindern	verhindern	NNP
cord-015365-iqdi99pd	732	10	,	,	,
cord-015365-iqdi99pd	732	11	wird	wird	NNP
cord-015365-iqdi99pd	732	12	heute	heute	NNP
cord-015365-iqdi99pd	732	13	routinemäßig	routinemäßig	NNP
cord-015365-iqdi99pd	732	14	in	in	IN
cord-015365-iqdi99pd	732	15	regelmäßigen	regelmäßigen	NNP
cord-015365-iqdi99pd	732	16	Abständen	Abständen	NNP
cord-015365-iqdi99pd	733	1	i	-PRON-	PRP
cord-015365-iqdi99pd	733	2	m	be	VBP
cord-015365-iqdi99pd	733	3	Verlauf	Verlauf	NNP
cord-015365-iqdi99pd	733	4	nach	nach	NNP
cord-015365-iqdi99pd	733	5	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	733	6	der	der	NN
cord-015365-iqdi99pd	733	7	direkte	direkte	NNP
cord-015365-iqdi99pd	733	8	und	und	XX
cord-015365-iqdi99pd	734	1	quantitative	quantitative	JJ
cord-015365-iqdi99pd	734	2	Nachweis	Nachweis	NNP
cord-015365-iqdi99pd	734	3	verschiedener	verschiedener	NNP
cord-015365-iqdi99pd	734	4	Viren	Viren	NNP
cord-015365-iqdi99pd	734	5	(	(	-LRB-
cord-015365-iqdi99pd	734	6	vor	vor	NNP
cord-015365-iqdi99pd	734	7	allem	allem	NNP
cord-015365-iqdi99pd	734	8	von	von	NNP
cord-015365-iqdi99pd	734	9	Zytomegalievirus	Zytomegalievirus	NNP
cord-015365-iqdi99pd	734	10	)	)	-RRB-
cord-015365-iqdi99pd	734	11	mittels	mittels	NNP
cord-015365-iqdi99pd	734	12	PCR	PCR	NNP
cord-015365-iqdi99pd	734	13	i	-PRON-	PRP
cord-015365-iqdi99pd	734	14	m	be	VBP
cord-015365-iqdi99pd	734	15	Blut	Blut	NNP
cord-015365-iqdi99pd	734	16	,	,	,
cord-015365-iqdi99pd	734	17	aber	aber	NNP
cord-015365-iqdi99pd	734	18	auch	auch	NNP
cord-015365-iqdi99pd	734	19	in	in	IN
cord-015365-iqdi99pd	734	20	verschiedenen	verschiedenen	NNP
cord-015365-iqdi99pd	734	21	anderen	anderen	NNP
cord-015365-iqdi99pd	734	22	Patientenmaterialien	Patientenmaterialien	NNP
cord-015365-iqdi99pd	734	23	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	734	24	.	.	.
cord-015365-iqdi99pd	735	1	Ziel	Ziel	NNP
cord-015365-iqdi99pd	735	2	der	der	NNP
cord-015365-iqdi99pd	735	3	Virusdiagnostik	Virusdiagnostik	NNP
cord-015365-iqdi99pd	736	1	ist	ist	NNP
cord-015365-iqdi99pd	736	2	es	es	NNP
cord-015365-iqdi99pd	736	3	hier	hier	NNP
cord-015365-iqdi99pd	736	4	nicht	nicht	NNP
cord-015365-iqdi99pd	737	1	so	so	RB
cord-015365-iqdi99pd	737	2	sehr	sehr	NNP
cord-015365-iqdi99pd	737	3	eine	eine	NNP
cord-015365-iqdi99pd	737	4	klinisch	klinisch	FW
cord-015365-iqdi99pd	737	5	relevante	relevante	NNP
cord-015365-iqdi99pd	737	6	Virusinfektion	Virusinfektion	NNP
cord-015365-iqdi99pd	737	7	nachzuweisen	nachzuweisen	NNP
cord-015365-iqdi99pd	737	8	,	,	,
cord-015365-iqdi99pd	738	1	sondern	sondern	NNP
cord-015365-iqdi99pd	738	2	vielmehr	vielmehr	NNP
cord-015365-iqdi99pd	738	3	das	das	NNP
cord-015365-iqdi99pd	738	4	Vorhanden	Vorhanden	NNP
cord-015365-iqdi99pd	738	5	-	-	HYPH
cord-015365-iqdi99pd	738	6	sein	sein	NNP
cord-015365-iqdi99pd	739	1	einer	einer	NNP
cord-015365-iqdi99pd	739	2	signifikanten	signifikanten	NNP
cord-015365-iqdi99pd	739	3	Virusreplikation	Virusreplikation	NNP
cord-015365-iqdi99pd	739	4	frühzeitig	frühzeitig	NN
cord-015365-iqdi99pd	739	5	,	,	,
cord-015365-iqdi99pd	740	1	noch	noch	NNP
cord-015365-iqdi99pd	740	2	vor	vor	NNP
cord-015365-iqdi99pd	741	1	Krankheitsbeginn	Krankheitsbeginn	NNP
cord-015365-iqdi99pd	741	2	zu	zu	NNP
cord-015365-iqdi99pd	741	3	erkennen	erkennen	NNP
cord-015365-iqdi99pd	741	4	.	.	.
cord-015365-iqdi99pd	742	1	Das	Das	NNP
cord-015365-iqdi99pd	742	2	ist	ist	NNP
cord-015365-iqdi99pd	742	3	dann	dann	NNP
cord-015365-iqdi99pd	742	4	auch	auch	NNP
cord-015365-iqdi99pd	742	5	die	die	VBP
cord-015365-iqdi99pd	742	6	Basis	Basis	NNP
cord-015365-iqdi99pd	742	7	für	für	NN
cord-015365-iqdi99pd	742	8	die	die	JJ
cord-015365-iqdi99pd	742	9	"	"	``
cord-015365-iqdi99pd	742	10	präemptive	präemptive	JJ
cord-015365-iqdi99pd	742	11	"	"	''
cord-015365-iqdi99pd	742	12	antivirale	antivirale	JJ
cord-015365-iqdi99pd	742	13	Therapie	Therapie	NNP
cord-015365-iqdi99pd	742	14	,	,	,
cord-015365-iqdi99pd	742	15	die	die	VB
cord-015365-iqdi99pd	742	16	gegeben	gegeben	NNP
cord-015365-iqdi99pd	742	17	wird	wird	NNP
cord-015365-iqdi99pd	742	18	,	,	,
cord-015365-iqdi99pd	742	19	wenn	wenn	NNP
cord-015365-iqdi99pd	742	20	die	die	VBP
cord-015365-iqdi99pd	742	21	Viruslast	Viruslast	NNP
cord-015365-iqdi99pd	742	22	eine	eine	FW
cord-015365-iqdi99pd	742	23	bestimmte	bestimmte	JJ
cord-015365-iqdi99pd	742	24	Höhe	Höhe	NNP
cord-015365-iqdi99pd	742	25	überschreitet	überschreitet	JJ
cord-015365-iqdi99pd	742	26	,	,	,
cord-015365-iqdi99pd	742	27	aber	aber	NNP
cord-015365-iqdi99pd	742	28	noch	noch	NNP
cord-015365-iqdi99pd	742	29	bevor	bevor	NNP
cord-015365-iqdi99pd	742	30	klinische	klinische	NNP
cord-015365-iqdi99pd	742	31	Symptome	Symptome	NNP
cord-015365-iqdi99pd	742	32	auftreten	auftreten	NNP
cord-015365-iqdi99pd	742	33	.	.	.
cord-015365-iqdi99pd	743	1	Die	die	VB
cord-015365-iqdi99pd	743	2	Festsetzung	Festsetzung	NNP
cord-015365-iqdi99pd	743	3	der	der	NNP
cord-015365-iqdi99pd	744	1	virologischen	virologischen	NNP
cord-015365-iqdi99pd	744	2	Grenzwerte	Grenzwerte	NNP
cord-015365-iqdi99pd	745	1	fü	fü	IN
cord-015365-iqdi99pd	746	1	r	r	LS
cord-015365-iqdi99pd	746	2	den	den	NNP
cord-015365-iqdi99pd	746	3	Einsatz	Einsatz	NNP
cord-015365-iqdi99pd	746	4	der	der	NNP
cord-015365-iqdi99pd	746	5	präemptive	präemptive	JJ
cord-015365-iqdi99pd	747	1	Therapie	Therapie	NNP
cord-015365-iqdi99pd	747	2	ist	ist	NNP
cord-015365-iqdi99pd	748	1	aber	aber	NNP
cord-015365-iqdi99pd	748	2	eine	eine	NNP
cord-015365-iqdi99pd	748	3	große	große	NNP
cord-015365-iqdi99pd	748	4	Herausforderung	Herausforderung	NNP
cord-015365-iqdi99pd	748	5	,	,	,
cord-015365-iqdi99pd	748	6	da	da	NNP
cord-015365-iqdi99pd	748	7	vor	vor	NNP
cord-015365-iqdi99pd	749	1	allem	allem	NNP
cord-015365-iqdi99pd	749	2	Herpesviren	Herpesviren	NNP
cord-015365-iqdi99pd	749	3	wie	wie	NNP
cord-015365-iqdi99pd	749	4	Zytomegalievirus	Zytomegalievirus	NNP
cord-015365-iqdi99pd	749	5	(	(	-LRB-
cord-015365-iqdi99pd	749	6	CMV	CMV	NNP
cord-015365-iqdi99pd	749	7	)	)	-RRB-
cord-015365-iqdi99pd	750	1	oder	oder	NNP
cord-015365-iqdi99pd	750	2	Epstein	Epstein	NNP
cord-015365-iqdi99pd	750	3	-	-	HYPH
cord-015365-iqdi99pd	750	4	Barr	Barr	NNP
cord-015365-iqdi99pd	750	5	Virus	Virus	NNP
cord-015365-iqdi99pd	750	6	(	(	-LRB-
cord-015365-iqdi99pd	750	7	EBV	EBV	NNP
cord-015365-iqdi99pd	750	8	)	)	-RRB-
cord-015365-iqdi99pd	750	9	,	,	.
cord-015365-iqdi99pd	751	1	aber	aber	NNP
cord-015365-iqdi99pd	751	2	auch	auch	NNP
cord-015365-iqdi99pd	751	3	Polyomaviren	Polyomaviren	NNP
cord-015365-iqdi99pd	752	1	auch	auch	NNP
cord-015365-iqdi99pd	752	2	ohne	ohne	NNP
cord-015365-iqdi99pd	752	3	jede	jede	NNP
cord-015365-iqdi99pd	752	4	Krankheitsrelevanz	Krankheitsrelevanz	NNP
cord-015365-iqdi99pd	753	1	i	-PRON-	PRP
cord-015365-iqdi99pd	753	2	m	be	VBP
cord-015365-iqdi99pd	753	3	Organismus	Organismus	NNP
cord-015365-iqdi99pd	753	4	nachgewiesen	nachgewiesen	NNP
cord-015365-iqdi99pd	753	5	werden	werden	NNP
cord-015365-iqdi99pd	753	6	können	können	NNP
cord-015365-iqdi99pd	753	7	.	.	.
cord-015365-iqdi99pd	754	1	Neben	Neben	NNP
cord-015365-iqdi99pd	754	2	den	den	NNP
cord-015365-iqdi99pd	754	3	quantitativen	quantitativen	NNP
cord-015365-iqdi99pd	754	4	PCR	PCR	NNP
cord-015365-iqdi99pd	754	5	Ergebnissen	Ergebnissen	NNP
cord-015365-iqdi99pd	754	6	hängt	hängt	NNP
cord-015365-iqdi99pd	754	7	der	der	NNP
cord-015365-iqdi99pd	754	8	Einsatz	Einsatz	NNP
cord-015365-iqdi99pd	754	9	einer	einer	NN
cord-015365-iqdi99pd	754	10	präemptiven	präemptiven	NN
cord-015365-iqdi99pd	754	11	Therapie	Therapie	NNP
cord-015365-iqdi99pd	754	12	auch	auch	NNP
cord-015365-iqdi99pd	754	13	von	von	NNP
cord-015365-iqdi99pd	754	14	bestimmten	bestimmten	NNP
cord-015365-iqdi99pd	754	15	weiteren	weiteren	NNP
cord-015365-iqdi99pd	754	16	Aspekten	Aspekten	NNP
cord-015365-iqdi99pd	754	17	ab	ab	NNP
cord-015365-iqdi99pd	754	18	,	,	,
cord-015365-iqdi99pd	754	19	wie	wie	NNP
cord-015365-iqdi99pd	754	20	vom	vom	NNP
cord-015365-iqdi99pd	755	1	Donor	donor	NN
cord-015365-iqdi99pd	755	2	/	/	SYM
cord-015365-iqdi99pd	755	3	Recipient	Recipient	NNP
cord-015365-iqdi99pd	755	4	Virus	Virus	NNP
cord-015365-iqdi99pd	755	5	-	-	HYPH
cord-015365-iqdi99pd	755	6	serostatus	serostatus	NNP
cord-015365-iqdi99pd	755	7	,	,	,
cord-015365-iqdi99pd	755	8	dem	dem	NNP
cord-015365-iqdi99pd	755	9	transplantierten	transplantierten	NNP
cord-015365-iqdi99pd	755	10	Organ	Organ	NNP
cord-015365-iqdi99pd	755	11	oder	oder	NNP
cord-015365-iqdi99pd	755	12	vom	vom	NNP
cord-015365-iqdi99pd	755	13	Material	Material	NNP
cord-015365-iqdi99pd	755	14	in	in	IN
cord-015365-iqdi99pd	755	15	dem	dem	JJ
cord-015365-iqdi99pd	755	16	man	man	NN
cord-015365-iqdi99pd	755	17	die	die	VB
cord-015365-iqdi99pd	755	18	Virusnukleinsäure	Virusnukleinsäure	NNP
cord-015365-iqdi99pd	755	19	nachweist	nachweist	NN
cord-015365-iqdi99pd	755	20	.	.	.
cord-015365-iqdi99pd	756	1	Daher	Daher	NNP
cord-015365-iqdi99pd	756	2	ist	ist	NNP
cord-015365-iqdi99pd	756	3	ein	ein	NN
cord-015365-iqdi99pd	756	4	enges	enge	NNS
cord-015365-iqdi99pd	756	5	Zusammenspiel	Zusammenspiel	NNP
cord-015365-iqdi99pd	756	6	von	von	NNP
cord-015365-iqdi99pd	756	7	virologischer	virologischer	NNP
cord-015365-iqdi99pd	756	8	Befunderstellung	Befunderstellung	NNP
cord-015365-iqdi99pd	756	9	,	,	,
cord-015365-iqdi99pd	756	10	Interpretation	Interpretation	NNP
cord-015365-iqdi99pd	756	11	und	und	IN
cord-015365-iqdi99pd	757	1	der	der	NNP
cord-015365-iqdi99pd	757	2	Kenntnis	Kenntnis	NNP
cord-015365-iqdi99pd	757	3	der	der	NNP
cord-015365-iqdi99pd	757	4	klinischen	klinischen	NNP
cord-015365-iqdi99pd	757	5	Aspekte	Aspekte	NNP
cord-015365-iqdi99pd	757	6	notwendig	notwendig	NNP
cord-015365-iqdi99pd	757	7	,	,	,
cord-015365-iqdi99pd	757	8	um	um	UH
cord-015365-iqdi99pd	758	1	eine	eine	NNP
cord-015365-iqdi99pd	758	2	optimale	optimale	NNP
cord-015365-iqdi99pd	758	3	virologische	virologische	NNP
cord-015365-iqdi99pd	758	4	Kontrolle	Kontrolle	NNP
cord-015365-iqdi99pd	758	5	der	der	NNP
cord-015365-iqdi99pd	758	6	einzelnen	einzelnen	NNP
cord-015365-iqdi99pd	758	7	Patienten	Patienten	NNP
cord-015365-iqdi99pd	758	8	zu	zu	NNP
cord-015365-iqdi99pd	758	9	erreichen	erreichen	NNP
cord-015365-iqdi99pd	758	10	.	.	.
cord-015365-iqdi99pd	759	1	Antivirale	Antivirale	NNP
cord-015365-iqdi99pd	759	2	Therapie	Therapie	NNP
cord-015365-iqdi99pd	759	3	bei	bei	NNP
cord-015365-iqdi99pd	759	4	Patienten	Patienten	NNP
cord-015365-iqdi99pd	759	5	nach	nach	NNP
cord-015365-iqdi99pd	759	6	Organ	Organ	NNP
cord-015365-iqdi99pd	759	7	-	-	HYPH
cord-015365-iqdi99pd	759	8	oder	oder	NNP
cord-015365-iqdi99pd	759	9	hämatopoetischer	hämatopoetischer	NNP
cord-015365-iqdi99pd	760	1	Stammzelltransplantation	Stammzelltransplantation	NNP
cord-015365-iqdi99pd	760	2	Klinische	Klinische	NNP
cord-015365-iqdi99pd	760	3	Abteilung	Abteilung	NNP
cord-015365-iqdi99pd	760	4	für	für	IN
cord-015365-iqdi99pd	760	5	Pädiatrische	Pädiatrische	NNP
cord-015365-iqdi99pd	760	6	Hämato-/Onkologie	Hämato-/Onkologie	NNP
cord-015365-iqdi99pd	760	7	,	,	,
cord-015365-iqdi99pd	761	1	Universitätsklinik	Universitätsklinik	NNP
cord-015365-iqdi99pd	761	2	für	für	IN
cord-015365-iqdi99pd	761	3	Kinder	Kinder	NNP
cord-015365-iqdi99pd	761	4	-	-	HYPH
cord-015365-iqdi99pd	761	5	und	und	NNP
cord-015365-iqdi99pd	761	6	Jugendheilkunde	Jugendheilkunde	NNP
cord-015365-iqdi99pd	761	7	,	,	,
cord-015365-iqdi99pd	761	8	Medizinische	Medizinische	NNP
cord-015365-iqdi99pd	761	9	Universität	Universität	NNP
cord-015365-iqdi99pd	761	10	Graz	Graz	NNP
cord-015365-iqdi99pd	761	11	,	,	,
cord-015365-iqdi99pd	761	12	Graz	Graz	NNP
cord-015365-iqdi99pd	761	13	,	,	,
cord-015365-iqdi99pd	761	14	Österreich	Österreich	NNP
cord-015365-iqdi99pd	761	15	Zahlreiche	Zahlreiche	NNP
cord-015365-iqdi99pd	762	1	humanpathogene	humanpathogene	NNP
cord-015365-iqdi99pd	762	2	Viren	Viren	NNP
cord-015365-iqdi99pd	762	3	persistieren	persistieren	NNP
cord-015365-iqdi99pd	762	4	nach	nach	NNP
cord-015365-iqdi99pd	762	5	Primärinfektion	Primärinfektion	NNP
cord-015365-iqdi99pd	763	1	i	-PRON-	PRP
cord-015365-iqdi99pd	763	2	m	be	VBP
cord-015365-iqdi99pd	763	3	Körper	Körper	NNP
cord-015365-iqdi99pd	763	4	und	und	IN
cord-015365-iqdi99pd	763	5	können	können	XX
cord-015365-iqdi99pd	764	1	unter	unter	NNP
cord-015365-iqdi99pd	764	2	geschwächter	geschwächter	NNP
cord-015365-iqdi99pd	765	1	Abwehrlage	Abwehrlage	NNP
cord-015365-iqdi99pd	765	2	reaktiviert	reaktiviert	NN
cord-015365-iqdi99pd	765	3	werden	werden	NNP
cord-015365-iqdi99pd	765	4	.	.	.
cord-015365-iqdi99pd	766	1	Zu	Zu	NNP
cord-015365-iqdi99pd	766	2	diesen	diesen	NNP
cord-015365-iqdi99pd	766	3	zählen	zählen	MD
cord-015365-iqdi99pd	766	4	die	die	VBP
cord-015365-iqdi99pd	766	5	Herpesviren	Herpesviren	NNP
cord-015365-iqdi99pd	766	6	Herpes	Herpes	NNP
cord-015365-iqdi99pd	767	1	simples	simple	NNS
cord-015365-iqdi99pd	767	2	1	1	CD
cord-015365-iqdi99pd	767	3	und	und	RB
cord-015365-iqdi99pd	767	4	2	2	CD
cord-015365-iqdi99pd	768	1	(	(	-LRB-
cord-015365-iqdi99pd	768	2	HSV	HSV	NNP
cord-015365-iqdi99pd	768	3	1	1	CD
cord-015365-iqdi99pd	768	4	,	,	,
cord-015365-iqdi99pd	768	5	2	2	CD
cord-015365-iqdi99pd	768	6	)	)	-RRB-
cord-015365-iqdi99pd	768	7	,	,	,
cord-015365-iqdi99pd	768	8	Cytomegalievirus	Cytomegalievirus	NNP
cord-015365-iqdi99pd	768	9	(	(	-LRB-
cord-015365-iqdi99pd	768	10	CMV	CMV	NNP
cord-015365-iqdi99pd	768	11	)	)	-RRB-
cord-015365-iqdi99pd	768	12	,	,	,
cord-015365-iqdi99pd	768	13	Epstein	Epstein	NNP
cord-015365-iqdi99pd	768	14	-	-	HYPH
cord-015365-iqdi99pd	768	15	Barr	Barr	NNP
cord-015365-iqdi99pd	768	16	-	-	HYPH
cord-015365-iqdi99pd	768	17	Virus	Virus	NNP
cord-015365-iqdi99pd	768	18	(	(	-LRB-
cord-015365-iqdi99pd	768	19	EBV	EBV	NNP
cord-015365-iqdi99pd	768	20	)	)	-RRB-
cord-015365-iqdi99pd	768	21	,	,	.
cord-015365-iqdi99pd	769	1	Varicella	Varicella	NNP
cord-015365-iqdi99pd	769	2	Zoster	Zoster	NNP
cord-015365-iqdi99pd	769	3	Virus	virus	NN
cord-015365-iqdi99pd	769	4	(	(	-LRB-
cord-015365-iqdi99pd	769	5	VZV	VZV	NNP
cord-015365-iqdi99pd	769	6	)	)	-RRB-
cord-015365-iqdi99pd	769	7	und	und	RB
cord-015365-iqdi99pd	770	1	HHV-6	HHV-6	NNP
cord-015365-iqdi99pd	770	2	sowie	sowie	CD
cord-015365-iqdi99pd	770	3	das	das	NNP
cord-015365-iqdi99pd	770	4	Parvovirus	Parvovirus	NNP
cord-015365-iqdi99pd	770	5	B	B	NNP
cord-015365-iqdi99pd	770	6	19	19	CD
cord-015365-iqdi99pd	770	7	(	(	-LRB-
cord-015365-iqdi99pd	770	8	PVB19	PVB19	NNP
cord-015365-iqdi99pd	770	9	)	)	-RRB-
cord-015365-iqdi99pd	770	10	,	,	,
cord-015365-iqdi99pd	770	11	das	das	NNP
cord-015365-iqdi99pd	770	12	Adenovirus	Adenovirus	NNP
cord-015365-iqdi99pd	770	13	(	(	-LRB-
cord-015365-iqdi99pd	770	14	ADV	ADV	NNP
cord-015365-iqdi99pd	770	15	)	)	-RRB-
cord-015365-iqdi99pd	770	16	,	,	,
cord-015365-iqdi99pd	770	17	die	die	VBP
cord-015365-iqdi99pd	770	18	Hepatitisviren	Hepatitisviren	NNP
cord-015365-iqdi99pd	770	19	B	B	NNP
cord-015365-iqdi99pd	770	20	(	(	-LRB-
cord-015365-iqdi99pd	770	21	HBV	HBV	NNP
cord-015365-iqdi99pd	770	22	)	)	-RRB-
cord-015365-iqdi99pd	771	1	und	und	NNP
cord-015365-iqdi99pd	772	1	C	C	NNP
cord-015365-iqdi99pd	772	2	(	(	-LRB-
cord-015365-iqdi99pd	772	3	HCV	HCV	NNP
cord-015365-iqdi99pd	772	4	)	)	-RRB-
cord-015365-iqdi99pd	773	1	und	und	NNP
cord-015365-iqdi99pd	774	1	die	die	VB
cord-015365-iqdi99pd	775	1	Polyomaviren	Polyomaviren	NNP
cord-015365-iqdi99pd	775	2	BK	BK	NNP
cord-015365-iqdi99pd	775	3	-	-	HYPH
cord-015365-iqdi99pd	775	4	Virus	Virus	NNP
cord-015365-iqdi99pd	776	1	(	(	-LRB-
cord-015365-iqdi99pd	776	2	BKV	BKV	NNP
cord-015365-iqdi99pd	776	3	)	)	-RRB-
cord-015365-iqdi99pd	776	4	und	und	IN
cord-015365-iqdi99pd	776	5	JC	JC	NNP
cord-015365-iqdi99pd	776	6	-	-	HYPH
cord-015365-iqdi99pd	776	7	Virus	Virus	NNP
cord-015365-iqdi99pd	776	8	(	(	-LRB-
cord-015365-iqdi99pd	776	9	JCV	JCV	NNP
cord-015365-iqdi99pd	776	10	)	)	-RRB-
cord-015365-iqdi99pd	776	11	.	.	.
cord-015365-iqdi99pd	777	1	Diese	Diese	NNP
cord-015365-iqdi99pd	777	2	und	und	IN
cord-015365-iqdi99pd	777	3	andere	andere	FW
cord-015365-iqdi99pd	777	4	Viren	Viren	NNP
cord-015365-iqdi99pd	777	5	(	(	-LRB-
cord-015365-iqdi99pd	777	6	z.	z.	NNP
cord-015365-iqdi99pd	777	7	B.	B.	NNP
cord-015365-iqdi99pd	777	8	Enteroviren	Enteroviren	NNP
cord-015365-iqdi99pd	777	9	)	)	-RRB-
cord-015365-iqdi99pd	778	1	können	können	UH
cord-015365-iqdi99pd	778	2	bei	bei	NNP
cord-015365-iqdi99pd	778	3	Empfängern	Empfängern	NNP
cord-015365-iqdi99pd	778	4	von	von	VBP
cord-015365-iqdi99pd	778	5	Organoder	Organoder	NNP
cord-015365-iqdi99pd	778	6	Stammzelltransplantationen	Stammzelltransplantationen	NNP
cord-015365-iqdi99pd	779	1	durch	durch	NNP
cord-015365-iqdi99pd	779	2	Primärinfektion	Primärinfektion	NNP
cord-015365-iqdi99pd	779	3	oder	oder	NN
cord-015365-iqdi99pd	779	4	Reaktivierung	Reaktivierung	NNP
cord-015365-iqdi99pd	779	5	zu	zu	NNP
cord-015365-iqdi99pd	779	6	schweren	schweren	NNP
cord-015365-iqdi99pd	779	7	Krankheitsverläufen	Krankheitsverläufen	NNP
cord-015365-iqdi99pd	779	8	(	(	-LRB-
cord-015365-iqdi99pd	779	9	"	"	``
cord-015365-iqdi99pd	779	10	Virus	virus	NN
cord-015365-iqdi99pd	779	11	-	-	HYPH
cord-015365-iqdi99pd	779	12	Sepsis	Sepsis	NNP
cord-015365-iqdi99pd	779	13	"	"	''
cord-015365-iqdi99pd	779	14	)	)	-RRB-
cord-015365-iqdi99pd	780	1	und	und	NNP
cord-015365-iqdi99pd	781	1	immunologischen	immunologischen	NNP
cord-015365-iqdi99pd	781	2	Prozessen	Prozessen	NNP
cord-015365-iqdi99pd	781	3	wie	wie	NNP
cord-015365-iqdi99pd	781	4	Transplantatabstoßung	Transplantatabstoßung	NNP
cord-015365-iqdi99pd	781	5	oder	oder	NN
cord-015365-iqdi99pd	781	6	Graft	graft	NN
cord-015365-iqdi99pd	781	7	-	-	HYPH
cord-015365-iqdi99pd	781	8	versus	versus	IN
cord-015365-iqdi99pd	781	9	-	-	HYPH
cord-015365-iqdi99pd	781	10	Host	host	NN
cord-015365-iqdi99pd	781	11	Disease	Disease	NNP
cord-015365-iqdi99pd	781	12	führen	führen	NNP
cord-015365-iqdi99pd	781	13	.	.	.
cord-015365-iqdi99pd	782	1	Neben	Neben	NNP
cord-015365-iqdi99pd	782	2	unspezifischen	unspezifischen	NNP
cord-015365-iqdi99pd	782	3	Maßnahmen	Maßnahmen	NNP
cord-015365-iqdi99pd	782	4	wie	wie	NNP
cord-015365-iqdi99pd	782	5	Reduktion	Reduktion	NNP
cord-015365-iqdi99pd	782	6	der	der	NNP
cord-015365-iqdi99pd	782	7	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	782	8	,	,	,
cord-015365-iqdi99pd	782	9	Gabe	Gabe	NNP
cord-015365-iqdi99pd	782	10	von	von	NNP
cord-015365-iqdi99pd	782	11	Immunglobulinen	Immunglobulinen	NNP
cord-015365-iqdi99pd	782	12	und	und	IN
cord-015365-iqdi99pd	782	13	Immunmodulation	Immunmodulation	NNP
cord-015365-iqdi99pd	782	14	mittels	mittels	NNP
cord-015365-iqdi99pd	783	1	Interferon	interferon	NN
cord-015365-iqdi99pd	783	2	,	,	,
cord-015365-iqdi99pd	783	3	wurde	wurde	NNP
cord-015365-iqdi99pd	783	4	in	in	IN
cord-015365-iqdi99pd	783	5	den	den	NNP
cord-015365-iqdi99pd	783	6	letzten	letzten	NNP
cord-015365-iqdi99pd	783	7	Jahren	Jahren	NNP
cord-015365-iqdi99pd	783	8	eine	eine	NNP
cord-015365-iqdi99pd	783	9	zunehmende	zunehmende	NNP
cord-015365-iqdi99pd	783	10	Zahl	Zahl	NNP
cord-015365-iqdi99pd	783	11	antiviraler	antiviraler	NN
cord-015365-iqdi99pd	783	12	Substanzen	Substanzen	NNP
cord-015365-iqdi99pd	783	13	verfügbar	verfügbar	NN
cord-015365-iqdi99pd	783	14	.	.	.
cord-015365-iqdi99pd	784	1	Deren	Deren	NNP
cord-015365-iqdi99pd	784	2	antiviraler	antiviraler	NN
cord-015365-iqdi99pd	784	3	Effekt	Effekt	NNP
cord-015365-iqdi99pd	784	4	beruht	beruht	NNP
cord-015365-iqdi99pd	784	5	auf	auf	NNP
cord-015365-iqdi99pd	784	6	unterschiedlichen	unterschiedlichen	NNP
cord-015365-iqdi99pd	784	7	Mechanismen	Mechanismen	NNP
cord-015365-iqdi99pd	784	8	:	:	:
cord-015365-iqdi99pd	785	1	Hemmung	Hemmung	NNP
cord-015365-iqdi99pd	785	2	der	der	NNP
cord-015365-iqdi99pd	785	3	Aufnahme	Aufnahme	NNP
cord-015365-iqdi99pd	785	4	der	der	NNP
cord-015365-iqdi99pd	785	5	Viren	Viren	NNP
cord-015365-iqdi99pd	785	6	in	in	IN
cord-015365-iqdi99pd	785	7	die	die	JJ
cord-015365-iqdi99pd	785	8	Wirtszelle	Wirtszelle	NNP
cord-015365-iqdi99pd	785	9	(	(	-LRB-
cord-015365-iqdi99pd	785	10	Amantadin	Amantadin	NNP
cord-015365-iqdi99pd	785	11	,	,	,
cord-015365-iqdi99pd	785	12	Pleconaril	Pleconaril	NNP
cord-015365-iqdi99pd	785	13	)	)	-RRB-
cord-015365-iqdi99pd	785	14	,	,	,
cord-015365-iqdi99pd	785	15	Inhibierung	Inhibierung	NNP
cord-015365-iqdi99pd	785	16	der	der	NNP
cord-015365-iqdi99pd	785	17	Replikation	Replikation	NNP
cord-015365-iqdi99pd	785	18	des	des	NN
cord-015365-iqdi99pd	786	1	viralen	viralen	NNP
cord-015365-iqdi99pd	786	2	Genoms	Genoms	NNP
cord-015365-iqdi99pd	786	3	(	(	-LRB-
cord-015365-iqdi99pd	786	4	Aciclovir	Aciclovir	NNP
cord-015365-iqdi99pd	786	5	,	,	,
cord-015365-iqdi99pd	786	6	Ganciclovir	Ganciclovir	NNP
cord-015365-iqdi99pd	786	7	,	,	,
cord-015365-iqdi99pd	786	8	Cidofovir	Cidofovir	NNP
cord-015365-iqdi99pd	786	9	,	,	,
cord-015365-iqdi99pd	786	10	Foscarnet	Foscarnet	NNP
cord-015365-iqdi99pd	786	11	,	,	,
cord-015365-iqdi99pd	786	12	Ribavirin	Ribavirin	NNP
cord-015365-iqdi99pd	786	13	)	)	-RRB-
cord-015365-iqdi99pd	786	14	,	,	,
cord-015365-iqdi99pd	786	15	Unterdrückung	Unterdrückung	NNP
cord-015365-iqdi99pd	786	16	der	der	NNP
cord-015365-iqdi99pd	786	17	Freisetzung	Freisetzung	NNP
cord-015365-iqdi99pd	786	18	von	von	NNP
cord-015365-iqdi99pd	786	19	Viruspartikeln	Viruspartikeln	NNP
cord-015365-iqdi99pd	786	20	aus	aus	NNP
cord-015365-iqdi99pd	786	21	der	der	NNP
cord-015365-iqdi99pd	786	22	Wirtszelle	Wirtszelle	NNP
cord-015365-iqdi99pd	786	23	(	(	-LRB-
cord-015365-iqdi99pd	786	24	Oseltamivir	Oseltamivir	NNP
cord-015365-iqdi99pd	786	25	,	,	,
cord-015365-iqdi99pd	786	26	Zanamivir	Zanamivir	NNP
cord-015365-iqdi99pd	786	27	)	)	-RRB-
cord-015365-iqdi99pd	786	28	.	.	.
cord-015365-iqdi99pd	787	1	All	all	DT
cord-015365-iqdi99pd	787	2	diese	diese	NNP
cord-015365-iqdi99pd	787	3	Substanzen	Substanzen	NNP
cord-015365-iqdi99pd	787	4	wirken	wirken	NNP
cord-015365-iqdi99pd	787	5	virustatisch	virustatisch	NNP
cord-015365-iqdi99pd	787	6	und	und	NNP
cord-015365-iqdi99pd	787	7	nicht	nicht	NNP
cord-015365-iqdi99pd	787	8	viruzid	viruzid	NNP
cord-015365-iqdi99pd	787	9	,	,	,
cord-015365-iqdi99pd	787	10	können	können	NNP
cord-015365-iqdi99pd	787	11	also	also	RB
cord-015365-iqdi99pd	787	12	die	die	VBP
cord-015365-iqdi99pd	787	13	Virusvermehrung	Virusvermehrung	NNP
cord-015365-iqdi99pd	787	14	hemmen	hemmen	NN
cord-015365-iqdi99pd	787	15	,	,	.
cord-015365-iqdi99pd	788	1	nicht	nicht	NNP
cord-015365-iqdi99pd	788	2	jedoch	jedoch	NNP
cord-015365-iqdi99pd	788	3	die	die	VBP
cord-015365-iqdi99pd	788	4	Viren	Viren	NNP
cord-015365-iqdi99pd	788	5	gänzlich	gänzlich	NNP
cord-015365-iqdi99pd	788	6	eliminieren	eliminieren	NNP
cord-015365-iqdi99pd	788	7	.	.	.
cord-015365-iqdi99pd	789	1	Während	Während	NNP
cord-015365-iqdi99pd	789	2	einige	einige	NNP
cord-015365-iqdi99pd	789	3	Substanzen	Substanzen	NNP
cord-015365-iqdi99pd	789	4	relativ	relativ	JJ
cord-015365-iqdi99pd	789	5	spezifisch	spezifisch	NN
cord-015365-iqdi99pd	789	6	in	in	IN
cord-015365-iqdi99pd	789	7	die	die	NN
cord-015365-iqdi99pd	790	1	Replikationsmechanismen	Replikationsmechanismen	NNP
cord-015365-iqdi99pd	790	2	einzelner	einzelner	NN
cord-015365-iqdi99pd	790	3	Viren	Viren	NNP
cord-015365-iqdi99pd	790	4	eingreifen	eingreifen	NNP
cord-015365-iqdi99pd	790	5	(	(	-LRB-
cord-015365-iqdi99pd	790	6	Aciclovir	Aciclovir	NNP
cord-015365-iqdi99pd	790	7	,	,	,
cord-015365-iqdi99pd	790	8	Ribavirin	Ribavirin	NNP
cord-015365-iqdi99pd	790	9	,	,	,
cord-015365-iqdi99pd	790	10	Oseltamivir	Oseltamivir	NNP
cord-015365-iqdi99pd	790	11	,	,	,
cord-015365-iqdi99pd	790	12	Zanamivir	Zanamivir	NNP
cord-015365-iqdi99pd	790	13	)	)	-RRB-
cord-015365-iqdi99pd	790	14	,	,	,
cord-015365-iqdi99pd	791	1	zeigen	zeigen	NNP
cord-015365-iqdi99pd	791	2	andere	andere	NNP
cord-015365-iqdi99pd	791	3	Substanzenmeist	Substanzenmeist	NNP
cord-015365-iqdi99pd	791	4	jene	jene	NNP
cord-015365-iqdi99pd	791	5	mit	mit	NNP
cord-015365-iqdi99pd	791	6	breiterem	breiterem	NNP
cord-015365-iqdi99pd	791	7	Wirkspektrum	Wirkspektrum	NNP
cord-015365-iqdi99pd	791	8	(	(	-LRB-
cord-015365-iqdi99pd	791	9	Cidofovir	Cidofovir	NNP
cord-015365-iqdi99pd	791	10	,	,	,
cord-015365-iqdi99pd	791	11	Foscarnet	Foscarnet	NNP
cord-015365-iqdi99pd	791	12	)	)	-RRB-
cord-015365-iqdi99pd	792	1	-auch	-auch	JJ
cord-015365-iqdi99pd	792	2	eine	eine	NNP
cord-015365-iqdi99pd	792	3	vermehrte	vermehrte	NNP
cord-015365-iqdi99pd	792	4	Aktivität	Aktivität	NNP
cord-015365-iqdi99pd	792	5	innerhalb	innerhalb	NNP
cord-015365-iqdi99pd	792	6	humaner	humaner	NN
cord-015365-iqdi99pd	792	7	,	,	,
cord-015365-iqdi99pd	792	8	molekularer	molekularer	NNP
cord-015365-iqdi99pd	792	9	Mechanismen	Mechanismen	NNP
cord-015365-iqdi99pd	792	10	,	,	,
cord-015365-iqdi99pd	792	11	was	be	VBD
cord-015365-iqdi99pd	792	12	zu	zu	NNP
cord-015365-iqdi99pd	793	1	einer	einer	NNP
cord-015365-iqdi99pd	793	2	beträchtlichen	beträchtlichen	NNP
cord-015365-iqdi99pd	793	3	Zahl	Zahl	NNP
cord-015365-iqdi99pd	794	1	unerwü	unerwü	NNP
cord-015365-iqdi99pd	794	2	nschter	nschter	NNP
cord-015365-iqdi99pd	795	1	Arzneimittelwirkungen	Arzneimittelwirkungen	NNP
cord-015365-iqdi99pd	795	2	fü	fü	IN
cord-015365-iqdi99pd	795	3	hrt	hrt	NNP
cord-015365-iqdi99pd	795	4	(	(	-LRB-
cord-015365-iqdi99pd	795	5	v.	v.	CC
cord-015365-iqdi99pd	795	6	a.	a.	NN
cord-015365-iqdi99pd	796	1	Nephro-	Nephro-	NNP
cord-015365-iqdi99pd	796	2	,	,	,
cord-015365-iqdi99pd	796	3	Myelo-	Myelo-	NNP
cord-015365-iqdi99pd	796	4	,	,	,
cord-015365-iqdi99pd	796	5	Neurotoxizität	Neurotoxizität	NNP
cord-015365-iqdi99pd	796	6	)	)	-RRB-
cord-015365-iqdi99pd	796	7	.	.	.
cord-015365-iqdi99pd	797	1	Handelsname	Handelsname	NNP
cord-015365-iqdi99pd	797	2	DNA	DNA	NNP
cord-015365-iqdi99pd	797	3	-	-	HYPH
cord-015365-iqdi99pd	797	4	Viren	Viren	NNP
cord-015365-iqdi99pd	797	5	RNA	RNA	NNP
cord-015365-iqdi99pd	797	6	-	-	HYPH
cord-015365-iqdi99pd	797	7	Viren	Viren	NNP
cord-015365-iqdi99pd	798	1	Ciprofloxacin	Ciprofloxacin	NNP
cord-015365-iqdi99pd	799	1	*	*	NFP
cord-015365-iqdi99pd	799	2	*	*	NFP
cord-015365-iqdi99pd	799	3	Ciproxin	Ciproxin	NNP
cord-015365-iqdi99pd	799	4	þ	þ	NNP
cord-015365-iqdi99pd	799	5	(	(	-LRB-
cord-015365-iqdi99pd	799	6	in	in	IN
cord-015365-iqdi99pd	799	7	vitro	vitro	FW
cord-015365-iqdi99pd	799	8	)	)	-RRB-
cord-015365-iqdi99pd	800	1	Wirkspektrum	Wirkspektrum	NNP
cord-015365-iqdi99pd	800	2	ausgewählter	ausgewählter	NN
cord-015365-iqdi99pd	800	3	Virustatika	Virustatika	NNP
cord-015365-iqdi99pd	801	1	(	(	-LRB-
cord-015365-iqdi99pd	801	2	ohne	ohne	NNP
cord-015365-iqdi99pd	801	3	anti	anti	NNP
cord-015365-iqdi99pd	801	4	-	-	NNP
cord-015365-iqdi99pd	801	5	retrovirale	retrovirale	JJ
cord-015365-iqdi99pd	801	6	Substanzen	Substanzen	NNP
cord-015365-iqdi99pd	801	7	)	)	-RRB-
cord-015365-iqdi99pd	802	1	Wirksamkeit	Wirksamkeit	NNP
cord-015365-iqdi99pd	802	2	entspricht	entspricht	NNP
cord-015365-iqdi99pd	803	1	nicht	nicht	NNP
cord-015365-iqdi99pd	803	2	den	den	NNP
cord-015365-iqdi99pd	803	3	zugelassenen	zugelassenen	NNP
cord-015365-iqdi99pd	803	4	Indikationen	Indikationen	NNP
cord-015365-iqdi99pd	804	1	*	*	NFP
cord-015365-iqdi99pd	804	2	experimentell	experimentell	NNP
cord-015365-iqdi99pd	804	3	,	,	,
cord-015365-iqdi99pd	804	4	nicht	nicht	NNP
cord-015365-iqdi99pd	804	5	verfügbar	verfügbar	NNP
cord-015365-iqdi99pd	805	1	*	*	NFP
cord-015365-iqdi99pd	805	2	*	*	NFP
cord-015365-iqdi99pd	805	3	experimentell	experimentell	NNP
cord-015365-iqdi99pd	806	1	Einige	Einige	NNP
cord-015365-iqdi99pd	806	2	Substanzen	Substanzen	NNP
cord-015365-iqdi99pd	806	3	haben	haben	NNP
cord-015365-iqdi99pd	807	1	i	-PRON-	PRP
cord-015365-iqdi99pd	807	2	m	be	VBP
cord-015365-iqdi99pd	807	3	Tierversuch	Tierversuch	NNP
cord-015365-iqdi99pd	807	4	ein	ein	NNP
cord-015365-iqdi99pd	807	5	carcinogenes	carcinogene	NNS
cord-015365-iqdi99pd	807	6	(	(	-LRB-
cord-015365-iqdi99pd	807	7	Ganciclovir	Ganciclovir	NNP
cord-015365-iqdi99pd	807	8	,	,	,
cord-015365-iqdi99pd	807	9	Cidofovir	Cidofovir	NNP
cord-015365-iqdi99pd	807	10	)	)	-RRB-
cord-015365-iqdi99pd	807	11	und	und	NNP
cord-015365-iqdi99pd	807	12	/	/	SYM
cord-015365-iqdi99pd	807	13	oder	oder	NNP
cord-015365-iqdi99pd	807	14	teratogenes	teratogenes	NNPS
cord-015365-iqdi99pd	807	15	(	(	-LRB-
cord-015365-iqdi99pd	807	16	Ganciclovir	Ganciclovir	NNP
cord-015365-iqdi99pd	807	17	,	,	,
cord-015365-iqdi99pd	807	18	Cidofovir	Cidofovir	NNP
cord-015365-iqdi99pd	807	19	,	,	,
cord-015365-iqdi99pd	807	20	Ribavirin	Ribavirin	NNP
cord-015365-iqdi99pd	807	21	)	)	-RRB-
cord-015365-iqdi99pd	808	1	Potenzial	Potenzial	NNP
cord-015365-iqdi99pd	808	2	gezeigt	gezeigt	VBZ
cord-015365-iqdi99pd	808	3	.	.	.
cord-015365-iqdi99pd	809	1	Unter	Unter	NNP
cord-015365-iqdi99pd	809	2	zu	zu	XX
cord-015365-iqdi99pd	810	1	geringer	geringer	NNP
cord-015365-iqdi99pd	810	2	Dosierung	Dosierung	NNP
cord-015365-iqdi99pd	811	1	und	und	NNP
cord-015365-iqdi99pd	812	1	/oder	/oder	NNP
cord-015365-iqdi99pd	812	2	mangelhafter	mangelhafter	NNP
cord-015365-iqdi99pd	812	3	Medikamenteneinnahme	Medikamenteneinnahme	NNP
cord-015365-iqdi99pd	812	4	kann	kann	NNP
cord-015365-iqdi99pd	812	5	es	es	XX
cord-015365-iqdi99pd	812	6	zu	zu	NNP
cord-015365-iqdi99pd	813	1	viralen	viralen	NNP
cord-015365-iqdi99pd	813	2	Mutationen	Mutationen	NNP
cord-015365-iqdi99pd	814	1	und	und	NNP
cord-015365-iqdi99pd	815	1	-daraus	-daraus	:
cord-015365-iqdi99pd	815	2	resultierend	resultierend	VB
cord-015365-iqdi99pd	816	1	-zur	-zur	.
cord-015365-iqdi99pd	817	1	Resistenzentwicklung	Resistenzentwicklung	NNP
cord-015365-iqdi99pd	817	2	kommen	kommen	NNP
cord-015365-iqdi99pd	817	3	.	.	.
cord-015365-iqdi99pd	818	1	Tabelle	Tabelle	NNP
cord-015365-iqdi99pd	818	2	1	1	CD
cord-015365-iqdi99pd	818	3	gibt	gibt	NNP
cord-015365-iqdi99pd	818	4	einen	einen	NNP
cord-015365-iqdi99pd	818	5	Ü	Ü	NNP
cord-015365-iqdi99pd	818	6	berblick	berblick	NNP
cord-015365-iqdi99pd	819	1	über	über	NNP
cord-015365-iqdi99pd	819	2	die	die	VBP
cord-015365-iqdi99pd	820	1	wichtigsten	wichtigsten	NNP
cord-015365-iqdi99pd	820	2	Virustatika	Virustatika	NNP
cord-015365-iqdi99pd	820	3	und	und	IN
cord-015365-iqdi99pd	820	4	deren	deren	NNP
cord-015365-iqdi99pd	820	5	Wirkspektrum	Wirkspektrum	NNP
cord-015365-iqdi99pd	820	6	.	.	.
cord-015365-iqdi99pd	821	1	Viele	Viele	NNP
cord-015365-iqdi99pd	821	2	dieser	dieser	NNP
cord-015365-iqdi99pd	822	1	Substanzen	substanzen	NN
cord-015365-iqdi99pd	822	2	sind	sind	NN
cord-015365-iqdi99pd	823	1	jedoch	jedoch	NNP
cord-015365-iqdi99pd	823	2	für	für	NNP
cord-015365-iqdi99pd	823	3	die	die	VBP
cord-015365-iqdi99pd	823	4	Anwendung	Anwendung	NNP
cord-015365-iqdi99pd	823	5	i	i	PRP
cord-015365-iqdi99pd	824	1	m	m	LS
cord-015365-iqdi99pd	824	2	"	"	``
cord-015365-iqdi99pd	824	3	Transplantations	Transplantations	NNP
cord-015365-iqdi99pd	824	4	-	-	HYPH
cord-015365-iqdi99pd	824	5	Setting	set	VBG
cord-015365-iqdi99pd	824	6	"	"	``
cord-015365-iqdi99pd	824	7	nicht	nicht	NNP
cord-015365-iqdi99pd	824	8	offiziell	offiziell	NNP
cord-015365-iqdi99pd	824	9	zugelassen	zugelassen	NNP
cord-015365-iqdi99pd	824	10	.	.	.
cord-015365-iqdi99pd	825	1	In	in	IN
cord-015365-iqdi99pd	825	2	Zukunft	Zukunft	NNP
cord-015365-iqdi99pd	825	3	sind	sind	NNP
cord-015365-iqdi99pd	825	4	weitere	weitere	NNP
cord-015365-iqdi99pd	825	5	,	,	,
cord-015365-iqdi99pd	825	6	teilweise	teilweise	RB
cord-015365-iqdi99pd	825	7	dzt	dzt	NN
cord-015365-iqdi99pd	825	8	.	.	.
cord-015365-iqdi99pd	826	1	noch	noch	NNP
cord-015365-iqdi99pd	826	2	experimentell	experimentell	NNP
cord-015365-iqdi99pd	827	1	eingesetzte	eingesetzte	NNP
cord-015365-iqdi99pd	828	1	Therapieoptionen	Therapieoptionen	NNP
cord-015365-iqdi99pd	828	2	zu	zu	NNP
cord-015365-iqdi99pd	828	3	erwarten	erwarten	NNP
cord-015365-iqdi99pd	828	4	:	:	:
cord-015365-iqdi99pd	829	1	so	so	RB
cord-015365-iqdi99pd	829	2	scheint	scheint	NNP
cord-015365-iqdi99pd	829	3	Ciprofloxacin	Ciprofloxacin	NNP
cord-015365-iqdi99pd	829	4	als	als	NNP
cord-015365-iqdi99pd	829	5	Gyrasehemmer	Gyrasehemmer	NNP
cord-015365-iqdi99pd	829	6	auch	auch	NNP
cord-015365-iqdi99pd	829	7	gegen	gegen	NNP
cord-015365-iqdi99pd	829	8	Polyomaviren	Polyomaviren	NNP
cord-015365-iqdi99pd	829	9	wirksam	wirksam	NNP
cord-015365-iqdi99pd	829	10	zu	zu	NNP
cord-015365-iqdi99pd	829	11	sein	sein	NNP
cord-015365-iqdi99pd	829	12	,	,	,
cord-015365-iqdi99pd	829	13	mit	mit	NNP
cord-015365-iqdi99pd	829	14	CMX001	CMX001	NNP
cord-015365-iqdi99pd	829	15	wird	wird	NNP
cord-015365-iqdi99pd	830	1	eine	eine	NNP
cord-015365-iqdi99pd	830	2	wirksamere	wirksamere	NNP
cord-015365-iqdi99pd	831	1	und	und	NNP
cord-015365-iqdi99pd	831	2	nebenwirkungsärmere	nebenwirkungsärmere	RB
cord-015365-iqdi99pd	832	1	Weiterentwicklung	Weiterentwicklung	NNP
cord-015365-iqdi99pd	832	2	von	von	NNP
cord-015365-iqdi99pd	832	3	Cidofovir	Cidofovir	NNP
cord-015365-iqdi99pd	832	4	derzeit	derzeit	NNP
cord-015365-iqdi99pd	832	5	klinischen	klinischen	NNP
cord-015365-iqdi99pd	832	6	Tests	Tests	NNPS
cord-015365-iqdi99pd	832	7	unterzogen	unterzogen	NNP
cord-015365-iqdi99pd	832	8	.	.	.
cord-015365-iqdi99pd	833	1	Reaktivierungen	Reaktivierungen	NNP
cord-015365-iqdi99pd	833	2	von	von	NNP
cord-015365-iqdi99pd	833	3	persistierenden	persistierenden	NNP
cord-015365-iqdi99pd	834	1	Virusinfektionen	Virusinfektionen	NNP
cord-015365-iqdi99pd	834	2	sind	sind	NNP
cord-015365-iqdi99pd	834	3	häufige	häufige	NNP
cord-015365-iqdi99pd	834	4	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	834	5	nach	nach	NNP
cord-015365-iqdi99pd	834	6	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	834	7	.	.	.
cord-015365-iqdi99pd	835	1	Je	Je	NNP
cord-015365-iqdi99pd	835	2	nach	nach	NNP
cord-015365-iqdi99pd	835	3	Risikokonstellation	Risikokonstellation	NNP
cord-015365-iqdi99pd	835	4	reicht	reicht	NNP
cord-015365-iqdi99pd	835	5	das	das	NNP
cord-015365-iqdi99pd	835	6	klinische	klinische	NNP
cord-015365-iqdi99pd	835	7	Spektrum	Spektrum	NNP
cord-015365-iqdi99pd	835	8	von	von	NNP
cord-015365-iqdi99pd	835	9	einem	einem	NNP
cord-015365-iqdi99pd	835	10	harmlosen	harmlosen	NNP
cord-015365-iqdi99pd	836	1	Infekt	infekt	NN
cord-015365-iqdi99pd	836	2	bis	bis	NN
cord-015365-iqdi99pd	836	3	zu	zu	XX
cord-015365-iqdi99pd	837	1	einem	einem	NNP
cord-015365-iqdi99pd	837	2	lebensbedrohlichen	lebensbedrohlichen	NNP
cord-015365-iqdi99pd	837	3	Infektionsverlauf	Infektionsverlauf	NNP
cord-015365-iqdi99pd	837	4	.	.	.
cord-015365-iqdi99pd	838	1	Die	die	VB
cord-015365-iqdi99pd	838	2	häufigsten	häufigsten	NNP
cord-015365-iqdi99pd	839	1	Pathogene	Pathogene	NNP
cord-015365-iqdi99pd	839	2	sind	sind	NNP
cord-015365-iqdi99pd	839	3	Cytomegalievirus	Cytomegalievirus	NNP
cord-015365-iqdi99pd	839	4	(	(	-LRB-
cord-015365-iqdi99pd	839	5	CMV	CMV	NNP
cord-015365-iqdi99pd	839	6	)	)	-RRB-
cord-015365-iqdi99pd	839	7	,	,	,
cord-015365-iqdi99pd	839	8	Epstein	Epstein	NNP
cord-015365-iqdi99pd	839	9	-	-	HYPH
cord-015365-iqdi99pd	839	10	Barr	Barr	NNP
cord-015365-iqdi99pd	839	11	Virus	Virus	NNP
cord-015365-iqdi99pd	839	12	(	(	-LRB-
cord-015365-iqdi99pd	839	13	EBV	EBV	NNP
cord-015365-iqdi99pd	839	14	)	)	-RRB-
cord-015365-iqdi99pd	840	1	und	und	NNP
cord-015365-iqdi99pd	841	1	Adenoviren	Adenoviren	NNP
cord-015365-iqdi99pd	841	2	(	(	-LRB-
cord-015365-iqdi99pd	841	3	ADV	ADV	NNP
cord-015365-iqdi99pd	841	4	)	)	-RRB-
cord-015365-iqdi99pd	841	5	.	.	.
cord-015365-iqdi99pd	842	1	Die	die	VB
cord-015365-iqdi99pd	843	1	Möglichkeiten	Möglichkeiten	NNP
cord-015365-iqdi99pd	843	2	der	der	NNP
cord-015365-iqdi99pd	843	3	virostatischen	virostatischen	NNP
cord-015365-iqdi99pd	844	1	Pharmakotherapie	Pharmakotherapie	NNP
cord-015365-iqdi99pd	844	2	sind	sind	NNP
cord-015365-iqdi99pd	844	3	meist	meist	NNP
cord-015365-iqdi99pd	844	4	limitiert	limitiert	NNP
cord-015365-iqdi99pd	844	5	.	.	.
cord-015365-iqdi99pd	845	1	Alle	Alle	NNP
cord-015365-iqdi99pd	845	2	drei	drei	NNP
cord-015365-iqdi99pd	845	3	Virusinfektionen	Virusinfektionen	NNP
cord-015365-iqdi99pd	845	4	haben	haben	NNP
cord-015365-iqdi99pd	845	5	gemeinsam	gemeinsam	NNP
cord-015365-iqdi99pd	845	6	,	,	,
cord-015365-iqdi99pd	845	7	dass	dass	NNP
cord-015365-iqdi99pd	845	8	fü	fü	IN
cord-015365-iqdi99pd	845	9	r	r	NNP
cord-015365-iqdi99pd	845	10	eine	eine	NNP
cord-015365-iqdi99pd	845	11	Elimination	Elimination	NNP
cord-015365-iqdi99pd	845	12	eine	eine	NNP
cord-015365-iqdi99pd	845	13	suffiziente	suffiziente	NNP
cord-015365-iqdi99pd	845	14	T	T	NNP
cord-015365-iqdi99pd	845	15	-	-	HYPH
cord-015365-iqdi99pd	845	16	Zellimmunität	Zellimmunität	NNP
cord-015365-iqdi99pd	845	17	notwendig	notwendig	JJ
cord-015365-iqdi99pd	845	18	ist	ist	NN
cord-015365-iqdi99pd	845	19	.	.	.
cord-015365-iqdi99pd	846	1	Darauf	Darauf	NNP
cord-015365-iqdi99pd	846	2	baut	baut	NNP
cord-015365-iqdi99pd	846	3	die	die	VB
cord-015365-iqdi99pd	846	4	Rationale	rationale	NN
cord-015365-iqdi99pd	846	5	eines	eine	NNS
cord-015365-iqdi99pd	846	6	adoptiven	adoptiven	NN
cord-015365-iqdi99pd	846	7	Immuntransfers	Immuntransfers	NNP
cord-015365-iqdi99pd	846	8	auf	auf	NNP
cord-015365-iqdi99pd	846	9	,	,	,
cord-015365-iqdi99pd	847	1	bei	bei	NNP
cord-015365-iqdi99pd	847	2	dem	dem	NNP
cord-015365-iqdi99pd	847	3	Ag	Ag	NNP
cord-015365-iqdi99pd	847	4	-	-	HYPH
cord-015365-iqdi99pd	847	5	spezifische	spezifische	NNP
cord-015365-iqdi99pd	847	6	T	T	NNP
cord-015365-iqdi99pd	847	7	-	-	HYPH
cord-015365-iqdi99pd	847	8	Zellen	Zellen	NNP
cord-015365-iqdi99pd	847	9	von	von	NNP
cord-015365-iqdi99pd	847	10	einem	einem	NNP
cord-015365-iqdi99pd	847	11	gesunden	gesunden	NNP
cord-015365-iqdi99pd	847	12	Spender	Spender	NNP
cord-015365-iqdi99pd	847	13	in	in	IN
cord-015365-iqdi99pd	847	14	einen	einen	JJ
cord-015365-iqdi99pd	847	15	erkrankten	erkrankten	FW
cord-015365-iqdi99pd	847	16	Empfänger	Empfänger	NNP
cord-015365-iqdi99pd	847	17	infundiert	infundiert	NN
cord-015365-iqdi99pd	847	18	werden	werden	NNP
cord-015365-iqdi99pd	847	19	.	.	.
cord-015365-iqdi99pd	848	1	Hierbei	Hierbei	NNP
cord-015365-iqdi99pd	848	2	ist	ist	NN
cord-015365-iqdi99pd	848	3	das	das	NNP
cord-015365-iqdi99pd	848	4	Therapieziel	Therapieziel	NNP
cord-015365-iqdi99pd	849	1	eine	eine	NNP
cord-015365-iqdi99pd	849	2	adaptive	adaptive	JJ
cord-015365-iqdi99pd	849	3	Immunität	Immunität	NNP
cord-015365-iqdi99pd	850	1	i	i	PRP
cord-015365-iqdi99pd	851	1	m	m	NNP
cord-015365-iqdi99pd	851	2	Empfänger	Empfänger	NNP
cord-015365-iqdi99pd	851	3	zu	zu	NNP
cord-015365-iqdi99pd	851	4	induzieren	induzieren	NNP
cord-015365-iqdi99pd	851	5	.	.	.
cord-015365-iqdi99pd	852	1	I	-PRON-	PRP
cord-015365-iqdi99pd	852	2	m	be	VBP
cord-015365-iqdi99pd	852	3	Rahmen	Rahmen	NNP
cord-015365-iqdi99pd	852	4	einer	einer	NNP
cord-015365-iqdi99pd	852	5	risikoadaptierten	risikoadaptierten	FW
cord-015365-iqdi99pd	852	6	Therapie	Therapie	NNP
cord-015365-iqdi99pd	852	7	wurde	wurde	NN
cord-015365-iqdi99pd	852	8	bei	bei	NNP
cord-015365-iqdi99pd	852	9	refraktären	refraktären	NNP
cord-015365-iqdi99pd	853	1	Virusreaktivierungen	Virusreaktivierungen	NNP
cord-015365-iqdi99pd	853	2	nach	nach	NNP
cord-015365-iqdi99pd	853	3	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	853	4	dieses	diese	VBD
cord-015365-iqdi99pd	853	5	Therapieverfahren	Therapieverfahren	NNP
cord-015365-iqdi99pd	853	6	angewendet	angewendet	NNP
cord-015365-iqdi99pd	853	7	.	.	.
cord-015365-iqdi99pd	854	1	Eine	Eine	NNP
cord-015365-iqdi99pd	854	2	Ag	Ag	NNP
cord-015365-iqdi99pd	854	3	-	-	HYPH
cord-015365-iqdi99pd	854	4	spezifische	spezifische	NNP
cord-015365-iqdi99pd	854	5	T	T	NNP
cord-015365-iqdi99pd	854	6	-	-	HYPH
cord-015365-iqdi99pd	854	7	Zellantwort	Zellantwort	NNP
cord-015365-iqdi99pd	854	8	konnte	konnte	NNP
cord-015365-iqdi99pd	855	1	i	i	PRP
cord-015365-iqdi99pd	856	1	m	m	LS
cord-015365-iqdi99pd	857	1	Empfänger	Empfänger	NNP
cord-015365-iqdi99pd	857	2	gegen	gegen	NNP
cord-015365-iqdi99pd	857	3	immundominante	immundominante	NNP
cord-015365-iqdi99pd	857	4	Epitope	Epitope	NNP
cord-015365-iqdi99pd	857	5	(	(	-LRB-
cord-015365-iqdi99pd	857	6	pp65	pp65	RB
cord-015365-iqdi99pd	857	7	fü	fü	IN
cord-015365-iqdi99pd	858	1	r	r	LS
cord-015365-iqdi99pd	858	2	CMV	CMV	NNP
cord-015365-iqdi99pd	858	3	,	,	,
cord-015365-iqdi99pd	858	4	Hexonprotein	Hexonprotein	NNP
cord-015365-iqdi99pd	858	5	fü	fü	IN
cord-015365-iqdi99pd	858	6	r	r	NN
cord-015365-iqdi99pd	858	7	ADV	ADV	NNP
cord-015365-iqdi99pd	859	1	und	und	NNP
cord-015365-iqdi99pd	860	1	EBNA1	EBNA1	NNP
cord-015365-iqdi99pd	861	1	fü	fü	IN
cord-015365-iqdi99pd	862	1	r	r	NNP
cord-015365-iqdi99pd	862	2	EBV	EBV	NNP
cord-015365-iqdi99pd	862	3	)	)	-RRB-
cord-015365-iqdi99pd	862	4	induziert	induziert	NNP
cord-015365-iqdi99pd	863	1	werden	werden	NNP
cord-015365-iqdi99pd	864	1	um	um	UH
cord-015365-iqdi99pd	864	2	den	den	NNP
cord-015365-iqdi99pd	864	3	Empfänger	Empfänger	NNP
cord-015365-iqdi99pd	864	4	vor	vor	NNP
cord-015365-iqdi99pd	864	5	Virus	Virus	NNP
cord-015365-iqdi99pd	864	6	-	-	HYPH
cord-015365-iqdi99pd	864	7	assoziierten	assoziierten	NNP
cord-015365-iqdi99pd	864	8	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	864	9	zu	zu	NNP
cord-015365-iqdi99pd	864	10	schü	schü	NNP
cord-015365-iqdi99pd	864	11	tzen	tzen	NNP
cord-015365-iqdi99pd	864	12	.	.	.
cord-015365-iqdi99pd	865	1	Background	background	NN
cord-015365-iqdi99pd	865	2	.	.	.
cord-015365-iqdi99pd	866	1	We	-PRON-	PRP
cord-015365-iqdi99pd	866	2	investigated	investigate	VBD
cord-015365-iqdi99pd	866	3	the	the	DT
cord-015365-iqdi99pd	866	4	safety	safety	NN
cord-015365-iqdi99pd	866	5	and	and	CC
cord-015365-iqdi99pd	866	6	efficacy	efficacy	NN
cord-015365-iqdi99pd	866	7	of	of	IN
cord-015365-iqdi99pd	866	8	T	T	NNP
cord-015365-iqdi99pd	866	9	and	and	CC
cord-015365-iqdi99pd	866	10	B	B	NNP
cord-015365-iqdi99pd	866	11	cell	cell	NN
cord-015365-iqdi99pd	866	12	depleted	deplete	VBD
cord-015365-iqdi99pd	866	13	peripheral	peripheral	JJ
cord-015365-iqdi99pd	866	14	stem	stem	NN
cord-015365-iqdi99pd	866	15	cells	cell	NNS
cord-015365-iqdi99pd	866	16	from	from	IN
cord-015365-iqdi99pd	866	17	full	full	JJ
cord-015365-iqdi99pd	866	18	haplotype	haplotype	NN
cord-015365-iqdi99pd	866	19	mismatched	mismatch	VBD
cord-015365-iqdi99pd	866	20	parental	parental	JJ
cord-015365-iqdi99pd	866	21	donors	donor	NNS
cord-015365-iqdi99pd	866	22	in	in	IN
cord-015365-iqdi99pd	866	23	pediatric	pediatric	JJ
cord-015365-iqdi99pd	866	24	patients	patient	NNS
cord-015365-iqdi99pd	866	25	.	.	.
cord-015365-iqdi99pd	867	1	Methods	method	NNS
cord-015365-iqdi99pd	867	2	.	.	.
cord-015365-iqdi99pd	868	1	Use	use	NN
cord-015365-iqdi99pd	868	2	of	of	IN
cord-015365-iqdi99pd	868	3	the	the	DT
cord-015365-iqdi99pd	868	4	Clinimacs	Clinimacs	NNP
cord-015365-iqdi99pd	868	5	system	system	NN
cord-015365-iqdi99pd	868	6	and	and	CC
cord-015365-iqdi99pd	868	7	CD3	CD3	NNP
cord-015365-iqdi99pd	868	8	/	/	SYM
cord-015365-iqdi99pd	868	9	CD19	CD19	NNP
cord-015365-iqdi99pd	868	10	coated	coat	VBD
cord-015365-iqdi99pd	868	11	magnetic	magnetic	JJ
cord-015365-iqdi99pd	868	12	microbeads	microbead	NNS
cord-015365-iqdi99pd	868	13	resulted	result	VBD
cord-015365-iqdi99pd	868	14	in	in	IN
cord-015365-iqdi99pd	868	15	a	a	DT
cord-015365-iqdi99pd	868	16	4	4	CD
cord-015365-iqdi99pd	868	17	log	log	NN
cord-015365-iqdi99pd	868	18	depletion	depletion	NN
cord-015365-iqdi99pd	868	19	of	of	IN
cord-015365-iqdi99pd	868	20	T	t	NN
cord-015365-iqdi99pd	868	21	cells	cell	NNS
cord-015365-iqdi99pd	868	22	and	and	CC
cord-015365-iqdi99pd	868	23	allowed	allow	VBN
cord-015365-iqdi99pd	868	24	to	to	TO
cord-015365-iqdi99pd	868	25	cotransfuse	cotransfuse	VB
cord-015365-iqdi99pd	868	26	high	high	JJ
cord-015365-iqdi99pd	868	27	numbers	number	NNS
cord-015365-iqdi99pd	868	28	of	of	IN
cord-015365-iqdi99pd	868	29	donor	donor	NN
cord-015365-iqdi99pd	868	30	NK	nk	NN
cord-015365-iqdi99pd	868	31	cells	cell	NNS
cord-015365-iqdi99pd	868	32	(	(	-LRB-
cord-015365-iqdi99pd	868	33	median	median	NN
cord-015365-iqdi99pd	868	34	:	:	:
cord-015365-iqdi99pd	868	35	107Â10	107â10	CD
cord-015365-iqdi99pd	868	36	6	6	CD
cord-015365-iqdi99pd	868	37	/kg	/kg	NFP
cord-015365-iqdi99pd	868	38	)	)	-RRB-
cord-015365-iqdi99pd	868	39	.	.	.
cord-015365-iqdi99pd	869	1	TBI	TBI	NNP
cord-015365-iqdi99pd	869	2	or	or	CC
cord-015365-iqdi99pd	869	3	busulfan	busulfan	NNP
cord-015365-iqdi99pd	869	4	based	base	VBN
cord-015365-iqdi99pd	869	5	myeloablative	myeloablative	NNP
cord-015365-iqdi99pd	869	6	regimens	regimens	NNPS
cord-015365-iqdi99pd	869	7	or	or	CC
cord-015365-iqdi99pd	869	8	a	a	DT
cord-015365-iqdi99pd	869	9	melphalan	melphalan	NN
cord-015365-iqdi99pd	869	10	based	base	VBN
cord-015365-iqdi99pd	869	11	intensity	intensity	NN
cord-015365-iqdi99pd	869	12	reduced	reduce	VBN
cord-015365-iqdi99pd	869	13	regimen	regimen	NN
cord-015365-iqdi99pd	869	14	were	be	VBD
cord-015365-iqdi99pd	869	15	used	use	VBN
cord-015365-iqdi99pd	869	16	.	.	.
cord-015365-iqdi99pd	870	1	All	all	DT
cord-015365-iqdi99pd	870	2	patients	patient	NNS
cord-015365-iqdi99pd	870	3	underwent	undergo	VBD
cord-015365-iqdi99pd	870	4	intensive	intensive	JJ
cord-015365-iqdi99pd	870	5	pretreatment	pretreatment	NN
cord-015365-iqdi99pd	870	6	according	accord	VBG
cord-015365-iqdi99pd	870	7	to	to	IN
cord-015365-iqdi99pd	870	8	current	current	JJ
cord-015365-iqdi99pd	870	9	study	study	NN
cord-015365-iqdi99pd	870	10	protocols	protocol	NNS
cord-015365-iqdi99pd	870	11	;	;	:
cord-015365-iqdi99pd	870	12	41/106	41/106	CD
cord-015365-iqdi99pd	870	13	already	already	RB
cord-015365-iqdi99pd	870	14	received	receive	VBN
cord-015365-iqdi99pd	870	15	previous	previous	JJ
cord-015365-iqdi99pd	870	16	allogeneic	allogeneic	NN
cord-015365-iqdi99pd	870	17	transplantations	transplantation	NNS
cord-015365-iqdi99pd	870	18	.	.	.
cord-015365-iqdi99pd	871	1	The	the	DT
cord-015365-iqdi99pd	871	2	diagnoses	diagnosis	NNS
cord-015365-iqdi99pd	871	3	were	be	VBD
cord-015365-iqdi99pd	871	4	:	:	:
cord-015365-iqdi99pd	871	5	acute	acute	JJ
cord-015365-iqdi99pd	871	6	leukemias	leukemia	NNS
cord-015365-iqdi99pd	871	7	and	and	CC
cord-015365-iqdi99pd	871	8	MDS	MDS	NNP
cord-015365-iqdi99pd	871	9	(	(	-LRB-
cord-015365-iqdi99pd	871	10	n	n	NN
cord-015365-iqdi99pd	871	11	¼	¼	NNP
cord-015365-iqdi99pd	871	12	60	60	CD
cord-015365-iqdi99pd	871	13	)	)	-RRB-
cord-015365-iqdi99pd	871	14	,	,	,
cord-015365-iqdi99pd	871	15	solid	solid	JJ
cord-015365-iqdi99pd	871	16	tumors	tumor	NNS
cord-015365-iqdi99pd	871	17	(	(	-LRB-
cord-015365-iqdi99pd	871	18	n	n	CC
cord-015365-iqdi99pd	871	19	¼	¼	NNP
cord-015365-iqdi99pd	871	20	32	32	CD
cord-015365-iqdi99pd	871	21	)	)	-RRB-
cord-015365-iqdi99pd	871	22	and	and	CC
cord-015365-iqdi99pd	871	23	nonmalignant	nonmalignant	NNP
cord-015365-iqdi99pd	871	24	diseases	disease	NNS
cord-015365-iqdi99pd	871	25	(	(	-LRB-
cord-015365-iqdi99pd	871	26	n	n	NN
cord-015365-iqdi99pd	871	27	¼	¼	NNP
cord-015365-iqdi99pd	871	28	14	14	CD
cord-015365-iqdi99pd	871	29	)	)	-RRB-
cord-015365-iqdi99pd	871	30	.	.	.
cord-015365-iqdi99pd	872	1	Results	result	NNS
cord-015365-iqdi99pd	872	2	.	.	.
cord-015365-iqdi99pd	873	1	Primary	primary	JJ
cord-015365-iqdi99pd	873	2	engraftment	engraftment	NN
cord-015365-iqdi99pd	873	3	occurred	occur	VBD
cord-015365-iqdi99pd	873	4	in	in	IN
cord-015365-iqdi99pd	873	5	89	89	CD
cord-015365-iqdi99pd	873	6	%	%	NN
cord-015365-iqdi99pd	873	7	of	of	IN
cord-015365-iqdi99pd	873	8	patients	patient	NNS
cord-015365-iqdi99pd	873	9	.	.	.
cord-015365-iqdi99pd	874	1	After	after	IN
cord-015365-iqdi99pd	874	2	TLI	TLI	NNP
cord-015365-iqdi99pd	874	3	based	base	VBD
cord-015365-iqdi99pd	874	4	reconditioning	reconditioning	NN
cord-015365-iqdi99pd	874	5	and	and	CC
cord-015365-iqdi99pd	874	6	second	second	JJ
cord-015365-iqdi99pd	874	7	haploidentical	haploidentical	JJ
cord-015365-iqdi99pd	874	8	stem	stem	NN
cord-015365-iqdi99pd	874	9	cell	cell	NN
cord-015365-iqdi99pd	874	10	donation	donation	NN
cord-015365-iqdi99pd	874	11	,	,	,
cord-015365-iqdi99pd	874	12	final	final	JJ
cord-015365-iqdi99pd	874	13	engraftment	engraftment	NN
cord-015365-iqdi99pd	874	14	was	be	VBD
cord-015365-iqdi99pd	874	15	achieved	achieve	VBN
cord-015365-iqdi99pd	874	16	in	in	IN
cord-015365-iqdi99pd	874	17	100	100	CD
cord-015365-iqdi99pd	874	18	%	%	NN
cord-015365-iqdi99pd	874	19	.	.	.
cord-015365-iqdi99pd	875	1	Median	median	JJ
cord-015365-iqdi99pd	875	2	time	time	NN
cord-015365-iqdi99pd	875	3	to	to	TO
cord-015365-iqdi99pd	875	4	reach	reach	VB
cord-015365-iqdi99pd	875	5	>	>	XX
cord-015365-iqdi99pd	875	6	500	500	CD
cord-015365-iqdi99pd	875	7	neutrophiles	neutrophile	NNS
cord-015365-iqdi99pd	875	8	/	/	SYM
cord-015365-iqdi99pd	875	9	ml	ml	NN
cord-015365-iqdi99pd	875	10	and	and	CC
cord-015365-iqdi99pd	875	11	independence	independence	NN
cord-015365-iqdi99pd	875	12	from	from	IN
cord-015365-iqdi99pd	875	13	platelet	platelet	NN
cord-015365-iqdi99pd	875	14	substitution	substitution	NN
cord-015365-iqdi99pd	875	15	was	be	VBD
cord-015365-iqdi99pd	875	16	10	10	CD
cord-015365-iqdi99pd	875	17	(	(	-LRB-
cord-015365-iqdi99pd	875	18	8	8	CD
cord-015365-iqdi99pd	875	19	-	-	SYM
cord-015365-iqdi99pd	875	20	15	15	CD
cord-015365-iqdi99pd	875	21	)	)	-RRB-
cord-015365-iqdi99pd	875	22	and	and	CC
cord-015365-iqdi99pd	875	23	9	9	CD
cord-015365-iqdi99pd	875	24	(	(	-LRB-
cord-015365-iqdi99pd	875	25	5	5	CD
cord-015365-iqdi99pd	875	26	-	-	SYM
cord-015365-iqdi99pd	875	27	59	59	CD
cord-015365-iqdi99pd	875	28	)	)	-RRB-
cord-015365-iqdi99pd	875	29	days	day	NNS
cord-015365-iqdi99pd	875	30	respectively	respectively	RB
cord-015365-iqdi99pd	875	31	.	.	.
cord-015365-iqdi99pd	876	1	35	35	CD
cord-015365-iqdi99pd	876	2	%	%	NN
cord-015365-iqdi99pd	876	3	of	of	IN
cord-015365-iqdi99pd	876	4	patients	patient	NNS
cord-015365-iqdi99pd	876	5	had	have	VBD
cord-015365-iqdi99pd	876	6	no	no	DT
cord-015365-iqdi99pd	876	7	GvHD	gvhd	NN
cord-015365-iqdi99pd	876	8	,	,	,
cord-015365-iqdi99pd	876	9	36	36	CD
cord-015365-iqdi99pd	876	10	%	%	NN
cord-015365-iqdi99pd	876	11	had	have	VBD
cord-015365-iqdi99pd	876	12	grade	grade	NN
cord-015365-iqdi99pd	876	13	I	-PRON-	PRP
cord-015365-iqdi99pd	876	14	,	,	,
cord-015365-iqdi99pd	876	15	23	23	CD
cord-015365-iqdi99pd	876	16	%	%	NN
cord-015365-iqdi99pd	876	17	had	have	VBD
cord-015365-iqdi99pd	876	18	grade	grade	NN
cord-015365-iqdi99pd	876	19	II	II	NNP
cord-015365-iqdi99pd	876	20	and	and	CC
cord-015365-iqdi99pd	876	21	4	4	CD
cord-015365-iqdi99pd	876	22	%	%	NN
cord-015365-iqdi99pd	876	23	had	have	VBD
cord-015365-iqdi99pd	876	24	grade	grade	NN
cord-015365-iqdi99pd	876	25	III	III	NNP
cord-015365-iqdi99pd	876	26	.	.	.
cord-015365-iqdi99pd	877	1	Chronic	chronic	NN
cord-015365-iqdi99pd	877	2	limited	limited	JJ
cord-015365-iqdi99pd	877	3	and	and	CC
cord-015365-iqdi99pd	877	4	extensive	extensive	JJ
cord-015365-iqdi99pd	877	5	GvHD	gvhd	NN
cord-015365-iqdi99pd	877	6	was	be	VBD
cord-015365-iqdi99pd	877	7	observed	observe	VBN
cord-015365-iqdi99pd	877	8	in	in	IN
cord-015365-iqdi99pd	877	9	8	8	CD
cord-015365-iqdi99pd	877	10	and	and	CC
cord-015365-iqdi99pd	877	11	11	11	CD
cord-015365-iqdi99pd	877	12	%	%	NN
cord-015365-iqdi99pd	877	13	.	.	.
cord-015365-iqdi99pd	878	1	Transplant	transplant	NN
cord-015365-iqdi99pd	878	2	related	relate	VBN
cord-015365-iqdi99pd	878	3	mortality	mortality	NN
cord-015365-iqdi99pd	878	4	was	be	VBD
cord-015365-iqdi99pd	878	5	0	0	CD
cord-015365-iqdi99pd	878	6	%	%	NN
cord-015365-iqdi99pd	878	7	at	at	IN
cord-015365-iqdi99pd	878	8	day	day	NN
cord-015365-iqdi99pd	878	9	100	100	CD
cord-015365-iqdi99pd	878	10	and	and	CC
cord-015365-iqdi99pd	878	11	8	8	CD
cord-015365-iqdi99pd	878	12	%	%	NN
cord-015365-iqdi99pd	878	13	at	at	IN
cord-015365-iqdi99pd	878	14	one	one	CD
cord-015365-iqdi99pd	878	15	year	year	NN
cord-015365-iqdi99pd	878	16	.	.	.
cord-015365-iqdi99pd	879	1	Event	event	NN
cord-015365-iqdi99pd	879	2	free	free	JJ
cord-015365-iqdi99pd	879	3	survival	survival	NN
cord-015365-iqdi99pd	879	4	at	at	IN
cord-015365-iqdi99pd	879	5	3	3	CD
cord-015365-iqdi99pd	879	6	years	year	NNS
cord-015365-iqdi99pd	879	7	was	be	VBD
cord-015365-iqdi99pd	879	8	66	66	CD
cord-015365-iqdi99pd	879	9	%	%	NN
cord-015365-iqdi99pd	879	10	for	for	IN
cord-015365-iqdi99pd	879	11	patients	patient	NNS
cord-015365-iqdi99pd	879	12	with	with	IN
cord-015365-iqdi99pd	879	13	leukemias	leukemia	NNS
cord-015365-iqdi99pd	879	14	in	in	IN
cord-015365-iqdi99pd	879	15	any	any	DT
cord-015365-iqdi99pd	879	16	CR	cr	NN
cord-015365-iqdi99pd	879	17	and	and	CC
cord-015365-iqdi99pd	879	18	80	80	CD
cord-015365-iqdi99pd	879	19	%	%	NN
cord-015365-iqdi99pd	879	20	for	for	IN
cord-015365-iqdi99pd	879	21	patients	patient	NNS
cord-015365-iqdi99pd	879	22	with	with	IN
cord-015365-iqdi99pd	879	23	nonmalignant	nonmalignant	NNP
cord-015365-iqdi99pd	879	24	diseases	disease	NNS
cord-015365-iqdi99pd	879	25	.	.	.
cord-015365-iqdi99pd	880	1	Over	over	IN
cord-015365-iqdi99pd	880	2	all	all	DT
cord-015365-iqdi99pd	880	3	survival	survival	NN
cord-015365-iqdi99pd	880	4	at	at	IN
cord-015365-iqdi99pd	880	5	2	2	CD
cord-015365-iqdi99pd	880	6	years	year	NNS
cord-015365-iqdi99pd	880	7	was	be	VBD
cord-015365-iqdi99pd	880	8	20	20	CD
cord-015365-iqdi99pd	880	9	%	%	NN
cord-015365-iqdi99pd	880	10	for	for	IN
cord-015365-iqdi99pd	880	11	patients	patient	NNS
cord-015365-iqdi99pd	880	12	with	with	IN
cord-015365-iqdi99pd	880	13	solid	solid	JJ
cord-015365-iqdi99pd	880	14	tumors	tumor	NNS
cord-015365-iqdi99pd	880	15	.	.	.
cord-015365-iqdi99pd	881	1	Relapse	relapse	NN
cord-015365-iqdi99pd	881	2	or	or	CC
cord-015365-iqdi99pd	881	3	progression	progression	NN
cord-015365-iqdi99pd	881	4	were	be	VBD
cord-015365-iqdi99pd	881	5	the	the	DT
cord-015365-iqdi99pd	881	6	major	major	JJ
cord-015365-iqdi99pd	881	7	causes	cause	NNS
cord-015365-iqdi99pd	881	8	of	of	IN
cord-015365-iqdi99pd	881	9	death	death	NN
cord-015365-iqdi99pd	881	10	.	.	.
cord-015365-iqdi99pd	882	1	Thus	thus	RB
cord-015365-iqdi99pd	882	2	,	,	,
cord-015365-iqdi99pd	882	3	pilot	pilot	NN
cord-015365-iqdi99pd	882	4	studies	study	NNS
cord-015365-iqdi99pd	882	5	with	with	IN
cord-015365-iqdi99pd	882	6	IL-15	IL-15	NNP
cord-015365-iqdi99pd	882	7	stimulated	stimulate	VBD
cord-015365-iqdi99pd	882	8	grafts	graft	NNS
cord-015365-iqdi99pd	882	9	and	and	CC
cord-015365-iqdi99pd	882	10	posttransplant	posttransplant	NN
cord-015365-iqdi99pd	882	11	donor	donor	NN
cord-015365-iqdi99pd	882	12	-	-	HYPH
cord-015365-iqdi99pd	882	13	NK	nk	NN
cord-015365-iqdi99pd	882	14	cell	cell	NN
cord-015365-iqdi99pd	882	15	infusions	infusion	NNS
cord-015365-iqdi99pd	882	16	were	be	VBD
cord-015365-iqdi99pd	882	17	initiated	initiate	VBN
cord-015365-iqdi99pd	882	18	and	and	CC
cord-015365-iqdi99pd	882	19	are	be	VBP
cord-015365-iqdi99pd	882	20	currently	currently	RB
cord-015365-iqdi99pd	882	21	ongoing	ongoing	JJ
cord-015365-iqdi99pd	882	22	.	.	.
cord-015365-iqdi99pd	883	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	883	2	.	.	.
cord-015365-iqdi99pd	884	1	Transplantation	transplantation	NN
cord-015365-iqdi99pd	884	2	of	of	IN
cord-015365-iqdi99pd	884	3	CD3/	CD3/	NNP
cord-015365-iqdi99pd	885	1	CD19	CD19	NNP
cord-015365-iqdi99pd	885	2	depleted	deplete	VBD
cord-015365-iqdi99pd	885	3	haploidentical	haploidentical	JJ
cord-015365-iqdi99pd	885	4	stem	stem	NN
cord-015365-iqdi99pd	885	5	cells	cell	NNS
cord-015365-iqdi99pd	885	6	resulted	result	VBD
cord-015365-iqdi99pd	885	7	in	in	IN
cord-015365-iqdi99pd	885	8	a	a	DT
cord-015365-iqdi99pd	885	9	fast	fast	JJ
cord-015365-iqdi99pd	885	10	recovery	recovery	NN
cord-015365-iqdi99pd	885	11	of	of	IN
cord-015365-iqdi99pd	885	12	neutrophiles	neutrophile	NNS
cord-015365-iqdi99pd	885	13	and	and	CC
cord-015365-iqdi99pd	885	14	platelets	platelet	NNS
cord-015365-iqdi99pd	885	15	.	.	.
cord-015365-iqdi99pd	886	1	Engraftment	Engraftment	NNP
cord-015365-iqdi99pd	886	2	rates	rate	NNS
cord-015365-iqdi99pd	886	3	similar	similar	JJ
cord-015365-iqdi99pd	886	4	to	to	IN
cord-015365-iqdi99pd	886	5	that	that	DT
cord-015365-iqdi99pd	886	6	of	of	IN
cord-015365-iqdi99pd	886	7	patients	patient	NNS
cord-015365-iqdi99pd	886	8	with	with	IN
cord-015365-iqdi99pd	886	9	myeloablative	myeloablative	JJ
cord-015365-iqdi99pd	886	10	standard	standard	JJ
cord-015365-iqdi99pd	886	11	conditioning	conditioning	NN
cord-015365-iqdi99pd	886	12	and	and	CC
cord-015365-iqdi99pd	886	13	positive	positive	JJ
cord-015365-iqdi99pd	886	14	selected	select	VBN
cord-015365-iqdi99pd	886	15	stem	stem	NN
cord-015365-iqdi99pd	886	16	cells	cell	NNS
cord-015365-iqdi99pd	886	17	could	could	MD
cord-015365-iqdi99pd	886	18	be	be	VB
cord-015365-iqdi99pd	886	19	achieved	achieve	VBN
cord-015365-iqdi99pd	886	20	,	,	,
cord-015365-iqdi99pd	886	21	possibly	possibly	RB
cord-015365-iqdi99pd	886	22	due	due	IN
cord-015365-iqdi99pd	886	23	to	to	IN
cord-015365-iqdi99pd	886	24	a	a	DT
cord-015365-iqdi99pd	886	25	graft	graft	NN
cord-015365-iqdi99pd	886	26	facilitating	facilitate	VBG
cord-015365-iqdi99pd	886	27	effect	effect	NN
cord-015365-iqdi99pd	886	28	of	of	IN
cord-015365-iqdi99pd	886	29	cotransfused	cotransfuse	VBN
cord-015365-iqdi99pd	886	30	NK	NK	NNP
cord-015365-iqdi99pd	886	31	cells	cell	NNS
cord-015365-iqdi99pd	886	32	.	.	.
cord-015365-iqdi99pd	887	1	The	the	DT
cord-015365-iqdi99pd	887	2	regimen	regimen	NN
cord-015365-iqdi99pd	887	3	helped	help	VBD
cord-015365-iqdi99pd	887	4	to	to	TO
cord-015365-iqdi99pd	887	5	minimize	minimize	VB
cord-015365-iqdi99pd	887	6	TRM	TRM	NNP
cord-015365-iqdi99pd	887	7	,	,	,
cord-015365-iqdi99pd	887	8	despite	despite	IN
cord-015365-iqdi99pd	887	9	intensive	intensive	JJ
cord-015365-iqdi99pd	887	10	pretreatment	pretreatment	NN
cord-015365-iqdi99pd	887	11	(	(	-LRB-
cord-015365-iqdi99pd	887	12	including	include	VBG
cord-015365-iqdi99pd	887	13	previous	previous	JJ
cord-015365-iqdi99pd	887	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	887	15	)	)	-RRB-
cord-015365-iqdi99pd	887	16	.	.	.
cord-015365-iqdi99pd	888	1	However	however	RB
cord-015365-iqdi99pd	888	2	,	,	,
cord-015365-iqdi99pd	888	3	relapse	relapse	NN
cord-015365-iqdi99pd	888	4	remains	remain	VBZ
cord-015365-iqdi99pd	888	5	a	a	DT
cord-015365-iqdi99pd	888	6	major	major	JJ
cord-015365-iqdi99pd	888	7	problem	problem	NN
cord-015365-iqdi99pd	888	8	and	and	CC
cord-015365-iqdi99pd	888	9	further	further	JJ
cord-015365-iqdi99pd	888	10	immunotherapeutic	immunotherapeutic	JJ
cord-015365-iqdi99pd	888	11	elements	element	NNS
cord-015365-iqdi99pd	888	12	have	have	VBP
cord-015365-iqdi99pd	888	13	to	to	TO
cord-015365-iqdi99pd	888	14	be	be	VB
cord-015365-iqdi99pd	888	15	evaluated	evaluate	VBN
cord-015365-iqdi99pd	888	16	.	.	.
cord-015365-iqdi99pd	889	1	Antibody	antibody	NN
cord-015365-iqdi99pd	889	2	based	base	VBN
cord-015365-iqdi99pd	889	3	immunotherapy	immunotherapy	NN
cord-015365-iqdi99pd	889	4	combined	combine	VBN
cord-015365-iqdi99pd	889	5	with	with	IN
cord-015365-iqdi99pd	889	6	haploidentical	haploidentical	JJ
cord-015365-iqdi99pd	889	7	stem	stem	NN
cord-015365-iqdi99pd	889	8	cell	cell	NN
cord-015365-iqdi99pd	889	9	transplantation	transplantation	NN
cord-015365-iqdi99pd	889	10	for	for	IN
cord-015365-iqdi99pd	889	11	high	high	JJ
cord-015365-iqdi99pd	889	12	risk	risk	NN
cord-015365-iqdi99pd	889	13	neuroblastoma	neuroblastoma	NN
cord-015365-iqdi99pd	889	14	Background	Background	NNP
cord-015365-iqdi99pd	889	15	.	.	.
cord-015365-iqdi99pd	890	1	Pediatric	pediatric	JJ
cord-015365-iqdi99pd	890	2	patients	patient	NNS
cord-015365-iqdi99pd	890	3	with	with	IN
cord-015365-iqdi99pd	890	4	relapsed	relapse	VBN
cord-015365-iqdi99pd	890	5	metastatic	metastatic	JJ
cord-015365-iqdi99pd	890	6	neuroblastomas	neuroblastomas	NNP
cord-015365-iqdi99pd	890	7	have	have	VBP
cord-015365-iqdi99pd	890	8	a	a	DT
cord-015365-iqdi99pd	890	9	poor	poor	JJ
cord-015365-iqdi99pd	890	10	prognosis	prognosis	NN
cord-015365-iqdi99pd	890	11	and	and	CC
cord-015365-iqdi99pd	890	12	additional	additional	JJ
cord-015365-iqdi99pd	890	13	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	890	14	strategies	strategy	NNS
cord-015365-iqdi99pd	890	15	are	be	VBP
cord-015365-iqdi99pd	890	16	warranted	warrant	VBN
cord-015365-iqdi99pd	890	17	.	.	.
cord-015365-iqdi99pd	891	1	We	-PRON-	PRP
cord-015365-iqdi99pd	891	2	present	present	VBP
cord-015365-iqdi99pd	891	3	preliminary	preliminary	JJ
cord-015365-iqdi99pd	891	4	results	result	NNS
cord-015365-iqdi99pd	891	5	with	with	IN
cord-015365-iqdi99pd	891	6	haploidentical	haploidentical	JJ
cord-015365-iqdi99pd	891	7	stem	stem	NN
cord-015365-iqdi99pd	891	8	cell	cell	NN
cord-015365-iqdi99pd	891	9	transplantation	transplantation	NN
cord-015365-iqdi99pd	891	10	and	and	CC
cord-015365-iqdi99pd	891	11	posttransplant	posttransplant	NN
cord-015365-iqdi99pd	891	12	immunotherapy	immunotherapy	NN
cord-015365-iqdi99pd	891	13	with	with	IN
cord-015365-iqdi99pd	891	14	an	an	DT
cord-015365-iqdi99pd	891	15	anti	anti	JJ
cord-015365-iqdi99pd	891	16	-	-	JJ
cord-015365-iqdi99pd	891	17	GD2	gd2	JJ
cord-015365-iqdi99pd	891	18	monoclonal	monoclonal	JJ
cord-015365-iqdi99pd	891	19	antibody	antibody	NN
cord-015365-iqdi99pd	891	20	(	(	-LRB-
cord-015365-iqdi99pd	891	21	CH14.18	CH14.18	NNP
cord-015365-iqdi99pd	891	22	CHO	CHO	NNP
cord-015365-iqdi99pd	891	23	)	)	-RRB-
cord-015365-iqdi99pd	891	24	.	.	.
cord-015365-iqdi99pd	892	1	Methods	method	NNS
cord-015365-iqdi99pd	892	2	.	.	.
cord-015365-iqdi99pd	893	1	T	T	NNP
cord-015365-iqdi99pd	893	2	and	and	CC
cord-015365-iqdi99pd	893	3	B	B	NNP
cord-015365-iqdi99pd	893	4	cell	cell	NN
cord-015365-iqdi99pd	893	5	depleted	deplete	VBD
cord-015365-iqdi99pd	893	6	haploidentical	haploidentical	JJ
cord-015365-iqdi99pd	893	7	stem	stem	NN
cord-015365-iqdi99pd	893	8	cells	cell	NNS
cord-015365-iqdi99pd	893	9	in	in	IN
cord-015365-iqdi99pd	893	10	combination	combination	NN
cord-015365-iqdi99pd	893	11	with	with	IN
cord-015365-iqdi99pd	893	12	a	a	DT
cord-015365-iqdi99pd	893	13	toxicity	toxicity	NN
cord-015365-iqdi99pd	893	14	reduced	reduce	VBN
cord-015365-iqdi99pd	893	15	conditioning	conditioning	NN
cord-015365-iqdi99pd	893	16	regime	regime	NN
cord-015365-iqdi99pd	893	17	(	(	-LRB-
cord-015365-iqdi99pd	893	18	melphalan	melphalan	NNP
cord-015365-iqdi99pd	893	19	,	,	,
cord-015365-iqdi99pd	893	20	thiotepa	thiotepa	NNP
cord-015365-iqdi99pd	893	21	,	,	,
cord-015365-iqdi99pd	893	22	fludarabine	fludarabine	NN
cord-015365-iqdi99pd	893	23	and	and	CC
cord-015365-iqdi99pd	893	24	OKT3	OKT3	NNP
cord-015365-iqdi99pd	893	25	,	,	,
cord-015365-iqdi99pd	893	26	now	now	RB
cord-015365-iqdi99pd	893	27	substituted	substitute	VBN
cord-015365-iqdi99pd	893	28	by	by	IN
cord-015365-iqdi99pd	893	29	low	low	JJ
cord-015365-iqdi99pd	893	30	dose	dose	NN
cord-015365-iqdi99pd	893	31	ATG	ATG	NNP
cord-015365-iqdi99pd	893	32	+	+	CC
cord-015365-iqdi99pd	893	33	Fresenius	Fresenius	NNP
cord-015365-iqdi99pd	893	34	)	)	-RRB-
cord-015365-iqdi99pd	893	35	were	be	VBD
cord-015365-iqdi99pd	893	36	used	use	VBN
cord-015365-iqdi99pd	893	37	for	for	IN
cord-015365-iqdi99pd	893	38	transplantation	transplantation	NN
cord-015365-iqdi99pd	893	39	.	.	.
cord-015365-iqdi99pd	894	1	In	in	IN
cord-015365-iqdi99pd	894	2	a	a	DT
cord-015365-iqdi99pd	894	3	subsequent	subsequent	JJ
cord-015365-iqdi99pd	894	4	clinical	clinical	JJ
cord-015365-iqdi99pd	894	5	trial	trial	NN
cord-015365-iqdi99pd	894	6	,	,	,
cord-015365-iqdi99pd	894	7	we	-PRON-	PRP
cord-015365-iqdi99pd	894	8	evaluate	evaluate	VBP
cord-015365-iqdi99pd	894	9	the	the	DT
cord-015365-iqdi99pd	894	10	feasibility	feasibility	NN
cord-015365-iqdi99pd	894	11	and	and	CC
cord-015365-iqdi99pd	894	12	safety	safety	NN
cord-015365-iqdi99pd	894	13	of	of	IN
cord-015365-iqdi99pd	894	14	antibody	antibody	NN
cord-015365-iqdi99pd	894	15	infusions	infusion	NNS
cord-015365-iqdi99pd	894	16	against	against	IN
cord-015365-iqdi99pd	894	17	the	the	DT
cord-015365-iqdi99pd	894	18	neuroblastoma	neuroblastoma	NN
cord-015365-iqdi99pd	894	19	antigen	antigen	NN
cord-015365-iqdi99pd	894	20	GD2	GD2	NNP
cord-015365-iqdi99pd	894	21	:	:	:
cord-015365-iqdi99pd	894	22	6	6	CD
cord-015365-iqdi99pd	894	23	cycles	cycle	NNS
cord-015365-iqdi99pd	894	24	of	of	IN
cord-015365-iqdi99pd	894	25	mAb	mab	NN
cord-015365-iqdi99pd	894	26	CH14.18	CH14.18	NNS
cord-015365-iqdi99pd	894	27	/	/	SYM
cord-015365-iqdi99pd	894	28	CHO	CHO	NNP
cord-015365-iqdi99pd	894	29	(	(	-LRB-
cord-015365-iqdi99pd	894	30	20	20	CD
cord-015365-iqdi99pd	894	31	mg	mg	NNP
cord-015365-iqdi99pd	894	32	/	/	SYM
cord-015365-iqdi99pd	894	33	m	m	NN
cord-015365-iqdi99pd	894	34	2	2	CD
cord-015365-iqdi99pd	894	35	infusion	infusion	NN
cord-015365-iqdi99pd	894	36	for	for	IN
cord-015365-iqdi99pd	894	37	5	5	CD
cord-015365-iqdi99pd	894	38	days	day	NNS
cord-015365-iqdi99pd	894	39	;	;	:
cord-015365-iqdi99pd	894	40	in	in	IN
cord-015365-iqdi99pd	894	41	cycles	cycle	NNS
cord-015365-iqdi99pd	894	42	4	4	CD
cord-015365-iqdi99pd	894	43	-	-	SYM
cord-015365-iqdi99pd	894	44	6	6	CD
cord-015365-iqdi99pd	894	45	,	,	,
cord-015365-iqdi99pd	894	46	1Â10	1â10	CD
cord-015365-iqdi99pd	894	47	6	6	CD
cord-015365-iqdi99pd	894	48	units	unit	NNS
cord-015365-iqdi99pd	894	49	/	/	SYM
cord-015365-iqdi99pd	894	50	m	m	NN
cord-015365-iqdi99pd	894	51	2	2	CD
cord-015365-iqdi99pd	894	52	interleukin	interleukin	NN
cord-015365-iqdi99pd	894	53	2	2	CD
cord-015365-iqdi99pd	894	54	(	(	-LRB-
cord-015365-iqdi99pd	894	55	IL-2	IL-2	NNP
cord-015365-iqdi99pd	894	56	)	)	-RRB-
cord-015365-iqdi99pd	894	57	is	be	VBZ
cord-015365-iqdi99pd	894	58	given	give	VBN
cord-015365-iqdi99pd	894	59	additionally	additionally	RB
cord-015365-iqdi99pd	894	60	on	on	IN
cord-015365-iqdi99pd	894	61	days	day	NNS
cord-015365-iqdi99pd	894	62	6	6	CD
cord-015365-iqdi99pd	894	63	,	,	,
cord-015365-iqdi99pd	894	64	8	8	CD
cord-015365-iqdi99pd	894	65	and	and	CC
cord-015365-iqdi99pd	894	66	10	10	CD
cord-015365-iqdi99pd	894	67	)	)	-RRB-
cord-015365-iqdi99pd	894	68	.	.	.
cord-015365-iqdi99pd	895	1	Results	result	NNS
cord-015365-iqdi99pd	895	2	.	.	.
cord-015365-iqdi99pd	896	1	Haplotransplantation	Haplotransplantation	NNP
cord-015365-iqdi99pd	896	2	without	without	IN
cord-015365-iqdi99pd	896	3	subsequent	subsequent	JJ
cord-015365-iqdi99pd	896	4	antibody	antibody	NN
cord-015365-iqdi99pd	896	5	infusions	infusion	NNS
cord-015365-iqdi99pd	896	6	resulted	result	VBD
cord-015365-iqdi99pd	896	7	in	in	IN
cord-015365-iqdi99pd	896	8	a	a	DT
cord-015365-iqdi99pd	896	9	2-year	2-year	NN
cord-015365-iqdi99pd	896	10	over	over	IN
cord-015365-iqdi99pd	896	11	all	all	DT
cord-015365-iqdi99pd	896	12	survival	survival	NN
cord-015365-iqdi99pd	896	13	of	of	IN
cord-015365-iqdi99pd	896	14	28	28	CD
cord-015365-iqdi99pd	896	15	%	%	NN
cord-015365-iqdi99pd	896	16	.	.	.
cord-015365-iqdi99pd	897	1	TRM	TRM	NNP
cord-015365-iqdi99pd	897	2	at	at	IN
cord-015365-iqdi99pd	897	3	day	day	NN
cord-015365-iqdi99pd	897	4	100	100	CD
cord-015365-iqdi99pd	897	5	was	be	VBD
cord-015365-iqdi99pd	897	6	0	0	CD
cord-015365-iqdi99pd	897	7	%	%	NN
cord-015365-iqdi99pd	897	8	,	,	,
cord-015365-iqdi99pd	897	9	single	single	JJ
cord-015365-iqdi99pd	897	10	cause	cause	NN
cord-015365-iqdi99pd	897	11	of	of	IN
cord-015365-iqdi99pd	897	12	death	death	NN
cord-015365-iqdi99pd	897	13	was	be	VBD
cord-015365-iqdi99pd	897	14	relapse/	relapse/	NN
cord-015365-iqdi99pd	897	15	progression	progression	NN
cord-015365-iqdi99pd	897	16	.	.	.
cord-015365-iqdi99pd	898	1	Thus	thus	RB
cord-015365-iqdi99pd	898	2	,	,	,
cord-015365-iqdi99pd	898	3	transplantation	transplantation	NN
cord-015365-iqdi99pd	898	4	itself	-PRON-	PRP
cord-015365-iqdi99pd	898	5	seems	seem	VBZ
cord-015365-iqdi99pd	898	6	to	to	TO
cord-015365-iqdi99pd	898	7	be	be	VB
cord-015365-iqdi99pd	898	8	not	not	RB
cord-015365-iqdi99pd	898	9	sufficient	sufficient	JJ
cord-015365-iqdi99pd	898	10	for	for	IN
cord-015365-iqdi99pd	898	11	most	most	JJS
cord-015365-iqdi99pd	898	12	patients	patient	NNS
cord-015365-iqdi99pd	898	13	but	but	CC
cord-015365-iqdi99pd	898	14	may	may	MD
cord-015365-iqdi99pd	898	15	be	be	VB
cord-015365-iqdi99pd	898	16	a	a	DT
cord-015365-iqdi99pd	898	17	platform	platform	NN
cord-015365-iqdi99pd	898	18	for	for	IN
cord-015365-iqdi99pd	898	19	further	further	JJ
cord-015365-iqdi99pd	898	20	immunotherapies	immunotherapy	NNS
cord-015365-iqdi99pd	898	21	on	on	IN
cord-015365-iqdi99pd	898	22	the	the	DT
cord-015365-iqdi99pd	898	23	basis	basis	NN
cord-015365-iqdi99pd	898	24	of	of	IN
cord-015365-iqdi99pd	898	25	antibody	antibody	NN
cord-015365-iqdi99pd	898	26	dependent	dependent	JJ
cord-015365-iqdi99pd	898	27	NK	NK	NNP
cord-015365-iqdi99pd	898	28	cell	cell	NN
cord-015365-iqdi99pd	898	29	mediated	mediate	VBN
cord-015365-iqdi99pd	898	30	cytotoxicity	cytotoxicity	NN
cord-015365-iqdi99pd	898	31	and	and	CC
cord-015365-iqdi99pd	898	32	complement	complement	VB
cord-015365-iqdi99pd	898	33	lysis	lysis	NN
cord-015365-iqdi99pd	898	34	.	.	.
cord-015365-iqdi99pd	899	1	12	12	CD
cord-015365-iqdi99pd	899	2	patients	patient	NNS
cord-015365-iqdi99pd	899	3	have	have	VBP
cord-015365-iqdi99pd	899	4	been	be	VBN
cord-015365-iqdi99pd	899	5	enrolled	enrol	VBN
cord-015365-iqdi99pd	899	6	in	in	IN
cord-015365-iqdi99pd	899	7	our	-PRON-	PRP$
cord-015365-iqdi99pd	899	8	CH14.18	CH14.18	NNP
cord-015365-iqdi99pd	899	9	study	study	NN
cord-015365-iqdi99pd	899	10	and	and	CC
cord-015365-iqdi99pd	899	11	received	receive	VBD
cord-015365-iqdi99pd	899	12	a	a	DT
cord-015365-iqdi99pd	899	13	total	total	NN
cord-015365-iqdi99pd	899	14	of	of	IN
cord-015365-iqdi99pd	899	15	42	42	CD
cord-015365-iqdi99pd	899	16	antibody	antibody	NN
cord-015365-iqdi99pd	899	17	cycles	cycle	NNS
cord-015365-iqdi99pd	899	18	.	.	.
cord-015365-iqdi99pd	900	1	Side	side	JJ
cord-015365-iqdi99pd	900	2	effects	effect	NNS
cord-015365-iqdi99pd	900	3	were	be	VBD
cord-015365-iqdi99pd	900	4	:	:	:
cord-015365-iqdi99pd	900	5	inflammation	inflammation	NN
cord-015365-iqdi99pd	900	6	symptoms	symptom	NNS
cord-015365-iqdi99pd	900	7	(	(	-LRB-
cord-015365-iqdi99pd	900	8	pain	pain	NN
cord-015365-iqdi99pd	900	9	42/42	42/42	CD
cord-015365-iqdi99pd	900	10	,	,	,
cord-015365-iqdi99pd	900	11	fever	fever	NN
cord-015365-iqdi99pd	900	12	36/42	36/42	CD
cord-015365-iqdi99pd	900	13	and	and	CC
cord-015365-iqdi99pd	900	14	CRP	CRP	NNP
cord-015365-iqdi99pd	900	15	elevation	elevation	NN
cord-015365-iqdi99pd	900	16	35/42	35/42	CD
cord-015365-iqdi99pd	900	17	cycles	cycle	NNS
cord-015365-iqdi99pd	900	18	)	)	-RRB-
cord-015365-iqdi99pd	900	19	,	,	,
cord-015365-iqdi99pd	900	20	which	which	WDT
cord-015365-iqdi99pd	900	21	decreased	decrease	VBD
cord-015365-iqdi99pd	900	22	or	or	CC
cord-015365-iqdi99pd	900	23	disappeared	disappear	VBD
cord-015365-iqdi99pd	900	24	by	by	IN
cord-015365-iqdi99pd	900	25	increasing	increase	VBG
cord-015365-iqdi99pd	900	26	cycle	cycle	NN
cord-015365-iqdi99pd	900	27	numbers	number	NNS
cord-015365-iqdi99pd	900	28	;	;	:
cord-015365-iqdi99pd	900	29	accommodation	accommodation	NN
cord-015365-iqdi99pd	900	30	disturbance	disturbance	NN
cord-015365-iqdi99pd	900	31	(	(	-LRB-
cord-015365-iqdi99pd	900	32	n	n	NN
cord-015365-iqdi99pd	900	33	¼	¼	NNP
cord-015365-iqdi99pd	900	34	3	3	CD
cord-015365-iqdi99pd	900	35	)	)	-RRB-
cord-015365-iqdi99pd	900	36	,	,	,
cord-015365-iqdi99pd	900	37	seizures	seizure	NNS
cord-015365-iqdi99pd	900	38	(	(	-LRB-
cord-015365-iqdi99pd	900	39	n	n	CC
cord-015365-iqdi99pd	900	40	¼	¼	NNP
cord-015365-iqdi99pd	900	41	2	2	CD
cord-015365-iqdi99pd	900	42	)	)	-RRB-
cord-015365-iqdi99pd	900	43	,	,	,
cord-015365-iqdi99pd	900	44	loss	loss	NN
cord-015365-iqdi99pd	900	45	of	of	IN
cord-015365-iqdi99pd	900	46	weight	weight	NN
cord-015365-iqdi99pd	900	47	(	(	-LRB-
cord-015365-iqdi99pd	900	48	n	n	NN
cord-015365-iqdi99pd	900	49	¼	¼	NNP
cord-015365-iqdi99pd	900	50	2	2	CD
cord-015365-iqdi99pd	900	51	)	)	-RRB-
cord-015365-iqdi99pd	900	52	.	.	.
cord-015365-iqdi99pd	901	1	During	during	IN
cord-015365-iqdi99pd	901	2	antibody	antibody	NN
cord-015365-iqdi99pd	901	3	infusions	infusion	NNS
cord-015365-iqdi99pd	901	4	,	,	,
cord-015365-iqdi99pd	901	5	endogenous	endogenous	JJ
cord-015365-iqdi99pd	901	6	secretion	secretion	NN
cord-015365-iqdi99pd	901	7	of	of	IN
cord-015365-iqdi99pd	901	8	IL-2	il-2	NN
cord-015365-iqdi99pd	901	9	in	in	IN
cord-015365-iqdi99pd	901	10	the	the	DT
cord-015365-iqdi99pd	901	11	patients	patient	NNS
cord-015365-iqdi99pd	901	12	was	be	VBD
cord-015365-iqdi99pd	901	13	significantly	significantly	RB
cord-015365-iqdi99pd	901	14	increased	increase	VBN
cord-015365-iqdi99pd	901	15	(	(	-LRB-
cord-015365-iqdi99pd	901	16	880	880	CD
cord-015365-iqdi99pd	901	17	U/	U/	NNP
cord-015365-iqdi99pd	901	18	ml	ml	XX
cord-015365-iqdi99pd	901	19	prior	prior	RB
cord-015365-iqdi99pd	901	20	vs.	vs.	NN
cord-015365-iqdi99pd	901	21	1580	1580	CD
cord-015365-iqdi99pd	901	22	U	U	NNP
cord-015365-iqdi99pd	901	23	/	/	SYM
cord-015365-iqdi99pd	901	24	ml	ml	NN
cord-015365-iqdi99pd	901	25	post	post	NN
cord-015365-iqdi99pd	901	26	)	)	-RRB-
cord-015365-iqdi99pd	901	27	,	,	,
cord-015365-iqdi99pd	901	28	which	which	WDT
cord-015365-iqdi99pd	901	29	resulted	result	VBD
cord-015365-iqdi99pd	901	30	in	in	IN
cord-015365-iqdi99pd	901	31	an	an	DT
cord-015365-iqdi99pd	901	32	also	also	RB
cord-015365-iqdi99pd	901	33	significantly	significantly	RB
cord-015365-iqdi99pd	901	34	increased	increase	VBN
cord-015365-iqdi99pd	901	35	stimulation	stimulation	NN
cord-015365-iqdi99pd	901	36	of	of	IN
cord-015365-iqdi99pd	901	37	natural	natural	JJ
cord-015365-iqdi99pd	901	38	killer	killer	NN
cord-015365-iqdi99pd	901	39	(	(	-LRB-
cord-015365-iqdi99pd	901	40	NK	NK	NNP
cord-015365-iqdi99pd	901	41	)	)	-RRB-
cord-015365-iqdi99pd	901	42	cells	cell	NNS
cord-015365-iqdi99pd	901	43	in	in	IN
cord-015365-iqdi99pd	901	44	peripheral	peripheral	JJ
cord-015365-iqdi99pd	901	45	blood	blood	NN
cord-015365-iqdi99pd	901	46	(	(	-LRB-
cord-015365-iqdi99pd	901	47	measured	measure	VBN
cord-015365-iqdi99pd	901	48	by	by	IN
cord-015365-iqdi99pd	901	49	CD69	CD69	NNP
cord-015365-iqdi99pd	901	50	expression	expression	NN
cord-015365-iqdi99pd	901	51	)	)	-RRB-
cord-015365-iqdi99pd	901	52	.	.	.
cord-015365-iqdi99pd	902	1	Predominantly	predominantly	RB
cord-015365-iqdi99pd	902	2	ADCC	ADCC	NNP
cord-015365-iqdi99pd	902	3	exerting	exert	VBG
cord-015365-iqdi99pd	902	4	NK	NK	NNP
cord-015365-iqdi99pd	902	5	cells	cell	NNS
cord-015365-iqdi99pd	902	6	(	(	-LRB-
cord-015365-iqdi99pd	902	7	with	with	IN
cord-015365-iqdi99pd	902	8	expression	expression	NN
cord-015365-iqdi99pd	902	9	of	of	IN
cord-015365-iqdi99pd	902	10	the	the	DT
cord-015365-iqdi99pd	902	11	Fc	Fc	NNP
cord-015365-iqdi99pd	902	12	-	-	HYPH
cord-015365-iqdi99pd	902	13	gamma	gamma	NN
cord-015365-iqdi99pd	902	14	receptor	receptor	NN
cord-015365-iqdi99pd	902	15	CD16	CD16	NNP
cord-015365-iqdi99pd	902	16	)	)	-RRB-
cord-015365-iqdi99pd	902	17	were	be	VBD
cord-015365-iqdi99pd	902	18	stimulated	stimulate	VBN
cord-015365-iqdi99pd	902	19	.	.	.
cord-015365-iqdi99pd	903	1	In	in	IN
cord-015365-iqdi99pd	903	2	3	3	CD
cord-015365-iqdi99pd	903	3	out	out	IN
cord-015365-iqdi99pd	903	4	of	of	IN
cord-015365-iqdi99pd	903	5	5	5	CD
cord-015365-iqdi99pd	903	6	investigated	investigate	VBN
cord-015365-iqdi99pd	903	7	patients	patient	NNS
cord-015365-iqdi99pd	903	8	,	,	,
cord-015365-iqdi99pd	903	9	NK	NK	NNP
cord-015365-iqdi99pd	903	10	cell	cell	NN
cord-015365-iqdi99pd	903	11	and	and	CC
cord-015365-iqdi99pd	903	12	complement	complement	NN
cord-015365-iqdi99pd	903	13	mediated	mediate	VBN
cord-015365-iqdi99pd	903	14	anti	anti	JJ
cord-015365-iqdi99pd	903	15	-	-	JJ
cord-015365-iqdi99pd	903	16	tumor	tumor	JJ
cord-015365-iqdi99pd	903	17	effects	effect	NNS
cord-015365-iqdi99pd	903	18	against	against	IN
cord-015365-iqdi99pd	903	19	neuroblastoma	neuroblastoma	NN
cord-015365-iqdi99pd	903	20	cells	cell	NNS
cord-015365-iqdi99pd	903	21	were	be	VBD
cord-015365-iqdi99pd	903	22	detectable	detectable	JJ
cord-015365-iqdi99pd	903	23	.	.	.
cord-015365-iqdi99pd	904	1	5	5	CD
cord-015365-iqdi99pd	904	2	patients	patient	NNS
cord-015365-iqdi99pd	904	3	finished	finish	VBD
cord-015365-iqdi99pd	904	4	the	the	DT
cord-015365-iqdi99pd	904	5	protocol	protocol	NN
cord-015365-iqdi99pd	904	6	so	so	RB
cord-015365-iqdi99pd	904	7	far	far	RB
cord-015365-iqdi99pd	904	8	and	and	CC
cord-015365-iqdi99pd	904	9	were	be	VBD
cord-015365-iqdi99pd	904	10	evaluable	evaluable	JJ
cord-015365-iqdi99pd	904	11	after	after	IN
cord-015365-iqdi99pd	904	12	6	6	CD
cord-015365-iqdi99pd	904	13	cycles	cycle	NNS
cord-015365-iqdi99pd	904	14	.	.	.
cord-015365-iqdi99pd	905	1	3/5	3/5	CD
cord-015365-iqdi99pd	905	2	patients	patient	NNS
cord-015365-iqdi99pd	905	3	responded	respond	VBD
cord-015365-iqdi99pd	905	4	and	and	CC
cord-015365-iqdi99pd	905	5	reached	reach	VBD
cord-015365-iqdi99pd	905	6	a	a	DT
cord-015365-iqdi99pd	905	7	complete	complete	JJ
cord-015365-iqdi99pd	905	8	remission	remission	NN
cord-015365-iqdi99pd	905	9	or	or	CC
cord-015365-iqdi99pd	905	10	improved	improve	VBD
cord-015365-iqdi99pd	905	11	their	-PRON-	PRP$
cord-015365-iqdi99pd	905	12	partial	partial	JJ
cord-015365-iqdi99pd	905	13	remission	remission	NN
cord-015365-iqdi99pd	905	14	,	,	,
cord-015365-iqdi99pd	905	15	2	2	CD
cord-015365-iqdi99pd	905	16	patients	patient	NNS
cord-015365-iqdi99pd	905	17	progressed	progress	VBD
cord-015365-iqdi99pd	905	18	.	.	.
cord-015365-iqdi99pd	906	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	906	2	.	.	.
cord-015365-iqdi99pd	907	1	Preliminary	preliminary	JJ
cord-015365-iqdi99pd	907	2	results	result	NNS
cord-015365-iqdi99pd	907	3	of	of	IN
cord-015365-iqdi99pd	907	4	our	-PRON-	PRP$
cord-015365-iqdi99pd	907	5	ongoing	ongoing	JJ
cord-015365-iqdi99pd	907	6	study	study	NN
cord-015365-iqdi99pd	907	7	suggest	suggest	VBP
cord-015365-iqdi99pd	907	8	an	an	DT
cord-015365-iqdi99pd	907	9	anti	anti	JJ
cord-015365-iqdi99pd	907	10	-	-	JJ
cord-015365-iqdi99pd	907	11	tumor	tumor	JJ
cord-015365-iqdi99pd	907	12	effect	effect	NN
cord-015365-iqdi99pd	907	13	of	of	IN
cord-015365-iqdi99pd	907	14	the	the	DT
cord-015365-iqdi99pd	907	15	donor	donor	NN
cord-015365-iqdi99pd	907	16	derived	derive	VBN
cord-015365-iqdi99pd	907	17	immune	immune	JJ
cord-015365-iqdi99pd	907	18	system	system	NN
cord-015365-iqdi99pd	907	19	in	in	IN
cord-015365-iqdi99pd	907	20	vitro	vitro	FW
cord-015365-iqdi99pd	907	21	and	and	CC
cord-015365-iqdi99pd	907	22	in	in	IN
cord-015365-iqdi99pd	907	23	vivo	vivo	NNP
cord-015365-iqdi99pd	907	24	.	.	.
cord-015365-iqdi99pd	908	1	SCT	SCT	NNP
cord-015365-iqdi99pd	908	2	from	from	IN
cord-015365-iqdi99pd	908	3	a	a	DT
cord-015365-iqdi99pd	908	4	matched	match	VBN
cord-015365-iqdi99pd	908	5	sibling	sibling	NN
cord-015365-iqdi99pd	908	6	donor	donor	NN
cord-015365-iqdi99pd	908	7	(	(	-LRB-
cord-015365-iqdi99pd	908	8	MSD	MSD	NNP
cord-015365-iqdi99pd	908	9	)	)	-RRB-
cord-015365-iqdi99pd	908	10	is	be	VBZ
cord-015365-iqdi99pd	908	11	the	the	DT
cord-015365-iqdi99pd	908	12	treatment	treatment	NN
cord-015365-iqdi99pd	908	13	of	of	IN
cord-015365-iqdi99pd	908	14	choice	choice	NN
cord-015365-iqdi99pd	908	15	for	for	IN
cord-015365-iqdi99pd	908	16	children	child	NNS
cord-015365-iqdi99pd	908	17	with	with	IN
cord-015365-iqdi99pd	908	18	SAA	SAA	NNP
cord-015365-iqdi99pd	908	19	,	,	,
cord-015365-iqdi99pd	908	20	however	however	RB
cord-015365-iqdi99pd	908	21	limited	limit	VBN
cord-015365-iqdi99pd	908	22	by	by	IN
cord-015365-iqdi99pd	908	23	donor	donor	NN
cord-015365-iqdi99pd	908	24	availability	availability	NN
cord-015365-iqdi99pd	908	25	.	.	.
cord-015365-iqdi99pd	909	1	Immunosuppression	Immunosuppression	NNP
cord-015365-iqdi99pd	909	2	(	(	-LRB-
cord-015365-iqdi99pd	909	3	IS	be	VBZ
cord-015365-iqdi99pd	909	4	)	)	-RRB-
cord-015365-iqdi99pd	909	5	as	as	IN
cord-015365-iqdi99pd	909	6	the	the	DT
cord-015365-iqdi99pd	909	7	other	other	JJ
cord-015365-iqdi99pd	909	8	option	option	NN
cord-015365-iqdi99pd	909	9	has	have	VBZ
cord-015365-iqdi99pd	909	10	the	the	DT
cord-015365-iqdi99pd	909	11	disadvantage	disadvantage	NN
cord-015365-iqdi99pd	909	12	of	of	IN
cord-015365-iqdi99pd	909	13	high	high	JJ
cord-015365-iqdi99pd	909	14	treatment	treatment	NN
cord-015365-iqdi99pd	909	15	failures	failure	NNS
cord-015365-iqdi99pd	909	16	.	.	.
cord-015365-iqdi99pd	910	1	7	7	CD
cord-015365-iqdi99pd	910	2	patients	patient	NNS
cord-015365-iqdi99pd	910	3	with	with	IN
cord-015365-iqdi99pd	910	4	SAA	SAA	NNP
cord-015365-iqdi99pd	910	5	without	without	IN
cord-015365-iqdi99pd	910	6	a	a	DT
cord-015365-iqdi99pd	910	7	MSD	msd	NN
cord-015365-iqdi99pd	910	8	and	and	CC
cord-015365-iqdi99pd	910	9	refractory	refractory	JJ
cord-015365-iqdi99pd	910	10	to	to	IN
cord-015365-iqdi99pd	910	11	previous	previous	JJ
cord-015365-iqdi99pd	910	12	IS	is	NN
cord-015365-iqdi99pd	910	13	,	,	,
cord-015365-iqdi99pd	910	14	median	median	JJ
cord-015365-iqdi99pd	910	15	age	age	NN
cord-015365-iqdi99pd	910	16	11	11	CD
cord-015365-iqdi99pd	910	17	years	year	NNS
cord-015365-iqdi99pd	910	18	(	(	-LRB-
cord-015365-iqdi99pd	910	19	5	5	CD
cord-015365-iqdi99pd	910	20	-	-	SYM
cord-015365-iqdi99pd	910	21	16	16	CD
cord-015365-iqdi99pd	910	22	)	)	-RRB-
cord-015365-iqdi99pd	910	23	,	,	,
cord-015365-iqdi99pd	910	24	median	median	JJ
cord-015365-iqdi99pd	910	25	interval	interval	NN
cord-015365-iqdi99pd	910	26	from	from	IN
cord-015365-iqdi99pd	910	27	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	910	28	to	to	IN
cord-015365-iqdi99pd	910	29	SCT	SCT	NNP
cord-015365-iqdi99pd	910	30	12	12	CD
cord-015365-iqdi99pd	910	31	months	month	NNS
cord-015365-iqdi99pd	910	32	(	(	-LRB-
cord-015365-iqdi99pd	910	33	3	3	CD
cord-015365-iqdi99pd	910	34	-	-	SYM
cord-015365-iqdi99pd	910	35	155	155	CD
cord-015365-iqdi99pd	910	36	)	)	-RRB-
cord-015365-iqdi99pd	910	37	and	and	CC
cord-015365-iqdi99pd	910	38	median	median	JJ
cord-015365-iqdi99pd	910	39	number	number	NN
cord-015365-iqdi99pd	910	40	of	of	IN
cord-015365-iqdi99pd	910	41	transfusions	transfusion	NNS
cord-015365-iqdi99pd	910	42	before	before	IN
cord-015365-iqdi99pd	910	43	SCT	SCT	NNP
cord-015365-iqdi99pd	910	44	55	55	CD
cord-015365-iqdi99pd	910	45	(	(	-LRB-
cord-015365-iqdi99pd	910	46	18	18	CD
cord-015365-iqdi99pd	910	47	-	-	SYM
cord-015365-iqdi99pd	910	48	116	116	CD
cord-015365-iqdi99pd	910	49	)	)	-RRB-
cord-015365-iqdi99pd	910	50	underwent	undergo	VBD
cord-015365-iqdi99pd	910	51	alternative	alternative	JJ
cord-015365-iqdi99pd	910	52	donor	donor	NN
cord-015365-iqdi99pd	910	53	SCT	SCT	NNP
cord-015365-iqdi99pd	910	54	.	.	.
cord-015365-iqdi99pd	911	1	Donors	donor	NNS
cord-015365-iqdi99pd	911	2	were	be	VBD
cord-015365-iqdi99pd	911	3	matched	match	VBN
cord-015365-iqdi99pd	911	4	unrelated	unrelated	JJ
cord-015365-iqdi99pd	911	5	(	(	-LRB-
cord-015365-iqdi99pd	911	6	MUD	mud	NN
cord-015365-iqdi99pd	911	7	)	)	-RRB-
cord-015365-iqdi99pd	911	8	(	(	-LRB-
cord-015365-iqdi99pd	911	9	n	n	CC
cord-015365-iqdi99pd	911	10	¼	¼	NNP
cord-015365-iqdi99pd	911	11	4	4	CD
cord-015365-iqdi99pd	911	12	)	)	-RRB-
cord-015365-iqdi99pd	911	13	,	,	.
cord-015365-iqdi99pd	912	1	mismatched	mismatched	JJ
cord-015365-iqdi99pd	912	2	unrelated	unrelated	JJ
cord-015365-iqdi99pd	912	3	(	(	-LRB-
cord-015365-iqdi99pd	912	4	n	n	CC
cord-015365-iqdi99pd	912	5	¼	¼	NNP
cord-015365-iqdi99pd	912	6	2	2	CD
cord-015365-iqdi99pd	912	7	)	)	-RRB-
cord-015365-iqdi99pd	912	8	and	and	CC
cord-015365-iqdi99pd	912	9	haploidentical	haploidentical	NNP
cord-015365-iqdi99pd	912	10	(	(	-LRB-
cord-015365-iqdi99pd	912	11	n	n	NNP
cord-015365-iqdi99pd	912	12	¼	¼	NNP
cord-015365-iqdi99pd	912	13	1	1	CD
cord-015365-iqdi99pd	912	14	)	)	-RRB-
cord-015365-iqdi99pd	912	15	.	.	.
cord-015365-iqdi99pd	913	1	Conditioning	conditioning	NN
cord-015365-iqdi99pd	913	2	regimens	regimen	NNS
cord-015365-iqdi99pd	913	3	contained	contain	VBD
cord-015365-iqdi99pd	913	4	cyclophosphamide	cyclophosphamide	NN
cord-015365-iqdi99pd	913	5	and	and	CC
cord-015365-iqdi99pd	913	6	either	either	CC
cord-015365-iqdi99pd	913	7	muromonab	muromonab	NN
cord-015365-iqdi99pd	913	8	-	-	HYPH
cord-015365-iqdi99pd	913	9	CD3	CD3	NNP
cord-015365-iqdi99pd	913	10	or	or	CC
cord-015365-iqdi99pd	913	11	anti	anti	JJ
cord-015365-iqdi99pd	913	12	-	-	JJ
cord-015365-iqdi99pd	913	13	thymocyte	thymocyte	JJ
cord-015365-iqdi99pd	913	14	globulin	globulin	NN
cord-015365-iqdi99pd	913	15	(	(	-LRB-
cord-015365-iqdi99pd	913	16	ATG	ATG	NNP
cord-015365-iqdi99pd	913	17	)	)	-RRB-
cord-015365-iqdi99pd	913	18	in	in	IN
cord-015365-iqdi99pd	913	19	7/7	7/7	CD
cord-015365-iqdi99pd	913	20	,	,	,
cord-015365-iqdi99pd	913	21	thiotepa	thiotepa	JJ
cord-015365-iqdi99pd	913	22	(	(	-LRB-
cord-015365-iqdi99pd	913	23	THT	THT	NNP
cord-015365-iqdi99pd	913	24	)	)	-RRB-
cord-015365-iqdi99pd	913	25	in	in	IN
cord-015365-iqdi99pd	913	26	6/7	6/7	CD
cord-015365-iqdi99pd	913	27	,	,	,
cord-015365-iqdi99pd	913	28	fludarabine	fludarabine	NNP
cord-015365-iqdi99pd	913	29	(	(	-LRB-
cord-015365-iqdi99pd	913	30	FLU	flu	NN
cord-015365-iqdi99pd	913	31	)	)	-RRB-
cord-015365-iqdi99pd	913	32	in	in	IN
cord-015365-iqdi99pd	913	33	5/7	5/7	CD
cord-015365-iqdi99pd	913	34	and	and	CC
cord-015365-iqdi99pd	913	35	total	total	JJ
cord-015365-iqdi99pd	913	36	lymphoid	lymphoid	JJ
cord-015365-iqdi99pd	913	37	irradiation	irradiation	NN
cord-015365-iqdi99pd	913	38	in	in	IN
cord-015365-iqdi99pd	913	39	2/7	2/7	CD
cord-015365-iqdi99pd	913	40	patients	patient	NNS
cord-015365-iqdi99pd	913	41	.	.	.
cord-015365-iqdi99pd	914	1	Grafts	graft	NNS
cord-015365-iqdi99pd	914	2	were	be	VBD
cord-015365-iqdi99pd	915	1	either	either	CC
cord-015365-iqdi99pd	915	2	CD34þ	CD34þ	NNP
cord-015365-iqdi99pd	915	3	selected	select	VBD
cord-015365-iqdi99pd	915	4	and/or	and/or	CC
cord-015365-iqdi99pd	915	5	CD3/19	cd3/19	NN
cord-015365-iqdi99pd	915	6	depleted	deplete	VBD
cord-015365-iqdi99pd	915	7	using	use	VBG
cord-015365-iqdi99pd	915	8	the	the	DT
cord-015365-iqdi99pd	915	9	Miltenyi	Miltenyi	NNP
cord-015365-iqdi99pd	915	10	CliniMACS	CliniMACS	NNP
cord-015365-iqdi99pd	915	11	device	device	NN
cord-015365-iqdi99pd	915	12	.	.	.
cord-015365-iqdi99pd	916	1	Median	median	JJ
cord-015365-iqdi99pd	916	2	yield	yield	NN
cord-015365-iqdi99pd	916	3	of	of	IN
cord-015365-iqdi99pd	916	4	purified	purify	VBN
cord-015365-iqdi99pd	916	5	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	916	6	cells	cell	NNS
cord-015365-iqdi99pd	916	7	was	be	VBD
cord-015365-iqdi99pd	916	8	10.17Â10	10.17â10	CD
cord-015365-iqdi99pd	916	9	6	6	CD
cord-015365-iqdi99pd	917	1	/kg	/kg	NFP
cord-015365-iqdi99pd	917	2	(	(	-LRB-
cord-015365-iqdi99pd	917	3	7.85	7.85	CD
cord-015365-iqdi99pd	917	4	-	-	SYM
cord-015365-iqdi99pd	917	5	24.3	24.3	CD
cord-015365-iqdi99pd	917	6	)	)	-RRB-
cord-015365-iqdi99pd	917	7	and	and	CC
cord-015365-iqdi99pd	917	8	median	median	JJ
cord-015365-iqdi99pd	917	9	CD3þ	CD3þ	NNP
cord-015365-iqdi99pd	917	10	number	number	NN
cord-015365-iqdi99pd	917	11	was	be	VBD
cord-015365-iqdi99pd	917	12	5.5Â10	5.5â10	CD
cord-015365-iqdi99pd	917	13	4	4	CD
cord-015365-iqdi99pd	917	14	/kg	/kg	.
cord-015365-iqdi99pd	917	15	(	(	-LRB-
cord-015365-iqdi99pd	917	16	0.84	0.84	CD
cord-015365-iqdi99pd	917	17	-	-	SYM
cord-015365-iqdi99pd	917	18	10	10	CD
cord-015365-iqdi99pd	917	19	)	)	-RRB-
cord-015365-iqdi99pd	917	20	.	.	.
cord-015365-iqdi99pd	918	1	All	all	DT
cord-015365-iqdi99pd	918	2	patients	patient	NNS
cord-015365-iqdi99pd	918	3	had	have	VBD
cord-015365-iqdi99pd	918	4	WBC	WBC	NNP
cord-015365-iqdi99pd	918	5	-	-	HYPH
cord-015365-iqdi99pd	918	6	engraftment	engraftment	NNP
cord-015365-iqdi99pd	918	7	on	on	IN
cord-015365-iqdi99pd	918	8	median	median	JJ
cord-015365-iqdi99pd	918	9	day	day	NN
cord-015365-iqdi99pd	918	10	10	10	CD
cord-015365-iqdi99pd	918	11	(	(	-LRB-
cord-015365-iqdi99pd	918	12	8	8	CD
cord-015365-iqdi99pd	918	13	-	-	SYM
cord-015365-iqdi99pd	918	14	12	12	CD
cord-015365-iqdi99pd	918	15	)	)	-RRB-
cord-015365-iqdi99pd	918	16	.	.	.
cord-015365-iqdi99pd	919	1	There	there	EX
cord-015365-iqdi99pd	919	2	was	be	VBD
cord-015365-iqdi99pd	919	3	no	no	DT
cord-015365-iqdi99pd	919	4	GVHD	GVHD	NNP
cord-015365-iqdi99pd	919	5	prophylaxis	prophylaxis	NN
cord-015365-iqdi99pd	919	6	in	in	IN
cord-015365-iqdi99pd	919	7	2	2	CD
cord-015365-iqdi99pd	919	8	patients	patient	NNS
cord-015365-iqdi99pd	919	9	and	and	CC
cord-015365-iqdi99pd	919	10	either	either	CC
cord-015365-iqdi99pd	919	11	cyclosporine	cyclosporine	NN
cord-015365-iqdi99pd	919	12	-	-	HYPH
cord-015365-iqdi99pd	919	13	A	a	NN
cord-015365-iqdi99pd	919	14	or	or	CC
cord-015365-iqdi99pd	919	15	mycophenolate	mycophenolate	NNP
cord-015365-iqdi99pd	919	16	mofetil	mofetil	NNP
cord-015365-iqdi99pd	919	17	up	up	IN
cord-015365-iqdi99pd	919	18	to	to	IN
cord-015365-iqdi99pd	919	19	day	day	NN
cord-015365-iqdi99pd	919	20	þ	þ	CD
cord-015365-iqdi99pd	919	21	60	60	CD
cord-015365-iqdi99pd	919	22	in	in	IN
cord-015365-iqdi99pd	919	23	5	5	CD
cord-015365-iqdi99pd	919	24	patients	patient	NNS
cord-015365-iqdi99pd	919	25	.	.	.
cord-015365-iqdi99pd	920	1	1	1	LS
cord-015365-iqdi99pd	920	2	MUD	MUD	NNP
cord-015365-iqdi99pd	920	3	-	-	HYPH
cord-015365-iqdi99pd	920	4	HSCT	HSCT	NNP
cord-015365-iqdi99pd	920	5	recipient	recipient	NN
cord-015365-iqdi99pd	920	6	who	who	WP
cord-015365-iqdi99pd	920	7	had	have	VBD
cord-015365-iqdi99pd	920	8	6	6	CD
cord-015365-iqdi99pd	920	9	IS	be	VBZ
cord-015365-iqdi99pd	920	10	courses	course	NNS
cord-015365-iqdi99pd	920	11	and	and	CC
cord-015365-iqdi99pd	920	12	the	the	DT
cord-015365-iqdi99pd	920	13	longest	long	JJS
cord-015365-iqdi99pd	920	14	interval	interval	NN
cord-015365-iqdi99pd	920	15	to	to	IN
cord-015365-iqdi99pd	920	16	HSCT	HSCT	NNP
cord-015365-iqdi99pd	920	17	(	(	-LRB-
cord-015365-iqdi99pd	920	18	13	13	CD
cord-015365-iqdi99pd	920	19	yrs	yr	NNS
cord-015365-iqdi99pd	920	20	)	)	-RRB-
cord-015365-iqdi99pd	920	21	and	and	CC
cord-015365-iqdi99pd	920	22	who	who	WP
cord-015365-iqdi99pd	920	23	received	receive	VBD
cord-015365-iqdi99pd	920	24	the	the	DT
cord-015365-iqdi99pd	920	25	highest	high	JJS
cord-015365-iqdi99pd	920	26	CD	cd	NN
cord-015365-iqdi99pd	920	27	3þ	3þ	NNS
cord-015365-iqdi99pd	920	28	dose	dose	NN
cord-015365-iqdi99pd	920	29	(	(	-LRB-
cord-015365-iqdi99pd	920	30	10Â10	10â10	CD
cord-015365-iqdi99pd	920	31	4	4	CD
cord-015365-iqdi99pd	920	32	/kg	/kg	NFP
cord-015365-iqdi99pd	920	33	)	)	-RRB-
cord-015365-iqdi99pd	920	34	developed	develop	VBD
cord-015365-iqdi99pd	920	35	GVHD	GVHD	NNP
cord-015365-iqdi99pd	920	36	(	(	-LRB-
cord-015365-iqdi99pd	920	37	grade	grade	NN
cord-015365-iqdi99pd	920	38	II	II	NNP
cord-015365-iqdi99pd	920	39	)	)	-RRB-
cord-015365-iqdi99pd	920	40	on	on	IN
cord-015365-iqdi99pd	920	41	day	day	NN
cord-015365-iqdi99pd	921	1	þ	þ	LS
cord-015365-iqdi99pd	921	2	125	125	CD
cord-015365-iqdi99pd	921	3	with	with	IN
cord-015365-iqdi99pd	921	4	progressive	progressive	JJ
cord-015365-iqdi99pd	921	5	kidney	kidney	NN
cord-015365-iqdi99pd	921	6	failure	failure	NN
cord-015365-iqdi99pd	921	7	due	due	JJ
cord-015365-iqdi99pd	921	8	to	to	IN
cord-015365-iqdi99pd	921	9	microangiopathic	microangiopathic	JJ
cord-015365-iqdi99pd	921	10	hemolytic	hemolytic	JJ
cord-015365-iqdi99pd	921	11	anemia	anemia	NN
cord-015365-iqdi99pd	921	12	.	.	.
cord-015365-iqdi99pd	922	1	All	all	DT
cord-015365-iqdi99pd	922	2	children	child	NNS
cord-015365-iqdi99pd	922	3	are	be	VBP
cord-015365-iqdi99pd	922	4	alive	alive	JJ
cord-015365-iqdi99pd	922	5	with	with	IN
cord-015365-iqdi99pd	922	6	a	a	DT
cord-015365-iqdi99pd	922	7	median	median	NN
cord-015365-iqdi99pd	922	8	follow	follow	NN
cord-015365-iqdi99pd	922	9	up	up	IN
cord-015365-iqdi99pd	922	10	of	of	IN
cord-015365-iqdi99pd	922	11	20	20	CD
cord-015365-iqdi99pd	922	12	months	month	NNS
cord-015365-iqdi99pd	922	13	(	(	-LRB-
cord-015365-iqdi99pd	922	14	8	8	CD
cord-015365-iqdi99pd	922	15	-	-	SYM
cord-015365-iqdi99pd	922	16	149	149	CD
cord-015365-iqdi99pd	922	17	)	)	-RRB-
cord-015365-iqdi99pd	922	18	with	with	IN
cord-015365-iqdi99pd	922	19	stable	stable	JJ
cord-015365-iqdi99pd	922	20	complete	complete	JJ
cord-015365-iqdi99pd	922	21	engraftment	engraftment	NN
cord-015365-iqdi99pd	922	22	and	and	CC
cord-015365-iqdi99pd	922	23	stable	stable	JJ
cord-015365-iqdi99pd	922	24	chimerism	chimerism	NN
cord-015365-iqdi99pd	922	25	of	of	IN
cord-015365-iqdi99pd	922	26	median	median	NN
cord-015365-iqdi99pd	922	27	98.5	98.5	CD
cord-015365-iqdi99pd	922	28	%	%	NN
cord-015365-iqdi99pd	922	29	(	(	-LRB-
cord-015365-iqdi99pd	922	30	90.65	90.65	CD
cord-015365-iqdi99pd	922	31	-	-	SYM
cord-015365-iqdi99pd	922	32	100	100	CD
cord-015365-iqdi99pd	922	33	)	)	-RRB-
cord-015365-iqdi99pd	922	34	.	.	.
cord-015365-iqdi99pd	923	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	923	2	.	.	.
cord-015365-iqdi99pd	924	1	Long	long	JJ
cord-015365-iqdi99pd	924	2	interval	interval	NN
cord-015365-iqdi99pd	924	3	to	to	IN
cord-015365-iqdi99pd	924	4	transplant	transplant	NN
cord-015365-iqdi99pd	924	5	,	,	,
cord-015365-iqdi99pd	924	6	multiple	multiple	JJ
cord-015365-iqdi99pd	924	7	transfusions	transfusion	NNS
cord-015365-iqdi99pd	924	8	and	and	CC
cord-015365-iqdi99pd	924	9	long	long	JJ
cord-015365-iqdi99pd	924	10	term	term	NN
cord-015365-iqdi99pd	924	11	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	924	12	before	before	IN
cord-015365-iqdi99pd	924	13	SCT	SCT	NNP
cord-015365-iqdi99pd	924	14	are	be	VBP
cord-015365-iqdi99pd	924	15	associated	associate	VBN
cord-015365-iqdi99pd	924	16	with	with	IN
cord-015365-iqdi99pd	924	17	poor	poor	JJ
cord-015365-iqdi99pd	924	18	alternative	alternative	JJ
cord-015365-iqdi99pd	924	19	donor	donor	NN
cord-015365-iqdi99pd	924	20	SCT	SCT	NNP
cord-015365-iqdi99pd	924	21	-	-	:
cord-015365-iqdi99pd	924	22	outcomes	outcome	NNS
cord-015365-iqdi99pd	924	23	in	in	IN
cord-015365-iqdi99pd	924	24	SAA	SAA	NNP
cord-015365-iqdi99pd	924	25	.	.	.
cord-015365-iqdi99pd	925	1	Cyclophosphamide	cyclophosphamide	NN
cord-015365-iqdi99pd	925	2	conditioning	conditioning	NN
cord-015365-iqdi99pd	925	3	including	include	VBG
cord-015365-iqdi99pd	925	4	FLU	flu	NN
cord-015365-iqdi99pd	925	5	,	,	,
cord-015365-iqdi99pd	925	6	THT	THT	NNP
cord-015365-iqdi99pd	925	7	and	and	CC
cord-015365-iqdi99pd	925	8	ATG	ATG	NNP
cord-015365-iqdi99pd	925	9	but	but	CC
cord-015365-iqdi99pd	925	10	without	without	IN
cord-015365-iqdi99pd	925	11	TLI	TLI	NNP
cord-015365-iqdi99pd	925	12	,	,	,
cord-015365-iqdi99pd	925	13	high	high	JJ
cord-015365-iqdi99pd	925	14	doses	dose	NNS
cord-015365-iqdi99pd	925	15	of	of	IN
cord-015365-iqdi99pd	925	16	purified	purify	VBN
cord-015365-iqdi99pd	925	17	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	925	18	cells	cell	NNS
cord-015365-iqdi99pd	925	19	and/or	and/or	CC
cord-015365-iqdi99pd	925	20	CD3/19	cd3/19	NN
cord-015365-iqdi99pd	925	21	depletion	depletion	NN
cord-015365-iqdi99pd	925	22	may	may	MD
cord-015365-iqdi99pd	925	23	prevent	prevent	VB
cord-015365-iqdi99pd	925	24	graft	graft	NN
cord-015365-iqdi99pd	925	25	rejection	rejection	NN
cord-015365-iqdi99pd	925	26	and	and	CC
cord-015365-iqdi99pd	925	27	GVHD	GVHD	NNP
cord-015365-iqdi99pd	925	28	and	and	CC
cord-015365-iqdi99pd	925	29	hasten	hasten	VB
cord-015365-iqdi99pd	925	30	engraftment	engraftment	NN
cord-015365-iqdi99pd	925	31	.	.	.
cord-015365-iqdi99pd	926	1	This	this	DT
cord-015365-iqdi99pd	926	2	may	may	MD
cord-015365-iqdi99pd	926	3	facilitate	facilitate	VB
cord-015365-iqdi99pd	926	4	the	the	DT
cord-015365-iqdi99pd	926	5	decision	decision	NN
cord-015365-iqdi99pd	926	6	for	for	IN
cord-015365-iqdi99pd	926	7	the	the	DT
cord-015365-iqdi99pd	926	8	earlier	early	JJR
cord-015365-iqdi99pd	926	9	use	use	NN
cord-015365-iqdi99pd	926	10	of	of	IN
cord-015365-iqdi99pd	926	11	unrelated	unrelated	JJ
cord-015365-iqdi99pd	926	12	stem	stem	NN
cord-015365-iqdi99pd	926	13	cells	cell	NNS
cord-015365-iqdi99pd	926	14	preventing	prevent	VBG
cord-015365-iqdi99pd	926	15	complications	complication	NNS
cord-015365-iqdi99pd	926	16	from	from	IN
cord-015365-iqdi99pd	926	17	prolonged	prolonged	JJ
cord-015365-iqdi99pd	926	18	and	and	CC
cord-015365-iqdi99pd	926	19	multiple	multiple	JJ
cord-015365-iqdi99pd	926	20	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	926	21	therapies	therapy	NNS
cord-015365-iqdi99pd	926	22	and	and	CC
cord-015365-iqdi99pd	926	23	presumably	presumably	RB
cord-015365-iqdi99pd	926	24	increasing	increase	VBG
cord-015365-iqdi99pd	926	25	the	the	DT
cord-015365-iqdi99pd	926	26	survival	survival	NN
cord-015365-iqdi99pd	926	27	of	of	IN
cord-015365-iqdi99pd	926	28	patients	patient	NNS
cord-015365-iqdi99pd	926	29	with	with	IN
cord-015365-iqdi99pd	926	30	SAA	SAA	NNP
cord-015365-iqdi99pd	926	31	without	without	IN
cord-015365-iqdi99pd	926	32	a	a	DT
cord-015365-iqdi99pd	926	33	matched	match	VBN
cord-015365-iqdi99pd	926	34	sibling	sibling	NN
cord-015365-iqdi99pd	926	35	donor	donor	NN
cord-015365-iqdi99pd	926	36	.	.	.
cord-015365-iqdi99pd	927	1	Extracorporeal	extracorporeal	JJ
cord-015365-iqdi99pd	927	2	photopheresis	photopheresis	NN
cord-015365-iqdi99pd	927	3	in	in	IN
cord-015365-iqdi99pd	927	4	patients	patient	NNS
cord-015365-iqdi99pd	927	5	with	with	IN
cord-015365-iqdi99pd	927	6	high	high	JJ
cord-015365-iqdi99pd	927	7	bleeding	bleeding	NN
cord-015365-iqdi99pd	927	8	risks	risk	NNS
cord-015365-iqdi99pd	927	9	Background	background	NN
cord-015365-iqdi99pd	927	10	.	.	.
cord-015365-iqdi99pd	928	1	For	for	IN
cord-015365-iqdi99pd	928	2	anticoagulation	anticoagulation	NN
cord-015365-iqdi99pd	928	3	in	in	IN
cord-015365-iqdi99pd	928	4	extracorporeal	extracorporeal	JJ
cord-015365-iqdi99pd	928	5	photopheresis	photopheresis	NN
cord-015365-iqdi99pd	928	6	(	(	-LRB-
cord-015365-iqdi99pd	928	7	ECP	ECP	NNP
cord-015365-iqdi99pd	928	8	)	)	-RRB-
cord-015365-iqdi99pd	928	9	to	to	TO
cord-015365-iqdi99pd	928	10	prevent	prevent	VB
cord-015365-iqdi99pd	928	11	clotting	clotting	NN
cord-015365-iqdi99pd	928	12	in	in	IN
cord-015365-iqdi99pd	928	13	the	the	DT
cord-015365-iqdi99pd	928	14	extracorporeal	extracorporeal	JJ
cord-015365-iqdi99pd	928	15	circuit	circuit	NN
cord-015365-iqdi99pd	928	16	,	,	,
cord-015365-iqdi99pd	928	17	the	the	DT
cord-015365-iqdi99pd	928	18	manufacturer	manufacturer	NN
cord-015365-iqdi99pd	928	19	's	's	POS
cord-015365-iqdi99pd	928	20	recommendation	recommendation	NN
cord-015365-iqdi99pd	928	21	is	be	VBZ
cord-015365-iqdi99pd	928	22	the	the	DT
cord-015365-iqdi99pd	928	23	use	use	NN
cord-015365-iqdi99pd	928	24	of	of	IN
cord-015365-iqdi99pd	928	25	heparin	heparin	NN
cord-015365-iqdi99pd	928	26	(	(	-LRB-
cord-015365-iqdi99pd	928	27	normally	normally	RB
cord-015365-iqdi99pd	928	28	10,000	10,000	CD
cord-015365-iqdi99pd	928	29	Units	unit	NNS
cord-015365-iqdi99pd	928	30	)	)	-RRB-
cord-015365-iqdi99pd	928	31	.	.	.
cord-015365-iqdi99pd	929	1	However	however	RB
cord-015365-iqdi99pd	929	2	,	,	,
cord-015365-iqdi99pd	929	3	patients	patient	NNS
cord-015365-iqdi99pd	929	4	with	with	IN
cord-015365-iqdi99pd	929	5	acute	acute	JJ
cord-015365-iqdi99pd	929	6	graft	graft	NN
cord-015365-iqdi99pd	929	7	-	-	HYPH
cord-015365-iqdi99pd	929	8	versushost	versushost	NN
cord-015365-iqdi99pd	929	9	disease	disease	NN
cord-015365-iqdi99pd	929	10	(	(	-LRB-
cord-015365-iqdi99pd	929	11	aGvHD	agvhd	NN
cord-015365-iqdi99pd	929	12	)	)	-RRB-
cord-015365-iqdi99pd	929	13	after	after	IN
cord-015365-iqdi99pd	929	14	allogeneic	allogeneic	JJ
cord-015365-iqdi99pd	929	15	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	929	16	stem	stem	NN
cord-015365-iqdi99pd	929	17	cell	cell	NN
cord-015365-iqdi99pd	929	18	transplantation	transplantation	NN
cord-015365-iqdi99pd	929	19	are	be	VBP
cord-015365-iqdi99pd	929	20	at	at	IN
cord-015365-iqdi99pd	929	21	high	high	JJ
cord-015365-iqdi99pd	929	22	risk	risk	NN
cord-015365-iqdi99pd	929	23	for	for	IN
cord-015365-iqdi99pd	929	24	bleeding	bleed	VBG
cord-015365-iqdi99pd	929	25	complications	complication	NNS
cord-015365-iqdi99pd	929	26	due	due	JJ
cord-015365-iqdi99pd	929	27	to	to	IN
cord-015365-iqdi99pd	929	28	low	low	JJ
cord-015365-iqdi99pd	929	29	platelet	platelet	NN
cord-015365-iqdi99pd	929	30	counts	count	NNS
cord-015365-iqdi99pd	929	31	,	,	,
cord-015365-iqdi99pd	929	32	intestinal	intestinal	JJ
cord-015365-iqdi99pd	929	33	lesions	lesion	NNS
cord-015365-iqdi99pd	929	34	from	from	IN
cord-015365-iqdi99pd	929	35	aGvHD	agvhd	NN
cord-015365-iqdi99pd	929	36	or	or	CC
cord-015365-iqdi99pd	929	37	impaired	impair	VBN
cord-015365-iqdi99pd	929	38	hepatic	hepatic	JJ
cord-015365-iqdi99pd	929	39	function	function	NN
cord-015365-iqdi99pd	929	40	.	.	.
cord-015365-iqdi99pd	930	1	For	for	IN
cord-015365-iqdi99pd	930	2	these	these	DT
cord-015365-iqdi99pd	930	3	patients	patient	NNS
cord-015365-iqdi99pd	930	4	,	,	,
cord-015365-iqdi99pd	930	5	alternative	alternative	JJ
cord-015365-iqdi99pd	930	6	anticoagulation	anticoagulation	NN
cord-015365-iqdi99pd	930	7	using	use	VBG
cord-015365-iqdi99pd	930	8	acid	acid	NN
cord-015365-iqdi99pd	930	9	citrate	citrate	NN
cord-015365-iqdi99pd	930	10	dextrose	dextrose	NN
cord-015365-iqdi99pd	930	11	(	(	-LRB-
cord-015365-iqdi99pd	930	12	ACD	ACD	NNP
cord-015365-iqdi99pd	930	13	-	-	HYPH
cord-015365-iqdi99pd	930	14	A	a	NN
cord-015365-iqdi99pd	930	15	)	)	-RRB-
cord-015365-iqdi99pd	930	16	has	have	VBZ
cord-015365-iqdi99pd	930	17	been	be	VBN
cord-015365-iqdi99pd	930	18	infrequently	infrequently	RB
cord-015365-iqdi99pd	930	19	used	use	VBN
cord-015365-iqdi99pd	930	20	in	in	IN
cord-015365-iqdi99pd	930	21	small	small	JJ
cord-015365-iqdi99pd	930	22	patient	patient	JJ
cord-015365-iqdi99pd	930	23	cohorts	cohort	NNS
cord-015365-iqdi99pd	930	24	.	.	.
cord-015365-iqdi99pd	931	1	Methods	method	NNS
cord-015365-iqdi99pd	931	2	.	.	.
cord-015365-iqdi99pd	932	1	We	-PRON-	PRP
cord-015365-iqdi99pd	932	2	investigated	investigate	VBD
cord-015365-iqdi99pd	932	3	the	the	DT
cord-015365-iqdi99pd	932	4	safety	safety	NN
cord-015365-iqdi99pd	932	5	and	and	CC
cord-015365-iqdi99pd	932	6	efficacy	efficacy	NN
cord-015365-iqdi99pd	932	7	of	of	IN
cord-015365-iqdi99pd	932	8	this	this	DT
cord-015365-iqdi99pd	932	9	approach	approach	NN
cord-015365-iqdi99pd	932	10	in	in	IN
cord-015365-iqdi99pd	932	11	94	94	CD
cord-015365-iqdi99pd	932	12	consecutive	consecutive	JJ
cord-015365-iqdi99pd	932	13	patients	patient	NNS
cord-015365-iqdi99pd	932	14	(	(	-LRB-
cord-015365-iqdi99pd	932	15	43	43	CD
cord-015365-iqdi99pd	932	16	male	male	NN
cord-015365-iqdi99pd	932	17	,	,	,
cord-015365-iqdi99pd	932	18	51	51	CD
cord-015365-iqdi99pd	932	19	female	female	NN
cord-015365-iqdi99pd	932	20	)	)	-RRB-
cord-015365-iqdi99pd	932	21	with	with	IN
cord-015365-iqdi99pd	932	22	aGvHD	agvhd	NN
cord-015365-iqdi99pd	932	23	(	(	-LRB-
cord-015365-iqdi99pd	932	24	45	45	CD
cord-015365-iqdi99pd	932	25	%	%	NN
cord-015365-iqdi99pd	932	26	with	with	IN
cord-015365-iqdi99pd	932	27	gut	gut	NN
cord-015365-iqdi99pd	932	28	GvHD	GvHD	NNP
cord-015365-iqdi99pd	932	29	)	)	-RRB-
cord-015365-iqdi99pd	932	30	undergoing	undergo	VBG
cord-015365-iqdi99pd	932	31	ECP	ECP	NNP
cord-015365-iqdi99pd	932	32	with	with	IN
cord-015365-iqdi99pd	932	33	ACD	ACD	NNP
cord-015365-iqdi99pd	932	34	-	-	HYPH
cord-015365-iqdi99pd	932	35	A	a	DT
cord-015365-iqdi99pd	932	36	anticoagulation	anticoagulation	NN
cord-015365-iqdi99pd	932	37	at	at	IN
cord-015365-iqdi99pd	932	38	a	a	DT
cord-015365-iqdi99pd	932	39	single	single	JJ
cord-015365-iqdi99pd	932	40	institution	institution	NN
cord-015365-iqdi99pd	932	41	2	2	CD
cord-015365-iqdi99pd	932	42	to	to	TO
cord-015365-iqdi99pd	932	43	3	3	CD
cord-015365-iqdi99pd	932	44	times	time	NNS
cord-015365-iqdi99pd	932	45	per	per	IN
cord-015365-iqdi99pd	932	46	week	week	NN
cord-015365-iqdi99pd	932	47	on	on	IN
cord-015365-iqdi99pd	932	48	a	a	DT
cord-015365-iqdi99pd	932	49	weekly	weekly	JJ
cord-015365-iqdi99pd	932	50	basis	basis	NN
cord-015365-iqdi99pd	932	51	until	until	IN
cord-015365-iqdi99pd	932	52	complete	complete	JJ
cord-015365-iqdi99pd	932	53	resolution	resolution	NN
cord-015365-iqdi99pd	932	54	of	of	IN
cord-015365-iqdi99pd	932	55	aGvHD	agvhd	NN
cord-015365-iqdi99pd	932	56	.	.	.
cord-015365-iqdi99pd	933	1	A	a	DT
cord-015365-iqdi99pd	933	2	total	total	NN
cord-015365-iqdi99pd	933	3	of	of	IN
cord-015365-iqdi99pd	933	4	1242	1242	CD
cord-015365-iqdi99pd	933	5	ECP	ECP	NNP
cord-015365-iqdi99pd	933	6	procedures	procedure	NNS
cord-015365-iqdi99pd	933	7	were	be	VBD
cord-015365-iqdi99pd	933	8	analyzed	analyze	VBN
cord-015365-iqdi99pd	933	9	with	with	IN
cord-015365-iqdi99pd	933	10	respect	respect	NN
cord-015365-iqdi99pd	933	11	to	to	IN
cord-015365-iqdi99pd	933	12	side	side	JJ
cord-015365-iqdi99pd	933	13	effects	effect	NNS
cord-015365-iqdi99pd	933	14	and	and	CC
cord-015365-iqdi99pd	933	15	changes	change	NNS
cord-015365-iqdi99pd	933	16	in	in	IN
cord-015365-iqdi99pd	933	17	haemoglobin	haemoglobin	NN
cord-015365-iqdi99pd	933	18	and	and	CC
cord-015365-iqdi99pd	933	19	platelet	platelet	NN
cord-015365-iqdi99pd	933	20	levels	level	NNS
cord-015365-iqdi99pd	933	21	.	.	.
cord-015365-iqdi99pd	934	1	Moreover	moreover	RB
cord-015365-iqdi99pd	934	2	,	,	,
cord-015365-iqdi99pd	934	3	in	in	IN
cord-015365-iqdi99pd	934	4	a	a	DT
cord-015365-iqdi99pd	934	5	proportion	proportion	NN
cord-015365-iqdi99pd	934	6	of	of	IN
cord-015365-iqdi99pd	934	7	ECP	ECP	NNP
cord-015365-iqdi99pd	934	8	treatments	treatment	NNS
cord-015365-iqdi99pd	934	9	activated	activate	VBD
cord-015365-iqdi99pd	934	10	partial	partial	JJ
cord-015365-iqdi99pd	934	11	thromboplastin	thromboplastin	NNP
cord-015365-iqdi99pd	934	12	time	time	NN
cord-015365-iqdi99pd	934	13	(	(	-LRB-
cord-015365-iqdi99pd	934	14	aPTT	aptt	NN
cord-015365-iqdi99pd	934	15	)	)	-RRB-
cord-015365-iqdi99pd	934	16	was	be	VBD
cord-015365-iqdi99pd	934	17	monitored	monitor	VBN
cord-015365-iqdi99pd	934	18	.	.	.
cord-015365-iqdi99pd	935	1	Priming	prime	VBG
cord-015365-iqdi99pd	935	2	of	of	IN
cord-015365-iqdi99pd	935	3	the	the	DT
cord-015365-iqdi99pd	935	4	separator	separator	NN
cord-015365-iqdi99pd	935	5	was	be	VBD
cord-015365-iqdi99pd	935	6	performed	perform	VBN
cord-015365-iqdi99pd	935	7	with	with	IN
cord-015365-iqdi99pd	935	8	1,000	1,000	CD
cord-015365-iqdi99pd	935	9	Units	unit	NNS
cord-015365-iqdi99pd	935	10	of	of	IN
cord-015365-iqdi99pd	935	11	heparin	heparin	NN
cord-015365-iqdi99pd	935	12	followed	follow	VBN
cord-015365-iqdi99pd	935	13	by	by	IN
cord-015365-iqdi99pd	935	14	anticoagulation	anticoagulation	NN
cord-015365-iqdi99pd	935	15	with	with	IN
cord-015365-iqdi99pd	935	16	ACD	ACD	NNP
cord-015365-iqdi99pd	935	17	-	-	HYPH
cord-015365-iqdi99pd	935	18	A	a	NN
cord-015365-iqdi99pd	935	19	at	at	IN
cord-015365-iqdi99pd	935	20	a	a	DT
cord-015365-iqdi99pd	935	21	ratio	ratio	NN
cord-015365-iqdi99pd	935	22	of	of	IN
cord-015365-iqdi99pd	935	23	1:10	1:10	CD
cord-015365-iqdi99pd	935	24	during	during	IN
cord-015365-iqdi99pd	935	25	the	the	DT
cord-015365-iqdi99pd	935	26	procedure	procedure	NN
cord-015365-iqdi99pd	935	27	.	.	.
cord-015365-iqdi99pd	936	1	Results	result	NNS
cord-015365-iqdi99pd	936	2	.	.	.
cord-015365-iqdi99pd	937	1	ECP	ECP	NNP
cord-015365-iqdi99pd	937	2	was	be	VBD
cord-015365-iqdi99pd	937	3	tolerated	tolerate	VBN
cord-015365-iqdi99pd	937	4	well	well	RB
cord-015365-iqdi99pd	937	5	by	by	IN
cord-015365-iqdi99pd	937	6	all	all	DT
cord-015365-iqdi99pd	937	7	patients	patient	NNS
cord-015365-iqdi99pd	937	8	.	.	.
cord-015365-iqdi99pd	938	1	In	in	IN
cord-015365-iqdi99pd	938	2	only	only	RB
cord-015365-iqdi99pd	938	3	0.2	0.2	CD
cord-015365-iqdi99pd	938	4	%	%	NN
cord-015365-iqdi99pd	938	5	of	of	IN
cord-015365-iqdi99pd	938	6	procedures	procedure	NNS
cord-015365-iqdi99pd	938	7	mild	mild	JJ
cord-015365-iqdi99pd	938	8	citrate	citrate	NN
cord-015365-iqdi99pd	938	9	reactions	reaction	NNS
cord-015365-iqdi99pd	938	10	seen	see	VBN
cord-015365-iqdi99pd	938	11	as	as	IN
cord-015365-iqdi99pd	938	12	transient	transient	JJ
cord-015365-iqdi99pd	938	13	paresthesias	paresthesia	NNS
cord-015365-iqdi99pd	938	14	were	be	VBD
cord-015365-iqdi99pd	938	15	observed	observe	VBN
cord-015365-iqdi99pd	938	16	but	but	CC
cord-015365-iqdi99pd	938	17	resolved	resolve	VBN
cord-015365-iqdi99pd	938	18	without	without	IN
cord-015365-iqdi99pd	938	19	the	the	DT
cord-015365-iqdi99pd	938	20	need	need	NN
cord-015365-iqdi99pd	938	21	for	for	IN
cord-015365-iqdi99pd	938	22	calcium	calcium	NN
cord-015365-iqdi99pd	938	23	substitution	substitution	NN
cord-015365-iqdi99pd	938	24	.	.	.
cord-015365-iqdi99pd	939	1	In	in	IN
cord-015365-iqdi99pd	939	2	no	no	DT
cord-015365-iqdi99pd	939	3	case	case	NN
cord-015365-iqdi99pd	939	4	bleeding	bleed	VBG
cord-015365-iqdi99pd	939	5	complications	complication	NNS
cord-015365-iqdi99pd	939	6	were	be	VBD
cord-015365-iqdi99pd	939	7	noted	note	VBN
cord-015365-iqdi99pd	939	8	during	during	IN
cord-015365-iqdi99pd	939	9	or	or	CC
cord-015365-iqdi99pd	939	10	after	after	IN
cord-015365-iqdi99pd	939	11	citrate	citrate	NN
cord-015365-iqdi99pd	939	12	anticoagulation	anticoagulation	NN
cord-015365-iqdi99pd	939	13	.	.	.
cord-015365-iqdi99pd	940	1	During	during	IN
cord-015365-iqdi99pd	940	2	ECP	ECP	NNP
cord-015365-iqdi99pd	940	3	,	,	,
cord-015365-iqdi99pd	940	4	aPTT	aptt	CD
cord-015365-iqdi99pd	940	5	levels	level	NNS
cord-015365-iqdi99pd	940	6	increased	increase	VBD
cord-015365-iqdi99pd	940	7	marginally	marginally	RB
cord-015365-iqdi99pd	940	8	from	from	IN
cord-015365-iqdi99pd	940	9	a	a	DT
cord-015365-iqdi99pd	940	10	median	median	NN
cord-015365-iqdi99pd	940	11	of	of	IN
cord-015365-iqdi99pd	940	12	32.1	32.1	CD
cord-015365-iqdi99pd	940	13	sec	sec	NNP
cord-015365-iqdi99pd	940	14	.	.	.
cord-015365-iqdi99pd	941	1	(	(	-LRB-
cord-015365-iqdi99pd	941	2	range	range	NN
cord-015365-iqdi99pd	941	3	,	,	,
cord-015365-iqdi99pd	941	4	25.3	25.3	CD
cord-015365-iqdi99pd	941	5	to	to	IN
cord-015365-iqdi99pd	941	6	44.5	44.5	CD
cord-015365-iqdi99pd	941	7	sec	sec	NNP
cord-015365-iqdi99pd	941	8	)	)	-RRB-
cord-015365-iqdi99pd	941	9	before	before	IN
cord-015365-iqdi99pd	941	10	to	to	IN
cord-015365-iqdi99pd	941	11	a	a	DT
cord-015365-iqdi99pd	941	12	medium	medium	NN
cord-015365-iqdi99pd	941	13	of	of	IN
cord-015365-iqdi99pd	941	14	35.4	35.4	CD
cord-015365-iqdi99pd	941	15	sec	sec	NNP
cord-015365-iqdi99pd	941	16	.	.	.
cord-015365-iqdi99pd	942	1	(	(	-LRB-
cord-015365-iqdi99pd	942	2	range	range	NN
cord-015365-iqdi99pd	942	3	,	,	,
cord-015365-iqdi99pd	942	4	25.4	25.4	CD
cord-015365-iqdi99pd	942	5	to	to	IN
cord-015365-iqdi99pd	942	6	54.7	54.7	CD
cord-015365-iqdi99pd	942	7	sec	sec	NNP
cord-015365-iqdi99pd	942	8	.	.	.
cord-015365-iqdi99pd	942	9	)	)	-RRB-
cord-015365-iqdi99pd	943	1	after	after	IN
cord-015365-iqdi99pd	943	2	ECP	ECP	NNP
cord-015365-iqdi99pd	943	3	,	,	,
cord-015365-iqdi99pd	943	4	respectively	respectively	RB
cord-015365-iqdi99pd	943	5	.	.	.
cord-015365-iqdi99pd	944	1	At	at	IN
cord-015365-iqdi99pd	944	2	start	start	NN
cord-015365-iqdi99pd	944	3	of	of	IN
cord-015365-iqdi99pd	944	4	ECP	ECP	NNP
cord-015365-iqdi99pd	944	5	51	51	CD
cord-015365-iqdi99pd	944	6	%	%	NN
cord-015365-iqdi99pd	944	7	of	of	IN
cord-015365-iqdi99pd	944	8	patients	patient	NNS
cord-015365-iqdi99pd	944	9	had	have	VBD
cord-015365-iqdi99pd	944	10	platelet	platelet	NN
cord-015365-iqdi99pd	944	11	counts	count	NNS
cord-015365-iqdi99pd	945	1	<	<	XX
cord-015365-iqdi99pd	945	2	100	100	CD
cord-015365-iqdi99pd	945	3	G	G	NNP
cord-015365-iqdi99pd	945	4	/	/	SYM
cord-015365-iqdi99pd	945	5	l	l	NN
cord-015365-iqdi99pd	945	6	and	and	CC
cord-015365-iqdi99pd	945	7	26	26	CD
cord-015365-iqdi99pd	945	8	%	%	NN
cord-015365-iqdi99pd	945	9	<	<	XX
cord-015365-iqdi99pd	945	10	50	50	CD
cord-015365-iqdi99pd	945	11	G	g	NN
cord-015365-iqdi99pd	945	12	/	/	SYM
cord-015365-iqdi99pd	945	13	L	l	NN
cord-015365-iqdi99pd	945	14	,	,	,
cord-015365-iqdi99pd	945	15	respectively	respectively	RB
cord-015365-iqdi99pd	945	16	.	.	.
cord-015365-iqdi99pd	946	1	Haemoglobin	haemoglobin	NN
cord-015365-iqdi99pd	946	2	and	and	CC
cord-015365-iqdi99pd	946	3	platelet	platelet	NN
cord-015365-iqdi99pd	946	4	counts	count	NNS
cord-015365-iqdi99pd	946	5	decreased	decrease	VBD
cord-015365-iqdi99pd	946	6	by	by	IN
cord-015365-iqdi99pd	946	7	11	11	CD
cord-015365-iqdi99pd	946	8	%	%	NN
cord-015365-iqdi99pd	946	9	and	and	CC
cord-015365-iqdi99pd	946	10	14	14	CD
cord-015365-iqdi99pd	946	11	%	%	NN
cord-015365-iqdi99pd	946	12	,	,	,
cord-015365-iqdi99pd	946	13	respectively	respectively	RB
cord-015365-iqdi99pd	946	14	.	.	.
cord-015365-iqdi99pd	947	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	947	2	.	.	.
cord-015365-iqdi99pd	948	1	In	in	IN
cord-015365-iqdi99pd	948	2	conclusion	conclusion	NN
cord-015365-iqdi99pd	948	3	,	,	,
cord-015365-iqdi99pd	948	4	citrate	citrate	NN
cord-015365-iqdi99pd	948	5	anticoagulation	anticoagulation	NN
cord-015365-iqdi99pd	948	6	during	during	IN
cord-015365-iqdi99pd	948	7	ECP	ECP	NNP
cord-015365-iqdi99pd	948	8	is	be	VBZ
cord-015365-iqdi99pd	948	9	a	a	DT
cord-015365-iqdi99pd	948	10	feasible	feasible	JJ
cord-015365-iqdi99pd	948	11	and	and	CC
cord-015365-iqdi99pd	948	12	safe	safe	JJ
cord-015365-iqdi99pd	948	13	alternative	alternative	NN
cord-015365-iqdi99pd	948	14	for	for	IN
cord-015365-iqdi99pd	948	15	patients	patient	NNS
cord-015365-iqdi99pd	948	16	with	with	IN
cord-015365-iqdi99pd	948	17	high	high	JJ
cord-015365-iqdi99pd	948	18	risk	risk	NN
cord-015365-iqdi99pd	948	19	for	for	IN
cord-015365-iqdi99pd	948	20	bleeding	bleed	VBG
cord-015365-iqdi99pd	948	21	complications	complication	NNS
cord-015365-iqdi99pd	948	22	,	,	,
cord-015365-iqdi99pd	948	23	especially	especially	RB
cord-015365-iqdi99pd	948	24	for	for	IN
cord-015365-iqdi99pd	948	25	those	those	DT
cord-015365-iqdi99pd	948	26	after	after	IN
cord-015365-iqdi99pd	948	27	allogeneic	allogeneic	JJ
cord-015365-iqdi99pd	948	28	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	948	29	stem	stem	NN
cord-015365-iqdi99pd	948	30	cell	cell	NN
cord-015365-iqdi99pd	948	31	transplantation	transplantation	NN
cord-015365-iqdi99pd	948	32	.	.	.
cord-015365-iqdi99pd	949	1	Allogeneic	allogeneic	IN
cord-015365-iqdi99pd	949	2	stem	stem	VBP
cord-015365-iqdi99pd	949	3	cell	cell	NN
cord-015365-iqdi99pd	949	4	transplantation	transplantation	NN
cord-015365-iqdi99pd	949	5	with	with	IN
cord-015365-iqdi99pd	949	6	reduced	reduce	VBN
cord-015365-iqdi99pd	949	7	intensity	intensity	NN
cord-015365-iqdi99pd	949	8	conditioning	conditioning	NN
cord-015365-iqdi99pd	949	9	in	in	IN
cord-015365-iqdi99pd	949	10	patients	patient	NNS
cord-015365-iqdi99pd	949	11	with	with	IN
cord-015365-iqdi99pd	949	12	therapy	therapy	NN
cord-015365-iqdi99pd	949	13	-	-	HYPH
cord-015365-iqdi99pd	949	14	related	relate	VBN
cord-015365-iqdi99pd	949	15	myeloid	myeloid	JJ
cord-015365-iqdi99pd	949	16	neoplasms	neoplasm	NNS
cord-015365-iqdi99pd	949	17	Background	Background	NNP
cord-015365-iqdi99pd	949	18	.	.	.
cord-015365-iqdi99pd	950	1	Therapy	therapy	NN
cord-015365-iqdi99pd	950	2	-	-	HYPH
cord-015365-iqdi99pd	950	3	related	relate	VBN
cord-015365-iqdi99pd	950	4	myeloid	myeloid	JJ
cord-015365-iqdi99pd	950	5	neoplasms	neoplasm	NNS
cord-015365-iqdi99pd	950	6	(	(	-LRB-
cord-015365-iqdi99pd	950	7	t	t	NNP
cord-015365-iqdi99pd	950	8	-	-	HYPH
cord-015365-iqdi99pd	950	9	MNs	MNs	NNP
cord-015365-iqdi99pd	950	10	)	)	-RRB-
cord-015365-iqdi99pd	950	11	occur	occur	VBP
cord-015365-iqdi99pd	950	12	as	as	IN
cord-015365-iqdi99pd	950	13	late	late	JJ
cord-015365-iqdi99pd	950	14	complication	complication	NN
cord-015365-iqdi99pd	950	15	after	after	IN
cord-015365-iqdi99pd	950	16	cytotoxic	cytotoxic	JJ
cord-015365-iqdi99pd	950	17	therapy	therapy	NN
cord-015365-iqdi99pd	950	18	for	for	IN
cord-015365-iqdi99pd	950	19	malignant	malignant	JJ
cord-015365-iqdi99pd	950	20	and	and	CC
cord-015365-iqdi99pd	950	21	non	non	JJ
cord-015365-iqdi99pd	950	22	-	-	JJ
cord-015365-iqdi99pd	950	23	malignant	malignant	JJ
cord-015365-iqdi99pd	950	24	disorders	disorder	NNS
cord-015365-iqdi99pd	950	25	.	.	.
cord-015365-iqdi99pd	951	1	In	in	IN
cord-015365-iqdi99pd	951	2	most	most	JJS
cord-015365-iqdi99pd	951	3	patients	patient	NNS
cord-015365-iqdi99pd	951	4	with	with	IN
cord-015365-iqdi99pd	951	5	t	t	NNP
cord-015365-iqdi99pd	951	6	-	-	HYPH
cord-015365-iqdi99pd	951	7	MNs	MNs	NNP
cord-015365-iqdi99pd	951	8	,	,	,
cord-015365-iqdi99pd	951	9	allogeneic	allogeneic	IN
cord-015365-iqdi99pd	951	10	haematopoietic	haematopoietic	JJ
cord-015365-iqdi99pd	951	11	stem	stem	NN
cord-015365-iqdi99pd	951	12	cell	cell	NN
cord-015365-iqdi99pd	951	13	transplantation	transplantation	NN
cord-015365-iqdi99pd	951	14	(	(	-LRB-
cord-015365-iqdi99pd	951	15	HSCT	HSCT	NNP
cord-015365-iqdi99pd	951	16	)	)	-RRB-
cord-015365-iqdi99pd	951	17	is	be	VBZ
cord-015365-iqdi99pd	951	18	the	the	DT
cord-015365-iqdi99pd	951	19	only	only	JJ
cord-015365-iqdi99pd	951	20	potentially	potentially	RB
cord-015365-iqdi99pd	951	21	curative	curative	JJ
cord-015365-iqdi99pd	951	22	approach	approach	NN
cord-015365-iqdi99pd	951	23	.	.	.
cord-015365-iqdi99pd	952	1	Performed	perform	VBN
cord-015365-iqdi99pd	952	2	with	with	IN
cord-015365-iqdi99pd	952	3	myeloablative	myeloablative	JJ
cord-015365-iqdi99pd	952	4	conditioning	conditioning	NN
cord-015365-iqdi99pd	952	5	this	this	DT
cord-015365-iqdi99pd	952	6	option	option	NN
cord-015365-iqdi99pd	952	7	is	be	VBZ
cord-015365-iqdi99pd	952	8	associated	associate	VBN
cord-015365-iqdi99pd	952	9	with	with	IN
cord-015365-iqdi99pd	952	10	a	a	DT
cord-015365-iqdi99pd	952	11	high	high	JJ
cord-015365-iqdi99pd	952	12	transplantrelated	transplantrelate	VBN
cord-015365-iqdi99pd	952	13	mortality	mortality	NN
cord-015365-iqdi99pd	952	14	(	(	-LRB-
cord-015365-iqdi99pd	952	15	TRM	TRM	NNP
cord-015365-iqdi99pd	952	16	)	)	-RRB-
cord-015365-iqdi99pd	952	17	.	.	.
cord-015365-iqdi99pd	953	1	Here	here	RB
cord-015365-iqdi99pd	953	2	we	-PRON-	PRP
cord-015365-iqdi99pd	953	3	report	report	VBP
cord-015365-iqdi99pd	953	4	our	-PRON-	PRP$
cord-015365-iqdi99pd	953	5	results	result	NNS
cord-015365-iqdi99pd	953	6	in	in	IN
cord-015365-iqdi99pd	953	7	using	use	VBG
cord-015365-iqdi99pd	953	8	reduced	reduce	VBN
cord-015365-iqdi99pd	953	9	intensity	intensity	NN
cord-015365-iqdi99pd	953	10	conditioning	conditioning	NN
cord-015365-iqdi99pd	953	11	(	(	-LRB-
cord-015365-iqdi99pd	953	12	RIC	RIC	NNP
cord-015365-iqdi99pd	953	13	)	)	-RRB-
cord-015365-iqdi99pd	953	14	in	in	IN
cord-015365-iqdi99pd	953	15	these	these	DT
cord-015365-iqdi99pd	953	16	patients	patient	NNS
cord-015365-iqdi99pd	953	17	.	.	.
cord-015365-iqdi99pd	954	1	Methods	method	NNS
cord-015365-iqdi99pd	954	2	.	.	.
cord-015365-iqdi99pd	955	1	Between	between	IN
cord-015365-iqdi99pd	955	2	July	July	NNP
cord-015365-iqdi99pd	955	3	2000	2000	CD
cord-015365-iqdi99pd	955	4	and	and	CC
cord-015365-iqdi99pd	955	5	February	February	NNP
cord-015365-iqdi99pd	955	6	2011	2011	CD
cord-015365-iqdi99pd	955	7	,	,	,
cord-015365-iqdi99pd	955	8	18	18	CD
cord-015365-iqdi99pd	955	9	patients	patient	NNS
cord-015365-iqdi99pd	955	10	(	(	-LRB-
cord-015365-iqdi99pd	955	11	male	male	NN
cord-015365-iqdi99pd	955	12	:	:	:
cord-015365-iqdi99pd	955	13	5	5	CD
cord-015365-iqdi99pd	955	14	;	;	,
cord-015365-iqdi99pd	955	15	female	female	JJ
cord-015365-iqdi99pd	955	16	:	:	:
cord-015365-iqdi99pd	955	17	13	13	CD
cord-015365-iqdi99pd	955	18	;	;	:
cord-015365-iqdi99pd	955	19	median	median	JJ
cord-015365-iqdi99pd	955	20	age	age	NN
cord-015365-iqdi99pd	955	21	:	:	:
cord-015365-iqdi99pd	955	22	48.5	48.5	CD
cord-015365-iqdi99pd	955	23	years	year	NNS
cord-015365-iqdi99pd	955	24	;	;	:
cord-015365-iqdi99pd	955	25	range	range	NN
cord-015365-iqdi99pd	955	26	:	:	:
cord-015365-iqdi99pd	955	27	28	28	CD
cord-015365-iqdi99pd	955	28	-	-	SYM
cord-015365-iqdi99pd	955	29	66	66	CD
cord-015365-iqdi99pd	955	30	)	)	-RRB-
cord-015365-iqdi99pd	955	31	with	with	IN
cord-015365-iqdi99pd	955	32	t	t	NNP
cord-015365-iqdi99pd	955	33	-	-	HYPH
cord-015365-iqdi99pd	955	34	MNs	MNs	NNP
cord-015365-iqdi99pd	955	35	underwent	undergo	VBD
cord-015365-iqdi99pd	955	36	RIC	RIC	NNP
cord-015365-iqdi99pd	955	37	HSCT	HSCT	NNP
cord-015365-iqdi99pd	955	38	either	either	CC
cord-015365-iqdi99pd	955	39	from	from	IN
cord-015365-iqdi99pd	955	40	a	a	DT
cord-015365-iqdi99pd	955	41	matched	match	VBN
cord-015365-iqdi99pd	955	42	sibling	sibling	NN
cord-015365-iqdi99pd	955	43	(	(	-LRB-
cord-015365-iqdi99pd	955	44	n	n	NNP
cord-015365-iqdi99pd	955	45	¼	¼	NNP
cord-015365-iqdi99pd	955	46	8)	8)	NNP
cord-015365-iqdi99pd	955	47	or	or	CC
cord-015365-iqdi99pd	955	48	a	a	DT
cord-015365-iqdi99pd	955	49	matched	match	VBN
cord-015365-iqdi99pd	955	50	unrelated	unrelated	JJ
cord-015365-iqdi99pd	955	51	(	(	-LRB-
cord-015365-iqdi99pd	955	52	n	n	NN
cord-015365-iqdi99pd	955	53	¼	¼	NNP
cord-015365-iqdi99pd	955	54	7	7	CD
cord-015365-iqdi99pd	955	55	)	)	-RRB-
cord-015365-iqdi99pd	955	56	or	or	CC
cord-015365-iqdi99pd	955	57	one	one	CD
cord-015365-iqdi99pd	955	58	antigen	antigen	NN
cord-015365-iqdi99pd	955	59	mismatched	mismatch	VBD
cord-015365-iqdi99pd	955	60	unrelated	unrelated	JJ
cord-015365-iqdi99pd	955	61	donor	donor	NN
cord-015365-iqdi99pd	955	62	(	(	-LRB-
cord-015365-iqdi99pd	955	63	n	n	NN
cord-015365-iqdi99pd	955	64	¼	¼	NNP
cord-015365-iqdi99pd	955	65	3	3	CD
cord-015365-iqdi99pd	955	66	)	)	-RRB-
cord-015365-iqdi99pd	955	67	.	.	.
cord-015365-iqdi99pd	956	1	Primary	primary	JJ
cord-015365-iqdi99pd	956	2	disorders	disorder	NNS
cord-015365-iqdi99pd	956	3	were	be	VBD
cord-015365-iqdi99pd	956	4	solid	solid	JJ
cord-015365-iqdi99pd	956	5	tumors	tumor	NNS
cord-015365-iqdi99pd	956	6	and	and	CC
cord-015365-iqdi99pd	956	7	haematologic	haematologic	JJ
cord-015365-iqdi99pd	956	8	malignancies	malignancy	NNS
cord-015365-iqdi99pd	956	9	in	in	IN
cord-015365-iqdi99pd	956	10	9	9	CD
cord-015365-iqdi99pd	956	11	patients	patient	NNS
cord-015365-iqdi99pd	956	12	each	each	DT
cord-015365-iqdi99pd	956	13	.	.	.
cord-015365-iqdi99pd	957	1	Patients	patient	NNS
cord-015365-iqdi99pd	957	2	presented	present	VBN
cord-015365-iqdi99pd	957	3	with	with	IN
cord-015365-iqdi99pd	957	4	t	t	NN
cord-015365-iqdi99pd	957	5	-	-	HYPH
cord-015365-iqdi99pd	957	6	MDS	MDS	NNP
cord-015365-iqdi99pd	957	7	(	(	-LRB-
cord-015365-iqdi99pd	957	8	n	n	NN
cord-015365-iqdi99pd	957	9	¼	¼	NNP
cord-015365-iqdi99pd	957	10	4	4	CD
cord-015365-iqdi99pd	957	11	)	)	-RRB-
cord-015365-iqdi99pd	957	12	,	,	,
cord-015365-iqdi99pd	957	13	t	t	NNP
cord-015365-iqdi99pd	957	14	-	-	HYPH
cord-015365-iqdi99pd	957	15	AML	AML	NNP
cord-015365-iqdi99pd	957	16	(	(	-LRB-
cord-015365-iqdi99pd	957	17	n	n	NNP
cord-015365-iqdi99pd	957	18	¼	¼	NNP
cord-015365-iqdi99pd	957	19	13	13	CD
cord-015365-iqdi99pd	957	20	)	)	-RRB-
cord-015365-iqdi99pd	957	21	and	and	CC
cord-015365-iqdi99pd	957	22	t	t	NN
cord-015365-iqdi99pd	957	23	-	-	HYPH
cord-015365-iqdi99pd	957	24	MDS	MDS	NNP
cord-015365-iqdi99pd	957	25	/	/	SYM
cord-015365-iqdi99pd	957	26	MPN	MPN	NNP
cord-015365-iqdi99pd	957	27	(	(	-LRB-
cord-015365-iqdi99pd	957	28	n	n	NNP
cord-015365-iqdi99pd	957	29	¼	¼	NNP
cord-015365-iqdi99pd	957	30	1	1	CD
cord-015365-iqdi99pd	957	31	)	)	-RRB-
cord-015365-iqdi99pd	957	32	.	.	.
cord-015365-iqdi99pd	958	1	Cytogenetic	cytogenetic	JJ
cord-015365-iqdi99pd	958	2	analysis	analysis	NN
cord-015365-iqdi99pd	958	3	revealed	reveal	VBD
cord-015365-iqdi99pd	958	4	clonal	clonal	JJ
cord-015365-iqdi99pd	958	5	aberrations	aberration	NNS
cord-015365-iqdi99pd	958	6	in	in	IN
cord-015365-iqdi99pd	958	7	15/18	15/18	CD
cord-015365-iqdi99pd	958	8	patients	patient	NNS
cord-015365-iqdi99pd	958	9	.	.	.
cord-015365-iqdi99pd	959	1	Nine	nine	CD
cord-015365-iqdi99pd	959	2	patients	patient	NNS
cord-015365-iqdi99pd	959	3	were	be	VBD
cord-015365-iqdi99pd	959	4	transplanted	transplant	VBN
cord-015365-iqdi99pd	959	5	in	in	IN
cord-015365-iqdi99pd	959	6	1st	1st	JJ
cord-015365-iqdi99pd	959	7	CR	cr	NN
cord-015365-iqdi99pd	959	8	,	,	,
cord-015365-iqdi99pd	959	9	one	one	CD
cord-015365-iqdi99pd	959	10	in	in	IN
cord-015365-iqdi99pd	959	11	2nd	2nd	JJ
cord-015365-iqdi99pd	959	12	CR	cr	NN
cord-015365-iqdi99pd	959	13	,	,	,
cord-015365-iqdi99pd	959	14	five	five	CD
cord-015365-iqdi99pd	959	15	in	in	IN
cord-015365-iqdi99pd	959	16	PR	PR	NNP
cord-015365-iqdi99pd	959	17	and	and	CC
cord-015365-iqdi99pd	959	18	three	three	CD
cord-015365-iqdi99pd	959	19	in	in	IN
cord-015365-iqdi99pd	959	20	relapsed	relapse	VBN
cord-015365-iqdi99pd	959	21	/	/	SYM
cord-015365-iqdi99pd	959	22	refractory	refractory	JJ
cord-015365-iqdi99pd	959	23	disease	disease	NN
cord-015365-iqdi99pd	959	24	.	.	.
cord-015365-iqdi99pd	960	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	960	2	,	,	,
cord-015365-iqdi99pd	960	3	five	five	CD
cord-015365-iqdi99pd	960	4	patients	patient	NNS
cord-015365-iqdi99pd	960	5	showed	show	VBD
cord-015365-iqdi99pd	960	6	persistant	persistant	JJ
cord-015365-iqdi99pd	960	7	primary	primary	JJ
cord-015365-iqdi99pd	960	8	disease	disease	NN
cord-015365-iqdi99pd	960	9	.	.	.
cord-015365-iqdi99pd	961	1	Conditioning	conditioning	NN
cord-015365-iqdi99pd	961	2	regimen	regimen	NN
cord-015365-iqdi99pd	961	3	consisted	consist	VBD
cord-015365-iqdi99pd	961	4	of	of	IN
cord-015365-iqdi99pd	961	5	fludarabine	fludarabine	NN
cord-015365-iqdi99pd	961	6	/	/	SYM
cord-015365-iqdi99pd	961	7	melphalan	melphalan	NNP
cord-015365-iqdi99pd	961	8	(	(	-LRB-
cord-015365-iqdi99pd	961	9	n	n	NNP
cord-015365-iqdi99pd	961	10	¼	¼	NNP
cord-015365-iqdi99pd	961	11	15	15	CD
cord-015365-iqdi99pd	961	12	)	)	-RRB-
cord-015365-iqdi99pd	961	13	or	or	CC
cord-015365-iqdi99pd	961	14	fludarabine/	fludarabine/	CD
cord-015365-iqdi99pd	961	15	low	low	JJ
cord-015365-iqdi99pd	961	16	-	-	HYPH
cord-015365-iqdi99pd	961	17	dose	dose	NN
cord-015365-iqdi99pd	961	18	TBI	TBI	NNP
cord-015365-iqdi99pd	961	19	(	(	-LRB-
cord-015365-iqdi99pd	961	20	n	n	NN
cord-015365-iqdi99pd	961	21	¼	¼	NNP
cord-015365-iqdi99pd	961	22	3	3	CD
cord-015365-iqdi99pd	961	23	)	)	-RRB-
cord-015365-iqdi99pd	961	24	.	.	.
cord-015365-iqdi99pd	962	1	GvHD	GvHD	NNP
cord-015365-iqdi99pd	962	2	prophylaxis	prophylaxis	NN
cord-015365-iqdi99pd	962	3	consisted	consist	VBD
cord-015365-iqdi99pd	962	4	of	of	IN
cord-015365-iqdi99pd	962	5	cyclosporine	cyclosporine	NN
cord-015365-iqdi99pd	962	6	and	and	CC
cord-015365-iqdi99pd	962	7	mycophenolate	mycophenolate	NNP
cord-015365-iqdi99pd	962	8	mofetil	mofetil	NNP
cord-015365-iqdi99pd	962	9	and	and	CC
cord-015365-iqdi99pd	962	10	additionally	additionally	RB
cord-015365-iqdi99pd	962	11	anti	anti	JJ
cord-015365-iqdi99pd	962	12	-	-	JJ
cord-015365-iqdi99pd	962	13	thymocyte	thymocyte	JJ
cord-015365-iqdi99pd	962	14	globulin	globulin	NN
cord-015365-iqdi99pd	962	15	in	in	IN
cord-015365-iqdi99pd	962	16	unrelated	unrelated	JJ
cord-015365-iqdi99pd	962	17	transplantations	transplantation	NNS
cord-015365-iqdi99pd	962	18	.	.	.
cord-015365-iqdi99pd	963	1	Results	result	NNS
cord-015365-iqdi99pd	963	2	.	.	.
cord-015365-iqdi99pd	964	1	After	after	IN
cord-015365-iqdi99pd	964	2	a	a	DT
cord-015365-iqdi99pd	964	3	median	median	JJ
cord-015365-iqdi99pd	964	4	follow	follow	NN
cord-015365-iqdi99pd	964	5	-	-	HYPH
cord-015365-iqdi99pd	964	6	up	up	NN
cord-015365-iqdi99pd	964	7	of	of	IN
cord-015365-iqdi99pd	964	8	31	31	CD
cord-015365-iqdi99pd	964	9	months	month	NNS
cord-015365-iqdi99pd	964	10	(	(	-LRB-
cord-015365-iqdi99pd	964	11	range	range	NN
cord-015365-iqdi99pd	964	12	:	:	:
cord-015365-iqdi99pd	964	13	3	3	CD
cord-015365-iqdi99pd	964	14	-	-	SYM
cord-015365-iqdi99pd	964	15	97	97	CD
cord-015365-iqdi99pd	964	16	)	)	-RRB-
cord-015365-iqdi99pd	964	17	9	9	CD
cord-015365-iqdi99pd	964	18	patients	patient	NNS
cord-015365-iqdi99pd	964	19	are	be	VBP
cord-015365-iqdi99pd	964	20	alive	alive	JJ
cord-015365-iqdi99pd	964	21	and	and	CC
cord-015365-iqdi99pd	964	22	in	in	IN
cord-015365-iqdi99pd	964	23	CR	CR	NNP
cord-015365-iqdi99pd	964	24	.	.	.
cord-015365-iqdi99pd	965	1	Causes	cause	NNS
cord-015365-iqdi99pd	965	2	of	of	IN
cord-015365-iqdi99pd	965	3	death	death	NN
cord-015365-iqdi99pd	965	4	were	be	VBD
cord-015365-iqdi99pd	965	5	:	:	:
cord-015365-iqdi99pd	965	6	relapse	relapse	NN
cord-015365-iqdi99pd	965	7	(	(	-LRB-
cord-015365-iqdi99pd	965	8	n	n	NN
cord-015365-iqdi99pd	965	9	¼	¼	NNP
cord-015365-iqdi99pd	965	10	4	4	CD
cord-015365-iqdi99pd	965	11	)	)	-RRB-
cord-015365-iqdi99pd	965	12	,	,	,
cord-015365-iqdi99pd	965	13	sepsis	sepsis	NN
cord-015365-iqdi99pd	965	14	/	/	SYM
cord-015365-iqdi99pd	965	15	multiorgan	multiorgan	NNP
cord-015365-iqdi99pd	965	16	failure	failure	NN
cord-015365-iqdi99pd	965	17	(	(	-LRB-
cord-015365-iqdi99pd	965	18	n	n	NN
cord-015365-iqdi99pd	965	19	¼	¼	NNP
cord-015365-iqdi99pd	965	20	4	4	CD
cord-015365-iqdi99pd	965	21	)	)	-RRB-
cord-015365-iqdi99pd	965	22	and	and	CC
cord-015365-iqdi99pd	965	23	GvHD	GvHD	NNP
cord-015365-iqdi99pd	965	24	(	(	-LRB-
cord-015365-iqdi99pd	965	25	n	n	NN
cord-015365-iqdi99pd	965	26	¼	¼	NNP
cord-015365-iqdi99pd	965	27	1	1	CD
cord-015365-iqdi99pd	965	28	)	)	-RRB-
cord-015365-iqdi99pd	965	29	.	.	.
cord-015365-iqdi99pd	966	1	Acute	acute	JJ
cord-015365-iqdi99pd	966	2	and	and	CC
cord-015365-iqdi99pd	966	3	chronic	chronic	JJ
cord-015365-iqdi99pd	966	4	GvHD	GvHD	NNP
cord-015365-iqdi99pd	966	5	was	be	VBD
cord-015365-iqdi99pd	966	6	observed	observe	VBN
cord-015365-iqdi99pd	966	7	in	in	IN
cord-015365-iqdi99pd	966	8	6	6	CD
cord-015365-iqdi99pd	966	9	and	and	CC
cord-015365-iqdi99pd	966	10	5	5	CD
cord-015365-iqdi99pd	966	11	patients	patient	NNS
cord-015365-iqdi99pd	966	12	,	,	,
cord-015365-iqdi99pd	966	13	respectively	respectively	RB
cord-015365-iqdi99pd	966	14	.	.	.
cord-015365-iqdi99pd	967	1	The	the	DT
cord-015365-iqdi99pd	967	2	estimated	estimate	VBN
cord-015365-iqdi99pd	967	3	OS	os	NN
cord-015365-iqdi99pd	967	4	is	be	VBZ
cord-015365-iqdi99pd	967	5	53.8	53.8	CD
cord-015365-iqdi99pd	967	6	%	%	NN
cord-015365-iqdi99pd	967	7	at	at	IN
cord-015365-iqdi99pd	967	8	one	one	CD
cord-015365-iqdi99pd	967	9	and	and	CC
cord-015365-iqdi99pd	967	10	47.9	47.9	CD
cord-015365-iqdi99pd	967	11	%	%	NN
cord-015365-iqdi99pd	967	12	at	at	IN
cord-015365-iqdi99pd	967	13	three	three	CD
cord-015365-iqdi99pd	967	14	years	year	NNS
cord-015365-iqdi99pd	967	15	;	;	:
cord-015365-iqdi99pd	967	16	the	the	DT
cord-015365-iqdi99pd	967	17	DFS	DFS	NNP
cord-015365-iqdi99pd	967	18	is	be	VBZ
cord-015365-iqdi99pd	967	19	48.1	48.1	CD
cord-015365-iqdi99pd	967	20	%	%	NN
cord-015365-iqdi99pd	967	21	at	at	IN
cord-015365-iqdi99pd	967	22	one	one	CD
cord-015365-iqdi99pd	967	23	and	and	CC
cord-015365-iqdi99pd	967	24	three	three	CD
cord-015365-iqdi99pd	967	25	years	year	NNS
cord-015365-iqdi99pd	967	26	,	,	,
cord-015365-iqdi99pd	967	27	respectively	respectively	RB
cord-015365-iqdi99pd	967	28	.	.	.
cord-015365-iqdi99pd	968	1	Of	of	IN
cord-015365-iqdi99pd	968	2	5	5	CD
cord-015365-iqdi99pd	968	3	patients	patient	NNS
cord-015365-iqdi99pd	968	4	transplanted	transplant	VBN
cord-015365-iqdi99pd	968	5	with	with	IN
cord-015365-iqdi99pd	968	6	active	active	JJ
cord-015365-iqdi99pd	968	7	primary	primary	JJ
cord-015365-iqdi99pd	968	8	neoplasms	neoplasm	NNS
cord-015365-iqdi99pd	968	9	,	,	,
cord-015365-iqdi99pd	968	10	2	2	CD
cord-015365-iqdi99pd	968	11	are	be	VBP
cord-015365-iqdi99pd	968	12	alive	alive	JJ
cord-015365-iqdi99pd	968	13	at	at	IN
cord-015365-iqdi99pd	968	14	1	1	CD
cord-015365-iqdi99pd	968	15	year	year	NN
cord-015365-iqdi99pd	968	16	showing	show	VBG
cord-015365-iqdi99pd	968	17	CR	cr	NN
cord-015365-iqdi99pd	968	18	of	of	IN
cord-015365-iqdi99pd	968	19	both	both	DT
cord-015365-iqdi99pd	968	20	primary	primary	JJ
cord-015365-iqdi99pd	968	21	and	and	CC
cord-015365-iqdi99pd	968	22	secondary	secondary	JJ
cord-015365-iqdi99pd	968	23	neoplasms	neoplasm	NNS
cord-015365-iqdi99pd	968	24	which	which	WDT
cord-015365-iqdi99pd	968	25	was	be	VBD
cord-015365-iqdi99pd	968	26	associated	associate	VBN
cord-015365-iqdi99pd	968	27	with	with	IN
cord-015365-iqdi99pd	968	28	the	the	DT
cord-015365-iqdi99pd	968	29	development	development	NN
cord-015365-iqdi99pd	968	30	of	of	IN
cord-015365-iqdi99pd	968	31	chronic	chronic	JJ
cord-015365-iqdi99pd	968	32	GvHD	GvHD	NNP
cord-015365-iqdi99pd	968	33	.	.	.
cord-015365-iqdi99pd	969	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	969	2	.	.	.
cord-015365-iqdi99pd	970	1	The	the	DT
cord-015365-iqdi99pd	970	2	results	result	NNS
cord-015365-iqdi99pd	970	3	of	of	IN
cord-015365-iqdi99pd	970	4	RIC	RIC	NNP
cord-015365-iqdi99pd	970	5	HSCT	HSCT	NNP
cord-015365-iqdi99pd	970	6	in	in	IN
cord-015365-iqdi99pd	970	7	these	these	DT
cord-015365-iqdi99pd	970	8	patients	patient	NNS
cord-015365-iqdi99pd	970	9	with	with	IN
cord-015365-iqdi99pd	970	10	poor	poor	JJ
cord-015365-iqdi99pd	970	11	risk	risk	NN
cord-015365-iqdi99pd	970	12	disease	disease	NN
cord-015365-iqdi99pd	970	13	are	be	VBP
cord-015365-iqdi99pd	970	14	encouraging	encourage	VBG
cord-015365-iqdi99pd	970	15	with	with	IN
cord-015365-iqdi99pd	970	16	respect	respect	NN
cord-015365-iqdi99pd	970	17	to	to	IN
cord-015365-iqdi99pd	970	18	TRM	TRM	NNP
cord-015365-iqdi99pd	970	19	,	,	,
cord-015365-iqdi99pd	970	20	relapse	relapse	NN
cord-015365-iqdi99pd	970	21	rate	rate	NN
cord-015365-iqdi99pd	970	22	and	and	CC
cord-015365-iqdi99pd	970	23	overall	overall	JJ
cord-015365-iqdi99pd	970	24	survival	survival	NN
cord-015365-iqdi99pd	970	25	.	.	.
cord-015365-iqdi99pd	971	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	971	2	data	datum	NNS
cord-015365-iqdi99pd	971	3	show	show	VBP
cord-015365-iqdi99pd	971	4	a	a	DT
cord-015365-iqdi99pd	971	5	more	more	RBR
cord-015365-iqdi99pd	971	6	favourable	favourable	JJ
cord-015365-iqdi99pd	971	7	outcome	outcome	NN
cord-015365-iqdi99pd	971	8	compared	compare	VBN
cord-015365-iqdi99pd	971	9	with	with	IN
cord-015365-iqdi99pd	971	10	previous	previous	JJ
cord-015365-iqdi99pd	971	11	reports	report	NNS
cord-015365-iqdi99pd	971	12	using	use	VBG
cord-015365-iqdi99pd	971	13	a	a	DT
cord-015365-iqdi99pd	971	14	myeloablative	myeloablative	JJ
cord-015365-iqdi99pd	971	15	conditioning	conditioning	NN
cord-015365-iqdi99pd	971	16	.	.	.
cord-015365-iqdi99pd	972	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	972	2	,	,	,
cord-015365-iqdi99pd	972	3	allogeneic	allogeneic	IN
cord-015365-iqdi99pd	972	4	HSCT	HSCT	NNP
cord-015365-iqdi99pd	972	5	should	should	MD
cord-015365-iqdi99pd	972	6	be	be	VB
cord-015365-iqdi99pd	972	7	considered	consider	VBN
cord-015365-iqdi99pd	972	8	as	as	IN
cord-015365-iqdi99pd	972	9	a	a	DT
cord-015365-iqdi99pd	972	10	potentially	potentially	RB
cord-015365-iqdi99pd	972	11	curative	curative	JJ
cord-015365-iqdi99pd	972	12	strategy	strategy	NN
cord-015365-iqdi99pd	972	13	for	for	IN
cord-015365-iqdi99pd	972	14	patients	patient	NNS
cord-015365-iqdi99pd	972	15	with	with	IN
cord-015365-iqdi99pd	972	16	t	t	NNP
cord-015365-iqdi99pd	972	17	-	-	HYPH
cord-015365-iqdi99pd	972	18	MNs	MNs	NNP
cord-015365-iqdi99pd	972	19	and	and	CC
cord-015365-iqdi99pd	972	20	persistant	persistant	JJ
cord-015365-iqdi99pd	972	21	primary	primary	JJ
cord-015365-iqdi99pd	972	22	malignancy	malignancy	NN
cord-015365-iqdi99pd	972	23	.	.	.
cord-015365-iqdi99pd	973	1	The	the	DT
cord-015365-iqdi99pd	973	2	bone	bone	NN
cord-015365-iqdi99pd	973	3	component	component	NN
cord-015365-iqdi99pd	973	4	of	of	IN
cord-015365-iqdi99pd	973	5	CTA	CTA	NNP
cord-015365-iqdi99pd	973	6	gives	give	VBZ
cord-015365-iqdi99pd	973	7	rise	rise	NN
cord-015365-iqdi99pd	973	8	to	to	IN
cord-015365-iqdi99pd	973	9	donor	donor	NN
cord-015365-iqdi99pd	973	10	HSCs	hsc	NNS
cord-015365-iqdi99pd	973	11	which	which	WDT
cord-015365-iqdi99pd	973	12	migrate	migrate	VBP
cord-015365-iqdi99pd	973	13	to	to	IN
cord-015365-iqdi99pd	973	14	recipient	recipient	NN
cord-015365-iqdi99pd	973	15	thymus	thymus	NN
cord-015365-iqdi99pd	973	16	and	and	CC
cord-015365-iqdi99pd	973	17	differentiate	differentiate	VB
cord-015365-iqdi99pd	973	18	to	to	TO
cord-015365-iqdi99pd	973	19	mature	mature	VB
cord-015365-iqdi99pd	973	20	T	t	NN
cord-015365-iqdi99pd	973	21	cells	cell	NNS
cord-015365-iqdi99pd	973	22	Background	background	NN
cord-015365-iqdi99pd	973	23	.	.	.
cord-015365-iqdi99pd	974	1	Composite	composite	JJ
cord-015365-iqdi99pd	974	2	Tissue	tissue	NN
cord-015365-iqdi99pd	974	3	Allotransplantation	Allotransplantation	NNP
cord-015365-iqdi99pd	974	4	(	(	-LRB-
cord-015365-iqdi99pd	974	5	CTA	CTA	NNP
cord-015365-iqdi99pd	974	6	)	)	-RRB-
cord-015365-iqdi99pd	974	7	is	be	VBZ
cord-015365-iqdi99pd	974	8	immunologically	immunologically	RB
cord-015365-iqdi99pd	974	9	unique	unique	JJ
cord-015365-iqdi99pd	974	10	in	in	IN
cord-015365-iqdi99pd	974	11	that	that	IN
cord-015365-iqdi99pd	974	12	it	-PRON-	PRP
cord-015365-iqdi99pd	974	13	represents	represent	VBZ
cord-015365-iqdi99pd	974	14	the	the	DT
cord-015365-iqdi99pd	974	15	only	only	JJ
cord-015365-iqdi99pd	974	16	type	type	NN
cord-015365-iqdi99pd	974	17	of	of	IN
cord-015365-iqdi99pd	974	18	graft	graft	NN
cord-015365-iqdi99pd	974	19	to	to	TO
cord-015365-iqdi99pd	974	20	include	include	VB
cord-015365-iqdi99pd	974	21	a	a	DT
cord-015365-iqdi99pd	974	22	vascularized	vascularized	JJ
cord-015365-iqdi99pd	974	23	functional	functional	JJ
cord-015365-iqdi99pd	974	24	bone	bone	NN
cord-015365-iqdi99pd	974	25	marrow	marrow	NN
cord-015365-iqdi99pd	974	26	component	component	NN
cord-015365-iqdi99pd	974	27	.	.	.
cord-015365-iqdi99pd	975	1	Here	here	RB
cord-015365-iqdi99pd	975	2	we	-PRON-	PRP
cord-015365-iqdi99pd	975	3	studied	study	VBD
cord-015365-iqdi99pd	975	4	if	if	IN
cord-015365-iqdi99pd	975	5	the	the	DT
cord-015365-iqdi99pd	975	6	bone	bone	NN
cord-015365-iqdi99pd	975	7	component	component	NN
cord-015365-iqdi99pd	975	8	of	of	IN
cord-015365-iqdi99pd	975	9	a	a	DT
cord-015365-iqdi99pd	975	10	composite	composite	JJ
cord-015365-iqdi99pd	975	11	tissue	tissue	NN
cord-015365-iqdi99pd	975	12	graft	graft	NN
cord-015365-iqdi99pd	975	13	represents	represent	VBZ
cord-015365-iqdi99pd	975	14	the	the	DT
cord-015365-iqdi99pd	975	15	source	source	NN
cord-015365-iqdi99pd	975	16	of	of	IN
cord-015365-iqdi99pd	975	17	HSCs	HSCs	NNP
cord-015365-iqdi99pd	975	18	that	that	WDT
cord-015365-iqdi99pd	975	19	differentiate	differentiate	VBP
cord-015365-iqdi99pd	975	20	in	in	IN
cord-015365-iqdi99pd	975	21	the	the	DT
cord-015365-iqdi99pd	975	22	thymus	thymus	NN
cord-015365-iqdi99pd	975	23	and	and	CC
cord-015365-iqdi99pd	975	24	thereby	thereby	RB
cord-015365-iqdi99pd	975	25	reconstitute	reconstitute	VB
cord-015365-iqdi99pd	975	26	a	a	DT
cord-015365-iqdi99pd	975	27	functional	functional	JJ
cord-015365-iqdi99pd	975	28	immune	immune	JJ
cord-015365-iqdi99pd	975	29	system	system	NN
cord-015365-iqdi99pd	975	30	(	(	-LRB-
cord-015365-iqdi99pd	975	31	CD3þ	CD3þ	NNP
cord-015365-iqdi99pd	975	32	T	T	NNP
cord-015365-iqdi99pd	975	33	cells	cell	NNS
cord-015365-iqdi99pd	975	34	in	in	IN
cord-015365-iqdi99pd	975	35	peripheral	peripheral	JJ
cord-015365-iqdi99pd	975	36	blood	blood	NN
cord-015365-iqdi99pd	975	37	/	/	SYM
cord-015365-iqdi99pd	975	38	lymphoid	lymphoid	JJ
cord-015365-iqdi99pd	975	39	organs	organ	NNS
cord-015365-iqdi99pd	975	40	)	)	-RRB-
cord-015365-iqdi99pd	975	41	in	in	IN
cord-015365-iqdi99pd	975	42	immuno	immuno	JJ
cord-015365-iqdi99pd	975	43	-	-	HYPH
cord-015365-iqdi99pd	975	44	deficient	deficient	JJ
cord-015365-iqdi99pd	975	45	B6	b6	NN
cord-015365-iqdi99pd	975	46	/	/	SYM
cord-015365-iqdi99pd	975	47	SCID	SCID	NNP
cord-015365-iqdi99pd	975	48	recipients	recipient	NNS
cord-015365-iqdi99pd	975	49	rather	rather	RB
cord-015365-iqdi99pd	975	50	than	than	IN
cord-015365-iqdi99pd	975	51	originate	originate	VB
cord-015365-iqdi99pd	975	52	from	from	IN
cord-015365-iqdi99pd	975	53	donor	donor	NN
cord-015365-iqdi99pd	975	54	mature	mature	JJ
cord-015365-iqdi99pd	975	55	passenger	passenger	NN
cord-015365-iqdi99pd	975	56	T	t	NN
cord-015365-iqdi99pd	975	57	cells	cell	NNS
cord-015365-iqdi99pd	975	58	that	that	WDT
cord-015365-iqdi99pd	975	59	expand	expand	VBP
cord-015365-iqdi99pd	975	60	in	in	IN
cord-015365-iqdi99pd	975	61	the	the	DT
cord-015365-iqdi99pd	975	62	host	host	NN
cord-015365-iqdi99pd	975	63	.	.	.
cord-015365-iqdi99pd	976	1	Methods	method	NNS
cord-015365-iqdi99pd	976	2	.	.	.
cord-015365-iqdi99pd	977	1	B6	B6	NNP
cord-015365-iqdi99pd	977	2	(	(	-LRB-
cord-015365-iqdi99pd	977	3	WT	WT	NNP
cord-015365-iqdi99pd	977	4	/	/	SYM
cord-015365-iqdi99pd	977	5	nude	nude	NNP
cord-015365-iqdi99pd	977	6	)	)	-RRB-
cord-015365-iqdi99pd	977	7	murine	murine	JJ
cord-015365-iqdi99pd	977	8	composite	composite	JJ
cord-015365-iqdi99pd	977	9	tissue	tissue	NN
cord-015365-iqdi99pd	977	10	grafts	graft	NNS
cord-015365-iqdi99pd	977	11	(	(	-LRB-
cord-015365-iqdi99pd	977	12	osteomyocutaneous	osteomyocutaneous	NNP
cord-015365-iqdi99pd	977	13	or	or	CC
cord-015365-iqdi99pd	977	14	myocutaneous	myocutaneous	NNP
cord-015365-iqdi99pd	977	15	)	)	-RRB-
cord-015365-iqdi99pd	977	16	were	be	VBD
cord-015365-iqdi99pd	977	17	transplanted	transplant	VBN
cord-015365-iqdi99pd	977	18	heterotopically	heterotopically	NNS
cord-015365-iqdi99pd	977	19	to	to	IN
cord-015365-iqdi99pd	977	20	B6	B6	NNP
cord-015365-iqdi99pd	977	21	(	(	-LRB-
cord-015365-iqdi99pd	977	22	WT	WT	NNP
cord-015365-iqdi99pd	977	23	/	/	SYM
cord-015365-iqdi99pd	977	24	scid	scid	NN
cord-015365-iqdi99pd	977	25	)	)	-RRB-
cord-015365-iqdi99pd	977	26	recipients	recipient	NNS
cord-015365-iqdi99pd	977	27	using	use	VBG
cord-015365-iqdi99pd	977	28	a	a	DT
cord-015365-iqdi99pd	977	29	non	non	JJ
cord-015365-iqdi99pd	977	30	-	-	JJ
cord-015365-iqdi99pd	977	31	suture	suture	JJ
cord-015365-iqdi99pd	977	32	cuff	cuff	NN
cord-015365-iqdi99pd	977	33	technique	technique	NN
cord-015365-iqdi99pd	977	34	for	for	IN
cord-015365-iqdi99pd	977	35	revascularization	revascularization	NN
cord-015365-iqdi99pd	977	36	.	.	.
cord-015365-iqdi99pd	978	1	Flow	flow	NN
cord-015365-iqdi99pd	978	2	cytometry	cytometry	NN
cord-015365-iqdi99pd	978	3	of	of	IN
cord-015365-iqdi99pd	978	4	peripheral	peripheral	JJ
cord-015365-iqdi99pd	978	5	blood	blood	NN
cord-015365-iqdi99pd	978	6	(	(	-LRB-
cord-015365-iqdi99pd	978	7	CD3þ	CD3þ	NNP
cord-015365-iqdi99pd	978	8	,	,	,
cord-015365-iqdi99pd	978	9	CD19þ	CD19þ	NNP
cord-015365-iqdi99pd	978	10	)	)	-RRB-
cord-015365-iqdi99pd	978	11	was	be	VBD
cord-015365-iqdi99pd	978	12	performed	perform	VBN
cord-015365-iqdi99pd	978	13	at	at	IN
cord-015365-iqdi99pd	978	14	pod	pod	NNP
cord-015365-iqdi99pd	978	15	7	7	CD
cord-015365-iqdi99pd	978	16	,	,	,
cord-015365-iqdi99pd	978	17	14	14	CD
cord-015365-iqdi99pd	978	18	,	,	,
cord-015365-iqdi99pd	978	19	21	21	CD
cord-015365-iqdi99pd	978	20	,	,	,
cord-015365-iqdi99pd	978	21	28	28	CD
cord-015365-iqdi99pd	978	22	,	,	,
cord-015365-iqdi99pd	978	23	56	56	CD
cord-015365-iqdi99pd	978	24	.	.	.
cord-015365-iqdi99pd	979	1	In	in	IN
cord-015365-iqdi99pd	979	2	addition	addition	NN
cord-015365-iqdi99pd	979	3	,	,	,
cord-015365-iqdi99pd	979	4	histopathology	histopathology	NN
cord-015365-iqdi99pd	979	5	(	(	-LRB-
cord-015365-iqdi99pd	979	6	H&E	H&E	NNP
cord-015365-iqdi99pd	979	7	)	)	-RRB-
cord-015365-iqdi99pd	979	8	and	and	CC
cord-015365-iqdi99pd	979	9	immunohistochemistry	immunohistochemistry	NN
cord-015365-iqdi99pd	979	10	of	of	IN
cord-015365-iqdi99pd	979	11	tissues	tissue	NNS
cord-015365-iqdi99pd	979	12	was	be	VBD
cord-015365-iqdi99pd	979	13	performed	perform	VBN
cord-015365-iqdi99pd	979	14	at	at	IN
cord-015365-iqdi99pd	979	15	indicated	indicate	VBN
cord-015365-iqdi99pd	979	16	time	time	NN
cord-015365-iqdi99pd	979	17	points	point	NNS
cord-015365-iqdi99pd	979	18	.	.	.
cord-015365-iqdi99pd	980	1	To	to	TO
cord-015365-iqdi99pd	980	2	assess	assess	VB
cord-015365-iqdi99pd	980	3	immunocompetence	immunocompetence	NN
cord-015365-iqdi99pd	980	4	,	,	,
cord-015365-iqdi99pd	980	5	allogeneic	allogeneic	IN
cord-015365-iqdi99pd	980	6	skin	skin	NN
cord-015365-iqdi99pd	980	7	grafts	graft	NNS
cord-015365-iqdi99pd	980	8	(	(	-LRB-
cord-015365-iqdi99pd	980	9	Balb	Balb	NNP
cord-015365-iqdi99pd	980	10	/	/	SYM
cord-015365-iqdi99pd	980	11	c	c	NN
cord-015365-iqdi99pd	980	12	)	)	-RRB-
cord-015365-iqdi99pd	980	13	were	be	VBD
cord-015365-iqdi99pd	980	14	transplanted	transplant	VBN
cord-015365-iqdi99pd	980	15	to	to	IN
cord-015365-iqdi99pd	980	16	either	either	CC
cord-015365-iqdi99pd	980	17	naïve	naïve	JJ
cord-015365-iqdi99pd	980	18	B6	B6	NNP
cord-015365-iqdi99pd	980	19	/	/	SYM
cord-015365-iqdi99pd	980	20	nude	nude	JJ
cord-015365-iqdi99pd	980	21	,	,	,
cord-015365-iqdi99pd	980	22	naïve	naïve	JJ
cord-015365-iqdi99pd	980	23	B6	B6	NNP
cord-015365-iqdi99pd	980	24	/	/	,
cord-015365-iqdi99pd	980	25	scid	scid	NN
cord-015365-iqdi99pd	980	26	or	or	CC
cord-015365-iqdi99pd	980	27	B6	B6	NNP
cord-015365-iqdi99pd	980	28	/	/	SYM
cord-015365-iqdi99pd	980	29	scid	scid	JJ
cord-015365-iqdi99pd	980	30	mice	mouse	NNS
cord-015365-iqdi99pd	980	31	that	that	WDT
cord-015365-iqdi99pd	980	32	prior	prior	RB
cord-015365-iqdi99pd	980	33	received	receive	VBD
cord-015365-iqdi99pd	980	34	a	a	DT
cord-015365-iqdi99pd	980	35	B6	b6	NN
cord-015365-iqdi99pd	980	36	/	/	SYM
cord-015365-iqdi99pd	980	37	nude	nude	JJ
cord-015365-iqdi99pd	980	38	CTA	CTA	NNP
cord-015365-iqdi99pd	980	39	.	.	.
cord-015365-iqdi99pd	981	1	Results	result	NNS
cord-015365-iqdi99pd	981	2	.	.	.
cord-015365-iqdi99pd	982	1	The	the	DT
cord-015365-iqdi99pd	982	2	surgical	surgical	JJ
cord-015365-iqdi99pd	982	3	success	success	NN
cord-015365-iqdi99pd	982	4	rate	rate	NN
cord-015365-iqdi99pd	982	5	was	be	VBD
cord-015365-iqdi99pd	982	6	85	85	CD
cord-015365-iqdi99pd	982	7	%	%	NN
cord-015365-iqdi99pd	982	8	in	in	IN
cord-015365-iqdi99pd	982	9	all	all	DT
cord-015365-iqdi99pd	982	10	groups	group	NNS
cord-015365-iqdi99pd	982	11	.	.	.
cord-015365-iqdi99pd	983	1	As	as	IN
cord-015365-iqdi99pd	983	2	expected	expect	VBN
cord-015365-iqdi99pd	983	3	no	no	DT
cord-015365-iqdi99pd	983	4	CD3þ	CD3þ	NNP
cord-015365-iqdi99pd	983	5	cells	cell	NNS
cord-015365-iqdi99pd	983	6	and	and	CC
cord-015365-iqdi99pd	983	7	no	no	DT
cord-015365-iqdi99pd	983	8	rejection	rejection	NN
cord-015365-iqdi99pd	983	9	of	of	IN
cord-015365-iqdi99pd	983	10	skin	skin	NN
cord-015365-iqdi99pd	983	11	allografts	allograft	NNS
cord-015365-iqdi99pd	983	12	were	be	VBD
cord-015365-iqdi99pd	983	13	detected	detect	VBN
cord-015365-iqdi99pd	983	14	in	in	IN
cord-015365-iqdi99pd	983	15	B6	b6	NN
cord-015365-iqdi99pd	983	16	/	/	SYM
cord-015365-iqdi99pd	983	17	nude	nude	NN
cord-015365-iqdi99pd	983	18	and	and	CC
cord-015365-iqdi99pd	983	19	B6	B6	NNP
cord-015365-iqdi99pd	983	20	/	/	SYM
cord-015365-iqdi99pd	983	21	scid	scid	JJ
cord-015365-iqdi99pd	983	22	controls	control	NNS
cord-015365-iqdi99pd	983	23	.	.	.
cord-015365-iqdi99pd	984	1	B6	b6	NN
cord-015365-iqdi99pd	984	2	/	/	SYM
cord-015365-iqdi99pd	984	3	scid	scid	JJ
cord-015365-iqdi99pd	984	4	mice	mouse	NNS
cord-015365-iqdi99pd	984	5	that	that	WDT
cord-015365-iqdi99pd	984	6	received	receive	VBD
cord-015365-iqdi99pd	984	7	B6	B6	NNP
cord-015365-iqdi99pd	984	8	/	/	SYM
cord-015365-iqdi99pd	984	9	nude	nude	NNP
cord-015365-iqdi99pd	984	10	osteomyocutaneous	osteomyocutaneous	NNP
cord-015365-iqdi99pd	984	11	flaps	flaps	NNP
cord-015365-iqdi99pd	984	12	demonstrated	demonstrate	VBD
cord-015365-iqdi99pd	984	13	B	B	NNP
cord-015365-iqdi99pd	984	14	and	and	CC
cord-015365-iqdi99pd	984	15	T	t	NN
cord-015365-iqdi99pd	984	16	cell	cell	NN
cord-015365-iqdi99pd	984	17	immunity	immunity	NN
cord-015365-iqdi99pd	984	18	from	from	IN
cord-015365-iqdi99pd	984	19	pod	pod	NN
cord-015365-iqdi99pd	984	20	7	7	CD
cord-015365-iqdi99pd	984	21	and	and	CC
cord-015365-iqdi99pd	984	22	21	21	CD
cord-015365-iqdi99pd	984	23	respectively	respectively	RB
cord-015365-iqdi99pd	984	24	.	.	.
cord-015365-iqdi99pd	985	1	The	the	DT
cord-015365-iqdi99pd	985	2	percentage	percentage	NN
cord-015365-iqdi99pd	985	3	of	of	IN
cord-015365-iqdi99pd	985	4	CD3þ	CD3þ	NNP
cord-015365-iqdi99pd	985	5	and	and	CC
cord-015365-iqdi99pd	985	6	CD19þ	CD19þ	NNP
cord-015365-iqdi99pd	985	7	cells	cell	NNS
cord-015365-iqdi99pd	985	8	within	within	IN
cord-015365-iqdi99pd	985	9	peripheral	peripheral	JJ
cord-015365-iqdi99pd	985	10	blood	blood	NN
cord-015365-iqdi99pd	985	11	mononuclear	mononuclear	NN
cord-015365-iqdi99pd	985	12	cells	cell	NNS
cord-015365-iqdi99pd	985	13	steadily	steadily	RB
cord-015365-iqdi99pd	985	14	increased	increase	VBD
cord-015365-iqdi99pd	985	15	to	to	IN
cord-015365-iqdi99pd	985	16	57.7	57.7	CD
cord-015365-iqdi99pd	985	17	%	%	NN
cord-015365-iqdi99pd	985	18	and	and	CC
cord-015365-iqdi99pd	985	19	17.1	17.1	CD
cord-015365-iqdi99pd	985	20	%	%	NN
cord-015365-iqdi99pd	985	21	respectively	respectively	RB
cord-015365-iqdi99pd	985	22	at	at	IN
cord-015365-iqdi99pd	985	23	pod	pod	NN
cord-015365-iqdi99pd	985	24	56	56	CD
cord-015365-iqdi99pd	985	25	.	.	.
cord-015365-iqdi99pd	986	1	Allogeneic	allogeneic	IN
cord-015365-iqdi99pd	986	2	skin	skin	NN
cord-015365-iqdi99pd	986	3	allografts	allograft	NNS
cord-015365-iqdi99pd	986	4	were	be	VBD
cord-015365-iqdi99pd	986	5	rejected	reject	VBN
cord-015365-iqdi99pd	986	6	2	2	CD
cord-015365-iqdi99pd	986	7	weeks	week	NNS
cord-015365-iqdi99pd	986	8	after	after	IN
cord-015365-iqdi99pd	986	9	transplantation	transplantation	NN
cord-015365-iqdi99pd	986	10	.	.	.
cord-015365-iqdi99pd	987	1	However	however	RB
cord-015365-iqdi99pd	987	2	,	,	,
cord-015365-iqdi99pd	987	3	no	no	DT
cord-015365-iqdi99pd	987	4	B	b	NN
cord-015365-iqdi99pd	987	5	and	and	CC
cord-015365-iqdi99pd	987	6	T	T	NNP
cord-015365-iqdi99pd	987	7	cell	cell	NN
cord-015365-iqdi99pd	987	8	reconstitution	reconstitution	NN
cord-015365-iqdi99pd	987	9	was	be	VBD
cord-015365-iqdi99pd	987	10	observed	observe	VBN
cord-015365-iqdi99pd	987	11	in	in	IN
cord-015365-iqdi99pd	987	12	B6	B6	NNP
cord-015365-iqdi99pd	987	13	/	/	SYM
cord-015365-iqdi99pd	987	14	scid	scid	JJ
cord-015365-iqdi99pd	987	15	mice	mouse	NNS
cord-015365-iqdi99pd	987	16	receiving	receive	VBG
cord-015365-iqdi99pd	987	17	B6	B6	NNP
cord-015365-iqdi99pd	987	18	/	/	SYM
cord-015365-iqdi99pd	987	19	nude	nude	JJ
cord-015365-iqdi99pd	987	20	myocutaneous	myocutaneous	JJ
cord-015365-iqdi99pd	987	21	flaps	flaps	NNP
cord-015365-iqdi99pd	987	22	(	(	-LRB-
cord-015365-iqdi99pd	987	23	without	without	IN
cord-015365-iqdi99pd	987	24	bone	bone	NN
cord-015365-iqdi99pd	987	25	component	component	NN
cord-015365-iqdi99pd	987	26	)	)	-RRB-
cord-015365-iqdi99pd	987	27	.	.	.
cord-015365-iqdi99pd	988	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	988	2	.	.	.
cord-015365-iqdi99pd	989	1	The	the	DT
cord-015365-iqdi99pd	989	2	vascularized	vascularized	JJ
cord-015365-iqdi99pd	989	3	bone	bone	NN
cord-015365-iqdi99pd	989	4	marrow	marrow	NN
cord-015365-iqdi99pd	989	5	component	component	NN
cord-015365-iqdi99pd	989	6	of	of	IN
cord-015365-iqdi99pd	989	7	CTA	CTA	NNP
cord-015365-iqdi99pd	989	8	provides	provide	VBZ
cord-015365-iqdi99pd	989	9	an	an	DT
cord-015365-iqdi99pd	989	10	effective	effective	JJ
cord-015365-iqdi99pd	989	11	source	source	NN
cord-015365-iqdi99pd	989	12	of	of	IN
cord-015365-iqdi99pd	989	13	HSCs	hscs	NN
cord-015365-iqdi99pd	989	14	to	to	TO
cord-015365-iqdi99pd	989	15	restore	restore	VB
cord-015365-iqdi99pd	989	16	immunocompetence	immunocompetence	NN
cord-015365-iqdi99pd	989	17	in	in	IN
cord-015365-iqdi99pd	989	18	T	T	NNP
cord-015365-iqdi99pd	989	19	-	-	HYPH
cord-015365-iqdi99pd	989	20	and	and	CC
cord-015365-iqdi99pd	989	21	B	b	NN
cord-015365-iqdi99pd	989	22	-	-	HYPH
cord-015365-iqdi99pd	989	23	cell	cell	NN
cord-015365-iqdi99pd	989	24	deficient	deficient	JJ
cord-015365-iqdi99pd	989	25	mice	mouse	NNS
cord-015365-iqdi99pd	989	26	.	.	.
cord-015365-iqdi99pd	990	1	This	this	DT
cord-015365-iqdi99pd	990	2	might	may	MD
cord-015365-iqdi99pd	990	3	also	also	RB
cord-015365-iqdi99pd	990	4	contribute	contribute	VB
cord-015365-iqdi99pd	990	5	to	to	IN
cord-015365-iqdi99pd	990	6	chimerism	chimerism	NN
cord-015365-iqdi99pd	990	7	induction	induction	NN
cord-015365-iqdi99pd	990	8	and	and	CC
cord-015365-iqdi99pd	990	9	maintenance	maintenance	NN
cord-015365-iqdi99pd	990	10	after	after	IN
cord-015365-iqdi99pd	990	11	CTA	CTA	NNP
cord-015365-iqdi99pd	990	12	and	and	CC
cord-015365-iqdi99pd	990	13	facilitate	facilitate	VB
cord-015365-iqdi99pd	990	14	the	the	DT
cord-015365-iqdi99pd	990	15	clinically	clinically	RB
cord-015365-iqdi99pd	990	16	observed	observe	VBN
cord-015365-iqdi99pd	990	17	immunoprivilege	immunoprivilege	NN
cord-015365-iqdi99pd	990	18	of	of	IN
cord-015365-iqdi99pd	990	19	CTAs	CTAs	NNPS
cord-015365-iqdi99pd	990	20	.	.	.
cord-015365-iqdi99pd	991	1	Early	early	RB
cord-015365-iqdi99pd	991	2	in	in	IN
cord-015365-iqdi99pd	991	3	vivo	vivo	NN
cord-015365-iqdi99pd	991	4	signaling	signal	VBG
cord-015365-iqdi99pd	991	5	events	event	NNS
cord-015365-iqdi99pd	991	6	involved	involve	VBN
cord-015365-iqdi99pd	991	7	in	in	IN
cord-015365-iqdi99pd	991	8	neo	neo	NNP
cord-015365-iqdi99pd	991	9	-	-	HYPH
cord-015365-iqdi99pd	991	10	vasculogenesis	vasculogenesis	NNP
cord-015365-iqdi99pd	991	11	via	via	IN
cord-015365-iqdi99pd	991	12	stem	stem	NN
cord-015365-iqdi99pd	991	13	cell	cell	NN
cord-015365-iqdi99pd	991	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	991	15	using	use	VBG
cord-015365-iqdi99pd	991	16	proteomic	proteomic	JJ
cord-015365-iqdi99pd	991	17	profiling	profiling	NN
cord-015365-iqdi99pd	991	18	Background	background	NN
cord-015365-iqdi99pd	991	19	.	.	.
cord-015365-iqdi99pd	992	1	The	the	DT
cord-015365-iqdi99pd	992	2	precise	precise	JJ
cord-015365-iqdi99pd	992	3	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	992	4	regulating	regulate	VBG
cord-015365-iqdi99pd	992	5	human	human	JJ
cord-015365-iqdi99pd	992	6	neo	neo	NNP
cord-015365-iqdi99pd	992	7	-	-	HYPH
cord-015365-iqdi99pd	992	8	vasculogenesis	vasculogenesis	NNP
cord-015365-iqdi99pd	992	9	and	and	CC
cord-015365-iqdi99pd	992	10	organ	organ	NN
cord-015365-iqdi99pd	992	11	regeneration	regeneration	NN
cord-015365-iqdi99pd	992	12	are	be	VBP
cord-015365-iqdi99pd	992	13	still	still	RB
cord-015365-iqdi99pd	992	14	unclear	unclear	JJ
cord-015365-iqdi99pd	992	15	.	.	.
cord-015365-iqdi99pd	993	1	It	-PRON-	PRP
cord-015365-iqdi99pd	993	2	has	have	VBZ
cord-015365-iqdi99pd	993	3	been	be	VBN
cord-015365-iqdi99pd	993	4	shown	show	VBN
cord-015365-iqdi99pd	993	5	that	that	IN
cord-015365-iqdi99pd	993	6	neo	neo	NNP
cord-015365-iqdi99pd	993	7	-	-	HYPH
cord-015365-iqdi99pd	993	8	vasculogenesis	vasculogenesis	NNP
cord-015365-iqdi99pd	993	9	can	can	MD
cord-015365-iqdi99pd	993	10	be	be	VB
cord-015365-iqdi99pd	993	11	induced	induce	VBN
cord-015365-iqdi99pd	993	12	in	in	IN
cord-015365-iqdi99pd	993	13	immunocompromised	immunocompromised	JJ
cord-015365-iqdi99pd	993	14	NOD	NOD	NNP
cord-015365-iqdi99pd	993	15	/	/	SYM
cord-015365-iqdi99pd	993	16	scid	scid	NNP
cord-015365-iqdi99pd	993	17	/	/	SYM
cord-015365-iqdi99pd	993	18	IL-2-receptor	il-2-receptor	CD
cord-015365-iqdi99pd	993	19	gamma	gamma	NN
cord-015365-iqdi99pd	993	20	-	-	HYPH
cord-015365-iqdi99pd	993	21	knockout	knockout	NN
cord-015365-iqdi99pd	993	22	(	(	-LRB-
cord-015365-iqdi99pd	993	23	NSG	NSG	NNP
cord-015365-iqdi99pd	993	24	)	)	-RRB-
cord-015365-iqdi99pd	993	25	mice	mouse	NNS
cord-015365-iqdi99pd	993	26	in	in	IN
cord-015365-iqdi99pd	993	27	vivo	vivo	NN
cord-015365-iqdi99pd	993	28	by	by	IN
cord-015365-iqdi99pd	993	29	transplantation	transplantation	NN
cord-015365-iqdi99pd	993	30	of	of	IN
cord-015365-iqdi99pd	993	31	human	human	JJ
cord-015365-iqdi99pd	993	32	bone	bone	NN
cord-015365-iqdi99pd	993	33	marrowderived	marrowderive	VBD
cord-015365-iqdi99pd	993	34	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	993	35	stem	stem	NN
cord-015365-iqdi99pd	993	36	and	and	CC
cord-015365-iqdi99pd	993	37	progenitor	progenitor	NN
cord-015365-iqdi99pd	993	38	cells	cell	NNS
cord-015365-iqdi99pd	993	39	(	(	-LRB-
cord-015365-iqdi99pd	993	40	hMSPCs	hmspcs	LS
cord-015365-iqdi99pd	993	41	)	)	-RRB-
cord-015365-iqdi99pd	993	42	and	and	CC
cord-015365-iqdi99pd	993	43	umbilical	umbilical	JJ
cord-015365-iqdi99pd	993	44	cord	cord	NN
cord-015365-iqdi99pd	993	45	-	-	HYPH
cord-015365-iqdi99pd	993	46	derived	derive	VBN
cord-015365-iqdi99pd	993	47	endothelial	endothelial	JJ
cord-015365-iqdi99pd	993	48	colony	colony	NN
cord-015365-iqdi99pd	993	49	-	-	HYPH
cord-015365-iqdi99pd	993	50	forming	form	VBG
cord-015365-iqdi99pd	993	51	progenitor	progenitor	NN
cord-015365-iqdi99pd	993	52	cells	cell	NNS
cord-015365-iqdi99pd	993	53	(	(	-LRB-
cord-015365-iqdi99pd	993	54	hECFCs	hecfcs	NN
cord-015365-iqdi99pd	993	55	)	)	-RRB-
cord-015365-iqdi99pd	993	56	,	,	,
cord-015365-iqdi99pd	993	57	whereas	whereas	IN
cord-015365-iqdi99pd	993	58	transplantation	transplantation	NN
cord-015365-iqdi99pd	993	59	of	of	IN
cord-015365-iqdi99pd	993	60	pure	pure	JJ
cord-015365-iqdi99pd	993	61	hMSPC	hMSPC	NNP
cord-015365-iqdi99pd	993	62	or	or	CC
cord-015365-iqdi99pd	993	63	hECFC	hecfc	JJ
cord-015365-iqdi99pd	993	64	cells	cell	NNS
cord-015365-iqdi99pd	993	65	lack	lack	VBP
cord-015365-iqdi99pd	993	66	the	the	DT
cord-015365-iqdi99pd	993	67	capacity	capacity	NN
cord-015365-iqdi99pd	993	68	to	to	TO
cord-015365-iqdi99pd	993	69	form	form	VB
cord-015365-iqdi99pd	993	70	stable	stable	JJ
cord-015365-iqdi99pd	993	71	functional	functional	JJ
cord-015365-iqdi99pd	993	72	vessels	vessel	NNS
cord-015365-iqdi99pd	993	73	(	(	-LRB-
cord-015365-iqdi99pd	993	74	Reinisch	Reinisch	NNP
cord-015365-iqdi99pd	993	75	et	et	NNP
cord-015365-iqdi99pd	993	76	al	al	NNP
cord-015365-iqdi99pd	993	77	.	.	.
cord-015365-iqdi99pd	994	1	,	,	,
cord-015365-iqdi99pd	994	2	Blood	blood	NN
cord-015365-iqdi99pd	994	3	,	,	,
cord-015365-iqdi99pd	994	4	2009	2009	CD
cord-015365-iqdi99pd	994	5	)	)	-RRB-
cord-015365-iqdi99pd	994	6	.	.	.
cord-015365-iqdi99pd	995	1	Understanding	understand	VBG
cord-015365-iqdi99pd	995	2	the	the	DT
cord-015365-iqdi99pd	995	3	activity	activity	NN
cord-015365-iqdi99pd	995	4	of	of	IN
cord-015365-iqdi99pd	995	5	the	the	DT
cord-015365-iqdi99pd	995	6	mediators	mediator	NNS
cord-015365-iqdi99pd	995	7	of	of	IN
cord-015365-iqdi99pd	995	8	neo	neo	NNP
cord-015365-iqdi99pd	995	9	-	-	HYPH
cord-015365-iqdi99pd	995	10	vasculogenesis	vasculogenesis	NNP
cord-015365-iqdi99pd	995	11	would	would	MD
cord-015365-iqdi99pd	995	12	provide	provide	VB
cord-015365-iqdi99pd	995	13	us	-PRON-	PRP
cord-015365-iqdi99pd	995	14	with	with	IN
cord-015365-iqdi99pd	995	15	tools	tool	NNS
cord-015365-iqdi99pd	995	16	to	to	TO
cord-015365-iqdi99pd	995	17	develop	develop	VB
cord-015365-iqdi99pd	995	18	strategies	strategy	NNS
cord-015365-iqdi99pd	995	19	for	for	IN
cord-015365-iqdi99pd	995	20	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	995	21	intervention	intervention	NN
cord-015365-iqdi99pd	995	22	as	as	RB
cord-015365-iqdi99pd	995	23	well	well	RB
cord-015365-iqdi99pd	995	24	as	as	IN
cord-015365-iqdi99pd	995	25	angiogenesis	angiogenesis	NN
cord-015365-iqdi99pd	995	26	and	and	CC
cord-015365-iqdi99pd	995	27	regenerative	regenerative	JJ
cord-015365-iqdi99pd	995	28	applications	application	NNS
cord-015365-iqdi99pd	995	29	.	.	.
cord-015365-iqdi99pd	996	1	Methods	method	NNS
cord-015365-iqdi99pd	996	2	.	.	.
cord-015365-iqdi99pd	997	1	Autologous	autologous	JJ
cord-015365-iqdi99pd	997	2	pairs	pair	NNS
cord-015365-iqdi99pd	997	3	of	of	IN
cord-015365-iqdi99pd	997	4	MSPCs	mspc	NNS
cord-015365-iqdi99pd	997	5	and	and	CC
cord-015365-iqdi99pd	997	6	ECFCs	ecfc	NNS
cord-015365-iqdi99pd	997	7	were	be	VBD
cord-015365-iqdi99pd	997	8	transplanted	transplant	VBN
cord-015365-iqdi99pd	997	9	subcutaneously	subcutaneously	RB
cord-015365-iqdi99pd	997	10	in	in	IN
cord-015365-iqdi99pd	997	11	Matrigel	Matrigel	NNP
cord-015365-iqdi99pd	997	12	plugs	plug	NNS
cord-015365-iqdi99pd	997	13	at	at	IN
cord-015365-iqdi99pd	997	14	a	a	DT
cord-015365-iqdi99pd	997	15	ratio	ratio	NN
cord-015365-iqdi99pd	997	16	of	of	IN
cord-015365-iqdi99pd	997	17	20:80	20:80	CD
cord-015365-iqdi99pd	997	18	into	into	IN
cord-015365-iqdi99pd	997	19	NSG	NSG	NNP
cord-015365-iqdi99pd	997	20	mice	mouse	NNS
cord-015365-iqdi99pd	997	21	and	and	CC
cord-015365-iqdi99pd	997	22	implants	implant	NNS
cord-015365-iqdi99pd	997	23	were	be	VBD
cord-015365-iqdi99pd	997	24	harvested	harvest	VBN
cord-015365-iqdi99pd	997	25	1	1	CD
cord-015365-iqdi99pd	997	26	day	day	NN
cord-015365-iqdi99pd	997	27	post	post	NN
cord-015365-iqdi99pd	997	28	transplantation	transplantation	NN
cord-015365-iqdi99pd	997	29	to	to	TO
cord-015365-iqdi99pd	997	30	investigate	investigate	VB
cord-015365-iqdi99pd	997	31	proteomic	proteomic	JJ
cord-015365-iqdi99pd	997	32	profiling	profiling	NN
cord-015365-iqdi99pd	997	33	using	use	VBG
cord-015365-iqdi99pd	997	34	KAM	KAM	NNP
cord-015365-iqdi99pd	997	35	1.3	1.3	CD
cord-015365-iqdi99pd	997	36	Antibody	Antibody	NNP
cord-015365-iqdi99pd	997	37	Microarray	Microarray	NNP
cord-015365-iqdi99pd	997	38	(	(	-LRB-
cord-015365-iqdi99pd	997	39	www.kinexus.ca	www.kinexus.ca	NNP
cord-015365-iqdi99pd	997	40	)	)	-RRB-
cord-015365-iqdi99pd	997	41	,	,	,
cord-015365-iqdi99pd	997	42	testing	test	VBG
cord-015365-iqdi99pd	997	43	over	over	IN
cord-015365-iqdi99pd	997	44	800	800	CD
cord-015365-iqdi99pd	997	45	signaling	signal	VBG
cord-015365-iqdi99pd	997	46	and	and	CC
cord-015365-iqdi99pd	997	47	phospho	phospho	NN
cord-015365-iqdi99pd	997	48	-	-	HYPH
cord-015365-iqdi99pd	997	49	proteins	protein	NNS
cord-015365-iqdi99pd	997	50	.	.	.
cord-015365-iqdi99pd	998	1	The	the	DT
cord-015365-iqdi99pd	998	2	state	state	NN
cord-015365-iqdi99pd	998	3	of	of	IN
cord-015365-iqdi99pd	998	4	vessel	vessel	NN
cord-015365-iqdi99pd	998	5	formation	formation	NN
cord-015365-iqdi99pd	998	6	and	and	CC
cord-015365-iqdi99pd	998	7	stability	stability	NN
cord-015365-iqdi99pd	998	8	of	of	IN
cord-015365-iqdi99pd	998	9	the	the	DT
cord-015365-iqdi99pd	998	10	transplants	transplant	NNS
cord-015365-iqdi99pd	998	11	were	be	VBD
cord-015365-iqdi99pd	998	12	verified	verify	VBN
cord-015365-iqdi99pd	998	13	by	by	IN
cord-015365-iqdi99pd	998	14	immunohistochemistry	immunohistochemistry	NN
cord-015365-iqdi99pd	998	15	of	of	IN
cord-015365-iqdi99pd	998	16	the	the	DT
cord-015365-iqdi99pd	998	17	explants	explant	NNS
cord-015365-iqdi99pd	998	18	2	2	CD
cord-015365-iqdi99pd	998	19	and	and	CC
cord-015365-iqdi99pd	998	20	8	8	CD
cord-015365-iqdi99pd	998	21	weeks	week	NNS
cord-015365-iqdi99pd	998	22	post	post	NN
cord-015365-iqdi99pd	998	23	transplantation	transplantation	NN
cord-015365-iqdi99pd	998	24	.	.	.
cord-015365-iqdi99pd	999	1	Results	result	NNS
cord-015365-iqdi99pd	999	2	.	.	.
cord-015365-iqdi99pd	1000	1	Protein	protein	NN
cord-015365-iqdi99pd	1000	2	microarray	microarray	NN
cord-015365-iqdi99pd	1000	3	data	data	NN
cord-015365-iqdi99pd	1000	4	analysis	analysis	NN
cord-015365-iqdi99pd	1000	5	revealed	reveal	VBD
cord-015365-iqdi99pd	1000	6	significant	significant	JJ
cord-015365-iqdi99pd	1000	7	alteration	alteration	NN
cord-015365-iqdi99pd	1000	8	in	in	IN
cord-015365-iqdi99pd	1000	9	the	the	DT
cord-015365-iqdi99pd	1000	10	expression	expression	NN
cord-015365-iqdi99pd	1000	11	and	and	CC
cord-015365-iqdi99pd	1000	12	activity	activity	NN
cord-015365-iqdi99pd	1000	13	of	of	IN
cord-015365-iqdi99pd	1000	14	components	component	NNS
cord-015365-iqdi99pd	1000	15	1	1	CD
cord-015365-iqdi99pd	1000	16	)	)	-RRB-
cord-015365-iqdi99pd	1000	17	regulating	regulate	VBG
cord-015365-iqdi99pd	1000	18	apoptosis	apoptosis	NN
cord-015365-iqdi99pd	1000	19	,	,	,
cord-015365-iqdi99pd	1000	20	mitotic	mitotic	JJ
cord-015365-iqdi99pd	1000	21	check	check	NN
cord-015365-iqdi99pd	1000	22	point	point	NN
cord-015365-iqdi99pd	1000	23	control	control	NN
cord-015365-iqdi99pd	1000	24	,	,	,
cord-015365-iqdi99pd	1000	25	and	and	CC
cord-015365-iqdi99pd	1000	26	centrosome	centrosome	NN
cord-015365-iqdi99pd	1000	27	structure	structure	NN
cord-015365-iqdi99pd	1000	28	;	;	:
cord-015365-iqdi99pd	1000	29	2	2	LS
cord-015365-iqdi99pd	1000	30	)	)	-RRB-
cord-015365-iqdi99pd	1000	31	modulating	modulate	VBG
cord-015365-iqdi99pd	1000	32	glycolysis	glycolysis	NN
cord-015365-iqdi99pd	1000	33	and	and	CC
cord-015365-iqdi99pd	1000	34	the	the	DT
cord-015365-iqdi99pd	1000	35	coordinated	coordinated	JJ
cord-015365-iqdi99pd	1000	36	expression	expression	NN
cord-015365-iqdi99pd	1000	37	of	of	IN
cord-015365-iqdi99pd	1000	38	cyto	cyto	JJ
cord-015365-iqdi99pd	1000	39	-	-	JJ
cord-015365-iqdi99pd	1000	40	protective	protective	JJ
cord-015365-iqdi99pd	1000	41	genes	gene	NNS
cord-015365-iqdi99pd	1000	42	;	;	:
cord-015365-iqdi99pd	1000	43	and	and	CC
cord-015365-iqdi99pd	1000	44	3	3	LS
cord-015365-iqdi99pd	1000	45	)	)	-RRB-
cord-015365-iqdi99pd	1000	46	mediating	mediate	VBG
cord-015365-iqdi99pd	1000	47	cell	cell	NN
cord-015365-iqdi99pd	1000	48	adhesion	adhesion	NN
cord-015365-iqdi99pd	1000	49	,	,	,
cord-015365-iqdi99pd	1000	50	migration	migration	NN
cord-015365-iqdi99pd	1000	51	and	and	CC
cord-015365-iqdi99pd	1000	52	tissue	tissue	NN
cord-015365-iqdi99pd	1000	53	invasion	invasion	NN
cord-015365-iqdi99pd	1000	54	.	.	.
cord-015365-iqdi99pd	1001	1	Selected	select	VBN
cord-015365-iqdi99pd	1001	2	targets	target	NNS
cord-015365-iqdi99pd	1001	3	are	be	VBP
cord-015365-iqdi99pd	1001	4	currently	currently	RB
cord-015365-iqdi99pd	1001	5	being	be	VBG
cord-015365-iqdi99pd	1001	6	validated	validate	VBN
cord-015365-iqdi99pd	1001	7	by	by	IN
cord-015365-iqdi99pd	1001	8	Western	western	JJ
cord-015365-iqdi99pd	1001	9	blotting	blotting	NN
cord-015365-iqdi99pd	1001	10	to	to	TO
cord-015365-iqdi99pd	1001	11	allow	allow	VB
cord-015365-iqdi99pd	1001	12	for	for	IN
cord-015365-iqdi99pd	1001	13	the	the	DT
cord-015365-iqdi99pd	1001	14	development	development	NN
cord-015365-iqdi99pd	1001	15	of	of	IN
cord-015365-iqdi99pd	1001	16	novel	novel	JJ
cord-015365-iqdi99pd	1001	17	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1001	18	intervention	intervention	NN
cord-015365-iqdi99pd	1001	19	strategies	strategy	NNS
cord-015365-iqdi99pd	1001	20	.	.	.
cord-015365-iqdi99pd	1002	1	A	a	DT
cord-015365-iqdi99pd	1002	2	detailed	detailed	JJ
cord-015365-iqdi99pd	1002	3	expression	expression	NN
cord-015365-iqdi99pd	1002	4	and	and	CC
cord-015365-iqdi99pd	1002	5	interactive	interactive	JJ
cord-015365-iqdi99pd	1002	6	network	network	NN
cord-015365-iqdi99pd	1002	7	analysis	analysis	NN
cord-015365-iqdi99pd	1002	8	of	of	IN
cord-015365-iqdi99pd	1002	9	targets	target	NNS
cord-015365-iqdi99pd	1002	10	will	will	MD
cord-015365-iqdi99pd	1002	11	be	be	VB
cord-015365-iqdi99pd	1002	12	presented	present	VBN
cord-015365-iqdi99pd	1002	13	and	and	CC
cord-015365-iqdi99pd	1002	14	discussed	discuss	VBN
cord-015365-iqdi99pd	1002	15	.	.	.
cord-015365-iqdi99pd	1003	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1003	2	.	.	.
cord-015365-iqdi99pd	1004	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	1004	2	data	datum	NNS
cord-015365-iqdi99pd	1004	3	confirm	confirm	VBP
cord-015365-iqdi99pd	1004	4	that	that	IN
cord-015365-iqdi99pd	1004	5	more	more	JJR
cord-015365-iqdi99pd	1004	6	than	than	IN
cord-015365-iqdi99pd	1004	7	one	one	CD
cord-015365-iqdi99pd	1004	8	purified	purify	VBN
cord-015365-iqdi99pd	1004	9	cell	cell	NN
cord-015365-iqdi99pd	1004	10	type	type	NN
cord-015365-iqdi99pd	1004	11	is	be	VBZ
cord-015365-iqdi99pd	1004	12	needed	need	VBN
cord-015365-iqdi99pd	1004	13	for	for	IN
cord-015365-iqdi99pd	1004	14	tissue	tissue	NN
cord-015365-iqdi99pd	1004	15	engineering	engineering	NN
cord-015365-iqdi99pd	1004	16	in	in	IN
cord-015365-iqdi99pd	1004	17	vivo	vivo	NN
cord-015365-iqdi99pd	1004	18	and	and	CC
cord-015365-iqdi99pd	1004	19	suggest	suggest	VBP
cord-015365-iqdi99pd	1004	20	that	that	IN
cord-015365-iqdi99pd	1004	21	composite	composite	JJ
cord-015365-iqdi99pd	1004	22	cellular	cellular	JJ
cord-015365-iqdi99pd	1004	23	transplantation	transplantation	NN
cord-015365-iqdi99pd	1004	24	may	may	MD
cord-015365-iqdi99pd	1004	25	be	be	VB
cord-015365-iqdi99pd	1004	26	useful	useful	JJ
cord-015365-iqdi99pd	1004	27	for	for	IN
cord-015365-iqdi99pd	1004	28	future	future	JJ
cord-015365-iqdi99pd	1004	29	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1004	30	strategies	strategy	NNS
cord-015365-iqdi99pd	1004	31	.	.	.
cord-015365-iqdi99pd	1005	1	Proteomic	proteomic	NN
cord-015365-iqdi99pd	1005	2	profiling	profiling	NN
cord-015365-iqdi99pd	1005	3	unraveled	unravel	VBD
cord-015365-iqdi99pd	1005	4	at	at	RB
cord-015365-iqdi99pd	1005	5	least	least	RBS
cord-015365-iqdi99pd	1005	6	three	three	CD
cord-015365-iqdi99pd	1005	7	distinct	distinct	JJ
cord-015365-iqdi99pd	1005	8	but	but	CC
cord-015365-iqdi99pd	1005	9	partially	partially	RB
cord-015365-iqdi99pd	1005	10	overlapping	overlap	VBG
cord-015365-iqdi99pd	1005	11	signaling	signal	VBG
cord-015365-iqdi99pd	1005	12	networks	network	NNS
cord-015365-iqdi99pd	1005	13	involved	involve	VBN
cord-015365-iqdi99pd	1005	14	in	in	IN
cord-015365-iqdi99pd	1005	15	the	the	DT
cord-015365-iqdi99pd	1005	16	complex	complex	JJ
cord-015365-iqdi99pd	1005	17	process	process	NN
cord-015365-iqdi99pd	1005	18	of	of	IN
cord-015365-iqdi99pd	1005	19	vascular	vascular	JJ
cord-015365-iqdi99pd	1005	20	regeneration	regeneration	NN
cord-015365-iqdi99pd	1005	21	.	.	.
cord-015365-iqdi99pd	1006	1	Understanding	understand	VBG
cord-015365-iqdi99pd	1006	2	the	the	DT
cord-015365-iqdi99pd	1006	3	origin	origin	NN
cord-015365-iqdi99pd	1006	4	and	and	CC
cord-015365-iqdi99pd	1006	5	activity	activity	NN
cord-015365-iqdi99pd	1006	6	of	of	IN
cord-015365-iqdi99pd	1006	7	the	the	DT
cord-015365-iqdi99pd	1006	8	mediators	mediator	NNS
cord-015365-iqdi99pd	1006	9	of	of	IN
cord-015365-iqdi99pd	1006	10	vessel	vessel	NN
cord-015365-iqdi99pd	1006	11	formation	formation	NN
cord-015365-iqdi99pd	1006	12	and	and	CC
cord-015365-iqdi99pd	1006	13	repair	repair	NN
cord-015365-iqdi99pd	1006	14	would	would	MD
cord-015365-iqdi99pd	1006	15	provide	provide	VB
cord-015365-iqdi99pd	1006	16	us	-PRON-	PRP
cord-015365-iqdi99pd	1006	17	with	with	IN
cord-015365-iqdi99pd	1006	18	tools	tool	NNS
cord-015365-iqdi99pd	1006	19	to	to	TO
cord-015365-iqdi99pd	1006	20	develop	develop	VB
cord-015365-iqdi99pd	1006	21	and	and	CC
cord-015365-iqdi99pd	1006	22	further	far	RBR
cord-015365-iqdi99pd	1006	23	optimize	optimize	VB
cord-015365-iqdi99pd	1006	24	novel	novel	JJ
cord-015365-iqdi99pd	1006	25	cell	cell	NN
cord-015365-iqdi99pd	1006	26	transplantation	transplantation	NN
cord-015365-iqdi99pd	1006	27	strategies	strategy	NNS
cord-015365-iqdi99pd	1006	28	.	.	.
cord-015365-iqdi99pd	1007	1	Oxygen	oxygen	NN
cord-015365-iqdi99pd	1007	2	sensing	sensing	NN
cord-015365-iqdi99pd	1007	3	of	of	IN
cord-015365-iqdi99pd	1007	4	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	1007	5	stem	stem	NN
cord-015365-iqdi99pd	1007	6	and	and	CC
cord-015365-iqdi99pd	1007	7	progenitor	progenitor	NN
cord-015365-iqdi99pd	1007	8	cells	cell	NNS
cord-015365-iqdi99pd	1007	9	promotes	promote	VBZ
cord-015365-iqdi99pd	1007	10	neo	neo	NNP
cord-015365-iqdi99pd	1007	11	-	-	HYPH
cord-015365-iqdi99pd	1007	12	vasculogenesis	vasculogenesis	NNP
cord-015365-iqdi99pd	1007	13	in	in	IN
cord-015365-iqdi99pd	1007	14	vivo	vivo	NNP
cord-015365-iqdi99pd	1007	15	Background	Background	NNP
cord-015365-iqdi99pd	1007	16	.	.	.
cord-015365-iqdi99pd	1008	1	Vascular	vascular	JJ
cord-015365-iqdi99pd	1008	2	regeneration	regeneration	NN
cord-015365-iqdi99pd	1008	3	requires	require	VBZ
cord-015365-iqdi99pd	1008	4	a	a	DT
cord-015365-iqdi99pd	1008	5	stringent	stringent	JJ
cord-015365-iqdi99pd	1008	6	interaction	interaction	NN
cord-015365-iqdi99pd	1008	7	of	of	IN
cord-015365-iqdi99pd	1008	8	somatic	somatic	JJ
cord-015365-iqdi99pd	1008	9	endothelial	endothelial	JJ
cord-015365-iqdi99pd	1008	10	colony	colony	NN
cord-015365-iqdi99pd	1008	11	-	-	HYPH
cord-015365-iqdi99pd	1008	12	forming	form	VBG
cord-015365-iqdi99pd	1008	13	progenitor	progenitor	NN
cord-015365-iqdi99pd	1008	14	cells	cell	NNS
cord-015365-iqdi99pd	1008	15	(	(	-LRB-
cord-015365-iqdi99pd	1008	16	ECFCs	ECFCs	NNP
cord-015365-iqdi99pd	1008	17	)	)	-RRB-
cord-015365-iqdi99pd	1008	18	with	with	IN
cord-015365-iqdi99pd	1008	19	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	1008	20	stem	stem	NN
cord-015365-iqdi99pd	1008	21	and	and	CC
cord-015365-iqdi99pd	1008	22	progenitor	progenitor	NN
cord-015365-iqdi99pd	1008	23	cells	cell	NNS
cord-015365-iqdi99pd	1008	24	(	(	-LRB-
cord-015365-iqdi99pd	1008	25	MSPCs	mspc	NNS
cord-015365-iqdi99pd	1008	26	)	)	-RRB-
cord-015365-iqdi99pd	1008	27	.	.	.
cord-015365-iqdi99pd	1009	1	Hypoxia	hypoxia	NN
cord-015365-iqdi99pd	1009	2	in	in	IN
cord-015365-iqdi99pd	1009	3	ischemic	ischemic	JJ
cord-015365-iqdi99pd	1009	4	tissue	tissue	NN
cord-015365-iqdi99pd	1009	5	is	be	VBZ
cord-015365-iqdi99pd	1009	6	a	a	DT
cord-015365-iqdi99pd	1009	7	key	key	JJ
cord-015365-iqdi99pd	1009	8	factor	factor	NN
cord-015365-iqdi99pd	1009	9	driving	drive	VBG
cord-015365-iqdi99pd	1009	10	the	the	DT
cord-015365-iqdi99pd	1009	11	revascularization	revascularization	NN
cord-015365-iqdi99pd	1009	12	machinery	machinery	NN
cord-015365-iqdi99pd	1009	13	.	.	.
cord-015365-iqdi99pd	1010	1	Because	because	IN
cord-015365-iqdi99pd	1010	2	ECFCs	ECFCs	NNP
cord-015365-iqdi99pd	1010	3	,	,	,
cord-015365-iqdi99pd	1010	4	despite	despite	IN
cord-015365-iqdi99pd	1010	5	hypoxic	hypoxic	JJ
cord-015365-iqdi99pd	1010	6	stimulation	stimulation	NN
cord-015365-iqdi99pd	1010	7	,	,	,
cord-015365-iqdi99pd	1010	8	only	only	RB
cord-015365-iqdi99pd	1010	9	form	form	NN
cord-015365-iqdi99pd	1010	10	patent	patent	NN
cord-015365-iqdi99pd	1010	11	vessels	vessel	NNS
cord-015365-iqdi99pd	1010	12	in	in	IN
cord-015365-iqdi99pd	1010	13	vivo	vivo	NN
cord-015365-iqdi99pd	1010	14	in	in	IN
cord-015365-iqdi99pd	1010	15	the	the	DT
cord-015365-iqdi99pd	1010	16	presence	presence	NN
cord-015365-iqdi99pd	1010	17	of	of	IN
cord-015365-iqdi99pd	1010	18	MSPCs	mspc	NNS
cord-015365-iqdi99pd	1010	19	,	,	,
cord-015365-iqdi99pd	1010	20	we	-PRON-	PRP
cord-015365-iqdi99pd	1010	21	hypothesized	hypothesize	VBD
cord-015365-iqdi99pd	1010	22	that	that	IN
cord-015365-iqdi99pd	1010	23	MSPCs	mspc	NNS
cord-015365-iqdi99pd	1010	24	play	play	VB
cord-015365-iqdi99pd	1010	25	a	a	DT
cord-015365-iqdi99pd	1010	26	decisive	decisive	JJ
cord-015365-iqdi99pd	1010	27	role	role	NN
cord-015365-iqdi99pd	1010	28	in	in	IN
cord-015365-iqdi99pd	1010	29	oxygen	oxygen	NN
cord-015365-iqdi99pd	1010	30	sensing	sensing	NN
cord-015365-iqdi99pd	1010	31	during	during	IN
cord-015365-iqdi99pd	1010	32	vasculogenesis	vasculogenesis	NN
cord-015365-iqdi99pd	1010	33	.	.	.
cord-015365-iqdi99pd	1011	1	Methods	method	NNS
cord-015365-iqdi99pd	1011	2	.	.	.
cord-015365-iqdi99pd	1012	1	Adult	adult	JJ
cord-015365-iqdi99pd	1012	2	human	human	NN
cord-015365-iqdi99pd	1012	3	ECFCs	ecfc	NNS
cord-015365-iqdi99pd	1012	4	were	be	VBD
cord-015365-iqdi99pd	1012	5	isolated	isolate	VBN
cord-015365-iqdi99pd	1012	6	directly	directly	RB
cord-015365-iqdi99pd	1012	7	from	from	IN
cord-015365-iqdi99pd	1012	8	whole	whole	JJ
cord-015365-iqdi99pd	1012	9	venous	venous	JJ
cord-015365-iqdi99pd	1012	10	blood	blood	NN
cord-015365-iqdi99pd	1012	11	and	and	CC
cord-015365-iqdi99pd	1012	12	MSPCs	mspc	NNS
cord-015365-iqdi99pd	1012	13	from	from	IN
cord-015365-iqdi99pd	1012	14	human	human	JJ
cord-015365-iqdi99pd	1012	15	bone	bone	NN
cord-015365-iqdi99pd	1012	16	marrow	marrow	NN
cord-015365-iqdi99pd	1012	17	aspirates	aspirate	NNS
cord-015365-iqdi99pd	1012	18	.	.	.
cord-015365-iqdi99pd	1013	1	Pooled	pool	VBN
cord-015365-iqdi99pd	1013	2	human	human	JJ
cord-015365-iqdi99pd	1013	3	platelet	platelet	NN
cord-015365-iqdi99pd	1013	4	lysate	lysate	NN
cord-015365-iqdi99pd	1013	5	entirely	entirely	RB
cord-015365-iqdi99pd	1013	6	replaced	replace	VBD
cord-015365-iqdi99pd	1013	7	fetal	fetal	JJ
cord-015365-iqdi99pd	1013	8	bovine	bovine	JJ
cord-015365-iqdi99pd	1013	9	serum	serum	NN
cord-015365-iqdi99pd	1013	10	during	during	IN
cord-015365-iqdi99pd	1013	11	cell	cell	NN
cord-015365-iqdi99pd	1013	12	culture	culture	NN
cord-015365-iqdi99pd	1013	13	.	.	.
cord-015365-iqdi99pd	1014	1	Progenitor	progenitor	NN
cord-015365-iqdi99pd	1014	2	cell	cell	NN
cord-015365-iqdi99pd	1014	3	phenotype	phenotype	NN
cord-015365-iqdi99pd	1014	4	,	,	,
cord-015365-iqdi99pd	1014	5	long	long	JJ
cord-015365-iqdi99pd	1014	6	-	-	HYPH
cord-015365-iqdi99pd	1014	7	term	term	NN
cord-015365-iqdi99pd	1014	8	proliferation	proliferation	NN
cord-015365-iqdi99pd	1014	9	,	,	,
cord-015365-iqdi99pd	1014	10	molecular	molecular	JJ
cord-015365-iqdi99pd	1014	11	cellular	cellular	JJ
cord-015365-iqdi99pd	1014	12	response	response	NN
cord-015365-iqdi99pd	1014	13	,	,	,
cord-015365-iqdi99pd	1014	14	wound	wind	VBD
cord-015365-iqdi99pd	1014	15	repair	repair	NN
cord-015365-iqdi99pd	1014	16	as	as	RB
cord-015365-iqdi99pd	1014	17	well	well	RB
cord-015365-iqdi99pd	1014	18	as	as	IN
cord-015365-iqdi99pd	1014	19	migratory	migratory	JJ
cord-015365-iqdi99pd	1014	20	and	and	CC
cord-015365-iqdi99pd	1014	21	vasculogenic	vasculogenic	JJ
cord-015365-iqdi99pd	1014	22	functions	function	NNS
cord-015365-iqdi99pd	1014	23	were	be	VBD
cord-015365-iqdi99pd	1014	24	monitored	monitor	VBN
cord-015365-iqdi99pd	1014	25	under	under	IN
cord-015365-iqdi99pd	1014	26	reduced	reduce	VBN
cord-015365-iqdi99pd	1014	27	oxygen	oxygen	NN
cord-015365-iqdi99pd	1014	28	levels	level	NNS
cord-015365-iqdi99pd	1014	29	(	(	-LRB-
cord-015365-iqdi99pd	1014	30	5	5	CD
cord-015365-iqdi99pd	1014	31	%	%	NN
cord-015365-iqdi99pd	1014	32	O	o	NN
cord-015365-iqdi99pd	1014	33	2	2	CD
cord-015365-iqdi99pd	1014	34	)	)	-RRB-
cord-015365-iqdi99pd	1014	35	,	,	,
cord-015365-iqdi99pd	1014	36	severe	severe	JJ
cord-015365-iqdi99pd	1014	37	hypoxia	hypoxia	NN
cord-015365-iqdi99pd	1014	38	(	(	-LRB-
cord-015365-iqdi99pd	1014	39	1	1	CD
cord-015365-iqdi99pd	1014	40	%	%	NN
cord-015365-iqdi99pd	1014	41	O	o	NN
cord-015365-iqdi99pd	1014	42	2	2	CD
cord-015365-iqdi99pd	1014	43	)	)	-RRB-
cord-015365-iqdi99pd	1014	44	and	and	CC
cord-015365-iqdi99pd	1014	45	standard	standard	JJ
cord-015365-iqdi99pd	1014	46	culture	culture	NN
cord-015365-iqdi99pd	1014	47	conditions	condition	NNS
cord-015365-iqdi99pd	1014	48	(	(	-LRB-
cord-015365-iqdi99pd	1014	49	20	20	CD
cord-015365-iqdi99pd	1014	50	%	%	NN
cord-015365-iqdi99pd	1014	51	O	o	NN
cord-015365-iqdi99pd	1014	52	2	2	CD
cord-015365-iqdi99pd	1014	53	)	)	-RRB-
cord-015365-iqdi99pd	1014	54	.	.	.
cord-015365-iqdi99pd	1015	1	ECFC	ECFC	NNP
cord-015365-iqdi99pd	1015	2	and	and	CC
cord-015365-iqdi99pd	1015	3	MSPC	MSPC	NNP
cord-015365-iqdi99pd	1015	4	interaction	interaction	NN
cord-015365-iqdi99pd	1015	5	in	in	IN
cord-015365-iqdi99pd	1015	6	vivo	vivo	NN
cord-015365-iqdi99pd	1015	7	and	and	CC
cord-015365-iqdi99pd	1015	8	the	the	DT
cord-015365-iqdi99pd	1015	9	influence	influence	NN
cord-015365-iqdi99pd	1015	10	of	of	IN
cord-015365-iqdi99pd	1015	11	protein	protein	NN
cord-015365-iqdi99pd	1015	12	synthesis	synthesis	NN
cord-015365-iqdi99pd	1015	13	were	be	VBD
cord-015365-iqdi99pd	1015	14	studied	study	VBN
cord-015365-iqdi99pd	1015	15	in	in	IN
cord-015365-iqdi99pd	1015	16	immune	immune	NN
cord-015365-iqdi99pd	1015	17	-	-	HYPH
cord-015365-iqdi99pd	1015	18	deficient	deficient	JJ
cord-015365-iqdi99pd	1015	19	NSG	NSG	NNP
cord-015365-iqdi99pd	1015	20	mice	mouse	NNS
cord-015365-iqdi99pd	1015	21	after	after	IN
cord-015365-iqdi99pd	1015	22	subcutaneous	subcutaneous	JJ
cord-015365-iqdi99pd	1015	23	injection	injection	NN
cord-015365-iqdi99pd	1015	24	with	with	IN
cord-015365-iqdi99pd	1015	25	matrigel	matrigel	NNP
cord-015365-iqdi99pd	1015	26	.	.	.
cord-015365-iqdi99pd	1016	1	Immune	immune	JJ
cord-015365-iqdi99pd	1016	2	histochemistry	histochemistry	NN
cord-015365-iqdi99pd	1016	3	and	and	CC
cord-015365-iqdi99pd	1016	4	TUNEL	TUNEL	NNP
cord-015365-iqdi99pd	1016	5	assays	assay	NNS
cord-015365-iqdi99pd	1016	6	were	be	VBD
cord-015365-iqdi99pd	1016	7	performed	perform	VBN
cord-015365-iqdi99pd	1016	8	on	on	IN
cord-015365-iqdi99pd	1016	9	explants	explant	NNS
cord-015365-iqdi99pd	1016	10	in	in	IN
cord-015365-iqdi99pd	1016	11	the	the	DT
cord-015365-iqdi99pd	1016	12	time	time	NN
cord-015365-iqdi99pd	1016	13	course	course	NN
cord-015365-iqdi99pd	1016	14	after	after	IN
cord-015365-iqdi99pd	1016	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	1016	16	.	.	.
cord-015365-iqdi99pd	1017	1	Results	result	NNS
cord-015365-iqdi99pd	1017	2	.	.	.
cord-015365-iqdi99pd	1018	1	In	in	IN
cord-015365-iqdi99pd	1018	2	vitro	vitro	FW
cord-015365-iqdi99pd	1018	3	ECFC	ECFC	NNP
cord-015365-iqdi99pd	1018	4	and	and	CC
cord-015365-iqdi99pd	1018	5	MSPC	MSPC	NNP
cord-015365-iqdi99pd	1018	6	proliferation	proliferation	NN
cord-015365-iqdi99pd	1018	7	was	be	VBD
cord-015365-iqdi99pd	1018	8	reduced	reduce	VBN
cord-015365-iqdi99pd	1018	9	with	with	IN
cord-015365-iqdi99pd	1018	10	declining	decline	VBG
cord-015365-iqdi99pd	1018	11	oxygen	oxygen	NN
cord-015365-iqdi99pd	1018	12	levels	level	NNS
cord-015365-iqdi99pd	1018	13	,	,	,
cord-015365-iqdi99pd	1018	14	while	while	IN
cord-015365-iqdi99pd	1018	15	the	the	DT
cord-015365-iqdi99pd	1018	16	absolute	absolute	JJ
cord-015365-iqdi99pd	1018	17	colony	colony	NN
cord-015365-iqdi99pd	1018	18	number	number	NN
cord-015365-iqdi99pd	1018	19	remained	remain	VBD
cord-015365-iqdi99pd	1018	20	unchanged	unchanged	JJ
cord-015365-iqdi99pd	1018	21	.	.	.
cord-015365-iqdi99pd	1019	1	ECFC	ECFC	NNP
cord-015365-iqdi99pd	1019	2	vascular	vascular	JJ
cord-015365-iqdi99pd	1019	3	wound	wind	VBD
cord-015365-iqdi99pd	1019	4	repair	repair	NN
cord-015365-iqdi99pd	1019	5	and	and	CC
cord-015365-iqdi99pd	1019	6	vascular	vascular	JJ
cord-015365-iqdi99pd	1019	7	-	-	HYPH
cord-015365-iqdi99pd	1019	8	like	like	JJ
cord-015365-iqdi99pd	1019	9	network	network	NN
cord-015365-iqdi99pd	1019	10	formation	formation	NN
cord-015365-iqdi99pd	1019	11	in	in	IN
cord-015365-iqdi99pd	1019	12	vitro	vitro	FW
cord-015365-iqdi99pd	1019	13	improved	improve	VBN
cord-015365-iqdi99pd	1019	14	with	with	IN
cord-015365-iqdi99pd	1019	15	escalating	escalate	VBG
cord-015365-iqdi99pd	1019	16	oxygen	oxygen	NN
cord-015365-iqdi99pd	1019	17	supply	supply	NN
cord-015365-iqdi99pd	1019	18	.	.	.
cord-015365-iqdi99pd	1020	1	ECFCs	ECFCs	NNP
cord-015365-iqdi99pd	1020	2	stabilize	stabilize	VB
cord-015365-iqdi99pd	1020	3	hypoxia	hypoxia	NN
cord-015365-iqdi99pd	1020	4	-	-	HYPH
cord-015365-iqdi99pd	1020	5	inducing	induce	VBG
cord-015365-iqdi99pd	1020	6	factor-1	factor-1	NNP
cord-015365-iqdi99pd	1021	1	(	(	-LRB-
cord-015365-iqdi99pd	1021	2	HIF-1	HIF-1	NNP
cord-015365-iqdi99pd	1021	3	)	)	-RRB-
cord-015365-iqdi99pd	1021	4	only	only	RB
cord-015365-iqdi99pd	1021	5	under	under	IN
cord-015365-iqdi99pd	1021	6	1	1	CD
cord-015365-iqdi99pd	1021	7	%	%	NN
cord-015365-iqdi99pd	1021	8	O	o	NN
cord-015365-iqdi99pd	1021	9	2	2	CD
cord-015365-iqdi99pd	1021	10	,	,	,
cord-015365-iqdi99pd	1021	11	while	while	IN
cord-015365-iqdi99pd	1021	12	MSPCs	mspc	NNS
cord-015365-iqdi99pd	1021	13	stabilize	stabilize	VBP
cord-015365-iqdi99pd	1021	14	HIF-1	HIF-1	NNP
cord-015365-iqdi99pd	1021	15	under	under	IN
cord-015365-iqdi99pd	1021	16	1	1	CD
cord-015365-iqdi99pd	1021	17	%	%	NN
cord-015365-iqdi99pd	1021	18	O	o	NN
cord-015365-iqdi99pd	1021	19	2	2	CD
cord-015365-iqdi99pd	1021	20	as	as	RB
cord-015365-iqdi99pd	1021	21	well	well	RB
cord-015365-iqdi99pd	1021	22	as	as	IN
cord-015365-iqdi99pd	1021	23	5	5	CD
cord-015365-iqdi99pd	1021	24	%	%	NN
cord-015365-iqdi99pd	1021	25	O	o	NN
cord-015365-iqdi99pd	1021	26	2	2	CD
cord-015365-iqdi99pd	1021	27	conditions	condition	NNS
cord-015365-iqdi99pd	1021	28	.	.	.
cord-015365-iqdi99pd	1022	1	In	in	IN
cord-015365-iqdi99pd	1022	2	a	a	DT
cord-015365-iqdi99pd	1022	3	mouse	mouse	NN
cord-015365-iqdi99pd	1022	4	model	model	NN
cord-015365-iqdi99pd	1022	5	,	,	,
cord-015365-iqdi99pd	1022	6	injected	inject	VBN
cord-015365-iqdi99pd	1022	7	ECFCs	ECFCs	NNP
cord-015365-iqdi99pd	1022	8	underwent	undergo	VBD
cord-015365-iqdi99pd	1022	9	apoptosis	apoptosis	NN
cord-015365-iqdi99pd	1022	10	after	after	IN
cord-015365-iqdi99pd	1022	11	1	1	CD
cord-015365-iqdi99pd	1022	12	day	day	NN
cord-015365-iqdi99pd	1022	13	and	and	CC
cord-015365-iqdi99pd	1022	14	attracted	attract	VBD
cord-015365-iqdi99pd	1022	15	mouse	mouse	NN
cord-015365-iqdi99pd	1022	16	leucocytes	leucocyte	NNS
cord-015365-iqdi99pd	1022	17	.	.	.
cord-015365-iqdi99pd	1023	1	In	in	IN
cord-015365-iqdi99pd	1023	2	vivo	vivo	NN
cord-015365-iqdi99pd	1023	3	co	co	JJ
cord-015365-iqdi99pd	1023	4	-	-	JJ
cord-015365-iqdi99pd	1023	5	cultured	cultured	JJ
cord-015365-iqdi99pd	1023	6	ECFCs	ecfc	NNS
cord-015365-iqdi99pd	1023	7	and	and	CC
cord-015365-iqdi99pd	1023	8	MSPCs	mspc	NNS
cord-015365-iqdi99pd	1023	9	formed	form	VBD
cord-015365-iqdi99pd	1023	10	perfused	perfuse	VBN
cord-015365-iqdi99pd	1023	11	human	human	JJ
cord-015365-iqdi99pd	1023	12	vessels	vessel	NNS
cord-015365-iqdi99pd	1023	13	7	7	CD
cord-015365-iqdi99pd	1023	14	days	day	NNS
cord-015365-iqdi99pd	1023	15	after	after	IN
cord-015365-iqdi99pd	1023	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	1023	17	.	.	.
cord-015365-iqdi99pd	1024	1	Perivascular	Perivascular	NNP
cord-015365-iqdi99pd	1024	2	cells	cell	NNS
cord-015365-iqdi99pd	1024	3	,	,	,
cord-015365-iqdi99pd	1024	4	but	but	CC
cord-015365-iqdi99pd	1024	5	not	not	RB
cord-015365-iqdi99pd	1024	6	ECFCs	ECFCs	NNP
cord-015365-iqdi99pd	1024	7	,	,	,
cord-015365-iqdi99pd	1024	8	in	in	IN
cord-015365-iqdi99pd	1024	9	vivo	vivo	NNP
cord-015365-iqdi99pd	1024	10	were	be	VBD
cord-015365-iqdi99pd	1024	11	positive	positive	JJ
cord-015365-iqdi99pd	1024	12	for	for	IN
cord-015365-iqdi99pd	1024	13	HIF-1	HIF-1	NNP
cord-015365-iqdi99pd	1024	14	.	.	.
cord-015365-iqdi99pd	1025	1	Inhibition	inhibition	NN
cord-015365-iqdi99pd	1025	2	of	of	IN
cord-015365-iqdi99pd	1025	3	MSPC	MSPC	NNP
cord-015365-iqdi99pd	1025	4	,	,	,
cord-015365-iqdi99pd	1025	5	but	but	CC
cord-015365-iqdi99pd	1025	6	not	not	RB
cord-015365-iqdi99pd	1025	7	ECFC	ECFC	NNP
cord-015365-iqdi99pd	1025	8	,	,	,
cord-015365-iqdi99pd	1025	9	protein	protein	NN
cord-015365-iqdi99pd	1025	10	synthesis	synthesis	NN
cord-015365-iqdi99pd	1025	11	and	and	CC
cord-015365-iqdi99pd	1025	12	HIF-1	HIF-1	NNP
cord-015365-iqdi99pd	1025	13	stabilization	stabilization	NN
cord-015365-iqdi99pd	1025	14	prior	prior	RB
cord-015365-iqdi99pd	1025	15	to	to	IN
cord-015365-iqdi99pd	1025	16	co	co	JJ
cord-015365-iqdi99pd	1025	17	-	-	NN
cord-015365-iqdi99pd	1025	18	implantation	implantation	JJ
cord-015365-iqdi99pd	1025	19	blocked	block	VBN
cord-015365-iqdi99pd	1025	20	vessel	vessel	NN
cord-015365-iqdi99pd	1025	21	formation	formation	NN
cord-015365-iqdi99pd	1025	22	.	.	.
cord-015365-iqdi99pd	1026	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1026	2	.	.	.
cord-015365-iqdi99pd	1027	1	These	these	DT
cord-015365-iqdi99pd	1027	2	data	datum	NNS
cord-015365-iqdi99pd	1027	3	indicate	indicate	VBP
cord-015365-iqdi99pd	1027	4	that	that	IN
cord-015365-iqdi99pd	1027	5	hypoxic	hypoxic	JJ
cord-015365-iqdi99pd	1027	6	ECFCs	ecfc	NNS
cord-015365-iqdi99pd	1027	7	alone	alone	RB
cord-015365-iqdi99pd	1027	8	are	be	VBP
cord-015365-iqdi99pd	1027	9	not	not	RB
cord-015365-iqdi99pd	1027	10	able	able	JJ
cord-015365-iqdi99pd	1027	11	to	to	TO
cord-015365-iqdi99pd	1027	12	function	function	VB
cord-015365-iqdi99pd	1027	13	in	in	IN
cord-015365-iqdi99pd	1027	14	vitro	vitro	FW
cord-015365-iqdi99pd	1027	15	and	and	CC
cord-015365-iqdi99pd	1027	16	form	form	VB
cord-015365-iqdi99pd	1027	17	patent	patent	NN
cord-015365-iqdi99pd	1027	18	vessels	vessel	NNS
cord-015365-iqdi99pd	1027	19	in	in	IN
cord-015365-iqdi99pd	1027	20	vivo	vivo	NN
cord-015365-iqdi99pd	1027	21	.	.	.
cord-015365-iqdi99pd	1028	1	MSPCs	mspc	NNS
cord-015365-iqdi99pd	1028	2	react	react	VB
cord-015365-iqdi99pd	1028	3	to	to	IN
cord-015365-iqdi99pd	1028	4	the	the	DT
cord-015365-iqdi99pd	1028	5	low	low	JJ
cord-015365-iqdi99pd	1028	6	oxygen	oxygen	NN
cord-015365-iqdi99pd	1028	7	environment	environment	NN
cord-015365-iqdi99pd	1028	8	and	and	CC
cord-015365-iqdi99pd	1028	9	promote	promote	VB
cord-015365-iqdi99pd	1028	10	ECFCs	ecfc	NNS
cord-015365-iqdi99pd	1028	11	to	to	TO
cord-015365-iqdi99pd	1028	12	form	form	VB
cord-015365-iqdi99pd	1028	13	vessels	vessel	NNS
cord-015365-iqdi99pd	1028	14	at	at	IN
cord-015365-iqdi99pd	1028	15	least	least	JJS
cord-015365-iqdi99pd	1028	16	in	in	IN
cord-015365-iqdi99pd	1028	17	part	part	NN
cord-015365-iqdi99pd	1028	18	by	by	IN
cord-015365-iqdi99pd	1028	19	rescuing	rescue	VBG
cord-015365-iqdi99pd	1028	20	ECFCs	ecfc	NNS
cord-015365-iqdi99pd	1028	21	from	from	IN
cord-015365-iqdi99pd	1028	22	hypoxia	hypoxia	NN
cord-015365-iqdi99pd	1028	23	-	-	HYPH
cord-015365-iqdi99pd	1028	24	induced	induce	VBN
cord-015365-iqdi99pd	1028	25	apoptosis	apoptosis	NN
cord-015365-iqdi99pd	1028	26	.	.	.
cord-015365-iqdi99pd	1029	1	This	this	DT
cord-015365-iqdi99pd	1029	2	suggests	suggest	VBZ
cord-015365-iqdi99pd	1029	3	that	that	IN
cord-015365-iqdi99pd	1029	4	oxygen	oxygen	NN
cord-015365-iqdi99pd	1029	5	sensing	sensing	NN
cord-015365-iqdi99pd	1029	6	MSPCs	mspc	NNS
cord-015365-iqdi99pd	1029	7	are	be	VBP
cord-015365-iqdi99pd	1029	8	a	a	DT
cord-015365-iqdi99pd	1029	9	key	key	JJ
cord-015365-iqdi99pd	1029	10	factor	factor	NN
cord-015365-iqdi99pd	1029	11	in	in	IN
cord-015365-iqdi99pd	1029	12	stem	stem	NN
cord-015365-iqdi99pd	1029	13	cell	cell	NN
cord-015365-iqdi99pd	1029	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	1029	15	and	and	CC
cord-015365-iqdi99pd	1029	16	regenerative	regenerative	JJ
cord-015365-iqdi99pd	1029	17	medicine	medicine	NN
cord-015365-iqdi99pd	1029	18	.	.	.
cord-015365-iqdi99pd	1030	1	Background	background	NN
cord-015365-iqdi99pd	1030	2	.	.	.
cord-015365-iqdi99pd	1031	1	Low	low	JJ
cord-015365-iqdi99pd	1031	2	sensitivity	sensitivity	NN
cord-015365-iqdi99pd	1031	3	and	and	CC
cord-015365-iqdi99pd	1031	4	specificity	specificity	NN
cord-015365-iqdi99pd	1031	5	rates	rate	NNS
cord-015365-iqdi99pd	1031	6	for	for	IN
cord-015365-iqdi99pd	1031	7	the	the	DT
cord-015365-iqdi99pd	1031	8	detection	detection	NN
cord-015365-iqdi99pd	1031	9	of	of	IN
cord-015365-iqdi99pd	1031	10	invasive	invasive	JJ
cord-015365-iqdi99pd	1031	11	pulmonary	pulmonary	JJ
cord-015365-iqdi99pd	1031	12	mycosis	mycosis	NN
cord-015365-iqdi99pd	1031	13	result	result	NN
cord-015365-iqdi99pd	1031	14	in	in	IN
cord-015365-iqdi99pd	1031	15	a	a	DT
cord-015365-iqdi99pd	1031	16	major	major	JJ
cord-015365-iqdi99pd	1031	17	cause	cause	NN
cord-015365-iqdi99pd	1031	18	of	of	IN
cord-015365-iqdi99pd	1031	19	mortality	mortality	NN
cord-015365-iqdi99pd	1031	20	among	among	IN
cord-015365-iqdi99pd	1031	21	immunosuppressed	immunosuppressed	JJ
cord-015365-iqdi99pd	1031	22	children	child	NNS
cord-015365-iqdi99pd	1031	23	.	.	.
cord-015365-iqdi99pd	1032	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1032	2	sought	seek	VBD
cord-015365-iqdi99pd	1032	3	to	to	TO
cord-015365-iqdi99pd	1032	4	determine	determine	VB
cord-015365-iqdi99pd	1032	5	the	the	DT
cord-015365-iqdi99pd	1032	6	accuracy	accuracy	NN
cord-015365-iqdi99pd	1032	7	of	of	IN
cord-015365-iqdi99pd	1032	8	percutaneous	percutaneous	JJ
cord-015365-iqdi99pd	1032	9	computed	compute	VBN
cord-015365-iqdi99pd	1032	10	tomographyguided	tomographyguide	VBN
cord-015365-iqdi99pd	1032	11	biopsy	biopsy	NN
cord-015365-iqdi99pd	1032	12	in	in	IN
cord-015365-iqdi99pd	1032	13	children	child	NNS
cord-015365-iqdi99pd	1032	14	with	with	IN
cord-015365-iqdi99pd	1032	15	cancer	cancer	NN
cord-015365-iqdi99pd	1032	16	and	and	CC
cord-015365-iqdi99pd	1032	17	hematopoetic	hematopoetic	JJ
cord-015365-iqdi99pd	1032	18	stem	stem	NN
cord-015365-iqdi99pd	1032	19	cell	cell	NN
cord-015365-iqdi99pd	1032	20	transplantion	transplantion	NN
cord-015365-iqdi99pd	1032	21	.	.	.
cord-015365-iqdi99pd	1033	1	Methods	method	NNS
cord-015365-iqdi99pd	1033	2	.	.	.
cord-015365-iqdi99pd	1034	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1034	2	retrospectively	retrospectively	RB
cord-015365-iqdi99pd	1034	3	reviewed	review	VBD
cord-015365-iqdi99pd	1034	4	17	17	CD
cord-015365-iqdi99pd	1034	5	imaging	imaging	NN
cord-015365-iqdi99pd	1034	6	-	-	HYPH
cord-015365-iqdi99pd	1034	7	guided	guide	VBN
cord-015365-iqdi99pd	1034	8	percutaneous	percutaneous	JJ
cord-015365-iqdi99pd	1034	9	biopsies	biopsy	NNS
cord-015365-iqdi99pd	1034	10	of	of	IN
cord-015365-iqdi99pd	1034	11	17	17	CD
cord-015365-iqdi99pd	1034	12	children	child	NNS
cord-015365-iqdi99pd	1034	13	for	for	IN
cord-015365-iqdi99pd	1034	14	suspicious	suspicious	JJ
cord-015365-iqdi99pd	1034	15	lesions	lesion	NNS
cord-015365-iqdi99pd	1034	16	detected	detect	VBN
cord-015365-iqdi99pd	1034	17	by	by	IN
cord-015365-iqdi99pd	1034	18	computed	compute	VBN
cord-015365-iqdi99pd	1034	19	tomography	tomography	NN
cord-015365-iqdi99pd	1034	20	.	.	.
cord-015365-iqdi99pd	1035	1	Thirteen	thirteen	CD
cord-015365-iqdi99pd	1035	2	were	be	VBD
cord-015365-iqdi99pd	1035	3	being	be	VBG
cord-015365-iqdi99pd	1035	4	treated	treat	VBN
cord-015365-iqdi99pd	1035	5	for	for	IN
cord-015365-iqdi99pd	1035	6	hematologic	hematologic	JJ
cord-015365-iqdi99pd	1035	7	malignancies	malignancy	NNS
cord-015365-iqdi99pd	1035	8	,	,	,
cord-015365-iqdi99pd	1035	9	three	three	CD
cord-015365-iqdi99pd	1035	10	for	for	IN
cord-015365-iqdi99pd	1035	11	solid	solid	JJ
cord-015365-iqdi99pd	1035	12	tumors	tumor	NNS
cord-015365-iqdi99pd	1035	13	,	,	,
cord-015365-iqdi99pd	1035	14	one	one	CD
cord-015365-iqdi99pd	1035	15	for	for	IN
cord-015365-iqdi99pd	1035	16	immunodeficiency	immunodeficiency	NN
cord-015365-iqdi99pd	1035	17	;	;	:
cord-015365-iqdi99pd	1035	18	47	47	CD
cord-015365-iqdi99pd	1035	19	%	%	NN
cord-015365-iqdi99pd	1035	20	had	have	VBD
cord-015365-iqdi99pd	1035	21	received	receive	VBN
cord-015365-iqdi99pd	1035	22	allogeneic	allogeneic	IN
cord-015365-iqdi99pd	1035	23	bone	bone	NN
cord-015365-iqdi99pd	1035	24	marrow	marrow	NN
cord-015365-iqdi99pd	1035	25	or	or	CC
cord-015365-iqdi99pd	1035	26	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1035	27	stem	stem	NN
cord-015365-iqdi99pd	1035	28	cell	cell	NN
cord-015365-iqdi99pd	1035	29	transplants	transplant	NNS
cord-015365-iqdi99pd	1035	30	.	.	.
cord-015365-iqdi99pd	1036	1	The	the	DT
cord-015365-iqdi99pd	1036	2	accuracy	accuracy	NN
cord-015365-iqdi99pd	1036	3	of	of	IN
cord-015365-iqdi99pd	1036	4	the	the	DT
cord-015365-iqdi99pd	1036	5	percutaneous	percutaneous	JJ
cord-015365-iqdi99pd	1036	6	lung	lung	NN
cord-015365-iqdi99pd	1036	7	biopsy	biopsy	NN
cord-015365-iqdi99pd	1036	8	was	be	VBD
cord-015365-iqdi99pd	1036	9	determined	determine	VBN
cord-015365-iqdi99pd	1036	10	by	by	IN
cord-015365-iqdi99pd	1036	11	subsequent	subsequent	JJ
cord-015365-iqdi99pd	1036	12	surgical	surgical	JJ
cord-015365-iqdi99pd	1036	13	resection	resection	NN
cord-015365-iqdi99pd	1036	14	,	,	,
cord-015365-iqdi99pd	1036	15	autopsy	autopsy	JJ
cord-015365-iqdi99pd	1036	16	,	,	,
cord-015365-iqdi99pd	1036	17	or	or	CC
cord-015365-iqdi99pd	1036	18	clinical	clinical	JJ
cord-015365-iqdi99pd	1036	19	course	course	NN
cord-015365-iqdi99pd	1036	20	.	.	.
cord-015365-iqdi99pd	1037	1	Results	result	NNS
cord-015365-iqdi99pd	1037	2	.	.	.
cord-015365-iqdi99pd	1038	1	Histopathological	Histopathological	NNP
cord-015365-iqdi99pd	1038	2	studies	study	NNS
cord-015365-iqdi99pd	1038	3	showed	show	VBD
cord-015365-iqdi99pd	1038	4	11	11	CD
cord-015365-iqdi99pd	1038	5	biopsy	biopsy	NN
cord-015365-iqdi99pd	1038	6	specimens	specimen	NNS
cord-015365-iqdi99pd	1038	7	with	with	IN
cord-015365-iqdi99pd	1038	8	septate	septate	JJ
cord-015365-iqdi99pd	1038	9	hyphae	hypha	NNS
cord-015365-iqdi99pd	1038	10	,	,	,
cord-015365-iqdi99pd	1038	11	indicating	indicate	VBG
cord-015365-iqdi99pd	1038	12	a	a	DT
cord-015365-iqdi99pd	1038	13	mold	mold	NN
cord-015365-iqdi99pd	1038	14	,	,	,
cord-015365-iqdi99pd	1038	15	including	include	VBG
cord-015365-iqdi99pd	1038	16	6	6	CD
cord-015365-iqdi99pd	1038	17	with	with	IN
cord-015365-iqdi99pd	1038	18	Aspergillus	Aspergillus	NNP
cord-015365-iqdi99pd	1038	19	,	,	,
cord-015365-iqdi99pd	1038	20	4	4	CD
cord-015365-iqdi99pd	1038	21	with	with	IN
cord-015365-iqdi99pd	1038	22	Mycoraceae	Mycoraceae	NNP
cord-015365-iqdi99pd	1038	23	,	,	,
cord-015365-iqdi99pd	1038	24	1	1	CD
cord-015365-iqdi99pd	1038	25	with	with	IN
cord-015365-iqdi99pd	1038	26	Aspergillus	Aspergillus	NNP
cord-015365-iqdi99pd	1038	27	and	and	CC
cord-015365-iqdi99pd	1038	28	Mycoraceae	Mycoraceae	NNP
cord-015365-iqdi99pd	1038	29	colonies	colony	NNS
cord-015365-iqdi99pd	1038	30	in	in	IN
cord-015365-iqdi99pd	1038	31	culture	culture	NN
cord-015365-iqdi99pd	1038	32	;	;	:
cord-015365-iqdi99pd	1038	33	2	2	CD
cord-015365-iqdi99pd	1038	34	specimens	specimen	NNS
cord-015365-iqdi99pd	1038	35	revealed	reveal	VBD
cord-015365-iqdi99pd	1038	36	Candida	Candida	NNP
cord-015365-iqdi99pd	1038	37	,	,	,
cord-015365-iqdi99pd	1038	38	1	1	CD
cord-015365-iqdi99pd	1038	39	Saccharomyces	saccharomyce	NNS
cord-015365-iqdi99pd	1038	40	.	.	.
cord-015365-iqdi99pd	1039	1	The	the	DT
cord-015365-iqdi99pd	1039	2	remaining	remain	VBG
cord-015365-iqdi99pd	1039	3	3	3	CD
cord-015365-iqdi99pd	1039	4	biopsies	biopsy	NNS
cord-015365-iqdi99pd	1039	5	revealed	reveal	VBD
cord-015365-iqdi99pd	1039	6	bronchiolits	bronchiolit	NNS
cord-015365-iqdi99pd	1039	7	obliterans	obliterans	NN
cord-015365-iqdi99pd	1039	8	pneumoniae	pneumoniae	NN
cord-015365-iqdi99pd	1039	9	.	.	.
cord-015365-iqdi99pd	1040	1	Invasive	invasive	JJ
cord-015365-iqdi99pd	1040	2	pulmonary	pulmonary	JJ
cord-015365-iqdi99pd	1040	3	mycosis	mycosis	NN
cord-015365-iqdi99pd	1040	4	was	be	VBD
cord-015365-iqdi99pd	1040	5	detected	detect	VBN
cord-015365-iqdi99pd	1040	6	by	by	IN
cord-015365-iqdi99pd	1040	7	percutaneous	percutaneous	JJ
cord-015365-iqdi99pd	1040	8	biopsy	biopsy	NN
cord-015365-iqdi99pd	1040	9	with	with	IN
cord-015365-iqdi99pd	1040	10	100	100	CD
cord-015365-iqdi99pd	1040	11	%	%	NN
cord-015365-iqdi99pd	1040	12	sensitivity	sensitivity	NN
cord-015365-iqdi99pd	1040	13	and	and	CC
cord-015365-iqdi99pd	1040	14	100	100	CD
cord-015365-iqdi99pd	1040	15	%	%	NN
cord-015365-iqdi99pd	1040	16	(	(	-LRB-
cord-015365-iqdi99pd	1040	17	14/14	14/14	CD
cord-015365-iqdi99pd	1040	18	)	)	-RRB-
cord-015365-iqdi99pd	1040	19	specificity	specificity	NN
cord-015365-iqdi99pd	1040	20	.	.	.
cord-015365-iqdi99pd	1041	1	Percutaneous	Percutaneous	NNP
cord-015365-iqdi99pd	1041	2	biopsy	biopsy	NN
cord-015365-iqdi99pd	1041	3	results	result	NNS
cord-015365-iqdi99pd	1041	4	influenced	influence	VBD
cord-015365-iqdi99pd	1041	5	the	the	DT
cord-015365-iqdi99pd	1041	6	surgical	surgical	JJ
cord-015365-iqdi99pd	1041	7	decision	decision	NN
cord-015365-iqdi99pd	1041	8	in	in	IN
cord-015365-iqdi99pd	1041	9	21	21	CD
cord-015365-iqdi99pd	1041	10	%	%	NN
cord-015365-iqdi99pd	1041	11	(	(	-LRB-
cord-015365-iqdi99pd	1041	12	3	3	CD
cord-015365-iqdi99pd	1041	13	of	of	IN
cord-015365-iqdi99pd	1041	14	14	14	CD
cord-015365-iqdi99pd	1041	15	)	)	-RRB-
cord-015365-iqdi99pd	1041	16	and	and	CC
cord-015365-iqdi99pd	1041	17	changed	change	VBD
cord-015365-iqdi99pd	1041	18	the	the	DT
cord-015365-iqdi99pd	1041	19	treatment	treatment	NN
cord-015365-iqdi99pd	1041	20	option	option	NN
cord-015365-iqdi99pd	1041	21	in	in	IN
cord-015365-iqdi99pd	1041	22	78	78	CD
cord-015365-iqdi99pd	1041	23	%	%	NN
cord-015365-iqdi99pd	1041	24	of	of	IN
cord-015365-iqdi99pd	1041	25	the	the	DT
cord-015365-iqdi99pd	1041	26	cases	case	NNS
cord-015365-iqdi99pd	1041	27	.	.	.
cord-015365-iqdi99pd	1042	1	Pneumothorax	Pneumothorax	NNP
cord-015365-iqdi99pd	1042	2	complicated	complicate	VBD
cord-015365-iqdi99pd	1042	3	the	the	DT
cord-015365-iqdi99pd	1042	4	biopsy	biopsy	NN
cord-015365-iqdi99pd	1042	5	in	in	IN
cord-015365-iqdi99pd	1042	6	one	one	CD
cord-015365-iqdi99pd	1042	7	patient	patient	NN
cord-015365-iqdi99pd	1042	8	.	.	.
cord-015365-iqdi99pd	1043	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1043	2	.	.	.
cord-015365-iqdi99pd	1044	1	Percutaneous	Percutaneous	NNP
cord-015365-iqdi99pd	1044	2	computed	compute	VBD
cord-015365-iqdi99pd	1044	3	tomography	tomography	NN
cord-015365-iqdi99pd	1044	4	-	-	HYPH
cord-015365-iqdi99pd	1044	5	guided	guide	VBN
cord-015365-iqdi99pd	1044	6	biopsy	biopsy	NN
cord-015365-iqdi99pd	1044	7	is	be	VBZ
cord-015365-iqdi99pd	1044	8	an	an	DT
cord-015365-iqdi99pd	1044	9	accurate	accurate	JJ
cord-015365-iqdi99pd	1044	10	technique	technique	NN
cord-015365-iqdi99pd	1044	11	for	for	IN
cord-015365-iqdi99pd	1044	12	the	the	DT
cord-015365-iqdi99pd	1044	13	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1044	14	of	of	IN
cord-015365-iqdi99pd	1044	15	invasive	invasive	JJ
cord-015365-iqdi99pd	1044	16	pulmonary	pulmonary	JJ
cord-015365-iqdi99pd	1044	17	mycosis	mycosis	NN
cord-015365-iqdi99pd	1044	18	in	in	IN
cord-015365-iqdi99pd	1044	19	children	child	NNS
cord-015365-iqdi99pd	1044	20	.	.	.
cord-015365-iqdi99pd	1045	1	It	-PRON-	PRP
cord-015365-iqdi99pd	1045	2	reveals	reveal	VBZ
cord-015365-iqdi99pd	1045	3	the	the	DT
cord-015365-iqdi99pd	1045	4	local	local	JJ
cord-015365-iqdi99pd	1045	5	epidemiology	epidemiology	NN
cord-015365-iqdi99pd	1045	6	,	,	,
cord-015365-iqdi99pd	1045	7	correctly	correctly	RB
cord-015365-iqdi99pd	1045	8	determines	determine	VBZ
cord-015365-iqdi99pd	1045	9	the	the	DT
cord-015365-iqdi99pd	1045	10	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1045	11	anti	anti	JJ
cord-015365-iqdi99pd	1045	12	-	-	JJ
cord-015365-iqdi99pd	1045	13	mycotic	mycotic	JJ
cord-015365-iqdi99pd	1045	14	agent	agent	NN
cord-015365-iqdi99pd	1045	15	and	and	CC
cord-015365-iqdi99pd	1045	16	influences	influence	VBZ
cord-015365-iqdi99pd	1045	17	the	the	DT
cord-015365-iqdi99pd	1045	18	choice	choice	NN
cord-015365-iqdi99pd	1045	19	of	of	IN
cord-015365-iqdi99pd	1045	20	prophylaxis	prophylaxis	NN
cord-015365-iqdi99pd	1045	21	for	for	IN
cord-015365-iqdi99pd	1045	22	invasive	invasive	JJ
cord-015365-iqdi99pd	1045	23	mycosis	mycosi	NNS
cord-015365-iqdi99pd	1045	24	.	.	.
cord-015365-iqdi99pd	1046	1	Methods	method	NNS
cord-015365-iqdi99pd	1046	2	.	.	.
cord-015365-iqdi99pd	1047	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1047	2	now	now	RB
cord-015365-iqdi99pd	1047	3	report	report	VBP
cord-015365-iqdi99pd	1047	4	for	for	IN
cord-015365-iqdi99pd	1047	5	the	the	DT
cord-015365-iqdi99pd	1047	6	first	first	JJ
cord-015365-iqdi99pd	1047	7	time	time	NN
cord-015365-iqdi99pd	1047	8	a	a	DT
cord-015365-iqdi99pd	1047	9	modified	modify	VBN
cord-015365-iqdi99pd	1047	10	implantation	implantation	NN
cord-015365-iqdi99pd	1047	11	technique	technique	NN
cord-015365-iqdi99pd	1047	12	by	by	IN
cord-015365-iqdi99pd	1047	13	cannulating	cannulate	VBG
cord-015365-iqdi99pd	1047	14	the	the	DT
cord-015365-iqdi99pd	1047	15	right	right	JJ
cord-015365-iqdi99pd	1047	16	atrium	atrium	NN
cord-015365-iqdi99pd	1047	17	in	in	IN
cord-015365-iqdi99pd	1047	18	order	order	NN
cord-015365-iqdi99pd	1047	19	to	to	TO
cord-015365-iqdi99pd	1047	20	reach	reach	VB
cord-015365-iqdi99pd	1047	21	better	well	JJR
cord-015365-iqdi99pd	1047	22	hemodynamics	hemodynamic	NNS
cord-015365-iqdi99pd	1047	23	for	for	IN
cord-015365-iqdi99pd	1047	24	right	right	JJ
cord-015365-iqdi99pd	1047	25	side	side	NN
cord-015365-iqdi99pd	1047	26	support	support	NN
cord-015365-iqdi99pd	1047	27	.	.	.
cord-015365-iqdi99pd	1048	1	To	to	TO
cord-015365-iqdi99pd	1048	2	place	place	VB
cord-015365-iqdi99pd	1048	3	the	the	DT
cord-015365-iqdi99pd	1048	4	HeartWare	HeartWare	NNP
cord-015365-iqdi99pd	1048	5	system	system	NN
cord-015365-iqdi99pd	1048	6	in	in	IN
cord-015365-iqdi99pd	1048	7	the	the	DT
cord-015365-iqdi99pd	1048	8	area	area	NN
cord-015365-iqdi99pd	1048	9	of	of	IN
cord-015365-iqdi99pd	1048	10	the	the	DT
cord-015365-iqdi99pd	1048	11	right	right	JJ
cord-015365-iqdi99pd	1048	12	atrium	atrium	NN
cord-015365-iqdi99pd	1048	13	we	-PRON-	PRP
cord-015365-iqdi99pd	1048	14	have	have	VBP
cord-015365-iqdi99pd	1048	15	created	create	VBN
cord-015365-iqdi99pd	1048	16	a	a	DT
cord-015365-iqdi99pd	1048	17	cavity	cavity	NN
cord-015365-iqdi99pd	1048	18	(	(	-LRB-
cord-015365-iqdi99pd	1048	19	8Â8	8â8	CD
cord-015365-iqdi99pd	1048	20	cm	cm	NN
cord-015365-iqdi99pd	1048	21	)	)	-RRB-
cord-015365-iqdi99pd	1048	22	in	in	IN
cord-015365-iqdi99pd	1048	23	the	the	DT
cord-015365-iqdi99pd	1048	24	right	right	JJ
cord-015365-iqdi99pd	1048	25	-	-	HYPH
cord-015365-iqdi99pd	1048	26	sided	sided	JJ
cord-015365-iqdi99pd	1048	27	pericardium	pericardium	NN
cord-015365-iqdi99pd	1048	28	using	use	VBG
cord-015365-iqdi99pd	1048	29	a	a	DT
cord-015365-iqdi99pd	1048	30	PTFE	PTFE	NNP
cord-015365-iqdi99pd	1048	31	membrane	membrane	NN
cord-015365-iqdi99pd	1048	32	.	.	.
cord-015365-iqdi99pd	1049	1	Results	result	NNS
cord-015365-iqdi99pd	1049	2	.	.	.
cord-015365-iqdi99pd	1050	1	The	the	DT
cord-015365-iqdi99pd	1050	2	design	design	NN
cord-015365-iqdi99pd	1050	3	of	of	IN
cord-015365-iqdi99pd	1050	4	the	the	DT
cord-015365-iqdi99pd	1050	5	HeartWare	HeartWare	NNP
cord-015365-iqdi99pd	1050	6	device	device	NN
cord-015365-iqdi99pd	1050	7	enables	enable	VBZ
cord-015365-iqdi99pd	1050	8	a	a	DT
cord-015365-iqdi99pd	1050	9	quick	quick	JJ
cord-015365-iqdi99pd	1050	10	and	and	CC
cord-015365-iqdi99pd	1050	11	less	less	RBR
cord-015365-iqdi99pd	1050	12	invasive	invasive	JJ
cord-015365-iqdi99pd	1050	13	implantation	implantation	NN
cord-015365-iqdi99pd	1050	14	.	.	.
cord-015365-iqdi99pd	1051	1	The	the	DT
cord-015365-iqdi99pd	1051	2	small	small	JJ
cord-015365-iqdi99pd	1051	3	size	size	NN
cord-015365-iqdi99pd	1051	4	of	of	IN
cord-015365-iqdi99pd	1051	5	the	the	DT
cord-015365-iqdi99pd	1051	6	pump	pump	NN
cord-015365-iqdi99pd	1051	7	allows	allow	VBZ
cord-015365-iqdi99pd	1051	8	for	for	IN
cord-015365-iqdi99pd	1051	9	intrapericardial	intrapericardial	JJ
cord-015365-iqdi99pd	1051	10	placement	placement	NN
cord-015365-iqdi99pd	1051	11	even	even	RB
cord-015365-iqdi99pd	1051	12	in	in	IN
cord-015365-iqdi99pd	1051	13	biventricular	biventricular	JJ
cord-015365-iqdi99pd	1051	14	support	support	NN
cord-015365-iqdi99pd	1051	15	.	.	.
cord-015365-iqdi99pd	1052	1	To	to	TO
cord-015365-iqdi99pd	1052	2	prevent	prevent	VB
cord-015365-iqdi99pd	1052	3	compromise	compromise	NN
cord-015365-iqdi99pd	1052	4	of	of	IN
cord-015365-iqdi99pd	1052	5	the	the	DT
cord-015365-iqdi99pd	1052	6	right	right	JJ
cord-015365-iqdi99pd	1052	7	atrium	atrium	NN
cord-015365-iqdi99pd	1052	8	it	-PRON-	PRP
cord-015365-iqdi99pd	1052	9	is	be	VBZ
cord-015365-iqdi99pd	1052	10	necessary	necessary	JJ
cord-015365-iqdi99pd	1052	11	to	to	TO
cord-015365-iqdi99pd	1052	12	build	build	VB
cord-015365-iqdi99pd	1052	13	a	a	DT
cord-015365-iqdi99pd	1052	14	cavity	cavity	NN
cord-015365-iqdi99pd	1052	15	in	in	IN
cord-015365-iqdi99pd	1052	16	the	the	DT
cord-015365-iqdi99pd	1052	17	pericardium	pericardium	NN
cord-015365-iqdi99pd	1052	18	for	for	IN
cord-015365-iqdi99pd	1052	19	pump	pump	NN
cord-015365-iqdi99pd	1052	20	placement	placement	NN
cord-015365-iqdi99pd	1052	21	.	.	.
cord-015365-iqdi99pd	1053	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1053	2	.	.	.
cord-015365-iqdi99pd	1054	1	Adequate	adequate	JJ
cord-015365-iqdi99pd	1054	2	pump	pump	NN
cord-015365-iqdi99pd	1054	3	flow	flow	NN
cord-015365-iqdi99pd	1054	4	was	be	VBD
cord-015365-iqdi99pd	1054	5	observed	observe	VBN
cord-015365-iqdi99pd	1054	6	during	during	IN
cord-015365-iqdi99pd	1054	7	total	total	JJ
cord-015365-iqdi99pd	1054	8	support	support	NN
cord-015365-iqdi99pd	1054	9	time	time	NN
cord-015365-iqdi99pd	1054	10	.	.	.
cord-015365-iqdi99pd	1055	1	The	the	DT
cord-015365-iqdi99pd	1055	2	presented	present	VBN
cord-015365-iqdi99pd	1055	3	implantation	implantation	NN
cord-015365-iqdi99pd	1055	4	technique	technique	NN
cord-015365-iqdi99pd	1055	5	allows	allow	VBZ
cord-015365-iqdi99pd	1055	6	a	a	DT
cord-015365-iqdi99pd	1055	7	safe	safe	JJ
cord-015365-iqdi99pd	1055	8	and	and	CC
cord-015365-iqdi99pd	1055	9	elegant	elegant	JJ
cord-015365-iqdi99pd	1055	10	bridging	bridging	NN
cord-015365-iqdi99pd	1055	11	-	-	HYPH
cord-015365-iqdi99pd	1055	12	to	to	IN
cord-015365-iqdi99pd	1055	13	-	-	HYPH
cord-015365-iqdi99pd	1055	14	transplant	transplant	NN
cord-015365-iqdi99pd	1055	15	in	in	IN
cord-015365-iqdi99pd	1055	16	Htx	Htx	NNP
cord-015365-iqdi99pd	1055	17	candidates	candidate	NNS
cord-015365-iqdi99pd	1055	18	representing	represent	VBG
cord-015365-iqdi99pd	1055	19	biventricular	biventricular	JJ
cord-015365-iqdi99pd	1055	20	failure	failure	NN
cord-015365-iqdi99pd	1055	21	.	.	.
cord-015365-iqdi99pd	1056	1	Use	use	NN
cord-015365-iqdi99pd	1056	2	of	of	IN
cord-015365-iqdi99pd	1056	3	cardiopulmonary	cardiopulmonary	JJ
cord-015365-iqdi99pd	1056	4	bypass	bypass	NN
cord-015365-iqdi99pd	1056	5	for	for	IN
cord-015365-iqdi99pd	1056	6	lung	lung	NN
cord-015365-iqdi99pd	1056	7	transplantation	transplantation	NN
cord-015365-iqdi99pd	1056	8	:	:	:
cord-015365-iqdi99pd	1056	9	institutional	institutional	JJ
cord-015365-iqdi99pd	1056	10	experience	experience	NN
cord-015365-iqdi99pd	1056	11	Background	Background	NNP
cord-015365-iqdi99pd	1056	12	.	.	.
cord-015365-iqdi99pd	1057	1	The	the	DT
cord-015365-iqdi99pd	1057	2	use	use	NN
cord-015365-iqdi99pd	1057	3	of	of	IN
cord-015365-iqdi99pd	1057	4	cardiopulmonary	cardiopulmonary	JJ
cord-015365-iqdi99pd	1057	5	bypass	bypass	NN
cord-015365-iqdi99pd	1057	6	(	(	-LRB-
cord-015365-iqdi99pd	1057	7	CPB	CPB	NNP
cord-015365-iqdi99pd	1057	8	)	)	-RRB-
cord-015365-iqdi99pd	1057	9	for	for	IN
cord-015365-iqdi99pd	1057	10	lung	lung	NN
cord-015365-iqdi99pd	1057	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	1057	12	is	be	VBZ
cord-015365-iqdi99pd	1057	13	still	still	RB
cord-015365-iqdi99pd	1057	14	judged	judge	VBN
cord-015365-iqdi99pd	1057	15	controversial	controversial	JJ
cord-015365-iqdi99pd	1057	16	.	.	.
cord-015365-iqdi99pd	1058	1	However	however	RB
cord-015365-iqdi99pd	1058	2	,	,	,
cord-015365-iqdi99pd	1058	3	in	in	IN
cord-015365-iqdi99pd	1058	4	30	30	CD
cord-015365-iqdi99pd	1058	5	%	%	NN
cord-015365-iqdi99pd	1058	6	of	of	IN
cord-015365-iqdi99pd	1058	7	lung	lung	NN
cord-015365-iqdi99pd	1058	8	transplantations	transplantation	NNS
cord-015365-iqdi99pd	1058	9	CPB	CPB	NNP
cord-015365-iqdi99pd	1058	10	support	support	VBP
cord-015365-iqdi99pd	1058	11	during	during	IN
cord-015365-iqdi99pd	1058	12	the	the	DT
cord-015365-iqdi99pd	1058	13	surgical	surgical	JJ
cord-015365-iqdi99pd	1058	14	procedure	procedure	NN
cord-015365-iqdi99pd	1058	15	is	be	VBZ
cord-015365-iqdi99pd	1058	16	required	require	VBN
cord-015365-iqdi99pd	1058	17	for	for	IN
cord-015365-iqdi99pd	1058	18	hemodynamic	hemodynamic	JJ
cord-015365-iqdi99pd	1058	19	and/or	and/or	CC
cord-015365-iqdi99pd	1058	20	respiratory	respiratory	JJ
cord-015365-iqdi99pd	1058	21	instability	instability	NN
cord-015365-iqdi99pd	1058	22	or	or	CC
cord-015365-iqdi99pd	1058	23	for	for	IN
cord-015365-iqdi99pd	1058	24	repair	repair	NN
cord-015365-iqdi99pd	1058	25	of	of	IN
cord-015365-iqdi99pd	1058	26	intracardiac	intracardiac	NNP
cord-015365-iqdi99pd	1058	27	pathologies	pathology	NNS
cord-015365-iqdi99pd	1058	28	.	.	.
cord-015365-iqdi99pd	1059	1	This	this	DT
cord-015365-iqdi99pd	1059	2	study	study	NN
cord-015365-iqdi99pd	1059	3	aimed	aim	VBD
cord-015365-iqdi99pd	1059	4	to	to	TO
cord-015365-iqdi99pd	1059	5	determine	determine	VB
cord-015365-iqdi99pd	1059	6	if	if	IN
cord-015365-iqdi99pd	1059	7	the	the	DT
cord-015365-iqdi99pd	1059	8	use	use	NN
cord-015365-iqdi99pd	1059	9	of	of	IN
cord-015365-iqdi99pd	1059	10	CPB	CPB	NNP
cord-015365-iqdi99pd	1059	11	has	have	VBZ
cord-015365-iqdi99pd	1059	12	an	an	DT
cord-015365-iqdi99pd	1059	13	effect	effect	NN
cord-015365-iqdi99pd	1059	14	on	on	IN
cord-015365-iqdi99pd	1059	15	survival	survival	NN
cord-015365-iqdi99pd	1059	16	.	.	.
cord-015365-iqdi99pd	1060	1	Methods	method	NNS
cord-015365-iqdi99pd	1060	2	.	.	.
cord-015365-iqdi99pd	1061	1	A	a	DT
cord-015365-iqdi99pd	1061	2	retrospective	retrospective	JJ
cord-015365-iqdi99pd	1061	3	review	review	NN
cord-015365-iqdi99pd	1061	4	of	of	IN
cord-015365-iqdi99pd	1061	5	190	190	CD
cord-015365-iqdi99pd	1061	6	lung	lung	NN
cord-015365-iqdi99pd	1061	7	transplants	transplant	NNS
cord-015365-iqdi99pd	1061	8	in	in	IN
cord-015365-iqdi99pd	1061	9	180	180	CD
cord-015365-iqdi99pd	1061	10	patients	patient	NNS
cord-015365-iqdi99pd	1061	11	(	(	-LRB-
cord-015365-iqdi99pd	1061	12	mean	mean	VB
cord-015365-iqdi99pd	1061	13	age	age	NN
cord-015365-iqdi99pd	1061	14	:	:	:
cord-015365-iqdi99pd	1061	15	59	59	CD
cord-015365-iqdi99pd	1061	16	years	year	NNS
cord-015365-iqdi99pd	1061	17	)	)	-RRB-
cord-015365-iqdi99pd	1061	18	with	with	IN
cord-015365-iqdi99pd	1061	19	different	different	JJ
cord-015365-iqdi99pd	1061	20	lung	lung	NN
cord-015365-iqdi99pd	1061	21	pathologies	pathology	NNS
cord-015365-iqdi99pd	1061	22	who	who	WP
cord-015365-iqdi99pd	1061	23	underwent	undergo	VBD
cord-015365-iqdi99pd	1061	24	bilateral	bilateral	JJ
cord-015365-iqdi99pd	1061	25	or	or	CC
cord-015365-iqdi99pd	1061	26	single	single	JJ
cord-015365-iqdi99pd	1061	27	lung	lung	NN
cord-015365-iqdi99pd	1061	28	transplantation	transplantation	NN
cord-015365-iqdi99pd	1061	29	between	between	IN
cord-015365-iqdi99pd	1061	30	November	November	NNP
cord-015365-iqdi99pd	1061	31	1993	1993	CD
cord-015365-iqdi99pd	1061	32	and	and	CC
cord-015365-iqdi99pd	1061	33	June	June	NNP
cord-015365-iqdi99pd	1061	34	2011	2011	CD
cord-015365-iqdi99pd	1061	35	was	be	VBD
cord-015365-iqdi99pd	1061	36	performed	perform	VBN
cord-015365-iqdi99pd	1061	37	.	.	.
cord-015365-iqdi99pd	1062	1	75	75	CD
cord-015365-iqdi99pd	1062	2	patients	patient	NNS
cord-015365-iqdi99pd	1062	3	(	(	-LRB-
cord-015365-iqdi99pd	1062	4	39.4	39.4	CD
cord-015365-iqdi99pd	1062	5	%	%	NN
cord-015365-iqdi99pd	1062	6	)	)	-RRB-
cord-015365-iqdi99pd	1062	7	in	in	IN
cord-015365-iqdi99pd	1062	8	whom	whom	WP
cord-015365-iqdi99pd	1062	9	elective	elective	JJ
cord-015365-iqdi99pd	1062	10	as	as	RB
cord-015365-iqdi99pd	1062	11	well	well	RB
cord-015365-iqdi99pd	1062	12	as	as	IN
cord-015365-iqdi99pd	1062	13	emergent	emergent	JJ
cord-015365-iqdi99pd	1062	14	CPB	CPB	NNP
cord-015365-iqdi99pd	1062	15	was	be	VBD
cord-015365-iqdi99pd	1062	16	necessary	necessary	JJ
cord-015365-iqdi99pd	1062	17	were	be	VBD
cord-015365-iqdi99pd	1062	18	compared	compare	VBN
cord-015365-iqdi99pd	1062	19	with	with	IN
cord-015365-iqdi99pd	1062	20	115	115	CD
cord-015365-iqdi99pd	1062	21	cases	case	NNS
cord-015365-iqdi99pd	1062	22	(	(	-LRB-
cord-015365-iqdi99pd	1062	23	60.6	60.6	CD
cord-015365-iqdi99pd	1062	24	%	%	NN
cord-015365-iqdi99pd	1062	25	)	)	-RRB-
cord-015365-iqdi99pd	1062	26	without	without	IN
cord-015365-iqdi99pd	1062	27	CPB	CPB	NNP
cord-015365-iqdi99pd	1062	28	.	.	.
cord-015365-iqdi99pd	1063	1	Results	result	NNS
cord-015365-iqdi99pd	1063	2	.	.	.
cord-015365-iqdi99pd	1064	1	The	the	DT
cord-015365-iqdi99pd	1064	2	indications	indication	NNS
cord-015365-iqdi99pd	1064	3	for	for	IN
cord-015365-iqdi99pd	1064	4	lung	lung	NN
cord-015365-iqdi99pd	1064	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	1064	6	were	be	VBD
cord-015365-iqdi99pd	1064	7	chronic	chronic	JJ
cord-015365-iqdi99pd	1064	8	obstructive	obstructive	JJ
cord-015365-iqdi99pd	1064	9	pulmonary	pulmonary	JJ
cord-015365-iqdi99pd	1064	10	disease	disease	NN
cord-015365-iqdi99pd	1064	11	(	(	-LRB-
cord-015365-iqdi99pd	1064	12	COPD	COPD	NNP
cord-015365-iqdi99pd	1064	13	,	,	,
cord-015365-iqdi99pd	1064	14	n	n	NN
cord-015365-iqdi99pd	1064	15	¼	¼	NNP
cord-015365-iqdi99pd	1064	16	111	111	CD
cord-015365-iqdi99pd	1064	17	)	)	-RRB-
cord-015365-iqdi99pd	1064	18	,	,	,
cord-015365-iqdi99pd	1064	19	fibrosis	fibrosis	NN
cord-015365-iqdi99pd	1064	20	(	(	-LRB-
cord-015365-iqdi99pd	1064	21	n	n	NNP
cord-015365-iqdi99pd	1064	22	¼	¼	NNP
cord-015365-iqdi99pd	1064	23	32	32	CD
cord-015365-iqdi99pd	1064	24	)	)	-RRB-
cord-015365-iqdi99pd	1064	25	,	,	.
cord-015365-iqdi99pd	1065	1	alpha-1	alpha-1	NN
cord-015365-iqdi99pd	1065	2	antitrypsin	antitrypsin	NN
cord-015365-iqdi99pd	1065	3	deficiency	deficiency	NN
cord-015365-iqdi99pd	1065	4	emphysema	emphysema	NN
cord-015365-iqdi99pd	1065	5	(	(	-LRB-
cord-015365-iqdi99pd	1065	6	n	n	NNP
cord-015365-iqdi99pd	1065	7	¼	¼	NNP
cord-015365-iqdi99pd	1065	8	13	13	CD
cord-015365-iqdi99pd	1065	9	)	)	-RRB-
cord-015365-iqdi99pd	1065	10	and	and	CC
cord-015365-iqdi99pd	1065	11	others	other	NNS
cord-015365-iqdi99pd	1065	12	(	(	-LRB-
cord-015365-iqdi99pd	1065	13	n	n	CC
cord-015365-iqdi99pd	1065	14	¼	¼	NNP
cord-015365-iqdi99pd	1065	15	34	34	CD
cord-015365-iqdi99pd	1065	16	)	)	-RRB-
cord-015365-iqdi99pd	1065	17	.	.	.
cord-015365-iqdi99pd	1066	1	The	the	DT
cord-015365-iqdi99pd	1066	2	follow	follow	NN
cord-015365-iqdi99pd	1066	3	up	up	RP
cord-015365-iqdi99pd	1066	4	period	period	NN
cord-015365-iqdi99pd	1066	5	ranged	range	VBD
cord-015365-iqdi99pd	1066	6	from	from	IN
cord-015365-iqdi99pd	1066	7	2	2	CD
cord-015365-iqdi99pd	1066	8	days	day	NNS
cord-015365-iqdi99pd	1066	9	to	to	IN
cord-015365-iqdi99pd	1066	10	14	14	CD
cord-015365-iqdi99pd	1066	11	years	year	NNS
cord-015365-iqdi99pd	1066	12	.	.	.
cord-015365-iqdi99pd	1067	1	Total	total	JJ
cord-015365-iqdi99pd	1067	2	mean	mean	JJ
cord-015365-iqdi99pd	1067	3	survival	survival	NN
cord-015365-iqdi99pd	1067	4	was	be	VBD
cord-015365-iqdi99pd	1067	5	980	980	CD
cord-015365-iqdi99pd	1067	6	days	day	NNS
cord-015365-iqdi99pd	1067	7	(	(	-LRB-
cord-015365-iqdi99pd	1067	8	range	range	NN
cord-015365-iqdi99pd	1067	9	0	0	CD
cord-015365-iqdi99pd	1067	10	to	to	IN
cord-015365-iqdi99pd	1067	11	5276	5276	CD
cord-015365-iqdi99pd	1067	12	days	day	NNS
cord-015365-iqdi99pd	1067	13	)	)	-RRB-
cord-015365-iqdi99pd	1067	14	.	.	.
cord-015365-iqdi99pd	1068	1	There	there	EX
cord-015365-iqdi99pd	1068	2	was	be	VBD
cord-015365-iqdi99pd	1068	3	no	no	DT
cord-015365-iqdi99pd	1068	4	significant	significant	JJ
cord-015365-iqdi99pd	1068	5	difference	difference	NN
cord-015365-iqdi99pd	1068	6	in	in	IN
cord-015365-iqdi99pd	1068	7	mortality	mortality	NN
cord-015365-iqdi99pd	1068	8	between	between	IN
cord-015365-iqdi99pd	1068	9	the	the	DT
cord-015365-iqdi99pd	1068	10	CPB	CPB	NNP
cord-015365-iqdi99pd	1068	11	and	and	CC
cord-015365-iqdi99pd	1068	12	the	the	DT
cord-015365-iqdi99pd	1068	13	control	control	NN
cord-015365-iqdi99pd	1068	14	group	group	NN
cord-015365-iqdi99pd	1068	15	(	(	-LRB-
cord-015365-iqdi99pd	1068	16	p	p	NN
cord-015365-iqdi99pd	1068	17	¼	¼	CD
cord-015365-iqdi99pd	1068	18	0.723	0.723	CD
cord-015365-iqdi99pd	1068	19	)	)	-RRB-
cord-015365-iqdi99pd	1068	20	.	.	.
cord-015365-iqdi99pd	1069	1	The	the	DT
cord-015365-iqdi99pd	1069	2	comparison	comparison	NN
cord-015365-iqdi99pd	1069	3	between	between	IN
cord-015365-iqdi99pd	1069	4	COPD	COPD	NNP
cord-015365-iqdi99pd	1069	5	patients	patient	NNS
cord-015365-iqdi99pd	1069	6	and	and	CC
cord-015365-iqdi99pd	1069	7	other	other	JJ
cord-015365-iqdi99pd	1069	8	indications	indication	NNS
cord-015365-iqdi99pd	1069	9	for	for	IN
cord-015365-iqdi99pd	1069	10	lung	lung	NN
cord-015365-iqdi99pd	1069	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	1069	12	also	also	RB
cord-015365-iqdi99pd	1069	13	revealed	reveal	VBD
cord-015365-iqdi99pd	1069	14	no	no	DT
cord-015365-iqdi99pd	1069	15	significant	significant	JJ
cord-015365-iqdi99pd	1069	16	difference	difference	NN
cord-015365-iqdi99pd	1069	17	in	in	IN
cord-015365-iqdi99pd	1069	18	survival	survival	NN
cord-015365-iqdi99pd	1069	19	(	(	-LRB-
cord-015365-iqdi99pd	1069	20	p	p	NN
cord-015365-iqdi99pd	1069	21	¼	¼	CD
cord-015365-iqdi99pd	1069	22	0.11	0.11	CD
cord-015365-iqdi99pd	1069	23	)	)	-RRB-
cord-015365-iqdi99pd	1069	24	.	.	.
cord-015365-iqdi99pd	1070	1	There	there	EX
cord-015365-iqdi99pd	1070	2	was	be	VBD
cord-015365-iqdi99pd	1070	3	also	also	RB
cord-015365-iqdi99pd	1070	4	no	no	DT
cord-015365-iqdi99pd	1070	5	difference	difference	NN
cord-015365-iqdi99pd	1070	6	between	between	IN
cord-015365-iqdi99pd	1070	7	COPD	COPD	NNP
cord-015365-iqdi99pd	1070	8	patients	patient	NNS
cord-015365-iqdi99pd	1070	9	in	in	IN
cord-015365-iqdi99pd	1070	10	whom	whom	WP
cord-015365-iqdi99pd	1070	11	surgery	surgery	NN
cord-015365-iqdi99pd	1070	12	was	be	VBD
cord-015365-iqdi99pd	1070	13	performed	perform	VBN
cord-015365-iqdi99pd	1070	14	with	with	IN
cord-015365-iqdi99pd	1070	15	CPB	CPB	NNP
cord-015365-iqdi99pd	1070	16	or	or	CC
cord-015365-iqdi99pd	1070	17	without	without	IN
cord-015365-iqdi99pd	1070	18	(	(	-LRB-
cord-015365-iqdi99pd	1070	19	p	p	NN
cord-015365-iqdi99pd	1070	20	¼	¼	NNP
cord-015365-iqdi99pd	1070	21	0.676	0.676	CD
cord-015365-iqdi99pd	1070	22	)	)	-RRB-
cord-015365-iqdi99pd	1070	23	.	.	.
cord-015365-iqdi99pd	1071	1	Survival	survival	NN
cord-015365-iqdi99pd	1071	2	rates	rate	NNS
cord-015365-iqdi99pd	1071	3	in	in	IN
cord-015365-iqdi99pd	1071	4	patients	patient	NNS
cord-015365-iqdi99pd	1071	5	over	over	IN
cord-015365-iqdi99pd	1071	6	60	60	CD
cord-015365-iqdi99pd	1071	7	years	year	NNS
cord-015365-iqdi99pd	1071	8	were	be	VBD
cord-015365-iqdi99pd	1071	9	similar	similar	JJ
cord-015365-iqdi99pd	1071	10	to	to	IN
cord-015365-iqdi99pd	1071	11	patients	patient	NNS
cord-015365-iqdi99pd	1071	12	under	under	IN
cord-015365-iqdi99pd	1071	13	60	60	CD
cord-015365-iqdi99pd	1071	14	independent	independent	JJ
cord-015365-iqdi99pd	1071	15	from	from	IN
cord-015365-iqdi99pd	1071	16	the	the	DT
cord-015365-iqdi99pd	1071	17	use	use	NN
cord-015365-iqdi99pd	1071	18	of	of	IN
cord-015365-iqdi99pd	1071	19	CPB	CPB	NNP
cord-015365-iqdi99pd	1071	20	(	(	-LRB-
cord-015365-iqdi99pd	1071	21	p	p	NN
cord-015365-iqdi99pd	1071	22	¼	¼	NNP
cord-015365-iqdi99pd	1071	23	0.676	0.676	CD
cord-015365-iqdi99pd	1071	24	)	)	-RRB-
cord-015365-iqdi99pd	1071	25	.	.	.
cord-015365-iqdi99pd	1072	1	There	there	EX
cord-015365-iqdi99pd	1072	2	was	be	VBD
cord-015365-iqdi99pd	1072	3	also	also	RB
cord-015365-iqdi99pd	1072	4	no	no	DT
cord-015365-iqdi99pd	1072	5	significant	significant	JJ
cord-015365-iqdi99pd	1072	6	difference	difference	NN
cord-015365-iqdi99pd	1072	7	in	in	IN
cord-015365-iqdi99pd	1072	8	the	the	DT
cord-015365-iqdi99pd	1072	9	usage	usage	NN
cord-015365-iqdi99pd	1072	10	of	of	IN
cord-015365-iqdi99pd	1072	11	CPB	CPB	NNP
cord-015365-iqdi99pd	1072	12	between	between	IN
cord-015365-iqdi99pd	1072	13	single	single	JJ
cord-015365-iqdi99pd	1072	14	versus	versus	IN
cord-015365-iqdi99pd	1072	15	bilateral	bilateral	JJ
cord-015365-iqdi99pd	1072	16	lung	lung	NN
cord-015365-iqdi99pd	1072	17	transplantation	transplantation	NN
cord-015365-iqdi99pd	1072	18	(	(	-LRB-
cord-015365-iqdi99pd	1072	19	p	p	NN
cord-015365-iqdi99pd	1072	20	¼	¼	CD
cord-015365-iqdi99pd	1072	21	0.44	0.44	CD
cord-015365-iqdi99pd	1072	22	)	)	-RRB-
cord-015365-iqdi99pd	1072	23	.	.	.
cord-015365-iqdi99pd	1073	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1073	2	.	.	.
cord-015365-iqdi99pd	1074	1	This	this	DT
cord-015365-iqdi99pd	1074	2	study	study	NN
cord-015365-iqdi99pd	1074	3	revealed	reveal	VBD
cord-015365-iqdi99pd	1074	4	no	no	DT
cord-015365-iqdi99pd	1074	5	increase	increase	NN
cord-015365-iqdi99pd	1074	6	in	in	IN
cord-015365-iqdi99pd	1074	7	mortality	mortality	NN
cord-015365-iqdi99pd	1074	8	after	after	IN
cord-015365-iqdi99pd	1074	9	lung	lung	NN
cord-015365-iqdi99pd	1074	10	transplantation	transplantation	NN
cord-015365-iqdi99pd	1074	11	when	when	WRB
cord-015365-iqdi99pd	1074	12	cardiopulmonary	cardiopulmonary	JJ
cord-015365-iqdi99pd	1074	13	bypass	bypass	NN
cord-015365-iqdi99pd	1074	14	was	be	VBD
cord-015365-iqdi99pd	1074	15	required	require	VBN
cord-015365-iqdi99pd	1074	16	.	.	.
cord-015365-iqdi99pd	1075	1	When	when	WRB
cord-015365-iqdi99pd	1075	2	CPB	CPB	NNP
cord-015365-iqdi99pd	1075	3	appears	appear	VBZ
cord-015365-iqdi99pd	1075	4	necessary	necessary	JJ
cord-015365-iqdi99pd	1075	5	it	-PRON-	PRP
cord-015365-iqdi99pd	1075	6	should	should	MD
cord-015365-iqdi99pd	1075	7	be	be	VB
cord-015365-iqdi99pd	1075	8	employed	employ	VBN
cord-015365-iqdi99pd	1075	9	right	right	RB
cord-015365-iqdi99pd	1075	10	away	away	RB
cord-015365-iqdi99pd	1075	11	to	to	TO
cord-015365-iqdi99pd	1075	12	avoid	avoid	VB
cord-015365-iqdi99pd	1075	13	hemodynamic	hemodynamic	JJ
cord-015365-iqdi99pd	1075	14	compromise	compromise	NN
cord-015365-iqdi99pd	1075	15	or	or	CC
cord-015365-iqdi99pd	1075	16	severe	severe	JJ
cord-015365-iqdi99pd	1075	17	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	1075	18	edema	edema	NN
cord-015365-iqdi99pd	1075	19	due	due	IN
cord-015365-iqdi99pd	1075	20	to	to	IN
cord-015365-iqdi99pd	1075	21	unacceptable	unacceptable	JJ
cord-015365-iqdi99pd	1075	22	pulmonary	pulmonary	JJ
cord-015365-iqdi99pd	1075	23	arterial	arterial	JJ
cord-015365-iqdi99pd	1075	24	pressures	pressure	NNS
cord-015365-iqdi99pd	1075	25	.	.	.
cord-015365-iqdi99pd	1076	1	Erfahrungsbericht	Erfahrungsbericht	NNP
cord-015365-iqdi99pd	1076	2	aus	aus	NNP
cord-015365-iqdi99pd	1076	3	dem	dem	NNP
cord-015365-iqdi99pd	1076	4	Deutschen	Deutschen	NNP
cord-015365-iqdi99pd	1076	5	Herzzentrum	Herzzentrum	NNP
cord-015365-iqdi99pd	1076	6	Berlin	Berlin	NNP
cord-015365-iqdi99pd	1076	7	 	 	_SP
cord-015365-iqdi99pd	1077	1	Successful	successful	JJ
cord-015365-iqdi99pd	1077	2	bridging	bridge	VBG
cord-015365-iqdi99pd	1077	3	to	to	IN
cord-015365-iqdi99pd	1077	4	heart	heart	NN
cord-015365-iqdi99pd	1077	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	1077	6	using	use	VBG
cord-015365-iqdi99pd	1077	7	the	the	DT
cord-015365-iqdi99pd	1077	8	Levitronix	Levitronix	NNP
cord-015365-iqdi99pd	1077	9	CentriMag	CentriMag	NNP
cord-015365-iqdi99pd	1077	10	system	system	NN
cord-015365-iqdi99pd	1077	11	and	and	CC
cord-015365-iqdi99pd	1077	12	DuraHeart	DuraHeart	NNP
cord-015365-iqdi99pd	1077	13	LVAD	LVAD	NNP
cord-015365-iqdi99pd	1077	14	in	in	IN
cord-015365-iqdi99pd	1077	15	a	a	DT
cord-015365-iqdi99pd	1077	16	patient	patient	NN
cord-015365-iqdi99pd	1077	17	with	with	IN
cord-015365-iqdi99pd	1077	18	resuscitation	resuscitation	NN
cord-015365-iqdi99pd	1077	19	related	relate	VBN
cord-015365-iqdi99pd	1077	20	liver	liver	NN
cord-015365-iqdi99pd	1077	21	injury	injury	NN
cord-015365-iqdi99pd	1077	22	N.	N.	NNP
cord-015365-iqdi99pd	1077	23	Reiss	Reiss	NNP
cord-015365-iqdi99pd	1077	24	1	1	CD
cord-015365-iqdi99pd	1077	25	,	,	,
cord-015365-iqdi99pd	1077	26	L.	L.	NNP
cord-015365-iqdi99pd	1077	27	Kizner	Kizner	NNP
cord-015365-iqdi99pd	1077	28	2	2	CD
cord-015365-iqdi99pd	1077	29	,	,	,
cord-015365-iqdi99pd	1077	30	U.	U.	NNP
cord-015365-iqdi99pd	1077	31	Schulz	Schulz	NNP
cord-015365-iqdi99pd	1078	1	2	2	LS
cord-015365-iqdi99pd	1078	2	1	1	CD
cord-015365-iqdi99pd	1078	3	Department	Department	NNP
cord-015365-iqdi99pd	1078	4	of	of	IN
cord-015365-iqdi99pd	1078	5	Cardiac	Cardiac	NNP
cord-015365-iqdi99pd	1078	6	Surgery	Surgery	NNP
cord-015365-iqdi99pd	1078	7	Heidelberg	Heidelberg	NNP
cord-015365-iqdi99pd	1078	8	,	,	,
cord-015365-iqdi99pd	1078	9	Universitätsklinikum	Universitätsklinikum	NNP
cord-015365-iqdi99pd	1078	10	Heidelberg	Heidelberg	NNP
cord-015365-iqdi99pd	1078	11	,	,	,
cord-015365-iqdi99pd	1078	12	Germany	Germany	NNP
cord-015365-iqdi99pd	1078	13	;	;	:
cord-015365-iqdi99pd	1078	14	2	2	CD
cord-015365-iqdi99pd	1078	15	Heart	Heart	NNP
cord-015365-iqdi99pd	1078	16	Center	Center	NNP
cord-015365-iqdi99pd	1078	17	North	North	NNP
cord-015365-iqdi99pd	1078	18	Rhine	Rhine	NNP
cord-015365-iqdi99pd	1078	19	-	-	HYPH
cord-015365-iqdi99pd	1078	20	Westphalia	Westphalia	NNP
cord-015365-iqdi99pd	1078	21	,	,	,
cord-015365-iqdi99pd	1078	22	Ruhr	Ruhr	NNP
cord-015365-iqdi99pd	1078	23	-	-	HYPH
cord-015365-iqdi99pd	1078	24	University	University	NNP
cord-015365-iqdi99pd	1078	25	of	of	IN
cord-015365-iqdi99pd	1078	26	Bochum	Bochum	NNP
cord-015365-iqdi99pd	1078	27	,	,	,
cord-015365-iqdi99pd	1078	28	Bad	Bad	NNP
cord-015365-iqdi99pd	1078	29	Oeynhausen	Oeynhausen	NNP
cord-015365-iqdi99pd	1078	30	,	,	,
cord-015365-iqdi99pd	1078	31	Germany	Germany	NNP
cord-015365-iqdi99pd	1078	32	Background	Background	NNP
cord-015365-iqdi99pd	1078	33	.	.	.
cord-015365-iqdi99pd	1079	1	Mortality	mortality	NN
cord-015365-iqdi99pd	1079	2	rates	rate	NNS
cord-015365-iqdi99pd	1079	3	from	from	IN
cord-015365-iqdi99pd	1079	4	cardiogenic	cardiogenic	JJ
cord-015365-iqdi99pd	1079	5	shock	shock	NN
cord-015365-iqdi99pd	1079	6	after	after	IN
cord-015365-iqdi99pd	1079	7	acute	acute	JJ
cord-015365-iqdi99pd	1079	8	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1079	9	infarction	infarction	NN
cord-015365-iqdi99pd	1079	10	remain	remain	VBP
cord-015365-iqdi99pd	1079	11	extremely	extremely	RB
cord-015365-iqdi99pd	1079	12	high	high	JJ
cord-015365-iqdi99pd	1079	13	.	.	.
cord-015365-iqdi99pd	1080	1	Efforts	effort	NNS
cord-015365-iqdi99pd	1080	2	have	have	VBP
cord-015365-iqdi99pd	1080	3	been	be	VBN
cord-015365-iqdi99pd	1080	4	made	make	VBN
cord-015365-iqdi99pd	1080	5	to	to	TO
cord-015365-iqdi99pd	1080	6	develop	develop	VB
cord-015365-iqdi99pd	1080	7	ventricular	ventricular	JJ
cord-015365-iqdi99pd	1080	8	assist	assist	VB
cord-015365-iqdi99pd	1080	9	devices	device	NNS
cord-015365-iqdi99pd	1080	10	capable	capable	JJ
cord-015365-iqdi99pd	1080	11	of	of	IN
cord-015365-iqdi99pd	1080	12	providing	provide	VBG
cord-015365-iqdi99pd	1080	13	complete	complete	JJ
cord-015365-iqdi99pd	1080	14	hemodynamic	hemodynamic	JJ
cord-015365-iqdi99pd	1080	15	support	support	NN
cord-015365-iqdi99pd	1080	16	in	in	IN
cord-015365-iqdi99pd	1080	17	this	this	DT
cord-015365-iqdi99pd	1080	18	situation	situation	NN
cord-015365-iqdi99pd	1080	19	.	.	.
cord-015365-iqdi99pd	1081	1	Mechanical	mechanical	JJ
cord-015365-iqdi99pd	1081	2	circulatory	circulatory	JJ
cord-015365-iqdi99pd	1081	3	assistance	assistance	NN
cord-015365-iqdi99pd	1081	4	represents	represent	VBZ
cord-015365-iqdi99pd	1081	5	an	an	DT
cord-015365-iqdi99pd	1081	6	evident	evident	JJ
cord-015365-iqdi99pd	1081	7	problem	problem	NN
cord-015365-iqdi99pd	1081	8	when	when	WRB
cord-015365-iqdi99pd	1081	9	bleeding	bleed	VBG
cord-015365-iqdi99pd	1081	10	complications	complication	NNS
cord-015365-iqdi99pd	1081	11	occur	occur	VBP
cord-015365-iqdi99pd	1081	12	.	.	.
cord-015365-iqdi99pd	1082	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1082	2	report	report	VBP
cord-015365-iqdi99pd	1082	3	a	a	DT
cord-015365-iqdi99pd	1082	4	very	very	RB
cord-015365-iqdi99pd	1082	5	rare	rare	JJ
cord-015365-iqdi99pd	1082	6	case	case	NN
cord-015365-iqdi99pd	1082	7	of	of	IN
cord-015365-iqdi99pd	1082	8	successful	successful	JJ
cord-015365-iqdi99pd	1082	9	bridging	bridging	NN
cord-015365-iqdi99pd	1082	10	to	to	IN
cord-015365-iqdi99pd	1082	11	heart	heart	NN
cord-015365-iqdi99pd	1082	12	transplantation	transplantation	NN
cord-015365-iqdi99pd	1082	13	despite	despite	IN
cord-015365-iqdi99pd	1082	14	severe	severe	JJ
cord-015365-iqdi99pd	1082	15	resuscitation	resuscitation	NN
cord-015365-iqdi99pd	1082	16	related	relate	VBD
cord-015365-iqdi99pd	1082	17	liver	liver	NN
cord-015365-iqdi99pd	1082	18	injury	injury	NN
cord-015365-iqdi99pd	1082	19	.	.	.
cord-015365-iqdi99pd	1083	1	Methods	method	NNS
cord-015365-iqdi99pd	1083	2	.	.	.
cord-015365-iqdi99pd	1084	1	A	a	DT
cord-015365-iqdi99pd	1084	2	54-year	54-year	JJ
cord-015365-iqdi99pd	1084	3	-	-	HYPH
cord-015365-iqdi99pd	1084	4	old	old	JJ
cord-015365-iqdi99pd	1084	5	male	male	JJ
cord-015365-iqdi99pd	1084	6	patient	patient	NN
cord-015365-iqdi99pd	1084	7	underwent	undergo	VBD
cord-015365-iqdi99pd	1084	8	failed	failed	JJ
cord-015365-iqdi99pd	1084	9	percutaneous	percutaneous	JJ
cord-015365-iqdi99pd	1084	10	coronary	coronary	NN
cord-015365-iqdi99pd	1084	11	intervention	intervention	NN
cord-015365-iqdi99pd	1084	12	of	of	IN
cord-015365-iqdi99pd	1084	13	LAD	LAD	NNP
cord-015365-iqdi99pd	1084	14	with	with	IN
cord-015365-iqdi99pd	1084	15	consecutive	consecutive	JJ
cord-015365-iqdi99pd	1084	16	prolonged	prolong	VBN
cord-015365-iqdi99pd	1084	17	resuscitation	resuscitation	NN
cord-015365-iqdi99pd	1084	18	.	.	.
cord-015365-iqdi99pd	1085	1	A	a	DT
cord-015365-iqdi99pd	1085	2	Levitronix	Levitronix	NNP
cord-015365-iqdi99pd	1085	3	CentriMag	CentriMag	NNP
cord-015365-iqdi99pd	1085	4	system	system	NN
cord-015365-iqdi99pd	1085	5	was	be	VBD
cord-015365-iqdi99pd	1085	6	implanted	implant	VBN
cord-015365-iqdi99pd	1085	7	via	via	IN
cord-015365-iqdi99pd	1085	8	femoral	femoral	JJ
cord-015365-iqdi99pd	1085	9	vessels	vessel	NNS
cord-015365-iqdi99pd	1085	10	for	for	IN
cord-015365-iqdi99pd	1085	11	rapid	rapid	JJ
cord-015365-iqdi99pd	1085	12	hemodynamic	hemodynamic	JJ
cord-015365-iqdi99pd	1085	13	stabilization	stabilization	NN
cord-015365-iqdi99pd	1085	14	.	.	.
cord-015365-iqdi99pd	1086	1	An	an	DT
cord-015365-iqdi99pd	1086	2	acute	acute	JJ
cord-015365-iqdi99pd	1086	3	laparotomy	laparotomy	NN
cord-015365-iqdi99pd	1086	4	was	be	VBD
cord-015365-iqdi99pd	1086	5	necessary	necessary	JJ
cord-015365-iqdi99pd	1086	6	because	because	IN
cord-015365-iqdi99pd	1086	7	of	of	IN
cord-015365-iqdi99pd	1086	8	severe	severe	JJ
cord-015365-iqdi99pd	1086	9	injury	injury	NN
cord-015365-iqdi99pd	1086	10	of	of	IN
cord-015365-iqdi99pd	1086	11	the	the	DT
cord-015365-iqdi99pd	1086	12	left	left	JJ
cord-015365-iqdi99pd	1086	13	lobe	lobe	NN
cord-015365-iqdi99pd	1086	14	of	of	IN
cord-015365-iqdi99pd	1086	15	the	the	DT
cord-015365-iqdi99pd	1086	16	liver	liver	NN
cord-015365-iqdi99pd	1086	17	.	.	.
cord-015365-iqdi99pd	1087	1	During	during	IN
cord-015365-iqdi99pd	1087	2	laparotomy	laparotomy	NN
cord-015365-iqdi99pd	1087	3	the	the	DT
cord-015365-iqdi99pd	1087	4	abdominal	abdominal	JJ
cord-015365-iqdi99pd	1087	5	cave	cave	NN
cord-015365-iqdi99pd	1087	6	was	be	VBD
cord-015365-iqdi99pd	1087	7	tamponated	tamponate	VBN
cord-015365-iqdi99pd	1087	8	by	by	IN
cord-015365-iqdi99pd	1087	9	multiple	multiple	JJ
cord-015365-iqdi99pd	1087	10	compresses	compress	NNS
cord-015365-iqdi99pd	1087	11	.	.	.
cord-015365-iqdi99pd	1088	1	Three	three	CD
cord-015365-iqdi99pd	1088	2	times	time	NNS
cord-015365-iqdi99pd	1088	3	relaparotomy	relaparotomy	NNP
cord-015365-iqdi99pd	1088	4	was	be	VBD
cord-015365-iqdi99pd	1088	5	necessary	necessary	JJ
cord-015365-iqdi99pd	1088	6	to	to	TO
cord-015365-iqdi99pd	1088	7	achieve	achieve	VB
cord-015365-iqdi99pd	1088	8	final	final	JJ
cord-015365-iqdi99pd	1088	9	hemostasis	hemostasis	NN
cord-015365-iqdi99pd	1088	10	.	.	.
cord-015365-iqdi99pd	1089	1	After	after	IN
cord-015365-iqdi99pd	1089	2	four	four	CD
cord-015365-iqdi99pd	1089	3	weeks	week	NNS
cord-015365-iqdi99pd	1089	4	of	of	IN
cord-015365-iqdi99pd	1089	5	Levitronix	Levitronix	NNP
cord-015365-iqdi99pd	1089	6	CentriMag	CentriMag	NNP
cord-015365-iqdi99pd	1089	7	support	support	VBP
cord-015365-iqdi99pd	1089	8	the	the	DT
cord-015365-iqdi99pd	1089	9	system	system	NN
cord-015365-iqdi99pd	1089	10	was	be	VBD
cord-015365-iqdi99pd	1089	11	switched	switch	VBN
cord-015365-iqdi99pd	1089	12	to	to	IN
cord-015365-iqdi99pd	1089	13	DuraHeart	DuraHeart	NNP
cord-015365-iqdi99pd	1089	14	LVAD	LVAD	NNP
cord-015365-iqdi99pd	1089	15	for	for	IN
cord-015365-iqdi99pd	1089	16	long	long	JJ
cord-015365-iqdi99pd	1089	17	-	-	HYPH
cord-015365-iqdi99pd	1089	18	term	term	NN
cord-015365-iqdi99pd	1089	19	assistance	assistance	NN
cord-015365-iqdi99pd	1089	20	as	as	IN
cord-015365-iqdi99pd	1089	21	a	a	DT
cord-015365-iqdi99pd	1089	22	bridge	bridge	NN
cord-015365-iqdi99pd	1089	23	-	-	HYPH
cord-015365-iqdi99pd	1089	24	to	to	IN
cord-015365-iqdi99pd	1089	25	-	-	HYPH
cord-015365-iqdi99pd	1089	26	transplant	transplant	NN
cord-015365-iqdi99pd	1089	27	.	.	.
cord-015365-iqdi99pd	1090	1	Results	result	NNS
cord-015365-iqdi99pd	1090	2	.	.	.
cord-015365-iqdi99pd	1091	1	Successful	successful	JJ
cord-015365-iqdi99pd	1091	2	heart	heart	NN
cord-015365-iqdi99pd	1091	3	transplantation	transplantation	NN
cord-015365-iqdi99pd	1091	4	was	be	VBD
cord-015365-iqdi99pd	1091	5	performed	perform	VBN
cord-015365-iqdi99pd	1091	6	after	after	IN
cord-015365-iqdi99pd	1091	7	complete	complete	JJ
cord-015365-iqdi99pd	1091	8	recovery	recovery	NN
cord-015365-iqdi99pd	1091	9	and	and	CC
cord-015365-iqdi99pd	1091	10	mobilization	mobilization	NN
cord-015365-iqdi99pd	1091	11	of	of	IN
cord-015365-iqdi99pd	1091	12	the	the	DT
cord-015365-iqdi99pd	1091	13	patient	patient	JJ
cord-015365-iqdi99pd	1091	14	320	320	CD
cord-015365-iqdi99pd	1091	15	days	day	NNS
cord-015365-iqdi99pd	1091	16	after	after	IN
cord-015365-iqdi99pd	1091	17	the	the	DT
cord-015365-iqdi99pd	1091	18	disastrous	disastrous	JJ
cord-015365-iqdi99pd	1091	19	and	and	CC
cord-015365-iqdi99pd	1091	20	hopeless	hopeless	JJ
cord-015365-iqdi99pd	1091	21	initial	initial	JJ
cord-015365-iqdi99pd	1091	22	situation	situation	NN
cord-015365-iqdi99pd	1091	23	.	.	.
cord-015365-iqdi99pd	1092	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1092	2	.	.	.
cord-015365-iqdi99pd	1093	1	The	the	DT
cord-015365-iqdi99pd	1093	2	present	present	JJ
cord-015365-iqdi99pd	1093	3	case	case	NN
cord-015365-iqdi99pd	1093	4	demonstrates	demonstrate	VBZ
cord-015365-iqdi99pd	1093	5	that	that	IN
cord-015365-iqdi99pd	1093	6	successful	successful	JJ
cord-015365-iqdi99pd	1093	7	bridging	bridging	NN
cord-015365-iqdi99pd	1093	8	to	to	IN
cord-015365-iqdi99pd	1093	9	heart	heart	NN
cord-015365-iqdi99pd	1093	10	transplantation	transplantation	NN
cord-015365-iqdi99pd	1093	11	is	be	VBZ
cord-015365-iqdi99pd	1093	12	possible	possible	JJ
cord-015365-iqdi99pd	1093	13	even	even	RB
cord-015365-iqdi99pd	1093	14	in	in	IN
cord-015365-iqdi99pd	1093	15	cases	case	NNS
cord-015365-iqdi99pd	1093	16	of	of	IN
cord-015365-iqdi99pd	1093	17	severe	severe	JJ
cord-015365-iqdi99pd	1093	18	bleeding	bleeding	JJ
cord-015365-iqdi99pd	1093	19	complications	complication	NNS
cord-015365-iqdi99pd	1093	20	.	.	.
cord-015365-iqdi99pd	1094	1	Special	special	JJ
cord-015365-iqdi99pd	1094	2	attention	attention	NN
cord-015365-iqdi99pd	1094	3	is	be	VBZ
cord-015365-iqdi99pd	1094	4	given	give	VBN
cord-015365-iqdi99pd	1094	5	to	to	IN
cord-015365-iqdi99pd	1094	6	the	the	DT
cord-015365-iqdi99pd	1094	7	thin	thin	JJ
cord-015365-iqdi99pd	1094	8	line	line	NN
cord-015365-iqdi99pd	1094	9	between	between	IN
cord-015365-iqdi99pd	1094	10	bleeding	bleed	VBG
cord-015365-iqdi99pd	1094	11	complication	complication	NN
cord-015365-iqdi99pd	1094	12	and	and	CC
cord-015365-iqdi99pd	1094	13	necessary	necessary	JJ
cord-015365-iqdi99pd	1094	14	anticoagulation	anticoagulation	NN
cord-015365-iqdi99pd	1094	15	because	because	IN
cord-015365-iqdi99pd	1094	16	of	of	IN
cord-015365-iqdi99pd	1094	17	mechanical	mechanical	JJ
cord-015365-iqdi99pd	1094	18	circulatory	circulatory	NN
cord-015365-iqdi99pd	1094	19	assist	assist	NN
cord-015365-iqdi99pd	1094	20	.	.	.
cord-015365-iqdi99pd	1095	1	Background	background	NN
cord-015365-iqdi99pd	1095	2	.	.	.
cord-015365-iqdi99pd	1096	1	Advagraf	Advagraf	NNP
cord-015365-iqdi99pd	1096	2	(	(	-LRB-
cord-015365-iqdi99pd	1096	3	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	1096	4	extended	extend	VBN
cord-015365-iqdi99pd	1096	5	-	-	HYPH
cord-015365-iqdi99pd	1096	6	release	release	NN
cord-015365-iqdi99pd	1096	7	capsules	capsule	NNS
cord-015365-iqdi99pd	1096	8	)	)	-RRB-
cord-015365-iqdi99pd	1096	9	has	have	VBZ
cord-015365-iqdi99pd	1096	10	been	be	VBN
cord-015365-iqdi99pd	1096	11	tested	test	VBN
cord-015365-iqdi99pd	1096	12	in	in	IN
cord-015365-iqdi99pd	1096	13	de	de	JJ
cord-015365-iqdi99pd	1096	14	-	-	JJ
cord-015365-iqdi99pd	1096	15	novo	novo	JJ
cord-015365-iqdi99pd	1096	16	liver	liver	NN
cord-015365-iqdi99pd	1096	17	and	and	CC
cord-015365-iqdi99pd	1096	18	renal	renal	JJ
cord-015365-iqdi99pd	1096	19	transplant	transplant	NN
cord-015365-iqdi99pd	1096	20	recipients	recipient	NNS
cord-015365-iqdi99pd	1096	21	.	.	.
cord-015365-iqdi99pd	1097	1	In	in	IN
cord-015365-iqdi99pd	1097	2	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1097	3	transplantation	transplantation	NN
cord-015365-iqdi99pd	1097	4	there	there	EX
cord-015365-iqdi99pd	1097	5	exists	exist	VBZ
cord-015365-iqdi99pd	1097	6	only	only	RB
cord-015365-iqdi99pd	1097	7	data	datum	NNS
cord-015365-iqdi99pd	1097	8	on	on	IN
cord-015365-iqdi99pd	1097	9	conversion	conversion	NN
cord-015365-iqdi99pd	1097	10	of	of	IN
cord-015365-iqdi99pd	1097	11	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	1097	12	to	to	IN
cord-015365-iqdi99pd	1097	13	advagraf	advagraf	NNP
cord-015365-iqdi99pd	1097	14	.	.	.
cord-015365-iqdi99pd	1098	1	The	the	DT
cord-015365-iqdi99pd	1098	2	aim	aim	NN
cord-015365-iqdi99pd	1098	3	of	of	IN
cord-015365-iqdi99pd	1098	4	this	this	DT
cord-015365-iqdi99pd	1098	5	analysis	analysis	NN
cord-015365-iqdi99pd	1098	6	was	be	VBD
cord-015365-iqdi99pd	1098	7	to	to	TO
cord-015365-iqdi99pd	1098	8	evaluate	evaluate	VB
cord-015365-iqdi99pd	1098	9	efficacy	efficacy	NN
cord-015365-iqdi99pd	1098	10	and	and	CC
cord-015365-iqdi99pd	1098	11	safety	safety	NN
cord-015365-iqdi99pd	1098	12	of	of	IN
cord-015365-iqdi99pd	1098	13	de	de	FW
cord-015365-iqdi99pd	1098	14	novo	novo	NNP
cord-015365-iqdi99pd	1098	15	use	use	NN
cord-015365-iqdi99pd	1098	16	of	of	IN
cord-015365-iqdi99pd	1098	17	advagraf	advagraf	NN
cord-015365-iqdi99pd	1098	18	in	in	IN
cord-015365-iqdi99pd	1098	19	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1098	20	transplant	transplant	NN
cord-015365-iqdi99pd	1098	21	patients	patient	NNS
cord-015365-iqdi99pd	1098	22	.	.	.
cord-015365-iqdi99pd	1099	1	Methods	method	NNS
cord-015365-iqdi99pd	1099	2	.	.	.
cord-015365-iqdi99pd	1100	1	10	10	CD
cord-015365-iqdi99pd	1100	2	patients	patient	NNS
cord-015365-iqdi99pd	1100	3	received	receive	VBD
cord-015365-iqdi99pd	1100	4	advagraf	advagraf	NN
cord-015365-iqdi99pd	1100	5	after	after	IN
cord-015365-iqdi99pd	1100	6	ATG	ATG	NNP
cord-015365-iqdi99pd	1100	7	induction	induction	NN
cord-015365-iqdi99pd	1100	8	therapy	therapy	NN
cord-015365-iqdi99pd	1100	9	,	,	,
cord-015365-iqdi99pd	1100	10	8.1	8.1	CD
cord-015365-iqdi99pd	1100	11	AE	AE	NNP
cord-015365-iqdi99pd	1100	12	3.3	3.3	CD
cord-015365-iqdi99pd	1100	13	days	day	NNS
cord-015365-iqdi99pd	1100	14	after	after	IN
cord-015365-iqdi99pd	1100	15	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1100	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	1100	17	.	.	.
cord-015365-iqdi99pd	1101	1	Mean	mean	JJ
cord-015365-iqdi99pd	1101	2	patient	patient	JJ
cord-015365-iqdi99pd	1101	3	age	age	NN
cord-015365-iqdi99pd	1101	4	was	be	VBD
cord-015365-iqdi99pd	1101	5	40.1	40.1	CD
cord-015365-iqdi99pd	1101	6	AE	AE	NNP
cord-015365-iqdi99pd	1101	7	16.4	16.4	CD
cord-015365-iqdi99pd	1101	8	years	year	NNS
cord-015365-iqdi99pd	1101	9	.	.	.
cord-015365-iqdi99pd	1102	1	All	all	DT
cord-015365-iqdi99pd	1102	2	patients	patient	NNS
cord-015365-iqdi99pd	1102	3	received	receive	VBD
cord-015365-iqdi99pd	1102	4	also	also	RB
cord-015365-iqdi99pd	1102	5	mycophenolate	mycophenolate	NNP
cord-015365-iqdi99pd	1102	6	and	and	CC
cord-015365-iqdi99pd	1102	7	steroids	steroid	NNS
cord-015365-iqdi99pd	1102	8	.	.	.
cord-015365-iqdi99pd	1103	1	Follow	follow	VB
cord-015365-iqdi99pd	1103	2	-	-	HYPH
cord-015365-iqdi99pd	1103	3	up	up	NN
cord-015365-iqdi99pd	1103	4	was	be	VBD
cord-015365-iqdi99pd	1103	5	4.4	4.4	CD
cord-015365-iqdi99pd	1103	6	AE	AE	NNP
cord-015365-iqdi99pd	1103	7	1.7	1.7	CD
cord-015365-iqdi99pd	1103	8	months	month	NNS
cord-015365-iqdi99pd	1103	9	.	.	.
cord-015365-iqdi99pd	1104	1	Dosages	dosage	NNS
cord-015365-iqdi99pd	1104	2	,	,	,
cord-015365-iqdi99pd	1104	3	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	1104	4	drug	drug	NN
cord-015365-iqdi99pd	1104	5	levels	level	NNS
cord-015365-iqdi99pd	1104	6	(	(	-LRB-
cord-015365-iqdi99pd	1104	7	tac	tac	NNP
cord-015365-iqdi99pd	1104	8	)	)	-RRB-
cord-015365-iqdi99pd	1104	9	and	and	CC
cord-015365-iqdi99pd	1104	10	creatinine	creatinine	NNP
cord-015365-iqdi99pd	1104	11	(	(	-LRB-
cord-015365-iqdi99pd	1104	12	crea	crea	NNP
cord-015365-iqdi99pd	1104	13	)	)	-RRB-
cord-015365-iqdi99pd	1104	14	levels	level	NNS
cord-015365-iqdi99pd	1104	15	were	be	VBD
cord-015365-iqdi99pd	1104	16	recorded	record	VBN
cord-015365-iqdi99pd	1104	17	1	1	CD
cord-015365-iqdi99pd	1104	18	,	,	,
cord-015365-iqdi99pd	1104	19	2	2	CD
cord-015365-iqdi99pd	1104	20	weeks	week	NNS
cord-015365-iqdi99pd	1104	21	and	and	CC
cord-015365-iqdi99pd	1104	22	1	1	CD
cord-015365-iqdi99pd	1104	23	to	to	TO
cord-015365-iqdi99pd	1104	24	six	six	CD
cord-015365-iqdi99pd	1104	25	months	month	NNS
cord-015365-iqdi99pd	1104	26	post	post	NN
cord-015365-iqdi99pd	1104	27	transplant	transplant	NN
cord-015365-iqdi99pd	1104	28	.	.	.
cord-015365-iqdi99pd	1105	1	Clinical	clinical	JJ
cord-015365-iqdi99pd	1105	2	events	event	NNS
cord-015365-iqdi99pd	1105	3	were	be	VBD
cord-015365-iqdi99pd	1105	4	defined	define	VBN
cord-015365-iqdi99pd	1105	5	as	as	IN
cord-015365-iqdi99pd	1105	6	acute	acute	JJ
cord-015365-iqdi99pd	1105	7	rejection	rejection	NN
cord-015365-iqdi99pd	1105	8	,	,	,
cord-015365-iqdi99pd	1105	9	infection	infection	NN
cord-015365-iqdi99pd	1105	10	type	type	NN
cord-015365-iqdi99pd	1105	11	,	,	,
cord-015365-iqdi99pd	1105	12	new	new	JJ
cord-015365-iqdi99pd	1105	13	onset	onset	NN
cord-015365-iqdi99pd	1105	14	diabetes	diabetes	NN
cord-015365-iqdi99pd	1105	15	mellitus	mellitus	NN
cord-015365-iqdi99pd	1105	16	(	(	-LRB-
cord-015365-iqdi99pd	1105	17	NODM	NODM	NNP
cord-015365-iqdi99pd	1105	18	)	)	-RRB-
cord-015365-iqdi99pd	1105	19	and	and	CC
cord-015365-iqdi99pd	1105	20	renal	renal	JJ
cord-015365-iqdi99pd	1105	21	dysfunction	dysfunction	NN
cord-015365-iqdi99pd	1105	22	.	.	.
cord-015365-iqdi99pd	1106	1	Results	result	NNS
cord-015365-iqdi99pd	1106	2	.	.	.
cord-015365-iqdi99pd	1107	1	Six	six	CD
cord-015365-iqdi99pd	1107	2	-	-	HYPH
cord-015365-iqdi99pd	1107	3	month	month	NN
cord-015365-iqdi99pd	1107	4	survival	survival	NN
cord-015365-iqdi99pd	1107	5	was	be	VBD
cord-015365-iqdi99pd	1107	6	100	100	CD
cord-015365-iqdi99pd	1107	7	%	%	NN
cord-015365-iqdi99pd	1107	8	.	.	.
cord-015365-iqdi99pd	1108	1	Two	two	CD
cord-015365-iqdi99pd	1108	2	patients	patient	NNS
cord-015365-iqdi99pd	1108	3	were	be	VBD
cord-015365-iqdi99pd	1108	4	converted	convert	VBN
cord-015365-iqdi99pd	1108	5	to	to	IN
cord-015365-iqdi99pd	1108	6	cyclosporine	cyclosporine	NN
cord-015365-iqdi99pd	1108	7	due	due	IN
cord-015365-iqdi99pd	1108	8	to	to	IN
cord-015365-iqdi99pd	1108	9	NODM	NODM	NNP
cord-015365-iqdi99pd	1108	10	1	1	CD
cord-015365-iqdi99pd	1108	11	and	and	CC
cord-015365-iqdi99pd	1108	12	3	3	CD
cord-015365-iqdi99pd	1108	13	months	month	NNS
cord-015365-iqdi99pd	1108	14	post	post	NN
cord-015365-iqdi99pd	1108	15	transplant	transplant	NN
cord-015365-iqdi99pd	1108	16	.	.	.
cord-015365-iqdi99pd	1109	1	No	no	DT
cord-015365-iqdi99pd	1109	2	rejection	rejection	NN
cord-015365-iqdi99pd	1109	3	episodes	episode	NNS
cord-015365-iqdi99pd	1109	4	were	be	VBD
cord-015365-iqdi99pd	1109	5	recorded	record	VBN
cord-015365-iqdi99pd	1109	6	during	during	IN
cord-015365-iqdi99pd	1109	7	follow	follow	NN
cord-015365-iqdi99pd	1109	8	-	-	HYPH
cord-015365-iqdi99pd	1109	9	up	up	NN
cord-015365-iqdi99pd	1109	10	.	.	.
cord-015365-iqdi99pd	1110	1	Two	two	CD
cord-015365-iqdi99pd	1110	2	infections	infection	NNS
cord-015365-iqdi99pd	1110	3	were	be	VBD
cord-015365-iqdi99pd	1110	4	documented	document	VBN
cord-015365-iqdi99pd	1110	5	6	6	CD
cord-015365-iqdi99pd	1110	6	months	month	NNS
cord-015365-iqdi99pd	1110	7	after	after	IN
cord-015365-iqdi99pd	1110	8	transplant	transplant	NN
cord-015365-iqdi99pd	1110	9	(	(	-LRB-
cord-015365-iqdi99pd	1110	10	bacterial	bacterial	JJ
cord-015365-iqdi99pd	1110	11	pneumonia	pneumonia	NN
cord-015365-iqdi99pd	1110	12	and	and	CC
cord-015365-iqdi99pd	1110	13	CMV	CMV	NNP
cord-015365-iqdi99pd	1110	14	infection	infection	NN
cord-015365-iqdi99pd	1110	15	)	)	-RRB-
cord-015365-iqdi99pd	1110	16	.	.	.
cord-015365-iqdi99pd	1111	1	Advagraf	Advagraf	NNP
cord-015365-iqdi99pd	1111	2	starting	starting	NN
cord-015365-iqdi99pd	1111	3	dose	dose	NN
cord-015365-iqdi99pd	1111	4	was	be	VBD
cord-015365-iqdi99pd	1111	5	6.2	6.2	CD
cord-015365-iqdi99pd	1111	6	AE	AE	NNP
cord-015365-iqdi99pd	1111	7	1.9	1.9	CD
cord-015365-iqdi99pd	1111	8	mg	mg	NNP
cord-015365-iqdi99pd	1111	9	/	/	SYM
cord-015365-iqdi99pd	1111	10	d	d	NN
cord-015365-iqdi99pd	1111	11	.	.	.
cord-015365-iqdi99pd	1112	1	Crea	Crea	NNP
cord-015365-iqdi99pd	1112	2	before	before	IN
cord-015365-iqdi99pd	1112	3	start	start	NN
cord-015365-iqdi99pd	1112	4	was	be	VBD
cord-015365-iqdi99pd	1112	5	1.14	1.14	CD
cord-015365-iqdi99pd	1112	6	AE	AE	NNP
cord-015365-iqdi99pd	1112	7	0.34	0.34	CD
cord-015365-iqdi99pd	1112	8	mg	mg	NNP
cord-015365-iqdi99pd	1112	9	/	/	SYM
cord-015365-iqdi99pd	1112	10	dl	dl	NNP
cord-015365-iqdi99pd	1112	11	.	.	.
cord-015365-iqdi99pd	1113	1	First	first	RB
cord-015365-iqdi99pd	1113	2	measured	measure	VBN
cord-015365-iqdi99pd	1113	3	tac	tac	NNP
cord-015365-iqdi99pd	1113	4	levels	level	NNS
cord-015365-iqdi99pd	1113	5	at	at	IN
cord-015365-iqdi99pd	1113	6	steady	steady	JJ
cord-015365-iqdi99pd	1113	7	state	state	NN
cord-015365-iqdi99pd	1113	8	(	(	-LRB-
cord-015365-iqdi99pd	1113	9	5	5	CD
cord-015365-iqdi99pd	1113	10	days	day	NNS
cord-015365-iqdi99pd	1113	11	post	post	VBP
cord-015365-iqdi99pd	1113	12	drug	drug	NN
cord-015365-iqdi99pd	1113	13	start	start	NN
cord-015365-iqdi99pd	1113	14	)	)	-RRB-
cord-015365-iqdi99pd	1113	15	were	be	VBD
cord-015365-iqdi99pd	1113	16	7.8	7.8	CD
cord-015365-iqdi99pd	1113	17	AE	AE	NNP
cord-015365-iqdi99pd	1113	18	3.7	3.7	CD
cord-015365-iqdi99pd	1113	19	ng	ng	NN
cord-015365-iqdi99pd	1113	20	/	/	SYM
cord-015365-iqdi99pd	1113	21	ml	ml	NN
cord-015365-iqdi99pd	1113	22	.	.	.
cord-015365-iqdi99pd	1114	1	Until	until	IN
cord-015365-iqdi99pd	1114	2	the	the	DT
cord-015365-iqdi99pd	1114	3	end	end	NN
cord-015365-iqdi99pd	1114	4	of	of	IN
cord-015365-iqdi99pd	1114	5	the	the	DT
cord-015365-iqdi99pd	1114	6	first	first	JJ
cord-015365-iqdi99pd	1114	7	month	month	NN
cord-015365-iqdi99pd	1114	8	advagraf	advagraf	NNP
cord-015365-iqdi99pd	1114	9	was	be	VBD
cord-015365-iqdi99pd	1114	10	slowly	slowly	RB
cord-015365-iqdi99pd	1114	11	increased	increase	VBN
cord-015365-iqdi99pd	1114	12	to	to	IN
cord-015365-iqdi99pd	1114	13	10.1	10.1	CD
cord-015365-iqdi99pd	1114	14	AE	AE	NNP
cord-015365-iqdi99pd	1114	15	1.9	1.9	CD
cord-015365-iqdi99pd	1114	16	mg	mg	NNP
cord-015365-iqdi99pd	1114	17	/	/	SYM
cord-015365-iqdi99pd	1114	18	d	d	XX
cord-015365-iqdi99pd	1114	19	with	with	IN
cord-015365-iqdi99pd	1114	20	tac	tac	NNP
cord-015365-iqdi99pd	1114	21	levels	level	NNS
cord-015365-iqdi99pd	1114	22	of	of	IN
cord-015365-iqdi99pd	1114	23	10.7	10.7	CD
cord-015365-iqdi99pd	1114	24	AE	AE	NNP
cord-015365-iqdi99pd	1114	25	2.8	2.8	CD
cord-015365-iqdi99pd	1114	26	ng	ng	NN
cord-015365-iqdi99pd	1114	27	/	/	SYM
cord-015365-iqdi99pd	1114	28	ml	ml	NN
cord-015365-iqdi99pd	1114	29	and	and	CC
cord-015365-iqdi99pd	1114	30	crea	crea	NNP
cord-015365-iqdi99pd	1114	31	of	of	IN
cord-015365-iqdi99pd	1114	32	1.22	1.22	CD
cord-015365-iqdi99pd	1114	33	AE	AE	NNP
cord-015365-iqdi99pd	1114	34	0.31	0.31	CD
cord-015365-iqdi99pd	1114	35	mg	mg	NNP
cord-015365-iqdi99pd	1114	36	/	/	SYM
cord-015365-iqdi99pd	1114	37	dl	dl	NNP
cord-015365-iqdi99pd	1114	38	.	.	.
cord-015365-iqdi99pd	1115	1	Three	three	CD
cord-015365-iqdi99pd	1115	2	and	and	CC
cord-015365-iqdi99pd	1115	3	six	six	CD
cord-015365-iqdi99pd	1115	4	month	month	NN
cord-015365-iqdi99pd	1115	5	drug	drug	NN
cord-015365-iqdi99pd	1115	6	doses	dose	NNS
cord-015365-iqdi99pd	1115	7	were	be	VBD
cord-015365-iqdi99pd	1115	8	9.3	9.3	CD
cord-015365-iqdi99pd	1115	9	AE	AE	NNP
cord-015365-iqdi99pd	1115	10	2.11	2.11	CD
cord-015365-iqdi99pd	1115	11	and	and	CC
cord-015365-iqdi99pd	1115	12	8.2	8.2	CD
cord-015365-iqdi99pd	1115	13	AE	AE	NNP
cord-015365-iqdi99pd	1115	14	0.8	0.8	CD
cord-015365-iqdi99pd	1115	15	mg	mg	NN
cord-015365-iqdi99pd	1115	16	with	with	IN
cord-015365-iqdi99pd	1115	17	corresponding	correspond	VBG
cord-015365-iqdi99pd	1115	18	tac	tac	NNP
cord-015365-iqdi99pd	1115	19	levels	level	NNS
cord-015365-iqdi99pd	1115	20	of	of	IN
cord-015365-iqdi99pd	1115	21	11.2	11.2	CD
cord-015365-iqdi99pd	1115	22	AE	AE	NNP
cord-015365-iqdi99pd	1115	23	2.9	2.9	CD
cord-015365-iqdi99pd	1115	24	and	and	CC
cord-015365-iqdi99pd	1115	25	11.2	11.2	CD
cord-015365-iqdi99pd	1115	26	AE	AE	NNP
cord-015365-iqdi99pd	1115	27	1.3	1.3	CD
cord-015365-iqdi99pd	1115	28	ng	ng	NN
cord-015365-iqdi99pd	1115	29	/	/	SYM
cord-015365-iqdi99pd	1115	30	ml	ml	NN
cord-015365-iqdi99pd	1115	31	.	.	.
cord-015365-iqdi99pd	1116	1	Crea	Crea	NNP
cord-015365-iqdi99pd	1116	2	was	be	VBD
cord-015365-iqdi99pd	1116	3	1.47	1.47	CD
cord-015365-iqdi99pd	1116	4	AE	AE	NNP
cord-015365-iqdi99pd	1116	5	0.22	0.22	CD
cord-015365-iqdi99pd	1116	6	and	and	CC
cord-015365-iqdi99pd	1116	7	1.49	1.49	CD
cord-015365-iqdi99pd	1116	8	AE	AE	NNP
cord-015365-iqdi99pd	1116	9	0.32	0.32	CD
cord-015365-iqdi99pd	1116	10	mg	mg	NNP
cord-015365-iqdi99pd	1116	11	/	/	SYM
cord-015365-iqdi99pd	1116	12	dl	dl	NNP
cord-015365-iqdi99pd	1116	13	.	.	.
cord-015365-iqdi99pd	1117	1	There	there	EX
cord-015365-iqdi99pd	1117	2	were	be	VBD
cord-015365-iqdi99pd	1117	3	no	no	DT
cord-015365-iqdi99pd	1117	4	events	event	NNS
cord-015365-iqdi99pd	1117	5	of	of	IN
cord-015365-iqdi99pd	1117	6	renal	renal	JJ
cord-015365-iqdi99pd	1117	7	failure	failure	NN
cord-015365-iqdi99pd	1117	8	.	.	.
cord-015365-iqdi99pd	1118	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1118	2	.	.	.
cord-015365-iqdi99pd	1119	1	Advagraf	Advagraf	NNP
cord-015365-iqdi99pd	1119	2	de	de	NNP
cord-015365-iqdi99pd	1119	3	-	-	JJ
cord-015365-iqdi99pd	1119	4	novo	novo	JJ
cord-015365-iqdi99pd	1119	5	therapy	therapy	NN
cord-015365-iqdi99pd	1119	6	shows	show	VBZ
cord-015365-iqdi99pd	1119	7	acceptable	acceptable	JJ
cord-015365-iqdi99pd	1119	8	efficacy	efficacy	NN
cord-015365-iqdi99pd	1119	9	and	and	CC
cord-015365-iqdi99pd	1119	10	safety	safety	NN
cord-015365-iqdi99pd	1119	11	early	early	RB
cord-015365-iqdi99pd	1119	12	after	after	IN
cord-015365-iqdi99pd	1119	13	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1119	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	1119	15	.	.	.
cord-015365-iqdi99pd	1120	1	ATGinduction	atginduction	NN
cord-015365-iqdi99pd	1120	2	therapy	therapy	NN
cord-015365-iqdi99pd	1120	3	might	may	MD
cord-015365-iqdi99pd	1120	4	be	be	VB
cord-015365-iqdi99pd	1120	5	responsible	responsible	JJ
cord-015365-iqdi99pd	1120	6	for	for	IN
cord-015365-iqdi99pd	1120	7	a	a	DT
cord-015365-iqdi99pd	1120	8	low	low	JJ
cord-015365-iqdi99pd	1120	9	risk	risk	NN
cord-015365-iqdi99pd	1120	10	of	of	IN
cord-015365-iqdi99pd	1120	11	acute	acute	JJ
cord-015365-iqdi99pd	1120	12	rejection	rejection	NN
cord-015365-iqdi99pd	1120	13	despite	despite	IN
cord-015365-iqdi99pd	1120	14	lower	low	JJR
cord-015365-iqdi99pd	1120	15	early	early	JJ
cord-015365-iqdi99pd	1120	16	tac	tac	NNP
cord-015365-iqdi99pd	1120	17	levels	level	NNS
cord-015365-iqdi99pd	1120	18	.	.	.
cord-015365-iqdi99pd	1121	1	Usage	usage	NN
cord-015365-iqdi99pd	1121	2	of	of	IN
cord-015365-iqdi99pd	1121	3	If	if	NN
cord-015365-iqdi99pd	1121	4	-	-	HYPH
cord-015365-iqdi99pd	1121	5	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	1121	6	in	in	IN
cord-015365-iqdi99pd	1121	7	regulation	regulation	NN
cord-015365-iqdi99pd	1121	8	of	of	IN
cord-015365-iqdi99pd	1121	9	heart	heart	NN
cord-015365-iqdi99pd	1121	10	rate	rate	NN
cord-015365-iqdi99pd	1121	11	after	after	IN
cord-015365-iqdi99pd	1121	12	heart	heart	NN
cord-015365-iqdi99pd	1121	13	transplantation	transplantation	NN
cord-015365-iqdi99pd	1121	14	Background	Background	NNP
cord-015365-iqdi99pd	1121	15	.	.	.
cord-015365-iqdi99pd	1122	1	Due	due	IN
cord-015365-iqdi99pd	1122	2	to	to	IN
cord-015365-iqdi99pd	1122	3	denervation	denervation	NN
cord-015365-iqdi99pd	1122	4	of	of	IN
cord-015365-iqdi99pd	1122	5	the	the	DT
cord-015365-iqdi99pd	1122	6	heart	heart	NN
cord-015365-iqdi99pd	1122	7	from	from	IN
cord-015365-iqdi99pd	1122	8	N.	N.	NNP
cord-015365-iqdi99pd	1122	9	vagus	vagus	NN
cord-015365-iqdi99pd	1122	10	,	,	,
cord-015365-iqdi99pd	1122	11	patients	patient	NNS
cord-015365-iqdi99pd	1122	12	physiologically	physiologically	RB
cord-015365-iqdi99pd	1122	13	have	have	VBP
cord-015365-iqdi99pd	1122	14	a	a	DT
cord-015365-iqdi99pd	1122	15	heart	heart	NN
cord-015365-iqdi99pd	1122	16	rate	rate	NN
cord-015365-iqdi99pd	1122	17	of	of	IN
cord-015365-iqdi99pd	1122	18	90	90	CD
cord-015365-iqdi99pd	1122	19	-	-	SYM
cord-015365-iqdi99pd	1122	20	100	100	CD
cord-015365-iqdi99pd	1122	21	beats	beat	NNS
cord-015365-iqdi99pd	1122	22	per	per	IN
cord-015365-iqdi99pd	1122	23	minute	minute	NN
cord-015365-iqdi99pd	1122	24	(	(	-LRB-
cord-015365-iqdi99pd	1122	25	bpm	bpm	NNP
cord-015365-iqdi99pd	1122	26	)	)	-RRB-
cord-015365-iqdi99pd	1122	27	after	after	IN
cord-015365-iqdi99pd	1122	28	heart	heart	NN
cord-015365-iqdi99pd	1122	29	transplantation	transplantation	NN
cord-015365-iqdi99pd	1122	30	.	.	.
cord-015365-iqdi99pd	1123	1	Inhibiting	inhibit	VBG
cord-015365-iqdi99pd	1123	2	the	the	DT
cord-015365-iqdi99pd	1123	3	funnychannels	funnychannel	NNS
cord-015365-iqdi99pd	1123	4	(	(	-LRB-
cord-015365-iqdi99pd	1123	5	If	if	IN
cord-015365-iqdi99pd	1123	6	)	)	-RRB-
cord-015365-iqdi99pd	1123	7	of	of	IN
cord-015365-iqdi99pd	1123	8	the	the	DT
cord-015365-iqdi99pd	1123	9	pacing	pacing	NN
cord-015365-iqdi99pd	1123	10	-	-	HYPH
cord-015365-iqdi99pd	1123	11	cells	cell	NNS
cord-015365-iqdi99pd	1123	12	of	of	IN
cord-015365-iqdi99pd	1123	13	the	the	DT
cord-015365-iqdi99pd	1123	14	sinus	sinus	NN
cord-015365-iqdi99pd	1123	15	node	node	NN
cord-015365-iqdi99pd	1123	16	reduces	reduce	VBZ
cord-015365-iqdi99pd	1123	17	ionic	ionic	NN
cord-015365-iqdi99pd	1123	18	-	-	HYPH
cord-015365-iqdi99pd	1123	19	influx	influx	JJ
cord-015365-iqdi99pd	1123	20	and	and	CC
cord-015365-iqdi99pd	1123	21	spontaneous	spontaneous	JJ
cord-015365-iqdi99pd	1123	22	depolarization	depolarization	NN
cord-015365-iqdi99pd	1123	23	and	and	CC
cord-015365-iqdi99pd	1123	24	hereby	hereby	RB
cord-015365-iqdi99pd	1123	25	decreases	decrease	VBZ
cord-015365-iqdi99pd	1123	26	the	the	DT
cord-015365-iqdi99pd	1123	27	heart	heart	NN
cord-015365-iqdi99pd	1123	28	rate	rate	NN
cord-015365-iqdi99pd	1123	29	.	.	.
cord-015365-iqdi99pd	1124	1	To	to	TO
cord-015365-iqdi99pd	1124	2	improve	improve	VB
cord-015365-iqdi99pd	1124	3	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1124	4	oxygenation	oxygenation	NN
cord-015365-iqdi99pd	1124	5	by	by	IN
cord-015365-iqdi99pd	1124	6	extending	extend	VBG
cord-015365-iqdi99pd	1124	7	diastolic	diastolic	JJ
cord-015365-iqdi99pd	1124	8	time	time	NN
cord-015365-iqdi99pd	1124	9	,	,	,
cord-015365-iqdi99pd	1124	10	reducing	reduce	VBG
cord-015365-iqdi99pd	1124	11	the	the	DT
cord-015365-iqdi99pd	1124	12	heart	heart	NN
cord-015365-iqdi99pd	1124	13	rate	rate	NN
cord-015365-iqdi99pd	1124	14	is	be	VBZ
cord-015365-iqdi99pd	1124	15	an	an	DT
cord-015365-iqdi99pd	1124	16	important	important	JJ
cord-015365-iqdi99pd	1124	17	goal	goal	NN
cord-015365-iqdi99pd	1124	18	for	for	IN
cord-015365-iqdi99pd	1124	19	these	these	DT
cord-015365-iqdi99pd	1124	20	patients	patient	NNS
cord-015365-iqdi99pd	1124	21	.	.	.
cord-015365-iqdi99pd	1125	1	Objective	objective	NN
cord-015365-iqdi99pd	1125	2	of	of	IN
cord-015365-iqdi99pd	1125	3	the	the	DT
cord-015365-iqdi99pd	1125	4	current	current	JJ
cord-015365-iqdi99pd	1125	5	study	study	NN
cord-015365-iqdi99pd	1125	6	is	be	VBZ
cord-015365-iqdi99pd	1125	7	to	to	TO
cord-015365-iqdi99pd	1125	8	show	show	VB
cord-015365-iqdi99pd	1125	9	the	the	DT
cord-015365-iqdi99pd	1125	10	efficacy	efficacy	NN
cord-015365-iqdi99pd	1125	11	of	of	IN
cord-015365-iqdi99pd	1125	12	the	the	DT
cord-015365-iqdi99pd	1125	13	If	if	IN
cord-015365-iqdi99pd	1125	14	-	-	HYPH
cord-015365-iqdi99pd	1125	15	inhibitor	inhibitor	NN
cord-015365-iqdi99pd	1125	16	ivabradine	ivabradine	NN
cord-015365-iqdi99pd	1125	17	(	(	-LRB-
cord-015365-iqdi99pd	1125	18	Procoralan	Procoralan	NNP
cord-015365-iqdi99pd	1125	19	+	+	CC
cord-015365-iqdi99pd	1125	20	)	)	-RRB-
cord-015365-iqdi99pd	1125	21	on	on	IN
cord-015365-iqdi99pd	1125	22	the	the	DT
cord-015365-iqdi99pd	1125	23	transplanted	transplanted	JJ
cord-015365-iqdi99pd	1125	24	heart	heart	NN
cord-015365-iqdi99pd	1125	25	.	.	.
cord-015365-iqdi99pd	1126	1	Methods	method	NNS
cord-015365-iqdi99pd	1126	2	.	.	.
cord-015365-iqdi99pd	1127	1	This	this	DT
cord-015365-iqdi99pd	1127	2	is	be	VBZ
cord-015365-iqdi99pd	1127	3	a	a	DT
cord-015365-iqdi99pd	1127	4	single	single	JJ
cord-015365-iqdi99pd	1127	5	-	-	HYPH
cord-015365-iqdi99pd	1127	6	center	center	NN
cord-015365-iqdi99pd	1127	7	retrospective	retrospective	JJ
cord-015365-iqdi99pd	1127	8	study	study	NN
cord-015365-iqdi99pd	1127	9	including	include	VBG
cord-015365-iqdi99pd	1127	10	143	143	CD
cord-015365-iqdi99pd	1127	11	patients	patient	NNS
cord-015365-iqdi99pd	1127	12	,	,	,
cord-015365-iqdi99pd	1127	13	who	who	WP
cord-015365-iqdi99pd	1127	14	underwent	undergo	VBD
cord-015365-iqdi99pd	1127	15	heart	heart	NN
cord-015365-iqdi99pd	1127	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	1127	17	from	from	IN
cord-015365-iqdi99pd	1127	18	1985	1985	CD
cord-015365-iqdi99pd	1127	19	to	to	IN
cord-015365-iqdi99pd	1127	20	2011	2011	CD
cord-015365-iqdi99pd	1127	21	at	at	IN
cord-015365-iqdi99pd	1127	22	our	-PRON-	PRP$
cord-015365-iqdi99pd	1127	23	center	center	NN
cord-015365-iqdi99pd	1127	24	in	in	IN
cord-015365-iqdi99pd	1127	25	Vienna	Vienna	NNP
cord-015365-iqdi99pd	1127	26	and	and	CC
cord-015365-iqdi99pd	1127	27	who	who	WP
cord-015365-iqdi99pd	1127	28	were	be	VBD
cord-015365-iqdi99pd	1127	29	in	in	IN
cord-015365-iqdi99pd	1127	30	need	need	NN
cord-015365-iqdi99pd	1127	31	of	of	IN
cord-015365-iqdi99pd	1127	32	a	a	DT
cord-015365-iqdi99pd	1127	33	heart	heart	NN
cord-015365-iqdi99pd	1127	34	rate	rate	NN
cord-015365-iqdi99pd	1127	35	regulating	regulate	VBG
cord-015365-iqdi99pd	1127	36	therapy	therapy	NN
cord-015365-iqdi99pd	1127	37	after	after	IN
cord-015365-iqdi99pd	1127	38	transplantation	transplantation	NN
cord-015365-iqdi99pd	1127	39	.	.	.
cord-015365-iqdi99pd	1128	1	Only	only	RB
cord-015365-iqdi99pd	1128	2	patients	patient	NNS
cord-015365-iqdi99pd	1128	3	in	in	IN
cord-015365-iqdi99pd	1128	4	stable	stable	JJ
cord-015365-iqdi99pd	1128	5	conditions	condition	NNS
cord-015365-iqdi99pd	1128	6	and	and	CC
cord-015365-iqdi99pd	1128	7	with	with	IN
cord-015365-iqdi99pd	1128	8	sinus	sinus	NN
cord-015365-iqdi99pd	1128	9	rhythm	rhythm	NN
cord-015365-iqdi99pd	1128	10	were	be	VBD
cord-015365-iqdi99pd	1128	11	treated	treat	VBN
cord-015365-iqdi99pd	1128	12	with	with	IN
cord-015365-iqdi99pd	1128	13	ivabradine	ivabradine	NN
cord-015365-iqdi99pd	1128	14	.	.	.
cord-015365-iqdi99pd	1129	1	An	an	DT
cord-015365-iqdi99pd	1129	2	average	average	JJ
cord-015365-iqdi99pd	1129	3	dose	dose	NN
cord-015365-iqdi99pd	1129	4	of	of	IN
cord-015365-iqdi99pd	1129	5	10	10	CD
cord-015365-iqdi99pd	1129	6	mg	mg	NN
cord-015365-iqdi99pd	1129	7	per	per	IN
cord-015365-iqdi99pd	1129	8	day	day	NN
cord-015365-iqdi99pd	1129	9	was	be	VBD
cord-015365-iqdi99pd	1129	10	used	use	VBN
cord-015365-iqdi99pd	1129	11	to	to	TO
cord-015365-iqdi99pd	1129	12	control	control	VB
cord-015365-iqdi99pd	1129	13	the	the	DT
cord-015365-iqdi99pd	1129	14	heart	heart	NN
cord-015365-iqdi99pd	1129	15	rate	rate	NN
cord-015365-iqdi99pd	1129	16	.	.	.
cord-015365-iqdi99pd	1130	1	Analyzed	analyze	VBN
cord-015365-iqdi99pd	1130	2	data	datum	NNS
cord-015365-iqdi99pd	1130	3	were	be	VBD
cord-015365-iqdi99pd	1130	4	collected	collect	VBN
cord-015365-iqdi99pd	1130	5	during	during	IN
cord-015365-iqdi99pd	1130	6	routine	routine	JJ
cord-015365-iqdi99pd	1130	7	checkups	checkup	NNS
cord-015365-iqdi99pd	1130	8	in	in	IN
cord-015365-iqdi99pd	1130	9	our	-PRON-	PRP$
cord-015365-iqdi99pd	1130	10	long	long	JJ
cord-015365-iqdi99pd	1130	11	-	-	HYPH
cord-015365-iqdi99pd	1130	12	term	term	NN
cord-015365-iqdi99pd	1130	13	outpatient	outpatient	NN
cord-015365-iqdi99pd	1130	14	-	-	HYPH
cord-015365-iqdi99pd	1130	15	clinic	clinic	NN
cord-015365-iqdi99pd	1130	16	and	and	CC
cord-015365-iqdi99pd	1130	17	during	during	IN
cord-015365-iqdi99pd	1130	18	ergometry	ergometry	NN
cord-015365-iqdi99pd	1130	19	examination	examination	NN
cord-015365-iqdi99pd	1130	20	by	by	IN
cord-015365-iqdi99pd	1130	21	periodical	periodical	JJ
cord-015365-iqdi99pd	1130	22	measurements	measurement	NNS
cord-015365-iqdi99pd	1130	23	of	of	IN
cord-015365-iqdi99pd	1130	24	heart	heart	NN
cord-015365-iqdi99pd	1130	25	-	-	HYPH
cord-015365-iqdi99pd	1130	26	rate	rate	NN
cord-015365-iqdi99pd	1130	27	,	,	,
cord-015365-iqdi99pd	1130	28	bloodpressure	bloodpressure	NN
cord-015365-iqdi99pd	1130	29	and	and	CC
cord-015365-iqdi99pd	1130	30	ECG	ECG	NNP
cord-015365-iqdi99pd	1130	31	.	.	.
cord-015365-iqdi99pd	1131	1	Results	result	NNS
cord-015365-iqdi99pd	1131	2	.	.	.
cord-015365-iqdi99pd	1132	1	Mean	mean	JJ
cord-015365-iqdi99pd	1132	2	age	age	NN
cord-015365-iqdi99pd	1132	3	at	at	IN
cord-015365-iqdi99pd	1132	4	the	the	DT
cord-015365-iqdi99pd	1132	5	time	time	NN
cord-015365-iqdi99pd	1132	6	of	of	IN
cord-015365-iqdi99pd	1132	7	transplantation	transplantation	NN
cord-015365-iqdi99pd	1132	8	was	be	VBD
cord-015365-iqdi99pd	1132	9	51.3	51.3	CD
cord-015365-iqdi99pd	1132	10	AE	AE	NNP
cord-015365-iqdi99pd	1132	11	11.9	11.9	CD
cord-015365-iqdi99pd	1132	12	years	year	NNS
cord-015365-iqdi99pd	1132	13	,	,	,
cord-015365-iqdi99pd	1132	14	117	117	CD
cord-015365-iqdi99pd	1132	15	patients	patient	NNS
cord-015365-iqdi99pd	1132	16	(	(	-LRB-
cord-015365-iqdi99pd	1132	17	81.8	81.8	CD
cord-015365-iqdi99pd	1132	18	%	%	NN
cord-015365-iqdi99pd	1132	19	)	)	-RRB-
cord-015365-iqdi99pd	1132	20	were	be	VBD
cord-015365-iqdi99pd	1132	21	male	male	JJ
cord-015365-iqdi99pd	1132	22	(	(	-LRB-
cord-015365-iqdi99pd	1132	23	age	age	NN
cord-015365-iqdi99pd	1132	24	16	16	CD
cord-015365-iqdi99pd	1132	25	-	-	SYM
cord-015365-iqdi99pd	1132	26	71	71	CD
cord-015365-iqdi99pd	1132	27	years	year	NNS
cord-015365-iqdi99pd	1132	28	)	)	-RRB-
cord-015365-iqdi99pd	1132	29	and	and	CC
cord-015365-iqdi99pd	1132	30	26	26	CD
cord-015365-iqdi99pd	1132	31	patients	patient	NNS
cord-015365-iqdi99pd	1132	32	(	(	-LRB-
cord-015365-iqdi99pd	1132	33	18.2	18.2	CD
cord-015365-iqdi99pd	1132	34	%	%	NN
cord-015365-iqdi99pd	1132	35	)	)	-RRB-
cord-015365-iqdi99pd	1132	36	were	be	VBD
cord-015365-iqdi99pd	1132	37	female	female	JJ
cord-015365-iqdi99pd	1132	38	(	(	-LRB-
cord-015365-iqdi99pd	1132	39	age	age	NN
cord-015365-iqdi99pd	1132	40	14	14	CD
cord-015365-iqdi99pd	1132	41	-	-	SYM
cord-015365-iqdi99pd	1132	42	68	68	CD
cord-015365-iqdi99pd	1132	43	years	year	NNS
cord-015365-iqdi99pd	1132	44	)	)	-RRB-
cord-015365-iqdi99pd	1132	45	.	.	.
cord-015365-iqdi99pd	1133	1	Before	before	IN
cord-015365-iqdi99pd	1133	2	establishing	establish	VBG
cord-015365-iqdi99pd	1133	3	the	the	DT
cord-015365-iqdi99pd	1133	4	Procoralan	Procoralan	NNP
cord-015365-iqdi99pd	1133	5	+	+	CC
cord-015365-iqdi99pd	1133	6	therapy	therapy	NN
cord-015365-iqdi99pd	1133	7	,	,	,
cord-015365-iqdi99pd	1133	8	patients	patient	NNS
cord-015365-iqdi99pd	1133	9	had	have	VBD
cord-015365-iqdi99pd	1133	10	an	an	DT
cord-015365-iqdi99pd	1133	11	average	average	JJ
cord-015365-iqdi99pd	1133	12	heart	heart	NN
cord-015365-iqdi99pd	1133	13	rate	rate	NN
cord-015365-iqdi99pd	1133	14	of	of	IN
cord-015365-iqdi99pd	1133	15	96.2	96.2	CD
cord-015365-iqdi99pd	1133	16	AE	AE	NNP
cord-015365-iqdi99pd	1133	17	11.9	11.9	CD
cord-015365-iqdi99pd	1133	18	bpm	bpm	NN
cord-015365-iqdi99pd	1133	19	.	.	.
cord-015365-iqdi99pd	1134	1	With	with	IN
cord-015365-iqdi99pd	1134	2	the	the	DT
cord-015365-iqdi99pd	1134	3	Procoralan	Procoralan	NNP
cord-015365-iqdi99pd	1134	4	+	+	CC
cord-015365-iqdi99pd	1134	5	therapy	therapy	NN
cord-015365-iqdi99pd	1134	6	,	,	,
cord-015365-iqdi99pd	1134	7	patients	patient	NNS
cord-015365-iqdi99pd	1134	8	had	have	VBD
cord-015365-iqdi99pd	1134	9	an	an	DT
cord-015365-iqdi99pd	1134	10	average	average	JJ
cord-015365-iqdi99pd	1134	11	heart	heart	NN
cord-015365-iqdi99pd	1134	12	rate	rate	NN
cord-015365-iqdi99pd	1134	13	of	of	IN
cord-015365-iqdi99pd	1134	14	83.1	83.1	CD
cord-015365-iqdi99pd	1134	15	AE	AE	NNP
cord-015365-iqdi99pd	1134	16	9.5	9.5	CD
cord-015365-iqdi99pd	1134	17	bpm	bpm	NN
cord-015365-iqdi99pd	1134	18	.	.	.
cord-015365-iqdi99pd	1135	1	After	after	IN
cord-015365-iqdi99pd	1135	2	an	an	DT
cord-015365-iqdi99pd	1135	3	average	average	JJ
cord-015365-iqdi99pd	1135	4	time	time	NN
cord-015365-iqdi99pd	1135	5	of	of	IN
cord-015365-iqdi99pd	1135	6	1.8	1.8	CD
cord-015365-iqdi99pd	1135	7	AE	AE	NNP
cord-015365-iqdi99pd	1135	8	1.4	1.4	CD
cord-015365-iqdi99pd	1135	9	years	year	NNS
cord-015365-iqdi99pd	1135	10	,	,	,
cord-015365-iqdi99pd	1135	11	usage	usage	NN
cord-015365-iqdi99pd	1135	12	of	of	IN
cord-015365-iqdi99pd	1135	13	ivabradine	ivabradine	NN
cord-015365-iqdi99pd	1135	14	has	have	VBZ
cord-015365-iqdi99pd	1135	15	reduced	reduce	VBN
cord-015365-iqdi99pd	1135	16	the	the	DT
cord-015365-iqdi99pd	1135	17	heart	heart	NN
cord-015365-iqdi99pd	1135	18	rate	rate	NN
cord-015365-iqdi99pd	1135	19	by	by	IN
cord-015365-iqdi99pd	1135	20	14.9	14.9	CD
cord-015365-iqdi99pd	1135	21	AE	AE	NNP
cord-015365-iqdi99pd	1135	22	9.4	9.4	CD
cord-015365-iqdi99pd	1135	23	%	%	NN
cord-015365-iqdi99pd	1135	24	.	.	.
cord-015365-iqdi99pd	1136	1	In	in	IN
cord-015365-iqdi99pd	1136	2	7	7	CD
cord-015365-iqdi99pd	1136	3	cases	case	NNS
cord-015365-iqdi99pd	1136	4	(	(	-LRB-
cord-015365-iqdi99pd	1136	5	4.8	4.8	CD
cord-015365-iqdi99pd	1136	6	%	%	NN
cord-015365-iqdi99pd	1136	7	)	)	-RRB-
cord-015365-iqdi99pd	1136	8	we	-PRON-	PRP
cord-015365-iqdi99pd	1136	9	had	have	VBD
cord-015365-iqdi99pd	1136	10	to	to	TO
cord-015365-iqdi99pd	1136	11	terminate	terminate	VB
cord-015365-iqdi99pd	1136	12	therapy	therapy	NN
cord-015365-iqdi99pd	1136	13	because	because	IN
cord-015365-iqdi99pd	1136	14	of	of	IN
cord-015365-iqdi99pd	1136	15	gastro	gastro	JJ
cord-015365-iqdi99pd	1136	16	-	-	JJ
cord-015365-iqdi99pd	1136	17	intestinal	intestinal	JJ
cord-015365-iqdi99pd	1136	18	side	side	NN
cord-015365-iqdi99pd	1136	19	effects	effect	NNS
cord-015365-iqdi99pd	1136	20	and	and	CC
cord-015365-iqdi99pd	1136	21	in	in	IN
cord-015365-iqdi99pd	1136	22	4	4	CD
cord-015365-iqdi99pd	1136	23	cases	case	NNS
cord-015365-iqdi99pd	1136	24	(	(	-LRB-
cord-015365-iqdi99pd	1136	25	2.7	2.7	CD
cord-015365-iqdi99pd	1136	26	%	%	NN
cord-015365-iqdi99pd	1136	27	)	)	-RRB-
cord-015365-iqdi99pd	1136	28	even	even	RB
cord-015365-iqdi99pd	1136	29	under	under	IN
cord-015365-iqdi99pd	1136	30	lowest	low	JJS
cord-015365-iqdi99pd	1136	31	ivabradine	ivabradine	NN
cord-015365-iqdi99pd	1136	32	dosage	dosage	NN
cord-015365-iqdi99pd	1136	33	patient	patient	NN
cord-015365-iqdi99pd	1136	34	developed	develop	VBD
cord-015365-iqdi99pd	1136	35	bradycardia	bradycardia	NN
cord-015365-iqdi99pd	1136	36	.	.	.
cord-015365-iqdi99pd	1137	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1137	2	.	.	.
cord-015365-iqdi99pd	1138	1	Using	use	VBG
cord-015365-iqdi99pd	1138	2	ivabradine	ivabradine	NN
cord-015365-iqdi99pd	1138	3	after	after	IN
cord-015365-iqdi99pd	1138	4	heart	heart	NN
cord-015365-iqdi99pd	1138	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	1138	6	is	be	VBZ
cord-015365-iqdi99pd	1138	7	a	a	DT
cord-015365-iqdi99pd	1138	8	safe	safe	JJ
cord-015365-iqdi99pd	1138	9	way	way	NN
cord-015365-iqdi99pd	1138	10	to	to	TO
cord-015365-iqdi99pd	1138	11	lower	lower	VB
cord-015365-iqdi99pd	1138	12	heart	heart	NN
cord-015365-iqdi99pd	1138	13	rate	rate	NN
cord-015365-iqdi99pd	1138	14	and	and	CC
cord-015365-iqdi99pd	1138	15	could	could	MD
cord-015365-iqdi99pd	1138	16	become	become	VB
cord-015365-iqdi99pd	1138	17	a	a	DT
cord-015365-iqdi99pd	1138	18	new	new	JJ
cord-015365-iqdi99pd	1138	19	indication	indication	NN
cord-015365-iqdi99pd	1138	20	for	for	IN
cord-015365-iqdi99pd	1138	21	If	if	NN
cord-015365-iqdi99pd	1138	22	-	-	HYPH
cord-015365-iqdi99pd	1138	23	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	1138	24	.	.	.
cord-015365-iqdi99pd	1139	1	The	the	DT
cord-015365-iqdi99pd	1139	2	individual	individual	JJ
cord-015365-iqdi99pd	1139	3	dosage	dosage	NN
cord-015365-iqdi99pd	1139	4	for	for	IN
cord-015365-iqdi99pd	1139	5	each	each	DT
cord-015365-iqdi99pd	1139	6	patient	patient	NN
cord-015365-iqdi99pd	1139	7	has	have	VBZ
cord-015365-iqdi99pd	1139	8	to	to	TO
cord-015365-iqdi99pd	1139	9	be	be	VB
cord-015365-iqdi99pd	1139	10	found	find	VBN
cord-015365-iqdi99pd	1139	11	in	in	IN
cord-015365-iqdi99pd	1139	12	augmenting	augment	VBG
cord-015365-iqdi99pd	1139	13	the	the	DT
cord-015365-iqdi99pd	1139	14	initial	initial	JJ
cord-015365-iqdi99pd	1139	15	daily	daily	JJ
cord-015365-iqdi99pd	1139	16	dosage	dosage	NN
cord-015365-iqdi99pd	1139	17	of	of	IN
cord-015365-iqdi99pd	1139	18	5	5	CD
cord-015365-iqdi99pd	1139	19	mg	mg	NNS
cord-015365-iqdi99pd	1139	20	slowly	slowly	RB
cord-015365-iqdi99pd	1139	21	to	to	IN
cord-015365-iqdi99pd	1139	22	the	the	DT
cord-015365-iqdi99pd	1139	23	optimum	optimum	JJ
cord-015365-iqdi99pd	1139	24	dosage	dosage	NN
cord-015365-iqdi99pd	1139	25	of	of	IN
cord-015365-iqdi99pd	1139	26	10	10	CD
cord-015365-iqdi99pd	1139	27	mg	mg	NN
cord-015365-iqdi99pd	1139	28	per	per	IN
cord-015365-iqdi99pd	1139	29	day	day	NN
cord-015365-iqdi99pd	1139	30	.	.	.
cord-015365-iqdi99pd	1140	1	Comparison	comparison	NN
cord-015365-iqdi99pd	1140	2	between	between	IN
cord-015365-iqdi99pd	1140	3	referral	referral	NN
cord-015365-iqdi99pd	1140	4	and	and	CC
cord-015365-iqdi99pd	1140	5	explant	explant	JJ
cord-015365-iqdi99pd	1140	6	diagnoses	diagnosis	NNS
cord-015365-iqdi99pd	1140	7	in	in	IN
cord-015365-iqdi99pd	1140	8	lung	lung	NN
cord-015365-iqdi99pd	1140	9	transplant	transplant	NN
cord-015365-iqdi99pd	1140	10	recipients	recipient	NNS
cord-015365-iqdi99pd	1140	11	:	:	:
cord-015365-iqdi99pd	1140	12	discrepancies	discrepancy	NNS
cord-015365-iqdi99pd	1140	13	and	and	CC
cord-015365-iqdi99pd	1140	14	additional	additional	JJ
cord-015365-iqdi99pd	1140	15	findings	finding	NNS
cord-015365-iqdi99pd	1140	16	Background	Background	NNP
cord-015365-iqdi99pd	1140	17	.	.	.
cord-015365-iqdi99pd	1141	1	Lung	lung	NN
cord-015365-iqdi99pd	1141	2	transplantation	transplantation	NN
cord-015365-iqdi99pd	1141	3	is	be	VBZ
cord-015365-iqdi99pd	1141	4	a	a	DT
cord-015365-iqdi99pd	1141	5	widely	widely	RB
cord-015365-iqdi99pd	1141	6	accepted	accept	VBN
cord-015365-iqdi99pd	1141	7	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1141	8	option	option	NN
cord-015365-iqdi99pd	1141	9	for	for	IN
cord-015365-iqdi99pd	1141	10	a	a	DT
cord-015365-iqdi99pd	1141	11	range	range	NN
cord-015365-iqdi99pd	1141	12	of	of	IN
cord-015365-iqdi99pd	1141	13	pulmonary	pulmonary	JJ
cord-015365-iqdi99pd	1141	14	conditions	condition	NNS
cord-015365-iqdi99pd	1141	15	in	in	IN
cord-015365-iqdi99pd	1141	16	which	which	WDT
cord-015365-iqdi99pd	1141	17	the	the	DT
cord-015365-iqdi99pd	1141	18	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1141	19	is	be	VBZ
cord-015365-iqdi99pd	1141	20	often	often	RB
cord-015365-iqdi99pd	1141	21	based	base	VBN
cord-015365-iqdi99pd	1141	22	on	on	IN
cord-015365-iqdi99pd	1141	23	clinical	clinical	JJ
cord-015365-iqdi99pd	1141	24	data	datum	NNS
cord-015365-iqdi99pd	1141	25	or	or	CC
cord-015365-iqdi99pd	1141	26	on	on	IN
cord-015365-iqdi99pd	1141	27	limited	limited	JJ
cord-015365-iqdi99pd	1141	28	biopsy	biopsy	NN
cord-015365-iqdi99pd	1141	29	material	material	NN
cord-015365-iqdi99pd	1141	30	.	.	.
cord-015365-iqdi99pd	1142	1	Posttransplantation	posttransplantation	NN
cord-015365-iqdi99pd	1142	2	complications	complication	NNS
cord-015365-iqdi99pd	1142	3	and	and	CC
cord-015365-iqdi99pd	1142	4	recurrence	recurrence	NN
cord-015365-iqdi99pd	1142	5	of	of	IN
cord-015365-iqdi99pd	1142	6	underlying	underlie	VBG
cord-015365-iqdi99pd	1142	7	disease	disease	NN
cord-015365-iqdi99pd	1142	8	may	may	MD
cord-015365-iqdi99pd	1142	9	be	be	VB
cord-015365-iqdi99pd	1142	10	related	relate	VBN
cord-015365-iqdi99pd	1142	11	to	to	IN
cord-015365-iqdi99pd	1142	12	the	the	DT
cord-015365-iqdi99pd	1142	13	primary	primary	JJ
cord-015365-iqdi99pd	1142	14	disease	disease	NN
cord-015365-iqdi99pd	1142	15	,	,	,
cord-015365-iqdi99pd	1142	16	and	and	CC
cord-015365-iqdi99pd	1142	17	an	an	DT
cord-015365-iqdi99pd	1142	18	accurate	accurate	JJ
cord-015365-iqdi99pd	1142	19	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1142	20	is	be	VBZ
cord-015365-iqdi99pd	1142	21	therefore	therefore	RB
cord-015365-iqdi99pd	1142	22	essential	essential	JJ
cord-015365-iqdi99pd	1142	23	.	.	.
cord-015365-iqdi99pd	1143	1	Methods	method	NNS
cord-015365-iqdi99pd	1143	2	.	.	.
cord-015365-iqdi99pd	1144	1	A	a	DT
cord-015365-iqdi99pd	1144	2	pathologic	pathologic	JJ
cord-015365-iqdi99pd	1144	3	review	review	NN
cord-015365-iqdi99pd	1144	4	was	be	VBD
cord-015365-iqdi99pd	1144	5	performed	perform	VBN
cord-015365-iqdi99pd	1144	6	on	on	IN
cord-015365-iqdi99pd	1144	7	1056	1056	CD
cord-015365-iqdi99pd	1144	8	primary	primary	JJ
cord-015365-iqdi99pd	1144	9	lung	lung	NN
cord-015365-iqdi99pd	1144	10	transplantations	transplantation	NNS
cord-015365-iqdi99pd	1144	11	over	over	IN
cord-015365-iqdi99pd	1144	12	a	a	DT
cord-015365-iqdi99pd	1144	13	period	period	NN
cord-015365-iqdi99pd	1144	14	of	of	IN
cord-015365-iqdi99pd	1144	15	22	22	CD
cord-015365-iqdi99pd	1144	16	years	year	NNS
cord-015365-iqdi99pd	1144	17	(	(	-LRB-
cord-015365-iqdi99pd	1144	18	1998	1998	CD
cord-015365-iqdi99pd	1144	19	to	to	IN
cord-015365-iqdi99pd	1144	20	2010	2010	CD
cord-015365-iqdi99pd	1144	21	)	)	-RRB-
cord-015365-iqdi99pd	1144	22	.	.	.
cord-015365-iqdi99pd	1145	1	Diagnoses	diagnosis	NNS
cord-015365-iqdi99pd	1145	2	of	of	IN
cord-015365-iqdi99pd	1145	3	native	native	JJ
cord-015365-iqdi99pd	1145	4	lungs	lung	NNS
cord-015365-iqdi99pd	1145	5	were	be	VBD
cord-015365-iqdi99pd	1145	6	compared	compare	VBN
cord-015365-iqdi99pd	1145	7	with	with	IN
cord-015365-iqdi99pd	1145	8	referral	referral	JJ
cord-015365-iqdi99pd	1145	9	diagnoses	diagnosis	NNS
cord-015365-iqdi99pd	1145	10	to	to	TO
cord-015365-iqdi99pd	1145	11	assess	assess	VB
cord-015365-iqdi99pd	1145	12	the	the	DT
cord-015365-iqdi99pd	1145	13	presence	presence	NN
cord-015365-iqdi99pd	1145	14	of	of	IN
cord-015365-iqdi99pd	1145	15	discrepancies	discrepancy	NNS
cord-015365-iqdi99pd	1145	16	or	or	CC
cord-015365-iqdi99pd	1145	17	expanded	expand	VBN
cord-015365-iqdi99pd	1145	18	results	result	NNS
cord-015365-iqdi99pd	1145	19	like	like	IN
cord-015365-iqdi99pd	1145	20	malignancies	malignancy	NNS
cord-015365-iqdi99pd	1145	21	or	or	CC
cord-015365-iqdi99pd	1145	22	infections	infection	NNS
cord-015365-iqdi99pd	1145	23	.	.	.
cord-015365-iqdi99pd	1146	1	Results	result	NNS
cord-015365-iqdi99pd	1146	2	.	.	.
cord-015365-iqdi99pd	1147	1	73	73	CD
cord-015365-iqdi99pd	1147	2	(	(	-LRB-
cord-015365-iqdi99pd	1147	3	7	7	CD
cord-015365-iqdi99pd	1147	4	%	%	NN
cord-015365-iqdi99pd	1147	5	)	)	-RRB-
cord-015365-iqdi99pd	1147	6	cases	case	NNS
cord-015365-iqdi99pd	1147	7	presented	present	VBD
cord-015365-iqdi99pd	1147	8	a	a	DT
cord-015365-iqdi99pd	1147	9	different	different	JJ
cord-015365-iqdi99pd	1147	10	or	or	CC
cord-015365-iqdi99pd	1147	11	expanded	expand	VBN
cord-015365-iqdi99pd	1147	12	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1147	13	.	.	.
cord-015365-iqdi99pd	1148	1	Discrepancies	discrepancy	NNS
cord-015365-iqdi99pd	1148	2	between	between	IN
cord-015365-iqdi99pd	1148	3	referral	referral	JJ
cord-015365-iqdi99pd	1148	4	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1148	5	and	and	CC
cord-015365-iqdi99pd	1148	6	histopathology	histopathology	NN
cord-015365-iqdi99pd	1148	7	were	be	VBD
cord-015365-iqdi99pd	1148	8	found	find	VBN
cord-015365-iqdi99pd	1148	9	in	in	IN
cord-015365-iqdi99pd	1148	10	34	34	CD
cord-015365-iqdi99pd	1148	11	of	of	IN
cord-015365-iqdi99pd	1148	12	1054	1054	CD
cord-015365-iqdi99pd	1148	13	cases	case	NNS
cord-015365-iqdi99pd	1148	14	(	(	-LRB-
cord-015365-iqdi99pd	1148	15	3	3	CD
cord-015365-iqdi99pd	1148	16	%	%	NN
cord-015365-iqdi99pd	1148	17	)	)	-RRB-
cord-015365-iqdi99pd	1148	18	.	.	.
cord-015365-iqdi99pd	1149	1	The	the	DT
cord-015365-iqdi99pd	1149	2	highest	high	JJS
cord-015365-iqdi99pd	1149	3	percentage	percentage	NN
cord-015365-iqdi99pd	1149	4	of	of	IN
cord-015365-iqdi99pd	1149	5	discordance	discordance	NN
cord-015365-iqdi99pd	1149	6	was	be	VBD
cord-015365-iqdi99pd	1149	7	depicted	depict	VBN
cord-015365-iqdi99pd	1149	8	in	in	IN
cord-015365-iqdi99pd	1149	9	chronic	chronic	JJ
cord-015365-iqdi99pd	1149	10	obstructive	obstructive	JJ
cord-015365-iqdi99pd	1149	11	lung	lung	NN
cord-015365-iqdi99pd	1149	12	diseases	disease	NNS
cord-015365-iqdi99pd	1149	13	(	(	-LRB-
cord-015365-iqdi99pd	1149	14	12	12	CD
cord-015365-iqdi99pd	1149	15	of	of	IN
cord-015365-iqdi99pd	1149	16	344	344	CD
cord-015365-iqdi99pd	1149	17	)	)	-RRB-
cord-015365-iqdi99pd	1149	18	,	,	,
cord-015365-iqdi99pd	1149	19	with	with	IN
cord-015365-iqdi99pd	1149	20	the	the	DT
cord-015365-iqdi99pd	1149	21	final	final	JJ
cord-015365-iqdi99pd	1149	22	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1149	23	of	of	IN
cord-015365-iqdi99pd	1149	24	UIP	UIP	NNP
cord-015365-iqdi99pd	1149	25	(	(	-LRB-
cord-015365-iqdi99pd	1149	26	n	n	NN
cord-015365-iqdi99pd	1149	27	¼	¼	NNP
cord-015365-iqdi99pd	1149	28	4	4	CD
cord-015365-iqdi99pd	1149	29	)	)	-RRB-
cord-015365-iqdi99pd	1149	30	,	,	,
cord-015365-iqdi99pd	1149	31	chronic	chronic	JJ
cord-015365-iqdi99pd	1149	32	interstitial	interstitial	JJ
cord-015365-iqdi99pd	1149	33	fibrosis	fibrosis	NN
cord-015365-iqdi99pd	1149	34	(	(	-LRB-
cord-015365-iqdi99pd	1149	35	n	n	NNP
cord-015365-iqdi99pd	1149	36	¼	¼	NNP
cord-015365-iqdi99pd	1149	37	4	4	CD
cord-015365-iqdi99pd	1149	38	)	)	-RRB-
cord-015365-iqdi99pd	1149	39	,	,	,
cord-015365-iqdi99pd	1149	40	silicosis	silicosis	NN
cord-015365-iqdi99pd	1149	41	(	(	-LRB-
cord-015365-iqdi99pd	1149	42	n	n	NN
cord-015365-iqdi99pd	1149	43	¼	¼	NNP
cord-015365-iqdi99pd	1149	44	2	2	CD
cord-015365-iqdi99pd	1149	45	)	)	-RRB-
cord-015365-iqdi99pd	1149	46	,	,	,
cord-015365-iqdi99pd	1149	47	LAM	LAM	NNP
cord-015365-iqdi99pd	1149	48	(	(	-LRB-
cord-015365-iqdi99pd	1149	49	n	n	NN
cord-015365-iqdi99pd	1149	50	¼	¼	NNP
cord-015365-iqdi99pd	1149	51	1	1	CD
cord-015365-iqdi99pd	1149	52	)	)	-RRB-
cord-015365-iqdi99pd	1149	53	and	and	CC
cord-015365-iqdi99pd	1149	54	sarcoidosis	sarcoidosis	NNP
cord-015365-iqdi99pd	1149	55	(	(	-LRB-
cord-015365-iqdi99pd	1149	56	n	n	CC
cord-015365-iqdi99pd	1149	57	¼	¼	NNP
cord-015365-iqdi99pd	1149	58	1	1	CD
cord-015365-iqdi99pd	1149	59	)	)	-RRB-
cord-015365-iqdi99pd	1149	60	.	.	.
cord-015365-iqdi99pd	1150	1	16	16	CD
cord-015365-iqdi99pd	1150	2	patients	patient	NNS
cord-015365-iqdi99pd	1150	3	who	who	WP
cord-015365-iqdi99pd	1150	4	were	be	VBD
cord-015365-iqdi99pd	1150	5	referred	refer	VBN
cord-015365-iqdi99pd	1150	6	with	with	IN
cord-015365-iqdi99pd	1150	7	the	the	DT
cord-015365-iqdi99pd	1150	8	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1150	9	of	of	IN
cord-015365-iqdi99pd	1150	10	an	an	DT
cord-015365-iqdi99pd	1150	11	interstitial	interstitial	JJ
cord-015365-iqdi99pd	1150	12	lung	lung	NN
cord-015365-iqdi99pd	1150	13	disease	disease	NN
cord-015365-iqdi99pd	1150	14	had	have	VBD
cord-015365-iqdi99pd	1150	15	predominantly	predominantly	RB
cord-015365-iqdi99pd	1150	16	emphysema	emphysema	NN
cord-015365-iqdi99pd	1150	17	(	(	-LRB-
cord-015365-iqdi99pd	1150	18	n	n	NN
cord-015365-iqdi99pd	1150	19	¼	¼	NNP
cord-015365-iqdi99pd	1150	20	12	12	CD
cord-015365-iqdi99pd	1150	21	)	)	-RRB-
cord-015365-iqdi99pd	1150	22	,	,	,
cord-015365-iqdi99pd	1150	23	bronchiectasis	bronchiectasis	NNP
cord-015365-iqdi99pd	1150	24	(	(	-LRB-
cord-015365-iqdi99pd	1150	25	n	n	NN
cord-015365-iqdi99pd	1150	26	¼	¼	NNP
cord-015365-iqdi99pd	1150	27	2	2	CD
cord-015365-iqdi99pd	1150	28	)	)	-RRB-
cord-015365-iqdi99pd	1150	29	and	and	CC
cord-015365-iqdi99pd	1150	30	histiocytosis	histiocytosis	NNP
cord-015365-iqdi99pd	1150	31	X	X	NNP
cord-015365-iqdi99pd	1150	32	(	(	-LRB-
cord-015365-iqdi99pd	1150	33	n	n	NNP
cord-015365-iqdi99pd	1150	34	¼	¼	NNP
cord-015365-iqdi99pd	1150	35	2	2	CD
cord-015365-iqdi99pd	1150	36	)	)	-RRB-
cord-015365-iqdi99pd	1150	37	.	.	.
cord-015365-iqdi99pd	1151	1	Expanded	expand	VBN
cord-015365-iqdi99pd	1151	2	results	result	NNS
cord-015365-iqdi99pd	1151	3	included	include	VBD
cord-015365-iqdi99pd	1151	4	Aspergillus	aspergillus	NN
cord-015365-iqdi99pd	1151	5	(	(	-LRB-
cord-015365-iqdi99pd	1151	6	n	n	NN
cord-015365-iqdi99pd	1151	7	¼	¼	NNP
cord-015365-iqdi99pd	1151	8	11	11	CD
cord-015365-iqdi99pd	1151	9	)	)	-RRB-
cord-015365-iqdi99pd	1151	10	and	and	CC
cord-015365-iqdi99pd	1151	11	mycobacterial	mycobacterial	NNP
cord-015365-iqdi99pd	1151	12	(	(	-LRB-
cord-015365-iqdi99pd	1151	13	n	n	NN
cord-015365-iqdi99pd	1151	14	¼	¼	NNP
cord-015365-iqdi99pd	1151	15	16	16	CD
cord-015365-iqdi99pd	1151	16	)	)	-RRB-
cord-015365-iqdi99pd	1151	17	infections	infection	NNS
cord-015365-iqdi99pd	1151	18	,	,	,
cord-015365-iqdi99pd	1151	19	carcinomas	carcinoma	NNS
cord-015365-iqdi99pd	1151	20	(	(	-LRB-
cord-015365-iqdi99pd	1151	21	n	n	NN
cord-015365-iqdi99pd	1151	22	¼	¼	NNP
cord-015365-iqdi99pd	1151	23	10	10	CD
cord-015365-iqdi99pd	1151	24	)	)	-RRB-
cord-015365-iqdi99pd	1151	25	,	,	,
cord-015365-iqdi99pd	1151	26	cystic	cystic	JJ
cord-015365-iqdi99pd	1151	27	adenomatoid	adenomatoid	NNP
cord-015365-iqdi99pd	1151	28	dysplasia	dysplasia	NNP
cord-015365-iqdi99pd	1151	29	(	(	-LRB-
cord-015365-iqdi99pd	1151	30	n	n	NNP
cord-015365-iqdi99pd	1151	31	¼	¼	NNP
cord-015365-iqdi99pd	1151	32	1	1	CD
cord-015365-iqdi99pd	1151	33	)	)	-RRB-
cord-015365-iqdi99pd	1151	34	and	and	CC
cord-015365-iqdi99pd	1151	35	carcinoid	carcinoid	NNP
cord-015365-iqdi99pd	1151	36	(	(	-LRB-
cord-015365-iqdi99pd	1151	37	n	n	NNP
cord-015365-iqdi99pd	1151	38	¼	¼	NNP
cord-015365-iqdi99pd	1151	39	1	1	CD
cord-015365-iqdi99pd	1151	40	)	)	-RRB-
cord-015365-iqdi99pd	1151	41	.	.	.
cord-015365-iqdi99pd	1152	1	However	however	RB
cord-015365-iqdi99pd	1152	2	,	,	,
cord-015365-iqdi99pd	1152	3	short	short	JJ
cord-015365-iqdi99pd	1152	4	-	-	HYPH
cord-015365-iqdi99pd	1152	5	and	and	CC
cord-015365-iqdi99pd	1152	6	long	long	JJ
cord-015365-iqdi99pd	1152	7	-	-	HYPH
cord-015365-iqdi99pd	1152	8	term	term	NN
cord-015365-iqdi99pd	1152	9	survival	survival	NN
cord-015365-iqdi99pd	1152	10	was	be	VBD
cord-015365-iqdi99pd	1152	11	not	not	RB
cord-015365-iqdi99pd	1152	12	different	different	JJ
cord-015365-iqdi99pd	1152	13	in	in	IN
cord-015365-iqdi99pd	1152	14	patients	patient	NNS
cord-015365-iqdi99pd	1152	15	with	with	IN
cord-015365-iqdi99pd	1152	16	different	different	JJ
cord-015365-iqdi99pd	1152	17	diagnoses	diagnosis	NNS
cord-015365-iqdi99pd	1152	18	,	,	,
cord-015365-iqdi99pd	1152	19	malignancies	malignancy	NNS
cord-015365-iqdi99pd	1152	20	or	or	CC
cord-015365-iqdi99pd	1152	21	implanted	implant	VBN
cord-015365-iqdi99pd	1152	22	infections	infection	NNS
cord-015365-iqdi99pd	1152	23	.	.	.
cord-015365-iqdi99pd	1153	1	Interestingly	interestingly	RB
cord-015365-iqdi99pd	1153	2	all	all	DT
cord-015365-iqdi99pd	1153	3	mycobacterial	mycobacterial	JJ
cord-015365-iqdi99pd	1153	4	infections	infection	NNS
cord-015365-iqdi99pd	1153	5	and	and	CC
cord-015365-iqdi99pd	1153	6	all	all	DT
cord-015365-iqdi99pd	1153	7	malignancies	malignancy	NNS
cord-015365-iqdi99pd	1153	8	occurred	occur	VBD
cord-015365-iqdi99pd	1153	9	in	in	IN
cord-015365-iqdi99pd	1153	10	patients	patient	NNS
cord-015365-iqdi99pd	1153	11	with	with	IN
cord-015365-iqdi99pd	1153	12	COPD	COPD	NNP
cord-015365-iqdi99pd	1153	13	.	.	.
cord-015365-iqdi99pd	1154	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1154	2	.	.	.
cord-015365-iqdi99pd	1155	1	On	on	IN
cord-015365-iqdi99pd	1155	2	account	account	NN
cord-015365-iqdi99pd	1155	3	of	of	IN
cord-015365-iqdi99pd	1155	4	this	this	DT
cord-015365-iqdi99pd	1155	5	high	high	JJ
cord-015365-iqdi99pd	1155	6	rate	rate	NN
cord-015365-iqdi99pd	1155	7	of	of	IN
cord-015365-iqdi99pd	1155	8	discrepancies	discrepancy	NNS
cord-015365-iqdi99pd	1155	9	and	and	CC
cord-015365-iqdi99pd	1155	10	its	-PRON-	PRP$
cord-015365-iqdi99pd	1155	11	possible	possible	JJ
cord-015365-iqdi99pd	1155	12	influence	influence	NN
cord-015365-iqdi99pd	1155	13	on	on	IN
cord-015365-iqdi99pd	1155	14	survival	survival	NN
cord-015365-iqdi99pd	1155	15	,	,	,
cord-015365-iqdi99pd	1155	16	frequently	frequently	RB
cord-015365-iqdi99pd	1155	17	repeated	repeat	VBD
cord-015365-iqdi99pd	1155	18	clinicopathologic	clinicopathologic	JJ
cord-015365-iqdi99pd	1155	19	investigations	investigation	NNS
cord-015365-iqdi99pd	1155	20	should	should	MD
cord-015365-iqdi99pd	1155	21	be	be	VB
cord-015365-iqdi99pd	1155	22	performed	perform	VBN
cord-015365-iqdi99pd	1155	23	during	during	IN
cord-015365-iqdi99pd	1155	24	the	the	DT
cord-015365-iqdi99pd	1155	25	waiting	waiting	NN
cord-015365-iqdi99pd	1155	26	list	list	NN
cord-015365-iqdi99pd	1155	27	period	period	NN
cord-015365-iqdi99pd	1155	28	.	.	.
cord-015365-iqdi99pd	1155	29	 	 	_SP
cord-015365-iqdi99pd	1156	1	Background	background	NN
cord-015365-iqdi99pd	1156	2	.	.	.
cord-015365-iqdi99pd	1157	1	Induction	induction	NN
cord-015365-iqdi99pd	1157	2	therapy	therapy	NN
cord-015365-iqdi99pd	1157	3	with	with	IN
cord-015365-iqdi99pd	1157	4	alemtuzumab	alemtuzumab	NNP
cord-015365-iqdi99pd	1157	5	,	,	,
cord-015365-iqdi99pd	1157	6	followed	follow	VBN
cord-015365-iqdi99pd	1157	7	by	by	IN
cord-015365-iqdi99pd	1157	8	lower	low	JJR
cord-015365-iqdi99pd	1157	9	than	than	IN
cord-015365-iqdi99pd	1157	10	conventional	conventional	JJ
cord-015365-iqdi99pd	1157	11	intensity	intensity	NN
cord-015365-iqdi99pd	1157	12	post	post	JJ
cord-015365-iqdi99pd	1157	13	-	-	JJ
cord-015365-iqdi99pd	1157	14	transplant	transplant	JJ
cord-015365-iqdi99pd	1157	15	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1157	16	,	,	,
cord-015365-iqdi99pd	1157	17	has	have	VBZ
cord-015365-iqdi99pd	1157	18	been	be	VBN
cord-015365-iqdi99pd	1157	19	associated	associate	VBN
cord-015365-iqdi99pd	1157	20	with	with	IN
cord-015365-iqdi99pd	1157	21	reduced	reduce	VBN
cord-015365-iqdi99pd	1157	22	morbidity	morbidity	NN
cord-015365-iqdi99pd	1157	23	and	and	CC
cord-015365-iqdi99pd	1157	24	mortality	mortality	NN
cord-015365-iqdi99pd	1157	25	in	in	IN
cord-015365-iqdi99pd	1157	26	abdominal	abdominal	JJ
cord-015365-iqdi99pd	1157	27	and	and	CC
cord-015365-iqdi99pd	1157	28	heart	heart	NN
cord-015365-iqdi99pd	1157	29	transplantation	transplantation	NN
cord-015365-iqdi99pd	1157	30	.	.	.
cord-015365-iqdi99pd	1158	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1158	2	performed	perform	VBD
cord-015365-iqdi99pd	1158	3	a	a	DT
cord-015365-iqdi99pd	1158	4	prospective	prospective	JJ
cord-015365-iqdi99pd	1158	5	randomized	randomized	JJ
cord-015365-iqdi99pd	1158	6	trial	trial	NN
cord-015365-iqdi99pd	1158	7	in	in	IN
cord-015365-iqdi99pd	1158	8	lung	lung	NN
cord-015365-iqdi99pd	1158	9	recipients	recipient	NNS
cord-015365-iqdi99pd	1158	10	receiving	receive	VBG
cord-015365-iqdi99pd	1158	11	alemtuzumab	alemtuzumab	NNS
cord-015365-iqdi99pd	1158	12	in	in	IN
cord-015365-iqdi99pd	1158	13	conjunction	conjunction	NN
cord-015365-iqdi99pd	1158	14	with	with	IN
cord-015365-iqdi99pd	1158	15	reduced	reduce	VBN
cord-015365-iqdi99pd	1158	16	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1158	17	compared	compare	VBN
cord-015365-iqdi99pd	1158	18	with	with	IN
cord-015365-iqdi99pd	1158	19	patients	patient	NNS
cord-015365-iqdi99pd	1158	20	receiving	receive	VBG
cord-015365-iqdi99pd	1158	21	thymoglobulin	thymoglobulin	NNP
cord-015365-iqdi99pd	1158	22	in	in	IN
cord-015365-iqdi99pd	1158	23	association	association	NN
cord-015365-iqdi99pd	1158	24	with	with	IN
cord-015365-iqdi99pd	1158	25	routinely	routinely	RB
cord-015365-iqdi99pd	1158	26	dosed	dose	VBN
cord-015365-iqdi99pd	1158	27	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1158	28	.	.	.
cord-015365-iqdi99pd	1159	1	Methods	method	NNS
cord-015365-iqdi99pd	1159	2	.	.	.
cord-015365-iqdi99pd	1160	1	60	60	CD
cord-015365-iqdi99pd	1160	2	lung	lung	NN
cord-015365-iqdi99pd	1160	3	TX	TX	NNP
cord-015365-iqdi99pd	1160	4	recipients	recipient	NNS
cord-015365-iqdi99pd	1160	5	were	be	VBD
cord-015365-iqdi99pd	1160	6	prospectively	prospectively	RB
cord-015365-iqdi99pd	1160	7	randomized	randomize	VBN
cord-015365-iqdi99pd	1160	8	in	in	IN
cord-015365-iqdi99pd	1160	9	two	two	CD
cord-015365-iqdi99pd	1160	10	groups	group	NNS
cord-015365-iqdi99pd	1160	11	:	:	:
cord-015365-iqdi99pd	1160	12	group	group	NN
cord-015365-iqdi99pd	1160	13	A	a	DT
cord-015365-iqdi99pd	1160	14	received	receive	VBD
cord-015365-iqdi99pd	1160	15	alemtuzumab	alemtuzumab	NNS
cord-015365-iqdi99pd	1160	16	in	in	IN
cord-015365-iqdi99pd	1160	17	conjunction	conjunction	NN
cord-015365-iqdi99pd	1160	18	with	with	IN
cord-015365-iqdi99pd	1160	19	early	early	JJ
cord-015365-iqdi99pd	1160	20	lower	low	JJR
cord-015365-iqdi99pd	1160	21	-	-	HYPH
cord-015365-iqdi99pd	1160	22	dose	dose	NN
cord-015365-iqdi99pd	1160	23	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	1160	24	,	,	,
cord-015365-iqdi99pd	1160	25	lower	low	JJR
cord-015365-iqdi99pd	1160	26	-	-	HYPH
cord-015365-iqdi99pd	1160	27	dose	dose	NN
cord-015365-iqdi99pd	1160	28	steroids	steroid	NNS
cord-015365-iqdi99pd	1160	29	,	,	,
cord-015365-iqdi99pd	1160	30	and	and	CC
cord-015365-iqdi99pd	1160	31	half	half	JJ
cord-015365-iqdi99pd	1160	32	-	-	HYPH
cord-015365-iqdi99pd	1160	33	dose	dose	NN
cord-015365-iqdi99pd	1160	34	mycophenolate	mycophenolate	NNP
cord-015365-iqdi99pd	1160	35	mofetil	mofetil	NNP
cord-015365-iqdi99pd	1160	36	,	,	,
cord-015365-iqdi99pd	1160	37	compared	compare	VBN
cord-015365-iqdi99pd	1160	38	with	with	IN
cord-015365-iqdi99pd	1160	39	group	group	NN
cord-015365-iqdi99pd	1160	40	B	b	NN
cord-015365-iqdi99pd	1160	41	receiving	receive	VBG
cord-015365-iqdi99pd	1160	42	thymoglobulin	thymoglobulin	NNP
cord-015365-iqdi99pd	1160	43	in	in	IN
cord-015365-iqdi99pd	1160	44	association	association	NN
cord-015365-iqdi99pd	1160	45	with	with	IN
cord-015365-iqdi99pd	1160	46	routinely	routinely	RB
cord-015365-iqdi99pd	1160	47	dosed	dose	VBN
cord-015365-iqdi99pd	1160	48	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1160	49	.	.	.
cord-015365-iqdi99pd	1161	1	Survival	survival	NN
cord-015365-iqdi99pd	1161	2	analyses	analysis	NNS
cord-015365-iqdi99pd	1161	3	examined	examine	VBD
cord-015365-iqdi99pd	1161	4	patient	patient	JJ
cord-015365-iqdi99pd	1161	5	and	and	CC
cord-015365-iqdi99pd	1161	6	graft	graft	NN
cord-015365-iqdi99pd	1161	7	survival	survival	NN
cord-015365-iqdi99pd	1161	8	,	,	,
cord-015365-iqdi99pd	1161	9	freedom	freedom	NN
cord-015365-iqdi99pd	1161	10	from	from	IN
cord-015365-iqdi99pd	1161	11	acute	acute	JJ
cord-015365-iqdi99pd	1161	12	cellular	cellular	JJ
cord-015365-iqdi99pd	1161	13	rejection	rejection	NN
cord-015365-iqdi99pd	1161	14	(	(	-LRB-
cord-015365-iqdi99pd	1161	15	ACR	ACR	NNP
cord-015365-iqdi99pd	1161	16	)	)	-RRB-
cord-015365-iqdi99pd	1161	17	,	,	,
cord-015365-iqdi99pd	1161	18	lymphocytic	lymphocytic	JJ
cord-015365-iqdi99pd	1161	19	bronchiolitis	bronchiolitis	NN
cord-015365-iqdi99pd	1161	20	,	,	,
cord-015365-iqdi99pd	1161	21	bronchiolitis	bronchiolitis	NNP
cord-015365-iqdi99pd	1161	22	obliterans	obliterans	NNP
cord-015365-iqdi99pd	1161	23	syndrome	syndrome	NNP
cord-015365-iqdi99pd	1161	24	(	(	-LRB-
cord-015365-iqdi99pd	1161	25	BOS	BOS	NNP
cord-015365-iqdi99pd	1161	26	)	)	-RRB-
cord-015365-iqdi99pd	1161	27	,	,	,
cord-015365-iqdi99pd	1161	28	kidney	kidney	NN
cord-015365-iqdi99pd	1161	29	function	function	NN
cord-015365-iqdi99pd	1161	30	,	,	,
cord-015365-iqdi99pd	1161	31	infectious	infectious	JJ
cord-015365-iqdi99pd	1161	32	complications	complication	NNS
cord-015365-iqdi99pd	1161	33	and	and	CC
cord-015365-iqdi99pd	1161	34	post	post	JJ
cord-015365-iqdi99pd	1161	35	-	-	JJ
cord-015365-iqdi99pd	1161	36	transplant	transplant	JJ
cord-015365-iqdi99pd	1161	37	lymphoproliferative	lymphoproliferative	JJ
cord-015365-iqdi99pd	1161	38	disorder	disorder	NN
cord-015365-iqdi99pd	1161	39	(	(	-LRB-
cord-015365-iqdi99pd	1161	40	PTLD	PTLD	NNP
cord-015365-iqdi99pd	1161	41	)	)	-RRB-
cord-015365-iqdi99pd	1161	42	.	.	.
cord-015365-iqdi99pd	1162	1	Results	result	NNS
cord-015365-iqdi99pd	1162	2	.	.	.
cord-015365-iqdi99pd	1163	1	There	there	EX
cord-015365-iqdi99pd	1163	2	were	be	VBD
cord-015365-iqdi99pd	1163	3	no	no	DT
cord-015365-iqdi99pd	1163	4	significant	significant	JJ
cord-015365-iqdi99pd	1163	5	differences	difference	NNS
cord-015365-iqdi99pd	1163	6	in	in	IN
cord-015365-iqdi99pd	1163	7	6-and	6-and	CD
cord-015365-iqdi99pd	1163	8	12month	12month	JJ
cord-015365-iqdi99pd	1163	9	survival	survival	NN
cord-015365-iqdi99pd	1163	10	(	(	-LRB-
cord-015365-iqdi99pd	1163	11	alemtuzumab	alemtuzumab	VBN
cord-015365-iqdi99pd	1163	12	96	96	CD
cord-015365-iqdi99pd	1163	13	%	%	NN
cord-015365-iqdi99pd	1163	14	vs.	vs.	IN
cord-015365-iqdi99pd	1163	15	ATG	ATG	NNP
cord-015365-iqdi99pd	1163	16	93	93	CD
cord-015365-iqdi99pd	1163	17	%	%	NN
cord-015365-iqdi99pd	1163	18	and	and	CC
cord-015365-iqdi99pd	1163	19	93	93	CD
cord-015365-iqdi99pd	1163	20	%	%	NN
cord-015365-iqdi99pd	1163	21	vs.	vs.	IN
cord-015365-iqdi99pd	1163	22	96	96	CD
cord-015365-iqdi99pd	1163	23	%	%	NN
cord-015365-iqdi99pd	1163	24	,	,	,
cord-015365-iqdi99pd	1163	25	respectively	respectively	RB
cord-015365-iqdi99pd	1163	26	,	,	,
cord-015365-iqdi99pd	1163	27	p	p	NN
cord-015365-iqdi99pd	1163	28	¼	¼	CD
cord-015365-iqdi99pd	1163	29	NS	NS	NNP
cord-015365-iqdi99pd	1163	30	)	)	-RRB-
cord-015365-iqdi99pd	1163	31	.	.	.
cord-015365-iqdi99pd	1164	1	Acute	acute	JJ
cord-015365-iqdi99pd	1164	2	cellular	cellular	JJ
cord-015365-iqdi99pd	1164	3	rejection	rejection	NN
cord-015365-iqdi99pd	1164	4	episodes	episode	NNS
cord-015365-iqdi99pd	1165	1	¼	¼	NNP
cord-015365-iqdi99pd	1165	2	A2	A2	NNP
cord-015365-iqdi99pd	1165	3	within	within	IN
cord-015365-iqdi99pd	1165	4	the	the	DT
cord-015365-iqdi99pd	1165	5	first	first	JJ
cord-015365-iqdi99pd	1165	6	TX	TX	NNP
cord-015365-iqdi99pd	1165	7	year	year	NN
cord-015365-iqdi99pd	1165	8	were	be	VBD
cord-015365-iqdi99pd	1165	9	significant	significant	JJ
cord-015365-iqdi99pd	1165	10	lower	lower	RBR
cord-015365-iqdi99pd	1165	11	in	in	IN
cord-015365-iqdi99pd	1165	12	group	group	NN
cord-015365-iqdi99pd	1165	13	A	A	NNP
cord-015365-iqdi99pd	1165	14	(	(	-LRB-
cord-015365-iqdi99pd	1165	15	alemtuzumab	alemtuzumab	JJ
cord-015365-iqdi99pd	1165	16	0	0	CD
cord-015365-iqdi99pd	1165	17	vs.	vs.	IN
cord-015365-iqdi99pd	1165	18	ATG	ATG	NNP
cord-015365-iqdi99pd	1165	19	0,33	0,33	NNP
cord-015365-iqdi99pd	1165	20	;	;	:
cord-015365-iqdi99pd	1165	21	p	p	NN
cord-015365-iqdi99pd	1165	22	¼	¼	CD
cord-015365-iqdi99pd	1165	23	0.019	0.019	CD
cord-015365-iqdi99pd	1165	24	)	)	-RRB-
cord-015365-iqdi99pd	1165	25	,	,	,
cord-015365-iqdi99pd	1165	26	lymphocytic	lymphocytic	JJ
cord-015365-iqdi99pd	1165	27	bronchiolitis	bronchiolitis	NN
cord-015365-iqdi99pd	1165	28	was	be	VBD
cord-015365-iqdi99pd	1165	29	not	not	RB
cord-015365-iqdi99pd	1165	30	different	different	JJ
cord-015365-iqdi99pd	1165	31	between	between	IN
cord-015365-iqdi99pd	1165	32	the	the	DT
cord-015365-iqdi99pd	1165	33	groups	group	NNS
cord-015365-iqdi99pd	1165	34	(	(	-LRB-
cord-015365-iqdi99pd	1165	35	cumulative	cumulative	JJ
cord-015365-iqdi99pd	1165	36	B	b	NN
cord-015365-iqdi99pd	1165	37	scores	score	NNS
cord-015365-iqdi99pd	1165	38	group	group	NN
cord-015365-iqdi99pd	1165	39	A	a	DT
cord-015365-iqdi99pd	1165	40	2.9	2.9	CD
cord-015365-iqdi99pd	1165	41	AE	AE	NNP
cord-015365-iqdi99pd	1165	42	2.7	2.7	CD
cord-015365-iqdi99pd	1165	43	vs.	vs.	NN
cord-015365-iqdi99pd	1165	44	group	group	NN
cord-015365-iqdi99pd	1165	45	B	B	NNP
cord-015365-iqdi99pd	1165	46	3.2	3.2	CD
cord-015365-iqdi99pd	1165	47	AE	AE	NNP
cord-015365-iqdi99pd	1165	48	2.3	2.3	CD
cord-015365-iqdi99pd	1165	49	per	per	IN
cord-015365-iqdi99pd	1165	50	patient	patient	NN
cord-015365-iqdi99pd	1165	51	,	,	,
cord-015365-iqdi99pd	1165	52	p	p	NN
cord-015365-iqdi99pd	1165	53	¼	¼	CD
cord-015365-iqdi99pd	1165	54	0.74	0.74	CD
cord-015365-iqdi99pd	1165	55	)	)	-RRB-
cord-015365-iqdi99pd	1165	56	.	.	.
cord-015365-iqdi99pd	1166	1	There	there	EX
cord-015365-iqdi99pd	1166	2	were	be	VBD
cord-015365-iqdi99pd	1166	3	no	no	DT
cord-015365-iqdi99pd	1166	4	significant	significant	JJ
cord-015365-iqdi99pd	1166	5	differences	difference	NNS
cord-015365-iqdi99pd	1166	6	in	in	IN
cord-015365-iqdi99pd	1166	7	bacterial	bacterial	JJ
cord-015365-iqdi99pd	1166	8	(	(	-LRB-
cord-015365-iqdi99pd	1166	9	group	group	NN
cord-015365-iqdi99pd	1166	10	A	a	DT
cord-015365-iqdi99pd	1166	11	2	2	CD
cord-015365-iqdi99pd	1166	12	.	.	.
cord-015365-iqdi99pd	1167	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1167	2	.	.	.
cord-015365-iqdi99pd	1168	1	Alemtuzumab	alemtuzumab	JJ
cord-015365-iqdi99pd	1168	2	induction	induction	NN
cord-015365-iqdi99pd	1168	3	in	in	IN
cord-015365-iqdi99pd	1168	4	conjunction	conjunction	NN
cord-015365-iqdi99pd	1168	5	with	with	IN
cord-015365-iqdi99pd	1168	6	reduced	reduce	VBN
cord-015365-iqdi99pd	1168	7	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1168	8	significantly	significantly	RB
cord-015365-iqdi99pd	1168	9	reduces	reduce	VBZ
cord-015365-iqdi99pd	1168	10	higher	high	JJR
cord-015365-iqdi99pd	1168	11	grade	grade	NN
cord-015365-iqdi99pd	1168	12	rejection	rejection	NN
cord-015365-iqdi99pd	1168	13	rates	rate	NNS
cord-015365-iqdi99pd	1168	14	with	with	IN
cord-015365-iqdi99pd	1168	15	comparable	comparable	JJ
cord-015365-iqdi99pd	1168	16	survival	survival	NN
cord-015365-iqdi99pd	1168	17	results	result	NNS
cord-015365-iqdi99pd	1168	18	and	and	CC
cord-015365-iqdi99pd	1168	19	infectious	infectious	JJ
cord-015365-iqdi99pd	1168	20	complications	complication	NNS
cord-015365-iqdi99pd	1168	21	to	to	IN
cord-015365-iqdi99pd	1168	22	high	high	JJ
cord-015365-iqdi99pd	1168	23	-	-	HYPH
cord-015365-iqdi99pd	1168	24	dose	dose	NN
cord-015365-iqdi99pd	1168	25	standard	standard	JJ
cord-015365-iqdi99pd	1168	26	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1168	27	.	.	.
cord-015365-iqdi99pd	1169	1	The	the	DT
cord-015365-iqdi99pd	1169	2	incidence	incidence	NN
cord-015365-iqdi99pd	1169	3	of	of	IN
cord-015365-iqdi99pd	1169	4	early	early	JJ
cord-015365-iqdi99pd	1169	5	BOS	BOS	NNP
cord-015365-iqdi99pd	1169	6	was	be	VBD
cord-015365-iqdi99pd	1169	7	higher	high	JJR
cord-015365-iqdi99pd	1169	8	after	after	IN
cord-015365-iqdi99pd	1169	9	alemtuzumab	alemtuzumab	JJ
cord-015365-iqdi99pd	1169	10	-	-	HYPH
cord-015365-iqdi99pd	1169	11	induction	induction	NN
cord-015365-iqdi99pd	1169	12	.	.	.
cord-015365-iqdi99pd	1170	1	Background	background	NN
cord-015365-iqdi99pd	1170	2	.	.	.
cord-015365-iqdi99pd	1171	1	Cardiac	cardiac	JJ
cord-015365-iqdi99pd	1171	2	allograft	allograft	NN
cord-015365-iqdi99pd	1171	3	vasculopathy	vasculopathy	NNP
cord-015365-iqdi99pd	1171	4	(	(	-LRB-
cord-015365-iqdi99pd	1171	5	CAV	CAV	NNP
cord-015365-iqdi99pd	1171	6	)	)	-RRB-
cord-015365-iqdi99pd	1171	7	is	be	VBZ
cord-015365-iqdi99pd	1171	8	a	a	DT
cord-015365-iqdi99pd	1171	9	major	major	JJ
cord-015365-iqdi99pd	1171	10	cause	cause	NN
cord-015365-iqdi99pd	1171	11	of	of	IN
cord-015365-iqdi99pd	1171	12	allograft	allograft	NN
cord-015365-iqdi99pd	1171	13	failure	failure	NN
cord-015365-iqdi99pd	1171	14	in	in	IN
cord-015365-iqdi99pd	1171	15	long	long	JJ
cord-015365-iqdi99pd	1171	16	-	-	HYPH
cord-015365-iqdi99pd	1171	17	term	term	NN
cord-015365-iqdi99pd	1171	18	heart	heart	NN
cord-015365-iqdi99pd	1171	19	transplant	transplant	NN
cord-015365-iqdi99pd	1171	20	patients	patient	NNS
cord-015365-iqdi99pd	1171	21	.	.	.
cord-015365-iqdi99pd	1172	1	Even	even	RB
cord-015365-iqdi99pd	1172	2	without	without	IN
cord-015365-iqdi99pd	1172	3	typical	typical	JJ
cord-015365-iqdi99pd	1172	4	angina	angina	NN
cord-015365-iqdi99pd	1172	5	symptoms	symptom	NNS
cord-015365-iqdi99pd	1172	6	and	and	CC
cord-015365-iqdi99pd	1172	7	diffuse	diffuse	JJ
cord-015365-iqdi99pd	1172	8	lesions	lesion	NNS
cord-015365-iqdi99pd	1172	9	,	,	,
cord-015365-iqdi99pd	1172	10	CAV	CAV	NNP
cord-015365-iqdi99pd	1172	11	resembles	resemble	VBZ
cord-015365-iqdi99pd	1172	12	atherosclerosis	atherosclerosis	NN
cord-015365-iqdi99pd	1172	13	,	,	,
cord-015365-iqdi99pd	1172	14	but	but	CC
cord-015365-iqdi99pd	1172	15	shows	show	VBZ
cord-015365-iqdi99pd	1172	16	more	more	RBR
cord-015365-iqdi99pd	1172	17	concentric	concentric	JJ
cord-015365-iqdi99pd	1172	18	rather	rather	RB
cord-015365-iqdi99pd	1172	19	than	than	IN
cord-015365-iqdi99pd	1172	20	eccentric	eccentric	JJ
cord-015365-iqdi99pd	1172	21	intimal	intimal	JJ
cord-015365-iqdi99pd	1172	22	proliferation	proliferation	NN
cord-015365-iqdi99pd	1172	23	.	.	.
cord-015365-iqdi99pd	1173	1	Both	both	DT
cord-015365-iqdi99pd	1173	2	,	,	,
cord-015365-iqdi99pd	1173	3	proximal	proximal	JJ
cord-015365-iqdi99pd	1173	4	and	and	CC
cord-015365-iqdi99pd	1173	5	distal	distal	JJ
cord-015365-iqdi99pd	1173	6	portions	portion	NNS
cord-015365-iqdi99pd	1173	7	of	of	IN
cord-015365-iqdi99pd	1173	8	the	the	DT
cord-015365-iqdi99pd	1173	9	coronary	coronary	JJ
cord-015365-iqdi99pd	1173	10	tree	tree	NN
cord-015365-iqdi99pd	1173	11	are	be	VBP
cord-015365-iqdi99pd	1173	12	involved	involve	VBN
cord-015365-iqdi99pd	1173	13	.	.	.
cord-015365-iqdi99pd	1174	1	Cardiac	cardiac	JJ
cord-015365-iqdi99pd	1174	2	angiographies	angiography	NNS
cord-015365-iqdi99pd	1174	3	are	be	VBP
cord-015365-iqdi99pd	1174	4	periodically	periodically	RB
cord-015365-iqdi99pd	1174	5	performed	perform	VBN
cord-015365-iqdi99pd	1174	6	in	in	IN
cord-015365-iqdi99pd	1174	7	the	the	DT
cord-015365-iqdi99pd	1174	8	routine	routine	JJ
cord-015365-iqdi99pd	1174	9	long	long	JJ
cord-015365-iqdi99pd	1174	10	-	-	HYPH
cord-015365-iqdi99pd	1174	11	term	term	NN
cord-015365-iqdi99pd	1174	12	follow	follow	VB
cord-015365-iqdi99pd	1174	13	up	up	RP
cord-015365-iqdi99pd	1174	14	after	after	IN
cord-015365-iqdi99pd	1174	15	heart	heart	NN
cord-015365-iqdi99pd	1174	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	1174	17	.	.	.
cord-015365-iqdi99pd	1175	1	Methods	method	NNS
cord-015365-iqdi99pd	1175	2	.	.	.
cord-015365-iqdi99pd	1176	1	Cardiac	cardiac	JJ
cord-015365-iqdi99pd	1176	2	angiographies	angiography	NNS
cord-015365-iqdi99pd	1176	3	and	and	CC
cord-015365-iqdi99pd	1176	4	interventions	intervention	NNS
cord-015365-iqdi99pd	1176	5	have	have	VBP
cord-015365-iqdi99pd	1176	6	been	be	VBN
cord-015365-iqdi99pd	1176	7	performed	perform	VBN
cord-015365-iqdi99pd	1176	8	on	on	IN
cord-015365-iqdi99pd	1176	9	19	19	CD
cord-015365-iqdi99pd	1176	10	patients	patient	NNS
cord-015365-iqdi99pd	1176	11	(	(	-LRB-
cord-015365-iqdi99pd	1176	12	17	17	CD
cord-015365-iqdi99pd	1176	13	male	male	NN
cord-015365-iqdi99pd	1176	14	and	and	CC
cord-015365-iqdi99pd	1176	15	2	2	CD
cord-015365-iqdi99pd	1176	16	female	female	NN
cord-015365-iqdi99pd	1176	17	)	)	-RRB-
cord-015365-iqdi99pd	1176	18	without	without	IN
cord-015365-iqdi99pd	1176	19	any	any	DT
cord-015365-iqdi99pd	1176	20	complications	complication	NNS
cord-015365-iqdi99pd	1176	21	and	and	CC
cord-015365-iqdi99pd	1176	22	substantial	substantial	JJ
cord-015365-iqdi99pd	1176	23	advantage	advantage	NN
cord-015365-iqdi99pd	1176	24	in	in	IN
cord-015365-iqdi99pd	1176	25	this	this	DT
cord-015365-iqdi99pd	1176	26	cohort	cohort	NN
cord-015365-iqdi99pd	1176	27	of	of	IN
cord-015365-iqdi99pd	1176	28	patients	patient	NNS
cord-015365-iqdi99pd	1176	29	.	.	.
cord-015365-iqdi99pd	1177	1	6	6	CD
cord-015365-iqdi99pd	1177	2	Patients	patient	NNS
cord-015365-iqdi99pd	1177	3	already	already	RB
cord-015365-iqdi99pd	1177	4	had	have	VBD
cord-015365-iqdi99pd	1177	5	previous	previous	JJ
cord-015365-iqdi99pd	1177	6	interventions	intervention	NNS
cord-015365-iqdi99pd	1177	7	.	.	.
cord-015365-iqdi99pd	1178	1	Mean	mean	JJ
cord-015365-iqdi99pd	1178	2	time	time	NN
cord-015365-iqdi99pd	1178	3	after	after	IN
cord-015365-iqdi99pd	1178	4	transplantation	transplantation	NN
cord-015365-iqdi99pd	1178	5	was	be	VBD
cord-015365-iqdi99pd	1178	6	11.4	11.4	CD
cord-015365-iqdi99pd	1178	7	AE	AE	NNP
cord-015365-iqdi99pd	1178	8	5.8	5.8	CD
cord-015365-iqdi99pd	1178	9	years	year	NNS
cord-015365-iqdi99pd	1178	10	.	.	.
cord-015365-iqdi99pd	1179	1	Results	result	NNS
cord-015365-iqdi99pd	1179	2	.	.	.
cord-015365-iqdi99pd	1180	1	Follow	follow	VB
cord-015365-iqdi99pd	1180	2	-	-	HYPH
cord-015365-iqdi99pd	1180	3	up	up	RP
cord-015365-iqdi99pd	1180	4	angiography	angiography	NN
cord-015365-iqdi99pd	1180	5	showed	show	VBD
cord-015365-iqdi99pd	1180	6	no	no	DT
cord-015365-iqdi99pd	1180	7	in	in	IN
cord-015365-iqdi99pd	1180	8	-	-	HYPH
cord-015365-iqdi99pd	1180	9	stent	stent	NN
cord-015365-iqdi99pd	1180	10	restenosis	restenosis	NN
cord-015365-iqdi99pd	1180	11	in	in	IN
cord-015365-iqdi99pd	1180	12	the	the	DT
cord-015365-iqdi99pd	1180	13	patients	patient	NNS
cord-015365-iqdi99pd	1180	14	with	with	IN
cord-015365-iqdi99pd	1180	15	previous	previous	JJ
cord-015365-iqdi99pd	1180	16	interventions	intervention	NNS
cord-015365-iqdi99pd	1180	17	after	after	IN
cord-015365-iqdi99pd	1180	18	a	a	DT
cord-015365-iqdi99pd	1180	19	mean	mean	JJ
cord-015365-iqdi99pd	1180	20	time	time	NN
cord-015365-iqdi99pd	1180	21	of	of	IN
cord-015365-iqdi99pd	1180	22	36	36	CD
cord-015365-iqdi99pd	1180	23	AE	AE	NNP
cord-015365-iqdi99pd	1180	24	18	18	CD
cord-015365-iqdi99pd	1180	25	months	month	NNS
cord-015365-iqdi99pd	1180	26	.	.	.
cord-015365-iqdi99pd	1181	1	3	3	CD
cord-015365-iqdi99pd	1181	2	patients	patient	NNS
cord-015365-iqdi99pd	1181	3	were	be	VBD
cord-015365-iqdi99pd	1181	4	in	in	IN
cord-015365-iqdi99pd	1181	5	need	need	NN
cord-015365-iqdi99pd	1181	6	of	of	IN
cord-015365-iqdi99pd	1181	7	interventions	intervention	NNS
cord-015365-iqdi99pd	1181	8	,	,	,
cord-015365-iqdi99pd	1181	9	2	2	CD
cord-015365-iqdi99pd	1181	10	of	of	IN
cord-015365-iqdi99pd	1181	11	them	-PRON-	PRP
cord-015365-iqdi99pd	1181	12	in	in	IN
cord-015365-iqdi99pd	1181	13	LADp3	LADp3	NNP
cord-015365-iqdi99pd	1181	14	with	with	IN
cord-015365-iqdi99pd	1181	15	endeavour	endeavour	NN
cord-015365-iqdi99pd	1181	16	stents	stent	NNS
cord-015365-iqdi99pd	1181	17	and	and	CC
cord-015365-iqdi99pd	1181	18	1	1	CD
cord-015365-iqdi99pd	1181	19	patient	patient	NN
cord-015365-iqdi99pd	1181	20	in	in	IN
cord-015365-iqdi99pd	1181	21	RCA1	RCA1	NNP
cord-015365-iqdi99pd	1181	22	with	with	IN
cord-015365-iqdi99pd	1181	23	cypher	cypher	NN
cord-015365-iqdi99pd	1181	24	stent	stent	NN
cord-015365-iqdi99pd	1181	25	.	.	.
cord-015365-iqdi99pd	1182	1	No	no	DT
cord-015365-iqdi99pd	1182	2	complications	complication	NNS
cord-015365-iqdi99pd	1182	3	have	have	VBP
cord-015365-iqdi99pd	1182	4	been	be	VBN
cord-015365-iqdi99pd	1182	5	observed	observe	VBN
cord-015365-iqdi99pd	1182	6	.	.	.
cord-015365-iqdi99pd	1183	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1183	2	.	.	.
cord-015365-iqdi99pd	1184	1	Radial	radial	JJ
cord-015365-iqdi99pd	1184	2	angiography	angiography	NN
cord-015365-iqdi99pd	1184	3	is	be	VBZ
cord-015365-iqdi99pd	1184	4	a	a	DT
cord-015365-iqdi99pd	1184	5	safer	safe	JJR
cord-015365-iqdi99pd	1184	6	method	method	NN
cord-015365-iqdi99pd	1184	7	for	for	IN
cord-015365-iqdi99pd	1184	8	routine	routine	JJ
cord-015365-iqdi99pd	1184	9	follow	follow	NN
cord-015365-iqdi99pd	1184	10	-	-	HYPH
cord-015365-iqdi99pd	1184	11	up	up	NN
cord-015365-iqdi99pd	1184	12	for	for	IN
cord-015365-iqdi99pd	1184	13	patients	patient	NNS
cord-015365-iqdi99pd	1184	14	after	after	IN
cord-015365-iqdi99pd	1184	15	heart	heart	NN
cord-015365-iqdi99pd	1184	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	1184	17	,	,	,
cord-015365-iqdi99pd	1184	18	especially	especially	RB
cord-015365-iqdi99pd	1184	19	in	in	IN
cord-015365-iqdi99pd	1184	20	long	long	JJ
cord-015365-iqdi99pd	1184	21	-	-	HYPH
cord-015365-iqdi99pd	1184	22	term	term	NN
cord-015365-iqdi99pd	1184	23	follow	follow	NN
cord-015365-iqdi99pd	1184	24	-	-	HYPH
cord-015365-iqdi99pd	1184	25	up	up	NN
cord-015365-iqdi99pd	1184	26	,	,	,
cord-015365-iqdi99pd	1184	27	as	as	IN
cord-015365-iqdi99pd	1184	28	femoral	femoral	JJ
cord-015365-iqdi99pd	1184	29	approach	approach	NN
cord-015365-iqdi99pd	1184	30	often	often	RB
cord-015365-iqdi99pd	1184	31	leads	lead	VBZ
cord-015365-iqdi99pd	1184	32	to	to	IN
cord-015365-iqdi99pd	1184	33	complications	complication	NNS
cord-015365-iqdi99pd	1184	34	.	.	.
cord-015365-iqdi99pd	1185	1	tation	tation	NNP
cord-015365-iqdi99pd	1185	2	and	and	CC
cord-015365-iqdi99pd	1185	3	repeated	repeat	VBD
cord-015365-iqdi99pd	1185	4	antigen	antigen	NN
cord-015365-iqdi99pd	1185	5	immunoadsorption	immunoadsorption	NN
cord-015365-iqdi99pd	1186	1	(	(	-LRB-
cord-015365-iqdi99pd	1186	2	Glycosor	Glycosor	NNP
cord-015365-iqdi99pd	1186	3	-	-	HYPH
cord-015365-iqdi99pd	1186	4	bABO	bABO	NNP
cord-015365-iqdi99pd	1186	5	)	)	-RRB-
cord-015365-iqdi99pd	1186	6	until	until	IN
cord-015365-iqdi99pd	1186	7	the	the	DT
cord-015365-iqdi99pd	1186	8	isoagglutinine	isoagglutinine	NNP
cord-015365-iqdi99pd	1186	9	titre	titre	NNP
cord-015365-iqdi99pd	1186	10	was	be	VBD
cord-015365-iqdi99pd	1186	11	less	less	JJR
cord-015365-iqdi99pd	1186	12	than	than	IN
cord-015365-iqdi99pd	1186	13	1:8	1:8	CD
cord-015365-iqdi99pd	1186	14	.	.	.
cord-015365-iqdi99pd	1187	1	In	in	IN
cord-015365-iqdi99pd	1187	2	addition	addition	NN
cord-015365-iqdi99pd	1187	3	intravenous	intravenous	JJ
cord-015365-iqdi99pd	1187	4	immunoglobulin	immunoglobulin	NN
cord-015365-iqdi99pd	1187	5	(	(	-LRB-
cord-015365-iqdi99pd	1187	6	Intratect	Intratect	NNP
cord-015365-iqdi99pd	1187	7	,	,	,
cord-015365-iqdi99pd	1187	8	Biotest	Biotest	NNP
cord-015365-iqdi99pd	1187	9	Pharma	Pharma	NNP
cord-015365-iqdi99pd	1187	10	)	)	-RRB-
cord-015365-iqdi99pd	1187	11	was	be	VBD
cord-015365-iqdi99pd	1187	12	administrated	administrate	VBN
cord-015365-iqdi99pd	1187	13	at	at	IN
cord-015365-iqdi99pd	1187	14	a	a	DT
cord-015365-iqdi99pd	1187	15	dose	dose	NN
cord-015365-iqdi99pd	1187	16	of	of	IN
cord-015365-iqdi99pd	1187	17	1.0	1.0	CD
cord-015365-iqdi99pd	1187	18	g	g	NN
cord-015365-iqdi99pd	1187	19	/	/	SYM
cord-015365-iqdi99pd	1187	20	kg	kg	NN
cord-015365-iqdi99pd	1187	21	body	body	NN
cord-015365-iqdi99pd	1187	22	weight	weight	NN
cord-015365-iqdi99pd	1187	23	after	after	IN
cord-015365-iqdi99pd	1187	24	each	each	DT
cord-015365-iqdi99pd	1187	25	immunoadsorption	immunoadsorption	NN
cord-015365-iqdi99pd	1187	26	.	.	.
cord-015365-iqdi99pd	1188	1	A	a	DT
cord-015365-iqdi99pd	1188	2	standard	standard	JJ
cord-015365-iqdi99pd	1188	3	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	1188	4	regimen	regimen	NN
cord-015365-iqdi99pd	1188	5	(	(	-LRB-
cord-015365-iqdi99pd	1188	6	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	1188	7	with	with	IN
cord-015365-iqdi99pd	1188	8	a	a	DT
cord-015365-iqdi99pd	1188	9	target	target	NN
cord-015365-iqdi99pd	1188	10	level	level	NN
cord-015365-iqdi99pd	1188	11	of	of	IN
cord-015365-iqdi99pd	1188	12	10	10	CD
cord-015365-iqdi99pd	1188	13	to	to	TO
cord-015365-iqdi99pd	1188	14	12	12	CD
cord-015365-iqdi99pd	1188	15	ng	ng	NN
cord-015365-iqdi99pd	1188	16	/	/	SYM
cord-015365-iqdi99pd	1188	17	ml	ml	NNP
cord-015365-iqdi99pd	1188	18	,	,	,
cord-015365-iqdi99pd	1188	19	mycophenolate	mycophenolate	NNP
cord-015365-iqdi99pd	1188	20	mofetil	mofetil	NNP
cord-015365-iqdi99pd	1188	21	at	at	IN
cord-015365-iqdi99pd	1188	22	a	a	DT
cord-015365-iqdi99pd	1188	23	dose	dose	NN
cord-015365-iqdi99pd	1188	24	of	of	IN
cord-015365-iqdi99pd	1188	25	1	1	CD
cord-015365-iqdi99pd	1188	26	g	g	NN
cord-015365-iqdi99pd	1188	27	twice	twice	PDT
cord-015365-iqdi99pd	1188	28	a	a	DT
cord-015365-iqdi99pd	1188	29	day	day	NN
cord-015365-iqdi99pd	1188	30	and	and	CC
cord-015365-iqdi99pd	1188	31	prednisolone	prednisolone	NN
cord-015365-iqdi99pd	1188	32	)	)	-RRB-
cord-015365-iqdi99pd	1188	33	with	with	IN
cord-015365-iqdi99pd	1188	34	IL-2	IL-2	NNP
cord-015365-iqdi99pd	1188	35	antibody	antibody	NN
cord-015365-iqdi99pd	1188	36	induction	induction	NN
cord-015365-iqdi99pd	1188	37	was	be	VBD
cord-015365-iqdi99pd	1188	38	started	start	VBN
cord-015365-iqdi99pd	1188	39	approximately	approximately	RB
cord-015365-iqdi99pd	1188	40	two	two	CD
cord-015365-iqdi99pd	1188	41	weeks	week	NNS
cord-015365-iqdi99pd	1188	42	prior	prior	RB
cord-015365-iqdi99pd	1188	43	to	to	IN
cord-015365-iqdi99pd	1188	44	kidney	kidney	NN
cord-015365-iqdi99pd	1188	45	transplantation	transplantation	NN
cord-015365-iqdi99pd	1188	46	.	.	.
cord-015365-iqdi99pd	1189	1	Results	result	NNS
cord-015365-iqdi99pd	1189	2	.	.	.
cord-015365-iqdi99pd	1190	1	A	a	DT
cord-015365-iqdi99pd	1190	2	total	total	NN
cord-015365-iqdi99pd	1190	3	of	of	IN
cord-015365-iqdi99pd	1190	4	seven	seven	CD
cord-015365-iqdi99pd	1190	5	ABO	ABO	NNP
cord-015365-iqdi99pd	1190	6	incompatible	incompatible	JJ
cord-015365-iqdi99pd	1190	7	kidney	kidney	NN
cord-015365-iqdi99pd	1190	8	transplantations	transplantation	NNS
cord-015365-iqdi99pd	1190	9	were	be	VBD
cord-015365-iqdi99pd	1190	10	performed	perform	VBN
cord-015365-iqdi99pd	1190	11	.	.	.
cord-015365-iqdi99pd	1191	1	Patients	patient	NNS
cord-015365-iqdi99pd	1191	2	'	'	POS
cord-015365-iqdi99pd	1191	3	characteristics	characteristic	NNS
cord-015365-iqdi99pd	1191	4	are	be	VBP
cord-015365-iqdi99pd	1191	5	summarised	summarise	VBN
cord-015365-iqdi99pd	1191	6	in	in	IN
cord-015365-iqdi99pd	1191	7	Table	Table	NNP
cord-015365-iqdi99pd	1191	8	1	1	CD
cord-015365-iqdi99pd	1191	9	.	.	.
cord-015365-iqdi99pd	1192	1	All	all	DT
cord-015365-iqdi99pd	1192	2	patients	patient	NNS
cord-015365-iqdi99pd	1192	3	showed	show	VBD
cord-015365-iqdi99pd	1192	4	an	an	DT
cord-015365-iqdi99pd	1192	5	immediate	immediate	JJ
cord-015365-iqdi99pd	1192	6	graft	graft	NN
cord-015365-iqdi99pd	1192	7	function	function	NN
cord-015365-iqdi99pd	1192	8	and	and	CC
cord-015365-iqdi99pd	1192	9	their	-PRON-	PRP$
cord-015365-iqdi99pd	1192	10	serum	serum	NN
cord-015365-iqdi99pd	1192	11	creatinine	creatinine	NN
cord-015365-iqdi99pd	1192	12	decreased	decrease	VBD
cord-015365-iqdi99pd	1192	13	to	to	IN
cord-015365-iqdi99pd	1192	14	a	a	DT
cord-015365-iqdi99pd	1192	15	median	median	JJ
cord-015365-iqdi99pd	1192	16	level	level	NN
cord-015365-iqdi99pd	1192	17	of	of	IN
cord-015365-iqdi99pd	1192	18	1.69	1.69	CD
cord-015365-iqdi99pd	1192	19	mg	mg	NNP
cord-015365-iqdi99pd	1192	20	/	/	SYM
cord-015365-iqdi99pd	1192	21	dl	dl	NNP
cord-015365-iqdi99pd	1192	22	(	(	-LRB-
cord-015365-iqdi99pd	1192	23	range	range	NN
cord-015365-iqdi99pd	1192	24	:	:	:
cord-015365-iqdi99pd	1192	25	1.09	1.09	CD
cord-015365-iqdi99pd	1192	26	-	-	SYM
cord-015365-iqdi99pd	1192	27	3.39	3.39	CD
cord-015365-iqdi99pd	1192	28	mg	mg	NNP
cord-015365-iqdi99pd	1192	29	/	/	SYM
cord-015365-iqdi99pd	1192	30	dl	dl	NNP
cord-015365-iqdi99pd	1192	31	)	)	-RRB-
cord-015365-iqdi99pd	1192	32	on	on	IN
cord-015365-iqdi99pd	1192	33	day	day	NN
cord-015365-iqdi99pd	1192	34	7	7	CD
cord-015365-iqdi99pd	1192	35	.	.	.
cord-015365-iqdi99pd	1193	1	In	in	IN
cord-015365-iqdi99pd	1193	2	one	one	CD
cord-015365-iqdi99pd	1193	3	patient	patient	NN
cord-015365-iqdi99pd	1193	4	there	there	EX
cord-015365-iqdi99pd	1193	5	was	be	VBD
cord-015365-iqdi99pd	1193	6	an	an	DT
cord-015365-iqdi99pd	1193	7	early	early	JJ
cord-015365-iqdi99pd	1193	8	loss	loss	NN
cord-015365-iqdi99pd	1193	9	of	of	IN
cord-015365-iqdi99pd	1193	10	graft	graft	NN
cord-015365-iqdi99pd	1193	11	function	function	NN
cord-015365-iqdi99pd	1193	12	due	due	IN
cord-015365-iqdi99pd	1193	13	to	to	IN
cord-015365-iqdi99pd	1193	14	thrombotic	thrombotic	JJ
cord-015365-iqdi99pd	1193	15	microangiopathy	microangiopathy	NNP
cord-015365-iqdi99pd	1193	16	despite	despite	IN
cord-015365-iqdi99pd	1193	17	rescue	rescue	NN
cord-015365-iqdi99pd	1193	18	treatment	treatment	NN
cord-015365-iqdi99pd	1193	19	with	with	IN
cord-015365-iqdi99pd	1193	20	bortezomib	bortezomib	NNP
cord-015365-iqdi99pd	1193	21	and	and	CC
cord-015365-iqdi99pd	1193	22	eculizumab	eculizumab	NNS
cord-015365-iqdi99pd	1193	23	leading	lead	VBG
cord-015365-iqdi99pd	1193	24	to	to	IN
cord-015365-iqdi99pd	1193	25	graft	graft	NN
cord-015365-iqdi99pd	1193	26	loss	loss	NN
cord-015365-iqdi99pd	1193	27	on	on	IN
cord-015365-iqdi99pd	1193	28	day	day	NN
cord-015365-iqdi99pd	1193	29	21	21	CD
cord-015365-iqdi99pd	1193	30	.	.	.
cord-015365-iqdi99pd	1194	1	After	after	IN
cord-015365-iqdi99pd	1194	2	a	a	DT
cord-015365-iqdi99pd	1194	3	median	median	NN
cord-015365-iqdi99pd	1194	4	follow	follow	NN
cord-015365-iqdi99pd	1194	5	up	up	IN
cord-015365-iqdi99pd	1194	6	of	of	IN
cord-015365-iqdi99pd	1194	7	3.7	3.7	CD
cord-015365-iqdi99pd	1194	8	months	month	NNS
cord-015365-iqdi99pd	1194	9	,	,	,
cord-015365-iqdi99pd	1194	10	serum	serum	NN
cord-015365-iqdi99pd	1194	11	creatinine	creatinine	NN
cord-015365-iqdi99pd	1194	12	averaged	average	VBD
cord-015365-iqdi99pd	1194	13	1.7	1.7	CD
cord-015365-iqdi99pd	1194	14	mg	mg	NNP
cord-015365-iqdi99pd	1194	15	/	/	SYM
cord-015365-iqdi99pd	1194	16	dl	dl	NNP
cord-015365-iqdi99pd	1194	17	(	(	-LRB-
cord-015365-iqdi99pd	1194	18	range	range	NN
cord-015365-iqdi99pd	1194	19	:	:	:
cord-015365-iqdi99pd	1194	20	1.25	1.25	CD
cord-015365-iqdi99pd	1194	21	-	-	SYM
cord-015365-iqdi99pd	1194	22	2.27	2.27	CD
cord-015365-iqdi99pd	1194	23	mg	mg	NNP
cord-015365-iqdi99pd	1194	24	/	/	SYM
cord-015365-iqdi99pd	1194	25	dl	dl	NNP
cord-015365-iqdi99pd	1194	26	)	)	-RRB-
cord-015365-iqdi99pd	1194	27	.	.	.
cord-015365-iqdi99pd	1195	1	In	in	IN
cord-015365-iqdi99pd	1195	2	the	the	DT
cord-015365-iqdi99pd	1195	3	performed	perform	VBN
cord-015365-iqdi99pd	1195	4	renal	renal	JJ
cord-015365-iqdi99pd	1195	5	biopsies	biopsy	NNS
cord-015365-iqdi99pd	1195	6	there	there	EX
cord-015365-iqdi99pd	1195	7	was	be	VBD
cord-015365-iqdi99pd	1195	8	no	no	DT
cord-015365-iqdi99pd	1195	9	evidence	evidence	NN
cord-015365-iqdi99pd	1195	10	of	of	IN
cord-015365-iqdi99pd	1195	11	relevant	relevant	JJ
cord-015365-iqdi99pd	1195	12	acute	acute	JJ
cord-015365-iqdi99pd	1195	13	or	or	CC
cord-015365-iqdi99pd	1195	14	chronic	chronic	JJ
cord-015365-iqdi99pd	1195	15	graft	graft	NN
cord-015365-iqdi99pd	1195	16	injury	injury	NN
cord-015365-iqdi99pd	1195	17	,	,	,
cord-015365-iqdi99pd	1195	18	all	all	DT
cord-015365-iqdi99pd	1195	19	allografts	allograft	NNS
cord-015365-iqdi99pd	1195	20	showed	show	VBD
cord-015365-iqdi99pd	1195	21	C4d	C4d	NNP
cord-015365-iqdi99pd	1195	22	positive	positive	JJ
cord-015365-iqdi99pd	1195	23	immunostaining	immunostaining	NN
cord-015365-iqdi99pd	1195	24	.	.	.
cord-015365-iqdi99pd	1196	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1196	2	.	.	.
cord-015365-iqdi99pd	1197	1	In	in	IN
cord-015365-iqdi99pd	1197	2	conclusion	conclusion	NN
cord-015365-iqdi99pd	1197	3	,	,	,
cord-015365-iqdi99pd	1197	4	our	-PRON-	PRP$
cord-015365-iqdi99pd	1197	5	small	small	JJ
cord-015365-iqdi99pd	1197	6	case	case	NN
cord-015365-iqdi99pd	1197	7	series	series	NN
cord-015365-iqdi99pd	1197	8	demonstrated	demonstrate	VBD
cord-015365-iqdi99pd	1197	9	that	that	IN
cord-015365-iqdi99pd	1197	10	perioperative	perioperative	JJ
cord-015365-iqdi99pd	1197	11	isoagglutinine	isoagglutinine	JJ
cord-015365-iqdi99pd	1197	12	removal	removal	NN
cord-015365-iqdi99pd	1197	13	in	in	IN
cord-015365-iqdi99pd	1197	14	combination	combination	NN
cord-015365-iqdi99pd	1197	15	with	with	IN
cord-015365-iqdi99pd	1197	16	rituximab	rituximab	NN
cord-015365-iqdi99pd	1197	17	is	be	VBZ
cord-015365-iqdi99pd	1197	18	an	an	DT
cord-015365-iqdi99pd	1197	19	effective	effective	JJ
cord-015365-iqdi99pd	1197	20	and	and	CC
cord-015365-iqdi99pd	1197	21	safe	safe	JJ
cord-015365-iqdi99pd	1197	22	protocol	protocol	NN
cord-015365-iqdi99pd	1197	23	for	for	IN
cord-015365-iqdi99pd	1197	24	ABO	ABO	NNP
cord-015365-iqdi99pd	1197	25	incompatible	incompatible	JJ
cord-015365-iqdi99pd	1197	26	transplantation	transplantation	NN
cord-015365-iqdi99pd	1197	27	.	.	.
cord-015365-iqdi99pd	1198	1	Therefore	therefore	RB
cord-015365-iqdi99pd	1198	2	we	-PRON-	PRP
cord-015365-iqdi99pd	1198	3	offer	offer	VBP
cord-015365-iqdi99pd	1198	4	ABO	ABO	NNP
cord-015365-iqdi99pd	1198	5	incompatible	incompatible	JJ
cord-015365-iqdi99pd	1198	6	kidney	kidney	NN
cord-015365-iqdi99pd	1198	7	transplantation	transplantation	NN
cord-015365-iqdi99pd	1198	8	to	to	IN
cord-015365-iqdi99pd	1198	9	patients	patient	NNS
cord-015365-iqdi99pd	1198	10	as	as	IN
cord-015365-iqdi99pd	1198	11	alternative	alternative	JJ
cord-015365-iqdi99pd	1198	12	to	to	IN
cord-015365-iqdi99pd	1198	13	cadaveric	cadaveric	JJ
cord-015365-iqdi99pd	1198	14	kidney	kidney	NN
cord-015365-iqdi99pd	1198	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	1198	16	to	to	TO
cord-015365-iqdi99pd	1198	17	shorten	shorten	VB
cord-015365-iqdi99pd	1198	18	the	the	DT
cord-015365-iqdi99pd	1198	19	waiting	wait	VBG
cord-015365-iqdi99pd	1198	20	time	time	NN
cord-015365-iqdi99pd	1198	21	on	on	IN
cord-015365-iqdi99pd	1198	22	dialysis	dialysis	NN
cord-015365-iqdi99pd	1198	23	.	.	.
cord-015365-iqdi99pd	1199	1	Background	background	NN
cord-015365-iqdi99pd	1199	2	.	.	.
cord-015365-iqdi99pd	1200	1	Amyloidosis	Amyloidosis	NNP
cord-015365-iqdi99pd	1200	2	is	be	VBZ
cord-015365-iqdi99pd	1200	3	a	a	DT
cord-015365-iqdi99pd	1200	4	protein	protein	NN
cord-015365-iqdi99pd	1200	5	misfolding	misfolde	VBG
cord-015365-iqdi99pd	1200	6	disorder	disorder	NN
cord-015365-iqdi99pd	1200	7	where	where	WRB
cord-015365-iqdi99pd	1200	8	conformationally	conformationally	RB
cord-015365-iqdi99pd	1200	9	changed	change	VBN
cord-015365-iqdi99pd	1200	10	proteins	protein	NNS
cord-015365-iqdi99pd	1200	11	are	be	VBP
cord-015365-iqdi99pd	1200	12	pathologically	pathologically	RB
cord-015365-iqdi99pd	1200	13	deposited	deposit	VBN
cord-015365-iqdi99pd	1200	14	as	as	IN
cord-015365-iqdi99pd	1200	15	abnormal	abnormal	JJ
cord-015365-iqdi99pd	1200	16	insoluble	insoluble	JJ
cord-015365-iqdi99pd	1200	17	fibrils	fibril	NNS
cord-015365-iqdi99pd	1200	18	in	in	IN
cord-015365-iqdi99pd	1200	19	distinct	distinct	JJ
cord-015365-iqdi99pd	1200	20	tissues	tissue	NNS
cord-015365-iqdi99pd	1200	21	potentially	potentially	RB
cord-015365-iqdi99pd	1200	22	leading	lead	VBG
cord-015365-iqdi99pd	1200	23	to	to	IN
cord-015365-iqdi99pd	1200	24	morphological	morphological	JJ
cord-015365-iqdi99pd	1200	25	and	and	CC
cord-015365-iqdi99pd	1200	26	functional	functional	JJ
cord-015365-iqdi99pd	1200	27	disintegration	disintegration	NN
cord-015365-iqdi99pd	1200	28	.	.	.
cord-015365-iqdi99pd	1201	1	Heredi	Heredi	NNP
cord-015365-iqdi99pd	1201	2	-	-	HYPH
cord-015365-iqdi99pd	1201	3	tary	tary	NNP
cord-015365-iqdi99pd	1201	4	amyloidosis	amyloidosis	NN
cord-015365-iqdi99pd	1201	5	is	be	VBZ
cord-015365-iqdi99pd	1201	6	a	a	DT
cord-015365-iqdi99pd	1201	7	rare	rare	JJ
cord-015365-iqdi99pd	1201	8	autosomal	autosomal	JJ
cord-015365-iqdi99pd	1201	9	-	-	HYPH
cord-015365-iqdi99pd	1201	10	dominant	dominant	JJ
cord-015365-iqdi99pd	1201	11	disorder	disorder	NN
cord-015365-iqdi99pd	1201	12	arising	arise	VBG
cord-015365-iqdi99pd	1201	13	from	from	IN
cord-015365-iqdi99pd	1201	14	mutations	mutation	NNS
cord-015365-iqdi99pd	1201	15	in	in	IN
cord-015365-iqdi99pd	1201	16	several	several	JJ
cord-015365-iqdi99pd	1201	17	genes	gene	NNS
cord-015365-iqdi99pd	1201	18	like	like	IN
cord-015365-iqdi99pd	1201	19	in	in	IN
cord-015365-iqdi99pd	1201	20	the	the	DT
cord-015365-iqdi99pd	1201	21	fibrinogen	fibrinogen	NN
cord-015365-iqdi99pd	1201	22	A	a	NN
cord-015365-iqdi99pd	1201	23	-	-	HYPH
cord-015365-iqdi99pd	1201	24	chain	chain	NN
cord-015365-iqdi99pd	1201	25	that	that	WDT
cord-015365-iqdi99pd	1201	26	affect	affect	VBP
cord-015365-iqdi99pd	1201	27	various	various	JJ
cord-015365-iqdi99pd	1201	28	organs	organ	NNS
cord-015365-iqdi99pd	1201	29	.	.	.
cord-015365-iqdi99pd	1202	1	Mutations	mutation	NNS
cord-015365-iqdi99pd	1202	2	in	in	IN
cord-015365-iqdi99pd	1202	3	the	the	DT
cord-015365-iqdi99pd	1202	4	fibrinogen	fibrinogen	NN
cord-015365-iqdi99pd	1202	5	A	a	NN
cord-015365-iqdi99pd	1202	6	-	-	HYPH
cord-015365-iqdi99pd	1202	7	chain	chain	NN
cord-015365-iqdi99pd	1202	8	have	have	VBP
cord-015365-iqdi99pd	1202	9	been	be	VBN
cord-015365-iqdi99pd	1202	10	discussed	discuss	VBN
cord-015365-iqdi99pd	1202	11	to	to	TO
cord-015365-iqdi99pd	1202	12	lead	lead	VB
cord-015365-iqdi99pd	1202	13	to	to	IN
cord-015365-iqdi99pd	1202	14	a	a	DT
cord-015365-iqdi99pd	1202	15	predominant	predominant	JJ
cord-015365-iqdi99pd	1202	16	renal	renal	JJ
cord-015365-iqdi99pd	1202	17	deposition	deposition	NN
cord-015365-iqdi99pd	1202	18	of	of	IN
cord-015365-iqdi99pd	1202	19	amyloid	amyloid	NN
cord-015365-iqdi99pd	1202	20	generally	generally	RB
cord-015365-iqdi99pd	1202	21	leading	lead	VBG
cord-015365-iqdi99pd	1202	22	to	to	IN
cord-015365-iqdi99pd	1202	23	ESRD	ESRD	NNP
cord-015365-iqdi99pd	1202	24	.	.	.
cord-015365-iqdi99pd	1203	1	Methods	method	NNS
cord-015365-iqdi99pd	1203	2	.	.	.
cord-015365-iqdi99pd	1204	1	Here	here	RB
cord-015365-iqdi99pd	1204	2	,	,	,
cord-015365-iqdi99pd	1204	3	we	-PRON-	PRP
cord-015365-iqdi99pd	1204	4	describe	describe	VBP
cord-015365-iqdi99pd	1204	5	a	a	DT
cord-015365-iqdi99pd	1204	6	large	large	JJ
cord-015365-iqdi99pd	1204	7	Spanish	spanish	JJ
cord-015365-iqdi99pd	1204	8	family	family	NN
cord-015365-iqdi99pd	1204	9	with	with	IN
cord-015365-iqdi99pd	1204	10	101	101	CD
cord-015365-iqdi99pd	1204	11	members	member	NNS
cord-015365-iqdi99pd	1204	12	affected	affect	VBN
cord-015365-iqdi99pd	1204	13	by	by	IN
cord-015365-iqdi99pd	1204	14	the	the	DT
cord-015365-iqdi99pd	1204	15	rare	rare	JJ
cord-015365-iqdi99pd	1204	16	fibrinogen	fibrinogen	NN
cord-015365-iqdi99pd	1204	17	R554L	r554l	NN
cord-015365-iqdi99pd	1204	18	mutation	mutation	NN
cord-015365-iqdi99pd	1204	19	and	and	CC
cord-015365-iqdi99pd	1204	20	isolated	isolate	VBN
cord-015365-iqdi99pd	1204	21	renal	renal	JJ
cord-015365-iqdi99pd	1204	22	amyloidosis	amyloidosis	NN
cord-015365-iqdi99pd	1204	23	.	.	.
cord-015365-iqdi99pd	1205	1	Results	result	NNS
cord-015365-iqdi99pd	1205	2	.	.	.
cord-015365-iqdi99pd	1206	1	Most	Most	JJS
cord-015365-iqdi99pd	1206	2	patients	patient	NNS
cord-015365-iqdi99pd	1206	3	presented	present	VBN
cord-015365-iqdi99pd	1206	4	with	with	IN
cord-015365-iqdi99pd	1206	5	late	late	JJ
cord-015365-iqdi99pd	1206	6	-	-	HYPH
cord-015365-iqdi99pd	1206	7	onset	onset	NN
cord-015365-iqdi99pd	1206	8	gross	gross	JJ
cord-015365-iqdi99pd	1206	9	proteinuria	proteinuria	NN
cord-015365-iqdi99pd	1206	10	and	and	CC
cord-015365-iqdi99pd	1206	11	a	a	DT
cord-015365-iqdi99pd	1206	12	variable	variable	JJ
cord-015365-iqdi99pd	1206	13	course	course	NN
cord-015365-iqdi99pd	1206	14	of	of	IN
cord-015365-iqdi99pd	1206	15	decline	decline	NN
cord-015365-iqdi99pd	1206	16	of	of	IN
cord-015365-iqdi99pd	1206	17	renal	renal	JJ
cord-015365-iqdi99pd	1206	18	function	function	NN
cord-015365-iqdi99pd	1206	19	.	.	.
cord-015365-iqdi99pd	1207	1	In	in	IN
cord-015365-iqdi99pd	1207	2	contrast	contrast	NN
cord-015365-iqdi99pd	1207	3	to	to	IN
cord-015365-iqdi99pd	1207	4	other	other	JJ
cord-015365-iqdi99pd	1207	5	reported	report	VBN
cord-015365-iqdi99pd	1207	6	fibrinogen	fibrinogen	NN
cord-015365-iqdi99pd	1207	7	A	A	NNP
cord-015365-iqdi99pd	1207	8	mutations	mutation	NNS
cord-015365-iqdi99pd	1207	9	,	,	,
cord-015365-iqdi99pd	1207	10	extrarenal	extrarenal	JJ
cord-015365-iqdi99pd	1207	11	involvement	involvement	NN
cord-015365-iqdi99pd	1207	12	or	or	CC
cord-015365-iqdi99pd	1207	13	accelerated	accelerated	JJ
cord-015365-iqdi99pd	1207	14	arteriosclerosis	arteriosclerosis	NN
cord-015365-iqdi99pd	1207	15	employing	employ	VBG
cord-015365-iqdi99pd	1207	16	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1207	17	magnetic	magnetic	JJ
cord-015365-iqdi99pd	1207	18	resonance	resonance	NN
cord-015365-iqdi99pd	1207	19	imaging	imaging	NN
cord-015365-iqdi99pd	1207	20	,	,	,
cord-015365-iqdi99pd	1207	21	carotid	carotid	JJ
cord-015365-iqdi99pd	1207	22	ultrasound	ultrasound	NN
cord-015365-iqdi99pd	1207	23	and	and	CC
cord-015365-iqdi99pd	1207	24	tissue	tissue	NN
cord-015365-iqdi99pd	1207	25	biopsy	biopsy	NN
cord-015365-iqdi99pd	1207	26	was	be	VBD
cord-015365-iqdi99pd	1207	27	not	not	RB
cord-015365-iqdi99pd	1207	28	observed	observe	VBN
cord-015365-iqdi99pd	1207	29	indicating	indicate	VBG
cord-015365-iqdi99pd	1207	30	a	a	DT
cord-015365-iqdi99pd	1207	31	highly	highly	RB
cord-015365-iqdi99pd	1207	32	selective	selective	JJ
cord-015365-iqdi99pd	1207	33	process	process	NN
cord-015365-iqdi99pd	1207	34	of	of	IN
cord-015365-iqdi99pd	1207	35	renal	renal	JJ
cord-015365-iqdi99pd	1207	36	amyloid	amyloid	NN
cord-015365-iqdi99pd	1207	37	deposition	deposition	NN
cord-015365-iqdi99pd	1207	38	.	.	.
cord-015365-iqdi99pd	1208	1	Histological	Histological	NNP
cord-015365-iqdi99pd	1208	2	analysis	analysis	NN
cord-015365-iqdi99pd	1208	3	revealed	reveal	VBD
cord-015365-iqdi99pd	1208	4	almost	almost	RB
cord-015365-iqdi99pd	1208	5	complete	complete	JJ
cord-015365-iqdi99pd	1208	6	obliteration	obliteration	NN
cord-015365-iqdi99pd	1208	7	of	of	IN
cord-015365-iqdi99pd	1208	8	the	the	DT
cord-015365-iqdi99pd	1208	9	glomerular	glomerular	JJ
cord-015365-iqdi99pd	1208	10	and	and	CC
cord-015365-iqdi99pd	1208	11	specifically	specifically	RB
cord-015365-iqdi99pd	1208	12	the	the	DT
cord-015365-iqdi99pd	1208	13	mesangial	mesangial	JJ
cord-015365-iqdi99pd	1208	14	architecture	architecture	NN
cord-015365-iqdi99pd	1208	15	despite	despite	IN
cord-015365-iqdi99pd	1208	16	moderately	moderately	RB
cord-015365-iqdi99pd	1208	17	reduced	reduce	VBN
cord-015365-iqdi99pd	1208	18	kidney	kidney	NN
cord-015365-iqdi99pd	1208	19	function	function	NN
cord-015365-iqdi99pd	1208	20	.	.	.
cord-015365-iqdi99pd	1209	1	Treatment	treatment	NN
cord-015365-iqdi99pd	1209	2	with	with	IN
cord-015365-iqdi99pd	1209	3	angiotensin	angiotensin	NN
cord-015365-iqdi99pd	1209	4	-	-	HYPH
cord-015365-iqdi99pd	1209	5	converting	convert	VBG
cord-015365-iqdi99pd	1209	6	enzyme	enzyme	NN
cord-015365-iqdi99pd	1209	7	and	and	CC
cord-015365-iqdi99pd	1210	1	subsequently	subsequently	RB
cord-015365-iqdi99pd	1210	2	angiotensin	angiotensin	NN
cord-015365-iqdi99pd	1210	3	-	-	HYPH
cord-015365-iqdi99pd	1210	4	II	II	NNP
cord-015365-iqdi99pd	1210	5	receptor	receptor	NN
cord-015365-iqdi99pd	1210	6	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	1210	7	did	do	VBD
cord-015365-iqdi99pd	1210	8	not	not	RB
cord-015365-iqdi99pd	1210	9	significantly	significantly	RB
cord-015365-iqdi99pd	1210	10	affect	affect	VB
cord-015365-iqdi99pd	1210	11	proteinuria	proteinuria	NN
cord-015365-iqdi99pd	1210	12	.	.	.
cord-015365-iqdi99pd	1211	1	Two	two	CD
cord-015365-iqdi99pd	1211	2	affected	affected	JJ
cord-015365-iqdi99pd	1211	3	members	member	NNS
cord-015365-iqdi99pd	1211	4	underwent	undergo	VBD
cord-015365-iqdi99pd	1211	5	renal	renal	JJ
cord-015365-iqdi99pd	1211	6	transplantation	transplantation	NN
cord-015365-iqdi99pd	1211	7	with	with	IN
cord-015365-iqdi99pd	1211	8	the	the	DT
cord-015365-iqdi99pd	1211	9	longest	long	JJS
cord-015365-iqdi99pd	1211	10	surviving	survive	VBG
cord-015365-iqdi99pd	1211	11	graft	graft	NN
cord-015365-iqdi99pd	1211	12	exhibiting	exhibit	VBG
cord-015365-iqdi99pd	1211	13	13	13	CD
cord-015365-iqdi99pd	1211	14	years	year	NNS
cord-015365-iqdi99pd	1211	15	of	of	IN
cord-015365-iqdi99pd	1211	16	survival	survival	NN
cord-015365-iqdi99pd	1211	17	and	and	CC
cord-015365-iqdi99pd	1211	18	graft	graft	NN
cord-015365-iqdi99pd	1211	19	failure	failure	NN
cord-015365-iqdi99pd	1211	20	due	due	JJ
cord-015365-iqdi99pd	1211	21	to	to	IN
cord-015365-iqdi99pd	1211	22	surgical	surgical	JJ
cord-015365-iqdi99pd	1211	23	and	and	CC
cord-015365-iqdi99pd	1211	24	infectious	infectious	JJ
cord-015365-iqdi99pd	1211	25	problems	problem	NNS
cord-015365-iqdi99pd	1211	26	,	,	,
cord-015365-iqdi99pd	1211	27	but	but	CC
cord-015365-iqdi99pd	1211	28	recurrence	recurrence	NN
cord-015365-iqdi99pd	1211	29	of	of	IN
cord-015365-iqdi99pd	1211	30	amyloidosis	amyloidosis	NN
cord-015365-iqdi99pd	1211	31	.	.	.
cord-015365-iqdi99pd	1212	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1212	2	.	.	.
cord-015365-iqdi99pd	1213	1	Collectively	collectively	RB
cord-015365-iqdi99pd	1213	2	,	,	,
cord-015365-iqdi99pd	1213	3	these	these	DT
cord-015365-iqdi99pd	1213	4	results	result	NNS
cord-015365-iqdi99pd	1213	5	introduce	introduce	VBP
cord-015365-iqdi99pd	1213	6	a	a	DT
cord-015365-iqdi99pd	1213	7	new	new	JJ
cord-015365-iqdi99pd	1213	8	perspective	perspective	NN
cord-015365-iqdi99pd	1213	9	on	on	IN
cord-015365-iqdi99pd	1213	10	this	this	DT
cord-015365-iqdi99pd	1213	11	atypical	atypical	JJ
cord-015365-iqdi99pd	1213	12	fibrinogen	fibrinogen	NN
cord-015365-iqdi99pd	1213	13	mutation	mutation	NN
cord-015365-iqdi99pd	1213	14	with	with	IN
cord-015365-iqdi99pd	1213	15	significant	significant	JJ
cord-015365-iqdi99pd	1213	16	pathophysiological	pathophysiological	JJ
cord-015365-iqdi99pd	1213	17	and	and	CC
cord-015365-iqdi99pd	1213	18	clinical	clinical	JJ
cord-015365-iqdi99pd	1213	19	impact	impact	NN
cord-015365-iqdi99pd	1213	20	also	also	RB
cord-015365-iqdi99pd	1213	21	with	with	IN
cord-015365-iqdi99pd	1213	22	regard	regard	NN
cord-015365-iqdi99pd	1213	23	to	to	IN
cord-015365-iqdi99pd	1213	24	novel	novel	JJ
cord-015365-iqdi99pd	1213	25	therapeutical	therapeutical	JJ
cord-015365-iqdi99pd	1213	26	approaches	approach	NNS
cord-015365-iqdi99pd	1213	27	.	.	.
cord-015365-iqdi99pd	1214	1	Methods	method	NNS
cord-015365-iqdi99pd	1214	2	.	.	.
cord-015365-iqdi99pd	1215	1	217	217	CD
cord-015365-iqdi99pd	1215	2	enteric	enteric	NN
cord-015365-iqdi99pd	1215	3	drained	drain	VBN
cord-015365-iqdi99pd	1215	4	whole	whole	JJ
cord-015365-iqdi99pd	1215	5	pancreas	pancreas	NN
cord-015365-iqdi99pd	1215	6	transplants	transplant	NNS
cord-015365-iqdi99pd	1215	7	(	(	-LRB-
cord-015365-iqdi99pd	1215	8	PTx	PTx	NNS
cord-015365-iqdi99pd	1215	9	)	)	-RRB-
cord-015365-iqdi99pd	1215	10	in	in	IN
cord-015365-iqdi99pd	1215	11	208	208	CD
cord-015365-iqdi99pd	1215	12	patients	patient	NNS
cord-015365-iqdi99pd	1215	13	performed	perform	VBN
cord-015365-iqdi99pd	1215	14	at	at	IN
cord-015365-iqdi99pd	1215	15	our	-PRON-	PRP$
cord-015365-iqdi99pd	1215	16	center	center	NN
cord-015365-iqdi99pd	1215	17	during	during	IN
cord-015365-iqdi99pd	1215	18	a	a	DT
cord-015365-iqdi99pd	1215	19	seven	seven	CD
cord-015365-iqdi99pd	1215	20	year	year	NN
cord-015365-iqdi99pd	1215	21	period	period	NN
cord-015365-iqdi99pd	1215	22	were	be	VBD
cord-015365-iqdi99pd	1215	23	retrospectively	retrospectively	RB
cord-015365-iqdi99pd	1215	24	analysed	analyse	VBN
cord-015365-iqdi99pd	1215	25	.	.	.
cord-015365-iqdi99pd	1216	1	Prophylactic	prophylactic	JJ
cord-015365-iqdi99pd	1216	2	immunosup-	immunosup-	NN
cord-015365-iqdi99pd	1216	3	Type	type	NN
cord-015365-iqdi99pd	1216	4	II	II	NNP
cord-015365-iqdi99pd	1216	5	DM	DM	NNP
cord-015365-iqdi99pd	1216	6	was	be	VBD
cord-015365-iqdi99pd	1216	7	defined	define	VBN
cord-015365-iqdi99pd	1216	8	as	as	IN
cord-015365-iqdi99pd	1216	9	requirement	requirement	NN
cord-015365-iqdi99pd	1216	10	of	of	IN
cord-015365-iqdi99pd	1216	11	insulin	insulin	NN
cord-015365-iqdi99pd	1216	12	or	or	CC
cord-015365-iqdi99pd	1216	13	oral	oral	JJ
cord-015365-iqdi99pd	1216	14	antidiabetics	antidiabetic	NNS
cord-015365-iqdi99pd	1216	15	in	in	IN
cord-015365-iqdi99pd	1216	16	the	the	DT
cord-015365-iqdi99pd	1216	17	presence	presence	NN
cord-015365-iqdi99pd	1216	18	of	of	IN
cord-015365-iqdi99pd	1216	19	C	c	NN
cord-015365-iqdi99pd	1216	20	-	-	HYPH
cord-015365-iqdi99pd	1216	21	peptide	peptide	NN
cord-015365-iqdi99pd	1216	22	production	production	NN
cord-015365-iqdi99pd	1216	23	to	to	TO
cord-015365-iqdi99pd	1216	24	maintain	maintain	VB
cord-015365-iqdi99pd	1216	25	blood	blood	NN
cord-015365-iqdi99pd	1216	26	glucose	glucose	NN
cord-015365-iqdi99pd	1216	27	levels	level	NNS
cord-015365-iqdi99pd	1216	28	<	<	XX
cord-015365-iqdi99pd	1216	29	200	200	CD
cord-015365-iqdi99pd	1217	1	mg	mg	NNP
cord-015365-iqdi99pd	1217	2	/	/	SYM
cord-015365-iqdi99pd	1217	3	dl	dl	NN
cord-015365-iqdi99pd	1217	4	.	.	.
cord-015365-iqdi99pd	1217	5	Results	result	NNS
cord-015365-iqdi99pd	1217	6	.	.	.
cord-015365-iqdi99pd	1218	1	Actuarial	actuarial	JJ
cord-015365-iqdi99pd	1218	2	patient	patient	NN
cord-015365-iqdi99pd	1218	3	,	,	,
cord-015365-iqdi99pd	1218	4	pancreas	pancreas	NN
cord-015365-iqdi99pd	1218	5	and	and	CC
cord-015365-iqdi99pd	1218	6	kidney	kidney	NN
cord-015365-iqdi99pd	1218	7	graft	graft	NN
cord-015365-iqdi99pd	1218	8	survival	survival	NN
cord-015365-iqdi99pd	1218	9	at	at	IN
cord-015365-iqdi99pd	1218	10	one	one	CD
cord-015365-iqdi99pd	1218	11	year	year	NN
cord-015365-iqdi99pd	1218	12	were	be	VBD
cord-015365-iqdi99pd	1218	13	96.4	96.4	CD
cord-015365-iqdi99pd	1218	14	%	%	NN
cord-015365-iqdi99pd	1218	15	,	,	,
cord-015365-iqdi99pd	1218	16	88.5	88.5	CD
cord-015365-iqdi99pd	1218	17	%	%	NN
cord-015365-iqdi99pd	1218	18	and	and	CC
cord-015365-iqdi99pd	1218	19	94.8	94.8	CD
cord-015365-iqdi99pd	1218	20	%	%	NN
cord-015365-iqdi99pd	1218	21	.	.	.
cord-015365-iqdi99pd	1219	1	At	at	IN
cord-015365-iqdi99pd	1219	2	last	last	JJ
cord-015365-iqdi99pd	1219	3	follow	follow	NN
cord-015365-iqdi99pd	1219	4	up	up	RP
cord-015365-iqdi99pd	1219	5	,	,	,
cord-015365-iqdi99pd	1219	6	two	two	CD
cord-015365-iqdi99pd	1219	7	patients	patient	NNS
cord-015365-iqdi99pd	1219	8	were	be	VBD
cord-015365-iqdi99pd	1219	9	lost	lose	VBN
cord-015365-iqdi99pd	1219	10	,	,	,
cord-015365-iqdi99pd	1219	11	30	30	CD
cord-015365-iqdi99pd	1219	12	patients	patient	NNS
cord-015365-iqdi99pd	1219	13	died	die	VBD
cord-015365-iqdi99pd	1219	14	,	,	,
cord-015365-iqdi99pd	1219	15	26	26	CD
cord-015365-iqdi99pd	1219	16	pancreatic	pancreatic	JJ
cord-015365-iqdi99pd	1219	17	grafts	graft	NNS
cord-015365-iqdi99pd	1219	18	and	and	CC
cord-015365-iqdi99pd	1219	19	16	16	CD
cord-015365-iqdi99pd	1219	20	renal	renal	JJ
cord-015365-iqdi99pd	1219	21	allografts	allograft	NNS
cord-015365-iqdi99pd	1219	22	were	be	VBD
cord-015365-iqdi99pd	1219	23	lost	lose	VBN
cord-015365-iqdi99pd	1219	24	.	.	.
cord-015365-iqdi99pd	1220	1	A	a	DT
cord-015365-iqdi99pd	1220	2	total	total	NN
cord-015365-iqdi99pd	1220	3	of	of	IN
cord-015365-iqdi99pd	1220	4	17	17	CD
cord-015365-iqdi99pd	1220	5	patients	patient	NNS
cord-015365-iqdi99pd	1220	6	were	be	VBD
cord-015365-iqdi99pd	1220	7	C	c	NN
cord-015365-iqdi99pd	1220	8	-	-	HYPH
cord-015365-iqdi99pd	1220	9	peptide	peptide	NN
cord-015365-iqdi99pd	1220	10	positive	positive	JJ
cord-015365-iqdi99pd	1220	11	at	at	IN
cord-015365-iqdi99pd	1220	12	the	the	DT
cord-015365-iqdi99pd	1220	13	time	time	NN
cord-015365-iqdi99pd	1220	14	of	of	IN
cord-015365-iqdi99pd	1220	15	PTx	PTx	NNS
cord-015365-iqdi99pd	1220	16	;	;	:
cord-015365-iqdi99pd	1220	17	three	three	CD
cord-015365-iqdi99pd	1220	18	patients	patient	NNS
cord-015365-iqdi99pd	1220	19	were	be	VBD
cord-015365-iqdi99pd	1220	20	excluded	exclude	VBN
cord-015365-iqdi99pd	1220	21	from	from	IN
cord-015365-iqdi99pd	1220	22	analysis	analysis	NN
cord-015365-iqdi99pd	1220	23	due	due	IN
cord-015365-iqdi99pd	1220	24	to	to	IN
cord-015365-iqdi99pd	1220	25	early	early	JJ
cord-015365-iqdi99pd	1220	26	graft	graft	NN
cord-015365-iqdi99pd	1220	27	loss	loss	NN
cord-015365-iqdi99pd	1220	28	(	(	-LRB-
cord-015365-iqdi99pd	1220	29	n	n	NN
cord-015365-iqdi99pd	1220	30	¼	¼	NNP
cord-015365-iqdi99pd	1220	31	2	2	CD
cord-015365-iqdi99pd	1220	32	)	)	-RRB-
cord-015365-iqdi99pd	1220	33	and	and	CC
cord-015365-iqdi99pd	1220	34	DM	DM	NNP
cord-015365-iqdi99pd	1220	35	type	type	NN
cord-015365-iqdi99pd	1220	36	II	II	NNP
cord-015365-iqdi99pd	1220	37	due	due	JJ
cord-015365-iqdi99pd	1220	38	to	to	IN
cord-015365-iqdi99pd	1220	39	partial	partial	JJ
cord-015365-iqdi99pd	1220	40	insufficiency	insufficiency	NN
cord-015365-iqdi99pd	1220	41	of	of	IN
cord-015365-iqdi99pd	1220	42	a	a	DT
cord-015365-iqdi99pd	1220	43	previous	previous	JJ
cord-015365-iqdi99pd	1220	44	pancreatic	pancreatic	NN
cord-015365-iqdi99pd	1220	45	allograft	allograft	NN
cord-015365-iqdi99pd	1220	46	(	(	-LRB-
cord-015365-iqdi99pd	1220	47	n	n	NN
cord-015365-iqdi99pd	1220	48	¼	¼	NNP
cord-015365-iqdi99pd	1220	49	1	1	CD
cord-015365-iqdi99pd	1220	50	)	)	-RRB-
cord-015365-iqdi99pd	1220	51	.	.	.
cord-015365-iqdi99pd	1221	1	Of	of	IN
cord-015365-iqdi99pd	1221	2	the	the	DT
cord-015365-iqdi99pd	1221	3	14	14	CD
cord-015365-iqdi99pd	1221	4	study	study	NN
cord-015365-iqdi99pd	1221	5	patients	patient	NNS
cord-015365-iqdi99pd	1221	6	(	(	-LRB-
cord-015365-iqdi99pd	1221	7	13	13	CD
cord-015365-iqdi99pd	1221	8	men/1	men/1	NN
cord-015365-iqdi99pd	1221	9	woman	woman	NN
cord-015365-iqdi99pd	1221	10	with	with	IN
cord-015365-iqdi99pd	1221	11	a	a	DT
cord-015365-iqdi99pd	1221	12	median	median	JJ
cord-015365-iqdi99pd	1221	13	age	age	NN
cord-015365-iqdi99pd	1221	14	of	of	IN
cord-015365-iqdi99pd	1221	15	56	56	CD
cord-015365-iqdi99pd	1221	16	[	[	-LRB-
cord-015365-iqdi99pd	1221	17	range	range	NN
cord-015365-iqdi99pd	1221	18	41	41	CD
cord-015365-iqdi99pd	1221	19	-	-	SYM
cord-015365-iqdi99pd	1221	20	62	62	CD
cord-015365-iqdi99pd	1221	21	]	]	-RRB-
cord-015365-iqdi99pd	1221	22	years	year	NNS
cord-015365-iqdi99pd	1221	23	,	,	,
cord-015365-iqdi99pd	1221	24	two	two	CD
cord-015365-iqdi99pd	1221	25	died	die	VBD
cord-015365-iqdi99pd	1221	26	[	[	-LRB-
cord-015365-iqdi99pd	1221	27	invasive	invasive	JJ
cord-015365-iqdi99pd	1221	28	fungal	fungal	JJ
cord-015365-iqdi99pd	1221	29	infection	infection	NN
cord-015365-iqdi99pd	1221	30	1	1	CD
cord-015365-iqdi99pd	1221	31	,	,	,
cord-015365-iqdi99pd	1221	32	intracerebral	intracerebral	JJ
cord-015365-iqdi99pd	1221	33	bleeding	bleed	VBG
cord-015365-iqdi99pd	1221	34	1	1	CD
cord-015365-iqdi99pd	1221	35	]	]	-RRB-
cord-015365-iqdi99pd	1221	36	)	)	-RRB-
cord-015365-iqdi99pd	1221	37	,	,	,
cord-015365-iqdi99pd	1221	38	another	another	DT
cord-015365-iqdi99pd	1221	39	two	two	CD
cord-015365-iqdi99pd	1221	40	lost	lose	VBD
cord-015365-iqdi99pd	1221	41	their	-PRON-	PRP$
cord-015365-iqdi99pd	1221	42	pancreatic	pancreatic	JJ
cord-015365-iqdi99pd	1221	43	graft	graft	NN
cord-015365-iqdi99pd	1221	44	[	[	-LRB-
cord-015365-iqdi99pd	1221	45	hyperacute	hyperacute	NN
cord-015365-iqdi99pd	1221	46	rejection	rejection	NN
cord-015365-iqdi99pd	1221	47	1	1	CD
cord-015365-iqdi99pd	1221	48	,	,	,
cord-015365-iqdi99pd	1221	49	chronic	chronic	JJ
cord-015365-iqdi99pd	1221	50	rejection	rejection	NN
cord-015365-iqdi99pd	1221	51	1	1	CD
cord-015365-iqdi99pd	1221	52	]	]	-RRB-
cord-015365-iqdi99pd	1221	53	)	)	-RRB-
cord-015365-iqdi99pd	1222	1	but	but	CC
cord-015365-iqdi99pd	1222	2	none	none	NN
cord-015365-iqdi99pd	1222	3	their	-PRON-	PRP$
cord-015365-iqdi99pd	1222	4	renal	renal	JJ
cord-015365-iqdi99pd	1222	5	graft	graft	NN
cord-015365-iqdi99pd	1222	6	.	.	.
cord-015365-iqdi99pd	1223	1	Rejection	rejection	NN
cord-015365-iqdi99pd	1223	2	rate	rate	NN
cord-015365-iqdi99pd	1223	3	was	be	VBD
cord-015365-iqdi99pd	1223	4	28.6	28.6	CD
cord-015365-iqdi99pd	1223	5	%	%	NN
cord-015365-iqdi99pd	1223	6	,	,	,
cord-015365-iqdi99pd	1223	7	infection	infection	NN
cord-015365-iqdi99pd	1223	8	rate	rate	NN
cord-015365-iqdi99pd	1223	9	64	64	CD
cord-015365-iqdi99pd	1223	10	%	%	NN
cord-015365-iqdi99pd	1223	11	and	and	CC
cord-015365-iqdi99pd	1223	12	surgical	surgical	JJ
cord-015365-iqdi99pd	1223	13	complication	complication	NN
cord-015365-iqdi99pd	1223	14	rate	rate	NN
cord-015365-iqdi99pd	1223	15	50	50	CD
cord-015365-iqdi99pd	1223	16	%	%	NN
cord-015365-iqdi99pd	1223	17	.	.	.
cord-015365-iqdi99pd	1224	1	Median	median	JJ
cord-015365-iqdi99pd	1224	2	serum	serum	NN
cord-015365-iqdi99pd	1224	3	creatinine	creatinine	NN
cord-015365-iqdi99pd	1224	4	at	at	IN
cord-015365-iqdi99pd	1224	5	5	5	CD
cord-015365-iqdi99pd	1224	6	years	year	NNS
cord-015365-iqdi99pd	1224	7	follow	follow	VBP
cord-015365-iqdi99pd	1224	8	up	up	RP
cord-015365-iqdi99pd	1224	9	was	be	VBD
cord-015365-iqdi99pd	1224	10	1.3	1.3	CD
cord-015365-iqdi99pd	1225	1	(	(	-LRB-
cord-015365-iqdi99pd	1225	2	range	range	VBP
cord-015365-iqdi99pd	1225	3	0.9	0.9	CD
cord-015365-iqdi99pd	1225	4	-	-	SYM
cord-015365-iqdi99pd	1225	5	3.6	3.6	CD
cord-015365-iqdi99pd	1225	6	)	)	-RRB-
cord-015365-iqdi99pd	1226	1	mg	mg	NNP
cord-015365-iqdi99pd	1226	2	/	/	SYM
cord-015365-iqdi99pd	1226	3	dl	dl	NNP
cord-015365-iqdi99pd	1226	4	and	and	CC
cord-015365-iqdi99pd	1226	5	HbA1c	HbA1c	NNP
cord-015365-iqdi99pd	1226	6	was	be	VBD
cord-015365-iqdi99pd	1226	7	median	median	JJ
cord-015365-iqdi99pd	1226	8	3.2	3.2	CD
cord-015365-iqdi99pd	1227	1	(	(	-LRB-
cord-015365-iqdi99pd	1227	2	range	range	VBP
cord-015365-iqdi99pd	1227	3	0.9	0.9	CD
cord-015365-iqdi99pd	1227	4	-	-	HYPH
cord-015365-iqdi99pd	1227	5	6.1)%	6.1)%	NNP
cord-015365-iqdi99pd	1227	6	.	.	.
cord-015365-iqdi99pd	1228	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1228	2	.	.	.
cord-015365-iqdi99pd	1229	1	Pancreas	pancreas	NN
cord-015365-iqdi99pd	1229	2	transplantation	transplantation	NN
cord-015365-iqdi99pd	1229	3	seems	seem	VBZ
cord-015365-iqdi99pd	1229	4	to	to	TO
cord-015365-iqdi99pd	1229	5	be	be	VB
cord-015365-iqdi99pd	1229	6	a	a	DT
cord-015365-iqdi99pd	1229	7	good	good	JJ
cord-015365-iqdi99pd	1229	8	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1229	9	option	option	NN
cord-015365-iqdi99pd	1229	10	of	of	IN
cord-015365-iqdi99pd	1229	11	selected	select	VBN
cord-015365-iqdi99pd	1229	12	patients	patient	NNS
cord-015365-iqdi99pd	1229	13	with	with	IN
cord-015365-iqdi99pd	1229	14	type	type	NN
cord-015365-iqdi99pd	1229	15	II	ii	CD
cord-015365-iqdi99pd	1229	16	DM	dm	NN
cord-015365-iqdi99pd	1229	17	.	.	.
cord-015365-iqdi99pd	1230	1	Due	due	IN
cord-015365-iqdi99pd	1230	2	to	to	IN
cord-015365-iqdi99pd	1230	3	the	the	DT
cord-015365-iqdi99pd	1230	4	fact	fact	NN
cord-015365-iqdi99pd	1230	5	that	that	IN
cord-015365-iqdi99pd	1230	6	these	these	DT
cord-015365-iqdi99pd	1230	7	patients	patient	NNS
cord-015365-iqdi99pd	1230	8	are	be	VBP
cord-015365-iqdi99pd	1230	9	older	old	JJR
cord-015365-iqdi99pd	1230	10	than	than	IN
cord-015365-iqdi99pd	1230	11	their	-PRON-	PRP$
cord-015365-iqdi99pd	1230	12	counterparts	counterpart	NNS
cord-015365-iqdi99pd	1230	13	with	with	IN
cord-015365-iqdi99pd	1230	14	type	type	NN
cord-015365-iqdi99pd	1230	15	I	-PRON-	PRP
cord-015365-iqdi99pd	1230	16	DM	dm	VBP
cord-015365-iqdi99pd	1230	17	and	and	CC
cord-015365-iqdi99pd	1230	18	the	the	DT
cord-015365-iqdi99pd	1230	19	fact	fact	NN
cord-015365-iqdi99pd	1230	20	that	that	IN
cord-015365-iqdi99pd	1230	21	we	-PRON-	PRP
cord-015365-iqdi99pd	1230	22	found	find	VBD
cord-015365-iqdi99pd	1230	23	these	these	DT
cord-015365-iqdi99pd	1230	24	patients	patient	NNS
cord-015365-iqdi99pd	1230	25	to	to	TO
cord-015365-iqdi99pd	1230	26	have	have	VB
cord-015365-iqdi99pd	1230	27	a	a	DT
cord-015365-iqdi99pd	1230	28	high	high	JJ
cord-015365-iqdi99pd	1230	29	infection	infection	NN
cord-015365-iqdi99pd	1230	30	rate	rate	NN
cord-015365-iqdi99pd	1230	31	,	,	,
cord-015365-iqdi99pd	1230	32	less	less	RBR
cord-015365-iqdi99pd	1230	33	intensive	intensive	JJ
cord-015365-iqdi99pd	1230	34	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	1230	35	regimens	regimen	NNS
cord-015365-iqdi99pd	1230	36	are	be	VBP
cord-015365-iqdi99pd	1230	37	recommended	recommend	VBN
cord-015365-iqdi99pd	1230	38	.	.	.
cord-015365-iqdi99pd	1231	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	1231	2	.	.	.
cord-015365-iqdi99pd	1232	1	Von	Von	NNP
cord-015365-iqdi99pd	1232	2	allen	allen	NNP
cord-015365-iqdi99pd	1233	1	1064	1064	CD
cord-015365-iqdi99pd	1233	2	Nierentransplantierten	Nierentransplantierten	NNP
cord-015365-iqdi99pd	1233	3	waren	waren	VBD
cord-015365-iqdi99pd	1233	4	132	132	CD
cord-015365-iqdi99pd	1234	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1234	2	(	(	-LRB-
cord-015365-iqdi99pd	1234	3	12	12	CD
cord-015365-iqdi99pd	1234	4	%	%	NN
cord-015365-iqdi99pd	1234	5	)	)	-RRB-
cord-015365-iqdi99pd	1235	1	Typ-1-oder	Typ-1-oder	NNP
cord-015365-iqdi99pd	1235	2	Typ-2-Diabetiker	typ-2-diabetiker	NN
cord-015365-iqdi99pd	1235	3	und	und	NNP
cord-015365-iqdi99pd	1235	4	hatten	hatten	NNP
cord-015365-iqdi99pd	1236	1	113	113	CD
cord-015365-iqdi99pd	1236	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1236	3	(	(	-LRB-
cord-015365-iqdi99pd	1236	4	11	11	CD
cord-015365-iqdi99pd	1236	5	%	%	NN
cord-015365-iqdi99pd	1236	6	)	)	-RRB-
cord-015365-iqdi99pd	1236	7	bereits	bereits	NNP
cord-015365-iqdi99pd	1236	8	PTDM	PTDM	NNP
cord-015365-iqdi99pd	1236	9	.	.	.
cord-015365-iqdi99pd	1237	1	Aus	Aus	NNP
cord-015365-iqdi99pd	1237	2	n	n	NNP
cord-015365-iqdi99pd	1237	3	¼	¼	NNP
cord-015365-iqdi99pd	1237	4	307	307	CD
cord-015365-iqdi99pd	1237	5	OGTTs	OGTTs	NNP
cord-015365-iqdi99pd	1237	6	ergab	ergab	NNP
cord-015365-iqdi99pd	1237	7	sich	sich	NNP
cord-015365-iqdi99pd	1237	8	PTDM	PTDM	NNP
cord-015365-iqdi99pd	1237	9	bei	bei	NNP
cord-015365-iqdi99pd	1237	10	29	29	CD
cord-015365-iqdi99pd	1238	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1238	2	(	(	-LRB-
cord-015365-iqdi99pd	1238	3	9	9	CD
cord-015365-iqdi99pd	1238	4	%	%	NN
cord-015365-iqdi99pd	1238	5	)	)	-RRB-
cord-015365-iqdi99pd	1239	1	und	und	IN
cord-015365-iqdi99pd	1239	2	IGT	IGT	NNP
cord-015365-iqdi99pd	1239	3	bei	bei	NNP
cord-015365-iqdi99pd	1239	4	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1239	5	62	62	CD
cord-015365-iqdi99pd	1239	6	(	(	-LRB-
cord-015365-iqdi99pd	1239	7	20	20	CD
cord-015365-iqdi99pd	1239	8	%	%	NN
cord-015365-iqdi99pd	1239	9	)	)	-RRB-
cord-015365-iqdi99pd	1239	10	.	.	.
cord-015365-iqdi99pd	1240	1	Signifikante	Signifikante	NNP
cord-015365-iqdi99pd	1240	2	Prädiktoren	Prädiktoren	NNP
cord-015365-iqdi99pd	1240	3	für	für	IN
cord-015365-iqdi99pd	1240	4	PTDM	PTDM	NNP
cord-015365-iqdi99pd	1241	1	und	und	NNP
cord-015365-iqdi99pd	1241	2	/	/	SYM
cord-015365-iqdi99pd	1241	3	oder	oder	NNP
cord-015365-iqdi99pd	1241	4	IGT	IGT	NNP
cord-015365-iqdi99pd	1241	5	beinhalteten	beinhalteten	NNP
cord-015365-iqdi99pd	1241	6	höheres	höheres	NNP
cord-015365-iqdi99pd	1242	1	Lebensalter	Lebensalter	NNP
cord-015365-iqdi99pd	1242	2	,	,	,
cord-015365-iqdi99pd	1242	3	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	1242	4	mit	mit	NNP
cord-015365-iqdi99pd	1242	5	Tacrolimus	Tacrolimus	NNP
cord-015365-iqdi99pd	1242	6	,	,	,
cord-015365-iqdi99pd	1242	7	höheres	höheres	NNP
cord-015365-iqdi99pd	1243	1	C	C	NNP
cord-015365-iqdi99pd	1243	2	-	-	HYPH
cord-015365-iqdi99pd	1243	3	reaktives	reaktive	NNS
cord-015365-iqdi99pd	1243	4	Protein	Protein	NNP
cord-015365-iqdi99pd	1243	5	und	und	XX
cord-015365-iqdi99pd	1244	1	niedrigeres	niedrigeres	NNP
cord-015365-iqdi99pd	1244	2	Serum	Serum	NNP
cord-015365-iqdi99pd	1244	3	-	-	HYPH
cord-015365-iqdi99pd	1244	4	Albumin	Albumin	NNP
cord-015365-iqdi99pd	1244	5	.	.	.
cord-015365-iqdi99pd	1245	1	OGTTs	OGTTs	NNP
cord-015365-iqdi99pd	1245	2	mit	mit	NNP
cord-015365-iqdi99pd	1245	3	Bestimmung	Bestimmung	NNP
cord-015365-iqdi99pd	1245	4	von	von	NNP
cord-015365-iqdi99pd	1245	5	Insulin	Insulin	NNP
cord-015365-iqdi99pd	1246	1	und	und	IN
cord-015365-iqdi99pd	1246	2	C	C	NNP
cord-015365-iqdi99pd	1246	3	-	-	HYPH
cord-015365-iqdi99pd	1246	4	Peptid	Peptid	NNP
cord-015365-iqdi99pd	1246	5	(	(	-LRB-
cord-015365-iqdi99pd	1246	6	n	n	CC
cord-015365-iqdi99pd	1246	7	¼	¼	NNP
cord-015365-iqdi99pd	1246	8	105	105	CD
cord-015365-iqdi99pd	1246	9	)	)	-RRB-
cord-015365-iqdi99pd	1247	1	zeigten	zeigten	NNP
cord-015365-iqdi99pd	1248	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1248	2	m	be	VBP
cord-015365-iqdi99pd	1248	3	Vergleich	Vergleich	NNP
cord-015365-iqdi99pd	1248	4	mit	mit	NNP
cord-015365-iqdi99pd	1249	1	1357	1357	CD
cord-015365-iqdi99pd	1250	1	OGTTs	OGTTs	NNP
cord-015365-iqdi99pd	1250	2	nicht	nicht	NNP
cord-015365-iqdi99pd	1250	3	-	-	HYPH
cord-015365-iqdi99pd	1250	4	transplantierter	transplantierter	NNP
cord-015365-iqdi99pd	1251	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1252	1	(	(	-LRB-
cord-015365-iqdi99pd	1252	2	Datensatz	Datensatz	NNP
cord-015365-iqdi99pd	1252	3	G.	G.	NNP
cord-015365-iqdi99pd	1252	4	Pacini	Pacini	NNP
cord-015365-iqdi99pd	1252	5	)	)	-RRB-
cord-015365-iqdi99pd	1253	1	eine	eine	NNP
cord-015365-iqdi99pd	1254	1	erhöhte	erhöhte	NNP
cord-015365-iqdi99pd	1254	2	Insulinsensitivität	Insulinsensitivität	NNP
cord-015365-iqdi99pd	1254	3	(	(	-LRB-
cord-015365-iqdi99pd	1254	4	OGIS	OGIS	NNP
cord-015365-iqdi99pd	1254	5	:	:	:
cord-015365-iqdi99pd	1255	1	414AE	414AE	VBN
cord-015365-iqdi99pd	1255	2	67	67	CD
cord-015365-iqdi99pd	1255	3	vs.	vs.	IN
cord-015365-iqdi99pd	1255	4	316AE	316AE	NNP
cord-015365-iqdi99pd	1255	5	53	53	CD
cord-015365-iqdi99pd	1256	1	mLÂmin	mLÂmin	NFP
cord-015365-iqdi99pd	1256	2	-1	-1	.
cord-015365-iqdi99pd	1257	1	Âm	âm	XX
cord-015365-iqdi99pd	1258	1	-2	-2	LS
cord-015365-iqdi99pd	1258	2	;	;	:
cord-015365-iqdi99pd	1258	3	ISIcomp	ISIcomp	NNP
cord-015365-iqdi99pd	1258	4	:	:	:
cord-015365-iqdi99pd	1259	1	6,6	6,6	CD
cord-015365-iqdi99pd	1259	2	AE	AE	NNP
cord-015365-iqdi99pd	1259	3	4,5	4,5	CD
cord-015365-iqdi99pd	1259	4	vs.	vs.	NN
cord-015365-iqdi99pd	1259	5	3,9AE	3,9ae	CD
cord-015365-iqdi99pd	1259	6	2,4	2,4	CD
cord-015365-iqdi99pd	1259	7	,	,	,
cord-015365-iqdi99pd	1260	1	beide	beide	NNP
cord-015365-iqdi99pd	1260	2	p	p	NN
cord-015365-iqdi99pd	1260	3	<	<	XX
cord-015365-iqdi99pd	1260	4	0,001	0,001	CD
cord-015365-iqdi99pd	1260	5	)	)	-RRB-
cord-015365-iqdi99pd	1260	6	.	.	.
cord-015365-iqdi99pd	1261	1	Diese	Diese	NNP
cord-015365-iqdi99pd	1261	2	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	1261	3	waren	waren	VBD
cord-015365-iqdi99pd	1261	4	in	in	IN
cord-015365-iqdi99pd	1261	5	Sensitivitäts	Sensitivitäts	NNP
cord-015365-iqdi99pd	1261	6	-	-	HYPH
cord-015365-iqdi99pd	1261	7	Analysen	Analysen	NNP
cord-015365-iqdi99pd	1261	8	gematchter	gematchter	NN
cord-015365-iqdi99pd	1261	9	OGTTs	ogtt	NNS
cord-015365-iqdi99pd	1261	10	(	(	-LRB-
cord-015365-iqdi99pd	1261	11	nach	nach	NNP
cord-015365-iqdi99pd	1261	12	Alter	Alter	NNP
cord-015365-iqdi99pd	1261	13	,	,	,
cord-015365-iqdi99pd	1261	14	BMI	BMI	NNP
cord-015365-iqdi99pd	1261	15	,	,	,
cord-015365-iqdi99pd	1261	16	Geschlecht	Geschlecht	NNP
cord-015365-iqdi99pd	1261	17	,	,	,
cord-015365-iqdi99pd	1261	18	2h	2h	CD
cord-015365-iqdi99pd	1261	19	-	-	:
cord-015365-iqdi99pd	1261	20	Blutzucker	Blutzucker	NNP
cord-015365-iqdi99pd	1261	21	i	-PRON-	PRP
cord-015365-iqdi99pd	1261	22	m	be	VBP
cord-015365-iqdi99pd	1261	23	OGTT	OGTT	NNP
cord-015365-iqdi99pd	1261	24	)	)	-RRB-
cord-015365-iqdi99pd	1261	25	konsistent	konsistent	NNP
cord-015365-iqdi99pd	1261	26	,	,	,
cord-015365-iqdi99pd	1261	27	des	des	NNP
cord-015365-iqdi99pd	1261	28	weiteren	weiteren	NNP
cord-015365-iqdi99pd	1261	29	hatten	hatten	NNP
cord-015365-iqdi99pd	1262	1	Nierentransplantierte	Nierentransplantierte	NNP
cord-015365-iqdi99pd	1262	2	mit	mit	NNP
cord-015365-iqdi99pd	1262	3	Normoglykämie	Normoglykämie	NNP
cord-015365-iqdi99pd	1262	4	(	(	-LRB-
cord-015365-iqdi99pd	1262	5	2h	2h	NNP
cord-015365-iqdi99pd	1262	6	-	-	HYPH
cord-015365-iqdi99pd	1262	7	Blutzucker	Blutzucker	NNP
cord-015365-iqdi99pd	1263	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1263	2	m	be	VBP
cord-015365-iqdi99pd	1263	3	OGTT	OGTT	NNP
cord-015365-iqdi99pd	1264	1	<	<	XX
cord-015365-iqdi99pd	1264	2	140	140	CD
cord-015365-iqdi99pd	1265	1	mg	mg	NNP
cord-015365-iqdi99pd	1265	2	/	/	SYM
cord-015365-iqdi99pd	1265	3	dL	dl	NN
cord-015365-iqdi99pd	1265	4	)	)	-RRB-
cord-015365-iqdi99pd	1265	5	ebenso	ebenso	NNP
cord-015365-iqdi99pd	1265	6	wie	wie	NNP
cord-015365-iqdi99pd	1265	7	mit	mit	NNP
cord-015365-iqdi99pd	1265	8	Hyperglykämie	Hyperglykämie	NNP
cord-015365-iqdi99pd	1265	9	(	(	-LRB-
cord-015365-iqdi99pd	1265	10	2h	2h	NNP
cord-015365-iqdi99pd	1265	11	-	-	HYPH
cord-015365-iqdi99pd	1265	12	Blutzucker	Blutzucker	NNP
cord-015365-iqdi99pd	1266	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1266	2	m	be	VBP
cord-015365-iqdi99pd	1266	3	OGTT	OGTT	NNP
cord-015365-iqdi99pd	1266	4	140	140	CD
cord-015365-iqdi99pd	1266	5	-	-	SYM
cord-015365-iqdi99pd	1266	6	199	199	CD
cord-015365-iqdi99pd	1267	1	mg	mg	NNP
cord-015365-iqdi99pd	1267	2	/	/	SYM
cord-015365-iqdi99pd	1267	3	dl	dl	NNP
cord-015365-iqdi99pd	1267	4	bzw	bzw	NNP
cord-015365-iqdi99pd	1267	5	.	.	.
cord-015365-iqdi99pd	1268	1	>	>	XX
cord-015365-iqdi99pd	1269	1	200	200	CD
cord-015365-iqdi99pd	1269	2	mg/	mg/	NN
cord-015365-iqdi99pd	1269	3	dL	dl	NN
cord-015365-iqdi99pd	1269	4	)	)	-RRB-
cord-015365-iqdi99pd	1270	1	signifikant	signifikant	NNP
cord-015365-iqdi99pd	1270	2	bessere	bessere	NNP
cord-015365-iqdi99pd	1270	3	Insulinsensitivität	Insulinsensitivität	NNP
cord-015365-iqdi99pd	1270	4	als	als	NN
cord-015365-iqdi99pd	1270	5	die	die	VBP
cord-015365-iqdi99pd	1270	6	Normalbevölkerung	Normalbevölkerung	NNP
cord-015365-iqdi99pd	1270	7	ohne	ohne	NNP
cord-015365-iqdi99pd	1270	8	oder	oder	NNP
cord-015365-iqdi99pd	1270	9	mit	mit	NNP
cord-015365-iqdi99pd	1270	10	IGT	IGT	NNP
cord-015365-iqdi99pd	1270	11	bzw	bzw	NNP
cord-015365-iqdi99pd	1270	12	.	.	.
cord-015365-iqdi99pd	1271	1	Typ-2-Diabetes	Typ-2-Diabetes	NNP
cord-015365-iqdi99pd	1271	2	.	.	.
cord-015365-iqdi99pd	1272	1	Die	die	VB
cord-015365-iqdi99pd	1272	2	Regressions	regression	NNS
cord-015365-iqdi99pd	1272	3	-	-	HYPH
cord-015365-iqdi99pd	1272	4	Kurven	Kurven	NNP
cord-015365-iqdi99pd	1272	5	der	der	NNP
cord-015365-iqdi99pd	1272	6	Insulin	Insulin	NNP
cord-015365-iqdi99pd	1272	7	-	-	HYPH
cord-015365-iqdi99pd	1272	8	Ausschüttung	Ausschüttung	NNP
cord-015365-iqdi99pd	1272	9	und	und	IN
cord-015365-iqdi99pd	1272	10	des	des	NNP
cord-015365-iqdi99pd	1272	11	insulinogenen	insulinogenen	NNP
cord-015365-iqdi99pd	1272	12	Index	Index	NNP
cord-015365-iqdi99pd	1272	13	,	,	,
cord-015365-iqdi99pd	1272	14	aufgetragen	aufgetragen	NNP
cord-015365-iqdi99pd	1272	15	gegen	gegen	NNP
cord-015365-iqdi99pd	1272	16	den	den	NNP
cord-015365-iqdi99pd	1272	17	2h	2h	NNP
cord-015365-iqdi99pd	1272	18	-	-	HYPH
cord-015365-iqdi99pd	1272	19	Blutzucker	Blutzucker	NNP
cord-015365-iqdi99pd	1273	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1273	2	m	be	VBP
cord-015365-iqdi99pd	1273	3	OGTT	OGTT	NNP
cord-015365-iqdi99pd	1273	4	,	,	,
cord-015365-iqdi99pd	1273	5	wiesen	wiesen	NNP
cord-015365-iqdi99pd	1273	6	zwischen	zwischen	NNP
cord-015365-iqdi99pd	1273	7	Transplantierten	Transplantierten	NNP
cord-015365-iqdi99pd	1273	8	und	und	IN
cord-015365-iqdi99pd	1274	1	Nicht	Nicht	NNP
cord-015365-iqdi99pd	1274	2	-	-	HYPH
cord-015365-iqdi99pd	1274	3	Transplantierten	Transplantierten	NNP
cord-015365-iqdi99pd	1274	4	eindeutige	eindeutige	VBZ
cord-015365-iqdi99pd	1274	5	Unterschiede	Unterschiede	NNP
cord-015365-iqdi99pd	1274	6	auf	auf	NNP
cord-015365-iqdi99pd	1274	7	,	,	,
cord-015365-iqdi99pd	1274	8	mit	mit	NNP
cord-015365-iqdi99pd	1274	9	besonders	besonders	NNP
cord-015365-iqdi99pd	1274	10	starkem	starkem	NNP
cord-015365-iqdi99pd	1274	11	Abfall	Abfall	NNP
cord-015365-iqdi99pd	1274	12	der	der	NNP
cord-015365-iqdi99pd	1274	13	Insulinsekretion	Insulinsekretion	NNP
cord-015365-iqdi99pd	1274	14	bei	bei	NNP
cord-015365-iqdi99pd	1274	15	Nierentransplantierten	Nierentransplantierten	NNP
cord-015365-iqdi99pd	1275	1	mit	mit	NNP
cord-015365-iqdi99pd	1275	2	2h	2h	NNP
cord-015365-iqdi99pd	1275	3	-	-	HYPH
cord-015365-iqdi99pd	1275	4	Blutzucker	Blutzucker	NNP
cord-015365-iqdi99pd	1275	5	-	-	HYPH
cord-015365-iqdi99pd	1275	6	Werten	Werten	NNP
cord-015365-iqdi99pd	1276	1	>	>	XX
cord-015365-iqdi99pd	1277	1	200	200	CD
cord-015365-iqdi99pd	1277	2	mg	mg	NNP
cord-015365-iqdi99pd	1277	3	/	/	SYM
cord-015365-iqdi99pd	1277	4	dL	dl	NN
cord-015365-iqdi99pd	1278	1	(	(	-LRB-
cord-015365-iqdi99pd	1278	2	Insulin	insulin	NN
cord-015365-iqdi99pd	1278	3	-	-	HYPH
cord-015365-iqdi99pd	1278	4	area	area	NN
cord-015365-iqdi99pd	1278	5	under	under	IN
cord-015365-iqdi99pd	1278	6	the	the	DT
cord-015365-iqdi99pd	1278	7	curve	curve	NN
cord-015365-iqdi99pd	1279	1	(	(	-LRB-
cord-015365-iqdi99pd	1279	2	AUC	AUC	NNP
cord-015365-iqdi99pd	1279	3	)	)	-RRB-
cord-015365-iqdi99pd	1279	4	3,4	3,4	CD
cord-015365-iqdi99pd	1279	5	AE	AE	NNP
cord-015365-iqdi99pd	1279	6	1,9	1,9	CD
cord-015365-iqdi99pd	1279	7	vs.	vs.	NN
cord-015365-iqdi99pd	1279	8	6,1	6,1	CD
cord-015365-iqdi99pd	1280	1	AE	AE	NNP
cord-015365-iqdi99pd	1280	2	3,4	3,4	CD
cord-015365-iqdi99pd	1281	1	mU	mU	NNP
cord-015365-iqdi99pd	1281	2	/	/	SYM
cord-015365-iqdi99pd	1281	3	mL	mL	NNP
cord-015365-iqdi99pd	1281	4	2h	2h	NN
cord-015365-iqdi99pd	1281	5	,	,	,
cord-015365-iqdi99pd	1281	6	p	p	NN
cord-015365-iqdi99pd	1281	7	¼	¼	NNP
cord-015365-iqdi99pd	1281	8	0,002	0,002	CD
cord-015365-iqdi99pd	1281	9	)	)	-RRB-
cord-015365-iqdi99pd	1281	10	.	.	.
cord-015365-iqdi99pd	1282	1	Eine	Eine	NNP
cord-015365-iqdi99pd	1282	2	Validierung	Validierung	NNP
cord-015365-iqdi99pd	1282	3	aller	aller	NNP
cord-015365-iqdi99pd	1282	4	verwendeter	verwendeter	NN
cord-015365-iqdi99pd	1283	1	OGTT	OGTT	NNP
cord-015365-iqdi99pd	1283	2	-	-	HYPH
cord-015365-iqdi99pd	1283	3	Indizes	Indizes	NNP
cord-015365-iqdi99pd	1283	4	erfolgte	erfolgte	NN
cord-015365-iqdi99pd	1284	1	anhand	anhand	NNP
cord-015365-iqdi99pd	1284	2	23	23	CD
cord-015365-iqdi99pd	1285	1	euglykämisch	euglykämisch	NNP
cord-015365-iqdi99pd	1285	2	-	-	HYPH
cord-015365-iqdi99pd	1285	3	hyperinsulinämischer	hyperinsulinämischer	NNP
cord-015365-iqdi99pd	1285	4	Clamps	Clamps	NNP
cord-015365-iqdi99pd	1285	5	.	.	.
cord-015365-iqdi99pd	1286	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	1286	2	.	.	.
cord-015365-iqdi99pd	1287	1	Insulin	Insulin	NNP
cord-015365-iqdi99pd	1287	2	-	-	HYPH
cord-015365-iqdi99pd	1287	3	Sekretionsverlust	Sekretionsverlust	NNP
cord-015365-iqdi99pd	1287	4	könnte	könnte	FW
cord-015365-iqdi99pd	1287	5	das	das	NNP
cord-015365-iqdi99pd	1287	6	dominante	dominante	NNP
cord-015365-iqdi99pd	1287	7	Problem	Problem	NNP
cord-015365-iqdi99pd	1287	8	bei	bei	NNP
cord-015365-iqdi99pd	1287	9	der	der	NNP
cord-015365-iqdi99pd	1287	10	Entwicklung	Entwicklung	NNP
cord-015365-iqdi99pd	1287	11	eines	eine	NNS
cord-015365-iqdi99pd	1288	1	PTDM	PTDM	NNP
cord-015365-iqdi99pd	1288	2	nach	nach	NNP
cord-015365-iqdi99pd	1288	3	Nierentransplantation	Nierentransplantation	NNP
cord-015365-iqdi99pd	1288	4	sein	sein	NNP
cord-015365-iqdi99pd	1288	5	und	und	NNP
cord-015365-iqdi99pd	1288	6	verlangt	verlangt	NNP
cord-015365-iqdi99pd	1289	1	nach	nach	NNP
cord-015365-iqdi99pd	1289	2	therapeutischen	therapeutischen	NNP
cord-015365-iqdi99pd	1289	3	Strategien	Strategien	NNP
cord-015365-iqdi99pd	1289	4	zum	zum	NNP
cord-015365-iqdi99pd	1289	5	Schutz	Schutz	NNP
cord-015365-iqdi99pd	1289	6	der	der	NNP
cord-015365-iqdi99pd	1289	7	Betazellen	Betazellen	NNP
cord-015365-iqdi99pd	1289	8	.	.	.
cord-015365-iqdi99pd	1290	1	Hämoglobinvariabilität	Hämoglobinvariabilität	NNP
cord-015365-iqdi99pd	1290	2	ist	ist	NN
cord-015365-iqdi99pd	1290	3	assoziiert	assoziiert	NN
cord-015365-iqdi99pd	1290	4	mit	mit	NNP
cord-015365-iqdi99pd	1290	5	Mortalität	Mortalität	NNP
cord-015365-iqdi99pd	1290	6	nach	nach	NNP
cord-015365-iqdi99pd	1290	7	Nierentransplantation	Nierentransplantation	NNP
cord-015365-iqdi99pd	1290	8	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	1290	9	.	.	.
cord-015365-iqdi99pd	1291	1	Die	die	VB
cord-015365-iqdi99pd	1291	2	Hazard	Hazard	NNP
cord-015365-iqdi99pd	1291	3	Ratio	Ratio	NNP
cord-015365-iqdi99pd	1291	4	(	(	-LRB-
cord-015365-iqdi99pd	1291	5	HR	HR	NNP
cord-015365-iqdi99pd	1291	6	)	)	-RRB-
cord-015365-iqdi99pd	1292	1	fü	fü	IN
cord-015365-iqdi99pd	1293	1	r	r	NNP
cord-015365-iqdi99pd	1293	2	Mortalität	Mortalität	NNP
cord-015365-iqdi99pd	1293	3	und	und	XX
cord-015365-iqdi99pd	1294	1	Transplantatversagen	Transplantatversagen	NNP
cord-015365-iqdi99pd	1294	2	stieg	stieg	NNP
cord-015365-iqdi99pd	1294	3	signifikant	signifikant	NNP
cord-015365-iqdi99pd	1294	4	mit	mit	NNP
cord-015365-iqdi99pd	1294	5	der	der	NNP
cord-015365-iqdi99pd	1294	6	Hämoglobinvariabilität	Hämoglobinvariabilität	NNP
cord-015365-iqdi99pd	1295	1	an	an	DT
cord-015365-iqdi99pd	1295	2	.	.	.
cord-015365-iqdi99pd	1296	1	I	-PRON-	PRP
cord-015365-iqdi99pd	1296	2	m	be	VBP
cord-015365-iqdi99pd	1296	3	linearen	linearen	NNP
cord-015365-iqdi99pd	1296	4	Modell	Modell	NNP
cord-015365-iqdi99pd	1296	5	betrug	betrug	NNP
cord-015365-iqdi99pd	1296	6	der	der	NNP
cord-015365-iqdi99pd	1296	7	Anstieg	Anstieg	NNP
cord-015365-iqdi99pd	1297	1	fü	fü	TO
cord-015365-iqdi99pd	1297	2	r	r	LS
cord-015365-iqdi99pd	1297	3	die	die	VB
cord-015365-iqdi99pd	1298	1	Mortalität	Mortalität	NNS
cord-015365-iqdi99pd	1298	2	2,35	2,35	CD
cord-015365-iqdi99pd	1299	1	(	(	-LRB-
cord-015365-iqdi99pd	1299	2	95	95	CD
cord-015365-iqdi99pd	1299	3	%	%	NN
cord-015365-iqdi99pd	1300	1	Konfidenzintervall	Konfidenzintervall	NNP
cord-015365-iqdi99pd	1300	2	1,75	1,75	CD
cord-015365-iqdi99pd	1300	3	-	-	HYPH
cord-015365-iqdi99pd	1300	4	3,17	3,17	NN
cord-015365-iqdi99pd	1300	5	;	;	:
cord-015365-iqdi99pd	1300	6	p	p	NN
cord-015365-iqdi99pd	1300	7	<	<	XX
cord-015365-iqdi99pd	1300	8	0,001	0,001	CD
cord-015365-iqdi99pd	1300	9	)	)	-RRB-
cord-015365-iqdi99pd	1300	10	,	,	,
cord-015365-iqdi99pd	1300	11	fü	fü	IN
cord-015365-iqdi99pd	1300	12	r	r	NN
cord-015365-iqdi99pd	1300	13	das	das	NNP
cord-015365-iqdi99pd	1300	14	funktionelle	funktionelle	NNP
cord-015365-iqdi99pd	1301	1	Transplantatversagen	Transplantatversagen	NNP
cord-015365-iqdi99pd	1301	2	2,45	2,45	CD
cord-015365-iqdi99pd	1301	3	(	(	-LRB-
cord-015365-iqdi99pd	1301	4	1,76	1,76	CD
cord-015365-iqdi99pd	1301	5	-	-	HYPH
cord-015365-iqdi99pd	1301	6	3,40	3,40	CD
cord-015365-iqdi99pd	1301	7	;	;	.
cord-015365-iqdi99pd	1302	1	p	p	LS
cord-015365-iqdi99pd	1302	2	<	<	XX
cord-015365-iqdi99pd	1302	3	0,001	0,001	CD
cord-015365-iqdi99pd	1302	4	)	)	-RRB-
cord-015365-iqdi99pd	1302	5	.	.	.
cord-015365-iqdi99pd	1303	1	In	in	IN
cord-015365-iqdi99pd	1303	2	einem	einem	NNP
cord-015365-iqdi99pd	1303	3	klinischen	klinischen	FW
cord-015365-iqdi99pd	1303	4	Expertenmodell	Expertenmodell	NNP
cord-015365-iqdi99pd	1303	5	,	,	,
cord-015365-iqdi99pd	1303	6	das	das	NNP
cord-015365-iqdi99pd	1303	7	fü	fü	IN
cord-015365-iqdi99pd	1303	8	r	r	NN
cord-015365-iqdi99pd	1303	9	die	die	VB
cord-015365-iqdi99pd	1303	10	Verwendung	Verwendung	NNP
cord-015365-iqdi99pd	1303	11	von	von	NNP
cord-015365-iqdi99pd	1303	12	ESA	ESA	NNP
cord-015365-iqdi99pd	1303	13	,	,	,
cord-015365-iqdi99pd	1303	14	Hämoglobin	Hämoglobin	NNP
cord-015365-iqdi99pd	1303	15	,	,	,
cord-015365-iqdi99pd	1303	16	Alter	Alter	NNP
cord-015365-iqdi99pd	1303	17	bei	bei	NNP
cord-015365-iqdi99pd	1303	18	der	der	NNP
cord-015365-iqdi99pd	1303	19	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	1303	20	,	,	,
cord-015365-iqdi99pd	1303	21	Diabetes	diabetes	NN
cord-015365-iqdi99pd	1303	22	,	,	,
cord-015365-iqdi99pd	1303	23	Tage	Tage	NNP
cord-015365-iqdi99pd	1303	24	an	an	DT
cord-015365-iqdi99pd	1303	25	der	der	NN
cord-015365-iqdi99pd	1303	26	Dialyse	Dialyse	NNP
cord-015365-iqdi99pd	1303	27	,	,	,
cord-015365-iqdi99pd	1303	28	glomeruläre	glomeruläre	NNP
cord-015365-iqdi99pd	1303	29	Filtrationsrate	Filtrationsrate	NNP
cord-015365-iqdi99pd	1303	30	,	,	,
cord-015365-iqdi99pd	1303	31	Abstoßung	Abstoßung	NNP
cord-015365-iqdi99pd	1303	32	und	und	IN
cord-015365-iqdi99pd	1303	33	Jahr	Jahr	NNP
cord-015365-iqdi99pd	1303	34	der	der	NNP
cord-015365-iqdi99pd	1303	35	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	1303	36	adjustiert	adjustiert	NN
cord-015365-iqdi99pd	1303	37	wurde	wurde	NN
cord-015365-iqdi99pd	1303	38	,	,	,
cord-015365-iqdi99pd	1303	39	war	war	NN
cord-015365-iqdi99pd	1304	1	die	die	VB
cord-015365-iqdi99pd	1305	1	Hämoglobinvariabilität	Hämoglobinvariabilität	NNP
cord-015365-iqdi99pd	1305	2	mit	mit	VBP
cord-015365-iqdi99pd	1305	3	der	der	NNP
cord-015365-iqdi99pd	1305	4	Mortalität	Mortalität	NNP
cord-015365-iqdi99pd	1305	5	assoziiert	assoziiert	NN
cord-015365-iqdi99pd	1305	6	(	(	-LRB-
cord-015365-iqdi99pd	1305	7	HR	hr	NN
cord-015365-iqdi99pd	1305	8	:	:	:
cord-015365-iqdi99pd	1305	9	2,11	2,11	CD
cord-015365-iqdi99pd	1305	10	;	;	.
cord-015365-iqdi99pd	1306	1	1,51	1,51	CD
cord-015365-iqdi99pd	1306	2	-	-	HYPH
cord-015365-iqdi99pd	1306	3	2,94	2,94	CD
cord-015365-iqdi99pd	1306	4	;	;	:
cord-015365-iqdi99pd	1306	5	p	p	NN
cord-015365-iqdi99pd	1306	6	<	<	XX
cord-015365-iqdi99pd	1306	7	0,001	0,001	CD
cord-015365-iqdi99pd	1306	8	)	)	-RRB-
cord-015365-iqdi99pd	1306	9	,	,	,
cord-015365-iqdi99pd	1306	10	jedoch	jedoch	NNP
cord-015365-iqdi99pd	1306	11	nicht	nicht	NNP
cord-015365-iqdi99pd	1306	12	fü	fü	NNP
cord-015365-iqdi99pd	1307	1	r	r	NNP
cord-015365-iqdi99pd	1307	2	das	das	NNP
cord-015365-iqdi99pd	1308	1	funktionelle	funktionelle	NNP
cord-015365-iqdi99pd	1308	2	Transplantatversagen	Transplantatversagen	NNP
cord-015365-iqdi99pd	1308	3	(	(	-LRB-
cord-015365-iqdi99pd	1308	4	HR	HR	NNP
cord-015365-iqdi99pd	1308	5	:	:	:
cord-015365-iqdi99pd	1308	6	1,34	1,34	CD
cord-015365-iqdi99pd	1308	7	;	;	:
cord-015365-iqdi99pd	1308	8	0,93	0,93	CD
cord-015365-iqdi99pd	1308	9	-	-	HYPH
cord-015365-iqdi99pd	1308	10	1,93	1,93	CD
cord-015365-iqdi99pd	1308	11	;	;	:
cord-015365-iqdi99pd	1308	12	p	p	NN
cord-015365-iqdi99pd	1308	13	¼	¼	NNP
cord-015365-iqdi99pd	1308	14	0,121	0,121	CD
cord-015365-iqdi99pd	1308	15	)	)	-RRB-
cord-015365-iqdi99pd	1308	16	.	.	.
cord-015365-iqdi99pd	1309	1	Ein	Ein	NNP
cord-015365-iqdi99pd	1309	2	ähnliches	ähnliches	NNP
cord-015365-iqdi99pd	1310	1	Ergebnis	Ergebnis	NNP
cord-015365-iqdi99pd	1310	2	erhielten	erhielten	NNP
cord-015365-iqdi99pd	1311	1	wir	wir	NNP
cord-015365-iqdi99pd	1311	2	beim	beim	NNP
cord-015365-iqdi99pd	1311	3	Purposeful	Purposeful	NNP
cord-015365-iqdi99pd	1311	4	Selection	Selection	NNP
cord-015365-iqdi99pd	1311	5	Modell	Modell	NNP
cord-015365-iqdi99pd	1311	6	:	:	:
cord-015365-iqdi99pd	1312	1	Die	die	VB
cord-015365-iqdi99pd	1313	1	Hämoglobinvariabilität	Hämoglobinvariabilität	NNP
cord-015365-iqdi99pd	1313	2	war	war	NN
cord-015365-iqdi99pd	1313	3	signifikant	signifikant	NN
cord-015365-iqdi99pd	1313	4	assoziiert	assoziiert	NNP
cord-015365-iqdi99pd	1313	5	mit	mit	NNP
cord-015365-iqdi99pd	1313	6	Mortalität	Mortalität	NNP
cord-015365-iqdi99pd	1313	7	(	(	-LRB-
cord-015365-iqdi99pd	1313	8	HR	HR	NNP
cord-015365-iqdi99pd	1313	9	:	:	:
cord-015365-iqdi99pd	1313	10	2,63	2,63	CD
cord-015365-iqdi99pd	1313	11	;	;	.
cord-015365-iqdi99pd	1314	1	1,70	1,70	NNP
cord-015365-iqdi99pd	1314	2	-	-	HYPH
cord-015365-iqdi99pd	1314	3	4,08	4,08	CD
cord-015365-iqdi99pd	1314	4	;	;	.
cord-015365-iqdi99pd	1315	1	p	p	LS
cord-015365-iqdi99pd	1315	2	<	<	XX
cord-015365-iqdi99pd	1315	3	0,001	0,001	CD
cord-015365-iqdi99pd	1315	4	)	)	-RRB-
cord-015365-iqdi99pd	1315	5	und	und	RB
cord-015365-iqdi99pd	1316	1	nicht	nicht	NNP
cord-015365-iqdi99pd	1316	2	signifikant	signifikant	NNP
cord-015365-iqdi99pd	1316	3	mit	mit	NNP
cord-015365-iqdi99pd	1316	4	dem	dem	NNP
cord-015365-iqdi99pd	1316	5	funktionellen	funktionellen	NNP
cord-015365-iqdi99pd	1316	6	Transplantatversagen	Transplantatversagen	NNP
cord-015365-iqdi99pd	1316	7	(	(	-LRB-
cord-015365-iqdi99pd	1316	8	HR	HR	NNP
cord-015365-iqdi99pd	1316	9	:	:	:
cord-015365-iqdi99pd	1316	10	1,27	1,27	CD
cord-015365-iqdi99pd	1316	11	;	;	:
cord-015365-iqdi99pd	1317	1	0,63	0,63	CD
cord-015365-iqdi99pd	1317	2	-	-	HYPH
cord-015365-iqdi99pd	1317	3	2,54	2,54	CD
cord-015365-iqdi99pd	1317	4	;	;	:
cord-015365-iqdi99pd	1317	5	p	p	NN
cord-015365-iqdi99pd	1317	6	¼	¼	NNP
cord-015365-iqdi99pd	1317	7	0,509	0,509	CD
cord-015365-iqdi99pd	1317	8	)	)	-RRB-
cord-015365-iqdi99pd	1317	9	.	.	.
cord-015365-iqdi99pd	1318	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	1318	2	.	.	.
cord-015365-iqdi99pd	1319	1	Hämoglobinvariabilität	Hämoglobinvariabilität	NNP
cord-015365-iqdi99pd	1319	2	unter	unter	JJ
cord-015365-iqdi99pd	1319	3	ESA	ESA	NNP
cord-015365-iqdi99pd	1319	4	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1319	5	nach	nach	NN
cord-015365-iqdi99pd	1319	6	Nierentransplantation	Nierentransplantation	NNP
cord-015365-iqdi99pd	1319	7	ist	ist	NN
cord-015365-iqdi99pd	1319	8	mit	mit	NNP
cord-015365-iqdi99pd	1319	9	erhöhter	erhöhter	NNP
cord-015365-iqdi99pd	1319	10	Mortalität	Mortalität	NNP
cord-015365-iqdi99pd	1319	11	assoziiert	assoziiert	NN
cord-015365-iqdi99pd	1319	12	.	.	.
cord-015365-iqdi99pd	1320	1	Influence	influence	NN
cord-015365-iqdi99pd	1320	2	of	of	IN
cord-015365-iqdi99pd	1320	3	recipient	recipient	NN
cord-015365-iqdi99pd	1320	4	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1320	5	genotypes	genotype	NNS
cord-015365-iqdi99pd	1320	6	on	on	IN
cord-015365-iqdi99pd	1320	7	the	the	DT
cord-015365-iqdi99pd	1320	8	pharmacokinetics	pharmacokinetic	NNS
cord-015365-iqdi99pd	1320	9	of	of	IN
cord-015365-iqdi99pd	1320	10	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	1320	11	in	in	IN
cord-015365-iqdi99pd	1320	12	liver	liver	NN
cord-015365-iqdi99pd	1320	13	transplant	transplant	NN
cord-015365-iqdi99pd	1320	14	recipients	recipient	NNS
cord-015365-iqdi99pd	1320	15	Background	Background	NNP
cord-015365-iqdi99pd	1320	16	.	.	.
cord-015365-iqdi99pd	1321	1	Tacrolimus	Tacrolimus	NNP
cord-015365-iqdi99pd	1321	2	,	,	,
cord-015365-iqdi99pd	1321	3	which	which	WDT
cord-015365-iqdi99pd	1321	4	is	be	VBZ
cord-015365-iqdi99pd	1321	5	widely	widely	RB
cord-015365-iqdi99pd	1321	6	used	use	VBN
cord-015365-iqdi99pd	1321	7	in	in	IN
cord-015365-iqdi99pd	1321	8	liver	liver	NN
cord-015365-iqdi99pd	1321	9	transplant	transplant	NN
cord-015365-iqdi99pd	1321	10	recipients	recipient	NNS
cord-015365-iqdi99pd	1321	11	,	,	,
cord-015365-iqdi99pd	1321	12	shows	show	VBZ
cord-015365-iqdi99pd	1321	13	high	high	JJ
cord-015365-iqdi99pd	1321	14	interindividual	interindividual	JJ
cord-015365-iqdi99pd	1321	15	variability	variability	NN
cord-015365-iqdi99pd	1321	16	in	in	IN
cord-015365-iqdi99pd	1321	17	pharmacokinetics	pharmacokinetic	NNS
cord-015365-iqdi99pd	1321	18	.	.	.
cord-015365-iqdi99pd	1322	1	It	-PRON-	PRP
cord-015365-iqdi99pd	1322	2	is	be	VBZ
cord-015365-iqdi99pd	1322	3	primarily	primarily	RB
cord-015365-iqdi99pd	1322	4	metabolized	metabolize	VBN
cord-015365-iqdi99pd	1322	5	by	by	IN
cord-015365-iqdi99pd	1322	6	hepatic	hepatic	JJ
cord-015365-iqdi99pd	1322	7	cytochrome	cytochrome	NN
cord-015365-iqdi99pd	1322	8	P450	P450	NNP
cord-015365-iqdi99pd	1322	9	3A4	3A4	NNPS
cord-015365-iqdi99pd	1322	10	and	and	CC
cord-015365-iqdi99pd	1322	11	3A5	3a5	CD
cord-015365-iqdi99pd	1322	12	(	(	-LRB-
cord-015365-iqdi99pd	1322	13	CYP	CYP	NNP
cord-015365-iqdi99pd	1322	14	)	)	-RRB-
cord-015365-iqdi99pd	1322	15	.	.	.
cord-015365-iqdi99pd	1323	1	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1323	2	is	be	VBZ
cord-015365-iqdi99pd	1323	3	also	also	RB
cord-015365-iqdi99pd	1323	4	expressed	express	VBN
cord-015365-iqdi99pd	1323	5	in	in	IN
cord-015365-iqdi99pd	1323	6	the	the	DT
cord-015365-iqdi99pd	1323	7	kidney	kidney	NN
cord-015365-iqdi99pd	1323	8	and	and	CC
cord-015365-iqdi99pd	1323	9	in	in	IN
cord-015365-iqdi99pd	1323	10	the	the	DT
cord-015365-iqdi99pd	1323	11	intestine	intestine	NN
cord-015365-iqdi99pd	1323	12	.	.	.
cord-015365-iqdi99pd	1324	1	In	in	IN
cord-015365-iqdi99pd	1324	2	this	this	DT
cord-015365-iqdi99pd	1324	3	study	study	NN
cord-015365-iqdi99pd	1324	4	,	,	,
cord-015365-iqdi99pd	1324	5	we	-PRON-	PRP
cord-015365-iqdi99pd	1324	6	evaluated	evaluate	VBD
cord-015365-iqdi99pd	1324	7	the	the	DT
cord-015365-iqdi99pd	1324	8	influence	influence	NN
cord-015365-iqdi99pd	1324	9	of	of	IN
cord-015365-iqdi99pd	1324	10	recipient	recipient	NN
cord-015365-iqdi99pd	1324	11	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1324	12	genotypes	genotype	NNS
cord-015365-iqdi99pd	1324	13	on	on	IN
cord-015365-iqdi99pd	1324	14	the	the	DT
cord-015365-iqdi99pd	1324	15	pharmacokinetics	pharmacokinetic	NNS
cord-015365-iqdi99pd	1324	16	of	of	IN
cord-015365-iqdi99pd	1324	17	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	1324	18	in	in	IN
cord-015365-iqdi99pd	1324	19	patients	patient	NNS
cord-015365-iqdi99pd	1324	20	after	after	IN
cord-015365-iqdi99pd	1324	21	liver	liver	NN
cord-015365-iqdi99pd	1324	22	transplantation	transplantation	NN
cord-015365-iqdi99pd	1324	23	.	.	.
cord-015365-iqdi99pd	1325	1	Methods	method	NNS
cord-015365-iqdi99pd	1325	2	.	.	.
cord-015365-iqdi99pd	1326	1	Patients	patient	NNS
cord-015365-iqdi99pd	1326	2	after	after	IN
cord-015365-iqdi99pd	1326	3	liver	liver	NN
cord-015365-iqdi99pd	1326	4	transplantation	transplantation	NN
cord-015365-iqdi99pd	1326	5	with	with	IN
cord-015365-iqdi99pd	1326	6	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	1326	7	maintenance	maintenance	NN
cord-015365-iqdi99pd	1326	8	therapy	therapy	NN
cord-015365-iqdi99pd	1326	9	were	be	VBD
cord-015365-iqdi99pd	1326	10	included	include	VBN
cord-015365-iqdi99pd	1326	11	into	into	IN
cord-015365-iqdi99pd	1326	12	the	the	DT
cord-015365-iqdi99pd	1326	13	study	study	NN
cord-015365-iqdi99pd	1326	14	.	.	.
cord-015365-iqdi99pd	1327	1	CYP3A5	cyp3a5	JJ
cord-015365-iqdi99pd	1327	2	genotypes	genotype	NNS
cord-015365-iqdi99pd	1327	3	of	of	IN
cord-015365-iqdi99pd	1327	4	the	the	DT
cord-015365-iqdi99pd	1327	5	recipients	recipient	NNS
cord-015365-iqdi99pd	1327	6	were	be	VBD
cord-015365-iqdi99pd	1327	7	established	establish	VBN
cord-015365-iqdi99pd	1327	8	.	.	.
cord-015365-iqdi99pd	1328	1	Clinical	clinical	JJ
cord-015365-iqdi99pd	1328	2	and	and	CC
cord-015365-iqdi99pd	1328	3	laboratory	laboratory	NN
cord-015365-iqdi99pd	1328	4	data	datum	NNS
cord-015365-iqdi99pd	1328	5	at	at	IN
cord-015365-iqdi99pd	1328	6	various	various	JJ
cord-015365-iqdi99pd	1328	7	time	time	NN
cord-015365-iqdi99pd	1328	8	points	point	NNS
cord-015365-iqdi99pd	1328	9	(	(	-LRB-
cord-015365-iqdi99pd	1328	10	1	1	CD
cord-015365-iqdi99pd	1328	11	month	month	NN
cord-015365-iqdi99pd	1328	12	,	,	,
cord-015365-iqdi99pd	1328	13	3	3	CD
cord-015365-iqdi99pd	1328	14	months	month	NNS
cord-015365-iqdi99pd	1328	15	,	,	,
cord-015365-iqdi99pd	1328	16	1	1	CD
cord-015365-iqdi99pd	1328	17	year	year	NN
cord-015365-iqdi99pd	1328	18	and	and	CC
cord-015365-iqdi99pd	1328	19	3	3	CD
cord-015365-iqdi99pd	1328	20	years	year	NNS
cord-015365-iqdi99pd	1328	21	after	after	IN
cord-015365-iqdi99pd	1328	22	start	start	NN
cord-015365-iqdi99pd	1328	23	of	of	IN
cord-015365-iqdi99pd	1328	24	medication	medication	NN
cord-015365-iqdi99pd	1328	25	with	with	IN
cord-015365-iqdi99pd	1328	26	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	1328	27	)	)	-RRB-
cord-015365-iqdi99pd	1328	28	were	be	VBD
cord-015365-iqdi99pd	1328	29	evaluated	evaluate	VBN
cord-015365-iqdi99pd	1328	30	retrospectively	retrospectively	RB
cord-015365-iqdi99pd	1328	31	.	.	.
cord-015365-iqdi99pd	1329	1	Doses	dose	NNS
cord-015365-iqdi99pd	1329	2	and	and	CC
cord-015365-iqdi99pd	1329	3	trough	trough	NN
cord-015365-iqdi99pd	1329	4	levels	level	NNS
cord-015365-iqdi99pd	1329	5	of	of	IN
cord-015365-iqdi99pd	1329	6	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	1329	7	were	be	VBD
cord-015365-iqdi99pd	1329	8	noted	note	VBN
cord-015365-iqdi99pd	1329	9	and	and	CC
cord-015365-iqdi99pd	1329	10	a	a	DT
cord-015365-iqdi99pd	1329	11	screening	screening	NN
cord-015365-iqdi99pd	1329	12	of	of	IN
cord-015365-iqdi99pd	1329	13	all	all	DT
cord-015365-iqdi99pd	1329	14	concomitant	concomitant	JJ
cord-015365-iqdi99pd	1329	15	medications	medication	NNS
cord-015365-iqdi99pd	1329	16	with	with	IN
cord-015365-iqdi99pd	1329	17	possible	possible	JJ
cord-015365-iqdi99pd	1329	18	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1329	19	interaction	interaction	NN
cord-015365-iqdi99pd	1329	20	was	be	VBD
cord-015365-iqdi99pd	1329	21	performed	perform	VBN
cord-015365-iqdi99pd	1329	22	.	.	.
cord-015365-iqdi99pd	1330	1	SPSS	SPSS	NNP
cord-015365-iqdi99pd	1330	2	for	for	IN
cord-015365-iqdi99pd	1330	3	windows	window	NNS
cord-015365-iqdi99pd	1330	4	(	(	-LRB-
cord-015365-iqdi99pd	1330	5	release	release	NN
cord-015365-iqdi99pd	1330	6	14.0	14.0	CD
cord-015365-iqdi99pd	1330	7	;	;	:
cord-015365-iqdi99pd	1330	8	SPSS	SPSS	NNP
cord-015365-iqdi99pd	1330	9	,	,	,
cord-015365-iqdi99pd	1330	10	Inc	Inc	NNP
cord-015365-iqdi99pd	1330	11	)	)	-RRB-
cord-015365-iqdi99pd	1330	12	was	be	VBD
cord-015365-iqdi99pd	1330	13	used	use	VBN
cord-015365-iqdi99pd	1330	14	for	for	IN
cord-015365-iqdi99pd	1330	15	statistical	statistical	JJ
cord-015365-iqdi99pd	1330	16	analyses	analysis	NNS
cord-015365-iqdi99pd	1330	17	.	.	.
cord-015365-iqdi99pd	1331	1	Continuous	continuous	JJ
cord-015365-iqdi99pd	1331	2	variables	variable	NNS
cord-015365-iqdi99pd	1331	3	were	be	VBD
cord-015365-iqdi99pd	1331	4	analyzed	analyze	VBN
cord-015365-iqdi99pd	1331	5	by	by	IN
cord-015365-iqdi99pd	1331	6	ANOVA	anova	NN
cord-015365-iqdi99pd	1331	7	-	-	HYPH
cord-015365-iqdi99pd	1331	8	test	test	NN
cord-015365-iqdi99pd	1331	9	and	and	CC
cord-015365-iqdi99pd	1331	10	presented	present	VBD
cord-015365-iqdi99pd	1331	11	as	as	IN
cord-015365-iqdi99pd	1331	12	means	mean	VBZ
cord-015365-iqdi99pd	1331	13	AE	AE	NNP
cord-015365-iqdi99pd	1331	14	standard	standard	JJ
cord-015365-iqdi99pd	1331	15	deviation	deviation	NN
cord-015365-iqdi99pd	1331	16	,	,	,
cord-015365-iqdi99pd	1331	17	variables	variable	NNS
cord-015365-iqdi99pd	1331	18	deviating	deviate	VBG
cord-015365-iqdi99pd	1331	19	from	from	IN
cord-015365-iqdi99pd	1331	20	normal	normal	JJ
cord-015365-iqdi99pd	1331	21	distribution	distribution	NN
cord-015365-iqdi99pd	1331	22	were	be	VBD
cord-015365-iqdi99pd	1331	23	analyzed	analyze	VBN
cord-015365-iqdi99pd	1331	24	by	by	IN
cord-015365-iqdi99pd	1331	25	rank	rank	NN
cord-015365-iqdi99pd	1331	26	sum	sum	NN
cord-015365-iqdi99pd	1331	27	test	test	NN
cord-015365-iqdi99pd	1331	28	and	and	CC
cord-015365-iqdi99pd	1331	29	presented	present	VBD
cord-015365-iqdi99pd	1331	30	as	as	IN
cord-015365-iqdi99pd	1331	31	median	median	NN
cord-015365-iqdi99pd	1331	32	and	and	CC
cord-015365-iqdi99pd	1331	33	range	range	NN
cord-015365-iqdi99pd	1331	34	.	.	.
cord-015365-iqdi99pd	1332	1	Categorical	categorical	JJ
cord-015365-iqdi99pd	1332	2	variables	variable	NNS
cord-015365-iqdi99pd	1332	3	are	be	VBP
cord-015365-iqdi99pd	1332	4	presented	present	VBN
cord-015365-iqdi99pd	1332	5	as	as	IN
cord-015365-iqdi99pd	1332	6	percentages	percentage	NNS
cord-015365-iqdi99pd	1332	7	and	and	CC
cord-015365-iqdi99pd	1332	8	were	be	VBD
cord-015365-iqdi99pd	1332	9	compared	compare	VBN
cord-015365-iqdi99pd	1332	10	by	by	IN
cord-015365-iqdi99pd	1332	11	chi	chi	JJ
cord-015365-iqdi99pd	1332	12	-	-	JJ
cord-015365-iqdi99pd	1332	13	square	square	JJ
cord-015365-iqdi99pd	1332	14	test	test	NN
cord-015365-iqdi99pd	1332	15	.	.	.
cord-015365-iqdi99pd	1333	1	The	the	DT
cord-015365-iqdi99pd	1333	2	criterion	criterion	NN
cord-015365-iqdi99pd	1333	3	for	for	IN
cord-015365-iqdi99pd	1333	4	statistical	statistical	JJ
cord-015365-iqdi99pd	1333	5	significance	significance	NN
cord-015365-iqdi99pd	1333	6	was	be	VBD
cord-015365-iqdi99pd	1333	7	p	p	NN
cord-015365-iqdi99pd	1333	8	<	<	XX
cord-015365-iqdi99pd	1333	9	0.05	0.05	CD
cord-015365-iqdi99pd	1333	10	.	.	.
cord-015365-iqdi99pd	1334	1	Results	result	NNS
cord-015365-iqdi99pd	1334	2	.	.	.
cord-015365-iqdi99pd	1335	1	Ninety	ninety	CD
cord-015365-iqdi99pd	1335	2	-	-	HYPH
cord-015365-iqdi99pd	1335	3	two	two	CD
cord-015365-iqdi99pd	1335	4	liver	liver	NN
cord-015365-iqdi99pd	1335	5	transplant	transplant	NN
cord-015365-iqdi99pd	1335	6	recipients	recipient	NNS
cord-015365-iqdi99pd	1335	7	participated	participate	VBD
cord-015365-iqdi99pd	1335	8	in	in	IN
cord-015365-iqdi99pd	1335	9	the	the	DT
cord-015365-iqdi99pd	1335	10	study	study	NN
cord-015365-iqdi99pd	1335	11	.	.	.
cord-015365-iqdi99pd	1336	1	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1336	2	genotypes	genotype	NNS
cord-015365-iqdi99pd	1336	3	were	be	VBD
cord-015365-iqdi99pd	1336	4	successfully	successfully	RB
cord-015365-iqdi99pd	1336	5	determined	determine	VBN
cord-015365-iqdi99pd	1336	6	in	in	IN
cord-015365-iqdi99pd	1336	7	all	all	DT
cord-015365-iqdi99pd	1336	8	subjects	subject	NNS
cord-015365-iqdi99pd	1336	9	and	and	CC
cord-015365-iqdi99pd	1336	10	did	do	VBD
cord-015365-iqdi99pd	1336	11	not	not	RB
cord-015365-iqdi99pd	1336	12	deviate	deviate	VB
cord-015365-iqdi99pd	1336	13	from	from	IN
cord-015365-iqdi99pd	1336	14	the	the	DT
cord-015365-iqdi99pd	1336	15	Hardy	Hardy	NNP
cord-015365-iqdi99pd	1336	16	-	-	HYPH
cord-015365-iqdi99pd	1336	17	Weinberg	Weinberg	NNP
cord-015365-iqdi99pd	1336	18	equilibirum	equilibirum	NN
cord-015365-iqdi99pd	1336	19	.	.	.
cord-015365-iqdi99pd	1337	1	86	86	CD
cord-015365-iqdi99pd	1337	2	%	%	NN
cord-015365-iqdi99pd	1337	3	of	of	IN
cord-015365-iqdi99pd	1337	4	the	the	DT
cord-015365-iqdi99pd	1337	5	patients	patient	NNS
cord-015365-iqdi99pd	1337	6	carried	carry	VBD
cord-015365-iqdi99pd	1337	7	the	the	DT
cord-015365-iqdi99pd	1337	8	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1337	9	*	*	NFP
cord-015365-iqdi99pd	1337	10	3/*3	3/*3	CD
cord-015365-iqdi99pd	1337	11	genotype	genotype	NN
cord-015365-iqdi99pd	1337	12	and	and	CC
cord-015365-iqdi99pd	1337	13	were	be	VBD
cord-015365-iqdi99pd	1337	14	thus	thus	RB
cord-015365-iqdi99pd	1337	15	classified	classify	VBN
cord-015365-iqdi99pd	1337	16	as	as	IN
cord-015365-iqdi99pd	1337	17	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1337	18	non	non	NNS
cord-015365-iqdi99pd	1337	19	-	-	NNS
cord-015365-iqdi99pd	1337	20	expressors	expressor	NNS
cord-015365-iqdi99pd	1337	21	.	.	.
cord-015365-iqdi99pd	1338	1	14	14	CD
cord-015365-iqdi99pd	1338	2	%	%	NN
cord-015365-iqdi99pd	1338	3	carried	carry	VBD
cord-015365-iqdi99pd	1338	4	the	the	DT
cord-015365-iqdi99pd	1338	5	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1338	6	*	*	NFP
cord-015365-iqdi99pd	1338	7	1/*3	1/*3	CD
cord-015365-iqdi99pd	1338	8	genotype	genotype	NN
cord-015365-iqdi99pd	1338	9	and	and	CC
cord-015365-iqdi99pd	1338	10	were	be	VBD
cord-015365-iqdi99pd	1338	11	classified	classify	VBN
cord-015365-iqdi99pd	1338	12	as	as	IN
cord-015365-iqdi99pd	1338	13	heterozygous	heterozygous	JJ
cord-015365-iqdi99pd	1338	14	expressors	expressor	NNS
cord-015365-iqdi99pd	1338	15	.	.	.
cord-015365-iqdi99pd	1339	1	No	no	DT
cord-015365-iqdi99pd	1339	2	homozygous	homozygous	JJ
cord-015365-iqdi99pd	1339	3	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1339	4	expressor	expressor	NNP
cord-015365-iqdi99pd	1339	5	(	(	-LRB-
cord-015365-iqdi99pd	1339	6	*	*	NFP
cord-015365-iqdi99pd	1339	7	1/*1	1/*1	CD
cord-015365-iqdi99pd	1339	8	)	)	-RRB-
cord-015365-iqdi99pd	1339	9	was	be	VBD
cord-015365-iqdi99pd	1339	10	found	find	VBN
cord-015365-iqdi99pd	1339	11	.	.	.
cord-015365-iqdi99pd	1340	1	Neither	neither	CC
cord-015365-iqdi99pd	1340	2	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	1340	3	dose	dose	NN
cord-015365-iqdi99pd	1340	4	nor	nor	CC
cord-015365-iqdi99pd	1340	5	levels	level	NNS
cord-015365-iqdi99pd	1340	6	were	be	VBD
cord-015365-iqdi99pd	1340	7	significantly	significantly	RB
cord-015365-iqdi99pd	1340	8	different	different	JJ
cord-015365-iqdi99pd	1340	9	between	between	IN
cord-015365-iqdi99pd	1340	10	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1340	11	expressors	expressor	NNS
cord-015365-iqdi99pd	1340	12	and	and	CC
cord-015365-iqdi99pd	1340	13	non	non	NNS
cord-015365-iqdi99pd	1340	14	-	-	NNS
cord-015365-iqdi99pd	1340	15	expressors	expressor	NNS
cord-015365-iqdi99pd	1340	16	at	at	IN
cord-015365-iqdi99pd	1340	17	any	any	DT
cord-015365-iqdi99pd	1340	18	point	point	NN
cord-015365-iqdi99pd	1340	19	of	of	IN
cord-015365-iqdi99pd	1340	20	time	time	NN
cord-015365-iqdi99pd	1340	21	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1340	22	.	.	.
cord-015365-iqdi99pd	1341	1	The	the	DT
cord-015365-iqdi99pd	1341	2	pharmacokinetics	pharmacokinetic	NNS
cord-015365-iqdi99pd	1341	3	of	of	IN
cord-015365-iqdi99pd	1341	4	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	1341	5	in	in	IN
cord-015365-iqdi99pd	1341	6	patients	patient	NNS
cord-015365-iqdi99pd	1341	7	after	after	IN
cord-015365-iqdi99pd	1341	8	liver	liver	NN
cord-015365-iqdi99pd	1341	9	transplantation	transplantation	NN
cord-015365-iqdi99pd	1341	10	is	be	VBZ
cord-015365-iqdi99pd	1341	11	not	not	RB
cord-015365-iqdi99pd	1341	12	influenced	influence	VBN
cord-015365-iqdi99pd	1341	13	by	by	IN
cord-015365-iqdi99pd	1341	14	the	the	DT
cord-015365-iqdi99pd	1341	15	recipient	recipient	NN
cord-015365-iqdi99pd	1341	16	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1341	17	genotype	genotype	NN
cord-015365-iqdi99pd	1341	18	.	.	.
cord-015365-iqdi99pd	1342	1	It	-PRON-	PRP
cord-015365-iqdi99pd	1342	2	is	be	VBZ
cord-015365-iqdi99pd	1342	3	mostly	mostly	RB
cord-015365-iqdi99pd	1342	4	the	the	DT
cord-015365-iqdi99pd	1342	5	hepatic	hepatic	JJ
cord-015365-iqdi99pd	1342	6	metabolism	metabolism	NN
cord-015365-iqdi99pd	1342	7	that	that	WDT
cord-015365-iqdi99pd	1342	8	contributes	contribute	VBZ
cord-015365-iqdi99pd	1342	9	to	to	IN
cord-015365-iqdi99pd	1342	10	the	the	DT
cord-015365-iqdi99pd	1342	11	excretion	excretion	NN
cord-015365-iqdi99pd	1342	12	of	of	IN
cord-015365-iqdi99pd	1342	13	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	1342	14	.	.	.
cord-015365-iqdi99pd	1343	1	The	the	DT
cord-015365-iqdi99pd	1343	2	donor	donor	NN
cord-015365-iqdi99pd	1343	3	CYP3A5	CYP3A5	NNP
cord-015365-iqdi99pd	1343	4	genotype	genotype	NN
cord-015365-iqdi99pd	1343	5	might	may	MD
cord-015365-iqdi99pd	1343	6	be	be	VB
cord-015365-iqdi99pd	1343	7	useful	useful	JJ
cord-015365-iqdi99pd	1343	8	to	to	TO
cord-015365-iqdi99pd	1343	9	predict	predict	VB
cord-015365-iqdi99pd	1343	10	the	the	DT
cord-015365-iqdi99pd	1343	11	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	1343	12	pharmacokinetics	pharmacokinetics	NNP
cord-015365-iqdi99pd	1343	13	.	.	.
cord-015365-iqdi99pd	1344	1	Background	background	NN
cord-015365-iqdi99pd	1344	2	.	.	.
cord-015365-iqdi99pd	1345	1	Due	due	IN
cord-015365-iqdi99pd	1345	2	to	to	IN
cord-015365-iqdi99pd	1345	3	predisposing	predisposing	JJ
cord-015365-iqdi99pd	1345	4	factors	factor	NNS
cord-015365-iqdi99pd	1345	5	like	like	IN
cord-015365-iqdi99pd	1345	6	massive	massive	JJ
cord-015365-iqdi99pd	1345	7	ascites	ascite	NNS
cord-015365-iqdi99pd	1345	8	or	or	CC
cord-015365-iqdi99pd	1345	9	kachexia	kachexia	NNP
cord-015365-iqdi99pd	1345	10	incisional	incisional	NNP
cord-015365-iqdi99pd	1346	1	hernias	hernia	NNS
cord-015365-iqdi99pd	1346	2	occur	occur	VBP
cord-015365-iqdi99pd	1346	3	in	in	IN
cord-015365-iqdi99pd	1346	4	about	about	RB
cord-015365-iqdi99pd	1346	5	30	30	CD
cord-015365-iqdi99pd	1346	6	%	%	NN
cord-015365-iqdi99pd	1346	7	of	of	IN
cord-015365-iqdi99pd	1346	8	patients	patient	NNS
cord-015365-iqdi99pd	1346	9	after	after	IN
cord-015365-iqdi99pd	1346	10	LTX	LTX	NNP
cord-015365-iqdi99pd	1346	11	.	.	.
cord-015365-iqdi99pd	1347	1	Following	follow	VBG
cord-015365-iqdi99pd	1347	2	LTX	LTX	NNP
cord-015365-iqdi99pd	1347	3	the	the	DT
cord-015365-iqdi99pd	1347	4	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	1347	5	regimen	regimen	NN
cord-015365-iqdi99pd	1347	6	has	have	VBZ
cord-015365-iqdi99pd	1347	7	been	be	VBN
cord-015365-iqdi99pd	1347	8	associated	associate	VBN
cord-015365-iqdi99pd	1347	9	with	with	IN
cord-015365-iqdi99pd	1347	10	the	the	DT
cord-015365-iqdi99pd	1347	11	development	development	NN
cord-015365-iqdi99pd	1347	12	of	of	IN
cord-015365-iqdi99pd	1347	13	incisional	incisional	NNP
cord-015365-iqdi99pd	1347	14	hernias	hernia	NNS
cord-015365-iqdi99pd	1347	15	.	.	.
cord-015365-iqdi99pd	1348	1	Appropriate	appropriate	JJ
cord-015365-iqdi99pd	1348	2	closure	closure	NN
cord-015365-iqdi99pd	1348	3	techniques	technique	NNS
cord-015365-iqdi99pd	1348	4	are	be	VBP
cord-015365-iqdi99pd	1348	5	still	still	RB
cord-015365-iqdi99pd	1348	6	controversially	controversially	RB
cord-015365-iqdi99pd	1348	7	discussed	discuss	VBN
cord-015365-iqdi99pd	1348	8	.	.	.
cord-015365-iqdi99pd	1349	1	The	the	DT
cord-015365-iqdi99pd	1349	2	usage	usage	NN
cord-015365-iqdi99pd	1349	3	of	of	IN
cord-015365-iqdi99pd	1349	4	Mesh	Mesh	NNP
cord-015365-iqdi99pd	1349	5	grafts	graft	NNS
cord-015365-iqdi99pd	1349	6	is	be	VBZ
cord-015365-iqdi99pd	1349	7	feasible	feasible	JJ
cord-015365-iqdi99pd	1349	8	in	in	IN
cord-015365-iqdi99pd	1349	9	those	those	DT
cord-015365-iqdi99pd	1349	10	patients	patient	NNS
cord-015365-iqdi99pd	1349	11	as	as	IN
cord-015365-iqdi99pd	1349	12	direct	direct	JJ
cord-015365-iqdi99pd	1349	13	closure	closure	NN
cord-015365-iqdi99pd	1349	14	often	often	RB
cord-015365-iqdi99pd	1349	15	results	result	VBZ
cord-015365-iqdi99pd	1349	16	in	in	IN
cord-015365-iqdi99pd	1349	17	hernia	hernia	NN
cord-015365-iqdi99pd	1349	18	reccurrence	reccurrence	NN
cord-015365-iqdi99pd	1349	19	.	.	.
cord-015365-iqdi99pd	1350	1	Methods	method	NNS
cord-015365-iqdi99pd	1350	2	and	and	CC
cord-015365-iqdi99pd	1350	3	Results	result	NNS
cord-015365-iqdi99pd	1350	4	.	.	.
cord-015365-iqdi99pd	1351	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1351	2	would	would	MD
cord-015365-iqdi99pd	1351	3	like	like	VB
cord-015365-iqdi99pd	1351	4	to	to	TO
cord-015365-iqdi99pd	1351	5	present	present	VB
cord-015365-iqdi99pd	1351	6	a	a	DT
cord-015365-iqdi99pd	1351	7	patient	patient	NN
cord-015365-iqdi99pd	1351	8	who	who	WP
cord-015365-iqdi99pd	1351	9	suffered	suffer	VBD
cord-015365-iqdi99pd	1351	10	from	from	IN
cord-015365-iqdi99pd	1351	11	an	an	DT
cord-015365-iqdi99pd	1351	12	incisional	incisional	JJ
cord-015365-iqdi99pd	1351	13	hernia	hernia	NN
cord-015365-iqdi99pd	1351	14	6	6	CD
cord-015365-iqdi99pd	1351	15	months	month	NNS
cord-015365-iqdi99pd	1351	16	following	follow	VBG
cord-015365-iqdi99pd	1351	17	LTX	LTX	NNP
cord-015365-iqdi99pd	1351	18	.	.	.
cord-015365-iqdi99pd	1352	1	The	the	DT
cord-015365-iqdi99pd	1352	2	hernia	hernia	NN
cord-015365-iqdi99pd	1352	3	was	be	VBD
cord-015365-iqdi99pd	1352	4	repaired	repair	VBN
cord-015365-iqdi99pd	1352	5	using	use	VBG
cord-015365-iqdi99pd	1352	6	a	a	DT
cord-015365-iqdi99pd	1352	7	Mesh	Mesh	NNP
cord-015365-iqdi99pd	1352	8	graft	graft	NN
cord-015365-iqdi99pd	1352	9	(	(	-LRB-
cord-015365-iqdi99pd	1352	10	Permacol	Permacol	NNP
cord-015365-iqdi99pd	1352	11	+	+	CC
cord-015365-iqdi99pd	1352	12	)	)	-RRB-
cord-015365-iqdi99pd	1352	13	which	which	WDT
cord-015365-iqdi99pd	1352	14	was	be	VBD
cord-015365-iqdi99pd	1352	15	placed	place	VBN
cord-015365-iqdi99pd	1352	16	in	in	IN
cord-015365-iqdi99pd	1352	17	a	a	DT
cord-015365-iqdi99pd	1352	18	sublay	sublay	NN
cord-015365-iqdi99pd	1352	19	technique	technique	NN
cord-015365-iqdi99pd	1352	20	.	.	.
cord-015365-iqdi99pd	1353	1	The	the	DT
cord-015365-iqdi99pd	1353	2	patient	patient	NN
cord-015365-iqdi99pd	1353	3	primarily	primarily	RB
cord-015365-iqdi99pd	1353	4	recovered	recover	VBD
cord-015365-iqdi99pd	1353	5	and	and	CC
cord-015365-iqdi99pd	1353	6	was	be	VBD
cord-015365-iqdi99pd	1353	7	dismissed	dismiss	VBN
cord-015365-iqdi99pd	1353	8	on	on	IN
cord-015365-iqdi99pd	1353	9	day	day	NN
cord-015365-iqdi99pd	1353	10	7	7	CD
cord-015365-iqdi99pd	1353	11	following	follow	VBG
cord-015365-iqdi99pd	1353	12	hernial	hernial	JJ
cord-015365-iqdi99pd	1353	13	repair	repair	NN
cord-015365-iqdi99pd	1353	14	.	.	.
cord-015365-iqdi99pd	1354	1	After	after	IN
cord-015365-iqdi99pd	1354	2	14	14	CD
cord-015365-iqdi99pd	1354	3	days	day	NNS
cord-015365-iqdi99pd	1354	4	he	-PRON-	PRP
cord-015365-iqdi99pd	1354	5	presented	present	VBD
cord-015365-iqdi99pd	1354	6	with	with	IN
cord-015365-iqdi99pd	1354	7	fever	fever	NN
cord-015365-iqdi99pd	1354	8	and	and	CC
cord-015365-iqdi99pd	1354	9	general	general	JJ
cord-015365-iqdi99pd	1354	10	illness	illness	NN
cord-015365-iqdi99pd	1354	11	.	.	.
cord-015365-iqdi99pd	1355	1	An	an	DT
cord-015365-iqdi99pd	1355	2	abdominal	abdominal	JJ
cord-015365-iqdi99pd	1355	3	CT	CT	NNP
cord-015365-iqdi99pd	1355	4	scan	scan	NN
cord-015365-iqdi99pd	1355	5	revealed	reveal	VBD
cord-015365-iqdi99pd	1355	6	a	a	DT
cord-015365-iqdi99pd	1355	7	fluid	fluid	JJ
cord-015365-iqdi99pd	1355	8	formation	formation	NN
cord-015365-iqdi99pd	1355	9	above	above	IN
cord-015365-iqdi99pd	1355	10	the	the	DT
cord-015365-iqdi99pd	1355	11	Mesh	Mesh	NNP
cord-015365-iqdi99pd	1355	12	graft	graft	NN
cord-015365-iqdi99pd	1355	13	.	.	.
cord-015365-iqdi99pd	1356	1	Open	open	JJ
cord-015365-iqdi99pd	1356	2	drainage	drainage	NN
cord-015365-iqdi99pd	1356	3	had	have	VBD
cord-015365-iqdi99pd	1356	4	to	to	TO
cord-015365-iqdi99pd	1356	5	be	be	VB
cord-015365-iqdi99pd	1356	6	performed	perform	VBN
cord-015365-iqdi99pd	1356	7	.	.	.
cord-015365-iqdi99pd	1357	1	The	the	DT
cord-015365-iqdi99pd	1357	2	healing	healing	NN
cord-015365-iqdi99pd	1357	3	of	of	IN
cord-015365-iqdi99pd	1357	4	the	the	DT
cord-015365-iqdi99pd	1357	5	wound	wound	NN
cord-015365-iqdi99pd	1357	6	was	be	VBD
cord-015365-iqdi99pd	1357	7	impaired	impair	VBN
cord-015365-iqdi99pd	1357	8	with	with	IN
cord-015365-iqdi99pd	1357	9	the	the	DT
cord-015365-iqdi99pd	1357	10	Permacol	Permacol	NNP
cord-015365-iqdi99pd	1357	11	+	+	CC
cord-015365-iqdi99pd	1357	12	graft	graft	NN
cord-015365-iqdi99pd	1357	13	completely	completely	RB
cord-015365-iqdi99pd	1357	14	visible	visible	JJ
cord-015365-iqdi99pd	1357	15	in	in	IN
cord-015365-iqdi99pd	1357	16	the	the	DT
cord-015365-iqdi99pd	1357	17	wound	wound	NN
cord-015365-iqdi99pd	1357	18	.	.	.
cord-015365-iqdi99pd	1358	1	VAC	VAC	NNP
cord-015365-iqdi99pd	1358	2	was	be	VBD
cord-015365-iqdi99pd	1358	3	applied	apply	VBN
cord-015365-iqdi99pd	1358	4	directly	directly	RB
cord-015365-iqdi99pd	1358	5	on	on	IN
cord-015365-iqdi99pd	1358	6	the	the	DT
cord-015365-iqdi99pd	1358	7	Permacol	Permacol	NNP
cord-015365-iqdi99pd	1358	8	+	+	CC
cord-015365-iqdi99pd	1358	9	patch	patch	NN
cord-015365-iqdi99pd	1358	10	.	.	.
cord-015365-iqdi99pd	1359	1	The	the	DT
cord-015365-iqdi99pd	1359	2	wound	wound	NN
cord-015365-iqdi99pd	1359	3	closed	close	VBD
cord-015365-iqdi99pd	1359	4	completely	completely	RB
cord-015365-iqdi99pd	1359	5	without	without	IN
cord-015365-iqdi99pd	1359	6	any	any	DT
cord-015365-iqdi99pd	1359	7	sings	sing	NNS
cord-015365-iqdi99pd	1359	8	of	of	IN
cord-015365-iqdi99pd	1359	9	reinfection	reinfection	NN
cord-015365-iqdi99pd	1359	10	or	or	CC
cord-015365-iqdi99pd	1359	11	peritonitis	peritonitis	NN
cord-015365-iqdi99pd	1359	12	until	until	IN
cord-015365-iqdi99pd	1359	13	now	now	RB
cord-015365-iqdi99pd	1359	14	.	.	.
cord-015365-iqdi99pd	1360	1	An	an	DT
cord-015365-iqdi99pd	1360	2	abdominal	abdominal	JJ
cord-015365-iqdi99pd	1360	3	CT	CT	NNP
cord-015365-iqdi99pd	1360	4	scan	scan	NN
cord-015365-iqdi99pd	1360	5	4	4	CD
cord-015365-iqdi99pd	1360	6	months	month	NNS
cord-015365-iqdi99pd	1360	7	showed	show	VBD
cord-015365-iqdi99pd	1360	8	no	no	DT
cord-015365-iqdi99pd	1360	9	pathologies	pathology	NNS
cord-015365-iqdi99pd	1360	10	.	.	.
cord-015365-iqdi99pd	1361	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1361	2	.	.	.
cord-015365-iqdi99pd	1362	1	The	the	DT
cord-015365-iqdi99pd	1362	2	usage	usage	NN
cord-015365-iqdi99pd	1362	3	of	of	IN
cord-015365-iqdi99pd	1362	4	a	a	DT
cord-015365-iqdi99pd	1362	5	Permacol	Permacol	NNP
cord-015365-iqdi99pd	1362	6	+	+	CC
cord-015365-iqdi99pd	1362	7	patch	patch	NN
cord-015365-iqdi99pd	1362	8	seems	seem	VBZ
cord-015365-iqdi99pd	1362	9	likely	likely	JJ
cord-015365-iqdi99pd	1362	10	to	to	TO
cord-015365-iqdi99pd	1362	11	repair	repair	VB
cord-015365-iqdi99pd	1362	12	incisional	incisional	JJ
cord-015365-iqdi99pd	1362	13	hernias	hernia	NNS
cord-015365-iqdi99pd	1362	14	after	after	IN
cord-015365-iqdi99pd	1362	15	LTX	LTX	NNP
cord-015365-iqdi99pd	1362	16	whereas	whereas	IN
cord-015365-iqdi99pd	1362	17	severe	severe	JJ
cord-015365-iqdi99pd	1362	18	wound	wound	JJ
cord-015365-iqdi99pd	1362	19	infections	infection	NNS
cord-015365-iqdi99pd	1362	20	might	may	MD
cord-015365-iqdi99pd	1362	21	occur	occur	VB
cord-015365-iqdi99pd	1362	22	after	after	IN
cord-015365-iqdi99pd	1362	23	the	the	DT
cord-015365-iqdi99pd	1362	24	placement	placement	NN
cord-015365-iqdi99pd	1362	25	of	of	IN
cord-015365-iqdi99pd	1362	26	biological	biological	JJ
cord-015365-iqdi99pd	1362	27	grafts	graft	NNS
cord-015365-iqdi99pd	1362	28	due	due	JJ
cord-015365-iqdi99pd	1362	29	to	to	IN
cord-015365-iqdi99pd	1362	30	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1362	31	.	.	.
cord-015365-iqdi99pd	1363	1	In	in	IN
cord-015365-iqdi99pd	1363	2	our	-PRON-	PRP$
cord-015365-iqdi99pd	1363	3	patient	patient	NN
cord-015365-iqdi99pd	1363	4	a	a	DT
cord-015365-iqdi99pd	1363	5	VAC	vac	NN
cord-015365-iqdi99pd	1363	6	treatment	treatment	NN
cord-015365-iqdi99pd	1363	7	was	be	VBD
cord-015365-iqdi99pd	1363	8	applied	apply	VBN
cord-015365-iqdi99pd	1363	9	and	and	CC
cord-015365-iqdi99pd	1363	10	managed	manage	VBD
cord-015365-iqdi99pd	1363	11	the	the	DT
cord-015365-iqdi99pd	1363	12	developed	develop	VBN
cord-015365-iqdi99pd	1363	13	infection	infection	NN
cord-015365-iqdi99pd	1363	14	well	well	RB
cord-015365-iqdi99pd	1363	15	even	even	RB
cord-015365-iqdi99pd	1363	16	if	if	IN
cord-015365-iqdi99pd	1363	17	it	-PRON-	PRP
cord-015365-iqdi99pd	1363	18	had	have	VBD
cord-015365-iqdi99pd	1363	19	to	to	TO
cord-015365-iqdi99pd	1363	20	be	be	VB
cord-015365-iqdi99pd	1363	21	placed	place	VBN
cord-015365-iqdi99pd	1363	22	directly	directly	RB
cord-015365-iqdi99pd	1363	23	on	on	IN
cord-015365-iqdi99pd	1363	24	the	the	DT
cord-015365-iqdi99pd	1363	25	patch	patch	NN
cord-015365-iqdi99pd	1363	26	.	.	.
cord-015365-iqdi99pd	1364	1	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	1364	2	.	.	.
cord-015365-iqdi99pd	1365	1	Empfänger	Empfänger	NNP
cord-015365-iqdi99pd	1365	2	-	-	HYPH
cord-015365-iqdi99pd	1365	3	Desensibilisierung	Desensibilisierung	NNP
cord-015365-iqdi99pd	1365	4	mittels	mittels	NNP
cord-015365-iqdi99pd	1365	5	Blutgruppen	Blutgruppen	NNP
cord-015365-iqdi99pd	1365	6	-	-	HYPH
cord-015365-iqdi99pd	1365	7	spezifischer	spezifischer	NNP
cord-015365-iqdi99pd	1365	8	Immunadsorption	Immunadsorption	NNP
cord-015365-iqdi99pd	1366	1	(	(	-LRB-
cord-015365-iqdi99pd	1366	2	ABO	ABO	NNP
cord-015365-iqdi99pd	1366	3	-	-	HYPH
cord-015365-iqdi99pd	1366	4	IA	IA	NNP
cord-015365-iqdi99pd	1366	5	)	)	-RRB-
cord-015365-iqdi99pd	1367	1	ist	ist	NNP
cord-015365-iqdi99pd	1367	2	derzeit	derzeit	NNP
cord-015365-iqdi99pd	1367	3	das	das	NNP
cord-015365-iqdi99pd	1367	4	Mittel	Mittel	NNP
cord-015365-iqdi99pd	1367	5	der	der	NNP
cord-015365-iqdi99pd	1367	6	Wahl	Wahl	NNP
cord-015365-iqdi99pd	1367	7	,	,	,
cord-015365-iqdi99pd	1367	8	um	um	UH
cord-015365-iqdi99pd	1367	9	eine	eine	NN
cord-015365-iqdi99pd	1367	10	erfolgreiche	erfolgreiche	JJ
cord-015365-iqdi99pd	1368	1	Transplantation	transplantation	NN
cord-015365-iqdi99pd	1368	2	über	über	NN
cord-015365-iqdi99pd	1368	3	die	die	VBP
cord-015365-iqdi99pd	1368	4	ABO	ABO	NNP
cord-015365-iqdi99pd	1368	5	-	-	HYPH
cord-015365-iqdi99pd	1368	6	Blutgruppen	Blutgruppen	NNP
cord-015365-iqdi99pd	1368	7	-	-	HYPH
cord-015365-iqdi99pd	1368	8	Barriere	Barriere	NNP
cord-015365-iqdi99pd	1368	9	zu	zu	NNP
cord-015365-iqdi99pd	1368	10	ermöglichen	ermöglichen	NN
cord-015365-iqdi99pd	1368	11	.	.	.
cord-015365-iqdi99pd	1369	1	Zu	Zu	NNP
cord-015365-iqdi99pd	1369	2	diesem	diesem	JJ
cord-015365-iqdi99pd	1369	3	Zweck	Zweck	NNP
cord-015365-iqdi99pd	1369	4	wäre	wäre	NNP
cord-015365-iqdi99pd	1369	5	der	der	NNP
cord-015365-iqdi99pd	1369	6	Einsatz	Einsatz	NNP
cord-015365-iqdi99pd	1369	7	von	von	NNP
cord-015365-iqdi99pd	1369	8	regenerierbaren	regenerierbaren	NNP
cord-015365-iqdi99pd	1369	9	,	,	,
cord-015365-iqdi99pd	1369	10	nicht	nicht	NNP
cord-015365-iqdi99pd	1369	11	-	-	HYPH
cord-015365-iqdi99pd	1369	12	Antigen	Antigen	NNP
cord-015365-iqdi99pd	1369	13	-	-	HYPH
cord-015365-iqdi99pd	1369	14	spezifischen	spezifischen	NNP
cord-015365-iqdi99pd	1369	15	(	(	-LRB-
cord-015365-iqdi99pd	1369	16	semiselektiven	semiselektiven	NNP
cord-015365-iqdi99pd	1369	17	)	)	-RRB-
cord-015365-iqdi99pd	1370	1	Adsorbern	Adsorbern	NNP
cord-015365-iqdi99pd	1370	2	ebenfalls	ebenfalls	NNP
cord-015365-iqdi99pd	1370	3	denkbar	denkbar	NNP
cord-015365-iqdi99pd	1370	4	,	,	,
cord-015365-iqdi99pd	1370	5	aber	aber	NNP
cord-015365-iqdi99pd	1370	6	die	die	VB
cord-015365-iqdi99pd	1371	1	Effizienz	Effizienz	NNP
cord-015365-iqdi99pd	1371	2	dieser	dieser	NNP
cord-015365-iqdi99pd	1371	3	Immunadsorptionsmaterialien	Immunadsorptionsmaterialien	NNP
cord-015365-iqdi99pd	1371	4	wurde	wurde	VBD
cord-015365-iqdi99pd	1371	5	in	in	IN
cord-015365-iqdi99pd	1371	6	diesem	diesem	JJ
cord-015365-iqdi99pd	1371	7	Zusammenhang	Zusammenhang	NNP
cord-015365-iqdi99pd	1371	8	noch	noch	NNP
cord-015365-iqdi99pd	1371	9	nicht	nicht	NNP
cord-015365-iqdi99pd	1371	10	getestet	getestet	NNP
cord-015365-iqdi99pd	1371	11	.	.	.
cord-015365-iqdi99pd	1372	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	1372	2	.	.	.
cord-015365-iqdi99pd	1373	1	Acht	Acht	NNP
cord-015365-iqdi99pd	1373	2	mit	mit	NNP
cord-015365-iqdi99pd	1373	3	ABO	ABO	NNP
cord-015365-iqdi99pd	1373	4	-	-	HYPH
cord-015365-iqdi99pd	1373	5	IA	IA	NNP
cord-015365-iqdi99pd	1373	6	behandelte	behandelte	NNP
cord-015365-iqdi99pd	1373	7	Transplantationskandidaten	Transplantationskandidaten	NNP
cord-015365-iqdi99pd	1373	8	und	und	IN
cord-015365-iqdi99pd	1373	9	39	39	CD
cord-015365-iqdi99pd	1373	10	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1373	11	,	,	,
cord-015365-iqdi99pd	1373	12	die	die	VBP
cord-015365-iqdi99pd	1373	13	mit	mit	NNP
cord-015365-iqdi99pd	1373	14	verschiedenen	verschiedenen	NNP
cord-015365-iqdi99pd	1374	1	Indikationen	Indikationen	NNP
cord-015365-iqdi99pd	1374	2	außerhalb	außerhalb	NN
cord-015365-iqdi99pd	1374	3	der	der	NNP
cord-015365-iqdi99pd	1374	4	ABO	ABO	NNP
cord-015365-iqdi99pd	1374	5	-	-	HYPH
cord-015365-iqdi99pd	1374	6	inkompatiblen	inkompatiblen	NNP
cord-015365-iqdi99pd	1375	1	Transplantation	transplantation	NN
cord-015365-iqdi99pd	1375	2	mit	mit	JJ
cord-015365-iqdi99pd	1376	1	semiselektiver	semiselektiver	NNP
cord-015365-iqdi99pd	1376	2	Immunadsorption	Immunadsorption	NNP
cord-015365-iqdi99pd	1376	3	behandelt	behandelt	NNP
cord-015365-iqdi99pd	1376	4	wurden	wurden	NNP
cord-015365-iqdi99pd	1376	5	,	,	,
cord-015365-iqdi99pd	1376	6	wurden	wurden	NNP
cord-015365-iqdi99pd	1376	7	in	in	IN
cord-015365-iqdi99pd	1376	8	die	die	JJ
cord-015365-iqdi99pd	1376	9	Studie	Studie	NNP
cord-015365-iqdi99pd	1376	10	inkludiert	inkludiert	JJ
cord-015365-iqdi99pd	1376	11	.	.	.
cord-015365-iqdi99pd	1377	1	Die	die	VB
cord-015365-iqdi99pd	1377	2	semiselektive	semiselektive	VBZ
cord-015365-iqdi99pd	1377	3	Behandlung	Behandlung	NNP
cord-015365-iqdi99pd	1377	4	basierte	basierte	NNP
cord-015365-iqdi99pd	1377	5	auf	auf	NNP
cord-015365-iqdi99pd	1377	6	IA	IA	NNP
cord-015365-iqdi99pd	1377	7	mit	mit	NNP
cord-015365-iqdi99pd	1377	8	Protein	Protein	NNP
cord-015365-iqdi99pd	1377	9	A	A	NNP
cord-015365-iqdi99pd	1377	10	,	,	,
cord-015365-iqdi99pd	1377	11	Peptid	Peptid	NNP
cord-015365-iqdi99pd	1377	12	-	-	HYPH
cord-015365-iqdi99pd	1377	13	Ligand	Ligand	NNP
cord-015365-iqdi99pd	1377	14	und	und	IN
cord-015365-iqdi99pd	1377	15	Anti	anti	JJ
cord-015365-iqdi99pd	1377	16	-	-	JJ
cord-015365-iqdi99pd	1377	17	human	human	JJ
cord-015365-iqdi99pd	1377	18	Immunglobulin	Immunglobulin	NNP
cord-015365-iqdi99pd	1377	19	Antikörpern	Antikörpern	NNP
cord-015365-iqdi99pd	1377	20	.	.	.
cord-015365-iqdi99pd	1378	1	Antikörper	Antikörper	NNP
cord-015365-iqdi99pd	1378	2	-	-	HYPH
cord-015365-iqdi99pd	1378	3	Muster	Muster	NNP
cord-015365-iqdi99pd	1378	4	(	(	-LRB-
cord-015365-iqdi99pd	1378	5	IgG	IgG	NNP
cord-015365-iqdi99pd	1378	6	,	,	,
cord-015365-iqdi99pd	1378	7	IgG1	IgG1	NNP
cord-015365-iqdi99pd	1378	8	-	-	HYPH
cord-015365-iqdi99pd	1378	9	4	4	CD
cord-015365-iqdi99pd	1378	10	Subklassen	Subklassen	NNP
cord-015365-iqdi99pd	1378	11	,	,	,
cord-015365-iqdi99pd	1378	12	IgM	IgM	NNP
cord-015365-iqdi99pd	1378	13	und	und	IN
cord-015365-iqdi99pd	1378	14	Komplement	Komplement	NNP
cord-015365-iqdi99pd	1378	15	-	-	HYPH
cord-015365-iqdi99pd	1378	16	fixierende	fixierende	NNP
cord-015365-iqdi99pd	1378	17	Reaktivitäten	Reaktivitäten	NNP
cord-015365-iqdi99pd	1378	18	)	)	-RRB-
cord-015365-iqdi99pd	1378	19	wurden	wurden	VBD
cord-015365-iqdi99pd	1378	20	mit	mit	NNP
cord-015365-iqdi99pd	1378	21	Durchflusszytometrie	Durchflusszytometrie	NNP
cord-015365-iqdi99pd	1378	22	und	und	IN
cord-015365-iqdi99pd	1378	23	konventionellen	konventionellen	NNP
cord-015365-iqdi99pd	1379	1	Agglutinationstests	Agglutinationstests	NNP
cord-015365-iqdi99pd	1379	2	analysiert	analysiert	VBP
cord-015365-iqdi99pd	1379	3	.	.	.
cord-015365-iqdi99pd	1380	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	1380	2	.	.	.
cord-015365-iqdi99pd	1381	1	Die	die	VB
cord-015365-iqdi99pd	1381	2	sensitive	sensitive	JJ
cord-015365-iqdi99pd	1381	3	Durchflusszytometrie	Durchflusszytometrie	NNP
cord-015365-iqdi99pd	1381	4	-	-	HYPH
cord-015365-iqdi99pd	1381	5	Analyse	Analyse	NNP
cord-015365-iqdi99pd	1381	6	der	der	NN
cord-015365-iqdi99pd	1381	7	mit	mit	NNP
cord-015365-iqdi99pd	1381	8	ABO	ABO	NNP
cord-015365-iqdi99pd	1381	9	-	-	HYPH
cord-015365-iqdi99pd	1381	10	IA	IA	NNP
cord-015365-iqdi99pd	1381	11	desensibilisierten	desensibilisierten	NNP
cord-015365-iqdi99pd	1381	12	Transplantationskandidaten	Transplantationskandidaten	NNP
cord-015365-iqdi99pd	1381	13	ergab	ergab	NN
cord-015365-iqdi99pd	1382	1	eine	eine	NNP
cord-015365-iqdi99pd	1382	2	profunde	profunde	NNP
cord-015365-iqdi99pd	1382	3	,	,	,
cord-015365-iqdi99pd	1382	4	aber	aber	NNP
cord-015365-iqdi99pd	1382	5	auch	auch	NNP
cord-015365-iqdi99pd	1382	6	oft	oft	NNP
cord-015365-iqdi99pd	1382	7	unvollständige	unvollständige	NNP
cord-015365-iqdi99pd	1382	8	Reduktion	Reduktion	NNP
cord-015365-iqdi99pd	1382	9	der	der	NNP
cord-015365-iqdi99pd	1382	10	ABO	ABO	NNP
cord-015365-iqdi99pd	1382	11	-	-	HYPH
cord-015365-iqdi99pd	1382	12	Blutgruppen	Blutgruppen	NNP
cord-015365-iqdi99pd	1382	13	-	-	HYPH
cord-015365-iqdi99pd	1382	14	spezifischen	spezifischen	NNS
cord-015365-iqdi99pd	1382	15	Antikörper	Antikörper	NNP
cord-015365-iqdi99pd	1382	16	(	(	-LRB-
cord-015365-iqdi99pd	1382	17	anti	anti	JJ
cord-015365-iqdi99pd	1382	18	-	-	JJ
cord-015365-iqdi99pd	1382	19	A/	A/	NNP
cord-015365-iqdi99pd	1382	20	B	B	NNP
cord-015365-iqdi99pd	1382	21	)	)	-RRB-
cord-015365-iqdi99pd	1382	22	.	.	.
cord-015365-iqdi99pd	1383	1	Persistierende	Persistierende	NNP
cord-015365-iqdi99pd	1383	2	Komplement	Komplement	NNP
cord-015365-iqdi99pd	1383	3	-	-	HYPH
cord-015365-iqdi99pd	1383	4	oder	oder	NNP
cord-015365-iqdi99pd	1383	5	auch	auch	JJ
cord-015365-iqdi99pd	1383	6	Nicht	Nicht	NNP
cord-015365-iqdi99pd	1383	7	-	-	HYPH
cord-015365-iqdi99pd	1383	8	Komplement	Komplement	NNP
cord-015365-iqdi99pd	1383	9	-	-	HYPH
cord-015365-iqdi99pd	1383	10	fixierende	fixierende	NNP
cord-015365-iqdi99pd	1383	11	Reaktivitäten	Reaktivitäten	NNP
cord-015365-iqdi99pd	1383	12	konnten	konnten	NNP
cord-015365-iqdi99pd	1383	13	jedoch	jedoch	NNP
cord-015365-iqdi99pd	1383	14	nicht	nicht	NNP
cord-015365-iqdi99pd	1383	15	mit	mit	NNP
cord-015365-iqdi99pd	1383	16	Abstoßung	Abstoßung	NNP
cord-015365-iqdi99pd	1383	17	oder	oder	NNP
cord-015365-iqdi99pd	1383	18	mit	mit	NNP
cord-015365-iqdi99pd	1383	19	C4d	C4d	NNP
cord-015365-iqdi99pd	1383	20	-	-	HYPH
cord-015365-iqdi99pd	1383	21	Ablagerung	Ablagerung	NNP
cord-015365-iqdi99pd	1383	22	in	in	IN
cord-015365-iqdi99pd	1383	23	Kapillaren	Kapillaren	NNP
cord-015365-iqdi99pd	1383	24	von	von	NNP
cord-015365-iqdi99pd	1383	25	Protokoll	Protokoll	NNP
cord-015365-iqdi99pd	1383	26	-	-	HYPH
cord-015365-iqdi99pd	1383	27	Biopsien	Biopsien	NNP
cord-015365-iqdi99pd	1383	28	assoziiert	assoziiert	NN
cord-015365-iqdi99pd	1383	29	werden	werden	NNP
cord-015365-iqdi99pd	1383	30	.	.	.
cord-015365-iqdi99pd	1384	1	Beim	Beim	NNP
cord-015365-iqdi99pd	1384	2	Vergleich	Vergleich	NNP
cord-015365-iqdi99pd	1384	3	zwischen	zwischen	NNP
cord-015365-iqdi99pd	1384	4	semiselektiver	semiselektiver	NNP
cord-015365-iqdi99pd	1385	1	und	und	NNP
cord-015365-iqdi99pd	1385	2	selektiver	selektiver	NNP
cord-015365-iqdi99pd	1385	3	IA	IA	NNP
cord-015365-iqdi99pd	1386	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1386	2	m	be	VBP
cord-015365-iqdi99pd	1386	3	Rahmen	Rahmen	NNP
cord-015365-iqdi99pd	1386	4	einer	einer	NNP
cord-015365-iqdi99pd	1386	5	einmaligen	einmaligen	NNP
cord-015365-iqdi99pd	1386	6	Behandlungssitzung	Behandlungssitzung	NNP
cord-015365-iqdi99pd	1386	7	stellten	stellten	NNP
cord-015365-iqdi99pd	1387	1	sich	sich	NNP
cord-015365-iqdi99pd	1387	2	die	die	VBP
cord-015365-iqdi99pd	1387	3	semiselektiven	semiselektiven	NNP
cord-015365-iqdi99pd	1387	4	Adsorber	Adsorber	NNP
cord-015365-iqdi99pd	1387	5	als	als	CD
cord-015365-iqdi99pd	1387	6	effizienter	effizienter	NN
cord-015365-iqdi99pd	1387	7	in	in	IN
cord-015365-iqdi99pd	1387	8	der	der	NNP
cord-015365-iqdi99pd	1387	9	Reduktion	Reduktion	NNP
cord-015365-iqdi99pd	1387	10	von	von	NNP
cord-015365-iqdi99pd	1387	11	anti	anti	NNP
cord-015365-iqdi99pd	1387	12	-	-	NNP
cord-015365-iqdi99pd	1387	13	A	A	NNP
cord-015365-iqdi99pd	1387	14	/	/	SYM
cord-015365-iqdi99pd	1387	15	B	B	NNP
cord-015365-iqdi99pd	1387	16	IgG	igg	NN
cord-015365-iqdi99pd	1387	17	heraus	heraus	NNP
cord-015365-iqdi99pd	1388	1	(	(	-LRB-
cord-015365-iqdi99pd	1388	2	Reduktion	Reduktion	NNP
cord-015365-iqdi99pd	1388	3	der	der	NNP
cord-015365-iqdi99pd	1388	4	Mediane	Mediane	NNP
cord-015365-iqdi99pd	1389	1	auf	auf	NNP
cord-015365-iqdi99pd	1389	2	28	28	CD
cord-015365-iqdi99pd	1389	3	%	%	NN
cord-015365-iqdi99pd	1389	4	der	der	NNP
cord-015365-iqdi99pd	1389	5	Ausgangswerte	Ausgangswerte	NNP
cord-015365-iqdi99pd	1389	6	versus	versus	IN
cord-015365-iqdi99pd	1389	7	59	59	CD
cord-015365-iqdi99pd	1389	8	%	%	NN
cord-015365-iqdi99pd	1389	9	bei	bei	NNP
cord-015365-iqdi99pd	1389	10	ABO	ABO	NNP
cord-015365-iqdi99pd	1389	11	-	-	HYPH
cord-015365-iqdi99pd	1389	12	IA	IA	NNP
cord-015365-iqdi99pd	1389	13	,	,	,
cord-015365-iqdi99pd	1389	14	p	p	NN
cord-015365-iqdi99pd	1389	15	<	<	XX
cord-015365-iqdi99pd	1389	16	0,001	0,001	CD
cord-015365-iqdi99pd	1389	17	)	)	-RRB-
cord-015365-iqdi99pd	1389	18	.	.	.
cord-015365-iqdi99pd	1390	1	I	-PRON-	PRP
cord-015365-iqdi99pd	1391	1	m	m	LS
cord-015365-iqdi99pd	1392	1	Gegensatz	Gegensatz	NNP
cord-015365-iqdi99pd	1392	2	dazu	dazu	NN
cord-015365-iqdi99pd	1392	3	wurden	wurden	VBD
cord-015365-iqdi99pd	1392	4	Blutgruppen	Blutgruppen	NNP
cord-015365-iqdi99pd	1392	5	-	-	HYPH
cord-015365-iqdi99pd	1392	6	spezifisches	spezifisches	NNP
cord-015365-iqdi99pd	1392	7	IgM	IgM	NNP
cord-015365-iqdi99pd	1392	8	(	(	-LRB-
cord-015365-iqdi99pd	1392	9	74	74	CD
cord-015365-iqdi99pd	1392	10	%	%	NN
cord-015365-iqdi99pd	1392	11	versus	versus	IN
cord-015365-iqdi99pd	1392	12	30	30	CD
cord-015365-iqdi99pd	1392	13	%	%	NN
cord-015365-iqdi99pd	1392	14	,	,	,
cord-015365-iqdi99pd	1392	15	p	p	NN
cord-015365-iqdi99pd	1392	16	<	<	XX
cord-015365-iqdi99pd	1392	17	0,001	0,001	CD
cord-015365-iqdi99pd	1392	18	)	)	-RRB-
cord-015365-iqdi99pd	1392	19	und	und	RB
cord-015365-iqdi99pd	1392	20	IgG3	IgG3	NNP
cord-015365-iqdi99pd	1392	21	(	(	-LRB-
cord-015365-iqdi99pd	1392	22	72	72	CD
cord-015365-iqdi99pd	1392	23	%	%	NN
cord-015365-iqdi99pd	1392	24	versus	versus	IN
cord-015365-iqdi99pd	1392	25	42	42	CD
cord-015365-iqdi99pd	1392	26	%	%	NN
cord-015365-iqdi99pd	1392	27	,	,	,
cord-015365-iqdi99pd	1392	28	p	p	NN
cord-015365-iqdi99pd	1392	29	<	<	XX
cord-015365-iqdi99pd	1392	30	0,05	0,05	XX
cord-015365-iqdi99pd	1392	31	)	)	-RRB-
cord-015365-iqdi99pd	1393	1	weniger	weniger	NNP
cord-015365-iqdi99pd	1393	2	gut	gut	NNP
cord-015365-iqdi99pd	1393	3	dezimiert	dezimiert	NNP
cord-015365-iqdi99pd	1393	4	,	,	,
cord-015365-iqdi99pd	1393	5	ohne	ohne	NNP
cord-015365-iqdi99pd	1393	6	erkennbare	erkennbare	NNP
cord-015365-iqdi99pd	1393	7	Unterschiede	Unterschiede	NNP
cord-015365-iqdi99pd	1394	1	zwischen	zwischen	NNP
cord-015365-iqdi99pd	1394	2	den	den	NNP
cord-015365-iqdi99pd	1394	3	getesteten	getesteten	NNP
cord-015365-iqdi99pd	1394	4	semiselektiven	semiselektiven	NNP
cord-015365-iqdi99pd	1394	5	Adsorber	Adsorber	NNP
cord-015365-iqdi99pd	1394	6	-	-	HYPH
cord-015365-iqdi99pd	1394	7	Typen	Typen	NNP
cord-015365-iqdi99pd	1394	8	.	.	.
cord-015365-iqdi99pd	1395	1	Eine	Eine	NNP
cord-015365-iqdi99pd	1395	2	Analyse	Analyse	NNP
cord-015365-iqdi99pd	1395	3	nach	nach	FW
cord-015365-iqdi99pd	1395	4	vier	vier	NNP
cord-015365-iqdi99pd	1395	5	konsekutiven	konsekutiven	NNP
cord-015365-iqdi99pd	1395	6	IA	IA	NNP
cord-015365-iqdi99pd	1395	7	-	-	HYPH
cord-015365-iqdi99pd	1395	8	Sitzungen	Sitzungen	NNP
cord-015365-iqdi99pd	1395	9	zeigte	zeigte	NNP
cord-015365-iqdi99pd	1395	10	,	,	,
cord-015365-iqdi99pd	1395	11	dass	dass	NNP
cord-015365-iqdi99pd	1395	12	die	die	VBP
cord-015365-iqdi99pd	1395	13	unterlegene	unterlegene	NNP
cord-015365-iqdi99pd	1395	14	Effizienz	Effizienz	NNP
cord-015365-iqdi99pd	1395	15	nicht	nicht	NNP
cord-015365-iqdi99pd	1395	16	durch	durch	NNP
cord-015365-iqdi99pd	1395	17	wiederholte	wiederholte	NNP
cord-015365-iqdi99pd	1395	18	Behandlungen	Behandlungen	NNP
cord-015365-iqdi99pd	1395	19	wettgemacht	wettgemacht	FW
cord-015365-iqdi99pd	1395	20	werden	werden	NNP
cord-015365-iqdi99pd	1395	21	konnte	konnte	NNP
cord-015365-iqdi99pd	1395	22	.	.	.
cord-015365-iqdi99pd	1396	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	1396	2	.	.	.
cord-015365-iqdi99pd	1397	1	Unsere	unsere	JJ
cord-015365-iqdi99pd	1398	1	Beobachtung	Beobachtung	NNP
cord-015365-iqdi99pd	1398	2	einer	einer	NNP
cord-015365-iqdi99pd	1398	3	limitierten	limitierten	NNP
cord-015365-iqdi99pd	1399	1	Adsorptionskapazität	Adsorptionskapazität	NNP
cord-015365-iqdi99pd	1400	1	bezü	bezü	NNP
cord-015365-iqdi99pd	1400	2	glich	glich	NNP
cord-015365-iqdi99pd	1401	1	bestimmter	bestimmter	NNP
cord-015365-iqdi99pd	1401	2	Blutgruppenspezifischer	Blutgruppenspezifischer	NNP
cord-015365-iqdi99pd	1401	3	Immunglobulin-(Sub-)Klassen	Immunglobulin-(Sub-)Klassen	NNP
cord-015365-iqdi99pd	1402	1	lässt	lässt	NNP
cord-015365-iqdi99pd	1403	1	zu	zu	NNP
cord-015365-iqdi99pd	1403	2	erhöhter	erhöhter	NNP
cord-015365-iqdi99pd	1404	1	Vorsicht	Vorsicht	NNP
cord-015365-iqdi99pd	1404	2	bei	bei	NNP
cord-015365-iqdi99pd	1404	3	der	der	NNP
cord-015365-iqdi99pd	1404	4	Verwendung	Verwendung	NNP
cord-015365-iqdi99pd	1404	5	von	von	NNP
cord-015365-iqdi99pd	1404	6	semiselektiven	semiselektiven	VBN
cord-015365-iqdi99pd	1404	7	Immunadsorptionstechniken	Immunadsorptionstechniken	NNP
cord-015365-iqdi99pd	1404	8	bei	bei	NNP
cord-015365-iqdi99pd	1404	9	ABO	ABO	NNP
cord-015365-iqdi99pd	1404	10	-	-	HYPH
cord-015365-iqdi99pd	1404	11	inkompatibler	inkompatibler	NNP
cord-015365-iqdi99pd	1404	12	Nierentransplantation	Nierentransplantation	NNP
cord-015365-iqdi99pd	1404	13	raten	raten	NNP
cord-015365-iqdi99pd	1404	14	.	.	.
cord-015365-iqdi99pd	1405	1	New	new	JJ
cord-015365-iqdi99pd	1405	2	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	1405	3	strategies	strategy	NNS
cord-015365-iqdi99pd	1405	4	for	for	IN
cord-015365-iqdi99pd	1405	5	preserving	preserve	VBG
cord-015365-iqdi99pd	1405	6	renal	renal	JJ
cord-015365-iqdi99pd	1405	7	function	function	NN
cord-015365-iqdi99pd	1405	8	and	and	CC
cord-015365-iqdi99pd	1405	9	improving	improve	VBG
cord-015365-iqdi99pd	1405	10	outcome	outcome	NN
cord-015365-iqdi99pd	1405	11	J.	J.	NNP
cord-015365-iqdi99pd	1405	12	M.	M.	NNP
cord-015365-iqdi99pd	1405	13	G.	G.	NNP
cord-015365-iqdi99pd	1405	14	Boira	Boira	NNP
cord-015365-iqdi99pd	1406	1	The	the	DT
cord-015365-iqdi99pd	1406	2	prevention	prevention	NN
cord-015365-iqdi99pd	1406	3	of	of	IN
cord-015365-iqdi99pd	1406	4	acute	acute	JJ
cord-015365-iqdi99pd	1406	5	rejection	rejection	NN
cord-015365-iqdi99pd	1406	6	(	(	-LRB-
cord-015365-iqdi99pd	1406	7	AR	AR	NNP
cord-015365-iqdi99pd	1406	8	)	)	-RRB-
cord-015365-iqdi99pd	1406	9	has	have	VBZ
cord-015365-iqdi99pd	1406	10	been	be	VBN
cord-015365-iqdi99pd	1406	11	the	the	DT
cord-015365-iqdi99pd	1406	12	main	main	JJ
cord-015365-iqdi99pd	1406	13	goal	goal	NN
cord-015365-iqdi99pd	1406	14	of	of	IN
cord-015365-iqdi99pd	1406	15	new	new	JJ
cord-015365-iqdi99pd	1406	16	immunosuppressants	immunosuppressant	NNS
cord-015365-iqdi99pd	1406	17	(	(	-LRB-
cord-015365-iqdi99pd	1406	18	IS	be	VBZ
cord-015365-iqdi99pd	1406	19	)	)	-RRB-
cord-015365-iqdi99pd	1406	20	introduced	introduce	VBN
cord-015365-iqdi99pd	1406	21	in	in	IN
cord-015365-iqdi99pd	1406	22	renal	renal	JJ
cord-015365-iqdi99pd	1406	23	transplantation	transplantation	NN
cord-015365-iqdi99pd	1406	24	in	in	IN
cord-015365-iqdi99pd	1406	25	the	the	DT
cord-015365-iqdi99pd	1406	26	last	last	JJ
cord-015365-iqdi99pd	1406	27	decades	decade	NNS
cord-015365-iqdi99pd	1406	28	.	.	.
cord-015365-iqdi99pd	1407	1	Nowadays	nowadays	RB
cord-015365-iqdi99pd	1407	2	-with	-with	.
cord-015365-iqdi99pd	1408	1	the	the	DT
cord-015365-iqdi99pd	1408	2	use	use	NN
cord-015365-iqdi99pd	1408	3	of	of	IN
cord-015365-iqdi99pd	1408	4	calcineurin	calcineurin	NN
cord-015365-iqdi99pd	1408	5	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	1408	6	as	as	IN
cord-015365-iqdi99pd	1408	7	mainstay	mainstay	NN
cord-015365-iqdi99pd	1408	8	IS	be	VBZ
cord-015365-iqdi99pd	1408	9	-the	-the	ADD
cord-015365-iqdi99pd	1408	10	rejection	rejection	NN
cord-015365-iqdi99pd	1408	11	rates	rate	NNS
cord-015365-iqdi99pd	1408	12	are	be	VBP
cord-015365-iqdi99pd	1408	13	low	low	JJ
cord-015365-iqdi99pd	1408	14	.	.	.
cord-015365-iqdi99pd	1409	1	However	however	RB
cord-015365-iqdi99pd	1409	2	the	the	DT
cord-015365-iqdi99pd	1409	3	nephrotoxicity	nephrotoxicity	NN
cord-015365-iqdi99pd	1409	4	of	of	IN
cord-015365-iqdi99pd	1409	5	these	these	DT
cord-015365-iqdi99pd	1409	6	agents	agent	NNS
cord-015365-iqdi99pd	1409	7	contribute	contribute	VBP
cord-015365-iqdi99pd	1409	8	to	to	IN
cord-015365-iqdi99pd	1409	9	the	the	DT
cord-015365-iqdi99pd	1409	10	chronic	chronic	JJ
cord-015365-iqdi99pd	1409	11	allograft	allograft	NN
cord-015365-iqdi99pd	1409	12	injury	injury	NN
cord-015365-iqdi99pd	1409	13	which	which	WDT
cord-015365-iqdi99pd	1409	14	may	may	MD
cord-015365-iqdi99pd	1409	15	result	result	VB
cord-015365-iqdi99pd	1409	16	in	in	IN
cord-015365-iqdi99pd	1409	17	graft	graft	NN
cord-015365-iqdi99pd	1409	18	loss	loss	NN
cord-015365-iqdi99pd	1409	19	in	in	IN
cord-015365-iqdi99pd	1409	20	the	the	DT
cord-015365-iqdi99pd	1409	21	long	long	JJ
cord-015365-iqdi99pd	1409	22	term	term	NN
cord-015365-iqdi99pd	1409	23	.	.	.
cord-015365-iqdi99pd	1410	1	New	New	NNP
cord-015365-iqdi99pd	1410	2	IS	IS	NNP
cord-015365-iqdi99pd	1410	3	agents	agent	NNS
cord-015365-iqdi99pd	1410	4	should	should	MD
cord-015365-iqdi99pd	1410	5	effectively	effectively	RB
cord-015365-iqdi99pd	1410	6	prevent	prevent	VB
cord-015365-iqdi99pd	1410	7	AR	AR	NNP
cord-015365-iqdi99pd	1410	8	and	and	CC
cord-015365-iqdi99pd	1410	9	preserve	preserve	VB
cord-015365-iqdi99pd	1410	10	renal	renal	JJ
cord-015365-iqdi99pd	1410	11	function	function	NN
cord-015365-iqdi99pd	1410	12	.	.	.
cord-015365-iqdi99pd	1411	1	New	new	JJ
cord-015365-iqdi99pd	1411	2	biologic	biologic	JJ
cord-015365-iqdi99pd	1411	3	and	and	CC
cord-015365-iqdi99pd	1411	4	small	small	JJ
cord-015365-iqdi99pd	1411	5	molecule	molecule	NN
cord-015365-iqdi99pd	1411	6	agents	agent	NNS
cord-015365-iqdi99pd	1411	7	are	be	VBP
cord-015365-iqdi99pd	1411	8	devoid	devoid	JJ
cord-015365-iqdi99pd	1411	9	of	of	IN
cord-015365-iqdi99pd	1411	10	nephrotoxicity	nephrotoxicity	NN
cord-015365-iqdi99pd	1411	11	and	and	CC
cord-015365-iqdi99pd	1411	12	interfere	interfere	VB
cord-015365-iqdi99pd	1411	13	with	with	IN
cord-015365-iqdi99pd	1411	14	crucial	crucial	JJ
cord-015365-iqdi99pd	1411	15	mechanism	mechanism	NN
cord-015365-iqdi99pd	1411	16	of	of	IN
cord-015365-iqdi99pd	1411	17	allo	allo	NN
cord-015365-iqdi99pd	1411	18	-	-	HYPH
cord-015365-iqdi99pd	1411	19	immune	immune	JJ
cord-015365-iqdi99pd	1411	20	response	response	NN
cord-015365-iqdi99pd	1411	21	.	.	.
cord-015365-iqdi99pd	1412	1	During	during	IN
cord-015365-iqdi99pd	1412	2	the	the	DT
cord-015365-iqdi99pd	1412	3	presentation	presentation	NN
cord-015365-iqdi99pd	1412	4	recent	recent	JJ
cord-015365-iqdi99pd	1412	5	data	datum	NNS
cord-015365-iqdi99pd	1412	6	on	on	IN
cord-015365-iqdi99pd	1412	7	new	new	JJ
cord-015365-iqdi99pd	1412	8	agents	agent	NNS
cord-015365-iqdi99pd	1412	9	and	and	CC
cord-015365-iqdi99pd	1412	10	regimes	regime	NNS
cord-015365-iqdi99pd	1412	11	under	under	IN
cord-015365-iqdi99pd	1412	12	development	development	NN
cord-015365-iqdi99pd	1412	13	in	in	IN
cord-015365-iqdi99pd	1412	14	the	the	DT
cord-015365-iqdi99pd	1412	15	prevention	prevention	NN
cord-015365-iqdi99pd	1412	16	of	of	IN
cord-015365-iqdi99pd	1412	17	AR	AR	NNP
cord-015365-iqdi99pd	1412	18	will	will	MD
cord-015365-iqdi99pd	1412	19	be	be	VB
cord-015365-iqdi99pd	1412	20	discussed	discuss	VBN
cord-015365-iqdi99pd	1412	21	.	.	.
cord-015365-iqdi99pd	1413	1	Das	Das	NNP
cord-015365-iqdi99pd	1413	2	Ziel	Ziel	NNP
cord-015365-iqdi99pd	1413	3	ist	ist	NN
cord-015365-iqdi99pd	1413	4	es	es	NNP
cord-015365-iqdi99pd	1413	5	daher	daher	NNP
cord-015365-iqdi99pd	1413	6	,	,	,
cord-015365-iqdi99pd	1413	7	zum	zum	NNP
cord-015365-iqdi99pd	1413	8	einen	einen	NNP
cord-015365-iqdi99pd	1413	9	die	die	VB
cord-015365-iqdi99pd	1413	10	Empfänger	Empfänger	NNP
cord-015365-iqdi99pd	1413	11	T	T	NNP
cord-015365-iqdi99pd	1413	12	-	-	HYPH
cord-015365-iqdi99pd	1413	13	Lymphozyten	Lymphozyten	NNP
cord-015365-iqdi99pd	1413	14	zu	zu	XX
cord-015365-iqdi99pd	1413	15	eliminieren	eliminieren	NNP
cord-015365-iqdi99pd	1414	1	oder	oder	NNP
cord-015365-iqdi99pd	1414	2	zu	zu	NNP
cord-015365-iqdi99pd	1414	3	tolerisieren	tolerisieren	NNP
cord-015365-iqdi99pd	1414	4	und	und	IN
cord-015365-iqdi99pd	1414	5	zum	zum	NNP
cord-015365-iqdi99pd	1414	6	anderen	anderen	NNP
cord-015365-iqdi99pd	1414	7	die	die	VBP
cord-015365-iqdi99pd	1415	1	Spender	Spender	NNP
cord-015365-iqdi99pd	1415	2	T	T	NNP
cord-015365-iqdi99pd	1415	3	-	-	HYPH
cord-015365-iqdi99pd	1415	4	Lymphozyten	Lymphozyten	NNP
cord-015365-iqdi99pd	1415	5	zu	zu	NNP
cord-015365-iqdi99pd	1415	6	tolerisieren	tolerisieren	NNS
cord-015365-iqdi99pd	1415	7	.	.	.
cord-015365-iqdi99pd	1416	1	Eine	Eine	NNP
cord-015365-iqdi99pd	1416	2	Methode	Methode	NNP
cord-015365-iqdi99pd	1416	3	,	,	,
cord-015365-iqdi99pd	1416	4	die	die	VB
cord-015365-iqdi99pd	1416	5	sich	sich	NNP
cord-015365-iqdi99pd	1416	6	zur	zur	NNP
cord-015365-iqdi99pd	1416	7	Eliminierung	Eliminierung	NNP
cord-015365-iqdi99pd	1416	8	und	und	XX
cord-015365-iqdi99pd	1417	1	Tolerisierung	Tolerisierung	NNP
cord-015365-iqdi99pd	1417	2	der	der	NNP
cord-015365-iqdi99pd	1417	3	Empfänger	Empfänger	NNP
cord-015365-iqdi99pd	1417	4	T	T	NNP
cord-015365-iqdi99pd	1417	5	-	-	HYPH
cord-015365-iqdi99pd	1417	6	Lymphozyten	Lymphozyten	NNP
cord-015365-iqdi99pd	1417	7	in	in	IN
cord-015365-iqdi99pd	1417	8	der	der	NNP
cord-015365-iqdi99pd	1417	9	Knochenmarktransplantation	Knochenmarktransplantation	NNP
cord-015365-iqdi99pd	1417	10	bewährt	bewährt	NN
cord-015365-iqdi99pd	1417	11	hat	hat	NN
cord-015365-iqdi99pd	1417	12	,	,	,
cord-015365-iqdi99pd	1417	13	ist	ist	NNP
cord-015365-iqdi99pd	1417	14	,	,	,
cord-015365-iqdi99pd	1417	15	neben	neben	NNP
cord-015365-iqdi99pd	1417	16	der	der	NNP
cord-015365-iqdi99pd	1417	17	medikamentösen	medikamentösen	NNP
cord-015365-iqdi99pd	1417	18	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1417	19	,	,	,
cord-015365-iqdi99pd	1417	20	die	die	VBP
cord-015365-iqdi99pd	1417	21	total	total	JJ
cord-015365-iqdi99pd	1417	22	nodale	nodale	JJ
cord-015365-iqdi99pd	1417	23	Lymphknotenbestrahlung	Lymphknotenbestrahlung	NNP
cord-015365-iqdi99pd	1417	24	.	.	.
cord-015365-iqdi99pd	1418	1	Damit	Damit	NNP
cord-015365-iqdi99pd	1418	2	können	können	NNP
cord-015365-iqdi99pd	1418	3	Abstoßungsreaktionen	Abstoßungsreaktionen	NNP
cord-015365-iqdi99pd	1418	4	selbst	selbst	NNP
cord-015365-iqdi99pd	1418	5	bei	bei	NNP
cord-015365-iqdi99pd	1418	6	HLA	HLA	NNP
cord-015365-iqdi99pd	1418	7	-	-	HYPH
cord-015365-iqdi99pd	1418	8	nichtidenten	nichtidenten	NNP
cord-015365-iqdi99pd	1419	1	Knochenmarktransplantationen	Knochenmarktransplantationen	NNP
cord-015365-iqdi99pd	1419	2	weitgehend	weitgehend	NNP
cord-015365-iqdi99pd	1419	3	verhindert	verhindert	NNP
cord-015365-iqdi99pd	1419	4	werden	werden	NNP
cord-015365-iqdi99pd	1419	5	.	.	.
cord-015365-iqdi99pd	1420	1	Zur	Zur	NNP
cord-015365-iqdi99pd	1420	2	Behandlung	Behandlung	NNP
cord-015365-iqdi99pd	1420	3	der	der	NNP
cord-015365-iqdi99pd	1420	4	GvHD	GvHD	NNP
cord-015365-iqdi99pd	1420	5	hat	hat	NN
cord-015365-iqdi99pd	1420	6	sich	sich	NNP
cord-015365-iqdi99pd	1420	7	in	in	IN
cord-015365-iqdi99pd	1420	8	der	der	NNP
cord-015365-iqdi99pd	1420	9	allogenen	allogenen	NNP
cord-015365-iqdi99pd	1420	10	Knochenmarktransplantation	Knochenmarktransplantation	NNP
cord-015365-iqdi99pd	1420	11	die	die	VBP
cord-015365-iqdi99pd	1420	12	extracorporale	extracorporale	NN
cord-015365-iqdi99pd	1420	13	Photopherese	Photopherese	NNP
cord-015365-iqdi99pd	1420	14	(	(	-LRB-
cord-015365-iqdi99pd	1420	15	ECP	ECP	NNP
cord-015365-iqdi99pd	1420	16	)	)	-RRB-
cord-015365-iqdi99pd	1420	17	bewährt	bewährt	NNP
cord-015365-iqdi99pd	1420	18	,	,	,
cord-015365-iqdi99pd	1420	19	die	die	VB
cord-015365-iqdi99pd	1420	20	durch	durch	NNP
cord-015365-iqdi99pd	1421	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1421	2	m	be	VBP
cord-015365-iqdi99pd	1421	3	einzelnen	einzelnen	NNP
cord-015365-iqdi99pd	1421	4	nicht	nicht	NNP
cord-015365-iqdi99pd	1421	5	vollkommen	vollkommen	NNP
cord-015365-iqdi99pd	1421	6	aufgeklärte	aufgeklärte	NNP
cord-015365-iqdi99pd	1421	7	Mechanismen	Mechanismen	NNP
cord-015365-iqdi99pd	1422	1	eine	eine	NNP
cord-015365-iqdi99pd	1422	2	Toleranz	Toleranz	NNP
cord-015365-iqdi99pd	1422	3	induziert	induziert	NN
cord-015365-iqdi99pd	1422	4	und	und	NNP
cord-015365-iqdi99pd	1422	5	somit	somit	NNP
cord-015365-iqdi99pd	1422	6	in	in	IN
cord-015365-iqdi99pd	1422	7	der	der	NN
cord-015365-iqdi99pd	1422	8	Lage	Lage	NNP
cord-015365-iqdi99pd	1422	9	ist	ist	NNP
cord-015365-iqdi99pd	1422	10	,	,	,
cord-015365-iqdi99pd	1422	11	die	die	VB
cord-015365-iqdi99pd	1422	12	GvHD	GvHD	NNP
cord-015365-iqdi99pd	1422	13	ohne	ohne	NNP
cord-015365-iqdi99pd	1422	14	intensive	intensive	JJ
cord-015365-iqdi99pd	1422	15	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	1422	16	zu	zu	NNP
cord-015365-iqdi99pd	1422	17	mildern	mildern	NNP
cord-015365-iqdi99pd	1422	18	oder	oder	NNP
cord-015365-iqdi99pd	1422	19	auch	auch	NNP
cord-015365-iqdi99pd	1422	20	ganz	ganz	NNP
cord-015365-iqdi99pd	1422	21	zu	zu	NNP
cord-015365-iqdi99pd	1422	22	eliminieren	eliminieren	NNP
cord-015365-iqdi99pd	1422	23	.	.	.
cord-015365-iqdi99pd	1423	1	Anhand	Anhand	NNP
cord-015365-iqdi99pd	1423	2	von	von	NNP
cord-015365-iqdi99pd	1423	3	Fallbeispielen	Fallbeispielen	NNP
cord-015365-iqdi99pd	1424	1	wird	wird	NNP
cord-015365-iqdi99pd	1424	2	diskutiert	diskutiert	NNP
cord-015365-iqdi99pd	1424	3	werden	werden	NNP
cord-015365-iqdi99pd	1425	1	,	,	,
cord-015365-iqdi99pd	1425	2	dass	dass	NNP
cord-015365-iqdi99pd	1425	3	die	die	VBP
cord-015365-iqdi99pd	1425	4	total	total	JJ
cord-015365-iqdi99pd	1425	5	nodale	nodale	NN
cord-015365-iqdi99pd	1426	1	Lymphknotenbestrahlung	Lymphknotenbestrahlung	NNP
cord-015365-iqdi99pd	1426	2	und	und	IN
cord-015365-iqdi99pd	1426	3	ECP	ECP	NNP
cord-015365-iqdi99pd	1426	4	auch	auch	NNP
cord-015365-iqdi99pd	1426	5	in	in	IN
cord-015365-iqdi99pd	1426	6	der	der	NNP
cord-015365-iqdi99pd	1426	7	Organtransplantation	Organtransplantation	NNP
cord-015365-iqdi99pd	1427	1	eine	eine	NNP
cord-015365-iqdi99pd	1427	2	Rolle	Rolle	NNP
cord-015365-iqdi99pd	1427	3	spielen	spielen	NNP
cord-015365-iqdi99pd	1427	4	könnten	könnten	NNP
cord-015365-iqdi99pd	1428	1	,	,	,
cord-015365-iqdi99pd	1428	2	da	da	NNP
cord-015365-iqdi99pd	1428	3	die	die	VBP
cord-015365-iqdi99pd	1428	4	Mechanismen	Mechanismen	NNP
cord-015365-iqdi99pd	1428	5	der	der	NNP
cord-015365-iqdi99pd	1428	6	Toleranz	Toleranz	NNP
cord-015365-iqdi99pd	1428	7	oder	oder	NNP
cord-015365-iqdi99pd	1428	8	Abstoßung	Abstoßung	NNP
cord-015365-iqdi99pd	1428	9	sich	sich	NNP
cord-015365-iqdi99pd	1428	10	prinzipiell	prinzipiell	NNP
cord-015365-iqdi99pd	1428	11	nicht	nicht	NNP
cord-015365-iqdi99pd	1428	12	von	von	NNP
cord-015365-iqdi99pd	1428	13	einer	einer	NNP
cord-015365-iqdi99pd	1428	14	Knochenmarktransplantation	Knochenmarktransplantation	NNP
cord-015365-iqdi99pd	1428	15	unterscheiden	unterscheiden	JJ
cord-015365-iqdi99pd	1428	16	.	.	.
cord-015365-iqdi99pd	1429	1	Plenarsitzung	Plenarsitzung	NNP
cord-015365-iqdi99pd	1429	2	IV	IV	NNP
cord-015365-iqdi99pd	1429	3	:	:	:
cord-015365-iqdi99pd	1430	1	Immun	Immun	NNP
cord-015365-iqdi99pd	1430	2	-	-	HYPH
cord-015365-iqdi99pd	1430	3	und	und	NNP
cord-015365-iqdi99pd	1431	1	Organtoleranz	Organtoleranz	NNP
cord-015365-iqdi99pd	1431	2	/	/	SYM
cord-015365-iqdi99pd	1431	3	Toleranzinduktion	Toleranzinduktion	NNP
cord-015365-iqdi99pd	1431	4	II	II	NNP
cord-015365-iqdi99pd	1431	5	067	067	CD
cord-015365-iqdi99pd	1431	6	Approaches	approach	NNS
cord-015365-iqdi99pd	1431	7	to	to	IN
cord-015365-iqdi99pd	1431	8	tolerance	tolerance	NN
cord-015365-iqdi99pd	1431	9	:	:	:
cord-015365-iqdi99pd	1431	10	mouse	mouse	NN
cord-015365-iqdi99pd	1431	11	to	to	IN
cord-015365-iqdi99pd	1431	12	man	man	VB
cord-015365-iqdi99pd	1431	13	Harvard	Harvard	NNP
cord-015365-iqdi99pd	1431	14	Medical	Medical	NNP
cord-015365-iqdi99pd	1431	15	School	School	NNP
cord-015365-iqdi99pd	1431	16	,	,	,
cord-015365-iqdi99pd	1431	17	Division	Division	NNP
cord-015365-iqdi99pd	1431	18	of	of	IN
cord-015365-iqdi99pd	1431	19	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	1431	20	,	,	,
cord-015365-iqdi99pd	1431	21	Massachusetts	Massachusetts	NNP
cord-015365-iqdi99pd	1431	22	General	General	NNP
cord-015365-iqdi99pd	1431	23	Hospital	Hospital	NNP
cord-015365-iqdi99pd	1431	24	,	,	,
cord-015365-iqdi99pd	1431	25	Boston	Boston	NNP
cord-015365-iqdi99pd	1431	26	,	,	,
cord-015365-iqdi99pd	1431	27	MA	MA	NNP
cord-015365-iqdi99pd	1431	28	,	,	,
cord-015365-iqdi99pd	1431	29	USA	USA	NNP
cord-015365-iqdi99pd	1432	1	Over	over	IN
cord-015365-iqdi99pd	1432	2	the	the	DT
cord-015365-iqdi99pd	1432	3	past	past	JJ
cord-015365-iqdi99pd	1432	4	two	two	CD
cord-015365-iqdi99pd	1432	5	decades	decade	NNS
cord-015365-iqdi99pd	1432	6	,	,	,
cord-015365-iqdi99pd	1432	7	non	non	JJ
cord-015365-iqdi99pd	1432	8	-	-	JJ
cord-015365-iqdi99pd	1432	9	specific	specific	JJ
cord-015365-iqdi99pd	1432	10	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1432	11	(	(	-LRB-
cord-015365-iqdi99pd	1432	12	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1432	13	)	)	-RRB-
cord-015365-iqdi99pd	1432	14	incorporating	incorporate	VBG
cord-015365-iqdi99pd	1432	15	polyclonal	polyclonal	JJ
cord-015365-iqdi99pd	1432	16	and	and	CC
cord-015365-iqdi99pd	1432	17	monoclonal	monoclonal	JJ
cord-015365-iqdi99pd	1432	18	antibodies	antibody	NNS
cord-015365-iqdi99pd	1432	19	,	,	,
cord-015365-iqdi99pd	1432	20	calcineurin	calcineurin	NNP
cord-015365-iqdi99pd	1432	21	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	1432	22	(	(	-LRB-
cord-015365-iqdi99pd	1432	23	CNI	CNI	NNP
cord-015365-iqdi99pd	1432	24	)	)	-RRB-
cord-015365-iqdi99pd	1432	25	,	,	,
cord-015365-iqdi99pd	1432	26	mTOR	mTOR	NNP
cord-015365-iqdi99pd	1432	27	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	1432	28	,	,	,
cord-015365-iqdi99pd	1432	29	anti	anti	NNS
cord-015365-iqdi99pd	1432	30	-	-	NNS
cord-015365-iqdi99pd	1432	31	metabolites	metabolite	NNS
cord-015365-iqdi99pd	1432	32	and	and	CC
cord-015365-iqdi99pd	1432	33	steroids	steroid	NNS
cord-015365-iqdi99pd	1432	34	have	have	VBP
cord-015365-iqdi99pd	1432	35	greatly	greatly	RB
cord-015365-iqdi99pd	1432	36	improved	improve	VBN
cord-015365-iqdi99pd	1432	37	early	early	JJ
cord-015365-iqdi99pd	1432	38	allograft	allograft	NN
cord-015365-iqdi99pd	1432	39	survival	survival	NN
cord-015365-iqdi99pd	1432	40	rates	rate	NNS
cord-015365-iqdi99pd	1432	41	.	.	.
cord-015365-iqdi99pd	1433	1	However	however	RB
cord-015365-iqdi99pd	1433	2	,	,	,
cord-015365-iqdi99pd	1433	3	the	the	DT
cord-015365-iqdi99pd	1433	4	rate	rate	NN
cord-015365-iqdi99pd	1433	5	of	of	IN
cord-015365-iqdi99pd	1433	6	chronic	chronic	JJ
cord-015365-iqdi99pd	1433	7	allograft	allograft	NN
cord-015365-iqdi99pd	1433	8	loss	loss	NN
cord-015365-iqdi99pd	1433	9	has	have	VBZ
cord-015365-iqdi99pd	1433	10	decreased	decrease	VBN
cord-015365-iqdi99pd	1433	11	only	only	RB
cord-015365-iqdi99pd	1433	12	modestly	modestly	RB
cord-015365-iqdi99pd	1433	13	over	over	IN
cord-015365-iqdi99pd	1433	14	that	that	DT
cord-015365-iqdi99pd	1433	15	observed	observe	VBD
cord-015365-iqdi99pd	1433	16	earlier	early	RBR
cord-015365-iqdi99pd	1433	17	.	.	.
cord-015365-iqdi99pd	1434	1	Following	follow	VBG
cord-015365-iqdi99pd	1434	2	kidney	kidney	NN
cord-015365-iqdi99pd	1434	3	transplantation	transplantation	NN
cord-015365-iqdi99pd	1434	4	,	,	,
cord-015365-iqdi99pd	1434	5	for	for	IN
cord-015365-iqdi99pd	1434	6	example	example	NN
cord-015365-iqdi99pd	1434	7	,	,	,
cord-015365-iqdi99pd	1434	8	the	the	DT
cord-015365-iqdi99pd	1434	9	rate	rate	NN
cord-015365-iqdi99pd	1434	10	of	of	IN
cord-015365-iqdi99pd	1434	11	chronic	chronic	JJ
cord-015365-iqdi99pd	1434	12	attrition	attrition	NN
cord-015365-iqdi99pd	1434	13	is	be	VBZ
cord-015365-iqdi99pd	1434	14	discouragingly	discouragingly	RB
cord-015365-iqdi99pd	1434	15	similar	similar	JJ
cord-015365-iqdi99pd	1434	16	to	to	IN
cord-015365-iqdi99pd	1434	17	that	that	DT
cord-015365-iqdi99pd	1434	18	observed	observe	VBD
cord-015365-iqdi99pd	1434	19	two	two	CD
cord-015365-iqdi99pd	1434	20	decades	decade	NNS
cord-015365-iqdi99pd	1434	21	ago	ago	RB
cord-015365-iqdi99pd	1434	22	,	,	,
cord-015365-iqdi99pd	1434	23	generally	generally	RB
cord-015365-iqdi99pd	1434	24	resulting	result	VBG
cord-015365-iqdi99pd	1434	25	from	from	IN
cord-015365-iqdi99pd	1434	26	"	"	``
cord-015365-iqdi99pd	1434	27	chronic	chronic	JJ
cord-015365-iqdi99pd	1434	28	rejection	rejection	NN
cord-015365-iqdi99pd	1434	29	"	"	''
cord-015365-iqdi99pd	1434	30	or	or	CC
cord-015365-iqdi99pd	1434	31	,	,	,
cord-015365-iqdi99pd	1434	32	perhaps	perhaps	RB
cord-015365-iqdi99pd	1434	33	more	more	RBR
cord-015365-iqdi99pd	1434	34	accurately	accurately	RB
cord-015365-iqdi99pd	1434	35	,	,	,
cord-015365-iqdi99pd	1434	36	"	"	``
cord-015365-iqdi99pd	1434	37	chronic	chronic	JJ
cord-015365-iqdi99pd	1434	38	allograft	allograft	NN
cord-015365-iqdi99pd	1434	39	nephropathy	nephropathy	NN
cord-015365-iqdi99pd	1434	40	"	"	''
cord-015365-iqdi99pd	1434	41	.	.	.
cord-015365-iqdi99pd	1435	1	The	the	DT
cord-015365-iqdi99pd	1435	2	relentless	relentless	JJ
cord-015365-iqdi99pd	1435	3	progression	progression	NN
cord-015365-iqdi99pd	1435	4	of	of	IN
cord-015365-iqdi99pd	1435	5	similar	similar	JJ
cord-015365-iqdi99pd	1435	6	histopathologic	histopathologic	JJ
cord-015365-iqdi99pd	1435	7	processes	process	NNS
cord-015365-iqdi99pd	1435	8	is	be	VBZ
cord-015365-iqdi99pd	1435	9	manifested	manifest	VBN
cord-015365-iqdi99pd	1435	10	as	as	IN
cord-015365-iqdi99pd	1435	11	vasculopathy	vasculopathy	NNP
cord-015365-iqdi99pd	1435	12	in	in	IN
cord-015365-iqdi99pd	1435	13	the	the	DT
cord-015365-iqdi99pd	1435	14	coronary	coronary	JJ
cord-015365-iqdi99pd	1435	15	arteries	artery	NNS
cord-015365-iqdi99pd	1435	16	of	of	IN
cord-015365-iqdi99pd	1435	17	heart	heart	NN
cord-015365-iqdi99pd	1435	18	allografts	allografts	NNP
cord-015365-iqdi99pd	1435	19	(	(	-LRB-
cord-015365-iqdi99pd	1435	20	CAV	CAV	NNP
cord-015365-iqdi99pd	1435	21	)	)	-RRB-
cord-015365-iqdi99pd	1435	22	and	and	CC
cord-015365-iqdi99pd	1435	23	in	in	IN
cord-015365-iqdi99pd	1435	24	lung	lung	NN
cord-015365-iqdi99pd	1435	25	transplants	transplant	NNS
cord-015365-iqdi99pd	1435	26	as	as	IN
cord-015365-iqdi99pd	1435	27	obliterative	obliterative	JJ
cord-015365-iqdi99pd	1435	28	bronchiolitis	bronchiolitis	NN
cord-015365-iqdi99pd	1435	29	(	(	-LRB-
cord-015365-iqdi99pd	1435	30	OB	OB	NNP
cord-015365-iqdi99pd	1435	31	)	)	-RRB-
cord-015365-iqdi99pd	1435	32	despite	despite	IN
cord-015365-iqdi99pd	1435	33	the	the	DT
cord-015365-iqdi99pd	1435	34	long	long	JJ
cord-015365-iqdi99pd	1435	35	-	-	HYPH
cord-015365-iqdi99pd	1435	36	term	term	NN
cord-015365-iqdi99pd	1435	37	administration	administration	NN
cord-015365-iqdi99pd	1435	38	of	of	IN
cord-015365-iqdi99pd	1435	39	currently	currently	RB
cord-015365-iqdi99pd	1435	40	available	available	JJ
cord-015365-iqdi99pd	1436	1	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1436	2	Thus	thus	RB
cord-015365-iqdi99pd	1436	3	,	,	,
cord-015365-iqdi99pd	1436	4	the	the	DT
cord-015365-iqdi99pd	1436	5	ultimate	ultimate	JJ
cord-015365-iqdi99pd	1436	6	goal	goal	NN
cord-015365-iqdi99pd	1436	7	of	of	IN
cord-015365-iqdi99pd	1436	8	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1436	9	for	for	IN
cord-015365-iqdi99pd	1436	10	transplant	transplant	NN
cord-015365-iqdi99pd	1436	11	recipients	recipient	NNS
cord-015365-iqdi99pd	1436	12	is	be	VBZ
cord-015365-iqdi99pd	1436	13	the	the	DT
cord-015365-iqdi99pd	1436	14	development	development	NN
cord-015365-iqdi99pd	1436	15	of	of	IN
cord-015365-iqdi99pd	1436	16	long	long	JJ
cord-015365-iqdi99pd	1436	17	-	-	HYPH
cord-015365-iqdi99pd	1436	18	term	term	NN
cord-015365-iqdi99pd	1436	19	donor	donor	NN
cord-015365-iqdi99pd	1436	20	-	-	HYPH
cord-015365-iqdi99pd	1436	21	specific	specific	JJ
cord-015365-iqdi99pd	1436	22	nonresponsiveness	nonresponsiveness	NN
cord-015365-iqdi99pd	1436	23	which	which	WDT
cord-015365-iqdi99pd	1436	24	leaves	leave	VBZ
cord-015365-iqdi99pd	1436	25	responses	response	NNS
cord-015365-iqdi99pd	1436	26	to	to	IN
cord-015365-iqdi99pd	1436	27	other	other	JJ
cord-015365-iqdi99pd	1436	28	foreign	foreign	JJ
cord-015365-iqdi99pd	1436	29	stimuli	stimulus	NNS
cord-015365-iqdi99pd	1436	30	intact	intact	JJ
cord-015365-iqdi99pd	1436	31	.	.	.
cord-015365-iqdi99pd	1437	1	Successful	successful	JJ
cord-015365-iqdi99pd	1437	2	induction	induction	NN
cord-015365-iqdi99pd	1437	3	of	of	IN
cord-015365-iqdi99pd	1437	4	"	"	``
cord-015365-iqdi99pd	1437	5	transplant	transplant	NN
cord-015365-iqdi99pd	1437	6	tolerance	tolerance	NN
cord-015365-iqdi99pd	1437	7	"	"	''
cord-015365-iqdi99pd	1437	8	would	would	MD
cord-015365-iqdi99pd	1437	9	avoid	avoid	VB
cord-015365-iqdi99pd	1437	10	the	the	DT
cord-015365-iqdi99pd	1437	11	complications	complication	NNS
cord-015365-iqdi99pd	1437	12	of	of	IN
cord-015365-iqdi99pd	1437	13	chronically	chronically	RB
cord-015365-iqdi99pd	1437	14	administered	administer	VBN
cord-015365-iqdi99pd	1437	15	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1437	16	and	and	CC
cord-015365-iqdi99pd	1437	17	reduce	reduce	VB
cord-015365-iqdi99pd	1437	18	the	the	DT
cord-015365-iqdi99pd	1437	19	risks	risk	NNS
cord-015365-iqdi99pd	1437	20	of	of	IN
cord-015365-iqdi99pd	1437	21	chronic	chronic	JJ
cord-015365-iqdi99pd	1437	22	rejection	rejection	NN
cord-015365-iqdi99pd	1437	23	.	.	.
cord-015365-iqdi99pd	1438	1	Numerous	numerous	JJ
cord-015365-iqdi99pd	1438	2	approaches	approach	NNS
cord-015365-iqdi99pd	1438	3	employing	employ	VBG
cord-015365-iqdi99pd	1438	4	both	both	DT
cord-015365-iqdi99pd	1438	5	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1438	6	and	and	CC
cord-015365-iqdi99pd	1438	7	central	central	JJ
cord-015365-iqdi99pd	1438	8	tolerance	tolerance	NN
cord-015365-iqdi99pd	1438	9	mechanistic	mechanistic	JJ
cord-015365-iqdi99pd	1438	10	strategies	strategy	NNS
cord-015365-iqdi99pd	1438	11	have	have	VBP
cord-015365-iqdi99pd	1438	12	been	be	VBN
cord-015365-iqdi99pd	1438	13	successfully	successfully	RB
cord-015365-iqdi99pd	1438	14	developed	develop	VBN
cord-015365-iqdi99pd	1438	15	in	in	IN
cord-015365-iqdi99pd	1438	16	rodent	rodent	NN
cord-015365-iqdi99pd	1438	17	models	model	NNS
cord-015365-iqdi99pd	1438	18	.	.	.
cord-015365-iqdi99pd	1439	1	Currently	currently	RB
cord-015365-iqdi99pd	1439	2	,	,	,
cord-015365-iqdi99pd	1439	3	several	several	JJ
cord-015365-iqdi99pd	1439	4	of	of	IN
cord-015365-iqdi99pd	1439	5	these	these	DT
cord-015365-iqdi99pd	1439	6	approaches	approach	NNS
cord-015365-iqdi99pd	1439	7	appear	appear	VBP
cord-015365-iqdi99pd	1439	8	to	to	TO
cord-015365-iqdi99pd	1439	9	be	be	VB
cord-015365-iqdi99pd	1439	10	clinically	clinically	RB
cord-015365-iqdi99pd	1439	11	applicable	applicable	JJ
cord-015365-iqdi99pd	1439	12	,	,	,
cord-015365-iqdi99pd	1439	13	having	have	VBG
cord-015365-iqdi99pd	1439	14	now	now	RB
cord-015365-iqdi99pd	1439	15	proved	prove	VBN
cord-015365-iqdi99pd	1439	16	to	to	TO
cord-015365-iqdi99pd	1439	17	be	be	VB
cord-015365-iqdi99pd	1439	18	effective	effective	JJ
cord-015365-iqdi99pd	1439	19	in	in	IN
cord-015365-iqdi99pd	1439	20	large	large	JJ
cord-015365-iqdi99pd	1439	21	animal	animal	NN
cord-015365-iqdi99pd	1439	22	models	model	NNS
cord-015365-iqdi99pd	1439	23	and	and	CC
cord-015365-iqdi99pd	1439	24	preliminary	preliminary	JJ
cord-015365-iqdi99pd	1439	25	clinical	clinical	JJ
cord-015365-iqdi99pd	1439	26	trials	trial	NNS
cord-015365-iqdi99pd	1439	27	.	.	.
cord-015365-iqdi99pd	1440	1	The	the	DT
cord-015365-iqdi99pd	1440	2	most	most	RBS
cord-015365-iqdi99pd	1440	3	successful	successful	JJ
cord-015365-iqdi99pd	1440	4	to	to	IN
cord-015365-iqdi99pd	1440	5	date	date	NN
cord-015365-iqdi99pd	1440	6	has	have	VBZ
cord-015365-iqdi99pd	1440	7	been	be	VBN
cord-015365-iqdi99pd	1440	8	induction	induction	NN
cord-015365-iqdi99pd	1440	9	of	of	IN
cord-015365-iqdi99pd	1440	10	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	1440	11	mixed	mixed	JJ
cord-015365-iqdi99pd	1440	12	chimerism	chimerism	NN
cord-015365-iqdi99pd	1440	13	.	.	.
cord-015365-iqdi99pd	1441	1	The	the	DT
cord-015365-iqdi99pd	1441	2	mixed	mixed	JJ
cord-015365-iqdi99pd	1441	3	chimerism	chimerism	NN
cord-015365-iqdi99pd	1441	4	approach	approach	NN
cord-015365-iqdi99pd	1441	5	,	,	,
cord-015365-iqdi99pd	1441	6	an	an	DT
cord-015365-iqdi99pd	1441	7	initially	initially	RB
cord-015365-iqdi99pd	1441	8	presumed	presume	VBN
cord-015365-iqdi99pd	1441	9	central	central	JJ
cord-015365-iqdi99pd	1441	10	tolerance	tolerance	NN
cord-015365-iqdi99pd	1441	11	strategy	strategy	NN
cord-015365-iqdi99pd	1441	12	,	,	,
cord-015365-iqdi99pd	1441	13	has	have	VBZ
cord-015365-iqdi99pd	1441	14	been	be	VBN
cord-015365-iqdi99pd	1441	15	extensively	extensively	RB
cord-015365-iqdi99pd	1441	16	studied	study	VBN
cord-015365-iqdi99pd	1441	17	in	in	IN
cord-015365-iqdi99pd	1441	18	our	-PRON-	PRP$
cord-015365-iqdi99pd	1441	19	laboratories	laboratory	NNS
cord-015365-iqdi99pd	1441	20	,	,	,
cord-015365-iqdi99pd	1441	21	first	first	RB
cord-015365-iqdi99pd	1441	22	in	in	IN
cord-015365-iqdi99pd	1441	23	rodent	rodent	NN
cord-015365-iqdi99pd	1441	24	,	,	,
cord-015365-iqdi99pd	1441	25	non	non	JJ
cord-015365-iqdi99pd	1441	26	-	-	JJ
cord-015365-iqdi99pd	1441	27	human	human	JJ
cord-015365-iqdi99pd	1441	28	primate	primate	NN
cord-015365-iqdi99pd	1441	29	,	,	,
cord-015365-iqdi99pd	1441	30	and	and	CC
cord-015365-iqdi99pd	1441	31	porcine	porcine	JJ
cord-015365-iqdi99pd	1441	32	models	model	NNS
cord-015365-iqdi99pd	1441	33	,	,	,
cord-015365-iqdi99pd	1441	34	and	and	CC
cord-015365-iqdi99pd	1441	35	now	now	RB
cord-015365-iqdi99pd	1441	36	in	in	IN
cord-015365-iqdi99pd	1441	37	human	human	JJ
cord-015365-iqdi99pd	1441	38	recipients	recipient	NNS
cord-015365-iqdi99pd	1441	39	of	of	IN
cord-015365-iqdi99pd	1441	40	renal	renal	JJ
cord-015365-iqdi99pd	1441	41	allografts	allograft	NNS
cord-015365-iqdi99pd	1441	42	.	.	.
cord-015365-iqdi99pd	1442	1	Using	use	VBG
cord-015365-iqdi99pd	1442	2	a	a	DT
cord-015365-iqdi99pd	1442	3	non	non	JJ
cord-015365-iqdi99pd	1442	4	-	-	JJ
cord-015365-iqdi99pd	1442	5	myeloablative	myeloablative	JJ
cord-015365-iqdi99pd	1442	6	conditioning	conditioning	NN
cord-015365-iqdi99pd	1442	7	regimen	regimen	NN
cord-015365-iqdi99pd	1442	8	followed	follow	VBN
cord-015365-iqdi99pd	1442	9	by	by	IN
cord-015365-iqdi99pd	1442	10	donor	donor	NN
cord-015365-iqdi99pd	1442	11	bone	bone	NN
cord-015365-iqdi99pd	1442	12	marrow	marrow	NN
cord-015365-iqdi99pd	1442	13	(	(	-LRB-
cord-015365-iqdi99pd	1442	14	DBM	DBM	NNP
cord-015365-iqdi99pd	1442	15	)	)	-RRB-
cord-015365-iqdi99pd	1442	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	1442	17	,	,	,
cord-015365-iqdi99pd	1442	18	we	-PRON-	PRP
cord-015365-iqdi99pd	1442	19	observed	observe	VBD
cord-015365-iqdi99pd	1442	20	successful	successful	JJ
cord-015365-iqdi99pd	1442	21	production	production	NN
cord-015365-iqdi99pd	1442	22	of	of	IN
cord-015365-iqdi99pd	1442	23	mixed	mixed	JJ
cord-015365-iqdi99pd	1442	24	chimerism	chimerism	NN
cord-015365-iqdi99pd	1442	25	in	in	IN
cord-015365-iqdi99pd	1442	26	non	non	JJ
cord-015365-iqdi99pd	1442	27	-	-	JJ
cord-015365-iqdi99pd	1442	28	human	human	JJ
cord-015365-iqdi99pd	1442	29	primate	primate	JJ
cord-015365-iqdi99pd	1442	30	renal	renal	JJ
cord-015365-iqdi99pd	1442	31	allograft	allograft	NN
cord-015365-iqdi99pd	1442	32	recipients	recipient	NNS
cord-015365-iqdi99pd	1442	33	,	,	,
cord-015365-iqdi99pd	1442	34	followed	follow	VBN
cord-015365-iqdi99pd	1442	35	by	by	IN
cord-015365-iqdi99pd	1442	36	normal	normal	JJ
cord-015365-iqdi99pd	1442	37	kidney	kidney	NN
cord-015365-iqdi99pd	1442	38	function	function	NN
cord-015365-iqdi99pd	1442	39	with	with	IN
cord-015365-iqdi99pd	1442	40	no	no	DT
cord-015365-iqdi99pd	1442	41	evidence	evidence	NN
cord-015365-iqdi99pd	1442	42	of	of	IN
cord-015365-iqdi99pd	1442	43	chronic	chronic	JJ
cord-015365-iqdi99pd	1442	44	rejection	rejection	NN
cord-015365-iqdi99pd	1442	45	for	for	IN
cord-015365-iqdi99pd	1442	46	periods	period	NNS
cord-015365-iqdi99pd	1442	47	as	as	RB
cord-015365-iqdi99pd	1442	48	long	long	JJ
cord-015365-iqdi99pd	1442	49	as	as	IN
cord-015365-iqdi99pd	1442	50	thirteen	thirteen	CD
cord-015365-iqdi99pd	1442	51	years	year	NNS
cord-015365-iqdi99pd	1442	52	after	after	IN
cord-015365-iqdi99pd	1442	53	discontinuing	discontinue	VBG
cord-015365-iqdi99pd	1442	54	all	all	DT
cord-015365-iqdi99pd	1443	1	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1443	2	In	in	IN
cord-015365-iqdi99pd	1443	3	vitro	vitro	FW
cord-015365-iqdi99pd	1443	4	studies	study	NNS
cord-015365-iqdi99pd	1443	5	of	of	IN
cord-015365-iqdi99pd	1443	6	these	these	DT
cord-015365-iqdi99pd	1443	7	recipients	recipient	NNS
cord-015365-iqdi99pd	1443	8	as	as	RB
cord-015365-iqdi99pd	1443	9	well	well	RB
cord-015365-iqdi99pd	1443	10	as	as	IN
cord-015365-iqdi99pd	1443	11	of	of	IN
cord-015365-iqdi99pd	1443	12	humans	human	NNS
cord-015365-iqdi99pd	1443	13	suggest	suggest	VBP
cord-015365-iqdi99pd	1443	14	that	that	IN
cord-015365-iqdi99pd	1443	15	both	both	DT
cord-015365-iqdi99pd	1443	16	central	central	JJ
cord-015365-iqdi99pd	1443	17	(	(	-LRB-
cord-015365-iqdi99pd	1443	18	clonal	clonal	JJ
cord-015365-iqdi99pd	1443	19	deletion	deletion	NN
cord-015365-iqdi99pd	1443	20	)	)	-RRB-
cord-015365-iqdi99pd	1443	21	and	and	CC
cord-015365-iqdi99pd	1443	22	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1443	23	(	(	-LRB-
cord-015365-iqdi99pd	1443	24	regulatory	regulatory	JJ
cord-015365-iqdi99pd	1443	25	cells	cell	NNS
cord-015365-iqdi99pd	1443	26	)	)	-RRB-
cord-015365-iqdi99pd	1443	27	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	1443	28	are	be	VBP
cord-015365-iqdi99pd	1443	29	involved	involve	VBN
cord-015365-iqdi99pd	1443	30	.	.	.
cord-015365-iqdi99pd	1444	1	Encouraged	encourage	VBN
cord-015365-iqdi99pd	1444	2	by	by	IN
cord-015365-iqdi99pd	1444	3	the	the	DT
cord-015365-iqdi99pd	1444	4	pre	pre	JJ
cord-015365-iqdi99pd	1444	5	-	-	JJ
cord-015365-iqdi99pd	1444	6	clinical	clinical	JJ
cord-015365-iqdi99pd	1444	7	studies	study	NNS
cord-015365-iqdi99pd	1444	8	,	,	,
cord-015365-iqdi99pd	1444	9	we	-PRON-	PRP
cord-015365-iqdi99pd	1444	10	have	have	VBP
cord-015365-iqdi99pd	1444	11	to	to	TO
cord-015365-iqdi99pd	1444	12	date	date	NN
cord-015365-iqdi99pd	1444	13	extended	extend	VBN
cord-015365-iqdi99pd	1444	14	this	this	DT
cord-015365-iqdi99pd	1444	15	approach	approach	NN
cord-015365-iqdi99pd	1444	16	to	to	IN
cord-015365-iqdi99pd	1444	17	20	20	CD
cord-015365-iqdi99pd	1444	18	human	human	JJ
cord-015365-iqdi99pd	1444	19	renal	renal	JJ
cord-015365-iqdi99pd	1444	20	allograft	allograft	NN
cord-015365-iqdi99pd	1444	21	recipients	recipient	NNS
cord-015365-iqdi99pd	1444	22	.	.	.
cord-015365-iqdi99pd	1445	1	Ten	ten	CD
cord-015365-iqdi99pd	1445	2	individuals	individual	NNS
cord-015365-iqdi99pd	1445	3	with	with	IN
cord-015365-iqdi99pd	1445	4	ESRD	ESRD	NNP
cord-015365-iqdi99pd	1445	5	secondary	secondary	JJ
cord-015365-iqdi99pd	1445	6	to	to	IN
cord-015365-iqdi99pd	1445	7	multiple	multiple	JJ
cord-015365-iqdi99pd	1445	8	myeloma	myeloma	NN
cord-015365-iqdi99pd	1445	9	received	receive	VBD
cord-015365-iqdi99pd	1445	10	a	a	DT
cord-015365-iqdi99pd	1445	11	nonmyeloablative	nonmyeloablative	JJ
cord-015365-iqdi99pd	1445	12	preparative	preparative	JJ
cord-015365-iqdi99pd	1445	13	regimen	regimen	NN
cord-015365-iqdi99pd	1445	14	consisting	consist	VBG
cord-015365-iqdi99pd	1445	15	of	of	IN
cord-015365-iqdi99pd	1445	16	perioperative	perioperative	JJ
cord-015365-iqdi99pd	1445	17	cyclophosphamide	cyclophosphamide	NN
cord-015365-iqdi99pd	1445	18	,	,	,
cord-015365-iqdi99pd	1445	19	equine	equine	NN
cord-015365-iqdi99pd	1445	20	ATG	ATG	NNP
cord-015365-iqdi99pd	1445	21	,	,	,
cord-015365-iqdi99pd	1445	22	CsA	csa	NN
cord-015365-iqdi99pd	1445	23	,	,	,
cord-015365-iqdi99pd	1445	24	and	and	CC
cord-015365-iqdi99pd	1445	25	thymic	thymic	JJ
cord-015365-iqdi99pd	1445	26	irradiation	irradiation	NN
cord-015365-iqdi99pd	1445	27	.	.	.
cord-015365-iqdi99pd	1446	1	The	the	DT
cord-015365-iqdi99pd	1446	2	recipients	recipient	NNS
cord-015365-iqdi99pd	1446	3	underwent	undergo	VBD
cord-015365-iqdi99pd	1446	4	HLA	HLA	NNP
cord-015365-iqdi99pd	1446	5	-	-	HYPH
cord-015365-iqdi99pd	1446	6	matched	match	VBN
cord-015365-iqdi99pd	1446	7	kidney	kidney	NN
cord-015365-iqdi99pd	1446	8	transplantation	transplantation	NN
cord-015365-iqdi99pd	1446	9	followed	follow	VBN
cord-015365-iqdi99pd	1446	10	by	by	IN
cord-015365-iqdi99pd	1446	11	iv	iv	CD
cord-015365-iqdi99pd	1446	12	infusion	infusion	NN
cord-015365-iqdi99pd	1446	13	of	of	IN
cord-015365-iqdi99pd	1446	14	DBM	DBM	NNP
cord-015365-iqdi99pd	1446	15	and	and	CC
cord-015365-iqdi99pd	1446	16	subsequent	subsequent	JJ
cord-015365-iqdi99pd	1446	17	donor	donor	NN
cord-015365-iqdi99pd	1446	18	lymphocyte	lymphocyte	NN
cord-015365-iqdi99pd	1446	19	infusions	infusion	NNS
cord-015365-iqdi99pd	1446	20	(	(	-LRB-
cord-015365-iqdi99pd	1446	21	DLI	DLI	NNP
cord-015365-iqdi99pd	1446	22	)	)	-RRB-
cord-015365-iqdi99pd	1446	23	to	to	TO
cord-015365-iqdi99pd	1446	24	enhance	enhance	VB
cord-015365-iqdi99pd	1446	25	the	the	DT
cord-015365-iqdi99pd	1446	26	anti	anti	JJ
cord-015365-iqdi99pd	1446	27	-	-	JJ
cord-015365-iqdi99pd	1446	28	myeloma	myeloma	JJ
cord-015365-iqdi99pd	1446	29	effect	effect	NN
cord-015365-iqdi99pd	1446	30	.	.	.
cord-015365-iqdi99pd	1447	1	Transient	transient	JJ
cord-015365-iqdi99pd	1447	2	lymphohematopoietic	lymphohematopoietic	JJ
cord-015365-iqdi99pd	1447	3	chimerism	chimerism	NN
cord-015365-iqdi99pd	1447	4	was	be	VBD
cord-015365-iqdi99pd	1447	5	achieved	achieve	VBN
cord-015365-iqdi99pd	1447	6	in	in	IN
cord-015365-iqdi99pd	1447	7	all	all	DT
cord-015365-iqdi99pd	1447	8	patients	patient	NNS
cord-015365-iqdi99pd	1447	9	and	and	CC
cord-015365-iqdi99pd	1447	10	only	only	RB
cord-015365-iqdi99pd	1447	11	two	two	CD
cord-015365-iqdi99pd	1447	12	reversible	reversible	JJ
cord-015365-iqdi99pd	1447	13	rejection	rejection	NN
cord-015365-iqdi99pd	1447	14	episodes	episode	NNS
cord-015365-iqdi99pd	1447	15	have	have	VBP
cord-015365-iqdi99pd	1447	16	occurred	occur	VBN
cord-015365-iqdi99pd	1447	17	with	with	IN
cord-015365-iqdi99pd	1447	18	a	a	DT
cord-015365-iqdi99pd	1447	19	follow	follow	NN
cord-015365-iqdi99pd	1447	20	-	-	HYPH
cord-015365-iqdi99pd	1447	21	up	up	NN
cord-015365-iqdi99pd	1447	22	of	of	IN
cord-015365-iqdi99pd	1447	23	1	1	CD
cord-015365-iqdi99pd	1447	24	to	to	TO
cord-015365-iqdi99pd	1447	25	13	13	CD
cord-015365-iqdi99pd	1447	26	years	year	NNS
cord-015365-iqdi99pd	1447	27	after	after	IN
cord-015365-iqdi99pd	1447	28	discontinuing	discontinue	VBG
cord-015365-iqdi99pd	1447	29	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1447	30	Longterm	Longterm	NNP
cord-015365-iqdi99pd	1447	31	control	control	NN
cord-015365-iqdi99pd	1447	32	of	of	IN
cord-015365-iqdi99pd	1447	33	the	the	DT
cord-015365-iqdi99pd	1447	34	underlying	underlying	JJ
cord-015365-iqdi99pd	1447	35	malignancy	malignancy	NN
cord-015365-iqdi99pd	1447	36	was	be	VBD
cord-015365-iqdi99pd	1447	37	better	well	JJR
cord-015365-iqdi99pd	1447	38	than	than	IN
cord-015365-iqdi99pd	1447	39	with	with	IN
cord-015365-iqdi99pd	1447	40	any	any	DT
cord-015365-iqdi99pd	1447	41	other	other	JJ
cord-015365-iqdi99pd	1447	42	currently	currently	RB
cord-015365-iqdi99pd	1447	43	available	available	JJ
cord-015365-iqdi99pd	1447	44	treatment	treatment	NN
cord-015365-iqdi99pd	1447	45	,	,	,
cord-015365-iqdi99pd	1447	46	but	but	CC
cord-015365-iqdi99pd	1447	47	4	4	CD
cord-015365-iqdi99pd	1447	48	of	of	IN
cord-015365-iqdi99pd	1447	49	these	these	DT
cord-015365-iqdi99pd	1447	50	individuals	individual	NNS
cord-015365-iqdi99pd	1447	51	required	require	VBD
cord-015365-iqdi99pd	1447	52	additional	additional	JJ
cord-015365-iqdi99pd	1447	53	therapy	therapy	NN
cord-015365-iqdi99pd	1447	54	for	for	IN
cord-015365-iqdi99pd	1447	55	recurrent	recurrent	JJ
cord-015365-iqdi99pd	1447	56	myeloma	myeloma	NN
cord-015365-iqdi99pd	1447	57	.	.	.
cord-015365-iqdi99pd	1448	1	Ten	ten	CD
cord-015365-iqdi99pd	1448	2	patients	patient	NNS
cord-015365-iqdi99pd	1448	3	with	with	IN
cord-015365-iqdi99pd	1448	4	ESRD	ESRD	NNP
cord-015365-iqdi99pd	1448	5	and	and	CC
cord-015365-iqdi99pd	1448	6	no	no	DT
cord-015365-iqdi99pd	1448	7	myeloma	myeloma	NN
cord-015365-iqdi99pd	1448	8	received	receive	VBD
cord-015365-iqdi99pd	1448	9	HLA	HLA	NNP
cord-015365-iqdi99pd	1448	10	-	-	HYPH
cord-015365-iqdi99pd	1448	11	mismatched	mismatch	VBN
cord-015365-iqdi99pd	1448	12	kidneys	kidney	NNS
cord-015365-iqdi99pd	1448	13	after	after	IN
cord-015365-iqdi99pd	1448	14	a	a	DT
cord-015365-iqdi99pd	1448	15	similar	similar	JJ
cord-015365-iqdi99pd	1448	16	conditioning	conditioning	NN
cord-015365-iqdi99pd	1448	17	regimen	regimen	NN
cord-015365-iqdi99pd	1448	18	except	except	IN
cord-015365-iqdi99pd	1448	19	that	that	IN
cord-015365-iqdi99pd	1448	20	MEDI-507	MEDI-507	NNP
cord-015365-iqdi99pd	1448	21	,	,	,
cord-015365-iqdi99pd	1448	22	an	an	DT
cord-015365-iqdi99pd	1448	23	anti	anti	JJ
cord-015365-iqdi99pd	1448	24	-	-	JJ
cord-015365-iqdi99pd	1448	25	CD-2	CD-2	NNP
cord-015365-iqdi99pd	1448	26	mAb	mAb	NNS
cord-015365-iqdi99pd	1448	27	,	,	,
cord-015365-iqdi99pd	1448	28	was	be	VBD
cord-015365-iqdi99pd	1448	29	used	use	VBN
cord-015365-iqdi99pd	1448	30	in	in	IN
cord-015365-iqdi99pd	1448	31	place	place	NN
cord-015365-iqdi99pd	1448	32	of	of	IN
cord-015365-iqdi99pd	1448	33	ATG	ATG	NNP
cord-015365-iqdi99pd	1448	34	and	and	CC
cord-015365-iqdi99pd	1448	35	DLI	DLI	NNP
cord-015365-iqdi99pd	1448	36	was	be	VBD
cord-015365-iqdi99pd	1448	37	not	not	RB
cord-015365-iqdi99pd	1448	38	used	use	VBN
cord-015365-iqdi99pd	1448	39	.	.	.
cord-015365-iqdi99pd	1449	1	Transient	transient	JJ
cord-015365-iqdi99pd	1449	2	mixed	mixed	JJ
cord-015365-iqdi99pd	1449	3	chimerism	chimerism	NN
cord-015365-iqdi99pd	1449	4	and	and	CC
cord-015365-iqdi99pd	1449	5	apparent	apparent	JJ
cord-015365-iqdi99pd	1449	6	allograft	allograft	NN
cord-015365-iqdi99pd	1449	7	tolerance	tolerance	NN
cord-015365-iqdi99pd	1449	8	has	have	VBZ
cord-015365-iqdi99pd	1449	9	been	be	VBN
cord-015365-iqdi99pd	1449	10	achieved	achieve	VBN
cord-015365-iqdi99pd	1449	11	in	in	IN
cord-015365-iqdi99pd	1449	12	7	7	CD
cord-015365-iqdi99pd	1449	13	of	of	IN
cord-015365-iqdi99pd	1449	14	these	these	DT
cord-015365-iqdi99pd	1449	15	recipients	recipient	NNS
cord-015365-iqdi99pd	1449	16	.	.	.
cord-015365-iqdi99pd	1450	1	These	these	DT
cord-015365-iqdi99pd	1450	2	7	7	CD
cord-015365-iqdi99pd	1450	3	patients	patient	NNS
cord-015365-iqdi99pd	1450	4	have	have	VBP
cord-015365-iqdi99pd	1450	5	received	receive	VBN
cord-015365-iqdi99pd	1450	6	no	no	DT
cord-015365-iqdi99pd	1450	7	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1450	8	for	for	IN
cord-015365-iqdi99pd	1450	9	periods	period	NNS
cord-015365-iqdi99pd	1450	10	of	of	IN
cord-015365-iqdi99pd	1450	11	2	2	CD
cord-015365-iqdi99pd	1450	12	-	-	SYM
cord-015365-iqdi99pd	1450	13	9	9	CD
cord-015365-iqdi99pd	1450	14	years	year	NNS
cord-015365-iqdi99pd	1450	15	.	.	.
cord-015365-iqdi99pd	1451	1	Two	two	CD
cord-015365-iqdi99pd	1451	2	allografts	allograft	NNS
cord-015365-iqdi99pd	1451	3	were	be	VBD
cord-015365-iqdi99pd	1451	4	lost	lose	VBN
cord-015365-iqdi99pd	1451	5	:	:	:
cord-015365-iqdi99pd	1451	6	acute	acute	JJ
cord-015365-iqdi99pd	1451	7	humoral	humoral	JJ
cord-015365-iqdi99pd	1451	8	rejection	rejection	NN
cord-015365-iqdi99pd	1451	9	(	(	-LRB-
cord-015365-iqdi99pd	1451	10	1	1	CD
cord-015365-iqdi99pd	1451	11	)	)	-RRB-
cord-015365-iqdi99pd	1451	12	;	;	:
cord-015365-iqdi99pd	1451	13	thrombotic	thrombotic	NNP
cord-015365-iqdi99pd	1451	14	micro	micro	NNP
cord-015365-iqdi99pd	1451	15	angiopathy	angiopathy	NNP
cord-015365-iqdi99pd	1451	16	(	(	-LRB-
cord-015365-iqdi99pd	1451	17	1	1	CD
cord-015365-iqdi99pd	1451	18	)	)	-RRB-
cord-015365-iqdi99pd	1451	19	and	and	CC
cord-015365-iqdi99pd	1451	20	the	the	DT
cord-015365-iqdi99pd	1451	21	last	last	JJ
cord-015365-iqdi99pd	1451	22	recipient	recipient	NN
cord-015365-iqdi99pd	1451	23	has	have	VBZ
cord-015365-iqdi99pd	1451	24	been	be	VBN
cord-015365-iqdi99pd	1451	25	returned	return	VBN
cord-015365-iqdi99pd	1451	26	to	to	IN
cord-015365-iqdi99pd	1451	27	chronic	chronic	JJ
cord-015365-iqdi99pd	1451	28	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1451	29	after	after	IN
cord-015365-iqdi99pd	1451	30	developing	develop	VBG
cord-015365-iqdi99pd	1451	31	acute	acute	JJ
cord-015365-iqdi99pd	1451	32	rejection	rejection	NN
cord-015365-iqdi99pd	1451	33	when	when	WRB
cord-015365-iqdi99pd	1451	34	I.S.	I.S.	NNP
cord-015365-iqdi99pd	1451	35	was	be	VBD
cord-015365-iqdi99pd	1451	36	withdrawn	withdraw	VBN
cord-015365-iqdi99pd	1451	37	.	.	.
cord-015365-iqdi99pd	1452	1	These	these	DT
cord-015365-iqdi99pd	1452	2	observations	observation	NNS
cord-015365-iqdi99pd	1452	3	plus	plus	CC
cord-015365-iqdi99pd	1452	4	similarly	similarly	RB
cord-015365-iqdi99pd	1452	5	encouraging	encouraging	JJ
cord-015365-iqdi99pd	1452	6	observations	observation	NNS
cord-015365-iqdi99pd	1452	7	in	in	IN
cord-015365-iqdi99pd	1452	8	several	several	JJ
cord-015365-iqdi99pd	1452	9	clinical	clinical	JJ
cord-015365-iqdi99pd	1452	10	trials	trial	NNS
cord-015365-iqdi99pd	1452	11	elsewhere	elsewhere	RB
cord-015365-iqdi99pd	1452	12	suggest	suggest	VBP
cord-015365-iqdi99pd	1452	13	that	that	IN
cord-015365-iqdi99pd	1452	14	tolerance	tolerance	NN
cord-015365-iqdi99pd	1452	15	induction	induction	NN
cord-015365-iqdi99pd	1452	16	may	may	MD
cord-015365-iqdi99pd	1452	17	become	become	VB
cord-015365-iqdi99pd	1452	18	a	a	DT
cord-015365-iqdi99pd	1452	19	more	more	RBR
cord-015365-iqdi99pd	1452	20	widely	widely	RB
cord-015365-iqdi99pd	1452	21	applicable	applicable	JJ
cord-015365-iqdi99pd	1452	22	clinical	clinical	JJ
cord-015365-iqdi99pd	1452	23	reality	reality	NN
cord-015365-iqdi99pd	1452	24	.	.	.
cord-015365-iqdi99pd	1453	1	Experimental	experimental	JJ
cord-015365-iqdi99pd	1453	2	rationale	rationale	NN
cord-015365-iqdi99pd	1453	3	for	for	IN
cord-015365-iqdi99pd	1453	4	using	use	VBG
cord-015365-iqdi99pd	1453	5	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	1453	6	stem	stem	NN
cord-015365-iqdi99pd	1453	7	cell	cell	NN
cord-015365-iqdi99pd	1453	8	transplantation	transplantation	NN
cord-015365-iqdi99pd	1453	9	for	for	IN
cord-015365-iqdi99pd	1453	10	tolerance	tolerance	NN
cord-015365-iqdi99pd	1453	11	induction	induction	NN
cord-015365-iqdi99pd	1454	1	It	-PRON-	PRP
cord-015365-iqdi99pd	1454	2	was	be	VBD
cord-015365-iqdi99pd	1454	3	recognized	recognize	VBN
cord-015365-iqdi99pd	1454	4	a	a	DT
cord-015365-iqdi99pd	1454	5	long	long	JJ
cord-015365-iqdi99pd	1454	6	time	time	NN
cord-015365-iqdi99pd	1454	7	ago	ago	RB
cord-015365-iqdi99pd	1454	8	that	that	IN
cord-015365-iqdi99pd	1454	9	an	an	DT
cord-015365-iqdi99pd	1454	10	individual	individual	NN
cord-015365-iqdi99pd	1454	11	that	that	WDT
cord-015365-iqdi99pd	1454	12	shares	share	NNS
cord-015365-iqdi99pd	1454	13	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	1454	14	cells	cell	NNS
cord-015365-iqdi99pd	1454	15	with	with	IN
cord-015365-iqdi99pd	1454	16	another	another	DT
cord-015365-iqdi99pd	1454	17	,	,	,
cord-015365-iqdi99pd	1454	18	becomes	become	VBZ
cord-015365-iqdi99pd	1454	19	tolerant	tolerant	JJ
cord-015365-iqdi99pd	1454	20	to	to	IN
cord-015365-iqdi99pd	1454	21	this	this	DT
cord-015365-iqdi99pd	1454	22	individual	individual	NN
cord-015365-iqdi99pd	1454	23	.	.	.
cord-015365-iqdi99pd	1455	1	Thus	thus	RB
cord-015365-iqdi99pd	1455	2	,	,	,
cord-015365-iqdi99pd	1455	3	a	a	DT
cord-015365-iqdi99pd	1455	4	recipient	recipient	NN
cord-015365-iqdi99pd	1455	5	of	of	IN
cord-015365-iqdi99pd	1455	6	a	a	DT
cord-015365-iqdi99pd	1455	7	successful	successful	JJ
cord-015365-iqdi99pd	1455	8	donor	donor	NN
cord-015365-iqdi99pd	1455	9	bone	bone	NN
cord-015365-iqdi99pd	1455	10	marrow	marrow	NN
cord-015365-iqdi99pd	1455	11	(	(	-LRB-
cord-015365-iqdi99pd	1455	12	BM	BM	NNP
cord-015365-iqdi99pd	1455	13	)	)	-RRB-
cord-015365-iqdi99pd	1455	14	transplant	transplant	NN
cord-015365-iqdi99pd	1455	15	(	(	-LRB-
cord-015365-iqdi99pd	1455	16	BMT	BMT	NNP
cord-015365-iqdi99pd	1455	17	)	)	-RRB-
cord-015365-iqdi99pd	1455	18	becomes	become	VBZ
cord-015365-iqdi99pd	1455	19	tolerant	tolerant	JJ
cord-015365-iqdi99pd	1455	20	toward	toward	IN
cord-015365-iqdi99pd	1455	21	the	the	DT
cord-015365-iqdi99pd	1455	22	donor	donor	NN
cord-015365-iqdi99pd	1455	23	.	.	.
cord-015365-iqdi99pd	1456	1	Triggered	trigger	VBN
cord-015365-iqdi99pd	1456	2	by	by	IN
cord-015365-iqdi99pd	1456	3	this	this	DT
cord-015365-iqdi99pd	1456	4	observation	observation	NN
cord-015365-iqdi99pd	1456	5	experimental	experimental	JJ
cord-015365-iqdi99pd	1456	6	studies	study	NNS
cord-015365-iqdi99pd	1456	7	have	have	VBP
cord-015365-iqdi99pd	1456	8	been	be	VBN
cord-015365-iqdi99pd	1456	9	systematically	systematically	RB
cord-015365-iqdi99pd	1456	10	addressing	address	VBG
cord-015365-iqdi99pd	1456	11	why	why	WRB
cord-015365-iqdi99pd	1456	12	and	and	CC
cord-015365-iqdi99pd	1456	13	how	how	WRB
cord-015365-iqdi99pd	1456	14	donor	donor	NN
cord-015365-iqdi99pd	1456	15	BM	bm	NN
cord-015365-iqdi99pd	1456	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	1456	17	achieves	achieve	VBZ
cord-015365-iqdi99pd	1456	18	tolerance	tolerance	NN
cord-015365-iqdi99pd	1456	19	.	.	.
cord-015365-iqdi99pd	1457	1	The	the	DT
cord-015365-iqdi99pd	1457	2	concept	concept	NN
cord-015365-iqdi99pd	1457	3	of	of	IN
cord-015365-iqdi99pd	1457	4	mixed	mixed	JJ
cord-015365-iqdi99pd	1457	5	chimerism	chimerism	NN
cord-015365-iqdi99pd	1457	6	-in	-in	:
cord-015365-iqdi99pd	1457	7	which	which	WDT
cord-015365-iqdi99pd	1457	8	a	a	DT
cord-015365-iqdi99pd	1457	9	substantial	substantial	JJ
cord-015365-iqdi99pd	1457	10	donor	donor	NN
cord-015365-iqdi99pd	1457	11	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	1457	12	cell	cell	NN
cord-015365-iqdi99pd	1457	13	proportion	proportion	NN
cord-015365-iqdi99pd	1457	14	co	co	NN
cord-015365-iqdi99pd	1457	15	-	-	NN
cord-015365-iqdi99pd	1457	16	exists	exist	VBZ
cord-015365-iqdi99pd	1457	17	with	with	IN
cord-015365-iqdi99pd	1457	18	the	the	DT
cord-015365-iqdi99pd	1457	19	recipient	recipient	NN
cord-015365-iqdi99pd	1457	20	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	1457	21	repertoire	repertoire	NN
cord-015365-iqdi99pd	1457	22	following	follow	VBG
cord-015365-iqdi99pd	1457	23	donor	donor	NN
cord-015365-iqdi99pd	1457	24	BMT	BMT	NNP
cord-015365-iqdi99pd	1457	25	-has	-has	:
cord-015365-iqdi99pd	1457	26	emerged	emerge	VBD
cord-015365-iqdi99pd	1457	27	as	as	IN
cord-015365-iqdi99pd	1457	28	a	a	DT
cord-015365-iqdi99pd	1457	29	promising	promising	JJ
cord-015365-iqdi99pd	1457	30	BMT	BMT	NNP
cord-015365-iqdi99pd	1457	31	-	-	HYPH
cord-015365-iqdi99pd	1457	32	based	base	VBN
cord-015365-iqdi99pd	1457	33	tolerance	tolerance	NN
cord-015365-iqdi99pd	1457	34	strategy	strategy	NN
cord-015365-iqdi99pd	1457	35	.	.	.
cord-015365-iqdi99pd	1458	1	Mixed	mixed	JJ
cord-015365-iqdi99pd	1458	2	chimerism	chimerism	NN
cord-015365-iqdi99pd	1458	3	leads	lead	VBZ
cord-015365-iqdi99pd	1458	4	to	to	IN
cord-015365-iqdi99pd	1458	5	a	a	DT
cord-015365-iqdi99pd	1458	6	particularly	particularly	RB
cord-015365-iqdi99pd	1458	7	robust	robust	JJ
cord-015365-iqdi99pd	1458	8	and	and	CC
cord-015365-iqdi99pd	1458	9	durable	durable	JJ
cord-015365-iqdi99pd	1458	10	type	type	NN
cord-015365-iqdi99pd	1458	11	of	of	IN
cord-015365-iqdi99pd	1458	12	tolerance	tolerance	NN
cord-015365-iqdi99pd	1458	13	.	.	.
cord-015365-iqdi99pd	1459	1	Central	central	JJ
cord-015365-iqdi99pd	1459	2	clonal	clonal	JJ
cord-015365-iqdi99pd	1459	3	deletion	deletion	NN
cord-015365-iqdi99pd	1459	4	of	of	IN
cord-015365-iqdi99pd	1459	5	immature	immature	JJ
cord-015365-iqdi99pd	1459	6	donorreactive	donorreactive	NN
cord-015365-iqdi99pd	1459	7	T	t	NN
cord-015365-iqdi99pd	1459	8	cells	cell	NNS
cord-015365-iqdi99pd	1459	9	was	be	VBD
cord-015365-iqdi99pd	1459	10	identified	identify	VBN
cord-015365-iqdi99pd	1459	11	as	as	IN
cord-015365-iqdi99pd	1459	12	a	a	DT
cord-015365-iqdi99pd	1459	13	key	key	JJ
cord-015365-iqdi99pd	1459	14	mechanism	mechanism	NN
cord-015365-iqdi99pd	1459	15	of	of	IN
cord-015365-iqdi99pd	1459	16	tolerance	tolerance	NN
cord-015365-iqdi99pd	1459	17	in	in	IN
cord-015365-iqdi99pd	1459	18	mixed	mixed	JJ
cord-015365-iqdi99pd	1459	19	chimeras	chimera	NNS
cord-015365-iqdi99pd	1459	20	and	and	CC
cord-015365-iqdi99pd	1459	21	seems	seem	VBZ
cord-015365-iqdi99pd	1459	22	to	to	TO
cord-015365-iqdi99pd	1459	23	be	be	VB
cord-015365-iqdi99pd	1459	24	in	in	IN
cord-015365-iqdi99pd	1459	25	large	large	JJ
cord-015365-iqdi99pd	1459	26	part	part	NN
cord-015365-iqdi99pd	1459	27	responsible	responsible	JJ
cord-015365-iqdi99pd	1459	28	for	for	IN
cord-015365-iqdi99pd	1459	29	the	the	DT
cord-015365-iqdi99pd	1459	30	robust	robust	JJ
cord-015365-iqdi99pd	1459	31	nature	nature	NN
cord-015365-iqdi99pd	1459	32	of	of	IN
cord-015365-iqdi99pd	1459	33	tolerance	tolerance	NN
cord-015365-iqdi99pd	1459	34	achieved	achieve	VBN
cord-015365-iqdi99pd	1459	35	.	.	.
cord-015365-iqdi99pd	1460	1	Peripheral	peripheral	JJ
cord-015365-iqdi99pd	1460	2	clonal	clonal	JJ
cord-015365-iqdi99pd	1460	3	deletion	deletion	NN
cord-015365-iqdi99pd	1460	4	of	of	IN
cord-015365-iqdi99pd	1460	5	mature	mature	JJ
cord-015365-iqdi99pd	1460	6	donor	donor	NN
cord-015365-iqdi99pd	1460	7	-	-	HYPH
cord-015365-iqdi99pd	1460	8	reactive	reactive	JJ
cord-015365-iqdi99pd	1460	9	T	t	NN
cord-015365-iqdi99pd	1460	10	cells	cell	NNS
cord-015365-iqdi99pd	1460	11	and	and	CC
cord-015365-iqdi99pd	1460	12	non	non	JJ
cord-015365-iqdi99pd	1460	13	-	-	JJ
cord-015365-iqdi99pd	1460	14	deletional	deletional	JJ
cord-015365-iqdi99pd	1460	15	(	(	-LRB-
cord-015365-iqdi99pd	1460	16	i.e.	i.e.	FW
cord-015365-iqdi99pd	1460	17	regulatory	regulatory	JJ
cord-015365-iqdi99pd	1460	18	)	)	-RRB-
cord-015365-iqdi99pd	1460	19	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	1460	20	also	also	RB
cord-015365-iqdi99pd	1460	21	contribute	contribute	VBP
cord-015365-iqdi99pd	1460	22	to	to	IN
cord-015365-iqdi99pd	1460	23	tolerance	tolerance	NN
cord-015365-iqdi99pd	1460	24	induction	induction	NN
cord-015365-iqdi99pd	1460	25	in	in	IN
cord-015365-iqdi99pd	1460	26	some	some	DT
cord-015365-iqdi99pd	1460	27	models	model	NNS
cord-015365-iqdi99pd	1460	28	.	.	.
cord-015365-iqdi99pd	1461	1	Overall	overall	RB
cord-015365-iqdi99pd	1461	2	,	,	,
cord-015365-iqdi99pd	1461	3	donor	donor	NN
cord-015365-iqdi99pd	1461	4	BMT	BMT	NNP
cord-015365-iqdi99pd	1461	5	emulates	emulate	VBZ
cord-015365-iqdi99pd	1461	6	many	many	JJ
cord-015365-iqdi99pd	1461	7	of	of	IN
cord-015365-iqdi99pd	1461	8	the	the	DT
cord-015365-iqdi99pd	1461	9	physiologic	physiologic	JJ
cord-015365-iqdi99pd	1461	10	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	1461	11	controlling	control	VBG
cord-015365-iqdi99pd	1461	12	self	self	NN
cord-015365-iqdi99pd	1461	13	-	-	HYPH
cord-015365-iqdi99pd	1461	14	tolerance	tolerance	NN
cord-015365-iqdi99pd	1461	15	,	,	,
cord-015365-iqdi99pd	1461	16	extending	extend	VBG
cord-015365-iqdi99pd	1461	17	them	-PRON-	PRP
cord-015365-iqdi99pd	1461	18	to	to	IN
cord-015365-iqdi99pd	1461	19	donor	donor	NN
cord-015365-iqdi99pd	1461	20	antigens	antigen	NNS
cord-015365-iqdi99pd	1461	21	.	.	.
cord-015365-iqdi99pd	1462	1	While	while	IN
cord-015365-iqdi99pd	1462	2	clinical	clinical	JJ
cord-015365-iqdi99pd	1462	3	translation	translation	NN
cord-015365-iqdi99pd	1462	4	of	of	IN
cord-015365-iqdi99pd	1462	5	the	the	DT
cord-015365-iqdi99pd	1462	6	mixed	mixed	JJ
cord-015365-iqdi99pd	1462	7	chimerism	chimerism	NN
cord-015365-iqdi99pd	1462	8	approach	approach	NN
cord-015365-iqdi99pd	1462	9	has	have	VBZ
cord-015365-iqdi99pd	1462	10	been	be	VBN
cord-015365-iqdi99pd	1462	11	achieved	achieve	VBN
cord-015365-iqdi99pd	1462	12	in	in	IN
cord-015365-iqdi99pd	1462	13	pilot	pilot	NN
cord-015365-iqdi99pd	1462	14	trials	trial	NNS
cord-015365-iqdi99pd	1462	15	,	,	,
cord-015365-iqdi99pd	1462	16	large	large	JJ
cord-015365-iqdi99pd	1462	17	-	-	HYPH
cord-015365-iqdi99pd	1462	18	scale	scale	NN
cord-015365-iqdi99pd	1462	19	application	application	NN
cord-015365-iqdi99pd	1462	20	in	in	IN
cord-015365-iqdi99pd	1462	21	routine	routine	JJ
cord-015365-iqdi99pd	1462	22	clinical	clinical	JJ
cord-015365-iqdi99pd	1462	23	practice	practice	NN
cord-015365-iqdi99pd	1462	24	awaits	await	VBZ
cord-015365-iqdi99pd	1462	25	minimally	minimally	RB
cord-015365-iqdi99pd	1462	26	toxic	toxic	JJ
cord-015365-iqdi99pd	1462	27	BMT	BMT	NNP
cord-015365-iqdi99pd	1462	28	regimens	regimen	NNS
cord-015365-iqdi99pd	1462	29	.	.	.
cord-015365-iqdi99pd	1463	1	Myelosuppressive	myelosuppressive	JJ
cord-015365-iqdi99pd	1463	2	and	and	CC
cord-015365-iqdi99pd	1463	3	cytotoxic	cytotoxic	JJ
cord-015365-iqdi99pd	1463	4	pre	pre	NNS
cord-015365-iqdi99pd	1463	5	-	-	NNS
cord-015365-iqdi99pd	1463	6	treatments	treatment	NNS
cord-015365-iqdi99pd	1463	7	commonly	commonly	RB
cord-015365-iqdi99pd	1463	8	employed	employ	VBN
cord-015365-iqdi99pd	1463	9	in	in	IN
cord-015365-iqdi99pd	1463	10	'	'	``
cord-015365-iqdi99pd	1463	11	conventional	conventional	JJ
cord-015365-iqdi99pd	1463	12	'	'	''
cord-015365-iqdi99pd	1463	13	BMT	BMT	NNP
cord-015365-iqdi99pd	1463	14	recipients	recipient	NNS
cord-015365-iqdi99pd	1463	15	would	would	MD
cord-015365-iqdi99pd	1463	16	be	be	VB
cord-015365-iqdi99pd	1463	17	unacceptable	unacceptable	JJ
cord-015365-iqdi99pd	1463	18	in	in	IN
cord-015365-iqdi99pd	1463	19	organ	organ	NN
cord-015365-iqdi99pd	1463	20	transplant	transplant	NN
cord-015365-iqdi99pd	1463	21	recipients	recipient	NNS
cord-015365-iqdi99pd	1463	22	.	.	.
cord-015365-iqdi99pd	1464	1	Therefore	therefore	RB
cord-015365-iqdi99pd	1464	2	,	,	,
cord-015365-iqdi99pd	1464	3	efforts	effort	NNS
cord-015365-iqdi99pd	1464	4	to	to	TO
cord-015365-iqdi99pd	1464	5	develop	develop	VB
cord-015365-iqdi99pd	1464	6	advanced	advanced	JJ
cord-015365-iqdi99pd	1464	7	,	,	,
cord-015365-iqdi99pd	1464	8	non	non	JJ
cord-015365-iqdi99pd	1464	9	-	-	JJ
cord-015365-iqdi99pd	1464	10	toxic	toxic	JJ
cord-015365-iqdi99pd	1464	11	murine	murine	NN
cord-015365-iqdi99pd	1464	12	BMT	BMT	NNP
cord-015365-iqdi99pd	1464	13	protocols	protocol	NNS
cord-015365-iqdi99pd	1464	14	are	be	VBP
cord-015365-iqdi99pd	1464	15	ongoing	ongoing	JJ
cord-015365-iqdi99pd	1464	16	.	.	.
cord-015365-iqdi99pd	1465	1	The	the	DT
cord-015365-iqdi99pd	1465	2	use	use	NN
cord-015365-iqdi99pd	1465	3	of	of	IN
cord-015365-iqdi99pd	1465	4	costimulation	costimulation	NN
cord-015365-iqdi99pd	1465	5	blockers	blocker	NNS
cord-015365-iqdi99pd	1465	6	and	and	CC
cord-015365-iqdi99pd	1465	7	,	,	,
cord-015365-iqdi99pd	1465	8	more	more	RBR
cord-015365-iqdi99pd	1465	9	recently	recently	RB
cord-015365-iqdi99pd	1465	10	,	,	,
cord-015365-iqdi99pd	1465	11	adjunctive	adjunctive	JJ
cord-015365-iqdi99pd	1465	12	T	T	NNP
cord-015365-iqdi99pd	1465	13	regulatory	regulatory	JJ
cord-015365-iqdi99pd	1465	14	cell	cell	NN
cord-015365-iqdi99pd	1465	15	therapy	therapy	NN
cord-015365-iqdi99pd	1465	16	have	have	VBP
cord-015365-iqdi99pd	1465	17	yielded	yield	VBN
cord-015365-iqdi99pd	1465	18	dramatically	dramatically	RB
cord-015365-iqdi99pd	1465	19	less	less	RBR
cord-015365-iqdi99pd	1465	20	toxic	toxic	JJ
cord-015365-iqdi99pd	1465	21	regimens	regimen	NNS
cord-015365-iqdi99pd	1465	22	which	which	WDT
cord-015365-iqdi99pd	1465	23	hold	hold	VBP
cord-015365-iqdi99pd	1465	24	promise	promise	NN
cord-015365-iqdi99pd	1465	25	for	for	IN
cord-015365-iqdi99pd	1465	26	clinical	clinical	JJ
cord-015365-iqdi99pd	1465	27	translation	translation	NN
cord-015365-iqdi99pd	1465	28	.	.	.
cord-015365-iqdi99pd	1466	1	Aspergillus	aspergillus	NN
cord-015365-iqdi99pd	1466	2	und	und	IN
cord-015365-iqdi99pd	1466	3	seltene	seltene	NNP
cord-015365-iqdi99pd	1466	4	Schimmelpilzinfektionen	Schimmelpilzinfektionen	NNP
cord-015365-iqdi99pd	1466	5	.	.	.
cord-015365-iqdi99pd	1467	1	Die	die	VB
cord-015365-iqdi99pd	1467	2	Inzidenz	Inzidenz	NNP
cord-015365-iqdi99pd	1467	3	der	der	NNP
cord-015365-iqdi99pd	1467	4	Aspergillose	Aspergillose	NNP
cord-015365-iqdi99pd	1467	5	bei	bei	NNP
cord-015365-iqdi99pd	1467	6	der	der	NNP
cord-015365-iqdi99pd	1467	7	allogenen	allogenen	NN
cord-015365-iqdi99pd	1467	8	Stammzelltransplantation	Stammzelltransplantation	NNP
cord-015365-iqdi99pd	1467	9	beträgt	beträgt	NNP
cord-015365-iqdi99pd	1467	10	zwischen	zwischen	NNP
cord-015365-iqdi99pd	1467	11	8	8	CD
cord-015365-iqdi99pd	1467	12	-	-	SYM
cord-015365-iqdi99pd	1467	13	25	25	CD
cord-015365-iqdi99pd	1467	14	%	%	NN
cord-015365-iqdi99pd	1467	15	.	.	.
cord-015365-iqdi99pd	1468	1	Aspergillussporen	Aspergillussporen	NNP
cord-015365-iqdi99pd	1468	2	kommen	kommen	NNP
cord-015365-iqdi99pd	1468	3	ubiquitär	ubiquitär	VBP
cord-015365-iqdi99pd	1468	4	in	in	IN
cord-015365-iqdi99pd	1468	5	der	der	NNP
cord-015365-iqdi99pd	1468	6	Umwelt	Umwelt	NNP
cord-015365-iqdi99pd	1468	7	vor	vor	NNP
cord-015365-iqdi99pd	1468	8	;	;	:
cord-015365-iqdi99pd	1468	9	ungefilterte	ungefilterte	NNP
cord-015365-iqdi99pd	1468	10	Luft	Luft	NNP
cord-015365-iqdi99pd	1468	11	aus	aus	NNP
cord-015365-iqdi99pd	1468	12	Belü	Belü	NNP
cord-015365-iqdi99pd	1468	13	ftungssystemen	ftungssystemen	NNP
cord-015365-iqdi99pd	1468	14	und	und	IN
cord-015365-iqdi99pd	1468	15	Staub	Staub	NNP
cord-015365-iqdi99pd	1468	16	bilden	bilden	NNP
cord-015365-iqdi99pd	1468	17	die	die	VB
cord-015365-iqdi99pd	1468	18	Hauptinfektionsquellen	Hauptinfektionsquellen	NNP
cord-015365-iqdi99pd	1468	19	.	.	.
cord-015365-iqdi99pd	1469	1	Aspergillussporen	Aspergillussporen	NNP
cord-015365-iqdi99pd	1469	2	werden	werden	NNP
cord-015365-iqdi99pd	1470	1	exogen	exogen	NNP
cord-015365-iqdi99pd	1470	2	durch	durch	NNP
cord-015365-iqdi99pd	1470	3	Inhalation	Inhalation	NNP
cord-015365-iqdi99pd	1470	4	erworben	erworben	NN
cord-015365-iqdi99pd	1470	5	.	.	.
cord-015365-iqdi99pd	1471	1	Die	die	VB
cord-015365-iqdi99pd	1471	2	Reduktion	Reduktion	NNP
cord-015365-iqdi99pd	1471	3	der	der	NNP
cord-015365-iqdi99pd	1471	4	Sporenlast	Sporenlast	NNP
cord-015365-iqdi99pd	1471	5	in	in	IN
cord-015365-iqdi99pd	1471	6	der	der	NNP
cord-015365-iqdi99pd	1471	7	Umgebung	Umgebung	NNP
cord-015365-iqdi99pd	1471	8	von	von	NNP
cord-015365-iqdi99pd	1471	9	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1471	10	"	"	''
cord-015365-iqdi99pd	1471	11	at	at	IN
cord-015365-iqdi99pd	1471	12	risk	risk	NN
cord-015365-iqdi99pd	1471	13	"	"	``
cord-015365-iqdi99pd	1471	14	ist	ist	FW
cord-015365-iqdi99pd	1471	15	die	die	VB
cord-015365-iqdi99pd	1471	16	wichtigste	wichtigste	NN
cord-015365-iqdi99pd	1471	17	prophylaktische	prophylaktische	NN
cord-015365-iqdi99pd	1471	18	Maßnahme	Maßnahme	NNP
cord-015365-iqdi99pd	1471	19	.	.	.
cord-015365-iqdi99pd	1472	1	Der	Der	NNP
cord-015365-iqdi99pd	1472	2	klinisch	klinisch	NNP
cord-015365-iqdi99pd	1472	3	wichtigste	wichtigste	NN
cord-015365-iqdi99pd	1472	4	Vertreter	Vertreter	NNP
cord-015365-iqdi99pd	1472	5	ist	ist	NN
cord-015365-iqdi99pd	1472	6	Aspergillus	aspergillus	NN
cord-015365-iqdi99pd	1472	7	fumigatus	fumigatus	NN
cord-015365-iqdi99pd	1472	8	.	.	.
cord-015365-iqdi99pd	1473	1	Die	die	VB
cord-015365-iqdi99pd	1473	2	Letalität	Letalität	NNP
cord-015365-iqdi99pd	1473	3	invasiver	invasiver	RB
cord-015365-iqdi99pd	1474	1	Aspergillosen	Aspergillosen	NNP
cord-015365-iqdi99pd	1474	2	liegt	liegt	NNP
cord-015365-iqdi99pd	1474	3	bei	bei	NNP
cord-015365-iqdi99pd	1474	4	70	70	CD
cord-015365-iqdi99pd	1474	5	-	-	SYM
cord-015365-iqdi99pd	1474	6	90	90	CD
cord-015365-iqdi99pd	1474	7	%	%	NN
cord-015365-iqdi99pd	1474	8	.	.	.
cord-015365-iqdi99pd	1475	1	Zu	Zu	NNP
cord-015365-iqdi99pd	1475	2	den	den	NNP
cord-015365-iqdi99pd	1475	3	anderen	anderen	NNP
cord-015365-iqdi99pd	1476	1	Schimmelpilzinfektionen	Schimmelpilzinfektionen	NNP
cord-015365-iqdi99pd	1476	2	zählen	zählen	NNP
cord-015365-iqdi99pd	1476	3	die	die	VBP
cord-015365-iqdi99pd	1476	4	Zygomykosen	Zygomykosen	NNP
cord-015365-iqdi99pd	1476	5	(	(	-LRB-
cord-015365-iqdi99pd	1476	6	Absidia-	Absidia-	NNP
cord-015365-iqdi99pd	1476	7	,	,	,
cord-015365-iqdi99pd	1476	8	Mucor	Mucor	NNP
cord-015365-iqdi99pd	1476	9	-	-	HYPH
cord-015365-iqdi99pd	1476	10	und	und	NNP
cord-015365-iqdi99pd	1476	11	Rhizopus	Rhizopus	NNP
cord-015365-iqdi99pd	1476	12	-	-	HYPH
cord-015365-iqdi99pd	1476	13	Spezies	Spezies	NNP
cord-015365-iqdi99pd	1476	14	)	)	-RRB-
cord-015365-iqdi99pd	1477	1	,	,	,
cord-015365-iqdi99pd	1477	2	die	die	VB
cord-015365-iqdi99pd	1477	3	insbesondere	insbesondere	FW
cord-015365-iqdi99pd	1477	4	bei	bei	NNP
cord-015365-iqdi99pd	1477	5	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1477	6	mit	mit	NNP
cord-015365-iqdi99pd	1477	7	Diabetes	Diabetes	NNP
cord-015365-iqdi99pd	1477	8	mellitus	mellitus	NN
cord-015365-iqdi99pd	1477	9	oder	oder	NN
cord-015365-iqdi99pd	1477	10	zunehmend	zunehmend	NNP
cord-015365-iqdi99pd	1477	11	bei	bei	NNP
cord-015365-iqdi99pd	1477	12	immunsupprimierten	immunsupprimierten	NNP
cord-015365-iqdi99pd	1477	13	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1477	14	unter	unter	NNP
cord-015365-iqdi99pd	1477	15	Voriconazol	Voriconazol	NNP
cord-015365-iqdi99pd	1477	16	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1477	17	auftreten	auftreten	NN
cord-015365-iqdi99pd	1477	18	.	.	.
cord-015365-iqdi99pd	1478	1	Die	die	VB
cord-015365-iqdi99pd	1478	2	Letalität	Letalität	NNP
cord-015365-iqdi99pd	1478	3	beim	beim	NNP
cord-015365-iqdi99pd	1479	1	Immungeschwächten	Immungeschwächten	NNP
cord-015365-iqdi99pd	1479	2	ist	ist	NNP
cord-015365-iqdi99pd	1479	3	annähernd	annähernd	NNP
cord-015365-iqdi99pd	1480	1	100	100	CD
cord-015365-iqdi99pd	1480	2	%	%	NN
cord-015365-iqdi99pd	1480	3	.	.	.
cord-015365-iqdi99pd	1481	1	Bei	Bei	NNP
cord-015365-iqdi99pd	1481	2	Empfängern	empfängern	JJ
cord-015365-iqdi99pd	1481	3	solider	solider	NN
cord-015365-iqdi99pd	1481	4	Organtransplantate	Organtransplantate	NNP
cord-015365-iqdi99pd	1481	5	konnte	konnte	NNP
cord-015365-iqdi99pd	1481	6	durch	durch	NNP
cord-015365-iqdi99pd	1481	7	Neuerungen	Neuerungen	NNP
cord-015365-iqdi99pd	1481	8	in	in	IN
cord-015365-iqdi99pd	1481	9	der	der	NNP
cord-015365-iqdi99pd	1481	10	Chirurgie	Chirurgie	NNP
cord-015365-iqdi99pd	1481	11	und	und	XX
cord-015365-iqdi99pd	1482	1	Intensivierung	Intensivierung	NNP
cord-015365-iqdi99pd	1482	2	der	der	NN
cord-015365-iqdi99pd	1482	3	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	1482	4	das	das	NNP
cord-015365-iqdi99pd	1482	5	Transplantatü	Transplantatü	NNP
cord-015365-iqdi99pd	1482	6	berleben	berleben	NN
cord-015365-iqdi99pd	1482	7	verbessert	verbessert	NNP
cord-015365-iqdi99pd	1482	8	werden	werden	NNP
cord-015365-iqdi99pd	1482	9	.	.	.
cord-015365-iqdi99pd	1483	1	Mit	Mit	NNP
cord-015365-iqdi99pd	1483	2	bis	bis	NNP
cord-015365-iqdi99pd	1483	3	zu	zu	XX
cord-015365-iqdi99pd	1484	1	15	15	CD
cord-015365-iqdi99pd	1484	2	%	%	NN
cord-015365-iqdi99pd	1484	3	ist	ist	NN
cord-015365-iqdi99pd	1484	4	die	die	VBP
cord-015365-iqdi99pd	1485	1	Inzidenz	Inzidenz	NNP
cord-015365-iqdi99pd	1485	2	bei	bei	NNP
cord-015365-iqdi99pd	1485	3	Herzund	Herzund	NNP
cord-015365-iqdi99pd	1485	4	Lungentransplantation	Lungentransplantation	NNP
cord-015365-iqdi99pd	1485	5	am	be	VBP
cord-015365-iqdi99pd	1485	6	höchsten	höchsten	NNP
cord-015365-iqdi99pd	1485	7	.	.	.
cord-015365-iqdi99pd	1486	1	Nach	Nach	NNP
cord-015365-iqdi99pd	1486	2	Lungentransplantation	Lungentransplantation	NNP
cord-015365-iqdi99pd	1486	3	treten	treten	NNP
cord-015365-iqdi99pd	1486	4	neben	neben	NNP
cord-015365-iqdi99pd	1486	5	der	der	NNP
cord-015365-iqdi99pd	1486	6	typischen	typischen	NNP
cord-015365-iqdi99pd	1486	7	pulmonalen	pulmonalen	NNP
cord-015365-iqdi99pd	1487	1	Aspergillose	Aspergillose	NNP
cord-015365-iqdi99pd	1487	2	gehäuft	gehäuft	NNP
cord-015365-iqdi99pd	1488	1	ulzerierende	ulzerierende	NNP
cord-015365-iqdi99pd	1488	2	Tracheobronchitis	Tracheobronchitis	NNP
cord-015365-iqdi99pd	1488	3	und	und	IN
cord-015365-iqdi99pd	1488	4	Aspergillose	Aspergillose	NNP
cord-015365-iqdi99pd	1488	5	der	der	NNP
cord-015365-iqdi99pd	1488	6	Bronchusanastomose	Bronchusanastomose	NNP
cord-015365-iqdi99pd	1488	7	auf	auf	NNP
cord-015365-iqdi99pd	1488	8	.	.	.
cord-015365-iqdi99pd	1489	1	Das	Das	NNP
cord-015365-iqdi99pd	1489	2	geringste	geringste	NNP
cord-015365-iqdi99pd	1490	1	Risiko	Risiko	NNP
cord-015365-iqdi99pd	1490	2	einer	einer	NNP
cord-015365-iqdi99pd	1490	3	invasiven	invasiven	NNP
cord-015365-iqdi99pd	1490	4	Aspergillose	Aspergillose	NNP
cord-015365-iqdi99pd	1490	5	besteht	besteht	NNP
cord-015365-iqdi99pd	1490	6	bei	bei	NNP
cord-015365-iqdi99pd	1490	7	Nierentransplantierten	Nierentransplantierten	NNP
cord-015365-iqdi99pd	1490	8	mit	mit	NNP
cord-015365-iqdi99pd	1490	9	1	1	CD
cord-015365-iqdi99pd	1490	10	%	%	NN
cord-015365-iqdi99pd	1490	11	Inzidenz	Inzidenz	NNP
cord-015365-iqdi99pd	1490	12	,	,	,
cord-015365-iqdi99pd	1490	13	die	die	VB
cord-015365-iqdi99pd	1490	14	Mortalität	Mortalität	NNP
cord-015365-iqdi99pd	1490	15	ist	ist	FW
cord-015365-iqdi99pd	1490	16	generell	generell	FW
cord-015365-iqdi99pd	1490	17	hoch	hoch	NN
cord-015365-iqdi99pd	1490	18	.	.	.
cord-015365-iqdi99pd	1491	1	Institut	Institut	NNP
cord-015365-iqdi99pd	1491	2	für	für	IN
cord-015365-iqdi99pd	1491	3	Hygiene	Hygiene	NNP
cord-015365-iqdi99pd	1491	4	,	,	,
cord-015365-iqdi99pd	1491	5	Mikrobiologie	Mikrobiologie	NNP
cord-015365-iqdi99pd	1491	6	und	und	IN
cord-015365-iqdi99pd	1491	7	Umweltmedizin	Umweltmedizin	NNP
cord-015365-iqdi99pd	1491	8	,	,	,
cord-015365-iqdi99pd	1491	9	Medizinische	Medizinische	NNP
cord-015365-iqdi99pd	1491	10	Universität	Universität	NNP
cord-015365-iqdi99pd	1491	11	Graz	Graz	NNP
cord-015365-iqdi99pd	1491	12	,	,	,
cord-015365-iqdi99pd	1491	13	Graz	Graz	NNP
cord-015365-iqdi99pd	1491	14	,	,	,
cord-015365-iqdi99pd	1491	15	Österreich	Österreich	NNP
cord-015365-iqdi99pd	1491	16	Pilzinfektionen	Pilzinfektionen	NNP
cord-015365-iqdi99pd	1491	17	spielen	spielen	NNP
cord-015365-iqdi99pd	1491	18	bei	bei	NNP
cord-015365-iqdi99pd	1491	19	Immunsupprimierten	Immunsupprimierten	NNP
cord-015365-iqdi99pd	1491	20	,	,	,
cord-015365-iqdi99pd	1491	21	vor	vor	NNP
cord-015365-iqdi99pd	1491	22	allem	allem	FW
cord-015365-iqdi99pd	1491	23	bei	bei	NNP
cord-015365-iqdi99pd	1491	24	Patientinnen	Patientinnen	NNP
cord-015365-iqdi99pd	1491	25	und	und	XX
cord-015365-iqdi99pd	1492	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1492	2	nach	nach	NNP
cord-015365-iqdi99pd	1492	3	Organ	Organ	NNP
cord-015365-iqdi99pd	1492	4	-	-	HYPH
cord-015365-iqdi99pd	1492	5	und	und	NNP
cord-015365-iqdi99pd	1492	6	Stammzelltransplantationen	Stammzelltransplantationen	NNP
cord-015365-iqdi99pd	1492	7	,	,	,
cord-015365-iqdi99pd	1492	8	eine	eine	NNP
cord-015365-iqdi99pd	1492	9	steigende	steigende	NNP
cord-015365-iqdi99pd	1492	10	Rolle	Rolle	NNP
cord-015365-iqdi99pd	1492	11	.	.	.
cord-015365-iqdi99pd	1493	1	Dabei	Dabei	NNP
cord-015365-iqdi99pd	1493	2	reicht	reicht	NNP
cord-015365-iqdi99pd	1493	3	das	das	NNP
cord-015365-iqdi99pd	1493	4	Spektrum	Spektrum	NNP
cord-015365-iqdi99pd	1493	5	der	der	NNP
cord-015365-iqdi99pd	1493	6	verursachenden	verursachenden	NNP
cord-015365-iqdi99pd	1494	1	Pilze	Pilze	NNP
cord-015365-iqdi99pd	1494	2	von	von	NNP
cord-015365-iqdi99pd	1494	3	Hefen	Hefen	NNP
cord-015365-iqdi99pd	1494	4	der	der	NNP
cord-015365-iqdi99pd	1494	5	Gattung	Gattung	NNP
cord-015365-iqdi99pd	1494	6	Candida	Candida	NNP
cord-015365-iqdi99pd	1495	1	zu	zu	NNP
cord-015365-iqdi99pd	1495	2	Schimmelpilzen	Schimmelpilzen	NNP
cord-015365-iqdi99pd	1495	3	der	der	NNP
cord-015365-iqdi99pd	1495	4	Gattung	Gattung	NNP
cord-015365-iqdi99pd	1495	5	Aspergillus	Aspergillus	NNP
cord-015365-iqdi99pd	1495	6	,	,	,
cord-015365-iqdi99pd	1495	7	wobei	wobei	FW
cord-015365-iqdi99pd	1495	8	auch	auch	NNP
cord-015365-iqdi99pd	1495	9	eine	eine	NNP
cord-015365-iqdi99pd	1495	10	Zunahme	Zunahme	NNP
cord-015365-iqdi99pd	1495	11	von	von	NNP
cord-015365-iqdi99pd	1495	12	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	1495	13	mit	mit	NNP
cord-015365-iqdi99pd	1495	14	anderen	anderen	NNP
cord-015365-iqdi99pd	1495	15	Schimmelpilzen	Schimmelpilzen	NNP
cord-015365-iqdi99pd	1496	1	wie	wie	NNP
cord-015365-iqdi99pd	1496	2	den	den	NNP
cord-015365-iqdi99pd	1496	3	Zygomyzeten	Zygomyzeten	NNP
cord-015365-iqdi99pd	1496	4	,	,	,
cord-015365-iqdi99pd	1497	1	Fusarien	Fusarien	NNP
cord-015365-iqdi99pd	1497	2	,	,	,
cord-015365-iqdi99pd	1497	3	Scedosporium	Scedosporium	NNP
cord-015365-iqdi99pd	1497	4	/	/	SYM
cord-015365-iqdi99pd	1497	5	Pseudallescheria	Pseudallescheria	NNP
cord-015365-iqdi99pd	1497	6	und	und	XX
cord-015365-iqdi99pd	1498	1	anderen	anderen	NNP
cord-015365-iqdi99pd	1498	2	zu	zu	NNP
cord-015365-iqdi99pd	1498	3	beobachten	beobachten	NNP
cord-015365-iqdi99pd	1498	4	ist	ist	NNP
cord-015365-iqdi99pd	1498	5	.	.	.
cord-015365-iqdi99pd	1499	1	Um	um	UH
cord-015365-iqdi99pd	1499	2	eine	eine	NNP
cord-015365-iqdi99pd	1499	3	zielgerichtete	zielgerichtete	NNP
cord-015365-iqdi99pd	1499	4	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1499	5	einleiten	einleiten	FW
cord-015365-iqdi99pd	1499	6	zu	zu	NNP
cord-015365-iqdi99pd	1499	7	können	können	NNP
cord-015365-iqdi99pd	1499	8	,	,	,
cord-015365-iqdi99pd	1499	9	ist	ist	NNP
cord-015365-iqdi99pd	1499	10	eine	eine	NNP
cord-015365-iqdi99pd	1499	11	schnelle	schnelle	NNP
cord-015365-iqdi99pd	1500	1	und	und	NNP
cord-015365-iqdi99pd	1500	2	genaue	genaue	NNP
cord-015365-iqdi99pd	1500	3	Diagnostik	Diagnostik	NNP
cord-015365-iqdi99pd	1500	4	unumgänglich	unumgänglich	NNP
cord-015365-iqdi99pd	1500	5	,	,	,
cord-015365-iqdi99pd	1500	6	da	da	NNP
cord-015365-iqdi99pd	1500	7	die	die	NNP
cord-015365-iqdi99pd	1500	8	einzelnen	einzelnen	NNP
cord-015365-iqdi99pd	1500	9	Pilzarten	Pilzarten	NNP
cord-015365-iqdi99pd	1500	10	teils	teils	NNP
cord-015365-iqdi99pd	1500	11	unterschiedliche	unterschiedliche	NN
cord-015365-iqdi99pd	1500	12	Antimykotika	Antimykotika	NNP
cord-015365-iqdi99pd	1500	13	-	-	HYPH
cord-015365-iqdi99pd	1500	14	Empfindlichkeitsspektren	Empfindlichkeitsspektren	NNP
cord-015365-iqdi99pd	1500	15	aufweisen	aufweisen	NN
cord-015365-iqdi99pd	1500	16	.	.	.
cord-015365-iqdi99pd	1501	1	Neben	Neben	NNP
cord-015365-iqdi99pd	1501	2	den	den	NNP
cord-015365-iqdi99pd	1501	3	klassischen	klassischen	NNP
cord-015365-iqdi99pd	1501	4	Kulturmethoden	Kulturmethoden	NNP
cord-015365-iqdi99pd	1501	5	,	,	,
cord-015365-iqdi99pd	1501	6	die	die	VBP
cord-015365-iqdi99pd	1501	7	trotz	trotz	NNP
cord-015365-iqdi99pd	1501	8	ihrer	ihrer	JJ
cord-015365-iqdi99pd	1501	9	relativen	relativen	NNP
cord-015365-iqdi99pd	1501	10	"	"	''
cord-015365-iqdi99pd	1502	1	Langsamkeit	Langsamkeit	NNP
cord-015365-iqdi99pd	1502	2	"	"	``
cord-015365-iqdi99pd	1502	3	nach	nach	NNP
cord-015365-iqdi99pd	1502	4	wie	wie	NN
cord-015365-iqdi99pd	1502	5	vor	vor	NNP
cord-015365-iqdi99pd	1502	6	unverzichtbar	unverzichtbar	NN
cord-015365-iqdi99pd	1502	7	sind	sind	NNP
cord-015365-iqdi99pd	1502	8	,	,	,
cord-015365-iqdi99pd	1502	9	wurden	wurden	NNP
cord-015365-iqdi99pd	1502	10	in	in	IN
cord-015365-iqdi99pd	1502	11	den	den	NNP
cord-015365-iqdi99pd	1502	12	letzten	letzten	NNP
cord-015365-iqdi99pd	1502	13	Jahren	Jahren	NNP
cord-015365-iqdi99pd	1502	14	Techniken	Techniken	NNP
cord-015365-iqdi99pd	1502	15	entwickelt	entwickelt	NNP
cord-015365-iqdi99pd	1502	16	,	,	,
cord-015365-iqdi99pd	1502	17	die	die	VB
cord-015365-iqdi99pd	1503	1	teilweise	teilweise	NNP
cord-015365-iqdi99pd	1503	2	innerhalb	innerhalb	NNP
cord-015365-iqdi99pd	1503	3	weniger	weniger	NNP
cord-015365-iqdi99pd	1503	4	Stunden	Stunden	NNP
cord-015365-iqdi99pd	1503	5	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	1503	6	bringen	bringen	NNP
cord-015365-iqdi99pd	1503	7	können	können	RB
cord-015365-iqdi99pd	1503	8	-vorausgesetzt	-vorausgesetzt	VBD
cord-015365-iqdi99pd	1503	9	,	,	,
cord-015365-iqdi99pd	1504	1	sie	sie	NNP
cord-015365-iqdi99pd	1504	2	werden	werden	NNP
cord-015365-iqdi99pd	1504	3	richtig	richtig	NNP
cord-015365-iqdi99pd	1504	4	angewandt	angewandt	NNP
cord-015365-iqdi99pd	1504	5	und	und	NNP
cord-015365-iqdi99pd	1504	6	interpretiert	interpretiert	NNP
cord-015365-iqdi99pd	1504	7	.	.	.
cord-015365-iqdi99pd	1505	1	Dazu	Dazu	NNP
cord-015365-iqdi99pd	1505	2	zählen	zählen	VBP
cord-015365-iqdi99pd	1505	3	insbesondere	insbesondere	NNP
cord-015365-iqdi99pd	1505	4	bildgebende	bildgebende	NNP
cord-015365-iqdi99pd	1505	5	Verfahren	Verfahren	NNP
cord-015365-iqdi99pd	1505	6	,	,	,
cord-015365-iqdi99pd	1505	7	molekularbiologische	molekularbiologische	NN
cord-015365-iqdi99pd	1505	8	Methoden	Methoden	NNP
cord-015365-iqdi99pd	1505	9	und	und	IN
cord-015365-iqdi99pd	1505	10	Antigen	Antigen	NNP
cord-015365-iqdi99pd	1505	11	-	-	HYPH
cord-015365-iqdi99pd	1505	12	Nachweise	Nachweise	NNP
cord-015365-iqdi99pd	1505	13	.	.	.
cord-015365-iqdi99pd	1506	1	Idealerweise	Idealerweise	NNP
cord-015365-iqdi99pd	1506	2	beruht	beruht	NN
cord-015365-iqdi99pd	1506	3	die	die	VB
cord-015365-iqdi99pd	1507	1	Diagnose	diagnose	VB
cord-015365-iqdi99pd	1507	2	einer	einer	NNP
cord-015365-iqdi99pd	1508	1	Pilzinfektion	Pilzinfektion	NNP
cord-015365-iqdi99pd	1508	2	auf	auf	NNP
cord-015365-iqdi99pd	1508	3	der	der	NNP
cord-015365-iqdi99pd	1508	4	Kombination	Kombination	NNP
cord-015365-iqdi99pd	1508	5	mehrerer	mehrerer	NN
cord-015365-iqdi99pd	1508	6	Techniken	Techniken	NNP
cord-015365-iqdi99pd	1508	7	,	,	,
cord-015365-iqdi99pd	1508	8	man	man	NN
cord-015365-iqdi99pd	1508	9	spricht	spricht	FW
cord-015365-iqdi99pd	1508	10	auch	auch	NNP
cord-015365-iqdi99pd	1508	11	von	von	NNP
cord-015365-iqdi99pd	1508	12	einer	einer	NNP
cord-015365-iqdi99pd	1508	13	Puzzle	Puzzle	NNP
cord-015365-iqdi99pd	1508	14	-	-	HYPH
cord-015365-iqdi99pd	1508	15	Diagnostik	Diagnostik	NNP
cord-015365-iqdi99pd	1508	16	.	.	.
cord-015365-iqdi99pd	1509	1	Die	die	VB
cord-015365-iqdi99pd	1509	2	einzelnen	einzelnen	NNP
cord-015365-iqdi99pd	1510	1	Techniken	Techniken	NNP
cord-015365-iqdi99pd	1510	2	zur	zur	NNP
cord-015365-iqdi99pd	1510	3	Diagnose	diagnose	VBP
cord-015365-iqdi99pd	1510	4	von	von	NNP
cord-015365-iqdi99pd	1510	5	Pilzinfektionen	Pilzinfektionen	NNP
cord-015365-iqdi99pd	1510	6	in	in	IN
cord-015365-iqdi99pd	1510	7	der	der	NNP
cord-015365-iqdi99pd	1510	8	Organ	Organ	NNP
cord-015365-iqdi99pd	1510	9	-	-	HYPH
cord-015365-iqdi99pd	1510	10	und	und	NNP
cord-015365-iqdi99pd	1510	11	Stammzelltransplantation	Stammzelltransplantation	NNP
cord-015365-iqdi99pd	1510	12	sollen	sollen	NNP
cord-015365-iqdi99pd	1510	13	vorgestellt	vorgestellt	NNP
cord-015365-iqdi99pd	1510	14	und	und	IN
cord-015365-iqdi99pd	1510	15	deren	deren	NNP
cord-015365-iqdi99pd	1510	16	Vor	Vor	NNP
cord-015365-iqdi99pd	1510	17	-	-	HYPH
cord-015365-iqdi99pd	1510	18	und	und	NNP
cord-015365-iqdi99pd	1510	19	Nachteile	Nachteile	NNP
cord-015365-iqdi99pd	1510	20	diskutiert	diskutiert	NN
cord-015365-iqdi99pd	1510	21	werden	werden	NNP
cord-015365-iqdi99pd	1510	22	.	.	.
cord-015365-iqdi99pd	1511	1	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1511	2	von	von	NNP
cord-015365-iqdi99pd	1511	3	Pilzinfektionen	Pilzinfektionen	NNP
cord-015365-iqdi99pd	1511	4	in	in	IN
cord-015365-iqdi99pd	1511	5	der	der	NNP
cord-015365-iqdi99pd	1511	6	Organ	Organ	NNP
cord-015365-iqdi99pd	1511	7	-	-	HYPH
cord-015365-iqdi99pd	1511	8	und	und	NNP
cord-015365-iqdi99pd	1511	9	Stammzelltransplantation	Stammzelltransplantation	NNP
cord-015365-iqdi99pd	1511	10	Universitätsklinik	Universitätsklinik	NNP
cord-015365-iqdi99pd	1511	11	für	für	IN
cord-015365-iqdi99pd	1511	12	Innere	Innere	NNP
cord-015365-iqdi99pd	1511	13	Medizin	Medizin	NNP
cord-015365-iqdi99pd	1511	14	,	,	,
cord-015365-iqdi99pd	1512	1	Medizinische	Medizinische	NNP
cord-015365-iqdi99pd	1512	2	Universität	Universität	NNP
cord-015365-iqdi99pd	1512	3	Graz	Graz	NNP
cord-015365-iqdi99pd	1512	4	,	,	,
cord-015365-iqdi99pd	1512	5	Graz	Graz	NNP
cord-015365-iqdi99pd	1512	6	,	,	,
cord-015365-iqdi99pd	1512	7	Österreich	Österreich	NNP
cord-015365-iqdi99pd	1512	8	Pilze	Pilze	NNP
cord-015365-iqdi99pd	1512	9	verursachen	verursachen	NN
cord-015365-iqdi99pd	1512	10	bei	bei	NNP
cord-015365-iqdi99pd	1512	11	Immunsupprimierten	Immunsupprimierten	NNP
cord-015365-iqdi99pd	1512	12	infektiöse	infektiöse	NNP
cord-015365-iqdi99pd	1512	13	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	1512	14	,	,	,
cord-015365-iqdi99pd	1512	15	die	die	VB
cord-015365-iqdi99pd	1512	16	von	von	NNP
cord-015365-iqdi99pd	1512	17	oberflächlichen	oberflächlichen	NNP
cord-015365-iqdi99pd	1513	1	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	1513	2	der	der	NN
cord-015365-iqdi99pd	1513	3	Haut/	Haut/	NNP
cord-015365-iqdi99pd	1513	4	Schleimhäute	Schleimhäute	NNP
cord-015365-iqdi99pd	1513	5	bis	bis	NNP
cord-015365-iqdi99pd	1513	6	zu	zu	NNP
cord-015365-iqdi99pd	1513	7	systemischen	systemischen	NNP
cord-015365-iqdi99pd	1513	8	,	,	,
cord-015365-iqdi99pd	1513	9	lebensbedrohlichen	lebensbedrohlichen	NNP
cord-015365-iqdi99pd	1513	10	Organinfektionen	Organinfektionen	NNP
cord-015365-iqdi99pd	1513	11	oder	oder	NNP
cord-015365-iqdi99pd	1513	12	Fungämien	Fungämien	NNP
cord-015365-iqdi99pd	1513	13	reichen	reichen	NNP
cord-015365-iqdi99pd	1513	14	.	.	.
cord-015365-iqdi99pd	1514	1	Auslöser	Auslöser	NNP
cord-015365-iqdi99pd	1514	2	dieser	dieser	NNP
cord-015365-iqdi99pd	1515	1	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	1515	2	sind	sind	NNP
cord-015365-iqdi99pd	1516	1	meist	meist	NNP
cord-015365-iqdi99pd	1516	2	Candida	Candida	NNP
cord-015365-iqdi99pd	1516	3	-	-	HYPH
cord-015365-iqdi99pd	1516	4	Arten	Arten	NNP
cord-015365-iqdi99pd	1516	5	,	,	,
cord-015365-iqdi99pd	1516	6	Aspergillus	Aspergillus	NNP
cord-015365-iqdi99pd	1516	7	-	-	HYPH
cord-015365-iqdi99pd	1516	8	Arten	Arten	NNP
cord-015365-iqdi99pd	1516	9	,	,	,
cord-015365-iqdi99pd	1516	10	andere	andere	JJ
cord-015365-iqdi99pd	1516	11	Schimmelpilze	Schimmelpilze	NNP
cord-015365-iqdi99pd	1516	12	wie	wie	NNP
cord-015365-iqdi99pd	1516	13	Zygomyceten	Zygomyceten	NNP
cord-015365-iqdi99pd	1516	14	,	,	,
cord-015365-iqdi99pd	1516	15	und	und	CC
cord-015365-iqdi99pd	1516	16	seltene	seltene	NNP
cord-015365-iqdi99pd	1516	17	andere	andere	NNP
cord-015365-iqdi99pd	1516	18	Pilze	Pilze	NNP
cord-015365-iqdi99pd	1516	19	.	.	.
cord-015365-iqdi99pd	1517	1	Zur	Zur	NNP
cord-015365-iqdi99pd	1517	2	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1517	3	der	der	NN
cord-015365-iqdi99pd	1517	4	systemischen	systemischen	NNS
cord-015365-iqdi99pd	1517	5	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	1517	6	stehen	stehen	NNP
cord-015365-iqdi99pd	1517	7	Polyene	Polyene	NNP
cord-015365-iqdi99pd	1517	8	(	(	-LRB-
cord-015365-iqdi99pd	1517	9	z.	z.	NNP
cord-015365-iqdi99pd	1517	10	B.	B.	NNP
cord-015365-iqdi99pd	1517	11	Amphotericin	Amphotericin	NNP
cord-015365-iqdi99pd	1517	12	B	B	NNP
cord-015365-iqdi99pd	1517	13	,	,	,
cord-015365-iqdi99pd	1517	14	lipid	lipid	NN
cord-015365-iqdi99pd	1517	15	-	-	HYPH
cord-015365-iqdi99pd	1517	16	assoziierte	assoziierte	NN
cord-015365-iqdi99pd	1517	17	Amphotericin	Amphotericin	NNP
cord-015365-iqdi99pd	1517	18	B	B	NNP
cord-015365-iqdi99pd	1517	19	Präparate	Präparate	NNP
cord-015365-iqdi99pd	1517	20	)	)	-RRB-
cord-015365-iqdi99pd	1517	21	,	,	,
cord-015365-iqdi99pd	1517	22	Azole	Azole	NNP
cord-015365-iqdi99pd	1517	23	(	(	-LRB-
cord-015365-iqdi99pd	1517	24	z.	z.	NNP
cord-015365-iqdi99pd	1517	25	B.	B.	NNP
cord-015365-iqdi99pd	1517	26	Fuconazol	Fuconazol	NNP
cord-015365-iqdi99pd	1517	27	,	,	,
cord-015365-iqdi99pd	1517	28	Itraconazol	Itraconazol	NNP
cord-015365-iqdi99pd	1517	29	,	,	,
cord-015365-iqdi99pd	1517	30	Voriconazol	Voriconazol	NNP
cord-015365-iqdi99pd	1517	31	,	,	,
cord-015365-iqdi99pd	1517	32	Posaconazol	Posaconazol	NNP
cord-015365-iqdi99pd	1517	33	)	)	-RRB-
cord-015365-iqdi99pd	1517	34	und	und	CC
cord-015365-iqdi99pd	1517	35	Echinocandine	Echinocandine	NNP
cord-015365-iqdi99pd	1517	36	(	(	-LRB-
cord-015365-iqdi99pd	1517	37	z.	z.	NNP
cord-015365-iqdi99pd	1517	38	B.	B.	NNP
cord-015365-iqdi99pd	1517	39	Caspofungin	Caspofungin	NNP
cord-015365-iqdi99pd	1517	40	,	,	,
cord-015365-iqdi99pd	1517	41	Anidulafungin	Anidulafungin	NNP
cord-015365-iqdi99pd	1517	42	,	,	,
cord-015365-iqdi99pd	1517	43	Micafungin	Micafungin	NNP
cord-015365-iqdi99pd	1517	44	)	)	-RRB-
cord-015365-iqdi99pd	1517	45	zur	zur	NNP
cord-015365-iqdi99pd	1517	46	Verfügung	Verfügung	NNP
cord-015365-iqdi99pd	1517	47	.	.	.
cord-015365-iqdi99pd	1518	1	Fluconazol	Fluconazol	NNP
cord-015365-iqdi99pd	1518	2	ist	ist	NNP
cord-015365-iqdi99pd	1518	3	ausschließlich	ausschließlich	NNS
cord-015365-iqdi99pd	1518	4	gegen	gegen	NNP
cord-015365-iqdi99pd	1518	5	Candida	Candida	NNP
cord-015365-iqdi99pd	1518	6	Arten	Arten	NNP
cord-015365-iqdi99pd	1518	7	wirksam	wirksam	NN
cord-015365-iqdi99pd	1518	8	.	.	.
cord-015365-iqdi99pd	1519	1	Die	die	VB
cord-015365-iqdi99pd	1519	2	anderen	anderen	NNP
cord-015365-iqdi99pd	1519	3	oben	oben	NNP
cord-015365-iqdi99pd	1519	4	genannnten	genannnten	NNP
cord-015365-iqdi99pd	1520	1	Antimykotika	Antimykotika	NNP
cord-015365-iqdi99pd	1520	2	sind	sind	NNP
cord-015365-iqdi99pd	1520	3	in	in	IN
cord-015365-iqdi99pd	1520	4	vitro	vitro	FW
cord-015365-iqdi99pd	1520	5	sowohl	sowohl	NNP
cord-015365-iqdi99pd	1520	6	gegen	gegen	NNP
cord-015365-iqdi99pd	1520	7	Candida	Candida	NNP
cord-015365-iqdi99pd	1520	8	-	-	HYPH
cord-015365-iqdi99pd	1520	9	als	als	NNP
cord-015365-iqdi99pd	1520	10	auch	auch	JJ
cord-015365-iqdi99pd	1520	11	Aspergillus	Aspergillus	NNP
cord-015365-iqdi99pd	1520	12	-	-	HYPH
cord-015365-iqdi99pd	1520	13	Arten	Arten	NNP
cord-015365-iqdi99pd	1520	14	wirksam	wirksam	NN
cord-015365-iqdi99pd	1520	15	.	.	.
cord-015365-iqdi99pd	1521	1	Für	Für	NNP
cord-015365-iqdi99pd	1521	2	die	die	VBP
cord-015365-iqdi99pd	1522	1	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1522	2	von	von	NNP
cord-015365-iqdi99pd	1523	1	Candida	Candida	NNP
cord-015365-iqdi99pd	1523	2	-	-	HYPH
cord-015365-iqdi99pd	1523	3	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	1523	4	eignen	eignen	NNP
cord-015365-iqdi99pd	1523	5	sich	sich	NNP
cord-015365-iqdi99pd	1523	6	abhängig	abhängig	NNP
cord-015365-iqdi99pd	1523	7	von	von	NNP
cord-015365-iqdi99pd	1523	8	der	der	NNP
cord-015365-iqdi99pd	1523	9	lokalen	lokalen	NNP
cord-015365-iqdi99pd	1523	10	Epidemiologie	Epidemiologie	NNP
cord-015365-iqdi99pd	1523	11	Fluconazol	Fluconazol	NNP
cord-015365-iqdi99pd	1523	12	,	,	,
cord-015365-iqdi99pd	1523	13	Echinocandine	Echinocandine	NNP
cord-015365-iqdi99pd	1523	14	oder	oder	NN
cord-015365-iqdi99pd	1523	15	Amphotericin	Amphotericin	NNP
cord-015365-iqdi99pd	1523	16	B	B	NNP
cord-015365-iqdi99pd	1523	17	-	-	HYPH
cord-015365-iqdi99pd	1523	18	Präparate	Präparate	NNP
cord-015365-iqdi99pd	1523	19	.	.	.
cord-015365-iqdi99pd	1524	1	Für	Für	NNP
cord-015365-iqdi99pd	1524	2	die	die	VBP
cord-015365-iqdi99pd	1524	3	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1524	4	von	von	NNP
cord-015365-iqdi99pd	1524	5	Aspergillus	Aspergillus	NNP
cord-015365-iqdi99pd	1524	6	-	-	HYPH
cord-015365-iqdi99pd	1524	7	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	1524	8	eignen	eignen	NNP
cord-015365-iqdi99pd	1524	9	sich	sich	NNP
cord-015365-iqdi99pd	1524	10	Voriconazol	Voriconazol	NNP
cord-015365-iqdi99pd	1524	11	,	,	,
cord-015365-iqdi99pd	1524	12	Posaconazol	Posaconazol	NNP
cord-015365-iqdi99pd	1524	13	,	,	,
cord-015365-iqdi99pd	1524	14	Amphotericin	Amphotericin	NNP
cord-015365-iqdi99pd	1524	15	B	B	NNP
cord-015365-iqdi99pd	1524	16	-	-	HYPH
cord-015365-iqdi99pd	1524	17	Präparate	Präparate	NNP
cord-015365-iqdi99pd	1524	18	oder	oder	NN
cord-015365-iqdi99pd	1524	19	Echinocandine	Echinocandine	NNP
cord-015365-iqdi99pd	1524	20	.	.	.
cord-015365-iqdi99pd	1525	1	Für	Für	NNP
cord-015365-iqdi99pd	1525	2	Zygomkosen	Zygomkosen	NNP
cord-015365-iqdi99pd	1525	3	stehen	stehen	NN
cord-015365-iqdi99pd	1525	4	Amphotericin	Amphotericin	NNP
cord-015365-iqdi99pd	1525	5	B	B	NNP
cord-015365-iqdi99pd	1525	6	-	-	:
cord-015365-iqdi99pd	1525	7	Präparate	Präparate	NNP
cord-015365-iqdi99pd	1525	8	und	und	IN
cord-015365-iqdi99pd	1525	9	Posaconazol	Posaconazol	NNP
cord-015365-iqdi99pd	1525	10	zu	zu	NNP
cord-015365-iqdi99pd	1525	11	Verfügung	Verfügung	NNP
cord-015365-iqdi99pd	1525	12	.	.	.
cord-015365-iqdi99pd	1526	1	Für	Für	NNP
cord-015365-iqdi99pd	1526	2	seltene	seltene	NNP
cord-015365-iqdi99pd	1527	1	Pilzinfektionen	Pilzinfektionen	NNP
cord-015365-iqdi99pd	1527	2	sind	sind	NNP
cord-015365-iqdi99pd	1528	1	adjuvante	adjuvante	NNP
cord-015365-iqdi99pd	1528	2	Therapeutika	Therapeutika	NNP
cord-015365-iqdi99pd	1529	1	(	(	-LRB-
cord-015365-iqdi99pd	1529	2	wie	wie	NNP
cord-015365-iqdi99pd	1529	3	z.	z.	NNP
cord-015365-iqdi99pd	1529	4	B.	B.	NNP
cord-015365-iqdi99pd	1529	5	Flucytosin	Flucytosin	NNP
cord-015365-iqdi99pd	1529	6	)	)	-RRB-
cord-015365-iqdi99pd	1529	7	vorhanden	vorhanden	NNP
cord-015365-iqdi99pd	1529	8	.	.	.
cord-015365-iqdi99pd	1530	1	Für	Für	NNP
cord-015365-iqdi99pd	1530	2	den	den	NNP
cord-015365-iqdi99pd	1530	3	Behandlungserfolg	Behandlungserfolg	NNP
cord-015365-iqdi99pd	1530	4	der	der	NNP
cord-015365-iqdi99pd	1530	5	schweren	schweren	NNP
cord-015365-iqdi99pd	1530	6	lebensbedrohlichen	lebensbedrohlichen	NNP
cord-015365-iqdi99pd	1531	1	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	1531	2	ist	ist	NN
cord-015365-iqdi99pd	1531	3	der	der	NNP
cord-015365-iqdi99pd	1531	4	Zeitpunkt	Zeitpunkt	NNP
cord-015365-iqdi99pd	1531	5	des	des	FW
cord-015365-iqdi99pd	1531	6	Therapiebeginns	Therapiebeginns	NNP
cord-015365-iqdi99pd	1531	7	und	und	IN
cord-015365-iqdi99pd	1531	8	das	das	NNP
cord-015365-iqdi99pd	1531	9	Spektrum	Spektrum	NNP
cord-015365-iqdi99pd	1531	10	der	der	NNP
cord-015365-iqdi99pd	1531	11	antifungalen	antifungalen	NNP
cord-015365-iqdi99pd	1531	12	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1531	13	relevant	relevant	JJ
cord-015365-iqdi99pd	1531	14	.	.	.
cord-015365-iqdi99pd	1532	1	Es	Es	NNP
cord-015365-iqdi99pd	1532	2	werden	werden	NNP
cord-015365-iqdi99pd	1532	3	empirische	empirische	NNP
cord-015365-iqdi99pd	1532	4	,	,	,
cord-015365-iqdi99pd	1532	5	kalkuliert	kalkuliert	NNP
cord-015365-iqdi99pd	1532	6	-	-	HYPH
cord-015365-iqdi99pd	1532	7	präemptive	präemptive	NNP
cord-015365-iqdi99pd	1532	8	und	und	IN
cord-015365-iqdi99pd	1532	9	zielgerichtete	zielgerichtete	NNP
cord-015365-iqdi99pd	1532	10	Therapien	Therapien	NNP
cord-015365-iqdi99pd	1532	11	unterschieden	unterschieden	JJ
cord-015365-iqdi99pd	1532	12	.	.	.
cord-015365-iqdi99pd	1533	1	Bei	Bei	NNP
cord-015365-iqdi99pd	1533	2	machne	machne	NNP
cord-015365-iqdi99pd	1534	1	Pilzinfektionen	Pilzinfektionen	NNP
cord-015365-iqdi99pd	1534	2	sind	sind	NNP
cord-015365-iqdi99pd	1535	1	chirurgische	chirurgische	NNP
cord-015365-iqdi99pd	1535	2	Sanierungen	Sanierungen	NNP
cord-015365-iqdi99pd	1535	3	zusätzlich	zusätzlich	NNP
cord-015365-iqdi99pd	1535	4	zur	zur	NNP
cord-015365-iqdi99pd	1535	5	antimykotischen	antimykotischen	NNP
cord-015365-iqdi99pd	1535	6	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1535	7	notwendig	notwendig	NNP
cord-015365-iqdi99pd	1535	8	.	.	.
cord-015365-iqdi99pd	1536	1	Die	die	VB
cord-015365-iqdi99pd	1536	2	einzelnen	einzelnen	NNP
cord-015365-iqdi99pd	1537	1	Therapioptionen	Therapioptionen	NNP
cord-015365-iqdi99pd	1537	2	zur	zur	NNP
cord-015365-iqdi99pd	1537	3	Behandlung	Behandlung	NNP
cord-015365-iqdi99pd	1537	4	von	von	NNP
cord-015365-iqdi99pd	1537	5	Pilzinfektionen	Pilzinfektionen	NNP
cord-015365-iqdi99pd	1537	6	in	in	IN
cord-015365-iqdi99pd	1537	7	der	der	NNP
cord-015365-iqdi99pd	1537	8	Organ	Organ	NNP
cord-015365-iqdi99pd	1537	9	-	-	HYPH
cord-015365-iqdi99pd	1537	10	und	und	NNP
cord-015365-iqdi99pd	1537	11	Stammzelltransplantation	Stammzelltransplantation	NNP
cord-015365-iqdi99pd	1537	12	sollen	sollen	NNP
cord-015365-iqdi99pd	1537	13	vorgestellt	vorgestellt	NNP
cord-015365-iqdi99pd	1537	14	und	und	IN
cord-015365-iqdi99pd	1537	15	deren	deren	NNP
cord-015365-iqdi99pd	1537	16	Vor	Vor	NNP
cord-015365-iqdi99pd	1537	17	-	-	HYPH
cord-015365-iqdi99pd	1537	18	und	und	NNP
cord-015365-iqdi99pd	1537	19	Nachteile	Nachteile	NNP
cord-015365-iqdi99pd	1537	20	diskutiert	diskutiert	NN
cord-015365-iqdi99pd	1537	21	werden	werden	NNP
cord-015365-iqdi99pd	1537	22	.	.	.
cord-015365-iqdi99pd	1538	1	Erlebenüberlebenund	Erlebenüberlebenund	NNP
cord-015365-iqdi99pd	1538	2	dann	dann	NNP
cord-015365-iqdi99pd	1538	3	?	?	.
cord-015365-iqdi99pd	1539	1	Lebensqualität	Lebensqualität	NNS
cord-015365-iqdi99pd	1539	2	nach	nach	VBP
cord-015365-iqdi99pd	1539	3	Herztransplantation	Herztransplantation	NNP
cord-015365-iqdi99pd	1539	4	Klinische	Klinische	NNP
cord-015365-iqdi99pd	1539	5	Abteilung	Abteilung	NNP
cord-015365-iqdi99pd	1539	6	für	für	IN
cord-015365-iqdi99pd	1539	7	Herzchirurgie	Herzchirurgie	NNP
cord-015365-iqdi99pd	1539	8	,	,	,
cord-015365-iqdi99pd	1539	9	Universitätsklinik	Universitätsklinik	NNP
cord-015365-iqdi99pd	1539	10	für	für	IN
cord-015365-iqdi99pd	1539	11	Chirurgie	Chirurgie	NNP
cord-015365-iqdi99pd	1539	12	,	,	,
cord-015365-iqdi99pd	1539	13	Medizinische	Medizinische	NNP
cord-015365-iqdi99pd	1539	14	Universität	Universität	NNP
cord-015365-iqdi99pd	1539	15	Wien	Wien	NNP
cord-015365-iqdi99pd	1539	16	,	,	,
cord-015365-iqdi99pd	1539	17	Wien	Wien	NNP
cord-015365-iqdi99pd	1539	18	,	,	,
cord-015365-iqdi99pd	1539	19	Österreich	Österreich	NNP
cord-015365-iqdi99pd	1539	20	Aus	Aus	NNP
cord-015365-iqdi99pd	1539	21	wissenschaftlicher	wissenschaftlicher	CC
cord-015365-iqdi99pd	1539	22	Perspektive	Perspektive	NNP
cord-015365-iqdi99pd	1539	23	ist	ist	NN
cord-015365-iqdi99pd	1539	24	der	der	NN
cord-015365-iqdi99pd	1539	25	Begriff	Begriff	NNP
cord-015365-iqdi99pd	1539	26	"	"	''
cord-015365-iqdi99pd	1539	27	Lebensqualität	Lebensqualität	NNPS
cord-015365-iqdi99pd	1539	28	"	"	''
cord-015365-iqdi99pd	1539	29	ein	ein	FW
cord-015365-iqdi99pd	1539	30	nicht	nicht	NNP
cord-015365-iqdi99pd	1539	31	direkt	direkt	NN
cord-015365-iqdi99pd	1539	32	beobachtbares	beobachtbares	NNP
cord-015365-iqdi99pd	1539	33	Konstrukt	Konstrukt	NNP
cord-015365-iqdi99pd	1539	34	,	,	,
cord-015365-iqdi99pd	1540	1	das	das	NNP
cord-015365-iqdi99pd	1540	2	die	die	VBP
cord-015365-iqdi99pd	1540	3	Bewertung	Bewertung	NNP
cord-015365-iqdi99pd	1540	4	des	des	NNP
cord-015365-iqdi99pd	1540	5	physischen	physischen	NNP
cord-015365-iqdi99pd	1540	6	,	,	,
cord-015365-iqdi99pd	1540	7	psychischen	psychischen	NNP
cord-015365-iqdi99pd	1540	8	und	und	IN
cord-015365-iqdi99pd	1540	9	sozialen	sozialen	NNP
cord-015365-iqdi99pd	1540	10	Zustandes	Zustandes	NNP
cord-015365-iqdi99pd	1540	11	einer	einer	NNP
cord-015365-iqdi99pd	1540	12	Person	Person	NNP
cord-015365-iqdi99pd	1540	13	in	in	IN
cord-015365-iqdi99pd	1540	14	seiner	seiner	NNP
cord-015365-iqdi99pd	1540	15	Zusammenschau	Zusammenschau	NNP
cord-015365-iqdi99pd	1540	16	bezeichnet	bezeichnet	NNP
cord-015365-iqdi99pd	1540	17	.	.	.
cord-015365-iqdi99pd	1541	1	Eine	Eine	NNP
cord-015365-iqdi99pd	1541	2	gute	gute	NNP
cord-015365-iqdi99pd	1541	3	Annäherung	Annäherung	NNP
cord-015365-iqdi99pd	1541	4	kann	kann	NNP
cord-015365-iqdi99pd	1541	5	auch	auch	NNP
cord-015365-iqdi99pd	1541	6	durch	durch	NNP
cord-015365-iqdi99pd	1541	7	den	den	NNP
cord-015365-iqdi99pd	1541	8	Begriff	Begriff	NNP
cord-015365-iqdi99pd	1541	9	"	"	''
cord-015365-iqdi99pd	1541	10	Lebenszufriedenheit	Lebenszufriedenheit	NNP
cord-015365-iqdi99pd	1541	11	"	"	''
cord-015365-iqdi99pd	1541	12	erfolgen	erfolgen	NN
cord-015365-iqdi99pd	1541	13	.	.	.
cord-015365-iqdi99pd	1542	1	I	-PRON-	PRP
cord-015365-iqdi99pd	1542	2	m	be	VBP
cord-015365-iqdi99pd	1543	1	Vortrag	Vortrag	NNP
cord-015365-iqdi99pd	1543	2	soll	soll	NNP
cord-015365-iqdi99pd	1544	1	vor	vor	NNP
cord-015365-iqdi99pd	1545	1	allem	allem	NNP
cord-015365-iqdi99pd	1545	2	auf	auf	NNP
cord-015365-iqdi99pd	1545	3	Langzeit	Langzeit	NNP
cord-015365-iqdi99pd	1545	4	-	-	HYPH
cord-015365-iqdi99pd	1545	5	Lebensqualitätsstudien	Lebensqualitätsstudien	NNP
cord-015365-iqdi99pd	1546	1	und	und	NNP
cord-015365-iqdi99pd	1546	2	die	die	VB
cord-015365-iqdi99pd	1546	3	psychische	psychische	NNP
cord-015365-iqdi99pd	1546	4	Verarbeitung	Verarbeitung	NNP
cord-015365-iqdi99pd	1546	5	der	der	NNP
cord-015365-iqdi99pd	1546	6	Herztransplantation	Herztransplantation	NNP
cord-015365-iqdi99pd	1546	7	Bezug	Bezug	NNP
cord-015365-iqdi99pd	1546	8	genommen	genommen	NNP
cord-015365-iqdi99pd	1547	1	werden	werden	NNP
cord-015365-iqdi99pd	1547	2	:	:	:
cord-015365-iqdi99pd	1547	3	wie	wie	NNP
cord-015365-iqdi99pd	1547	4	ändert	ändert	NNP
cord-015365-iqdi99pd	1547	5	sich	sich	NNP
cord-015365-iqdi99pd	1547	6	das	das	NNP
cord-015365-iqdi99pd	1547	7	Leben	Leben	NNP
cord-015365-iqdi99pd	1547	8	der	der	NNP
cord-015365-iqdi99pd	1547	9	PatientInnen	PatientInnen	NNP
cord-015365-iqdi99pd	1547	10	nach	nach	NNP
cord-015365-iqdi99pd	1547	11	einer	einer	NNP
cord-015365-iqdi99pd	1548	1	oft	oft	NNP
cord-015365-iqdi99pd	1548	2	schicksalhaften	schicksalhaften	NNP
cord-015365-iqdi99pd	1548	3	schweren	schweren	NNP
cord-015365-iqdi99pd	1549	1	Erkrankung	Erkrankung	NNP
cord-015365-iqdi99pd	1549	2	und	und	IN
cord-015365-iqdi99pd	1549	3	lebenserhaltenden	lebenserhaltenden	JJ
cord-015365-iqdi99pd	1549	4	Transplantation	transplantation	NN
cord-015365-iqdi99pd	1549	5	?	?	.
cord-015365-iqdi99pd	1550	1	In	in	IN
cord-015365-iqdi99pd	1550	2	einer	einer	NNP
cord-015365-iqdi99pd	1550	3	prospektiven	prospektiven	NNP
cord-015365-iqdi99pd	1550	4	Studie	Studie	NNP
cord-015365-iqdi99pd	1550	5	unserer	unserer	JJ
cord-015365-iqdi99pd	1550	6	Abteilung	Abteilung	NNP
cord-015365-iqdi99pd	1550	7	über	über	NNP
cord-015365-iqdi99pd	1550	8	Lebensqualität	Lebensqualität	NNP
cord-015365-iqdi99pd	1550	9	ein	ein	NNP
cord-015365-iqdi99pd	1550	10	,	,	,
cord-015365-iqdi99pd	1550	11	fünf	fünf	NNP
cord-015365-iqdi99pd	1550	12	und	und	IN
cord-015365-iqdi99pd	1550	13	10	10	CD
cord-015365-iqdi99pd	1550	14	Jahre	Jahre	NNP
cord-015365-iqdi99pd	1550	15	nach	nach	NNP
cord-015365-iqdi99pd	1550	16	Herztransplantation	Herztransplantation	NNP
cord-015365-iqdi99pd	1550	17	zeigte	zeigte	NNP
cord-015365-iqdi99pd	1550	18	sich	sich	NNP
cord-015365-iqdi99pd	1550	19	z.	z.	NNP
cord-015365-iqdi99pd	1550	20	B.	B.	NNP
cord-015365-iqdi99pd	1550	21	eine	eine	NNP
cord-015365-iqdi99pd	1551	1	Schere	Schere	NNP
cord-015365-iqdi99pd	1552	1	zwischen	zwischen	NNP
cord-015365-iqdi99pd	1552	2	konstant	konstant	NNP
cord-015365-iqdi99pd	1552	3	durchaus	durchaus	NNP
cord-015365-iqdi99pd	1552	4	guter	guter	NNP
cord-015365-iqdi99pd	1552	5	Lebensqualität	Lebensqualität	NNP
cord-015365-iqdi99pd	1552	6	in	in	IN
cord-015365-iqdi99pd	1552	7	physischer	physischer	NNP
cord-015365-iqdi99pd	1552	8	und	und	NNP
cord-015365-iqdi99pd	1552	9	zunehmend	zunehmend	NNP
cord-015365-iqdi99pd	1552	10	abnehmender	abnehmender	NNP
cord-015365-iqdi99pd	1552	11	Lebensqualität	Lebensqualität	NNP
cord-015365-iqdi99pd	1552	12	in	in	IN
cord-015365-iqdi99pd	1552	13	physischer	physischer	NNP
cord-015365-iqdi99pd	1552	14	Hinsicht	Hinsicht	NNP
cord-015365-iqdi99pd	1552	15	(	(	-LRB-
cord-015365-iqdi99pd	1552	16	v.	v.	IN
cord-015365-iqdi99pd	1552	17	a.	a.	NN
cord-015365-iqdi99pd	1552	18	Depression	depression	NN
cord-015365-iqdi99pd	1552	19	,	,	,
cord-015365-iqdi99pd	1553	1	Labilität	Labilität	NNS
cord-015365-iqdi99pd	1553	2	und	und	RB
cord-015365-iqdi99pd	1554	1	Dysphorie	Dysphorie	NNP
cord-015365-iqdi99pd	1554	2	)	)	-RRB-
cord-015365-iqdi99pd	1554	3	.	.	.
cord-015365-iqdi99pd	1555	1	Es	Es	NNP
cord-015365-iqdi99pd	1555	2	werden	werden	NNP
cord-015365-iqdi99pd	1555	3	Gründe	Gründe	NNP
cord-015365-iqdi99pd	1555	4	für	für	IN
cord-015365-iqdi99pd	1555	5	diese	diese	NNP
cord-015365-iqdi99pd	1555	6	Differenz	Differenz	NNP
cord-015365-iqdi99pd	1555	7	diskutiert	diskutiert	NNP
cord-015365-iqdi99pd	1555	8	,	,	,
cord-015365-iqdi99pd	1555	9	Lösungsmöglichkeiten	Lösungsmöglichkeiten	NNP
cord-015365-iqdi99pd	1555	10	besprochen	besprochen	NNP
cord-015365-iqdi99pd	1555	11	.	.	.
cord-015365-iqdi99pd	1556	1	Ferner	Ferner	NNP
cord-015365-iqdi99pd	1556	2	ist	ist	NN
cord-015365-iqdi99pd	1556	3	die	die	VBP
cord-015365-iqdi99pd	1556	4	Frage	frage	NN
cord-015365-iqdi99pd	1556	5	interessant	interessant	JJ
cord-015365-iqdi99pd	1556	6	,	,	,
cord-015365-iqdi99pd	1557	1	ob	ob	NNP
cord-015365-iqdi99pd	1557	2	Persönlichkeitsfaktoren	Persönlichkeitsfaktoren	NNP
cord-015365-iqdi99pd	1557	3	Einfluß	Einfluß	NNP
cord-015365-iqdi99pd	1557	4	haben	haben	VBP
cord-015365-iqdi99pd	1557	5	auf	auf	NNP
cord-015365-iqdi99pd	1557	6	Langzeitüberleben	Langzeitüberleben	NNP
cord-015365-iqdi99pd	1557	7	und	und	IN
cord-015365-iqdi99pd	1557	8	Lebensqualität	Lebensqualität	NNPS
cord-015365-iqdi99pd	1557	9	bzw	bzw	NNP
cord-015365-iqdi99pd	1557	10	.	.	.
cord-015365-iqdi99pd	1558	1	-zufriedenheit	-zufriedenheit	:
cord-015365-iqdi99pd	1558	2	:	:	:
cord-015365-iqdi99pd	1559	1	wer	wer	NNP
cord-015365-iqdi99pd	1560	1	lebt	lebt	NNP
cord-015365-iqdi99pd	1560	2	länger	länger	NNP
cord-015365-iqdi99pd	1560	3	,	,	,
cord-015365-iqdi99pd	1560	4	wer	wer	NNP
cord-015365-iqdi99pd	1560	5	lebt	lebt	NNP
cord-015365-iqdi99pd	1560	6	besser	besser	NNP
cord-015365-iqdi99pd	1560	7	?	?	.
cord-015365-iqdi99pd	1561	1	Es	Es	NNP
cord-015365-iqdi99pd	1561	2	werden	werden	NNP
cord-015365-iqdi99pd	1561	3	klinisch	klinisch	NNP
cord-015365-iqdi99pd	1561	4	-	-	HYPH
cord-015365-iqdi99pd	1561	5	psychologische	psychologische	NNP
cord-015365-iqdi99pd	1561	6	Studien	Studien	NNP
cord-015365-iqdi99pd	1561	7	vorgestellt	vorgestellt	NNP
cord-015365-iqdi99pd	1561	8	,	,	,
cord-015365-iqdi99pd	1561	9	die	die	VB
cord-015365-iqdi99pd	1561	10	belegen	belegen	NNP
cord-015365-iqdi99pd	1561	11	,	,	,
cord-015365-iqdi99pd	1561	12	dass	dass	NNP
cord-015365-iqdi99pd	1561	13	ein	ein	NNP
cord-015365-iqdi99pd	1561	14	bestimmtes	bestimmtes	NNPS
cord-015365-iqdi99pd	1561	15	Persönlichkeitsmuster	Persönlichkeitsmuster	NNP
cord-015365-iqdi99pd	1562	1	(	(	-LRB-
cord-015365-iqdi99pd	1562	2	Typ	Typ	NNP
cord-015365-iqdi99pd	1562	3	D	D	NNP
cord-015365-iqdi99pd	1562	4	,	,	,
cord-015365-iqdi99pd	1562	5	Denollet	Denollet	NNP
cord-015365-iqdi99pd	1562	6	1996	1996	CD
cord-015365-iqdi99pd	1562	7	)	)	-RRB-
cord-015365-iqdi99pd	1563	1	Für	Für	NNP
cord-015365-iqdi99pd	1563	2	die	die	VBP
cord-015365-iqdi99pd	1563	3	drei	drei	NNS
cord-015365-iqdi99pd	1563	4	am	be	VBP
cord-015365-iqdi99pd	1564	1	häufigsten	häufigsten	NNP
cord-015365-iqdi99pd	1564	2	durchgeführten	durchgeführten	NNP
cord-015365-iqdi99pd	1564	3	pädiatrischen	pädiatrischen	NNP
cord-015365-iqdi99pd	1564	4	Organtransplantationen	Organtransplantationen	NNP
cord-015365-iqdi99pd	1565	1	(	(	-LRB-
cord-015365-iqdi99pd	1565	2	Niere	Niere	NNP
cord-015365-iqdi99pd	1565	3	,	,	,
cord-015365-iqdi99pd	1565	4	Leber	Leber	NNP
cord-015365-iqdi99pd	1565	5	,	,	,
cord-015365-iqdi99pd	1565	6	Herz	Herz	NNP
cord-015365-iqdi99pd	1565	7	)	)	-RRB-
cord-015365-iqdi99pd	1565	8	wird	wird	NNP
cord-015365-iqdi99pd	1565	9	der	der	NNP
cord-015365-iqdi99pd	1565	10	jeweils	jeweils	NNP
cord-015365-iqdi99pd	1565	11	aktuelle	aktuelle	NNP
cord-015365-iqdi99pd	1565	12	Forschungsstand	Forschungsstand	NNP
cord-015365-iqdi99pd	1565	13	referiert	referiert	NN
cord-015365-iqdi99pd	1565	14	.	.	.
cord-015365-iqdi99pd	1566	1	Darüber	Darüber	NNP
cord-015365-iqdi99pd	1566	2	hinaus	hinaus	NNP
cord-015365-iqdi99pd	1566	3	werden	werden	NNP
cord-015365-iqdi99pd	1566	4	zwei	zwei	NNP
cord-015365-iqdi99pd	1566	5	spezifische	spezifische	NNP
cord-015365-iqdi99pd	1566	6	Problembereiche	Problembereiche	NNP
cord-015365-iqdi99pd	1566	7	in	in	IN
cord-015365-iqdi99pd	1566	8	der	der	NNP
cord-015365-iqdi99pd	1566	9	pädiatrischen	pädiatrischen	NNP
cord-015365-iqdi99pd	1566	10	Organtransplantation	Organtransplantation	NNP
cord-015365-iqdi99pd	1566	11	dargestellt	dargestellt	NNP
cord-015365-iqdi99pd	1566	12	,	,	,
cord-015365-iqdi99pd	1567	1	das	das	NNP
cord-015365-iqdi99pd	1567	2	Problem	Problem	NNP
cord-015365-iqdi99pd	1567	3	der	der	NNP
cord-015365-iqdi99pd	1567	4	Compliance	Compliance	NNP
cord-015365-iqdi99pd	1567	5	/	/	SYM
cord-015365-iqdi99pd	1567	6	Adherence	Adherence	NNP
cord-015365-iqdi99pd	1567	7	und	und	NNP
cord-015365-iqdi99pd	1568	1	der	der	NNP
cord-015365-iqdi99pd	1568	2	Transition	Transition	NNP
cord-015365-iqdi99pd	1568	3	von	von	NNP
cord-015365-iqdi99pd	1568	4	der	der	NNP
cord-015365-iqdi99pd	1568	5	Kinder	Kinder	NNP
cord-015365-iqdi99pd	1568	6	-	-	HYPH
cord-015365-iqdi99pd	1568	7	und	und	NNP
cord-015365-iqdi99pd	1568	8	Jugendmedizin	Jugendmedizin	NNP
cord-015365-iqdi99pd	1568	9	in	in	IN
cord-015365-iqdi99pd	1568	10	die	die	JJ
cord-015365-iqdi99pd	1568	11	Erwachsenenmedizin	Erwachsenenmedizin	NNP
cord-015365-iqdi99pd	1568	12	.	.	.
cord-015365-iqdi99pd	1569	1	Die	die	VB
cord-015365-iqdi99pd	1569	2	Studien	Studien	NNP
cord-015365-iqdi99pd	1569	3	unterscheiden	unterscheiden	JJ
cord-015365-iqdi99pd	1569	4	sich	sich	NNP
cord-015365-iqdi99pd	1569	5	hinsichtlich	hinsichtlich	NNP
cord-015365-iqdi99pd	1569	6	der	der	NNP
cord-015365-iqdi99pd	1569	7	Operationalisierung	Operationalisierung	NNP
cord-015365-iqdi99pd	1569	8	der	der	NNP
cord-015365-iqdi99pd	1569	9	LQ	LQ	NNP
cord-015365-iqdi99pd	1569	10	,	,	,
cord-015365-iqdi99pd	1569	11	des	des	NNP
cord-015365-iqdi99pd	1569	12	Studiendesigns	Studiendesigns	NNP
cord-015365-iqdi99pd	1569	13	,	,	,
cord-015365-iqdi99pd	1569	14	der	der	NNP
cord-015365-iqdi99pd	1569	15	Dauer	Dauer	NNP
cord-015365-iqdi99pd	1569	16	des	des	FW
cord-015365-iqdi99pd	1569	17	Follow	follow	NN
cord-015365-iqdi99pd	1569	18	-	-	HYPH
cord-015365-iqdi99pd	1569	19	ups	up	NNS
cord-015365-iqdi99pd	1570	1	und	und	IN
cord-015365-iqdi99pd	1570	2	des	des	NNP
cord-015365-iqdi99pd	1570	3	Altersbereichs	Altersbereichs	NNP
cord-015365-iqdi99pd	1570	4	der	der	NNP
cord-015365-iqdi99pd	1570	5	Kinder	Kinder	NNP
cord-015365-iqdi99pd	1570	6	.	.	.
cord-015365-iqdi99pd	1571	1	Prospektive	Prospektive	NNP
cord-015365-iqdi99pd	1571	2	Längsschnittstudien	Längsschnittstudien	NNP
cord-015365-iqdi99pd	1571	3	mit	mit	VBD
cord-015365-iqdi99pd	1571	4	größeren	größeren	NNP
cord-015365-iqdi99pd	1571	5	Stichproben	Stichproben	NNP
cord-015365-iqdi99pd	1571	6	in	in	IN
cord-015365-iqdi99pd	1571	7	multizentrischer	multizentrischer	NNP
cord-015365-iqdi99pd	1571	8	Zusammenarbeit	Zusammenarbeit	NNP
cord-015365-iqdi99pd	1571	9	unter	unter	NNP
cord-015365-iqdi99pd	1571	10	Einbeziehung	Einbeziehung	NNP
cord-015365-iqdi99pd	1571	11	möglichst	möglichst	NNP
cord-015365-iqdi99pd	1571	12	spezifischer	spezifischer	NNP
cord-015365-iqdi99pd	1572	1	Erhebungsmethoden	Erhebungsmethoden	NNP
cord-015365-iqdi99pd	1572	2	sind	sind	NNP
cord-015365-iqdi99pd	1573	1	erforderlich	erforderlich	NNP
cord-015365-iqdi99pd	1573	2	,	,	,
cord-015365-iqdi99pd	1573	3	um	um	UH
cord-015365-iqdi99pd	1573	4	die	die	VBP
cord-015365-iqdi99pd	1573	5	postoperative	postoperative	JJ
cord-015365-iqdi99pd	1573	6	Entwicklung	Entwicklung	NNP
cord-015365-iqdi99pd	1573	7	der	der	NNP
cord-015365-iqdi99pd	1573	8	Kinder	Kinder	NNP
cord-015365-iqdi99pd	1573	9	besser	besser	NNP
cord-015365-iqdi99pd	1573	10	beurteilen	beurteilen	VBN
cord-015365-iqdi99pd	1573	11	zu	zu	NNP
cord-015365-iqdi99pd	1573	12	können	können	NNP
cord-015365-iqdi99pd	1573	13	.	.	.
cord-015365-iqdi99pd	1574	1	Vor	Vor	NNP
cord-015365-iqdi99pd	1574	2	dem	dem	NNP
cord-015365-iqdi99pd	1574	3	Hintergrund	Hintergrund	NNP
cord-015365-iqdi99pd	1574	4	einer	einer	NNP
cord-015365-iqdi99pd	1575	1	neuen	neuen	NNP
cord-015365-iqdi99pd	1575	2	Ä	Ä	NNP
cord-015365-iqdi99pd	1575	3	ra	ra	NNP
cord-015365-iqdi99pd	1576	1	der	der	NNP
cord-015365-iqdi99pd	1576	2	immunsuppressiven	immunsuppressiven	NNP
cord-015365-iqdi99pd	1576	3	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1576	4	(	(	-LRB-
cord-015365-iqdi99pd	1576	5	Steroidminimierung	Steroidminimierung	NNP
cord-015365-iqdi99pd	1576	6	,	,	,
cord-015365-iqdi99pd	1576	7	individualisierte	individualisierte	NNS
cord-015365-iqdi99pd	1576	8	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1576	9	)	)	-RRB-
cord-015365-iqdi99pd	1577	1	kann	kann	NNP
cord-015365-iqdi99pd	1577	2	hier	hier	NNP
cord-015365-iqdi99pd	1577	3	zukünftig	zukünftig	NNP
cord-015365-iqdi99pd	1578	1	eine	eine	NNP
cord-015365-iqdi99pd	1579	1	weitere	weitere	NNP
cord-015365-iqdi99pd	1579	2	Steigerung	Steigerung	NNP
cord-015365-iqdi99pd	1579	3	der	der	NNP
cord-015365-iqdi99pd	1580	1	LQ	LQ	NNP
cord-015365-iqdi99pd	1580	2	erwartet	erwartet	NNP
cord-015365-iqdi99pd	1580	3	werden	werden	NNP
cord-015365-iqdi99pd	1580	4	.	.	.
cord-015365-iqdi99pd	1581	1	Background	background	NN
cord-015365-iqdi99pd	1581	2	.	.	.
cord-015365-iqdi99pd	1582	1	Autologous	autologous	JJ
cord-015365-iqdi99pd	1582	2	stem	stem	NN
cord-015365-iqdi99pd	1582	3	cell	cell	NN
cord-015365-iqdi99pd	1582	4	transplantation	transplantation	NN
cord-015365-iqdi99pd	1582	5	(	(	-LRB-
cord-015365-iqdi99pd	1582	6	ASCT	ASCT	NNP
cord-015365-iqdi99pd	1582	7	)	)	-RRB-
cord-015365-iqdi99pd	1582	8	is	be	VBZ
cord-015365-iqdi99pd	1582	9	a	a	DT
cord-015365-iqdi99pd	1582	10	curative	curative	JJ
cord-015365-iqdi99pd	1582	11	procedure	procedure	NN
cord-015365-iqdi99pd	1582	12	for	for	IN
cord-015365-iqdi99pd	1582	13	a	a	DT
cord-015365-iqdi99pd	1582	14	variety	variety	NN
cord-015365-iqdi99pd	1582	15	of	of	IN
cord-015365-iqdi99pd	1582	16	haemato	haemato	JJ
cord-015365-iqdi99pd	1582	17	-	-	HYPH
cord-015365-iqdi99pd	1582	18	oncological	oncological	JJ
cord-015365-iqdi99pd	1582	19	malignancies	malignancy	NNS
cord-015365-iqdi99pd	1582	20	and	and	CC
cord-015365-iqdi99pd	1582	21	depends	depend	VBZ
cord-015365-iqdi99pd	1582	22	on	on	IN
cord-015365-iqdi99pd	1582	23	the	the	DT
cord-015365-iqdi99pd	1582	24	transplantation	transplantation	NN
cord-015365-iqdi99pd	1582	25	of	of	IN
cord-015365-iqdi99pd	1582	26	sufficient	sufficient	JJ
cord-015365-iqdi99pd	1582	27	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1582	28	cells	cell	NNS
cord-015365-iqdi99pd	1582	29	(	(	-LRB-
cord-015365-iqdi99pd	1582	30	threshold	threshold	NN
cord-015365-iqdi99pd	1582	31	of	of	IN
cord-015365-iqdi99pd	1582	32	>	>	$
cord-015365-iqdi99pd	1582	33	2Â10	2â10	CD
cord-015365-iqdi99pd	1582	34	6	6	CD
cord-015365-iqdi99pd	1582	35	/kg	/kg	.
cord-015365-iqdi99pd	1582	36	)	)	-RRB-
cord-015365-iqdi99pd	1582	37	to	to	TO
cord-015365-iqdi99pd	1582	38	ensure	ensure	VB
cord-015365-iqdi99pd	1582	39	sustained	sustain	VBN
cord-015365-iqdi99pd	1582	40	engraftment	engraftment	NN
cord-015365-iqdi99pd	1582	41	.	.	.
cord-015365-iqdi99pd	1583	1	In	in	IN
cord-015365-iqdi99pd	1583	2	the	the	DT
cord-015365-iqdi99pd	1583	3	last	last	JJ
cord-015365-iqdi99pd	1583	4	decade	decade	NN
cord-015365-iqdi99pd	1583	5	,	,	,
cord-015365-iqdi99pd	1583	6	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1583	7	blood	blood	NN
cord-015365-iqdi99pd	1583	8	stem	stem	NN
cord-015365-iqdi99pd	1583	9	cells	cell	NNS
cord-015365-iqdi99pd	1583	10	(	(	-LRB-
cord-015365-iqdi99pd	1583	11	PBSC	PBSC	NNP
cord-015365-iqdi99pd	1583	12	)	)	-RRB-
cord-015365-iqdi99pd	1583	13	have	have	VBP
cord-015365-iqdi99pd	1583	14	completely	completely	RB
cord-015365-iqdi99pd	1583	15	replaced	replace	VBN
cord-015365-iqdi99pd	1583	16	bone	bone	NN
cord-015365-iqdi99pd	1583	17	marrow	marrow	NN
cord-015365-iqdi99pd	1583	18	(	(	-LRB-
cord-015365-iqdi99pd	1583	19	BM	BM	NNP
cord-015365-iqdi99pd	1583	20	)	)	-RRB-
cord-015365-iqdi99pd	1583	21	as	as	IN
cord-015365-iqdi99pd	1583	22	preferred	prefer	VBN
cord-015365-iqdi99pd	1583	23	stem	stem	NN
cord-015365-iqdi99pd	1583	24	cell	cell	NN
cord-015365-iqdi99pd	1583	25	graft	graft	NN
cord-015365-iqdi99pd	1583	26	in	in	IN
cord-015365-iqdi99pd	1583	27	ASCT	ASCT	NNP
cord-015365-iqdi99pd	1583	28	.	.	.
cord-015365-iqdi99pd	1584	1	However	however	RB
cord-015365-iqdi99pd	1584	2	,	,	,
cord-015365-iqdi99pd	1584	3	a	a	DT
cord-015365-iqdi99pd	1584	4	number	number	NN
cord-015365-iqdi99pd	1584	5	of	of	IN
cord-015365-iqdi99pd	1584	6	patients	patient	NNS
cord-015365-iqdi99pd	1584	7	fail	fail	VBP
cord-015365-iqdi99pd	1584	8	to	to	TO
cord-015365-iqdi99pd	1584	9	mobilize	mobilize	VB
cord-015365-iqdi99pd	1584	10	the	the	DT
cord-015365-iqdi99pd	1584	11	threshold	threshold	NN
cord-015365-iqdi99pd	1584	12	of	of	IN
cord-015365-iqdi99pd	1584	13	>	>	XX
cord-015365-iqdi99pd	1585	1	2Â10	2â10	CD
cord-015365-iqdi99pd	1585	2	6	6	CD
cord-015365-iqdi99pd	1586	1	/kg	/kg	.
cord-015365-iqdi99pd	1587	1	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1587	2	cells	cell	NNS
cord-015365-iqdi99pd	1587	3	.	.	.
cord-015365-iqdi99pd	1588	1	In	in	IN
cord-015365-iqdi99pd	1588	2	these	these	DT
cord-015365-iqdi99pd	1588	3	poor	poor	JJ
cord-015365-iqdi99pd	1588	4	mobilizers	mobilizer	NNS
cord-015365-iqdi99pd	1588	5	,	,	,
cord-015365-iqdi99pd	1588	6	BM	BM	NNP
cord-015365-iqdi99pd	1588	7	harvest	harvest	NN
cord-015365-iqdi99pd	1588	8	was	be	VBD
cord-015365-iqdi99pd	1588	9	the	the	DT
cord-015365-iqdi99pd	1588	10	only	only	JJ
cord-015365-iqdi99pd	1588	11	possibility	possibility	NN
cord-015365-iqdi99pd	1588	12	to	to	TO
cord-015365-iqdi99pd	1588	13	collect	collect	VB
cord-015365-iqdi99pd	1588	14	sufficient	sufficient	JJ
cord-015365-iqdi99pd	1588	15	numbers	number	NNS
cord-015365-iqdi99pd	1588	16	of	of	IN
cord-015365-iqdi99pd	1588	17	stem	stem	NN
cord-015365-iqdi99pd	1588	18	cells	cell	NNS
cord-015365-iqdi99pd	1588	19	so	so	RB
cord-015365-iqdi99pd	1588	20	far	far	RB
cord-015365-iqdi99pd	1588	21	.	.	.
cord-015365-iqdi99pd	1589	1	Recently	recently	RB
cord-015365-iqdi99pd	1589	2	,	,	,
cord-015365-iqdi99pd	1589	3	the	the	DT
cord-015365-iqdi99pd	1589	4	chemokine	chemokine	NN
cord-015365-iqdi99pd	1589	5	-	-	HYPH
cord-015365-iqdi99pd	1589	6	receptor	receptor	NN
cord-015365-iqdi99pd	1589	7	antagonist	antagonist	NN
cord-015365-iqdi99pd	1589	8	plerixafor	plerixafor	NN
cord-015365-iqdi99pd	1589	9	has	have	VBZ
cord-015365-iqdi99pd	1589	10	shown	show	VBN
cord-015365-iqdi99pd	1589	11	to	to	TO
cord-015365-iqdi99pd	1589	12	enhance	enhance	VB
cord-015365-iqdi99pd	1589	13	stem	stem	NN
cord-015365-iqdi99pd	1589	14	cell	cell	NN
cord-015365-iqdi99pd	1589	15	mobilization	mobilization	NN
cord-015365-iqdi99pd	1589	16	in	in	IN
cord-015365-iqdi99pd	1589	17	patients	patient	NNS
cord-015365-iqdi99pd	1589	18	who	who	WP
cord-015365-iqdi99pd	1589	19	demonstrated	demonstrate	VBD
cord-015365-iqdi99pd	1589	20	with	with	IN
cord-015365-iqdi99pd	1589	21	previous	previous	JJ
cord-015365-iqdi99pd	1589	22	mobilization	mobilization	NN
cord-015365-iqdi99pd	1589	23	failure	failure	NN
cord-015365-iqdi99pd	1589	24	with	with	IN
cord-015365-iqdi99pd	1589	25	an	an	DT
cord-015365-iqdi99pd	1589	26	overall	overall	JJ
cord-015365-iqdi99pd	1589	27	success	success	NN
cord-015365-iqdi99pd	1589	28	rate	rate	NN
cord-015365-iqdi99pd	1589	29	of	of	IN
cord-015365-iqdi99pd	1589	30	about	about	RB
cord-015365-iqdi99pd	1589	31	70	70	CD
cord-015365-iqdi99pd	1589	32	%	%	NN
cord-015365-iqdi99pd	1589	33	.	.	.
cord-015365-iqdi99pd	1590	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1590	2	here	here	RB
cord-015365-iqdi99pd	1590	3	report	report	VBP
cord-015365-iqdi99pd	1590	4	4	4	CD
cord-015365-iqdi99pd	1590	5	patients	patient	NNS
cord-015365-iqdi99pd	1590	6	with	with	IN
cord-015365-iqdi99pd	1590	7	mobilization	mobilization	NN
cord-015365-iqdi99pd	1590	8	failure	failure	NN
cord-015365-iqdi99pd	1590	9	in	in	IN
cord-015365-iqdi99pd	1590	10	whom	whom	WP
cord-015365-iqdi99pd	1590	11	G	G	NNP
cord-015365-iqdi99pd	1590	12	-	-	HYPH
cord-015365-iqdi99pd	1590	13	CSF	CSF	NNP
cord-015365-iqdi99pd	1590	14	primed	prime	VBN
cord-015365-iqdi99pd	1590	15	BM	BM	NNP
cord-015365-iqdi99pd	1590	16	as	as	RB
cord-015365-iqdi99pd	1590	17	well	well	RB
cord-015365-iqdi99pd	1590	18	as	as	IN
cord-015365-iqdi99pd	1590	19	plerixafor	plerixafor	NN
cord-015365-iqdi99pd	1590	20	primed	prime	VBN
cord-015365-iqdi99pd	1590	21	PBSC	PBSC	NNP
cord-015365-iqdi99pd	1590	22	were	be	VBD
cord-015365-iqdi99pd	1590	23	collected	collect	VBN
cord-015365-iqdi99pd	1590	24	.	.	.
cord-015365-iqdi99pd	1591	1	Methods	method	NNS
cord-015365-iqdi99pd	1591	2	.	.	.
cord-015365-iqdi99pd	1592	1	Four	four	CD
cord-015365-iqdi99pd	1592	2	heavily	heavily	RB
cord-015365-iqdi99pd	1592	3	pretreated	pretreate	VBN
cord-015365-iqdi99pd	1592	4	patients	patient	NNS
cord-015365-iqdi99pd	1592	5	(	(	-LRB-
cord-015365-iqdi99pd	1592	6	median	median	NN
cord-015365-iqdi99pd	1592	7	of	of	IN
cord-015365-iqdi99pd	1592	8	10	10	CD
cord-015365-iqdi99pd	1592	9	chemotherapy	chemotherapy	NN
cord-015365-iqdi99pd	1592	10	cycles	cycle	NNS
cord-015365-iqdi99pd	1592	11	,	,	,
cord-015365-iqdi99pd	1592	12	range	range	VBP
cord-015365-iqdi99pd	1592	13	8	8	CD
cord-015365-iqdi99pd	1592	14	-	-	SYM
cord-015365-iqdi99pd	1592	15	17	17	CD
cord-015365-iqdi99pd	1592	16	)	)	-RRB-
cord-015365-iqdi99pd	1592	17	with	with	IN
cord-015365-iqdi99pd	1592	18	non	non	JJ
cord-015365-iqdi99pd	1592	19	-	-	JJ
cord-015365-iqdi99pd	1592	20	Hodgkin	hodgkin	JJ
cord-015365-iqdi99pd	1592	21	lymphoma	lymphoma	NN
cord-015365-iqdi99pd	1592	22	(	(	-LRB-
cord-015365-iqdi99pd	1592	23	NHL	NHL	NNP
cord-015365-iqdi99pd	1592	24	,	,	,
cord-015365-iqdi99pd	1592	25	n	n	NN
cord-015365-iqdi99pd	1592	26	¼	¼	NN
cord-015365-iqdi99pd	1592	27	3	3	CD
cord-015365-iqdi99pd	1592	28	.	.	.
cord-015365-iqdi99pd	1592	29	)	)	-RRB-
cord-015365-iqdi99pd	1592	30	and	and	CC
cord-015365-iqdi99pd	1592	31	germ	germ	NN
cord-015365-iqdi99pd	1592	32	cell	cell	NN
cord-015365-iqdi99pd	1592	33	cancer	cancer	NN
cord-015365-iqdi99pd	1592	34	(	(	-LRB-
cord-015365-iqdi99pd	1592	35	n	n	NNP
cord-015365-iqdi99pd	1592	36	¼	¼	NNP
cord-015365-iqdi99pd	1592	37	1	1	CD
cord-015365-iqdi99pd	1592	38	)	)	-RRB-
cord-015365-iqdi99pd	1592	39	presented	present	VBN
cord-015365-iqdi99pd	1592	40	with	with	IN
cord-015365-iqdi99pd	1592	41	mobilization	mobilization	NN
cord-015365-iqdi99pd	1592	42	failure	failure	NN
cord-015365-iqdi99pd	1592	43	after	after	IN
cord-015365-iqdi99pd	1592	44	1	1	CD
cord-015365-iqdi99pd	1592	45	-	-	SYM
cord-015365-iqdi99pd	1592	46	7	7	CD
cord-015365-iqdi99pd	1592	47	mobilization	mobilization	NN
cord-015365-iqdi99pd	1592	48	attempts	attempt	NNS
cord-015365-iqdi99pd	1592	49	.	.	.
cord-015365-iqdi99pd	1593	1	In	in	IN
cord-015365-iqdi99pd	1593	2	the	the	DT
cord-015365-iqdi99pd	1593	3	3	3	CD
cord-015365-iqdi99pd	1593	4	NHL	NHL	NNP
cord-015365-iqdi99pd	1593	5	patients	patient	NNS
cord-015365-iqdi99pd	1593	6	BM	BM	NNP
cord-015365-iqdi99pd	1593	7	was	be	VBD
cord-015365-iqdi99pd	1593	8	harvested	harvest	VBN
cord-015365-iqdi99pd	1593	9	after	after	IN
cord-015365-iqdi99pd	1593	10	unsuccessful	unsuccessful	JJ
cord-015365-iqdi99pd	1593	11	PBSC	PBSC	NNP
cord-015365-iqdi99pd	1593	12	collection	collection	NN
cord-015365-iqdi99pd	1593	13	with	with	IN
cord-015365-iqdi99pd	1593	14	plerixafor	plerixafor	NN
cord-015365-iqdi99pd	1593	15	.	.	.
cord-015365-iqdi99pd	1594	1	In	in	IN
cord-015365-iqdi99pd	1594	2	the	the	DT
cord-015365-iqdi99pd	1594	3	patient	patient	NN
cord-015365-iqdi99pd	1594	4	with	with	IN
cord-015365-iqdi99pd	1594	5	germ	germ	NN
cord-015365-iqdi99pd	1594	6	cell	cell	NN
cord-015365-iqdi99pd	1594	7	tumor	tumor	NN
cord-015365-iqdi99pd	1594	8	before	before	IN
cord-015365-iqdi99pd	1594	9	plerixafor	plerixafor	NN
cord-015365-iqdi99pd	1594	10	primed	prime	VBD
cord-015365-iqdi99pd	1594	11	PBSC	PBSC	NNP
cord-015365-iqdi99pd	1594	12	collection	collection	NN
cord-015365-iqdi99pd	1594	13	was	be	VBD
cord-015365-iqdi99pd	1594	14	done	do	VBN
cord-015365-iqdi99pd	1594	15	after	after	IN
cord-015365-iqdi99pd	1594	16	insufficient	insufficient	JJ
cord-015365-iqdi99pd	1594	17	BM	BM	NNP
cord-015365-iqdi99pd	1594	18	harvest	harvest	NN
cord-015365-iqdi99pd	1594	19	.	.	.
cord-015365-iqdi99pd	1595	1	Results	result	NNS
cord-015365-iqdi99pd	1595	2	.	.	.
cord-015365-iqdi99pd	1596	1	In	in	IN
cord-015365-iqdi99pd	1596	2	the	the	DT
cord-015365-iqdi99pd	1596	3	3	3	CD
cord-015365-iqdi99pd	1596	4	NHL	NHL	NNP
cord-015365-iqdi99pd	1596	5	patients	patient	NNS
cord-015365-iqdi99pd	1596	6	plerixafor	plerixafor	NN
cord-015365-iqdi99pd	1596	7	enhanced	enhance	VBN
cord-015365-iqdi99pd	1596	8	PBSC	PBSC	NNP
cord-015365-iqdi99pd	1596	9	revealed	reveal	VBD
cord-015365-iqdi99pd	1596	10	an	an	DT
cord-015365-iqdi99pd	1596	11	insufficient	insufficient	JJ
cord-015365-iqdi99pd	1596	12	number	number	NN
cord-015365-iqdi99pd	1596	13	of	of	IN
cord-015365-iqdi99pd	1596	14	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1596	15	cells	cell	NNS
cord-015365-iqdi99pd	1596	16	(	(	-LRB-
cord-015365-iqdi99pd	1596	17	i.e.	i.e.	FW
cord-015365-iqdi99pd	1596	18	0.64-	0.64-	CD
cord-015365-iqdi99pd	1597	1	1.15Â10	1.15â10	CD
cord-015365-iqdi99pd	1598	1	6	6	CD
cord-015365-iqdi99pd	1599	1	/kg	/kg	.
cord-015365-iqdi99pd	1600	1	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1600	2	cells	cell	NNS
cord-015365-iqdi99pd	1600	3	in	in	IN
cord-015365-iqdi99pd	1600	4	2	2	CD
cord-015365-iqdi99pd	1600	5	-	-	SYM
cord-015365-iqdi99pd	1600	6	3	3	CD
cord-015365-iqdi99pd	1600	7	leukaphereses	leukapherese	NNS
cord-015365-iqdi99pd	1600	8	procedures	procedure	NNS
cord-015365-iqdi99pd	1600	9	)	)	-RRB-
cord-015365-iqdi99pd	1600	10	.	.	.
cord-015365-iqdi99pd	1601	1	Therefore	therefore	RB
cord-015365-iqdi99pd	1601	2	BM	BM	NNP
cord-015365-iqdi99pd	1601	3	was	be	VBD
cord-015365-iqdi99pd	1601	4	harvested	harvest	VBN
cord-015365-iqdi99pd	1601	5	after	after	IN
cord-015365-iqdi99pd	1601	6	G	G	NNP
cord-015365-iqdi99pd	1601	7	-	-	HYPH
cord-015365-iqdi99pd	1601	8	CSF	csf	NN
cord-015365-iqdi99pd	1601	9	stimulation	stimulation	NN
cord-015365-iqdi99pd	1601	10	.	.	.
cord-015365-iqdi99pd	1602	1	However	however	RB
cord-015365-iqdi99pd	1602	2	,	,	,
cord-015365-iqdi99pd	1602	3	again	again	RB
cord-015365-iqdi99pd	1602	4	we	-PRON-	PRP
cord-015365-iqdi99pd	1602	5	failed	fail	VBD
cord-015365-iqdi99pd	1602	6	to	to	TO
cord-015365-iqdi99pd	1602	7	obtain	obtain	VB
cord-015365-iqdi99pd	1602	8	enough	enough	JJ
cord-015365-iqdi99pd	1602	9	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1602	10	cells	cell	NNS
cord-015365-iqdi99pd	1602	11	in	in	IN
cord-015365-iqdi99pd	1602	12	all	all	DT
cord-015365-iqdi99pd	1602	13	of	of	IN
cord-015365-iqdi99pd	1602	14	them	-PRON-	PRP
cord-015365-iqdi99pd	1602	15	(	(	-LRB-
cord-015365-iqdi99pd	1602	16	0.16	0.16	CD
cord-015365-iqdi99pd	1602	17	to	to	IN
cord-015365-iqdi99pd	1602	18	0.62Â10	0.62â10	CD
cord-015365-iqdi99pd	1602	19	6	6	CD
cord-015365-iqdi99pd	1602	20	/kg	/kg	.
cord-015365-iqdi99pd	1602	21	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1602	22	cells	cell	NNS
cord-015365-iqdi99pd	1602	23	)	)	-RRB-
cord-015365-iqdi99pd	1602	24	.	.	.
cord-015365-iqdi99pd	1603	1	In	in	IN
cord-015365-iqdi99pd	1603	2	the	the	DT
cord-015365-iqdi99pd	1603	3	patient	patient	NN
cord-015365-iqdi99pd	1603	4	with	with	IN
cord-015365-iqdi99pd	1603	5	germ	germ	NN
cord-015365-iqdi99pd	1603	6	cell	cell	NN
cord-015365-iqdi99pd	1603	7	cancer	cancer	NN
cord-015365-iqdi99pd	1603	8	a	a	DT
cord-015365-iqdi99pd	1603	9	collection	collection	NN
cord-015365-iqdi99pd	1603	10	of	of	IN
cord-015365-iqdi99pd	1603	11	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1603	12	cells	cell	NNS
cord-015365-iqdi99pd	1603	13	from	from	IN
cord-015365-iqdi99pd	1603	14	the	the	DT
cord-015365-iqdi99pd	1603	15	BM	BM	NNP
cord-015365-iqdi99pd	1603	16	was	be	VBD
cord-015365-iqdi99pd	1603	17	carried	carry	VBN
cord-015365-iqdi99pd	1603	18	out	out	RP
cord-015365-iqdi99pd	1603	19	as	as	IN
cord-015365-iqdi99pd	1603	20	first	first	JJ
cord-015365-iqdi99pd	1603	21	salvage	salvage	NN
cord-015365-iqdi99pd	1603	22	procedure	procedure	NN
cord-015365-iqdi99pd	1603	23	after	after	IN
cord-015365-iqdi99pd	1603	24	the	the	DT
cord-015365-iqdi99pd	1603	25	failure	failure	NN
cord-015365-iqdi99pd	1603	26	of	of	IN
cord-015365-iqdi99pd	1603	27	conventional	conventional	JJ
cord-015365-iqdi99pd	1603	28	mobilization	mobilization	NN
cord-015365-iqdi99pd	1603	29	(	(	-LRB-
cord-015365-iqdi99pd	1603	30	0.9Â10	0.9â10	CD
cord-015365-iqdi99pd	1603	31	6	6	CD
cord-015365-iqdi99pd	1604	1	/kg	/kg	NFP
cord-015365-iqdi99pd	1604	2	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1604	3	cells	cell	NNS
cord-015365-iqdi99pd	1604	4	)	)	-RRB-
cord-015365-iqdi99pd	1604	5	.	.	.
cord-015365-iqdi99pd	1605	1	Thus	thus	RB
cord-015365-iqdi99pd	1605	2	,	,	,
cord-015365-iqdi99pd	1605	3	in	in	IN
cord-015365-iqdi99pd	1605	4	a	a	DT
cord-015365-iqdi99pd	1605	5	next	next	JJ
cord-015365-iqdi99pd	1605	6	attempt	attempt	NN
cord-015365-iqdi99pd	1605	7	PBSCs	pbsc	NNS
cord-015365-iqdi99pd	1605	8	were	be	VBD
cord-015365-iqdi99pd	1605	9	mobilized	mobilize	VBN
cord-015365-iqdi99pd	1605	10	with	with	IN
cord-015365-iqdi99pd	1605	11	G	G	NNP
cord-015365-iqdi99pd	1605	12	-	-	HYPH
cord-015365-iqdi99pd	1605	13	CSF	CSF	NNP
cord-015365-iqdi99pd	1605	14	and	and	CC
cord-015365-iqdi99pd	1605	15	plerixafor	plerixafor	NN
cord-015365-iqdi99pd	1605	16	resulting	result	VBG
cord-015365-iqdi99pd	1605	17	in	in	IN
cord-015365-iqdi99pd	1605	18	a	a	DT
cord-015365-iqdi99pd	1605	19	successful	successful	JJ
cord-015365-iqdi99pd	1605	20	harvest	harvest	NN
cord-015365-iqdi99pd	1605	21	(	(	-LRB-
cord-015365-iqdi99pd	1605	22	3.36Â10	3.36â10	CD
cord-015365-iqdi99pd	1605	23	6	6	CD
cord-015365-iqdi99pd	1605	24	/kg	/kg	NFP
cord-015365-iqdi99pd	1605	25	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1605	26	cells	cell	NNS
cord-015365-iqdi99pd	1605	27	in	in	IN
cord-015365-iqdi99pd	1605	28	one	one	CD
cord-015365-iqdi99pd	1605	29	leukapheresis	leukapheresis	NN
cord-015365-iqdi99pd	1605	30	)	)	-RRB-
cord-015365-iqdi99pd	1605	31	.	.	.
cord-015365-iqdi99pd	1606	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1606	2	.	.	.
cord-015365-iqdi99pd	1607	1	Reviewing	review	VBG
cord-015365-iqdi99pd	1607	2	our	-PRON-	PRP$
cord-015365-iqdi99pd	1607	3	cases	case	NNS
cord-015365-iqdi99pd	1607	4	one	one	PRP
cord-015365-iqdi99pd	1607	5	might	may	MD
cord-015365-iqdi99pd	1607	6	speculate	speculate	VB
cord-015365-iqdi99pd	1607	7	that	that	IN
cord-015365-iqdi99pd	1607	8	a	a	DT
cord-015365-iqdi99pd	1607	9	BM	BM	NNP
cord-015365-iqdi99pd	1607	10	harvest	harvest	NN
cord-015365-iqdi99pd	1607	11	after	after	IN
cord-015365-iqdi99pd	1607	12	failure	failure	NN
cord-015365-iqdi99pd	1607	13	of	of	IN
cord-015365-iqdi99pd	1607	14	stem	stem	NN
cord-015365-iqdi99pd	1607	15	cell	cell	NN
cord-015365-iqdi99pd	1607	16	mobilization	mobilization	NN
cord-015365-iqdi99pd	1607	17	with	with	IN
cord-015365-iqdi99pd	1607	18	G	G	NNP
cord-015365-iqdi99pd	1607	19	-	-	HYPH
cord-015365-iqdi99pd	1607	20	CSF	CSF	NNP
cord-015365-iqdi99pd	1607	21	and	and	CC
cord-015365-iqdi99pd	1607	22	plerixafor	plerixafor	NN
cord-015365-iqdi99pd	1607	23	does	do	VBZ
cord-015365-iqdi99pd	1607	24	not	not	RB
cord-015365-iqdi99pd	1607	25	yield	yield	VB
cord-015365-iqdi99pd	1607	26	in	in	IN
cord-015365-iqdi99pd	1607	27	sufficient	sufficient	JJ
cord-015365-iqdi99pd	1607	28	CD34þ	cd34þ	NN
cord-015365-iqdi99pd	1607	29	cell	cell	NN
cord-015365-iqdi99pd	1607	30	numbers	number	NNS
cord-015365-iqdi99pd	1607	31	.	.	.
cord-015365-iqdi99pd	1608	1	Transient	transient	JJ
cord-015365-iqdi99pd	1608	2	Elastography	Elastography	NNP
cord-015365-iqdi99pd	1608	3	(	(	-LRB-
cord-015365-iqdi99pd	1608	4	FibroScan	FibroScan	NNP
cord-015365-iqdi99pd	1608	5	)	)	-RRB-
cord-015365-iqdi99pd	1608	6	for	for	IN
cord-015365-iqdi99pd	1608	7	the	the	DT
cord-015365-iqdi99pd	1608	8	prediction	prediction	NN
cord-015365-iqdi99pd	1608	9	of	of	IN
cord-015365-iqdi99pd	1608	10	liver	liver	NN
cord-015365-iqdi99pd	1608	11	toxicity	toxicity	NN
cord-015365-iqdi99pd	1608	12	following	follow	VBG
cord-015365-iqdi99pd	1608	13	autologous	autologous	JJ
cord-015365-iqdi99pd	1608	14	or	or	CC
cord-015365-iqdi99pd	1608	15	allogeneic	allogeneic	IN
cord-015365-iqdi99pd	1608	16	HSCT	HSCT	NNP
cord-015365-iqdi99pd	1608	17	J.	J.	NNP
cord-015365-iqdi99pd	1608	18	Auberger	Auberger	NNP
cord-015365-iqdi99pd	1608	19	1,2	1,2	CD
cord-015365-iqdi99pd	1608	20	,	,	,
cord-015365-iqdi99pd	1608	21	I.	I.	NNP
cord-015365-iqdi99pd	1608	22	Graziadei	Graziadei	NNP
cord-015365-iqdi99pd	1608	23	3	3	CD
cord-015365-iqdi99pd	1608	24	,	,	,
cord-015365-iqdi99pd	1608	25	W.	W.	NNP
cord-015365-iqdi99pd	1608	26	Vogel	Vogel	NNP
cord-015365-iqdi99pd	1608	27	3	3	CD
cord-015365-iqdi99pd	1608	28	,	,	,
cord-015365-iqdi99pd	1608	29	J.	J.	NNP
cord-015365-iqdi99pd	1608	30	Clausen	Clausen	NNP
cord-015365-iqdi99pd	1608	31	1,2	1,2	CD
cord-015365-iqdi99pd	1608	32	,	,	,
cord-015365-iqdi99pd	1608	33	D.	D.	NNP
cord-015365-iqdi99pd	1608	34	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	1608	35	.	.	.
cord-015365-iqdi99pd	1609	1	Lebertoxizität	Lebertoxizität	NNP
cord-015365-iqdi99pd	1609	2	oder	oder	NN
cord-015365-iqdi99pd	1609	3	das	das	NNP
cord-015365-iqdi99pd	1609	4	Sinusoidale	Sinusoidale	NNP
cord-015365-iqdi99pd	1609	5	Obstruktions	Obstruktions	NNP
cord-015365-iqdi99pd	1609	6	-	-	HYPH
cord-015365-iqdi99pd	1609	7	Syndrom	Syndrom	NNP
cord-015365-iqdi99pd	1609	8	(	(	-LRB-
cord-015365-iqdi99pd	1609	9	SOS	SOS	NNP
cord-015365-iqdi99pd	1609	10	)	)	-RRB-
cord-015365-iqdi99pd	1609	11	gehören	gehören	NNP
cord-015365-iqdi99pd	1610	1	zu	zu	NNP
cord-015365-iqdi99pd	1610	2	den	den	NNP
cord-015365-iqdi99pd	1610	3	häufigsten	häufigsten	NNP
cord-015365-iqdi99pd	1611	1	Organtoxizitäten	Organtoxizitäten	NNP
cord-015365-iqdi99pd	1611	2	nach	nach	NNP
cord-015365-iqdi99pd	1611	3	zytoreduktiver	zytoreduktiver	NNP
cord-015365-iqdi99pd	1611	4	Hochdosis	Hochdosis	NNP
cord-015365-iqdi99pd	1611	5	-	-	HYPH
cord-015365-iqdi99pd	1611	6	Chemo-/Radiotherapie	Chemo-/Radiotherapie	NNP
cord-015365-iqdi99pd	1611	7	bei	bei	NNP
cord-015365-iqdi99pd	1611	8	autologer	autologer	NNP
cord-015365-iqdi99pd	1611	9	oder	oder	NNP
cord-015365-iqdi99pd	1611	10	allogener	allogener	NNP
cord-015365-iqdi99pd	1611	11	HSCT	HSCT	NNP
cord-015365-iqdi99pd	1611	12	.	.	.
cord-015365-iqdi99pd	1612	1	Die	die	VB
cord-015365-iqdi99pd	1612	2	transiente	transiente	NNP
cord-015365-iqdi99pd	1613	1	Elastographie	Elastographie	NNP
cord-015365-iqdi99pd	1614	1	(	(	-LRB-
cord-015365-iqdi99pd	1614	2	Fibroscan	Fibroscan	NNP
cord-015365-iqdi99pd	1614	3	,	,	,
cord-015365-iqdi99pd	1614	4	FS	FS	NNP
cord-015365-iqdi99pd	1614	5	)	)	-RRB-
cord-015365-iqdi99pd	1614	6	ist	ist	NNP
cord-015365-iqdi99pd	1614	7	eine	eine	NNP
cord-015365-iqdi99pd	1614	8	neue	neue	NNP
cord-015365-iqdi99pd	1614	9	,	,	,
cord-015365-iqdi99pd	1614	10	schnell	schnell	NNP
cord-015365-iqdi99pd	1614	11	zugängliche	zugängliche	NNP
cord-015365-iqdi99pd	1614	12	und	und	IN
cord-015365-iqdi99pd	1614	13	nicht	nicht	NNP
cord-015365-iqdi99pd	1614	14	-	-	HYPH
cord-015365-iqdi99pd	1614	15	invasive	invasive	JJ
cord-015365-iqdi99pd	1614	16	Methode	Methode	NNP
cord-015365-iqdi99pd	1614	17	eine	eine	NN
cord-015365-iqdi99pd	1615	1	Leberfibrose	Leberfibrose	NNP
cord-015365-iqdi99pd	1615	2	ü	ü	NN
cord-015365-iqdi99pd	1616	1	ber	ber	NNP
cord-015365-iqdi99pd	1616	2	die	die	NNP
cord-015365-iqdi99pd	1617	1	Lebersteifigkeit	Lebersteifigkeit	NNP
cord-015365-iqdi99pd	1618	1	(	(	-LRB-
cord-015365-iqdi99pd	1618	2	LS	LS	NNP
cord-015365-iqdi99pd	1618	3	)	)	-RRB-
cord-015365-iqdi99pd	1618	4	zu	zu	NNP
cord-015365-iqdi99pd	1618	5	bestimmen	bestimmen	NNP
cord-015365-iqdi99pd	1619	1	und	und	NNP
cord-015365-iqdi99pd	1619	2	wird	wird	NNP
cord-015365-iqdi99pd	1619	3	bereits	bereits	NNP
cord-015365-iqdi99pd	1619	4	erfolgreich	erfolgreich	NNP
cord-015365-iqdi99pd	1619	5	bei	bei	NNP
cord-015365-iqdi99pd	1619	6	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1619	7	mit	mit	NNP
cord-015365-iqdi99pd	1619	8	Hepatitis	Hepatitis	NNP
cord-015365-iqdi99pd	1619	9	C	C	NNP
cord-015365-iqdi99pd	1619	10	und	und	NNP
cord-015365-iqdi99pd	1620	1	alkoholischer	alkoholischer	NNP
cord-015365-iqdi99pd	1620	2	Lebererkrankung	Lebererkrankung	NNP
cord-015365-iqdi99pd	1620	3	eingesetzt	eingesetzt	VBD
cord-015365-iqdi99pd	1620	4	.	.	.
cord-015365-iqdi99pd	1621	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	1621	2	.	.	.
cord-015365-iqdi99pd	1622	1	Zwischen	Zwischen	NNP
cord-015365-iqdi99pd	1622	2	April	April	NNP
cord-015365-iqdi99pd	1622	3	2009	2009	CD
cord-015365-iqdi99pd	1622	4	und	und	IN
cord-015365-iqdi99pd	1622	5	Oktober	Oktober	NNP
cord-015365-iqdi99pd	1622	6	2010	2010	CD
cord-015365-iqdi99pd	1622	7	wurden	wurden	VBD
cord-015365-iqdi99pd	1622	8	67	67	CD
cord-015365-iqdi99pd	1622	9	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1622	10	FS	FS	NNP
cord-015365-iqdi99pd	1622	11	-	-	HYPH
cord-015365-iqdi99pd	1622	12	Messungen	Messungen	NNP
cord-015365-iqdi99pd	1623	1	während	während	NNP
cord-015365-iqdi99pd	1623	2	der	der	NNP
cord-015365-iqdi99pd	1623	3	Routine	Routine	NNP
cord-015365-iqdi99pd	1623	4	-	-	HYPH
cord-015365-iqdi99pd	1623	5	Abdomensonographie	Abdomensonographie	NNP
cord-015365-iqdi99pd	1624	1	i	i	PRP
cord-015365-iqdi99pd	1625	1	m	m	NNP
cord-015365-iqdi99pd	1625	2	Rahmen	Rahmen	NNP
cord-015365-iqdi99pd	1626	1	der	der	NNP
cord-015365-iqdi99pd	1626	2	Transplantvoruntersuchungen	Transplantvoruntersuchungen	NNP
cord-015365-iqdi99pd	1627	1	vor	vor	NNP
cord-015365-iqdi99pd	1627	2	autologer	autologer	NNP
cord-015365-iqdi99pd	1627	3	(	(	-LRB-
cord-015365-iqdi99pd	1627	4	n	n	NN
cord-015365-iqdi99pd	1627	5	¼	¼	NNP
cord-015365-iqdi99pd	1627	6	37	37	CD
cord-015365-iqdi99pd	1627	7	)	)	-RRB-
cord-015365-iqdi99pd	1627	8	oder	oder	NNP
cord-015365-iqdi99pd	1627	9	allogener	allogener	NNP
cord-015365-iqdi99pd	1627	10	(	(	-LRB-
cord-015365-iqdi99pd	1627	11	n	n	NN
cord-015365-iqdi99pd	1627	12	¼	¼	NNP
cord-015365-iqdi99pd	1627	13	30	30	CD
cord-015365-iqdi99pd	1627	14	)	)	-RRB-
cord-015365-iqdi99pd	1627	15	Transplantation	transplantation	NN
cord-015365-iqdi99pd	1627	16	zugeführt	zugeführt	NN
cord-015365-iqdi99pd	1627	17	.	.	.
cord-015365-iqdi99pd	1628	1	Die	die	VB
cord-015365-iqdi99pd	1629	1	Konditionierung	Konditionierung	NNP
cord-015365-iqdi99pd	1629	2	bestand	bestand	NNP
cord-015365-iqdi99pd	1629	3	aus	aus	NNP
cord-015365-iqdi99pd	1629	4	HD	HD	NNP
cord-015365-iqdi99pd	1629	5	MEL	MEL	NNP
cord-015365-iqdi99pd	1629	6	(	(	-LRB-
cord-015365-iqdi99pd	1629	7	140	140	CD
cord-015365-iqdi99pd	1629	8	-	-	SYM
cord-015365-iqdi99pd	1629	9	200	200	CD
cord-015365-iqdi99pd	1629	10	mg	mg	NNP
cord-015365-iqdi99pd	1629	11	/	/	SYM
cord-015365-iqdi99pd	1629	12	m	m	NNP
cord-015365-iqdi99pd	1629	13	2	2	CD
cord-015365-iqdi99pd	1629	14	)	)	-RRB-
cord-015365-iqdi99pd	1629	15	,	,	.
cord-015365-iqdi99pd	1630	1	BEAM	BEAM	NNP
cord-015365-iqdi99pd	1630	2	oder	oder	NNP
cord-015365-iqdi99pd	1630	3	anderen	anderen	NNP
cord-015365-iqdi99pd	1631	1	krankheitsspezifischen	krankheitsspezifischen	NNP
cord-015365-iqdi99pd	1631	2	Hochdosisschemata	Hochdosisschemata	NNP
cord-015365-iqdi99pd	1632	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1632	2	m	be	VBP
cord-015365-iqdi99pd	1632	3	Rahmen	Rahmen	NNP
cord-015365-iqdi99pd	1632	4	autologer	autologer	NN
cord-015365-iqdi99pd	1632	5	Transplantationen	Transplantationen	NNP
cord-015365-iqdi99pd	1632	6	.	.	.
cord-015365-iqdi99pd	1633	1	Allogene	Allogene	NNP
cord-015365-iqdi99pd	1633	2	Transplantationen	Transplantationen	NNP
cord-015365-iqdi99pd	1633	3	wurden	wurden	XX
cord-015365-iqdi99pd	1633	4	nach	nach	NNP
cord-015365-iqdi99pd	1633	5	myeloablativer	myeloablativer	NNP
cord-015365-iqdi99pd	1633	6	Konditionierung	Konditionierung	NNP
cord-015365-iqdi99pd	1633	7	(	(	-LRB-
cord-015365-iqdi99pd	1633	8	MAC	MAC	NNP
cord-015365-iqdi99pd	1633	9	,	,	,
cord-015365-iqdi99pd	1633	10	n	n	NN
cord-015365-iqdi99pd	1633	11	¼	¼	NNP
cord-015365-iqdi99pd	1633	12	18	18	CD
cord-015365-iqdi99pd	1633	13	)	)	-RRB-
cord-015365-iqdi99pd	1633	14	oder	oder	NNP
cord-015365-iqdi99pd	1633	15	in	in	IN
cord-015365-iqdi99pd	1633	16	reduzierter	reduzierter	JJ
cord-015365-iqdi99pd	1633	17	Intensität	Intensität	NNP
cord-015365-iqdi99pd	1633	18	,	,	,
cord-015365-iqdi99pd	1633	19	hauptsächlich	hauptsächlich	NN
cord-015365-iqdi99pd	1633	20	BUFLU	BUFLU	NNP
cord-015365-iqdi99pd	1633	21	basiert	basiert	NNP
cord-015365-iqdi99pd	1633	22	(	(	-LRB-
cord-015365-iqdi99pd	1633	23	RIC	RIC	NNP
cord-015365-iqdi99pd	1633	24	,	,	,
cord-015365-iqdi99pd	1633	25	n	n	NN
cord-015365-iqdi99pd	1633	26	¼	¼	NNP
cord-015365-iqdi99pd	1633	27	12	12	CD
cord-015365-iqdi99pd	1633	28	)	)	-RRB-
cord-015365-iqdi99pd	1633	29	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	1633	30	.	.	.
cord-015365-iqdi99pd	1634	1	Die	die	VB
cord-015365-iqdi99pd	1635	1	Lebertoxizität	Lebertoxizität	NNP
cord-015365-iqdi99pd	1635	2	wurde	wurde	VBD
cord-015365-iqdi99pd	1635	3	anhand	anhand	NNP
cord-015365-iqdi99pd	1635	4	des	des	NNP
cord-015365-iqdi99pd	1635	5	maximalen	maximalen	NNP
cord-015365-iqdi99pd	1635	6	Serumbilirubins	Serumbilirubins	NNP
cord-015365-iqdi99pd	1635	7	,	,	,
cord-015365-iqdi99pd	1635	8	der	der	NNP
cord-015365-iqdi99pd	1635	9	Anzahl	Anzahl	NNP
cord-015365-iqdi99pd	1635	10	der	der	NNP
cord-015365-iqdi99pd	1635	11	Tage	Tage	NNP
cord-015365-iqdi99pd	1635	12	mit	mit	NNP
cord-015365-iqdi99pd	1635	13	einem	einem	NNP
cord-015365-iqdi99pd	1635	14	Bilirubin	bilirubin	NN
cord-015365-iqdi99pd	1636	1	>	>	NFP
cord-015365-iqdi99pd	1636	2	2	2	CD
cord-015365-iqdi99pd	1636	3	mg	mg	NNP
cord-015365-iqdi99pd	1636	4	/	/	SYM
cord-015365-iqdi99pd	1636	5	dL	dl	NN
cord-015365-iqdi99pd	1636	6	und	und	NNP
cord-015365-iqdi99pd	1636	7	der	der	NNP
cord-015365-iqdi99pd	1636	8	prozentualen	prozentualen	NNP
cord-015365-iqdi99pd	1636	9	,	,	,
cord-015365-iqdi99pd	1636	10	maximalen	maximalen	NNP
cord-015365-iqdi99pd	1636	11	Gewichtszunahme	Gewichtszunahme	NNP
cord-015365-iqdi99pd	1636	12	bis	bis	NNP
cord-015365-iqdi99pd	1636	13	zum	zum	NNP
cord-015365-iqdi99pd	1636	14	Tag	tag	NN
cord-015365-iqdi99pd	1636	15	þ20	þ20	IN
cord-015365-iqdi99pd	1636	16	definiert	definiert	NNP
cord-015365-iqdi99pd	1636	17	.	.	.
cord-015365-iqdi99pd	1637	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	1637	2	.	.	.
cord-015365-iqdi99pd	1638	1	Das	Das	NNP
cord-015365-iqdi99pd	1638	2	maximale	maximale	NNP
cord-015365-iqdi99pd	1638	3	Serum	Serum	NNP
cord-015365-iqdi99pd	1638	4	Bilirubin	bilirubin	NN
cord-015365-iqdi99pd	1638	5	vor	vor	NN
cord-015365-iqdi99pd	1639	1	Tag	tag	NN
cord-015365-iqdi99pd	1639	2	þ20	þ20	IN
cord-015365-iqdi99pd	1639	3	betrug	betrug	NNP
cord-015365-iqdi99pd	1639	4	1,18	1,18	CD
cord-015365-iqdi99pd	1639	5	(	(	-LRB-
cord-015365-iqdi99pd	1639	6	range	range	NN
cord-015365-iqdi99pd	1639	7	,	,	,
cord-015365-iqdi99pd	1639	8	0,44	0,44	CD
cord-015365-iqdi99pd	1639	9	-	-	SYM
cord-015365-iqdi99pd	1639	10	11,72	11,72	CD
cord-015365-iqdi99pd	1639	11	)	)	-RRB-
cord-015365-iqdi99pd	1640	1	mg	mg	NNP
cord-015365-iqdi99pd	1640	2	/	/	SYM
cord-015365-iqdi99pd	1640	3	dL	dL	NNP
cord-015365-iqdi99pd	1640	4	,	,	,
cord-015365-iqdi99pd	1640	5	der	der	NNP
cord-015365-iqdi99pd	1640	6	mediane	mediane	NNP
cord-015365-iqdi99pd	1640	7	Zeitpunkt	Zeitpunkt	NNP
cord-015365-iqdi99pd	1640	8	mit	mit	NNP
cord-015365-iqdi99pd	1640	9	einem	einem	NNP
cord-015365-iqdi99pd	1640	10	Serumbilirubin	Serumbilirubin	NNP
cord-015365-iqdi99pd	1640	11	!	!	.
cord-015365-iqdi99pd	1641	1	2	2	LS
cord-015365-iqdi99pd	1642	1	mg	mg	NNP
cord-015365-iqdi99pd	1642	2	/	/	SYM
cord-015365-iqdi99pd	1642	3	dL	dl	NN
cord-015365-iqdi99pd	1642	4	war	war	NN
cord-015365-iqdi99pd	1642	5	10,5	10,5	CD
cord-015365-iqdi99pd	1643	1	(	(	-LRB-
cord-015365-iqdi99pd	1643	2	range	range	NN
cord-015365-iqdi99pd	1643	3	,	,	,
cord-015365-iqdi99pd	1643	4	1	1	CD
cord-015365-iqdi99pd	1643	5	-	-	SYM
cord-015365-iqdi99pd	1643	6	20	20	CD
cord-015365-iqdi99pd	1643	7	)	)	-RRB-
cord-015365-iqdi99pd	1643	8	Tage	tage	NN
cord-015365-iqdi99pd	1644	1	und	und	NNP
cord-015365-iqdi99pd	1644	2	die	die	VB
cord-015365-iqdi99pd	1644	3	mediane	mediane	NNP
cord-015365-iqdi99pd	1644	4	prozentualen	prozentualen	NNP
cord-015365-iqdi99pd	1644	5	Gewichtszunahme	Gewichtszunahme	NNP
cord-015365-iqdi99pd	1644	6	war	war	NN
cord-015365-iqdi99pd	1644	7	5,2	5,2	CD
cord-015365-iqdi99pd	1644	8	%	%	NN
cord-015365-iqdi99pd	1644	9	(	(	-LRB-
cord-015365-iqdi99pd	1644	10	range	range	NN
cord-015365-iqdi99pd	1644	11	,	,	,
cord-015365-iqdi99pd	1644	12	0,1	0,1	CD
cord-015365-iqdi99pd	1644	13	-	-	:
cord-015365-iqdi99pd	1644	14	17,2	17,2	CD
cord-015365-iqdi99pd	1644	15	)	)	-RRB-
cord-015365-iqdi99pd	1644	16	.	.	.
cord-015365-iqdi99pd	1645	1	Lebertoxizität	Lebertoxizität	NNP
cord-015365-iqdi99pd	1645	2	wurde	wurde	VBD
cord-015365-iqdi99pd	1645	3	häufiger	häufiger	NNP
cord-015365-iqdi99pd	1645	4	nach	nach	NNP
cord-015365-iqdi99pd	1645	5	MAC	MAC	NNP
cord-015365-iqdi99pd	1645	6	vs.	vs.	FW
cord-015365-iqdi99pd	1645	7	RIC	RIC	NNP
cord-015365-iqdi99pd	1645	8	Konditionierung	Konditionierung	NNP
cord-015365-iqdi99pd	1645	9	beobachtet	beobachtet	NNP
cord-015365-iqdi99pd	1645	10	,	,	,
cord-015365-iqdi99pd	1645	11	wenngleich	wenngleich	NNP
cord-015365-iqdi99pd	1645	12	nicht	nicht	NNP
cord-015365-iqdi99pd	1645	13	statistisch	statistisch	NNP
cord-015365-iqdi99pd	1645	14	signifikant	signifikant	NNP
cord-015365-iqdi99pd	1645	15	(	(	-LRB-
cord-015365-iqdi99pd	1645	16	50	50	CD
cord-015365-iqdi99pd	1645	17	%	%	NN
cord-015365-iqdi99pd	1645	18	vs.	vs.	IN
cord-015365-iqdi99pd	1645	19	33	33	CD
cord-015365-iqdi99pd	1645	20	%	%	NN
cord-015365-iqdi99pd	1645	21	,	,	,
cord-015365-iqdi99pd	1645	22	p	p	NN
cord-015365-iqdi99pd	1645	23	¼	¼	NNP
cord-015365-iqdi99pd	1645	24	0,25	0,25	NNP
cord-015365-iqdi99pd	1645	25	)	)	-RRB-
cord-015365-iqdi99pd	1645	26	.	.	.
cord-015365-iqdi99pd	1646	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1646	2	,	,	,
cord-015365-iqdi99pd	1646	3	die	die	VB
cord-015365-iqdi99pd	1646	4	eine	eine	JJ
cord-015365-iqdi99pd	1646	5	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	1646	6	(	(	-LRB-
cord-015365-iqdi99pd	1646	7	IS	be	VBZ
cord-015365-iqdi99pd	1646	8	)	)	-RRB-
cord-015365-iqdi99pd	1646	9	mit	mit	NNP
cord-015365-iqdi99pd	1646	10	CsA	CsA	NNP
cord-015365-iqdi99pd	1646	11	/	/	SYM
cord-015365-iqdi99pd	1646	12	MTX	MTX	NNP
cord-015365-iqdi99pd	1646	13	erhielten	erhielten	NNP
cord-015365-iqdi99pd	1646	14	,	,	,
cord-015365-iqdi99pd	1647	1	zeigten	zeigten	NNP
cord-015365-iqdi99pd	1647	2	häufiger	häufiger	NNP
cord-015365-iqdi99pd	1648	1	Anzeichen	Anzeichen	NNP
cord-015365-iqdi99pd	1648	2	einer	einer	NNP
cord-015365-iqdi99pd	1649	1	Lebertoxizität	Lebertoxizität	NNP
cord-015365-iqdi99pd	1649	2	verglichen	verglichen	NNP
cord-015365-iqdi99pd	1649	3	mit	mit	NNP
cord-015365-iqdi99pd	1649	4	Pat	Pat	NNP
cord-015365-iqdi99pd	1649	5	.	.	.
cord-015365-iqdi99pd	1650	1	,	,	,
cord-015365-iqdi99pd	1650	2	die	die	VB
cord-015365-iqdi99pd	1651	1	CsA	CsA	NNP
cord-015365-iqdi99pd	1651	2	/	/	SYM
cord-015365-iqdi99pd	1651	3	MMF	MMF	NNP
cord-015365-iqdi99pd	1652	1	oder	oder	NNP
cord-015365-iqdi99pd	1652	2	keine	keine	NNP
cord-015365-iqdi99pd	1652	3	IS	be	VBZ
cord-015365-iqdi99pd	1652	4	erhielten	erhielten	NNP
cord-015365-iqdi99pd	1652	5	(	(	-LRB-
cord-015365-iqdi99pd	1652	6	83	83	CD
cord-015365-iqdi99pd	1652	7	%	%	NN
cord-015365-iqdi99pd	1652	8	vs.	vs.	IN
cord-015365-iqdi99pd	1652	9	18	18	CD
cord-015365-iqdi99pd	1652	10	%	%	NN
cord-015365-iqdi99pd	1652	11	)	)	-RRB-
cord-015365-iqdi99pd	1652	12	.	.	.
cord-015365-iqdi99pd	1653	1	Die	die	VB
cord-015365-iqdi99pd	1653	2	mediane	mediane	NNP
cord-015365-iqdi99pd	1653	3	LS	LS	NNP
cord-015365-iqdi99pd	1653	4	vor	vor	NN
cord-015365-iqdi99pd	1654	1	Transplantation	transplantation	NN
cord-015365-iqdi99pd	1654	2	war	war	NN
cord-015365-iqdi99pd	1655	1	5,4	5,4	CD
cord-015365-iqdi99pd	1656	1	kP	kp	XX
cord-015365-iqdi99pd	1657	1	(	(	-LRB-
cord-015365-iqdi99pd	1657	2	range	range	NN
cord-015365-iqdi99pd	1657	3	,	,	,
cord-015365-iqdi99pd	1657	4	2,3	2,3	CD
cord-015365-iqdi99pd	1657	5	-	-	HYPH
cord-015365-iqdi99pd	1657	6	62,7	62,7	CD
cord-015365-iqdi99pd	1657	7	)	)	-RRB-
cord-015365-iqdi99pd	1657	8	.	.	.
cord-015365-iqdi99pd	1658	1	Die	die	VB
cord-015365-iqdi99pd	1658	2	LS	LS	NNP
cord-015365-iqdi99pd	1658	3	korrelierte	korrelierte	NNP
cord-015365-iqdi99pd	1658	4	signifikant	signifikant	NNP
cord-015365-iqdi99pd	1658	5	mit	mit	NNP
cord-015365-iqdi99pd	1658	6	der	der	NNP
cord-015365-iqdi99pd	1658	7	GOT	get	VBN
cord-015365-iqdi99pd	1658	8	und	und	IN
cord-015365-iqdi99pd	1658	9	GPT	gpt	NN
cord-015365-iqdi99pd	1658	10	vor	vor	NN
cord-015365-iqdi99pd	1658	11	Transplantation	transplantation	NN
cord-015365-iqdi99pd	1658	12	in	in	IN
cord-015365-iqdi99pd	1658	13	der	der	NNP
cord-015365-iqdi99pd	1658	14	gesamten	gesamten	NNP
cord-015365-iqdi99pd	1658	15	Kohorte	Kohorte	NNP
cord-015365-iqdi99pd	1658	16	und	und	NNP
cord-015365-iqdi99pd	1658	17	mit	mit	NNP
cord-015365-iqdi99pd	1658	18	GPT	GPT	NNP
cord-015365-iqdi99pd	1658	19	,	,	,
cord-015365-iqdi99pd	1658	20	gGT	gGT	VBN
cord-015365-iqdi99pd	1658	21	und	und	IN
cord-015365-iqdi99pd	1658	22	AP	AP	NNP
cord-015365-iqdi99pd	1658	23	bei	bei	NNP
cord-015365-iqdi99pd	1658	24	Pat	Pat	NNP
cord-015365-iqdi99pd	1658	25	.	.	.
cord-015365-iqdi99pd	1659	1	mit	mit	NNP
cord-015365-iqdi99pd	1659	2	mehr	mehr	JJ
cord-015365-iqdi99pd	1659	3	als	als	NNP
cord-015365-iqdi99pd	1659	4	10d	10d	NNS
cord-015365-iqdi99pd	1660	1	Bilirubin	bilirubin	NN
cord-015365-iqdi99pd	1660	2	>	>	XX
cord-015365-iqdi99pd	1661	1	2	2	CD
cord-015365-iqdi99pd	1661	2	mg	mg	NNP
cord-015365-iqdi99pd	1661	3	/	/	SYM
cord-015365-iqdi99pd	1661	4	dl	dl	NN
cord-015365-iqdi99pd	1661	5	bis	bis	NNP
cord-015365-iqdi99pd	1661	6	zum	zum	NNP
cord-015365-iqdi99pd	1661	7	Tag	tag	NN
cord-015365-iqdi99pd	1661	8	þ	þ	NNP
cord-015365-iqdi99pd	1662	1	20	20	CD
cord-015365-iqdi99pd	1662	2	.	.	.
cord-015365-iqdi99pd	1663	1	Zwischen	Zwischen	NNP
cord-015365-iqdi99pd	1663	2	der	der	NNP
cord-015365-iqdi99pd	1663	3	LS	LS	NNP
cord-015365-iqdi99pd	1663	4	vor	vor	NN
cord-015365-iqdi99pd	1663	5	HSCT	HSCT	NNP
cord-015365-iqdi99pd	1663	6	und	und	IN
cord-015365-iqdi99pd	1663	7	Zeichen	Zeichen	NNP
cord-015365-iqdi99pd	1663	8	der	der	NNP
cord-015365-iqdi99pd	1663	9	Lebertoxizität	Lebertoxizität	NNP
cord-015365-iqdi99pd	1663	10	(	(	-LRB-
cord-015365-iqdi99pd	1663	11	definiert	definiert	NNP
cord-015365-iqdi99pd	1663	12	als	als	NNP
cord-015365-iqdi99pd	1663	13	max	max	NNP
cord-015365-iqdi99pd	1663	14	.	.	.
cord-015365-iqdi99pd	1664	1	Serumbilirubin	Serumbilirubin	NNP
cord-015365-iqdi99pd	1664	2	,	,	,
cord-015365-iqdi99pd	1664	3	Anzahl	Anzahl	NNP
cord-015365-iqdi99pd	1664	4	der	der	NNP
cord-015365-iqdi99pd	1664	5	Tage	Tage	NNP
cord-015365-iqdi99pd	1664	6	mit	mit	NNP
cord-015365-iqdi99pd	1664	7	Bilirubin	bilirubin	NN
cord-015365-iqdi99pd	1665	1	>	>	NFP
cord-015365-iqdi99pd	1665	2	2	2	CD
cord-015365-iqdi99pd	1665	3	mg	mg	NNP
cord-015365-iqdi99pd	1665	4	/	/	SYM
cord-015365-iqdi99pd	1665	5	dL	dl	NN
cord-015365-iqdi99pd	1665	6	und	und	NNP
cord-015365-iqdi99pd	1665	7	prozentualer	prozentualer	NNP
cord-015365-iqdi99pd	1665	8	Gewichtszunahme	Gewichtszunahme	NNP
cord-015365-iqdi99pd	1665	9	)	)	-RRB-
cord-015365-iqdi99pd	1666	1	nach	nach	NNP
cord-015365-iqdi99pd	1666	2	HSCT	HSCT	NNP
cord-015365-iqdi99pd	1666	3	konnte	konnte	NNP
cord-015365-iqdi99pd	1666	4	keine	keine	NNP
cord-015365-iqdi99pd	1666	5	signifikante	signifikante	NNP
cord-015365-iqdi99pd	1666	6	Korrelation	Korrelation	NNP
cord-015365-iqdi99pd	1666	7	hergestellt	hergestellt	NNP
cord-015365-iqdi99pd	1666	8	werden	werden	NNP
cord-015365-iqdi99pd	1666	9	.	.	.
cord-015365-iqdi99pd	1667	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	1667	2	.	.	.
cord-015365-iqdi99pd	1668	1	Die	die	VB
cord-015365-iqdi99pd	1668	2	nicht	nicht	NNP
cord-015365-iqdi99pd	1668	3	-	-	HYPH
cord-015365-iqdi99pd	1668	4	invasive	invasive	JJ
cord-015365-iqdi99pd	1668	5	transiente	transiente	NNP
cord-015365-iqdi99pd	1669	1	Elastographie	Elastographie	NNP
cord-015365-iqdi99pd	1670	1	(	(	-LRB-
cord-015365-iqdi99pd	1670	2	Fibroscan	Fibroscan	NNP
cord-015365-iqdi99pd	1670	3	)	)	-RRB-
cord-015365-iqdi99pd	1670	4	ist	ist	NNP
cord-015365-iqdi99pd	1670	5	nicht	nicht	NNP
cord-015365-iqdi99pd	1670	6	wegweisend	wegweisend	NNP
cord-015365-iqdi99pd	1670	7	,	,	,
cord-015365-iqdi99pd	1670	8	um	um	UH
cord-015365-iqdi99pd	1670	9	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1670	10	zu	zu	NNP
cord-015365-iqdi99pd	1670	11	identifizieren	identifizieren	NNP
cord-015365-iqdi99pd	1670	12	,	,	,
cord-015365-iqdi99pd	1670	13	die	die	VBP
cord-015365-iqdi99pd	1670	14	ein	ein	NNP
cord-015365-iqdi99pd	1670	15	hohes	hohes	NNP
cord-015365-iqdi99pd	1670	16	Risiko	Risiko	NNP
cord-015365-iqdi99pd	1670	17	für	für	NNS
cord-015365-iqdi99pd	1670	18	die	die	VBP
cord-015365-iqdi99pd	1670	19	Entwicklung	Entwicklung	NNP
cord-015365-iqdi99pd	1670	20	einer	einer	NNP
cord-015365-iqdi99pd	1671	1	Lebertoxizität	Lebertoxizität	NNP
cord-015365-iqdi99pd	1671	2	nach	nach	VBP
cord-015365-iqdi99pd	1671	3	autologer	autologer	NNP
cord-015365-iqdi99pd	1671	4	oder	oder	NNP
cord-015365-iqdi99pd	1671	5	allogener	allogener	NNP
cord-015365-iqdi99pd	1671	6	Transplantation	transplantation	NN
cord-015365-iqdi99pd	1671	7	aufweisen	aufweisen	NNP
cord-015365-iqdi99pd	1671	8	.	.	.
cord-015365-iqdi99pd	1672	1	Norovirus	norovirus	NN
cord-015365-iqdi99pd	1672	2	associated	associate	VBN
cord-015365-iqdi99pd	1672	3	hemophagocytic	hemophagocytic	JJ
cord-015365-iqdi99pd	1672	4	lymphohistiocytosis	lymphohistiocytosis	NN
cord-015365-iqdi99pd	1672	5	(	(	-LRB-
cord-015365-iqdi99pd	1672	6	HLH	HLH	NNP
cord-015365-iqdi99pd	1672	7	)	)	-RRB-
cord-015365-iqdi99pd	1672	8	after	after	IN
cord-015365-iqdi99pd	1672	9	unrelated	unrelated	JJ
cord-015365-iqdi99pd	1672	10	bone	bone	NN
cord-015365-iqdi99pd	1672	11	marrow	marrow	NN
cord-015365-iqdi99pd	1672	12	transplantation	transplantation	NN
cord-015365-iqdi99pd	1672	13	(	(	-LRB-
cord-015365-iqdi99pd	1672	14	BMT	BMT	NNP
cord-015365-iqdi99pd	1672	15	)	)	-RRB-
cord-015365-iqdi99pd	1672	16	in	in	IN
cord-015365-iqdi99pd	1672	17	a	a	DT
cord-015365-iqdi99pd	1672	18	boy	boy	NN
cord-015365-iqdi99pd	1672	19	with	with	IN
cord-015365-iqdi99pd	1672	20	refractory	refractory	JJ
cord-015365-iqdi99pd	1672	21	AML	AML	NNP
cord-015365-iqdi99pd	1672	22	G.	G.	NNP
cord-015365-iqdi99pd	1672	23	Kropshofer	Kropshofer	NNP
cord-015365-iqdi99pd	1672	24	,	,	,
cord-015365-iqdi99pd	1672	25	C.	C.	NNP
cord-015365-iqdi99pd	1672	26	Salvador	Salvador	NNP
cord-015365-iqdi99pd	1672	27	,	,	,
cord-015365-iqdi99pd	1672	28	R.	R.	NNP
cord-015365-iqdi99pd	1672	29	Crazzolara	Crazzolara	NNP
cord-015365-iqdi99pd	1672	30	,	,	,
cord-015365-iqdi99pd	1672	31	B.	B.	NNP
cord-015365-iqdi99pd	1672	32	Meister	Meister	NNP
cord-015365-iqdi99pd	1672	33	Background	Background	NNP
cord-015365-iqdi99pd	1672	34	.	.	.
cord-015365-iqdi99pd	1673	1	HLH	HLH	NNP
cord-015365-iqdi99pd	1673	2	is	be	VBZ
cord-015365-iqdi99pd	1673	3	a	a	DT
cord-015365-iqdi99pd	1673	4	potentially	potentially	RB
cord-015365-iqdi99pd	1673	5	life	life	NN
cord-015365-iqdi99pd	1673	6	threatening	threaten	VBG
cord-015365-iqdi99pd	1673	7	macrophage	macrophage	NN
cord-015365-iqdi99pd	1673	8	activating	activate	VBG
cord-015365-iqdi99pd	1673	9	syndrome	syndrome	NN
cord-015365-iqdi99pd	1673	10	which	which	WDT
cord-015365-iqdi99pd	1673	11	leads	lead	VBZ
cord-015365-iqdi99pd	1673	12	to	to	IN
cord-015365-iqdi99pd	1673	13	massive	massive	JJ
cord-015365-iqdi99pd	1673	14	hyperinflammation	hyperinflammation	NN
cord-015365-iqdi99pd	1673	15	through	through	IN
cord-015365-iqdi99pd	1673	16	an	an	DT
cord-015365-iqdi99pd	1673	17	exaggerated	exaggerated	JJ
cord-015365-iqdi99pd	1673	18	but	but	CC
cord-015365-iqdi99pd	1673	19	ineffective	ineffective	JJ
cord-015365-iqdi99pd	1673	20	immune	immune	JJ
cord-015365-iqdi99pd	1673	21	response	response	NN
cord-015365-iqdi99pd	1673	22	.	.	.
cord-015365-iqdi99pd	1674	1	Diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1674	2	after	after	IN
cord-015365-iqdi99pd	1674	3	BMT	BMT	NNP
cord-015365-iqdi99pd	1674	4	is	be	VBZ
cord-015365-iqdi99pd	1674	5	complicated	complicate	VBN
cord-015365-iqdi99pd	1674	6	by	by	IN
cord-015365-iqdi99pd	1674	7	other	other	JJ
cord-015365-iqdi99pd	1674	8	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	1674	9	syndroms	syndrom	NNS
cord-015365-iqdi99pd	1674	10	like	like	IN
cord-015365-iqdi99pd	1674	11	engraftment	engraftment	NNP
cord-015365-iqdi99pd	1674	12	syndrome	syndrome	NN
cord-015365-iqdi99pd	1674	13	,	,	,
cord-015365-iqdi99pd	1674	14	capillary	capillary	JJ
cord-015365-iqdi99pd	1674	15	leak	leak	NN
cord-015365-iqdi99pd	1674	16	syndrome	syndrome	NN
cord-015365-iqdi99pd	1674	17	,	,	,
cord-015365-iqdi99pd	1674	18	venoocclusive	venoocclusive	JJ
cord-015365-iqdi99pd	1674	19	disease	disease	NN
cord-015365-iqdi99pd	1674	20	and	and	CC
cord-015365-iqdi99pd	1674	21	systemic	systemic	JJ
cord-015365-iqdi99pd	1674	22	infections	infection	NNS
cord-015365-iqdi99pd	1674	23	.	.	.
cord-015365-iqdi99pd	1675	1	Methods	method	NNS
cord-015365-iqdi99pd	1675	2	and	and	CC
cord-015365-iqdi99pd	1675	3	Results	result	NNS
cord-015365-iqdi99pd	1675	4	.	.	.
cord-015365-iqdi99pd	1676	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1676	2	report	report	VBP
cord-015365-iqdi99pd	1676	3	on	on	IN
cord-015365-iqdi99pd	1676	4	a	a	DT
cord-015365-iqdi99pd	1676	5	meanwhile	meanwhile	RB
cord-015365-iqdi99pd	1676	6	24month	24month	JJ
cord-015365-iqdi99pd	1676	7	-	-	HYPH
cord-015365-iqdi99pd	1676	8	old	old	JJ
cord-015365-iqdi99pd	1676	9	boy	boy	NN
cord-015365-iqdi99pd	1676	10	with	with	IN
cord-015365-iqdi99pd	1676	11	AML	AML	NNP
cord-015365-iqdi99pd	1676	12	(	(	-LRB-
cord-015365-iqdi99pd	1676	13	M4	M4	NNP
cord-015365-iqdi99pd	1676	14	)	)	-RRB-
cord-015365-iqdi99pd	1676	15	relapse	relapse	NN
cord-015365-iqdi99pd	1676	16	.	.	.
cord-015365-iqdi99pd	1677	1	Already	already	RB
cord-015365-iqdi99pd	1677	2	in	in	IN
cord-015365-iqdi99pd	1677	3	phase	phase	NN
cord-015365-iqdi99pd	1677	4	of	of	IN
cord-015365-iqdi99pd	1677	5	maintenance	maintenance	NN
cord-015365-iqdi99pd	1677	6	chemotherapy	chemotherapy	NN
cord-015365-iqdi99pd	1677	7	he	-PRON-	PRP
cord-015365-iqdi99pd	1677	8	acquired	acquire	VBD
cord-015365-iqdi99pd	1677	9	a	a	DT
cord-015365-iqdi99pd	1677	10	gastrointestinal	gastrointestinal	JJ
cord-015365-iqdi99pd	1677	11	infection	infection	NN
cord-015365-iqdi99pd	1677	12	with	with	IN
cord-015365-iqdi99pd	1677	13	norovirus	norovirus	NN
cord-015365-iqdi99pd	1677	14	.	.	.
cord-015365-iqdi99pd	1678	1	Reinduction	reinduction	NN
cord-015365-iqdi99pd	1678	2	chemotherapy	chemotherapy	NN
cord-015365-iqdi99pd	1678	3	was	be	VBD
cord-015365-iqdi99pd	1678	4	performed	perform	VBN
cord-015365-iqdi99pd	1678	5	with	with	IN
cord-015365-iqdi99pd	1678	6	FLAG	FLAG	NNP
cord-015365-iqdi99pd	1678	7	/	/	SYM
cord-015365-iqdi99pd	1678	8	Daunoxome	Daunoxome	NNP
cord-015365-iqdi99pd	1678	9	and	and	CC
cord-015365-iqdi99pd	1678	10	FLAMSA	FLAMSA	NNP
cord-015365-iqdi99pd	1678	11	-he	-he	ADD
cord-015365-iqdi99pd	1678	12	never	never	RB
cord-015365-iqdi99pd	1678	13	reached	reach	VBD
cord-015365-iqdi99pd	1678	14	a	a	DT
cord-015365-iqdi99pd	1678	15	complete	complete	JJ
cord-015365-iqdi99pd	1678	16	remission	remission	NN
cord-015365-iqdi99pd	1678	17	.	.	.
cord-015365-iqdi99pd	1679	1	So	so	RB
cord-015365-iqdi99pd	1679	2	we	-PRON-	PRP
cord-015365-iqdi99pd	1679	3	decided	decide	VBD
cord-015365-iqdi99pd	1679	4	to	to	TO
cord-015365-iqdi99pd	1679	5	perform	perform	VB
cord-015365-iqdi99pd	1679	6	an	an	DT
cord-015365-iqdi99pd	1679	7	allogeneic	allogeneic	NN
cord-015365-iqdi99pd	1679	8	BMT	BMT	NNP
cord-015365-iqdi99pd	1679	9	(	(	-LRB-
cord-015365-iqdi99pd	1679	10	MUD	MUD	NNP
cord-015365-iqdi99pd	1679	11	)	)	-RRB-
cord-015365-iqdi99pd	1679	12	in	in	IN
cord-015365-iqdi99pd	1679	13	aplasia	aplasia	NNP
cord-015365-iqdi99pd	1679	14	.	.	.
cord-015365-iqdi99pd	1680	1	Conditioning	conditioning	NN
cord-015365-iqdi99pd	1680	2	regimen	regimen	NN
cord-015365-iqdi99pd	1680	3	consisted	consist	VBD
cord-015365-iqdi99pd	1680	4	of	of	IN
cord-015365-iqdi99pd	1680	5	iv	iv	NNP
cord-015365-iqdi99pd	1680	6	busulfan	busulfan	NNP
cord-015365-iqdi99pd	1680	7	,	,	,
cord-015365-iqdi99pd	1680	8	cyclophosphamide	cyclophosphamide	NN
cord-015365-iqdi99pd	1680	9	and	and	CC
cord-015365-iqdi99pd	1680	10	melphalan	melphalan	NNP
cord-015365-iqdi99pd	1680	11	.	.	.
cord-015365-iqdi99pd	1681	1	There	there	EX
cord-015365-iqdi99pd	1681	2	were	be	VBD
cord-015365-iqdi99pd	1681	3	no	no	DT
cord-015365-iqdi99pd	1681	4	early	early	JJ
cord-015365-iqdi99pd	1681	5	complications	complication	NNS
cord-015365-iqdi99pd	1681	6	despite	despite	IN
cord-015365-iqdi99pd	1681	7	his	-PRON-	PRP$
cord-015365-iqdi99pd	1681	8	ongoing	ongoing	JJ
cord-015365-iqdi99pd	1681	9	norovirus	norovirus	NN
cord-015365-iqdi99pd	1681	10	infection	infection	NN
cord-015365-iqdi99pd	1681	11	.	.	.
cord-015365-iqdi99pd	1682	1	Leukocyte	Leukocyte	NNP
cord-015365-iqdi99pd	1682	2	engraftment	engraftment	NN
cord-015365-iqdi99pd	1682	3	was	be	VBD
cord-015365-iqdi99pd	1682	4	obtained	obtain	VBN
cord-015365-iqdi99pd	1682	5	on	on	IN
cord-015365-iqdi99pd	1682	6	day	day	NN
cord-015365-iqdi99pd	1682	7	þ20	þ20	IN
cord-015365-iqdi99pd	1682	8	.	.	.
cord-015365-iqdi99pd	1683	1	Bone	bone	NN
cord-015365-iqdi99pd	1683	2	marrow	marrow	NN
cord-015365-iqdi99pd	1683	3	at	at	IN
cord-015365-iqdi99pd	1683	4	day	day	NN
cord-015365-iqdi99pd	1684	1	þ28	þ28	NNP
cord-015365-iqdi99pd	1684	2	showed	show	VBD
cord-015365-iqdi99pd	1684	3	a	a	DT
cord-015365-iqdi99pd	1684	4	nearly	nearly	RB
cord-015365-iqdi99pd	1684	5	normocellular	normocellular	JJ
cord-015365-iqdi99pd	1684	6	bone	bone	NN
cord-015365-iqdi99pd	1684	7	marrow	marrow	NN
cord-015365-iqdi99pd	1684	8	and	and	CC
cord-015365-iqdi99pd	1684	9	full	full	JJ
cord-015365-iqdi99pd	1684	10	donor	donor	NN
cord-015365-iqdi99pd	1684	11	chimerism	chimerism	NN
cord-015365-iqdi99pd	1684	12	.	.	.
cord-015365-iqdi99pd	1685	1	At	at	IN
cord-015365-iqdi99pd	1685	2	day	day	NN
cord-015365-iqdi99pd	1685	3	þ40	þ40	NNP
cord-015365-iqdi99pd	1685	4	the	the	DT
cord-015365-iqdi99pd	1685	5	patient	patient	NN
cord-015365-iqdi99pd	1685	6	impressed	impress	VBN
cord-015365-iqdi99pd	1685	7	with	with	IN
cord-015365-iqdi99pd	1685	8	persistent	persistent	JJ
cord-015365-iqdi99pd	1685	9	fever	fever	NN
cord-015365-iqdi99pd	1685	10	despite	despite	IN
cord-015365-iqdi99pd	1685	11	antimicrobial	antimicrobial	JJ
cord-015365-iqdi99pd	1685	12	therapy	therapy	NN
cord-015365-iqdi99pd	1685	13	,	,	,
cord-015365-iqdi99pd	1685	14	his	-PRON-	PRP$
cord-015365-iqdi99pd	1685	15	general	general	JJ
cord-015365-iqdi99pd	1685	16	status	status	NN
cord-015365-iqdi99pd	1685	17	deteriorated	deteriorate	VBD
cord-015365-iqdi99pd	1685	18	.	.	.
cord-015365-iqdi99pd	1686	1	He	-PRON-	PRP
cord-015365-iqdi99pd	1686	2	developed	develop	VBD
cord-015365-iqdi99pd	1686	3	CNS	CNS	NNP
cord-015365-iqdi99pd	1686	4	symptoms	symptom	NNS
cord-015365-iqdi99pd	1686	5	with	with	IN
cord-015365-iqdi99pd	1686	6	vertical	vertical	JJ
cord-015365-iqdi99pd	1686	7	nystagmus	nystagmus	NN
cord-015365-iqdi99pd	1686	8	,	,	,
cord-015365-iqdi99pd	1686	9	increasing	increase	VBG
cord-015365-iqdi99pd	1686	10	hepatosplenomegaly	hepatosplenomegaly	NNS
cord-015365-iqdi99pd	1686	11	and	and	CC
cord-015365-iqdi99pd	1686	12	respiratory	respiratory	JJ
cord-015365-iqdi99pd	1686	13	insufficiency	insufficiency	NN
cord-015365-iqdi99pd	1686	14	.	.	.
cord-015365-iqdi99pd	1687	1	Laboratory	laboratory	NN
cord-015365-iqdi99pd	1687	2	findings	finding	NNS
cord-015365-iqdi99pd	1687	3	showed	show	VBD
cord-015365-iqdi99pd	1687	4	hyperferritinemia	hyperferritinemia	NNP
cord-015365-iqdi99pd	1687	5	(	(	-LRB-
cord-015365-iqdi99pd	1687	6	45000	45000	CD
cord-015365-iqdi99pd	1687	7	mg	mg	NNP
cord-015365-iqdi99pd	1687	8	/	/	SYM
cord-015365-iqdi99pd	1687	9	l	l	NNP
cord-015365-iqdi99pd	1687	10	)	)	-RRB-
cord-015365-iqdi99pd	1687	11	,	,	,
cord-015365-iqdi99pd	1687	12	a	a	DT
cord-015365-iqdi99pd	1687	13	subsequent	subsequent	JJ
cord-015365-iqdi99pd	1687	14	pancytopenia	pancytopenia	NNP
cord-015365-iqdi99pd	1687	15	,	,	,
cord-015365-iqdi99pd	1687	16	hypofibrinogenemia	hypofibrinogenemia	NN
cord-015365-iqdi99pd	1687	17	,	,	,
cord-015365-iqdi99pd	1687	18	elevated	elevated	JJ
cord-015365-iqdi99pd	1687	19	D	D	NNP
cord-015365-iqdi99pd	1687	20	-	-	HYPH
cord-015365-iqdi99pd	1687	21	Dimer	Dimer	NNP
cord-015365-iqdi99pd	1687	22	(	(	-LRB-
cord-015365-iqdi99pd	1687	23	34000	34000	CD
cord-015365-iqdi99pd	1687	24	mg	mg	NNP
cord-015365-iqdi99pd	1687	25	/	/	SYM
cord-015365-iqdi99pd	1687	26	l	l	NNP
cord-015365-iqdi99pd	1687	27	)	)	-RRB-
cord-015365-iqdi99pd	1687	28	and	and	CC
cord-015365-iqdi99pd	1687	29	hypertriglyceridemia	hypertriglyceridemia	NNP
cord-015365-iqdi99pd	1687	30	(	(	-LRB-
cord-015365-iqdi99pd	1687	31	723	723	CD
cord-015365-iqdi99pd	1687	32	mg	mg	NNP
cord-015365-iqdi99pd	1687	33	/	/	SYM
cord-015365-iqdi99pd	1687	34	dl	dl	NNP
cord-015365-iqdi99pd	1687	35	)	)	-RRB-
cord-015365-iqdi99pd	1687	36	.	.	.
cord-015365-iqdi99pd	1688	1	Intensive	intensive	JJ
cord-015365-iqdi99pd	1688	2	care	care	NN
cord-015365-iqdi99pd	1688	3	was	be	VBD
cord-015365-iqdi99pd	1688	4	necessary	necessary	JJ
cord-015365-iqdi99pd	1688	5	including	include	VBG
cord-015365-iqdi99pd	1688	6	high	high	JJ
cord-015365-iqdi99pd	1688	7	doses	dose	NNS
cord-015365-iqdi99pd	1688	8	of	of	IN
cord-015365-iqdi99pd	1688	9	catecholamines	catecholamine	NNS
cord-015365-iqdi99pd	1688	10	.	.	.
cord-015365-iqdi99pd	1689	1	Subsequent	subsequent	JJ
cord-015365-iqdi99pd	1689	2	bone	bone	NN
cord-015365-iqdi99pd	1689	3	marrow	marrow	NN
cord-015365-iqdi99pd	1689	4	aspiration	aspiration	NN
cord-015365-iqdi99pd	1689	5	revealed	reveal	VBD
cord-015365-iqdi99pd	1689	6	an	an	DT
cord-015365-iqdi99pd	1689	7	aplastic	aplastic	JJ
cord-015365-iqdi99pd	1689	8	bone	bone	NN
cord-015365-iqdi99pd	1689	9	marrow	marrow	NN
cord-015365-iqdi99pd	1689	10	and	and	CC
cord-015365-iqdi99pd	1689	11	hemophagocytosis	hemophagocytosis	NN
cord-015365-iqdi99pd	1689	12	.	.	.
cord-015365-iqdi99pd	1690	1	The	the	DT
cord-015365-iqdi99pd	1690	2	patient	patient	NN
cord-015365-iqdi99pd	1690	3	underwent	undergo	VBD
cord-015365-iqdi99pd	1690	4	ventilation	ventilation	NN
cord-015365-iqdi99pd	1690	5	support	support	NN
cord-015365-iqdi99pd	1690	6	for	for	IN
cord-015365-iqdi99pd	1690	7	17	17	CD
cord-015365-iqdi99pd	1690	8	days	day	NNS
cord-015365-iqdi99pd	1690	9	.	.	.
cord-015365-iqdi99pd	1691	1	Treatment	treatment	NN
cord-015365-iqdi99pd	1691	2	included	include	VBD
cord-015365-iqdi99pd	1691	3	DXM	DXM	NNP
cord-015365-iqdi99pd	1691	4	10	10	CD
cord-015365-iqdi99pd	1692	1	mg	mg	NNP
cord-015365-iqdi99pd	1692	2	/	/	SYM
cord-015365-iqdi99pd	1692	3	m	m	NNP
cord-015365-iqdi99pd	1693	1	2	2	LS
cord-015365-iqdi99pd	1693	2	/d	/d	NN
cord-015365-iqdi99pd	1693	3	for	for	IN
cord-015365-iqdi99pd	1693	4	14	14	CD
cord-015365-iqdi99pd	1693	5	days	day	NNS
cord-015365-iqdi99pd	1694	1	,	,	,
cord-015365-iqdi99pd	1694	2	then	then	RB
cord-015365-iqdi99pd	1694	3	DXM	DXM	NNP
cord-015365-iqdi99pd	1694	4	was	be	VBD
cord-015365-iqdi99pd	1694	5	tapered	taper	VBN
cord-015365-iqdi99pd	1694	6	to	to	IN
cord-015365-iqdi99pd	1694	7	5	5	CD
cord-015365-iqdi99pd	1694	8	mg	mg	NNP
cord-015365-iqdi99pd	1694	9	/	/	SYM
cord-015365-iqdi99pd	1694	10	kg	kg	NNP
cord-015365-iqdi99pd	1694	11	/	/	SYM
cord-015365-iqdi99pd	1694	12	d	d	NN
cord-015365-iqdi99pd	1694	13	.	.	.
cord-015365-iqdi99pd	1695	1	Etoposide	Etoposide	NNP
cord-015365-iqdi99pd	1695	2	(	(	-LRB-
cord-015365-iqdi99pd	1695	3	150	150	CD
cord-015365-iqdi99pd	1695	4	mg	mg	NNP
cord-015365-iqdi99pd	1695	5	/	/	SYM
cord-015365-iqdi99pd	1695	6	kg	kg	NNP
cord-015365-iqdi99pd	1695	7	)	)	-RRB-
cord-015365-iqdi99pd	1695	8	was	be	VBD
cord-015365-iqdi99pd	1695	9	given	give	VBN
cord-015365-iqdi99pd	1695	10	three	three	CD
cord-015365-iqdi99pd	1695	11	times	time	NNS
cord-015365-iqdi99pd	1695	12	until	until	IN
cord-015365-iqdi99pd	1695	13	now	now	RB
cord-015365-iqdi99pd	1695	14	.	.	.
cord-015365-iqdi99pd	1696	1	Considering	consider	VBG
cord-015365-iqdi99pd	1696	2	the	the	DT
cord-015365-iqdi99pd	1696	3	long	long	JJ
cord-015365-iqdi99pd	1696	4	aplastic	aplastic	NN
cord-015365-iqdi99pd	1696	5	phase	phase	NN
cord-015365-iqdi99pd	1696	6	and	and	CC
cord-015365-iqdi99pd	1696	7	the	the	DT
cord-015365-iqdi99pd	1696	8	ongoing	ongoing	JJ
cord-015365-iqdi99pd	1696	9	hemophagocytosis	hemophagocytosis	NN
cord-015365-iqdi99pd	1696	10	we	-PRON-	PRP
cord-015365-iqdi99pd	1696	11	decided	decide	VBD
cord-015365-iqdi99pd	1696	12	to	to	TO
cord-015365-iqdi99pd	1696	13	give	give	VB
cord-015365-iqdi99pd	1696	14	him	-PRON-	PRP
cord-015365-iqdi99pd	1696	15	stem	stem	NN
cord-015365-iqdi99pd	1696	16	cell	cell	NN
cord-015365-iqdi99pd	1696	17	support	support	NN
cord-015365-iqdi99pd	1696	18	(	(	-LRB-
cord-015365-iqdi99pd	1696	19	remaining	remain	VBG
cord-015365-iqdi99pd	1696	20	frozen	frozen	JJ
cord-015365-iqdi99pd	1696	21	bone	bone	NN
cord-015365-iqdi99pd	1696	22	marrow	marrow	NN
cord-015365-iqdi99pd	1696	23	from	from	IN
cord-015365-iqdi99pd	1696	24	the	the	DT
cord-015365-iqdi99pd	1696	25	same	same	JJ
cord-015365-iqdi99pd	1696	26	donor	donor	NN
cord-015365-iqdi99pd	1696	27	)	)	-RRB-
cord-015365-iqdi99pd	1696	28	without	without	IN
cord-015365-iqdi99pd	1696	29	reconditioning	reconditioning	NN
cord-015365-iqdi99pd	1696	30	.	.	.
cord-015365-iqdi99pd	1697	1	Four	four	CD
cord-015365-iqdi99pd	1697	2	days	day	NNS
cord-015365-iqdi99pd	1697	3	later	later	RB
cord-015365-iqdi99pd	1697	4	we	-PRON-	PRP
cord-015365-iqdi99pd	1697	5	went	go	VBD
cord-015365-iqdi99pd	1697	6	on	on	RP
cord-015365-iqdi99pd	1697	7	with	with	IN
cord-015365-iqdi99pd	1697	8	a	a	DT
cord-015365-iqdi99pd	1697	9	monoclonal	monoclonal	JJ
cord-015365-iqdi99pd	1697	10	anti	anti	JJ
cord-015365-iqdi99pd	1697	11	-	-	JJ
cord-015365-iqdi99pd	1697	12	CD25	cd25	JJ
cord-015365-iqdi99pd	1697	13	antibody	antibody	NN
cord-015365-iqdi99pd	1697	14	(	(	-LRB-
cord-015365-iqdi99pd	1697	15	Simulect	Simulect	NNP
cord-015365-iqdi99pd	1697	16	+	+	CC
cord-015365-iqdi99pd	1697	17	)	)	-RRB-
cord-015365-iqdi99pd	1697	18	.	.	.
cord-015365-iqdi99pd	1698	1	The	the	DT
cord-015365-iqdi99pd	1698	2	boy	boy	NN
cord-015365-iqdi99pd	1698	3	improved	improve	VBD
cord-015365-iqdi99pd	1698	4	but	but	CC
cord-015365-iqdi99pd	1698	5	therapy	therapy	NN
cord-015365-iqdi99pd	1698	6	is	be	VBZ
cord-015365-iqdi99pd	1698	7	still	still	RB
cord-015365-iqdi99pd	1698	8	ongoing	ongoing	JJ
cord-015365-iqdi99pd	1698	9	.	.	.
cord-015365-iqdi99pd	1699	1	The	the	DT
cord-015365-iqdi99pd	1699	2	outcome	outcome	NN
cord-015365-iqdi99pd	1699	3	at	at	IN
cord-015365-iqdi99pd	1699	4	the	the	DT
cord-015365-iqdi99pd	1699	5	moment	moment	NN
cord-015365-iqdi99pd	1699	6	is	be	VBZ
cord-015365-iqdi99pd	1699	7	unclear	unclear	JJ
cord-015365-iqdi99pd	1699	8	.	.	.
cord-015365-iqdi99pd	1700	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1700	2	.	.	.
cord-015365-iqdi99pd	1701	1	HLH	HLH	NNP
cord-015365-iqdi99pd	1701	2	still	still	RB
cord-015365-iqdi99pd	1701	3	is	be	VBZ
cord-015365-iqdi99pd	1701	4	a	a	DT
cord-015365-iqdi99pd	1701	5	rarely	rarely	RB
cord-015365-iqdi99pd	1701	6	seen	see	VBN
cord-015365-iqdi99pd	1701	7	complication	complication	NN
cord-015365-iqdi99pd	1701	8	after	after	IN
cord-015365-iqdi99pd	1701	9	BMT	BMT	NNP
cord-015365-iqdi99pd	1701	10	,	,	,
cord-015365-iqdi99pd	1701	11	therefore	therefore	RB
cord-015365-iqdi99pd	1701	12	early	early	JJ
cord-015365-iqdi99pd	1701	13	diagnosis	diagnosis	NN
cord-015365-iqdi99pd	1701	14	is	be	VBZ
cord-015365-iqdi99pd	1701	15	necessary	necessary	JJ
cord-015365-iqdi99pd	1701	16	to	to	TO
cord-015365-iqdi99pd	1701	17	start	start	VB
cord-015365-iqdi99pd	1701	18	therapy	therapy	NN
cord-015365-iqdi99pd	1701	19	promptly	promptly	RB
cord-015365-iqdi99pd	1701	20	.	.	.
cord-015365-iqdi99pd	1702	1	The	the	DT
cord-015365-iqdi99pd	1702	2	role	role	NN
cord-015365-iqdi99pd	1702	3	of	of	IN
cord-015365-iqdi99pd	1702	4	monoclonal	monoclonal	JJ
cord-015365-iqdi99pd	1702	5	anti	anti	JJ
cord-015365-iqdi99pd	1702	6	-	-	JJ
cord-015365-iqdi99pd	1702	7	CD25	cd25	JJ
cord-015365-iqdi99pd	1702	8	antibody	antibody	NN
cord-015365-iqdi99pd	1702	9	and	and	CC
cord-015365-iqdi99pd	1702	10	anti	anti	NNP
cord-015365-iqdi99pd	1702	11	TNF	TNF	NNP
cord-015365-iqdi99pd	1702	12	-	-	HYPH
cord-015365-iqdi99pd	1702	13	antibody	antibody	NN
cord-015365-iqdi99pd	1702	14	as	as	IN
cord-015365-iqdi99pd	1702	15	part	part	NN
cord-015365-iqdi99pd	1702	16	of	of	IN
cord-015365-iqdi99pd	1702	17	therapy	therapy	NN
cord-015365-iqdi99pd	1702	18	is	be	VBZ
cord-015365-iqdi99pd	1702	19	unclear	unclear	JJ
cord-015365-iqdi99pd	1702	20	yet	yet	RB
cord-015365-iqdi99pd	1702	21	.	.	.
cord-015365-iqdi99pd	1703	1	Up	up	IN
cord-015365-iqdi99pd	1703	2	to	to	IN
cord-015365-iqdi99pd	1703	3	now	now	RB
cord-015365-iqdi99pd	1703	4	there	there	EX
cord-015365-iqdi99pd	1703	5	is	be	VBZ
cord-015365-iqdi99pd	1703	6	no	no	DT
cord-015365-iqdi99pd	1703	7	report	report	NN
cord-015365-iqdi99pd	1703	8	of	of	IN
cord-015365-iqdi99pd	1703	9	norovirus	norovirus	NN
cord-015365-iqdi99pd	1703	10	triggering	trigger	VBG
cord-015365-iqdi99pd	1703	11	HLH	HLH	NNP
cord-015365-iqdi99pd	1703	12	.	.	.
cord-015365-iqdi99pd	1704	1	Therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1704	2	effect	effect	NN
cord-015365-iqdi99pd	1704	3	of	of	IN
cord-015365-iqdi99pd	1704	4	allogeneic	allogeneic	NN
cord-015365-iqdi99pd	1704	5	bone	bone	NN
cord-015365-iqdi99pd	1704	6	marrow	marrow	NN
cord-015365-iqdi99pd	1704	7	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	1704	8	stem	stem	NN
cord-015365-iqdi99pd	1704	9	cell	cell	NN
cord-015365-iqdi99pd	1704	10	transplantation	transplantation	NN
cord-015365-iqdi99pd	1704	11	on	on	IN
cord-015365-iqdi99pd	1704	12	liver	liver	NN
cord-015365-iqdi99pd	1704	13	chronic	chronic	JJ
cord-015365-iqdi99pd	1704	14	damage	damage	NN
cord-015365-iqdi99pd	1704	15	in	in	IN
cord-015365-iqdi99pd	1704	16	rats	rat	NNS
cord-015365-iqdi99pd	1704	17	Methods	method	NNS
cord-015365-iqdi99pd	1704	18	.	.	.
cord-015365-iqdi99pd	1705	1	75	75	CD
cord-015365-iqdi99pd	1705	2	male	male	JJ
cord-015365-iqdi99pd	1705	3	rats	rat	NNS
cord-015365-iqdi99pd	1705	4	divided	divide	VBN
cord-015365-iqdi99pd	1705	5	in	in	IN
cord-015365-iqdi99pd	1705	6	3	3	CD
cord-015365-iqdi99pd	1705	7	groups	group	NNS
cord-015365-iqdi99pd	1705	8	in	in	IN
cord-015365-iqdi99pd	1705	9	which	which	WDT
cord-015365-iqdi99pd	1705	10	chronic	chronic	JJ
cord-015365-iqdi99pd	1705	11	hepatitis	hepatitis	NN
cord-015365-iqdi99pd	1705	12	was	be	VBD
cord-015365-iqdi99pd	1705	13	modeled	model	VBN
cord-015365-iqdi99pd	1705	14	by	by	IN
cord-015365-iqdi99pd	1705	15	means	mean	NNS
cord-015365-iqdi99pd	1705	16	of	of	IN
cord-015365-iqdi99pd	1705	17	CCL	CCL	NNP
cord-015365-iqdi99pd	1705	18	4	4	CD
cord-015365-iqdi99pd	1705	19	.	.	.
cord-015365-iqdi99pd	1706	1	1st	1st	NN
cord-015365-iqdi99pd	1707	1	(	(	-LRB-
cord-015365-iqdi99pd	1707	2	n	n	NN
cord-015365-iqdi99pd	1707	3	¼	¼	NNP
cord-015365-iqdi99pd	1707	4	25	25	CD
cord-015365-iqdi99pd	1707	5	)	)	-RRB-
cord-015365-iqdi99pd	1707	6	received	receive	VBD
cord-015365-iqdi99pd	1707	7	single	single	JJ
cord-015365-iqdi99pd	1707	8	transplantation	transplantation	NN
cord-015365-iqdi99pd	1707	9	of	of	IN
cord-015365-iqdi99pd	1707	10	2.5Â10	2.5â10	CD
cord-015365-iqdi99pd	1707	11	6	6	CD
cord-015365-iqdi99pd	1707	12	MSC	MSC	NNP
cord-015365-iqdi99pd	1707	13	on	on	IN
cord-015365-iqdi99pd	1707	14	3rd	3rd	JJ
cord-015365-iqdi99pd	1707	15	day	day	NN
cord-015365-iqdi99pd	1707	16	after	after	IN
cord-015365-iqdi99pd	1707	17	modelling	modelling	NN
cord-015365-iqdi99pd	1707	18	.	.	.
cord-015365-iqdi99pd	1708	1	In	in	IN
cord-015365-iqdi99pd	1708	2	2nd	2nd	JJ
cord-015365-iqdi99pd	1708	3	(	(	-LRB-
cord-015365-iqdi99pd	1708	4	n	n	NN
cord-015365-iqdi99pd	1708	5	¼	¼	NNP
cord-015365-iqdi99pd	1708	6	25	25	CD
cord-015365-iqdi99pd	1708	7	)	)	-RRB-
cord-015365-iqdi99pd	1708	8	MSC	MSC	NNP
cord-015365-iqdi99pd	1708	9	were	be	VBD
cord-015365-iqdi99pd	1708	10	injected	inject	VBN
cord-015365-iqdi99pd	1708	11	twice	twice	RB
cord-015365-iqdi99pd	1708	12	in	in	IN
cord-015365-iqdi99pd	1708	13	a	a	DT
cord-015365-iqdi99pd	1708	14	dose	dose	NN
cord-015365-iqdi99pd	1708	15	of	of	IN
cord-015365-iqdi99pd	1708	16	2.5Â10	2.5â10	CD
cord-015365-iqdi99pd	1708	17	6	6	CD
cord-015365-iqdi99pd	1708	18	cells	cell	NNS
cord-015365-iqdi99pd	1708	19	on	on	IN
cord-015365-iqdi99pd	1708	20	days	day	NNS
cord-015365-iqdi99pd	1708	21	3	3	CD
cord-015365-iqdi99pd	1708	22	and	and	CC
cord-015365-iqdi99pd	1708	23	10	10	CD
cord-015365-iqdi99pd	1708	24	after	after	IN
cord-015365-iqdi99pd	1708	25	modelling	modelling	NN
cord-015365-iqdi99pd	1708	26	.	.	.
cord-015365-iqdi99pd	1709	1	3rd	3rd	NNP
cord-015365-iqdi99pd	1709	2	group	group	NNP
cord-015365-iqdi99pd	1709	3	was	be	VBD
cord-015365-iqdi99pd	1709	4	control	control	NN
cord-015365-iqdi99pd	1709	5	group	group	NN
cord-015365-iqdi99pd	1709	6	(	(	-LRB-
cord-015365-iqdi99pd	1709	7	CG	CG	NNP
cord-015365-iqdi99pd	1709	8	,	,	,
cord-015365-iqdi99pd	1709	9	n	n	NN
cord-015365-iqdi99pd	1709	10	¼	¼	CD
cord-015365-iqdi99pd	1709	11	25	25	CD
cord-015365-iqdi99pd	1709	12	)	)	-RRB-
cord-015365-iqdi99pd	1709	13	.	.	.
cord-015365-iqdi99pd	1710	1	Biochemical	biochemical	JJ
cord-015365-iqdi99pd	1710	2	indices	index	NNS
cord-015365-iqdi99pd	1710	3	:	:	:
cord-015365-iqdi99pd	1710	4	ALT	ALT	NNP
cord-015365-iqdi99pd	1710	5	,	,	,
cord-015365-iqdi99pd	1710	6	AST	AST	NNP
cord-015365-iqdi99pd	1710	7	,	,	,
cord-015365-iqdi99pd	1710	8	ALP	ALP	NNP
cord-015365-iqdi99pd	1710	9	;	;	:
cord-015365-iqdi99pd	1710	10	cytokines	cytokine	NNS
cord-015365-iqdi99pd	1710	11	(	(	-LRB-
cord-015365-iqdi99pd	1710	12	IFN-	IFN-	NNP
cord-015365-iqdi99pd	1710	13	,	,	,
cord-015365-iqdi99pd	1710	14	TNF-	TNF-	NNP
cord-015365-iqdi99pd	1710	15	,	,	,
cord-015365-iqdi99pd	1710	16	IL-4	IL-4	NNP
cord-015365-iqdi99pd	1710	17	,	,	,
cord-015365-iqdi99pd	1710	18	IL-10	IL-10	NNP
cord-015365-iqdi99pd	1710	19	)	)	-RRB-
cord-015365-iqdi99pd	1710	20	were	be	VBD
cord-015365-iqdi99pd	1710	21	studied	study	VBN
cord-015365-iqdi99pd	1710	22	during	during	IN
cord-015365-iqdi99pd	1710	23	5	5	CD
cord-015365-iqdi99pd	1710	24	weeks	week	NNS
cord-015365-iqdi99pd	1710	25	.	.	.
cord-015365-iqdi99pd	1711	1	Liver	liver	NN
cord-015365-iqdi99pd	1711	2	histology	histology	NN
cord-015365-iqdi99pd	1711	3	were	be	VBD
cord-015365-iqdi99pd	1711	4	studied	study	VBN
cord-015365-iqdi99pd	1711	5	after	after	IN
cord-015365-iqdi99pd	1711	6	7	7	CD
cord-015365-iqdi99pd	1711	7	,	,	,
cord-015365-iqdi99pd	1711	8	14	14	CD
cord-015365-iqdi99pd	1711	9	,	,	,
cord-015365-iqdi99pd	1711	10	21	21	CD
cord-015365-iqdi99pd	1711	11	,	,	,
cord-015365-iqdi99pd	1711	12	28	28	CD
cord-015365-iqdi99pd	1711	13	,	,	,
cord-015365-iqdi99pd	1711	14	60	60	CD
cord-015365-iqdi99pd	1711	15	,	,	,
cord-015365-iqdi99pd	1711	16	90	90	CD
cord-015365-iqdi99pd	1711	17	days	day	NNS
cord-015365-iqdi99pd	1711	18	.	.	.
cord-015365-iqdi99pd	1712	1	Immunohistochemical	immunohistochemical	JJ
cord-015365-iqdi99pd	1712	2	methods	method	NNS
cord-015365-iqdi99pd	1712	3	:	:	:
cord-015365-iqdi99pd	1712	4	-SMA	-sma	ADD
cord-015365-iqdi99pd	1712	5	,	,	,
cord-015365-iqdi99pd	1712	6	caspase-3	caspase-3	NNP
cord-015365-iqdi99pd	1712	7	,	,	,
cord-015365-iqdi99pd	1712	8	AFP	AFP	NNP
cord-015365-iqdi99pd	1712	9	and	and	CC
cord-015365-iqdi99pd	1712	10	PCNA	PCNA	NNP
cord-015365-iqdi99pd	1712	11	were	be	VBD
cord-015365-iqdi99pd	1712	12	used	use	VBN
cord-015365-iqdi99pd	1712	13	.	.	.
cord-015365-iqdi99pd	1713	1	Results	result	NNS
cord-015365-iqdi99pd	1713	2	.	.	.
cord-015365-iqdi99pd	1714	1	At	at	IN
cord-015365-iqdi99pd	1714	2	the	the	DT
cord-015365-iqdi99pd	1714	3	1	1	CD
cord-015365-iqdi99pd	1714	4	-	-	SYM
cord-015365-iqdi99pd	1714	5	3	3	CD
cord-015365-iqdi99pd	1714	6	weeks	week	NNS
cord-015365-iqdi99pd	1714	7	the	the	DT
cord-015365-iqdi99pd	1714	8	AST	ast	NN
cord-015365-iqdi99pd	1714	9	,	,	,
cord-015365-iqdi99pd	1714	10	ALT	ALT	NNP
cord-015365-iqdi99pd	1714	11	and	and	CC
cord-015365-iqdi99pd	1714	12	ALP	ALP	NNP
cord-015365-iqdi99pd	1714	13	were	be	VBD
cord-015365-iqdi99pd	1714	14	increased	increase	VBN
cord-015365-iqdi99pd	1714	15	in	in	IN
cord-015365-iqdi99pd	1714	16	all	all	DT
cord-015365-iqdi99pd	1714	17	groups	group	NNS
cord-015365-iqdi99pd	1714	18	,	,	,
cord-015365-iqdi99pd	1714	19	but	but	CC
cord-015365-iqdi99pd	1714	20	in	in	IN
cord-015365-iqdi99pd	1714	21	the	the	DT
cord-015365-iqdi99pd	1714	22	CG	CG	NNP
cord-015365-iqdi99pd	1714	23	level	level	NN
cord-015365-iqdi99pd	1714	24	of	of	IN
cord-015365-iqdi99pd	1714	25	indices	index	NNS
cord-015365-iqdi99pd	1714	26	above	above	RB
cord-015365-iqdi99pd	1714	27	was	be	VBD
cord-015365-iqdi99pd	1714	28	higher	high	JJR
cord-015365-iqdi99pd	1714	29	.	.	.
cord-015365-iqdi99pd	1715	1	Analysis	analysis	NN
cord-015365-iqdi99pd	1715	2	of	of	IN
cord-015365-iqdi99pd	1715	3	morphologic	morphologic	JJ
cord-015365-iqdi99pd	1715	4	changes	change	NNS
cord-015365-iqdi99pd	1715	5	in	in	IN
cord-015365-iqdi99pd	1715	6	liver	liver	NN
cord-015365-iqdi99pd	1715	7	resulted	result	VBN
cord-015365-iqdi99pd	1715	8	in	in	IN
cord-015365-iqdi99pd	1715	9	following	follow	VBG
cord-015365-iqdi99pd	1715	10	findings	finding	NNS
cord-015365-iqdi99pd	1715	11	:	:	:
cord-015365-iqdi99pd	1715	12	on	on	IN
cord-015365-iqdi99pd	1715	13	7th	7th	JJ
cord-015365-iqdi99pd	1715	14	and	and	CC
cord-015365-iqdi99pd	1715	15	14th	14th	JJ
cord-015365-iqdi99pd	1715	16	day	day	NN
cord-015365-iqdi99pd	1715	17	liver	liver	NN
cord-015365-iqdi99pd	1715	18	fatty	fatty	JJ
cord-015365-iqdi99pd	1715	19	degeneration	degeneration	NN
cord-015365-iqdi99pd	1715	20	was	be	VBD
cord-015365-iqdi99pd	1715	21	in	in	IN
cord-015365-iqdi99pd	1715	22	all	all	DT
cord-015365-iqdi99pd	1715	23	groups	group	NNS
cord-015365-iqdi99pd	1715	24	,	,	,
cord-015365-iqdi99pd	1715	25	but	but	CC
cord-015365-iqdi99pd	1715	26	its	-PRON-	PRP$
cord-015365-iqdi99pd	1715	27	appearance	appearance	NN
cord-015365-iqdi99pd	1715	28	was	be	VBD
cord-015365-iqdi99pd	1715	29	stronger	strong	JJR
cord-015365-iqdi99pd	1715	30	in	in	IN
cord-015365-iqdi99pd	1715	31	the	the	DT
cord-015365-iqdi99pd	1715	32	1st	1st	NN
cord-015365-iqdi99pd	1715	33	and	and	CC
cord-015365-iqdi99pd	1715	34	especially	especially	RB
cord-015365-iqdi99pd	1715	35	in	in	IN
cord-015365-iqdi99pd	1715	36	CG	CG	NNP
cord-015365-iqdi99pd	1715	37	.	.	.
cord-015365-iqdi99pd	1716	1	In	in	IN
cord-015365-iqdi99pd	1716	2	60	60	CD
cord-015365-iqdi99pd	1716	3	and	and	CC
cord-015365-iqdi99pd	1716	4	90	90	CD
cord-015365-iqdi99pd	1716	5	days	day	NNS
cord-015365-iqdi99pd	1716	6	the	the	DT
cord-015365-iqdi99pd	1716	7	fibrosis	fibrosis	NN
cord-015365-iqdi99pd	1716	8	became	become	VBD
cord-015365-iqdi99pd	1716	9	more	more	RBR
cord-015365-iqdi99pd	1716	10	severe	severe	JJ
cord-015365-iqdi99pd	1716	11	in	in	IN
cord-015365-iqdi99pd	1716	12	CG	CG	NNP
cord-015365-iqdi99pd	1716	13	,	,	,
cord-015365-iqdi99pd	1716	14	but	but	CC
cord-015365-iqdi99pd	1716	15	after	after	IN
cord-015365-iqdi99pd	1716	16	MSC	MSC	NNP
cord-015365-iqdi99pd	1716	17	application	application	VBP
cord-015365-iqdi99pd	1716	18	a	a	DT
cord-015365-iqdi99pd	1716	19	resorption	resorption	NN
cord-015365-iqdi99pd	1716	20	of	of	IN
cord-015365-iqdi99pd	1716	21	fibrosis	fibrosis	NN
cord-015365-iqdi99pd	1716	22	occurred	occur	VBD
cord-015365-iqdi99pd	1716	23	(	(	-LRB-
cord-015365-iqdi99pd	1716	24	especially	especially	RB
cord-015365-iqdi99pd	1716	25	in	in	IN
cord-015365-iqdi99pd	1716	26	2nd	2nd	NN
cord-015365-iqdi99pd	1716	27	)	)	-RRB-
cord-015365-iqdi99pd	1716	28	.	.	.
cord-015365-iqdi99pd	1717	1	It	-PRON-	PRP
cord-015365-iqdi99pd	1717	2	is	be	VBZ
cord-015365-iqdi99pd	1717	3	important	important	JJ
cord-015365-iqdi99pd	1717	4	to	to	TO
cord-015365-iqdi99pd	1717	5	note	note	VB
cord-015365-iqdi99pd	1717	6	that	that	DT
cord-015365-iqdi99pd	1717	7	connective	connective	JJ
cord-015365-iqdi99pd	1717	8	tissue	tissue	NN
cord-015365-iqdi99pd	1717	9	forming	form	VBG
cord-015365-iqdi99pd	1717	10	in	in	IN
cord-015365-iqdi99pd	1717	11	liver	liver	NN
cord-015365-iqdi99pd	1717	12	after	after	IN
cord-015365-iqdi99pd	1717	13	MSC	MSC	NNP
cord-015365-iqdi99pd	1717	14	application	application	NN
cord-015365-iqdi99pd	1717	15	had	have	VBD
cord-015365-iqdi99pd	1717	16	two	two	CD
cord-015365-iqdi99pd	1717	17	-	-	HYPH
cord-015365-iqdi99pd	1717	18	phase	phase	NN
cord-015365-iqdi99pd	1717	19	dynamics	dynamic	NNS
cord-015365-iqdi99pd	1717	20	:	:	:
cord-015365-iqdi99pd	1717	21	at	at	IN
cord-015365-iqdi99pd	1717	22	first	first	RB
cord-015365-iqdi99pd	1717	23	an	an	DT
cord-015365-iqdi99pd	1717	24	area	area	NN
cord-015365-iqdi99pd	1717	25	of	of	IN
cord-015365-iqdi99pd	1717	26	connective	connective	JJ
cord-015365-iqdi99pd	1717	27	tissue	tissue	NN
cord-015365-iqdi99pd	1717	28	sharply	sharply	RB
cord-015365-iqdi99pd	1717	29	increased	increase	VBD
cord-015365-iqdi99pd	1717	30	and	and	CC
cord-015365-iqdi99pd	1717	31	then	then	RB
cord-015365-iqdi99pd	1717	32	gradually	gradually	RB
cord-015365-iqdi99pd	1717	33	decreased	decrease	VBD
cord-015365-iqdi99pd	1717	34	.	.	.
cord-015365-iqdi99pd	1718	1	It	-PRON-	PRP
cord-015365-iqdi99pd	1718	2	was	be	VBD
cord-015365-iqdi99pd	1718	3	found	find	VBN
cord-015365-iqdi99pd	1718	4	out	out	RP
cord-015365-iqdi99pd	1718	5	that	that	IN
cord-015365-iqdi99pd	1718	6	the	the	DT
cord-015365-iqdi99pd	1718	7	-SMA	-sma	NN
cord-015365-iqdi99pd	1718	8	and	and	CC
cord-015365-iqdi99pd	1718	9	caspase	caspase	NN
cord-015365-iqdi99pd	1718	10	3	3	CD
cord-015365-iqdi99pd	1718	11	expression	expression	NN
cord-015365-iqdi99pd	1718	12	after	after	IN
cord-015365-iqdi99pd	1718	13	MSC	MSC	NNP
cord-015365-iqdi99pd	1718	14	application	application	NN
cord-015365-iqdi99pd	1718	15	had	have	VBD
cord-015365-iqdi99pd	1718	16	also	also	RB
cord-015365-iqdi99pd	1718	17	two	two	CD
cord-015365-iqdi99pd	1718	18	-	-	HYPH
cord-015365-iqdi99pd	1718	19	phase	phase	NN
cord-015365-iqdi99pd	1718	20	dynamics	dynamic	NNS
cord-015365-iqdi99pd	1718	21	:	:	:
cord-015365-iqdi99pd	1718	22	at	at	IN
cord-015365-iqdi99pd	1718	23	1	1	CD
cord-015365-iqdi99pd	1718	24	-	-	SYM
cord-015365-iqdi99pd	1718	25	2	2	CD
cord-015365-iqdi99pd	1718	26	weeks	week	NNS
cord-015365-iqdi99pd	1718	27	these	these	DT
cord-015365-iqdi99pd	1718	28	indices	index	NNS
cord-015365-iqdi99pd	1718	29	were	be	VBD
cord-015365-iqdi99pd	1718	30	increased	increase	VBN
cord-015365-iqdi99pd	1718	31	and	and	CC
cord-015365-iqdi99pd	1718	32	then	then	RB
cord-015365-iqdi99pd	1718	33	(	(	-LRB-
cord-015365-iqdi99pd	1718	34	3	3	CD
cord-015365-iqdi99pd	1718	35	-	-	SYM
cord-015365-iqdi99pd	1718	36	4	4	CD
cord-015365-iqdi99pd	1718	37	weeks	week	NNS
cord-015365-iqdi99pd	1718	38	)	)	-RRB-
cord-015365-iqdi99pd	1718	39	began	begin	VBD
cord-015365-iqdi99pd	1718	40	to	to	TO
cord-015365-iqdi99pd	1718	41	decrease	decrease	VB
cord-015365-iqdi99pd	1718	42	,	,	,
cord-015365-iqdi99pd	1718	43	becoming	become	VBG
cord-015365-iqdi99pd	1718	44	lower	low	JJR
cord-015365-iqdi99pd	1718	45	than	than	IN
cord-015365-iqdi99pd	1718	46	in	in	IN
cord-015365-iqdi99pd	1718	47	CG	CG	NNP
cord-015365-iqdi99pd	1718	48	.	.	.
cord-015365-iqdi99pd	1719	1	At	at	IN
cord-015365-iqdi99pd	1719	2	first	first	JJ
cord-015365-iqdi99pd	1719	3	weeks	week	NNS
cord-015365-iqdi99pd	1719	4	cytokines	cytokine	NNS
cord-015365-iqdi99pd	1719	5	disbalance	disbalance	NN
cord-015365-iqdi99pd	1719	6	was	be	VBD
cord-015365-iqdi99pd	1719	7	identified	identify	VBN
cord-015365-iqdi99pd	1719	8	in	in	IN
cord-015365-iqdi99pd	1719	9	all	all	DT
cord-015365-iqdi99pd	1719	10	groups	group	NNS
cord-015365-iqdi99pd	1719	11	,	,	,
cord-015365-iqdi99pd	1719	12	but	but	CC
cord-015365-iqdi99pd	1719	13	in	in	IN
cord-015365-iqdi99pd	1719	14	MSC	MSC	NNP
cord-015365-iqdi99pd	1719	15	groups	group	NNS
cord-015365-iqdi99pd	1719	16	cytokines	cytokine	NNS
cord-015365-iqdi99pd	1719	17	disbalance	disbalance	NN
cord-015365-iqdi99pd	1719	18	was	be	VBD
cord-015365-iqdi99pd	1719	19	less	less	RBR
cord-015365-iqdi99pd	1719	20	expressed	express	VBN
cord-015365-iqdi99pd	1719	21	on	on	IN
cord-015365-iqdi99pd	1719	22	5th	5th	JJ
cord-015365-iqdi99pd	1719	23	week	week	NN
cord-015365-iqdi99pd	1719	24	.	.	.
cord-015365-iqdi99pd	1720	1	AFP	AFP	NNP
cord-015365-iqdi99pd	1720	2	and	and	CC
cord-015365-iqdi99pd	1720	3	PCNA	PCNA	NNP
cord-015365-iqdi99pd	1720	4	expression	expression	NN
cord-015365-iqdi99pd	1720	5	rates	rate	NNS
cord-015365-iqdi99pd	1720	6	were	be	VBD
cord-015365-iqdi99pd	1720	7	higher	high	JJR
cord-015365-iqdi99pd	1720	8	in	in	IN
cord-015365-iqdi99pd	1720	9	MSC	MSC	NNP
cord-015365-iqdi99pd	1720	10	groups	group	NNS
cord-015365-iqdi99pd	1720	11	,	,	,
cord-015365-iqdi99pd	1720	12	than	than	IN
cord-015365-iqdi99pd	1720	13	in	in	IN
cord-015365-iqdi99pd	1720	14	CG	CG	NNP
cord-015365-iqdi99pd	1720	15	up	up	RP
cord-015365-iqdi99pd	1720	16	to	to	IN
cord-015365-iqdi99pd	1720	17	end	end	NN
cord-015365-iqdi99pd	1720	18	of	of	IN
cord-015365-iqdi99pd	1720	19	examination	examination	NN
cord-015365-iqdi99pd	1720	20	.	.	.
cord-015365-iqdi99pd	1721	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1721	2	.	.	.
cord-015365-iqdi99pd	1722	1	MSCs	mscs	JJ
cord-015365-iqdi99pd	1722	2	transplantation	transplantation	NN
cord-015365-iqdi99pd	1722	3	for	for	IN
cord-015365-iqdi99pd	1722	4	therapy	therapy	NN
cord-015365-iqdi99pd	1722	5	of	of	IN
cord-015365-iqdi99pd	1722	6	liver	liver	NN
cord-015365-iqdi99pd	1722	7	damage	damage	NN
cord-015365-iqdi99pd	1722	8	can	can	MD
cord-015365-iqdi99pd	1722	9	reduce	reduce	VB
cord-015365-iqdi99pd	1722	10	liver	liver	NN
cord-015365-iqdi99pd	1722	11	fibrosis	fibrosis	NN
cord-015365-iqdi99pd	1722	12	,	,	,
cord-015365-iqdi99pd	1722	13	but	but	CC
cord-015365-iqdi99pd	1722	14	this	this	DT
cord-015365-iqdi99pd	1722	15	process	process	NN
cord-015365-iqdi99pd	1722	16	has	have	VBZ
cord-015365-iqdi99pd	1722	17	two	two	CD
cord-015365-iqdi99pd	1722	18	-	-	HYPH
cord-015365-iqdi99pd	1722	19	phase	phase	NN
cord-015365-iqdi99pd	1722	20	dynamics	dynamic	NNS
cord-015365-iqdi99pd	1722	21	(	(	-LRB-
cord-015365-iqdi99pd	1722	22	firstly	firstly	RB
cord-015365-iqdi99pd	1722	23	increasing	increase	VBG
cord-015365-iqdi99pd	1722	24	and	and	CC
cord-015365-iqdi99pd	1722	25	then	then	RB
cord-015365-iqdi99pd	1722	26	decreasing	decrease	VBG
cord-015365-iqdi99pd	1722	27	of	of	IN
cord-015365-iqdi99pd	1722	28	fibrosis	fibrosis	NN
cord-015365-iqdi99pd	1722	29	)	)	-RRB-
cord-015365-iqdi99pd	1722	30	which	which	WDT
cord-015365-iqdi99pd	1722	31	can	can	MD
cord-015365-iqdi99pd	1722	32	explain	explain	VB
cord-015365-iqdi99pd	1722	33	the	the	DT
cord-015365-iqdi99pd	1722	34	contradictory	contradictory	JJ
cord-015365-iqdi99pd	1722	35	information	information	NN
cord-015365-iqdi99pd	1722	36	on	on	IN
cord-015365-iqdi99pd	1722	37	the	the	DT
cord-015365-iqdi99pd	1722	38	cell	cell	NN
cord-015365-iqdi99pd	1722	39	therapy	therapy	NN
cord-015365-iqdi99pd	1722	40	of	of	IN
cord-015365-iqdi99pd	1722	41	chronic	chronic	JJ
cord-015365-iqdi99pd	1722	42	hepatitis	hepatitis	NNP
cord-015365-iqdi99pd	1722	43	.	.	.
cord-015365-iqdi99pd	1723	1	Background	background	NN
cord-015365-iqdi99pd	1723	2	.	.	.
cord-015365-iqdi99pd	1724	1	Treatment	treatment	NN
cord-015365-iqdi99pd	1724	2	of	of	IN
cord-015365-iqdi99pd	1724	3	chronic	chronic	JJ
cord-015365-iqdi99pd	1724	4	liver	liver	NN
cord-015365-iqdi99pd	1724	5	failure	failure	NN
cord-015365-iqdi99pd	1724	6	in	in	IN
cord-015365-iqdi99pd	1724	7	pretransplant	pretransplant	JJ
cord-015365-iqdi99pd	1724	8	period	period	NN
cord-015365-iqdi99pd	1724	9	is	be	VBZ
cord-015365-iqdi99pd	1724	10	an	an	DT
cord-015365-iqdi99pd	1724	11	actual	actual	JJ
cord-015365-iqdi99pd	1724	12	problem	problem	NN
cord-015365-iqdi99pd	1724	13	of	of	IN
cord-015365-iqdi99pd	1724	14	medicine	medicine	NN
cord-015365-iqdi99pd	1724	15	.	.	.
cord-015365-iqdi99pd	1725	1	This	this	DT
cord-015365-iqdi99pd	1725	2	investigation	investigation	NN
cord-015365-iqdi99pd	1725	3	was	be	VBD
cord-015365-iqdi99pd	1725	4	undertaken	undertake	VBN
cord-015365-iqdi99pd	1725	5	for	for	IN
cord-015365-iqdi99pd	1725	6	working	work	VBG
cord-015365-iqdi99pd	1725	7	out	out	IN
cord-015365-iqdi99pd	1725	8	of	of	IN
cord-015365-iqdi99pd	1725	9	biounit	biounit	NNP
cord-015365-iqdi99pd	1725	10	containing	contain	VBG
cord-015365-iqdi99pd	1725	11	viable	viable	JJ
cord-015365-iqdi99pd	1725	12	liver	liver	NN
cord-015365-iqdi99pd	1725	13	cell	cell	NN
cord-015365-iqdi99pd	1725	14	(	(	-LRB-
cord-015365-iqdi99pd	1725	15	LC	LC	NNP
cord-015365-iqdi99pd	1725	16	)	)	-RRB-
cord-015365-iqdi99pd	1725	17	and	and	CC
cord-015365-iqdi99pd	1725	18	multipotent	multipotent	JJ
cord-015365-iqdi99pd	1725	19	mesenchymal	mesenchymal	JJ
cord-015365-iqdi99pd	1725	20	stromal	stromal	NN
cord-015365-iqdi99pd	1725	21	cells	cell	NNS
cord-015365-iqdi99pd	1725	22	(	(	-LRB-
cord-015365-iqdi99pd	1725	23	MMSC	MMSC	NNP
cord-015365-iqdi99pd	1725	24	)	)	-RRB-
cord-015365-iqdi99pd	1725	25	,	,	,
cord-015365-iqdi99pd	1725	26	which	which	WDT
cord-015365-iqdi99pd	1725	27	could	could	MD
cord-015365-iqdi99pd	1725	28	support	support	VB
cord-015365-iqdi99pd	1725	29	the	the	DT
cord-015365-iqdi99pd	1725	30	functioning	function	VBG
cord-015365-iqdi99pd	1725	31	and	and	CC
cord-015365-iqdi99pd	1725	32	recovered	recover	VBD
cord-015365-iqdi99pd	1725	33	regeneration	regeneration	NN
cord-015365-iqdi99pd	1725	34	of	of	IN
cord-015365-iqdi99pd	1725	35	damaged	damaged	JJ
cord-015365-iqdi99pd	1725	36	liver	liver	NN
cord-015365-iqdi99pd	1725	37	for	for	IN
cord-015365-iqdi99pd	1725	38	a	a	DT
cord-015365-iqdi99pd	1725	39	long	long	JJ
cord-015365-iqdi99pd	1725	40	time	time	NN
cord-015365-iqdi99pd	1725	41	.	.	.
cord-015365-iqdi99pd	1726	1	Methods	method	NNS
cord-015365-iqdi99pd	1726	2	.	.	.
cord-015365-iqdi99pd	1727	1	Chronic	chronic	JJ
cord-015365-iqdi99pd	1727	2	liver	liver	NN
cord-015365-iqdi99pd	1727	3	damage	damage	NN
cord-015365-iqdi99pd	1727	4	was	be	VBD
cord-015365-iqdi99pd	1727	5	modeled	model	VBN
cord-015365-iqdi99pd	1727	6	on	on	IN
cord-015365-iqdi99pd	1727	7	Wistar	Wistar	NNP
cord-015365-iqdi99pd	1727	8	rats	rat	NNS
cord-015365-iqdi99pd	1727	9	by	by	IN
cord-015365-iqdi99pd	1727	10	means	mean	NNS
cord-015365-iqdi99pd	1727	11	of	of	IN
cord-015365-iqdi99pd	1727	12	0.3	0.3	CD
cord-015365-iqdi99pd	1727	13	ml	ml	NN
cord-015365-iqdi99pd	1727	14	CCl	CCl	NNS
cord-015365-iqdi99pd	1727	15	4	4	CD
cord-015365-iqdi99pd	1727	16	on	on	IN
cord-015365-iqdi99pd	1727	17	100	100	CD
cord-015365-iqdi99pd	1727	18	g	g	NN
cord-015365-iqdi99pd	1727	19	rat	rat	NN
cord-015365-iqdi99pd	1727	20	weights	weight	NNS
cord-015365-iqdi99pd	1727	21	within	within	IN
cord-015365-iqdi99pd	1727	22	6	6	CD
cord-015365-iqdi99pd	1727	23	weeks	week	NNS
cord-015365-iqdi99pd	1727	24	.	.	.
cord-015365-iqdi99pd	1728	1	Adult	Adult	NNP
cord-015365-iqdi99pd	1728	2	Wistar	Wistar	NNP
cord-015365-iqdi99pd	1728	3	rats	rat	NNS
cord-015365-iqdi99pd	1728	4	were	be	VBD
cord-015365-iqdi99pd	1728	5	also	also	RB
cord-015365-iqdi99pd	1728	6	used	use	VBN
cord-015365-iqdi99pd	1728	7	as	as	IN
cord-015365-iqdi99pd	1728	8	donor	donor	NN
cord-015365-iqdi99pd	1728	9	cells	cell	NNS
cord-015365-iqdi99pd	1728	10	.	.	.
cord-015365-iqdi99pd	1729	1	Isolated	isolated	JJ
cord-015365-iqdi99pd	1729	2	cells	cell	NNS
cord-015365-iqdi99pd	1729	3	were	be	VBD
cord-015365-iqdi99pd	1729	4	cultivated	cultivate	VBN
cord-015365-iqdi99pd	1729	5	in	in	IN
cord-015365-iqdi99pd	1729	6	10	10	CD
cord-015365-iqdi99pd	1729	7	days	day	NNS
cord-015365-iqdi99pd	1729	8	:	:	:
cord-015365-iqdi99pd	1729	9	at	at	IN
cord-015365-iqdi99pd	1729	10	first	first	JJ
cord-015365-iqdi99pd	1729	11	MMSC	MMSC	NNP
cord-015365-iqdi99pd	1729	12	during	during	IN
cord-015365-iqdi99pd	1729	13	7	7	CD
cord-015365-iqdi99pd	1729	14	days	day	NNS
cord-015365-iqdi99pd	1729	15	then	then	RB
cord-015365-iqdi99pd	1729	16	the	the	DT
cord-015365-iqdi99pd	1729	17	same	same	JJ
cord-015365-iqdi99pd	1729	18	MMSC	MMSC	NNP
cord-015365-iqdi99pd	1729	19	together	together	RB
cord-015365-iqdi99pd	1729	20	with	with	IN
cord-015365-iqdi99pd	1729	21	LC	LC	NNP
cord-015365-iqdi99pd	1729	22	in	in	IN
cord-015365-iqdi99pd	1729	23	3	3	CD
cord-015365-iqdi99pd	1729	24	days	day	NNS
cord-015365-iqdi99pd	1729	25	on	on	IN
cord-015365-iqdi99pd	1729	26	Cytodex	Cytodex	NNP
cord-015365-iqdi99pd	1729	27	.	.	.
cord-015365-iqdi99pd	1730	1	Suspension	suspension	NN
cord-015365-iqdi99pd	1730	2	of	of	IN
cord-015365-iqdi99pd	1730	3	LC	LC	NNP
cord-015365-iqdi99pd	1730	4	2.5	2.5	CD
cord-015365-iqdi99pd	1730	5	-	-	HYPH
cord-015365-iqdi99pd	1730	6	4.0Â10	4.0â10	CD
cord-015365-iqdi99pd	1730	7	6	6	CD
cord-015365-iqdi99pd	1730	8	cells	cell	NNS
cord-015365-iqdi99pd	1730	9	/	/	SYM
cord-015365-iqdi99pd	1730	10	cm	cm	NN
cord-015365-iqdi99pd	1730	11	3	3	CD
cord-015365-iqdi99pd	1730	12	and	and	CC
cord-015365-iqdi99pd	1730	13	MMSC	MMSC	NNP
cord-015365-iqdi99pd	1730	14	0.5	0.5	CD
cord-015365-iqdi99pd	1730	15	-	-	HYPH
cord-015365-iqdi99pd	1730	16	0.8Â10	0.8â10	CD
cord-015365-iqdi99pd	1730	17	6	6	CD
cord-015365-iqdi99pd	1730	18	cells/	cells/	CD
cord-015365-iqdi99pd	1730	19	cm	cm	NNP
cord-015365-iqdi99pd	1730	20	3	3	CD
cord-015365-iqdi99pd	1730	21	was	be	VBD
cord-015365-iqdi99pd	1730	22	applied	apply	VBN
cord-015365-iqdi99pd	1730	23	on	on	IN
cord-015365-iqdi99pd	1730	24	biodegradable	biodegradable	JJ
cord-015365-iqdi99pd	1730	25	matrixes	matrix	NNS
cord-015365-iqdi99pd	1730	26	"	"	``
cord-015365-iqdi99pd	1730	27	Sphero	Sphero	NNP
cord-015365-iqdi99pd	1730	28	+	+	SYM
cord-015365-iqdi99pd	1730	29	Gel	gel	NN
cord-015365-iqdi99pd	1730	30	"	"	''
cord-015365-iqdi99pd	1730	31	.	.	.
cord-015365-iqdi99pd	1731	1	Formed	form	VBN
cord-015365-iqdi99pd	1731	2	biounits	biounit	NNS
cord-015365-iqdi99pd	1731	3	were	be	VBD
cord-015365-iqdi99pd	1731	4	transplantated	transplantate	VBN
cord-015365-iqdi99pd	1731	5	into	into	IN
cord-015365-iqdi99pd	1731	6	rat	rat	NN
cord-015365-iqdi99pd	1731	7	liver	liver	NN
cord-015365-iqdi99pd	1731	8	.	.	.
cord-015365-iqdi99pd	1732	1	Survival	survival	NN
cord-015365-iqdi99pd	1732	2	of	of	IN
cord-015365-iqdi99pd	1732	3	transplanted	transplanted	JJ
cord-015365-iqdi99pd	1732	4	cells	cell	NNS
cord-015365-iqdi99pd	1732	5	and	and	CC
cord-015365-iqdi99pd	1732	6	liver	liver	NN
cord-015365-iqdi99pd	1732	7	morphology	morphology	NN
cord-015365-iqdi99pd	1732	8	were	be	VBD
cord-015365-iqdi99pd	1732	9	investigated	investigate	VBN
cord-015365-iqdi99pd	1732	10	in	in	IN
cord-015365-iqdi99pd	1732	11	365	365	CD
cord-015365-iqdi99pd	1732	12	days	day	NNS
cord-015365-iqdi99pd	1732	13	after	after	IN
cord-015365-iqdi99pd	1732	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	1732	15	by	by	IN
cord-015365-iqdi99pd	1732	16	using	use	VBG
cord-015365-iqdi99pd	1732	17	hematoxylin	hematoxylin	NNP
cord-015365-iqdi99pd	1732	18	and	and	CC
cord-015365-iqdi99pd	1732	19	eosin	eosin	NN
cord-015365-iqdi99pd	1732	20	staining	staining	NN
cord-015365-iqdi99pd	1732	21	,	,	,
cord-015365-iqdi99pd	1732	22	Masson	Masson	NNP
cord-015365-iqdi99pd	1732	23	's	's	POS
cord-015365-iqdi99pd	1732	24	trichrome	trichrome	JJ
cord-015365-iqdi99pd	1732	25	staining	staining	NN
cord-015365-iqdi99pd	1732	26	.	.	.
cord-015365-iqdi99pd	1733	1	Cell	cell	NN
cord-015365-iqdi99pd	1733	2	viability	viability	NN
cord-015365-iqdi99pd	1733	3	and	and	CC
cord-015365-iqdi99pd	1733	4	cellular	cellular	JJ
cord-015365-iqdi99pd	1733	5	phenotype	phenotype	NN
cord-015365-iqdi99pd	1733	6	were	be	VBD
cord-015365-iqdi99pd	1733	7	investigated	investigate	VBN
cord-015365-iqdi99pd	1733	8	by	by	IN
cord-015365-iqdi99pd	1733	9	trypan	trypan	NNP
cord-015365-iqdi99pd	1733	10	blue	blue	JJ
cord-015365-iqdi99pd	1733	11	staining	staining	NN
cord-015365-iqdi99pd	1733	12	and	and	CC
cord-015365-iqdi99pd	1733	13	immunohistochemically	immunohistochemically	NN
cord-015365-iqdi99pd	1733	14	(	(	-LRB-
cord-015365-iqdi99pd	1733	15	cytokeratine	cytokeratine	NNP
cord-015365-iqdi99pd	1733	16	18	18	CD
cord-015365-iqdi99pd	1733	17	and	and	CC
cord-015365-iqdi99pd	1733	18	mitochondrial	mitochondrial	JJ
cord-015365-iqdi99pd	1733	19	antigen	antigen	NN
cord-015365-iqdi99pd	1733	20	)	)	-RRB-
cord-015365-iqdi99pd	1733	21	.	.	.
cord-015365-iqdi99pd	1734	1	Results	result	NNS
cord-015365-iqdi99pd	1734	2	.	.	.
cord-015365-iqdi99pd	1735	1	Before	before	IN
cord-015365-iqdi99pd	1735	2	biounit	biounit	VBN
cord-015365-iqdi99pd	1735	3	transplantation	transplantation	NN
cord-015365-iqdi99pd	1735	4	liver	liver	NN
cord-015365-iqdi99pd	1735	5	damage	damage	NN
cord-015365-iqdi99pd	1735	6	was	be	VBD
cord-015365-iqdi99pd	1735	7	characterized	characterize	VBN
cord-015365-iqdi99pd	1735	8	by	by	IN
cord-015365-iqdi99pd	1735	9	:	:	:
cord-015365-iqdi99pd	1735	10	fatty	fatty	JJ
cord-015365-iqdi99pd	1735	11	,	,	,
cord-015365-iqdi99pd	1735	12	lymphoid	lymphoid	JJ
cord-015365-iqdi99pd	1735	13	-	-	HYPH
cord-015365-iqdi99pd	1735	14	cellular	cellular	JJ
cord-015365-iqdi99pd	1735	15	infiltration	infiltration	NN
cord-015365-iqdi99pd	1735	16	and	and	CC
cord-015365-iqdi99pd	1735	17	proliferation	proliferation	NN
cord-015365-iqdi99pd	1735	18	of	of	IN
cord-015365-iqdi99pd	1735	19	histioblasts	histioblast	NNS
cord-015365-iqdi99pd	1735	20	and	and	CC
cord-015365-iqdi99pd	1735	21	macrophages	macrophage	NNS
cord-015365-iqdi99pd	1735	22	;	;	:
cord-015365-iqdi99pd	1735	23	porto	porto	NNP
cord-015365-iqdi99pd	1735	24	-	-	HYPH
cord-015365-iqdi99pd	1735	25	portal	portal	JJ
cord-015365-iqdi99pd	1735	26	sclerosis	sclerosis	NN
cord-015365-iqdi99pd	1735	27	;	;	:
cord-015365-iqdi99pd	1735	28	hydropic	hydropic	NNP
cord-015365-iqdi99pd	1735	29	dystrophia	dystrophia	NNP
cord-015365-iqdi99pd	1735	30	and	and	CC
cord-015365-iqdi99pd	1735	31	focal	focal	JJ
cord-015365-iqdi99pd	1735	32	necrosis	necrosis	NN
cord-015365-iqdi99pd	1735	33	of	of	IN
cord-015365-iqdi99pd	1735	34	hepatocytes	hepatocyte	NNS
cord-015365-iqdi99pd	1735	35	.	.	.
cord-015365-iqdi99pd	1736	1	In	in	IN
cord-015365-iqdi99pd	1736	2	365	365	CD
cord-015365-iqdi99pd	1736	3	days	day	NNS
cord-015365-iqdi99pd	1736	4	after	after	IN
cord-015365-iqdi99pd	1736	5	biounit	biounit	NNP
cord-015365-iqdi99pd	1736	6	transplantation	transplantation	NN
cord-015365-iqdi99pd	1736	7	it	-PRON-	PRP
cord-015365-iqdi99pd	1736	8	was	be	VBD
cord-015365-iqdi99pd	1736	9	detected	detect	VBN
cord-015365-iqdi99pd	1736	10	:	:	:
cord-015365-iqdi99pd	1736	11	viable	viable	JJ
cord-015365-iqdi99pd	1736	12	hepatocytes	hepatocyte	NNS
cord-015365-iqdi99pd	1736	13	,	,	,
cord-015365-iqdi99pd	1736	14	neogenic	neogenic	NNP
cord-015365-iqdi99pd	1736	15	plethoric	plethoric	NNP
cord-015365-iqdi99pd	1736	16	vessels	vessel	NNS
cord-015365-iqdi99pd	1736	17	,	,	,
cord-015365-iqdi99pd	1736	18	neogenic	neogenic	NNP
cord-015365-iqdi99pd	1736	19	plethoric	plethoric	NNP
cord-015365-iqdi99pd	1736	20	bile	bile	NN
cord-015365-iqdi99pd	1736	21	duct	duct	NN
cord-015365-iqdi99pd	1736	22	in	in	IN
cord-015365-iqdi99pd	1736	23	biounit	biounit	NNP
cord-015365-iqdi99pd	1736	24	.	.	.
cord-015365-iqdi99pd	1737	1	Liver	liver	NN
cord-015365-iqdi99pd	1737	2	damage	damage	NN
cord-015365-iqdi99pd	1737	3	(	(	-LRB-
cord-015365-iqdi99pd	1737	4	dystrophia	dystrophia	NNP
cord-015365-iqdi99pd	1737	5	,	,	,
cord-015365-iqdi99pd	1737	6	safe	safe	JJ
cord-015365-iqdi99pd	1737	7	structure	structure	NN
cord-015365-iqdi99pd	1737	8	of	of	IN
cord-015365-iqdi99pd	1737	9	a	a	DT
cord-015365-iqdi99pd	1737	10	liver	liver	NN
cord-015365-iqdi99pd	1737	11	,	,	,
cord-015365-iqdi99pd	1737	12	beam	beam	NN
cord-015365-iqdi99pd	1737	13	structure	structure	NN
cord-015365-iqdi99pd	1737	14	,	,	,
cord-015365-iqdi99pd	1737	15	fatty	fatty	JJ
cord-015365-iqdi99pd	1737	16	vacuoles	vacuole	NNS
cord-015365-iqdi99pd	1737	17	inside	inside	IN
cord-015365-iqdi99pd	1737	18	hepatocytes	hepatocyte	NNS
cord-015365-iqdi99pd	1737	19	and	and	CC
cord-015365-iqdi99pd	1737	20	other	other	JJ
cord-015365-iqdi99pd	1737	21	indices	index	NNS
cord-015365-iqdi99pd	1737	22	)	)	-RRB-
cord-015365-iqdi99pd	1737	23	were	be	VBD
cord-015365-iqdi99pd	1737	24	significant	significant	JJ
cord-015365-iqdi99pd	1737	25	less	less	RBR
cord-015365-iqdi99pd	1737	26	after	after	IN
cord-015365-iqdi99pd	1737	27	biounit	biounit	VBN
cord-015365-iqdi99pd	1737	28	transplantation	transplantation	NN
cord-015365-iqdi99pd	1737	29	than	than	IN
cord-015365-iqdi99pd	1737	30	in	in	IN
cord-015365-iqdi99pd	1737	31	control	control	NN
cord-015365-iqdi99pd	1737	32	group	group	NN
cord-015365-iqdi99pd	1737	33	without	without	IN
cord-015365-iqdi99pd	1737	34	biounit	biounit	NNP
cord-015365-iqdi99pd	1737	35	transplantation	transplantation	NN
cord-015365-iqdi99pd	1737	36	.	.	.
cord-015365-iqdi99pd	1738	1	Restoration	restoration	NN
cord-015365-iqdi99pd	1738	2	of	of	IN
cord-015365-iqdi99pd	1738	3	hepatic	hepatic	JJ
cord-015365-iqdi99pd	1738	4	lobe	lobe	NN
cord-015365-iqdi99pd	1738	5	structure	structure	NN
cord-015365-iqdi99pd	1738	6	was	be	VBD
cord-015365-iqdi99pd	1738	7	better	well	JJR
cord-015365-iqdi99pd	1738	8	in	in	IN
cord-015365-iqdi99pd	1738	9	studied	study	VBN
cord-015365-iqdi99pd	1738	10	group	group	NN
cord-015365-iqdi99pd	1738	11	.	.	.
cord-015365-iqdi99pd	1739	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1739	2	.	.	.
cord-015365-iqdi99pd	1740	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	1740	2	preliminary	preliminary	JJ
cord-015365-iqdi99pd	1740	3	studies	study	NNS
cord-015365-iqdi99pd	1740	4	demonstrate	demonstrate	VBP
cord-015365-iqdi99pd	1740	5	that	that	IN
cord-015365-iqdi99pd	1740	6	in	in	IN
cord-015365-iqdi99pd	1740	7	biounit	biounit	VBN
cord-015365-iqdi99pd	1740	8	after	after	IN
cord-015365-iqdi99pd	1740	9	transplantation	transplantation	NN
cord-015365-iqdi99pd	1740	10	into	into	IN
cord-015365-iqdi99pd	1740	11	damage	damage	NN
cord-015365-iqdi99pd	1740	12	liver	liver	NN
cord-015365-iqdi99pd	1740	13	there	there	EX
cord-015365-iqdi99pd	1740	14	is	be	VBZ
cord-015365-iqdi99pd	1740	15	formation	formation	NN
cord-015365-iqdi99pd	1740	16	of	of	IN
cord-015365-iqdi99pd	1740	17	morphologic	morphologic	JJ
cord-015365-iqdi99pd	1740	18	structures	structure	NNS
cord-015365-iqdi99pd	1740	19	of	of	IN
cord-015365-iqdi99pd	1740	20	liver	liver	NN
cord-015365-iqdi99pd	1740	21	(	(	-LRB-
cord-015365-iqdi99pd	1740	22	viable	viable	JJ
cord-015365-iqdi99pd	1740	23	cell	cell	NN
cord-015365-iqdi99pd	1740	24	,	,	,
cord-015365-iqdi99pd	1740	25	vessels	vessel	NNS
cord-015365-iqdi99pd	1740	26	,	,	,
cord-015365-iqdi99pd	1740	27	bile	bile	NN
cord-015365-iqdi99pd	1740	28	ducts	duct	NNS
cord-015365-iqdi99pd	1740	29	)	)	-RRB-
cord-015365-iqdi99pd	1740	30	;	;	:
cord-015365-iqdi99pd	1740	31	other	other	JJ
cord-015365-iqdi99pd	1740	32	words	word	NNS
cord-015365-iqdi99pd	1740	33	the	the	DT
cord-015365-iqdi99pd	1740	34	used	use	VBN
cord-015365-iqdi99pd	1740	35	method	method	NN
cord-015365-iqdi99pd	1740	36	allows	allow	VBZ
cord-015365-iqdi99pd	1740	37	to	to	TO
cord-015365-iqdi99pd	1740	38	carry	carry	VB
cord-015365-iqdi99pd	1740	39	out	out	RP
cord-015365-iqdi99pd	1740	40	organotypic	organotypic	JJ
cord-015365-iqdi99pd	1740	41	liver	liver	NN
cord-015365-iqdi99pd	1740	42	remodeling	remodeling	NN
cord-015365-iqdi99pd	1740	43	into	into	IN
cord-015365-iqdi99pd	1740	44	biounit	biounit	NNP
cord-015365-iqdi99pd	1740	45	and	and	CC
cord-015365-iqdi99pd	1740	46	to	to	TO
cord-015365-iqdi99pd	1740	47	support	support	VB
cord-015365-iqdi99pd	1740	48	the	the	DT
cord-015365-iqdi99pd	1740	49	function	function	NN
cord-015365-iqdi99pd	1740	50	of	of	IN
cord-015365-iqdi99pd	1740	51	the	the	DT
cord-015365-iqdi99pd	1740	52	damaged	damage	VBN
cord-015365-iqdi99pd	1740	53	liver	liver	NN
cord-015365-iqdi99pd	1740	54	.	.	.
cord-015365-iqdi99pd	1741	1	Thereby	thereby	RB
cord-015365-iqdi99pd	1741	2	the	the	DT
cord-015365-iqdi99pd	1741	3	suggested	suggest	VBN
cord-015365-iqdi99pd	1741	4	method	method	NN
cord-015365-iqdi99pd	1741	5	is	be	VBZ
cord-015365-iqdi99pd	1741	6	a	a	DT
cord-015365-iqdi99pd	1741	7	perspective	perspective	NN
cord-015365-iqdi99pd	1741	8	one	one	NN
cord-015365-iqdi99pd	1741	9	and	and	CC
cord-015365-iqdi99pd	1741	10	can	can	MD
cord-015365-iqdi99pd	1741	11	be	be	VB
cord-015365-iqdi99pd	1741	12	used	use	VBN
cord-015365-iqdi99pd	1741	13	as	as	IN
cord-015365-iqdi99pd	1741	14	technology	technology	NN
cord-015365-iqdi99pd	1741	15	of	of	IN
cord-015365-iqdi99pd	1741	16	building	build	VBG
cord-015365-iqdi99pd	1741	17	intracorporeal	intracorporeal	NN
cord-015365-iqdi99pd	1741	18	biounit	biounit	VBN
cord-015365-iqdi99pd	1741	19	for	for	IN
cord-015365-iqdi99pd	1741	20	the	the	DT
cord-015365-iqdi99pd	1741	21	long	long	JJ
cord-015365-iqdi99pd	1741	22	-	-	HYPH
cord-015365-iqdi99pd	1741	23	term	term	NN
cord-015365-iqdi99pd	1741	24	auxiliary	auxiliary	JJ
cord-015365-iqdi99pd	1741	25	supporting	supporting	NN
cord-015365-iqdi99pd	1741	26	of	of	IN
cord-015365-iqdi99pd	1741	27	the	the	DT
cord-015365-iqdi99pd	1741	28	damaged	damage	VBN
cord-015365-iqdi99pd	1741	29	organs	organ	NNS
cord-015365-iqdi99pd	1741	30	.	.	.
cord-015365-iqdi99pd	1742	1	Liposomales	Liposomales	NNP
cord-015365-iqdi99pd	1742	2	Amphotericin	Amphotericin	NNP
cord-015365-iqdi99pd	1742	3	B	b	NN
cord-015365-iqdi99pd	1742	4	als	als	NN
cord-015365-iqdi99pd	1743	1	Prophylaxe	Prophylaxe	NNP
cord-015365-iqdi99pd	1743	2	invasiver	invasiver	NNP
cord-015365-iqdi99pd	1744	1	Pilzinfektionen	Pilzinfektionen	NNP
cord-015365-iqdi99pd	1744	2	nach	nach	NNP
cord-015365-iqdi99pd	1744	3	hämatopoietischer	hämatopoietischer	NNP
cord-015365-iqdi99pd	1744	4	Stammzelltransplantation	Stammzelltransplantation	NNP
cord-015365-iqdi99pd	1744	5	bei	bei	NNP
cord-015365-iqdi99pd	1744	6	pädiatrischen	pädiatrischen	NNP
cord-015365-iqdi99pd	1744	7	und	und	RB
cord-015365-iqdi99pd	1744	8	adoleszenten	adoleszenten	NNP
cord-015365-iqdi99pd	1745	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1745	2	photericin	photericin	NNS
cord-015365-iqdi99pd	1746	1	B	B	NNP
cord-015365-iqdi99pd	1746	2	(	(	-LRB-
cord-015365-iqdi99pd	1746	3	LAMB	LAMB	NNP
cord-015365-iqdi99pd	1746	4	)	)	-RRB-
cord-015365-iqdi99pd	1747	1	sind	sind	NNP
cord-015365-iqdi99pd	1748	1	ein	ein	NNP
cord-015365-iqdi99pd	1748	2	breites	breites	NNP
cord-015365-iqdi99pd	1748	3	antifungales	antifungales	NNP
cord-015365-iqdi99pd	1748	4	Spektrum	Spektrum	NNP
cord-015365-iqdi99pd	1748	5	,	,	,
cord-015365-iqdi99pd	1748	6	eine	eine	NNP
cord-015365-iqdi99pd	1748	7	lange	lange	NNP
cord-015365-iqdi99pd	1748	8	Eliminations	Eliminations	NNPS
cord-015365-iqdi99pd	1748	9	-	-	HYPH
cord-015365-iqdi99pd	1748	10	Halbwertszeit	Halbwertszeit	NNP
cord-015365-iqdi99pd	1748	11	,	,	,
cord-015365-iqdi99pd	1748	12	und	und	IN
cord-015365-iqdi99pd	1748	13	i	-PRON-	PRP
cord-015365-iqdi99pd	1748	14	m	be	VBP
cord-015365-iqdi99pd	1748	15	Vergleich	Vergleich	NNP
cord-015365-iqdi99pd	1748	16	zu	zu	NNP
cord-015365-iqdi99pd	1748	17	den	den	NNP
cord-015365-iqdi99pd	1748	18	neuen	neuen	NNP
cord-015365-iqdi99pd	1748	19	Azolen	Azolen	NNP
cord-015365-iqdi99pd	1748	20	weniger	weniger	NNP
cord-015365-iqdi99pd	1748	21	Medikamenten	Medikamenten	NNP
cord-015365-iqdi99pd	1748	22	-	-	HYPH
cord-015365-iqdi99pd	1748	23	Interaktionen	Interaktionen	NNP
cord-015365-iqdi99pd	1748	24	.	.	.
cord-015365-iqdi99pd	1749	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	1749	2	.	.	.
cord-015365-iqdi99pd	1750	1	I	-PRON-	PRP
cord-015365-iqdi99pd	1750	2	m	be	VBP
cord-015365-iqdi99pd	1750	3	Zeitraum	Zeitraum	NNP
cord-015365-iqdi99pd	1750	4	2009	2009	CD
cord-015365-iqdi99pd	1750	5	-	-	SYM
cord-015365-iqdi99pd	1750	6	2010	2010	CD
cord-015365-iqdi99pd	1750	7	wurden	wurden	NNS
cord-015365-iqdi99pd	1750	8	bei	bei	NNP
cord-015365-iqdi99pd	1750	9	20	20	CD
cord-015365-iqdi99pd	1751	1	konsekutiven	konsekutiven	NNP
cord-015365-iqdi99pd	1751	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1752	1	(	(	-LRB-
cord-015365-iqdi99pd	1752	2	medianes	medianes	NNP
cord-015365-iqdi99pd	1752	3	Alter	Alter	NNP
cord-015365-iqdi99pd	1752	4	:	:	:
cord-015365-iqdi99pd	1752	5	11,4	11,4	CD
cord-015365-iqdi99pd	1752	6	Jahre	Jahre	NNP
cord-015365-iqdi99pd	1752	7	;	;	:
cord-015365-iqdi99pd	1753	1	m	m	NNP
cord-015365-iqdi99pd	1753	2	:	:	:
cord-015365-iqdi99pd	1753	3	w	w	NNP
cord-015365-iqdi99pd	1753	4	¼	¼	NNP
cord-015365-iqdi99pd	1753	5	8:12	8:12	CD
cord-015365-iqdi99pd	1753	6	)	)	-RRB-
cord-015365-iqdi99pd	1753	7	insgesamt	insgesamt	NNP
cord-015365-iqdi99pd	1753	8	23	23	CD
cord-015365-iqdi99pd	1753	9	HSZT	HSZT	NNP
cord-015365-iqdi99pd	1753	10	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	1753	11	:	:	:
cord-015365-iqdi99pd	1753	12	12	12	CD
cord-015365-iqdi99pd	1753	13	autologe	autologe	NNP
cord-015365-iqdi99pd	1753	14	(	(	-LRB-
cord-015365-iqdi99pd	1753	15	davon	davon	NNP
cord-015365-iqdi99pd	1753	16	3	3	CD
cord-015365-iqdi99pd	1754	1	Tandem	Tandem	NNP
cord-015365-iqdi99pd	1754	2	-	-	HYPH
cord-015365-iqdi99pd	1754	3	Transplantationen	Transplantationen	NNP
cord-015365-iqdi99pd	1754	4	)	)	-RRB-
cord-015365-iqdi99pd	1754	5	und	und	VBD
cord-015365-iqdi99pd	1754	6	11	11	CD
cord-015365-iqdi99pd	1754	7	allogene	allogene	NN
cord-015365-iqdi99pd	1754	8	SZT	SZT	NNP
cord-015365-iqdi99pd	1754	9	,	,	,
cord-015365-iqdi99pd	1754	10	wegen	wegen	NNP
cord-015365-iqdi99pd	1754	11	soliden	soliden	NNP
cord-015365-iqdi99pd	1754	12	Tumoren	Tumoren	NNP
cord-015365-iqdi99pd	1754	13	(	(	-LRB-
cord-015365-iqdi99pd	1754	14	n	n	NNP
cord-015365-iqdi99pd	1754	15	¼	¼	NNP
cord-015365-iqdi99pd	1754	16	7	7	CD
cord-015365-iqdi99pd	1754	17	)	)	-RRB-
cord-015365-iqdi99pd	1754	18	,	,	,
cord-015365-iqdi99pd	1754	19	rezidivierter	rezidivierter	NNP
cord-015365-iqdi99pd	1754	20	schwerer	schwerer	NNP
cord-015365-iqdi99pd	1754	21	aplastischer	aplastischer	NNP
cord-015365-iqdi99pd	1754	22	Anämie	Anämie	NNP
cord-015365-iqdi99pd	1754	23	(	(	-LRB-
cord-015365-iqdi99pd	1754	24	n	n	NNP
cord-015365-iqdi99pd	1754	25	¼	¼	NNP
cord-015365-iqdi99pd	1754	26	5	5	CD
cord-015365-iqdi99pd	1754	27	)	)	-RRB-
cord-015365-iqdi99pd	1754	28	,	,	.
cord-015365-iqdi99pd	1755	1	malignen	malignen	NNP
cord-015365-iqdi99pd	1755	2	hämatologischen	hämatologischen	NNP
cord-015365-iqdi99pd	1755	3	Erkrankungen	Erkrankungen	NNP
cord-015365-iqdi99pd	1755	4	(	(	-LRB-
cord-015365-iqdi99pd	1755	5	n	n	NN
cord-015365-iqdi99pd	1755	6	¼	¼	NNP
cord-015365-iqdi99pd	1755	7	5	5	CD
cord-015365-iqdi99pd	1755	8	)	)	-RRB-
cord-015365-iqdi99pd	1755	9	,	,	.
cord-015365-iqdi99pd	1756	1	Mb	Mb	NNP
cord-015365-iqdi99pd	1756	2	.	.	.
cord-015365-iqdi99pd	1757	1	Hurler	Hurler	NNP
cord-015365-iqdi99pd	1757	2	(	(	-LRB-
cord-015365-iqdi99pd	1757	3	n	n	NN
cord-015365-iqdi99pd	1757	4	¼	¼	NNP
cord-015365-iqdi99pd	1757	5	2	2	CD
cord-015365-iqdi99pd	1757	6	)	)	-RRB-
cord-015365-iqdi99pd	1757	7	bzw	bzw	NNP
cord-015365-iqdi99pd	1757	8	.	.	.
cord-015365-iqdi99pd	1758	1	Mb	Mb	NNP
cord-015365-iqdi99pd	1758	2	Crohn	Crohn	NNP
cord-015365-iqdi99pd	1758	3	(	(	-LRB-
cord-015365-iqdi99pd	1758	4	n	n	NNP
cord-015365-iqdi99pd	1758	5	¼	¼	NNP
cord-015365-iqdi99pd	1758	6	1	1	CD
cord-015365-iqdi99pd	1758	7	)	)	-RRB-
cord-015365-iqdi99pd	1758	8	.	.	.
cord-015365-iqdi99pd	1759	1	Autolog	Autolog	NNP
cord-015365-iqdi99pd	1759	2	transplantierte	transplantierte	NNP
cord-015365-iqdi99pd	1760	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1760	2	erhielten	erhielten	NNP
cord-015365-iqdi99pd	1761	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1761	2	m	be	VBP
cord-015365-iqdi99pd	1761	3	Median	Median	NNP
cord-015365-iqdi99pd	1761	4	7,46Â10	7,46â10	CD
cord-015365-iqdi99pd	1761	5	6	6	CD
cord-015365-iqdi99pd	1762	1	/kg	/kg	.
cord-015365-iqdi99pd	1763	1	CD34þ	CD34þ	NNP
cord-015365-iqdi99pd	1763	2	Zellen	Zellen	NNP
cord-015365-iqdi99pd	1763	3	/	/	,
cord-015365-iqdi99pd	1763	4	kg	kg	NNP
cord-015365-iqdi99pd	1764	1	und	und	NNP
cord-015365-iqdi99pd	1764	2	erreichten	erreichten	NNP
cord-015365-iqdi99pd	1764	3	am	be	VBP
cord-015365-iqdi99pd	1765	1	Median	median	JJ
cord-015365-iqdi99pd	1765	2	Tag	tag	NN
cord-015365-iqdi99pd	1765	3	þ	þ	NNP
cord-015365-iqdi99pd	1766	1	9,5	9,5	NNP
cord-015365-iqdi99pd	1766	2	das	das	NNP
cord-015365-iqdi99pd	1766	3	leukozytäre	leukozytäre	NNP
cord-015365-iqdi99pd	1766	4	Engraftment	Engraftment	NNP
cord-015365-iqdi99pd	1766	5	.	.	.
cord-015365-iqdi99pd	1767	1	Allogene	Allogene	NNP
cord-015365-iqdi99pd	1767	2	Stammzellquellen	Stammzellquellen	NNP
cord-015365-iqdi99pd	1767	3	waren	waren	NNP
cord-015365-iqdi99pd	1768	1	periphere	periphere	NNP
cord-015365-iqdi99pd	1768	2	Stammzellen	Stammzellen	NNP
cord-015365-iqdi99pd	1768	3	(	(	-LRB-
cord-015365-iqdi99pd	1768	4	CD34þ	CD34þ	VBN
cord-015365-iqdi99pd	1768	5	selektioniert	selektioniert	VB
cord-015365-iqdi99pd	1769	1	und	und	NNP
cord-015365-iqdi99pd	1769	2	/	/	SYM
cord-015365-iqdi99pd	1769	3	oder	oder	NNP
cord-015365-iqdi99pd	1769	4	CD3/19	CD3/19	NNP
cord-015365-iqdi99pd	1769	5	depletiert	depletiert	NNP
cord-015365-iqdi99pd	1769	6	)	)	-RRB-
cord-015365-iqdi99pd	1769	7	in	in	IN
cord-015365-iqdi99pd	1769	8	9	9	CD
cord-015365-iqdi99pd	1769	9	und	und	IN
cord-015365-iqdi99pd	1769	10	Knochenmark	Knochenmark	NNP
cord-015365-iqdi99pd	1769	11	in	in	IN
cord-015365-iqdi99pd	1769	12	2	2	CD
cord-015365-iqdi99pd	1769	13	Fällen	Fällen	NNP
cord-015365-iqdi99pd	1770	1	;	;	:
cord-015365-iqdi99pd	1770	2	Spender	Spender	NNP
cord-015365-iqdi99pd	1770	3	waren	waren	NNP
cord-015365-iqdi99pd	1770	4	HLA	HLA	NNP
cord-015365-iqdi99pd	1770	5	-	-	HYPH
cord-015365-iqdi99pd	1770	6	idente	idente	NNP
cord-015365-iqdi99pd	1771	1	Fremd-(n	Fremd-(n	NNP
cord-015365-iqdi99pd	1771	2	¼	¼	NNP
cord-015365-iqdi99pd	1771	3	9	9	CD
cord-015365-iqdi99pd	1771	4	)	)	-RRB-
cord-015365-iqdi99pd	1771	5	bzw	bzw	NNP
cord-015365-iqdi99pd	1771	6	.	.	.
cord-015365-iqdi99pd	1772	1	Geschwisterspender	Geschwisterspender	NNP
cord-015365-iqdi99pd	1772	2	(	(	-LRB-
cord-015365-iqdi99pd	1772	3	n	n	NN
cord-015365-iqdi99pd	1772	4	¼	¼	NNP
cord-015365-iqdi99pd	1772	5	1	1	CD
cord-015365-iqdi99pd	1772	6	)	)	-RRB-
cord-015365-iqdi99pd	1772	7	und	und	RB
cord-015365-iqdi99pd	1773	1	ein	ein	NNP
cord-015365-iqdi99pd	1773	2	haploidenter	haploidenter	NNP
cord-015365-iqdi99pd	1773	3	Elternteil	Elternteil	NNP
cord-015365-iqdi99pd	1773	4	.	.	.
cord-015365-iqdi99pd	1774	1	Die	die	VB
cord-015365-iqdi99pd	1774	2	mediane	mediane	NNP
cord-015365-iqdi99pd	1774	3	Stammzellzahl	Stammzellzahl	NNP
cord-015365-iqdi99pd	1774	4	lag	lag	VBP
cord-015365-iqdi99pd	1774	5	bei	bei	NNP
cord-015365-iqdi99pd	1774	6	15,37Â10	15,37â10	CD
cord-015365-iqdi99pd	1774	7	6	6	CD
cord-015365-iqdi99pd	1774	8	CD34þZellen	CD34þZellen	NNP
cord-015365-iqdi99pd	1774	9	/	/	SYM
cord-015365-iqdi99pd	1774	10	kg	kg	NN
cord-015365-iqdi99pd	1774	11	;	;	:
cord-015365-iqdi99pd	1775	1	das	das	NNP
cord-015365-iqdi99pd	1775	2	leukozytäre	leukozytäre	NNP
cord-015365-iqdi99pd	1775	3	Engraftment	Engraftment	NNP
cord-015365-iqdi99pd	1775	4	erfolgte	erfolgte	NN
cord-015365-iqdi99pd	1776	1	i	i	PRP
cord-015365-iqdi99pd	1777	1	m	m	NNP
cord-015365-iqdi99pd	1777	2	Median	Median	NNP
cord-015365-iqdi99pd	1777	3	am	be	VBP
cord-015365-iqdi99pd	1777	4	Tag	tag	NN
cord-015365-iqdi99pd	1777	5	þ	þ	NNP
cord-015365-iqdi99pd	1777	6	11	11	CD
cord-015365-iqdi99pd	1777	7	.	.	.
cord-015365-iqdi99pd	1778	1	Bei	Bei	NNP
cord-015365-iqdi99pd	1778	2	5	5	CD
cord-015365-iqdi99pd	1779	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1779	2	trat	trat	NNP
cord-015365-iqdi99pd	1779	3	eine	eine	NNP
cord-015365-iqdi99pd	1779	4	Graft	graft	NN
cord-015365-iqdi99pd	1779	5	-	-	HYPH
cord-015365-iqdi99pd	1779	6	versus	versus	IN
cord-015365-iqdi99pd	1779	7	-	-	HYPH
cord-015365-iqdi99pd	1779	8	host	host	NN
cord-015365-iqdi99pd	1779	9	-	-	:
cord-015365-iqdi99pd	1779	10	Erkrankung	Erkrankung	NNP
cord-015365-iqdi99pd	1779	11	(	(	-LRB-
cord-015365-iqdi99pd	1779	12	GVH	GVH	NNP
cord-015365-iqdi99pd	1779	13	)	)	-RRB-
cord-015365-iqdi99pd	1779	14	auf	auf	NNP
cord-015365-iqdi99pd	1779	15	,	,	,
cord-015365-iqdi99pd	1779	16	davon	davon	NNP
cord-015365-iqdi99pd	1779	17	einmal	einmal	NNP
cord-015365-iqdi99pd	1779	18	eine	eine	NNP
cord-015365-iqdi99pd	1779	19	GVH	GVH	NNP
cord-015365-iqdi99pd	1779	20	IV	IV	NNP
cord-015365-iqdi99pd	1779	21	.	.	.
cord-015365-iqdi99pd	1780	1	Die	die	VB
cord-015365-iqdi99pd	1780	2	LAMB	LAMB	NNP
cord-015365-iqdi99pd	1780	3	-	-	HYPH
cord-015365-iqdi99pd	1780	4	Prophylaxe	Prophylaxe	VBN
cord-015365-iqdi99pd	1780	5	wurde	wurde	NN
cord-015365-iqdi99pd	1780	6	in	in	IN
cord-015365-iqdi99pd	1780	7	einer	einer	NNP
cord-015365-iqdi99pd	1780	8	Dosis	Dosis	NNP
cord-015365-iqdi99pd	1780	9	von	von	NNP
cord-015365-iqdi99pd	1780	10	5	5	CD
cord-015365-iqdi99pd	1780	11	mg	mg	NNP
cord-015365-iqdi99pd	1780	12	/	/	SYM
cord-015365-iqdi99pd	1780	13	kg	kg	NNP
cord-015365-iqdi99pd	1780	14	in	in	IN
cord-015365-iqdi99pd	1780	15	3-tägigen	3-tägigen	CD
cord-015365-iqdi99pd	1780	16	(	(	-LRB-
cord-015365-iqdi99pd	1780	17	n	n	NN
cord-015365-iqdi99pd	1780	18	¼	¼	NNP
cord-015365-iqdi99pd	1780	19	15	15	CD
cord-015365-iqdi99pd	1780	20	)	)	-RRB-
cord-015365-iqdi99pd	1781	1	oder	oder	NNP
cord-015365-iqdi99pd	1782	1	2-tägigen	2-tägigen	NNP
cord-015365-iqdi99pd	1782	2	(	(	-LRB-
cord-015365-iqdi99pd	1782	3	n	n	CC
cord-015365-iqdi99pd	1782	4	¼	¼	NNP
cord-015365-iqdi99pd	1782	5	8)	8)	NNP
cord-015365-iqdi99pd	1782	6	Intervallen	Intervallen	NNP
cord-015365-iqdi99pd	1782	7	gestartet	gestartet	NNP
cord-015365-iqdi99pd	1782	8	,	,	,
cord-015365-iqdi99pd	1782	9	bei	bei	NNP
cord-015365-iqdi99pd	1782	10	2	2	CD
cord-015365-iqdi99pd	1782	11	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1782	12	mit	mit	NNP
cord-015365-iqdi99pd	1782	13	refraktärer	refraktärer	NN
cord-015365-iqdi99pd	1782	14	AML	AML	NNP
cord-015365-iqdi99pd	1782	15	am	be	VBP
cord-015365-iqdi99pd	1782	16	Tag	Tag	NNP
cord-015365-iqdi99pd	1782	17	À46	à46	JJ
cord-015365-iqdi99pd	1782	18	bzw	bzw	NN
cord-015365-iqdi99pd	1782	19	.	.	.
cord-015365-iqdi99pd	1783	1	À42	À42	NNP
cord-015365-iqdi99pd	1783	2	,	,	,
cord-015365-iqdi99pd	1783	3	bei	bei	NNP
cord-015365-iqdi99pd	1783	4	allen	allen	NNP
cord-015365-iqdi99pd	1783	5	anderen	anderen	NNP
cord-015365-iqdi99pd	1783	6	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1784	1	i	i	PRP
cord-015365-iqdi99pd	1785	1	m	m	NNP
cord-015365-iqdi99pd	1785	2	Median	Median	NNP
cord-015365-iqdi99pd	1785	3	am	am	NN
cord-015365-iqdi99pd	1785	4	Tag	Tag	NNP
cord-015365-iqdi99pd	1785	5	À3	à3	CD
cord-015365-iqdi99pd	1785	6	.	.	.
cord-015365-iqdi99pd	1786	1	Die	die	VB
cord-015365-iqdi99pd	1787	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1787	2	erhielten	erhielten	NNP
cord-015365-iqdi99pd	1788	1	i	-PRON-	PRP
cord-015365-iqdi99pd	1788	2	m	be	VBP
cord-015365-iqdi99pd	1788	3	Median	Median	NNP
cord-015365-iqdi99pd	1788	4	11	11	CD
cord-015365-iqdi99pd	1788	5	,	,	,
cord-015365-iqdi99pd	1788	6	prophylaktische	prophylaktische	NN
cord-015365-iqdi99pd	1788	7	Dosen	Dosen	NNP
cord-015365-iqdi99pd	1788	8	bis	bis	NNP
cord-015365-iqdi99pd	1788	9	zu	zu	XX
cord-015365-iqdi99pd	1789	1	Median	median	JJ
cord-015365-iqdi99pd	1789	2	Tag	tag	NN
cord-015365-iqdi99pd	1789	3	þ20,5	þ20,5	NNP
cord-015365-iqdi99pd	1789	4	(	(	-LRB-
cord-015365-iqdi99pd	1789	5	þ11	þ11	DT
cord-015365-iqdi99pd	1789	6	bis	bis	NN
cord-015365-iqdi99pd	1789	7	þ43	þ43	NN
cord-015365-iqdi99pd	1789	8	)	)	-RRB-
cord-015365-iqdi99pd	1789	9	.	.	.
cord-015365-iqdi99pd	1790	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	1790	2	.	.	.
cord-015365-iqdi99pd	1791	1	Bei	Bei	NNP
cord-015365-iqdi99pd	1791	2	8	8	CD
cord-015365-iqdi99pd	1791	3	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1791	4	wurden	wurden	VBD
cord-015365-iqdi99pd	1791	5	wegen	wegen	NNP
cord-015365-iqdi99pd	1791	6	Fieber	Fieber	NNP
cord-015365-iqdi99pd	1792	1	oder	oder	NNP
cord-015365-iqdi99pd	1792	2	CRP	CRP	NNP
cord-015365-iqdi99pd	1792	3	-	-	HYPH
cord-015365-iqdi99pd	1792	4	Anstieg	Anstieg	NNP
cord-015365-iqdi99pd	1792	5	die	die	VBP
cord-015365-iqdi99pd	1792	6	Infusionsintervalle	Infusionsintervalle	NNP
cord-015365-iqdi99pd	1792	7	verkürzt	verkürzt	NN
cord-015365-iqdi99pd	1792	8	.	.	.
cord-015365-iqdi99pd	1793	1	Eine	Eine	NNP
cord-015365-iqdi99pd	1793	2	intermittierende	intermittierende	NNP
cord-015365-iqdi99pd	1793	3	Candida	Candida	NNP
cord-015365-iqdi99pd	1793	4	-	-	HYPH
cord-015365-iqdi99pd	1793	5	Kolonisation	Kolonisation	NNP
cord-015365-iqdi99pd	1793	6	wurde	wurde	NN
cord-015365-iqdi99pd	1793	7	durch	durch	NNP
cord-015365-iqdi99pd	1793	8	wöchentliche	wöchentliche	NNP
cord-015365-iqdi99pd	1793	9	Ü	Ü	NNP
cord-015365-iqdi99pd	1793	10	berwachungskulturen	berwachungskulturen	NNP
cord-015365-iqdi99pd	1793	11	bei	bei	NNP
cord-015365-iqdi99pd	1793	12	9	9	CD
cord-015365-iqdi99pd	1794	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1794	2	detektiert	detektiert	NN
cord-015365-iqdi99pd	1794	3	.	.	.
cord-015365-iqdi99pd	1795	1	Wöchentliche	Wöchentliche	NNP
cord-015365-iqdi99pd	1795	2	Galaktomannan	Galaktomannan	NNP
cord-015365-iqdi99pd	1795	3	-	-	HYPH
cord-015365-iqdi99pd	1795	4	Test	Test	NNP
cord-015365-iqdi99pd	1795	5	blieben	blieben	NN
cord-015365-iqdi99pd	1795	6	bei	bei	NNP
cord-015365-iqdi99pd	1795	7	17	17	CD
cord-015365-iqdi99pd	1795	8	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1795	9	durchgehend	durchgehend	NN
cord-015365-iqdi99pd	1795	10	negativ	negativ	NNP
cord-015365-iqdi99pd	1795	11	,	,	,
cord-015365-iqdi99pd	1795	12	2	2	CD
cord-015365-iqdi99pd	1795	13	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1795	14	hatten	hatten	NNP
cord-015365-iqdi99pd	1796	1	je	je	NNP
cord-015365-iqdi99pd	1796	2	ein	ein	NNP
cord-015365-iqdi99pd	1796	3	einzelnes	einzelne	VBZ
cord-015365-iqdi99pd	1796	4	positives	positives	NNPS
cord-015365-iqdi99pd	1796	5	Testergebnis	Testergebnis	NNP
cord-015365-iqdi99pd	1796	6	;	;	:
cord-015365-iqdi99pd	1796	7	keiner	keiner	NNP
cord-015365-iqdi99pd	1796	8	dieser	dieser	NNP
cord-015365-iqdi99pd	1796	9	19	19	CD
cord-015365-iqdi99pd	1796	10	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1796	11	entwickelte	entwickelte	NNP
cord-015365-iqdi99pd	1796	12	während	während	JJ
cord-015365-iqdi99pd	1796	13	einer	einer	NNP
cord-015365-iqdi99pd	1796	14	medianen	medianen	NNP
cord-015365-iqdi99pd	1796	15	Nachbeobachtungszeit	Nachbeobachtungszeit	NNP
cord-015365-iqdi99pd	1796	16	von	von	NNP
cord-015365-iqdi99pd	1796	17	10	10	CD
cord-015365-iqdi99pd	1797	1	Monaten	Monaten	NNP
cord-015365-iqdi99pd	1797	2	eine	eine	NNP
cord-015365-iqdi99pd	1797	3	invasive	invasive	JJ
cord-015365-iqdi99pd	1797	4	Pilzinfektion	Pilzinfektion	NNP
cord-015365-iqdi99pd	1797	5	.	.	.
cord-015365-iqdi99pd	1798	1	Eine	Eine	NNP
cord-015365-iqdi99pd	1798	2	Patientin	Patientin	NNP
cord-015365-iqdi99pd	1798	3	mit	mit	NNP
cord-015365-iqdi99pd	1798	4	GVH	GVH	NNP
cord-015365-iqdi99pd	1798	5	IV	IV	NNP
cord-015365-iqdi99pd	1798	6	unter	unter	NNP
cord-015365-iqdi99pd	1798	7	multimodaler	multimodaler	NNP
cord-015365-iqdi99pd	1798	8	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	1798	9	und	und	IN
cord-015365-iqdi99pd	1798	10	wiederholt	wiederholt	NN
cord-015365-iqdi99pd	1798	11	positiven	positiven	NNP
cord-015365-iqdi99pd	1798	12	Galaktomannan	Galaktomannan	NNP
cord-015365-iqdi99pd	1798	13	-	-	HYPH
cord-015365-iqdi99pd	1798	14	Tests	Tests	NNP
cord-015365-iqdi99pd	1798	15	entwickelte	entwickelte	NNP
cord-015365-iqdi99pd	1798	16	trotz	trotz	NNP
cord-015365-iqdi99pd	1798	17	kontinuierlicher	kontinuierlicher	NNP
cord-015365-iqdi99pd	1798	18	präemptiver	präemptiver	NNP
cord-015365-iqdi99pd	1798	19	Therapie	Therapie	NNP
cord-015365-iqdi99pd	1798	20	mit	mit	NNP
cord-015365-iqdi99pd	1798	21	LAMB	LAMB	NNP
cord-015365-iqdi99pd	1798	22	alternierend	alternierend	NN
cord-015365-iqdi99pd	1798	23	mit	mit	NNP
cord-015365-iqdi99pd	1798	24	Caspofungin	Caspofungin	NNP
cord-015365-iqdi99pd	1799	1	präfinal	präfinal	NNP
cord-015365-iqdi99pd	1799	2	eine	eine	NNP
cord-015365-iqdi99pd	1799	3	Aspergillus	Aspergillus	NNP
cord-015365-iqdi99pd	1799	4	-	-	HYPH
cord-015365-iqdi99pd	1799	5	Pneumonie	Pneumonie	NNP
cord-015365-iqdi99pd	1799	6	und	und	IN
cord-015365-iqdi99pd	1799	7	verstarb	verstarb	NN
cord-015365-iqdi99pd	1799	8	am	be	VBP
cord-015365-iqdi99pd	1799	9	Tag	tag	NN
cord-015365-iqdi99pd	1799	10	þ140	þ140	NNP
cord-015365-iqdi99pd	1799	11	.	.	.
cord-015365-iqdi99pd	1800	1	Bei	Bei	NNP
cord-015365-iqdi99pd	1800	2	keinem	keinem	NN
cord-015365-iqdi99pd	1800	3	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1800	4	mußte	mußte	NN
cord-015365-iqdi99pd	1800	5	LAMB	LAMB	NNP
cord-015365-iqdi99pd	1800	6	wegen	wegen	NNP
cord-015365-iqdi99pd	1801	1	infusionsassoziierter	infusionsassoziierter	NNP
cord-015365-iqdi99pd	1801	2	Nebenwirkungen	Nebenwirkungen	NNP
cord-015365-iqdi99pd	1801	3	abgesetzt	abgesetzt	VBD
cord-015365-iqdi99pd	1801	4	werden	werden	NNP
cord-015365-iqdi99pd	1801	5	;	;	:
cord-015365-iqdi99pd	1801	6	die	die	VB
cord-015365-iqdi99pd	1801	7	Hauptnebenwirkung	Hauptnebenwirkung	NNP
cord-015365-iqdi99pd	1801	8	war	war	NN
cord-015365-iqdi99pd	1801	9	eine	eine	NNP
cord-015365-iqdi99pd	1801	10	Hypokaliämie	Hypokaliämie	NNP
cord-015365-iqdi99pd	1801	11	,	,	,
cord-015365-iqdi99pd	1801	12	die	die	VBP
cord-015365-iqdi99pd	1801	13	in	in	IN
cord-015365-iqdi99pd	1801	14	20/23	20/23	CD
cord-015365-iqdi99pd	1801	15	Anwendungen	Anwendungen	NNP
cord-015365-iqdi99pd	1801	16	substitutionsbedürftig	substitutionsbedürftig	NNP
cord-015365-iqdi99pd	1801	17	war	war	NN
cord-015365-iqdi99pd	1801	18	.	.	.
cord-015365-iqdi99pd	1802	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	1802	2	.	.	.
cord-015365-iqdi99pd	1803	1	Die	die	VB
cord-015365-iqdi99pd	1803	2	intermittierende	intermittierende	NNP
cord-015365-iqdi99pd	1803	3	antifungale	antifungale	.
cord-015365-iqdi99pd	1804	1	Prophylaxe	Prophylaxe	NNP
cord-015365-iqdi99pd	1804	2	mit	mit	NN
cord-015365-iqdi99pd	1804	3	LAMB	LAMB	NNP
cord-015365-iqdi99pd	1804	4	nach	nach	NNP
cord-015365-iqdi99pd	1804	5	autologer	autologer	NNP
cord-015365-iqdi99pd	1804	6	bzw	bzw	NNP
cord-015365-iqdi99pd	1804	7	.	.	.
cord-015365-iqdi99pd	1805	1	allogener	allogener	JJ
cord-015365-iqdi99pd	1805	2	SZT	SZT	NNP
cord-015365-iqdi99pd	1805	3	war	war	NN
cord-015365-iqdi99pd	1805	4	bei	bei	NN
cord-015365-iqdi99pd	1805	5	19/20	19/20	CD
cord-015365-iqdi99pd	1805	6	Patienten	Patienten	NNP
cord-015365-iqdi99pd	1805	7	erfolgreich	erfolgreich	RB
cord-015365-iqdi99pd	1805	8	.	.	.
cord-015365-iqdi99pd	1806	1	Die	die	VB
cord-015365-iqdi99pd	1806	2	Nebenwirkungen	Nebenwirkungen	NNP
cord-015365-iqdi99pd	1806	3	beschränkten	beschränkten	VBD
cord-015365-iqdi99pd	1806	4	sich	sich	NNP
cord-015365-iqdi99pd	1806	5	auf	auf	NNP
cord-015365-iqdi99pd	1806	6	eine	eine	NNP
cord-015365-iqdi99pd	1806	7	substitutionsbedürftige	substitutionsbedürftige	NNP
cord-015365-iqdi99pd	1806	8	Hypokaliämie	Hypokaliämie	NNP
cord-015365-iqdi99pd	1806	9	.	.	.
cord-015365-iqdi99pd	1807	1	Background	background	NN
cord-015365-iqdi99pd	1807	2	.	.	.
cord-015365-iqdi99pd	1808	1	Late	late	JJ
cord-015365-iqdi99pd	1808	2	complications	complication	NNS
cord-015365-iqdi99pd	1808	3	including	include	VBG
cord-015365-iqdi99pd	1808	4	diabetic	diabetic	JJ
cord-015365-iqdi99pd	1808	5	vasculopathy	vasculopathy	NNP
cord-015365-iqdi99pd	1808	6	,	,	,
cord-015365-iqdi99pd	1808	7	retinopathy	retinopathy	NN
cord-015365-iqdi99pd	1808	8	and	and	CC
cord-015365-iqdi99pd	1808	9	neuropathy	neuropathy	NN
cord-015365-iqdi99pd	1808	10	are	be	VBP
cord-015365-iqdi99pd	1808	11	still	still	RB
cord-015365-iqdi99pd	1808	12	serious	serious	JJ
cord-015365-iqdi99pd	1808	13	problems	problem	NNS
cord-015365-iqdi99pd	1808	14	in	in	IN
cord-015365-iqdi99pd	1808	15	the	the	DT
cord-015365-iqdi99pd	1808	16	treatment	treatment	NN
cord-015365-iqdi99pd	1808	17	of	of	IN
cord-015365-iqdi99pd	1808	18	diabetes	diabetes	NN
cord-015365-iqdi99pd	1808	19	mellitus	mellitus	NN
cord-015365-iqdi99pd	1808	20	.	.	.
cord-015365-iqdi99pd	1809	1	Whole	whole	JJ
cord-015365-iqdi99pd	1809	2	pancreas	pancreas	NN
cord-015365-iqdi99pd	1809	3	transplantation	transplantation	NN
cord-015365-iqdi99pd	1809	4	or	or	CC
cord-015365-iqdi99pd	1809	5	human	human	JJ
cord-015365-iqdi99pd	1809	6	islet	islet	NN
cord-015365-iqdi99pd	1809	7	cell	cell	NN
cord-015365-iqdi99pd	1809	8	transplantation	transplantation	NN
cord-015365-iqdi99pd	1809	9	are	be	VBP
cord-015365-iqdi99pd	1809	10	alternatives	alternative	NNS
cord-015365-iqdi99pd	1809	11	but	but	CC
cord-015365-iqdi99pd	1809	12	limited	limit	VBN
cord-015365-iqdi99pd	1809	13	due	due	IN
cord-015365-iqdi99pd	1809	14	to	to	IN
cord-015365-iqdi99pd	1809	15	the	the	DT
cord-015365-iqdi99pd	1809	16	organ	organ	NN
cord-015365-iqdi99pd	1809	17	shortage	shortage	NN
cord-015365-iqdi99pd	1809	18	and	and	CC
cord-015365-iqdi99pd	1809	19	lifelong	lifelong	JJ
cord-015365-iqdi99pd	1809	20	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1809	21	.	.	.
cord-015365-iqdi99pd	1810	1	The	the	DT
cord-015365-iqdi99pd	1810	2	use	use	NN
cord-015365-iqdi99pd	1810	3	of	of	IN
cord-015365-iqdi99pd	1810	4	immune	immune	JJ
cord-015365-iqdi99pd	1810	5	isolated	isolate	VBN
cord-015365-iqdi99pd	1810	6	porcine	porcine	JJ
cord-015365-iqdi99pd	1810	7	islet	islet	NN
cord-015365-iqdi99pd	1810	8	cells	cell	NNS
cord-015365-iqdi99pd	1810	9	(	(	-LRB-
cord-015365-iqdi99pd	1810	10	PIC	pic	NN
cord-015365-iqdi99pd	1810	11	)	)	-RRB-
cord-015365-iqdi99pd	1810	12	could	could	MD
cord-015365-iqdi99pd	1810	13	offer	offer	VB
cord-015365-iqdi99pd	1810	14	a	a	DT
cord-015365-iqdi99pd	1810	15	feasible	feasible	JJ
cord-015365-iqdi99pd	1810	16	alternative	alternative	NN
cord-015365-iqdi99pd	1810	17	.	.	.
cord-015365-iqdi99pd	1811	1	In	in	IN
cord-015365-iqdi99pd	1811	2	this	this	DT
cord-015365-iqdi99pd	1811	3	study	study	NN
cord-015365-iqdi99pd	1811	4	,	,	,
cord-015365-iqdi99pd	1811	5	the	the	DT
cord-015365-iqdi99pd	1811	6	safety	safety	NN
cord-015365-iqdi99pd	1811	7	and	and	CC
cord-015365-iqdi99pd	1811	8	applicability	applicability	NN
cord-015365-iqdi99pd	1811	9	of	of	IN
cord-015365-iqdi99pd	1811	10	three	three	CD
cord-015365-iqdi99pd	1811	11	possible	possible	JJ
cord-015365-iqdi99pd	1811	12	implantation	implantation	NN
cord-015365-iqdi99pd	1811	13	sites	site	NNS
cord-015365-iqdi99pd	1811	14	for	for	IN
cord-015365-iqdi99pd	1811	15	Sodium	sodium	NN
cord-015365-iqdi99pd	1811	16	Cellulose	Cellulose	NNP
cord-015365-iqdi99pd	1811	17	Sulfate	Sulfate	NNP
cord-015365-iqdi99pd	1811	18	(	(	-LRB-
cord-015365-iqdi99pd	1811	19	SCS	SCS	NNP
cord-015365-iqdi99pd	1811	20	)	)	-RRB-
cord-015365-iqdi99pd	1811	21	microencapsulated	microencapsulate	VBN
cord-015365-iqdi99pd	1811	22	PIC	PIC	NNP
cord-015365-iqdi99pd	1811	23	were	be	VBD
cord-015365-iqdi99pd	1811	24	evaluated	evaluate	VBN
cord-015365-iqdi99pd	1811	25	in	in	IN
cord-015365-iqdi99pd	1811	26	five	five	CD
cord-015365-iqdi99pd	1811	27	healthy	healthy	JJ
cord-015365-iqdi99pd	1811	28	beagle	beagle	NN
cord-015365-iqdi99pd	1811	29	dogs	dog	NNS
cord-015365-iqdi99pd	1811	30	.	.	.
cord-015365-iqdi99pd	1812	1	Methods	method	NNS
cord-015365-iqdi99pd	1812	2	.	.	.
cord-015365-iqdi99pd	1813	1	Five	five	CD
cord-015365-iqdi99pd	1813	2	healthy	healthy	JJ
cord-015365-iqdi99pd	1813	3	,	,	,
cord-015365-iqdi99pd	1813	4	male	male	JJ
cord-015365-iqdi99pd	1813	5	castrated	castrate	VBN
cord-015365-iqdi99pd	1813	6	Beagle	Beagle	NNP
cord-015365-iqdi99pd	1813	7	dogs	dog	NNS
cord-015365-iqdi99pd	1813	8	were	be	VBD
cord-015365-iqdi99pd	1813	9	used	use	VBN
cord-015365-iqdi99pd	1813	10	for	for	IN
cord-015365-iqdi99pd	1813	11	this	this	DT
cord-015365-iqdi99pd	1813	12	study	study	NN
cord-015365-iqdi99pd	1813	13	.	.	.
cord-015365-iqdi99pd	1814	1	SCS	SCS	NNP
cord-015365-iqdi99pd	1814	2	microencapsulated	microencapsulate	VBN
cord-015365-iqdi99pd	1814	3	PIC	PIC	NNP
cord-015365-iqdi99pd	1814	4	were	be	VBD
cord-015365-iqdi99pd	1814	5	implanted	implant	VBN
cord-015365-iqdi99pd	1814	6	in	in	IN
cord-015365-iqdi99pd	1814	7	the	the	DT
cord-015365-iqdi99pd	1814	8	subcutaneous	subcutaneous	JJ
cord-015365-iqdi99pd	1814	9	tissue	tissue	NN
cord-015365-iqdi99pd	1814	10	,	,	,
cord-015365-iqdi99pd	1814	11	the	the	DT
cord-015365-iqdi99pd	1814	12	omentum	omentum	NN
cord-015365-iqdi99pd	1814	13	and	and	CC
cord-015365-iqdi99pd	1814	14	the	the	DT
cord-015365-iqdi99pd	1814	15	gastric	gastric	JJ
cord-015365-iqdi99pd	1814	16	submucosa	submucosa	NN
cord-015365-iqdi99pd	1814	17	.	.	.
cord-015365-iqdi99pd	1815	1	Surgery	surgery	NN
cord-015365-iqdi99pd	1815	2	time	time	NN
cord-015365-iqdi99pd	1815	3	and	and	CC
cord-015365-iqdi99pd	1815	4	intraoperative	intraoperative	JJ
cord-015365-iqdi99pd	1815	5	complications	complication	NNS
cord-015365-iqdi99pd	1815	6	were	be	VBD
cord-015365-iqdi99pd	1815	7	monitored	monitor	VBN
cord-015365-iqdi99pd	1815	8	.	.	.
cord-015365-iqdi99pd	1816	1	Implantation	implantation	NN
cord-015365-iqdi99pd	1816	2	in	in	IN
cord-015365-iqdi99pd	1816	3	the	the	DT
cord-015365-iqdi99pd	1816	4	omentum	omentum	NN
cord-015365-iqdi99pd	1816	5	and	and	CC
cord-015365-iqdi99pd	1816	6	gastric	gastric	NNP
cord-015365-iqdi99pd	1816	7	submucosa	submucosa	NNP
cord-015365-iqdi99pd	1816	8	was	be	VBD
cord-015365-iqdi99pd	1816	9	performed	perform	VBN
cord-015365-iqdi99pd	1816	10	laparoscopic	laparoscopic	JJ
cord-015365-iqdi99pd	1816	11	assisted	assist	VBN
cord-015365-iqdi99pd	1816	12	.	.	.
cord-015365-iqdi99pd	1817	1	All	all	DT
cord-015365-iqdi99pd	1817	2	animals	animal	NNS
cord-015365-iqdi99pd	1817	3	were	be	VBD
cord-015365-iqdi99pd	1817	4	continuously	continuously	RB
cord-015365-iqdi99pd	1817	5	monitored	monitor	VBN
cord-015365-iqdi99pd	1817	6	including	include	VBG
cord-015365-iqdi99pd	1817	7	clinical	clinical	JJ
cord-015365-iqdi99pd	1817	8	examinations	examination	NNS
cord-015365-iqdi99pd	1817	9	and	and	CC
cord-015365-iqdi99pd	1817	10	complete	complete	VB
cord-015365-iqdi99pd	1817	11	blood	blood	NN
cord-015365-iqdi99pd	1817	12	counts	count	NNS
cord-015365-iqdi99pd	1817	13	for	for	IN
cord-015365-iqdi99pd	1817	14	possible	possible	JJ
cord-015365-iqdi99pd	1817	15	occurring	occur	VBG
cord-015365-iqdi99pd	1817	16	side	side	NN
cord-015365-iqdi99pd	1817	17	effects	effect	NNS
cord-015365-iqdi99pd	1817	18	.	.	.
cord-015365-iqdi99pd	1818	1	On	on	IN
cord-015365-iqdi99pd	1818	2	day	day	NN
cord-015365-iqdi99pd	1818	3	À3	à3	CD
cord-015365-iqdi99pd	1818	4	,	,	,
cord-015365-iqdi99pd	1818	5	30	30	CD
cord-015365-iqdi99pd	1818	6	and	and	CC
cord-015365-iqdi99pd	1818	7	90	90	CD
cord-015365-iqdi99pd	1818	8	a	a	DT
cord-015365-iqdi99pd	1818	9	glucagon	glucagon	NN
cord-015365-iqdi99pd	1818	10	stimulation	stimulation	NN
cord-015365-iqdi99pd	1818	11	test	test	NN
cord-015365-iqdi99pd	1818	12	was	be	VBD
cord-015365-iqdi99pd	1818	13	performed	perform	VBN
cord-015365-iqdi99pd	1818	14	to	to	TO
cord-015365-iqdi99pd	1818	15	assess	assess	VB
cord-015365-iqdi99pd	1818	16	-cell	-cell	JJ
cord-015365-iqdi99pd	1818	17	function	function	NN
cord-015365-iqdi99pd	1818	18	and	and	CC
cord-015365-iqdi99pd	1818	19	glucose	glucose	NN
cord-015365-iqdi99pd	1818	20	metabolism	metabolism	NN
cord-015365-iqdi99pd	1818	21	.	.	.
cord-015365-iqdi99pd	1819	1	On	on	IN
cord-015365-iqdi99pd	1819	2	day	day	NN
cord-015365-iqdi99pd	1819	3	À3	à3	CD
cord-015365-iqdi99pd	1819	4	,	,	,
cord-015365-iqdi99pd	1819	5	1	1	CD
cord-015365-iqdi99pd	1819	6	,	,	,
cord-015365-iqdi99pd	1819	7	3	3	CD
cord-015365-iqdi99pd	1819	8	,	,	,
cord-015365-iqdi99pd	1819	9	12	12	CD
cord-015365-iqdi99pd	1819	10	,	,	,
cord-015365-iqdi99pd	1819	11	30	30	CD
cord-015365-iqdi99pd	1819	12	,	,	,
cord-015365-iqdi99pd	1819	13	60	60	CD
cord-015365-iqdi99pd	1819	14	and	and	CC
cord-015365-iqdi99pd	1819	15	90	90	CD
cord-015365-iqdi99pd	1819	16	fasting	fast	VBG
cord-015365-iqdi99pd	1819	17	glucose	glucose	NN
cord-015365-iqdi99pd	1819	18	and	and	CC
cord-015365-iqdi99pd	1819	19	insulin	insulin	NN
cord-015365-iqdi99pd	1819	20	were	be	VBD
cord-015365-iqdi99pd	1819	21	measured	measure	VBN
cord-015365-iqdi99pd	1819	22	.	.	.
cord-015365-iqdi99pd	1820	1	Blood	blood	NN
cord-015365-iqdi99pd	1820	2	samples	sample	NNS
cord-015365-iqdi99pd	1820	3	were	be	VBD
cord-015365-iqdi99pd	1820	4	taken	take	VBN
cord-015365-iqdi99pd	1820	5	to	to	TO
cord-015365-iqdi99pd	1820	6	check	check	VB
cord-015365-iqdi99pd	1820	7	a	a	DT
cord-015365-iqdi99pd	1820	8	possible	possible	JJ
cord-015365-iqdi99pd	1820	9	porcine	porcine	JJ
cord-015365-iqdi99pd	1820	10	endogenous	endogenous	JJ
cord-015365-iqdi99pd	1820	11	retrovirus	retrovirus	NN
cord-015365-iqdi99pd	1820	12	(	(	-LRB-
cord-015365-iqdi99pd	1820	13	PERV	perv	NN
cord-015365-iqdi99pd	1820	14	)	)	-RRB-
cord-015365-iqdi99pd	1820	15	transmission	transmission	NN
cord-015365-iqdi99pd	1820	16	.	.	.
cord-015365-iqdi99pd	1821	1	Biopsies	biopsy	NNS
cord-015365-iqdi99pd	1821	2	of	of	IN
cord-015365-iqdi99pd	1821	3	all	all	DT
cord-015365-iqdi99pd	1821	4	implantation	implantation	NN
cord-015365-iqdi99pd	1821	5	sites	site	NNS
cord-015365-iqdi99pd	1821	6	were	be	VBD
cord-015365-iqdi99pd	1821	7	obtained	obtain	VBN
cord-015365-iqdi99pd	1821	8	for	for	IN
cord-015365-iqdi99pd	1821	9	histopathology	histopathology	NN
cord-015365-iqdi99pd	1821	10	on	on	IN
cord-015365-iqdi99pd	1821	11	day	day	NN
cord-015365-iqdi99pd	1821	12	90	90	CD
cord-015365-iqdi99pd	1821	13	.	.	.
cord-015365-iqdi99pd	1822	1	Results	result	NNS
cord-015365-iqdi99pd	1822	2	.	.	.
cord-015365-iqdi99pd	1823	1	No	no	DT
cord-015365-iqdi99pd	1823	2	technical	technical	JJ
cord-015365-iqdi99pd	1823	3	complications	complication	NNS
cord-015365-iqdi99pd	1823	4	occurred	occur	VBD
cord-015365-iqdi99pd	1823	5	at	at	IN
cord-015365-iqdi99pd	1823	6	the	the	DT
cord-015365-iqdi99pd	1823	7	subcutis	subcutis	NN
cord-015365-iqdi99pd	1823	8	and	and	CC
cord-015365-iqdi99pd	1823	9	omentum	omentum	NN
cord-015365-iqdi99pd	1823	10	site	site	NN
cord-015365-iqdi99pd	1823	11	.	.	.
cord-015365-iqdi99pd	1824	1	At	at	IN
cord-015365-iqdi99pd	1824	2	the	the	DT
cord-015365-iqdi99pd	1824	3	gastric	gastric	JJ
cord-015365-iqdi99pd	1824	4	submucosa	submucosa	NNPS
cord-015365-iqdi99pd	1824	5	only	only	RB
cord-015365-iqdi99pd	1824	6	a	a	DT
cord-015365-iqdi99pd	1824	7	limited	limited	JJ
cord-015365-iqdi99pd	1824	8	amount	amount	NN
cord-015365-iqdi99pd	1824	9	of	of	IN
cord-015365-iqdi99pd	1824	10	cells	cell	NNS
cord-015365-iqdi99pd	1824	11	could	could	MD
cord-015365-iqdi99pd	1824	12	be	be	VB
cord-015365-iqdi99pd	1824	13	implanted	implant	VBN
cord-015365-iqdi99pd	1824	14	.	.	.
cord-015365-iqdi99pd	1825	1	Delayed	delay	VBN
cord-015365-iqdi99pd	1825	2	wound	wound	NN
cord-015365-iqdi99pd	1825	3	healing	healing	NN
cord-015365-iqdi99pd	1825	4	at	at	IN
cord-015365-iqdi99pd	1825	5	the	the	DT
cord-015365-iqdi99pd	1825	6	subcutaneous	subcutaneous	JJ
cord-015365-iqdi99pd	1825	7	implantation	implantation	NN
cord-015365-iqdi99pd	1825	8	site	site	NN
cord-015365-iqdi99pd	1825	9	was	be	VBD
cord-015365-iqdi99pd	1825	10	observed	observe	VBN
cord-015365-iqdi99pd	1825	11	in	in	IN
cord-015365-iqdi99pd	1825	12	three	three	CD
cord-015365-iqdi99pd	1825	13	out	out	IN
cord-015365-iqdi99pd	1825	14	of	of	IN
cord-015365-iqdi99pd	1825	15	five	five	CD
cord-015365-iqdi99pd	1825	16	dogs	dog	NNS
cord-015365-iqdi99pd	1825	17	.	.	.
cord-015365-iqdi99pd	1826	1	No	no	DT
cord-015365-iqdi99pd	1826	2	further	further	JJ
cord-015365-iqdi99pd	1826	3	side	side	NN
cord-015365-iqdi99pd	1826	4	effects	effect	NNS
cord-015365-iqdi99pd	1826	5	occured	occur	VBD
cord-015365-iqdi99pd	1826	6	during	during	IN
cord-015365-iqdi99pd	1826	7	the	the	DT
cord-015365-iqdi99pd	1826	8	study	study	NN
cord-015365-iqdi99pd	1826	9	period	period	NN
cord-015365-iqdi99pd	1826	10	.	.	.
cord-015365-iqdi99pd	1827	1	Transmission	transmission	NN
cord-015365-iqdi99pd	1827	2	of	of	IN
cord-015365-iqdi99pd	1827	3	PERV	perv	NN
cord-015365-iqdi99pd	1827	4	was	be	VBD
cord-015365-iqdi99pd	1827	5	not	not	RB
cord-015365-iqdi99pd	1827	6	detected	detect	VBN
cord-015365-iqdi99pd	1827	7	.	.	.
cord-015365-iqdi99pd	1828	1	Glucagon	glucagon	NN
cord-015365-iqdi99pd	1828	2	stimulation	stimulation	NN
cord-015365-iqdi99pd	1828	3	tests	test	NNS
cord-015365-iqdi99pd	1828	4	showed	show	VBD
cord-015365-iqdi99pd	1828	5	a	a	DT
cord-015365-iqdi99pd	1828	6	trend	trend	NN
cord-015365-iqdi99pd	1828	7	towards	towards	IN
cord-015365-iqdi99pd	1828	8	a	a	DT
cord-015365-iqdi99pd	1828	9	faster	fast	JJR
cord-015365-iqdi99pd	1828	10	response	response	NN
cord-015365-iqdi99pd	1828	11	to	to	IN
cord-015365-iqdi99pd	1828	12	a	a	DT
cord-015365-iqdi99pd	1828	13	glucagon	glucagon	NN
cord-015365-iqdi99pd	1828	14	stimulus	stimulus	NN
cord-015365-iqdi99pd	1828	15	and	and	CC
cord-015365-iqdi99pd	1828	16	an	an	DT
cord-015365-iqdi99pd	1828	17	increased	increase	VBN
cord-015365-iqdi99pd	1828	18	insulin	insulin	NN
cord-015365-iqdi99pd	1828	19	peak	peak	NN
cord-015365-iqdi99pd	1828	20	.	.	.
cord-015365-iqdi99pd	1829	1	Histopathology	Histopathology	NNP
cord-015365-iqdi99pd	1829	2	results	result	NNS
cord-015365-iqdi99pd	1829	3	have	have	VBP
cord-015365-iqdi99pd	1829	4	not	not	RB
cord-015365-iqdi99pd	1829	5	been	be	VBN
cord-015365-iqdi99pd	1829	6	completely	completely	RB
cord-015365-iqdi99pd	1829	7	evaluated	evaluate	VBN
cord-015365-iqdi99pd	1829	8	yet	yet	RB
cord-015365-iqdi99pd	1829	9	.	.	.
cord-015365-iqdi99pd	1830	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1830	2	.	.	.
cord-015365-iqdi99pd	1831	1	First	first	JJ
cord-015365-iqdi99pd	1831	2	results	result	NNS
cord-015365-iqdi99pd	1831	3	show	show	VBP
cord-015365-iqdi99pd	1831	4	that	that	IN
cord-015365-iqdi99pd	1831	5	SCS	SCS	NNP
cord-015365-iqdi99pd	1831	6	microencapsulated	microencapsulate	VBN
cord-015365-iqdi99pd	1831	7	PIC	PIC	NNP
cord-015365-iqdi99pd	1831	8	do	do	VBP
cord-015365-iqdi99pd	1831	9	not	not	RB
cord-015365-iqdi99pd	1831	10	cause	cause	VB
cord-015365-iqdi99pd	1831	11	any	any	DT
cord-015365-iqdi99pd	1831	12	harmful	harmful	JJ
cord-015365-iqdi99pd	1831	13	side	side	NN
cord-015365-iqdi99pd	1831	14	effects	effect	NNS
cord-015365-iqdi99pd	1831	15	to	to	IN
cord-015365-iqdi99pd	1831	16	the	the	DT
cord-015365-iqdi99pd	1831	17	recipients	recipient	NNS
cord-015365-iqdi99pd	1831	18	concerning	concern	VBG
cord-015365-iqdi99pd	1831	19	application	application	NN
cord-015365-iqdi99pd	1831	20	.	.	.
cord-015365-iqdi99pd	1832	1	No	no	DT
cord-015365-iqdi99pd	1832	2	transmission	transmission	NN
cord-015365-iqdi99pd	1832	3	of	of	IN
cord-015365-iqdi99pd	1832	4	PERV	perv	NN
cord-015365-iqdi99pd	1832	5	was	be	VBD
cord-015365-iqdi99pd	1832	6	detected	detect	VBN
cord-015365-iqdi99pd	1832	7	.	.	.
cord-015365-iqdi99pd	1833	1	The	the	DT
cord-015365-iqdi99pd	1833	2	outcome	outcome	NN
cord-015365-iqdi99pd	1833	3	of	of	IN
cord-015365-iqdi99pd	1833	4	histopathology	histopathology	NN
cord-015365-iqdi99pd	1833	5	in	in	IN
cord-015365-iqdi99pd	1833	6	combination	combination	NN
cord-015365-iqdi99pd	1833	7	with	with	IN
cord-015365-iqdi99pd	1833	8	the	the	DT
cord-015365-iqdi99pd	1833	9	clinical	clinical	JJ
cord-015365-iqdi99pd	1833	10	results	result	NNS
cord-015365-iqdi99pd	1833	11	will	will	MD
cord-015365-iqdi99pd	1833	12	display	display	VB
cord-015365-iqdi99pd	1833	13	the	the	DT
cord-015365-iqdi99pd	1833	14	efficacy	efficacy	NN
cord-015365-iqdi99pd	1833	15	of	of	IN
cord-015365-iqdi99pd	1833	16	this	this	DT
cord-015365-iqdi99pd	1833	17	treatment	treatment	NN
cord-015365-iqdi99pd	1833	18	and	and	CC
cord-015365-iqdi99pd	1833	19	the	the	DT
cord-015365-iqdi99pd	1833	20	expected	expect	VBN
cord-015365-iqdi99pd	1833	21	differences	difference	NNS
cord-015365-iqdi99pd	1833	22	in	in	IN
cord-015365-iqdi99pd	1833	23	transplantation	transplantation	NN
cord-015365-iqdi99pd	1833	24	sites	site	NNS
cord-015365-iqdi99pd	1833	25	.	.	.
cord-015365-iqdi99pd	1834	1	Background	background	NN
cord-015365-iqdi99pd	1834	2	.	.	.
cord-015365-iqdi99pd	1835	1	Heart	heart	NN
cord-015365-iqdi99pd	1835	2	failure	failure	NN
cord-015365-iqdi99pd	1835	3	following	follow	VBG
cord-015365-iqdi99pd	1835	4	acute	acute	JJ
cord-015365-iqdi99pd	1835	5	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1835	6	infarction	infarction	NN
cord-015365-iqdi99pd	1835	7	(	(	-LRB-
cord-015365-iqdi99pd	1835	8	AMI	AMI	NNP
cord-015365-iqdi99pd	1835	9	)	)	-RRB-
cord-015365-iqdi99pd	1835	10	is	be	VBZ
cord-015365-iqdi99pd	1835	11	a	a	DT
cord-015365-iqdi99pd	1835	12	major	major	JJ
cord-015365-iqdi99pd	1835	13	cause	cause	NN
cord-015365-iqdi99pd	1835	14	of	of	IN
cord-015365-iqdi99pd	1835	15	morbidity	morbidity	NN
cord-015365-iqdi99pd	1835	16	and	and	CC
cord-015365-iqdi99pd	1835	17	mortality	mortality	NN
cord-015365-iqdi99pd	1835	18	.	.	.
cord-015365-iqdi99pd	1836	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	1836	2	previous	previous	JJ
cord-015365-iqdi99pd	1836	3	observation	observation	NN
cord-015365-iqdi99pd	1836	4	that	that	IN
cord-015365-iqdi99pd	1836	5	injection	injection	NN
cord-015365-iqdi99pd	1836	6	of	of	IN
cord-015365-iqdi99pd	1836	7	apoptotic	apoptotic	JJ
cord-015365-iqdi99pd	1836	8	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1836	9	blood	blood	NN
cord-015365-iqdi99pd	1836	10	mononuclear	mononuclear	NN
cord-015365-iqdi99pd	1836	11	cells	cell	NNS
cord-015365-iqdi99pd	1836	12	(	(	-LRB-
cord-015365-iqdi99pd	1836	13	PBMC	PBMC	NNP
cord-015365-iqdi99pd	1836	14	)	)	-RRB-
cord-015365-iqdi99pd	1836	15	was	be	VBD
cord-015365-iqdi99pd	1836	16	able	able	JJ
cord-015365-iqdi99pd	1836	17	to	to	TO
cord-015365-iqdi99pd	1836	18	restore	restore	VB
cord-015365-iqdi99pd	1836	19	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1836	20	function	function	NN
cord-015365-iqdi99pd	1836	21	in	in	IN
cord-015365-iqdi99pd	1836	22	a	a	DT
cord-015365-iqdi99pd	1836	23	rat	rat	NN
cord-015365-iqdi99pd	1836	24	acute	acute	JJ
cord-015365-iqdi99pd	1836	25	ischaemia	ischaemia	NN
cord-015365-iqdi99pd	1836	26	model	model	NN
cord-015365-iqdi99pd	1836	27	prompted	prompt	VBD
cord-015365-iqdi99pd	1836	28	us	-PRON-	PRP
cord-015365-iqdi99pd	1836	29	to	to	TO
cord-015365-iqdi99pd	1836	30	study	study	VB
cord-015365-iqdi99pd	1836	31	the	the	DT
cord-015365-iqdi99pd	1836	32	effect	effect	NN
cord-015365-iqdi99pd	1836	33	of	of	IN
cord-015365-iqdi99pd	1836	34	soluble	soluble	JJ
cord-015365-iqdi99pd	1836	35	factors	factor	NNS
cord-015365-iqdi99pd	1836	36	derived	derive	VBN
cord-015365-iqdi99pd	1836	37	from	from	IN
cord-015365-iqdi99pd	1836	38	apoptotic	apoptotic	JJ
cord-015365-iqdi99pd	1836	39	PBMC	PBMC	NNP
cord-015365-iqdi99pd	1836	40	on	on	IN
cord-015365-iqdi99pd	1836	41	ventricular	ventricular	JJ
cord-015365-iqdi99pd	1836	42	remodelling	remodelling	NN
cord-015365-iqdi99pd	1836	43	after	after	IN
cord-015365-iqdi99pd	1836	44	AMI	AMI	NNP
cord-015365-iqdi99pd	1836	45	.	.	.
cord-015365-iqdi99pd	1837	1	Methods	method	NNS
cord-015365-iqdi99pd	1837	2	.	.	.
cord-015365-iqdi99pd	1838	1	Cell	cell	NN
cord-015365-iqdi99pd	1838	2	culture	culture	NN
cord-015365-iqdi99pd	1838	3	supernatants	supernatant	NNS
cord-015365-iqdi99pd	1838	4	derived	derive	VBN
cord-015365-iqdi99pd	1838	5	from	from	IN
cord-015365-iqdi99pd	1838	6	irradiated	irradiate	VBN
cord-015365-iqdi99pd	1838	7	apoptotic	apoptotic	JJ
cord-015365-iqdi99pd	1838	8	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1838	9	blood	blood	NN
cord-015365-iqdi99pd	1838	10	mononuclear	mononuclear	NN
cord-015365-iqdi99pd	1838	11	cells	cell	NNS
cord-015365-iqdi99pd	1838	12	(	(	-LRB-
cord-015365-iqdi99pd	1838	13	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1838	14	)	)	-RRB-
cord-015365-iqdi99pd	1838	15	were	be	VBD
cord-015365-iqdi99pd	1838	16	collected	collect	VBN
cord-015365-iqdi99pd	1838	17	and	and	CC
cord-015365-iqdi99pd	1838	18	injected	inject	VBN
cord-015365-iqdi99pd	1838	19	as	as	IN
cord-015365-iqdi99pd	1838	20	a	a	DT
cord-015365-iqdi99pd	1838	21	single	single	JJ
cord-015365-iqdi99pd	1838	22	dose	dose	NN
cord-015365-iqdi99pd	1838	23	intravenously	intravenously	RB
cord-015365-iqdi99pd	1838	24	after	after	IN
cord-015365-iqdi99pd	1838	25	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1838	26	infarction	infarction	NN
cord-015365-iqdi99pd	1838	27	in	in	IN
cord-015365-iqdi99pd	1838	28	an	an	DT
cord-015365-iqdi99pd	1838	29	experimental	experimental	JJ
cord-015365-iqdi99pd	1838	30	AMI	AMI	NNP
cord-015365-iqdi99pd	1838	31	rat	rat	NN
cord-015365-iqdi99pd	1838	32	model	model	NN
cord-015365-iqdi99pd	1838	33	and	and	CC
cord-015365-iqdi99pd	1838	34	in	in	IN
cord-015365-iqdi99pd	1838	35	a	a	DT
cord-015365-iqdi99pd	1838	36	porcine	porcine	JJ
cord-015365-iqdi99pd	1838	37	reperfused	reperfuse	VBN
cord-015365-iqdi99pd	1838	38	AMI	AMI	NNP
cord-015365-iqdi99pd	1838	39	model	model	NN
cord-015365-iqdi99pd	1838	40	.	.	.
cord-015365-iqdi99pd	1839	1	MRI	MRI	NNP
cord-015365-iqdi99pd	1839	2	and	and	CC
cord-015365-iqdi99pd	1839	3	echocardiography	echocardiography	NN
cord-015365-iqdi99pd	1839	4	were	be	VBD
cord-015365-iqdi99pd	1839	5	used	use	VBN
cord-015365-iqdi99pd	1839	6	to	to	TO
cord-015365-iqdi99pd	1839	7	quantitate	quantitate	VB
cord-015365-iqdi99pd	1839	8	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1839	9	function	function	NN
cord-015365-iqdi99pd	1839	10	.	.	.
cord-015365-iqdi99pd	1840	1	Immunohistology	Immunohistology	NNP
cord-015365-iqdi99pd	1840	2	and	and	CC
cord-015365-iqdi99pd	1840	3	flowcytometry	flowcytometry	NNP
cord-015365-iqdi99pd	1840	4	were	be	VBD
cord-015365-iqdi99pd	1840	5	used	use	VBN
cord-015365-iqdi99pd	1840	6	to	to	TO
cord-015365-iqdi99pd	1840	7	analyse	analyse	VB
cord-015365-iqdi99pd	1840	8	the	the	DT
cord-015365-iqdi99pd	1840	9	cellular	cellular	JJ
cord-015365-iqdi99pd	1840	10	components	component	NNS
cord-015365-iqdi99pd	1840	11	.	.	.
cord-015365-iqdi99pd	1841	1	Analysis	analysis	NN
cord-015365-iqdi99pd	1841	2	of	of	IN
cord-015365-iqdi99pd	1841	3	soluble	soluble	JJ
cord-015365-iqdi99pd	1841	4	factors	factor	NNS
cord-015365-iqdi99pd	1841	5	present	present	JJ
cord-015365-iqdi99pd	1841	6	in	in	IN
cord-015365-iqdi99pd	1841	7	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1841	8	was	be	VBD
cord-015365-iqdi99pd	1841	9	performed	perform	VBN
cord-015365-iqdi99pd	1841	10	with	with	IN
cord-015365-iqdi99pd	1841	11	proteome	proteome	NN
cord-015365-iqdi99pd	1841	12	membrane	membrane	NN
cord-015365-iqdi99pd	1841	13	arrays	array	NNS
cord-015365-iqdi99pd	1841	14	and	and	CC
cord-015365-iqdi99pd	1841	15	activation	activation	NN
cord-015365-iqdi99pd	1841	16	of	of	IN
cord-015365-iqdi99pd	1841	17	signalling	signal	VBG
cord-015365-iqdi99pd	1841	18	cascades	cascade	NNS
cord-015365-iqdi99pd	1841	19	in	in	IN
cord-015365-iqdi99pd	1841	20	human	human	JJ
cord-015365-iqdi99pd	1841	21	cardiomyocytes	cardiomyocyte	NNS
cord-015365-iqdi99pd	1841	22	by	by	IN
cord-015365-iqdi99pd	1841	23	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1841	24	in	in	IN
cord-015365-iqdi99pd	1841	25	vitro	vitro	FW
cord-015365-iqdi99pd	1841	26	was	be	VBD
cord-015365-iqdi99pd	1841	27	studied	study	VBN
cord-015365-iqdi99pd	1841	28	by	by	IN
cord-015365-iqdi99pd	1841	29	immunoblot	immunoblot	NNP
cord-015365-iqdi99pd	1841	30	-	-	HYPH
cord-015365-iqdi99pd	1841	31	analysis	analysis	NN
cord-015365-iqdi99pd	1841	32	.	.	.
cord-015365-iqdi99pd	1842	1	Results	result	NNS
cord-015365-iqdi99pd	1842	2	.	.	.
cord-015365-iqdi99pd	1843	1	Intravenous	intravenous	JJ
cord-015365-iqdi99pd	1843	2	administration	administration	NN
cord-015365-iqdi99pd	1843	3	of	of	IN
cord-015365-iqdi99pd	1843	4	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1843	5	resulted	result	VBD
cord-015365-iqdi99pd	1843	6	in	in	IN
cord-015365-iqdi99pd	1843	7	a	a	DT
cord-015365-iqdi99pd	1843	8	reduction	reduction	NN
cord-015365-iqdi99pd	1843	9	of	of	IN
cord-015365-iqdi99pd	1843	10	scar	scar	NN
cord-015365-iqdi99pd	1843	11	extension	extension	NN
cord-015365-iqdi99pd	1843	12	in	in	IN
cord-015365-iqdi99pd	1843	13	both	both	DT
cord-015365-iqdi99pd	1843	14	models	model	NNS
cord-015365-iqdi99pd	1843	15	.	.	.
cord-015365-iqdi99pd	1844	1	Hearts	heart	NNS
cord-015365-iqdi99pd	1844	2	explanted	explante	VBN
cord-015365-iqdi99pd	1844	3	from	from	IN
cord-015365-iqdi99pd	1844	4	animals	animal	NNS
cord-015365-iqdi99pd	1844	5	infused	infuse	VBN
cord-015365-iqdi99pd	1844	6	with	with	IN
cord-015365-iqdi99pd	1844	7	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1844	8	evidenced	evidence	VBN
cord-015365-iqdi99pd	1844	9	less	less	RBR
cord-015365-iqdi99pd	1844	10	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1844	11	necrosis	necrosis	NN
cord-015365-iqdi99pd	1844	12	after	after	IN
cord-015365-iqdi99pd	1844	13	24	24	CD
cord-015365-iqdi99pd	1844	14	hrs	hrs	NN
cord-015365-iqdi99pd	1844	15	.	.	.
cord-015365-iqdi99pd	1845	1	Troponin	Troponin	NNP
cord-015365-iqdi99pd	1845	2	-	-	:
cord-015365-iqdi99pd	1845	3	I	-PRON-	PRP
cord-015365-iqdi99pd	1845	4	release	release	NN
cord-015365-iqdi99pd	1845	5	was	be	VBD
cord-015365-iqdi99pd	1845	6	less	less	JJR
cord-015365-iqdi99pd	1845	7	than	than	IN
cord-015365-iqdi99pd	1845	8	in	in	IN
cord-015365-iqdi99pd	1845	9	animals	animal	NNS
cord-015365-iqdi99pd	1845	10	treated	treat	VBN
cord-015365-iqdi99pd	1845	11	with	with	IN
cord-015365-iqdi99pd	1845	12	medium	medium	NN
cord-015365-iqdi99pd	1845	13	as	as	IN
cord-015365-iqdi99pd	1845	14	control	control	NN
cord-015365-iqdi99pd	1845	15	.	.	.
cord-015365-iqdi99pd	1846	1	In	in	IN
cord-015365-iqdi99pd	1846	2	the	the	DT
cord-015365-iqdi99pd	1846	3	porcine	porcine	JJ
cord-015365-iqdi99pd	1846	4	AMI	AMI	NNP
cord-015365-iqdi99pd	1846	5	model	model	NN
cord-015365-iqdi99pd	1846	6	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1846	7	led	lead	VBD
cord-015365-iqdi99pd	1846	8	to	to	IN
cord-015365-iqdi99pd	1846	9	an	an	DT
cord-015365-iqdi99pd	1846	10	improvement	improvement	NN
cord-015365-iqdi99pd	1846	11	of	of	IN
cord-015365-iqdi99pd	1846	12	ejection	ejection	NN
cord-015365-iqdi99pd	1846	13	fraction	fraction	NN
cord-015365-iqdi99pd	1846	14	(	(	-LRB-
cord-015365-iqdi99pd	1846	15	57.0	57.0	CD
cord-015365-iqdi99pd	1846	16	%	%	NN
cord-015365-iqdi99pd	1846	17	vs.	vs.	IN
cord-015365-iqdi99pd	1846	18	40.5	40.5	CD
cord-015365-iqdi99pd	1846	19	%	%	NN
cord-015365-iqdi99pd	1846	20	,	,	,
cord-015365-iqdi99pd	1846	21	p	p	NN
cord-015365-iqdi99pd	1846	22	<	<	XX
cord-015365-iqdi99pd	1846	23	0.01	0.01	CD
cord-015365-iqdi99pd	1846	24	)	)	-RRB-
cord-015365-iqdi99pd	1846	25	,	,	,
cord-015365-iqdi99pd	1846	26	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1846	27	output	output	NN
cord-015365-iqdi99pd	1846	28	(	(	-LRB-
cord-015365-iqdi99pd	1846	29	4.0	4.0	CD
cord-015365-iqdi99pd	1846	30	vs.	vs.	NN
cord-015365-iqdi99pd	1846	31	2.4	2.4	CD
cord-015365-iqdi99pd	1846	32	l	l	NN
cord-015365-iqdi99pd	1846	33	/	/	SYM
cord-015365-iqdi99pd	1846	34	min	min	NNP
cord-015365-iqdi99pd	1846	35	.	.	NNP
cord-015365-iqdi99pd	1846	36	,	,	,
cord-015365-iqdi99pd	1846	37	p	p	NN
cord-015365-iqdi99pd	1846	38	<	<	XX
cord-015365-iqdi99pd	1846	39	0.001	0.001	CD
cord-015365-iqdi99pd	1846	40	)	)	-RRB-
cord-015365-iqdi99pd	1846	41	and	and	CC
cord-015365-iqdi99pd	1846	42	a	a	DT
cord-015365-iqdi99pd	1846	43	reduced	reduce	VBN
cord-015365-iqdi99pd	1846	44	infarction	infarction	NN
cord-015365-iqdi99pd	1846	45	size	size	NN
cord-015365-iqdi99pd	1846	46	(	(	-LRB-
cord-015365-iqdi99pd	1846	47	12.6	12.6	CD
cord-015365-iqdi99pd	1846	48	%	%	NN
cord-015365-iqdi99pd	1846	49	vs.	vs.	CC
cord-015365-iqdi99pd	1846	50	6.9	6.9	CD
cord-015365-iqdi99pd	1846	51	%	%	NN
cord-015365-iqdi99pd	1846	52	,	,	,
cord-015365-iqdi99pd	1846	53	p	p	NN
cord-015365-iqdi99pd	1846	54	<	<	XX
cord-015365-iqdi99pd	1846	55	0.02	0.02	CD
cord-015365-iqdi99pd	1846	56	)	)	-RRB-
cord-015365-iqdi99pd	1846	57	as	as	IN
cord-015365-iqdi99pd	1846	58	determined	determine	VBN
cord-015365-iqdi99pd	1846	59	by	by	IN
cord-015365-iqdi99pd	1846	60	MRI	MRI	NNP
cord-015365-iqdi99pd	1846	61	.	.	.
cord-015365-iqdi99pd	1847	1	Administration	Administration	NNP
cord-015365-iqdi99pd	1847	2	of	of	IN
cord-015365-iqdi99pd	1847	3	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1847	4	in	in	IN
cord-015365-iqdi99pd	1847	5	the	the	DT
cord-015365-iqdi99pd	1847	6	rat	rat	NN
cord-015365-iqdi99pd	1847	7	AMI	AMI	NNP
cord-015365-iqdi99pd	1847	8	model	model	NN
cord-015365-iqdi99pd	1847	9	caused	cause	VBD
cord-015365-iqdi99pd	1847	10	increased	increase	VBN
cord-015365-iqdi99pd	1847	11	presence	presence	NN
cord-015365-iqdi99pd	1847	12	of	of	IN
cord-015365-iqdi99pd	1847	13	CD68	CD68	NNP
cord-015365-iqdi99pd	1847	14	þ	þ	NNP
cord-015365-iqdi99pd	1847	15	macrophages	macrophage	NNS
cord-015365-iqdi99pd	1847	16	and	and	CC
cord-015365-iqdi99pd	1847	17	c	c	NN
cord-015365-iqdi99pd	1847	18	-	-	HYPH
cord-015365-iqdi99pd	1847	19	kitþ	kitþ	VBN
cord-015365-iqdi99pd	1847	20	endothelial	endothelial	JJ
cord-015365-iqdi99pd	1847	21	progenitor	progenitor	NN
cord-015365-iqdi99pd	1847	22	cells	cell	NNS
cord-015365-iqdi99pd	1847	23	(	(	-LRB-
cord-015365-iqdi99pd	1847	24	EPC	EPC	NNP
cord-015365-iqdi99pd	1847	25	)	)	-RRB-
cord-015365-iqdi99pd	1847	26	in	in	IN
cord-015365-iqdi99pd	1847	27	the	the	DT
cord-015365-iqdi99pd	1847	28	infarcted	infarcted	JJ
cord-015365-iqdi99pd	1847	29	myocardium	myocardium	NN
cord-015365-iqdi99pd	1847	30	within	within	IN
cord-015365-iqdi99pd	1847	31	72	72	CD
cord-015365-iqdi99pd	1847	32	hrs	hrs	NN
cord-015365-iqdi99pd	1847	33	.	.	.
cord-015365-iqdi99pd	1848	1	Exposure	exposure	NN
cord-015365-iqdi99pd	1848	2	of	of	IN
cord-015365-iqdi99pd	1848	3	human	human	JJ
cord-015365-iqdi99pd	1848	4	cardiomyocytes	cardiomyocyte	NNS
cord-015365-iqdi99pd	1848	5	with	with	IN
cord-015365-iqdi99pd	1848	6	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1848	7	in	in	IN
cord-015365-iqdi99pd	1848	8	vitro	vitro	FW
cord-015365-iqdi99pd	1848	9	triggered	trigger	VBN
cord-015365-iqdi99pd	1848	10	activation	activation	NN
cord-015365-iqdi99pd	1848	11	of	of	IN
cord-015365-iqdi99pd	1848	12	pro	pro	JJ
cord-015365-iqdi99pd	1848	13	-	-	JJ
cord-015365-iqdi99pd	1848	14	survival	survival	JJ
cord-015365-iqdi99pd	1848	15	signalling	signalling	NN
cord-015365-iqdi99pd	1848	16	-	-	HYPH
cord-015365-iqdi99pd	1848	17	cascades	cascade	NNS
cord-015365-iqdi99pd	1848	18	(	(	-LRB-
cord-015365-iqdi99pd	1848	19	AKT	AKT	NNP
cord-015365-iqdi99pd	1848	20	,	,	,
cord-015365-iqdi99pd	1848	21	p38	p38	NN
cord-015365-iqdi99pd	1848	22	MAPK	MAPK	NNP
cord-015365-iqdi99pd	1848	23	,	,	,
cord-015365-iqdi99pd	1848	24	Erk1/2	Erk1/2	NNP
cord-015365-iqdi99pd	1848	25	,	,	,
cord-015365-iqdi99pd	1848	26	CREB	CREB	NNP
cord-015365-iqdi99pd	1848	27	,	,	,
cord-015365-iqdi99pd	1848	28	c	c	NNP
cord-015365-iqdi99pd	1848	29	-	-	:
cord-015365-iqdi99pd	1848	30	Jun	Jun	NNP
cord-015365-iqdi99pd	1848	31	)	)	-RRB-
cord-015365-iqdi99pd	1848	32	and	and	CC
cord-015365-iqdi99pd	1848	33	anti	anti	JJ
cord-015365-iqdi99pd	1848	34	-	-	JJ
cord-015365-iqdi99pd	1848	35	apoptotic	apoptotic	JJ
cord-015365-iqdi99pd	1848	36	gene	gene	NN
cord-015365-iqdi99pd	1848	37	products	product	NNS
cord-015365-iqdi99pd	1848	38	(	(	-LRB-
cord-015365-iqdi99pd	1848	39	Bcl-2	Bcl-2	NNP
cord-015365-iqdi99pd	1848	40	,	,	,
cord-015365-iqdi99pd	1848	41	BAG1	BAG1	NNP
cord-015365-iqdi99pd	1848	42	)	)	-RRB-
cord-015365-iqdi99pd	1848	43	.	.	.
cord-015365-iqdi99pd	1849	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1849	2	.	.	.
cord-015365-iqdi99pd	1850	1	Intravenous	intravenous	JJ
cord-015365-iqdi99pd	1850	2	infusion	infusion	NN
cord-015365-iqdi99pd	1850	3	of	of	IN
cord-015365-iqdi99pd	1850	4	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1850	5	attenuated	attenuated	JJ
cord-015365-iqdi99pd	1850	6	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1850	7	remodelling	remodelling	NN
cord-015365-iqdi99pd	1850	8	in	in	IN
cord-015365-iqdi99pd	1850	9	both	both	DT
cord-015365-iqdi99pd	1850	10	models	model	NNS
cord-015365-iqdi99pd	1850	11	of	of	IN
cord-015365-iqdi99pd	1850	12	experimental	experimental	JJ
cord-015365-iqdi99pd	1850	13	AMI	AMI	NNP
cord-015365-iqdi99pd	1850	14	.	.	.
cord-015365-iqdi99pd	1851	1	This	this	DT
cord-015365-iqdi99pd	1851	2	effect	effect	NN
cord-015365-iqdi99pd	1851	3	seems	seem	VBZ
cord-015365-iqdi99pd	1851	4	to	to	TO
cord-015365-iqdi99pd	1851	5	be	be	VB
cord-015365-iqdi99pd	1851	6	due	due	JJ
cord-015365-iqdi99pd	1851	7	to	to	IN
cord-015365-iqdi99pd	1851	8	the	the	DT
cord-015365-iqdi99pd	1851	9	activation	activation	NN
cord-015365-iqdi99pd	1851	10	of	of	IN
cord-015365-iqdi99pd	1851	11	pro	pro	JJ
cord-015365-iqdi99pd	1851	12	-	-	JJ
cord-015365-iqdi99pd	1851	13	survival	survival	JJ
cord-015365-iqdi99pd	1851	14	signalling	signalling	NN
cord-015365-iqdi99pd	1851	15	cascades	cascade	NNS
cord-015365-iqdi99pd	1851	16	in	in	IN
cord-015365-iqdi99pd	1851	17	the	the	DT
cord-015365-iqdi99pd	1851	18	affected	affect	VBN
cord-015365-iqdi99pd	1851	19	cardiomyocytes	cardiomyocyte	NNS
cord-015365-iqdi99pd	1851	20	and	and	CC
cord-015365-iqdi99pd	1851	21	to	to	IN
cord-015365-iqdi99pd	1851	22	a	a	DT
cord-015365-iqdi99pd	1851	23	higher	high	JJR
cord-015365-iqdi99pd	1851	24	presence	presence	NN
cord-015365-iqdi99pd	1851	25	of	of	IN
cord-015365-iqdi99pd	1851	26	regenerative	regenerative	JJ
cord-015365-iqdi99pd	1851	27	cells	cell	NNS
cord-015365-iqdi99pd	1851	28	(	(	-LRB-
cord-015365-iqdi99pd	1851	29	EPCs	epc	NNS
cord-015365-iqdi99pd	1851	30	,	,	,
cord-015365-iqdi99pd	1851	31	macrophages	macrophage	NNS
cord-015365-iqdi99pd	1851	32	)	)	-RRB-
cord-015365-iqdi99pd	1851	33	within	within	IN
cord-015365-iqdi99pd	1851	34	the	the	DT
cord-015365-iqdi99pd	1851	35	ischaemic	ischaemic	JJ
cord-015365-iqdi99pd	1851	36	tissue	tissue	NN
cord-015365-iqdi99pd	1851	37	.	.	.
cord-015365-iqdi99pd	1852	1	APOSEC	APOSEC	NNP
cord-015365-iqdi99pd	1852	2	represents	represent	VBZ
cord-015365-iqdi99pd	1852	3	a	a	DT
cord-015365-iqdi99pd	1852	4	"	"	``
cord-015365-iqdi99pd	1852	5	biological	biological	JJ
cord-015365-iqdi99pd	1852	6	"	"	''
cord-015365-iqdi99pd	1852	7	which	which	WDT
cord-015365-iqdi99pd	1852	8	prevents	prevent	VBZ
cord-015365-iqdi99pd	1852	9	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1852	10	infarction	infarction	NN
cord-015365-iqdi99pd	1852	11	by	by	IN
cord-015365-iqdi99pd	1852	12	causing	cause	VBG
cord-015365-iqdi99pd	1852	13	peri	peri	JJ
cord-015365-iqdi99pd	1852	14	-	-	HYPH
cord-015365-iqdi99pd	1852	15	infarct	infarct	NN
cord-015365-iqdi99pd	1852	16	conditioning	conditioning	NN
cord-015365-iqdi99pd	1852	17	and	and	CC
cord-015365-iqdi99pd	1852	18	stimulation	stimulation	NN
cord-015365-iqdi99pd	1852	19	of	of	IN
cord-015365-iqdi99pd	1852	20	regenerative	regenerative	JJ
cord-015365-iqdi99pd	1852	21	effects	effect	NNS
cord-015365-iqdi99pd	1852	22	in	in	IN
cord-015365-iqdi99pd	1852	23	the	the	DT
cord-015365-iqdi99pd	1852	24	hypoxic	hypoxic	JJ
cord-015365-iqdi99pd	1852	25	myocardium	myocardium	NN
cord-015365-iqdi99pd	1852	26	.	.	.
cord-015365-iqdi99pd	1853	1	Anti	anti	JJ
cord-015365-iqdi99pd	1853	2	-	-	JJ
cord-015365-iqdi99pd	1853	3	thymocyte	thymocyte	JJ
cord-015365-iqdi99pd	1853	4	globulin	globulin	NN
cord-015365-iqdi99pd	1853	5	(	(	-LRB-
cord-015365-iqdi99pd	1853	6	ATG	ATG	NNP
cord-015365-iqdi99pd	1853	7	)	)	-RRB-
cord-015365-iqdi99pd	1853	8	reduces	reduce	VBZ
cord-015365-iqdi99pd	1853	9	damage	damage	NN
cord-015365-iqdi99pd	1853	10	caused	cause	VBN
cord-015365-iqdi99pd	1853	11	by	by	IN
cord-015365-iqdi99pd	1853	12	ischaemia	ischaemia	NN
cord-015365-iqdi99pd	1853	13	and	and	CC
cord-015365-iqdi99pd	1853	14	preserves	preserve	VBZ
cord-015365-iqdi99pd	1853	15	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1853	16	function	function	NN
cord-015365-iqdi99pd	1853	17	after	after	IN
cord-015365-iqdi99pd	1853	18	experimental	experimental	JJ
cord-015365-iqdi99pd	1853	19	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1853	20	infarction	infarction	NN
cord-015365-iqdi99pd	1853	21	Background	Background	NNP
cord-015365-iqdi99pd	1853	22	.	.	.
cord-015365-iqdi99pd	1854	1	Myocardial	myocardial	JJ
cord-015365-iqdi99pd	1854	2	infarction	infarction	NN
cord-015365-iqdi99pd	1854	3	(	(	-LRB-
cord-015365-iqdi99pd	1854	4	MI	MI	NNP
cord-015365-iqdi99pd	1854	5	)	)	-RRB-
cord-015365-iqdi99pd	1854	6	is	be	VBZ
cord-015365-iqdi99pd	1854	7	one	one	CD
cord-015365-iqdi99pd	1854	8	of	of	IN
cord-015365-iqdi99pd	1854	9	the	the	DT
cord-015365-iqdi99pd	1854	10	leading	lead	VBG
cord-015365-iqdi99pd	1854	11	causes	cause	NNS
cord-015365-iqdi99pd	1854	12	of	of	IN
cord-015365-iqdi99pd	1854	13	death	death	NN
cord-015365-iqdi99pd	1854	14	in	in	IN
cord-015365-iqdi99pd	1854	15	the	the	DT
cord-015365-iqdi99pd	1854	16	western	western	JJ
cord-015365-iqdi99pd	1854	17	world	world	NN
cord-015365-iqdi99pd	1854	18	.	.	.
cord-015365-iqdi99pd	1855	1	Consequent	consequent	JJ
cord-015365-iqdi99pd	1855	2	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	1855	3	reactions	reaction	NNS
cord-015365-iqdi99pd	1855	4	initiate	initiate	VBP
cord-015365-iqdi99pd	1855	5	and	and	CC
cord-015365-iqdi99pd	1855	6	sustain	sustain	VBP
cord-015365-iqdi99pd	1855	7	remodeling	remodeling	NN
cord-015365-iqdi99pd	1855	8	of	of	IN
cord-015365-iqdi99pd	1855	9	the	the	DT
cord-015365-iqdi99pd	1855	10	damaged	damage	VBN
cord-015365-iqdi99pd	1855	11	myocardium	myocardium	NN
cord-015365-iqdi99pd	1855	12	,	,	,
cord-015365-iqdi99pd	1855	13	which	which	WDT
cord-015365-iqdi99pd	1855	14	can	can	MD
cord-015365-iqdi99pd	1855	15	worsen	worsen	VB
cord-015365-iqdi99pd	1855	16	the	the	DT
cord-015365-iqdi99pd	1855	17	outcome	outcome	NN
cord-015365-iqdi99pd	1855	18	additionally	additionally	RB
cord-015365-iqdi99pd	1855	19	.	.	.
cord-015365-iqdi99pd	1856	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	1856	2	previous	previous	JJ
cord-015365-iqdi99pd	1856	3	findings	finding	NNS
cord-015365-iqdi99pd	1856	4	suggest	suggest	VBP
cord-015365-iqdi99pd	1856	5	that	that	IN
cord-015365-iqdi99pd	1856	6	apoptotic	apoptotic	JJ
cord-015365-iqdi99pd	1856	7	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1856	8	blood	blood	NN
cord-015365-iqdi99pd	1856	9	mononuclear	mononuclear	NN
cord-015365-iqdi99pd	1856	10	cells	cell	NNS
cord-015365-iqdi99pd	1856	11	(	(	-LRB-
cord-015365-iqdi99pd	1856	12	PBMCs	pbmc	NNS
cord-015365-iqdi99pd	1856	13	)	)	-RRB-
cord-015365-iqdi99pd	1856	14	,	,	,
cord-015365-iqdi99pd	1856	15	injected	inject	VBN
cord-015365-iqdi99pd	1856	16	intravenously	intravenously	RB
cord-015365-iqdi99pd	1856	17	after	after	IN
cord-015365-iqdi99pd	1856	18	MI	MI	NNP
cord-015365-iqdi99pd	1856	19	in	in	IN
cord-015365-iqdi99pd	1856	20	rats	rat	NNS
cord-015365-iqdi99pd	1856	21	,	,	,
cord-015365-iqdi99pd	1856	22	can	can	MD
cord-015365-iqdi99pd	1856	23	attenuate	attenuate	VB
cord-015365-iqdi99pd	1856	24	inflammation	inflammation	NN
cord-015365-iqdi99pd	1856	25	and	and	CC
cord-015365-iqdi99pd	1856	26	subsequently	subsequently	RB
cord-015365-iqdi99pd	1856	27	improve	improve	VB
cord-015365-iqdi99pd	1856	28	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1856	29	function	function	NN
cord-015365-iqdi99pd	1856	30	after	after	IN
cord-015365-iqdi99pd	1856	31	MI	MI	NNP
cord-015365-iqdi99pd	1856	32	.	.	.
cord-015365-iqdi99pd	1857	1	In	in	IN
cord-015365-iqdi99pd	1857	2	this	this	DT
cord-015365-iqdi99pd	1857	3	study	study	NN
cord-015365-iqdi99pd	1857	4	we	-PRON-	PRP
cord-015365-iqdi99pd	1857	5	sought	seek	VBD
cord-015365-iqdi99pd	1857	6	to	to	TO
cord-015365-iqdi99pd	1857	7	investigate	investigate	VB
cord-015365-iqdi99pd	1857	8	,	,	,
cord-015365-iqdi99pd	1857	9	if	if	IN
cord-015365-iqdi99pd	1857	10	anti	anti	JJ
cord-015365-iqdi99pd	1857	11	-	-	JJ
cord-015365-iqdi99pd	1857	12	thymocyte	thymocyte	JJ
cord-015365-iqdi99pd	1857	13	globulin	globulin	NN
cord-015365-iqdi99pd	1857	14	(	(	-LRB-
cord-015365-iqdi99pd	1857	15	ATG	ATG	NNP
cord-015365-iqdi99pd	1857	16	)	)	-RRB-
cord-015365-iqdi99pd	1857	17	as	as	IN
cord-015365-iqdi99pd	1857	18	a	a	DT
cord-015365-iqdi99pd	1857	19	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1857	20	agent	agent	NN
cord-015365-iqdi99pd	1857	21	inducing	induce	VBG
cord-015365-iqdi99pd	1857	22	apoptosis	apoptosis	NN
cord-015365-iqdi99pd	1857	23	in	in	IN
cord-015365-iqdi99pd	1857	24	white	white	JJ
cord-015365-iqdi99pd	1857	25	blood	blood	NN
cord-015365-iqdi99pd	1857	26	cells	cell	NNS
cord-015365-iqdi99pd	1857	27	,	,	,
cord-015365-iqdi99pd	1857	28	evidences	evidence	NNS
cord-015365-iqdi99pd	1857	29	similar	similar	JJ
cord-015365-iqdi99pd	1857	30	effects	effect	NNS
cord-015365-iqdi99pd	1857	31	after	after	IN
cord-015365-iqdi99pd	1857	32	experimental	experimental	JJ
cord-015365-iqdi99pd	1857	33	MI	MI	NNP
cord-015365-iqdi99pd	1857	34	in	in	IN
cord-015365-iqdi99pd	1857	35	rats	rat	NNS
cord-015365-iqdi99pd	1857	36	.	.	.
cord-015365-iqdi99pd	1858	1	Methods	method	NNS
cord-015365-iqdi99pd	1858	2	.	.	.
cord-015365-iqdi99pd	1859	1	To	to	TO
cord-015365-iqdi99pd	1859	2	study	study	VB
cord-015365-iqdi99pd	1859	3	effects	effect	NNS
cord-015365-iqdi99pd	1859	4	of	of	IN
cord-015365-iqdi99pd	1859	5	ATG	ATG	NNP
cord-015365-iqdi99pd	1859	6	in	in	IN
cord-015365-iqdi99pd	1859	7	vitro	vitro	FW
cord-015365-iqdi99pd	1859	8	,	,	,
cord-015365-iqdi99pd	1859	9	we	-PRON-	PRP
cord-015365-iqdi99pd	1859	10	incubated	incubate	VBD
cord-015365-iqdi99pd	1859	11	whole	whole	JJ
cord-015365-iqdi99pd	1859	12	blood	blood	NN
cord-015365-iqdi99pd	1859	13	and	and	CC
cord-015365-iqdi99pd	1859	14	PBMC	PBMC	NNP
cord-015365-iqdi99pd	1859	15	cell	cell	NN
cord-015365-iqdi99pd	1859	16	cultures	culture	NNS
cord-015365-iqdi99pd	1859	17	with	with	IN
cord-015365-iqdi99pd	1859	18	this	this	DT
cord-015365-iqdi99pd	1859	19	polyclonal	polyclonal	JJ
cord-015365-iqdi99pd	1859	20	antibody	antibody	NN
cord-015365-iqdi99pd	1859	21	for	for	IN
cord-015365-iqdi99pd	1859	22	24	24	CD
cord-015365-iqdi99pd	1859	23	hours	hour	NNS
cord-015365-iqdi99pd	1859	24	.	.	.
cord-015365-iqdi99pd	1860	1	ELISA	ELISA	NNP
cord-015365-iqdi99pd	1860	2	was	be	VBD
cord-015365-iqdi99pd	1860	3	utilized	utilize	VBN
cord-015365-iqdi99pd	1860	4	to	to	TO
cord-015365-iqdi99pd	1860	5	assess	assess	VB
cord-015365-iqdi99pd	1860	6	changes	change	NNS
cord-015365-iqdi99pd	1860	7	in	in	IN
cord-015365-iqdi99pd	1860	8	the	the	DT
cord-015365-iqdi99pd	1860	9	secretion	secretion	NN
cord-015365-iqdi99pd	1860	10	profile	profile	NN
cord-015365-iqdi99pd	1860	11	of	of	IN
cord-015365-iqdi99pd	1860	12	various	various	JJ
cord-015365-iqdi99pd	1860	13	cytokines	cytokine	NNS
cord-015365-iqdi99pd	1860	14	.	.	.
cord-015365-iqdi99pd	1861	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	1861	2	,	,	,
cord-015365-iqdi99pd	1861	3	we	-PRON-	PRP
cord-015365-iqdi99pd	1861	4	conducted	conduct	VBD
cord-015365-iqdi99pd	1861	5	an	an	DT
cord-015365-iqdi99pd	1861	6	in	in	IN
cord-015365-iqdi99pd	1861	7	vivo	vivo	NN
cord-015365-iqdi99pd	1861	8	study	study	NN
cord-015365-iqdi99pd	1861	9	in	in	IN
cord-015365-iqdi99pd	1861	10	an	an	DT
cord-015365-iqdi99pd	1861	11	experimental	experimental	JJ
cord-015365-iqdi99pd	1861	12	rat	rat	NN
cord-015365-iqdi99pd	1861	13	model	model	NN
cord-015365-iqdi99pd	1861	14	of	of	IN
cord-015365-iqdi99pd	1861	15	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1861	16	infarction	infarction	NN
cord-015365-iqdi99pd	1861	17	.	.	.
cord-015365-iqdi99pd	1862	1	Rodents	rodent	NNS
cord-015365-iqdi99pd	1862	2	were	be	VBD
cord-015365-iqdi99pd	1862	3	injected	inject	VBN
cord-015365-iqdi99pd	1862	4	with	with	IN
cord-015365-iqdi99pd	1862	5	ATG	ATG	NNP
cord-015365-iqdi99pd	1862	6	(	(	-LRB-
cord-015365-iqdi99pd	1862	7	10	10	CD
cord-015365-iqdi99pd	1862	8	mg	mg	NN
cord-015365-iqdi99pd	1862	9	/	/	SYM
cord-015365-iqdi99pd	1862	10	rat	rat	NN
cord-015365-iqdi99pd	1862	11	)	)	-RRB-
cord-015365-iqdi99pd	1862	12	after	after	IN
cord-015365-iqdi99pd	1862	13	ligation	ligation	NN
cord-015365-iqdi99pd	1862	14	of	of	IN
cord-015365-iqdi99pd	1862	15	the	the	DT
cord-015365-iqdi99pd	1862	16	left	left	JJ
cord-015365-iqdi99pd	1862	17	anterior	anterior	JJ
cord-015365-iqdi99pd	1862	18	descending	descend	VBG
cord-015365-iqdi99pd	1862	19	(	(	-LRB-
cord-015365-iqdi99pd	1862	20	LAD	lad	NN
cord-015365-iqdi99pd	1862	21	)	)	-RRB-
cord-015365-iqdi99pd	1862	22	artery	artery	NN
cord-015365-iqdi99pd	1862	23	.	.	.
cord-015365-iqdi99pd	1863	1	Untreated	untreated	JJ
cord-015365-iqdi99pd	1863	2	and	and	CC
cord-015365-iqdi99pd	1863	3	sham	sham	NN
cord-015365-iqdi99pd	1863	4	operated	operate	VBN
cord-015365-iqdi99pd	1863	5	animals	animal	NNS
cord-015365-iqdi99pd	1863	6	served	serve	VBD
cord-015365-iqdi99pd	1863	7	as	as	IN
cord-015365-iqdi99pd	1863	8	controls	control	NNS
cord-015365-iqdi99pd	1863	9	.	.	.
cord-015365-iqdi99pd	1864	1	Short	short	JJ
cord-015365-iqdi99pd	1864	2	term	term	NN
cord-015365-iqdi99pd	1864	3	effects	effect	NNS
cord-015365-iqdi99pd	1864	4	were	be	VBD
cord-015365-iqdi99pd	1864	5	evaluated	evaluate	VBN
cord-015365-iqdi99pd	1864	6	by	by	IN
cord-015365-iqdi99pd	1864	7	immunohistology	immunohistology	NN
cord-015365-iqdi99pd	1864	8	after	after	IN
cord-015365-iqdi99pd	1864	9	three	three	CD
cord-015365-iqdi99pd	1864	10	days	day	NNS
cord-015365-iqdi99pd	1864	11	.	.	.
cord-015365-iqdi99pd	1865	1	Echocardiography	echocardiography	NN
cord-015365-iqdi99pd	1865	2	and	and	CC
cord-015365-iqdi99pd	1865	3	assessment	assessment	NN
cord-015365-iqdi99pd	1865	4	of	of	IN
cord-015365-iqdi99pd	1865	5	infarction	infarction	NN
cord-015365-iqdi99pd	1865	6	size	size	NN
cord-015365-iqdi99pd	1865	7	by	by	IN
cord-015365-iqdi99pd	1865	8	planimetry	planimetry	NNP
cord-015365-iqdi99pd	1865	9	depicted	depict	VBD
cord-015365-iqdi99pd	1865	10	the	the	DT
cord-015365-iqdi99pd	1865	11	outcome	outcome	NN
cord-015365-iqdi99pd	1865	12	after	after	IN
cord-015365-iqdi99pd	1865	13	six	six	CD
cord-015365-iqdi99pd	1865	14	weeks	week	NNS
cord-015365-iqdi99pd	1865	15	.	.	.
cord-015365-iqdi99pd	1866	1	Results	result	NNS
cord-015365-iqdi99pd	1866	2	.	.	.
cord-015365-iqdi99pd	1867	1	Cytokines	cytokine	NNS
cord-015365-iqdi99pd	1867	2	and	and	CC
cord-015365-iqdi99pd	1867	3	chemokines	chemokine	NNS
cord-015365-iqdi99pd	1867	4	held	hold	VBD
cord-015365-iqdi99pd	1867	5	responsible	responsible	JJ
cord-015365-iqdi99pd	1867	6	for	for	IN
cord-015365-iqdi99pd	1867	7	cardioprotective	cardioprotective	JJ
cord-015365-iqdi99pd	1867	8	and	and	CC
cord-015365-iqdi99pd	1867	9	neo	neo	JJ
cord-015365-iqdi99pd	1867	10	-	-	JJ
cord-015365-iqdi99pd	1867	11	angiogenic	angiogenic	JJ
cord-015365-iqdi99pd	1867	12	effects	effect	NNS
cord-015365-iqdi99pd	1867	13	(	(	-LRB-
cord-015365-iqdi99pd	1867	14	e.g.	e.g.	RB
cord-015365-iqdi99pd	1867	15	IL-1RA	il-1ra	NN
cord-015365-iqdi99pd	1867	16	,	,	,
cord-015365-iqdi99pd	1867	17	IL-8	IL-8	NNP
cord-015365-iqdi99pd	1867	18	,	,	,
cord-015365-iqdi99pd	1867	19	MCP-1	MCP-1	NNP
cord-015365-iqdi99pd	1867	20	)	)	-RRB-
cord-015365-iqdi99pd	1867	21	were	be	VBD
cord-015365-iqdi99pd	1867	22	significantly	significantly	RB
cord-015365-iqdi99pd	1867	23	elevated	elevate	VBN
cord-015365-iqdi99pd	1867	24	in	in	IN
cord-015365-iqdi99pd	1867	25	ATG	ATG	NNP
cord-015365-iqdi99pd	1867	26	groups	group	NNS
cord-015365-iqdi99pd	1867	27	over	over	IN
cord-015365-iqdi99pd	1867	28	controls	control	NNS
cord-015365-iqdi99pd	1867	29	in	in	IN
cord-015365-iqdi99pd	1867	30	vitro	vitro	FW
cord-015365-iqdi99pd	1867	31	.	.	.
cord-015365-iqdi99pd	1868	1	Histology	histology	NN
cord-015365-iqdi99pd	1868	2	of	of	IN
cord-015365-iqdi99pd	1868	3	in	in	IN
cord-015365-iqdi99pd	1868	4	vivo	vivo	NN
cord-015365-iqdi99pd	1868	5	experiments	experiment	NNS
cord-015365-iqdi99pd	1868	6	confirmed	confirm	VBD
cord-015365-iqdi99pd	1868	7	these	these	DT
cord-015365-iqdi99pd	1868	8	data	datum	NNS
cord-015365-iqdi99pd	1868	9	,	,	,
cord-015365-iqdi99pd	1868	10	as	as	IN
cord-015365-iqdi99pd	1868	11	ATG	ATG	NNP
cord-015365-iqdi99pd	1868	12	treated	treat	VBD
cord-015365-iqdi99pd	1868	13	animals	animal	NNS
cord-015365-iqdi99pd	1868	14	had	have	VBD
cord-015365-iqdi99pd	1868	15	a	a	DT
cord-015365-iqdi99pd	1868	16	reduced	reduce	VBN
cord-015365-iqdi99pd	1868	17	area	area	NN
cord-015365-iqdi99pd	1868	18	of	of	IN
cord-015365-iqdi99pd	1868	19	necrosis	necrosis	NN
cord-015365-iqdi99pd	1868	20	three	three	CD
cord-015365-iqdi99pd	1868	21	days	day	NNS
cord-015365-iqdi99pd	1868	22	after	after	IN
cord-015365-iqdi99pd	1868	23	AMI	AMI	NNP
cord-015365-iqdi99pd	1868	24	(	(	-LRB-
cord-015365-iqdi99pd	1868	25	10.7	10.7	CD
cord-015365-iqdi99pd	1868	26	%	%	NN
cord-015365-iqdi99pd	1868	27	vs.	vs.	CC
cord-015365-iqdi99pd	1868	28	20.6	20.6	CD
cord-015365-iqdi99pd	1868	29	%	%	NN
cord-015365-iqdi99pd	1868	30	)	)	-RRB-
cord-015365-iqdi99pd	1868	31	,	,	,
cord-015365-iqdi99pd	1868	32	smaller	small	JJR
cord-015365-iqdi99pd	1868	33	infarct	infarct	NN
cord-015365-iqdi99pd	1868	34	scars	scar	NNS
cord-015365-iqdi99pd	1868	35	after	after	IN
cord-015365-iqdi99pd	1868	36	six	six	CD
cord-015365-iqdi99pd	1868	37	weeks	week	NNS
cord-015365-iqdi99pd	1868	38	and	and	CC
cord-015365-iqdi99pd	1868	39	an	an	DT
cord-015365-iqdi99pd	1868	40	increased	increase	VBN
cord-015365-iqdi99pd	1868	41	infiltration	infiltration	NN
cord-015365-iqdi99pd	1868	42	of	of	IN
cord-015365-iqdi99pd	1868	43	macrophages	macrophage	NNS
cord-015365-iqdi99pd	1868	44	.	.	.
cord-015365-iqdi99pd	1869	1	Echocardiography	echocardiography	NN
cord-015365-iqdi99pd	1869	2	revealed	reveal	VBD
cord-015365-iqdi99pd	1869	3	a	a	DT
cord-015365-iqdi99pd	1869	4	treatment	treatment	NN
cord-015365-iqdi99pd	1869	5	advantage	advantage	NN
cord-015365-iqdi99pd	1869	6	of	of	IN
cord-015365-iqdi99pd	1869	7	ATG	ATG	NNP
cord-015365-iqdi99pd	1869	8	,	,	,
cord-015365-iqdi99pd	1869	9	as	as	IN
cord-015365-iqdi99pd	1869	10	rodents	rodent	NNS
cord-015365-iqdi99pd	1869	11	enrolled	enrol	VBN
cord-015365-iqdi99pd	1869	12	in	in	IN
cord-015365-iqdi99pd	1869	13	this	this	DT
cord-015365-iqdi99pd	1869	14	study	study	NN
cord-015365-iqdi99pd	1869	15	group	group	NN
cord-015365-iqdi99pd	1869	16	evidenced	evidence	VBD
cord-015365-iqdi99pd	1869	17	an	an	DT
cord-015365-iqdi99pd	1869	18	ejection	ejection	NN
cord-015365-iqdi99pd	1869	19	fraction	fraction	NN
cord-015365-iqdi99pd	1869	20	of	of	IN
cord-015365-iqdi99pd	1869	21	52.35	52.35	CD
cord-015365-iqdi99pd	1869	22	%	%	NN
cord-015365-iqdi99pd	1869	23	AE	AE	NNP
cord-015365-iqdi99pd	1869	24	1.96	1.96	CD
cord-015365-iqdi99pd	1869	25	%	%	NN
cord-015365-iqdi99pd	1869	26	compared	compare	VBN
cord-015365-iqdi99pd	1869	27	to	to	IN
cord-015365-iqdi99pd	1869	28	42.91	42.91	CD
cord-015365-iqdi99pd	1869	29	%	%	NN
cord-015365-iqdi99pd	1869	30	AE	AE	NNP
cord-015365-iqdi99pd	1869	31	2.22	2.22	CD
cord-015365-iqdi99pd	1869	32	%	%	NN
cord-015365-iqdi99pd	1869	33	in	in	IN
cord-015365-iqdi99pd	1869	34	controls	control	NNS
cord-015365-iqdi99pd	1869	35	(	(	-LRB-
cord-015365-iqdi99pd	1869	36	n	n	NNP
cord-015365-iqdi99pd	1869	37	¼	¼	NNP
cord-015365-iqdi99pd	1869	38	13	13	CD
cord-015365-iqdi99pd	1869	39	,	,	,
cord-015365-iqdi99pd	1869	40	p	p	NN
cord-015365-iqdi99pd	1869	41	<	<	XX
cord-015365-iqdi99pd	1869	42	0.001	0.001	CD
cord-015365-iqdi99pd	1869	43	)	)	-RRB-
cord-015365-iqdi99pd	1869	44	.	.	.
cord-015365-iqdi99pd	1870	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1870	2	.	.	.
cord-015365-iqdi99pd	1871	1	Via	via	IN
cord-015365-iqdi99pd	1871	2	the	the	DT
cord-015365-iqdi99pd	1871	3	mechanism	mechanism	NN
cord-015365-iqdi99pd	1871	4	of	of	IN
cord-015365-iqdi99pd	1871	5	apoptosis	apoptosis	NN
cord-015365-iqdi99pd	1871	6	,	,	,
cord-015365-iqdi99pd	1871	7	ATG	ATG	NNP
cord-015365-iqdi99pd	1871	8	induces	induce	VBZ
cord-015365-iqdi99pd	1871	9	a	a	DT
cord-015365-iqdi99pd	1871	10	plethora	plethora	NN
cord-015365-iqdi99pd	1871	11	of	of	IN
cord-015365-iqdi99pd	1871	12	pro	pro	JJ
cord-015365-iqdi99pd	1871	13	-	-	JJ
cord-015365-iqdi99pd	1871	14	angiogenic	angiogenic	JJ
cord-015365-iqdi99pd	1871	15	and	and	CC
cord-015365-iqdi99pd	1871	16	immune	immune	JJ
cord-015365-iqdi99pd	1871	17	-	-	HYPH
cord-015365-iqdi99pd	1871	18	modulatory	modulatory	JJ
cord-015365-iqdi99pd	1871	19	factors	factor	NNS
cord-015365-iqdi99pd	1871	20	.	.	.
cord-015365-iqdi99pd	1872	1	Secretion	secretion	NN
cord-015365-iqdi99pd	1872	2	of	of	IN
cord-015365-iqdi99pd	1872	3	this	this	DT
cord-015365-iqdi99pd	1872	4	ensemble	ensemble	NN
cord-015365-iqdi99pd	1872	5	of	of	IN
cord-015365-iqdi99pd	1872	6	cytokines	cytokine	NNS
cord-015365-iqdi99pd	1872	7	and	and	CC
cord-015365-iqdi99pd	1872	8	chemokines	chemokine	NNS
cord-015365-iqdi99pd	1872	9	attracts	attract	VBZ
cord-015365-iqdi99pd	1872	10	macrophages	macrophage	NNS
cord-015365-iqdi99pd	1872	11	/	/	SYM
cord-015365-iqdi99pd	1872	12	monocytes	monocyte	VBZ
cord-015365-iqdi99pd	1872	13	into	into	IN
cord-015365-iqdi99pd	1872	14	the	the	DT
cord-015365-iqdi99pd	1872	15	infarcted	infarcted	JJ
cord-015365-iqdi99pd	1872	16	area	area	NN
cord-015365-iqdi99pd	1872	17	,	,	,
cord-015365-iqdi99pd	1872	18	and	and	CC
cord-015365-iqdi99pd	1872	19	attenuates	attenuate	VBZ
cord-015365-iqdi99pd	1872	20	inflammation	inflammation	NN
cord-015365-iqdi99pd	1872	21	after	after	IN
cord-015365-iqdi99pd	1872	22	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1872	23	infarction	infarction	NN
cord-015365-iqdi99pd	1872	24	.	.	.
cord-015365-iqdi99pd	1873	1	In	in	IN
cord-015365-iqdi99pd	1873	2	conclusion	conclusion	NN
cord-015365-iqdi99pd	1873	3	,	,	,
cord-015365-iqdi99pd	1873	4	interaction	interaction	NN
cord-015365-iqdi99pd	1873	5	of	of	IN
cord-015365-iqdi99pd	1873	6	these	these	DT
cord-015365-iqdi99pd	1873	7	factors	factor	NNS
cord-015365-iqdi99pd	1873	8	can	can	MD
cord-015365-iqdi99pd	1873	9	significantly	significantly	RB
cord-015365-iqdi99pd	1873	10	reduce	reduce	VB
cord-015365-iqdi99pd	1873	11	infarction	infarction	NN
cord-015365-iqdi99pd	1873	12	size	size	NN
cord-015365-iqdi99pd	1873	13	and	and	CC
cord-015365-iqdi99pd	1873	14	improve	improve	VB
cord-015365-iqdi99pd	1873	15	left	leave	VBN
cord-015365-iqdi99pd	1873	16	ventricular	ventricular	JJ
cord-015365-iqdi99pd	1873	17	function	function	NN
cord-015365-iqdi99pd	1873	18	after	after	IN
cord-015365-iqdi99pd	1873	19	experimental	experimental	JJ
cord-015365-iqdi99pd	1873	20	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1873	21	infarction	infarction	NN
cord-015365-iqdi99pd	1873	22	in	in	IN
cord-015365-iqdi99pd	1873	23	rats	rat	NNS
cord-015365-iqdi99pd	1873	24	.	.	.
cord-015365-iqdi99pd	1874	1	Secretion	secretion	NN
cord-015365-iqdi99pd	1874	2	of	of	IN
cord-015365-iqdi99pd	1874	3	cytokines	cytokine	NNS
cord-015365-iqdi99pd	1874	4	and	and	CC
cord-015365-iqdi99pd	1874	5	chemokines	chemokine	NNS
cord-015365-iqdi99pd	1874	6	by	by	IN
cord-015365-iqdi99pd	1874	7	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1874	8	blood	blood	NN
cord-015365-iqdi99pd	1874	9	mononuclear	mononuclear	NN
cord-015365-iqdi99pd	1874	10	cells	cell	NNS
cord-015365-iqdi99pd	1874	11	is	be	VBZ
cord-015365-iqdi99pd	1874	12	triggered	trigger	VBN
cord-015365-iqdi99pd	1874	13	by	by	IN
cord-015365-iqdi99pd	1874	14	coagulation	coagulation	NN
cord-015365-iqdi99pd	1874	15	products	product	NNS
cord-015365-iqdi99pd	1874	16	these	these	DT
cord-015365-iqdi99pd	1874	17	mediators	mediator	NNS
cord-015365-iqdi99pd	1874	18	systemic	systemic	JJ
cord-015365-iqdi99pd	1874	19	in	in	IN
cord-015365-iqdi99pd	1874	20	immune	immune	JJ
cord-015365-iqdi99pd	1874	21	activation	activation	NN
cord-015365-iqdi99pd	1874	22	/	/	SYM
cord-015365-iqdi99pd	1874	23	sepsis	sepsis	NN
cord-015365-iqdi99pd	1874	24	,	,	,
cord-015365-iqdi99pd	1874	25	wound	wind	VBN
cord-015365-iqdi99pd	1874	26	healing	healing	NN
cord-015365-iqdi99pd	1874	27	,	,	,
cord-015365-iqdi99pd	1874	28	autoimmune	autoimmune	NN
cord-015365-iqdi99pd	1874	29	-	-	HYPH
cord-015365-iqdi99pd	1874	30	diseases	disease	NNS
cord-015365-iqdi99pd	1874	31	,	,	,
cord-015365-iqdi99pd	1874	32	artherosclerosis	artherosclerosis	NN
cord-015365-iqdi99pd	1874	33	and	and	CC
cord-015365-iqdi99pd	1874	34	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1874	35	infarction	infarction	NN
cord-015365-iqdi99pd	1874	36	.	.	.
cord-015365-iqdi99pd	1875	1	However	however	RB
cord-015365-iqdi99pd	1875	2	,	,	,
cord-015365-iqdi99pd	1875	3	cytokines	cytokine	NNS
cord-015365-iqdi99pd	1875	4	and	and	CC
cord-015365-iqdi99pd	1875	5	chemokines	chemokine	NNS
cord-015365-iqdi99pd	1875	6	are	be	VBP
cord-015365-iqdi99pd	1875	7	usually	usually	RB
cord-015365-iqdi99pd	1875	8	not	not	RB
cord-015365-iqdi99pd	1875	9	considered	consider	VBN
cord-015365-iqdi99pd	1875	10	to	to	TO
cord-015365-iqdi99pd	1875	11	be	be	VB
cord-015365-iqdi99pd	1875	12	very	very	RB
cord-015365-iqdi99pd	1875	13	stable	stable	JJ
cord-015365-iqdi99pd	1875	14	after	after	IN
cord-015365-iqdi99pd	1875	15	blood	blood	NN
cord-015365-iqdi99pd	1875	16	collection	collection	NN
cord-015365-iqdi99pd	1875	17	,	,	,
cord-015365-iqdi99pd	1875	18	which	which	WDT
cord-015365-iqdi99pd	1875	19	might	may	MD
cord-015365-iqdi99pd	1875	20	therefore	therefore	RB
cord-015365-iqdi99pd	1875	21	alter	alter	VB
cord-015365-iqdi99pd	1875	22	test	test	NN
cord-015365-iqdi99pd	1875	23	.	.	.
cord-015365-iqdi99pd	1876	1	Results	result	NNS
cord-015365-iqdi99pd	1876	2	.	.	.
cord-015365-iqdi99pd	1877	1	Thus	thus	RB
cord-015365-iqdi99pd	1877	2	,	,	,
cord-015365-iqdi99pd	1877	3	the	the	DT
cord-015365-iqdi99pd	1877	4	aim	aim	NN
cord-015365-iqdi99pd	1877	5	of	of	IN
cord-015365-iqdi99pd	1877	6	the	the	DT
cord-015365-iqdi99pd	1877	7	pilot	pilot	NN
cord-015365-iqdi99pd	1877	8	study	study	NN
cord-015365-iqdi99pd	1877	9	was	be	VBD
cord-015365-iqdi99pd	1877	10	to	to	TO
cord-015365-iqdi99pd	1877	11	obtain	obtain	VB
cord-015365-iqdi99pd	1877	12	better	well	JJR
cord-015365-iqdi99pd	1877	13	knowledge	knowledge	NN
cord-015365-iqdi99pd	1877	14	about	about	IN
cord-015365-iqdi99pd	1877	15	stability	stability	NN
cord-015365-iqdi99pd	1877	16	of	of	IN
cord-015365-iqdi99pd	1877	17	these	these	DT
cord-015365-iqdi99pd	1877	18	mediators	mediator	NNS
cord-015365-iqdi99pd	1877	19	in	in	IN
cord-015365-iqdi99pd	1877	20	blood	blood	NN
cord-015365-iqdi99pd	1877	21	samples	sample	NNS
cord-015365-iqdi99pd	1877	22	for	for	IN
cord-015365-iqdi99pd	1877	23	interpretation	interpretation	NN
cord-015365-iqdi99pd	1877	24	of	of	IN
cord-015365-iqdi99pd	1877	25	test	test	NN
cord-015365-iqdi99pd	1877	26	results	result	NNS
cord-015365-iqdi99pd	1877	27	.	.	.
cord-015365-iqdi99pd	1878	1	Methods	method	NNS
cord-015365-iqdi99pd	1878	2	.	.	.
cord-015365-iqdi99pd	1879	1	Venous	venous	JJ
cord-015365-iqdi99pd	1879	2	blood	blood	NN
cord-015365-iqdi99pd	1879	3	was	be	VBD
cord-015365-iqdi99pd	1879	4	taken	take	VBN
cord-015365-iqdi99pd	1879	5	from	from	IN
cord-015365-iqdi99pd	1879	6	healthy	healthy	JJ
cord-015365-iqdi99pd	1879	7	probands	proband	NNS
cord-015365-iqdi99pd	1879	8	(	(	-LRB-
cord-015365-iqdi99pd	1879	9	n	n	CC
cord-015365-iqdi99pd	1879	10	¼	¼	NNP
cord-015365-iqdi99pd	1879	11	7	7	CD
cord-015365-iqdi99pd	1879	12	)	)	-RRB-
cord-015365-iqdi99pd	1879	13	using	use	VBG
cord-015365-iqdi99pd	1879	14	different	different	JJ
cord-015365-iqdi99pd	1879	15	blood	blood	NN
cord-015365-iqdi99pd	1879	16	tubes	tube	NNS
cord-015365-iqdi99pd	1879	17	(	(	-LRB-
cord-015365-iqdi99pd	1879	18	serum	serum	NN
cord-015365-iqdi99pd	1879	19	,	,	,
cord-015365-iqdi99pd	1879	20	heparin	heparin	NN
cord-015365-iqdi99pd	1879	21	plasma	plasma	NN
cord-015365-iqdi99pd	1879	22	and	and	CC
cord-015365-iqdi99pd	1879	23	EDTA	EDTA	NNP
cord-015365-iqdi99pd	1879	24	plasma	plasma	NN
cord-015365-iqdi99pd	1879	25	)	)	-RRB-
cord-015365-iqdi99pd	1879	26	.	.	.
cord-015365-iqdi99pd	1880	1	Blood	blood	NN
cord-015365-iqdi99pd	1880	2	tubes	tube	NNS
cord-015365-iqdi99pd	1880	3	were	be	VBD
cord-015365-iqdi99pd	1880	4	either	either	RB
cord-015365-iqdi99pd	1880	5	centrifuged	centrifuge	VBN
cord-015365-iqdi99pd	1880	6	initially	initially	RB
cord-015365-iqdi99pd	1880	7	within	within	IN
cord-015365-iqdi99pd	1880	8	20	20	CD
cord-015365-iqdi99pd	1880	9	minutes	minute	NNS
cord-015365-iqdi99pd	1880	10	after	after	IN
cord-015365-iqdi99pd	1880	11	venipuncture	venipuncture	NN
cord-015365-iqdi99pd	1880	12	and	and	CC
cord-015365-iqdi99pd	1880	13	kept	keep	VBD
cord-015365-iqdi99pd	1880	14	frozen	freeze	VBN
cord-015365-iqdi99pd	1880	15	at	at	IN
cord-015365-iqdi99pd	1880	16	À80	À80	NNP
cord-015365-iqdi99pd	1880	17	until	until	IN
cord-015365-iqdi99pd	1880	18	further	further	JJ
cord-015365-iqdi99pd	1880	19	testing	testing	NN
cord-015365-iqdi99pd	1880	20	or	or	CC
cord-015365-iqdi99pd	1880	21	were	be	VBD
cord-015365-iqdi99pd	1880	22	stored	store	VBN
cord-015365-iqdi99pd	1880	23	at	at	IN
cord-015365-iqdi99pd	1880	24	4	4	CD
cord-015365-iqdi99pd	1880	25	C	C	NNP
cord-015365-iqdi99pd	1880	26	,	,	,
cord-015365-iqdi99pd	1880	27	at	at	IN
cord-015365-iqdi99pd	1880	28	room	room	NN
cord-015365-iqdi99pd	1880	29	temperature	temperature	NN
cord-015365-iqdi99pd	1880	30	(	(	-LRB-
cord-015365-iqdi99pd	1880	31	RT	RT	NNP
cord-015365-iqdi99pd	1880	32	)	)	-RRB-
cord-015365-iqdi99pd	1880	33	or	or	CC
cord-015365-iqdi99pd	1880	34	at	at	IN
cord-015365-iqdi99pd	1880	35	37	37	CD
cord-015365-iqdi99pd	1880	36	for	for	IN
cord-015365-iqdi99pd	1880	37	up	up	IN
cord-015365-iqdi99pd	1880	38	to	to	TO
cord-015365-iqdi99pd	1880	39	24	24	CD
cord-015365-iqdi99pd	1880	40	hours	hour	NNS
cord-015365-iqdi99pd	1880	41	.	.	.
cord-015365-iqdi99pd	1881	1	Samples	sample	NNS
cord-015365-iqdi99pd	1881	2	were	be	VBD
cord-015365-iqdi99pd	1881	3	evaluated	evaluate	VBN
cord-015365-iqdi99pd	1881	4	for	for	IN
cord-015365-iqdi99pd	1881	5	IL-1ß	IL-1ß	NNS
cord-015365-iqdi99pd	1881	6	,	,	,
cord-015365-iqdi99pd	1881	7	IL-6	IL-6	NNP
cord-015365-iqdi99pd	1881	8	,	,	,
cord-015365-iqdi99pd	1881	9	TNF	TNF	NNP
cord-015365-iqdi99pd	1881	10	-	-	:
cord-015365-iqdi99pd	1881	11	and	and	CC
cord-015365-iqdi99pd	1881	12	for	for	IN
cord-015365-iqdi99pd	1881	13	selected	select	VBN
cord-015365-iqdi99pd	1881	14	chemokines	chemokine	NNS
cord-015365-iqdi99pd	1881	15	such	such	JJ
cord-015365-iqdi99pd	1881	16	as	as	IN
cord-015365-iqdi99pd	1881	17	interleukin-8	interleukin-8	NNP
cord-015365-iqdi99pd	1881	18	,	,	,
cord-015365-iqdi99pd	1882	1	epithelial	epithelial	JJ
cord-015365-iqdi99pd	1882	2	neutrophil	neutrophil	NN
cord-015365-iqdi99pd	1882	3	-	-	HYPH
cord-015365-iqdi99pd	1882	4	activating	activate	VBG
cord-015365-iqdi99pd	1882	5	protein	protein	NN
cord-015365-iqdi99pd	1882	6	78	78	CD
cord-015365-iqdi99pd	1882	7	(	(	-LRB-
cord-015365-iqdi99pd	1882	8	ENA-78	ENA-78	NNP
cord-015365-iqdi99pd	1882	9	)	)	-RRB-
cord-015365-iqdi99pd	1882	10	and	and	CC
cord-015365-iqdi99pd	1882	11	granulocyte	granulocyte	NN
cord-015365-iqdi99pd	1882	12	chemotactic	chemotactic	JJ
cord-015365-iqdi99pd	1882	13	peptide-2	peptide-2	NNP
cord-015365-iqdi99pd	1883	1	(	(	-LRB-
cord-015365-iqdi99pd	1883	2	GCP-2	gcp-2	RB
cord-015365-iqdi99pd	1883	3	)	)	-RRB-
cord-015365-iqdi99pd	1883	4	using	use	VBG
cord-015365-iqdi99pd	1883	5	commercially	commercially	RB
cord-015365-iqdi99pd	1883	6	available	available	JJ
cord-015365-iqdi99pd	1883	7	enzyme	enzyme	NN
cord-015365-iqdi99pd	1883	8	-	-	HYPH
cord-015365-iqdi99pd	1883	9	linked	link	VBN
cord-015365-iqdi99pd	1883	10	immunosorbent	immunosorbent	JJ
cord-015365-iqdi99pd	1883	11	assay	assay	NN
cord-015365-iqdi99pd	1883	12	(	(	-LRB-
cord-015365-iqdi99pd	1883	13	ELISA	ELISA	NNP
cord-015365-iqdi99pd	1883	14	)	)	-RRB-
cord-015365-iqdi99pd	1883	15	kits	kit	NNS
cord-015365-iqdi99pd	1883	16	.	.	.
cord-015365-iqdi99pd	1884	1	Results	result	NNS
cord-015365-iqdi99pd	1884	2	.	.	.
cord-015365-iqdi99pd	1885	1	Interestingly	interestingly	RB
cord-015365-iqdi99pd	1885	2	all	all	DT
cord-015365-iqdi99pd	1885	3	examined	examine	VBN
cord-015365-iqdi99pd	1885	4	mediators	mediator	NNS
cord-015365-iqdi99pd	1885	5	rise	rise	VB
cord-015365-iqdi99pd	1885	6	when	when	WRB
cord-015365-iqdi99pd	1885	7	samples	sample	NNS
cord-015365-iqdi99pd	1885	8	were	be	VBD
cord-015365-iqdi99pd	1885	9	stored	store	VBN
cord-015365-iqdi99pd	1885	10	above	above	IN
cord-015365-iqdi99pd	1885	11	room	room	NN
cord-015365-iqdi99pd	1885	12	temperature	temperature	NN
cord-015365-iqdi99pd	1885	13	for	for	IN
cord-015365-iqdi99pd	1885	14	more	more	JJR
cord-015365-iqdi99pd	1885	15	than	than	IN
cord-015365-iqdi99pd	1885	16	4	4	CD
cord-015365-iqdi99pd	1885	17	hours	hour	NNS
cord-015365-iqdi99pd	1885	18	in	in	IN
cord-015365-iqdi99pd	1885	19	serum	serum	NN
cord-015365-iqdi99pd	1885	20	tubes	tube	NNS
cord-015365-iqdi99pd	1885	21	.	.	.
cord-015365-iqdi99pd	1886	1	The	the	DT
cord-015365-iqdi99pd	1886	2	rise	rise	NN
cord-015365-iqdi99pd	1886	3	of	of	IN
cord-015365-iqdi99pd	1886	4	serum	serum	NN
cord-015365-iqdi99pd	1886	5	chemokine	chemokine	NN
cord-015365-iqdi99pd	1886	6	and	and	CC
cord-015365-iqdi99pd	1886	7	cytokine	cytokine	NN
cord-015365-iqdi99pd	1886	8	levels	level	NNS
cord-015365-iqdi99pd	1886	9	culminated	culminate	VBD
cord-015365-iqdi99pd	1886	10	in	in	IN
cord-015365-iqdi99pd	1886	11	a	a	DT
cord-015365-iqdi99pd	1886	12	79-fold	79-fold	CD
cord-015365-iqdi99pd	1886	13	increase	increase	NN
cord-015365-iqdi99pd	1886	14	for	for	IN
cord-015365-iqdi99pd	1886	15	IL-6	IL-6	NNP
cord-015365-iqdi99pd	1886	16	(	(	-LRB-
cord-015365-iqdi99pd	1886	17	p	p	NN
cord-015365-iqdi99pd	1886	18	<	<	XX
cord-015365-iqdi99pd	1886	19	0.0081	0.0081	CD
cord-015365-iqdi99pd	1886	20	)	)	-RRB-
cord-015365-iqdi99pd	1886	21	,	,	,
cord-015365-iqdi99pd	1886	22	a	a	DT
cord-015365-iqdi99pd	1886	23	22-fold	22-fold	CD
cord-015365-iqdi99pd	1886	24	increase	increase	NN
cord-015365-iqdi99pd	1886	25	for	for	IN
cord-015365-iqdi99pd	1886	26	ENA-78	ENA-78	NNP
cord-015365-iqdi99pd	1887	1	(	(	-LRB-
cord-015365-iqdi99pd	1887	2	p	p	NN
cord-015365-iqdi99pd	1887	3	<	<	XX
cord-015365-iqdi99pd	1887	4	0.0006	0.0006	CD
cord-015365-iqdi99pd	1887	5	)	)	-RRB-
cord-015365-iqdi99pd	1887	6	and	and	CC
cord-015365-iqdi99pd	1887	7	a	a	DT
cord-015365-iqdi99pd	1887	8	17-fold	17-fold	JJ
cord-015365-iqdi99pd	1887	9	increase	increase	NN
cord-015365-iqdi99pd	1887	10	for	for	IN
cord-015365-iqdi99pd	1887	11	GCP-2	gcp-2	JJ
cord-015365-iqdi99pd	1887	12	(	(	-LRB-
cord-015365-iqdi99pd	1887	13	p	p	NN
cord-015365-iqdi99pd	1887	14	<	<	XX
cord-015365-iqdi99pd	1887	15	0.0026	0.0026	CD
cord-015365-iqdi99pd	1887	16	)	)	-RRB-
cord-015365-iqdi99pd	1887	17	compared	compare	VBN
cord-015365-iqdi99pd	1887	18	to	to	IN
cord-015365-iqdi99pd	1887	19	basic	basic	JJ
cord-015365-iqdi99pd	1887	20	values	value	NNS
cord-015365-iqdi99pd	1887	21	.	.	.
cord-015365-iqdi99pd	1888	1	Serum	serum	NN
cord-015365-iqdi99pd	1888	2	levels	level	NNS
cord-015365-iqdi99pd	1888	3	of	of	IN
cord-015365-iqdi99pd	1889	1	IL-1	IL-1	NNP
cord-015365-iqdi99pd	1889	2	and	and	CC
cord-015365-iqdi99pd	1889	3	TNF	TNF	NNP
cord-015365-iqdi99pd	1889	4	-	-	:
cord-015365-iqdi99pd	1889	5	where	where	WRB
cord-015365-iqdi99pd	1889	6	not	not	RB
cord-015365-iqdi99pd	1889	7	detectable	detectable	JJ
cord-015365-iqdi99pd	1889	8	at	at	IN
cord-015365-iqdi99pd	1889	9	basic	basic	JJ
cord-015365-iqdi99pd	1889	10	samples	sample	NNS
cord-015365-iqdi99pd	1889	11	but	but	CC
cord-015365-iqdi99pd	1889	12	rise	rise	VBP
cord-015365-iqdi99pd	1889	13	up	up	IN
cord-015365-iqdi99pd	1889	14	to	to	IN
cord-015365-iqdi99pd	1889	15	1157	1157	CD
cord-015365-iqdi99pd	1889	16	pg	pg	NN
cord-015365-iqdi99pd	1889	17	/	/	SYM
cord-015365-iqdi99pd	1889	18	ml	ml	NN
cord-015365-iqdi99pd	1889	19	(	(	-LRB-
cord-015365-iqdi99pd	1889	20	mean	mean	VB
cord-015365-iqdi99pd	1889	21	IL-1	IL-1	NNP
cord-015365-iqdi99pd	1889	22	,	,	,
cord-015365-iqdi99pd	1889	23	p	p	NN
cord-015365-iqdi99pd	1889	24	<	<	XX
cord-015365-iqdi99pd	1889	25	0.03	0.03	CD
cord-015365-iqdi99pd	1889	26	)	)	-RRB-
cord-015365-iqdi99pd	1889	27	and	and	CC
cord-015365-iqdi99pd	1889	28	488	488	CD
cord-015365-iqdi99pd	1889	29	pg	pg	NN
cord-015365-iqdi99pd	1889	30	/	/	SYM
cord-015365-iqdi99pd	1889	31	ml	ml	NN
cord-015365-iqdi99pd	1890	1	(	(	-LRB-
cord-015365-iqdi99pd	1890	2	mean	mean	VB
cord-015365-iqdi99pd	1891	1	TNF-	TNF-	NNP
cord-015365-iqdi99pd	1891	2	,	,	,
cord-015365-iqdi99pd	1891	3	p	p	NN
cord-015365-iqdi99pd	1891	4	<	<	XX
cord-015365-iqdi99pd	1891	5	0.03	0.03	CD
cord-015365-iqdi99pd	1891	6	)	)	-RRB-
cord-015365-iqdi99pd	1891	7	.	.	.
cord-015365-iqdi99pd	1892	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1892	2	.	.	.
cord-015365-iqdi99pd	1893	1	These	these	DT
cord-015365-iqdi99pd	1893	2	data	datum	NNS
cord-015365-iqdi99pd	1893	3	indicate	indicate	VBP
cord-015365-iqdi99pd	1893	4	that	that	IN
cord-015365-iqdi99pd	1893	5	the	the	DT
cord-015365-iqdi99pd	1893	6	most	most	RBS
cord-015365-iqdi99pd	1893	7	chemokine	chemokine	NN
cord-015365-iqdi99pd	1893	8	and	and	CC
cord-015365-iqdi99pd	1893	9	cytokine	cytokine	NN
cord-015365-iqdi99pd	1893	10	levels	level	NNS
cord-015365-iqdi99pd	1893	11	remain	remain	VBP
cord-015365-iqdi99pd	1893	12	stable	stable	JJ
cord-015365-iqdi99pd	1893	13	when	when	WRB
cord-015365-iqdi99pd	1893	14	analysed	analyse	VBN
cord-015365-iqdi99pd	1893	15	within	within	IN
cord-015365-iqdi99pd	1893	16	a	a	DT
cord-015365-iqdi99pd	1893	17	short	short	JJ
cord-015365-iqdi99pd	1893	18	interval	interval	NN
cord-015365-iqdi99pd	1893	19	after	after	IN
cord-015365-iqdi99pd	1893	20	venipuncture	venipuncture	NN
cord-015365-iqdi99pd	1893	21	.	.	.
cord-015365-iqdi99pd	1894	1	When	when	WRB
cord-015365-iqdi99pd	1894	2	tubes	tube	NNS
cord-015365-iqdi99pd	1894	3	were	be	VBD
cord-015365-iqdi99pd	1894	4	exposed	expose	VBN
cord-015365-iqdi99pd	1894	5	to	to	IN
cord-015365-iqdi99pd	1894	6	temperatures	temperature	NNS
cord-015365-iqdi99pd	1894	7	higher	high	JJR
cord-015365-iqdi99pd	1894	8	than	than	IN
cord-015365-iqdi99pd	1894	9	24	24	CD
cord-015365-iqdi99pd	1894	10	(	(	-LRB-
cord-015365-iqdi99pd	1894	11	RT	RT	NNP
cord-015365-iqdi99pd	1894	12	)	)	-RRB-
cord-015365-iqdi99pd	1894	13	,	,	,
cord-015365-iqdi99pd	1894	14	levels	level	NNS
cord-015365-iqdi99pd	1894	15	of	of	IN
cord-015365-iqdi99pd	1894	16	measured	measured	JJ
cord-015365-iqdi99pd	1894	17	chemokines	chemokine	NNS
cord-015365-iqdi99pd	1894	18	increased	increase	VBD
cord-015365-iqdi99pd	1894	19	dramatically	dramatically	RB
cord-015365-iqdi99pd	1894	20	.	.	.
cord-015365-iqdi99pd	1894	21	 	 	_SP
cord-015365-iqdi99pd	1895	1	Background	background	NN
cord-015365-iqdi99pd	1895	2	.	.	.
cord-015365-iqdi99pd	1896	1	Rabbit	Rabbit	NNP
cord-015365-iqdi99pd	1896	2	antithymocyte	antithymocyte	NN
cord-015365-iqdi99pd	1896	3	globulin	globulin	NN
cord-015365-iqdi99pd	1896	4	(	(	-LRB-
cord-015365-iqdi99pd	1896	5	rATG	rATG	NNP
cord-015365-iqdi99pd	1896	6	)	)	-RRB-
cord-015365-iqdi99pd	1896	7	is	be	VBZ
cord-015365-iqdi99pd	1896	8	widely	widely	RB
cord-015365-iqdi99pd	1896	9	used	use	VBN
cord-015365-iqdi99pd	1896	10	as	as	IN
cord-015365-iqdi99pd	1896	11	induction	induction	NN
cord-015365-iqdi99pd	1896	12	agent	agent	NN
cord-015365-iqdi99pd	1896	13	in	in	IN
cord-015365-iqdi99pd	1896	14	solid	solid	JJ
cord-015365-iqdi99pd	1896	15	organ	organ	NN
cord-015365-iqdi99pd	1896	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	1896	17	.	.	.
cord-015365-iqdi99pd	1897	1	Beside	beside	IN
cord-015365-iqdi99pd	1897	2	depletion	depletion	NN
cord-015365-iqdi99pd	1897	3	of	of	IN
cord-015365-iqdi99pd	1897	4	circulating	circulate	VBG
cord-015365-iqdi99pd	1897	5	lymphocytes	lymphocyte	NNS
cord-015365-iqdi99pd	1897	6	there	there	EX
cord-015365-iqdi99pd	1897	7	is	be	VBZ
cord-015365-iqdi99pd	1897	8	a	a	DT
cord-015365-iqdi99pd	1897	9	growing	grow	VBG
cord-015365-iqdi99pd	1897	10	body	body	NN
cord-015365-iqdi99pd	1897	11	of	of	IN
cord-015365-iqdi99pd	1897	12	evidence	evidence	NN
cord-015365-iqdi99pd	1897	13	suggesting	suggest	VBG
cord-015365-iqdi99pd	1897	14	that	that	IN
cord-015365-iqdi99pd	1897	15	rATG	rATG	NNP
cord-015365-iqdi99pd	1897	16	may	may	MD
cord-015365-iqdi99pd	1897	17	also	also	RB
cord-015365-iqdi99pd	1897	18	play	play	VB
cord-015365-iqdi99pd	1897	19	a	a	DT
cord-015365-iqdi99pd	1897	20	pivotal	pivotal	JJ
cord-015365-iqdi99pd	1897	21	role	role	NN
cord-015365-iqdi99pd	1897	22	in	in	IN
cord-015365-iqdi99pd	1897	23	modulating	modulate	VBG
cord-015365-iqdi99pd	1897	24	the	the	DT
cord-015365-iqdi99pd	1897	25	immune	immune	JJ
cord-015365-iqdi99pd	1897	26	system	system	NN
cord-015365-iqdi99pd	1897	27	.	.	.
cord-015365-iqdi99pd	1898	1	As	as	IN
cord-015365-iqdi99pd	1898	2	blood	blood	NN
cord-015365-iqdi99pd	1898	3	circulating	circulate	VBG
cord-015365-iqdi99pd	1898	4	endothelial	endothelial	JJ
cord-015365-iqdi99pd	1898	5	cells	cell	NNS
cord-015365-iqdi99pd	1898	6	(	(	-LRB-
cord-015365-iqdi99pd	1898	7	CECs	cec	NNS
cord-015365-iqdi99pd	1898	8	)	)	-RRB-
cord-015365-iqdi99pd	1898	9	and	and	CC
cord-015365-iqdi99pd	1898	10	circulating	circulate	VBG
cord-015365-iqdi99pd	1898	11	hematopoietic	hematopoietic	JJ
cord-015365-iqdi99pd	1898	12	progenitor	progenitor	NN
cord-015365-iqdi99pd	1898	13	cells	cell	NNS
cord-015365-iqdi99pd	1898	14	(	(	-LRB-
cord-015365-iqdi99pd	1898	15	CPCs	CPCs	NNP
cord-015365-iqdi99pd	1898	16	)	)	-RRB-
cord-015365-iqdi99pd	1898	17	represent	represent	VBP
cord-015365-iqdi99pd	1898	18	two	two	CD
cord-015365-iqdi99pd	1898	19	minute	minute	NN
cord-015365-iqdi99pd	1898	20	fractions	fraction	NNS
cord-015365-iqdi99pd	1898	21	(	(	-LRB-
cord-015365-iqdi99pd	1898	22	CECs	cec	NNS
cord-015365-iqdi99pd	1898	23	:	:	:
cord-015365-iqdi99pd	1898	24	0.1	0.1	CD
cord-015365-iqdi99pd	1898	25	%	%	NN
cord-015365-iqdi99pd	1898	26	to	to	TO
cord-015365-iqdi99pd	1898	27	6.0	6.0	CD
cord-015365-iqdi99pd	1898	28	%	%	NN
cord-015365-iqdi99pd	1898	29	and	and	CC
cord-015365-iqdi99pd	1898	30	CPCs	cpc	NNS
cord-015365-iqdi99pd	1898	31	:	:	:
cord-015365-iqdi99pd	1898	32	0.01	0.01	CD
cord-015365-iqdi99pd	1898	33	-	-	HYPH
cord-015365-iqdi99pd	1898	34	0.20	0.20	CD
cord-015365-iqdi99pd	1898	35	%	%	NN
cord-015365-iqdi99pd	1898	36	)	)	-RRB-
cord-015365-iqdi99pd	1898	37	of	of	IN
cord-015365-iqdi99pd	1898	38	blood	blood	NN
cord-015365-iqdi99pd	1898	39	mononuclear	mononuclear	NN
cord-015365-iqdi99pd	1898	40	cells	cell	NNS
cord-015365-iqdi99pd	1898	41	that	that	WDT
cord-015365-iqdi99pd	1898	42	are	be	VBP
cord-015365-iqdi99pd	1898	43	thought	think	VBN
cord-015365-iqdi99pd	1898	44	to	to	TO
cord-015365-iqdi99pd	1898	45	play	play	VB
cord-015365-iqdi99pd	1898	46	important	important	JJ
cord-015365-iqdi99pd	1898	47	roles	role	NNS
cord-015365-iqdi99pd	1898	48	in	in	IN
cord-015365-iqdi99pd	1898	49	tissue	tissue	NN
cord-015365-iqdi99pd	1898	50	vascularisation	vascularisation	NN
cord-015365-iqdi99pd	1898	51	,	,	,
cord-015365-iqdi99pd	1898	52	the	the	DT
cord-015365-iqdi99pd	1898	53	study	study	NN
cord-015365-iqdi99pd	1898	54	of	of	IN
cord-015365-iqdi99pd	1898	55	both	both	DT
cord-015365-iqdi99pd	1898	56	cell	cell	NN
cord-015365-iqdi99pd	1898	57	types	type	NNS
cord-015365-iqdi99pd	1898	58	is	be	VBZ
cord-015365-iqdi99pd	1898	59	currently	currently	RB
cord-015365-iqdi99pd	1898	60	suggested	suggest	VBN
cord-015365-iqdi99pd	1898	61	as	as	IN
cord-015365-iqdi99pd	1898	62	surrogate	surrogate	JJ
cord-015365-iqdi99pd	1898	63	markers	marker	NNS
cord-015365-iqdi99pd	1898	64	for	for	IN
cord-015365-iqdi99pd	1898	65	numerous	numerous	JJ
cord-015365-iqdi99pd	1898	66	pathologies	pathology	NNS
cord-015365-iqdi99pd	1898	67	.	.	.
cord-015365-iqdi99pd	1899	1	Especially	especially	RB
cord-015365-iqdi99pd	1899	2	the	the	DT
cord-015365-iqdi99pd	1899	3	noninvasive	noninvasive	JJ
cord-015365-iqdi99pd	1899	4	endothelial	endothelial	JJ
cord-015365-iqdi99pd	1899	5	evaluation	evaluation	NN
cord-015365-iqdi99pd	1899	6	as	as	IN
cord-015365-iqdi99pd	1899	7	an	an	DT
cord-015365-iqdi99pd	1899	8	early	early	JJ
cord-015365-iqdi99pd	1899	9	index	index	NN
cord-015365-iqdi99pd	1899	10	of	of	IN
cord-015365-iqdi99pd	1899	11	vascular	vascular	JJ
cord-015365-iqdi99pd	1899	12	injury	injury	NN
cord-015365-iqdi99pd	1899	13	following	follow	VBG
cord-015365-iqdi99pd	1899	14	kidney	kidney	NN
cord-015365-iqdi99pd	1899	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	1899	16	has	have	VBZ
cord-015365-iqdi99pd	1899	17	been	be	VBN
cord-015365-iqdi99pd	1899	18	already	already	RB
cord-015365-iqdi99pd	1899	19	demonstrated	demonstrate	VBN
cord-015365-iqdi99pd	1899	20	.	.	.
cord-015365-iqdi99pd	1900	1	Methods	method	NNS
cord-015365-iqdi99pd	1900	2	.	.	.
cord-015365-iqdi99pd	1901	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1901	2	used	use	VBD
cord-015365-iqdi99pd	1901	3	four	four	CD
cord-015365-iqdi99pd	1901	4	surface	surface	NN
cord-015365-iqdi99pd	1901	5	markers	marker	NNS
cord-015365-iqdi99pd	1901	6	to	to	TO
cord-015365-iqdi99pd	1901	7	identify	identify	VB
cord-015365-iqdi99pd	1901	8	viable	viable	JJ
cord-015365-iqdi99pd	1901	9	CECs	cec	NNS
cord-015365-iqdi99pd	1901	10	as	as	IN
cord-015365-iqdi99pd	1901	11	CD31bright	CD31bright	NNP
cord-015365-iqdi99pd	1901	12	,	,	,
cord-015365-iqdi99pd	1901	13	CD34dim	CD34dim	NNP
cord-015365-iqdi99pd	1901	14	,	,	,
cord-015365-iqdi99pd	1901	15	CD45-	CD45-	NNP
cord-015365-iqdi99pd	1901	16	,	,	,
cord-015365-iqdi99pd	1901	17	CD133-and	cd133-and	VB
cord-015365-iqdi99pd	1901	18	viable	viable	JJ
cord-015365-iqdi99pd	1901	19	CPCs	cpc	NNS
cord-015365-iqdi99pd	1901	20	as	as	IN
cord-015365-iqdi99pd	1901	21	CD34bright	CD34bright	NNP
cord-015365-iqdi99pd	1901	22	,	,	,
cord-015365-iqdi99pd	1901	23	CD133þ	CD133þ	NNP
cord-015365-iqdi99pd	1901	24	,	,	,
cord-015365-iqdi99pd	1901	25	CD45dim	CD45dim	NNP
cord-015365-iqdi99pd	1901	26	,	,	,
cord-015365-iqdi99pd	1901	27	CD31	CD31	NNP
cord-015365-iqdi99pd	1901	28	þ	þ	CD
cord-015365-iqdi99pd	1901	29	cells	cell	NNS
cord-015365-iqdi99pd	1901	30	in	in	IN
cord-015365-iqdi99pd	1901	31	the	the	DT
cord-015365-iqdi99pd	1901	32	peripheral	peripheral	JJ
cord-015365-iqdi99pd	1901	33	blood	blood	NN
cord-015365-iqdi99pd	1901	34	of	of	IN
cord-015365-iqdi99pd	1901	35	liver	liver	NN
cord-015365-iqdi99pd	1901	36	transplanted	transplant	VBN
cord-015365-iqdi99pd	1901	37	recipients	recipient	NNS
cord-015365-iqdi99pd	1901	38	(	(	-LRB-
cord-015365-iqdi99pd	1901	39	n	n	CC
cord-015365-iqdi99pd	1901	40	¼	¼	NNP
cord-015365-iqdi99pd	1901	41	28	28	CD
cord-015365-iqdi99pd	1901	42	)	)	-RRB-
cord-015365-iqdi99pd	1901	43	until	until	IN
cord-015365-iqdi99pd	1901	44	day	day	NN
cord-015365-iqdi99pd	1901	45	20	20	CD
cord-015365-iqdi99pd	1901	46	post	post	NN
cord-015365-iqdi99pd	1901	47	transplantation	transplantation	NN
cord-015365-iqdi99pd	1901	48	via	via	IN
cord-015365-iqdi99pd	1901	49	FACS	FACS	NNP
cord-015365-iqdi99pd	1901	50	-	-	HYPH
cord-015365-iqdi99pd	1901	51	analysis	analysis	NN
cord-015365-iqdi99pd	1901	52	.	.	.
cord-015365-iqdi99pd	1902	1	Results	result	NNS
cord-015365-iqdi99pd	1902	2	.	.	.
cord-015365-iqdi99pd	1903	1	An	an	DT
cord-015365-iqdi99pd	1903	2	induction	induction	NN
cord-015365-iqdi99pd	1903	3	of	of	IN
cord-015365-iqdi99pd	1903	4	CECs	cec	NNS
cord-015365-iqdi99pd	1903	5	was	be	VBD
cord-015365-iqdi99pd	1903	6	exclusively	exclusively	RB
cord-015365-iqdi99pd	1903	7	observed	observe	VBN
cord-015365-iqdi99pd	1903	8	for	for	IN
cord-015365-iqdi99pd	1903	9	rATG	rATG	VBN
cord-015365-iqdi99pd	1903	10	-	-	HYPH
cord-015365-iqdi99pd	1903	11	treated	treat	VBN
cord-015365-iqdi99pd	1903	12	patients	patient	NNS
cord-015365-iqdi99pd	1903	13	(	(	-LRB-
cord-015365-iqdi99pd	1903	14	n	n	CC
cord-015365-iqdi99pd	1903	15	¼	¼	NNP
cord-015365-iqdi99pd	1903	16	17	17	CD
cord-015365-iqdi99pd	1903	17	)	)	-RRB-
cord-015365-iqdi99pd	1903	18	increasing	increase	VBG
cord-015365-iqdi99pd	1903	19	from	from	IN
cord-015365-iqdi99pd	1903	20	0.56	0.56	CD
cord-015365-iqdi99pd	1903	21	%	%	NN
cord-015365-iqdi99pd	1903	22	AE	AE	NNP
cord-015365-iqdi99pd	1903	23	0.98	0.98	CD
cord-015365-iqdi99pd	1903	24	%	%	NN
cord-015365-iqdi99pd	1903	25	pre	pre	JJ
cord-015365-iqdi99pd	1903	26	transplantation	transplantation	NN
cord-015365-iqdi99pd	1903	27	to	to	IN
cord-015365-iqdi99pd	1903	28	1.83	1.83	CD
cord-015365-iqdi99pd	1903	29	%	%	NN
cord-015365-iqdi99pd	1903	30	AE	AE	NNP
cord-015365-iqdi99pd	1903	31	1.85	1.85	CD
cord-015365-iqdi99pd	1903	32	%	%	NN
cord-015365-iqdi99pd	1903	33	at	at	IN
cord-015365-iqdi99pd	1903	34	day	day	NN
cord-015365-iqdi99pd	1903	35	1	1	CD
cord-015365-iqdi99pd	1903	36	-	-	SYM
cord-015365-iqdi99pd	1903	37	2	2	CD
cord-015365-iqdi99pd	1903	38	post	post	NN
cord-015365-iqdi99pd	1903	39	transplantation	transplantation	NN
cord-015365-iqdi99pd	1903	40	compared	compare	VBN
cord-015365-iqdi99pd	1903	41	with	with	IN
cord-015365-iqdi99pd	1903	42	control	control	NN
cord-015365-iqdi99pd	1903	43	patients	patient	NNS
cord-015365-iqdi99pd	1903	44	receiving	receive	VBG
cord-015365-iqdi99pd	1903	45	standard	standard	JJ
cord-015365-iqdi99pd	1903	46	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	1903	47	(	(	-LRB-
cord-015365-iqdi99pd	1903	48	n	n	NN
cord-015365-iqdi99pd	1903	49	¼	¼	NNP
cord-015365-iqdi99pd	1903	50	11	11	CD
cord-015365-iqdi99pd	1903	51	)	)	-RRB-
cord-015365-iqdi99pd	1903	52	(	(	-LRB-
cord-015365-iqdi99pd	1903	53	p	p	NN
cord-015365-iqdi99pd	1903	54	<	<	XX
cord-015365-iqdi99pd	1903	55	0.04	0.04	CD
cord-015365-iqdi99pd	1903	56	)	)	-RRB-
cord-015365-iqdi99pd	1903	57	.	.	.
cord-015365-iqdi99pd	1904	1	In	in	IN
cord-015365-iqdi99pd	1904	2	addition	addition	NN
cord-015365-iqdi99pd	1904	3	,	,	,
cord-015365-iqdi99pd	1904	4	the	the	DT
cord-015365-iqdi99pd	1904	5	induction	induction	NN
cord-015365-iqdi99pd	1904	6	of	of	IN
cord-015365-iqdi99pd	1904	7	CPCs	CPCs	NNP
cord-015365-iqdi99pd	1904	8	was	be	VBD
cord-015365-iqdi99pd	1904	9	even	even	RB
cord-015365-iqdi99pd	1904	10	more	more	RBR
cord-015365-iqdi99pd	1904	11	pronounced	pronounced	JJ
cord-015365-iqdi99pd	1904	12	illustrating	illustrate	VBG
cord-015365-iqdi99pd	1904	13	an	an	DT
cord-015365-iqdi99pd	1904	14	increase	increase	NN
cord-015365-iqdi99pd	1904	15	in	in	IN
cord-015365-iqdi99pd	1904	16	rATG	ratg	JJ
cord-015365-iqdi99pd	1904	17	treated	treat	VBN
cord-015365-iqdi99pd	1904	18	patients	patient	NNS
cord-015365-iqdi99pd	1904	19	from	from	IN
cord-015365-iqdi99pd	1904	20	0.20	0.20	CD
cord-015365-iqdi99pd	1904	21	%	%	NN
cord-015365-iqdi99pd	1904	22	AE	AE	NNP
cord-015365-iqdi99pd	1904	23	0.26	0.26	CD
cord-015365-iqdi99pd	1904	24	%	%	NN
cord-015365-iqdi99pd	1904	25	pre	pre	JJ
cord-015365-iqdi99pd	1904	26	transplantation	transplantation	NN
cord-015365-iqdi99pd	1904	27	to	to	IN
cord-015365-iqdi99pd	1904	28	1.55	1.55	CD
cord-015365-iqdi99pd	1904	29	%	%	NN
cord-015365-iqdi99pd	1904	30	AE	AE	NNP
cord-015365-iqdi99pd	1904	31	1.75	1.75	CD
cord-015365-iqdi99pd	1904	32	%	%	NN
cord-015365-iqdi99pd	1904	33	at	at	IN
cord-015365-iqdi99pd	1904	34	day	day	NN
cord-015365-iqdi99pd	1904	35	1	1	CD
cord-015365-iqdi99pd	1904	36	-	-	SYM
cord-015365-iqdi99pd	1904	37	2	2	CD
cord-015365-iqdi99pd	1904	38	post	post	NN
cord-015365-iqdi99pd	1904	39	transplantation	transplantation	NN
cord-015365-iqdi99pd	1904	40	(	(	-LRB-
cord-015365-iqdi99pd	1904	41	p	p	NN
cord-015365-iqdi99pd	1904	42	<	<	XX
cord-015365-iqdi99pd	1904	43	0.001	0.001	CD
cord-015365-iqdi99pd	1904	44	)	)	-RRB-
cord-015365-iqdi99pd	1904	45	.	.	.
cord-015365-iqdi99pd	1905	1	A	a	DT
cord-015365-iqdi99pd	1905	2	significant	significant	JJ
cord-015365-iqdi99pd	1905	3	elevation	elevation	NN
cord-015365-iqdi99pd	1905	4	of	of	IN
cord-015365-iqdi99pd	1905	5	blood	blood	NN
cord-015365-iqdi99pd	1905	6	CPCs	cpc	NNS
cord-015365-iqdi99pd	1905	7	is	be	VBZ
cord-015365-iqdi99pd	1905	8	still	still	RB
cord-015365-iqdi99pd	1905	9	detectable	detectable	JJ
cord-015365-iqdi99pd	1905	10	at	at	IN
cord-015365-iqdi99pd	1905	11	day	day	NN
cord-015365-iqdi99pd	1905	12	5	5	CD
cord-015365-iqdi99pd	1905	13	(	(	-LRB-
cord-015365-iqdi99pd	1905	14	p	p	NN
cord-015365-iqdi99pd	1905	15	¼	¼	CD
cord-015365-iqdi99pd	1905	16	0.0379	0.0379	CD
cord-015365-iqdi99pd	1905	17	compared	compare	VBN
cord-015365-iqdi99pd	1905	18	with	with	IN
cord-015365-iqdi99pd	1905	19	controls	control	NNS
cord-015365-iqdi99pd	1905	20	)	)	-RRB-
cord-015365-iqdi99pd	1905	21	and	and	CC
cord-015365-iqdi99pd	1905	22	starts	start	VBZ
cord-015365-iqdi99pd	1905	23	to	to	TO
cord-015365-iqdi99pd	1905	24	decline	decline	VB
cord-015365-iqdi99pd	1905	25	at	at	IN
cord-015365-iqdi99pd	1905	26	day	day	NN
cord-015365-iqdi99pd	1905	27	10	10	CD
cord-015365-iqdi99pd	1905	28	post	post	NN
cord-015365-iqdi99pd	1905	29	transplantation	transplantation	NN
cord-015365-iqdi99pd	1905	30	.	.	.
cord-015365-iqdi99pd	1906	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1906	2	.	.	.
cord-015365-iqdi99pd	1907	1	In	in	IN
cord-015365-iqdi99pd	1907	2	summary	summary	NN
cord-015365-iqdi99pd	1907	3	we	-PRON-	PRP
cord-015365-iqdi99pd	1907	4	illustrated	illustrate	VBD
cord-015365-iqdi99pd	1907	5	that	that	IN
cord-015365-iqdi99pd	1907	6	both	both	DT
cord-015365-iqdi99pd	1907	7	CECs	cec	NNS
cord-015365-iqdi99pd	1907	8	and	and	CC
cord-015365-iqdi99pd	1907	9	CPCs	CPCs	NNPS
cord-015365-iqdi99pd	1907	10	were	be	VBD
cord-015365-iqdi99pd	1907	11	detectable	detectable	JJ
cord-015365-iqdi99pd	1907	12	in	in	IN
cord-015365-iqdi99pd	1907	13	numbers	number	NNS
cord-015365-iqdi99pd	1907	14	that	that	WDT
cord-015365-iqdi99pd	1907	15	allows	allow	VBZ
cord-015365-iqdi99pd	1907	16	kinetic	kinetic	JJ
cord-015365-iqdi99pd	1907	17	monitoring	monitoring	NN
cord-015365-iqdi99pd	1907	18	of	of	IN
cord-015365-iqdi99pd	1907	19	these	these	DT
cord-015365-iqdi99pd	1907	20	cell	cell	NN
cord-015365-iqdi99pd	1907	21	types	type	NNS
cord-015365-iqdi99pd	1907	22	post	post	VBP
cord-015365-iqdi99pd	1907	23	transplantation	transplantation	NN
cord-015365-iqdi99pd	1907	24	and	and	CC
cord-015365-iqdi99pd	1907	25	that	that	IN
cord-015365-iqdi99pd	1907	26	rATG	ratg	JJ
cord-015365-iqdi99pd	1907	27	treatment	treatment	NN
cord-015365-iqdi99pd	1907	28	results	result	NNS
cord-015365-iqdi99pd	1907	29	in	in	IN
cord-015365-iqdi99pd	1907	30	a	a	DT
cord-015365-iqdi99pd	1907	31	transient	transient	JJ
cord-015365-iqdi99pd	1907	32	induction	induction	NN
cord-015365-iqdi99pd	1907	33	.	.	.
cord-015365-iqdi99pd	1908	1	As	as	IN
cord-015365-iqdi99pd	1908	2	clinical	clinical	JJ
cord-015365-iqdi99pd	1908	3	correlations	correlation	NNS
cord-015365-iqdi99pd	1908	4	between	between	IN
cord-015365-iqdi99pd	1908	5	the	the	DT
cord-015365-iqdi99pd	1908	6	concentration	concentration	NN
cord-015365-iqdi99pd	1908	7	of	of	IN
cord-015365-iqdi99pd	1908	8	these	these	DT
cord-015365-iqdi99pd	1908	9	two	two	CD
cord-015365-iqdi99pd	1908	10	populations	population	NNS
cord-015365-iqdi99pd	1908	11	and	and	CC
cord-015365-iqdi99pd	1908	12	the	the	DT
cord-015365-iqdi99pd	1908	13	effect	effect	NN
cord-015365-iqdi99pd	1908	14	of	of	IN
cord-015365-iqdi99pd	1908	15	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	1908	16	regimens	regimen	NNS
cord-015365-iqdi99pd	1908	17	has	have	VBZ
cord-015365-iqdi99pd	1908	18	been	be	VBN
cord-015365-iqdi99pd	1908	19	already	already	RB
cord-015365-iqdi99pd	1908	20	proven	prove	VBN
cord-015365-iqdi99pd	1908	21	,	,	,
cord-015365-iqdi99pd	1908	22	validation	validation	NN
cord-015365-iqdi99pd	1908	23	of	of	IN
cord-015365-iqdi99pd	1908	24	these	these	DT
cord-015365-iqdi99pd	1908	25	cell	cell	NN
cord-015365-iqdi99pd	1908	26	populations	population	NNS
cord-015365-iqdi99pd	1908	27	as	as	IN
cord-015365-iqdi99pd	1908	28	biomarkers	biomarker	NNS
cord-015365-iqdi99pd	1908	29	in	in	IN
cord-015365-iqdi99pd	1908	30	the	the	DT
cord-015365-iqdi99pd	1908	31	setting	setting	NN
cord-015365-iqdi99pd	1908	32	of	of	IN
cord-015365-iqdi99pd	1908	33	solid	solid	JJ
cord-015365-iqdi99pd	1908	34	organ	organ	NN
cord-015365-iqdi99pd	1908	35	transplantation	transplantation	NN
cord-015365-iqdi99pd	1908	36	remains	remain	VBZ
cord-015365-iqdi99pd	1908	37	to	to	TO
cord-015365-iqdi99pd	1908	38	be	be	VB
cord-015365-iqdi99pd	1908	39	determined	determine	VBN
cord-015365-iqdi99pd	1908	40	.	.	.
cord-015365-iqdi99pd	1909	1	Background	background	NN
cord-015365-iqdi99pd	1909	2	.	.	.
cord-015365-iqdi99pd	1910	1	Lipocalin-2	Lipocalin-2	NNP
cord-015365-iqdi99pd	1911	1	(	(	-LRB-
cord-015365-iqdi99pd	1911	2	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	1911	3	)	)	-RRB-
cord-015365-iqdi99pd	1911	4	has	have	VBZ
cord-015365-iqdi99pd	1911	5	been	be	VBN
cord-015365-iqdi99pd	1911	6	described	describe	VBN
cord-015365-iqdi99pd	1911	7	as	as	IN
cord-015365-iqdi99pd	1911	8	a	a	DT
cord-015365-iqdi99pd	1911	9	marker	marker	NN
cord-015365-iqdi99pd	1911	10	and	and	CC
cord-015365-iqdi99pd	1911	11	potential	potential	JJ
cord-015365-iqdi99pd	1911	12	positive	positive	JJ
cord-015365-iqdi99pd	1911	13	modulator	modulator	NN
cord-015365-iqdi99pd	1911	14	of	of	IN
cord-015365-iqdi99pd	1911	15	inflammation	inflammation	NN
cord-015365-iqdi99pd	1911	16	during	during	IN
cord-015365-iqdi99pd	1911	17	ischemia	ischemia	NN
cord-015365-iqdi99pd	1911	18	/	/	SYM
cord-015365-iqdi99pd	1911	19	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	1911	20	injury	injury	NN
cord-015365-iqdi99pd	1911	21	(	(	-LRB-
cord-015365-iqdi99pd	1911	22	IRI	IRI	NNP
cord-015365-iqdi99pd	1911	23	)	)	-RRB-
cord-015365-iqdi99pd	1911	24	following	follow	VBG
cord-015365-iqdi99pd	1911	25	solid	solid	JJ
cord-015365-iqdi99pd	1911	26	organ	organ	NN
cord-015365-iqdi99pd	1911	27	transplantation	transplantation	NN
cord-015365-iqdi99pd	1911	28	.	.	.
cord-015365-iqdi99pd	1912	1	Data	datum	NNS
cord-015365-iqdi99pd	1912	2	on	on	IN
cord-015365-iqdi99pd	1912	3	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	1912	4	expression	expression	NN
cord-015365-iqdi99pd	1912	5	during	during	IN
cord-015365-iqdi99pd	1912	6	allograft	allograft	NN
cord-015365-iqdi99pd	1912	7	rejection	rejection	NN
cord-015365-iqdi99pd	1912	8	have	have	VBP
cord-015365-iqdi99pd	1912	9	been	be	VBN
cord-015365-iqdi99pd	1912	10	missing	miss	VBG
cord-015365-iqdi99pd	1912	11	so	so	RB
cord-015365-iqdi99pd	1912	12	far	far	RB
cord-015365-iqdi99pd	1912	13	.	.	.
cord-015365-iqdi99pd	1913	1	Methods	method	NNS
cord-015365-iqdi99pd	1913	2	.	.	.
cord-015365-iqdi99pd	1914	1	Sera	Sera	NNP
cord-015365-iqdi99pd	1914	2	of	of	IN
cord-015365-iqdi99pd	1914	3	68	68	CD
cord-015365-iqdi99pd	1914	4	patients	patient	NNS
cord-015365-iqdi99pd	1914	5	undergoing	undergo	VBG
cord-015365-iqdi99pd	1914	6	orthotopic	orthotopic	JJ
cord-015365-iqdi99pd	1914	7	liver	liver	NN
cord-015365-iqdi99pd	1914	8	transplantation	transplantation	NN
cord-015365-iqdi99pd	1914	9	were	be	VBD
cord-015365-iqdi99pd	1914	10	collected	collect	VBN
cord-015365-iqdi99pd	1914	11	preoperatively	preoperatively	RB
cord-015365-iqdi99pd	1914	12	and	and	CC
cord-015365-iqdi99pd	1914	13	postoperatively	postoperatively	RB
cord-015365-iqdi99pd	1914	14	from	from	IN
cord-015365-iqdi99pd	1914	15	day	day	NN
cord-015365-iqdi99pd	1914	16	1	1	CD
cord-015365-iqdi99pd	1914	17	to	to	IN
cord-015365-iqdi99pd	1914	18	15	15	CD
cord-015365-iqdi99pd	1914	19	.	.	.
cord-015365-iqdi99pd	1915	1	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	1915	2	was	be	VBD
cord-015365-iqdi99pd	1915	3	analyzed	analyze	VBN
cord-015365-iqdi99pd	1915	4	by	by	IN
cord-015365-iqdi99pd	1915	5	ELISA	ELISA	NNP
cord-015365-iqdi99pd	1915	6	and	and	CC
cord-015365-iqdi99pd	1915	7	expression	expression	NN
cord-015365-iqdi99pd	1915	8	levels	level	NNS
cord-015365-iqdi99pd	1915	9	were	be	VBD
cord-015365-iqdi99pd	1915	10	correlated	correlate	VBN
cord-015365-iqdi99pd	1915	11	with	with	IN
cord-015365-iqdi99pd	1915	12	parameters	parameter	NNS
cord-015365-iqdi99pd	1915	13	of	of	IN
cord-015365-iqdi99pd	1915	14	allograft	allograft	NN
cord-015365-iqdi99pd	1915	15	rejection	rejection	NN
cord-015365-iqdi99pd	1915	16	.	.	.
cord-015365-iqdi99pd	1916	1	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	1916	2	expression	expression	NN
cord-015365-iqdi99pd	1916	3	was	be	VBD
cord-015365-iqdi99pd	1916	4	further	further	RB
cord-015365-iqdi99pd	1916	5	correlated	correlate	VBN
cord-015365-iqdi99pd	1916	6	with	with	IN
cord-015365-iqdi99pd	1916	7	preexistent	preexistent	JJ
cord-015365-iqdi99pd	1916	8	malignancy	malignancy	NN
cord-015365-iqdi99pd	1916	9	,	,	,
cord-015365-iqdi99pd	1916	10	postoperative	postoperative	JJ
cord-015365-iqdi99pd	1916	11	renal	renal	JJ
cord-015365-iqdi99pd	1916	12	failure	failure	NN
cord-015365-iqdi99pd	1916	13	and	and	CC
cord-015365-iqdi99pd	1916	14	various	various	JJ
cord-015365-iqdi99pd	1916	15	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	1916	16	regimens	regimen	NNS
cord-015365-iqdi99pd	1916	17	.	.	.
cord-015365-iqdi99pd	1917	1	Results	result	NNS
cord-015365-iqdi99pd	1917	2	.	.	.
cord-015365-iqdi99pd	1918	1	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	1918	2	serum	serum	NN
cord-015365-iqdi99pd	1918	3	levels	level	NNS
cord-015365-iqdi99pd	1918	4	were	be	VBD
cord-015365-iqdi99pd	1918	5	elevated	elevate	VBN
cord-015365-iqdi99pd	1918	6	3	3	CD
cord-015365-iqdi99pd	1918	7	to	to	TO
cord-015365-iqdi99pd	1918	8	7	7	CD
cord-015365-iqdi99pd	1918	9	fold	fold	VB
cord-015365-iqdi99pd	1918	10	immediately	immediately	RB
cord-015365-iqdi99pd	1918	11	after	after	IN
cord-015365-iqdi99pd	1918	12	liver	liver	NN
cord-015365-iqdi99pd	1918	13	transplantation	transplantation	NN
cord-015365-iqdi99pd	1918	14	due	due	IN
cord-015365-iqdi99pd	1918	15	to	to	IN
cord-015365-iqdi99pd	1918	16	IRI	IRI	NNP
cord-015365-iqdi99pd	1918	17	and	and	CC
cord-015365-iqdi99pd	1918	18	also	also	RB
cord-015365-iqdi99pd	1918	19	increased	increase	VBD
cord-015365-iqdi99pd	1918	20	prior	prior	RB
cord-015365-iqdi99pd	1918	21	to	to	IN
cord-015365-iqdi99pd	1918	22	clinically	clinically	RB
cord-015365-iqdi99pd	1918	23	diagnosed	diagnose	VBN
cord-015365-iqdi99pd	1918	24	acute	acute	JJ
cord-015365-iqdi99pd	1918	25	rejection	rejection	NN
cord-015365-iqdi99pd	1918	26	,	,	,
cord-015365-iqdi99pd	1918	27	however	however	RB
cord-015365-iqdi99pd	1918	28	not	not	RB
cord-015365-iqdi99pd	1918	29	statistically	statistically	RB
cord-015365-iqdi99pd	1918	30	significant	significant	JJ
cord-015365-iqdi99pd	1918	31	(	(	-LRB-
cord-015365-iqdi99pd	1918	32	p	p	NN
cord-015365-iqdi99pd	1918	33	>	>	XX
cord-015365-iqdi99pd	1918	34	0.05	0.05	CD
cord-015365-iqdi99pd	1918	35	)	)	-RRB-
cord-015365-iqdi99pd	1918	36	but	but	CC
cord-015365-iqdi99pd	1918	37	closely	closely	RB
cord-015365-iqdi99pd	1918	38	related	related	JJ
cord-015365-iqdi99pd	1918	39	to	to	IN
cord-015365-iqdi99pd	1918	40	an	an	DT
cord-015365-iqdi99pd	1918	41	elevation	elevation	NN
cord-015365-iqdi99pd	1918	42	of	of	IN
cord-015365-iqdi99pd	1918	43	routinely	routinely	RB
cord-015365-iqdi99pd	1918	44	used	use	VBN
cord-015365-iqdi99pd	1918	45	laboratory	laboratory	NN
cord-015365-iqdi99pd	1918	46	parameters	parameter	NNS
cord-015365-iqdi99pd	1918	47	.	.	.
cord-015365-iqdi99pd	1919	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1919	2	.	.	.
cord-015365-iqdi99pd	1920	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	1920	2	data	datum	NNS
cord-015365-iqdi99pd	1920	3	suggest	suggest	VBP
cord-015365-iqdi99pd	1920	4	Lcn-2	Lcn-2	NNP
cord-015365-iqdi99pd	1920	5	to	to	TO
cord-015365-iqdi99pd	1920	6	be	be	VB
cord-015365-iqdi99pd	1920	7	a	a	DT
cord-015365-iqdi99pd	1920	8	chemoattractant	chemoattractant	JJ
cord-015365-iqdi99pd	1920	9	stimulus	stimulus	NN
cord-015365-iqdi99pd	1920	10	for	for	IN
cord-015365-iqdi99pd	1920	11	infiltrating	infiltrate	VBG
cord-015365-iqdi99pd	1920	12	immune	immune	JJ
cord-015365-iqdi99pd	1920	13	competent	competent	JJ
cord-015365-iqdi99pd	1920	14	cells	cell	NNS
cord-015365-iqdi99pd	1920	15	into	into	IN
cord-015365-iqdi99pd	1920	16	the	the	DT
cord-015365-iqdi99pd	1920	17	allograft	allograft	NN
cord-015365-iqdi99pd	1920	18	following	follow	VBG
cord-015365-iqdi99pd	1920	19	solid	solid	JJ
cord-015365-iqdi99pd	1920	20	organ	organ	NN
cord-015365-iqdi99pd	1920	21	transplantation	transplantation	NN
cord-015365-iqdi99pd	1920	22	.	.	.
cord-015365-iqdi99pd	1921	1	It	-PRON-	PRP
cord-015365-iqdi99pd	1921	2	is	be	VBZ
cord-015365-iqdi99pd	1921	3	an	an	DT
cord-015365-iqdi99pd	1921	4	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	1921	5	marker	marker	NN
cord-015365-iqdi99pd	1921	6	which	which	WDT
cord-015365-iqdi99pd	1921	7	is	be	VBZ
cord-015365-iqdi99pd	1921	8	upregulated	upregulate	VBN
cord-015365-iqdi99pd	1921	9	during	during	IN
cord-015365-iqdi99pd	1921	10	acute	acute	JJ
cord-015365-iqdi99pd	1921	11	graft	graft	NN
cord-015365-iqdi99pd	1921	12	rejection	rejection	NN
cord-015365-iqdi99pd	1921	13	and	and	CC
cord-015365-iqdi99pd	1921	14	its	-PRON-	PRP$
cord-015365-iqdi99pd	1921	15	elevation	elevation	NN
cord-015365-iqdi99pd	1921	16	prior	prior	RB
cord-015365-iqdi99pd	1921	17	to	to	IN
cord-015365-iqdi99pd	1921	18	routinely	routinely	RB
cord-015365-iqdi99pd	1921	19	used	use	VBN
cord-015365-iqdi99pd	1921	20	parameters	parameter	NNS
cord-015365-iqdi99pd	1921	21	of	of	IN
cord-015365-iqdi99pd	1921	22	acute	acute	JJ
cord-015365-iqdi99pd	1921	23	rejection	rejection	NN
cord-015365-iqdi99pd	1921	24	might	may	MD
cord-015365-iqdi99pd	1921	25	be	be	VB
cord-015365-iqdi99pd	1921	26	an	an	DT
cord-015365-iqdi99pd	1921	27	important	important	JJ
cord-015365-iqdi99pd	1921	28	tool	tool	NN
cord-015365-iqdi99pd	1921	29	for	for	IN
cord-015365-iqdi99pd	1921	30	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1921	31	intervention	intervention	NN
cord-015365-iqdi99pd	1921	32	.	.	.
cord-015365-iqdi99pd	1922	1	Effect	effect	NN
cord-015365-iqdi99pd	1922	2	of	of	IN
cord-015365-iqdi99pd	1922	3	oxidative	oxidative	JJ
cord-015365-iqdi99pd	1922	4	stress	stress	NN
cord-015365-iqdi99pd	1922	5	and	and	CC
cord-015365-iqdi99pd	1922	6	endotoxin	endotoxin	NN
cord-015365-iqdi99pd	1922	7	on	on	IN
cord-015365-iqdi99pd	1922	8	albumin	albumin	NN
cord-015365-iqdi99pd	1922	9	in	in	IN
cord-015365-iqdi99pd	1922	10	brain	brain	NN
cord-015365-iqdi99pd	1922	11	death	death	NN
cord-015365-iqdi99pd	1922	12	Background	Background	NNP
cord-015365-iqdi99pd	1922	13	.	.	.
cord-015365-iqdi99pd	1923	1	Albumin	albumin	NN
cord-015365-iqdi99pd	1923	2	binds	bind	VBZ
cord-015365-iqdi99pd	1923	3	and	and	CC
cord-015365-iqdi99pd	1923	4	detoxifies	detoxify	VBZ
cord-015365-iqdi99pd	1923	5	endotoxin	endotoxin	NN
cord-015365-iqdi99pd	1923	6	in	in	IN
cord-015365-iqdi99pd	1923	7	healthy	healthy	JJ
cord-015365-iqdi99pd	1923	8	people	people	NNS
cord-015365-iqdi99pd	1923	9	.	.	.
cord-015365-iqdi99pd	1924	1	Oxidative	oxidative	JJ
cord-015365-iqdi99pd	1924	2	stress	stress	NN
cord-015365-iqdi99pd	1924	3	leads	lead	VBZ
cord-015365-iqdi99pd	1924	4	to	to	IN
cord-015365-iqdi99pd	1924	5	protein	protein	NN
cord-015365-iqdi99pd	1924	6	oxidation	oxidation	NN
cord-015365-iqdi99pd	1924	7	and	and	CC
cord-015365-iqdi99pd	1924	8	thus	thus	RB
cord-015365-iqdi99pd	1924	9	to	to	IN
cord-015365-iqdi99pd	1924	10	impaired	impair	VBN
cord-015365-iqdi99pd	1924	11	binding	binding	JJ
cord-015365-iqdi99pd	1924	12	properties	property	NNS
cord-015365-iqdi99pd	1924	13	of	of	IN
cord-015365-iqdi99pd	1924	14	albumin	albumin	NN
cord-015365-iqdi99pd	1924	15	.	.	.
cord-015365-iqdi99pd	1925	1	This	this	DT
cord-015365-iqdi99pd	1925	2	,	,	,
cord-015365-iqdi99pd	1925	3	in	in	IN
cord-015365-iqdi99pd	1925	4	combination	combination	NN
cord-015365-iqdi99pd	1925	5	with	with	IN
cord-015365-iqdi99pd	1925	6	increased	increase	VBN
cord-015365-iqdi99pd	1925	7	gut	gut	NN
cord-015365-iqdi99pd	1925	8	permeability	permeability	NN
cord-015365-iqdi99pd	1925	9	leads	lead	VBZ
cord-015365-iqdi99pd	1925	10	to	to	IN
cord-015365-iqdi99pd	1925	11	appearance	appearance	NN
cord-015365-iqdi99pd	1925	12	of	of	IN
cord-015365-iqdi99pd	1925	13	endotoxin	endotoxin	NN
cord-015365-iqdi99pd	1925	14	in	in	IN
cord-015365-iqdi99pd	1925	15	the	the	DT
cord-015365-iqdi99pd	1925	16	systemic	systemic	JJ
cord-015365-iqdi99pd	1925	17	circulation	circulation	NN
cord-015365-iqdi99pd	1925	18	and	and	CC
cord-015365-iqdi99pd	1925	19	further	further	RB
cord-015365-iqdi99pd	1925	20	to	to	IN
cord-015365-iqdi99pd	1925	21	impaired	impaired	JJ
cord-015365-iqdi99pd	1925	22	organ	organ	NN
cord-015365-iqdi99pd	1925	23	function	function	NN
cord-015365-iqdi99pd	1925	24	.	.	.
cord-015365-iqdi99pd	1926	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1926	2	hypothesise	hypothesise	VBP
cord-015365-iqdi99pd	1926	3	that	that	IN
cord-015365-iqdi99pd	1926	4	these	these	DT
cord-015365-iqdi99pd	1926	5	processes	process	NNS
cord-015365-iqdi99pd	1926	6	occur	occur	VBP
cord-015365-iqdi99pd	1926	7	in	in	IN
cord-015365-iqdi99pd	1926	8	serum	serum	NN
cord-015365-iqdi99pd	1926	9	of	of	IN
cord-015365-iqdi99pd	1926	10	brain	brain	NN
cord-015365-iqdi99pd	1926	11	-	-	HYPH
cord-015365-iqdi99pd	1926	12	dead	dead	JJ
cord-015365-iqdi99pd	1926	13	organ	organ	NN
cord-015365-iqdi99pd	1926	14	donors	donor	NNS
cord-015365-iqdi99pd	1926	15	.	.	.
cord-015365-iqdi99pd	1927	1	Methods	method	NNS
cord-015365-iqdi99pd	1927	2	.	.	.
cord-015365-iqdi99pd	1928	1	Endotoxin	endotoxin	NN
cord-015365-iqdi99pd	1928	2	was	be	VBD
cord-015365-iqdi99pd	1928	3	determined	determine	VBN
cord-015365-iqdi99pd	1928	4	with	with	IN
cord-015365-iqdi99pd	1928	5	an	an	DT
cord-015365-iqdi99pd	1928	6	adapted	adapt	VBN
cord-015365-iqdi99pd	1928	7	limulus	limulus	NNP
cord-015365-iqdi99pd	1928	8	amoebocyte	amoebocyte	NNP
cord-015365-iqdi99pd	1928	9	lysate	lysate	NN
cord-015365-iqdi99pd	1928	10	assay	assay	NN
cord-015365-iqdi99pd	1928	11	.	.	.
cord-015365-iqdi99pd	1929	1	Albumin	albumin	NN
cord-015365-iqdi99pd	1929	2	fractions	fraction	NNS
cord-015365-iqdi99pd	1929	3	and	and	CC
cord-015365-iqdi99pd	1929	4	binding	bind	VBG
cord-015365-iqdi99pd	1929	5	capacity	capacity	NN
cord-015365-iqdi99pd	1929	6	were	be	VBD
cord-015365-iqdi99pd	1929	7	determined	determine	VBN
cord-015365-iqdi99pd	1929	8	by	by	IN
cord-015365-iqdi99pd	1929	9	HPLC	HPLC	NNP
cord-015365-iqdi99pd	1929	10	.	.	.
cord-015365-iqdi99pd	1930	1	FlowCytomixTM	FlowCytomixTM	NNP
cord-015365-iqdi99pd	1930	2	was	be	VBD
cord-015365-iqdi99pd	1930	3	used	use	VBN
cord-015365-iqdi99pd	1930	4	for	for	IN
cord-015365-iqdi99pd	1930	5	determination	determination	NN
cord-015365-iqdi99pd	1930	6	of	of	IN
cord-015365-iqdi99pd	1930	7	cytokine	cytokine	NN
cord-015365-iqdi99pd	1930	8	levels	level	NNS
cord-015365-iqdi99pd	1930	9	.	.	.
cord-015365-iqdi99pd	1931	1	Results	result	NNS
cord-015365-iqdi99pd	1931	2	.	.	.
cord-015365-iqdi99pd	1932	1	Eighty	eighty	CD
cord-015365-iqdi99pd	1932	2	-	-	HYPH
cord-015365-iqdi99pd	1932	3	four	four	CD
cord-015365-iqdi99pd	1932	4	brain	brain	NN
cord-015365-iqdi99pd	1932	5	-	-	HYPH
cord-015365-iqdi99pd	1932	6	dead	dead	JJ
cord-015365-iqdi99pd	1932	7	organ	organ	NN
cord-015365-iqdi99pd	1932	8	donors	donor	NNS
cord-015365-iqdi99pd	1932	9	were	be	VBD
cord-015365-iqdi99pd	1932	10	enrolled	enrol	VBN
cord-015365-iqdi99pd	1932	11	and	and	CC
cord-015365-iqdi99pd	1932	12	categorized	categorize	VBN
cord-015365-iqdi99pd	1932	13	by	by	IN
cord-015365-iqdi99pd	1932	14	the	the	DT
cord-015365-iqdi99pd	1932	15	length	length	NN
cord-015365-iqdi99pd	1932	16	of	of	IN
cord-015365-iqdi99pd	1932	17	intensive	intensive	JJ
cord-015365-iqdi99pd	1932	18	care	care	NN
cord-015365-iqdi99pd	1932	19	unit	unit	NN
cord-015365-iqdi99pd	1932	20	(	(	-LRB-
cord-015365-iqdi99pd	1932	21	ICU	ICU	NNP
cord-015365-iqdi99pd	1932	22	)	)	-RRB-
cord-015365-iqdi99pd	1932	23	stay	stay	VBP
cord-015365-iqdi99pd	1932	24	.	.	.
cord-015365-iqdi99pd	1933	1	Albumin	albumin	NN
cord-015365-iqdi99pd	1933	2	binding	binding	NN
cord-015365-iqdi99pd	1933	3	capacity	capacity	NN
cord-015365-iqdi99pd	1933	4	for	for	IN
cord-015365-iqdi99pd	1933	5	dansylsarcosine	dansylsarcosine	NN
cord-015365-iqdi99pd	1933	6	was	be	VBD
cord-015365-iqdi99pd	1933	7	reduced	reduce	VBN
cord-015365-iqdi99pd	1933	8	in	in	IN
cord-015365-iqdi99pd	1933	9	brain	brain	NN
cord-015365-iqdi99pd	1933	10	-	-	HYPH
cord-015365-iqdi99pd	1933	11	dead	dead	JJ
cord-015365-iqdi99pd	1933	12	patients	patient	NNS
cord-015365-iqdi99pd	1933	13	compared	compare	VBN
cord-015365-iqdi99pd	1933	14	to	to	IN
cord-015365-iqdi99pd	1933	15	controls	control	NNS
cord-015365-iqdi99pd	1933	16	.	.	.
cord-015365-iqdi99pd	1934	1	Endotoxin	endotoxin	NN
cord-015365-iqdi99pd	1934	2	positivity	positivity	NN
cord-015365-iqdi99pd	1934	3	in	in	IN
cord-015365-iqdi99pd	1934	4	16.7	16.7	CD
cord-015365-iqdi99pd	1934	5	%	%	NN
cord-015365-iqdi99pd	1934	6	of	of	IN
cord-015365-iqdi99pd	1934	7	donors	donor	NNS
cord-015365-iqdi99pd	1934	8	was	be	VBD
cord-015365-iqdi99pd	1934	9	associated	associate	VBN
cord-015365-iqdi99pd	1934	10	with	with	IN
cord-015365-iqdi99pd	1934	11	decreased	decrease	VBN
cord-015365-iqdi99pd	1934	12	binding	bind	VBG
cord-015365-iqdi99pd	1934	13	capacity	capacity	NN
cord-015365-iqdi99pd	1934	14	in	in	IN
cord-015365-iqdi99pd	1934	15	donors	donor	NNS
cord-015365-iqdi99pd	1934	16	and	and	CC
cord-015365-iqdi99pd	1934	17	worse	bad	JJR
cord-015365-iqdi99pd	1934	18	survival	survival	NN
cord-015365-iqdi99pd	1934	19	of	of	IN
cord-015365-iqdi99pd	1934	20	recipients	recipient	NNS
cord-015365-iqdi99pd	1934	21	.	.	.
cord-015365-iqdi99pd	1935	1	Lengths	Lengths	NNP
cord-015365-iqdi99pd	1935	2	of	of	IN
cord-015365-iqdi99pd	1935	3	ICU	ICU	NNP
cord-015365-iqdi99pd	1935	4	stay	stay	NN
cord-015365-iqdi99pd	1935	5	increased	increase	VBN
cord-015365-iqdi99pd	1935	6	albumin	albumin	NN
cord-015365-iqdi99pd	1935	7	oxidation	oxidation	NN
cord-015365-iqdi99pd	1935	8	.	.	.
cord-015365-iqdi99pd	1936	1	In	in	IN
cord-015365-iqdi99pd	1936	2	addition	addition	NN
cord-015365-iqdi99pd	1936	3	,	,	,
cord-015365-iqdi99pd	1936	4	IL-6	IL-6	NNP
cord-015365-iqdi99pd	1936	5	,	,	,
cord-015365-iqdi99pd	1936	6	IL-8	IL-8	NNP
cord-015365-iqdi99pd	1936	7	,	,	,
cord-015365-iqdi99pd	1936	8	IL-10	IL-10	NNP
cord-015365-iqdi99pd	1936	9	and	and	CC
cord-015365-iqdi99pd	1936	10	IL-1	IL-1	NNP
cord-015365-iqdi99pd	1936	11	levels	level	NNS
cord-015365-iqdi99pd	1936	12	were	be	VBD
cord-015365-iqdi99pd	1936	13	elevated	elevate	VBN
cord-015365-iqdi99pd	1936	14	in	in	IN
cord-015365-iqdi99pd	1936	15	patients	patient	NNS
cord-015365-iqdi99pd	1936	16	,	,	,
cord-015365-iqdi99pd	1936	17	whereas	whereas	IN
cord-015365-iqdi99pd	1936	18	IFN	IFN	NNP
cord-015365-iqdi99pd	1936	19	-	-	HYPH
cord-015365-iqdi99pd	1936	20	levels	level	NNS
cord-015365-iqdi99pd	1936	21	were	be	VBD
cord-015365-iqdi99pd	1936	22	within	within	IN
cord-015365-iqdi99pd	1936	23	the	the	DT
cord-015365-iqdi99pd	1936	24	normal	normal	JJ
cord-015365-iqdi99pd	1936	25	range	range	NN
cord-015365-iqdi99pd	1936	26	.	.	.
cord-015365-iqdi99pd	1937	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1937	2	.	.	.
cord-015365-iqdi99pd	1938	1	We	-PRON-	PRP
cord-015365-iqdi99pd	1938	2	conclude	conclude	VBP
cord-015365-iqdi99pd	1938	3	that	that	IN
cord-015365-iqdi99pd	1938	4	oxidative	oxidative	JJ
cord-015365-iqdi99pd	1938	5	stress	stress	NN
cord-015365-iqdi99pd	1938	6	and	and	CC
cord-015365-iqdi99pd	1938	7	systemic	systemic	JJ
cord-015365-iqdi99pd	1938	8	endotoxemia	endotoxemia	NN
cord-015365-iqdi99pd	1938	9	is	be	VBZ
cord-015365-iqdi99pd	1938	10	present	present	JJ
cord-015365-iqdi99pd	1938	11	in	in	IN
cord-015365-iqdi99pd	1938	12	brain	brain	NN
cord-015365-iqdi99pd	1938	13	-	-	HYPH
cord-015365-iqdi99pd	1938	14	dead	dead	JJ
cord-015365-iqdi99pd	1938	15	organ	organ	NN
cord-015365-iqdi99pd	1938	16	donors	donor	NNS
cord-015365-iqdi99pd	1938	17	what	what	WP
cord-015365-iqdi99pd	1938	18	might	may	MD
cord-015365-iqdi99pd	1938	19	affect	affect	VB
cord-015365-iqdi99pd	1938	20	recipient	recipient	NN
cord-015365-iqdi99pd	1938	21	survival	survival	NN
cord-015365-iqdi99pd	1938	22	.	.	.
cord-015365-iqdi99pd	1939	1	High	high	JJ
cord-015365-iqdi99pd	1939	2	endotoxin	endotoxin	NN
cord-015365-iqdi99pd	1939	3	levels	level	NNS
cord-015365-iqdi99pd	1939	4	might	may	MD
cord-015365-iqdi99pd	1939	5	be	be	VB
cord-015365-iqdi99pd	1939	6	due	due	JJ
cord-015365-iqdi99pd	1939	7	to	to	IN
cord-015365-iqdi99pd	1939	8	increased	increase	VBN
cord-015365-iqdi99pd	1939	9	gut	gut	NN
cord-015365-iqdi99pd	1939	10	permeability	permeability	NN
cord-015365-iqdi99pd	1939	11	and	and	CC
cord-015365-iqdi99pd	1939	12	decreased	decrease	VBD
cord-015365-iqdi99pd	1939	13	binding	bind	VBG
cord-015365-iqdi99pd	1939	14	capacity	capacity	NN
cord-015365-iqdi99pd	1939	15	of	of	IN
cord-015365-iqdi99pd	1939	16	albumin	albumin	NN
cord-015365-iqdi99pd	1939	17	influenced	influence	VBN
cord-015365-iqdi99pd	1939	18	not	not	RB
cord-015365-iqdi99pd	1939	19	only	only	RB
cord-015365-iqdi99pd	1939	20	by	by	IN
cord-015365-iqdi99pd	1939	21	higher	high	JJR
cord-015365-iqdi99pd	1939	22	albumin	albumin	NN
cord-015365-iqdi99pd	1939	23	oxidation	oxidation	NN
cord-015365-iqdi99pd	1939	24	.	.	.
cord-015365-iqdi99pd	1940	1	Evidence	evidence	NN
cord-015365-iqdi99pd	1940	2	of	of	IN
cord-015365-iqdi99pd	1940	3	lymphoid	lymphoid	JJ
cord-015365-iqdi99pd	1940	4	neogenesis	neogenesis	NN
cord-015365-iqdi99pd	1940	5	in	in	IN
cord-015365-iqdi99pd	1940	6	skin	skin	NN
cord-015365-iqdi99pd	1940	7	biopsies	biopsy	NNS
cord-015365-iqdi99pd	1940	8	of	of	IN
cord-015365-iqdi99pd	1940	9	human	human	JJ
cord-015365-iqdi99pd	1940	10	hand	hand	NN
cord-015365-iqdi99pd	1940	11	allografts	allograft	NNS
cord-015365-iqdi99pd	1940	12	during	during	IN
cord-015365-iqdi99pd	1940	13	rejection	rejection	NN
cord-015365-iqdi99pd	1940	14	Background	Background	NNP
cord-015365-iqdi99pd	1940	15	.	.	.
cord-015365-iqdi99pd	1941	1	Excessive	excessive	JJ
cord-015365-iqdi99pd	1941	2	production	production	NN
cord-015365-iqdi99pd	1941	3	of	of	IN
cord-015365-iqdi99pd	1941	4	reactive	reactive	JJ
cord-015365-iqdi99pd	1941	5	oxygen	oxygen	NN
cord-015365-iqdi99pd	1941	6	species	specie	NNS
cord-015365-iqdi99pd	1942	1	(	(	-LRB-
cord-015365-iqdi99pd	1942	2	ROS	ROS	NNP
cord-015365-iqdi99pd	1942	3	)	)	-RRB-
cord-015365-iqdi99pd	1942	4	is	be	VBZ
cord-015365-iqdi99pd	1942	5	a	a	DT
cord-015365-iqdi99pd	1942	6	major	major	JJ
cord-015365-iqdi99pd	1942	7	contributor	contributor	NN
cord-015365-iqdi99pd	1942	8	to	to	IN
cord-015365-iqdi99pd	1942	9	the	the	DT
cord-015365-iqdi99pd	1942	10	development	development	NN
cord-015365-iqdi99pd	1942	11	of	of	IN
cord-015365-iqdi99pd	1942	12	ischemia	ischemia	NN
cord-015365-iqdi99pd	1942	13	-	-	HYPH
cord-015365-iqdi99pd	1942	14	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	1942	15	injury	injury	NN
cord-015365-iqdi99pd	1942	16	(	(	-LRB-
cord-015365-iqdi99pd	1942	17	IRI	IRI	NNP
cord-015365-iqdi99pd	1942	18	)	)	-RRB-
cord-015365-iqdi99pd	1942	19	in	in	IN
cord-015365-iqdi99pd	1942	20	the	the	DT
cord-015365-iqdi99pd	1942	21	course	course	NN
cord-015365-iqdi99pd	1942	22	of	of	IN
cord-015365-iqdi99pd	1942	23	solid	solid	JJ
cord-015365-iqdi99pd	1942	24	organ	organ	NN
cord-015365-iqdi99pd	1942	25	transplantation	transplantation	NN
cord-015365-iqdi99pd	1942	26	.	.	.
cord-015365-iqdi99pd	1943	1	In	in	IN
cord-015365-iqdi99pd	1943	2	particular	particular	JJ
cord-015365-iqdi99pd	1943	3	mitochondria	mitochondria	NN
cord-015365-iqdi99pd	1943	4	-	-	HYPH
cord-015365-iqdi99pd	1943	5	derived	derive	VBN
cord-015365-iqdi99pd	1943	6	ROS	ROS	NNP
cord-015365-iqdi99pd	1943	7	are	be	VBP
cord-015365-iqdi99pd	1943	8	critical	critical	JJ
cord-015365-iqdi99pd	1943	9	for	for	IN
cord-015365-iqdi99pd	1943	10	the	the	DT
cord-015365-iqdi99pd	1943	11	initiation	initiation	NN
cord-015365-iqdi99pd	1943	12	and	and	CC
cord-015365-iqdi99pd	1943	13	progression	progression	NN
cord-015365-iqdi99pd	1943	14	of	of	IN
cord-015365-iqdi99pd	1943	15	IRI	IRI	NNP
cord-015365-iqdi99pd	1943	16	,	,	,
cord-015365-iqdi99pd	1943	17	which	which	WDT
cord-015365-iqdi99pd	1943	18	restricts	restrict	VBZ
cord-015365-iqdi99pd	1943	19	the	the	DT
cord-015365-iqdi99pd	1943	20	pool	pool	NN
cord-015365-iqdi99pd	1943	21	of	of	IN
cord-015365-iqdi99pd	1943	22	donor	donor	NN
cord-015365-iqdi99pd	1943	23	organs	organ	NNS
cord-015365-iqdi99pd	1943	24	and	and	CC
cord-015365-iqdi99pd	1943	25	results	result	NNS
cord-015365-iqdi99pd	1943	26	in	in	IN
cord-015365-iqdi99pd	1943	27	elaborate	elaborate	JJ
cord-015365-iqdi99pd	1943	28	follow	follow	NN
cord-015365-iqdi99pd	1943	29	up	up	RP
cord-015365-iqdi99pd	1943	30	treatments	treatment	NNS
cord-015365-iqdi99pd	1943	31	.	.	.
cord-015365-iqdi99pd	1944	1	In	in	IN
cord-015365-iqdi99pd	1944	2	various	various	JJ
cord-015365-iqdi99pd	1944	3	in	in	IN
cord-015365-iqdi99pd	1944	4	vivo	vivo	FW
cord-015365-iqdi99pd	1944	5	(	(	-LRB-
cord-015365-iqdi99pd	1944	6	IR	IR	NNP
cord-015365-iqdi99pd	1944	7	)	)	-RRB-
cord-015365-iqdi99pd	1944	8	and	and	CC
cord-015365-iqdi99pd	1944	9	in	in	IN
cord-015365-iqdi99pd	1944	10	vitro	vitro	FW
cord-015365-iqdi99pd	1944	11	(	(	-LRB-
cord-015365-iqdi99pd	1944	12	hypoxia	hypoxia	NN
cord-015365-iqdi99pd	1944	13	/	/	SYM
cord-015365-iqdi99pd	1944	14	reoxygenation	reoxygenation	NN
cord-015365-iqdi99pd	1944	15	,	,	,
cord-015365-iqdi99pd	1944	16	HR	HR	NNP
cord-015365-iqdi99pd	1944	17	)	)	-RRB-
cord-015365-iqdi99pd	1944	18	models	model	NNS
cord-015365-iqdi99pd	1944	19	we	-PRON-	PRP
cord-015365-iqdi99pd	1944	20	observed	observe	VBD
cord-015365-iqdi99pd	1944	21	a	a	DT
cord-015365-iqdi99pd	1944	22	consistent	consistent	JJ
cord-015365-iqdi99pd	1944	23	pattern	pattern	NN
cord-015365-iqdi99pd	1944	24	in	in	IN
cord-015365-iqdi99pd	1944	25	the	the	DT
cord-015365-iqdi99pd	1944	26	activation	activation	NN
cord-015365-iqdi99pd	1944	27	of	of	IN
cord-015365-iqdi99pd	1944	28	key	key	JJ
cord-015365-iqdi99pd	1944	29	intracellular	intracellular	JJ
cord-015365-iqdi99pd	1944	30	signaling	signal	VBG
cord-015365-iqdi99pd	1944	31	pathways	pathway	NNS
cord-015365-iqdi99pd	1944	32	.	.	.
cord-015365-iqdi99pd	1945	1	Most	most	RBS
cord-015365-iqdi99pd	1945	2	strikingly	strikingly	RB
cord-015365-iqdi99pd	1945	3	the	the	DT
cord-015365-iqdi99pd	1945	4	use	use	NN
cord-015365-iqdi99pd	1945	5	of	of	IN
cord-015365-iqdi99pd	1945	6	p38	p38	CD
cord-015365-iqdi99pd	1945	7	specific	specific	JJ
cord-015365-iqdi99pd	1945	8	inhibitors	inhibitor	NNS
cord-015365-iqdi99pd	1945	9	prevented	prevent	VBD
cord-015365-iqdi99pd	1945	10	mitochondrial	mitochondrial	JJ
cord-015365-iqdi99pd	1945	11	ROS	ROS	NNP
cord-015365-iqdi99pd	1945	12	production	production	NN
cord-015365-iqdi99pd	1945	13	and	and	CC
cord-015365-iqdi99pd	1945	14	cell	cell	NN
cord-015365-iqdi99pd	1945	15	death	death	NN
cord-015365-iqdi99pd	1945	16	.	.	.
cord-015365-iqdi99pd	1946	1	Here	here	RB
cord-015365-iqdi99pd	1946	2	we	-PRON-	PRP
cord-015365-iqdi99pd	1946	3	further	further	RB
cord-015365-iqdi99pd	1946	4	dissected	dissect	VBD
cord-015365-iqdi99pd	1946	5	the	the	DT
cord-015365-iqdi99pd	1946	6	contribution	contribution	NN
cord-015365-iqdi99pd	1946	7	of	of	IN
cord-015365-iqdi99pd	1946	8	p38	p38	CD
cord-015365-iqdi99pd	1946	9	to	to	IN
cord-015365-iqdi99pd	1946	10	IR	IR	NNP
cord-015365-iqdi99pd	1946	11	-	-	:
cord-015365-iqdi99pd	1946	12	and	and	CC
cord-015365-iqdi99pd	1946	13	HR	hr	NN
cord-015365-iqdi99pd	1946	14	-	-	HYPH
cord-015365-iqdi99pd	1946	15	induced	induce	VBN
cord-015365-iqdi99pd	1946	16	damage	damage	NN
cord-015365-iqdi99pd	1946	17	and	and	CC
cord-015365-iqdi99pd	1946	18	provide	provide	VB
cord-015365-iqdi99pd	1946	19	first	first	JJ
cord-015365-iqdi99pd	1946	20	evidence	evidence	NN
cord-015365-iqdi99pd	1946	21	for	for	IN
cord-015365-iqdi99pd	1946	22	a	a	DT
cord-015365-iqdi99pd	1946	23	therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	1946	24	benefit	benefit	NN
cord-015365-iqdi99pd	1946	25	of	of	IN
cord-015365-iqdi99pd	1946	26	p38	p38	CD
cord-015365-iqdi99pd	1946	27	inhibition	inhibition	NN
cord-015365-iqdi99pd	1946	28	by	by	IN
cord-015365-iqdi99pd	1946	29	BIRB-796	BIRB-796	NNP
cord-015365-iqdi99pd	1946	30	in	in	IN
cord-015365-iqdi99pd	1946	31	vivo	vivo	NN
cord-015365-iqdi99pd	1946	32	.	.	.
cord-015365-iqdi99pd	1947	1	Methods	method	NNS
cord-015365-iqdi99pd	1947	2	.	.	.
cord-015365-iqdi99pd	1948	1	Kidney	kidney	NN
cord-015365-iqdi99pd	1948	2	transplantation	transplantation	NN
cord-015365-iqdi99pd	1948	3	and	and	CC
cord-015365-iqdi99pd	1948	4	kidney	kidney	NN
cord-015365-iqdi99pd	1948	5	clamping	clamp	VBG
cord-015365-iqdi99pd	1948	6	in	in	IN
cord-015365-iqdi99pd	1948	7	the	the	DT
cord-015365-iqdi99pd	1948	8	rat	rat	NN
cord-015365-iqdi99pd	1948	9	were	be	VBD
cord-015365-iqdi99pd	1948	10	used	use	VBN
cord-015365-iqdi99pd	1948	11	for	for	IN
cord-015365-iqdi99pd	1948	12	the	the	DT
cord-015365-iqdi99pd	1948	13	induction	induction	NN
cord-015365-iqdi99pd	1948	14	of	of	IN
cord-015365-iqdi99pd	1948	15	IRI	IRI	NNP
cord-015365-iqdi99pd	1948	16	.	.	.
cord-015365-iqdi99pd	1949	1	H	H	NNP
cord-015365-iqdi99pd	1949	2	/	/	SYM
cord-015365-iqdi99pd	1949	3	R	r	NN
cord-015365-iqdi99pd	1949	4	was	be	VBD
cord-015365-iqdi99pd	1949	5	analyzed	analyze	VBN
cord-015365-iqdi99pd	1949	6	in	in	IN
cord-015365-iqdi99pd	1949	7	HL-1	HL-1	NNP
cord-015365-iqdi99pd	1949	8	cardiomyocytes	cardiomyocyte	NNS
cord-015365-iqdi99pd	1949	9	and	and	CC
cord-015365-iqdi99pd	1949	10	primary	primary	JJ
cord-015365-iqdi99pd	1949	11	MEFs	mef	NNS
cord-015365-iqdi99pd	1949	12	.	.	.
cord-015365-iqdi99pd	1950	1	Intracellular	Intracellular	NNP
cord-015365-iqdi99pd	1950	2	signaling	signaling	NN
cord-015365-iqdi99pd	1950	3	was	be	VBD
cord-015365-iqdi99pd	1950	4	monitored	monitor	VBN
cord-015365-iqdi99pd	1950	5	by	by	IN
cord-015365-iqdi99pd	1950	6	using	use	VBG
cord-015365-iqdi99pd	1950	7	phosphorylation	phosphorylation	JJ
cord-015365-iqdi99pd	1950	8	specific	specific	JJ
cord-015365-iqdi99pd	1950	9	antibodies	antibody	NNS
cord-015365-iqdi99pd	1950	10	.	.	.
cord-015365-iqdi99pd	1951	1	Mitochondrial	mitochondrial	JJ
cord-015365-iqdi99pd	1951	2	ROS	ROS	NNP
cord-015365-iqdi99pd	1951	3	levels	level	NNS
cord-015365-iqdi99pd	1951	4	were	be	VBD
cord-015365-iqdi99pd	1951	5	determined	determine	VBN
cord-015365-iqdi99pd	1951	6	by	by	IN
cord-015365-iqdi99pd	1951	7	imaging	image	VBG
cord-015365-iqdi99pd	1951	8	of	of	IN
cord-015365-iqdi99pd	1951	9	Mitotracker	Mitotracker	NNP
cord-015365-iqdi99pd	1951	10	Red	Red	NNP
cord-015365-iqdi99pd	1951	11	CM-	CM-	NNP
cord-015365-iqdi99pd	1952	1	H2XROS	H2XROS	NNP
cord-015365-iqdi99pd	1952	2	.	.	.
cord-015365-iqdi99pd	1953	1	ROS	ROS	NNP
cord-015365-iqdi99pd	1953	2	/	/	SYM
cord-015365-iqdi99pd	1953	3	NOS	NOS	NNP
cord-015365-iqdi99pd	1953	4	-	-	HYPH
cord-015365-iqdi99pd	1953	5	induced	induce	VBN
cord-015365-iqdi99pd	1953	6	tissue	tissue	NN
cord-015365-iqdi99pd	1953	7	damage	damage	NN
cord-015365-iqdi99pd	1953	8	was	be	VBD
cord-015365-iqdi99pd	1953	9	visualized	visualize	VBN
cord-015365-iqdi99pd	1953	10	by	by	IN
cord-015365-iqdi99pd	1953	11	3-nitrotyrosine	3-nitrotyrosine	CD
cord-015365-iqdi99pd	1953	12	specific	specific	JJ
cord-015365-iqdi99pd	1953	13	antibodies	antibody	NNS
cord-015365-iqdi99pd	1953	14	.	.	.
cord-015365-iqdi99pd	1954	1	To	to	TO
cord-015365-iqdi99pd	1954	2	assess	assess	VB
cord-015365-iqdi99pd	1954	3	acute	acute	JJ
cord-015365-iqdi99pd	1954	4	kidney	kidney	NN
cord-015365-iqdi99pd	1954	5	injury	injury	NN
cord-015365-iqdi99pd	1954	6	(	(	-LRB-
cord-015365-iqdi99pd	1954	7	AKI	AKI	NNP
cord-015365-iqdi99pd	1954	8	)	)	-RRB-
cord-015365-iqdi99pd	1955	1	HSP70	HSP70	NNP
cord-015365-iqdi99pd	1955	2	expression	expression	NN
cord-015365-iqdi99pd	1955	3	was	be	VBD
cord-015365-iqdi99pd	1955	4	monitored	monitor	VBN
cord-015365-iqdi99pd	1955	5	by	by	IN
cord-015365-iqdi99pd	1955	6	immunoblotting	immunoblotte	VBG
cord-015365-iqdi99pd	1955	7	,	,	,
cord-015365-iqdi99pd	1955	8	serum	serum	NN
cord-015365-iqdi99pd	1955	9	creatinine	creatinine	NN
cord-015365-iqdi99pd	1955	10	and	and	CC
cord-015365-iqdi99pd	1955	11	urea	urea	NN
cord-015365-iqdi99pd	1955	12	were	be	VBD
cord-015365-iqdi99pd	1955	13	determined	determine	VBN
cord-015365-iqdi99pd	1955	14	,	,	,
cord-015365-iqdi99pd	1955	15	and	and	CC
cord-015365-iqdi99pd	1955	16	serum	serum	NN
cord-015365-iqdi99pd	1955	17	cystatin	cystatin	NNP
cord-015365-iqdi99pd	1955	18	c	c	NNP
cord-015365-iqdi99pd	1955	19	and	and	CC
cord-015365-iqdi99pd	1955	20	NGAL	NGAL	NNP
cord-015365-iqdi99pd	1955	21	concentrations	concentration	NNS
cord-015365-iqdi99pd	1955	22	were	be	VBD
cord-015365-iqdi99pd	1955	23	measured	measure	VBN
cord-015365-iqdi99pd	1955	24	by	by	IN
cord-015365-iqdi99pd	1955	25	ELISA	ELISA	NNP
cord-015365-iqdi99pd	1955	26	.	.	.
cord-015365-iqdi99pd	1956	1	Results	result	NNS
cord-015365-iqdi99pd	1956	2	.	.	.
cord-015365-iqdi99pd	1957	1	The	the	DT
cord-015365-iqdi99pd	1957	2	expression	expression	NN
cord-015365-iqdi99pd	1957	3	patterns	pattern	NNS
cord-015365-iqdi99pd	1957	4	for	for	IN
cord-015365-iqdi99pd	1957	5	all	all	DT
cord-015365-iqdi99pd	1957	6	p38	p38	CD
cord-015365-iqdi99pd	1957	7	isoforms	isoform	NNS
cord-015365-iqdi99pd	1957	8	were	be	VBD
cord-015365-iqdi99pd	1957	9	established	establish	VBN
cord-015365-iqdi99pd	1957	10	in	in	IN
cord-015365-iqdi99pd	1957	11	HL-1	HL-1	NNP
cord-015365-iqdi99pd	1957	12	cells	cell	NNS
cord-015365-iqdi99pd	1957	13	and	and	CC
cord-015365-iqdi99pd	1957	14	siRNA	sirna	NN
cord-015365-iqdi99pd	1957	15	-	-	HYPH
cord-015365-iqdi99pd	1957	16	mediated	mediate	VBN
cord-015365-iqdi99pd	1957	17	knockdown	knockdown	NN
cord-015365-iqdi99pd	1957	18	of	of	IN
cord-015365-iqdi99pd	1957	19	the	the	DT
cord-015365-iqdi99pd	1957	20	predominant	predominant	JJ
cord-015365-iqdi99pd	1957	21	isoform	isoform	NN
cord-015365-iqdi99pd	1957	22	(	(	-LRB-
cord-015365-iqdi99pd	1957	23	p38Alpha	p38alpha	UH
cord-015365-iqdi99pd	1957	24	)	)	-RRB-
cord-015365-iqdi99pd	1957	25	reduced	reduce	VBN
cord-015365-iqdi99pd	1957	26	ROS	ROS	NNP
cord-015365-iqdi99pd	1957	27	production	production	NN
cord-015365-iqdi99pd	1957	28	,	,	,
cord-015365-iqdi99pd	1957	29	confirming	confirm	VBG
cord-015365-iqdi99pd	1957	30	the	the	DT
cord-015365-iqdi99pd	1957	31	critical	critical	JJ
cord-015365-iqdi99pd	1957	32	role	role	NN
cord-015365-iqdi99pd	1957	33	of	of	IN
cord-015365-iqdi99pd	1957	34	p38	p38	CD
cord-015365-iqdi99pd	1957	35	.	.	.
cord-015365-iqdi99pd	1958	1	Preliminary	preliminary	JJ
cord-015365-iqdi99pd	1958	2	data	datum	NNS
cord-015365-iqdi99pd	1958	3	suggested	suggest	VBD
cord-015365-iqdi99pd	1958	4	the	the	DT
cord-015365-iqdi99pd	1958	5	requirement	requirement	NN
cord-015365-iqdi99pd	1958	6	of	of	IN
cord-015365-iqdi99pd	1958	7	MAPKAP	MAPKAP	NNP
cord-015365-iqdi99pd	1958	8	kinase	kinase	NNP
cord-015365-iqdi99pd	1958	9	2	2	CD
cord-015365-iqdi99pd	1958	10	(	(	-LRB-
cord-015365-iqdi99pd	1958	11	MK2	MK2	NNP
cord-015365-iqdi99pd	1958	12	)	)	-RRB-
cord-015365-iqdi99pd	1958	13	rather	rather	RB
cord-015365-iqdi99pd	1958	14	than	than	IN
cord-015365-iqdi99pd	1958	15	the	the	DT
cord-015365-iqdi99pd	1958	16	transcription	transcription	NN
cord-015365-iqdi99pd	1958	17	factor	factor	NN
cord-015365-iqdi99pd	1958	18	ATF-2	ATF-2	NNP
cord-015365-iqdi99pd	1958	19	downstream	downstream	RB
cord-015365-iqdi99pd	1958	20	of	of	IN
cord-015365-iqdi99pd	1958	21	p38	p38	CD
cord-015365-iqdi99pd	1958	22	.	.	.
cord-015365-iqdi99pd	1959	1	As	as	IN
cord-015365-iqdi99pd	1959	2	observed	observe	VBN
cord-015365-iqdi99pd	1959	3	in	in	IN
cord-015365-iqdi99pd	1959	4	other	other	JJ
cord-015365-iqdi99pd	1959	5	settings	setting	NNS
cord-015365-iqdi99pd	1959	6	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	1959	7	following	follow	VBG
cord-015365-iqdi99pd	1959	8	kidney	kidney	NN
cord-015365-iqdi99pd	1959	9	clamping	clamp	VBG
cord-015365-iqdi99pd	1959	10	or	or	CC
cord-015365-iqdi99pd	1959	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	1959	12	was	be	VBD
cord-015365-iqdi99pd	1959	13	marked	mark	VBN
cord-015365-iqdi99pd	1959	14	by	by	IN
cord-015365-iqdi99pd	1959	15	a	a	DT
cord-015365-iqdi99pd	1959	16	profound	profound	JJ
cord-015365-iqdi99pd	1959	17	increase	increase	NN
cord-015365-iqdi99pd	1959	18	in	in	IN
cord-015365-iqdi99pd	1959	19	the	the	DT
cord-015365-iqdi99pd	1959	20	activity	activity	NN
cord-015365-iqdi99pd	1959	21	of	of	IN
cord-015365-iqdi99pd	1959	22	p38	p38	CD
cord-015365-iqdi99pd	1959	23	,	,	,
cord-015365-iqdi99pd	1959	24	its	-PRON-	PRP$
cord-015365-iqdi99pd	1959	25	upstream	upstream	JJ
cord-015365-iqdi99pd	1959	26	kinases	kinase	NNS
cord-015365-iqdi99pd	1959	27	MKK3/6	mkk3/6	IN
cord-015365-iqdi99pd	1959	28	and	and	CC
cord-015365-iqdi99pd	1959	29	the	the	DT
cord-015365-iqdi99pd	1959	30	putative	putative	JJ
cord-015365-iqdi99pd	1959	31	effector	effector	NN
cord-015365-iqdi99pd	1959	32	MK2	MK2	NNP
cord-015365-iqdi99pd	1959	33	.	.	.
cord-015365-iqdi99pd	1960	1	Application	application	NN
cord-015365-iqdi99pd	1960	2	of	of	IN
cord-015365-iqdi99pd	1960	3	BIRB-796	birb-796	NN
cord-015365-iqdi99pd	1960	4	prevented	prevent	VBD
cord-015365-iqdi99pd	1960	5	deterioration	deterioration	NN
cord-015365-iqdi99pd	1960	6	of	of	IN
cord-015365-iqdi99pd	1960	7	kidney	kidney	NN
cord-015365-iqdi99pd	1960	8	function	function	NN
cord-015365-iqdi99pd	1960	9	following	follow	VBG
cord-015365-iqdi99pd	1960	10	IR	IR	NNP
cord-015365-iqdi99pd	1960	11	based	base	VBN
cord-015365-iqdi99pd	1960	12	on	on	IN
cord-015365-iqdi99pd	1960	13	reduced	reduce	VBN
cord-015365-iqdi99pd	1960	14	serum	serum	NN
cord-015365-iqdi99pd	1960	15	creatinine	creatinine	NN
cord-015365-iqdi99pd	1960	16	,	,	,
cord-015365-iqdi99pd	1960	17	urea	urea	NN
cord-015365-iqdi99pd	1960	18	,	,	,
cord-015365-iqdi99pd	1960	19	cystatin	cystatin	NNP
cord-015365-iqdi99pd	1960	20	c	c	NN
cord-015365-iqdi99pd	1960	21	and	and	CC
cord-015365-iqdi99pd	1960	22	NGAL	NGAL	NNP
cord-015365-iqdi99pd	1960	23	levels	level	NNS
cord-015365-iqdi99pd	1960	24	in	in	IN
cord-015365-iqdi99pd	1960	25	animals	animal	NNS
cord-015365-iqdi99pd	1960	26	treated	treat	VBN
cord-015365-iqdi99pd	1960	27	with	with	IN
cord-015365-iqdi99pd	1960	28	the	the	DT
cord-015365-iqdi99pd	1960	29	inhibitor	inhibitor	NN
cord-015365-iqdi99pd	1960	30	.	.	.
cord-015365-iqdi99pd	1961	1	P38	P38	NNP
cord-015365-iqdi99pd	1961	2	inhibition	inhibition	NN
cord-015365-iqdi99pd	1961	3	also	also	RB
cord-015365-iqdi99pd	1961	4	protected	protect	VBN
cord-015365-iqdi99pd	1961	5	from	from	IN
cord-015365-iqdi99pd	1961	6	oxidative	oxidative	JJ
cord-015365-iqdi99pd	1961	7	damage	damage	NN
cord-015365-iqdi99pd	1961	8	.	.	.
cord-015365-iqdi99pd	1962	1	Thus	thus	RB
cord-015365-iqdi99pd	1962	2	the	the	DT
cord-015365-iqdi99pd	1962	3	inhibition	inhibition	NN
cord-015365-iqdi99pd	1962	4	of	of	IN
cord-015365-iqdi99pd	1962	5	p38	p38	NNP
cord-015365-iqdi99pd	1962	6	prevents	prevent	VBZ
cord-015365-iqdi99pd	1962	7	key	key	JJ
cord-015365-iqdi99pd	1962	8	processes	process	NNS
cord-015365-iqdi99pd	1962	9	,	,	,
cord-015365-iqdi99pd	1962	10	which	which	WDT
cord-015365-iqdi99pd	1962	11	are	be	VBP
cord-015365-iqdi99pd	1962	12	essential	essential	JJ
cord-015365-iqdi99pd	1962	13	for	for	IN
cord-015365-iqdi99pd	1962	14	the	the	DT
cord-015365-iqdi99pd	1962	15	development	development	NN
cord-015365-iqdi99pd	1962	16	of	of	IN
cord-015365-iqdi99pd	1962	17	IRI	IRI	NNP
cord-015365-iqdi99pd	1962	18	.	.	.
cord-015365-iqdi99pd	1963	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1963	2	.	.	.
cord-015365-iqdi99pd	1964	1	Inhibiting	inhibit	VBG
cord-015365-iqdi99pd	1964	2	p38	p38	JJ
cord-015365-iqdi99pd	1964	3	signaling	signal	VBG
cord-015365-iqdi99pd	1964	4	during	during	IN
cord-015365-iqdi99pd	1964	5	IR	IR	NNP
cord-015365-iqdi99pd	1964	6	and	and	CC
cord-015365-iqdi99pd	1964	7	HR	HR	NNP
cord-015365-iqdi99pd	1964	8	may	may	MD
cord-015365-iqdi99pd	1964	9	provide	provide	VB
cord-015365-iqdi99pd	1964	10	a	a	DT
cord-015365-iqdi99pd	1964	11	potent	potent	JJ
cord-015365-iqdi99pd	1964	12	strategy	strategy	NN
cord-015365-iqdi99pd	1964	13	for	for	IN
cord-015365-iqdi99pd	1964	14	limiting	limit	VBG
cord-015365-iqdi99pd	1964	15	IRI	IRI	NNP
cord-015365-iqdi99pd	1964	16	.	.	.
cord-015365-iqdi99pd	1965	1	The	the	DT
cord-015365-iqdi99pd	1965	2	role	role	NN
cord-015365-iqdi99pd	1965	3	of	of	IN
cord-015365-iqdi99pd	1965	4	constitutively	constitutively	RB
cord-015365-iqdi99pd	1965	5	expressed	express	VBN
cord-015365-iqdi99pd	1965	6	nitric	nitric	JJ
cord-015365-iqdi99pd	1965	7	oxide	oxide	NN
cord-015365-iqdi99pd	1965	8	synthases	synthase	NNS
cord-015365-iqdi99pd	1965	9	in	in	IN
cord-015365-iqdi99pd	1965	10	ischemiareperfusion	ischemiareperfusion	NN
cord-015365-iqdi99pd	1965	11	-	-	HYPH
cord-015365-iqdi99pd	1965	12	injury	injury	NN
cord-015365-iqdi99pd	1965	13	Background	background	NN
cord-015365-iqdi99pd	1965	14	.	.	.
cord-015365-iqdi99pd	1966	1	Single	single	JJ
cord-015365-iqdi99pd	1966	2	shot	shot	JJ
cord-015365-iqdi99pd	1966	3	donor	donor	NN
cord-015365-iqdi99pd	1966	4	therapy	therapy	NN
cord-015365-iqdi99pd	1966	5	with	with	IN
cord-015365-iqdi99pd	1966	6	the	the	DT
cord-015365-iqdi99pd	1966	7	essential	essential	JJ
cord-015365-iqdi99pd	1966	8	nitric	nitric	NN
cord-015365-iqdi99pd	1966	9	oxide	oxide	NN
cord-015365-iqdi99pd	1966	10	synthase	synthase	NN
cord-015365-iqdi99pd	1966	11	cofactor	cofactor	NN
cord-015365-iqdi99pd	1966	12	(	(	-LRB-
cord-015365-iqdi99pd	1966	13	NOS	NOS	NNP
cord-015365-iqdi99pd	1966	14	)	)	-RRB-
cord-015365-iqdi99pd	1966	15	tetrahydrobiopterin	tetrahydrobiopterin	NNP
cord-015365-iqdi99pd	1966	16	(	(	-LRB-
cord-015365-iqdi99pd	1966	17	H4B	h4b	NN
cord-015365-iqdi99pd	1966	18	)	)	-RRB-
cord-015365-iqdi99pd	1966	19	was	be	VBD
cord-015365-iqdi99pd	1966	20	shown	show	VBN
cord-015365-iqdi99pd	1966	21	to	to	TO
cord-015365-iqdi99pd	1966	22	attenuate	attenuate	VB
cord-015365-iqdi99pd	1966	23	ischemia	ischemia	NN
cord-015365-iqdi99pd	1966	24	-	-	HYPH
cord-015365-iqdi99pd	1966	25	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	1966	26	-	-	HYPH
cord-015365-iqdi99pd	1966	27	injury	injury	NN
cord-015365-iqdi99pd	1966	28	-	-	HYPH
cord-015365-iqdi99pd	1966	29	related	relate	VBN
cord-015365-iqdi99pd	1966	30	pancreatitis	pancreatitis	NN
cord-015365-iqdi99pd	1966	31	in	in	IN
cord-015365-iqdi99pd	1966	32	a	a	DT
cord-015365-iqdi99pd	1966	33	murine	murine	JJ
cord-015365-iqdi99pd	1966	34	pancreas	pancreas	NN
cord-015365-iqdi99pd	1966	35	transplantation	transplantation	NN
cord-015365-iqdi99pd	1966	36	(	(	-LRB-
cord-015365-iqdi99pd	1966	37	PTX	PTX	NNP
cord-015365-iqdi99pd	1966	38	)	)	-RRB-
cord-015365-iqdi99pd	1966	39	model	model	NN
cord-015365-iqdi99pd	1966	40	.	.	.
cord-015365-iqdi99pd	1967	1	Since	since	IN
cord-015365-iqdi99pd	1967	2	underlying	underlie	VBG
cord-015365-iqdi99pd	1967	3	mechanisms	mechanism	NNS
cord-015365-iqdi99pd	1967	4	of	of	IN
cord-015365-iqdi99pd	1967	5	tetrahydrobiopterin	tetrahydrobiopterin	NN
cord-015365-iqdi99pd	1967	6	-	-	HYPH
cord-015365-iqdi99pd	1967	7	mediated	mediate	VBN
cord-015365-iqdi99pd	1967	8	protection	protection	NN
cord-015365-iqdi99pd	1967	9	are	be	VBP
cord-015365-iqdi99pd	1967	10	still	still	RB
cord-015365-iqdi99pd	1967	11	controversially	controversially	RB
cord-015365-iqdi99pd	1967	12	discussed	discuss	VBN
cord-015365-iqdi99pd	1967	13	,	,	,
cord-015365-iqdi99pd	1967	14	we	-PRON-	PRP
cord-015365-iqdi99pd	1967	15	aimed	aim	VBD
cord-015365-iqdi99pd	1967	16	to	to	TO
cord-015365-iqdi99pd	1967	17	investigate	investigate	VB
cord-015365-iqdi99pd	1967	18	,	,	,
cord-015365-iqdi99pd	1967	19	whether	whether	IN
cord-015365-iqdi99pd	1967	20	the	the	DT
cord-015365-iqdi99pd	1967	21	two	two	CD
cord-015365-iqdi99pd	1967	22	constitutively	constitutively	RB
cord-015365-iqdi99pd	1967	23	expressed	express	VBN
cord-015365-iqdi99pd	1967	24	NOS	NOS	NNP
cord-015365-iqdi99pd	1967	25	-	-	HYPH
cord-015365-iqdi99pd	1967	26	isoforms	isoform	NNS
cord-015365-iqdi99pd	1967	27	represent	represent	VBP
cord-015365-iqdi99pd	1967	28	its	-PRON-	PRP$
cord-015365-iqdi99pd	1967	29	major	major	JJ
cord-015365-iqdi99pd	1967	30	targets	target	NNS
cord-015365-iqdi99pd	1967	31	using	use	VBG
cord-015365-iqdi99pd	1967	32	endothelial	endothelial	JJ
cord-015365-iqdi99pd	1967	33	(	(	-LRB-
cord-015365-iqdi99pd	1967	34	eNOS-/-	eNOS-/-	''
cord-015365-iqdi99pd	1967	35	)	)	-RRB-
cord-015365-iqdi99pd	1967	36	and	and	CC
cord-015365-iqdi99pd	1967	37	neuronal	neuronal	JJ
cord-015365-iqdi99pd	1967	38	NOS	NOS	NNP
cord-015365-iqdi99pd	1967	39	(	(	-LRB-
cord-015365-iqdi99pd	1967	40	nNOS-/-	nNOS-/-	NNP
cord-015365-iqdi99pd	1967	41	)	)	-RRB-
cord-015365-iqdi99pd	1967	42	knockout	knockout	NN
cord-015365-iqdi99pd	1967	43	mice	mouse	NNS
cord-015365-iqdi99pd	1967	44	.	.	.
cord-015365-iqdi99pd	1968	1	Methods	method	NNS
cord-015365-iqdi99pd	1968	2	.	.	.
cord-015365-iqdi99pd	1969	1	In	in	IN
cord-015365-iqdi99pd	1969	2	a	a	DT
cord-015365-iqdi99pd	1969	3	heterotopic	heterotopic	NNP
cord-015365-iqdi99pd	1969	4	PTX	PTX	NNP
cord-015365-iqdi99pd	1969	5	-	-	HYPH
cord-015365-iqdi99pd	1969	6	model	model	NN
cord-015365-iqdi99pd	1969	7	syngeneic	syngeneic	NNS
cord-015365-iqdi99pd	1969	8	C57BL6	c57bl6	NN
cord-015365-iqdi99pd	1969	9	mice	mouse	NNS
cord-015365-iqdi99pd	1969	10	(	(	-LRB-
cord-015365-iqdi99pd	1969	11	wild	wild	JJ
cord-015365-iqdi99pd	1969	12	-	-	HYPH
cord-015365-iqdi99pd	1969	13	type	type	NN
cord-015365-iqdi99pd	1969	14	,	,	,
cord-015365-iqdi99pd	1969	15	eNOS-/-and	eNOS-/-and	NNP
cord-015365-iqdi99pd	1969	16	nNOS-/-	nNOS-/-	NNP
cord-015365-iqdi99pd	1969	17	)	)	-RRB-
cord-015365-iqdi99pd	1969	18	were	be	VBD
cord-015365-iqdi99pd	1969	19	used	use	VBN
cord-015365-iqdi99pd	1969	20	as	as	IN
cord-015365-iqdi99pd	1969	21	donorrecipient	donorrecipient	NN
cord-015365-iqdi99pd	1969	22	pairs	pair	NNS
cord-015365-iqdi99pd	1969	23	.	.	.
cord-015365-iqdi99pd	1970	1	Non	non	JJ
cord-015365-iqdi99pd	1970	2	-	-	JJ
cord-015365-iqdi99pd	1970	3	transplanted	transplanted	JJ
cord-015365-iqdi99pd	1970	4	animals	animal	NNS
cord-015365-iqdi99pd	1970	5	served	serve	VBD
cord-015365-iqdi99pd	1970	6	as	as	IN
cord-015365-iqdi99pd	1970	7	controls	control	NNS
cord-015365-iqdi99pd	1970	8	.	.	.
cord-015365-iqdi99pd	1971	1	Following	follow	VBG
cord-015365-iqdi99pd	1971	2	a	a	DT
cord-015365-iqdi99pd	1971	3	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	1971	4	time	time	NN
cord-015365-iqdi99pd	1971	5	of	of	IN
cord-015365-iqdi99pd	1971	6	4	4	CD
cord-015365-iqdi99pd	1971	7	h	h	NN
cord-015365-iqdi99pd	1971	8	,	,	,
cord-015365-iqdi99pd	1971	9	graft	graft	NN
cord-015365-iqdi99pd	1971	10	microcirculation	microcirculation	NN
cord-015365-iqdi99pd	1971	11	was	be	VBD
cord-015365-iqdi99pd	1971	12	analyzed	analyze	VBN
cord-015365-iqdi99pd	1971	13	by	by	IN
cord-015365-iqdi99pd	1971	14	intravital	intravital	JJ
cord-015365-iqdi99pd	1971	15	fluorescence	fluorescence	NN
cord-015365-iqdi99pd	1971	16	microscopy	microscopy	NN
cord-015365-iqdi99pd	1971	17	.	.	.
cord-015365-iqdi99pd	1972	1	Parenchymal	parenchymal	JJ
cord-015365-iqdi99pd	1972	2	damage	damage	NN
cord-015365-iqdi99pd	1972	3	as	as	RB
cord-015365-iqdi99pd	1972	4	well	well	RB
cord-015365-iqdi99pd	1972	5	as	as	IN
cord-015365-iqdi99pd	1972	6	peroxynitrite	peroxynitrite	NN
cord-015365-iqdi99pd	1972	7	-	-	HYPH
cord-015365-iqdi99pd	1972	8	formation	formation	NN
cord-015365-iqdi99pd	1972	9	were	be	VBD
cord-015365-iqdi99pd	1972	10	assessed	assess	VBN
cord-015365-iqdi99pd	1972	11	by	by	IN
cord-015365-iqdi99pd	1972	12	H&E	H&E	NNP
cord-015365-iqdi99pd	1972	13	-	-	HYPH
cord-015365-iqdi99pd	1972	14	staining	stain	VBG
cord-015365-iqdi99pd	1972	15	and	and	CC
cord-015365-iqdi99pd	1972	16	immunohistochemistry	immunohistochemistry	NN
cord-015365-iqdi99pd	1972	17	.	.	.
cord-015365-iqdi99pd	1973	1	H4B	h4b	NN
cord-015365-iqdi99pd	1973	2	levels	level	NNS
cord-015365-iqdi99pd	1973	3	were	be	VBD
cord-015365-iqdi99pd	1973	4	determined	determine	VBN
cord-015365-iqdi99pd	1973	5	by	by	IN
cord-015365-iqdi99pd	1973	6	high	high	JJ
cord-015365-iqdi99pd	1973	7	-	-	HYPH
cord-015365-iqdi99pd	1973	8	performance	performance	NN
cord-015365-iqdi99pd	1973	9	liquid	liquid	NN
cord-015365-iqdi99pd	1973	10	chromatography	chromatography	NN
cord-015365-iqdi99pd	1973	11	(	(	-LRB-
cord-015365-iqdi99pd	1973	12	HPLC	HPLC	NNP
cord-015365-iqdi99pd	1973	13	)	)	-RRB-
cord-015365-iqdi99pd	1973	14	.	.	.
cord-015365-iqdi99pd	1974	1	Finally	finally	RB
cord-015365-iqdi99pd	1974	2	,	,	,
cord-015365-iqdi99pd	1974	3	all	all	DT
cord-015365-iqdi99pd	1974	4	groups	group	NNS
cord-015365-iqdi99pd	1974	5	where	where	WRB
cord-015365-iqdi99pd	1974	6	tested	test	VBN
cord-015365-iqdi99pd	1974	7	for	for	IN
cord-015365-iqdi99pd	1974	8	recipient	recipient	NN
cord-015365-iqdi99pd	1974	9	survival	survival	NN
cord-015365-iqdi99pd	1974	10	.	.	.
cord-015365-iqdi99pd	1975	1	Results	result	NNS
cord-015365-iqdi99pd	1975	2	.	.	.
cord-015365-iqdi99pd	1976	1	Compared	compare	VBN
cord-015365-iqdi99pd	1976	2	to	to	IN
cord-015365-iqdi99pd	1976	3	non	non	JJ
cord-015365-iqdi99pd	1976	4	-	-	JJ
cord-015365-iqdi99pd	1976	5	transplanted	transplanted	JJ
cord-015365-iqdi99pd	1976	6	controls	control	NNS
cord-015365-iqdi99pd	1976	7	,	,	,
cord-015365-iqdi99pd	1976	8	prolonged	prolong	VBN
cord-015365-iqdi99pd	1976	9	CIT	CIT	NNP
cord-015365-iqdi99pd	1976	10	significantly	significantly	RB
cord-015365-iqdi99pd	1976	11	worsened	worsen	VBD
cord-015365-iqdi99pd	1976	12	microcirculation	microcirculation	NN
cord-015365-iqdi99pd	1976	13	in	in	IN
cord-015365-iqdi99pd	1976	14	untreated	untreated	JJ
cord-015365-iqdi99pd	1976	15	wildtype	wildtype	NN
cord-015365-iqdi99pd	1976	16	and	and	CC
cord-015365-iqdi99pd	1976	17	eNOS-/-grafts	enos-/-graft	NNS
cord-015365-iqdi99pd	1977	1	(	(	-LRB-
cord-015365-iqdi99pd	1977	2	p	p	NN
cord-015365-iqdi99pd	1977	3	<	<	XX
cord-015365-iqdi99pd	1977	4	0.05	0.05	CD
cord-015365-iqdi99pd	1977	5	)	)	-RRB-
cord-015365-iqdi99pd	1977	6	,	,	,
cord-015365-iqdi99pd	1977	7	whereas	whereas	IN
cord-015365-iqdi99pd	1977	8	no	no	DT
cord-015365-iqdi99pd	1977	9	deterioration	deterioration	NN
cord-015365-iqdi99pd	1977	10	was	be	VBD
cord-015365-iqdi99pd	1977	11	measured	measure	VBN
cord-015365-iqdi99pd	1977	12	in	in	IN
cord-015365-iqdi99pd	1977	13	untreated	untreated	JJ
cord-015365-iqdi99pd	1977	14	nNOS-/-	nnos-/-	NN
cord-015365-iqdi99pd	1977	15	.	.	.
cord-015365-iqdi99pd	1978	1	While	while	IN
cord-015365-iqdi99pd	1978	2	H4B	h4b	NN
cord-015365-iqdi99pd	1978	3	-	-	HYPH
cord-015365-iqdi99pd	1978	4	pre	pre	NN
cord-015365-iqdi99pd	1978	5	-	-	NN
cord-015365-iqdi99pd	1978	6	treatment	treatment	NN
cord-015365-iqdi99pd	1978	7	significantly	significantly	RB
cord-015365-iqdi99pd	1978	8	restored	restore	VBD
cord-015365-iqdi99pd	1978	9	capillary	capillary	JJ
cord-015365-iqdi99pd	1978	10	blood	blood	NN
cord-015365-iqdi99pd	1978	11	flow	flow	NN
cord-015365-iqdi99pd	1978	12	in	in	IN
cord-015365-iqdi99pd	1978	13	wild	wild	JJ
cord-015365-iqdi99pd	1978	14	-	-	HYPH
cord-015365-iqdi99pd	1978	15	types	type	NNS
cord-015365-iqdi99pd	1978	16	and	and	CC
cord-015365-iqdi99pd	1978	17	eNOS-/-(p	enos-/-(p	NN
cord-015365-iqdi99pd	1978	18	<	<	XX
cord-015365-iqdi99pd	1978	19	0.01	0.01	CD
cord-015365-iqdi99pd	1978	20	)	)	-RRB-
cord-015365-iqdi99pd	1978	21	,	,	,
cord-015365-iqdi99pd	1978	22	no	no	DT
cord-015365-iqdi99pd	1978	23	further	further	JJ
cord-015365-iqdi99pd	1978	24	beneficial	beneficial	JJ
cord-015365-iqdi99pd	1978	25	effect	effect	NN
cord-015365-iqdi99pd	1978	26	was	be	VBD
cord-015365-iqdi99pd	1978	27	observed	observe	VBN
cord-015365-iqdi99pd	1978	28	in	in	IN
cord-015365-iqdi99pd	1978	29	nNOS-/-(p	nNOS-/-(p	NNP
cord-015365-iqdi99pd	1978	30	>	>	XX
cord-015365-iqdi99pd	1978	31	0.05	0.05	CD
cord-015365-iqdi99pd	1978	32	)	)	-RRB-
cord-015365-iqdi99pd	1978	33	.	.	.
cord-015365-iqdi99pd	1979	1	In	in	IN
cord-015365-iqdi99pd	1979	2	contrast	contrast	NN
cord-015365-iqdi99pd	1979	3	to	to	IN
cord-015365-iqdi99pd	1979	4	untreated	untreated	JJ
cord-015365-iqdi99pd	1979	5	wild	wild	JJ
cord-015365-iqdi99pd	1979	6	-	-	HYPH
cord-015365-iqdi99pd	1979	7	type	type	NN
cord-015365-iqdi99pd	1979	8	and	and	CC
cord-015365-iqdi99pd	1979	9	eNOS-/-graft	enos-/-graft	NN
cord-015365-iqdi99pd	1979	10	,	,	,
cord-015365-iqdi99pd	1979	11	nNOS-/-grafts	nnos-/-graft	NNS
cord-015365-iqdi99pd	1979	12	developed	develop	VBD
cord-015365-iqdi99pd	1979	13	minor	minor	JJ
cord-015365-iqdi99pd	1979	14	parenchymal	parenchymal	NN
cord-015365-iqdi99pd	1979	15	damage	damage	NN
cord-015365-iqdi99pd	1979	16	following	follow	VBG
cord-015365-iqdi99pd	1979	17	prolonged	prolong	VBN
cord-015365-iqdi99pd	1979	18	CIT	cit	NN
cord-015365-iqdi99pd	1979	19	,	,	,
cord-015365-iqdi99pd	1979	20	which	which	WDT
cord-015365-iqdi99pd	1979	21	could	could	MD
cord-015365-iqdi99pd	1979	22	be	be	VB
cord-015365-iqdi99pd	1979	23	slightly	slightly	RB
cord-015365-iqdi99pd	1979	24	ameliorated	ameliorate	VBN
cord-015365-iqdi99pd	1979	25	by	by	IN
cord-015365-iqdi99pd	1979	26	tetrahydrobiopterin	tetrahydrobiopterin	NNP
cord-015365-iqdi99pd	1979	27	pre	pre	VBN
cord-015365-iqdi99pd	1979	28	-	-	NN
cord-015365-iqdi99pd	1979	29	treatment	treatment	NN
cord-015365-iqdi99pd	1979	30	.	.	.
cord-015365-iqdi99pd	1980	1	There	there	EX
cord-015365-iqdi99pd	1980	2	were	be	VBD
cord-015365-iqdi99pd	1980	3	n't	not	RB
cord-015365-iqdi99pd	1980	4	any	any	DT
cord-015365-iqdi99pd	1980	5	significant	significant	JJ
cord-015365-iqdi99pd	1980	6	differences	difference	NNS
cord-015365-iqdi99pd	1980	7	between	between	IN
cord-015365-iqdi99pd	1980	8	the	the	DT
cord-015365-iqdi99pd	1980	9	analyzed	analyze	VBN
cord-015365-iqdi99pd	1980	10	groups	group	NNS
cord-015365-iqdi99pd	1980	11	regarding	regard	VBG
cord-015365-iqdi99pd	1980	12	intragraft	intragraft	NNP
cord-015365-iqdi99pd	1980	13	nitrotyrosine	nitrotyrosine	NNP
cord-015365-iqdi99pd	1980	14	formation	formation	NN
cord-015365-iqdi99pd	1980	15	.	.	.
cord-015365-iqdi99pd	1981	1	While	while	IN
cord-015365-iqdi99pd	1981	2	H4B	h4b	CD
cord-015365-iqdi99pd	1981	3	pre	pre	JJ
cord-015365-iqdi99pd	1981	4	-	-	JJ
cord-015365-iqdi99pd	1981	5	treatment	treatment	JJ
cord-015365-iqdi99pd	1981	6	extended	extend	VBN
cord-015365-iqdi99pd	1981	7	survival	survival	NN
cord-015365-iqdi99pd	1981	8	of	of	IN
cord-015365-iqdi99pd	1981	9	all	all	DT
cord-015365-iqdi99pd	1981	10	recipients	recipient	NNS
cord-015365-iqdi99pd	1981	11	,	,	,
cord-015365-iqdi99pd	1981	12	significantly	significantly	RB
cord-015365-iqdi99pd	1981	13	prolonged	prolong	VBD
cord-015365-iqdi99pd	1981	14	recipient	recipient	NN
cord-015365-iqdi99pd	1981	15	survival	survival	NN
cord-015365-iqdi99pd	1981	16	was	be	VBD
cord-015365-iqdi99pd	1981	17	also	also	RB
cord-015365-iqdi99pd	1981	18	achieved	achieve	VBN
cord-015365-iqdi99pd	1981	19	if	if	IN
cord-015365-iqdi99pd	1981	20	donors	donor	NNS
cord-015365-iqdi99pd	1981	21	were	be	VBD
cord-015365-iqdi99pd	1981	22	untreated	untreated	JJ
cord-015365-iqdi99pd	1981	23	nNOS-/-(p	nNOS-/-(p	NNP
cord-015365-iqdi99pd	1981	24	<	<	XX
cord-015365-iqdi99pd	1981	25	0.01	0.01	CD
cord-015365-iqdi99pd	1981	26	)	)	-RRB-
cord-015365-iqdi99pd	1981	27	.	.	.
cord-015365-iqdi99pd	1982	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	1982	2	.	.	.
cord-015365-iqdi99pd	1983	1	These	these	DT
cord-015365-iqdi99pd	1983	2	observations	observation	NNS
cord-015365-iqdi99pd	1983	3	in	in	IN
cord-015365-iqdi99pd	1983	4	pancreatic	pancreatic	JJ
cord-015365-iqdi99pd	1983	5	grafts	graft	NNS
cord-015365-iqdi99pd	1983	6	lacking	lack	VBG
cord-015365-iqdi99pd	1983	7	nNOS	nnos	NN
cord-015365-iqdi99pd	1983	8	suggest	suggest	VBP
cord-015365-iqdi99pd	1983	9	,	,	,
cord-015365-iqdi99pd	1983	10	that	that	IN
cord-015365-iqdi99pd	1983	11	instead	instead	RB
cord-015365-iqdi99pd	1983	12	of	of	IN
cord-015365-iqdi99pd	1983	13	the	the	DT
cord-015365-iqdi99pd	1983	14	endothelial	endothelial	JJ
cord-015365-iqdi99pd	1983	15	isoform	isoform	NN
cord-015365-iqdi99pd	1983	16	,	,	,
cord-015365-iqdi99pd	1983	17	it	-PRON-	PRP
cord-015365-iqdi99pd	1983	18	is	be	VBZ
cord-015365-iqdi99pd	1983	19	the	the	DT
cord-015365-iqdi99pd	1983	20	neuronal	neuronal	JJ
cord-015365-iqdi99pd	1983	21	isoform	isoform	NN
cord-015365-iqdi99pd	1983	22	to	to	TO
cord-015365-iqdi99pd	1983	23	be	be	VB
cord-015365-iqdi99pd	1983	24	crucially	crucially	RB
cord-015365-iqdi99pd	1983	25	involved	involve	VBN
cord-015365-iqdi99pd	1983	26	in	in	IN
cord-015365-iqdi99pd	1983	27	the	the	DT
cord-015365-iqdi99pd	1983	28	promotion	promotion	NN
cord-015365-iqdi99pd	1983	29	of	of	IN
cord-015365-iqdi99pd	1983	30	ischemia	ischemia	NN
cord-015365-iqdi99pd	1983	31	-	-	HYPH
cord-015365-iqdi99pd	1983	32	reperfusion	reperfusion	NN
cord-015365-iqdi99pd	1983	33	-	-	HYPH
cord-015365-iqdi99pd	1983	34	injury	injury	NN
cord-015365-iqdi99pd	1983	35	in	in	IN
cord-015365-iqdi99pd	1983	36	this	this	DT
cord-015365-iqdi99pd	1983	37	model	model	NN
cord-015365-iqdi99pd	1983	38	,	,	,
cord-015365-iqdi99pd	1983	39	representing	represent	VBG
cord-015365-iqdi99pd	1983	40	therefore	therefore	RB
cord-015365-iqdi99pd	1983	41	the	the	DT
cord-015365-iqdi99pd	1983	42	major	major	JJ
cord-015365-iqdi99pd	1983	43	target	target	NN
cord-015365-iqdi99pd	1983	44	of	of	IN
cord-015365-iqdi99pd	1983	45	tetrahydrobiopterin	tetrahydrobiopterin	NN
cord-015365-iqdi99pd	1983	46	mediated	mediate	VBD
cord-015365-iqdi99pd	1983	47	protection	protection	NN
cord-015365-iqdi99pd	1983	48	.	.	.
cord-015365-iqdi99pd	1984	1	Nutrazeutika	Nutrazeutika	NNP
cord-015365-iqdi99pd	1984	2	optimieren	optimieren	TO
cord-015365-iqdi99pd	1984	3	die	die	VBP
cord-015365-iqdi99pd	1984	4	Organfunktion	Organfunktion	NNP
cord-015365-iqdi99pd	1984	5	in	in	IN
cord-015365-iqdi99pd	1984	6	einem	einem	NNP
cord-015365-iqdi99pd	1984	7	Rattennieren	Rattennieren	NNP
cord-015365-iqdi99pd	1984	8	-	-	HYPH
cord-015365-iqdi99pd	1984	9	Ischämie	Ischämie	NNP
cord-015365-iqdi99pd	1984	10	-	-	HYPH
cord-015365-iqdi99pd	1984	11	Reperfusionsmode	Reperfusionsmode	NNP
cord-015365-iqdi99pd	1984	12	P.	P.	NNP
cord-015365-iqdi99pd	1984	13	Gehwolf	Gehwolf	NNP
cord-015365-iqdi99pd	1984	14	1	1	CD
cord-015365-iqdi99pd	1984	15	,	,	,
cord-015365-iqdi99pd	1984	16	F.	F.	NNP
cord-015365-iqdi99pd	1984	17	M.	M.	NNP
cord-015365-iqdi99pd	1984	18	Struller	Struller	NNP
cord-015365-iqdi99pd	1984	19	1	1	CD
cord-015365-iqdi99pd	1984	20	,	,	,
cord-015365-iqdi99pd	1984	21	A.	A.	NNP
cord-015365-iqdi99pd	1984	22	Kostron	Kostron	NNP
cord-015365-iqdi99pd	1984	23	1	1	CD
cord-015365-iqdi99pd	1984	24	,	,	,
cord-015365-iqdi99pd	1984	25	M.	M.	NNP
cord-015365-iqdi99pd	1984	26	Wolzt	Wolzt	NNP
cord-015365-iqdi99pd	1984	27	2	2	CD
cord-015365-iqdi99pd	1984	28	,	,	,
cord-015365-iqdi99pd	1984	29	F.	F.	NNP
cord-015365-iqdi99pd	1984	30	Bach	Bach	NNP
cord-015365-iqdi99pd	1984	31	3	3	CD
cord-015365-iqdi99pd	1984	32	,	,	,
cord-015365-iqdi99pd	1984	33	L.	L.	NNP
cord-015365-iqdi99pd	1984	34	Otterbein	Otterbein	NNP
cord-015365-iqdi99pd	1984	35	3	3	CD
cord-015365-iqdi99pd	1984	36	,	,	,
cord-015365-iqdi99pd	1984	37	B.	B.	NNP
cord-015365-iqdi99pd	1984	38	Wegiel	Wegiel	NNP
cord-015365-iqdi99pd	1984	39	3	3	CD
cord-015365-iqdi99pd	1984	40	,	,	,
cord-015365-iqdi99pd	1984	41	J.	J.	NNP
cord-015365-iqdi99pd	1984	42	Pratschke	Pratschke	NNP
cord-015365-iqdi99pd	1984	43	1	1	CD
cord-015365-iqdi99pd	1984	44	,	,	,
cord-015365-iqdi99pd	1984	45	R.	R.	NNP
cord-015365-iqdi99pd	1984	46	Öllinger	Öllinger	NNP
cord-015365-iqdi99pd	1984	47	1	1	CD
cord-015365-iqdi99pd	1984	48	tion	tion	NN
cord-015365-iqdi99pd	1984	49	,	,	,
cord-015365-iqdi99pd	1984	50	and	and	CC
cord-015365-iqdi99pd	1984	51	angiogenic	angiogenic	JJ
cord-015365-iqdi99pd	1984	52	sprouting	sprout	VBG
cord-015365-iqdi99pd	1984	53	in	in	IN
cord-015365-iqdi99pd	1984	54	vitro	vitro	FW
cord-015365-iqdi99pd	1984	55	,	,	,
cord-015365-iqdi99pd	1984	56	and	and	CC
cord-015365-iqdi99pd	1984	57	angiogenesis	angiogenesis	NN
cord-015365-iqdi99pd	1984	58	in	in	IN
cord-015365-iqdi99pd	1984	59	a	a	DT
cord-015365-iqdi99pd	1984	60	chicken	chicken	NN
cord-015365-iqdi99pd	1984	61	embryochorioallantoic	embryochorioallantoic	NN
cord-015365-iqdi99pd	1984	62	membrane	membrane	NN
cord-015365-iqdi99pd	1984	63	assay	assay	NN
cord-015365-iqdi99pd	1984	64	.	.	.
cord-015365-iqdi99pd	1985	1	5	5	LS
cord-015365-iqdi99pd	1985	2	0	0	CD
cord-015365-iqdi99pd	1986	1	-methoxy	-methoxy	NNP
cord-015365-iqdi99pd	1986	2	leoligin	leoligin	NNP
cord-015365-iqdi99pd	1986	3	was	be	VBD
cord-015365-iqdi99pd	1986	4	consequently	consequently	RB
cord-015365-iqdi99pd	1986	5	analyzed	analyze	VBN
cord-015365-iqdi99pd	1986	6	in	in	IN
cord-015365-iqdi99pd	1986	7	an	an	DT
cord-015365-iqdi99pd	1986	8	in	in	IN
cord-015365-iqdi99pd	1986	9	vivo	vivo	FW
cord-015365-iqdi99pd	1986	10	rat	rat	NN
cord-015365-iqdi99pd	1986	11	MI	MI	NNP
cord-015365-iqdi99pd	1986	12	model	model	NN
cord-015365-iqdi99pd	1986	13	.	.	.
cord-015365-iqdi99pd	1987	1	The	the	DT
cord-015365-iqdi99pd	1987	2	novel	novel	JJ
cord-015365-iqdi99pd	1987	3	compound	compound	NN
cord-015365-iqdi99pd	1987	4	potently	potently	RB
cord-015365-iqdi99pd	1987	5	stimulated	stimulate	VBD
cord-015365-iqdi99pd	1987	6	angiogenesis	angiogenesis	NN
cord-015365-iqdi99pd	1987	7	in	in	IN
cord-015365-iqdi99pd	1987	8	the	the	DT
cord-015365-iqdi99pd	1987	9	peri	peri	JJ
cord-015365-iqdi99pd	1987	10	-	-	HYPH
cord-015365-iqdi99pd	1987	11	infarction	infarction	NN
cord-015365-iqdi99pd	1987	12	zone	zone	NN
cord-015365-iqdi99pd	1987	13	and	and	CC
cord-015365-iqdi99pd	1987	14	led	lead	VBD
cord-015365-iqdi99pd	1987	15	to	to	IN
cord-015365-iqdi99pd	1987	16	a	a	DT
cord-015365-iqdi99pd	1987	17	significant	significant	JJ
cord-015365-iqdi99pd	1987	18	increase	increase	NN
cord-015365-iqdi99pd	1987	19	in	in	IN
cord-015365-iqdi99pd	1987	20	the	the	DT
cord-015365-iqdi99pd	1987	21	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1987	22	ejection	ejection	NN
cord-015365-iqdi99pd	1987	23	fraction	fraction	NN
cord-015365-iqdi99pd	1987	24	(	(	-LRB-
cord-015365-iqdi99pd	1987	25	plus	plus	CC
cord-015365-iqdi99pd	1987	26	20	20	CD
cord-015365-iqdi99pd	1987	27	%	%	NN
cord-015365-iqdi99pd	1987	28	28	28	CD
cord-015365-iqdi99pd	1987	29	days	day	NNS
cord-015365-iqdi99pd	1987	30	after	after	IN
cord-015365-iqdi99pd	1987	31	MI	MI	NNP
cord-015365-iqdi99pd	1987	32	)	)	-RRB-
cord-015365-iqdi99pd	1987	33	in	in	IN
cord-015365-iqdi99pd	1987	34	animals	animal	NNS
cord-015365-iqdi99pd	1987	35	treated	treat	VBN
cord-015365-iqdi99pd	1987	36	with	with	IN
cord-015365-iqdi99pd	1987	37	5	5	CD
cord-015365-iqdi99pd	1987	38	0	0	CD
cord-015365-iqdi99pd	1988	1	-methoxy	-methoxy	NNP
cord-015365-iqdi99pd	1988	2	leoligin	leoligin	NNP
cord-015365-iqdi99pd	1988	3	.	.	.
cord-015365-iqdi99pd	1989	1	Based	base	VBN
cord-015365-iqdi99pd	1989	2	on	on	IN
cord-015365-iqdi99pd	1989	3	microarray	microarray	NN
cord-015365-iqdi99pd	1989	4	analyses	analysis	NNS
cord-015365-iqdi99pd	1989	5	followed	follow	VBN
cord-015365-iqdi99pd	1989	6	by	by	IN
cord-015365-iqdi99pd	1989	7	knockdown	knockdown	NN
cord-015365-iqdi99pd	1989	8	and	and	CC
cord-015365-iqdi99pd	1989	9	over	over	IN
cord-015365-iqdi99pd	1989	10	-	-	HYPH
cord-015365-iqdi99pd	1989	11	expression	expression	NN
cord-015365-iqdi99pd	1989	12	experiments	experiment	NNS
cord-015365-iqdi99pd	1989	13	in	in	IN
cord-015365-iqdi99pd	1989	14	vitro	vitro	FW
cord-015365-iqdi99pd	1989	15	Cyp26B1	Cyp26B1	NNP
cord-015365-iqdi99pd	1989	16	was	be	VBD
cord-015365-iqdi99pd	1989	17	identified	identify	VBN
cord-015365-iqdi99pd	1989	18	as	as	IN
cord-015365-iqdi99pd	1989	19	the	the	DT
cord-015365-iqdi99pd	1989	20	central	central	JJ
cord-015365-iqdi99pd	1989	21	players	player	NNS
cord-015365-iqdi99pd	1989	22	in	in	IN
cord-015365-iqdi99pd	1989	23	5	5	CD
cord-015365-iqdi99pd	1989	24	0	0	CD
cord-015365-iqdi99pd	1990	1	-methoxy	-methoxy	:
cord-015365-iqdi99pd	1990	2	leoligin	leoligin	NNP
cord-015365-iqdi99pd	1990	3	-	-	HYPH
cord-015365-iqdi99pd	1990	4	induced	induce	VBN
cord-015365-iqdi99pd	1990	5	angiogenesis	angiogenesis	NN
cord-015365-iqdi99pd	1990	6	induction	induction	NN
cord-015365-iqdi99pd	1990	7	.	.	.
cord-015365-iqdi99pd	1991	1	Conclusion	conclusion	NN
cord-015365-iqdi99pd	1991	2	.	.	.
cord-015365-iqdi99pd	1992	1	The	the	DT
cord-015365-iqdi99pd	1992	2	data	datum	NNS
cord-015365-iqdi99pd	1992	3	presented	present	VBN
cord-015365-iqdi99pd	1992	4	herein	herein	RB
cord-015365-iqdi99pd	1992	5	indicate	indicate	VBP
cord-015365-iqdi99pd	1992	6	that	that	IN
cord-015365-iqdi99pd	1992	7	5	5	CD
cord-015365-iqdi99pd	1992	8	0methoxy	0methoxy	CD
cord-015365-iqdi99pd	1992	9	leoligin	leoligin	NNP
cord-015365-iqdi99pd	1992	10	induces	induce	VBZ
cord-015365-iqdi99pd	1992	11	angiogenesis	angiogenesis	NN
cord-015365-iqdi99pd	1992	12	in	in	IN
cord-015365-iqdi99pd	1992	13	the	the	DT
cord-015365-iqdi99pd	1992	14	peri	peri	NN
cord-015365-iqdi99pd	1992	15	-	-	HYPH
cord-015365-iqdi99pd	1992	16	infraction	infraction	NN
cord-015365-iqdi99pd	1992	17	area	area	NN
cord-015365-iqdi99pd	1992	18	after	after	IN
cord-015365-iqdi99pd	1992	19	MI	MI	NNP
cord-015365-iqdi99pd	1992	20	via	via	IN
cord-015365-iqdi99pd	1992	21	upregulation	upregulation	NN
cord-015365-iqdi99pd	1992	22	of	of	IN
cord-015365-iqdi99pd	1992	23	Cyp26B1	Cyp26B1	NNP
cord-015365-iqdi99pd	1992	24	.	.	.
cord-015365-iqdi99pd	1993	1	5	5	LS
cord-015365-iqdi99pd	1993	2	0	0	CD
cord-015365-iqdi99pd	1994	1	-methoxy	-methoxy	.
cord-015365-iqdi99pd	1995	1	leoligininduced	leoligininduced	NNP
cord-015365-iqdi99pd	1995	2	capillarisation	capillarisation	NN
cord-015365-iqdi99pd	1995	3	is	be	VBZ
cord-015365-iqdi99pd	1995	4	capable	capable	JJ
cord-015365-iqdi99pd	1995	5	of	of	IN
cord-015365-iqdi99pd	1995	6	partially	partially	RB
cord-015365-iqdi99pd	1995	7	restoring	restore	VBG
cord-015365-iqdi99pd	1995	8	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1995	9	function	function	NN
cord-015365-iqdi99pd	1995	10	after	after	IN
cord-015365-iqdi99pd	1995	11	MI	MI	NNP
cord-015365-iqdi99pd	1995	12	.	.	.
cord-015365-iqdi99pd	1996	1	Therefore	therefore	RB
cord-015365-iqdi99pd	1996	2	this	this	DT
cord-015365-iqdi99pd	1996	3	novel	novel	JJ
cord-015365-iqdi99pd	1996	4	compound	compound	NN
cord-015365-iqdi99pd	1996	5	could	could	MD
cord-015365-iqdi99pd	1996	6	be	be	VB
cord-015365-iqdi99pd	1996	7	able	able	JJ
cord-015365-iqdi99pd	1996	8	to	to	TO
cord-015365-iqdi99pd	1996	9	positively	positively	RB
cord-015365-iqdi99pd	1996	10	influence	influence	VB
cord-015365-iqdi99pd	1996	11	post	post	NN
cord-015365-iqdi99pd	1996	12	MI	MI	NNP
cord-015365-iqdi99pd	1996	13	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1996	14	remodeling	remodeling	NN
cord-015365-iqdi99pd	1996	15	and	and	CC
cord-015365-iqdi99pd	1996	16	even	even	RB
cord-015365-iqdi99pd	1996	17	induce	induce	VB
cord-015365-iqdi99pd	1996	18	myocardial	myocardial	JJ
cord-015365-iqdi99pd	1996	19	recovery	recovery	NN
cord-015365-iqdi99pd	1996	20	.	.	.
cord-015365-iqdi99pd	1997	1	This	this	DT
cord-015365-iqdi99pd	1997	2	or	or	CC
cord-015365-iqdi99pd	1997	3	other	other	JJ
cord-015365-iqdi99pd	1997	4	pharmacological	pharmacological	JJ
cord-015365-iqdi99pd	1997	5	strategies	strategy	NNS
cord-015365-iqdi99pd	1997	6	to	to	TO
cord-015365-iqdi99pd	1997	7	induce	induce	VB
cord-015365-iqdi99pd	1997	8	neoangiogenesis	neoangiogenesis	NNP
cord-015365-iqdi99pd	1997	9	could	could	MD
cord-015365-iqdi99pd	1997	10	preserve	preserve	VB
cord-015365-iqdi99pd	1997	11	organ	organ	NN
cord-015365-iqdi99pd	1997	12	function	function	NN
cord-015365-iqdi99pd	1997	13	and	and	CC
cord-015365-iqdi99pd	1997	14	avoid	avoid	VB
cord-015365-iqdi99pd	1997	15	several	several	JJ
cord-015365-iqdi99pd	1997	16	patients	patient	NNS
cord-015365-iqdi99pd	1997	17	ending	end	VBG
cord-015365-iqdi99pd	1997	18	on	on	IN
cord-015365-iqdi99pd	1997	19	the	the	DT
cord-015365-iqdi99pd	1997	20	waiting	waiting	NN
cord-015365-iqdi99pd	1997	21	list	list	NN
cord-015365-iqdi99pd	1997	22	for	for	IN
cord-015365-iqdi99pd	1997	23	cardiac	cardiac	JJ
cord-015365-iqdi99pd	1997	24	transplantation	transplantation	NN
cord-015365-iqdi99pd	1997	25	.	.	.
cord-015365-iqdi99pd	1998	1	Background	background	NN
cord-015365-iqdi99pd	1998	2	.	.	.
cord-015365-iqdi99pd	1999	1	A	a	DT
cord-015365-iqdi99pd	1999	2	major	major	JJ
cord-015365-iqdi99pd	1999	3	reason	reason	NN
cord-015365-iqdi99pd	1999	4	of	of	IN
cord-015365-iqdi99pd	1999	5	vein	vein	NN
cord-015365-iqdi99pd	1999	6	graft	graft	NN
cord-015365-iqdi99pd	1999	7	failure	failure	NN
cord-015365-iqdi99pd	1999	8	after	after	IN
cord-015365-iqdi99pd	1999	9	coronary	coronary	JJ
cord-015365-iqdi99pd	1999	10	artery	artery	NN
cord-015365-iqdi99pd	1999	11	bypass	bypass	NN
cord-015365-iqdi99pd	1999	12	grafting	grafting	NN
cord-015365-iqdi99pd	1999	13	is	be	VBZ
cord-015365-iqdi99pd	1999	14	neointimal	neointimal	JJ
cord-015365-iqdi99pd	1999	15	hyperplasia	hyperplasia	NN
cord-015365-iqdi99pd	1999	16	.	.	.
cord-015365-iqdi99pd	2000	1	Several	several	JJ
cord-015365-iqdi99pd	2000	2	clinical	clinical	JJ
cord-015365-iqdi99pd	2000	3	studies	study	NNS
cord-015365-iqdi99pd	2000	4	revealed	reveal	VBD
cord-015365-iqdi99pd	2000	5	that	that	IN
cord-015365-iqdi99pd	2000	6	the	the	DT
cord-015365-iqdi99pd	2000	7	patency	patency	NN
cord-015365-iqdi99pd	2000	8	rates	rate	NNS
cord-015365-iqdi99pd	2000	9	of	of	IN
cord-015365-iqdi99pd	2000	10	arterial	arterial	JJ
cord-015365-iqdi99pd	2000	11	conduits	conduit	NNS
cord-015365-iqdi99pd	2000	12	are	be	VBP
cord-015365-iqdi99pd	2000	13	better	well	JJR
cord-015365-iqdi99pd	2000	14	than	than	IN
cord-015365-iqdi99pd	2000	15	those	those	DT
cord-015365-iqdi99pd	2000	16	of	of	IN
cord-015365-iqdi99pd	2000	17	venous	venous	JJ
cord-015365-iqdi99pd	2000	18	conduits	conduit	NNS
cord-015365-iqdi99pd	2000	19	.	.	.
cord-015365-iqdi99pd	2001	1	In	in	IN
cord-015365-iqdi99pd	2001	2	the	the	DT
cord-015365-iqdi99pd	2001	3	current	current	JJ
cord-015365-iqdi99pd	2001	4	study	study	NN
cord-015365-iqdi99pd	2001	5	,	,	,
cord-015365-iqdi99pd	2001	6	we	-PRON-	PRP
cord-015365-iqdi99pd	2001	7	aimed	aim	VBD
cord-015365-iqdi99pd	2001	8	to	to	TO
cord-015365-iqdi99pd	2001	9	improve	improve	VB
cord-015365-iqdi99pd	2001	10	the	the	DT
cord-015365-iqdi99pd	2001	11	patency	patency	NN
cord-015365-iqdi99pd	2001	12	rate	rate	NN
cord-015365-iqdi99pd	2001	13	of	of	IN
cord-015365-iqdi99pd	2001	14	experimental	experimental	JJ
cord-015365-iqdi99pd	2001	15	vein	vein	NN
cord-015365-iqdi99pd	2001	16	grafts	graft	NNS
cord-015365-iqdi99pd	2001	17	by	by	IN
cord-015365-iqdi99pd	2001	18	induction	induction	NN
cord-015365-iqdi99pd	2001	19	of	of	IN
cord-015365-iqdi99pd	2001	20	graft	graft	NN
cord-015365-iqdi99pd	2001	21	arterialisation	arterialisation	NN
cord-015365-iqdi99pd	2001	22	by	by	IN
cord-015365-iqdi99pd	2001	23	transplantation	transplantation	NN
cord-015365-iqdi99pd	2001	24	of	of	IN
cord-015365-iqdi99pd	2001	25	homologous	homologous	JJ
cord-015365-iqdi99pd	2001	26	skeletal	skeletal	JJ
cord-015365-iqdi99pd	2001	27	myoblasts	myoblast	NNS
cord-015365-iqdi99pd	2001	28	.	.	.
cord-015365-iqdi99pd	2002	1	Methods	method	NNS
cord-015365-iqdi99pd	2002	2	.	.	.
cord-015365-iqdi99pd	2003	1	For	for	IN
cord-015365-iqdi99pd	2003	2	the	the	DT
cord-015365-iqdi99pd	2003	3	experiments	experiment	NNS
cord-015365-iqdi99pd	2003	4	we	-PRON-	PRP
cord-015365-iqdi99pd	2003	5	isolated	isolate	VBD
cord-015365-iqdi99pd	2003	6	skeletal	skeletal	JJ
cord-015365-iqdi99pd	2003	7	myoblasts	myoblast	NNS
cord-015365-iqdi99pd	2003	8	from	from	IN
cord-015365-iqdi99pd	2003	9	C57	C57	NNP
cord-015365-iqdi99pd	2003	10	/	/	SYM
cord-015365-iqdi99pd	2003	11	Bl6	Bl6	NNP
cord-015365-iqdi99pd	2003	12	mice	mouse	NNS
cord-015365-iqdi99pd	2003	13	.	.	.
cord-015365-iqdi99pd	2004	1	Syngenic	Syngenic	NNP
cord-015365-iqdi99pd	2004	2	C57	C57	NNP
cord-015365-iqdi99pd	2004	3	/	/	SYM
cord-015365-iqdi99pd	2004	4	Bl6	bl6	NN
cord-015365-iqdi99pd	2004	5	mice	mouse	NNS
cord-015365-iqdi99pd	2004	6	underwent	undergo	VBD
cord-015365-iqdi99pd	2004	7	interposition	interposition	NN
cord-015365-iqdi99pd	2004	8	of	of	IN
cord-015365-iqdi99pd	2004	9	the	the	DT
cord-015365-iqdi99pd	2004	10	vena	vena	NNP
cord-015365-iqdi99pd	2004	11	cava	cava	NNP
cord-015365-iqdi99pd	2004	12	inferior	inferior	JJ
cord-015365-iqdi99pd	2004	13	from	from	IN
cord-015365-iqdi99pd	2004	14	donor	donor	NN
cord-015365-iqdi99pd	2004	15	mice	mouse	NNS
cord-015365-iqdi99pd	2004	16	into	into	IN
cord-015365-iqdi99pd	2004	17	the	the	DT
cord-015365-iqdi99pd	2004	18	common	common	JJ
cord-015365-iqdi99pd	2004	19	carotid	carotid	JJ
cord-015365-iqdi99pd	2004	20	artery	artery	NN
cord-015365-iqdi99pd	2004	21	of	of	IN
cord-015365-iqdi99pd	2004	22	recipient	recipient	NN
cord-015365-iqdi99pd	2004	23	mice	mouse	NNS
cord-015365-iqdi99pd	2004	24	.	.	.
cord-015365-iqdi99pd	2005	1	We	-PRON-	PRP
cord-015365-iqdi99pd	2005	2	used	use	VBD
cord-015365-iqdi99pd	2005	3	2	2	CD
cord-015365-iqdi99pd	2005	4	experimental	experimental	JJ
cord-015365-iqdi99pd	2005	5	groups	group	NNS
cord-015365-iqdi99pd	2005	6	:	:	:
cord-015365-iqdi99pd	2005	7	one	one	CD
cord-015365-iqdi99pd	2005	8	control	control	NN
cord-015365-iqdi99pd	2005	9	group	group	NN
cord-015365-iqdi99pd	2005	10	,	,	,
cord-015365-iqdi99pd	2005	11	where	where	WRB
cord-015365-iqdi99pd	2005	12	we	-PRON-	PRP
cord-015365-iqdi99pd	2005	13	applied	apply	VBD
cord-015365-iqdi99pd	2005	14	only	only	RB
cord-015365-iqdi99pd	2005	15	the	the	DT
cord-015365-iqdi99pd	2005	16	control	control	NN
cord-015365-iqdi99pd	2005	17	medium	medium	NN
cord-015365-iqdi99pd	2005	18	without	without	IN
cord-015365-iqdi99pd	2005	19	any	any	DT
cord-015365-iqdi99pd	2005	20	cells	cell	NNS
cord-015365-iqdi99pd	2005	21	on	on	IN
cord-015365-iqdi99pd	2005	22	the	the	DT
cord-015365-iqdi99pd	2005	23	vein	vein	NN
cord-015365-iqdi99pd	2005	24	grafts	graft	NNS
cord-015365-iqdi99pd	2005	25	and	and	CC
cord-015365-iqdi99pd	2005	26	a	a	DT
cord-015365-iqdi99pd	2005	27	treatment	treatment	NN
cord-015365-iqdi99pd	2005	28	group	group	NN
cord-015365-iqdi99pd	2005	29	where	where	WRB
cord-015365-iqdi99pd	2005	30	we	-PRON-	PRP
cord-015365-iqdi99pd	2005	31	applied	apply	VBD
cord-015365-iqdi99pd	2005	32	skeletal	skeletal	JJ
cord-015365-iqdi99pd	2005	33	myoblast	myoblast	NN
cord-015365-iqdi99pd	2005	34	periadventially	periadventially	RB
cord-015365-iqdi99pd	2005	35	on	on	IN
cord-015365-iqdi99pd	2005	36	the	the	DT
cord-015365-iqdi99pd	2005	37	grafts	graft	NNS
cord-015365-iqdi99pd	2005	38	.	.	.
cord-015365-iqdi99pd	2006	1	After	after	IN
cord-015365-iqdi99pd	2006	2	4	4	CD
cord-015365-iqdi99pd	2006	3	weeks	week	NNS
cord-015365-iqdi99pd	2006	4	of	of	IN
cord-015365-iqdi99pd	2006	5	follow	follow	VB
cord-015365-iqdi99pd	2006	6	up	up	RP
cord-015365-iqdi99pd	2006	7	veins	vein	NNS
cord-015365-iqdi99pd	2006	8	were	be	VBD
cord-015365-iqdi99pd	2006	9	harvested	harvest	VBN
cord-015365-iqdi99pd	2006	10	,	,	,
cord-015365-iqdi99pd	2006	11	embedded	embed	VBN
cord-015365-iqdi99pd	2006	12	in	in	IN
cord-015365-iqdi99pd	2006	13	paraffin	paraffin	NN
cord-015365-iqdi99pd	2006	14	and	and	CC
cord-015365-iqdi99pd	2006	15	underwent	undergo	VBD
cord-015365-iqdi99pd	2006	16	histological	histological	JJ
cord-015365-iqdi99pd	2006	17	evaluation	evaluation	NN
cord-015365-iqdi99pd	2006	18	.	.	.
cord-015365-iqdi99pd	2007	1	Results	result	NNS
cord-015365-iqdi99pd	2007	2	.	.	.
cord-015365-iqdi99pd	2008	1	4	4	CD
cord-015365-iqdi99pd	2008	2	weeks	week	NNS
cord-015365-iqdi99pd	2008	3	after	after	IN
cord-015365-iqdi99pd	2008	4	surgery	surgery	NN
cord-015365-iqdi99pd	2008	5	the	the	DT
cord-015365-iqdi99pd	2008	6	neointimal	neointimal	JJ
cord-015365-iqdi99pd	2008	7	thickness	thickness	NN
cord-015365-iqdi99pd	2008	8	in	in	IN
cord-015365-iqdi99pd	2008	9	the	the	DT
cord-015365-iqdi99pd	2008	10	control	control	NN
cord-015365-iqdi99pd	2008	11	group	group	NN
cord-015365-iqdi99pd	2008	12	was	be	VBD
cord-015365-iqdi99pd	2008	13	56	56	CD
cord-015365-iqdi99pd	2008	14	mm	mm	NN
cord-015365-iqdi99pd	2008	15	(	(	-LRB-
cord-015365-iqdi99pd	2008	16	15	15	CD
cord-015365-iqdi99pd	2008	17	-	-	SYM
cord-015365-iqdi99pd	2008	18	60	60	CD
cord-015365-iqdi99pd	2008	19	)	)	-RRB-
cord-015365-iqdi99pd	2008	20	,	,	,
cord-015365-iqdi99pd	2008	21	whereas	whereas	IN
cord-015365-iqdi99pd	2008	22	in	in	IN
cord-015365-iqdi99pd	2008	23	the	the	DT
cord-015365-iqdi99pd	2008	24	treatment	treatment	NN
cord-015365-iqdi99pd	2008	25	group	group	NN
cord-015365-iqdi99pd	2008	26	we	-PRON-	PRP
cord-015365-iqdi99pd	2008	27	found	find	VBD
cord-015365-iqdi99pd	2008	28	neointimal	neointimal	JJ
cord-015365-iqdi99pd	2008	29	thickness	thickness	NN
cord-015365-iqdi99pd	2008	30	levels	level	NNS
cord-015365-iqdi99pd	2008	31	of	of	IN
cord-015365-iqdi99pd	2008	32	183	183	CD
cord-015365-iqdi99pd	2008	33	mm	mm	NN
cord-015365-iqdi99pd	2008	34	(	(	-LRB-
cord-015365-iqdi99pd	2008	35	152	152	CD
cord-015365-iqdi99pd	2008	36	-	-	SYM
cord-015365-iqdi99pd	2008	37	204	204	CD
cord-015365-iqdi99pd	2008	38	)	)	-RRB-
cord-015365-iqdi99pd	2009	1	(	(	-LRB-
cord-015365-iqdi99pd	2009	2	p	p	NN
cord-015365-iqdi99pd	2009	3	<	<	XX
cord-015365-iqdi99pd	2009	4	0.001	0.001	CD
cord-015365-iqdi99pd	2009	5	)	)	-RRB-
cord-015365-iqdi99pd	2009	6	.	.	.
cord-015365-iqdi99pd	2010	1	Apart	apart	RB
cord-015365-iqdi99pd	2010	2	from	from	IN
cord-015365-iqdi99pd	2010	3	that	that	DT
cord-015365-iqdi99pd	2010	4	we	-PRON-	PRP
cord-015365-iqdi99pd	2010	5	could	could	MD
cord-015365-iqdi99pd	2010	6	show	show	VB
cord-015365-iqdi99pd	2010	7	that	that	IN
cord-015365-iqdi99pd	2010	8	cells	cell	NNS
cord-015365-iqdi99pd	2010	9	remain	remain	VBP
cord-015365-iqdi99pd	2010	10	on	on	IN
cord-015365-iqdi99pd	2010	11	the	the	DT
cord-015365-iqdi99pd	2010	12	outside	outside	NN
cord-015365-iqdi99pd	2010	13	of	of	IN
cord-015365-iqdi99pd	2010	14	the	the	DT
cord-015365-iqdi99pd	2010	15	vein	vein	NN
cord-015365-iqdi99pd	2010	16	wall	wall	NN
cord-015365-iqdi99pd	2010	17	even	even	RB
cord-015365-iqdi99pd	2010	18	after	after	IN
cord-015365-iqdi99pd	2010	19	4	4	CD
cord-015365-iqdi99pd	2010	20	weeks	week	NNS
cord-015365-iqdi99pd	2010	21	.	.	.
cord-015365-iqdi99pd	2011	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2011	2	.	.	.
cord-015365-iqdi99pd	2012	1	Application	application	NN
cord-015365-iqdi99pd	2012	2	of	of	IN
cord-015365-iqdi99pd	2012	3	skeletal	skeletal	JJ
cord-015365-iqdi99pd	2012	4	myoblasts	myoblast	NNS
cord-015365-iqdi99pd	2012	5	does	do	VBZ
cord-015365-iqdi99pd	2012	6	not	not	RB
cord-015365-iqdi99pd	2012	7	induce	induce	VB
cord-015365-iqdi99pd	2012	8	vascular	vascular	JJ
cord-015365-iqdi99pd	2012	9	regeneration	regeneration	NN
cord-015365-iqdi99pd	2012	10	after	after	IN
cord-015365-iqdi99pd	2012	11	vein	vein	NN
cord-015365-iqdi99pd	2012	12	graft	graft	NN
cord-015365-iqdi99pd	2012	13	failure	failure	NN
cord-015365-iqdi99pd	2012	14	and	and	CC
cord-015365-iqdi99pd	2012	15	does	do	VBZ
cord-015365-iqdi99pd	2012	16	not	not	RB
cord-015365-iqdi99pd	2012	17	reduce	reduce	VB
cord-015365-iqdi99pd	2012	18	neointimal	neointimal	JJ
cord-015365-iqdi99pd	2012	19	hyperplasia	hyperplasia	NN
cord-015365-iqdi99pd	2012	20	.	.	.
cord-015365-iqdi99pd	2013	1	Moreover	moreover	RB
cord-015365-iqdi99pd	2013	2	application	application	NN
cord-015365-iqdi99pd	2013	3	of	of	IN
cord-015365-iqdi99pd	2013	4	these	these	DT
cord-015365-iqdi99pd	2013	5	cells	cell	NNS
cord-015365-iqdi99pd	2013	6	leads	lead	VBZ
cord-015365-iqdi99pd	2013	7	to	to	IN
cord-015365-iqdi99pd	2013	8	a	a	DT
cord-015365-iqdi99pd	2013	9	severe	severe	JJ
cord-015365-iqdi99pd	2013	10	induction	induction	NN
cord-015365-iqdi99pd	2013	11	of	of	IN
cord-015365-iqdi99pd	2013	12	neointimal	neointimal	JJ
cord-015365-iqdi99pd	2013	13	hyperplasia	hyperplasia	NN
cord-015365-iqdi99pd	2013	14	in	in	IN
cord-015365-iqdi99pd	2013	15	a	a	DT
cord-015365-iqdi99pd	2013	16	murine	murine	JJ
cord-015365-iqdi99pd	2013	17	vein	vein	NN
cord-015365-iqdi99pd	2013	18	graft	graft	NN
cord-015365-iqdi99pd	2013	19	model	model	NN
cord-015365-iqdi99pd	2013	20	.	.	.
cord-015365-iqdi99pd	2014	1	This	this	DT
cord-015365-iqdi99pd	2014	2	might	may	MD
cord-015365-iqdi99pd	2014	3	be	be	VB
cord-015365-iqdi99pd	2014	4	due	due	JJ
cord-015365-iqdi99pd	2014	5	to	to	IN
cord-015365-iqdi99pd	2014	6	secretion	secretion	NN
cord-015365-iqdi99pd	2014	7	of	of	IN
cord-015365-iqdi99pd	2014	8	growth	growth	NN
cord-015365-iqdi99pd	2014	9	factors	factor	NNS
cord-015365-iqdi99pd	2014	10	by	by	IN
cord-015365-iqdi99pd	2014	11	the	the	DT
cord-015365-iqdi99pd	2014	12	cells	cell	NNS
cord-015365-iqdi99pd	2014	13	.	.	.
cord-015365-iqdi99pd	2015	1	Background	background	NN
cord-015365-iqdi99pd	2015	2	.	.	.
cord-015365-iqdi99pd	2016	1	Based	base	VBN
cord-015365-iqdi99pd	2016	2	on	on	IN
cord-015365-iqdi99pd	2016	3	international	international	JJ
cord-015365-iqdi99pd	2016	4	recommendations	recommendation	NNS
cord-015365-iqdi99pd	2016	5	combined	combine	VBN
cord-015365-iqdi99pd	2016	6	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	2016	7	is	be	VBZ
cord-015365-iqdi99pd	2016	8	used	use	VBN
cord-015365-iqdi99pd	2016	9	after	after	IN
cord-015365-iqdi99pd	2016	10	kidney	kidney	NN
cord-015365-iqdi99pd	2016	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	2016	12	in	in	IN
cord-015365-iqdi99pd	2016	13	children	child	NNS
cord-015365-iqdi99pd	2016	14	.	.	.
cord-015365-iqdi99pd	2017	1	A	a	DT
cord-015365-iqdi99pd	2017	2	common	common	JJ
cord-015365-iqdi99pd	2017	3	regimen	regimen	NN
cord-015365-iqdi99pd	2017	4	is	be	VBZ
cord-015365-iqdi99pd	2017	5	based	base	VBN
cord-015365-iqdi99pd	2017	6	on	on	IN
cord-015365-iqdi99pd	2017	7	steroids	steroid	NNS
cord-015365-iqdi99pd	2017	8	,	,	,
cord-015365-iqdi99pd	2017	9	mycophenolat	mycophenolat	NNP
cord-015365-iqdi99pd	2017	10	-	-	HYPH
cord-015365-iqdi99pd	2017	11	mofetil	mofetil	NNP
cord-015365-iqdi99pd	2017	12	and	and	CC
cord-015365-iqdi99pd	2017	13	cyclosporin	cyclosporin	VB
cord-015365-iqdi99pd	2017	14	A	a	NN
cord-015365-iqdi99pd	2017	15	with	with	IN
cord-015365-iqdi99pd	2017	16	IL-2	IL-2	NNP
cord-015365-iqdi99pd	2017	17	antagonist	antagonist	NN
cord-015365-iqdi99pd	2017	18	induction	induction	NN
cord-015365-iqdi99pd	2017	19	.	.	.
cord-015365-iqdi99pd	2018	1	One	one	CD
cord-015365-iqdi99pd	2018	2	third	third	NN
cord-015365-iqdi99pd	2018	3	of	of	IN
cord-015365-iqdi99pd	2018	4	the	the	DT
cord-015365-iqdi99pd	2018	5	patients	patient	NNS
cord-015365-iqdi99pd	2018	6	had	have	VBD
cord-015365-iqdi99pd	2018	7	to	to	TO
cord-015365-iqdi99pd	2018	8	be	be	VB
cord-015365-iqdi99pd	2018	9	switched	switch	VBN
cord-015365-iqdi99pd	2018	10	from	from	IN
cord-015365-iqdi99pd	2018	11	cyclosporin	cyclosporin	NNP
cord-015365-iqdi99pd	2018	12	A	A	NNP
cord-015365-iqdi99pd	2018	13	to	to	IN
cord-015365-iqdi99pd	2018	14	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2018	15	,	,	,
cord-015365-iqdi99pd	2018	16	due	due	IN
cord-015365-iqdi99pd	2018	17	to	to	IN
cord-015365-iqdi99pd	2018	18	dermatologic	dermatologic	JJ
cord-015365-iqdi99pd	2018	19	cosmetic	cosmetic	JJ
cord-015365-iqdi99pd	2018	20	side	side	NN
cord-015365-iqdi99pd	2018	21	effects	effect	NNS
cord-015365-iqdi99pd	2018	22	.	.	.
cord-015365-iqdi99pd	2019	1	Thus	thus	RB
cord-015365-iqdi99pd	2019	2	,	,	,
cord-015365-iqdi99pd	2019	3	TABIC	TABIC	NNP
cord-015365-iqdi99pd	2019	4	was	be	VBD
cord-015365-iqdi99pd	2019	5	established	establish	VBN
cord-015365-iqdi99pd	2019	6	as	as	IN
cord-015365-iqdi99pd	2019	7	a	a	DT
cord-015365-iqdi99pd	2019	8	novel	novel	JJ
cord-015365-iqdi99pd	2019	9	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	2019	10	regimen	regimen	NN
cord-015365-iqdi99pd	2019	11	.	.	.
cord-015365-iqdi99pd	2020	1	Aim	aim	VB
cord-015365-iqdi99pd	2020	2	of	of	IN
cord-015365-iqdi99pd	2020	3	the	the	DT
cord-015365-iqdi99pd	2020	4	present	present	JJ
cord-015365-iqdi99pd	2020	5	registry	registry	NN
cord-015365-iqdi99pd	2020	6	is	be	VBZ
cord-015365-iqdi99pd	2020	7	to	to	TO
cord-015365-iqdi99pd	2020	8	perform	perform	VB
cord-015365-iqdi99pd	2020	9	quality	quality	NN
cord-015365-iqdi99pd	2020	10	assurance	assurance	NN
cord-015365-iqdi99pd	2020	11	and	and	CC
cord-015365-iqdi99pd	2020	12	to	to	TO
cord-015365-iqdi99pd	2020	13	evaluate	evaluate	VB
cord-015365-iqdi99pd	2020	14	a	a	DT
cord-015365-iqdi99pd	2020	15	risk	risk	NN
cord-015365-iqdi99pd	2020	16	/	/	SYM
cord-015365-iqdi99pd	2020	17	benefit	benefit	NN
cord-015365-iqdi99pd	2020	18	analysis	analysis	NN
cord-015365-iqdi99pd	2020	19	of	of	IN
cord-015365-iqdi99pd	2020	20	the	the	DT
cord-015365-iqdi99pd	2020	21	TABIC	TABIC	NNP
cord-015365-iqdi99pd	2020	22	-	-	HYPH
cord-015365-iqdi99pd	2020	23	regimen	regimen	NN
cord-015365-iqdi99pd	2020	24	compared	compare	VBN
cord-015365-iqdi99pd	2020	25	to	to	IN
cord-015365-iqdi99pd	2020	26	previous	previous	JJ
cord-015365-iqdi99pd	2020	27	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	2020	28	regimens	regimen	NNS
cord-015365-iqdi99pd	2020	29	in	in	IN
cord-015365-iqdi99pd	2020	30	children	child	NNS
cord-015365-iqdi99pd	2020	31	undergoing	undergo	VBG
cord-015365-iqdi99pd	2020	32	kidney	kidney	NN
cord-015365-iqdi99pd	2020	33	transplantation	transplantation	NN
cord-015365-iqdi99pd	2020	34	at	at	IN
cord-015365-iqdi99pd	2020	35	our	-PRON-	PRP$
cord-015365-iqdi99pd	2020	36	center	center	NN
cord-015365-iqdi99pd	2020	37	.	.	.
cord-015365-iqdi99pd	2021	1	Methods	method	NNS
cord-015365-iqdi99pd	2021	2	.	.	.
cord-015365-iqdi99pd	2022	1	In	in	IN
cord-015365-iqdi99pd	2022	2	this	this	DT
cord-015365-iqdi99pd	2022	3	observational	observational	JJ
cord-015365-iqdi99pd	2022	4	single	single	JJ
cord-015365-iqdi99pd	2022	5	-	-	HYPH
cord-015365-iqdi99pd	2022	6	center	center	NN
cord-015365-iqdi99pd	2022	7	study	study	NN
cord-015365-iqdi99pd	2022	8	,	,	,
cord-015365-iqdi99pd	2022	9	32	32	CD
cord-015365-iqdi99pd	2022	10	consecutive	consecutive	JJ
cord-015365-iqdi99pd	2022	11	patients	patient	NNS
cord-015365-iqdi99pd	2022	12	undergoing	undergo	VBG
cord-015365-iqdi99pd	2022	13	kidney	kidney	NN
cord-015365-iqdi99pd	2022	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	2022	15	between	between	IN
cord-015365-iqdi99pd	2022	16	December	December	NNP
cord-015365-iqdi99pd	2022	17	2005	2005	CD
cord-015365-iqdi99pd	2022	18	and	and	CC
cord-015365-iqdi99pd	2022	19	October	October	NNP
cord-015365-iqdi99pd	2022	20	2011	2011	CD
cord-015365-iqdi99pd	2022	21	at	at	IN
cord-015365-iqdi99pd	2022	22	our	-PRON-	PRP$
cord-015365-iqdi99pd	2022	23	center	center	NN
cord-015365-iqdi99pd	2022	24	,	,	,
cord-015365-iqdi99pd	2022	25	were	be	VBD
cord-015365-iqdi99pd	2022	26	enrolled	enrol	VBN
cord-015365-iqdi99pd	2022	27	.	.	.
cord-015365-iqdi99pd	2023	1	Patients	patient	NNS
cord-015365-iqdi99pd	2023	2	who	who	WP
cord-015365-iqdi99pd	2023	3	were	be	VBD
cord-015365-iqdi99pd	2023	4	not	not	RB
cord-015365-iqdi99pd	2023	5	treated	treat	VBN
cord-015365-iqdi99pd	2023	6	according	accord	VBG
cord-015365-iqdi99pd	2023	7	to	to	IN
cord-015365-iqdi99pd	2023	8	the	the	DT
cord-015365-iqdi99pd	2023	9	TABIC	TABIC	NNP
cord-015365-iqdi99pd	2023	10	-	-	HYPH
cord-015365-iqdi99pd	2023	11	scheme	scheme	NN
cord-015365-iqdi99pd	2023	12	served	serve	VBD
cord-015365-iqdi99pd	2023	13	as	as	IN
cord-015365-iqdi99pd	2023	14	a	a	DT
cord-015365-iqdi99pd	2023	15	historic	historic	JJ
cord-015365-iqdi99pd	2023	16	control	control	NN
cord-015365-iqdi99pd	2023	17	.	.	.
cord-015365-iqdi99pd	2024	1	The	the	DT
cord-015365-iqdi99pd	2024	2	end	end	NN
cord-015365-iqdi99pd	2024	3	-	-	HYPH
cord-015365-iqdi99pd	2024	4	point	point	NN
cord-015365-iqdi99pd	2024	5	was	be	VBD
cord-015365-iqdi99pd	2024	6	a	a	DT
cord-015365-iqdi99pd	2024	7	combination	combination	NN
cord-015365-iqdi99pd	2024	8	of	of	IN
cord-015365-iqdi99pd	2024	9	death	death	NN
cord-015365-iqdi99pd	2024	10	and	and	CC
cord-015365-iqdi99pd	2024	11	graft	graft	NN
cord-015365-iqdi99pd	2024	12	loss	loss	NN
cord-015365-iqdi99pd	2024	13	.	.	.
cord-015365-iqdi99pd	2025	1	Results	result	NNS
cord-015365-iqdi99pd	2025	2	.	.	.
cord-015365-iqdi99pd	2026	1	5	5	CD
cord-015365-iqdi99pd	2026	2	patients	patient	NNS
cord-015365-iqdi99pd	2026	3	(	(	-LRB-
cord-015365-iqdi99pd	2026	4	16	16	CD
cord-015365-iqdi99pd	2026	5	%	%	NN
cord-015365-iqdi99pd	2026	6	)	)	-RRB-
cord-015365-iqdi99pd	2026	7	had	have	VBD
cord-015365-iqdi99pd	2026	8	to	to	TO
cord-015365-iqdi99pd	2026	9	be	be	VB
cord-015365-iqdi99pd	2026	10	switched	switch	VBN
cord-015365-iqdi99pd	2026	11	from	from	IN
cord-015365-iqdi99pd	2026	12	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2026	13	to	to	IN
cord-015365-iqdi99pd	2026	14	rapamycin	rapamycin	NNS
cord-015365-iqdi99pd	2026	15	due	due	IN
cord-015365-iqdi99pd	2026	16	to	to	IN
cord-015365-iqdi99pd	2026	17	side	side	JJ
cord-015365-iqdi99pd	2026	18	effects	effect	NNS
cord-015365-iqdi99pd	2026	19	.	.	.
cord-015365-iqdi99pd	2027	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	2027	2	,	,	,
cord-015365-iqdi99pd	2027	3	5	5	CD
cord-015365-iqdi99pd	2027	4	patients	patient	NNS
cord-015365-iqdi99pd	2027	5	(	(	-LRB-
cord-015365-iqdi99pd	2027	6	16	16	CD
cord-015365-iqdi99pd	2027	7	%	%	NN
cord-015365-iqdi99pd	2027	8	)	)	-RRB-
cord-015365-iqdi99pd	2027	9	suffered	suffer	VBD
cord-015365-iqdi99pd	2027	10	from	from	IN
cord-015365-iqdi99pd	2027	11	acute	acute	JJ
cord-015365-iqdi99pd	2027	12	rejection	rejection	NN
cord-015365-iqdi99pd	2027	13	,	,	,
cord-015365-iqdi99pd	2027	14	but	but	CC
cord-015365-iqdi99pd	2027	15	no	no	DT
cord-015365-iqdi99pd	2027	16	graft	graft	NN
cord-015365-iqdi99pd	2027	17	loss	loss	NN
cord-015365-iqdi99pd	2027	18	was	be	VBD
cord-015365-iqdi99pd	2027	19	observed	observe	VBN
cord-015365-iqdi99pd	2027	20	.	.	.
cord-015365-iqdi99pd	2028	1	Within	within	IN
cord-015365-iqdi99pd	2028	2	follow	follow	NN
cord-015365-iqdi99pd	2028	3	-	-	HYPH
cord-015365-iqdi99pd	2028	4	up	up	NN
cord-015365-iqdi99pd	2028	5	,	,	,
cord-015365-iqdi99pd	2028	6	no	no	DT
cord-015365-iqdi99pd	2028	7	patient	patient	NN
cord-015365-iqdi99pd	2028	8	reached	reach	VBD
cord-015365-iqdi99pd	2028	9	the	the	DT
cord-015365-iqdi99pd	2028	10	combined	combined	JJ
cord-015365-iqdi99pd	2028	11	end	end	NN
cord-015365-iqdi99pd	2028	12	-	-	HYPH
cord-015365-iqdi99pd	2028	13	point	point	NN
cord-015365-iqdi99pd	2028	14	(	(	-LRB-
cord-015365-iqdi99pd	2028	15	100	100	CD
cord-015365-iqdi99pd	2028	16	%	%	NN
cord-015365-iqdi99pd	2028	17	kidney	kidney	NN
cord-015365-iqdi99pd	2028	18	transplant	transplant	NN
cord-015365-iqdi99pd	2028	19	as	as	RB
cord-015365-iqdi99pd	2028	20	well	well	RB
cord-015365-iqdi99pd	2028	21	as	as	IN
cord-015365-iqdi99pd	2028	22	100	100	CD
cord-015365-iqdi99pd	2028	23	%	%	NN
cord-015365-iqdi99pd	2028	24	patients	patient	NNS
cord-015365-iqdi99pd	2028	25	survival	survival	NN
cord-015365-iqdi99pd	2028	26	)	)	-RRB-
cord-015365-iqdi99pd	2028	27	.	.	.
cord-015365-iqdi99pd	2029	1	A	a	DT
cord-015365-iqdi99pd	2029	2	Kaplan	Kaplan	NNP
cord-015365-iqdi99pd	2029	3	-	-	HYPH
cord-015365-iqdi99pd	2029	4	Meier	Meier	NNP
cord-015365-iqdi99pd	2029	5	-	-	HYPH
cord-015365-iqdi99pd	2029	6	analysis	analysis	NN
cord-015365-iqdi99pd	2029	7	revealed	reveal	VBD
cord-015365-iqdi99pd	2029	8	a	a	DT
cord-015365-iqdi99pd	2029	9	significantly	significantly	RB
cord-015365-iqdi99pd	2029	10	better	well	JJR
cord-015365-iqdi99pd	2029	11	outcome	outcome	NN
cord-015365-iqdi99pd	2029	12	for	for	IN
cord-015365-iqdi99pd	2029	13	patients	patient	NNS
cord-015365-iqdi99pd	2029	14	treated	treat	VBN
cord-015365-iqdi99pd	2029	15	with	with	IN
cord-015365-iqdi99pd	2029	16	the	the	DT
cord-015365-iqdi99pd	2029	17	TABIC	TABIC	NNP
cord-015365-iqdi99pd	2029	18	-	-	HYPH
cord-015365-iqdi99pd	2029	19	scheme	scheme	NN
cord-015365-iqdi99pd	2029	20	compared	compare	VBN
cord-015365-iqdi99pd	2029	21	to	to	IN
cord-015365-iqdi99pd	2029	22	controls	control	NNS
cord-015365-iqdi99pd	2029	23	(	(	-LRB-
cord-015365-iqdi99pd	2029	24	5	5	CD
cord-015365-iqdi99pd	2029	25	years	year	NNS
cord-015365-iqdi99pd	2029	26	event	event	NN
cord-015365-iqdi99pd	2029	27	free	free	JJ
cord-015365-iqdi99pd	2029	28	survival	survival	NN
cord-015365-iqdi99pd	2029	29	,	,	,
cord-015365-iqdi99pd	2029	30	TABIC	TABIC	NNP
cord-015365-iqdi99pd	2029	31	vs.	vs.	IN
cord-015365-iqdi99pd	2029	32	non	non	JJ
cord-015365-iqdi99pd	2029	33	-	-	JJ
cord-015365-iqdi99pd	2029	34	TABIC	tabic	JJ
cord-015365-iqdi99pd	2029	35	:	:	:
cord-015365-iqdi99pd	2029	36	100	100	CD
cord-015365-iqdi99pd	2029	37	%	%	NN
cord-015365-iqdi99pd	2029	38	vs.	vs.	IN
cord-015365-iqdi99pd	2029	39	79	79	CD
cord-015365-iqdi99pd	2029	40	%	%	NN
cord-015365-iqdi99pd	2029	41	,	,	,
cord-015365-iqdi99pd	2029	42	p	p	NN
cord-015365-iqdi99pd	2029	43	¼	¼	CD
cord-015365-iqdi99pd	2029	44	0.048	0.048	CD
cord-015365-iqdi99pd	2029	45	)	)	-RRB-
cord-015365-iqdi99pd	2029	46	.	.	.
cord-015365-iqdi99pd	2030	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2030	2	.	.	.
cord-015365-iqdi99pd	2031	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	2031	2	data	datum	NNS
cord-015365-iqdi99pd	2031	3	show	show	VBP
cord-015365-iqdi99pd	2031	4	that	that	IN
cord-015365-iqdi99pd	2031	5	the	the	DT
cord-015365-iqdi99pd	2031	6	TABIC	TABIC	NNP
cord-015365-iqdi99pd	2031	7	-	-	HYPH
cord-015365-iqdi99pd	2031	8	regimen	regimen	NN
cord-015365-iqdi99pd	2031	9	is	be	VBZ
cord-015365-iqdi99pd	2031	10	efficient	efficient	JJ
cord-015365-iqdi99pd	2031	11	and	and	CC
cord-015365-iqdi99pd	2031	12	safe	safe	JJ
cord-015365-iqdi99pd	2031	13	compared	compare	VBN
cord-015365-iqdi99pd	2031	14	to	to	TO
cord-015365-iqdi99pd	2031	15	cyclosporin	cyclosporin	VB
cord-015365-iqdi99pd	2031	16	A	a	DT
cord-015365-iqdi99pd	2031	17	based	base	VBN
cord-015365-iqdi99pd	2031	18	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	2031	19	.	.	.
cord-015365-iqdi99pd	2032	1	Tacrolimus	Tacrolimus	NNP
cord-015365-iqdi99pd	2032	2	is	be	VBZ
cord-015365-iqdi99pd	2032	3	associated	associate	VBN
cord-015365-iqdi99pd	2032	4	with	with	IN
cord-015365-iqdi99pd	2032	5	a	a	DT
cord-015365-iqdi99pd	2032	6	significantly	significantly	RB
cord-015365-iqdi99pd	2032	7	better	well	JJR
cord-015365-iqdi99pd	2032	8	graft	graft	NN
cord-015365-iqdi99pd	2032	9	and	and	CC
cord-015365-iqdi99pd	2032	10	patient	patient	JJ
cord-015365-iqdi99pd	2032	11	survival	survival	NN
cord-015365-iqdi99pd	2032	12	.	.	.
cord-015365-iqdi99pd	2033	1	Therefore	therefore	RB
cord-015365-iqdi99pd	2033	2	,	,	,
cord-015365-iqdi99pd	2033	3	it	-PRON-	PRP
cord-015365-iqdi99pd	2033	4	should	should	MD
cord-015365-iqdi99pd	2033	5	be	be	VB
cord-015365-iqdi99pd	2033	6	considered	consider	VBN
cord-015365-iqdi99pd	2033	7	as	as	IN
cord-015365-iqdi99pd	2033	8	standard	standard	JJ
cord-015365-iqdi99pd	2033	9	therapy	therapy	NN
cord-015365-iqdi99pd	2033	10	after	after	IN
cord-015365-iqdi99pd	2033	11	kidney	kidney	NN
cord-015365-iqdi99pd	2033	12	transplantation	transplantation	NN
cord-015365-iqdi99pd	2033	13	in	in	IN
cord-015365-iqdi99pd	2033	14	children	child	NNS
cord-015365-iqdi99pd	2033	15	.	.	.
cord-015365-iqdi99pd	2034	1	Falsely	falsely	RB
cord-015365-iqdi99pd	2034	2	elevated	elevate	VBN
cord-015365-iqdi99pd	2034	3	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2034	4	concentrations	concentration	NNS
cord-015365-iqdi99pd	2034	5	in	in	IN
cord-015365-iqdi99pd	2034	6	two	two	CD
cord-015365-iqdi99pd	2034	7	kidney	kidney	NN
cord-015365-iqdi99pd	2034	8	allograft	allograft	NN
cord-015365-iqdi99pd	2034	9	recipients	recipient	NNS
cord-015365-iqdi99pd	2034	10	using	use	VBG
cord-015365-iqdi99pd	2034	11	the	the	DT
cord-015365-iqdi99pd	2034	12	affinity	affinity	NN
cord-015365-iqdi99pd	2034	13	column	column	NN
cord-015365-iqdi99pd	2034	14	-	-	HYPH
cord-015365-iqdi99pd	2034	15	mediated	mediate	VBN
cord-015365-iqdi99pd	2034	16	immunoassay	immunoassay	NN
cord-015365-iqdi99pd	2034	17	(	(	-LRB-
cord-015365-iqdi99pd	2034	18	ACMIA	ACMIA	NNP
cord-015365-iqdi99pd	2034	19	)	)	-RRB-
cord-015365-iqdi99pd	2034	20	method	method	NN
cord-015365-iqdi99pd	2034	21	:	:	:
cord-015365-iqdi99pd	2034	22	identification	identification	NN
cord-015365-iqdi99pd	2034	23	of	of	IN
cord-015365-iqdi99pd	2034	24	IgG	IgG	NNP
cord-015365-iqdi99pd	2034	25	isotype	isotype	JJ
cord-015365-iqdi99pd	2034	26	rheumatoid	rheumatoid	NNP
cord-015365-iqdi99pd	2034	27	factor	factor	NN
cord-015365-iqdi99pd	2034	28	as	as	IN
cord-015365-iqdi99pd	2034	29	causative	causative	JJ
cord-015365-iqdi99pd	2034	30	endogenous	endogenous	JJ
cord-015365-iqdi99pd	2034	31	antibodies	antibody	NNS
cord-015365-iqdi99pd	2034	32	Background	Background	NNP
cord-015365-iqdi99pd	2034	33	.	.	.
cord-015365-iqdi99pd	2035	1	Therapeutic	therapeutic	JJ
cord-015365-iqdi99pd	2035	2	monitoring	monitoring	NN
cord-015365-iqdi99pd	2035	3	of	of	IN
cord-015365-iqdi99pd	2035	4	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2035	5	is	be	VBZ
cord-015365-iqdi99pd	2035	6	currently	currently	RB
cord-015365-iqdi99pd	2035	7	performed	perform	VBN
cord-015365-iqdi99pd	2035	8	employing	employ	VBG
cord-015365-iqdi99pd	2035	9	ACMIA	ACMIA	NNP
cord-015365-iqdi99pd	2035	10	in	in	IN
cord-015365-iqdi99pd	2035	11	several	several	JJ
cord-015365-iqdi99pd	2035	12	transplant	transplant	NN
cord-015365-iqdi99pd	2035	13	centers	center	NNS
cord-015365-iqdi99pd	2035	14	.	.	.
cord-015365-iqdi99pd	2036	1	Here	here	RB
cord-015365-iqdi99pd	2036	2	we	-PRON-	PRP
cord-015365-iqdi99pd	2036	3	report	report	VBP
cord-015365-iqdi99pd	2036	4	on	on	IN
cord-015365-iqdi99pd	2036	5	two	two	CD
cord-015365-iqdi99pd	2036	6	renal	renal	JJ
cord-015365-iqdi99pd	2036	7	transplant	transplant	NN
cord-015365-iqdi99pd	2036	8	patients	patient	NNS
cord-015365-iqdi99pd	2036	9	displaying	display	VBG
cord-015365-iqdi99pd	2036	10	excessive	excessive	JJ
cord-015365-iqdi99pd	2036	11	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2036	12	levels	level	NNS
cord-015365-iqdi99pd	2036	13	either	either	CC
cord-015365-iqdi99pd	2036	14	not	not	RB
cord-015365-iqdi99pd	2036	15	corresponding	correspond	VBG
cord-015365-iqdi99pd	2036	16	to	to	IN
cord-015365-iqdi99pd	2036	17	oral	oral	JJ
cord-015365-iqdi99pd	2036	18	drug	drug	NN
cord-015365-iqdi99pd	2036	19	dosage	dosage	NN
cord-015365-iqdi99pd	2036	20	or	or	CC
cord-015365-iqdi99pd	2036	21	without	without	IN
cord-015365-iqdi99pd	2036	22	taking	take	VBG
cord-015365-iqdi99pd	2036	23	the	the	DT
cord-015365-iqdi99pd	2036	24	drug	drug	NN
cord-015365-iqdi99pd	2036	25	at	at	RB
cord-015365-iqdi99pd	2036	26	all	all	RB
cord-015365-iqdi99pd	2036	27	.	.	.
cord-015365-iqdi99pd	2037	1	Various	various	JJ
cord-015365-iqdi99pd	2037	2	antibodies	antibody	NNS
cord-015365-iqdi99pd	2037	3	,	,	,
cord-015365-iqdi99pd	2037	4	such	such	JJ
cord-015365-iqdi99pd	2037	5	as	as	IN
cord-015365-iqdi99pd	2037	6	anti	anti	JJ
cord-015365-iqdi99pd	2037	7	ds	ds	NNP
cord-015365-iqdi99pd	2037	8	-	-	HYPH
cord-015365-iqdi99pd	2037	9	DNA	DNA	NNP
cord-015365-iqdi99pd	2037	10	antibodies	antibody	NNS
cord-015365-iqdi99pd	2037	11	or	or	CC
cord-015365-iqdi99pd	2037	12	heterophilic	heterophilic	NNP
cord-015365-iqdi99pd	2037	13	antibodies	antibody	NNS
cord-015365-iqdi99pd	2037	14	,	,	,
cord-015365-iqdi99pd	2037	15	have	have	VBP
cord-015365-iqdi99pd	2037	16	been	be	VBN
cord-015365-iqdi99pd	2037	17	identified	identify	VBN
cord-015365-iqdi99pd	2037	18	in	in	IN
cord-015365-iqdi99pd	2037	19	previous	previous	JJ
cord-015365-iqdi99pd	2037	20	cases	case	NNS
cord-015365-iqdi99pd	2037	21	of	of	IN
cord-015365-iqdi99pd	2037	22	falsely	falsely	RB
cord-015365-iqdi99pd	2037	23	elevated	elevate	VBN
cord-015365-iqdi99pd	2037	24	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2037	25	measurements	measurement	NNS
cord-015365-iqdi99pd	2037	26	and	and	CC
cord-015365-iqdi99pd	2037	27	have	have	VBP
cord-015365-iqdi99pd	2037	28	been	be	VBN
cord-015365-iqdi99pd	2037	29	suggested	suggest	VBN
cord-015365-iqdi99pd	2037	30	as	as	IN
cord-015365-iqdi99pd	2037	31	a	a	DT
cord-015365-iqdi99pd	2037	32	possible	possible	JJ
cord-015365-iqdi99pd	2037	33	cause	cause	NN
cord-015365-iqdi99pd	2037	34	for	for	IN
cord-015365-iqdi99pd	2037	35	interaction	interaction	NN
cord-015365-iqdi99pd	2037	36	with	with	IN
cord-015365-iqdi99pd	2037	37	the	the	DT
cord-015365-iqdi99pd	2037	38	tacrolimus	tacrolimus	NNP
cord-015365-iqdi99pd	2037	39	assay	assay	NN
cord-015365-iqdi99pd	2037	40	.	.	.
cord-015365-iqdi99pd	2038	1	Methods	method	NNS
cord-015365-iqdi99pd	2038	2	and	and	CC
cord-015365-iqdi99pd	2038	3	Results	result	NNS
cord-015365-iqdi99pd	2038	4	.	.	.
cord-015365-iqdi99pd	2039	1	In	in	IN
cord-015365-iqdi99pd	2039	2	our	-PRON-	PRP$
cord-015365-iqdi99pd	2039	3	observations	observation	NNS
cord-015365-iqdi99pd	2039	4	,	,	,
cord-015365-iqdi99pd	2039	5	both	both	DT
cord-015365-iqdi99pd	2039	6	patients	patient	NNS
cord-015365-iqdi99pd	2039	7	were	be	VBD
cord-015365-iqdi99pd	2039	8	on	on	IN
cord-015365-iqdi99pd	2039	9	a	a	DT
cord-015365-iqdi99pd	2039	10	stable	stable	JJ
cord-015365-iqdi99pd	2039	11	,	,	,
cord-015365-iqdi99pd	2039	12	long	long	JJ
cord-015365-iqdi99pd	2039	13	-	-	HYPH
cord-015365-iqdi99pd	2039	14	term	term	NN
cord-015365-iqdi99pd	2039	15	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2039	16	-	-	HYPH
cord-015365-iqdi99pd	2039	17	based	base	VBN
cord-015365-iqdi99pd	2039	18	immunosuppressive	immunosuppressive	JJ
cord-015365-iqdi99pd	2039	19	regimen	regimen	NN
cord-015365-iqdi99pd	2039	20	.	.	.
cord-015365-iqdi99pd	2040	1	In	in	IN
cord-015365-iqdi99pd	2040	2	the	the	DT
cord-015365-iqdi99pd	2040	3	first	first	JJ
cord-015365-iqdi99pd	2040	4	patient	patient	NN
cord-015365-iqdi99pd	2040	5	the	the	DT
cord-015365-iqdi99pd	2040	6	elevated	elevated	JJ
cord-015365-iqdi99pd	2040	7	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2040	8	trough	trough	NN
cord-015365-iqdi99pd	2040	9	levels	level	NNS
cord-015365-iqdi99pd	2040	10	were	be	VBD
cord-015365-iqdi99pd	2040	11	only	only	RB
cord-015365-iqdi99pd	2040	12	observed	observe	VBN
cord-015365-iqdi99pd	2040	13	after	after	IN
cord-015365-iqdi99pd	2040	14	loss	loss	NN
cord-015365-iqdi99pd	2040	15	of	of	IN
cord-015365-iqdi99pd	2040	16	graft	graft	NN
cord-015365-iqdi99pd	2040	17	function	function	NN
cord-015365-iqdi99pd	2040	18	(	(	-LRB-
cord-015365-iqdi99pd	2040	19	6	6	CD
cord-015365-iqdi99pd	2040	20	years	year	NNS
cord-015365-iqdi99pd	2040	21	posttransplant	posttransplant	NNP
cord-015365-iqdi99pd	2040	22	)	)	-RRB-
cord-015365-iqdi99pd	2040	23	while	while	IN
cord-015365-iqdi99pd	2040	24	the	the	DT
cord-015365-iqdi99pd	2040	25	patient	patient	NN
cord-015365-iqdi99pd	2040	26	was	be	VBD
cord-015365-iqdi99pd	2040	27	not	not	RB
cord-015365-iqdi99pd	2040	28	longer	long	JJR
cord-015365-iqdi99pd	2040	29	on	on	IN
cord-015365-iqdi99pd	2040	30	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2040	31	,	,	,
cord-015365-iqdi99pd	2040	32	as	as	IN
cord-015365-iqdi99pd	2040	33	the	the	DT
cord-015365-iqdi99pd	2040	34	patient	patient	NN
cord-015365-iqdi99pd	2040	35	was	be	VBD
cord-015365-iqdi99pd	2040	36	on	on	IN
cord-015365-iqdi99pd	2040	37	hemodialysis	hemodialysis	NN
cord-015365-iqdi99pd	2040	38	again	again	RB
cord-015365-iqdi99pd	2040	39	.	.	.
cord-015365-iqdi99pd	2041	1	The	the	DT
cord-015365-iqdi99pd	2041	2	second	second	JJ
cord-015365-iqdi99pd	2041	3	patient	patient	NN
cord-015365-iqdi99pd	2041	4	currently	currently	RB
cord-015365-iqdi99pd	2041	5	still	still	RB
cord-015365-iqdi99pd	2041	6	has	have	VBZ
cord-015365-iqdi99pd	2041	7	a	a	DT
cord-015365-iqdi99pd	2041	8	functioning	function	VBG
cord-015365-iqdi99pd	2041	9	graft	graft	NN
cord-015365-iqdi99pd	2041	10	,	,	,
cord-015365-iqdi99pd	2041	11	although	although	IN
cord-015365-iqdi99pd	2041	12	he	-PRON-	PRP
cord-015365-iqdi99pd	2041	13	is	be	VBZ
cord-015365-iqdi99pd	2041	14	taking	take	VBG
cord-015365-iqdi99pd	2041	15	minute	minute	JJ
cord-015365-iqdi99pd	2041	16	amounts	amount	NNS
cord-015365-iqdi99pd	2041	17	of	of	IN
cord-015365-iqdi99pd	2041	18	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2041	19	.	.	.
cord-015365-iqdi99pd	2042	1	All	all	DT
cord-015365-iqdi99pd	2042	2	rheumatoid	rheumatoid	JJ
cord-015365-iqdi99pd	2042	3	and	and	CC
cord-015365-iqdi99pd	2042	4	immunologic	immunologic	JJ
cord-015365-iqdi99pd	2042	5	tests	test	NNS
cord-015365-iqdi99pd	2042	6	(	(	-LRB-
cord-015365-iqdi99pd	2042	7	including	include	VBG
cord-015365-iqdi99pd	2042	8	anti	anti	JJ
cord-015365-iqdi99pd	2042	9	ds	ds	NNP
cord-015365-iqdi99pd	2042	10	-	-	HYPH
cord-015365-iqdi99pd	2042	11	DNA	DNA	NNP
cord-015365-iqdi99pd	2042	12	antibodies	antibody	NNS
cord-015365-iqdi99pd	2042	13	)	)	-RRB-
cord-015365-iqdi99pd	2042	14	were	be	VBD
cord-015365-iqdi99pd	2042	15	negative	negative	JJ
cord-015365-iqdi99pd	2042	16	,	,	,
cord-015365-iqdi99pd	2042	17	except	except	IN
cord-015365-iqdi99pd	2042	18	IgG	igg	NN
cord-015365-iqdi99pd	2042	19	isotype	isotype	JJ
cord-015365-iqdi99pd	2042	20	rheumatoid	rheumatoid	NN
cord-015365-iqdi99pd	2042	21	factors	factor	NNS
cord-015365-iqdi99pd	2042	22	,	,	,
cord-015365-iqdi99pd	2042	23	which	which	WDT
cord-015365-iqdi99pd	2042	24	proved	prove	VBD
cord-015365-iqdi99pd	2042	25	to	to	TO
cord-015365-iqdi99pd	2042	26	be	be	VB
cord-015365-iqdi99pd	2042	27	highly	highly	RB
cord-015365-iqdi99pd	2042	28	positive	positive	JJ
cord-015365-iqdi99pd	2042	29	in	in	IN
cord-015365-iqdi99pd	2042	30	both	both	DT
cord-015365-iqdi99pd	2042	31	patients	patient	NNS
cord-015365-iqdi99pd	2042	32	.	.	.
cord-015365-iqdi99pd	2043	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2043	2	.	.	.
cord-015365-iqdi99pd	2044	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	2044	2	results	result	NNS
cord-015365-iqdi99pd	2044	3	show	show	VBP
cord-015365-iqdi99pd	2044	4	that	that	IN
cord-015365-iqdi99pd	2044	5	certain	certain	JJ
cord-015365-iqdi99pd	2044	6	patients	patient	NNS
cord-015365-iqdi99pd	2044	7	with	with	IN
cord-015365-iqdi99pd	2044	8	positive	positive	JJ
cord-015365-iqdi99pd	2044	9	IgG	igg	NN
cord-015365-iqdi99pd	2044	10	isotype	isotype	JJ
cord-015365-iqdi99pd	2044	11	rheumatoid	rheumatoid	NN
cord-015365-iqdi99pd	2044	12	factor	factor	NN
cord-015365-iqdi99pd	2044	13	can	can	MD
cord-015365-iqdi99pd	2044	14	exhibit	exhibit	VB
cord-015365-iqdi99pd	2044	15	false	false	JJ
cord-015365-iqdi99pd	2044	16	-	-	HYPH
cord-015365-iqdi99pd	2044	17	positive	positive	JJ
cord-015365-iqdi99pd	2044	18	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2044	19	trough	trough	NN
cord-015365-iqdi99pd	2044	20	levels	level	NNS
cord-015365-iqdi99pd	2044	21	when	when	WRB
cord-015365-iqdi99pd	2044	22	using	use	VBG
cord-015365-iqdi99pd	2044	23	the	the	DT
cord-015365-iqdi99pd	2044	24	ACMIA	ACMIA	NNP
cord-015365-iqdi99pd	2044	25	assay	assay	NN
cord-015365-iqdi99pd	2044	26	.	.	.
cord-015365-iqdi99pd	2045	1	It	-PRON-	PRP
cord-015365-iqdi99pd	2045	2	can	can	MD
cord-015365-iqdi99pd	2045	3	therefore	therefore	RB
cord-015365-iqdi99pd	2045	4	be	be	VB
cord-015365-iqdi99pd	2045	5	concluded	conclude	VBN
cord-015365-iqdi99pd	2045	6	that	that	IN
cord-015365-iqdi99pd	2045	7	abnormally	abnormally	RB
cord-015365-iqdi99pd	2045	8	high	high	JJ
cord-015365-iqdi99pd	2045	9	drug	drug	NN
cord-015365-iqdi99pd	2045	10	levels	level	NNS
cord-015365-iqdi99pd	2045	11	should	should	MD
cord-015365-iqdi99pd	2045	12	be	be	VB
cord-015365-iqdi99pd	2045	13	verified	verify	VBN
cord-015365-iqdi99pd	2045	14	by	by	IN
cord-015365-iqdi99pd	2045	15	mass	mass	NN
cord-015365-iqdi99pd	2045	16	spectrometry	spectrometry	NN
cord-015365-iqdi99pd	2045	17	methods	method	NNS
cord-015365-iqdi99pd	2045	18	.	.	.
cord-015365-iqdi99pd	2046	1	Further	further	JJ
cord-015365-iqdi99pd	2046	2	studies	study	NNS
cord-015365-iqdi99pd	2046	3	are	be	VBP
cord-015365-iqdi99pd	2046	4	underway	underway	JJ
cord-015365-iqdi99pd	2046	5	to	to	TO
cord-015365-iqdi99pd	2046	6	determine	determine	VB
cord-015365-iqdi99pd	2046	7	whether	whether	IN
cord-015365-iqdi99pd	2046	8	non	non	JJ
cord-015365-iqdi99pd	2046	9	-	-	JJ
cord-015365-iqdi99pd	2046	10	transplanted	transplanted	JJ
cord-015365-iqdi99pd	2046	11	patients	patient	NNS
cord-015365-iqdi99pd	2046	12	with	with	IN
cord-015365-iqdi99pd	2046	13	positive	positive	JJ
cord-015365-iqdi99pd	2046	14	rheumatoid	rheumatoid	NN
cord-015365-iqdi99pd	2046	15	factors	factor	NNS
cord-015365-iqdi99pd	2046	16	also	also	RB
cord-015365-iqdi99pd	2046	17	display	display	VBP
cord-015365-iqdi99pd	2046	18	falsely	falsely	RB
cord-015365-iqdi99pd	2046	19	elevated	elevate	VBN
cord-015365-iqdi99pd	2046	20	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2046	21	values	value	NNS
cord-015365-iqdi99pd	2046	22	and	and	CC
cord-015365-iqdi99pd	2046	23	also	also	RB
cord-015365-iqdi99pd	2046	24	if	if	IN
cord-015365-iqdi99pd	2046	25	this	this	DT
cord-015365-iqdi99pd	2046	26	can	can	MD
cord-015365-iqdi99pd	2046	27	be	be	VB
cord-015365-iqdi99pd	2046	28	suppressed	suppress	VBN
cord-015365-iqdi99pd	2046	29	after	after	IN
cord-015365-iqdi99pd	2046	30	preincubation	preincubation	NN
cord-015365-iqdi99pd	2046	31	with	with	IN
cord-015365-iqdi99pd	2046	32	immunoglobulin	immunoglobulin	NN
cord-015365-iqdi99pd	2046	33	blocking	block	VBG
cord-015365-iqdi99pd	2046	34	reagents	reagent	NNS
cord-015365-iqdi99pd	2046	35	specific	specific	JJ
cord-015365-iqdi99pd	2046	36	for	for	IN
cord-015365-iqdi99pd	2046	37	the	the	DT
cord-015365-iqdi99pd	2046	38	IgG	IgG	NNP
cord-015365-iqdi99pd	2046	39	isotype	isotype	JJ
cord-015365-iqdi99pd	2046	40	rheumatoid	rheumatoid	NNP
cord-015365-iqdi99pd	2046	41	factor	factor	NN
cord-015365-iqdi99pd	2046	42	.	.	.
cord-015365-iqdi99pd	2047	1	Background	background	NN
cord-015365-iqdi99pd	2047	2	.	.	.
cord-015365-iqdi99pd	2048	1	The	the	DT
cord-015365-iqdi99pd	2048	2	impact	impact	NN
cord-015365-iqdi99pd	2048	3	of	of	IN
cord-015365-iqdi99pd	2048	4	vesicoureteral	vesicoureteral	JJ
cord-015365-iqdi99pd	2048	5	reflux	reflux	NN
cord-015365-iqdi99pd	2048	6	after	after	IN
cord-015365-iqdi99pd	2048	7	renal	renal	JJ
cord-015365-iqdi99pd	2048	8	transplantation	transplantation	NN
cord-015365-iqdi99pd	2048	9	has	have	VBZ
cord-015365-iqdi99pd	2048	10	been	be	VBN
cord-015365-iqdi99pd	2048	11	a	a	DT
cord-015365-iqdi99pd	2048	12	matter	matter	NN
cord-015365-iqdi99pd	2048	13	of	of	IN
cord-015365-iqdi99pd	2048	14	debate	debate	NN
cord-015365-iqdi99pd	2048	15	in	in	IN
cord-015365-iqdi99pd	2048	16	the	the	DT
cord-015365-iqdi99pd	2048	17	past	past	NN
cord-015365-iqdi99pd	2048	18	with	with	IN
cord-015365-iqdi99pd	2048	19	small	small	JJ
cord-015365-iqdi99pd	2048	20	studies	study	NNS
cord-015365-iqdi99pd	2048	21	reporting	report	VBG
cord-015365-iqdi99pd	2048	22	controversial	controversial	JJ
cord-015365-iqdi99pd	2048	23	results	result	NNS
cord-015365-iqdi99pd	2048	24	.	.	.
cord-015365-iqdi99pd	2049	1	The	the	DT
cord-015365-iqdi99pd	2049	2	aim	aim	NN
cord-015365-iqdi99pd	2049	3	of	of	IN
cord-015365-iqdi99pd	2049	4	the	the	DT
cord-015365-iqdi99pd	2049	5	present	present	JJ
cord-015365-iqdi99pd	2049	6	study	study	NN
cord-015365-iqdi99pd	2049	7	was	be	VBD
cord-015365-iqdi99pd	2049	8	to	to	TO
cord-015365-iqdi99pd	2049	9	evaluate	evaluate	VB
cord-015365-iqdi99pd	2049	10	the	the	DT
cord-015365-iqdi99pd	2049	11	effect	effect	NN
cord-015365-iqdi99pd	2049	12	of	of	IN
cord-015365-iqdi99pd	2049	13	early	early	JJ
cord-015365-iqdi99pd	2049	14	post	post	JJ
cord-015365-iqdi99pd	2049	15	-	-	NN
cord-015365-iqdi99pd	2049	16	transplantation	transplantation	JJ
cord-015365-iqdi99pd	2049	17	VUR	VUR	NNP
cord-015365-iqdi99pd	2049	18	on	on	IN
cord-015365-iqdi99pd	2049	19	long	long	JJ
cord-015365-iqdi99pd	2049	20	-	-	HYPH
cord-015365-iqdi99pd	2049	21	term	term	NN
cord-015365-iqdi99pd	2049	22	renal	renal	JJ
cord-015365-iqdi99pd	2049	23	allograft	allograft	NN
cord-015365-iqdi99pd	2049	24	performance	performance	NN
cord-015365-iqdi99pd	2049	25	,	,	,
cord-015365-iqdi99pd	2049	26	incidences	incidence	NNS
cord-015365-iqdi99pd	2049	27	of	of	IN
cord-015365-iqdi99pd	2049	28	urinary	urinary	JJ
cord-015365-iqdi99pd	2049	29	tract	tract	NN
cord-015365-iqdi99pd	2049	30	infections	infection	NNS
cord-015365-iqdi99pd	2049	31	(	(	-LRB-
cord-015365-iqdi99pd	2049	32	UTI	UTI	NNP
cord-015365-iqdi99pd	2049	33	)	)	-RRB-
cord-015365-iqdi99pd	2049	34	,	,	,
cord-015365-iqdi99pd	2049	35	rejection	rejection	NN
cord-015365-iqdi99pd	2049	36	rates	rate	NNS
cord-015365-iqdi99pd	2049	37	,	,	,
cord-015365-iqdi99pd	2049	38	graft	graft	NN
cord-015365-iqdi99pd	2049	39	and	and	CC
cord-015365-iqdi99pd	2049	40	patient	patient	JJ
cord-015365-iqdi99pd	2049	41	survival	survival	NN
cord-015365-iqdi99pd	2049	42	in	in	IN
cord-015365-iqdi99pd	2049	43	a	a	DT
cord-015365-iqdi99pd	2049	44	large	large	JJ
cord-015365-iqdi99pd	2049	45	cohort	cohort	NN
cord-015365-iqdi99pd	2049	46	series	series	NN
cord-015365-iqdi99pd	2049	47	.	.	.
cord-015365-iqdi99pd	2050	1	Methods	method	NNS
cord-015365-iqdi99pd	2050	2	.	.	.
cord-015365-iqdi99pd	2051	1	Retrospective	retrospective	JJ
cord-015365-iqdi99pd	2051	2	study	study	NN
cord-015365-iqdi99pd	2051	3	of	of	IN
cord-015365-iqdi99pd	2051	4	646	646	CD
cord-015365-iqdi99pd	2051	5	consecutive	consecutive	JJ
cord-015365-iqdi99pd	2051	6	renal	renal	JJ
cord-015365-iqdi99pd	2051	7	transplant	transplant	NN
cord-015365-iqdi99pd	2051	8	patients	patient	NNS
cord-015365-iqdi99pd	2051	9	with	with	IN
cord-015365-iqdi99pd	2051	10	routine	routine	JJ
cord-015365-iqdi99pd	2051	11	post	post	JJ
cord-015365-iqdi99pd	2051	12	-	-	JJ
cord-015365-iqdi99pd	2051	13	transplantation	transplantation	JJ
cord-015365-iqdi99pd	2051	14	vesicocystourethero	vesicocystourethero	NNS
cord-015365-iqdi99pd	2051	15	-	-	HYPH
cord-015365-iqdi99pd	2051	16	graphy	graphy	NN
cord-015365-iqdi99pd	2051	17	(	(	-LRB-
cord-015365-iqdi99pd	2051	18	VCUG	VCUG	NNP
cord-015365-iqdi99pd	2051	19	)	)	-RRB-
cord-015365-iqdi99pd	2051	20	.	.	.
cord-015365-iqdi99pd	2052	1	Uretero	Uretero	NNP
cord-015365-iqdi99pd	2052	2	-	-	HYPH
cord-015365-iqdi99pd	2052	3	neocystostomy	neocystostomy	NNP
cord-015365-iqdi99pd	2052	4	was	be	VBD
cord-015365-iqdi99pd	2052	5	performed	perform	VBN
cord-015365-iqdi99pd	2052	6	in	in	IN
cord-015365-iqdi99pd	2052	7	an	an	DT
cord-015365-iqdi99pd	2052	8	antirefluxive	antirefluxive	JJ
cord-015365-iqdi99pd	2052	9	fashion	fashion	NN
cord-015365-iqdi99pd	2052	10	using	use	VBG
cord-015365-iqdi99pd	2052	11	extravesical	extravesical	NNP
cord-015365-iqdi99pd	2052	12	submucosal	submucosal	NNP
cord-015365-iqdi99pd	2052	13	tunneling	tunneling	NN
cord-015365-iqdi99pd	2052	14	.	.	.
cord-015365-iqdi99pd	2053	1	VCUG	VCUG	NNP
cord-015365-iqdi99pd	2053	2	was	be	VBD
cord-015365-iqdi99pd	2053	3	performed	perform	VBN
cord-015365-iqdi99pd	2053	4	prior	prior	RB
cord-015365-iqdi99pd	2053	5	to	to	IN
cord-015365-iqdi99pd	2053	6	discharge	discharge	NN
cord-015365-iqdi99pd	2053	7	according	accord	VBG
cord-015365-iqdi99pd	2053	8	to	to	IN
cord-015365-iqdi99pd	2053	9	the	the	DT
cord-015365-iqdi99pd	2053	10	international	international	JJ
cord-015365-iqdi99pd	2053	11	grading	grading	NN
cord-015365-iqdi99pd	2053	12	system	system	NN
cord-015365-iqdi99pd	2053	13	and	and	CC
cord-015365-iqdi99pd	2053	14	reviewed	review	VBN
cord-015365-iqdi99pd	2053	15	by	by	IN
cord-015365-iqdi99pd	2053	16	an	an	DT
cord-015365-iqdi99pd	2053	17	independent	independent	JJ
cord-015365-iqdi99pd	2053	18	radiologist	radiologist	NN
cord-015365-iqdi99pd	2053	19	and	and	CC
cord-015365-iqdi99pd	2053	20	urologist	urologist	NN
cord-015365-iqdi99pd	2053	21	.	.	.
cord-015365-iqdi99pd	2054	1	Results	result	NNS
cord-015365-iqdi99pd	2054	2	.	.	.
cord-015365-iqdi99pd	2055	1	Overall	overall	RB
cord-015365-iqdi99pd	2055	2	,	,	,
cord-015365-iqdi99pd	2055	3	263	263	CD
cord-015365-iqdi99pd	2055	4	of	of	IN
cord-015365-iqdi99pd	2055	5	the	the	DT
cord-015365-iqdi99pd	2055	6	646	646	CD
cord-015365-iqdi99pd	2055	7	(	(	-LRB-
cord-015365-iqdi99pd	2055	8	40.7	40.7	CD
cord-015365-iqdi99pd	2055	9	%	%	NN
cord-015365-iqdi99pd	2055	10	)	)	-RRB-
cord-015365-iqdi99pd	2055	11	kidney	kidney	NN
cord-015365-iqdi99pd	2055	12	transplant	transplant	NN
cord-015365-iqdi99pd	2055	13	recipients	recipient	NNS
cord-015365-iqdi99pd	2055	14	were	be	VBD
cord-015365-iqdi99pd	2055	15	diagnosed	diagnose	VBN
cord-015365-iqdi99pd	2055	16	with	with	IN
cord-015365-iqdi99pd	2055	17	VUR	VUR	NNP
cord-015365-iqdi99pd	2055	18	by	by	IN
cord-015365-iqdi99pd	2055	19	VCUG	VCUG	NNP
cord-015365-iqdi99pd	2055	20	at	at	IN
cord-015365-iqdi99pd	2055	21	discharge	discharge	NN
cord-015365-iqdi99pd	2055	22	.	.	.
cord-015365-iqdi99pd	2056	1	Patients	patient	NNS
cord-015365-iqdi99pd	2056	2	had	have	VBD
cord-015365-iqdi99pd	2056	3	VUR	VUR	NNP
cord-015365-iqdi99pd	2056	4	grade	grade	NN
cord-015365-iqdi99pd	2056	5	I	I	NNP
cord-015365-iqdi99pd	2056	6	,	,	,
cord-015365-iqdi99pd	2056	7	II	II	NNP
cord-015365-iqdi99pd	2056	8	,	,	,
cord-015365-iqdi99pd	2056	9	III	III	NNP
cord-015365-iqdi99pd	2056	10	and	and	CC
cord-015365-iqdi99pd	2056	11	IV	IV	NNP
cord-015365-iqdi99pd	2056	12	in	in	IN
cord-015365-iqdi99pd	2056	13	7.9	7.9	CD
cord-015365-iqdi99pd	2056	14	%	%	NN
cord-015365-iqdi99pd	2056	15	,	,	,
cord-015365-iqdi99pd	2056	16	19.8	19.8	CD
cord-015365-iqdi99pd	2056	17	%	%	NN
cord-015365-iqdi99pd	2056	18	,	,	,
cord-015365-iqdi99pd	2056	19	10.2	10.2	CD
cord-015365-iqdi99pd	2056	20	%	%	NN
cord-015365-iqdi99pd	2056	21	,	,	,
cord-015365-iqdi99pd	2056	22	and	and	CC
cord-015365-iqdi99pd	2056	23	2.8	2.8	CD
cord-015365-iqdi99pd	2056	24	%	%	NN
cord-015365-iqdi99pd	2056	25	,	,	,
cord-015365-iqdi99pd	2056	26	respectively	respectively	RB
cord-015365-iqdi99pd	2056	27	.	.	.
cord-015365-iqdi99pd	2057	1	No	no	DT
cord-015365-iqdi99pd	2057	2	grade	grade	NN
cord-015365-iqdi99pd	2057	3	V	v	NN
cord-015365-iqdi99pd	2057	4	reflux	reflux	NN
cord-015365-iqdi99pd	2057	5	was	be	VBD
cord-015365-iqdi99pd	2057	6	seen	see	VBN
cord-015365-iqdi99pd	2057	7	.	.	.
cord-015365-iqdi99pd	2058	1	VUR	VUR	NNP
cord-015365-iqdi99pd	2058	2	showed	show	VBD
cord-015365-iqdi99pd	2058	3	no	no	DT
cord-015365-iqdi99pd	2058	4	significant	significant	JJ
cord-015365-iqdi99pd	2058	5	impact	impact	NN
cord-015365-iqdi99pd	2058	6	on	on	IN
cord-015365-iqdi99pd	2058	7	death	death	NN
cord-015365-iqdi99pd	2058	8	-	-	HYPH
cord-015365-iqdi99pd	2058	9	censored	censor	VBN
cord-015365-iqdi99pd	2058	10	graft	graft	NN
cord-015365-iqdi99pd	2058	11	survival	survival	NN
cord-015365-iqdi99pd	2058	12	,	,	,
cord-015365-iqdi99pd	2058	13	patient	patient	JJ
cord-015365-iqdi99pd	2058	14	survival	survival	NN
cord-015365-iqdi99pd	2058	15	,	,	,
cord-015365-iqdi99pd	2058	16	proteinuria	proteinuria	NN
cord-015365-iqdi99pd	2058	17	or	or	CC
cord-015365-iqdi99pd	2058	18	UTI	UTI	NNP
cord-015365-iqdi99pd	2058	19	.	.	.
cord-015365-iqdi99pd	2059	1	Patients	patient	NNS
cord-015365-iqdi99pd	2059	2	with	with	IN
cord-015365-iqdi99pd	2059	3	VUR	VUR	NNP
cord-015365-iqdi99pd	2059	4	had	have	VBD
cord-015365-iqdi99pd	2059	5	a	a	DT
cord-015365-iqdi99pd	2059	6	significantly	significantly	RB
cord-015365-iqdi99pd	2059	7	lower	low	JJR
cord-015365-iqdi99pd	2059	8	GFR	GFR	NNP
cord-015365-iqdi99pd	2059	9	at	at	IN
cord-015365-iqdi99pd	2059	10	one	one	CD
cord-015365-iqdi99pd	2059	11	year	year	NN
cord-015365-iqdi99pd	2059	12	after	after	IN
cord-015365-iqdi99pd	2059	13	transplantation	transplantation	NN
cord-015365-iqdi99pd	2059	14	than	than	IN
cord-015365-iqdi99pd	2059	15	patients	patient	NNS
cord-015365-iqdi99pd	2059	16	without	without	IN
cord-015365-iqdi99pd	2059	17	VUR	VUR	NNP
cord-015365-iqdi99pd	2059	18	(	(	-LRB-
cord-015365-iqdi99pd	2059	19	60	60	CD
cord-015365-iqdi99pd	2059	20	vs.	vs.	NN
cord-015365-iqdi99pd	2059	21	52	52	CD
cord-015365-iqdi99pd	2059	22	ml	ml	NNS
cord-015365-iqdi99pd	2059	23	/	/	SYM
cord-015365-iqdi99pd	2059	24	min/1,73	min/1,73	CD
cord-015365-iqdi99pd	2059	25	m	m	NNP
cord-015365-iqdi99pd	2059	26	2	2	CD
cord-015365-iqdi99pd	2059	27	,	,	,
cord-015365-iqdi99pd	2059	28	p	p	NN
cord-015365-iqdi99pd	2059	29	¼	¼	CD
cord-015365-iqdi99pd	2059	30	0.021	0.021	CD
cord-015365-iqdi99pd	2059	31	)	)	-RRB-
cord-015365-iqdi99pd	2059	32	,	,	,
cord-015365-iqdi99pd	2059	33	this	this	DT
cord-015365-iqdi99pd	2059	34	difference	difference	NN
cord-015365-iqdi99pd	2059	35	was	be	VBD
cord-015365-iqdi99pd	2059	36	no	no	RB
cord-015365-iqdi99pd	2059	37	longer	long	RBR
cord-015365-iqdi99pd	2059	38	seen	see	VBN
cord-015365-iqdi99pd	2059	39	at	at	IN
cord-015365-iqdi99pd	2059	40	3	3	CD
cord-015365-iqdi99pd	2059	41	and	and	CC
cord-015365-iqdi99pd	2059	42	5	5	CD
cord-015365-iqdi99pd	2059	43	years	year	NNS
cord-015365-iqdi99pd	2059	44	.	.	.
cord-015365-iqdi99pd	2060	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2060	2	.	.	.
cord-015365-iqdi99pd	2061	1	Although	although	IN
cord-015365-iqdi99pd	2061	2	VUR	VUR	NNP
cord-015365-iqdi99pd	2061	3	is	be	VBZ
cord-015365-iqdi99pd	2061	4	a	a	DT
cord-015365-iqdi99pd	2061	5	common	common	JJ
cord-015365-iqdi99pd	2061	6	finding	finding	NN
cord-015365-iqdi99pd	2061	7	in	in	IN
cord-015365-iqdi99pd	2061	8	patients	patient	NNS
cord-015365-iqdi99pd	2061	9	after	after	IN
cord-015365-iqdi99pd	2061	10	renal	renal	JJ
cord-015365-iqdi99pd	2061	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	2061	12	,	,	,
cord-015365-iqdi99pd	2061	13	it	-PRON-	PRP
cord-015365-iqdi99pd	2061	14	has	have	VBZ
cord-015365-iqdi99pd	2061	15	no	no	DT
cord-015365-iqdi99pd	2061	16	impact	impact	NN
cord-015365-iqdi99pd	2061	17	on	on	IN
cord-015365-iqdi99pd	2061	18	death	death	NN
cord-015365-iqdi99pd	2061	19	-	-	HYPH
cord-015365-iqdi99pd	2061	20	censored	censor	VBN
cord-015365-iqdi99pd	2061	21	graft	graft	NN
cord-015365-iqdi99pd	2061	22	survival	survival	NN
cord-015365-iqdi99pd	2061	23	,	,	,
cord-015365-iqdi99pd	2061	24	patient	patient	JJ
cord-015365-iqdi99pd	2061	25	survival	survival	NN
cord-015365-iqdi99pd	2061	26	,	,	,
cord-015365-iqdi99pd	2061	27	proteinuria	proteinuria	NN
cord-015365-iqdi99pd	2061	28	or	or	CC
cord-015365-iqdi99pd	2061	29	UTI	UTI	NNP
cord-015365-iqdi99pd	2061	30	and	and	CC
cord-015365-iqdi99pd	2061	31	only	only	RB
cord-015365-iqdi99pd	2061	32	a	a	DT
cord-015365-iqdi99pd	2061	33	short	short	JJ
cord-015365-iqdi99pd	2061	34	term	term	NN
cord-015365-iqdi99pd	2061	35	effect	effect	NN
cord-015365-iqdi99pd	2061	36	on	on	IN
cord-015365-iqdi99pd	2061	37	renal	renal	JJ
cord-015365-iqdi99pd	2061	38	graft	graft	NN
cord-015365-iqdi99pd	2061	39	function	function	NN
cord-015365-iqdi99pd	2061	40	that	that	WDT
cord-015365-iqdi99pd	2061	41	was	be	VBD
cord-015365-iqdi99pd	2061	42	no	no	RB
cord-015365-iqdi99pd	2061	43	longer	long	RBR
cord-015365-iqdi99pd	2061	44	seen	see	VBN
cord-015365-iqdi99pd	2061	45	in	in	IN
cord-015365-iqdi99pd	2061	46	long	long	JJ
cord-015365-iqdi99pd	2061	47	term	term	NN
cord-015365-iqdi99pd	2061	48	follow	follow	VB
cord-015365-iqdi99pd	2061	49	up	up	RP
cord-015365-iqdi99pd	2061	50	.	.	.
cord-015365-iqdi99pd	2062	1	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	2062	2	.	.	.
cord-015365-iqdi99pd	2063	1	Der	Der	NNP
cord-015365-iqdi99pd	2063	2	Einfluss	Einfluss	NNP
cord-015365-iqdi99pd	2063	3	von	von	NN
cord-015365-iqdi99pd	2063	4	primär	primär	NN
cord-015365-iqdi99pd	2063	5	unentdeckten	unentdeckten	NNP
cord-015365-iqdi99pd	2063	6	hepatozelluären	hepatozelluären	NNP
cord-015365-iqdi99pd	2064	1	Karzinomen	Karzinomen	NNP
cord-015365-iqdi99pd	2064	2	(	(	-LRB-
cord-015365-iqdi99pd	2064	3	HCC	HCC	NNP
cord-015365-iqdi99pd	2064	4	)	)	-RRB-
cord-015365-iqdi99pd	2064	5	auf	auf	NNP
cord-015365-iqdi99pd	2064	6	das	das	NNP
cord-015365-iqdi99pd	2064	7	Ü	Ü	NNP
cord-015365-iqdi99pd	2064	8	berleben	berleben	NNP
cord-015365-iqdi99pd	2064	9	nach	nach	NNP
cord-015365-iqdi99pd	2064	10	Lebertransplantation	Lebertransplantation	NNP
cord-015365-iqdi99pd	2064	11	wird	wird	NNP
cord-015365-iqdi99pd	2064	12	in	in	IN
cord-015365-iqdi99pd	2064	13	der	der	NNP
cord-015365-iqdi99pd	2064	14	Literatur	Literatur	NNP
cord-015365-iqdi99pd	2064	15	kontroversiell	kontroversiell	NNP
cord-015365-iqdi99pd	2064	16	diskutiert	diskutiert	NNP
cord-015365-iqdi99pd	2064	17	.	.	.
cord-015365-iqdi99pd	2065	1	Ziel	Ziel	NNP
cord-015365-iqdi99pd	2065	2	dieser	dieser	NNP
cord-015365-iqdi99pd	2065	3	Studie	Studie	NNP
cord-015365-iqdi99pd	2065	4	war	war	NN
cord-015365-iqdi99pd	2065	5	es	es	NNP
cord-015365-iqdi99pd	2065	6	,	,	,
cord-015365-iqdi99pd	2065	7	die	die	VBP
cord-015365-iqdi99pd	2065	8	Rate	rate	NN
cord-015365-iqdi99pd	2065	9	von	von	NNP
cord-015365-iqdi99pd	2065	10	okkulten	okkulten	VBN
cord-015365-iqdi99pd	2065	11	Karzinomen	Karzinomen	NNP
cord-015365-iqdi99pd	2065	12	in	in	IN
cord-015365-iqdi99pd	2065	13	unserem	unserem	NNP
cord-015365-iqdi99pd	2065	14	Kollektiv	Kollektiv	NNP
cord-015365-iqdi99pd	2066	1	an	an	DT
cord-015365-iqdi99pd	2066	2	äthyltoxischer	äthyltoxischer	NNP
cord-015365-iqdi99pd	2066	3	Zirrhose	Zirrhose	NNP
cord-015365-iqdi99pd	2066	4	erkrankter	erkrankter	NN
cord-015365-iqdi99pd	2066	5	und	und	VBD
cord-015365-iqdi99pd	2066	6	für	für	JJ
cord-015365-iqdi99pd	2066	7	diese	diese	JJ
cord-015365-iqdi99pd	2066	8	Indikation	Indikation	NNP
cord-015365-iqdi99pd	2066	9	transplantierter	transplantierter	NN
cord-015365-iqdi99pd	2066	10	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2066	11	der	der	NNP
cord-015365-iqdi99pd	2066	12	letzten	letzten	NNP
cord-015365-iqdi99pd	2066	13	10	10	CD
cord-015365-iqdi99pd	2067	1	Jahre	Jahre	NNP
cord-015365-iqdi99pd	2067	2	zu	zu	NNP
cord-015365-iqdi99pd	2067	3	erheben	erheben	NNP
cord-015365-iqdi99pd	2068	1	und	und	IN
cord-015365-iqdi99pd	2068	2	den	den	NNP
cord-015365-iqdi99pd	2068	3	Einfluss	Einfluss	NNP
cord-015365-iqdi99pd	2068	4	auf	auf	NNP
cord-015365-iqdi99pd	2068	5	das	das	NNP
cord-015365-iqdi99pd	2068	6	rezidivfreie	rezidivfreie	XX
cord-015365-iqdi99pd	2068	7	uund	uund	RB
cord-015365-iqdi99pd	2068	8	Gesamtüberleben	Gesamtüberleben	NNP
cord-015365-iqdi99pd	2068	9	nach	nach	NNP
cord-015365-iqdi99pd	2068	10	Lebertransplantation	Lebertransplantation	NNP
cord-015365-iqdi99pd	2068	11	zu	zu	NNP
cord-015365-iqdi99pd	2068	12	untersuchen	untersuchen	NNP
cord-015365-iqdi99pd	2068	13	.	.	.
cord-015365-iqdi99pd	2069	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	2069	2	.	.	.
cord-015365-iqdi99pd	2070	1	Retropektive	Retropektive	NNP
cord-015365-iqdi99pd	2070	2	Analyse	Analyse	NNP
cord-015365-iqdi99pd	2070	3	von	von	NNP
cord-015365-iqdi99pd	2070	4	285	285	CD
cord-015365-iqdi99pd	2070	5	wegen	wegen	NNP
cord-015365-iqdi99pd	2070	6	äthyltoxischer	äthyltoxischer	NNP
cord-015365-iqdi99pd	2070	7	Zirrhose	Zirrhose	NNP
cord-015365-iqdi99pd	2070	8	gelisteter	gelisteter	NNP
cord-015365-iqdi99pd	2071	1	und	und	NNP
cord-015365-iqdi99pd	2072	1	transplantierter	transplantierter	NNP
cord-015365-iqdi99pd	2073	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2074	1	i	-PRON-	PRP
cord-015365-iqdi99pd	2074	2	m	be	VBP
cord-015365-iqdi99pd	2074	3	Zeitraum	Zeitraum	NNP
cord-015365-iqdi99pd	2074	4	von	von	NNP
cord-015365-iqdi99pd	2074	5	1998	1998	CD
cord-015365-iqdi99pd	2075	1	bis	bis	NNP
cord-015365-iqdi99pd	2075	2	2008	2008	CD
cord-015365-iqdi99pd	2075	3	.	.	.
cord-015365-iqdi99pd	2076	1	Neben	Neben	NNP
cord-015365-iqdi99pd	2076	2	den	den	NNP
cord-015365-iqdi99pd	2077	1	Baseline	Baseline	NNP
cord-015365-iqdi99pd	2078	1	Parametern	Parametern	NNP
cord-015365-iqdi99pd	2078	2	wurden	wurden	VBD
cord-015365-iqdi99pd	2078	3	alle	alle	NNP
cord-015365-iqdi99pd	2078	4	Explanthistologien	Explanthistologien	NNP
cord-015365-iqdi99pd	2078	5	ausgewertet	ausgewertet	NNP
cord-015365-iqdi99pd	2078	6	.	.	.
cord-015365-iqdi99pd	2079	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2079	2	.	.	.
cord-015365-iqdi99pd	2080	1	Dreizehn	Dreizehn	NNP
cord-015365-iqdi99pd	2080	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2080	3	(	(	-LRB-
cord-015365-iqdi99pd	2080	4	4,5	4,5	CD
cord-015365-iqdi99pd	2080	5	%	%	NN
cord-015365-iqdi99pd	2080	6	)	)	-RRB-
cord-015365-iqdi99pd	2081	1	zeigten	zeigten	NNP
cord-015365-iqdi99pd	2081	2	ein	ein	NNP
cord-015365-iqdi99pd	2081	3	HCC	HCC	NNP
cord-015365-iqdi99pd	2081	4	in	in	IN
cord-015365-iqdi99pd	2081	5	der	der	NNP
cord-015365-iqdi99pd	2081	6	Explanthistologie	Explanthistologie	NNP
cord-015365-iqdi99pd	2081	7	.	.	.
cord-015365-iqdi99pd	2082	1	Drei	Drei	NNP
cord-015365-iqdi99pd	2082	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2082	3	waren	waren	XX
cord-015365-iqdi99pd	2083	1	außerhalb	außerhalb	NNP
cord-015365-iqdi99pd	2083	2	der	der	NNP
cord-015365-iqdi99pd	2083	3	Mailand	Mailand	NNP
cord-015365-iqdi99pd	2083	4	Kriterien	Kriterien	NNP
cord-015365-iqdi99pd	2083	5	und	und	IN
cord-015365-iqdi99pd	2083	6	19	19	CD
cord-015365-iqdi99pd	2084	1	von	von	NNP
cord-015365-iqdi99pd	2084	2	27	27	CD
cord-015365-iqdi99pd	2084	3	Herden	Herden	NNP
cord-015365-iqdi99pd	2084	4	waren	waren	NNS
cord-015365-iqdi99pd	2085	1	größer	größer	NNP
cord-015365-iqdi99pd	2085	2	als	als	NNP
cord-015365-iqdi99pd	2085	3	1	1	CD
cord-015365-iqdi99pd	2085	4	cm	cm	NN
cord-015365-iqdi99pd	2085	5	.	.	.
cord-015365-iqdi99pd	2086	1	Die	die	VB
cord-015365-iqdi99pd	2086	2	Wartezeit	Wartezeit	NNP
cord-015365-iqdi99pd	2086	3	der	der	NNP
cord-015365-iqdi99pd	2086	4	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2086	5	betrug	betrug	NNP
cord-015365-iqdi99pd	2087	1	i	-PRON-	PRP
cord-015365-iqdi99pd	2087	2	m	be	VBP
cord-015365-iqdi99pd	2087	3	Median	median	JJ
cord-015365-iqdi99pd	2087	4	2,7	2,7	CD
cord-015365-iqdi99pd	2087	5	Monate	Monate	NNP
cord-015365-iqdi99pd	2087	6	.	.	.
cord-015365-iqdi99pd	2088	1	Nach	Nach	NNP
cord-015365-iqdi99pd	2088	2	2004	2004	CD
cord-015365-iqdi99pd	2088	3	gab	gab	NN
cord-015365-iqdi99pd	2089	1	es	es	NNP
cord-015365-iqdi99pd	2089	2	keine	keine	NNP
cord-015365-iqdi99pd	2089	3	okkulten	okkulten	NNP
cord-015365-iqdi99pd	2089	4	HCCs	HCCs	NNP
cord-015365-iqdi99pd	2089	5	in	in	IN
cord-015365-iqdi99pd	2089	6	unserem	unserem	NNP
cord-015365-iqdi99pd	2089	7	Kollektiv	Kollektiv	NNP
cord-015365-iqdi99pd	2089	8	.	.	.
cord-015365-iqdi99pd	2090	1	Ein	Ein	NNP
cord-015365-iqdi99pd	2090	2	Ü	Ü	NNP
cord-015365-iqdi99pd	2090	3	berlebensnachteil	berlebensnachteil	NN
cord-015365-iqdi99pd	2091	1	fü	fü	IN
cord-015365-iqdi99pd	2092	1	r	r	LS
cord-015365-iqdi99pd	2092	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2092	3	mit	mit	NNP
cord-015365-iqdi99pd	2093	1	okkultem	okkultem	IN
cord-015365-iqdi99pd	2093	2	HCC	HCC	NNP
cord-015365-iqdi99pd	2093	3	gegenü	gegenü	NN
cord-015365-iqdi99pd	2093	4	ber	ber	NNP
cord-015365-iqdi99pd	2093	5	der	der	NNP
cord-015365-iqdi99pd	2093	6	Normalgruppe	Normalgruppe	NNP
cord-015365-iqdi99pd	2093	7	konnte	konnte	NNP
cord-015365-iqdi99pd	2093	8	in	in	IN
cord-015365-iqdi99pd	2093	9	diesem	diesem	JJ
cord-015365-iqdi99pd	2093	10	Kollektiv	Kollektiv	NNP
cord-015365-iqdi99pd	2093	11	nicht	nicht	NNP
cord-015365-iqdi99pd	2093	12	gezeigt	gezeigt	NNP
cord-015365-iqdi99pd	2093	13	werden	werden	NNP
cord-015365-iqdi99pd	2093	14	.	.	.
cord-015365-iqdi99pd	2094	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	2094	2	.	.	.
cord-015365-iqdi99pd	2095	1	Die	die	VB
cord-015365-iqdi99pd	2095	2	kurze	kurze	NNP
cord-015365-iqdi99pd	2095	3	Wartezeit	Wartezeit	NNP
cord-015365-iqdi99pd	2095	4	der	der	NNP
cord-015365-iqdi99pd	2095	5	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2095	6	mit	mit	VBD
cord-015365-iqdi99pd	2095	7	okkultem	okkultem	XX
cord-015365-iqdi99pd	2096	1	HCC	HCC	NNP
cord-015365-iqdi99pd	2096	2	sowie	sowie	NNP
cord-015365-iqdi99pd	2096	3	die	die	VBP
cord-015365-iqdi99pd	2096	4	Tumorgröße	Tumorgröße	NNP
cord-015365-iqdi99pd	2096	5	legt	legt	NNP
cord-015365-iqdi99pd	2096	6	nahe	nahe	NNP
cord-015365-iqdi99pd	2096	7	,	,	,
cord-015365-iqdi99pd	2096	8	dass	dass	NNP
cord-015365-iqdi99pd	2096	9	bei	bei	NNP
cord-015365-iqdi99pd	2096	10	diesen	diesen	NNP
cord-015365-iqdi99pd	2096	11	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2096	12	bereits	bereits	NN
cord-015365-iqdi99pd	2096	13	vor	vor	NNP
cord-015365-iqdi99pd	2096	14	der	der	NNP
cord-015365-iqdi99pd	2096	15	Listung	Listung	NNP
cord-015365-iqdi99pd	2096	16	das	das	NNP
cord-015365-iqdi99pd	2096	17	HCC	HCC	NNP
cord-015365-iqdi99pd	2096	18	unentdeckt	unentdeckt	NNS
cord-015365-iqdi99pd	2096	19	blieb	blieb	NNP
cord-015365-iqdi99pd	2096	20	,	,	,
cord-015365-iqdi99pd	2097	1	während	während	NNP
cord-015365-iqdi99pd	2097	2	es	es	NNP
cord-015365-iqdi99pd	2097	3	später	später	NNP
cord-015365-iqdi99pd	2097	4	mit	mit	NNP
cord-015365-iqdi99pd	2097	5	Verbesserung	Verbesserung	NNP
cord-015365-iqdi99pd	2097	6	der	der	NNP
cord-015365-iqdi99pd	2097	7	radiologischen	radiologischen	NNP
cord-015365-iqdi99pd	2097	8	Technik	Technik	NNP
cord-015365-iqdi99pd	2097	9	sowie	sowie	NNP
cord-015365-iqdi99pd	2097	10	längerer	längerer	NNP
cord-015365-iqdi99pd	2098	1	Wartezeit	Wartezeit	NNP
cord-015365-iqdi99pd	2099	1	i	-PRON-	PRP
cord-015365-iqdi99pd	2099	2	m	be	VBP
cord-015365-iqdi99pd	2099	3	Rahmen	Rahmen	NNP
cord-015365-iqdi99pd	2099	4	des	des	NNP
cord-015365-iqdi99pd	2099	5	Screenings	Screenings	NNP
cord-015365-iqdi99pd	2099	6	entdeckt	entdeckt	NN
cord-015365-iqdi99pd	2099	7	wurde	wurde	FW
cord-015365-iqdi99pd	2099	8	.	.	.
cord-015365-iqdi99pd	2100	1	Rein	Rein	NNP
cord-015365-iqdi99pd	2100	2	deskriptiv	deskriptiv	NNP
cord-015365-iqdi99pd	2100	3	zeigte	zeigte	NNP
cord-015365-iqdi99pd	2100	4	sich	sich	NNP
cord-015365-iqdi99pd	2100	5	in	in	IN
cord-015365-iqdi99pd	2100	6	unserem	unserem	NNP
cord-015365-iqdi99pd	2100	7	Kollektiv	Kollektiv	NNP
cord-015365-iqdi99pd	2100	8	kein	kein	NNP
cord-015365-iqdi99pd	2100	9	Ü	Ü	NNP
cord-015365-iqdi99pd	2100	10	berlebensnachteil	berlebensnachteil	NNP
cord-015365-iqdi99pd	2100	11	für	für	NNP
cord-015365-iqdi99pd	2100	12	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2100	13	mit	mit	NNP
cord-015365-iqdi99pd	2100	14	okkultem	okkultem	NNP
cord-015365-iqdi99pd	2100	15	HCC	HCC	NNP
cord-015365-iqdi99pd	2100	16	.	.	.
cord-015365-iqdi99pd	2101	1	Ist	Ist	NNP
cord-015365-iqdi99pd	2101	2	die	die	VBP
cord-015365-iqdi99pd	2101	3	ungeplante	ungeplante	JJ
cord-015365-iqdi99pd	2101	4	Reoperation	reoperation	NN
cord-015365-iqdi99pd	2101	5	nach	nach	NNP
cord-015365-iqdi99pd	2101	6	Nierentransplantation	Nierentransplantation	NNP
cord-015365-iqdi99pd	2101	7	ein	ein	NNP
cord-015365-iqdi99pd	2101	8	Indikator	Indikator	NNP
cord-015365-iqdi99pd	2101	9	für	für	IN
cord-015365-iqdi99pd	2101	10	Organverlust	Organverlust	NNP
cord-015365-iqdi99pd	2101	11	?	?	.
cord-015365-iqdi99pd	2102	1	K.	K.	NNP
cord-015365-iqdi99pd	2102	2	Huber	Huber	NNP
cord-015365-iqdi99pd	2102	3	1	1	CD
cord-015365-iqdi99pd	2102	4	,	,	,
cord-015365-iqdi99pd	2102	5	A.	A.	NNP
cord-015365-iqdi99pd	2102	6	Krause	Krause	NNP
cord-015365-iqdi99pd	2102	7	1	1	CD
cord-015365-iqdi99pd	2102	8	,	,	,
cord-015365-iqdi99pd	2102	9	O.	O.	NNP
cord-015365-iqdi99pd	2102	10	Gangl	Gangl	NNP
cord-015365-iqdi99pd	2102	11	1	1	CD
cord-015365-iqdi99pd	2102	12	,	,	,
cord-015365-iqdi99pd	2102	13	W.	W.	NNP
cord-015365-iqdi99pd	2102	14	Enkner	Enkner	NNP
cord-015365-iqdi99pd	2102	15	2	2	CD
cord-015365-iqdi99pd	2102	16	,	,	,
cord-015365-iqdi99pd	2102	17	R.	R.	NNP
cord-015365-iqdi99pd	2102	18	Oberbauer	Oberbauer	NNP
cord-015365-iqdi99pd	2102	19	2	2	CD
cord-015365-iqdi99pd	2102	20	,	,	,
cord-015365-iqdi99pd	2102	21	R.	R.	NNP
cord-015365-iqdi99pd	2102	22	Függer	Függer	NNP
cord-015365-iqdi99pd	2102	23	1	1	CD
cord-015365-iqdi99pd	2102	24	Ö	Ö	NNP
cord-015365-iqdi99pd	2102	25	sophagusvarizen	sophagusvarizen	NN
cord-015365-iqdi99pd	2103	1	(	(	-LRB-
cord-015365-iqdi99pd	2103	2	Grad	Grad	NNP
cord-015365-iqdi99pd	2103	3	II	II	NNP
cord-015365-iqdi99pd	2103	4	;	;	:
cord-015365-iqdi99pd	2103	5	>	>	NFP
cord-015365-iqdi99pd	2103	6	5	5	CD
cord-015365-iqdi99pd	2103	7	mm	mm	NN
cord-015365-iqdi99pd	2103	8	unter	unter	JJ
cord-015365-iqdi99pd	2103	9	Insufflation	Insufflation	NNP
cord-015365-iqdi99pd	2103	10	)	)	-RRB-
cord-015365-iqdi99pd	2104	1	während	während	NNP
cord-015365-iqdi99pd	2104	2	der	der	NNP
cord-015365-iqdi99pd	2104	3	oLT	oLT	NNP
cord-015365-iqdi99pd	2105	1	aufgetreten	aufgetreten	NNP
cord-015365-iqdi99pd	2105	2	sind	sind	NNP
cord-015365-iqdi99pd	2105	3	und	und	NNP
cord-015365-iqdi99pd	2105	4	mittels	mittels	NNPS
cord-015365-iqdi99pd	2105	5	Ballontamponade	Ballontamponade	NNP
cord-015365-iqdi99pd	2105	6	behandelt	behandelt	NNP
cord-015365-iqdi99pd	2105	7	wurden	wurden	VBD
cord-015365-iqdi99pd	2105	8	.	.	.
cord-015365-iqdi99pd	2106	1	Vergleicht	Vergleicht	NNP
cord-015365-iqdi99pd	2106	2	man	man	NN
cord-015365-iqdi99pd	2106	3	die	die	VB
cord-015365-iqdi99pd	2106	4	beiden	beiden	JJ
cord-015365-iqdi99pd	2106	5	Patientenkollektive	Patientenkollektive	NNP
cord-015365-iqdi99pd	2106	6	(	(	-LRB-
cord-015365-iqdi99pd	2106	7	mit	mit	NNP
cord-015365-iqdi99pd	2106	8	und	und	NNP
cord-015365-iqdi99pd	2106	9	ohne	ohne	NNP
cord-015365-iqdi99pd	2106	10	Krampfadern	Krampfadern	NNP
cord-015365-iqdi99pd	2106	11	)	)	-RRB-
cord-015365-iqdi99pd	2106	12	,	,	,
cord-015365-iqdi99pd	2106	13	so	so	RB
cord-015365-iqdi99pd	2106	14	ist	ist	FW
cord-015365-iqdi99pd	2106	15	das	das	NNP
cord-015365-iqdi99pd	2106	16	Ergebnis	Ergebnis	NNP
cord-015365-iqdi99pd	2106	17	statistisch	statistisch	NNP
cord-015365-iqdi99pd	2106	18	nicht	nicht	NNP
cord-015365-iqdi99pd	2106	19	signifikant	signifikant	NNP
cord-015365-iqdi99pd	2106	20	:	:	:
cord-015365-iqdi99pd	2106	21	Chi	Chi	NNP
cord-015365-iqdi99pd	2106	22	-	-	HYPH
cord-015365-iqdi99pd	2106	23	Quadrat	Quadrat	NNP
cord-015365-iqdi99pd	2106	24	-	-	HYPH
cord-015365-iqdi99pd	2106	25	Test	Test	NNP
cord-015365-iqdi99pd	2106	26	,	,	,
cord-015365-iqdi99pd	2106	27	p	p	NN
cord-015365-iqdi99pd	2106	28	¼	¼	NNP
cord-015365-iqdi99pd	2106	29	0,61	0,61	CD
cord-015365-iqdi99pd	2106	30	.	.	.
cord-015365-iqdi99pd	2107	1	Alle	Alle	NNP
cord-015365-iqdi99pd	2107	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2107	3	erhielten	erhielten	NN
cord-015365-iqdi99pd	2108	1	i	i	PRP
cord-015365-iqdi99pd	2109	1	m	m	NNP
cord-015365-iqdi99pd	2109	2	Median	Median	NNP
cord-015365-iqdi99pd	2109	3	2	2	CD
cord-015365-iqdi99pd	2110	1	Einheiten	Einheiten	NNP
cord-015365-iqdi99pd	2110	2	Erythrozytenkonzentrate	Erythrozytenkonzentrate	NNP
cord-015365-iqdi99pd	2110	3	(	(	-LRB-
cord-015365-iqdi99pd	2110	4	Bereich	Bereich	NNP
cord-015365-iqdi99pd	2110	5	0	0	CD
cord-015365-iqdi99pd	2110	6	bis	bis	NNP
cord-015365-iqdi99pd	2110	7	70	70	CD
cord-015365-iqdi99pd	2110	8	Einheiten	Einheiten	NNP
cord-015365-iqdi99pd	2110	9	)	)	-RRB-
cord-015365-iqdi99pd	2110	10	,	,	,
cord-015365-iqdi99pd	2110	11	7	7	CD
cord-015365-iqdi99pd	2110	12	Einheiten	Einheiten	NNP
cord-015365-iqdi99pd	2110	13	Fresh	Fresh	NNP
cord-015365-iqdi99pd	2110	14	Frozen	Frozen	NNP
cord-015365-iqdi99pd	2110	15	Plasma	Plasma	NNP
cord-015365-iqdi99pd	2110	16	(	(	-LRB-
cord-015365-iqdi99pd	2110	17	Bereich	Bereich	NNP
cord-015365-iqdi99pd	2110	18	von	von	NNP
cord-015365-iqdi99pd	2110	19	0	0	CD
cord-015365-iqdi99pd	2110	20	bis	bis	NNP
cord-015365-iqdi99pd	2110	21	60	60	CD
cord-015365-iqdi99pd	2110	22	Einheiten	Einheiten	NNP
cord-015365-iqdi99pd	2110	23	)	)	-RRB-
cord-015365-iqdi99pd	2110	24	und	und	RB
cord-015365-iqdi99pd	2111	1	0	0	NFP
cord-015365-iqdi99pd	2111	2	Thrombozytenkonzentrate	Thrombozytenkonzentrate	NNP
cord-015365-iqdi99pd	2111	3	(	(	-LRB-
cord-015365-iqdi99pd	2111	4	Bereich	Bereich	NNP
cord-015365-iqdi99pd	2111	5	0	0	CD
cord-015365-iqdi99pd	2111	6	bis	bis	NN
cord-015365-iqdi99pd	2111	7	4	4	CD
cord-015365-iqdi99pd	2111	8	Einheiten	Einheiten	NNP
cord-015365-iqdi99pd	2111	9	)	)	-RRB-
cord-015365-iqdi99pd	2111	10	.	.	.
cord-015365-iqdi99pd	2112	1	Obwohl	Obwohl	NNP
cord-015365-iqdi99pd	2112	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2112	3	mit	mit	NNP
cord-015365-iqdi99pd	2112	4	Krampfadern	Krampfadern	NNP
cord-015365-iqdi99pd	2113	1	eine	eine	NNP
cord-015365-iqdi99pd	2113	2	signifikant	signifikant	NNP
cord-015365-iqdi99pd	2113	3	längere	längere	NNP
cord-015365-iqdi99pd	2113	4	Prothrombinzeit	Prothrombinzeit	NNP
cord-015365-iqdi99pd	2113	5	und	und	XX
cord-015365-iqdi99pd	2114	1	eine	eine	NNP
cord-015365-iqdi99pd	2114	2	geringere	geringere	NNP
cord-015365-iqdi99pd	2114	3	Thrombozytenzahl	Thrombozytenzahl	NNP
cord-015365-iqdi99pd	2114	4	aufwiesen	aufwiesen	NNP
cord-015365-iqdi99pd	2114	5	,	,	,
cord-015365-iqdi99pd	2114	6	bestand	bestand	VB
cord-015365-iqdi99pd	2114	7	gegenü	gegenü	NNP
cord-015365-iqdi99pd	2114	8	ber	ber	NNP
cord-015365-iqdi99pd	2114	9	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2114	10	ohne	ohne	NNP
cord-015365-iqdi99pd	2114	11	Varizen	Varizen	NNP
cord-015365-iqdi99pd	2114	12	kein	kein	NNP
cord-015365-iqdi99pd	2114	13	Unterschied	Unterschied	NNP
cord-015365-iqdi99pd	2114	14	in	in	IN
cord-015365-iqdi99pd	2114	15	der	der	NNP
cord-015365-iqdi99pd	2114	16	Verwendung	Verwendung	NNP
cord-015365-iqdi99pd	2114	17	von	von	NNP
cord-015365-iqdi99pd	2114	18	Blutprodukten	Blutprodukten	NNP
cord-015365-iqdi99pd	2114	19	.	.	.
cord-015365-iqdi99pd	2115	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	2115	2	.	.	.
cord-015365-iqdi99pd	2116	1	Die	die	VB
cord-015365-iqdi99pd	2117	1	TEE	tee	NN
cord-015365-iqdi99pd	2117	2	scheint	scheint	NNP
cord-015365-iqdi99pd	2117	3	bei	bei	NNP
cord-015365-iqdi99pd	2117	4	oLT	oLT	NNP
cord-015365-iqdi99pd	2118	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2118	2	mit	mit	VBP
cord-015365-iqdi99pd	2118	3	dokumentierten	dokumentierten	NNP
cord-015365-iqdi99pd	2118	4	Ö	Ö	NNP
cord-015365-iqdi99pd	2118	5	sophagusvarizen	sophagusvarizen	NNP
cord-015365-iqdi99pd	2118	6	eine	eine	NNP
cord-015365-iqdi99pd	2118	7	allgemein	allgemein	NNP
cord-015365-iqdi99pd	2118	8	sichere	sichere	NNP
cord-015365-iqdi99pd	2118	9	Methode	Methode	NNP
cord-015365-iqdi99pd	2118	10	zur	zur	NNP
cord-015365-iqdi99pd	2118	11	Kontrolle	Kontrolle	NNP
cord-015365-iqdi99pd	2118	12	der	der	NN
cord-015365-iqdi99pd	2118	13	Herzfunktion	Herzfunktion	NNP
cord-015365-iqdi99pd	2118	14	zu	zu	NNP
cord-015365-iqdi99pd	2118	15	sein	sein	NNP
cord-015365-iqdi99pd	2118	16	.	.	.
cord-015365-iqdi99pd	2119	1	Entwicklung	Entwicklung	NNP
cord-015365-iqdi99pd	2119	2	des	des	NNP
cord-015365-iqdi99pd	2119	3	Anteils	Anteils	NNP
cord-015365-iqdi99pd	2119	4	an	an	DT
cord-015365-iqdi99pd	2120	1	Leberspendern	Leberspendern	NNP
cord-015365-iqdi99pd	2120	2	mit	mit	NNP
cord-015365-iqdi99pd	2120	3	erweiterten	erweiterten	VBN
cord-015365-iqdi99pd	2120	4	Spenderkriterien	Spenderkriterien	NNP
cord-015365-iqdi99pd	2120	5	innerhalb	innerhalb	NNP
cord-015365-iqdi99pd	2120	6	der	der	NNP
cord-015365-iqdi99pd	2120	7	letzten	letzten	NNP
cord-015365-iqdi99pd	2120	8	Dekade	Dekade	NNP
cord-015365-iqdi99pd	2120	9	an	an	DT
cord-015365-iqdi99pd	2120	10	der	der	NN
cord-015365-iqdi99pd	2120	11	Universitätsklinik	Universitätsklinik	NNP
cord-015365-iqdi99pd	2120	12	für	für	IN
cord-015365-iqdi99pd	2120	13	Transplantationschirurgie	Transplantationschirurgie	NNP
cord-015365-iqdi99pd	2120	14	Wien	Wien	NNP
cord-015365-iqdi99pd	2120	15	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	2120	16	.	.	.
cord-015365-iqdi99pd	2121	1	Die	die	VB
cord-015365-iqdi99pd	2121	2	Anzahl	Anzahl	NNP
cord-015365-iqdi99pd	2121	3	der	der	NNP
cord-015365-iqdi99pd	2121	4	jährlich	jährlich	NNP
cord-015365-iqdi99pd	2121	5	durchgeführten	durchgeführten	NNP
cord-015365-iqdi99pd	2122	1	Lebertransplantationen	Lebertransplantationen	NNP
cord-015365-iqdi99pd	2122	2	ist	ist	NN
cord-015365-iqdi99pd	2122	3	von	von	NNP
cord-015365-iqdi99pd	2122	4	der	der	NNP
cord-015365-iqdi99pd	2122	5	Anzahl	Anzahl	NNP
cord-015365-iqdi99pd	2122	6	der	der	NNP
cord-015365-iqdi99pd	2122	7	gemeldeten	gemeldeten	VBN
cord-015365-iqdi99pd	2122	8	Organspender	Organspender	NNP
cord-015365-iqdi99pd	2122	9	abhängig	abhängig	NNS
cord-015365-iqdi99pd	2122	10	.	.	.
cord-015365-iqdi99pd	2123	1	Allerdings	Allerdings	NNP
cord-015365-iqdi99pd	2123	2	eignet	eignet	VBZ
cord-015365-iqdi99pd	2123	3	sich	sich	NNP
cord-015365-iqdi99pd	2123	4	nicht	nicht	NNP
cord-015365-iqdi99pd	2123	5	jeder	jeder	NNP
cord-015365-iqdi99pd	2123	6	Organspender	Organspender	NNP
cord-015365-iqdi99pd	2123	7	als	als	NN
cord-015365-iqdi99pd	2123	8	Leberspender	Leberspender	NNP
cord-015365-iqdi99pd	2123	9	.	.	.
cord-015365-iqdi99pd	2124	1	Ziel	Ziel	NNP
cord-015365-iqdi99pd	2124	2	dieser	dieser	NNP
cord-015365-iqdi99pd	2124	3	Studie	Studie	NNP
cord-015365-iqdi99pd	2124	4	ist	ist	NNP
cord-015365-iqdi99pd	2124	5	es	es	NNP
cord-015365-iqdi99pd	2124	6	,	,	,
cord-015365-iqdi99pd	2124	7	die	die	VB
cord-015365-iqdi99pd	2125	1	Evolution	evolution	NN
cord-015365-iqdi99pd	2125	2	der	der	NN
cord-015365-iqdi99pd	2125	3	Leberspender	Leberspender	NNP
cord-015365-iqdi99pd	2125	4	innerhalb	innerhalb	NNP
cord-015365-iqdi99pd	2125	5	der	der	NNP
cord-015365-iqdi99pd	2125	6	letzten	letzten	NNP
cord-015365-iqdi99pd	2125	7	10	10	CD
cord-015365-iqdi99pd	2125	8	Jahre	Jahre	NNP
cord-015365-iqdi99pd	2125	9	zu	zu	NNP
cord-015365-iqdi99pd	2125	10	verfolgen	verfolgen	NNP
cord-015365-iqdi99pd	2125	11	.	.	.
cord-015365-iqdi99pd	2126	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	2126	2	Methodik	Methodik	NNP
cord-015365-iqdi99pd	2126	3	.	.	.
cord-015365-iqdi99pd	2127	1	I	-PRON-	PRP
cord-015365-iqdi99pd	2127	2	m	be	VBP
cord-015365-iqdi99pd	2127	3	Zeitraum	Zeitraum	NNP
cord-015365-iqdi99pd	2127	4	von	von	NNP
cord-015365-iqdi99pd	2127	5	Jänner	Jänner	NNP
cord-015365-iqdi99pd	2127	6	1994	1994	CD
cord-015365-iqdi99pd	2127	7	bis	bis	NNP
cord-015365-iqdi99pd	2127	8	Juli	Juli	NNP
cord-015365-iqdi99pd	2127	9	2011	2011	CD
cord-015365-iqdi99pd	2127	10	wurden	wurden	NNP
cord-015365-iqdi99pd	2127	11	an	an	DT
cord-015365-iqdi99pd	2127	12	der	der	NN
cord-015365-iqdi99pd	2127	13	Medizinischen	Medizinischen	NNP
cord-015365-iqdi99pd	2127	14	Universität	Universität	NNP
cord-015365-iqdi99pd	2127	15	Wien	Wien	NNP
cord-015365-iqdi99pd	2127	16	,	,	,
cord-015365-iqdi99pd	2127	17	Abteilung	Abteilung	NNP
cord-015365-iqdi99pd	2127	18	für	für	IN
cord-015365-iqdi99pd	2127	19	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	2128	1	22	22	CD
cord-015365-iqdi99pd	2129	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2129	2	,	,	,
cord-015365-iqdi99pd	2129	3	davon	davon	NNP
cord-015365-iqdi99pd	2129	4	18	18	CD
cord-015365-iqdi99pd	2129	5	männlich	männlich	NNP
cord-015365-iqdi99pd	2129	6	und	und	IN
cord-015365-iqdi99pd	2129	7	4	4	CD
cord-015365-iqdi99pd	2129	8	weiblich	weiblich	NNP
cord-015365-iqdi99pd	2129	9	,	,	,
cord-015365-iqdi99pd	2129	10	mit	mit	NNP
cord-015365-iqdi99pd	2129	11	einem	einem	NNP
cord-015365-iqdi99pd	2129	12	medianen	medianen	NNP
cord-015365-iqdi99pd	2129	13	Durchschnittsalter	Durchschnittsalter	NNP
cord-015365-iqdi99pd	2129	14	von	von	NNP
cord-015365-iqdi99pd	2129	15	51	51	CD
cord-015365-iqdi99pd	2129	16	Jahren	Jahren	NNP
cord-015365-iqdi99pd	2129	17	kombiniert	kombiniert	NNP
cord-015365-iqdi99pd	2129	18	Leber	Leber	NNP
cord-015365-iqdi99pd	2129	19	und	und	IN
cord-015365-iqdi99pd	2129	20	Niere	Niere	NNP
cord-015365-iqdi99pd	2129	21	transplantiert	transplantiert	NNP
cord-015365-iqdi99pd	2129	22	.	.	.
cord-015365-iqdi99pd	2130	1	Inkludiert	inkludiert	JJ
cord-015365-iqdi99pd	2130	2	wurden	wurden	VBD
cord-015365-iqdi99pd	2130	3	bei	bei	NNP
cord-015365-iqdi99pd	2130	4	dieser	dieser	NNP
cord-015365-iqdi99pd	2130	5	retrospektiven	retrospektiven	NNP
cord-015365-iqdi99pd	2130	6	Analyse	Analyse	NNP
cord-015365-iqdi99pd	2130	7	nur	nur	NNP
cord-015365-iqdi99pd	2130	8	einzeitig	einzeitig	NN
cord-015365-iqdi99pd	2130	9	transplantierte	transplantierte	NNS
cord-015365-iqdi99pd	2130	10	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2130	11	.	.	.
cord-015365-iqdi99pd	2131	1	Die	die	VB
cord-015365-iqdi99pd	2131	2	Indikationen	Indikationen	NNP
cord-015365-iqdi99pd	2131	3	zur	zur	NNP
cord-015365-iqdi99pd	2131	4	Lebertransplantation	Lebertransplantation	NNP
cord-015365-iqdi99pd	2131	5	waren	waren	XX
cord-015365-iqdi99pd	2132	1	wie	wie	NNP
cord-015365-iqdi99pd	2132	2	folgt	folgt	NNP
cord-015365-iqdi99pd	2132	3	verteilt	verteilt	NNP
cord-015365-iqdi99pd	2132	4	:	:	:
cord-015365-iqdi99pd	2133	1	Virushepatitis	Virushepatitis	NNP
cord-015365-iqdi99pd	2133	2	(	(	-LRB-
cord-015365-iqdi99pd	2133	3	n	n	CC
cord-015365-iqdi99pd	2133	4	¼	¼	NNP
cord-015365-iqdi99pd	2133	5	6	6	CD
cord-015365-iqdi99pd	2133	6	)	)	-RRB-
cord-015365-iqdi99pd	2133	7	,	,	,
cord-015365-iqdi99pd	2133	8	Malignom	Malignom	NNP
cord-015365-iqdi99pd	2133	9	(	(	-LRB-
cord-015365-iqdi99pd	2133	10	n	n	CC
cord-015365-iqdi99pd	2133	11	¼	¼	NNP
cord-015365-iqdi99pd	2133	12	4	4	CD
cord-015365-iqdi99pd	2133	13	)	)	-RRB-
cord-015365-iqdi99pd	2133	14	,	,	,
cord-015365-iqdi99pd	2133	15	metabolische	metabolische	NNP
cord-015365-iqdi99pd	2133	16	Zirrhose	Zirrhose	NNP
cord-015365-iqdi99pd	2134	1	(	(	-LRB-
cord-015365-iqdi99pd	2134	2	n	n	JJ
cord-015365-iqdi99pd	2134	3	¼	¼	NNP
cord-015365-iqdi99pd	2134	4	5	5	CD
cord-015365-iqdi99pd	2134	5	)	)	-RRB-
cord-015365-iqdi99pd	2134	6	,	,	,
cord-015365-iqdi99pd	2134	7	Oxalose	Oxalose	NNP
cord-015365-iqdi99pd	2134	8	(	(	-LRB-
cord-015365-iqdi99pd	2134	9	n	n	NN
cord-015365-iqdi99pd	2134	10	¼	¼	NNP
cord-015365-iqdi99pd	2134	11	3	3	CD
cord-015365-iqdi99pd	2134	12	)	)	-RRB-
cord-015365-iqdi99pd	2134	13	,	,	,
cord-015365-iqdi99pd	2134	14	sklerosierende	sklerosierende	NNP
cord-015365-iqdi99pd	2134	15	Cholangitis	Cholangitis	NNP
cord-015365-iqdi99pd	2134	16	(	(	-LRB-
cord-015365-iqdi99pd	2134	17	n	n	NN
cord-015365-iqdi99pd	2134	18	¼	¼	NNP
cord-015365-iqdi99pd	2134	19	1	1	CD
cord-015365-iqdi99pd	2134	20	)	)	-RRB-
cord-015365-iqdi99pd	2134	21	,	,	,
cord-015365-iqdi99pd	2134	22	Hämochromatose	Hämochromatose	NNP
cord-015365-iqdi99pd	2134	23	(	(	-LRB-
cord-015365-iqdi99pd	2134	24	n	n	NNP
cord-015365-iqdi99pd	2134	25	¼	¼	NNP
cord-015365-iqdi99pd	2134	26	1	1	CD
cord-015365-iqdi99pd	2134	27	)	)	-RRB-
cord-015365-iqdi99pd	2134	28	,	,	,
cord-015365-iqdi99pd	2134	29	Citrullinämie	Citrullinämie	NNP
cord-015365-iqdi99pd	2134	30	(	(	-LRB-
cord-015365-iqdi99pd	2134	31	n	n	NNP
cord-015365-iqdi99pd	2134	32	¼	¼	NNP
cord-015365-iqdi99pd	2134	33	1	1	CD
cord-015365-iqdi99pd	2134	34	)	)	-RRB-
cord-015365-iqdi99pd	2135	1	und	und	NNP
cord-015365-iqdi99pd	2136	1	zystische	zystische	NNP
cord-015365-iqdi99pd	2136	2	Zirrhose	Zirrhose	NNP
cord-015365-iqdi99pd	2137	1	(	(	-LRB-
cord-015365-iqdi99pd	2137	2	n	n	CC
cord-015365-iqdi99pd	2137	3	¼	¼	NNP
cord-015365-iqdi99pd	2137	4	1	1	CD
cord-015365-iqdi99pd	2137	5	)	)	-RRB-
cord-015365-iqdi99pd	2137	6	.	.	.
cord-015365-iqdi99pd	2138	1	Die	die	VB
cord-015365-iqdi99pd	2138	2	Nierentransplantation	Nierentransplantation	NNP
cord-015365-iqdi99pd	2138	3	erfolgte	erfolgte	NN
cord-015365-iqdi99pd	2139	1	aufgrund	aufgrund	NNP
cord-015365-iqdi99pd	2139	2	von	von	NNP
cord-015365-iqdi99pd	2139	3	:	:	:
cord-015365-iqdi99pd	2140	1	chronischer	chronischer	NNP
cord-015365-iqdi99pd	2141	1	Niereninsuffizienz	Niereninsuffizienz	NNP
cord-015365-iqdi99pd	2141	2	o.	o.	NNP
cord-015365-iqdi99pd	2141	3	n.	n.	NN
cord-015365-iqdi99pd	2141	4	B.	B.	NNP
cord-015365-iqdi99pd	2142	1	(	(	-LRB-
cord-015365-iqdi99pd	2142	2	n	n	CC
cord-015365-iqdi99pd	2142	3	¼	¼	NNP
cord-015365-iqdi99pd	2142	4	7	7	CD
cord-015365-iqdi99pd	2142	5	)	)	-RRB-
cord-015365-iqdi99pd	2142	6	,	,	,
cord-015365-iqdi99pd	2142	7	Glomerulonephritis	Glomerulonephritis	NNP
cord-015365-iqdi99pd	2142	8	(	(	-LRB-
cord-015365-iqdi99pd	2142	9	n	n	CC
cord-015365-iqdi99pd	2142	10	¼	¼	NNP
cord-015365-iqdi99pd	2142	11	4	4	CD
cord-015365-iqdi99pd	2142	12	)	)	-RRB-
cord-015365-iqdi99pd	2142	13	,	,	,
cord-015365-iqdi99pd	2142	14	metabolischer	metabolischer	NNP
cord-015365-iqdi99pd	2142	15	Nephropathie	Nephropathie	NNP
cord-015365-iqdi99pd	2142	16	(	(	-LRB-
cord-015365-iqdi99pd	2142	17	n	n	NN
cord-015365-iqdi99pd	2142	18	¼	¼	NNP
cord-015365-iqdi99pd	2142	19	4	4	CD
cord-015365-iqdi99pd	2142	20	)	)	-RRB-
cord-015365-iqdi99pd	2142	21	,	,	,
cord-015365-iqdi99pd	2142	22	Oxalose	Oxalose	NNP
cord-015365-iqdi99pd	2142	23	(	(	-LRB-
cord-015365-iqdi99pd	2142	24	n	n	NN
cord-015365-iqdi99pd	2142	25	¼	¼	NNP
cord-015365-iqdi99pd	2142	26	3	3	CD
cord-015365-iqdi99pd	2142	27	)	)	-RRB-
cord-015365-iqdi99pd	2142	28	,	,	,
cord-015365-iqdi99pd	2142	29	Pyelonephritis	Pyelonephritis	NNP
cord-015365-iqdi99pd	2142	30	(	(	-LRB-
cord-015365-iqdi99pd	2142	31	n	n	CC
cord-015365-iqdi99pd	2142	32	¼	¼	NNP
cord-015365-iqdi99pd	2142	33	1	1	CD
cord-015365-iqdi99pd	2142	34	)	)	-RRB-
cord-015365-iqdi99pd	2142	35	,	,	,
cord-015365-iqdi99pd	2142	36	Hantavirus	Hantavirus	NNP
cord-015365-iqdi99pd	2142	37	(	(	-LRB-
cord-015365-iqdi99pd	2142	38	n	n	NN
cord-015365-iqdi99pd	2142	39	¼	¼	NNP
cord-015365-iqdi99pd	2142	40	1	1	CD
cord-015365-iqdi99pd	2142	41	)	)	-RRB-
cord-015365-iqdi99pd	2142	42	,	,	,
cord-015365-iqdi99pd	2142	43	IgA	IgA	NNP
cord-015365-iqdi99pd	2142	44	-	-	HYPH
cord-015365-iqdi99pd	2142	45	Nephropathie	Nephropathie	NNP
cord-015365-iqdi99pd	2142	46	(	(	-LRB-
cord-015365-iqdi99pd	2142	47	n	n	NN
cord-015365-iqdi99pd	2142	48	¼	¼	NNP
cord-015365-iqdi99pd	2142	49	1	1	CD
cord-015365-iqdi99pd	2142	50	)	)	-RRB-
cord-015365-iqdi99pd	2142	51	und	und	CC
cord-015365-iqdi99pd	2142	52	Cyclosporin	Cyclosporin	NNP
cord-015365-iqdi99pd	2142	53	-	-	HYPH
cord-015365-iqdi99pd	2142	54	induziert	induziert	NNP
cord-015365-iqdi99pd	2142	55	(	(	-LRB-
cord-015365-iqdi99pd	2142	56	n	n	NN
cord-015365-iqdi99pd	2142	57	¼	¼	NNP
cord-015365-iqdi99pd	2142	58	1	1	CD
cord-015365-iqdi99pd	2142	59	)	)	-RRB-
cord-015365-iqdi99pd	2142	60	.	.	.
cord-015365-iqdi99pd	2143	1	72	72	CD
cord-015365-iqdi99pd	2143	2	%	%	NN
cord-015365-iqdi99pd	2143	3	(	(	-LRB-
cord-015365-iqdi99pd	2143	4	n	n	NN
cord-015365-iqdi99pd	2143	5	¼	¼	NNP
cord-015365-iqdi99pd	2143	6	16	16	CD
cord-015365-iqdi99pd	2143	7	)	)	-RRB-
cord-015365-iqdi99pd	2143	8	der	der	NNP
cord-015365-iqdi99pd	2143	9	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2143	10	waren	waren	NN
cord-015365-iqdi99pd	2143	11	zum	zum	NNP
cord-015365-iqdi99pd	2143	12	Zeitpunkt	Zeitpunkt	NNP
cord-015365-iqdi99pd	2143	13	der	der	NNP
cord-015365-iqdi99pd	2143	14	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	2143	15	dialysepflichtig	dialysepflichtig	NN
cord-015365-iqdi99pd	2143	16	,	,	,
cord-015365-iqdi99pd	2143	17	davon	davon	NNP
cord-015365-iqdi99pd	2143	18	13	13	CD
cord-015365-iqdi99pd	2144	1	an	an	DT
cord-015365-iqdi99pd	2144	2	der	der	NN
cord-015365-iqdi99pd	2144	3	Hämodialyse	Hämodialyse	NNP
cord-015365-iqdi99pd	2144	4	und	und	IN
cord-015365-iqdi99pd	2145	1	3	3	CD
cord-015365-iqdi99pd	2145	2	erhielten	erhielten	NNP
cord-015365-iqdi99pd	2145	3	Peritonealdialyse	Peritonealdialyse	NNP
cord-015365-iqdi99pd	2145	4	.	.	.
cord-015365-iqdi99pd	2146	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2146	2	.	.	.
cord-015365-iqdi99pd	2147	1	Die	die	VB
cord-015365-iqdi99pd	2148	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2148	2	waren	waren	VBD
cord-015365-iqdi99pd	2148	3	durchschnittliche	durchschnittliche	NNP
cord-015365-iqdi99pd	2148	4	121	121	CD
cord-015365-iqdi99pd	2148	5	Tage	Tage	NNP
cord-015365-iqdi99pd	2148	6	gleichzeitig	gleichzeitig	NNP
cord-015365-iqdi99pd	2148	7	für	für	IN
cord-015365-iqdi99pd	2148	8	Leber	Leber	NNP
cord-015365-iqdi99pd	2148	9	und	und	IN
cord-015365-iqdi99pd	2148	10	Niere	Niere	NNP
cord-015365-iqdi99pd	2148	11	gelistet	gelistet	NNP
cord-015365-iqdi99pd	2149	1	und	und	NNP
cord-015365-iqdi99pd	2149	2	der	der	NNP
cord-015365-iqdi99pd	2149	3	mediane	mediane	NNP
cord-015365-iqdi99pd	2149	4	MELD	MELD	NNP
cord-015365-iqdi99pd	2149	5	(	(	-LRB-
cord-015365-iqdi99pd	2149	6	Model	model	NN
cord-015365-iqdi99pd	2149	7	for	for	IN
cord-015365-iqdi99pd	2149	8	End	end	NN
cord-015365-iqdi99pd	2149	9	-	-	HYPH
cord-015365-iqdi99pd	2149	10	Stage	stage	NN
cord-015365-iqdi99pd	2149	11	Liver	Liver	NNP
cord-015365-iqdi99pd	2149	12	Disease	Disease	NNP
cord-015365-iqdi99pd	2149	13	)	)	-RRB-
cord-015365-iqdi99pd	2150	1	Score	Score	NNP
cord-015365-iqdi99pd	2150	2	betrug	betrug	NNP
cord-015365-iqdi99pd	2150	3	bei	bei	NNP
cord-015365-iqdi99pd	2150	4	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	2150	5	22	22	CD
cord-015365-iqdi99pd	2150	6	.	.	.
cord-015365-iqdi99pd	2151	1	Die	die	VB
cord-015365-iqdi99pd	2151	2	1-und	1-und	CD
cord-015365-iqdi99pd	2151	3	5-Jahresüberlebensrate	5-Jahresüberlebensrate	NNP
cord-015365-iqdi99pd	2151	4	betrug	betrug	NNP
cord-015365-iqdi99pd	2151	5	bei	bei	NNP
cord-015365-iqdi99pd	2151	6	unseren	unseren	NNP
cord-015365-iqdi99pd	2152	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2152	2	81	81	CD
cord-015365-iqdi99pd	2152	3	%	%	NN
cord-015365-iqdi99pd	2152	4	und	und	IN
cord-015365-iqdi99pd	2152	5	67	67	CD
cord-015365-iqdi99pd	2152	6	%	%	NN
cord-015365-iqdi99pd	2152	7	.	.	.
cord-015365-iqdi99pd	2153	1	Unmittelbar	Unmittelbar	NNP
cord-015365-iqdi99pd	2153	2	postoperativ	postoperativ	JJ
cord-015365-iqdi99pd	2153	3	verstarben	verstarben	NN
cord-015365-iqdi99pd	2154	1	3	3	CD
cord-015365-iqdi99pd	2154	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2154	3	,	,	,
cord-015365-iqdi99pd	2154	4	davon	davon	NNP
cord-015365-iqdi99pd	2154	5	2	2	CD
cord-015365-iqdi99pd	2154	6	an	an	DT
cord-015365-iqdi99pd	2154	7	einer	einer	NNP
cord-015365-iqdi99pd	2154	8	Sepsis	sepsis	NN
cord-015365-iqdi99pd	2154	9	und	und	IN
cord-015365-iqdi99pd	2154	10	einer	einer	NNP
cord-015365-iqdi99pd	2154	11	in	in	IN
cord-015365-iqdi99pd	2154	12	Folge	Folge	NNP
cord-015365-iqdi99pd	2154	13	einer	einer	NNP
cord-015365-iqdi99pd	2154	14	primären	primären	NNP
cord-015365-iqdi99pd	2154	15	Nichtfunktion	Nichtfunktion	NNP
cord-015365-iqdi99pd	2154	16	der	der	NNP
cord-015365-iqdi99pd	2154	17	Leber	Leber	NNP
cord-015365-iqdi99pd	2154	18	.	.	.
cord-015365-iqdi99pd	2155	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	2155	2	.	.	.
cord-015365-iqdi99pd	2156	1	Die	die	VB
cord-015365-iqdi99pd	2156	2	KLNT	KLNT	NNP
cord-015365-iqdi99pd	2156	3	stellt	stellt	NNP
cord-015365-iqdi99pd	2156	4	an	an	DT
cord-015365-iqdi99pd	2156	5	unserem	unserem	JJ
cord-015365-iqdi99pd	2156	6	Zentrum	Zentrum	NNP
cord-015365-iqdi99pd	2156	7	eine	eine	NNP
cord-015365-iqdi99pd	2156	8	gute	gute	NNP
cord-015365-iqdi99pd	2156	9	Therapieoption	Therapieoption	NNP
cord-015365-iqdi99pd	2156	10	bei	bei	NNP
cord-015365-iqdi99pd	2156	11	terminaler	terminaler	NNP
cord-015365-iqdi99pd	2156	12	Leber	Leber	NNP
cord-015365-iqdi99pd	2156	13	-	-	HYPH
cord-015365-iqdi99pd	2156	14	und	und	NNP
cord-015365-iqdi99pd	2156	15	Nierenerkrankung	Nierenerkrankung	NNP
cord-015365-iqdi99pd	2156	16	dar	dar	NNP
cord-015365-iqdi99pd	2156	17	.	.	.
cord-015365-iqdi99pd	2157	1	Laut	Laut	NNP
cord-015365-iqdi99pd	2157	2	ELTR	ELTR	NNP
cord-015365-iqdi99pd	2157	3	beträgt	beträgt	NN
cord-015365-iqdi99pd	2157	4	die	die	VBP
cord-015365-iqdi99pd	2157	5	1-und	1-und	CD
cord-015365-iqdi99pd	2157	6	5-Jahresüberlebensrate	5-Jahresüberlebensrate	NNP
cord-015365-iqdi99pd	2157	7	für	für	JJ
cord-015365-iqdi99pd	2157	8	alleinige	alleinige	NNP
cord-015365-iqdi99pd	2157	9	orthotope	orthotope	NNP
cord-015365-iqdi99pd	2157	10	Lebertransplantation	Lebertransplantation	NNP
cord-015365-iqdi99pd	2157	11	78	78	CD
cord-015365-iqdi99pd	2157	12	%	%	NN
cord-015365-iqdi99pd	2157	13	bzw	bzw	NNP
cord-015365-iqdi99pd	2157	14	.	.	.
cord-015365-iqdi99pd	2158	1	64	64	CD
cord-015365-iqdi99pd	2158	2	%	%	NN
cord-015365-iqdi99pd	2158	3	und	und	IN
cord-015365-iqdi99pd	2158	4	ist	ist	NNP
cord-015365-iqdi99pd	2158	5	daher	daher	NNP
cord-015365-iqdi99pd	2158	6	mit	mit	NNP
cord-015365-iqdi99pd	2158	7	unseren	unseren	NNP
cord-015365-iqdi99pd	2158	8	Resultaten	Resultaten	NNP
cord-015365-iqdi99pd	2158	9	vergleichbar	vergleichbar	NN
cord-015365-iqdi99pd	2158	10	.	.	.
cord-015365-iqdi99pd	2159	1	Die	die	VB
cord-015365-iqdi99pd	2159	2	hohe	hohe	NNP
cord-015365-iqdi99pd	2160	1	perioperative	perioperative	NNP
cord-015365-iqdi99pd	2160	2	Mortalität	Mortalität	NNP
cord-015365-iqdi99pd	2160	3	der	der	VBP
cord-015365-iqdi99pd	2160	4	KLNT	KLNT	NNP
cord-015365-iqdi99pd	2160	5	spricht	spricht	NNP
cord-015365-iqdi99pd	2160	6	für	für	IN
cord-015365-iqdi99pd	2160	7	ein	ein	NNP
cord-015365-iqdi99pd	2160	8	rezent	rezent	NNP
cord-015365-iqdi99pd	2160	9	diskutiertes	diskutiertes	NNP
cord-015365-iqdi99pd	2160	10	zweizeitiges	zweizeitiges	NNP
cord-015365-iqdi99pd	2160	11	Vorgehen	Vorgehen	NNP
cord-015365-iqdi99pd	2160	12	,	,	,
cord-015365-iqdi99pd	2160	13	um	um	UH
cord-015365-iqdi99pd	2160	14	einen	einen	NNP
cord-015365-iqdi99pd	2160	15	möglichen	möglichen	NNP
cord-015365-iqdi99pd	2160	16	Organverlust	Organverlust	NNP
cord-015365-iqdi99pd	2160	17	zu	zu	NNP
cord-015365-iqdi99pd	2160	18	vermeiden	vermeiden	NNP
cord-015365-iqdi99pd	2160	19	.	.	.
cord-015365-iqdi99pd	2161	1	Orthotopic	Orthotopic	NNP
cord-015365-iqdi99pd	2161	2	liver	liver	NN
cord-015365-iqdi99pd	2161	3	transplantation	transplantation	NN
cord-015365-iqdi99pd	2161	4	(	(	-LRB-
cord-015365-iqdi99pd	2161	5	OLT	OLT	NNP
cord-015365-iqdi99pd	2161	6	)	)	-RRB-
cord-015365-iqdi99pd	2161	7	under	under	IN
cord-015365-iqdi99pd	2161	8	the	the	DT
cord-015365-iqdi99pd	2161	9	use	use	NN
cord-015365-iqdi99pd	2161	10	of	of	IN
cord-015365-iqdi99pd	2161	11	a	a	DT
cord-015365-iqdi99pd	2161	12	protective	protective	JJ
cord-015365-iqdi99pd	2161	13	filter	filter	NN
cord-015365-iqdi99pd	2161	14	against	against	IN
cord-015365-iqdi99pd	2161	15	phototoxicity	phototoxicity	NN
cord-015365-iqdi99pd	2161	16	in	in	IN
cord-015365-iqdi99pd	2161	17	a	a	DT
cord-015365-iqdi99pd	2161	18	patient	patient	NN
cord-015365-iqdi99pd	2161	19	suffering	suffer	VBG
cord-015365-iqdi99pd	2161	20	from	from	IN
cord-015365-iqdi99pd	2161	21	erythropoietic	erythropoietic	NNP
cord-015365-iqdi99pd	2161	22	protoporphyria	protoporphyria	NNP
cord-015365-iqdi99pd	2161	23	(	(	-LRB-
cord-015365-iqdi99pd	2161	24	EPP	EPP	NNP
cord-015365-iqdi99pd	2161	25	)	)	-RRB-
cord-015365-iqdi99pd	2161	26	with	with	IN
cord-015365-iqdi99pd	2161	27	liver	liver	NN
cord-015365-iqdi99pd	2161	28	cirrhosis	cirrhosis	NN
cord-015365-iqdi99pd	2161	29	Background	Background	NNP
cord-015365-iqdi99pd	2161	30	.	.	.
cord-015365-iqdi99pd	2162	1	Erythropoietic	Erythropoietic	NNP
cord-015365-iqdi99pd	2162	2	protoporphyria	protoporphyria	NNP
cord-015365-iqdi99pd	2162	3	(	(	-LRB-
cord-015365-iqdi99pd	2162	4	EPP	EPP	NNP
cord-015365-iqdi99pd	2162	5	)	)	-RRB-
cord-015365-iqdi99pd	2162	6	is	be	VBZ
cord-015365-iqdi99pd	2162	7	a	a	DT
cord-015365-iqdi99pd	2162	8	rare	rare	JJ
cord-015365-iqdi99pd	2162	9	condition	condition	NN
cord-015365-iqdi99pd	2162	10	arising	arise	VBG
cord-015365-iqdi99pd	2162	11	from	from	IN
cord-015365-iqdi99pd	2162	12	a	a	DT
cord-015365-iqdi99pd	2162	13	deficiency	deficiency	NN
cord-015365-iqdi99pd	2162	14	in	in	IN
cord-015365-iqdi99pd	2162	15	the	the	DT
cord-015365-iqdi99pd	2162	16	enzyme	enzyme	NN
cord-015365-iqdi99pd	2162	17	ferrochelatase	ferrochelatase	NN
cord-015365-iqdi99pd	2162	18	,	,	,
cord-015365-iqdi99pd	2162	19	leading	lead	VBG
cord-015365-iqdi99pd	2162	20	to	to	IN
cord-015365-iqdi99pd	2162	21	abnormally	abnormally	RB
cord-015365-iqdi99pd	2162	22	high	high	JJ
cord-015365-iqdi99pd	2162	23	levels	level	NNS
cord-015365-iqdi99pd	2162	24	of	of	IN
cord-015365-iqdi99pd	2162	25	protoporphyrin	protoporphyrin	NNP
cord-015365-iqdi99pd	2162	26	in	in	IN
cord-015365-iqdi99pd	2162	27	the	the	DT
cord-015365-iqdi99pd	2162	28	tissue	tissue	NN
cord-015365-iqdi99pd	2162	29	.	.	.
cord-015365-iqdi99pd	2163	1	Apart	apart	RB
cord-015365-iqdi99pd	2163	2	from	from	IN
cord-015365-iqdi99pd	2163	3	increased	increase	VBN
cord-015365-iqdi99pd	2163	4	photosensitivity	photosensitivity	NN
cord-015365-iqdi99pd	2163	5	leading	lead	VBG
cord-015365-iqdi99pd	2163	6	to	to	IN
cord-015365-iqdi99pd	2163	7	acute	acute	JJ
cord-015365-iqdi99pd	2163	8	and	and	CC
cord-015365-iqdi99pd	2163	9	chronic	chronic	JJ
cord-015365-iqdi99pd	2163	10	skin	skin	NN
cord-015365-iqdi99pd	2163	11	changes	change	NNS
cord-015365-iqdi99pd	2163	12	,	,	,
cord-015365-iqdi99pd	2163	13	in	in	IN
cord-015365-iqdi99pd	2163	14	a	a	DT
cord-015365-iqdi99pd	2163	15	small	small	JJ
cord-015365-iqdi99pd	2163	16	number	number	NN
cord-015365-iqdi99pd	2163	17	of	of	IN
cord-015365-iqdi99pd	2163	18	cases	case	NNS
cord-015365-iqdi99pd	2163	19	protoporphyrin	protoporphyrin	NNP
cord-015365-iqdi99pd	2163	20	deposits	deposit	NNS
cord-015365-iqdi99pd	2163	21	and	and	CC
cord-015365-iqdi99pd	2163	22	pigment	pigment	NN
cord-015365-iqdi99pd	2163	23	loading	loading	NN
cord-015365-iqdi99pd	2163	24	of	of	IN
cord-015365-iqdi99pd	2163	25	the	the	DT
cord-015365-iqdi99pd	2163	26	hepatocytes	hepatocyte	NNS
cord-015365-iqdi99pd	2163	27	cause	cause	VBP
cord-015365-iqdi99pd	2163	28	liver	liver	NN
cord-015365-iqdi99pd	2163	29	cirrhosis	cirrhosis	NN
cord-015365-iqdi99pd	2163	30	.	.	.
cord-015365-iqdi99pd	2164	1	In	in	IN
cord-015365-iqdi99pd	2164	2	these	these	DT
cord-015365-iqdi99pd	2164	3	patients	patient	NNS
cord-015365-iqdi99pd	2164	4	liver	liver	NN
cord-015365-iqdi99pd	2164	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	2164	6	is	be	VBZ
cord-015365-iqdi99pd	2164	7	the	the	DT
cord-015365-iqdi99pd	2164	8	therapy	therapy	NN
cord-015365-iqdi99pd	2164	9	of	of	IN
cord-015365-iqdi99pd	2164	10	choice	choice	NN
cord-015365-iqdi99pd	2164	11	.	.	.
cord-015365-iqdi99pd	2165	1	Nevertheless	nevertheless	RB
cord-015365-iqdi99pd	2165	2	intestinal	intestinal	JJ
cord-015365-iqdi99pd	2165	3	ulceration	ulceration	NN
cord-015365-iqdi99pd	2165	4	,	,	,
cord-015365-iqdi99pd	2165	5	bleeding	bleed	VBG
cord-015365-iqdi99pd	2165	6	and	and	CC
cord-015365-iqdi99pd	2165	7	ultimately	ultimately	RB
cord-015365-iqdi99pd	2165	8	multiorgan	multiorgan	NNP
cord-015365-iqdi99pd	2165	9	failure	failure	NN
cord-015365-iqdi99pd	2165	10	can	can	MD
cord-015365-iqdi99pd	2165	11	occur	occur	VB
cord-015365-iqdi99pd	2165	12	if	if	IN
cord-015365-iqdi99pd	2165	13	no	no	DT
cord-015365-iqdi99pd	2165	14	protective	protective	JJ
cord-015365-iqdi99pd	2165	15	measures	measure	NNS
cord-015365-iqdi99pd	2165	16	are	be	VBP
cord-015365-iqdi99pd	2165	17	taken	take	VBN
cord-015365-iqdi99pd	2165	18	against	against	IN
cord-015365-iqdi99pd	2165	19	phototoxic	phototoxic	JJ
cord-015365-iqdi99pd	2165	20	injury	injury	NN
cord-015365-iqdi99pd	2165	21	during	during	IN
cord-015365-iqdi99pd	2165	22	surgery	surgery	NN
cord-015365-iqdi99pd	2165	23	.	.	.
cord-015365-iqdi99pd	2166	1	Methods	method	NNS
cord-015365-iqdi99pd	2166	2	and	and	CC
cord-015365-iqdi99pd	2166	3	Results	result	NNS
cord-015365-iqdi99pd	2166	4	.	.	.
cord-015365-iqdi99pd	2167	1	We	-PRON-	PRP
cord-015365-iqdi99pd	2167	2	would	would	MD
cord-015365-iqdi99pd	2167	3	like	like	VB
cord-015365-iqdi99pd	2167	4	to	to	TO
cord-015365-iqdi99pd	2167	5	present	present	VB
cord-015365-iqdi99pd	2167	6	the	the	DT
cord-015365-iqdi99pd	2167	7	case	case	NN
cord-015365-iqdi99pd	2167	8	of	of	IN
cord-015365-iqdi99pd	2167	9	a	a	DT
cord-015365-iqdi99pd	2167	10	36-year	36-year	JJ
cord-015365-iqdi99pd	2167	11	-	-	HYPH
cord-015365-iqdi99pd	2167	12	old	old	JJ
cord-015365-iqdi99pd	2167	13	patient	patient	NN
cord-015365-iqdi99pd	2167	14	who	who	WP
cord-015365-iqdi99pd	2167	15	was	be	VBD
cord-015365-iqdi99pd	2167	16	admitted	admit	VBN
cord-015365-iqdi99pd	2167	17	to	to	IN
cord-015365-iqdi99pd	2167	18	our	-PRON-	PRP$
cord-015365-iqdi99pd	2167	19	department	department	NN
cord-015365-iqdi99pd	2167	20	for	for	IN
cord-015365-iqdi99pd	2167	21	liver	liver	NN
cord-015365-iqdi99pd	2167	22	transplantation	transplantation	NN
cord-015365-iqdi99pd	2167	23	.	.	.
cord-015365-iqdi99pd	2168	1	EPP	EPP	NNP
cord-015365-iqdi99pd	2168	2	had	have	VBD
cord-015365-iqdi99pd	2168	3	been	be	VBN
cord-015365-iqdi99pd	2168	4	diagnosed	diagnose	VBN
cord-015365-iqdi99pd	2168	5	32	32	CD
cord-015365-iqdi99pd	2168	6	years	year	NNS
cord-015365-iqdi99pd	2168	7	ago	ago	RB
cord-015365-iqdi99pd	2168	8	.	.	.
cord-015365-iqdi99pd	2169	1	The	the	DT
cord-015365-iqdi99pd	2169	2	patient	patient	NN
cord-015365-iqdi99pd	2169	3	suffered	suffer	VBD
cord-015365-iqdi99pd	2169	4	from	from	IN
cord-015365-iqdi99pd	2169	5	typical	typical	JJ
cord-015365-iqdi99pd	2169	6	skin	skin	NN
cord-015365-iqdi99pd	2169	7	changes	change	NNS
cord-015365-iqdi99pd	2169	8	and	and	CC
cord-015365-iqdi99pd	2169	9	cholestatic	cholestatic	JJ
cord-015365-iqdi99pd	2169	10	liver	liver	NN
cord-015365-iqdi99pd	2169	11	cirrhosis	cirrhosis	NN
cord-015365-iqdi99pd	2169	12	had	have	VBD
cord-015365-iqdi99pd	2169	13	been	be	VBN
cord-015365-iqdi99pd	2169	14	histologically	histologically	RB
cord-015365-iqdi99pd	2169	15	confirmed	confirm	VBN
cord-015365-iqdi99pd	2169	16	.	.	.
cord-015365-iqdi99pd	2170	1	OLT	OLT	NNP
cord-015365-iqdi99pd	2170	2	was	be	VBD
cord-015365-iqdi99pd	2170	3	performed	perform	VBN
cord-015365-iqdi99pd	2170	4	successfully	successfully	RB
cord-015365-iqdi99pd	2170	5	using	use	VBG
cord-015365-iqdi99pd	2170	6	protective	protective	JJ
cord-015365-iqdi99pd	2170	7	measures	measure	NNS
cord-015365-iqdi99pd	2170	8	to	to	TO
cord-015365-iqdi99pd	2170	9	prevent	prevent	VB
cord-015365-iqdi99pd	2170	10	phototoxic	phototoxic	JJ
cord-015365-iqdi99pd	2170	11	injury	injury	NN
cord-015365-iqdi99pd	2170	12	to	to	IN
cord-015365-iqdi99pd	2170	13	the	the	DT
cord-015365-iqdi99pd	2170	14	abdominal	abdominal	JJ
cord-015365-iqdi99pd	2170	15	organs	organ	NNS
cord-015365-iqdi99pd	2170	16	.	.	.
cord-015365-iqdi99pd	2171	1	A	a	DT
cord-015365-iqdi99pd	2171	2	flexible	flexible	JJ
cord-015365-iqdi99pd	2171	3	yellow	yellow	JJ
cord-015365-iqdi99pd	2171	4	filter	filter	NN
cord-015365-iqdi99pd	2171	5	omitting	omit	VBG
cord-015365-iqdi99pd	2171	6	wavelengths	wavelength	NNS
cord-015365-iqdi99pd	2171	7	below	below	IN
cord-015365-iqdi99pd	2171	8	470	470	CD
cord-015365-iqdi99pd	2171	9	nm	nm	NN
cord-015365-iqdi99pd	2171	10	was	be	VBD
cord-015365-iqdi99pd	2171	11	applied	apply	VBN
cord-015365-iqdi99pd	2171	12	to	to	IN
cord-015365-iqdi99pd	2171	13	operating	operate	VBG
cord-015365-iqdi99pd	2171	14	room	room	NN
cord-015365-iqdi99pd	2171	15	luminaires	luminaire	NNS
cord-015365-iqdi99pd	2171	16	to	to	TO
cord-015365-iqdi99pd	2171	17	avoid	avoid	VB
cord-015365-iqdi99pd	2171	18	phototoxic	phototoxic	JJ
cord-015365-iqdi99pd	2171	19	injury	injury	NN
cord-015365-iqdi99pd	2171	20	while	while	IN
cord-015365-iqdi99pd	2171	21	maintaining	maintain	VBG
cord-015365-iqdi99pd	2171	22	visual	visual	JJ
cord-015365-iqdi99pd	2171	23	colour	colour	NN
cord-015365-iqdi99pd	2171	24	perception	perception	NN
cord-015365-iqdi99pd	2171	25	of	of	IN
cord-015365-iqdi99pd	2171	26	the	the	DT
cord-015365-iqdi99pd	2171	27	surgeons	surgeon	NNS
cord-015365-iqdi99pd	2171	28	.	.	.
cord-015365-iqdi99pd	2172	1	The	the	DT
cord-015365-iqdi99pd	2172	2	immediate	immediate	JJ
cord-015365-iqdi99pd	2172	3	postoperative	postoperative	JJ
cord-015365-iqdi99pd	2172	4	period	period	NN
cord-015365-iqdi99pd	2172	5	was	be	VBD
cord-015365-iqdi99pd	2172	6	without	without	IN
cord-015365-iqdi99pd	2172	7	any	any	DT
cord-015365-iqdi99pd	2172	8	complications	complication	NNS
cord-015365-iqdi99pd	2172	9	related	relate	VBN
cord-015365-iqdi99pd	2172	10	to	to	IN
cord-015365-iqdi99pd	2172	11	the	the	DT
cord-015365-iqdi99pd	2172	12	EPP	EPP	NNP
cord-015365-iqdi99pd	2172	13	.	.	.
cord-015365-iqdi99pd	2173	1	Seven	seven	CD
cord-015365-iqdi99pd	2173	2	months	month	NNS
cord-015365-iqdi99pd	2173	3	after	after	IN
cord-015365-iqdi99pd	2173	4	transplantation	transplantation	NN
cord-015365-iqdi99pd	2173	5	the	the	DT
cord-015365-iqdi99pd	2173	6	patient	patient	NN
cord-015365-iqdi99pd	2173	7	is	be	VBZ
cord-015365-iqdi99pd	2173	8	in	in	IN
cord-015365-iqdi99pd	2173	9	good	good	JJ
cord-015365-iqdi99pd	2173	10	general	general	JJ
cord-015365-iqdi99pd	2173	11	health	health	NN
cord-015365-iqdi99pd	2173	12	and	and	CC
cord-015365-iqdi99pd	2173	13	liver	liver	NN
cord-015365-iqdi99pd	2173	14	function	function	NN
cord-015365-iqdi99pd	2173	15	tests	test	NNS
cord-015365-iqdi99pd	2173	16	show	show	VBP
cord-015365-iqdi99pd	2173	17	good	good	JJ
cord-015365-iqdi99pd	2173	18	results	result	NNS
cord-015365-iqdi99pd	2173	19	.	.	.
cord-015365-iqdi99pd	2174	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2174	2	.	.	.
cord-015365-iqdi99pd	2175	1	OLT	OLT	NNP
cord-015365-iqdi99pd	2175	2	is	be	VBZ
cord-015365-iqdi99pd	2175	3	a	a	DT
cord-015365-iqdi99pd	2175	4	suitable	suitable	JJ
cord-015365-iqdi99pd	2175	5	treatment	treatment	NN
cord-015365-iqdi99pd	2175	6	for	for	IN
cord-015365-iqdi99pd	2175	7	patients	patient	NNS
cord-015365-iqdi99pd	2175	8	suffering	suffer	VBG
cord-015365-iqdi99pd	2175	9	from	from	IN
cord-015365-iqdi99pd	2175	10	EPP	EPP	NNP
cord-015365-iqdi99pd	2175	11	with	with	IN
cord-015365-iqdi99pd	2175	12	hepatic	hepatic	JJ
cord-015365-iqdi99pd	2175	13	involvement	involvement	NN
cord-015365-iqdi99pd	2175	14	and	and	CC
cord-015365-iqdi99pd	2175	15	cholestatic	cholestatic	JJ
cord-015365-iqdi99pd	2175	16	cirrhosis	cirrhosis	NN
cord-015365-iqdi99pd	2175	17	if	if	IN
cord-015365-iqdi99pd	2175	18	protective	protective	JJ
cord-015365-iqdi99pd	2175	19	measures	measure	NNS
cord-015365-iqdi99pd	2175	20	against	against	IN
cord-015365-iqdi99pd	2175	21	phototoxic	phototoxic	JJ
cord-015365-iqdi99pd	2175	22	injuries	injury	NNS
cord-015365-iqdi99pd	2175	23	are	be	VBP
cord-015365-iqdi99pd	2175	24	used	use	VBN
cord-015365-iqdi99pd	2175	25	during	during	IN
cord-015365-iqdi99pd	2175	26	surgery	surgery	NN
cord-015365-iqdi99pd	2175	27	.	.	.
cord-015365-iqdi99pd	2176	1	Günstige	Günstige	NNP
cord-015365-iqdi99pd	2176	2	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2176	3	nach	nach	NNP
cord-015365-iqdi99pd	2176	4	schweren	schweren	NNP
cord-015365-iqdi99pd	2176	5	immunologischen	immunologischen	NNP
cord-015365-iqdi99pd	2176	6	und	und	NNP
cord-015365-iqdi99pd	2176	7	infektiösen	infektiösen	NNP
cord-015365-iqdi99pd	2177	1	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	2177	2	nach	nach	NNP
cord-015365-iqdi99pd	2177	3	Dünndarm	Dünndarm	NNP
cord-015365-iqdi99pd	2177	4	-	-	HYPH
cord-015365-iqdi99pd	2177	5	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	2177	6	:	:	:
cord-015365-iqdi99pd	2177	7	ein	ein	NNP
cord-015365-iqdi99pd	2177	8	Fallbericht	Fallbericht	NNP
cord-015365-iqdi99pd	2177	9	C.	C.	NNP
cord-015365-iqdi99pd	2177	10	Bösmüller	Bösmüller	NNP
cord-015365-iqdi99pd	2177	11	1	1	CD
cord-015365-iqdi99pd	2177	12	,	,	,
cord-015365-iqdi99pd	2177	13	A.	A.	NNP
cord-015365-iqdi99pd	2177	14	Weißenbacher	Weißenbacher	NNP
cord-015365-iqdi99pd	2177	15	1	1	CD
cord-015365-iqdi99pd	2177	16	,	,	,
cord-015365-iqdi99pd	2177	17	M.	M.	NNP
cord-015365-iqdi99pd	2177	18	Biebl	Biebl	NNP
cord-015365-iqdi99pd	2177	19	1	1	CD
cord-015365-iqdi99pd	2177	20	,	,	,
cord-015365-iqdi99pd	2177	21	R.	R.	NNP
cord-015365-iqdi99pd	2177	22	Öllinger	Öllinger	NNP
cord-015365-iqdi99pd	2177	23	1	1	CD
cord-015365-iqdi99pd	2177	24	,	,	,
cord-015365-iqdi99pd	2177	25	S.	S.	NNP
cord-015365-iqdi99pd	2177	26	Schneeberger	Schneeberger	NNP
cord-015365-iqdi99pd	2177	27	1	1	CD
cord-015365-iqdi99pd	2177	28	,	,	,
cord-015365-iqdi99pd	2177	29	F.	F.	NNP
cord-015365-iqdi99pd	2177	30	Aigner	Aigner	NNP
cord-015365-iqdi99pd	2177	31	1	1	CD
cord-015365-iqdi99pd	2178	1	,	,	,
cord-015365-iqdi99pd	2178	2	S.	S.	NNP
cord-015365-iqdi99pd	2178	3	Weiß	Weiß	NNP
cord-015365-iqdi99pd	2178	4	1	1	CD
cord-015365-iqdi99pd	2178	5	,	,	,
cord-015365-iqdi99pd	2178	6	R.	R.	NNP
cord-015365-iqdi99pd	2178	7	Oberhuber	Oberhuber	NNP
cord-015365-iqdi99pd	2178	8	1	1	CD
cord-015365-iqdi99pd	2178	9	,	,	,
cord-015365-iqdi99pd	2178	10	C.	C.	NNP
cord-015365-iqdi99pd	2178	11	Ensinger	Ensinger	NNP
cord-015365-iqdi99pd	2178	12	2	2	CD
cord-015365-iqdi99pd	2178	13	,	,	,
cord-015365-iqdi99pd	2178	14	J.	J.	NNP
cord-015365-iqdi99pd	2178	15	Pratschke	Pratschke	NNP
cord-015365-iqdi99pd	2178	16	1	1	CD
cord-015365-iqdi99pd	2178	17	uneventful	uneventful	JJ
cord-015365-iqdi99pd	2178	18	course	course	NN
cord-015365-iqdi99pd	2178	19	after	after	IN
cord-015365-iqdi99pd	2178	20	transplantation	transplantation	NN
cord-015365-iqdi99pd	2178	21	with	with	IN
cord-015365-iqdi99pd	2178	22	only	only	RB
cord-015365-iqdi99pd	2178	23	three	three	CD
cord-015365-iqdi99pd	2178	24	mild	mild	JJ
cord-015365-iqdi99pd	2178	25	acute	acute	JJ
cord-015365-iqdi99pd	2178	26	rejection	rejection	NN
cord-015365-iqdi99pd	2178	27	episodes	episode	NNS
cord-015365-iqdi99pd	2178	28	within	within	IN
cord-015365-iqdi99pd	2178	29	11	11	CD
cord-015365-iqdi99pd	2178	30	years	year	NNS
cord-015365-iqdi99pd	2178	31	.	.	.
cord-015365-iqdi99pd	2179	1	Due	due	IN
cord-015365-iqdi99pd	2179	2	to	to	IN
cord-015365-iqdi99pd	2179	3	a	a	DT
cord-015365-iqdi99pd	2179	4	fracture	fracture	NN
cord-015365-iqdi99pd	2179	5	of	of	IN
cord-015365-iqdi99pd	2179	6	the	the	DT
cord-015365-iqdi99pd	2179	7	right	right	JJ
cord-015365-iqdi99pd	2179	8	allograft	allograft	NN
cord-015365-iqdi99pd	2179	9	radius	radius	NN
cord-015365-iqdi99pd	2179	10	requiring	require	VBG
cord-015365-iqdi99pd	2179	11	surgery	surgery	NN
cord-015365-iqdi99pd	2179	12	at	at	IN
cord-015365-iqdi99pd	2179	13	10.5	10.5	CD
cord-015365-iqdi99pd	2179	14	years	year	NNS
cord-015365-iqdi99pd	2179	15	posttransplant	posttransplant	NN
cord-015365-iqdi99pd	2179	16	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	2179	17	(	(	-LRB-
cord-015365-iqdi99pd	2179	18	IS	is	NN
cord-015365-iqdi99pd	2179	19	)	)	-RRB-
cord-015365-iqdi99pd	2179	20	was	be	VBD
cord-015365-iqdi99pd	2179	21	switched	switch	VBN
cord-015365-iqdi99pd	2179	22	from	from	IN
cord-015365-iqdi99pd	2179	23	sirolimusmonotherapy	sirolimusmonotherapy	NNP
cord-015365-iqdi99pd	2179	24	to	to	IN
cord-015365-iqdi99pd	2179	25	prednisone	prednisone	NNP
cord-015365-iqdi99pd	2179	26	.	.	.
cord-015365-iqdi99pd	2180	1	One	one	CD
cord-015365-iqdi99pd	2180	2	month	month	NN
cord-015365-iqdi99pd	2180	3	thereafter	thereafter	RB
cord-015365-iqdi99pd	2180	4	the	the	DT
cord-015365-iqdi99pd	2180	5	patient	patient	NN
cord-015365-iqdi99pd	2180	6	experienced	experience	VBD
cord-015365-iqdi99pd	2180	7	metabolic	metabolic	JJ
cord-015365-iqdi99pd	2180	8	deterioration	deterioration	NN
cord-015365-iqdi99pd	2180	9	(	(	-LRB-
cord-015365-iqdi99pd	2180	10	hypothyroidism	hypothyroidism	NN
cord-015365-iqdi99pd	2180	11	,	,	,
cord-015365-iqdi99pd	2180	12	hyperlipidemia	hyperlipidemia	NN
cord-015365-iqdi99pd	2180	13	and	and	CC
cord-015365-iqdi99pd	2180	14	hyperglycemia	hyperglycemia	NN
cord-015365-iqdi99pd	2180	15	)	)	-RRB-
cord-015365-iqdi99pd	2180	16	and	and	CC
cord-015365-iqdi99pd	2180	17	developed	develop	VBD
cord-015365-iqdi99pd	2180	18	an	an	DT
cord-015365-iqdi99pd	2180	19	exanthema	exanthema	NN
cord-015365-iqdi99pd	2180	20	and	and	CC
cord-015365-iqdi99pd	2180	21	pruritus	pruritus	NN
cord-015365-iqdi99pd	2180	22	on	on	IN
cord-015365-iqdi99pd	2180	23	the	the	DT
cord-015365-iqdi99pd	2180	24	trunk	trunk	NN
cord-015365-iqdi99pd	2180	25	and	and	CC
cord-015365-iqdi99pd	2180	26	the	the	DT
cord-015365-iqdi99pd	2180	27	upper	upper	JJ
cord-015365-iqdi99pd	2180	28	extremities	extremity	NNS
cord-015365-iqdi99pd	2180	29	,	,	,
cord-015365-iqdi99pd	2180	30	including	include	VBG
cord-015365-iqdi99pd	2180	31	both	both	CC
cord-015365-iqdi99pd	2180	32	the	the	DT
cord-015365-iqdi99pd	2180	33	recipient	recipient	NN
cord-015365-iqdi99pd	2180	34	's	's	POS
cord-015365-iqdi99pd	2180	35	own	own	JJ
cord-015365-iqdi99pd	2180	36	skin	skin	NN
cord-015365-iqdi99pd	2180	37	and	and	CC
cord-015365-iqdi99pd	2180	38	the	the	DT
cord-015365-iqdi99pd	2180	39	allograft	allograft	NN
cord-015365-iqdi99pd	2180	40	skin	skin	NN
cord-015365-iqdi99pd	2180	41	.	.	.
cord-015365-iqdi99pd	2181	1	BP	BP	NNP
cord-015365-iqdi99pd	2181	2	was	be	VBD
cord-015365-iqdi99pd	2181	3	diagnosed	diagnose	VBN
cord-015365-iqdi99pd	2181	4	upon	upon	IN
cord-015365-iqdi99pd	2181	5	direct	direct	JJ
cord-015365-iqdi99pd	2181	6	immunofluorescence	immunofluorescence	NN
cord-015365-iqdi99pd	2181	7	of	of	IN
cord-015365-iqdi99pd	2181	8	skin	skin	NN
cord-015365-iqdi99pd	2181	9	biopsies	biopsy	NNS
cord-015365-iqdi99pd	2181	10	(	(	-LRB-
cord-015365-iqdi99pd	2181	11	linear	linear	NNP
cord-015365-iqdi99pd	2181	12	C3	C3	NNP
cord-015365-iqdi99pd	2181	13	and	and	CC
cord-015365-iqdi99pd	2181	14	IgG	igg	NN
cord-015365-iqdi99pd	2181	15	deposits	deposit	NNS
cord-015365-iqdi99pd	2181	16	along	along	IN
cord-015365-iqdi99pd	2181	17	the	the	DT
cord-015365-iqdi99pd	2181	18	basement	basement	NN
cord-015365-iqdi99pd	2181	19	membrane	membrane	NN
cord-015365-iqdi99pd	2181	20	zone	zone	NN
cord-015365-iqdi99pd	2181	21	)	)	-RRB-
cord-015365-iqdi99pd	2181	22	and	and	CC
cord-015365-iqdi99pd	2181	23	detection	detection	NN
cord-015365-iqdi99pd	2181	24	of	of	IN
cord-015365-iqdi99pd	2181	25	serum	serum	NN
cord-015365-iqdi99pd	2181	26	autoantibodies	autoantibody	NNS
cord-015365-iqdi99pd	2181	27	against	against	IN
cord-015365-iqdi99pd	2181	28	the	the	DT
cord-015365-iqdi99pd	2181	29	BP	BP	NNP
cord-015365-iqdi99pd	2181	30	antigen	antigen	NN
cord-015365-iqdi99pd	2181	31	2	2	CD
cord-015365-iqdi99pd	2182	1	(	(	-LRB-
cord-015365-iqdi99pd	2182	2	BP180nc16a	bp180nc16a	NN
cord-015365-iqdi99pd	2182	3	:	:	:
cord-015365-iqdi99pd	2182	4	142	142	CD
cord-015365-iqdi99pd	2182	5	U	u	NN
cord-015365-iqdi99pd	2182	6	/	/	SYM
cord-015365-iqdi99pd	2182	7	l	l	NN
cord-015365-iqdi99pd	2182	8	)	)	-RRB-
cord-015365-iqdi99pd	2182	9	.	.	.
cord-015365-iqdi99pd	2183	1	Histology	histology	NN
cord-015365-iqdi99pd	2183	2	showed	show	VBD
cord-015365-iqdi99pd	2183	3	a	a	DT
cord-015365-iqdi99pd	2183	4	partial	partial	JJ
cord-015365-iqdi99pd	2183	5	separation	separation	NN
cord-015365-iqdi99pd	2183	6	along	along	IN
cord-015365-iqdi99pd	2183	7	the	the	DT
cord-015365-iqdi99pd	2183	8	dermalepidermal	dermalepidermal	JJ
cord-015365-iqdi99pd	2183	9	junction	junction	NN
cord-015365-iqdi99pd	2183	10	and	and	CC
cord-015365-iqdi99pd	2183	11	a	a	DT
cord-015365-iqdi99pd	2183	12	mild	mild	JJ
cord-015365-iqdi99pd	2183	13	perivascular	perivascular	JJ
cord-015365-iqdi99pd	2183	14	infiltration	infiltration	NN
cord-015365-iqdi99pd	2183	15	consisting	consist	VBG
cord-015365-iqdi99pd	2183	16	of	of	IN
cord-015365-iqdi99pd	2183	17	lymphocytes	lymphocyte	NNS
cord-015365-iqdi99pd	2183	18	,	,	,
cord-015365-iqdi99pd	2183	19	eosinophils	eosinophil	NNS
cord-015365-iqdi99pd	2183	20	and	and	CC
cord-015365-iqdi99pd	2183	21	granulocytes	granulocyte	NNS
cord-015365-iqdi99pd	2183	22	.	.	.
cord-015365-iqdi99pd	2184	1	Cell	cell	NN
cord-015365-iqdi99pd	2184	2	counts	count	NNS
cord-015365-iqdi99pd	2184	3	were	be	VBD
cord-015365-iqdi99pd	2184	4	within	within	IN
cord-015365-iqdi99pd	2184	5	normal	normal	JJ
cord-015365-iqdi99pd	2184	6	range	range	NN
cord-015365-iqdi99pd	2184	7	.	.	.
cord-015365-iqdi99pd	2185	1	No	no	DT
cord-015365-iqdi99pd	2185	2	donor	donor	NN
cord-015365-iqdi99pd	2185	3	specific	specific	JJ
cord-015365-iqdi99pd	2185	4	antibodies	antibody	NNS
cord-015365-iqdi99pd	2185	5	were	be	VBD
cord-015365-iqdi99pd	2185	6	detected	detect	VBN
cord-015365-iqdi99pd	2185	7	.	.	.
cord-015365-iqdi99pd	2186	1	Skin	skin	NN
cord-015365-iqdi99pd	2186	2	lesions	lesion	NNS
cord-015365-iqdi99pd	2186	3	disappeared	disappear	VBD
cord-015365-iqdi99pd	2186	4	under	under	IN
cord-015365-iqdi99pd	2186	5	intensified	intensify	VBN
cord-015365-iqdi99pd	2186	6	therapy	therapy	NN
cord-015365-iqdi99pd	2186	7	with	with	IN
cord-015365-iqdi99pd	2186	8	prednisone	prednisone	NNP
cord-015365-iqdi99pd	2186	9	.	.	.
cord-015365-iqdi99pd	2187	1	While	while	IN
cord-015365-iqdi99pd	2187	2	conversion	conversion	NN
cord-015365-iqdi99pd	2187	3	of	of	IN
cord-015365-iqdi99pd	2187	4	IS	is	NN
cord-015365-iqdi99pd	2187	5	and	and	CC
cord-015365-iqdi99pd	2187	6	metabolic	metabolic	JJ
cord-015365-iqdi99pd	2187	7	deterioration	deterioration	NN
cord-015365-iqdi99pd	2187	8	might	may	MD
cord-015365-iqdi99pd	2187	9	have	have	VB
cord-015365-iqdi99pd	2187	10	contributed	contribute	VBN
cord-015365-iqdi99pd	2187	11	to	to	IN
cord-015365-iqdi99pd	2187	12	development	development	NN
cord-015365-iqdi99pd	2187	13	of	of	IN
cord-015365-iqdi99pd	2187	14	BP	BP	NNP
cord-015365-iqdi99pd	2187	15	after	after	IN
cord-015365-iqdi99pd	2187	16	hand	hand	NN
cord-015365-iqdi99pd	2187	17	transplantation	transplantation	NN
cord-015365-iqdi99pd	2187	18	,	,	,
cord-015365-iqdi99pd	2187	19	the	the	DT
cord-015365-iqdi99pd	2187	20	pathomechanism	pathomechanism	NN
cord-015365-iqdi99pd	2187	21	remains	remain	VBZ
cord-015365-iqdi99pd	2187	22	unclear	unclear	JJ
cord-015365-iqdi99pd	2187	23	.	.	.
cord-015365-iqdi99pd	2188	1	Belatacept	belatacept	NN
cord-015365-iqdi99pd	2188	2	treatment	treatment	NN
cord-015365-iqdi99pd	2188	3	for	for	IN
cord-015365-iqdi99pd	2188	4	2	2	CD
cord-015365-iqdi99pd	2188	5	years	year	NNS
cord-015365-iqdi99pd	2188	6	after	after	IN
cord-015365-iqdi99pd	2188	7	liver	liver	NN
cord-015365-iqdi99pd	2188	8	transplantation	transplantation	NN
cord-015365-iqdi99pd	2188	9	is	be	VBZ
cord-015365-iqdi99pd	2188	10	not	not	RB
cord-015365-iqdi99pd	2188	11	associated	associate	VBN
cord-015365-iqdi99pd	2188	12	with	with	IN
cord-015365-iqdi99pd	2188	13	overt	overt	JJ
cord-015365-iqdi99pd	2188	14	immunomodulation	immunomodulation	NN
cord-015365-iqdi99pd	2188	15	Background	Background	NNP
cord-015365-iqdi99pd	2188	16	.	.	.
cord-015365-iqdi99pd	2189	1	Belatacept	Belatacept	NNP
cord-015365-iqdi99pd	2189	2	is	be	VBZ
cord-015365-iqdi99pd	2189	3	a	a	DT
cord-015365-iqdi99pd	2189	4	costimulation	costimulation	NN
cord-015365-iqdi99pd	2189	5	blocker	blocker	NN
cord-015365-iqdi99pd	2189	6	with	with	IN
cord-015365-iqdi99pd	2189	7	immunomodulatory	immunomodulatory	JJ
cord-015365-iqdi99pd	2189	8	properties	property	NNS
cord-015365-iqdi99pd	2189	9	in	in	IN
cord-015365-iqdi99pd	2189	10	the	the	DT
cord-015365-iqdi99pd	2189	11	experimental	experimental	JJ
cord-015365-iqdi99pd	2189	12	setting	setting	NN
cord-015365-iqdi99pd	2189	13	.	.	.
cord-015365-iqdi99pd	2190	1	Moreover	moreover	RB
cord-015365-iqdi99pd	2190	2	,	,	,
cord-015365-iqdi99pd	2190	3	the	the	DT
cord-015365-iqdi99pd	2190	4	liver	liver	NN
cord-015365-iqdi99pd	2190	5	graft	graft	NN
cord-015365-iqdi99pd	2190	6	itself	-PRON-	PRP
cord-015365-iqdi99pd	2190	7	has	have	VBZ
cord-015365-iqdi99pd	2190	8	been	be	VBN
cord-015365-iqdi99pd	2190	9	claimed	claim	VBN
cord-015365-iqdi99pd	2190	10	to	to	TO
cord-015365-iqdi99pd	2190	11	have	have	VB
cord-015365-iqdi99pd	2190	12	'	'	``
cord-015365-iqdi99pd	2190	13	tolerogenic	tolerogenic	JJ
cord-015365-iqdi99pd	2190	14	'	'	''
cord-015365-iqdi99pd	2190	15	properties	property	NNS
cord-015365-iqdi99pd	2190	16	.	.	.
cord-015365-iqdi99pd	2191	1	The	the	DT
cord-015365-iqdi99pd	2191	2	belatacept	belatacept	NN
cord-015365-iqdi99pd	2191	3	multi	multi	JJ
cord-015365-iqdi99pd	2191	4	-	-	JJ
cord-015365-iqdi99pd	2191	5	center	center	JJ
cord-015365-iqdi99pd	2191	6	phase	phase	NN
cord-015365-iqdi99pd	2191	7	II	ii	CD
cord-015365-iqdi99pd	2191	8	liver	liver	NN
cord-015365-iqdi99pd	2191	9	transplantation	transplantation	NN
cord-015365-iqdi99pd	2191	10	trial	trial	NN
cord-015365-iqdi99pd	2191	11	was	be	VBD
cord-015365-iqdi99pd	2191	12	terminated	terminate	VBN
cord-015365-iqdi99pd	2191	13	during	during	IN
cord-015365-iqdi99pd	2191	14	the	the	DT
cord-015365-iqdi99pd	2191	15	long	long	JJ
cord-015365-iqdi99pd	2191	16	-	-	HYPH
cord-015365-iqdi99pd	2191	17	term	term	NN
cord-015365-iqdi99pd	2191	18	extension	extension	NN
cord-015365-iqdi99pd	2191	19	period	period	NN
cord-015365-iqdi99pd	2191	20	on	on	IN
cord-015365-iqdi99pd	2191	21	the	the	DT
cord-015365-iqdi99pd	2191	22	recommendation	recommendation	NN
cord-015365-iqdi99pd	2191	23	of	of	IN
cord-015365-iqdi99pd	2191	24	the	the	DT
cord-015365-iqdi99pd	2191	25	Data	Data	NNP
cord-015365-iqdi99pd	2191	26	Monitoring	Monitoring	NNP
cord-015365-iqdi99pd	2191	27	Committee	Committee	NNP
cord-015365-iqdi99pd	2191	28	.	.	.
cord-015365-iqdi99pd	2192	1	This	this	DT
cord-015365-iqdi99pd	2192	2	situation	situation	NN
cord-015365-iqdi99pd	2192	3	gave	give	VBD
cord-015365-iqdi99pd	2192	4	us	-PRON-	PRP
cord-015365-iqdi99pd	2192	5	the	the	DT
cord-015365-iqdi99pd	2192	6	unique	unique	JJ
cord-015365-iqdi99pd	2192	7	opportunity	opportunity	NN
cord-015365-iqdi99pd	2192	8	to	to	TO
cord-015365-iqdi99pd	2192	9	evaluate	evaluate	VB
cord-015365-iqdi99pd	2192	10	the	the	DT
cord-015365-iqdi99pd	2192	11	minimum	minimum	JJ
cord-015365-iqdi99pd	2192	12	immunosuppression	immunosuppression	NN
cord-015365-iqdi99pd	2192	13	required	require	VBN
cord-015365-iqdi99pd	2192	14	in	in	IN
cord-015365-iqdi99pd	2192	15	liver	liver	NN
cord-015365-iqdi99pd	2192	16	transplant	transplant	NN
cord-015365-iqdi99pd	2192	17	recipients	recipient	NNS
cord-015365-iqdi99pd	2192	18	after	after	IN
cord-015365-iqdi99pd	2192	19	>	>	XX
cord-015365-iqdi99pd	2192	20	2	2	CD
cord-015365-iqdi99pd	2192	21	years	year	NNS
cord-015365-iqdi99pd	2192	22	of	of	IN
cord-015365-iqdi99pd	2192	23	treatment	treatment	NN
cord-015365-iqdi99pd	2192	24	with	with	IN
cord-015365-iqdi99pd	2192	25	belatacept	belatacept	NN
cord-015365-iqdi99pd	2192	26	.	.	.
cord-015365-iqdi99pd	2193	1	Methods	method	NNS
cord-015365-iqdi99pd	2193	2	.	.	.
cord-015365-iqdi99pd	2194	1	In	in	IN
cord-015365-iqdi99pd	2194	2	our	-PRON-	PRP$
cord-015365-iqdi99pd	2194	3	center	center	NN
cord-015365-iqdi99pd	2194	4	all	all	DT
cord-015365-iqdi99pd	2194	5	belatacept	belatacept	NN
cord-015365-iqdi99pd	2194	6	patients	patient	NNS
cord-015365-iqdi99pd	2194	7	(	(	-LRB-
cord-015365-iqdi99pd	2194	8	n	n	CC
cord-015365-iqdi99pd	2194	9	¼	¼	NNP
cord-015365-iqdi99pd	2194	10	4	4	CD
cord-015365-iqdi99pd	2194	11	)	)	-RRB-
cord-015365-iqdi99pd	2194	12	were	be	VBD
cord-015365-iqdi99pd	2194	13	switched	switch	VBN
cord-015365-iqdi99pd	2194	14	to	to	IN
cord-015365-iqdi99pd	2194	15	MMF	MMF	NNP
cord-015365-iqdi99pd	2194	16	monotherapy	monotherapy	JJ
cord-015365-iqdi99pd	2195	1	(	(	-LRB-
cord-015365-iqdi99pd	2195	2	2Â1	2â1	CD
cord-015365-iqdi99pd	2195	3	g	g	NN
cord-015365-iqdi99pd	2195	4	/	/	SYM
cord-015365-iqdi99pd	2195	5	day	day	NN
cord-015365-iqdi99pd	2195	6	)	)	-RRB-
cord-015365-iqdi99pd	2195	7	after	after	IN
cord-015365-iqdi99pd	2195	8	discontinuation	discontinuation	NN
cord-015365-iqdi99pd	2195	9	of	of	IN
cord-015365-iqdi99pd	2195	10	belatacept	belatacept	NN
cord-015365-iqdi99pd	2195	11	.	.	.
cord-015365-iqdi99pd	2196	1	We	-PRON-	PRP
cord-015365-iqdi99pd	2196	2	prospectively	prospectively	RB
cord-015365-iqdi99pd	2196	3	assessed	assess	VBD
cord-015365-iqdi99pd	2196	4	the	the	DT
cord-015365-iqdi99pd	2196	5	occurrence	occurrence	NN
cord-015365-iqdi99pd	2196	6	of	of	IN
cord-015365-iqdi99pd	2196	7	acute	acute	JJ
cord-015365-iqdi99pd	2196	8	rejection	rejection	NN
cord-015365-iqdi99pd	2196	9	and	and	CC
cord-015365-iqdi99pd	2196	10	evaluated	evaluate	VBN
cord-015365-iqdi99pd	2196	11	kidney	kidney	NN
cord-015365-iqdi99pd	2196	12	function	function	NN
cord-015365-iqdi99pd	2196	13	(	(	-LRB-
cord-015365-iqdi99pd	2196	14	calculated	calculate	VBN
cord-015365-iqdi99pd	2196	15	GFR	GFR	NNP
cord-015365-iqdi99pd	2196	16	;	;	:
cord-015365-iqdi99pd	2196	17	MDRD	MDRD	NNP
cord-015365-iqdi99pd	2196	18	)	)	-RRB-
cord-015365-iqdi99pd	2196	19	over	over	IN
cord-015365-iqdi99pd	2196	20	time	time	NN
cord-015365-iqdi99pd	2196	21	in	in	IN
cord-015365-iqdi99pd	2196	22	comparison	comparison	NN
cord-015365-iqdi99pd	2196	23	to	to	IN
cord-015365-iqdi99pd	2196	24	tacrolimus	tacrolimus	NN
cord-015365-iqdi99pd	2196	25	-	-	HYPH
cord-015365-iqdi99pd	2196	26	treated	treat	VBN
cord-015365-iqdi99pd	2196	27	patients	patient	NNS
cord-015365-iqdi99pd	2196	28	enrolled	enrol	VBN
cord-015365-iqdi99pd	2196	29	in	in	IN
cord-015365-iqdi99pd	2196	30	the	the	DT
cord-015365-iqdi99pd	2196	31	control	control	NN
cord-015365-iqdi99pd	2196	32	groups	group	NNS
cord-015365-iqdi99pd	2196	33	of	of	IN
cord-015365-iqdi99pd	2196	34	the	the	DT
cord-015365-iqdi99pd	2196	35	multi	multi	JJ
cord-015365-iqdi99pd	2196	36	-	-	JJ
cord-015365-iqdi99pd	2196	37	center	center	JJ
cord-015365-iqdi99pd	2196	38	trial	trial	NN
cord-015365-iqdi99pd	2196	39	(	(	-LRB-
cord-015365-iqdi99pd	2196	40	n	n	NN
cord-015365-iqdi99pd	2196	41	¼	¼	NNP
cord-015365-iqdi99pd	2196	42	4	4	CD
cord-015365-iqdi99pd	2196	43	)	)	-RRB-
cord-015365-iqdi99pd	2196	44	.	.	.
cord-015365-iqdi99pd	2197	1	Results	result	NNS
cord-015365-iqdi99pd	2197	2	.	.	.
cord-015365-iqdi99pd	2198	1	The	the	DT
cord-015365-iqdi99pd	2198	2	mean	mean	JJ
cord-015365-iqdi99pd	2198	3	period	period	NN
cord-015365-iqdi99pd	2198	4	from	from	IN
cord-015365-iqdi99pd	2198	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	2198	6	to	to	IN
cord-015365-iqdi99pd	2198	7	withdrawal	withdrawal	NN
cord-015365-iqdi99pd	2198	8	of	of	IN
cord-015365-iqdi99pd	2198	9	belatacept	belatacept	NN
cord-015365-iqdi99pd	2198	10	was	be	VBD
cord-015365-iqdi99pd	2198	11	30	30	CD
cord-015365-iqdi99pd	2198	12	months	month	NNS
cord-015365-iqdi99pd	2199	1	(	(	-LRB-
cord-015365-iqdi99pd	2199	2	range	range	VBP
cord-015365-iqdi99pd	2199	3	25	25	CD
cord-015365-iqdi99pd	2199	4	-	-	SYM
cord-015365-iqdi99pd	2199	5	35	35	CD
cord-015365-iqdi99pd	2199	6	)	)	-RRB-
cord-015365-iqdi99pd	2199	7	.	.	.
cord-015365-iqdi99pd	2200	1	GFR	GFR	NNP
cord-015365-iqdi99pd	2200	2	at	at	IN
cord-015365-iqdi99pd	2200	3	the	the	DT
cord-015365-iqdi99pd	2200	4	time	time	NN
cord-015365-iqdi99pd	2200	5	of	of	IN
cord-015365-iqdi99pd	2200	6	withdrawal	withdrawal	NN
cord-015365-iqdi99pd	2200	7	was	be	VBD
cord-015365-iqdi99pd	2200	8	more	more	JJR
cord-015365-iqdi99pd	2200	9	than	than	IN
cord-015365-iqdi99pd	2200	10	60	60	CD
cord-015365-iqdi99pd	2200	11	ml/	ml/	JJ
cord-015365-iqdi99pd	2201	1	min/1.73	min/1.73	NNP
cord-015365-iqdi99pd	2201	2	m	m	CD
cord-015365-iqdi99pd	2201	3	2	2	CD
cord-015365-iqdi99pd	2201	4	in	in	IN
cord-015365-iqdi99pd	2201	5	the	the	DT
cord-015365-iqdi99pd	2201	6	belatacept	belatacept	NN
cord-015365-iqdi99pd	2201	7	group	group	NN
cord-015365-iqdi99pd	2202	1	(	(	-LRB-
cord-015365-iqdi99pd	2202	2	4/4	4/4	CD
cord-015365-iqdi99pd	2202	3	;	;	:
cord-015365-iqdi99pd	2202	4	mean	mean	VB
cord-015365-iqdi99pd	2202	5	:	:	:
cord-015365-iqdi99pd	2202	6	101	101	CD
cord-015365-iqdi99pd	2202	7	ml	ml	XX
cord-015365-iqdi99pd	2202	8	[	[	-LRB-
cord-015365-iqdi99pd	2202	9	range	range	NN
cord-015365-iqdi99pd	2202	10	89	89	CD
cord-015365-iqdi99pd	2202	11	-	-	SYM
cord-015365-iqdi99pd	2202	12	114	114	CD
cord-015365-iqdi99pd	2202	13	]	]	-RRB-
cord-015365-iqdi99pd	2202	14	)	)	-RRB-
cord-015365-iqdi99pd	2202	15	,	,	,
cord-015365-iqdi99pd	2202	16	whereas	whereas	IN
cord-015365-iqdi99pd	2202	17	3	3	CD
cord-015365-iqdi99pd	2202	18	out	out	IN
cord-015365-iqdi99pd	2202	19	of	of	IN
cord-015365-iqdi99pd	2202	20	4	4	CD
cord-015365-iqdi99pd	2202	21	patients	patient	NNS
cord-015365-iqdi99pd	2202	22	in	in	IN
cord-015365-iqdi99pd	2202	23	the	the	DT
cord-015365-iqdi99pd	2202	24	control	control	NN
cord-015365-iqdi99pd	2202	25	group	group	NN
cord-015365-iqdi99pd	2202	26	had	have	VBD
cord-015365-iqdi99pd	2202	27	a	a	DT
cord-015365-iqdi99pd	2202	28	GFR	GFR	NNP
cord-015365-iqdi99pd	2202	29	below	below	IN
cord-015365-iqdi99pd	2202	30	60	60	CD
cord-015365-iqdi99pd	2202	31	ml	ml	NNS
cord-015365-iqdi99pd	2202	32	/	/	SYM
cord-015365-iqdi99pd	2202	33	min/	min/	NN
cord-015365-iqdi99pd	2202	34	1.73	1.73	CD
cord-015365-iqdi99pd	2202	35	m	m	NN
cord-015365-iqdi99pd	2202	36	2	2	CD
cord-015365-iqdi99pd	2202	37	with	with	IN
cord-015365-iqdi99pd	2202	38	a	a	DT
cord-015365-iqdi99pd	2202	39	mean	mean	NN
cord-015365-iqdi99pd	2202	40	of	of	IN
cord-015365-iqdi99pd	2202	41	57.92	57.92	CD
cord-015365-iqdi99pd	2202	42	ml	ml	NN
cord-015365-iqdi99pd	2202	43	/	/	SYM
cord-015365-iqdi99pd	2202	44	min/1.73	min/1.73	JJ
cord-015365-iqdi99pd	2202	45	m	m	CD
cord-015365-iqdi99pd	2202	46	2	2	CD
cord-015365-iqdi99pd	2202	47	(	(	-LRB-
cord-015365-iqdi99pd	2202	48	range	range	VBP
cord-015365-iqdi99pd	2202	49	36	36	CD
cord-015365-iqdi99pd	2202	50	-	-	SYM
cord-015365-iqdi99pd	2202	51	98	98	CD
cord-015365-iqdi99pd	2202	52	)	)	-RRB-
cord-015365-iqdi99pd	2203	1	(	(	-LRB-
cord-015365-iqdi99pd	2203	2	p	p	NN
cord-015365-iqdi99pd	2203	3	¼	¼	CD
cord-015365-iqdi99pd	2203	4	0.026	0.026	CD
cord-015365-iqdi99pd	2203	5	)	)	-RRB-
cord-015365-iqdi99pd	2203	6	.	.	.
cord-015365-iqdi99pd	2204	1	Five	five	CD
cord-015365-iqdi99pd	2204	2	months	month	NNS
cord-015365-iqdi99pd	2204	3	after	after	IN
cord-015365-iqdi99pd	2204	4	belatacept	belatacept	NN
cord-015365-iqdi99pd	2204	5	discontinuation	discontinuation	NN
cord-015365-iqdi99pd	2204	6	kidney	kidney	NN
cord-015365-iqdi99pd	2204	7	function	function	NN
cord-015365-iqdi99pd	2204	8	declined	decline	VBD
cord-015365-iqdi99pd	2204	9	on	on	IN
cord-015365-iqdi99pd	2204	10	average	average	JJ
cord-015365-iqdi99pd	2204	11	by	by	IN
cord-015365-iqdi99pd	2204	12	19.22	19.22	CD
cord-015365-iqdi99pd	2204	13	ml	ml	NN
cord-015365-iqdi99pd	2204	14	(	(	-LRB-
cord-015365-iqdi99pd	2204	15	range	range	VB
cord-015365-iqdi99pd	2204	16	À45	À45	NNP
cord-015365-iqdi99pd	2204	17	to	to	IN
cord-015365-iqdi99pd	2204	18	þ3,5	þ3,5	NNP
cord-015365-iqdi99pd	2204	19	)	)	-RRB-
cord-015365-iqdi99pd	2204	20	(	(	-LRB-
cord-015365-iqdi99pd	2204	21	follow	follow	VB
cord-015365-iqdi99pd	2204	22	-	-	HYPH
cord-015365-iqdi99pd	2204	23	up	up	NN
cord-015365-iqdi99pd	2204	24	ongoing	ongoing	JJ
cord-015365-iqdi99pd	2204	25	)	)	-RRB-
cord-015365-iqdi99pd	2204	26	.	.	.
cord-015365-iqdi99pd	2205	1	After	after	IN
cord-015365-iqdi99pd	2205	2	belatacept	belatacept	NN
cord-015365-iqdi99pd	2205	3	withdrawal	withdrawal	NN
cord-015365-iqdi99pd	2205	4	all	all	DT
cord-015365-iqdi99pd	2205	5	4	4	CD
cord-015365-iqdi99pd	2205	6	patients	patient	NNS
cord-015365-iqdi99pd	2205	7	developed	develop	VBD
cord-015365-iqdi99pd	2205	8	3-fold	3-fold	CD
cord-015365-iqdi99pd	2205	9	elevated	elevated	JJ
cord-015365-iqdi99pd	2205	10	liver	liver	NN
cord-015365-iqdi99pd	2205	11	enzymes	enzyme	NNS
cord-015365-iqdi99pd	2205	12	(	(	-LRB-
cord-015365-iqdi99pd	2205	13	ASAT	ASAT	NNP
cord-015365-iqdi99pd	2205	14	,	,	,
cord-015365-iqdi99pd	2205	15	ALAT	ALAT	NNP
cord-015365-iqdi99pd	2205	16	)	)	-RRB-
cord-015365-iqdi99pd	2205	17	within	within	IN
cord-015365-iqdi99pd	2205	18	10.3	10.3	CD
cord-015365-iqdi99pd	2205	19	weeks	week	NNS
cord-015365-iqdi99pd	2205	20	after	after	IN
cord-015365-iqdi99pd	2205	21	EOT	EOT	NNP
cord-015365-iqdi99pd	2205	22	(	(	-LRB-
cord-015365-iqdi99pd	2205	23	7	7	CD
cord-015365-iqdi99pd	2205	24	-	-	SYM
cord-015365-iqdi99pd	2205	25	14	14	CD
cord-015365-iqdi99pd	2205	26	)	)	-RRB-
cord-015365-iqdi99pd	2206	1	(	(	-LRB-
cord-015365-iqdi99pd	2206	2	Biopsies	biopsy	NNS
cord-015365-iqdi99pd	2206	3	were	be	VBD
cord-015365-iqdi99pd	2206	4	not	not	RB
cord-015365-iqdi99pd	2206	5	performed	perform	VBN
cord-015365-iqdi99pd	2206	6	,	,	,
cord-015365-iqdi99pd	2206	7	mostly	mostly	RB
cord-015365-iqdi99pd	2206	8	due	due	JJ
cord-015365-iqdi99pd	2206	9	to	to	IN
cord-015365-iqdi99pd	2206	10	lack	lack	NN
cord-015365-iqdi99pd	2206	11	of	of	IN
cord-015365-iqdi99pd	2206	12	consent	consent	NN
cord-015365-iqdi99pd	2206	13	.	.	.
cord-015365-iqdi99pd	2206	14	)	)	-RRB-
cord-015365-iqdi99pd	2206	15	.	.	.
cord-015365-iqdi99pd	2207	1	Patients	patient	NNS
cord-015365-iqdi99pd	2207	2	were	be	VBD
cord-015365-iqdi99pd	2207	3	therefore	therefore	RB
cord-015365-iqdi99pd	2207	4	switched	switch	VBN
cord-015365-iqdi99pd	2207	5	to	to	IN
cord-015365-iqdi99pd	2207	6	triple	triple	JJ
cord-015365-iqdi99pd	2207	7	therapy	therapy	NN
cord-015365-iqdi99pd	2207	8	with	with	IN
cord-015365-iqdi99pd	2207	9	corticosteroids	corticosteroid	NNS
cord-015365-iqdi99pd	2207	10	,	,	,
cord-015365-iqdi99pd	2207	11	CNIs	cni	NNS
cord-015365-iqdi99pd	2207	12	and	and	CC
cord-015365-iqdi99pd	2207	13	MMF	mmf	NN
cord-015365-iqdi99pd	2207	14	.	.	.
cord-015365-iqdi99pd	2208	1	Graft	graft	NN
cord-015365-iqdi99pd	2208	2	dysfunction	dysfunction	NN
cord-015365-iqdi99pd	2208	3	resolved	resolve	VBD
cord-015365-iqdi99pd	2208	4	within	within	IN
cord-015365-iqdi99pd	2208	5	one	one	CD
cord-015365-iqdi99pd	2208	6	to	to	TO
cord-015365-iqdi99pd	2208	7	three	three	CD
cord-015365-iqdi99pd	2208	8	weeks	week	NNS
cord-015365-iqdi99pd	2208	9	after	after	IN
cord-015365-iqdi99pd	2208	10	switch	switch	NN
cord-015365-iqdi99pd	2208	11	.	.	.
cord-015365-iqdi99pd	2209	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2209	2	.	.	.
cord-015365-iqdi99pd	2210	1	Consistent	consistent	JJ
cord-015365-iqdi99pd	2210	2	with	with	IN
cord-015365-iqdi99pd	2210	3	results	result	NNS
cord-015365-iqdi99pd	2210	4	from	from	IN
cord-015365-iqdi99pd	2210	5	the	the	DT
cord-015365-iqdi99pd	2210	6	multi	multi	JJ
cord-015365-iqdi99pd	2210	7	-	-	JJ
cord-015365-iqdi99pd	2210	8	center	center	JJ
cord-015365-iqdi99pd	2210	9	trial	trial	NN
cord-015365-iqdi99pd	2210	10	,	,	,
cord-015365-iqdi99pd	2210	11	patients	patient	NNS
cord-015365-iqdi99pd	2210	12	treated	treat	VBN
cord-015365-iqdi99pd	2210	13	with	with	IN
cord-015365-iqdi99pd	2210	14	belatacept	belatacept	NN
cord-015365-iqdi99pd	2210	15	showed	show	VBD
cord-015365-iqdi99pd	2210	16	better	well	JJR
cord-015365-iqdi99pd	2210	17	kidney	kidney	NN
cord-015365-iqdi99pd	2210	18	function	function	NN
cord-015365-iqdi99pd	2210	19	compared	compare	VBN
cord-015365-iqdi99pd	2210	20	to	to	IN
cord-015365-iqdi99pd	2210	21	those	those	DT
cord-015365-iqdi99pd	2210	22	treated	treat	VBN
cord-015365-iqdi99pd	2210	23	with	with	IN
cord-015365-iqdi99pd	2210	24	CNIs	cni	NNS
cord-015365-iqdi99pd	2210	25	.	.	.
cord-015365-iqdi99pd	2211	1	MMF	MMF	NNP
cord-015365-iqdi99pd	2211	2	monotherapy	monotherapy	RB
cord-015365-iqdi99pd	2211	3	following	follow	VBG
cord-015365-iqdi99pd	2211	4	withdrawal	withdrawal	NN
cord-015365-iqdi99pd	2211	5	of	of	IN
cord-015365-iqdi99pd	2211	6	belatacept	belatacept	NN
cord-015365-iqdi99pd	2211	7	is	be	VBZ
cord-015365-iqdi99pd	2211	8	associated	associate	VBN
cord-015365-iqdi99pd	2211	9	with	with	IN
cord-015365-iqdi99pd	2211	10	a	a	DT
cord-015365-iqdi99pd	2211	11	high	high	JJ
cord-015365-iqdi99pd	2211	12	risk	risk	NN
cord-015365-iqdi99pd	2211	13	of	of	IN
cord-015365-iqdi99pd	2211	14	rejection	rejection	NN
cord-015365-iqdi99pd	2211	15	.	.	.
cord-015365-iqdi99pd	2212	1	Thus	thus	RB
cord-015365-iqdi99pd	2212	2	belatacept	belatacept	NNP
cord-015365-iqdi99pd	2212	3	has	have	VBZ
cord-015365-iqdi99pd	2212	4	no	no	DT
cord-015365-iqdi99pd	2212	5	obvious	obvious	JJ
cord-015365-iqdi99pd	2212	6	immunomodulatory	immunomodulatory	JJ
cord-015365-iqdi99pd	2212	7	effect	effect	NN
cord-015365-iqdi99pd	2212	8	in	in	IN
cord-015365-iqdi99pd	2212	9	liver	liver	NN
cord-015365-iqdi99pd	2212	10	transplant	transplant	NN
cord-015365-iqdi99pd	2212	11	recipients	recipient	NNS
cord-015365-iqdi99pd	2212	12	that	that	WDT
cord-015365-iqdi99pd	2212	13	would	would	MD
cord-015365-iqdi99pd	2212	14	be	be	VB
cord-015365-iqdi99pd	2212	15	sufficient	sufficient	JJ
cord-015365-iqdi99pd	2212	16	to	to	TO
cord-015365-iqdi99pd	2212	17	allow	allow	VB
cord-015365-iqdi99pd	2212	18	a	a	DT
cord-015365-iqdi99pd	2212	19	high	high	JJ
cord-015365-iqdi99pd	2212	20	success	success	NN
cord-015365-iqdi99pd	2212	21	rate	rate	NN
cord-015365-iqdi99pd	2212	22	of	of	IN
cord-015365-iqdi99pd	2212	23	minimization	minimization	NN
cord-015365-iqdi99pd	2212	24	strategies	strategy	NNS
cord-015365-iqdi99pd	2212	25	.	.	.
cord-015365-iqdi99pd	2213	1	Ausgezeichnete	Ausgezeichnete	NNP
cord-015365-iqdi99pd	2213	2	Blutdruckkontrolle	Blutdruckkontrolle	NNP
cord-015365-iqdi99pd	2213	3	nach	nach	NNP
cord-015365-iqdi99pd	2213	4	Nierentransplantation	Nierentransplantation	NNP
cord-015365-iqdi99pd	2213	5	durch	durch	NN
cord-015365-iqdi99pd	2213	6	antihypertensive	antihypertensive	JJ
cord-015365-iqdi99pd	2213	7	Mehrfachtherapie	Mehrfachtherapie	NNP
cord-015365-iqdi99pd	2214	1	-Entwicklungen	-Entwicklungen	.
cord-015365-iqdi99pd	2215	1	der	der	NNP
cord-015365-iqdi99pd	2215	2	letzten	letzten	NNP
cord-015365-iqdi99pd	2216	1	20	20	CD
cord-015365-iqdi99pd	2216	2	Jahre	Jahre	NNP
cord-015365-iqdi99pd	2216	3	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	2216	4	.	.	.
cord-015365-iqdi99pd	2217	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2217	2	mit	mit	VBP
cord-015365-iqdi99pd	2217	3	terminalen	terminalen	NNP
cord-015365-iqdi99pd	2217	4	Lebererkrankungen	Lebererkrankungen	NNP
cord-015365-iqdi99pd	2217	5	entwickeln	entwickeln	NNP
cord-015365-iqdi99pd	2218	1	gehäuft	gehäuft	NNP
cord-015365-iqdi99pd	2219	1	Ö	Ö	NNP
cord-015365-iqdi99pd	2219	2	sophagusvarizen	sophagusvarizen	NNP
cord-015365-iqdi99pd	2219	3	auf	auf	NNP
cord-015365-iqdi99pd	2219	4	Basis	Basis	NNP
cord-015365-iqdi99pd	2219	5	einer	einer	NNP
cord-015365-iqdi99pd	2219	6	portalen	portalen	VBN
cord-015365-iqdi99pd	2219	7	Hypertension	hypertension	NN
cord-015365-iqdi99pd	2219	8	.	.	.
cord-015365-iqdi99pd	2220	1	Ziel	Ziel	NNP
cord-015365-iqdi99pd	2220	2	dieser	dieser	NNP
cord-015365-iqdi99pd	2220	3	Studie	Studie	NNP
cord-015365-iqdi99pd	2220	4	ist	ist	NNP
cord-015365-iqdi99pd	2220	5	es	es	NNP
cord-015365-iqdi99pd	2220	6	,	,	,
cord-015365-iqdi99pd	2220	7	die	die	VB
cord-015365-iqdi99pd	2221	1	Inzidenz	Inzidenz	NNP
cord-015365-iqdi99pd	2221	2	von	von	NNP
cord-015365-iqdi99pd	2221	3	Ö	Ö	NNP
cord-015365-iqdi99pd	2221	4	sophagusvarizen	sophagusvarizen	NN
cord-015365-iqdi99pd	2222	1	und	und	NNP
cord-015365-iqdi99pd	2222	2	deren	deren	NNP
cord-015365-iqdi99pd	2222	3	Korrelation	Korrelation	NNP
cord-015365-iqdi99pd	2222	4	mit	mit	NNP
cord-015365-iqdi99pd	2222	5	dem	dem	NNP
cord-015365-iqdi99pd	2222	6	Grad	Grad	NNP
cord-015365-iqdi99pd	2222	7	der	der	NN
cord-015365-iqdi99pd	2222	8	Lebererkrankung	Lebererkrankung	NNP
cord-015365-iqdi99pd	2222	9	bei	bei	NNP
cord-015365-iqdi99pd	2222	10	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2222	11	,	,	,
cord-015365-iqdi99pd	2222	12	die	die	VBP
cord-015365-iqdi99pd	2222	13	auf	auf	NNP
cord-015365-iqdi99pd	2222	14	der	der	NNP
cord-015365-iqdi99pd	2222	15	Leberwarteliste	Leberwarteliste	NNP
cord-015365-iqdi99pd	2222	16	stehen	stehen	NNP
cord-015365-iqdi99pd	2222	17	,	,	,
cord-015365-iqdi99pd	2222	18	zu	zu	NNP
cord-015365-iqdi99pd	2222	19	errechnen	errechnen	NNP
cord-015365-iqdi99pd	2222	20	.	.	.
cord-015365-iqdi99pd	2223	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	2223	2	.	.	.
cord-015365-iqdi99pd	2224	1	Hierfür	Hierfür	NNP
cord-015365-iqdi99pd	2224	2	wurden	wurden	NNS
cord-015365-iqdi99pd	2224	3	die	die	VBP
cord-015365-iqdi99pd	2224	4	Daten	Daten	NNP
cord-015365-iqdi99pd	2224	5	von	von	NNP
cord-015365-iqdi99pd	2224	6	512	512	CD
cord-015365-iqdi99pd	2224	7	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2224	8	,	,	,
cord-015365-iqdi99pd	2224	9	die	die	VBP
cord-015365-iqdi99pd	2224	10	zwischen	zwischen	NNP
cord-015365-iqdi99pd	2224	11	2002	2002	CD
cord-015365-iqdi99pd	2224	12	und	und	IN
cord-015365-iqdi99pd	2224	13	2010	2010	CD
cord-015365-iqdi99pd	2224	14	an	an	DT
cord-015365-iqdi99pd	2224	15	der	der	NNP
cord-015365-iqdi99pd	2224	16	Universitätsklinik	Universitätsklinik	NNP
cord-015365-iqdi99pd	2224	17	für	für	IN
cord-015365-iqdi99pd	2224	18	Chirurgie	Chirurgie	NNP
cord-015365-iqdi99pd	2224	19	lebertransplantiert	lebertransplantiert	NNP
cord-015365-iqdi99pd	2224	20	wurden	wurden	NNP
cord-015365-iqdi99pd	2224	21	,	,	,
cord-015365-iqdi99pd	2224	22	analysiert	analysiert	NNP
cord-015365-iqdi99pd	2224	23	.	.	.
cord-015365-iqdi99pd	2225	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2225	2	,	,	,
cord-015365-iqdi99pd	2225	3	die	die	VB
cord-015365-iqdi99pd	2225	4	die	die	VB
cord-015365-iqdi99pd	2226	1	Lebertransplantation	Lebertransplantation	NNP
cord-015365-iqdi99pd	2226	2	aufgrund	aufgrund	IN
cord-015365-iqdi99pd	2226	3	eines	eines	NNP
cord-015365-iqdi99pd	2226	4	akuten	akuten	NNP
cord-015365-iqdi99pd	2226	5	Leberausfalls	Leberausfalls	NNP
cord-015365-iqdi99pd	2226	6	benötigten	benötigten	NNP
cord-015365-iqdi99pd	2226	7	und	und	IN
cord-015365-iqdi99pd	2226	8	solche	solche	NNP
cord-015365-iqdi99pd	2226	9	,	,	,
cord-015365-iqdi99pd	2226	10	bei	bei	NNP
cord-015365-iqdi99pd	2226	11	denen	denen	NNP
cord-015365-iqdi99pd	2226	12	die	die	VBP
cord-015365-iqdi99pd	2226	13	Daten	Daten	NNP
cord-015365-iqdi99pd	2226	14	unvollständig	unvollständig	NNP
cord-015365-iqdi99pd	2226	15	waren	waren	NNP
cord-015365-iqdi99pd	2226	16	,	,	,
cord-015365-iqdi99pd	2226	17	wurden	wurden	NNP
cord-015365-iqdi99pd	2226	18	aus	aus	NNP
cord-015365-iqdi99pd	2226	19	der	der	NNP
cord-015365-iqdi99pd	2226	20	Studie	Studie	NNP
cord-015365-iqdi99pd	2226	21	ausgeschlossen	ausgeschlossen	NNP
cord-015365-iqdi99pd	2226	22	.	.	.
cord-015365-iqdi99pd	2227	1	Somit	Somit	NNP
cord-015365-iqdi99pd	2227	2	umfasst	umfasst	NNP
cord-015365-iqdi99pd	2227	3	die	die	VBP
cord-015365-iqdi99pd	2227	4	Studie	Studie	NNP
cord-015365-iqdi99pd	2227	5	396	396	CD
cord-015365-iqdi99pd	2227	6	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2227	7	(	(	-LRB-
cord-015365-iqdi99pd	2227	8	77	77	CD
cord-015365-iqdi99pd	2227	9	%	%	NN
cord-015365-iqdi99pd	2227	10	)	)	-RRB-
cord-015365-iqdi99pd	2227	11	.	.	.
cord-015365-iqdi99pd	2228	1	Die	die	VB
cord-015365-iqdi99pd	2228	2	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2228	3	werden	werden	NNP
cord-015365-iqdi99pd	2228	4	median	median	NN
cord-015365-iqdi99pd	2228	5	in	in	IN
cord-015365-iqdi99pd	2228	6	der	der	NNP
cord-015365-iqdi99pd	2228	7	25	25	CD
cord-015365-iqdi99pd	2228	8	.	.	.
cord-015365-iqdi99pd	2229	1	und	und	NNP
cord-015365-iqdi99pd	2229	2	der	der	NNP
cord-015365-iqdi99pd	2229	3	75	75	CD
cord-015365-iqdi99pd	2229	4	.	.	.
cord-015365-iqdi99pd	2230	1	Perzentile	Perzentile	NNP
cord-015365-iqdi99pd	2230	2	angegeben	angegeben	NNP
cord-015365-iqdi99pd	2230	3	.	.	.
cord-015365-iqdi99pd	2231	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2231	2	.	.	.
cord-015365-iqdi99pd	2232	1	Die	die	VB
cord-015365-iqdi99pd	2233	1	Lebertransplantierten	Lebertransplantierten	NNP
cord-015365-iqdi99pd	2233	2	waren	waren	XX
cord-015365-iqdi99pd	2234	1	i	i	PRP
cord-015365-iqdi99pd	2235	1	m	m	NNP
cord-015365-iqdi99pd	2235	2	Median	Median	NNP
cord-015365-iqdi99pd	2235	3	54	54	CD
cord-015365-iqdi99pd	2235	4	(	(	-LRB-
cord-015365-iqdi99pd	2235	5	48	48	CD
cord-015365-iqdi99pd	2235	6	-	-	SYM
cord-015365-iqdi99pd	2235	7	60	60	CD
cord-015365-iqdi99pd	2235	8	)	)	-RRB-
cord-015365-iqdi99pd	2235	9	Jahre	Jahre	NNP
cord-015365-iqdi99pd	2235	10	alt	alt	NN
cord-015365-iqdi99pd	2235	11	.	.	.
cord-015365-iqdi99pd	2236	1	I	-PRON-	PRP
cord-015365-iqdi99pd	2237	1	m	m	NNP
cord-015365-iqdi99pd	2237	2	Median	Median	NNP
cord-015365-iqdi99pd	2237	3	lagen	lagen	NNP
cord-015365-iqdi99pd	2237	4	227	227	CD
cord-015365-iqdi99pd	2237	5	Tage	Tage	NNP
cord-015365-iqdi99pd	2237	6	(	(	-LRB-
cord-015365-iqdi99pd	2237	7	125	125	CD
cord-015365-iqdi99pd	2237	8	-	-	SYM
cord-015365-iqdi99pd	2237	9	368	368	CD
cord-015365-iqdi99pd	2237	10	)	)	-RRB-
cord-015365-iqdi99pd	2238	1	zwischen	zwischen	NNP
cord-015365-iqdi99pd	2238	2	der	der	NNP
cord-015365-iqdi99pd	2238	3	letzten	letzten	FW
cord-015365-iqdi99pd	2238	4	Ö	Ö	NNP
cord-015365-iqdi99pd	2238	5	sophagogastroduodenoskopie	sophagogastroduodenoskopie	NNP
cord-015365-iqdi99pd	2238	6	und	und	NNP
cord-015365-iqdi99pd	2238	7	der	der	NNP
cord-015365-iqdi99pd	2238	8	Lebertransplantation	Lebertransplantation	NNP
cord-015365-iqdi99pd	2238	9	.	.	.
cord-015365-iqdi99pd	2239	1	287	287	CD
cord-015365-iqdi99pd	2239	2	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2239	3	(	(	-LRB-
cord-015365-iqdi99pd	2239	4	72,5	72,5	CD
cord-015365-iqdi99pd	2239	5	%	%	NN
cord-015365-iqdi99pd	2239	6	)	)	-RRB-
cord-015365-iqdi99pd	2239	7	zeigten	zeigten	NNP
cord-015365-iqdi99pd	2239	8	Varizen	Varizen	NNP
cord-015365-iqdi99pd	2239	9	:	:	:
cord-015365-iqdi99pd	2239	10	130	130	CD
cord-015365-iqdi99pd	2239	11	(	(	-LRB-
cord-015365-iqdi99pd	2239	12	32,8	32,8	CD
cord-015365-iqdi99pd	2239	13	%	%	NN
cord-015365-iqdi99pd	2239	14	)	)	-RRB-
cord-015365-iqdi99pd	2240	1	Varizen	Varizen	NNP
cord-015365-iqdi99pd	2240	2	Grad	Grad	NNP
cord-015365-iqdi99pd	2241	1	I	-PRON-	PRP
cord-015365-iqdi99pd	2241	2	(	(	-LRB-
cord-015365-iqdi99pd	2241	3	<	<	NNP
cord-015365-iqdi99pd	2241	4	5	5	CD
cord-015365-iqdi99pd	2241	5	mm	mm	NN
cord-015365-iqdi99pd	2241	6	bei	bei	NNP
cord-015365-iqdi99pd	2241	7	Insufflation	Insufflation	NNP
cord-015365-iqdi99pd	2241	8	)	)	-RRB-
cord-015365-iqdi99pd	2241	9	und	und	XX
cord-015365-iqdi99pd	2242	1	157	157	CD
cord-015365-iqdi99pd	2242	2	(	(	-LRB-
cord-015365-iqdi99pd	2242	3	39,6	39,6	CD
cord-015365-iqdi99pd	2242	4	%	%	NN
cord-015365-iqdi99pd	2242	5	)	)	-RRB-
cord-015365-iqdi99pd	2243	1	Var	var	NN
cord-015365-iqdi99pd	2243	2	-	-	HYPH
cord-015365-iqdi99pd	2243	3	izen	izen	JJ
cord-015365-iqdi99pd	2243	4	Grad	Grad	NNP
cord-015365-iqdi99pd	2243	5	II	II	NNP
cord-015365-iqdi99pd	2244	1	(	(	-LRB-
cord-015365-iqdi99pd	2244	2	>	>	NFP
cord-015365-iqdi99pd	2244	3	5	5	CD
cord-015365-iqdi99pd	2244	4	mm	mm	NN
cord-015365-iqdi99pd	2244	5	bei	bei	NNP
cord-015365-iqdi99pd	2244	6	Insufflation	Insufflation	NNP
cord-015365-iqdi99pd	2244	7	)	)	-RRB-
cord-015365-iqdi99pd	2244	8	.	.	.
cord-015365-iqdi99pd	2245	1	Red	Red	NNP
cord-015365-iqdi99pd	2245	2	Spot	Spot	NNP
cord-015365-iqdi99pd	2245	3	Signs	Signs	NNPS
cord-015365-iqdi99pd	2245	4	fand	fand	VBP
cord-015365-iqdi99pd	2245	5	man	man	NN
cord-015365-iqdi99pd	2245	6	bei	bei	NNP
cord-015365-iqdi99pd	2245	7	40	40	CD
cord-015365-iqdi99pd	2246	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2246	2	(	(	-LRB-
cord-015365-iqdi99pd	2246	3	10,1	10,1	CD
cord-015365-iqdi99pd	2246	4	%	%	NN
cord-015365-iqdi99pd	2246	5	)	)	-RRB-
cord-015365-iqdi99pd	2246	6	.	.	.
cord-015365-iqdi99pd	2247	1	82,2	82,2	CD
cord-015365-iqdi99pd	2247	2	%	%	NN
cord-015365-iqdi99pd	2247	3	der	der	NNP
cord-015365-iqdi99pd	2247	4	Varizen	Varizen	NNP
cord-015365-iqdi99pd	2247	5	lokalisierten	lokalisierten	NNP
cord-015365-iqdi99pd	2247	6	sich	sich	NNP
cord-015365-iqdi99pd	2248	1	i	-PRON-	PRP
cord-015365-iqdi99pd	2248	2	m	be	VBP
cord-015365-iqdi99pd	2248	3	Ö	Ö	NNP
cord-015365-iqdi99pd	2248	4	sophagus	sophagus	NNP
cord-015365-iqdi99pd	2248	5	,	,	,
cord-015365-iqdi99pd	2248	6	4,2	4,2	CD
cord-015365-iqdi99pd	2248	7	%	%	NN
cord-015365-iqdi99pd	2249	1	i	-PRON-	PRP
cord-015365-iqdi99pd	2249	2	m	be	VBP
cord-015365-iqdi99pd	2249	3	Magen	Magen	NNP
cord-015365-iqdi99pd	2249	4	und	und	XX
cord-015365-iqdi99pd	2250	1	13,6	13,6	CD
cord-015365-iqdi99pd	2250	2	%	%	NN
cord-015365-iqdi99pd	2251	1	i	-PRON-	PRP
cord-015365-iqdi99pd	2251	2	m	be	VBP
cord-015365-iqdi99pd	2251	3	Ö	ö	NN
cord-015365-iqdi99pd	2251	4	sophagus	sophagus	NNP
cord-015365-iqdi99pd	2251	5	und	und	IN
cord-015365-iqdi99pd	2251	6	Magen	Magen	NNP
cord-015365-iqdi99pd	2251	7	.	.	.
cord-015365-iqdi99pd	2252	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2252	2	mit	mit	NNP
cord-015365-iqdi99pd	2252	3	ösophagealen	ösophagealen	NNP
cord-015365-iqdi99pd	2253	1	Varizen	Varizen	NNP
cord-015365-iqdi99pd	2253	2	zeigten	zeigten	NNP
cord-015365-iqdi99pd	2254	1	signifikant	signifikant	NNP
cord-015365-iqdi99pd	2255	1	niedrigere	niedrigere	NNP
cord-015365-iqdi99pd	2255	2	Serum	Serum	NNP
cord-015365-iqdi99pd	2255	3	-	-	HYPH
cord-015365-iqdi99pd	2255	4	Natrium	Natrium	NNP
cord-015365-iqdi99pd	2255	5	Werte	Werte	NNPS
cord-015365-iqdi99pd	2256	1	und	und	NNP
cord-015365-iqdi99pd	2256	2	Thrombozytenzahlen	Thrombozytenzahlen	NNP
cord-015365-iqdi99pd	2257	1	und	und	NNP
cord-015365-iqdi99pd	2258	1	signifikant	signifikant	NNP
cord-015365-iqdi99pd	2258	2	höhere	höhere	NNP
cord-015365-iqdi99pd	2258	3	Ammoniak	Ammoniak	NNP
cord-015365-iqdi99pd	2258	4	-	-	HYPH
cord-015365-iqdi99pd	2258	5	Spiegel	Spiegel	NNP
cord-015365-iqdi99pd	2258	6	,	,	,
cord-015365-iqdi99pd	2259	1	Prothrombinzeiten	prothrombinzeiten	NN
cord-015365-iqdi99pd	2259	2	und	und	XX
cord-015365-iqdi99pd	2260	1	MELD	meld	VB
cord-015365-iqdi99pd	2260	2	-	-	HYPH
cord-015365-iqdi99pd	2260	3	Scores	score	NNS
cord-015365-iqdi99pd	2260	4	als	als	NN
cord-015365-iqdi99pd	2260	5	solche	solche	NN
cord-015365-iqdi99pd	2260	6	ohne	ohne	NNP
cord-015365-iqdi99pd	2260	7	Varizen	Varizen	NNP
cord-015365-iqdi99pd	2260	8	.	.	.
cord-015365-iqdi99pd	2261	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	2261	2	.	.	.
cord-015365-iqdi99pd	2262	1	Ö	Ö	NNP
cord-015365-iqdi99pd	2262	2	sophagusvarizen	sophagusvarizen	NNP
cord-015365-iqdi99pd	2262	3	treten	treten	NNP
cord-015365-iqdi99pd	2262	4	gehäuft	gehäuft	NNP
cord-015365-iqdi99pd	2262	5	bei	bei	NNP
cord-015365-iqdi99pd	2262	6	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2262	7	mit	mit	VBP
cord-015365-iqdi99pd	2262	8	terminalen	terminalen	NNP
cord-015365-iqdi99pd	2262	9	Lebererkrankungen	Lebererkrankungen	NNP
cord-015365-iqdi99pd	2262	10	auf	auf	NNP
cord-015365-iqdi99pd	2262	11	und	und	XX
cord-015365-iqdi99pd	2263	1	werden	werden	NNP
cord-015365-iqdi99pd	2263	2	von	von	NNP
cord-015365-iqdi99pd	2263	3	einer	einer	NNP
cord-015365-iqdi99pd	2264	1	Verschlechterung	Verschlechterung	NNP
cord-015365-iqdi99pd	2264	2	der	der	NNP
cord-015365-iqdi99pd	2264	3	Labor	Labor	NNP
cord-015365-iqdi99pd	2264	4	-	-	HYPH
cord-015365-iqdi99pd	2264	5	und	und	IN
cord-015365-iqdi99pd	2264	6	MELD	MELD	NNP
cord-015365-iqdi99pd	2264	7	-	-	HYPH
cord-015365-iqdi99pd	2264	8	Werte	Werte	NNP
cord-015365-iqdi99pd	2264	9	begleitet	begleitet	VBN
cord-015365-iqdi99pd	2264	10	.	.	.
cord-015365-iqdi99pd	2265	1	Background	background	NN
cord-015365-iqdi99pd	2265	2	.	.	.
cord-015365-iqdi99pd	2266	1	A	a	DT
cord-015365-iqdi99pd	2266	2	project	project	NN
cord-015365-iqdi99pd	2266	3	called	call	VBN
cord-015365-iqdi99pd	2266	4	Transplant	Transplant	NNP
cord-015365-iqdi99pd	2266	5	Procurement	Procurement	NNP
cord-015365-iqdi99pd	2266	6	Management	Management	NNP
cord-015365-iqdi99pd	2266	7	(	(	-LRB-
cord-015365-iqdi99pd	2266	8	TPM	TPM	NNP
cord-015365-iqdi99pd	2266	9	)	)	-RRB-
cord-015365-iqdi99pd	2266	10	was	be	VBD
cord-015365-iqdi99pd	2266	11	created	create	VBN
cord-015365-iqdi99pd	2266	12	in	in	IN
cord-015365-iqdi99pd	2266	13	Barcelona	Barcelona	NNP
cord-015365-iqdi99pd	2266	14	,	,	,
cord-015365-iqdi99pd	2266	15	Spain	Spain	NNP
cord-015365-iqdi99pd	2266	16	.	.	.
cord-015365-iqdi99pd	2267	1	The	the	DT
cord-015365-iqdi99pd	2267	2	aim	aim	NN
cord-015365-iqdi99pd	2267	3	of	of	IN
cord-015365-iqdi99pd	2267	4	this	this	DT
cord-015365-iqdi99pd	2267	5	project	project	NN
cord-015365-iqdi99pd	2267	6	is	be	VBZ
cord-015365-iqdi99pd	2267	7	to	to	TO
cord-015365-iqdi99pd	2267	8	provide	provide	VB
cord-015365-iqdi99pd	2267	9	profound	profound	JJ
cord-015365-iqdi99pd	2267	10	knowledge	knowledge	NN
cord-015365-iqdi99pd	2267	11	and	and	CC
cord-015365-iqdi99pd	2267	12	skills	skill	NNS
cord-015365-iqdi99pd	2267	13	for	for	IN
cord-015365-iqdi99pd	2267	14	health	health	NN
cord-015365-iqdi99pd	2267	15	care	care	NN
cord-015365-iqdi99pd	2267	16	professionals	professional	NNS
cord-015365-iqdi99pd	2267	17	,	,	,
cord-015365-iqdi99pd	2267	18	working	work	VBG
cord-015365-iqdi99pd	2267	19	in	in	IN
cord-015365-iqdi99pd	2267	20	the	the	DT
cord-015365-iqdi99pd	2267	21	transplantation	transplantation	NN
cord-015365-iqdi99pd	2267	22	field	field	NN
cord-015365-iqdi99pd	2267	23	with	with	IN
cord-015365-iqdi99pd	2267	24	the	the	DT
cord-015365-iqdi99pd	2267	25	final	final	JJ
cord-015365-iqdi99pd	2267	26	purpose	purpose	NN
cord-015365-iqdi99pd	2267	27	of	of	IN
cord-015365-iqdi99pd	2267	28	promoting	promote	VBG
cord-015365-iqdi99pd	2267	29	and	and	CC
cord-015365-iqdi99pd	2267	30	increasing	increase	VBG
cord-015365-iqdi99pd	2267	31	donation	donation	NN
cord-015365-iqdi99pd	2267	32	rates	rate	NNS
cord-015365-iqdi99pd	2267	33	.	.	.
cord-015365-iqdi99pd	2268	1	We	-PRON-	PRP
cord-015365-iqdi99pd	2268	2	evaluated	evaluate	VBD
cord-015365-iqdi99pd	2268	3	the	the	DT
cord-015365-iqdi99pd	2268	4	effects	effect	NNS
cord-015365-iqdi99pd	2268	5	of	of	IN
cord-015365-iqdi99pd	2268	6	this	this	DT
cord-015365-iqdi99pd	2268	7	program	program	NN
cord-015365-iqdi99pd	2268	8	on	on	IN
cord-015365-iqdi99pd	2268	9	donor	donor	NN
cord-015365-iqdi99pd	2268	10	outcome	outcome	NN
cord-015365-iqdi99pd	2268	11	and	and	CC
cord-015365-iqdi99pd	2268	12	the	the	DT
cord-015365-iqdi99pd	2268	13	organ	organ	NN
cord-015365-iqdi99pd	2268	14	procurement	procurement	NN
cord-015365-iqdi99pd	2268	15	in	in	IN
cord-015365-iqdi99pd	2268	16	a	a	DT
cord-015365-iqdi99pd	2268	17	single	single	JJ
cord-015365-iqdi99pd	2268	18	center	center	NN
cord-015365-iqdi99pd	2268	19	analysis	analysis	NN
cord-015365-iqdi99pd	2268	20	.	.	.
cord-015365-iqdi99pd	2269	1	Methods	method	NNS
cord-015365-iqdi99pd	2269	2	.	.	.
cord-015365-iqdi99pd	2270	1	Number	number	NN
cord-015365-iqdi99pd	2270	2	of	of	IN
cord-015365-iqdi99pd	2270	3	donor	donor	NN
cord-015365-iqdi99pd	2270	4	procurements	procurement	NNS
cord-015365-iqdi99pd	2270	5	over	over	IN
cord-015365-iqdi99pd	2270	6	a	a	DT
cord-015365-iqdi99pd	2270	7	1-year	1-year	CD
cord-015365-iqdi99pd	2270	8	period	period	NN
cord-015365-iqdi99pd	2270	9	,	,	,
cord-015365-iqdi99pd	2270	10	from	from	IN
cord-015365-iqdi99pd	2270	11	June	June	NNP
cord-015365-iqdi99pd	2270	12	1st	1st	NN
cord-015365-iqdi99pd	2270	13	,	,	,
cord-015365-iqdi99pd	2270	14	2010	2010	CD
cord-015365-iqdi99pd	2270	15	to	to	IN
cord-015365-iqdi99pd	2270	16	May	May	NNP
cord-015365-iqdi99pd	2270	17	31st	31st	NN
cord-015365-iqdi99pd	2270	18	,	,	,
cord-015365-iqdi99pd	2270	19	2011	2011	CD
cord-015365-iqdi99pd	2270	20	,	,	,
cord-015365-iqdi99pd	2270	21	evaluated	evaluate	VBN
cord-015365-iqdi99pd	2270	22	at	at	IN
cord-015365-iqdi99pd	2270	23	the	the	DT
cord-015365-iqdi99pd	2270	24	transplant	transplant	NN
cord-015365-iqdi99pd	2270	25	center	center	NN
cord-015365-iqdi99pd	2270	26	of	of	IN
cord-015365-iqdi99pd	2270	27	the	the	DT
cord-015365-iqdi99pd	2270	28	Medical	Medical	NNP
cord-015365-iqdi99pd	2270	29	University	University	NNP
cord-015365-iqdi99pd	2270	30	Vienna	Vienna	NNP
cord-015365-iqdi99pd	2270	31	,	,	,
cord-015365-iqdi99pd	2270	32	the	the	DT
cord-015365-iqdi99pd	2270	33	sixmonth	sixmonth	JJ
cord-015365-iqdi99pd	2270	34	period	period	NN
cord-015365-iqdi99pd	2270	35	before	before	RB
cord-015365-iqdi99pd	2270	36	and	and	CC
cord-015365-iqdi99pd	2270	37	after	after	IN
cord-015365-iqdi99pd	2270	38	participation	participation	NN
cord-015365-iqdi99pd	2270	39	in	in	IN
cord-015365-iqdi99pd	2270	40	the	the	DT
cord-015365-iqdi99pd	2270	41	TPM	TPM	NNP
cord-015365-iqdi99pd	2270	42	-	-	HYPH
cord-015365-iqdi99pd	2270	43	course	course	NN
cord-015365-iqdi99pd	2270	44	(	(	-LRB-
cord-015365-iqdi99pd	2270	45	Nov	Nov	NNP
cord-015365-iqdi99pd	2270	46	22nd	22nd	NN
cord-015365-iqdi99pd	2270	47	to	to	IN
cord-015365-iqdi99pd	2270	48	Nov	Nov	NNP
cord-015365-iqdi99pd	2270	49	26th	26th	NN
cord-015365-iqdi99pd	2270	50	,	,	,
cord-015365-iqdi99pd	2270	51	2010	2010	CD
cord-015365-iqdi99pd	2270	52	)	)	-RRB-
cord-015365-iqdi99pd	2270	53	.	.	.
cord-015365-iqdi99pd	2271	1	Results	result	NNS
cord-015365-iqdi99pd	2271	2	.	.	.
cord-015365-iqdi99pd	2272	1	In	in	IN
cord-015365-iqdi99pd	2272	2	the	the	DT
cord-015365-iqdi99pd	2272	3	1st	1st	JJ
cord-015365-iqdi99pd	2272	4	evaluation	evaluation	NN
cord-015365-iqdi99pd	2272	5	period	period	NN
cord-015365-iqdi99pd	2272	6	from	from	IN
cord-015365-iqdi99pd	2272	7	June	June	NNP
cord-015365-iqdi99pd	2272	8	1st	1st	NN
cord-015365-iqdi99pd	2272	9	to	to	IN
cord-015365-iqdi99pd	2272	10	Nov	Nov	NNP
cord-015365-iqdi99pd	2272	11	30th	30th	NN
cord-015365-iqdi99pd	2272	12	,	,	,
cord-015365-iqdi99pd	2272	13	2010	2010	CD
cord-015365-iqdi99pd	2272	14	74	74	CD
cord-015365-iqdi99pd	2272	15	potential	potential	JJ
cord-015365-iqdi99pd	2272	16	donors	donor	NNS
cord-015365-iqdi99pd	2272	17	were	be	VBD
cord-015365-iqdi99pd	2272	18	reported	report	VBN
cord-015365-iqdi99pd	2272	19	in	in	IN
cord-015365-iqdi99pd	2272	20	our	-PRON-	PRP$
cord-015365-iqdi99pd	2272	21	center	center	NN
cord-015365-iqdi99pd	2272	22	out	out	IN
cord-015365-iqdi99pd	2272	23	of	of	IN
cord-015365-iqdi99pd	2272	24	which	which	WDT
cord-015365-iqdi99pd	2272	25	31	31	CD
cord-015365-iqdi99pd	2272	26	became	become	VBD
cord-015365-iqdi99pd	2272	27	actual	actual	JJ
cord-015365-iqdi99pd	2272	28	donors	donor	NNS
cord-015365-iqdi99pd	2272	29	.	.	.
cord-015365-iqdi99pd	2273	1	Within	within	IN
cord-015365-iqdi99pd	2273	2	the	the	DT
cord-015365-iqdi99pd	2273	3	43	43	CD
cord-015365-iqdi99pd	2273	4	missed	miss	VBN
cord-015365-iqdi99pd	2273	5	donors	donor	NNS
cord-015365-iqdi99pd	2273	6	23	23	CD
cord-015365-iqdi99pd	2273	7	did	do	VBD
cord-015365-iqdi99pd	2273	8	not	not	RB
cord-015365-iqdi99pd	2273	9	fulfill	fulfill	VB
cord-015365-iqdi99pd	2273	10	brain	brain	NN
cord-015365-iqdi99pd	2273	11	dead	dead	JJ
cord-015365-iqdi99pd	2273	12	criteria	criterion	NNS
cord-015365-iqdi99pd	2273	13	.	.	.
cord-015365-iqdi99pd	2274	1	Moreover	moreover	RB
cord-015365-iqdi99pd	2274	2	twelve	twelve	CD
cord-015365-iqdi99pd	2274	3	donors	donor	NNS
cord-015365-iqdi99pd	2274	4	could	could	MD
cord-015365-iqdi99pd	2274	5	not	not	RB
cord-015365-iqdi99pd	2274	6	be	be	VB
cord-015365-iqdi99pd	2274	7	realized	realize	VBN
cord-015365-iqdi99pd	2274	8	because	because	IN
cord-015365-iqdi99pd	2274	9	of	of	IN
cord-015365-iqdi99pd	2274	10	their	-PRON-	PRP$
cord-015365-iqdi99pd	2274	11	co	co	NNS
cord-015365-iqdi99pd	2274	12	-	-	NNS
cord-015365-iqdi99pd	2274	13	morbidities	morbidity	NNS
cord-015365-iqdi99pd	2274	14	and	and	CC
cord-015365-iqdi99pd	2274	15	eight	eight	CD
cord-015365-iqdi99pd	2274	16	due	due	JJ
cord-015365-iqdi99pd	2274	17	to	to	IN
cord-015365-iqdi99pd	2274	18	opposition	opposition	NN
cord-015365-iqdi99pd	2274	19	against	against	IN
cord-015365-iqdi99pd	2274	20	organ	organ	NN
cord-015365-iqdi99pd	2274	21	donation	donation	NN
cord-015365-iqdi99pd	2274	22	.	.	.
cord-015365-iqdi99pd	2275	1	In	in	IN
cord-015365-iqdi99pd	2275	2	the	the	DT
cord-015365-iqdi99pd	2275	3	comparable	comparable	JJ
cord-015365-iqdi99pd	2275	4	2nd	2nd	JJ
cord-015365-iqdi99pd	2275	5	period	period	NN
cord-015365-iqdi99pd	2275	6	from	from	IN
cord-015365-iqdi99pd	2275	7	Dec	Dec	NNP
cord-015365-iqdi99pd	2275	8	1st	1st	NN
cord-015365-iqdi99pd	2275	9	to	to	IN
cord-015365-iqdi99pd	2275	10	May	May	NNP
cord-015365-iqdi99pd	2275	11	31st	31st	NN
cord-015365-iqdi99pd	2275	12	,	,	,
cord-015365-iqdi99pd	2275	13	2011	2011	CD
cord-015365-iqdi99pd	2275	14	we	-PRON-	PRP
cord-015365-iqdi99pd	2275	15	registered	register	VBD
cord-015365-iqdi99pd	2275	16	an	an	DT
cord-015365-iqdi99pd	2275	17	increase	increase	NN
cord-015365-iqdi99pd	2275	18	of	of	IN
cord-015365-iqdi99pd	2275	19	42	42	CD
cord-015365-iqdi99pd	2275	20	actual	actual	JJ
cord-015365-iqdi99pd	2275	21	donors	donor	NNS
cord-015365-iqdi99pd	2275	22	out	out	IN
cord-015365-iqdi99pd	2275	23	of	of	IN
cord-015365-iqdi99pd	2275	24	69	69	CD
cord-015365-iqdi99pd	2275	25	potentials	potential	NNS
cord-015365-iqdi99pd	2275	26	.	.	.
cord-015365-iqdi99pd	2276	1	Thirteen	thirteen	CD
cord-015365-iqdi99pd	2276	2	donors	donor	NNS
cord-015365-iqdi99pd	2276	3	were	be	VBD
cord-015365-iqdi99pd	2276	4	missed	miss	VBN
cord-015365-iqdi99pd	2276	5	because	because	IN
cord-015365-iqdi99pd	2276	6	of	of	IN
cord-015365-iqdi99pd	2276	7	unaccomplished	unaccomplished	JJ
cord-015365-iqdi99pd	2276	8	brain	brain	NN
cord-015365-iqdi99pd	2276	9	dead	dead	JJ
cord-015365-iqdi99pd	2276	10	criteria	criterion	NNS
cord-015365-iqdi99pd	2276	11	.	.	.
cord-015365-iqdi99pd	2277	1	Moreover	moreover	RB
cord-015365-iqdi99pd	2277	2	eight	eight	CD
cord-015365-iqdi99pd	2277	3	donors	donor	NNS
cord-015365-iqdi99pd	2277	4	were	be	VBD
cord-015365-iqdi99pd	2277	5	lost	lose	VBN
cord-015365-iqdi99pd	2277	6	due	due	IN
cord-015365-iqdi99pd	2277	7	to	to	IN
cord-015365-iqdi99pd	2277	8	their	-PRON-	PRP$
cord-015365-iqdi99pd	2277	9	co	co	NNS
cord-015365-iqdi99pd	2277	10	-	-	NNS
cord-015365-iqdi99pd	2277	11	morbidities	morbidity	NNS
cord-015365-iqdi99pd	2277	12	and	and	CC
cord-015365-iqdi99pd	2277	13	six	six	CD
cord-015365-iqdi99pd	2277	14	because	because	IN
cord-015365-iqdi99pd	2277	15	of	of	IN
cord-015365-iqdi99pd	2277	16	opposition	opposition	NN
cord-015365-iqdi99pd	2277	17	against	against	IN
cord-015365-iqdi99pd	2277	18	organ	organ	NN
cord-015365-iqdi99pd	2277	19	donation	donation	NN
cord-015365-iqdi99pd	2277	20	.	.	.
cord-015365-iqdi99pd	2278	1	However	however	RB
cord-015365-iqdi99pd	2278	2	during	during	IN
cord-015365-iqdi99pd	2278	3	this	this	DT
cord-015365-iqdi99pd	2278	4	evaluation	evaluation	NN
cord-015365-iqdi99pd	2278	5	period	period	NN
cord-015365-iqdi99pd	2278	6	the	the	DT
cord-015365-iqdi99pd	2278	7	donor	donor	NN
cord-015365-iqdi99pd	2278	8	rates	rate	NNS
cord-015365-iqdi99pd	2278	9	increased	increase	VBD
cord-015365-iqdi99pd	2278	10	for	for	IN
cord-015365-iqdi99pd	2278	11	about	about	RB
cord-015365-iqdi99pd	2278	12	35	35	CD
cord-015365-iqdi99pd	2278	13	%	%	NN
cord-015365-iqdi99pd	2278	14	.	.	.
cord-015365-iqdi99pd	2279	1	The	the	DT
cord-015365-iqdi99pd	2279	2	procurement	procurement	NN
cord-015365-iqdi99pd	2279	3	of	of	IN
cord-015365-iqdi99pd	2279	4	transplantable	transplantable	JJ
cord-015365-iqdi99pd	2279	5	kidneys	kidney	NNS
cord-015365-iqdi99pd	2279	6	increased	increase	VBD
cord-015365-iqdi99pd	2279	7	from	from	IN
cord-015365-iqdi99pd	2279	8	60	60	CD
cord-015365-iqdi99pd	2279	9	to	to	IN
cord-015365-iqdi99pd	2279	10	66	66	CD
cord-015365-iqdi99pd	2279	11	,	,	,
cord-015365-iqdi99pd	2279	12	transplantable	transplantable	JJ
cord-015365-iqdi99pd	2279	13	lungs	lung	NNS
cord-015365-iqdi99pd	2279	14	increased	increase	VBD
cord-015365-iqdi99pd	2279	15	from	from	IN
cord-015365-iqdi99pd	2279	16	12	12	CD
cord-015365-iqdi99pd	2279	17	to	to	TO
cord-015365-iqdi99pd	2279	18	13	13	CD
cord-015365-iqdi99pd	2279	19	and	and	CC
cord-015365-iqdi99pd	2279	20	in	in	IN
cord-015365-iqdi99pd	2279	21	liver	liver	NN
cord-015365-iqdi99pd	2279	22	procurement	procurement	NN
cord-015365-iqdi99pd	2279	23	,	,	,
cord-015365-iqdi99pd	2279	24	we	-PRON-	PRP
cord-015365-iqdi99pd	2279	25	could	could	MD
cord-015365-iqdi99pd	2279	26	even	even	RB
cord-015365-iqdi99pd	2279	27	register	register	VB
cord-015365-iqdi99pd	2279	28	an	an	DT
cord-015365-iqdi99pd	2279	29	increase	increase	NN
cord-015365-iqdi99pd	2279	30	from	from	IN
cord-015365-iqdi99pd	2279	31	13	13	CD
cord-015365-iqdi99pd	2279	32	to	to	TO
cord-015365-iqdi99pd	2279	33	22	22	CD
cord-015365-iqdi99pd	2279	34	transplantable	transplantable	JJ
cord-015365-iqdi99pd	2279	35	organs	organ	NNS
cord-015365-iqdi99pd	2279	36	.	.	.
cord-015365-iqdi99pd	2280	1	Only	only	RB
cord-015365-iqdi99pd	2280	2	in	in	IN
cord-015365-iqdi99pd	2280	3	heart	heart	NN
cord-015365-iqdi99pd	2280	4	procurement	procurement	NN
cord-015365-iqdi99pd	2280	5	we	-PRON-	PRP
cord-015365-iqdi99pd	2280	6	registered	register	VBD
cord-015365-iqdi99pd	2280	7	a	a	DT
cord-015365-iqdi99pd	2280	8	decrease	decrease	NN
cord-015365-iqdi99pd	2280	9	from	from	IN
cord-015365-iqdi99pd	2280	10	16	16	CD
cord-015365-iqdi99pd	2280	11	to	to	TO
cord-015365-iqdi99pd	2280	12	13	13	CD
cord-015365-iqdi99pd	2280	13	transplantable	transplantable	JJ
cord-015365-iqdi99pd	2280	14	organs	organ	NNS
cord-015365-iqdi99pd	2280	15	.	.	.
cord-015365-iqdi99pd	2281	1	These	these	DT
cord-015365-iqdi99pd	2281	2	results	result	NNS
cord-015365-iqdi99pd	2281	3	show	show	VBP
cord-015365-iqdi99pd	2281	4	a	a	DT
cord-015365-iqdi99pd	2281	5	remarkable	remarkable	JJ
cord-015365-iqdi99pd	2281	6	effect	effect	NN
cord-015365-iqdi99pd	2281	7	of	of	IN
cord-015365-iqdi99pd	2281	8	this	this	DT
cord-015365-iqdi99pd	2281	9	training	training	NN
cord-015365-iqdi99pd	2281	10	program	program	NN
cord-015365-iqdi99pd	2281	11	as	as	RB
cord-015365-iqdi99pd	2281	12	well	well	RB
cord-015365-iqdi99pd	2281	13	as	as	IN
cord-015365-iqdi99pd	2281	14	the	the	DT
cord-015365-iqdi99pd	2281	15	fluctuation	fluctuation	NN
cord-015365-iqdi99pd	2281	16	of	of	IN
cord-015365-iqdi99pd	2281	17	potential	potential	JJ
cord-015365-iqdi99pd	2281	18	donors	donor	NNS
cord-015365-iqdi99pd	2281	19	and	and	CC
cord-015365-iqdi99pd	2281	20	the	the	DT
cord-015365-iqdi99pd	2281	21	diverse	diverse	JJ
cord-015365-iqdi99pd	2281	22	potential	potential	NN
cord-015365-iqdi99pd	2281	23	of	of	IN
cord-015365-iqdi99pd	2281	24	organ	organ	NN
cord-015365-iqdi99pd	2281	25	recovery	recovery	NN
cord-015365-iqdi99pd	2281	26	during	during	IN
cord-015365-iqdi99pd	2281	27	this	this	DT
cord-015365-iqdi99pd	2281	28	year	year	NN
cord-015365-iqdi99pd	2281	29	.	.	.
cord-015365-iqdi99pd	2282	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2282	2	.	.	.
cord-015365-iqdi99pd	2283	1	After	after	IN
cord-015365-iqdi99pd	2283	2	all	all	DT
cord-015365-iqdi99pd	2283	3	training	training	NN
cord-015365-iqdi99pd	2283	4	programs	program	NNS
cord-015365-iqdi99pd	2283	5	in	in	IN
cord-015365-iqdi99pd	2283	6	organ	organ	NN
cord-015365-iqdi99pd	2283	7	donation	donation	NN
cord-015365-iqdi99pd	2283	8	are	be	VBP
cord-015365-iqdi99pd	2283	9	an	an	DT
cord-015365-iqdi99pd	2283	10	interesting	interesting	JJ
cord-015365-iqdi99pd	2283	11	field	field	NN
cord-015365-iqdi99pd	2283	12	and	and	CC
cord-015365-iqdi99pd	2283	13	seem	seem	VBP
cord-015365-iqdi99pd	2283	14	to	to	TO
cord-015365-iqdi99pd	2283	15	increase	increase	VB
cord-015365-iqdi99pd	2283	16	organ	organ	NN
cord-015365-iqdi99pd	2283	17	donation	donation	NN
cord-015365-iqdi99pd	2283	18	rates	rate	NNS
cord-015365-iqdi99pd	2283	19	.	.	.
cord-015365-iqdi99pd	2284	1	Efforts	effort	NNS
cord-015365-iqdi99pd	2284	2	have	have	VBP
cord-015365-iqdi99pd	2284	3	to	to	TO
cord-015365-iqdi99pd	2284	4	be	be	VB
cord-015365-iqdi99pd	2284	5	made	make	VBN
cord-015365-iqdi99pd	2284	6	to	to	TO
cord-015365-iqdi99pd	2284	7	provide	provide	VB
cord-015365-iqdi99pd	2284	8	and	and	CC
cord-015365-iqdi99pd	2284	9	spread	spread	VB
cord-015365-iqdi99pd	2284	10	profound	profound	JJ
cord-015365-iqdi99pd	2284	11	knowledge	knowledge	NN
cord-015365-iqdi99pd	2284	12	and	and	CC
cord-015365-iqdi99pd	2284	13	skills	skill	NNS
cord-015365-iqdi99pd	2284	14	for	for	IN
cord-015365-iqdi99pd	2284	15	health	health	NN
cord-015365-iqdi99pd	2284	16	care	care	NN
cord-015365-iqdi99pd	2284	17	professionals	professional	NNS
cord-015365-iqdi99pd	2284	18	,	,	,
cord-015365-iqdi99pd	2284	19	working	work	VBG
cord-015365-iqdi99pd	2284	20	in	in	IN
cord-015365-iqdi99pd	2284	21	the	the	DT
cord-015365-iqdi99pd	2284	22	transplantation	transplantation	NN
cord-015365-iqdi99pd	2284	23	field	field	NN
cord-015365-iqdi99pd	2284	24	.	.	.
cord-015365-iqdi99pd	2285	1	pneumonia	pneumonia	NN
cord-015365-iqdi99pd	2285	2	and	and	CC
cord-015365-iqdi99pd	2285	3	had	have	VBD
cord-015365-iqdi99pd	2285	4	to	to	TO
cord-015365-iqdi99pd	2285	5	be	be	VB
cord-015365-iqdi99pd	2285	6	admitted	admit	VBN
cord-015365-iqdi99pd	2285	7	.	.	.
cord-015365-iqdi99pd	2286	1	The	the	DT
cord-015365-iqdi99pd	2286	2	patient	patient	NN
cord-015365-iqdi99pd	2286	3	with	with	IN
cord-015365-iqdi99pd	2286	4	BOS	BOS	NNP
cord-015365-iqdi99pd	2286	5	II	II	NNP
cord-015365-iqdi99pd	2286	6	died	die	VBD
cord-015365-iqdi99pd	2286	7	due	due	JJ
cord-015365-iqdi99pd	2286	8	to	to	IN
cord-015365-iqdi99pd	2286	9	acute	acute	JJ
cord-015365-iqdi99pd	2286	10	respiratory	respiratory	JJ
cord-015365-iqdi99pd	2286	11	distress	distress	NN
cord-015365-iqdi99pd	2286	12	syndrome	syndrome	NN
cord-015365-iqdi99pd	2286	13	(	(	-LRB-
cord-015365-iqdi99pd	2286	14	ARDS	ARDS	NNP
cord-015365-iqdi99pd	2286	15	)	)	-RRB-
cord-015365-iqdi99pd	2286	16	.	.	.
cord-015365-iqdi99pd	2287	1	Both	both	DT
cord-015365-iqdi99pd	2287	2	patients	patient	NNS
cord-015365-iqdi99pd	2287	3	received	receive	VBD
cord-015365-iqdi99pd	2287	4	no	no	DT
cord-015365-iqdi99pd	2287	5	vaccination	vaccination	NN
cord-015365-iqdi99pd	2287	6	.	.	.
cord-015365-iqdi99pd	2288	1	The	the	DT
cord-015365-iqdi99pd	2288	2	other	other	JJ
cord-015365-iqdi99pd	2288	3	two	two	CD
cord-015365-iqdi99pd	2288	4	LTRs	ltr	NNS
cord-015365-iqdi99pd	2288	5	,	,	,
cord-015365-iqdi99pd	2288	6	one	one	CD
cord-015365-iqdi99pd	2288	7	with	with	IN
cord-015365-iqdi99pd	2288	8	BOS	BOS	NNP
cord-015365-iqdi99pd	2289	1	I	-PRON-	PRP
cord-015365-iqdi99pd	2289	2	the	the	DT
cord-015365-iqdi99pd	2289	3	other	other	JJ
cord-015365-iqdi99pd	2289	4	with	with	IN
cord-015365-iqdi99pd	2289	5	BOS	BOS	NNP
cord-015365-iqdi99pd	2289	6	II	II	NNP
cord-015365-iqdi99pd	2289	7	and	and	CC
cord-015365-iqdi99pd	2289	8	active	active	JJ
cord-015365-iqdi99pd	2289	9	vaccination	vaccination	NN
cord-015365-iqdi99pd	2289	10	protection	protection	NN
cord-015365-iqdi99pd	2289	11	were	be	VBD
cord-015365-iqdi99pd	2289	12	treated	treat	VBN
cord-015365-iqdi99pd	2289	13	with	with	IN
cord-015365-iqdi99pd	2289	14	Oseltamivir	Oseltamivir	NNP
cord-015365-iqdi99pd	2289	15	at	at	IN
cord-015365-iqdi99pd	2289	16	the	the	DT
cord-015365-iqdi99pd	2289	17	time	time	NN
cord-015365-iqdi99pd	2289	18	of	of	IN
cord-015365-iqdi99pd	2289	19	the	the	DT
cord-015365-iqdi99pd	2289	20	first	first	JJ
cord-015365-iqdi99pd	2289	21	clinical	clinical	JJ
cord-015365-iqdi99pd	2289	22	assessment	assessment	NN
cord-015365-iqdi99pd	2289	23	,	,	,
cord-015365-iqdi99pd	2289	24	without	without	IN
cord-015365-iqdi99pd	2289	25	any	any	DT
cord-015365-iqdi99pd	2289	26	further	further	JJ
cord-015365-iqdi99pd	2289	27	respiratory	respiratory	JJ
cord-015365-iqdi99pd	2289	28	complications	complication	NNS
cord-015365-iqdi99pd	2289	29	.	.	.
cord-015365-iqdi99pd	2290	1	Therapy	therapy	NN
cord-015365-iqdi99pd	2290	2	with	with	IN
cord-015365-iqdi99pd	2290	3	Oseltamivir	Oseltamivir	NNP
cord-015365-iqdi99pd	2290	4	was	be	VBD
cord-015365-iqdi99pd	2290	5	only	only	RB
cord-015365-iqdi99pd	2290	6	started	start	VBN
cord-015365-iqdi99pd	2290	7	with	with	IN
cord-015365-iqdi99pd	2290	8	clinical	clinical	JJ
cord-015365-iqdi99pd	2290	9	assessment	assessment	NN
cord-015365-iqdi99pd	2290	10	within	within	IN
cord-015365-iqdi99pd	2290	11	the	the	DT
cord-015365-iqdi99pd	2290	12	first	first	JJ
cord-015365-iqdi99pd	2290	13	48	48	CD
cord-015365-iqdi99pd	2290	14	hours	hour	NNS
cord-015365-iqdi99pd	2290	15	.	.	.
cord-015365-iqdi99pd	2291	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2291	2	.	.	.
cord-015365-iqdi99pd	2292	1	Our	-PRON-	PRP$
cord-015365-iqdi99pd	2292	2	review	review	NN
cord-015365-iqdi99pd	2292	3	shows	show	VBZ
cord-015365-iqdi99pd	2292	4	a	a	DT
cord-015365-iqdi99pd	2292	5	causal	causal	JJ
cord-015365-iqdi99pd	2292	6	link	link	NN
cord-015365-iqdi99pd	2292	7	between	between	IN
cord-015365-iqdi99pd	2292	8	preexisting	preexist	VBG
cord-015365-iqdi99pd	2292	9	BOS	BOS	NNP
cord-015365-iqdi99pd	2292	10	,	,	,
cord-015365-iqdi99pd	2292	11	vaccination	vaccination	NN
cord-015365-iqdi99pd	2292	12	state	state	NN
cord-015365-iqdi99pd	2292	13	and	and	CC
cord-015365-iqdi99pd	2292	14	the	the	DT
cord-015365-iqdi99pd	2292	15	severeness	severeness	NN
cord-015365-iqdi99pd	2292	16	of	of	IN
cord-015365-iqdi99pd	2292	17	respiratory	respiratory	JJ
cord-015365-iqdi99pd	2292	18	symptoms	symptom	NNS
cord-015365-iqdi99pd	2292	19	after	after	IN
cord-015365-iqdi99pd	2292	20	infection	infection	NN
cord-015365-iqdi99pd	2292	21	with	with	IN
cord-015365-iqdi99pd	2292	22	community	community	NN
cord-015365-iqdi99pd	2292	23	acquired	acquire	VBD
cord-015365-iqdi99pd	2292	24	respiratory	respiratory	JJ
cord-015365-iqdi99pd	2292	25	viruses	virus	NNS
cord-015365-iqdi99pd	2292	26	and	and	CC
cord-015365-iqdi99pd	2292	27	the	the	DT
cord-015365-iqdi99pd	2292	28	clinical	clinical	JJ
cord-015365-iqdi99pd	2292	29	effectiveness	effectiveness	NN
cord-015365-iqdi99pd	2292	30	of	of	IN
cord-015365-iqdi99pd	2292	31	seasonal	seasonal	JJ
cord-015365-iqdi99pd	2292	32	influenza	influenza	NN
cord-015365-iqdi99pd	2292	33	vaccination	vaccination	NN
cord-015365-iqdi99pd	2292	34	especially	especially	RB
cord-015365-iqdi99pd	2292	35	in	in	IN
cord-015365-iqdi99pd	2292	36	BOS	BOS	NNP
cord-015365-iqdi99pd	2292	37	patients	patient	NNS
cord-015365-iqdi99pd	2292	38	.	.	.
cord-015365-iqdi99pd	2293	1	A.	A.	NNP
cord-015365-iqdi99pd	2293	2	Scheed	Scheed	NNP
cord-015365-iqdi99pd	2293	3	1	1	CD
cord-015365-iqdi99pd	2293	4	,	,	,
cord-015365-iqdi99pd	2293	5	A.	A.	NNP
cord-015365-iqdi99pd	2293	6	Aliabadi	Aliabadi	NNP
cord-015365-iqdi99pd	2293	7	2	2	CD
cord-015365-iqdi99pd	2293	8	,	,	,
cord-015365-iqdi99pd	2293	9	P.	P.	NNP
cord-015365-iqdi99pd	2293	10	Jaksch	Jaksch	NNP
cord-015365-iqdi99pd	2293	11	1	1	CD
cord-015365-iqdi99pd	2293	12	,	,	,
cord-015365-iqdi99pd	2293	13	S.	S.	NNP
cord-015365-iqdi99pd	2293	14	Taghavi	Taghavi	NNP
cord-015365-iqdi99pd	2293	15	1	1	CD
cord-015365-iqdi99pd	2293	16	,	,	,
cord-015365-iqdi99pd	2293	17	W.	W.	NNP
cord-015365-iqdi99pd	2293	18	Klepetko	Klepetko	NNP
cord-015365-iqdi99pd	2293	19	1	1	CD
cord-015365-iqdi99pd	2293	20	,	,	,
cord-015365-iqdi99pd	2293	21	A.	A.	NNP
cord-015365-iqdi99pd	2293	22	Zuckermann	Zuckermann	NNP
cord-015365-iqdi99pd	2293	23	2	2	CD
cord-015365-iqdi99pd	2293	24	Bei	Bei	NNP
cord-015365-iqdi99pd	2293	25	836	836	CD
cord-015365-iqdi99pd	2293	26	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2293	27	mit	mit	NN
cord-015365-iqdi99pd	2293	28	funktionierendem	funktionierendem	JJ
cord-015365-iqdi99pd	2293	29	Transplantat	Transplantat	NNP
cord-015365-iqdi99pd	2293	30	ein	ein	NNP
cord-015365-iqdi99pd	2293	31	Jahr	Jahr	NNP
cord-015365-iqdi99pd	2293	32	nach	nach	NN
cord-015365-iqdi99pd	2293	33	der	der	NNP
cord-015365-iqdi99pd	2293	34	Transplantation	Transplantation	NNP
cord-015365-iqdi99pd	2293	35	,	,	,
cord-015365-iqdi99pd	2293	36	die	die	VBP
cord-015365-iqdi99pd	2293	37	in	in	IN
cord-015365-iqdi99pd	2293	38	unterschiedlichen	unterschiedlichen	NN
cord-015365-iqdi99pd	2293	39	Perioden	Perioden	NNP
cord-015365-iqdi99pd	2294	1	1990/1991	1990/1991	CD
cord-015365-iqdi99pd	2294	2	(	(	-LRB-
cord-015365-iqdi99pd	2294	3	n	n	CC
cord-015365-iqdi99pd	2294	4	¼	¼	NNP
cord-015365-iqdi99pd	2294	5	129	129	CD
cord-015365-iqdi99pd	2294	6	)	)	-RRB-
cord-015365-iqdi99pd	2294	7	sowie	sowie	CD
cord-015365-iqdi99pd	2294	8	die	die	VBP
cord-015365-iqdi99pd	2295	1	i	-PRON-	PRP
cord-015365-iqdi99pd	2295	2	m	be	VBP
cord-015365-iqdi99pd	2295	3	Rahmen	Rahmen	NNP
cord-015365-iqdi99pd	2295	4	von	von	NNP
cord-015365-iqdi99pd	2295	5	Patientenselbstmessungen	Patientenselbstmessungen	NNP
cord-015365-iqdi99pd	2295	6	erhobenen	erhobenen	NNP
cord-015365-iqdi99pd	2295	7	Blutdruckwerte	Blutdruckwerte	NNP
cord-015365-iqdi99pd	2295	8	analysiert	analysiert	NN
cord-015365-iqdi99pd	2295	9	Bei	Bei	NNP
cord-015365-iqdi99pd	2295	10	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2295	11	,	,	,
cord-015365-iqdi99pd	2295	12	die	die	VBP
cord-015365-iqdi99pd	2295	13	auf	auf	NNP
cord-015365-iqdi99pd	2295	14	der	der	NNP
cord-015365-iqdi99pd	2295	15	Leberwarteliste	Leberwarteliste	NNP
cord-015365-iqdi99pd	2295	16	stehen	stehen	NNP
cord-015365-iqdi99pd	2295	17	,	,	,
cord-015365-iqdi99pd	2295	18	korrelieren	korrelieren	NNP
cord-015365-iqdi99pd	2295	19	ösophagogastrale	ösophagogastrale	NNP
cord-015365-iqdi99pd	2295	20	Varizen	Varizen	NNP
cord-015365-iqdi99pd	2295	21	mit	mit	NNP
cord-015365-iqdi99pd	2295	22	dem	dem	NNP
cord-015365-iqdi99pd	2295	23	Grad	Grad	NNP
cord-015365-iqdi99pd	2295	24	der	der	NNP
cord-015365-iqdi99pd	2295	25	Lebererkrankung	Lebererkrankung	NNP
cord-015365-iqdi99pd	2295	26	R.	R.	NNP
cord-015365-iqdi99pd	2295	27	Schwarzer	Schwarzer	NNP
cord-015365-iqdi99pd	2295	28	1	1	CD
cord-015365-iqdi99pd	2295	29	,	,	,
cord-015365-iqdi99pd	2295	30	M.	M.	NNP
cord-015365-iqdi99pd	2295	31	Thum	Thum	NNP
cord-015365-iqdi99pd	2295	32	1	1	CD
cord-015365-iqdi99pd	2295	33	,	,	,
cord-015365-iqdi99pd	2295	34	R.	R.	NNP
cord-015365-iqdi99pd	2295	35	Karatosic	Karatosic	NNP
cord-015365-iqdi99pd	2295	36	2	2	CD
cord-015365-iqdi99pd	2295	37	,	,	,
cord-015365-iqdi99pd	2296	1	U.	U.	NNP
cord-015365-iqdi99pd	2296	2	Burger	Burger	NNP
cord-015365-iqdi99pd	2296	3	-	-	HYPH
cord-015365-iqdi99pd	2296	4	Klepp	Klepp	NNP
cord-015365-iqdi99pd	2296	5	Mark	Mark	NNP
cord-015365-iqdi99pd	2296	6	1	1	CD
cord-015365-iqdi99pd	2296	7	of	of	IN
cord-015365-iqdi99pd	2296	8	recipient-	recipient-	NN
cord-015365-iqdi99pd	2296	9	,	,	,
cord-015365-iqdi99pd	2296	10	donor	donor	NN
cord-015365-iqdi99pd	2296	11	-	-	HYPH
cord-015365-iqdi99pd	2296	12	and	and	CC
cord-015365-iqdi99pd	2296	13	transplantcharacteristics	transplantcharacteristic	NNS
cord-015365-iqdi99pd	2296	14	were	be	VBD
cord-015365-iqdi99pd	2296	15	analyzed	analyze	VBN
cord-015365-iqdi99pd	2296	16	using	use	VBG
cord-015365-iqdi99pd	2296	17	uni	uni	NN
cord-015365-iqdi99pd	2296	18	-	-	HYPH
cord-015365-iqdi99pd	2296	19	and	and	CC
cord-015365-iqdi99pd	2296	20	multivariate	multivariate	JJ
cord-015365-iqdi99pd	2296	21	analyses	analysis	NNS
cord-015365-iqdi99pd	2296	22	Kinder	Kinder	NNP
cord-015365-iqdi99pd	2296	23	mit	mit	NNP
cord-015365-iqdi99pd	2296	24	hoch	hoch	NNP
cord-015365-iqdi99pd	2296	25	ungünstigem	ungünstigem	NNP
cord-015365-iqdi99pd	2296	26	SVM	SVM	NNP
cord-015365-iqdi99pd	2296	27	hatten	hatten	NNP
cord-015365-iqdi99pd	2296	28	höhere	höhere	NNP
cord-015365-iqdi99pd	2296	29	24h	24h	NNPS
cord-015365-iqdi99pd	2296	30	-	-	HYPH
cord-015365-iqdi99pd	2296	31	RR	RR	NNP
cord-015365-iqdi99pd	2296	32	Werte	Werte	NNP
cord-015365-iqdi99pd	2296	33	.	.	.
cord-015365-iqdi99pd	2297	1	Die	die	VB
cord-015365-iqdi99pd	2297	2	RR	RR	NNP
cord-015365-iqdi99pd	2297	3	-	-	HYPH
cord-015365-iqdi99pd	2297	4	Differenz	Differenz	NNP
cord-015365-iqdi99pd	2297	5	aus	aus	NNP
cord-015365-iqdi99pd	2297	6	Klinik	Klinik	NNP
cord-015365-iqdi99pd	2297	7	-	-	HYPH
cord-015365-iqdi99pd	2297	8	RR	RR	NNP
cord-015365-iqdi99pd	2297	9	und	und	IN
cord-015365-iqdi99pd	2297	10	24hRR	24hRR	NNP
cord-015365-iqdi99pd	2297	11	war	war	NN
cord-015365-iqdi99pd	2297	12	jedoch	jedoch	NNP
cord-015365-iqdi99pd	2297	13	höher	höher	RBR
cord-015365-iqdi99pd	2297	14	bei	bei	NNP
cord-015365-iqdi99pd	2297	15	Kindern	Kindern	NNP
cord-015365-iqdi99pd	2297	16	mit	mit	NNP
cord-015365-iqdi99pd	2297	17	günstigem	günstigem	NNP
cord-015365-iqdi99pd	2297	18	SVM	SVM	NNP
cord-015365-iqdi99pd	2297	19	.	.	.
cord-015365-iqdi99pd	2298	1	Es	Es	NNP
cord-015365-iqdi99pd	2298	2	konnte	konnte	NNP
cord-015365-iqdi99pd	2298	3	kein	kein	NNP
cord-015365-iqdi99pd	2298	4	Zusammenhang	Zusammenhang	NNP
cord-015365-iqdi99pd	2298	5	zwischen	zwischen	NNP
cord-015365-iqdi99pd	2298	6	SVM	SVM	NNP
cord-015365-iqdi99pd	2298	7	und	und	IN
cord-015365-iqdi99pd	2298	8	Klinik	Klinik	NNP
cord-015365-iqdi99pd	2298	9	-	-	HYPH
cord-015365-iqdi99pd	2298	10	RR	RR	NNP
cord-015365-iqdi99pd	2298	11	gefunden	gefunden	NN
cord-015365-iqdi99pd	2298	12	werden	werden	NNP
cord-015365-iqdi99pd	2298	13	.	.	.
cord-015365-iqdi99pd	2299	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	2299	2	.	.	.
cord-015365-iqdi99pd	2300	1	Unsere	Unsere	NNP
cord-015365-iqdi99pd	2300	2	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2300	3	zeigen	zeigen	NNP
cord-015365-iqdi99pd	2300	4	,	,	,
cord-015365-iqdi99pd	2300	5	dass	dass	NNP
cord-015365-iqdi99pd	2300	6	Stressverarbeitungsmechanismen	Stressverarbeitungsmechanismen	NNP
cord-015365-iqdi99pd	2300	7	bei	bei	NNP
cord-015365-iqdi99pd	2300	8	der	der	NNP
cord-015365-iqdi99pd	2300	9	Blutdruck	Blutdruck	NNP
cord-015365-iqdi99pd	2300	10	-	-	HYPH
cord-015365-iqdi99pd	2300	11	Regulation	Regulation	NNP
cord-015365-iqdi99pd	2300	12	nach	nach	NN
cord-015365-iqdi99pd	2300	13	NTX	NTX	NNP
cord-015365-iqdi99pd	2301	1	eine	eine	NNP
cord-015365-iqdi99pd	2301	2	Rolle	Rolle	NNP
cord-015365-iqdi99pd	2301	3	spielen	spielen	NNP
cord-015365-iqdi99pd	2301	4	Attitude	Attitude	NNP
cord-015365-iqdi99pd	2301	5	towards	towards	IN
cord-015365-iqdi99pd	2301	6	xenotransplantation	xenotransplantation	NN
cord-015365-iqdi99pd	2301	7	of	of	IN
cord-015365-iqdi99pd	2301	8	patients	patient	NNS
cord-015365-iqdi99pd	2301	9	prior	prior	RB
cord-015365-iqdi99pd	2301	10	and	and	CC
cord-015365-iqdi99pd	2301	11	after	after	IN
cord-015365-iqdi99pd	2301	12	human	human	JJ
cord-015365-iqdi99pd	2301	13	organ	organ	NN
cord-015365-iqdi99pd	2301	14	transplantation	transplantation	NN
cord-015365-iqdi99pd	2301	15	V	V	NNP
cord-015365-iqdi99pd	2301	16	53	53	CD
cord-015365-iqdi99pd	2302	1	I	-PRON-	PRP
cord-015365-iqdi99pd	2303	1	Iberer	Iberer	NNP
cord-015365-iqdi99pd	2303	2	,	,	,
cord-015365-iqdi99pd	2303	3	F.	F.	NNP
cord-015365-iqdi99pd	2303	4	30	30	CD
cord-015365-iqdi99pd	2303	5	43	43	CD
cord-015365-iqdi99pd	2303	6	Ö	Ö	NNP
cord-015365-iqdi99pd	2303	7	ttl	ttl	NN
cord-015365-iqdi99pd	2303	8	,	,	,
cord-015365-iqdi99pd	2303	9	K.	K.	NNP
cord-015365-iqdi99pd	2303	10	41	41	CD
cord-015365-iqdi99pd	2303	11	P	p	NN
cord-015365-iqdi99pd	2303	12	Pacini	Pacini	NNP
cord-015365-iqdi99pd	2303	13	Druck	Druck	NNP
cord-015365-iqdi99pd	2303	14	:	:	:
cord-015365-iqdi99pd	2303	15	Holzhausen	Holzhausen	NNP
cord-015365-iqdi99pd	2303	16	Druck	Druck	NNP
cord-015365-iqdi99pd	2303	17	GmbH	GmbH	NNP
cord-015365-iqdi99pd	2303	18	,	,	,
cord-015365-iqdi99pd	2303	19	1140	1140	CD
cord-015365-iqdi99pd	2303	20	Wien	Wien	NNP
cord-015365-iqdi99pd	2303	21	Ö	Ö	NNP
cord-015365-iqdi99pd	2303	22	sterreich	sterreich	NN
cord-015365-iqdi99pd	2303	23	.	.	.
cord-015365-iqdi99pd	2304	1	-Verlagsort	-Verlagsort	:
cord-015365-iqdi99pd	2304	2	:	:	:
cord-015365-iqdi99pd	2305	1	Wien	Wien	NNP
cord-015365-iqdi99pd	2305	2	.	.	.
cord-015365-iqdi99pd	2306	1	-Herstellungsort	-Herstellungsort	:
cord-015365-iqdi99pd	2306	2	:	:	:
cord-015365-iqdi99pd	2306	3	Wien	Wien	NNP
cord-015365-iqdi99pd	2306	4	.	.	.
cord-015365-iqdi99pd	2307	1	Printed	print	VBN
cord-015365-iqdi99pd	2307	2	in	in	IN
cord-015365-iqdi99pd	2307	3	Austria	Austria	NNP
cord-015365-iqdi99pd	2308	1	P.	P.	NNP
cord-015365-iqdi99pd	2308	2	b.	b.	NNP
cord-015365-iqdi99pd	2308	3	b.=	b.=	NNP
cord-015365-iqdi99pd	2308	4	=	=	SYM
cord-015365-iqdi99pd	2308	5	Erscheinungsort	Erscheinungsort	NNP
cord-015365-iqdi99pd	2308	6	:	:	:
cord-015365-iqdi99pd	2309	1	Wien=	wien=	NN
cord-015365-iqdi99pd	2309	2	=	=	.
cord-015365-iqdi99pd	2310	1	Verlagspostamt	Verlagspostamt	NNP
cord-015365-iqdi99pd	2310	2	1201	1201	CD
cord-015365-iqdi99pd	2311	1	Wien	Wien	NNP
cord-015365-iqdi99pd	2311	2	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2311	3	.	.	.
cord-015365-iqdi99pd	2312	1	Unter	Unter	NNP
cord-015365-iqdi99pd	2312	2	konsequenter	konsequenter	NNP
cord-015365-iqdi99pd	2312	3	systemischer	systemischer	NNP
cord-015365-iqdi99pd	2313	1	und	und	NNP
cord-015365-iqdi99pd	2314	1	topischer	topischer	NNP
cord-015365-iqdi99pd	2314	2	Therapie	Therapie	NNP
cord-015365-iqdi99pd	2314	3	mit	mit	NNP
cord-015365-iqdi99pd	2314	4	liposomalem	liposomalem	NN
cord-015365-iqdi99pd	2314	5	Amphotericin	Amphotericin	NNP
cord-015365-iqdi99pd	2314	6	B	B	NNP
cord-015365-iqdi99pd	2314	7	gefolgt	gefolgt	NNP
cord-015365-iqdi99pd	2314	8	von	von	NNP
cord-015365-iqdi99pd	2314	9	Voriconazol	Voriconazol	NNP
cord-015365-iqdi99pd	2314	10	,	,	,
cord-015365-iqdi99pd	2314	11	und	und	IN
cord-015365-iqdi99pd	2314	12	Reduktion	Reduktion	NNP
cord-015365-iqdi99pd	2314	13	der	der	NNP
cord-015365-iqdi99pd	2314	14	Immunosuppression	Immunosuppression	NNP
cord-015365-iqdi99pd	2314	15	(	(	-LRB-
cord-015365-iqdi99pd	2314	16	Tacrolimusspiegel	Tacrolimusspiegel	NNP
cord-015365-iqdi99pd	2314	17	um	um	UH
cord-015365-iqdi99pd	2314	18	10	10	CD
cord-015365-iqdi99pd	2314	19	ng	ng	NN
cord-015365-iqdi99pd	2314	20	/	/	SYM
cord-015365-iqdi99pd	2314	21	ml	ml	XX
cord-015365-iqdi99pd	2314	22	,	,	,
cord-015365-iqdi99pd	2314	23	Cortison	Cortison	NNP
cord-015365-iqdi99pd	2314	24	10	10	CD
cord-015365-iqdi99pd	2314	25	mg	mg	NNP
cord-015365-iqdi99pd	2314	26	)	)	-RRB-
cord-015365-iqdi99pd	2315	1	,	,	,
cord-015365-iqdi99pd	2315	2	war	war	NN
cord-015365-iqdi99pd	2315	3	die	die	VBP
cord-015365-iqdi99pd	2315	4	Pneumonie	Pneumonie	NNP
cord-015365-iqdi99pd	2315	5	rückläufig	rückläufig	NN
cord-015365-iqdi99pd	2315	6	bis	bis	NNP
cord-015365-iqdi99pd	2315	7	zum	zum	NNP
cord-015365-iqdi99pd	2315	8	9	9	CD
cord-015365-iqdi99pd	2315	9	.	.	.
cord-015365-iqdi99pd	2316	1	po	po	NNP
cord-015365-iqdi99pd	2316	2	.	.	.
cord-015365-iqdi99pd	2317	1	Monat	Monat	NNP
cord-015365-iqdi99pd	2317	2	.	.	.
cord-015365-iqdi99pd	2318	1	I	-PRON-	PRP
cord-015365-iqdi99pd	2319	1	m	m	NNP
cord-015365-iqdi99pd	2319	2	12	12	CD
cord-015365-iqdi99pd	2319	3	.	.	.
cord-015365-iqdi99pd	2320	1	po	po	NNP
cord-015365-iqdi99pd	2320	2	.	.	.
cord-015365-iqdi99pd	2321	1	Monat	Monat	NNP
cord-015365-iqdi99pd	2321	2	ist	ist	NNP
cord-015365-iqdi99pd	2321	3	die	die	VBP
cord-015365-iqdi99pd	2321	4	Patientin	Patientin	NNP
cord-015365-iqdi99pd	2321	5	in	in	IN
cord-015365-iqdi99pd	2321	6	gutem	gutem	NNP
cord-015365-iqdi99pd	2321	7	Allgemeinzustand	Allgemeinzustand	NNP
cord-015365-iqdi99pd	2321	8	mit	mit	NNP
cord-015365-iqdi99pd	2321	9	klinisch	klinisch	NNP
cord-015365-iqdi99pd	2321	10	-	-	HYPH
cord-015365-iqdi99pd	2321	11	bioptisch	bioptisch	JJ
cord-015365-iqdi99pd	2321	12	bestätigter	bestätigter	NNP
cord-015365-iqdi99pd	2321	13	stabiler	stabiler	NNP
cord-015365-iqdi99pd	2321	14	Transplantatfunktion	Transplantatfunktion	NNP
cord-015365-iqdi99pd	2321	15	,	,	,
cord-015365-iqdi99pd	2321	16	ausreichender	ausreichender	NNP
cord-015365-iqdi99pd	2321	17	oraler	oraler	NNP
cord-015365-iqdi99pd	2321	18	Ernährung	Ernährung	NNP
cord-015365-iqdi99pd	2321	19	,	,	,
cord-015365-iqdi99pd	2321	20	stabilem	stabilem	NNP
cord-015365-iqdi99pd	2321	21	Körpergewicht	Körpergewicht	NNP
cord-015365-iqdi99pd	2321	22	,	,	,
cord-015365-iqdi99pd	2322	1	normaler	normaler	NNP
cord-015365-iqdi99pd	2322	2	Leukozytenzahl	Leukozytenzahl	NNP
cord-015365-iqdi99pd	2322	3	nach	nach	NNP
cord-015365-iqdi99pd	2322	4	beherrschten	beherrschten	NNP
cord-015365-iqdi99pd	2323	1	Infektionen	Infektionen	NNP
cord-015365-iqdi99pd	2323	2	(	(	-LRB-
cord-015365-iqdi99pd	2323	3	Zystitis	Zystitis	NNP
cord-015365-iqdi99pd	2323	4	,	,	,
cord-015365-iqdi99pd	2323	5	Lidabszeß	Lidabszeß	NNP
cord-015365-iqdi99pd	2323	6	,	,	,
cord-015365-iqdi99pd	2323	7	Herpesstomatitis).Schlussfolgerungen	Herpesstomatitis).Schlussfolgerungen	NNP
cord-015365-iqdi99pd	2323	8	.	.	.
cord-015365-iqdi99pd	2324	1	Unter	unter	JJ
cord-015365-iqdi99pd	2324	2	sorgfältiger	sorgfältiger	NNP
cord-015365-iqdi99pd	2324	3	Anpassung	Anpassung	NNP
cord-015365-iqdi99pd	2324	4	der	der	NNP
cord-015365-iqdi99pd	2324	5	Immunosuppression	Immunosuppression	NNP
cord-015365-iqdi99pd	2325	1	und	und	IN
cord-015365-iqdi99pd	2325	2	konsequenter	konsequenter	NNP
cord-015365-iqdi99pd	2325	3	antimikrobieller	antimikrobieller	NNP
cord-015365-iqdi99pd	2325	4	Therapie	Therapie	NNP
cord-015365-iqdi99pd	2325	5	konnten	konnten	NNP
cord-015365-iqdi99pd	2326	1	eine	eine	NNP
cord-015365-iqdi99pd	2326	2	stabile	stabile	NNP
cord-015365-iqdi99pd	2326	3	Transplantatfunktion	Transplantatfunktion	NNP
cord-015365-iqdi99pd	2326	4	und	und	IN
cord-015365-iqdi99pd	2326	5	Lebensqualität	Lebensqualität	NNP
cord-015365-iqdi99pd	2326	6	erreicht	erreicht	JJ
cord-015365-iqdi99pd	2326	7	werden	werden	NNP
cord-015365-iqdi99pd	2326	8	nach	nach	NNP
cord-015365-iqdi99pd	2326	9	schwerer	schwerer	NNP
cord-015365-iqdi99pd	2326	10	akuter	akuter	NNP
cord-015365-iqdi99pd	2326	11	Abstoßungsreaktion	Abstoßungsreaktion	NNP
cord-015365-iqdi99pd	2326	12	,	,	,
cord-015365-iqdi99pd	2326	13	CMV	CMV	NNP
cord-015365-iqdi99pd	2326	14	-	-	HYPH
cord-015365-iqdi99pd	2326	15	Transplantatenteritis	Transplantatenteritis	NNP
cord-015365-iqdi99pd	2326	16	und	und	IN
cord-015365-iqdi99pd	2326	17	Aspergilluspneumonie	Aspergilluspneumonie	NNP
cord-015365-iqdi99pd	2326	18	.	.	.
cord-015365-iqdi99pd	2327	1	Bullous	Bullous	NNP
cord-015365-iqdi99pd	2327	2	pemphigoid	pemphigoid	NNP
cord-015365-iqdi99pd	2327	3	11	11	CD
cord-015365-iqdi99pd	2327	4	years	year	NNS
cord-015365-iqdi99pd	2327	5	after	after	IN
cord-015365-iqdi99pd	2327	6	bilateral	bilateral	JJ
cord-015365-iqdi99pd	2327	7	hand	hand	NN
cord-015365-iqdi99pd	2327	8	transplantation	transplantation	NN
cord-015365-iqdi99pd	2327	9	 	 	_SP
cord-015365-iqdi99pd	2328	1	Background	background	NN
cord-015365-iqdi99pd	2328	2	.	.	.
cord-015365-iqdi99pd	2329	1	Expression	expression	NN
cord-015365-iqdi99pd	2329	2	of	of	IN
cord-015365-iqdi99pd	2329	3	peripheral	peripheral	JJ
cord-015365-iqdi99pd	2329	4	-	-	HYPH
cord-015365-iqdi99pd	2329	5	node	node	NN
cord-015365-iqdi99pd	2329	6	-	-	HYPH
cord-015365-iqdi99pd	2329	7	addressin	addressin	NNP
cord-015365-iqdi99pd	2329	8	(	(	-LRB-
cord-015365-iqdi99pd	2329	9	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2329	10	)	)	-RRB-
cord-015365-iqdi99pd	2329	11	on	on	IN
cord-015365-iqdi99pd	2329	12	endothelial	endothelial	JJ
cord-015365-iqdi99pd	2329	13	cells	cell	NNS
cord-015365-iqdi99pd	2329	14	indicates	indicate	VBZ
cord-015365-iqdi99pd	2329	15	presence	presence	NN
cord-015365-iqdi99pd	2329	16	of	of	IN
cord-015365-iqdi99pd	2329	17	tertiary	tertiary	JJ
cord-015365-iqdi99pd	2329	18	lymphoid	lymphoid	JJ
cord-015365-iqdi99pd	2329	19	organs	organ	NNS
cord-015365-iqdi99pd	2329	20	(	(	-LRB-
cord-015365-iqdi99pd	2329	21	TLO	TLO	NNP
cord-015365-iqdi99pd	2329	22	)	)	-RRB-
cord-015365-iqdi99pd	2329	23	in	in	IN
cord-015365-iqdi99pd	2329	24	chronic	chronic	JJ
cord-015365-iqdi99pd	2329	25	autoimmunity	autoimmunity	NN
cord-015365-iqdi99pd	2329	26	and	and	CC
cord-015365-iqdi99pd	2329	27	allograft	allograft	NN
cord-015365-iqdi99pd	2329	28	rejection	rejection	NN
cord-015365-iqdi99pd	2329	29	.	.	.
cord-015365-iqdi99pd	2330	1	We	-PRON-	PRP
cord-015365-iqdi99pd	2330	2	herein	herein	RB
cord-015365-iqdi99pd	2330	3	investigated	investigate	VBD
cord-015365-iqdi99pd	2330	4	the	the	DT
cord-015365-iqdi99pd	2330	5	expression	expression	NN
cord-015365-iqdi99pd	2330	6	of	of	IN
cord-015365-iqdi99pd	2330	7	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2330	8	in	in	IN
cord-015365-iqdi99pd	2330	9	skin	skin	NN
cord-015365-iqdi99pd	2330	10	biopsies	biopsy	NNS
cord-015365-iqdi99pd	2330	11	of	of	IN
cord-015365-iqdi99pd	2330	12	human	human	JJ
cord-015365-iqdi99pd	2330	13	hand	hand	NN
cord-015365-iqdi99pd	2330	14	allografts	allograft	NNS
cord-015365-iqdi99pd	2330	15	for	for	IN
cord-015365-iqdi99pd	2330	16	evidence	evidence	NN
cord-015365-iqdi99pd	2330	17	of	of	IN
cord-015365-iqdi99pd	2330	18	TLO	TLO	NNP
cord-015365-iqdi99pd	2330	19	after	after	IN
cord-015365-iqdi99pd	2330	20	composite	composite	JJ
cord-015365-iqdi99pd	2330	21	tissue	tissue	NN
cord-015365-iqdi99pd	2330	22	allotransplantation	allotransplantation	NN
cord-015365-iqdi99pd	2330	23	.	.	.
cord-015365-iqdi99pd	2331	1	Methods	method	NNS
cord-015365-iqdi99pd	2331	2	.	.	.
cord-015365-iqdi99pd	2332	1	167	167	CD
cord-015365-iqdi99pd	2332	2	skin	skin	NN
cord-015365-iqdi99pd	2332	3	biopsies	biopsy	NNS
cord-015365-iqdi99pd	2332	4	of	of	IN
cord-015365-iqdi99pd	2332	5	11	11	CD
cord-015365-iqdi99pd	2332	6	hand	hand	NN
cord-015365-iqdi99pd	2332	7	allografts	allograft	NNS
cord-015365-iqdi99pd	2332	8	were	be	VBD
cord-015365-iqdi99pd	2332	9	collected	collect	VBN
cord-015365-iqdi99pd	2332	10	over	over	IN
cord-015365-iqdi99pd	2332	11	10	10	CD
cord-015365-iqdi99pd	2332	12	years	year	NNS
cord-015365-iqdi99pd	2332	13	and	and	CC
cord-015365-iqdi99pd	2332	14	assessed	assess	VBN
cord-015365-iqdi99pd	2332	15	by	by	IN
cord-015365-iqdi99pd	2332	16	HE	HE	NNP
cord-015365-iqdi99pd	2332	17	-	-	HYPH
cord-015365-iqdi99pd	2332	18	histology	histology	NN
cord-015365-iqdi99pd	2332	19	and	and	CC
cord-015365-iqdi99pd	2332	20	immunohistochemistry	immunohistochemistry	NN
cord-015365-iqdi99pd	2332	21	using	use	VBG
cord-015365-iqdi99pd	2332	22	antibodies	antibody	NNS
cord-015365-iqdi99pd	2332	23	for	for	IN
cord-015365-iqdi99pd	2332	24	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2332	25	,	,	,
cord-015365-iqdi99pd	2332	26	CD3	CD3	NNP
cord-015365-iqdi99pd	2332	27	,	,	,
cord-015365-iqdi99pd	2332	28	CD4	CD4	NNP
cord-015365-iqdi99pd	2332	29	,	,	,
cord-015365-iqdi99pd	2332	30	CD8	CD8	NNP
cord-015365-iqdi99pd	2332	31	,	,	,
cord-015365-iqdi99pd	2332	32	CD20	CD20	NNP
cord-015365-iqdi99pd	2332	33	,	,	,
cord-015365-iqdi99pd	2332	34	C4d	C4d	NNP
cord-015365-iqdi99pd	2332	35	,	,	,
cord-015365-iqdi99pd	2332	36	CD68	CD68	NNP
cord-015365-iqdi99pd	2332	37	,	,	,
cord-015365-iqdi99pd	2332	38	LFA-1	LFA-1	NNP
cord-015365-iqdi99pd	2332	39	,	,	,
cord-015365-iqdi99pd	2332	40	ICAM-1	ICAM-1	NNP
cord-015365-iqdi99pd	2332	41	,	,	,
cord-015365-iqdi99pd	2332	42	E	e	NN
cord-015365-iqdi99pd	2332	43	-	-	NN
cord-015365-iqdi99pd	2332	44	selectin	selectin	JJ
cord-015365-iqdi99pd	2332	45	,	,	,
cord-015365-iqdi99pd	2332	46	P	p	NN
cord-015365-iqdi99pd	2332	47	-	-	HYPH
cord-015365-iqdi99pd	2332	48	selectin	selectin	NNP
cord-015365-iqdi99pd	2332	49	,	,	,
cord-015365-iqdi99pd	2332	50	VE	VE	NNP
cord-015365-iqdi99pd	2332	51	-	-	HYPH
cord-015365-iqdi99pd	2332	52	cadherin	cadherin	NN
cord-015365-iqdi99pd	2332	53	,	,	,
cord-015365-iqdi99pd	2332	54	HLA	HLA	NNP
cord-015365-iqdi99pd	2332	55	-	-	HYPH
cord-015365-iqdi99pd	2332	56	DR	DR	NNP
cord-015365-iqdi99pd	2332	57	,	,	,
cord-015365-iqdi99pd	2332	58	Psoriasin	Psoriasin	NNP
cord-015365-iqdi99pd	2332	59	,	,	,
cord-015365-iqdi99pd	2332	60	IDO	IDO	NNP
cord-015365-iqdi99pd	2332	61	and	and	CC
cord-015365-iqdi99pd	2332	62	Foxp3	Foxp3	NNP
cord-015365-iqdi99pd	2332	63	.	.	.
cord-015365-iqdi99pd	2333	1	Levels	level	NNS
cord-015365-iqdi99pd	2333	2	of	of	IN
cord-015365-iqdi99pd	2333	3	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2333	4	expression	expression	NN
cord-015365-iqdi99pd	2333	5	was	be	VBD
cord-015365-iqdi99pd	2333	6	assessed	assess	VBN
cord-015365-iqdi99pd	2333	7	semiquantitatively	semiquantitatively	NNP
cord-015365-iqdi99pd	2333	8	(	(	-LRB-
cord-015365-iqdi99pd	2333	9	%	%	NN
cord-015365-iqdi99pd	2333	10	of	of	IN
cord-015365-iqdi99pd	2333	11	PNAdþ	PNAdþ	NNP
cord-015365-iqdi99pd	2333	12	vessels	vessel	NNS
cord-015365-iqdi99pd	2333	13	:	:	:
cord-015365-iqdi99pd	2333	14	0	0	CD
cord-015365-iqdi99pd	2333	15	,	,	,
cord-015365-iqdi99pd	2333	16	1	1	CD
cord-015365-iqdi99pd	2333	17	,	,	,
cord-015365-iqdi99pd	2333	18	2	2	CD
cord-015365-iqdi99pd	2333	19	,	,	,
cord-015365-iqdi99pd	2333	20	3	3	CD
cord-015365-iqdi99pd	2333	21	and	and	CC
cord-015365-iqdi99pd	2333	22	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2333	23	staining	stain	VBG
cord-015365-iqdi99pd	2333	24	intensity	intensity	NN
cord-015365-iqdi99pd	2333	25	:	:	:
cord-015365-iqdi99pd	2333	26	0	0	CD
cord-015365-iqdi99pd	2333	27	,	,	,
cord-015365-iqdi99pd	2333	28	1	1	CD
cord-015365-iqdi99pd	2333	29	,	,	,
cord-015365-iqdi99pd	2333	30	2	2	CD
cord-015365-iqdi99pd	2333	31	,	,	,
cord-015365-iqdi99pd	2333	32	3	3	CD
cord-015365-iqdi99pd	2333	33	)	)	-RRB-
cord-015365-iqdi99pd	2333	34	and	and	CC
cord-015365-iqdi99pd	2333	35	correlated	correlate	VBD
cord-015365-iqdi99pd	2333	36	with	with	IN
cord-015365-iqdi99pd	2333	37	rejection	rejection	NN
cord-015365-iqdi99pd	2333	38	grade	grade	NN
cord-015365-iqdi99pd	2333	39	,	,	,
cord-015365-iqdi99pd	2333	40	characterization	characterization	NN
cord-015365-iqdi99pd	2333	41	of	of	IN
cord-015365-iqdi99pd	2333	42	the	the	DT
cord-015365-iqdi99pd	2333	43	infiltrate	infiltrate	NN
cord-015365-iqdi99pd	2333	44	,	,	,
cord-015365-iqdi99pd	2333	45	expression	expression	NN
cord-015365-iqdi99pd	2333	46	of	of	IN
cord-015365-iqdi99pd	2333	47	adhesion	adhesion	NN
cord-015365-iqdi99pd	2333	48	molecules	molecule	NNS
cord-015365-iqdi99pd	2333	49	and	and	CC
cord-015365-iqdi99pd	2333	50	time	time	NN
cord-015365-iqdi99pd	2333	51	after	after	IN
cord-015365-iqdi99pd	2333	52	transplantation	transplantation	NN
cord-015365-iqdi99pd	2333	53	.	.	.
cord-015365-iqdi99pd	2334	1	Results	result	NNS
cord-015365-iqdi99pd	2334	2	.	.	.
cord-015365-iqdi99pd	2335	1	Rejection	rejection	NN
cord-015365-iqdi99pd	2335	2	ranged	range	VBD
cord-015365-iqdi99pd	2335	3	from	from	IN
cord-015365-iqdi99pd	2335	4	grade	grade	NN
cord-015365-iqdi99pd	2335	5	0	0	CD
cord-015365-iqdi99pd	2335	6	to	to	IN
cord-015365-iqdi99pd	2335	7	IV	IV	NNP
cord-015365-iqdi99pd	2336	1	(	(	-LRB-
cord-015365-iqdi99pd	2336	2	mean	mean	VB
cord-015365-iqdi99pd	2336	3	score	score	NN
cord-015365-iqdi99pd	2336	4	:	:	:
cord-015365-iqdi99pd	2336	5	0.79	0.79	CD
cord-015365-iqdi99pd	2336	6	AE	AE	NNP
cord-015365-iqdi99pd	2336	7	1.05	1.05	CD
cord-015365-iqdi99pd	2336	8	)	)	-RRB-
cord-015365-iqdi99pd	2336	9	.	.	.
cord-015365-iqdi99pd	2337	1	Upon	upon	IN
cord-015365-iqdi99pd	2337	2	rejection	rejection	NN
cord-015365-iqdi99pd	2337	3	,	,	,
cord-015365-iqdi99pd	2337	4	expression	expression	NN
cord-015365-iqdi99pd	2337	5	of	of	IN
cord-015365-iqdi99pd	2337	6	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2337	7	was	be	VBD
cord-015365-iqdi99pd	2337	8	increased	increase	VBN
cord-015365-iqdi99pd	2337	9	in	in	IN
cord-015365-iqdi99pd	2337	10	endothelial	endothelial	JJ
cord-015365-iqdi99pd	2337	11	cells	cell	NNS
cord-015365-iqdi99pd	2337	12	(	(	-LRB-
cord-015365-iqdi99pd	2337	13	grade	grade	NN
cord-015365-iqdi99pd	2337	14	0	0	CD
cord-015365-iqdi99pd	2337	15	:	:	:
cord-015365-iqdi99pd	2337	16	0.24	0.24	CD
cord-015365-iqdi99pd	2337	17	AE	AE	NNP
cord-015365-iqdi99pd	2337	18	0.48	0.48	CD
cord-015365-iqdi99pd	2337	19	vs.	vs.	IN
cord-015365-iqdi99pd	2337	20	all	all	DT
cord-015365-iqdi99pd	2337	21	grades	grade	NNS
cord-015365-iqdi99pd	2337	22	of	of	IN
cord-015365-iqdi99pd	2337	23	rejection	rejection	NN
cord-015365-iqdi99pd	2337	24	:	:	:
cord-015365-iqdi99pd	2337	25	0.44	0.44	CD
cord-015365-iqdi99pd	2337	26	AE	AE	NNP
cord-015365-iqdi99pd	2337	27	0.62	0.62	CD
cord-015365-iqdi99pd	2337	28	)	)	-RRB-
cord-015365-iqdi99pd	2337	29	.	.	.
cord-015365-iqdi99pd	2338	1	Most	most	RBS
cord-015365-iqdi99pd	2338	2	often	often	RB
cord-015365-iqdi99pd	2338	3	PNAd	PNAd	VBZ
cord-015365-iqdi99pd	2338	4	expression	expression	NN
cord-015365-iqdi99pd	2338	5	was	be	VBD
cord-015365-iqdi99pd	2338	6	only	only	RB
cord-015365-iqdi99pd	2338	7	found	find	VBN
cord-015365-iqdi99pd	2338	8	in	in	IN
cord-015365-iqdi99pd	2338	9	few	few	JJ
cord-015365-iqdi99pd	2338	10	vessels	vessel	NNS
cord-015365-iqdi99pd	2338	11	(	(	-LRB-
cord-015365-iqdi99pd	2338	12	1	1	CD
cord-015365-iqdi99pd	2338	13	-	-	SYM
cord-015365-iqdi99pd	2338	14	10	10	CD
cord-015365-iqdi99pd	2338	15	%	%	NN
cord-015365-iqdi99pd	2338	16	)	)	-RRB-
cord-015365-iqdi99pd	2338	17	.	.	.
cord-015365-iqdi99pd	2339	1	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2339	2	staining	stain	VBG
cord-015365-iqdi99pd	2339	3	intensity	intensity	NN
cord-015365-iqdi99pd	2339	4	was	be	VBD
cord-015365-iqdi99pd	2339	5	increased	increase	VBN
cord-015365-iqdi99pd	2339	6	the	the	DT
cord-015365-iqdi99pd	2339	7	higher	high	JJR
cord-015365-iqdi99pd	2339	8	the	the	DT
cord-015365-iqdi99pd	2339	9	grade	grade	NN
cord-015365-iqdi99pd	2339	10	of	of	IN
cord-015365-iqdi99pd	2339	11	rejection	rejection	NN
cord-015365-iqdi99pd	2339	12	(	(	-LRB-
cord-015365-iqdi99pd	2339	13	grade	grade	NN
cord-015365-iqdi99pd	2339	14	0	0	CD
cord-015365-iqdi99pd	2339	15	:	:	:
cord-015365-iqdi99pd	2339	16	0.38	0.38	CD
cord-015365-iqdi99pd	2339	17	AE	AE	NNP
cord-015365-iqdi99pd	2339	18	0.76	0.76	CD
cord-015365-iqdi99pd	2339	19	;	;	:
cord-015365-iqdi99pd	2339	20	grade	grade	NN
cord-015365-iqdi99pd	2339	21	I	-PRON-	PRP
cord-015365-iqdi99pd	2339	22	:	:	:
cord-015365-iqdi99pd	2339	23	0.41	0.41	CD
cord-015365-iqdi99pd	2339	24	AE	AE	NNP
cord-015365-iqdi99pd	2339	25	0.74	0.74	CD
cord-015365-iqdi99pd	2339	26	;	;	:
cord-015365-iqdi99pd	2339	27	grade	grade	NN
cord-015365-iqdi99pd	2339	28	II	II	NNP
cord-015365-iqdi99pd	2339	29	:	:	:
cord-015365-iqdi99pd	2339	30	0.67	0.67	CD
cord-015365-iqdi99pd	2339	31	AE	AE	NNP
cord-015365-iqdi99pd	2339	32	0.80	0.80	CD
cord-015365-iqdi99pd	2339	33	;	;	:
cord-015365-iqdi99pd	2339	34	grade	grade	NN
cord-015365-iqdi99pd	2339	35	III	III	NNP
cord-015365-iqdi99pd	2339	36	:	:	:
cord-015365-iqdi99pd	2339	37	0.73	0.73	CD
cord-015365-iqdi99pd	2339	38	AE	AE	NNP
cord-015365-iqdi99pd	2339	39	0.91	0.91	CD
cord-015365-iqdi99pd	2339	40	;	;	:
cord-015365-iqdi99pd	2339	41	grade	grade	NN
cord-015365-iqdi99pd	2339	42	IV	IV	NNP
cord-015365-iqdi99pd	2339	43	:	:	:
cord-015365-iqdi99pd	2339	44	0.50	0.50	CD
cord-015365-iqdi99pd	2339	45	AE	AE	NNP
cord-015365-iqdi99pd	2339	46	0.58	0.58	CD
cord-015365-iqdi99pd	2339	47	)	)	-RRB-
cord-015365-iqdi99pd	2339	48	.	.	.
cord-015365-iqdi99pd	2340	1	Intense	intense	JJ
cord-015365-iqdi99pd	2340	2	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2340	3	-	-	:
cord-015365-iqdi99pd	2340	4	staining	staining	NN
cord-015365-iqdi99pd	2340	5	was	be	VBD
cord-015365-iqdi99pd	2340	6	associated	associate	VBN
cord-015365-iqdi99pd	2340	7	with	with	IN
cord-015365-iqdi99pd	2340	8	more	more	JJR
cord-015365-iqdi99pd	2340	9	CD4þ	CD4þ	NNP
cord-015365-iqdi99pd	2340	10	and	and	CC
cord-015365-iqdi99pd	2340	11	CD8	CD8	NNP
cord-015365-iqdi99pd	2340	12	þ	þ	NNP
cord-015365-iqdi99pd	2340	13	infiltrating	infiltrate	VBG
cord-015365-iqdi99pd	2340	14	T	t	NN
cord-015365-iqdi99pd	2340	15	-	-	HYPH
cord-015365-iqdi99pd	2340	16	cells	cell	NNS
cord-015365-iqdi99pd	2340	17	,	,	,
cord-015365-iqdi99pd	2340	18	but	but	CC
cord-015365-iqdi99pd	2340	19	less	less	JJR
cord-015365-iqdi99pd	2340	20	B	b	NN
cord-015365-iqdi99pd	2340	21	-	-	HYPH
cord-015365-iqdi99pd	2340	22	cells	cell	NNS
cord-015365-iqdi99pd	2340	23	and	and	CC
cord-015365-iqdi99pd	2340	24	macrophages	macrophage	NNS
cord-015365-iqdi99pd	2340	25	,	,	,
cord-015365-iqdi99pd	2340	26	compared	compare	VBN
cord-015365-iqdi99pd	2340	27	to	to	IN
cord-015365-iqdi99pd	2340	28	mild	mild	JJ
cord-015365-iqdi99pd	2340	29	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2340	30	staining	stain	VBG
cord-015365-iqdi99pd	2340	31	intensity	intensity	NN
cord-015365-iqdi99pd	2340	32	(	(	-LRB-
cord-015365-iqdi99pd	2340	33	CD4	CD4	NNP
cord-015365-iqdi99pd	2340	34	þ	þ	NNP
cord-015365-iqdi99pd	2340	35	cells	cell	NNS
cord-015365-iqdi99pd	2340	36	49.00	49.00	CD
cord-015365-iqdi99pd	2340	37	%	%	NN
cord-015365-iqdi99pd	2340	38	AE	AE	NNP
cord-015365-iqdi99pd	2340	39	29.89	29.89	CD
cord-015365-iqdi99pd	2340	40	%	%	NN
cord-015365-iqdi99pd	2340	41	;	;	:
cord-015365-iqdi99pd	2340	42	CD8	CD8	NNP
cord-015365-iqdi99pd	2340	43	þ	þ	NNP
cord-015365-iqdi99pd	2340	44	cells	cell	NNS
cord-015365-iqdi99pd	2340	45	31.00	31.00	CD
cord-015365-iqdi99pd	2340	46	%	%	NN
cord-015365-iqdi99pd	2340	47	AE	AE	NNP
cord-015365-iqdi99pd	2340	48	22.34	22.34	CD
cord-015365-iqdi99pd	2340	49	%	%	NN
cord-015365-iqdi99pd	2340	50	;	;	.
cord-015365-iqdi99pd	2341	1	CD20	CD20	NNP
cord-015365-iqdi99pd	2341	2	þ	þ	NNP
cord-015365-iqdi99pd	2341	3	B	b	NN
cord-015365-iqdi99pd	2341	4	-	-	HYPH
cord-015365-iqdi99pd	2341	5	cells	cell	NNS
cord-015365-iqdi99pd	2341	6	0.50	0.50	CD
cord-015365-iqdi99pd	2341	7	%	%	NN
cord-015365-iqdi99pd	2341	8	AE	AE	NNP
cord-015365-iqdi99pd	2341	9	1.54	1.54	CD
cord-015365-iqdi99pd	2341	10	%	%	NN
cord-015365-iqdi99pd	2341	11	;	;	:
cord-015365-iqdi99pd	2341	12	CD68	CD68	NNP
cord-015365-iqdi99pd	2341	13	þ	þ	NNP
cord-015365-iqdi99pd	2341	14	macrophages	macrophage	VBZ
cord-015365-iqdi99pd	2341	15	0.57	0.57	CD
cord-015365-iqdi99pd	2341	16	AE	AE	NNP
cord-015365-iqdi99pd	2341	17	0.60	0.60	CD
cord-015365-iqdi99pd	2341	18	vs.	vs.	NN
cord-015365-iqdi99pd	2342	1	CD4	CD4	NNP
cord-015365-iqdi99pd	2342	2	þ	þ	NNP
cord-015365-iqdi99pd	2342	3	cells	cell	VBZ
cord-015365-iqdi99pd	2342	4	37.35	37.35	CD
cord-015365-iqdi99pd	2342	5	%	%	NN
cord-015365-iqdi99pd	2342	6	AE	AE	NNP
cord-015365-iqdi99pd	2342	7	40.82	40.82	CD
cord-015365-iqdi99pd	2342	8	%	%	NN
cord-015365-iqdi99pd	2342	9	;	;	:
cord-015365-iqdi99pd	2342	10	CD8þcells	CD8þcells	NNP
cord-015365-iqdi99pd	2342	11	27.35	27.35	CD
cord-015365-iqdi99pd	2342	12	%	%	NN
cord-015365-iqdi99pd	2342	13	AE	AE	NNP
cord-015365-iqdi99pd	2342	14	35.93	35.93	CD
cord-015365-iqdi99pd	2342	15	%	%	NN
cord-015365-iqdi99pd	2342	16	;	;	:
cord-015365-iqdi99pd	2342	17	CD20	cd20	NN
cord-015365-iqdi99pd	2342	18	þ	þ	NNP
cord-015365-iqdi99pd	2342	19	B	b	NN
cord-015365-iqdi99pd	2342	20	-	-	HYPH
cord-015365-iqdi99pd	2342	21	cells	cell	NNS
cord-015365-iqdi99pd	2343	1	0.94	0.94	CD
cord-015365-iqdi99pd	2343	2	%	%	NN
cord-015365-iqdi99pd	2343	3	AE	AE	NNP
cord-015365-iqdi99pd	2343	4	2.02	2.02	CD
cord-015365-iqdi99pd	2343	5	%	%	NN
cord-015365-iqdi99pd	2343	6	;	;	:
cord-015365-iqdi99pd	2343	7	CD68þmacrophages	cd68þmacrophage	VBZ
cord-015365-iqdi99pd	2343	8	0.67	0.67	CD
cord-015365-iqdi99pd	2343	9	AE	AE	NNP
cord-015365-iqdi99pd	2343	10	0.66	0.66	CD
cord-015365-iqdi99pd	2343	11	)	)	-RRB-
cord-015365-iqdi99pd	2343	12	.	.	.
cord-015365-iqdi99pd	2344	1	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2344	2	expression	expression	NN
cord-015365-iqdi99pd	2344	3	correlated	correlate	VBD
cord-015365-iqdi99pd	2344	4	well	well	RB
cord-015365-iqdi99pd	2344	5	with	with	IN
cord-015365-iqdi99pd	2344	6	CD3þcells	CD3þcells	NNP
cord-015365-iqdi99pd	2344	7	and	and	CC
cord-015365-iqdi99pd	2344	8	CD20þBcells	cd20þbcell	NNS
cord-015365-iqdi99pd	2344	9	.	.	.
cord-015365-iqdi99pd	2345	1	Poor	poor	JJ
cord-015365-iqdi99pd	2345	2	correlation	correlation	NN
cord-015365-iqdi99pd	2345	3	was	be	VBD
cord-015365-iqdi99pd	2345	4	found	find	VBN
cord-015365-iqdi99pd	2345	5	for	for	IN
cord-015365-iqdi99pd	2345	6	expression	expression	NN
cord-015365-iqdi99pd	2345	7	of	of	IN
cord-015365-iqdi99pd	2345	8	adhesion	adhesion	NN
cord-015365-iqdi99pd	2345	9	molecules	molecule	NNS
cord-015365-iqdi99pd	2345	10	,	,	,
cord-015365-iqdi99pd	2345	11	IDO	IDO	NNP
cord-015365-iqdi99pd	2345	12	and	and	CC
cord-015365-iqdi99pd	2345	13	Foxp3	Foxp3	NNP
cord-015365-iqdi99pd	2345	14	,	,	,
cord-015365-iqdi99pd	2345	15	except	except	IN
cord-015365-iqdi99pd	2345	16	for	for	IN
cord-015365-iqdi99pd	2345	17	LFA-1þ	LFA-1þ	NNP
cord-015365-iqdi99pd	2345	18	infiltrating	infiltrate	VBG
cord-015365-iqdi99pd	2345	19	cells	cell	NNS
cord-015365-iqdi99pd	2345	20	.	.	.
cord-015365-iqdi99pd	2346	1	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2346	2	expression	expression	NN
cord-015365-iqdi99pd	2346	3	was	be	VBD
cord-015365-iqdi99pd	2346	4	observed	observe	VBN
cord-015365-iqdi99pd	2346	5	at	at	IN
cord-015365-iqdi99pd	2346	6	all	all	DT
cord-015365-iqdi99pd	2346	7	time	time	NN
cord-015365-iqdi99pd	2346	8	-	-	HYPH
cord-015365-iqdi99pd	2346	9	points	point	NNS
cord-015365-iqdi99pd	2346	10	after	after	IN
cord-015365-iqdi99pd	2346	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	2346	12	;	;	:
cord-015365-iqdi99pd	2346	13	however	however	RB
cord-015365-iqdi99pd	2346	14	,	,	,
cord-015365-iqdi99pd	2346	15	staining	stain	VBG
cord-015365-iqdi99pd	2346	16	intensity	intensity	NN
cord-015365-iqdi99pd	2346	17	was	be	VBD
cord-015365-iqdi99pd	2346	18	enhanced	enhance	VBN
cord-015365-iqdi99pd	2346	19	very	very	RB
cord-015365-iqdi99pd	2346	20	early	early	JJ
cord-015365-iqdi99pd	2346	21	and	and	CC
cord-015365-iqdi99pd	2346	22	late	late	JJ
cord-015365-iqdi99pd	2346	23	after	after	IN
cord-015365-iqdi99pd	2346	24	transplantation	transplantation	NN
cord-015365-iqdi99pd	2346	25	.	.	.
cord-015365-iqdi99pd	2347	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2347	2	.	.	.
cord-015365-iqdi99pd	2348	1	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2348	2	expression	expression	NN
cord-015365-iqdi99pd	2348	3	in	in	IN
cord-015365-iqdi99pd	2348	4	endothelial	endothelial	JJ
cord-015365-iqdi99pd	2348	5	cells	cell	NNS
cord-015365-iqdi99pd	2348	6	is	be	VBZ
cord-015365-iqdi99pd	2348	7	increased	increase	VBN
cord-015365-iqdi99pd	2348	8	in	in	IN
cord-015365-iqdi99pd	2348	9	skin	skin	NN
cord-015365-iqdi99pd	2348	10	biopsies	biopsy	NNS
cord-015365-iqdi99pd	2348	11	of	of	IN
cord-015365-iqdi99pd	2348	12	human	human	JJ
cord-015365-iqdi99pd	2348	13	hand	hand	NN
cord-015365-iqdi99pd	2348	14	allografts	allograft	NNS
cord-015365-iqdi99pd	2348	15	indicating	indicate	VBG
cord-015365-iqdi99pd	2348	16	presence	presence	NN
cord-015365-iqdi99pd	2348	17	of	of	IN
cord-015365-iqdi99pd	2348	18	TLO	TLO	NNP
cord-015365-iqdi99pd	2348	19	.	.	.
cord-015365-iqdi99pd	2349	1	Further	further	JJ
cord-015365-iqdi99pd	2349	2	investigations	investigation	NNS
cord-015365-iqdi99pd	2349	3	are	be	VBP
cord-015365-iqdi99pd	2349	4	needed	need	VBN
cord-015365-iqdi99pd	2349	5	to	to	TO
cord-015365-iqdi99pd	2349	6	enlighten	enlighten	VB
cord-015365-iqdi99pd	2349	7	the	the	DT
cord-015365-iqdi99pd	2349	8	role	role	NN
cord-015365-iqdi99pd	2349	9	of	of	IN
cord-015365-iqdi99pd	2349	10	PNAd	PNAd	NNS
cord-015365-iqdi99pd	2349	11	and	and	CC
cord-015365-iqdi99pd	2349	12	TLOs	TLOs	NNPS
cord-015365-iqdi99pd	2349	13	in	in	IN
cord-015365-iqdi99pd	2349	14	composite	composite	JJ
cord-015365-iqdi99pd	2349	15	tissue	tissue	NN
cord-015365-iqdi99pd	2349	16	allotransplantation	allotransplantation	NN
cord-015365-iqdi99pd	2349	17	.	.	.
cord-015365-iqdi99pd	2350	1	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	2350	2	.	.	.
cord-015365-iqdi99pd	2351	1	Die	die	VB
cord-015365-iqdi99pd	2351	2	zum	zum	NNP
cord-015365-iqdi99pd	2351	3	Hämabbau	Hämabbau	NNP
cord-015365-iqdi99pd	2352	1	notwendige	notwendige	NNP
cord-015365-iqdi99pd	2352	2	induzierbare	induzierbare	NNP
cord-015365-iqdi99pd	2353	1	Hämoxygenase-1	Hämoxygenase-1	NNP
cord-015365-iqdi99pd	2354	1	(	(	-LRB-
cord-015365-iqdi99pd	2354	2	HO-1	HO-1	NNP
cord-015365-iqdi99pd	2354	3	)	)	-RRB-
cord-015365-iqdi99pd	2354	4	wirkt	wirkt	NNP
cord-015365-iqdi99pd	2354	5	stark	stark	JJ
cord-015365-iqdi99pd	2354	6	antiinflammatorisch	antiinflammatorisch	NNP
cord-015365-iqdi99pd	2355	1	und	und	NNP
cord-015365-iqdi99pd	2355	2	schützt	schützt	NNP
cord-015365-iqdi99pd	2355	3	vor	vor	NNP
cord-015365-iqdi99pd	2355	4	Ischämie	Ischämie	NNP
cord-015365-iqdi99pd	2355	5	-	-	HYPH
cord-015365-iqdi99pd	2355	6	und	und	NNP
cord-015365-iqdi99pd	2355	7	Reperfusionsschäden	Reperfusionsschäden	NNP
cord-015365-iqdi99pd	2355	8	(	(	-LRB-
cord-015365-iqdi99pd	2355	9	IRS	IRS	NNP
cord-015365-iqdi99pd	2355	10	)	)	-RRB-
cord-015365-iqdi99pd	2355	11	.	.	.
cord-015365-iqdi99pd	2356	1	Eine	Eine	NNP
cord-015365-iqdi99pd	2356	2	klinische	klinische	NNP
cord-015365-iqdi99pd	2356	3	Anwendung	Anwendung	NNP
cord-015365-iqdi99pd	2356	4	i	-PRON-	PRP
cord-015365-iqdi99pd	2356	5	m	be	VBP
cord-015365-iqdi99pd	2356	6	Sinne	Sinne	NNP
cord-015365-iqdi99pd	2357	1	einer	einer	NNP
cord-015365-iqdi99pd	2357	2	HO-1-Induktion	HO-1-Induktion	NNP
cord-015365-iqdi99pd	2357	3	ist	ist	NNP
cord-015365-iqdi99pd	2357	4	aufgrund	aufgrund	NNP
cord-015365-iqdi99pd	2357	5	der	der	NNP
cord-015365-iqdi99pd	2357	6	Hepatotoxizität	Hepatotoxizität	NNP
cord-015365-iqdi99pd	2357	7	der	der	NNP
cord-015365-iqdi99pd	2357	8	experimentell	experimentell	NNP
cord-015365-iqdi99pd	2357	9	verwendeten	verwendeten	NNP
cord-015365-iqdi99pd	2357	10	HO-1-Induktoren	HO-1-Induktoren	NNP
cord-015365-iqdi99pd	2357	11	nicht	nicht	NNP
cord-015365-iqdi99pd	2357	12	möglich	möglich	NNP
cord-015365-iqdi99pd	2357	13	.	.	.
cord-015365-iqdi99pd	2358	1	Ziel	Ziel	NNP
cord-015365-iqdi99pd	2358	2	der	der	NNP
cord-015365-iqdi99pd	2358	3	Studie	Studie	NNP
cord-015365-iqdi99pd	2358	4	war	war	NN
cord-015365-iqdi99pd	2358	5	es	es	NN
cord-015365-iqdi99pd	2358	6	,	,	,
cord-015365-iqdi99pd	2358	7	natürlich	natürlich	NNP
cord-015365-iqdi99pd	2358	8	vorkommende	vorkommende	NNP
cord-015365-iqdi99pd	2358	9	Nutrazeutika	Nutrazeutika	NNP
cord-015365-iqdi99pd	2358	10	auf	auf	NNP
cord-015365-iqdi99pd	2358	11	Ihr	Ihr	NNP
cord-015365-iqdi99pd	2358	12	Potential	potential	JJ
cord-015365-iqdi99pd	2358	13	zur	zur	NN
cord-015365-iqdi99pd	2358	14	HO-1	HO-1	NNP
cord-015365-iqdi99pd	2358	15	Induktion	Induktion	NNP
cord-015365-iqdi99pd	2358	16	zu	zu	NNP
cord-015365-iqdi99pd	2358	17	untersuchen	untersuchen	NNP
cord-015365-iqdi99pd	2358	18	.	.	.
cord-015365-iqdi99pd	2359	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	2359	2	.	.	.
cord-015365-iqdi99pd	2360	1	Verschiedene	Verschiedene	NNP
cord-015365-iqdi99pd	2360	2	Nutrazeutika	Nutrazeutika	NNP
cord-015365-iqdi99pd	2360	3	wurden	wurden	VBD
cord-015365-iqdi99pd	2360	4	in	in	IN
cord-015365-iqdi99pd	2360	5	Hinblick	Hinblick	NNP
cord-015365-iqdi99pd	2360	6	auf	auf	NNP
cord-015365-iqdi99pd	2360	7	die	die	VB
cord-015365-iqdi99pd	2360	8	HO-1-Induktion	ho-1-induktion	NN
cord-015365-iqdi99pd	2360	9	mittels	mittel	NNS
cord-015365-iqdi99pd	2360	10	PCR	PCR	NNP
cord-015365-iqdi99pd	2360	11	getestet	getestet	NNP
cord-015365-iqdi99pd	2360	12	.	.	.
cord-015365-iqdi99pd	2361	1	In	in	IN
cord-015365-iqdi99pd	2361	2	einem	einem	NNP
cord-015365-iqdi99pd	2361	3	etablierten	etablierten	NNP
cord-015365-iqdi99pd	2361	4	Ratten	Ratten	NNP
cord-015365-iqdi99pd	2361	5	-	-	HYPH
cord-015365-iqdi99pd	2361	6	Nierenarterien	Nierenarterien	NNP
cord-015365-iqdi99pd	2361	7	-	-	HYPH
cord-015365-iqdi99pd	2361	8	Klemmmodell	Klemmmodell	NNP
cord-015365-iqdi99pd	2362	1	wurde	wurde	NNP
cord-015365-iqdi99pd	2362	2	ein	ein	NNP
cord-015365-iqdi99pd	2362	3	IRS	IRS	NNP
cord-015365-iqdi99pd	2362	4	gesetzt	gesetzt	NN
cord-015365-iqdi99pd	2362	5	,	,	,
cord-015365-iqdi99pd	2362	6	Nierenfunktionsparameter	Nierenfunktionsparameter	NNP
cord-015365-iqdi99pd	2362	7	und	und	XX
cord-015365-iqdi99pd	2363	1	HO-1	HO-1	NNP
cord-015365-iqdi99pd	2363	2	Expression	Expression	NNP
cord-015365-iqdi99pd	2363	3	wurden	wurden	XX
cord-015365-iqdi99pd	2364	1	zu	zu	NNP
cord-015365-iqdi99pd	2364	2	festgelegten	festgelegten	NNP
cord-015365-iqdi99pd	2364	3	Zeitpunkten	Zeitpunkten	NNP
cord-015365-iqdi99pd	2364	4	bestimmt	bestimmt	NNP
cord-015365-iqdi99pd	2364	5	,	,	,
cord-015365-iqdi99pd	2364	6	histologische	histologische	NNP
cord-015365-iqdi99pd	2364	7	Untersuchungen	Untersuchungen	NNP
cord-015365-iqdi99pd	2364	8	wurde	wurde	NNP
cord-015365-iqdi99pd	2364	9	durchgefü	durchgefü	NNP
cord-015365-iqdi99pd	2364	10	hrt	hrt	NNP
cord-015365-iqdi99pd	2364	11	.	.	.
cord-015365-iqdi99pd	2365	1	Die	die	VB
cord-015365-iqdi99pd	2365	2	Nutrazeutika	Nutrazeutika	NNP
cord-015365-iqdi99pd	2365	3	wurden	wurden	VBD
cord-015365-iqdi99pd	2365	4	24	24	CD
cord-015365-iqdi99pd	2365	5	h	h	NN
cord-015365-iqdi99pd	2365	6	vor	vor	NN
cord-015365-iqdi99pd	2366	1	Ischämie	Ischämie	NNP
cord-015365-iqdi99pd	2366	2	und	und	IN
cord-015365-iqdi99pd	2366	3	unmittelbar	unmittelbar	NNP
cord-015365-iqdi99pd	2366	4	nach	nach	NNP
cord-015365-iqdi99pd	2366	5	Reperfusion	Reperfusion	NNP
cord-015365-iqdi99pd	2366	6	oral	oral	JJ
cord-015365-iqdi99pd	2366	7	appliziert	appliziert	NN
cord-015365-iqdi99pd	2366	8	.	.	.
cord-015365-iqdi99pd	2367	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2367	2	.	.	.
cord-015365-iqdi99pd	2368	1	Zwei	Zwei	NNP
cord-015365-iqdi99pd	2368	2	der	der	NN
cord-015365-iqdi99pd	2368	3	getesteten	getesteten	NNP
cord-015365-iqdi99pd	2369	1	Nutrazeutika	Nutrazeutika	NNP
cord-015365-iqdi99pd	2370	1	führten	führten	NNP
cord-015365-iqdi99pd	2370	2	zu	zu	NNP
cord-015365-iqdi99pd	2371	1	einer	einer	NNP
cord-015365-iqdi99pd	2371	2	starken	starken	VBD
cord-015365-iqdi99pd	2371	3	Hochregulation	Hochregulation	NNP
cord-015365-iqdi99pd	2372	1	(	(	-LRB-
cord-015365-iqdi99pd	2372	2	Resveratrol	resveratrol	NN
cord-015365-iqdi99pd	2372	3	:	:	:
cord-015365-iqdi99pd	2372	4	11-fach	11-fach	CD
cord-015365-iqdi99pd	2372	5	,	,	,
cord-015365-iqdi99pd	2372	6	Ginseng	ginseng	NN
cord-015365-iqdi99pd	2372	7	:	:	:
cord-015365-iqdi99pd	2372	8	17fach	17fach	LS
cord-015365-iqdi99pd	2372	9	)	)	-RRB-
cord-015365-iqdi99pd	2372	10	der	der	NNP
cord-015365-iqdi99pd	2372	11	HO-1	HO-1	NNP
cord-015365-iqdi99pd	2372	12	Expression	Expression	NNP
cord-015365-iqdi99pd	2372	13	.	.	.
cord-015365-iqdi99pd	2373	1	I	-PRON-	PRP
cord-015365-iqdi99pd	2374	1	m	m	LS
cord-015365-iqdi99pd	2375	1	Nierenarterien	Nierenarterien	NNP
cord-015365-iqdi99pd	2375	2	-	-	HYPH
cord-015365-iqdi99pd	2375	3	Klemmmodell	Klemmmodell	NNP
cord-015365-iqdi99pd	2375	4	kam	kam	NNP
cord-015365-iqdi99pd	2376	1	es	es	NNP
cord-015365-iqdi99pd	2376	2	nach	nach	NNP
cord-015365-iqdi99pd	2376	3	48	48	CD
cord-015365-iqdi99pd	2376	4	Stunden	Stunden	NNP
cord-015365-iqdi99pd	2376	5	zu	zu	NNP
cord-015365-iqdi99pd	2376	6	einem	einem	NNP
cord-015365-iqdi99pd	2377	1	Anstieg	Anstieg	NNP
cord-015365-iqdi99pd	2377	2	des	des	NNP
cord-015365-iqdi99pd	2377	3	Serum	Serum	NNP
cord-015365-iqdi99pd	2377	4	-	-	HYPH
cord-015365-iqdi99pd	2377	5	Kreatinin	Kreatinin	NNP
cord-015365-iqdi99pd	2377	6	von	von	NNP
cord-015365-iqdi99pd	2377	7	0,38	0,38	CD
cord-015365-iqdi99pd	2378	1	mg	mg	NNP
cord-015365-iqdi99pd	2378	2	/	/	SYM
cord-015365-iqdi99pd	2378	3	dl	dl	NNP
cord-015365-iqdi99pd	2378	4	AE	AE	NNP
cord-015365-iqdi99pd	2378	5	0,07	0,07	CD
cord-015365-iqdi99pd	2379	1	auf	auf	NNP
cord-015365-iqdi99pd	2379	2	3,06	3,06	NNP
cord-015365-iqdi99pd	2379	3	mg	mg	NNP
cord-015365-iqdi99pd	2379	4	/	/	SYM
cord-015365-iqdi99pd	2379	5	dl	dl	NNP
cord-015365-iqdi99pd	2379	6	AE	AE	NNP
cord-015365-iqdi99pd	2379	7	0,86	0,86	NNP
cord-015365-iqdi99pd	2379	8	in	in	IN
cord-015365-iqdi99pd	2379	9	den	den	NNP
cord-015365-iqdi99pd	2379	10	Kontrolltieren	Kontrolltieren	NNP
cord-015365-iqdi99pd	2379	11	.	.	.
cord-015365-iqdi99pd	2380	1	Die	die	VB
cord-015365-iqdi99pd	2381	1	Applikation	Applikation	NNP
cord-015365-iqdi99pd	2381	2	von	von	NNP
cord-015365-iqdi99pd	2381	3	beiden	beiden	NNP
cord-015365-iqdi99pd	2382	1	Nutrazeutika	Nutrazeutika	NNP
cord-015365-iqdi99pd	2382	2	in	in	IN
cord-015365-iqdi99pd	2382	3	einer	einer	NNP
cord-015365-iqdi99pd	2382	4	Dosierung	Dosierung	NNP
cord-015365-iqdi99pd	2382	5	von	von	NNP
cord-015365-iqdi99pd	2383	1	10	10	CD
cord-015365-iqdi99pd	2383	2	mg	mg	NNP
cord-015365-iqdi99pd	2383	3	/	/	SYM
cord-015365-iqdi99pd	2383	4	kg	kg	NNP
cord-015365-iqdi99pd	2383	5	(	(	-LRB-
cord-015365-iqdi99pd	2383	6	Resveratrol	Resveratrol	NNP
cord-015365-iqdi99pd	2383	7	,	,	,
cord-015365-iqdi99pd	2383	8	48h	48h	NNPS
cord-015365-iqdi99pd	2383	9	-	-	:
cord-015365-iqdi99pd	2383	10	Kreatinin	Kreatinin	NNP
cord-015365-iqdi99pd	2383	11	0,54	0,54	CD
cord-015365-iqdi99pd	2383	12	mg	mg	NNP
cord-015365-iqdi99pd	2383	13	/	/	SYM
cord-015365-iqdi99pd	2383	14	dl	dl	NNP
cord-015365-iqdi99pd	2383	15	AE	AE	NNP
cord-015365-iqdi99pd	2383	16	0,23	0,23	CD
cord-015365-iqdi99pd	2383	17	)	)	-RRB-
cord-015365-iqdi99pd	2383	18	bzw	bzw	NNP
cord-015365-iqdi99pd	2383	19	.	.	.
cord-015365-iqdi99pd	2384	1	30	30	CD
cord-015365-iqdi99pd	2384	2	mg	mg	NN
cord-015365-iqdi99pd	2384	3	/	/	SYM
cord-015365-iqdi99pd	2384	4	kg	kg	NNP
cord-015365-iqdi99pd	2384	5	(	(	-LRB-
cord-015365-iqdi99pd	2384	6	Ginseng	Ginseng	NNP
cord-015365-iqdi99pd	2384	7	,	,	,
cord-015365-iqdi99pd	2385	1	48h	48h	NNP
cord-015365-iqdi99pd	2385	2	-	-	:
cord-015365-iqdi99pd	2385	3	Kreatinin	Kreatinin	NNP
cord-015365-iqdi99pd	2385	4	0,53	0,53	CD
cord-015365-iqdi99pd	2385	5	mg	mg	NNP
cord-015365-iqdi99pd	2385	6	/	/	SYM
cord-015365-iqdi99pd	2385	7	dl	dl	NNP
cord-015365-iqdi99pd	2385	8	AE	AE	NNP
cord-015365-iqdi99pd	2385	9	0,06	0,06	NNP
cord-015365-iqdi99pd	2385	10	)	)	-RRB-
cord-015365-iqdi99pd	2386	1	verhinderte	verhinderte	NNP
cord-015365-iqdi99pd	2386	2	dramatisch	dramatisch	NNP
cord-015365-iqdi99pd	2386	3	die	die	VBP
cord-015365-iqdi99pd	2386	4	Einschränkung	Einschränkung	NNP
cord-015365-iqdi99pd	2386	5	der	der	NNP
cord-015365-iqdi99pd	2386	6	Nierenfunktion	Nierenfunktion	NNP
cord-015365-iqdi99pd	2386	7	(	(	-LRB-
cord-015365-iqdi99pd	2386	8	p	p	NN
cord-015365-iqdi99pd	2386	9	<	<	XX
cord-015365-iqdi99pd	2386	10	0,0001	0,0001	.
cord-015365-iqdi99pd	2386	11	für	für	JJ
cord-015365-iqdi99pd	2386	12	beide	beide	NN
cord-015365-iqdi99pd	2386	13	vs.	vs.	FW
cord-015365-iqdi99pd	2386	14	Kontrolle	Kontrolle	NNP
cord-015365-iqdi99pd	2386	15	)	)	-RRB-
cord-015365-iqdi99pd	2386	16	.	.	.
cord-015365-iqdi99pd	2387	1	Die	die	VB
cord-015365-iqdi99pd	2387	2	kompetitive	kompetitive	NNP
cord-015365-iqdi99pd	2388	1	Antagonisierung	Antagonisierung	NNP
cord-015365-iqdi99pd	2388	2	durch	durch	NNP
cord-015365-iqdi99pd	2388	3	SnPP	SnPP	NNP
cord-015365-iqdi99pd	2388	4	(	(	-LRB-
cord-015365-iqdi99pd	2388	5	5	5	CD
cord-015365-iqdi99pd	2388	6	mg	mg	NNP
cord-015365-iqdi99pd	2388	7	/	/	SYM
cord-015365-iqdi99pd	2388	8	kg	kg	NNP
cord-015365-iqdi99pd	2388	9	/	/	SYM
cord-015365-iqdi99pd	2388	10	KG	KG	NNP
cord-015365-iqdi99pd	2388	11	)	)	-RRB-
cord-015365-iqdi99pd	2388	12	konnte	konnte	NNP
cord-015365-iqdi99pd	2388	13	diesen	diesen	NNP
cord-015365-iqdi99pd	2388	14	positiven	positiven	NNP
cord-015365-iqdi99pd	2388	15	Effekt	Effekt	NNP
cord-015365-iqdi99pd	2388	16	vermindern	vermindern	NN
cord-015365-iqdi99pd	2388	17	.	.	.
cord-015365-iqdi99pd	2389	1	Histologische	Histologische	NNP
cord-015365-iqdi99pd	2389	2	und	und	IN
cord-015365-iqdi99pd	2390	1	immunhistochemische	immunhistochemische	NNP
cord-015365-iqdi99pd	2390	2	Auswertungen	Auswertungen	NNP
cord-015365-iqdi99pd	2390	3	unterstützen	unterstützen	NNP
cord-015365-iqdi99pd	2390	4	die	die	VB
cord-015365-iqdi99pd	2390	5	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2390	6	.	.	.
cord-015365-iqdi99pd	2391	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	2391	2	.	.	.
cord-015365-iqdi99pd	2392	1	Die	die	VB
cord-015365-iqdi99pd	2392	2	Anwendung	Anwendung	NNP
cord-015365-iqdi99pd	2392	3	von	von	NNP
cord-015365-iqdi99pd	2393	1	fü	fü	IN
cord-015365-iqdi99pd	2394	1	r	r	LS
cord-015365-iqdi99pd	2394	2	Menschen	Menschen	NNP
cord-015365-iqdi99pd	2394	3	ungefährlichen	ungefährlichen	NNP
cord-015365-iqdi99pd	2395	1	Nutrazeutika	Nutrazeutika	NNP
cord-015365-iqdi99pd	2396	1	stellt	stellt	NNP
cord-015365-iqdi99pd	2396	2	eine	eine	NNP
cord-015365-iqdi99pd	2396	3	ausgezeichnete	ausgezeichnete	NN
cord-015365-iqdi99pd	2396	4	Möglichkeit	Möglichkeit	NNP
cord-015365-iqdi99pd	2396	5	dar	dar	NNP
cord-015365-iqdi99pd	2396	6	,	,	,
cord-015365-iqdi99pd	2396	7	die	die	VB
cord-015365-iqdi99pd	2397	1	HO-1	HO-1	NNP
cord-015365-iqdi99pd	2397	2	zu	zu	NNP
cord-015365-iqdi99pd	2397	3	induzieren	induzieren	NNP
cord-015365-iqdi99pd	2398	1	und	und	IN
cord-015365-iqdi99pd	2398	2	den	den	NNP
cord-015365-iqdi99pd	2398	3	IRS	IRS	NNP
cord-015365-iqdi99pd	2398	4	zu	zu	NNP
cord-015365-iqdi99pd	2398	5	minimieren	minimieren	NNP
cord-015365-iqdi99pd	2398	6	.	.	.
cord-015365-iqdi99pd	2399	1	The	the	DT
cord-015365-iqdi99pd	2399	2	novel	novel	JJ
cord-015365-iqdi99pd	2399	3	compound	compound	NN
cord-015365-iqdi99pd	2399	4	5	5	CD
cord-015365-iqdi99pd	2399	5	0	0	CD
cord-015365-iqdi99pd	2400	1	-methoxy	-methoxy	:
cord-015365-iqdi99pd	2400	2	leoligin	leoligin	NNP
cord-015365-iqdi99pd	2400	3	increases	increase	VBZ
cord-015365-iqdi99pd	2400	4	the	the	DT
cord-015365-iqdi99pd	2400	5	ejection	ejection	NN
cord-015365-iqdi99pd	2400	6	fraction	fraction	NN
cord-015365-iqdi99pd	2400	7	of	of	IN
cord-015365-iqdi99pd	2400	8	infarcted	infarcted	JJ
cord-015365-iqdi99pd	2400	9	rat	rat	NN
cord-015365-iqdi99pd	2400	10	hearts	heart	NNS
cord-015365-iqdi99pd	2400	11	by	by	IN
cord-015365-iqdi99pd	2400	12	promoting	promote	VBG
cord-015365-iqdi99pd	2400	13	CYP26B1dependent	CYP26B1dependent	.
cord-015365-iqdi99pd	2400	14	angiogenesis	angiogenesis	NN
cord-015365-iqdi99pd	2400	15	Background	background	NN
cord-015365-iqdi99pd	2400	16	.	.	.
cord-015365-iqdi99pd	2401	1	In	in	IN
cord-015365-iqdi99pd	2401	2	times	time	NNS
cord-015365-iqdi99pd	2401	3	of	of	IN
cord-015365-iqdi99pd	2401	4	organ	organ	NN
cord-015365-iqdi99pd	2401	5	shortage	shortage	NN
cord-015365-iqdi99pd	2401	6	strategies	strategy	NNS
cord-015365-iqdi99pd	2401	7	to	to	IN
cord-015365-iqdi99pd	2401	8	recovery	recovery	NN
cord-015365-iqdi99pd	2401	9	damaged	damage	VBN
cord-015365-iqdi99pd	2401	10	organs	organ	NNS
cord-015365-iqdi99pd	2401	11	seem	seem	VBP
cord-015365-iqdi99pd	2401	12	to	to	TO
cord-015365-iqdi99pd	2401	13	be	be	VB
cord-015365-iqdi99pd	2401	14	valuable	valuable	JJ
cord-015365-iqdi99pd	2401	15	options	option	NNS
cord-015365-iqdi99pd	2401	16	to	to	TO
cord-015365-iqdi99pd	2401	17	face	face	VB
cord-015365-iqdi99pd	2401	18	this	this	DT
cord-015365-iqdi99pd	2401	19	problem	problem	NN
cord-015365-iqdi99pd	2401	20	.	.	.
cord-015365-iqdi99pd	2402	1	Cellular	cellular	JJ
cord-015365-iqdi99pd	2402	2	based	base	VBN
cord-015365-iqdi99pd	2402	3	strategies	strategy	NNS
cord-015365-iqdi99pd	2402	4	to	to	TO
cord-015365-iqdi99pd	2402	5	recover	recover	VB
cord-015365-iqdi99pd	2402	6	ischemic	ischemic	JJ
cord-015365-iqdi99pd	2402	7	myocardium	myocardium	NN
cord-015365-iqdi99pd	2402	8	have	have	VBP
cord-015365-iqdi99pd	2402	9	shown	show	VBN
cord-015365-iqdi99pd	2402	10	promising	promise	VBG
cord-015365-iqdi99pd	2402	11	experimental	experimental	JJ
cord-015365-iqdi99pd	2402	12	results	result	NNS
cord-015365-iqdi99pd	2402	13	but	but	CC
cord-015365-iqdi99pd	2402	14	the	the	DT
cord-015365-iqdi99pd	2402	15	clinical	clinical	JJ
cord-015365-iqdi99pd	2402	16	evidence	evidence	NN
cord-015365-iqdi99pd	2402	17	is	be	VBZ
cord-015365-iqdi99pd	2402	18	scarce	scarce	JJ
cord-015365-iqdi99pd	2402	19	.	.	.
cord-015365-iqdi99pd	2403	1	Especially	especially	RB
cord-015365-iqdi99pd	2403	2	the	the	DT
cord-015365-iqdi99pd	2403	3	lack	lack	NN
cord-015365-iqdi99pd	2403	4	of	of	IN
cord-015365-iqdi99pd	2403	5	angiogenesis	angiogenesis	NN
cord-015365-iqdi99pd	2403	6	in	in	IN
cord-015365-iqdi99pd	2403	7	cardiac	cardiac	JJ
cord-015365-iqdi99pd	2403	8	peri	peri	NN
cord-015365-iqdi99pd	2403	9	-	-	HYPH
cord-015365-iqdi99pd	2403	10	infarction	infarction	NN
cord-015365-iqdi99pd	2403	11	and	and	CC
cord-015365-iqdi99pd	2403	12	infarction	infarction	NN
cord-015365-iqdi99pd	2403	13	areas	area	NNS
cord-015365-iqdi99pd	2403	14	is	be	VBZ
cord-015365-iqdi99pd	2403	15	one	one	CD
cord-015365-iqdi99pd	2403	16	of	of	IN
cord-015365-iqdi99pd	2403	17	the	the	DT
cord-015365-iqdi99pd	2403	18	most	most	RBS
cord-015365-iqdi99pd	2403	19	important	important	JJ
cord-015365-iqdi99pd	2403	20	problems	problem	NNS
cord-015365-iqdi99pd	2403	21	in	in	IN
cord-015365-iqdi99pd	2403	22	functional	functional	JJ
cord-015365-iqdi99pd	2403	23	cardiac	cardiac	JJ
cord-015365-iqdi99pd	2403	24	recovery	recovery	NN
cord-015365-iqdi99pd	2403	25	after	after	IN
cord-015365-iqdi99pd	2403	26	myocardial	myocardial	JJ
cord-015365-iqdi99pd	2403	27	infarction	infarction	NN
cord-015365-iqdi99pd	2403	28	(	(	-LRB-
cord-015365-iqdi99pd	2403	29	MI	MI	NNP
cord-015365-iqdi99pd	2403	30	)	)	-RRB-
cord-015365-iqdi99pd	2403	31	.	.	.
cord-015365-iqdi99pd	2404	1	While	while	IN
cord-015365-iqdi99pd	2404	2	searching	search	VBG
cord-015365-iqdi99pd	2404	3	for	for	IN
cord-015365-iqdi99pd	2404	4	possible	possible	JJ
cord-015365-iqdi99pd	2404	5	pharmacological	pharmacological	JJ
cord-015365-iqdi99pd	2404	6	strategies	strategy	NNS
cord-015365-iqdi99pd	2404	7	to	to	TO
cord-015365-iqdi99pd	2404	8	stimulate	stimulate	VB
cord-015365-iqdi99pd	2404	9	angiogenesis	angiogenesis	NN
cord-015365-iqdi99pd	2404	10	after	after	IN
cord-015365-iqdi99pd	2404	11	MI	MI	NNP
cord-015365-iqdi99pd	2404	12	we	-PRON-	PRP
cord-015365-iqdi99pd	2404	13	conducted	conduct	VBD
cord-015365-iqdi99pd	2404	14	a	a	DT
cord-015365-iqdi99pd	2404	15	screen	screen	NN
cord-015365-iqdi99pd	2404	16	for	for	IN
cord-015365-iqdi99pd	2404	17	plant	plant	NN
cord-015365-iqdi99pd	2404	18	compounds	compound	NNS
cord-015365-iqdi99pd	2404	19	with	with	IN
cord-015365-iqdi99pd	2404	20	pro	pro	JJ
cord-015365-iqdi99pd	2404	21	-	-	JJ
cord-015365-iqdi99pd	2404	22	neoangiogenetic	neoangiogenetic	JJ
cord-015365-iqdi99pd	2404	23	properties	property	NNS
cord-015365-iqdi99pd	2404	24	.	.	.
cord-015365-iqdi99pd	2405	1	Methods	method	NNS
cord-015365-iqdi99pd	2405	2	and	and	CC
cord-015365-iqdi99pd	2405	3	Results	result	NNS
cord-015365-iqdi99pd	2405	4	.	.	.
cord-015365-iqdi99pd	2406	1	5	5	LS
cord-015365-iqdi99pd	2406	2	0	0	CD
cord-015365-iqdi99pd	2407	1	-methoxy	-methoxy	NNP
cord-015365-iqdi99pd	2407	2	leoligin	leoligin	NNP
cord-015365-iqdi99pd	2407	3	,	,	,
cord-015365-iqdi99pd	2407	4	a	a	DT
cord-015365-iqdi99pd	2407	5	compound	compound	NN
cord-015365-iqdi99pd	2407	6	isolated	isolate	VBN
cord-015365-iqdi99pd	2407	7	from	from	IN
cord-015365-iqdi99pd	2407	8	the	the	DT
cord-015365-iqdi99pd	2407	9	roots	root	NNS
cord-015365-iqdi99pd	2407	10	of	of	IN
cord-015365-iqdi99pd	2407	11	Leontopodium	Leontopodium	NNP
cord-015365-iqdi99pd	2407	12	alpinum	alpinum	NN
cord-015365-iqdi99pd	2407	13	(	(	-LRB-
cord-015365-iqdi99pd	2407	14	Edelweiss	Edelweiss	NNP
cord-015365-iqdi99pd	2407	15	)	)	-RRB-
cord-015365-iqdi99pd	2407	16	potently	potently	RB
cord-015365-iqdi99pd	2407	17	stimulated	stimulate	VBD
cord-015365-iqdi99pd	2407	18	endothelial	endothelial	JJ
cord-015365-iqdi99pd	2407	19	cell	cell	NN
cord-015365-iqdi99pd	2407	20	migration	migration	NN
cord-015365-iqdi99pd	2407	21	,	,	,
cord-015365-iqdi99pd	2407	22	tube	tube	NN
cord-015365-iqdi99pd	2407	23	forma	forma	NN
cord-015365-iqdi99pd	2407	24	-	-	HYPH
cord-015365-iqdi99pd	2407	25	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	2407	26	.	.	.
cord-015365-iqdi99pd	2408	1	Ungeplante	Ungeplante	NNP
cord-015365-iqdi99pd	2408	2	Reoperationen	Reoperationen	NNP
cord-015365-iqdi99pd	2408	3	dienen	dienen	NNP
cord-015365-iqdi99pd	2408	4	als	als	NNP
cord-015365-iqdi99pd	2408	5	Indikator	Indikator	NNP
cord-015365-iqdi99pd	2408	6	der	der	NNP
cord-015365-iqdi99pd	2408	7	Qualitätskontrolle	Qualitätskontrolle	NNP
cord-015365-iqdi99pd	2408	8	in	in	IN
cord-015365-iqdi99pd	2408	9	der	der	NNP
cord-015365-iqdi99pd	2408	10	Chirurgie	Chirurgie	NNP
cord-015365-iqdi99pd	2408	11	.	.	.
cord-015365-iqdi99pd	2409	1	Daten	Daten	NNP
cord-015365-iqdi99pd	2409	2	für	für	FW
cord-015365-iqdi99pd	2409	3	die	die	VBP
cord-015365-iqdi99pd	2409	4	Nierentransplantation	Nierentransplantation	NNP
cord-015365-iqdi99pd	2409	5	liegen	liegen	NNP
cord-015365-iqdi99pd	2409	6	noch	noch	FW
cord-015365-iqdi99pd	2409	7	nicht	nicht	FW
cord-015365-iqdi99pd	2409	8	vor	vor	NNP
cord-015365-iqdi99pd	2409	9	.	.	.
cord-015365-iqdi99pd	2410	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	2410	2	.	.	.
cord-015365-iqdi99pd	2411	1	Retrospektive	Retrospektive	NNP
cord-015365-iqdi99pd	2411	2	Analyse	Analyse	NNP
cord-015365-iqdi99pd	2411	3	von	von	NNP
cord-015365-iqdi99pd	2411	4	320	320	CD
cord-015365-iqdi99pd	2411	5	Nierentransplantationen	Nierentransplantationen	NNP
cord-015365-iqdi99pd	2411	6	zwischen	zwischen	NNP
cord-015365-iqdi99pd	2411	7	9/2002	9/2002	CD
cord-015365-iqdi99pd	2412	1	und	und	NNP
cord-015365-iqdi99pd	2413	1	12/2010	12/2010	CD
cord-015365-iqdi99pd	2413	2	.	.	.
cord-015365-iqdi99pd	2414	1	Die	die	VB
cord-015365-iqdi99pd	2415	1	Anzahl	Anzahl	NNP
cord-015365-iqdi99pd	2415	2	der	der	NNP
cord-015365-iqdi99pd	2415	3	ungeplanten	ungeplanten	NNP
cord-015365-iqdi99pd	2415	4	Reoperationen	Reoperationen	NNP
cord-015365-iqdi99pd	2415	5	und	und	IN
cord-015365-iqdi99pd	2415	6	Ursache	Ursache	NNP
cord-015365-iqdi99pd	2415	7	,	,	,
cord-015365-iqdi99pd	2415	8	Mortalität	Mortalität	NNP
cord-015365-iqdi99pd	2415	9	,	,	,
cord-015365-iqdi99pd	2416	1	Kreatininspiegel	Kreatininspiegel	NNP
cord-015365-iqdi99pd	2416	2	1	1	CD
cord-015365-iqdi99pd	2416	3	Monat	Monat	NNP
cord-015365-iqdi99pd	2416	4	und	und	XX
cord-015365-iqdi99pd	2417	1	1	1	LS
cord-015365-iqdi99pd	2417	2	Jahr	Jahr	NNP
cord-015365-iqdi99pd	2417	3	post	post	NN
cord-015365-iqdi99pd	2417	4	TX	TX	NNP
cord-015365-iqdi99pd	2418	1	und	und	NNP
cord-015365-iqdi99pd	2418	2	die	die	VBP
cord-015365-iqdi99pd	2418	3	Art	art	NN
cord-015365-iqdi99pd	2418	4	der	der	NN
cord-015365-iqdi99pd	2418	5	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	2418	6	in	in	IN
cord-015365-iqdi99pd	2418	7	Bezug	Bezug	NNP
cord-015365-iqdi99pd	2418	8	zum	zum	NNP
cord-015365-iqdi99pd	2418	9	Organverlust	Organverlust	NNP
cord-015365-iqdi99pd	2418	10	wurden	wurden	VBD
cord-015365-iqdi99pd	2418	11	als	als	NNP
cord-015365-iqdi99pd	2418	12	mögliche	mögliche	NN
cord-015365-iqdi99pd	2418	13	Risikofaktoren	Risikofaktoren	NNP
cord-015365-iqdi99pd	2418	14	evaluiert	evaluiert	NN
cord-015365-iqdi99pd	2418	15	.	.	.
cord-015365-iqdi99pd	2419	1	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2419	2	.	.	.
cord-015365-iqdi99pd	2420	1	In	in	IN
cord-015365-iqdi99pd	2420	2	der	der	NN
cord-015365-iqdi99pd	2420	3	Analyse	Analyse	NNP
cord-015365-iqdi99pd	2420	4	unseres	unseres	NNP
cord-015365-iqdi99pd	2420	5	Patientenkollektives	Patientenkollektives	NNP
cord-015365-iqdi99pd	2420	6	(	(	-LRB-
cord-015365-iqdi99pd	2420	7	320	320	CD
cord-015365-iqdi99pd	2420	8	Nierentransplantationen	Nierentransplantationen	NNP
cord-015365-iqdi99pd	2420	9	über	über	NNP
cord-015365-iqdi99pd	2420	10	100	100	CD
cord-015365-iqdi99pd	2420	11	Monate	Monate	NNP
cord-015365-iqdi99pd	2420	12	)	)	-RRB-
cord-015365-iqdi99pd	2420	13	zeigt	zeigt	NNP
cord-015365-iqdi99pd	2420	14	sich	sich	NNP
cord-015365-iqdi99pd	2420	15	eine	eine	NNP
cord-015365-iqdi99pd	2420	16	14	14	CD
cord-015365-iqdi99pd	2420	17	%	%	NN
cord-015365-iqdi99pd	2420	18	ige	ige	NNP
cord-015365-iqdi99pd	2420	19	Reoperationsrate	Reoperationsrate	NNP
cord-015365-iqdi99pd	2420	20	,	,	,
cord-015365-iqdi99pd	2420	21	dies	die	VBZ
cord-015365-iqdi99pd	2420	22	entspricht	entspricht	NNP
cord-015365-iqdi99pd	2421	1	46	46	CD
cord-015365-iqdi99pd	2421	2	Reoperationen	Reoperationen	NNP
cord-015365-iqdi99pd	2421	3	,	,	,
cord-015365-iqdi99pd	2421	4	wobei	wobei	JJ
cord-015365-iqdi99pd	2421	5	bei	bei	NNP
cord-015365-iqdi99pd	2421	6	16	16	CD
cord-015365-iqdi99pd	2421	7	%	%	NN
cord-015365-iqdi99pd	2421	8	der	der	NNP
cord-015365-iqdi99pd	2421	9	Reoperierten	Reoperierten	NNP
cord-015365-iqdi99pd	2421	10	mehr	mehr	JJ
cord-015365-iqdi99pd	2421	11	als	als	NNP
cord-015365-iqdi99pd	2421	12	eine	eine	NNP
cord-015365-iqdi99pd	2421	13	Reoperation	Reoperation	NNP
cord-015365-iqdi99pd	2421	14	notwendig	notwendig	JJ
cord-015365-iqdi99pd	2421	15	war	war	NN
cord-015365-iqdi99pd	2421	16	.	.	.
cord-015365-iqdi99pd	2422	1	Ursächlich	Ursächlich	NNP
cord-015365-iqdi99pd	2422	2	dafür	dafür	NNP
cord-015365-iqdi99pd	2422	3	waren	waren	NNP
cord-015365-iqdi99pd	2423	1	vordergründig	vordergründig	NNP
cord-015365-iqdi99pd	2423	2	Gefäßkomplikationen	Gefäßkomplikationen	NNP
cord-015365-iqdi99pd	2423	3	(	(	-LRB-
cord-015365-iqdi99pd	2423	4	30	30	CD
cord-015365-iqdi99pd	2423	5	%	%	NN
cord-015365-iqdi99pd	2423	6	)	)	-RRB-
cord-015365-iqdi99pd	2424	1	gefolgt	gefolgt	NNP
cord-015365-iqdi99pd	2424	2	von	von	NNP
cord-015365-iqdi99pd	2424	3	Hämatomausräumungen	Hämatomausräumungen	NNP
cord-015365-iqdi99pd	2424	4	und	und	IN
cord-015365-iqdi99pd	2424	5	Wundinfektionen	Wundinfektionen	NNP
cord-015365-iqdi99pd	2424	6	,	,	,
cord-015365-iqdi99pd	2424	7	welche	welche	NNP
cord-015365-iqdi99pd	2424	8	einer	einer	NNP
cord-015365-iqdi99pd	2424	9	operativen	operativen	NNP
cord-015365-iqdi99pd	2424	10	Sanierung	Sanierung	NNP
cord-015365-iqdi99pd	2424	11	bedurften	bedurften	NNP
cord-015365-iqdi99pd	2424	12	(	(	-LRB-
cord-015365-iqdi99pd	2424	13	28	28	CD
cord-015365-iqdi99pd	2424	14	%	%	NN
cord-015365-iqdi99pd	2424	15	)	)	-RRB-
cord-015365-iqdi99pd	2424	16	.	.	.
cord-015365-iqdi99pd	2425	1	Seltener	Seltener	NNP
cord-015365-iqdi99pd	2425	2	kam	kam	NNP
cord-015365-iqdi99pd	2425	3	es	es	XX
cord-015365-iqdi99pd	2425	4	zu	zu	NNP
cord-015365-iqdi99pd	2425	5	Reoperationen	Reoperationen	NNP
cord-015365-iqdi99pd	2425	6	aufgrund	aufgrund	IN
cord-015365-iqdi99pd	2425	7	urologischer	urologischer	JJ
cord-015365-iqdi99pd	2425	8	Ursachen	Ursachen	NNP
cord-015365-iqdi99pd	2425	9	(	(	-LRB-
cord-015365-iqdi99pd	2425	10	20	20	CD
cord-015365-iqdi99pd	2425	11	%	%	NN
cord-015365-iqdi99pd	2425	12	)	)	-RRB-
cord-015365-iqdi99pd	2425	13	,	,	.
cord-015365-iqdi99pd	2426	1	Lymphozelen	Lymphozelen	NNP
cord-015365-iqdi99pd	2426	2	und	und	IN
cord-015365-iqdi99pd	2426	3	abdomineller	abdomineller	NNP
cord-015365-iqdi99pd	2426	4	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	2426	5	(	(	-LRB-
cord-015365-iqdi99pd	2426	6	je	je	NNP
cord-015365-iqdi99pd	2426	7	6,5	6,5	CD
cord-015365-iqdi99pd	2426	8	%	%	NN
cord-015365-iqdi99pd	2426	9	)	)	-RRB-
cord-015365-iqdi99pd	2426	10	.	.	.
cord-015365-iqdi99pd	2427	1	Von	Von	NNP
cord-015365-iqdi99pd	2427	2	insgesamt	insgesamt	NNP
cord-015365-iqdi99pd	2428	1	40	40	CD
cord-015365-iqdi99pd	2428	2	Organverlusten	Organverlusten	NNP
cord-015365-iqdi99pd	2428	3	waren	waren	XX
cord-015365-iqdi99pd	2429	1	17	17	CD
cord-015365-iqdi99pd	2429	2	bei	bei	NNP
cord-015365-iqdi99pd	2429	3	reoperierten	reoperierten	NNP
cord-015365-iqdi99pd	2430	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2430	2	(	(	-LRB-
cord-015365-iqdi99pd	2430	3	das	das	NNP
cord-015365-iqdi99pd	2430	4	entspricht	entspricht	NNP
cord-015365-iqdi99pd	2431	1	43	43	CD
cord-015365-iqdi99pd	2431	2	%	%	NN
cord-015365-iqdi99pd	2431	3	der	der	NN
cord-015365-iqdi99pd	2431	4	reoperierten	reoperierten	FW
cord-015365-iqdi99pd	2431	5	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2431	6	)	)	-RRB-
cord-015365-iqdi99pd	2432	1	und	und	IN
cord-015365-iqdi99pd	2432	2	23	23	CD
cord-015365-iqdi99pd	2432	3	(	(	-LRB-
cord-015365-iqdi99pd	2432	4	9	9	CD
cord-015365-iqdi99pd	2432	5	%	%	NN
cord-015365-iqdi99pd	2432	6	)	)	-RRB-
cord-015365-iqdi99pd	2433	1	bei	bei	NNP
cord-015365-iqdi99pd	2433	2	nicht	nicht	NNP
cord-015365-iqdi99pd	2433	3	reoperierten	reoperierten	NNP
cord-015365-iqdi99pd	2433	4	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2433	5	zu	zu	NNP
cord-015365-iqdi99pd	2433	6	verzeichnen	verzeichnen	NNP
cord-015365-iqdi99pd	2433	7	(	(	-LRB-
cord-015365-iqdi99pd	2433	8	p	p	NN
cord-015365-iqdi99pd	2433	9	<	<	XX
cord-015365-iqdi99pd	2433	10	0,001	0,001	CD
cord-015365-iqdi99pd	2433	11	)	)	-RRB-
cord-015365-iqdi99pd	2433	12	.	.	.
cord-015365-iqdi99pd	2434	1	In	in	IN
cord-015365-iqdi99pd	2434	2	der	der	NNP
cord-015365-iqdi99pd	2434	3	Subanalyse	Subanalyse	NNP
cord-015365-iqdi99pd	2434	4	der	der	NNP
cord-015365-iqdi99pd	2434	5	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	2434	6	,	,	,
cord-015365-iqdi99pd	2434	7	welche	welche	NNP
cord-015365-iqdi99pd	2434	8	zu	zu	NNP
cord-015365-iqdi99pd	2434	9	Reoperationen	Reoperationen	NNP
cord-015365-iqdi99pd	2434	10	führten	führten	NNP
cord-015365-iqdi99pd	2434	11	,	,	,
cord-015365-iqdi99pd	2434	12	sind	sind	NNP
cord-015365-iqdi99pd	2434	13	Gefäßkomplikationen	Gefäßkomplikationen	NNP
cord-015365-iqdi99pd	2434	14	die	die	VBP
cord-015365-iqdi99pd	2434	15	häufigste	häufigste	NN
cord-015365-iqdi99pd	2434	16	Ursache	Ursache	NNP
cord-015365-iqdi99pd	2434	17	für	für	IN
cord-015365-iqdi99pd	2434	18	vorzeitigen	vorzeitigen	NNP
cord-015365-iqdi99pd	2434	19	Organverlust	Organverlust	NNP
cord-015365-iqdi99pd	2434	20	(	(	-LRB-
cord-015365-iqdi99pd	2434	21	64	64	CD
cord-015365-iqdi99pd	2434	22	%	%	NN
cord-015365-iqdi99pd	2435	1	,	,	,
cord-015365-iqdi99pd	2435	2	das	das	NNP
cord-015365-iqdi99pd	2435	3	entspricht	entspricht	NNP
cord-015365-iqdi99pd	2435	4	9	9	CD
cord-015365-iqdi99pd	2435	5	von	von	NNP
cord-015365-iqdi99pd	2435	6	14	14	CD
cord-015365-iqdi99pd	2435	7	Reoperationen	Reoperationen	NNP
cord-015365-iqdi99pd	2435	8	vs.	vs.	IN
cord-015365-iqdi99pd	2435	9	33	33	CD
cord-015365-iqdi99pd	2435	10	%	%	NN
cord-015365-iqdi99pd	2435	11	bei	bei	NNP
cord-015365-iqdi99pd	2435	12	Lymphozelen	Lymphozelen	NNP
cord-015365-iqdi99pd	2435	13	,	,	,
cord-015365-iqdi99pd	2435	14	33	33	CD
cord-015365-iqdi99pd	2435	15	%	%	NN
cord-015365-iqdi99pd	2435	16	bei	bei	NNP
cord-015365-iqdi99pd	2435	17	abdominellen	abdominellen	NNP
cord-015365-iqdi99pd	2435	18	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	2435	19	,	,	,
cord-015365-iqdi99pd	2435	20	31	31	CD
cord-015365-iqdi99pd	2435	21	%	%	NN
cord-015365-iqdi99pd	2435	22	bei	bei	NNP
cord-015365-iqdi99pd	2435	23	Weichteilproblemen	Weichteilproblemen	NNP
cord-015365-iqdi99pd	2435	24	und	und	IN
cord-015365-iqdi99pd	2435	25	11	11	CD
cord-015365-iqdi99pd	2435	26	%	%	NN
cord-015365-iqdi99pd	2435	27	bei	bei	NNP
cord-015365-iqdi99pd	2435	28	urologischen	urologischen	NNP
cord-015365-iqdi99pd	2435	29	Komplikationen	Komplikationen	NNP
cord-015365-iqdi99pd	2435	30	)	)	-RRB-
cord-015365-iqdi99pd	2435	31	.	.	.
cord-015365-iqdi99pd	2436	1	In	in	IN
cord-015365-iqdi99pd	2436	2	Bezug	Bezug	NNP
cord-015365-iqdi99pd	2436	3	zur	zur	NNP
cord-015365-iqdi99pd	2436	4	Immunsuppression	Immunsuppression	NNP
cord-015365-iqdi99pd	2436	5	konnten	konnten	NNP
cord-015365-iqdi99pd	2436	6	keine	keine	NNP
cord-015365-iqdi99pd	2436	7	statistisch	statistisch	NN
cord-015365-iqdi99pd	2436	8	signifikanten	signifikanten	NNP
cord-015365-iqdi99pd	2436	9	Unterschiede	Unterschiede	NNP
cord-015365-iqdi99pd	2436	10	erhoben	erhoben	NNP
cord-015365-iqdi99pd	2436	11	werden	werden	NNP
cord-015365-iqdi99pd	2436	12	.	.	.
cord-015365-iqdi99pd	2437	1	Ein	Ein	NNP
cord-015365-iqdi99pd	2437	2	erhöhtes	erhöhte	NNS
cord-015365-iqdi99pd	2438	1	Serum	serum	NN
cord-015365-iqdi99pd	2438	2	-	-	HYPH
cord-015365-iqdi99pd	2438	3	Kreatinin	Kreatinin	NNP
cord-015365-iqdi99pd	2438	4	nach	nach	NN
cord-015365-iqdi99pd	2438	5	1	1	CD
cord-015365-iqdi99pd	2438	6	Monat	Monat	NNP
cord-015365-iqdi99pd	2438	7	(	(	-LRB-
cord-015365-iqdi99pd	2438	8	Kreatinin	Kreatinin	NNP
cord-015365-iqdi99pd	2438	9	>	>	XX
cord-015365-iqdi99pd	2439	1	2	2	LS
cord-015365-iqdi99pd	2439	2	)	)	-RRB-
cord-015365-iqdi99pd	2440	1	fand	fand	UH
cord-015365-iqdi99pd	2440	2	sich	sich	NNP
cord-015365-iqdi99pd	2440	3	bei	bei	NNP
cord-015365-iqdi99pd	2440	4	42	42	CD
cord-015365-iqdi99pd	2440	5	%	%	NN
cord-015365-iqdi99pd	2440	6	der	der	NN
cord-015365-iqdi99pd	2440	7	reoperierten	reoperierten	NNP
cord-015365-iqdi99pd	2440	8	vs.	vs.	FW
cord-015365-iqdi99pd	2440	9	16,5	16,5	CD
cord-015365-iqdi99pd	2440	10	%	%	NN
cord-015365-iqdi99pd	2440	11	der	der	NN
cord-015365-iqdi99pd	2440	12	nicht	nicht	NNP
cord-015365-iqdi99pd	2440	13	reoperierten	reoperierten	NNP
cord-015365-iqdi99pd	2441	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2441	2	(	(	-LRB-
cord-015365-iqdi99pd	2441	3	p	p	NN
cord-015365-iqdi99pd	2441	4	<	<	XX
cord-015365-iqdi99pd	2441	5	0,001	0,001	CD
cord-015365-iqdi99pd	2441	6	)	)	-RRB-
cord-015365-iqdi99pd	2441	7	.	.	.
cord-015365-iqdi99pd	2442	1	Nach	Nach	NNP
cord-015365-iqdi99pd	2442	2	einem	einem	NNP
cord-015365-iqdi99pd	2442	3	Jahr	Jahr	NNP
cord-015365-iqdi99pd	2442	4	war	war	NN
cord-015365-iqdi99pd	2442	5	das	das	NNP
cord-015365-iqdi99pd	2442	6	Kreatinin	Kreatinin	NNP
cord-015365-iqdi99pd	2442	7	bei	bei	NNP
cord-015365-iqdi99pd	2442	8	37	37	CD
cord-015365-iqdi99pd	2442	9	%	%	NN
cord-015365-iqdi99pd	2442	10	der	der	NN
cord-015365-iqdi99pd	2442	11	reoperierten	reoperierten	NNP
cord-015365-iqdi99pd	2443	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2443	2	>	>	XX
cord-015365-iqdi99pd	2444	1	2	2	LS
cord-015365-iqdi99pd	2444	2	,	,	,
cord-015365-iqdi99pd	2444	3	hingegen	hingegen	NNP
cord-015365-iqdi99pd	2444	4	nur	nur	NNP
cord-015365-iqdi99pd	2444	5	bei	bei	NNP
cord-015365-iqdi99pd	2444	6	16,5	16,5	CD
cord-015365-iqdi99pd	2444	7	%	%	NN
cord-015365-iqdi99pd	2445	1	der	der	NNP
cord-015365-iqdi99pd	2445	2	nicht	nicht	NNP
cord-015365-iqdi99pd	2445	3	reoperierten	reoperierten	NNP
cord-015365-iqdi99pd	2445	4	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2445	5	(	(	-LRB-
cord-015365-iqdi99pd	2445	6	p	p	NN
cord-015365-iqdi99pd	2445	7	¼	¼	CD
cord-015365-iqdi99pd	2445	8	0,005	0,005	CD
cord-015365-iqdi99pd	2445	9	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2445	10	.	.	.
cord-015365-iqdi99pd	2446	1	Varizen	varizen	NN
cord-015365-iqdi99pd	2446	2	wurden	wurden	VBD
cord-015365-iqdi99pd	2446	3	mittels	mittels	NNP
cord-015365-iqdi99pd	2446	4	Ö	Ö	NNP
cord-015365-iqdi99pd	2446	5	sophago	sophago	NNP
cord-015365-iqdi99pd	2446	6	-	-	HYPH
cord-015365-iqdi99pd	2446	7	Gastroskopie	Gastroskopie	NNP
cord-015365-iqdi99pd	2446	8	in	in	IN
cord-015365-iqdi99pd	2446	9	287	287	CD
cord-015365-iqdi99pd	2446	10	(	(	-LRB-
cord-015365-iqdi99pd	2446	11	72,5	72,5	CD
cord-015365-iqdi99pd	2446	12	%	%	NN
cord-015365-iqdi99pd	2446	13	)	)	-RRB-
cord-015365-iqdi99pd	2447	1	von	von	NNP
cord-015365-iqdi99pd	2447	2	396	396	CD
cord-015365-iqdi99pd	2447	3	untersuchten	untersuchten	NNP
cord-015365-iqdi99pd	2447	4	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2447	5	dokumentiert	dokumentiert	NN
cord-015365-iqdi99pd	2447	6	,	,	,
cord-015365-iqdi99pd	2447	7	wobei	wobei	FW
cord-015365-iqdi99pd	2447	8	nur	nur	NNP
cord-015365-iqdi99pd	2447	9	in	in	IN
cord-015365-iqdi99pd	2447	10	einem	einem	NNP
cord-015365-iqdi99pd	2447	11	Fall	Fall	NNP
cord-015365-iqdi99pd	2447	12	schwere	schwere	NN
cord-015365-iqdi99pd	2447	13	Blutungen	Blutungen	NNP
cord-015365-iqdi99pd	2447	14	aus	aus	NNP
cord-015365-iqdi99pd	2447	15	Case	Case	NNP
cord-015365-iqdi99pd	2447	16	Report	Report	NNP
cord-015365-iqdi99pd	2447	17	.	.	.
cord-015365-iqdi99pd	2448	1	11	11	CD
cord-015365-iqdi99pd	2448	2	years	year	NNS
cord-015365-iqdi99pd	2448	3	after	after	IN
cord-015365-iqdi99pd	2448	4	bilateral	bilateral	JJ
cord-015365-iqdi99pd	2448	5	hand	hand	NN
cord-015365-iqdi99pd	2448	6	transplantation	transplantation	NN
cord-015365-iqdi99pd	2448	7	a	a	DT
cord-015365-iqdi99pd	2448	8	patient	patient	NN
cord-015365-iqdi99pd	2448	9	developed	develop	VBD
cord-015365-iqdi99pd	2448	10	a	a	DT
cord-015365-iqdi99pd	2448	11	bullous	bullous	JJ
cord-015365-iqdi99pd	2448	12	pemphigoid	pemphigoid	NN
cord-015365-iqdi99pd	2448	13	(	(	-LRB-
cord-015365-iqdi99pd	2448	14	BP	BP	NNP
cord-015365-iqdi99pd	2448	15	)	)	-RRB-
cord-015365-iqdi99pd	2448	16	,	,	,
cord-015365-iqdi99pd	2448	17	which	which	WDT
cord-015365-iqdi99pd	2448	18	is	be	VBZ
cord-015365-iqdi99pd	2448	19	an	an	DT
cord-015365-iqdi99pd	2448	20	autoimmune	autoimmune	JJ
cord-015365-iqdi99pd	2448	21	blistering	blistering	JJ
cord-015365-iqdi99pd	2448	22	skin	skin	NN
cord-015365-iqdi99pd	2448	23	disease	disease	NN
cord-015365-iqdi99pd	2448	24	,	,	,
cord-015365-iqdi99pd	2448	25	characterized	characterize	VBN
cord-015365-iqdi99pd	2448	26	by	by	IN
cord-015365-iqdi99pd	2448	27	autoantibodies	autoantibody	NNS
cord-015365-iqdi99pd	2448	28	targeting	target	VBG
cord-015365-iqdi99pd	2448	29	the	the	DT
cord-015365-iqdi99pd	2448	30	type	type	NN
cord-015365-iqdi99pd	2448	31	XVII	XVII	NNP
cord-015365-iqdi99pd	2448	32	collagen	collagen	NN
cord-015365-iqdi99pd	2448	33	component	component	NN
cord-015365-iqdi99pd	2448	34	of	of	IN
cord-015365-iqdi99pd	2448	35	hemidesmosomes	hemidesmosome	NNS
cord-015365-iqdi99pd	2448	36	in	in	IN
cord-015365-iqdi99pd	2448	37	the	the	DT
cord-015365-iqdi99pd	2448	38	skin	skin	NN
cord-015365-iqdi99pd	2448	39	basement	basement	NN
cord-015365-iqdi99pd	2448	40	membrane	membrane	NN
cord-015365-iqdi99pd	2448	41	zone	zone	NN
cord-015365-iqdi99pd	2448	42	.	.	.
cord-015365-iqdi99pd	2449	1	This	this	DT
cord-015365-iqdi99pd	2449	2	is	be	VBZ
cord-015365-iqdi99pd	2449	3	the	the	DT
cord-015365-iqdi99pd	2449	4	first	first	JJ
cord-015365-iqdi99pd	2449	5	report	report	NN
cord-015365-iqdi99pd	2449	6	on	on	IN
cord-015365-iqdi99pd	2449	7	an	an	DT
cord-015365-iqdi99pd	2449	8	autoimmune	autoimmune	JJ
cord-015365-iqdi99pd	2449	9	complication	complication	NN
cord-015365-iqdi99pd	2449	10	in	in	IN
cord-015365-iqdi99pd	2449	11	a	a	DT
cord-015365-iqdi99pd	2449	12	patient	patient	NN
cord-015365-iqdi99pd	2449	13	after	after	IN
cord-015365-iqdi99pd	2449	14	vascularized	vascularized	JJ
cord-015365-iqdi99pd	2449	15	composite	composite	JJ
cord-015365-iqdi99pd	2449	16	allotransplantation	allotransplantation	NN
cord-015365-iqdi99pd	2449	17	(	(	-LRB-
cord-015365-iqdi99pd	2449	18	VCA	VCA	NNP
cord-015365-iqdi99pd	2449	19	)	)	-RRB-
cord-015365-iqdi99pd	2449	20	.	.	.
cord-015365-iqdi99pd	2450	1	The	the	DT
cord-015365-iqdi99pd	2450	2	patient	patient	NN
cord-015365-iqdi99pd	2450	3	showed	show	VBD
cord-015365-iqdi99pd	2450	4	a	a	DT
cord-015365-iqdi99pd	2450	5	quite	quite	JJ
cord-015365-iqdi99pd	2450	6	Background	background	NN
cord-015365-iqdi99pd	2450	7	.	.	.
cord-015365-iqdi99pd	2451	1	The	the	DT
cord-015365-iqdi99pd	2451	2	Mounier	Mounier	NNP
cord-015365-iqdi99pd	2451	3	-	-	HYPH
cord-015365-iqdi99pd	2451	4	Kuhn	Kuhn	NNP
cord-015365-iqdi99pd	2451	5	syndrome	syndrome	NN
cord-015365-iqdi99pd	2451	6	(	(	-LRB-
cord-015365-iqdi99pd	2451	7	MKS	MKS	NNP
cord-015365-iqdi99pd	2451	8	)	)	-RRB-
cord-015365-iqdi99pd	2451	9	is	be	VBZ
cord-015365-iqdi99pd	2451	10	a	a	DT
cord-015365-iqdi99pd	2451	11	rare	rare	JJ
cord-015365-iqdi99pd	2451	12	disease	disease	NN
cord-015365-iqdi99pd	2451	13	characterized	characterize	VBN
cord-015365-iqdi99pd	2451	14	by	by	IN
cord-015365-iqdi99pd	2451	15	a	a	DT
cord-015365-iqdi99pd	2451	16	pathological	pathological	JJ
cord-015365-iqdi99pd	2451	17	dilation	dilation	NN
cord-015365-iqdi99pd	2451	18	of	of	IN
cord-015365-iqdi99pd	2451	19	the	the	DT
cord-015365-iqdi99pd	2451	20	trachea	trachea	NN
cord-015365-iqdi99pd	2451	21	and	and	CC
cord-015365-iqdi99pd	2451	22	the	the	DT
cord-015365-iqdi99pd	2451	23	bronchial	bronchial	JJ
cord-015365-iqdi99pd	2451	24	system	system	NN
cord-015365-iqdi99pd	2451	25	.	.	.
cord-015365-iqdi99pd	2452	1	The	the	DT
cord-015365-iqdi99pd	2452	2	etiology	etiology	NN
cord-015365-iqdi99pd	2452	3	of	of	IN
cord-015365-iqdi99pd	2452	4	the	the	DT
cord-015365-iqdi99pd	2452	5	disorder	disorder	NN
cord-015365-iqdi99pd	2452	6	remains	remain	VBZ
cord-015365-iqdi99pd	2452	7	elusive	elusive	JJ
cord-015365-iqdi99pd	2452	8	but	but	CC
cord-015365-iqdi99pd	2452	9	genetic	genetic	JJ
cord-015365-iqdi99pd	2452	10	alterations	alteration	NNS
cord-015365-iqdi99pd	2452	11	and	and	CC
cord-015365-iqdi99pd	2452	12	degradation	degradation	NN
cord-015365-iqdi99pd	2452	13	of	of	IN
cord-015365-iqdi99pd	2452	14	elastic	elastic	JJ
cord-015365-iqdi99pd	2452	15	fibers	fiber	NNS
cord-015365-iqdi99pd	2452	16	are	be	VBP
cord-015365-iqdi99pd	2452	17	thought	think	VBN
cord-015365-iqdi99pd	2452	18	to	to	TO
cord-015365-iqdi99pd	2452	19	be	be	VB
cord-015365-iqdi99pd	2452	20	involved	involve	VBN
cord-015365-iqdi99pd	2452	21	in	in	IN
cord-015365-iqdi99pd	2452	22	the	the	DT
cord-015365-iqdi99pd	2452	23	pathogenesis	pathogenesis	NN
cord-015365-iqdi99pd	2452	24	.	.	.
cord-015365-iqdi99pd	2453	1	No	no	DT
cord-015365-iqdi99pd	2453	2	causative	causative	JJ
cord-015365-iqdi99pd	2453	3	treatment	treatment	NN
cord-015365-iqdi99pd	2453	4	is	be	VBZ
cord-015365-iqdi99pd	2453	5	available	available	JJ
cord-015365-iqdi99pd	2453	6	although	although	IN
cord-015365-iqdi99pd	2453	7	transplantation	transplantation	NN
cord-015365-iqdi99pd	2453	8	is	be	VBZ
cord-015365-iqdi99pd	2453	9	an	an	DT
cord-015365-iqdi99pd	2453	10	option	option	NN
cord-015365-iqdi99pd	2453	11	for	for	IN
cord-015365-iqdi99pd	2453	12	endstage	endstage	NN
cord-015365-iqdi99pd	2453	13	disease	disease	NN
cord-015365-iqdi99pd	2453	14	.	.	.
cord-015365-iqdi99pd	2454	1	Here	here	RB
cord-015365-iqdi99pd	2454	2	,	,	,
cord-015365-iqdi99pd	2454	3	we	-PRON-	PRP
cord-015365-iqdi99pd	2454	4	describe	describe	VBP
cord-015365-iqdi99pd	2454	5	a	a	DT
cord-015365-iqdi99pd	2454	6	patient	patient	NN
cord-015365-iqdi99pd	2454	7	suffering	suffer	VBG
cord-015365-iqdi99pd	2454	8	from	from	IN
cord-015365-iqdi99pd	2454	9	MKS	MKS	NNP
cord-015365-iqdi99pd	2454	10	who	who	WP
cord-015365-iqdi99pd	2454	11	received	receive	VBD
cord-015365-iqdi99pd	2454	12	a	a	DT
cord-015365-iqdi99pd	2454	13	lung	lung	NN
cord-015365-iqdi99pd	2454	14	transplant	transplant	NN
cord-015365-iqdi99pd	2454	15	at	at	IN
cord-015365-iqdi99pd	2454	16	our	-PRON-	PRP$
cord-015365-iqdi99pd	2454	17	department	department	NN
cord-015365-iqdi99pd	2454	18	.	.	.
cord-015365-iqdi99pd	2455	1	Methods	method	NNS
cord-015365-iqdi99pd	2455	2	.	.	.
cord-015365-iqdi99pd	2456	1	A	a	DT
cord-015365-iqdi99pd	2456	2	39-year	39-year	JJ
cord-015365-iqdi99pd	2456	3	-	-	HYPH
cord-015365-iqdi99pd	2456	4	old	old	JJ
cord-015365-iqdi99pd	2456	5	male	male	JJ
cord-015365-iqdi99pd	2456	6	never	never	RB
cord-015365-iqdi99pd	2456	7	-	-	HYPH
cord-015365-iqdi99pd	2456	8	smoker	smoker	NN
cord-015365-iqdi99pd	2456	9	presented	present	VBN
cord-015365-iqdi99pd	2456	10	at	at	IN
cord-015365-iqdi99pd	2456	11	our	-PRON-	PRP$
cord-015365-iqdi99pd	2456	12	department	department	NN
cord-015365-iqdi99pd	2456	13	for	for	IN
cord-015365-iqdi99pd	2456	14	evaluation	evaluation	NN
cord-015365-iqdi99pd	2456	15	for	for	IN
cord-015365-iqdi99pd	2456	16	a	a	DT
cord-015365-iqdi99pd	2456	17	lung	lung	NN
cord-015365-iqdi99pd	2456	18	transplantat	transplantat	NN
cord-015365-iqdi99pd	2456	19	.	.	.
cord-015365-iqdi99pd	2457	1	The	the	DT
cord-015365-iqdi99pd	2457	2	patient	patient	NN
cord-015365-iqdi99pd	2457	3	suffered	suffer	VBD
cord-015365-iqdi99pd	2457	4	from	from	IN
cord-015365-iqdi99pd	2457	5	Mounier	Mounier	NNP
cord-015365-iqdi99pd	2457	6	-	-	HYPH
cord-015365-iqdi99pd	2457	7	Kuhn	Kuhn	NNP
cord-015365-iqdi99pd	2457	8	syndrome	syndrome	NN
cord-015365-iqdi99pd	2457	9	(	(	-LRB-
cord-015365-iqdi99pd	2457	10	MKS	MKS	NNP
cord-015365-iqdi99pd	2457	11	)	)	-RRB-
cord-015365-iqdi99pd	2457	12	with	with	IN
cord-015365-iqdi99pd	2457	13	greatly	greatly	RB
cord-015365-iqdi99pd	2457	14	dilated	dilated	JJ
cord-015365-iqdi99pd	2457	15	trachea	trachea	NN
cord-015365-iqdi99pd	2457	16	and	and	CC
cord-015365-iqdi99pd	2457	17	bronchi	bronchi	NN
cord-015365-iqdi99pd	2457	18	.	.	.
cord-015365-iqdi99pd	2458	1	Since	since	IN
cord-015365-iqdi99pd	2458	2	a	a	DT
cord-015365-iqdi99pd	2458	3	familial	familial	JJ
cord-015365-iqdi99pd	2458	4	clustering	clustering	NN
cord-015365-iqdi99pd	2458	5	of	of	IN
cord-015365-iqdi99pd	2458	6	Mounier	Mounier	NNP
cord-015365-iqdi99pd	2458	7	-	-	HYPH
cord-015365-iqdi99pd	2458	8	Kuhn	Kuhn	NNP
cord-015365-iqdi99pd	2458	9	syndrome	syndrome	NN
cord-015365-iqdi99pd	2458	10	is	be	VBZ
cord-015365-iqdi99pd	2458	11	discussed	discuss	VBN
cord-015365-iqdi99pd	2458	12	in	in	IN
cord-015365-iqdi99pd	2458	13	the	the	DT
cord-015365-iqdi99pd	2458	14	literature	literature	NN
cord-015365-iqdi99pd	2458	15	,	,	,
cord-015365-iqdi99pd	2458	16	we	-PRON-	PRP
cord-015365-iqdi99pd	2458	17	performed	perform	VBD
cord-015365-iqdi99pd	2458	18	a	a	DT
cord-015365-iqdi99pd	2458	19	chromosomal	chromosomal	JJ
cord-015365-iqdi99pd	2458	20	analysis	analysis	NN
cord-015365-iqdi99pd	2458	21	and	and	CC
cord-015365-iqdi99pd	2458	22	an	an	DT
cord-015365-iqdi99pd	2458	23	array	array	NN
cord-015365-iqdi99pd	2458	24	-	-	HYPH
cord-015365-iqdi99pd	2458	25	CGH	CGH	NNP
cord-015365-iqdi99pd	2458	26	to	to	TO
cord-015365-iqdi99pd	2458	27	search	search	VB
cord-015365-iqdi99pd	2458	28	for	for	IN
cord-015365-iqdi99pd	2458	29	genetic	genetic	JJ
cord-015365-iqdi99pd	2458	30	abnormalities	abnormality	NNS
cord-015365-iqdi99pd	2458	31	.	.	.
cord-015365-iqdi99pd	2459	1	At	at	IN
cord-015365-iqdi99pd	2459	2	the	the	DT
cord-015365-iqdi99pd	2459	3	time	time	NN
cord-015365-iqdi99pd	2459	4	of	of	IN
cord-015365-iqdi99pd	2459	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	2459	6	we	-PRON-	PRP
cord-015365-iqdi99pd	2459	7	collected	collect	VBD
cord-015365-iqdi99pd	2459	8	samples	sample	NNS
cord-015365-iqdi99pd	2459	9	from	from	IN
cord-015365-iqdi99pd	2459	10	the	the	DT
cord-015365-iqdi99pd	2459	11	bronchi	bronchi	NN
cord-015365-iqdi99pd	2459	12	and	and	CC
cord-015365-iqdi99pd	2459	13	performed	perform	VBD
cord-015365-iqdi99pd	2459	14	hematoxylin	hematoxylin	NNP
cord-015365-iqdi99pd	2459	15	and	and	CC
cord-015365-iqdi99pd	2459	16	eosin	eosin	NNP
cord-015365-iqdi99pd	2459	17	(	(	-LRB-
cord-015365-iqdi99pd	2459	18	HE	HE	NNP
cord-015365-iqdi99pd	2459	19	)	)	-RRB-
cord-015365-iqdi99pd	2459	20	,	,	,
cord-015365-iqdi99pd	2459	21	Elastic	Elastic	NNP
cord-015365-iqdi99pd	2459	22	van	van	NNP
cord-015365-iqdi99pd	2459	23	-	-	HYPH
cord-015365-iqdi99pd	2459	24	Gieson	Gieson	NNP
cord-015365-iqdi99pd	2459	25	's	's	POS
cord-015365-iqdi99pd	2459	26	(	(	-LRB-
cord-015365-iqdi99pd	2459	27	EVG	EVG	NNP
cord-015365-iqdi99pd	2459	28	)	)	-RRB-
cord-015365-iqdi99pd	2459	29	and	and	CC
cord-015365-iqdi99pd	2459	30	immunohistochemical	immunohistochemical	JJ
cord-015365-iqdi99pd	2459	31	stains	stain	NNS
cord-015365-iqdi99pd	2459	32	.	.	.
cord-015365-iqdi99pd	2460	1	Specimens	specimen	NNS
cord-015365-iqdi99pd	2460	2	of	of	IN
cord-015365-iqdi99pd	2460	3	main	main	JJ
cord-015365-iqdi99pd	2460	4	bronchi	bronchi	NN
cord-015365-iqdi99pd	2460	5	from	from	IN
cord-015365-iqdi99pd	2460	6	the	the	DT
cord-015365-iqdi99pd	2460	7	donor	donor	NN
cord-015365-iqdi99pd	2460	8	lung	lung	NN
cord-015365-iqdi99pd	2460	9	harvested	harvest	VBN
cord-015365-iqdi99pd	2460	10	for	for	IN
cord-015365-iqdi99pd	2460	11	transplant	transplant	NN
cord-015365-iqdi99pd	2460	12	served	serve	VBD
cord-015365-iqdi99pd	2460	13	as	as	IN
cord-015365-iqdi99pd	2460	14	control	control	NN
cord-015365-iqdi99pd	2460	15	.	.	.
cord-015365-iqdi99pd	2461	1	Results	result	NNS
cord-015365-iqdi99pd	2461	2	.	.	.
cord-015365-iqdi99pd	2462	1	The	the	DT
cord-015365-iqdi99pd	2462	2	chromosomal	chromosomal	JJ
cord-015365-iqdi99pd	2462	3	analysis	analysis	NN
cord-015365-iqdi99pd	2462	4	and	and	CC
cord-015365-iqdi99pd	2462	5	array	array	NN
cord-015365-iqdi99pd	2462	6	-	-	HYPH
cord-015365-iqdi99pd	2462	7	CGH	CGH	NNP
cord-015365-iqdi99pd	2462	8	revealed	reveal	VBD
cord-015365-iqdi99pd	2462	9	that	that	IN
cord-015365-iqdi99pd	2462	10	the	the	DT
cord-015365-iqdi99pd	2462	11	patient	patient	NN
cord-015365-iqdi99pd	2462	12	's	's	POS
cord-015365-iqdi99pd	2462	13	genome	genome	NN
cord-015365-iqdi99pd	2462	14	was	be	VBD
cord-015365-iqdi99pd	2462	15	completely	completely	RB
cord-015365-iqdi99pd	2462	16	unremarkable	unremarkable	JJ
cord-015365-iqdi99pd	2462	17	,	,	,
cord-015365-iqdi99pd	2462	18	the	the	DT
cord-015365-iqdi99pd	2462	19	karyogram	karyogram	NN
cord-015365-iqdi99pd	2462	20	as	as	RB
cord-015365-iqdi99pd	2462	21	well	well	RB
cord-015365-iqdi99pd	2462	22	as	as	IN
cord-015365-iqdi99pd	2462	23	the	the	DT
cord-015365-iqdi99pd	2462	24	genome	genome	NN
cord-015365-iqdi99pd	2462	25	hybridization	hybridization	NN
cord-015365-iqdi99pd	2462	26	showed	show	VBD
cord-015365-iqdi99pd	2462	27	no	no	DT
cord-015365-iqdi99pd	2462	28	significant	significant	JJ
cord-015365-iqdi99pd	2462	29	gain	gain	NN
cord-015365-iqdi99pd	2462	30	or	or	CC
cord-015365-iqdi99pd	2462	31	loss	loss	NN
cord-015365-iqdi99pd	2462	32	in	in	IN
cord-015365-iqdi99pd	2462	33	known	know	VBN
cord-015365-iqdi99pd	2462	34	encoding	encoding	NN
cord-015365-iqdi99pd	2462	35	regions	region	NNS
cord-015365-iqdi99pd	2462	36	.	.	.
cord-015365-iqdi99pd	2463	1	Through	through	IN
cord-015365-iqdi99pd	2463	2	the	the	DT
cord-015365-iqdi99pd	2463	3	histological	histological	JJ
cord-015365-iqdi99pd	2463	4	evaluation	evaluation	NN
cord-015365-iqdi99pd	2463	5	we	-PRON-	PRP
cord-015365-iqdi99pd	2463	6	found	find	VBD
cord-015365-iqdi99pd	2463	7	considerably	considerably	RB
cord-015365-iqdi99pd	2463	8	lower	low	JJR
cord-015365-iqdi99pd	2463	9	amounts	amount	NNS
cord-015365-iqdi99pd	2463	10	of	of	IN
cord-015365-iqdi99pd	2463	11	elastic	elastic	JJ
cord-015365-iqdi99pd	2463	12	and	and	CC
cord-015365-iqdi99pd	2463	13	collagen	collagen	NN
cord-015365-iqdi99pd	2463	14	fibers	fiber	NNS
cord-015365-iqdi99pd	2463	15	in	in	IN
cord-015365-iqdi99pd	2463	16	the	the	DT
cord-015365-iqdi99pd	2463	17	submucosal	submucosal	NNP
cord-015365-iqdi99pd	2463	18	layer	layer	NN
cord-015365-iqdi99pd	2463	19	in	in	IN
cord-015365-iqdi99pd	2463	20	the	the	DT
cord-015365-iqdi99pd	2463	21	patient	patient	NN
cord-015365-iqdi99pd	2463	22	compared	compare	VBN
cord-015365-iqdi99pd	2463	23	to	to	IN
cord-015365-iqdi99pd	2463	24	healthy	healthy	JJ
cord-015365-iqdi99pd	2463	25	controls	control	NNS
cord-015365-iqdi99pd	2463	26	.	.	.
cord-015365-iqdi99pd	2464	1	Furthermore	furthermore	RB
cord-015365-iqdi99pd	2464	2	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	2464	3	infiltrates	infiltrate	NNS
cord-015365-iqdi99pd	2464	4	were	be	VBD
cord-015365-iqdi99pd	2464	5	present	present	JJ
cord-015365-iqdi99pd	2464	6	in	in	IN
cord-015365-iqdi99pd	2464	7	the	the	DT
cord-015365-iqdi99pd	2464	8	connective	connective	JJ
cord-015365-iqdi99pd	2464	9	tissue	tissue	NN
cord-015365-iqdi99pd	2464	10	throughout	throughout	IN
cord-015365-iqdi99pd	2464	11	the	the	DT
cord-015365-iqdi99pd	2464	12	whole	whole	JJ
cord-015365-iqdi99pd	2464	13	histological	histological	JJ
cord-015365-iqdi99pd	2464	14	specimen	specimen	NN
cord-015365-iqdi99pd	2464	15	.	.	.
cord-015365-iqdi99pd	2465	1	Since	since	IN
cord-015365-iqdi99pd	2465	2	chronic	chronic	JJ
cord-015365-iqdi99pd	2465	3	inflammation	inflammation	NN
cord-015365-iqdi99pd	2465	4	is	be	VBZ
cord-015365-iqdi99pd	2465	5	known	know	VBN
cord-015365-iqdi99pd	2465	6	to	to	TO
cord-015365-iqdi99pd	2465	7	result	result	VB
cord-015365-iqdi99pd	2465	8	in	in	IN
cord-015365-iqdi99pd	2465	9	tissue	tissue	NN
cord-015365-iqdi99pd	2465	10	remodeling	remodeling	NN
cord-015365-iqdi99pd	2465	11	we	-PRON-	PRP
cord-015365-iqdi99pd	2465	12	performed	perform	VBD
cord-015365-iqdi99pd	2465	13	immunohistological	immunohistological	JJ
cord-015365-iqdi99pd	2465	14	staining	staining	NN
cord-015365-iqdi99pd	2465	15	of	of	IN
cord-015365-iqdi99pd	2465	16	different	different	JJ
cord-015365-iqdi99pd	2465	17	matrix	matrix	NN
cord-015365-iqdi99pd	2465	18	metalloproteinases	metalloproteinase	NNS
cord-015365-iqdi99pd	2465	19	.	.	.
cord-015365-iqdi99pd	2466	1	MMP1	MMP1	NNP
cord-015365-iqdi99pd	2466	2	,	,	,
cord-015365-iqdi99pd	2466	3	MMP2	MMP2	NNP
cord-015365-iqdi99pd	2466	4	,	,	,
cord-015365-iqdi99pd	2466	5	MMP3	MMP3	NNP
cord-015365-iqdi99pd	2466	6	and	and	CC
cord-015365-iqdi99pd	2466	7	MMP9	MMP9	NNP
cord-015365-iqdi99pd	2466	8	were	be	VBD
cord-015365-iqdi99pd	2466	9	detected	detect	VBN
cord-015365-iqdi99pd	2466	10	in	in	IN
cord-015365-iqdi99pd	2466	11	MKS	MKS	NNP
cord-015365-iqdi99pd	2466	12	tissue	tissue	NN
cord-015365-iqdi99pd	2466	13	,	,	,
cord-015365-iqdi99pd	2466	14	but	but	CC
cord-015365-iqdi99pd	2466	15	were	be	VBD
cord-015365-iqdi99pd	2466	16	totally	totally	RB
cord-015365-iqdi99pd	2466	17	absent	absent	JJ
cord-015365-iqdi99pd	2466	18	in	in	IN
cord-015365-iqdi99pd	2466	19	control	control	NN
cord-015365-iqdi99pd	2466	20	bronchi	bronchi	NN
cord-015365-iqdi99pd	2466	21	.	.	.
cord-015365-iqdi99pd	2467	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2467	2	.	.	.
cord-015365-iqdi99pd	2468	1	Based	base	VBN
cord-015365-iqdi99pd	2468	2	on	on	IN
cord-015365-iqdi99pd	2468	3	these	these	DT
cord-015365-iqdi99pd	2468	4	findings	finding	NNS
cord-015365-iqdi99pd	2468	5	we	-PRON-	PRP
cord-015365-iqdi99pd	2468	6	hypothesize	hypothesize	VBP
cord-015365-iqdi99pd	2468	7	that	that	IN
cord-015365-iqdi99pd	2468	8	the	the	DT
cord-015365-iqdi99pd	2468	9	pathophysiology	pathophysiology	NN
cord-015365-iqdi99pd	2468	10	of	of	IN
cord-015365-iqdi99pd	2468	11	MKS	MKS	NNP
cord-015365-iqdi99pd	2468	12	is	be	VBZ
cord-015365-iqdi99pd	2468	13	of	of	IN
cord-015365-iqdi99pd	2468	14	a	a	DT
cord-015365-iqdi99pd	2468	15	chronic	chronic	JJ
cord-015365-iqdi99pd	2468	16	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	2468	17	type	type	NN
cord-015365-iqdi99pd	2468	18	leading	lead	VBG
cord-015365-iqdi99pd	2468	19	to	to	IN
cord-015365-iqdi99pd	2468	20	tissue	tissue	NN
cord-015365-iqdi99pd	2468	21	destruction	destruction	NN
cord-015365-iqdi99pd	2468	22	and	and	CC
cord-015365-iqdi99pd	2468	23	a	a	DT
cord-015365-iqdi99pd	2468	24	loss	loss	NN
cord-015365-iqdi99pd	2468	25	of	of	IN
cord-015365-iqdi99pd	2468	26	elastic	elastic	JJ
cord-015365-iqdi99pd	2468	27	fibers	fiber	NNS
cord-015365-iqdi99pd	2468	28	,	,	,
cord-015365-iqdi99pd	2468	29	possibly	possibly	RB
cord-015365-iqdi99pd	2468	30	due	due	IN
cord-015365-iqdi99pd	2468	31	to	to	IN
cord-015365-iqdi99pd	2468	32	upregulation	upregulation	NN
cord-015365-iqdi99pd	2468	33	of	of	IN
cord-015365-iqdi99pd	2468	34	MMP	MMP	NNP
cord-015365-iqdi99pd	2468	35	.	.	.
cord-015365-iqdi99pd	2469	1	The	the	DT
cord-015365-iqdi99pd	2469	2	triggering	trigger	VBG
cord-015365-iqdi99pd	2469	3	mechanism(s	mechanism(s	NN
cord-015365-iqdi99pd	2469	4	)	)	-RRB-
cord-015365-iqdi99pd	2469	5	for	for	IN
cord-015365-iqdi99pd	2469	6	this	this	DT
cord-015365-iqdi99pd	2469	7	inflammatory	inflammatory	JJ
cord-015365-iqdi99pd	2469	8	reaction	reaction	NN
cord-015365-iqdi99pd	2469	9	remain	remain	VBP
cord-015365-iqdi99pd	2469	10	elusive	elusive	JJ
cord-015365-iqdi99pd	2469	11	,	,	,
cord-015365-iqdi99pd	2469	12	but	but	CC
cord-015365-iqdi99pd	2469	13	since	since	IN
cord-015365-iqdi99pd	2469	14	MKS	MKS	NNP
cord-015365-iqdi99pd	2469	15	has	have	VBZ
cord-015365-iqdi99pd	2469	16	been	be	VBN
cord-015365-iqdi99pd	2469	17	reported	report	VBN
cord-015365-iqdi99pd	2469	18	to	to	TO
cord-015365-iqdi99pd	2469	19	be	be	VB
cord-015365-iqdi99pd	2469	20	associated	associate	VBN
cord-015365-iqdi99pd	2469	21	with	with	IN
cord-015365-iqdi99pd	2469	22	autoimmune	autoimmune	JJ
cord-015365-iqdi99pd	2469	23	diseases	disease	NNS
cord-015365-iqdi99pd	2469	24	,	,	,
cord-015365-iqdi99pd	2469	25	an	an	DT
cord-015365-iqdi99pd	2469	26	autoimmune	autoimmune	JJ
cord-015365-iqdi99pd	2469	27	reaction	reaction	NN
cord-015365-iqdi99pd	2469	28	against	against	IN
cord-015365-iqdi99pd	2469	29	components	component	NNS
cord-015365-iqdi99pd	2469	30	of	of	IN
cord-015365-iqdi99pd	2469	31	the	the	DT
cord-015365-iqdi99pd	2469	32	major	major	JJ
cord-015365-iqdi99pd	2469	33	airways	airway	NNS
cord-015365-iqdi99pd	2469	34	could	could	MD
cord-015365-iqdi99pd	2469	35	be	be	VB
cord-015365-iqdi99pd	2469	36	one	one	CD
cord-015365-iqdi99pd	2469	37	possible	possible	JJ
cord-015365-iqdi99pd	2469	38	explanation	explanation	NN
cord-015365-iqdi99pd	2469	39	.	.	.
cord-015365-iqdi99pd	2470	1	Background	background	NN
cord-015365-iqdi99pd	2470	2	.	.	.
cord-015365-iqdi99pd	2471	1	Lung	lung	NN
cord-015365-iqdi99pd	2471	2	transplant	transplant	NN
cord-015365-iqdi99pd	2471	3	recipients	recipient	NNS
cord-015365-iqdi99pd	2471	4	(	(	-LRB-
cord-015365-iqdi99pd	2471	5	LTRs	LTRs	NNP
cord-015365-iqdi99pd	2471	6	)	)	-RRB-
cord-015365-iqdi99pd	2471	7	are	be	VBP
cord-015365-iqdi99pd	2471	8	uniquely	uniquely	RB
cord-015365-iqdi99pd	2471	9	predisposed	predisposed	JJ
cord-015365-iqdi99pd	2471	10	in	in	IN
cord-015365-iqdi99pd	2471	11	developing	develop	VBG
cord-015365-iqdi99pd	2471	12	severe	severe	JJ
cord-015365-iqdi99pd	2471	13	complications	complication	NNS
cord-015365-iqdi99pd	2471	14	associated	associate	VBN
cord-015365-iqdi99pd	2471	15	with	with	IN
cord-015365-iqdi99pd	2471	16	community	community	NN
cord-015365-iqdi99pd	2471	17	acquired	acquire	VBD
cord-015365-iqdi99pd	2471	18	respiratory	respiratory	JJ
cord-015365-iqdi99pd	2471	19	viral	viral	JJ
cord-015365-iqdi99pd	2471	20	infections	infection	NNS
cord-015365-iqdi99pd	2471	21	(	(	-LRB-
cord-015365-iqdi99pd	2471	22	CARV	CARV	NNP
cord-015365-iqdi99pd	2471	23	)	)	-RRB-
cord-015365-iqdi99pd	2471	24	.	.	.
cord-015365-iqdi99pd	2472	1	We	-PRON-	PRP
cord-015365-iqdi99pd	2472	2	report	report	VBP
cord-015365-iqdi99pd	2472	3	the	the	DT
cord-015365-iqdi99pd	2472	4	outcomes	outcome	NNS
cord-015365-iqdi99pd	2472	5	of	of	IN
cord-015365-iqdi99pd	2472	6	influenza	influenza	NN
cord-015365-iqdi99pd	2472	7	infections	infection	NNS
cord-015365-iqdi99pd	2472	8	in	in	IN
cord-015365-iqdi99pd	2472	9	a	a	DT
cord-015365-iqdi99pd	2472	10	cohort	cohort	NN
cord-015365-iqdi99pd	2472	11	of	of	IN
cord-015365-iqdi99pd	2472	12	82	82	CD
cord-015365-iqdi99pd	2472	13	screened	screen	VBN
cord-015365-iqdi99pd	2472	14	lung	lung	NN
cord-015365-iqdi99pd	2472	15	transplant	transplant	NN
cord-015365-iqdi99pd	2472	16	recipients	recipient	NNS
cord-015365-iqdi99pd	2472	17	at	at	IN
cord-015365-iqdi99pd	2472	18	our	-PRON-	PRP$
cord-015365-iqdi99pd	2472	19	center	center	NN
cord-015365-iqdi99pd	2472	20	.	.	.
cord-015365-iqdi99pd	2473	1	Methods	method	NNS
cord-015365-iqdi99pd	2473	2	.	.	.
cord-015365-iqdi99pd	2474	1	Data	datum	NNS
cord-015365-iqdi99pd	2474	2	were	be	VBD
cord-015365-iqdi99pd	2474	3	collected	collect	VBN
cord-015365-iqdi99pd	2474	4	from	from	IN
cord-015365-iqdi99pd	2474	5	December	December	NNP
cord-015365-iqdi99pd	2474	6	2010	2010	CD
cord-015365-iqdi99pd	2474	7	to	to	IN
cord-015365-iqdi99pd	2474	8	March	March	NNP
cord-015365-iqdi99pd	2474	9	2011	2011	CD
cord-015365-iqdi99pd	2474	10	on	on	IN
cord-015365-iqdi99pd	2474	11	using	use	VBG
cord-015365-iqdi99pd	2474	12	real	real	JJ
cord-015365-iqdi99pd	2474	13	-	-	HYPH
cord-015365-iqdi99pd	2474	14	time	time	NN
cord-015365-iqdi99pd	2474	15	polymerase	polymerase	NN
cord-015365-iqdi99pd	2474	16	chain	chain	NN
cord-015365-iqdi99pd	2474	17	reaction	reaction	NN
cord-015365-iqdi99pd	2474	18	(	(	-LRB-
cord-015365-iqdi99pd	2474	19	PCR	PCR	NNP
cord-015365-iqdi99pd	2474	20	)	)	-RRB-
cord-015365-iqdi99pd	2474	21	from	from	IN
cord-015365-iqdi99pd	2474	22	nasal	nasal	JJ
cord-015365-iqdi99pd	2474	23	secretion	secretion	NN
cord-015365-iqdi99pd	2474	24	.	.	.
cord-015365-iqdi99pd	2475	1	During	during	IN
cord-015365-iqdi99pd	2475	2	this	this	DT
cord-015365-iqdi99pd	2475	3	period	period	NN
cord-015365-iqdi99pd	2475	4	245	245	CD
cord-015365-iqdi99pd	2475	5	patients	patient	NNS
cord-015365-iqdi99pd	2475	6	frequented	frequent	VBD
cord-015365-iqdi99pd	2475	7	our	-PRON-	PRP$
cord-015365-iqdi99pd	2475	8	out	out	JJ
cord-015365-iqdi99pd	2475	9	patient	patient	JJ
cord-015365-iqdi99pd	2475	10	department	department	NN
cord-015365-iqdi99pd	2475	11	for	for	IN
cord-015365-iqdi99pd	2475	12	thoracic	thoracic	JJ
cord-015365-iqdi99pd	2475	13	surgery	surgery	NN
cord-015365-iqdi99pd	2475	14	.	.	.
cord-015365-iqdi99pd	2476	1	All	all	DT
cord-015365-iqdi99pd	2476	2	LTRs	LTRs	NNPS
cord-015365-iqdi99pd	2476	3	(	(	-LRB-
cord-015365-iqdi99pd	2476	4	n	n	CC
cord-015365-iqdi99pd	2476	5	¼	¼	NNP
cord-015365-iqdi99pd	2476	6	82	82	CD
cord-015365-iqdi99pd	2476	7	)	)	-RRB-
cord-015365-iqdi99pd	2476	8	with	with	IN
cord-015365-iqdi99pd	2476	9	respiratory	respiratory	JJ
cord-015365-iqdi99pd	2476	10	symptoms	symptom	NNS
cord-015365-iqdi99pd	2476	11	were	be	VBD
cord-015365-iqdi99pd	2476	12	screened	screen	VBN
cord-015365-iqdi99pd	2476	13	.	.	.
cord-015365-iqdi99pd	2477	1	There	there	EX
cord-015365-iqdi99pd	2477	2	were	be	VBD
cord-015365-iqdi99pd	2477	3	9	9	CD
cord-015365-iqdi99pd	2477	4	(	(	-LRB-
cord-015365-iqdi99pd	2477	5	10	10	CD
cord-015365-iqdi99pd	2477	6	,	,	,
cord-015365-iqdi99pd	2477	7	9	9	CD
cord-015365-iqdi99pd	2477	8	%	%	NN
cord-015365-iqdi99pd	2477	9	)	)	-RRB-
cord-015365-iqdi99pd	2477	10	confirmed	confirm	VBD
cord-015365-iqdi99pd	2477	11	cases	case	NNS
cord-015365-iqdi99pd	2477	12	.	.	.
cord-015365-iqdi99pd	2478	1	H1N1	H1N1	NNP
cord-015365-iqdi99pd	2478	2	infection	infection	NN
cord-015365-iqdi99pd	2478	3	was	be	VBD
cord-015365-iqdi99pd	2478	4	diagnosed	diagnose	VBN
cord-015365-iqdi99pd	2478	5	in	in	IN
cord-015365-iqdi99pd	2478	6	5	5	CD
cord-015365-iqdi99pd	2478	7	,	,	,
cord-015365-iqdi99pd	2478	8	influenza	influenza	NN
cord-015365-iqdi99pd	2478	9	B	b	NN
cord-015365-iqdi99pd	2478	10	in	in	IN
cord-015365-iqdi99pd	2478	11	4	4	CD
cord-015365-iqdi99pd	2478	12	lung	lung	NN
cord-015365-iqdi99pd	2478	13	transplant	transplant	NN
cord-015365-iqdi99pd	2478	14	recipients	recipient	NNS
cord-015365-iqdi99pd	2478	15	,	,	,
cord-015365-iqdi99pd	2478	16	median	median	NN
cord-015365-iqdi99pd	2478	17	age	age	NN
cord-015365-iqdi99pd	2478	18	36	36	CD
cord-015365-iqdi99pd	2478	19	(	(	-LRB-
cord-015365-iqdi99pd	2478	20	26	26	CD
cord-015365-iqdi99pd	2478	21	-	-	SYM
cord-015365-iqdi99pd	2478	22	65	65	CD
cord-015365-iqdi99pd	2478	23	)	)	-RRB-
cord-015365-iqdi99pd	2478	24	years	year	NNS
cord-015365-iqdi99pd	2478	25	,	,	,
cord-015365-iqdi99pd	2478	26	with	with	IN
cord-015365-iqdi99pd	2478	27	a	a	DT
cord-015365-iqdi99pd	2478	28	median	median	NN
cord-015365-iqdi99pd	2478	29	of	of	IN
cord-015365-iqdi99pd	2478	30	6	6	CD
cord-015365-iqdi99pd	2478	31	(	(	-LRB-
cord-015365-iqdi99pd	2478	32	1,1	1,1	CD
cord-015365-iqdi99pd	2478	33	-	-	SYM
cord-015365-iqdi99pd	2478	34	12	12	CD
cord-015365-iqdi99pd	2478	35	)	)	-RRB-
cord-015365-iqdi99pd	2478	36	years	year	NNS
cord-015365-iqdi99pd	2478	37	post	post	NN
cord-015365-iqdi99pd	2478	38	lung	lung	NN
cord-015365-iqdi99pd	2478	39	transplantation	transplantation	NN
cord-015365-iqdi99pd	2478	40	.	.	.
cord-015365-iqdi99pd	2479	1	Results	result	NNS
cord-015365-iqdi99pd	2479	2	.	.	.
cord-015365-iqdi99pd	2480	1	All	all	DT
cord-015365-iqdi99pd	2480	2	patients	patient	NNS
cord-015365-iqdi99pd	2480	3	with	with	IN
cord-015365-iqdi99pd	2480	4	BOS	BOS	NNP
cord-015365-iqdi99pd	2480	5	grade	grade	NN
cord-015365-iqdi99pd	2480	6	0	0	NFP
cord-015365-iqdi99pd	2480	7	(	(	-LRB-
cord-015365-iqdi99pd	2480	8	bronchiolitis	bronchiolitis	NNP
cord-015365-iqdi99pd	2480	9	obliterans	obliterans	NNP
cord-015365-iqdi99pd	2480	10	syndrome	syndrome	NNP
cord-015365-iqdi99pd	2480	11	,	,	,
cord-015365-iqdi99pd	2480	12	n	n	NN
cord-015365-iqdi99pd	2480	13	¼	¼	NNP
cord-015365-iqdi99pd	2480	14	5	5	CD
cord-015365-iqdi99pd	2480	15	)	)	-RRB-
cord-015365-iqdi99pd	2480	16	were	be	VBD
cord-015365-iqdi99pd	2480	17	treated	treat	VBN
cord-015365-iqdi99pd	2480	18	symptomatically	symptomatically	RB
cord-015365-iqdi99pd	2480	19	alone	alone	JJ
cord-015365-iqdi99pd	2480	20	,	,	,
cord-015365-iqdi99pd	2480	21	with	with	IN
cord-015365-iqdi99pd	2480	22	no	no	DT
cord-015365-iqdi99pd	2480	23	further	further	JJ
cord-015365-iqdi99pd	2480	24	impact	impact	NN
cord-015365-iqdi99pd	2480	25	on	on	IN
cord-015365-iqdi99pd	2480	26	their	-PRON-	PRP$
cord-015365-iqdi99pd	2480	27	lung	lung	NN
cord-015365-iqdi99pd	2480	28	function	function	NN
cord-015365-iqdi99pd	2480	29	.	.	.
cord-015365-iqdi99pd	2481	1	Two	two	CD
cord-015365-iqdi99pd	2481	2	patients	patient	NNS
cord-015365-iqdi99pd	2481	3	of	of	IN
cord-015365-iqdi99pd	2481	4	this	this	DT
cord-015365-iqdi99pd	2481	5	group	group	NN
cord-015365-iqdi99pd	2481	6	were	be	VBD
cord-015365-iqdi99pd	2481	7	vaccinated	vaccinate	VBN
cord-015365-iqdi99pd	2481	8	for	for	IN
cord-015365-iqdi99pd	2481	9	seasonal	seasonal	JJ
cord-015365-iqdi99pd	2481	10	influenza	influenza	NN
cord-015365-iqdi99pd	2481	11	.	.	.
cord-015365-iqdi99pd	2482	1	Among	among	IN
cord-015365-iqdi99pd	2482	2	the	the	DT
cord-015365-iqdi99pd	2482	3	group	group	NN
cord-015365-iqdi99pd	2482	4	of	of	IN
cord-015365-iqdi99pd	2482	5	patients	patient	NNS
cord-015365-iqdi99pd	2482	6	with	with	IN
cord-015365-iqdi99pd	2482	7	pre	pre	JJ
cord-015365-iqdi99pd	2482	8	-	-	JJ
cord-015365-iqdi99pd	2482	9	existing	existing	JJ
cord-015365-iqdi99pd	2482	10	BOS	BOS	NNP
cord-015365-iqdi99pd	2482	11	(	(	-LRB-
cord-015365-iqdi99pd	2482	12	n	n	NN
cord-015365-iqdi99pd	2482	13	¼	¼	NNP
cord-015365-iqdi99pd	2482	14	4	4	CD
cord-015365-iqdi99pd	2482	15	)	)	-RRB-
cord-015365-iqdi99pd	2482	16	,	,	,
cord-015365-iqdi99pd	2482	17	two	two	CD
cord-015365-iqdi99pd	2482	18	lung	lung	NN
cord-015365-iqdi99pd	2482	19	transplant	transplant	NN
cord-015365-iqdi99pd	2482	20	recipients	recipient	NNS
cord-015365-iqdi99pd	2482	21	,	,	,
cord-015365-iqdi99pd	2482	22	one	one	CD
cord-015365-iqdi99pd	2482	23	with	with	IN
cord-015365-iqdi99pd	2482	24	BOS	BOS	NNP
cord-015365-iqdi99pd	2482	25	I	I	NNP
cord-015365-iqdi99pd	2482	26	,	,	,
cord-015365-iqdi99pd	2482	27	the	the	DT
cord-015365-iqdi99pd	2482	28	other	other	JJ
cord-015365-iqdi99pd	2482	29	with	with	IN
cord-015365-iqdi99pd	2482	30	BOS	BOS	NNP
cord-015365-iqdi99pd	2482	31	II	II	NNP
cord-015365-iqdi99pd	2482	32	developed	develop	VBD
cord-015365-iqdi99pd	2482	33	Grundlagen	Grundlagen	NNP
cord-015365-iqdi99pd	2482	34	.	.	.
cord-015365-iqdi99pd	2483	1	Eine	Eine	NNP
cord-015365-iqdi99pd	2483	2	Vielzahl	Vielzahl	NNP
cord-015365-iqdi99pd	2483	3	von	von	NNP
cord-015365-iqdi99pd	2483	4	Medikamenten	Medikamenten	NNP
cord-015365-iqdi99pd	2483	5	mit	mit	NNP
cord-015365-iqdi99pd	2483	6	potentiell	potentiell	NNP
cord-015365-iqdi99pd	2483	7	toxischen	toxischen	NNP
cord-015365-iqdi99pd	2484	1	Nebenwirkungen	Nebenwirkungen	NNP
cord-015365-iqdi99pd	2484	2	auf	auf	NNP
cord-015365-iqdi99pd	2484	3	den	den	NNP
cord-015365-iqdi99pd	2484	4	Respirationstrakt	Respirationstrakt	NNP
cord-015365-iqdi99pd	2484	5	sind	sind	NNP
cord-015365-iqdi99pd	2484	6	bekannt	bekannt	NNP
cord-015365-iqdi99pd	2484	7	.	.	.
cord-015365-iqdi99pd	2485	1	Zytotoxische	Zytotoxische	NNP
cord-015365-iqdi99pd	2485	2	Substanzen	Substanzen	NNP
cord-015365-iqdi99pd	2485	3	wie	wie	VBD
cord-015365-iqdi99pd	2485	4	Methotrexat	Methotrexat	NNP
cord-015365-iqdi99pd	2485	5	oder	oder	NN
cord-015365-iqdi99pd	2485	6	Bleomycin	Bleomycin	NNP
cord-015365-iqdi99pd	2486	1	und	und	NNP
cord-015365-iqdi99pd	2486	2	andere	andere	NNP
cord-015365-iqdi99pd	2486	3	Pharmaka	Pharmaka	NNP
cord-015365-iqdi99pd	2487	1	wie	wie	NNP
cord-015365-iqdi99pd	2487	2	Amiodaron	Amiodaron	NNP
cord-015365-iqdi99pd	2487	3	oder	oder	NNP
cord-015365-iqdi99pd	2488	1	diverse	diverse	JJ
cord-015365-iqdi99pd	2488	2	Antibiotika	Antibiotika	NNP
cord-015365-iqdi99pd	2488	3	werden	werden	NNP
cord-015365-iqdi99pd	2488	4	am	be	VBP
cord-015365-iqdi99pd	2488	5	häufigsten	häufigsten	NNP
cord-015365-iqdi99pd	2488	6	als	als	NNP
cord-015365-iqdi99pd	2489	1	Ursache	Ursache	NNP
cord-015365-iqdi99pd	2490	1	fü	fü	IN
cord-015365-iqdi99pd	2490	2	r	r	NNP
cord-015365-iqdi99pd	2490	3	eine	eine	NNP
cord-015365-iqdi99pd	2490	4	medikamentös	medikamentös	NNP
cord-015365-iqdi99pd	2490	5	induzierte	induzierte	NNP
cord-015365-iqdi99pd	2490	6	interstitielle	interstitielle	NNP
cord-015365-iqdi99pd	2490	7	Lungenerkrankung	Lungenerkrankung	NNP
cord-015365-iqdi99pd	2490	8	genannt	genannt	NNP
cord-015365-iqdi99pd	2490	9	.	.	.
cord-015365-iqdi99pd	2491	1	Methodik	Methodik	NNP
cord-015365-iqdi99pd	2491	2	und	und	IN
cord-015365-iqdi99pd	2491	3	Ergebnisse	Ergebnisse	NNP
cord-015365-iqdi99pd	2491	4	.	.	.
cord-015365-iqdi99pd	2492	1	Wir	Wir	NNP
cord-015365-iqdi99pd	2492	2	berichten	berichten	NNP
cord-015365-iqdi99pd	2492	3	den	den	NNP
cord-015365-iqdi99pd	2492	4	Fall	Fall	NNP
cord-015365-iqdi99pd	2492	5	eines	eine	NNS
cord-015365-iqdi99pd	2493	1	64jährigen	64jährigen	CD
cord-015365-iqdi99pd	2494	1	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2494	2	,	,	,
cord-015365-iqdi99pd	2494	3	der	der	NNP
cord-015365-iqdi99pd	2494	4	i	-PRON-	PRP
cord-015365-iqdi99pd	2494	5	m	be	VBP
cord-015365-iqdi99pd	2494	6	Oktober	Oktober	NNP
cord-015365-iqdi99pd	2494	7	2010	2010	CD
cord-015365-iqdi99pd	2494	8	wegen	wegen	NNP
cord-015365-iqdi99pd	2494	9	dilatativer	dilatativer	NNP
cord-015365-iqdi99pd	2494	10	Kardiomypathie	Kardiomypathie	NNP
cord-015365-iqdi99pd	2494	11	mit	mit	NNP
cord-015365-iqdi99pd	2494	12	terminaler	terminaler	NNP
cord-015365-iqdi99pd	2494	13	Herzinsuffizienz	Herzinsuffizienz	NNP
cord-015365-iqdi99pd	2494	14	eine	eine	NNP
cord-015365-iqdi99pd	2494	15	orthotope	orthotope	NN
cord-015365-iqdi99pd	2494	16	Herztransplantation	Herztransplantation	NNP
cord-015365-iqdi99pd	2494	17	erhielt	erhielt	NNP
cord-015365-iqdi99pd	2494	18	.	.	.
cord-015365-iqdi99pd	2495	1	Zu	Zu	NNP
cord-015365-iqdi99pd	2495	2	diesem	diesem	NNP
cord-015365-iqdi99pd	2495	3	Zeitpunkt	Zeitpunkt	NNP
cord-015365-iqdi99pd	2495	4	bestand	bestand	NN
cord-015365-iqdi99pd	2495	5	radiologisch	radiologisch	NNP
cord-015365-iqdi99pd	2495	6	bereits	bereits	NNP
cord-015365-iqdi99pd	2495	7	der	der	NNP
cord-015365-iqdi99pd	2495	8	Verdacht	Verdacht	NNP
cord-015365-iqdi99pd	2495	9	auf	auf	NNP
cord-015365-iqdi99pd	2495	10	eine	eine	NNP
cord-015365-iqdi99pd	2496	1	Amiodaron	Amiodaron	NNP
cord-015365-iqdi99pd	2496	2	-	-	HYPH
cord-015365-iqdi99pd	2496	3	induzierte	induzierte	NNS
cord-015365-iqdi99pd	2496	4	Lungenfibrose	Lungenfibrose	NNP
cord-015365-iqdi99pd	2496	5	mit	mit	VBP
cord-015365-iqdi99pd	2496	6	funktionell	funktionell	NNP
cord-015365-iqdi99pd	2496	7	reduzierten	reduzierten	NNP
cord-015365-iqdi99pd	2496	8	Werten	Werten	NNP
cord-015365-iqdi99pd	2496	9	:	:	:
cord-015365-iqdi99pd	2496	10	VC	VC	NNP
cord-015365-iqdi99pd	2496	11	3,49	3,49	NNP
cord-015365-iqdi99pd	2496	12	l	l	NN
cord-015365-iqdi99pd	2496	13	(	(	-LRB-
cord-015365-iqdi99pd	2496	14	73	73	CD
cord-015365-iqdi99pd	2496	15	%	%	NN
cord-015365-iqdi99pd	2496	16	)	)	-RRB-
cord-015365-iqdi99pd	2496	17	,	,	.
cord-015365-iqdi99pd	2497	1	FEV1	FEV1	NNP
cord-015365-iqdi99pd	2497	2	3,28	3,28	CD
cord-015365-iqdi99pd	2497	3	l	l	NN
cord-015365-iqdi99pd	2497	4	(	(	-LRB-
cord-015365-iqdi99pd	2497	5	86	86	CD
cord-015365-iqdi99pd	2497	6	%	%	NN
cord-015365-iqdi99pd	2497	7	)	)	-RRB-
cord-015365-iqdi99pd	2497	8	,	,	.
cord-015365-iqdi99pd	2498	1	MEF50	mef50	JJ
cord-015365-iqdi99pd	2499	1	6,52	6,52	NNP
cord-015365-iqdi99pd	2499	2	l	l	NNP
cord-015365-iqdi99pd	2499	3	(	(	-LRB-
cord-015365-iqdi99pd	2499	4	135	135	CD
cord-015365-iqdi99pd	2499	5	%	%	NN
cord-015365-iqdi99pd	2499	6	)	)	-RRB-
cord-015365-iqdi99pd	2499	7	und	und	RB
cord-015365-iqdi99pd	2500	1	TLC	TLC	NNP
cord-015365-iqdi99pd	2500	2	5,88	5,88	CD
cord-015365-iqdi99pd	2500	3	l	l	NN
cord-015365-iqdi99pd	2500	4	(	(	-LRB-
cord-015365-iqdi99pd	2500	5	84	84	CD
cord-015365-iqdi99pd	2500	6	%	%	NN
cord-015365-iqdi99pd	2500	7	)	)	-RRB-
cord-015365-iqdi99pd	2500	8	.	.	.
cord-015365-iqdi99pd	2501	1	Der	Der	NNP
cord-015365-iqdi99pd	2501	2	postoperative	postoperative	JJ
cord-015365-iqdi99pd	2501	3	Verlauf	Verlauf	NNP
cord-015365-iqdi99pd	2501	4	gestaltete	gestaltete	NNP
cord-015365-iqdi99pd	2501	5	sich	sich	NNP
cord-015365-iqdi99pd	2501	6	von	von	NNP
cord-015365-iqdi99pd	2501	7	kardialer	kardialer	NNP
cord-015365-iqdi99pd	2501	8	Seite	Seite	NNP
cord-015365-iqdi99pd	2501	9	komplikationslos	komplikationslos	NNP
cord-015365-iqdi99pd	2502	1	,	,	,
cord-015365-iqdi99pd	2502	2	allerdings	allerdings	NNP
cord-015365-iqdi99pd	2502	3	war	war	NN
cord-015365-iqdi99pd	2502	4	der	der	NNP
cord-015365-iqdi99pd	2502	5	Patient	Patient	NNP
cord-015365-iqdi99pd	2502	6	respiratorisch	respiratorisch	NNP
cord-015365-iqdi99pd	2502	7	stark	stark	NNP
cord-015365-iqdi99pd	2502	8	limitiert	limitiert	NN
cord-015365-iqdi99pd	2502	9	.	.	.
cord-015365-iqdi99pd	2503	1	Der	Der	NNP
cord-015365-iqdi99pd	2503	2	Weaningprozess	Weaningprozess	NNP
cord-015365-iqdi99pd	2503	3	gestaltete	gestaltete	NN
cord-015365-iqdi99pd	2503	4	sich	sich	NNP
cord-015365-iqdi99pd	2503	5	aufgrund	aufgrund	NNP
cord-015365-iqdi99pd	2503	6	einer	einer	NNP
cord-015365-iqdi99pd	2503	7	Lobärpneumonie	Lobärpneumonie	NNP
cord-015365-iqdi99pd	2503	8	protrahiert	protrahiert	NN
cord-015365-iqdi99pd	2503	9	.	.	.
cord-015365-iqdi99pd	2504	1	Auch	Auch	NNP
cord-015365-iqdi99pd	2504	2	auf	auf	NNP
cord-015365-iqdi99pd	2504	3	der	der	NNP
cord-015365-iqdi99pd	2504	4	Normalstation	Normalstation	NNP
cord-015365-iqdi99pd	2504	5	fiel	fiel	NNP
cord-015365-iqdi99pd	2504	6	bei	bei	NNP
cord-015365-iqdi99pd	2504	7	geringsten	geringsten	NNP
cord-015365-iqdi99pd	2504	8	Belastungen	Belastungen	NNP
cord-015365-iqdi99pd	2504	9	die	die	VBP
cord-015365-iqdi99pd	2504	10	Sauerstoffsättigung	Sauerstoffsättigung	NNP
cord-015365-iqdi99pd	2504	11	auf	auf	NN
cord-015365-iqdi99pd	2504	12	bis	bis	NNP
cord-015365-iqdi99pd	2504	13	zu	zu	NNP
cord-015365-iqdi99pd	2504	14	87	87	CD
cord-015365-iqdi99pd	2504	15	%	%	NN
cord-015365-iqdi99pd	2504	16	.	.	.
cord-015365-iqdi99pd	2505	1	Die	die	VB
cord-015365-iqdi99pd	2505	2	Lungenfunktion	lungenfunktion	NN
cord-015365-iqdi99pd	2505	3	2	2	CD
cord-015365-iqdi99pd	2505	4	Monate	monate	NN
cord-015365-iqdi99pd	2506	1	nach	nach	NNP
cord-015365-iqdi99pd	2506	2	HTX	HTX	NNP
cord-015365-iqdi99pd	2506	3	ergab	ergab	NNP
cord-015365-iqdi99pd	2506	4	eine	eine	NNP
cord-015365-iqdi99pd	2506	5	restriktive	restriktive	NNP
cord-015365-iqdi99pd	2506	6	Ventilationsstörung	Ventilationsstörung	NNP
cord-015365-iqdi99pd	2506	7	mit	mit	NNP
cord-015365-iqdi99pd	2506	8	VC	VC	NNP
cord-015365-iqdi99pd	2506	9	1,33	1,33	NNP
cord-015365-iqdi99pd	2506	10	l	l	NN
cord-015365-iqdi99pd	2506	11	(	(	-LRB-
cord-015365-iqdi99pd	2506	12	37,9	37,9	CD
cord-015365-iqdi99pd	2506	13	%	%	NN
cord-015365-iqdi99pd	2506	14	)	)	-RRB-
cord-015365-iqdi99pd	2506	15	,	,	,
cord-015365-iqdi99pd	2506	16	FEV1	FEV1	NNP
cord-015365-iqdi99pd	2506	17	1,29	1,29	CD
cord-015365-iqdi99pd	2506	18	l	l	NNP
cord-015365-iqdi99pd	2506	19	(	(	-LRB-
cord-015365-iqdi99pd	2506	20	34,3	34,3	CD
cord-015365-iqdi99pd	2506	21	%	%	NN
cord-015365-iqdi99pd	2506	22	)	)	-RRB-
cord-015365-iqdi99pd	2506	23	,	,	.
cord-015365-iqdi99pd	2507	1	MEF50	MEF50	NNP
cord-015365-iqdi99pd	2507	2	3,3	3,3	CD
cord-015365-iqdi99pd	2507	3	l	l	NN
cord-015365-iqdi99pd	2507	4	(	(	-LRB-
cord-015365-iqdi99pd	2507	5	71,2	71,2	CD
cord-015365-iqdi99pd	2507	6	%	%	NN
cord-015365-iqdi99pd	2507	7	)	)	-RRB-
cord-015365-iqdi99pd	2507	8	,	,	,
cord-015365-iqdi99pd	2507	9	TLC	TLC	NNP
cord-015365-iqdi99pd	2507	10	2,76	2,76	NNP
cord-015365-iqdi99pd	2508	1	(	(	-LRB-
cord-015365-iqdi99pd	2508	2	39,4	39,4	CD
cord-015365-iqdi99pd	2508	3	%	%	NN
cord-015365-iqdi99pd	2508	4	)	)	-RRB-
cord-015365-iqdi99pd	2508	5	,	,	.
cord-015365-iqdi99pd	2509	1	PaO2	PaO2	NNS
cord-015365-iqdi99pd	2509	2	52,8	52,8	CD
cord-015365-iqdi99pd	2509	3	%	%	NN
cord-015365-iqdi99pd	2509	4	und	und	NNP
cord-015365-iqdi99pd	2510	1	PaCO2	paco2	NN
cord-015365-iqdi99pd	2510	2	38,7	38,7	CD
cord-015365-iqdi99pd	2510	3	%	%	NN
cord-015365-iqdi99pd	2510	4	.	.	.
cord-015365-iqdi99pd	2511	1	Zur	Zur	NNP
cord-015365-iqdi99pd	2511	2	Histologiegewinnung	Histologiegewinnung	NNP
cord-015365-iqdi99pd	2511	3	wurde	wurde	NNP
cord-015365-iqdi99pd	2511	4	nach	nach	NNP
cord-015365-iqdi99pd	2511	5	inkonklusiver	inkonklusiver	NNP
cord-015365-iqdi99pd	2512	1	Bronchoskopie	Bronchoskopie	NNP
cord-015365-iqdi99pd	2512	2	eine	eine	NNP
cord-015365-iqdi99pd	2512	3	offene	offene	NNP
cord-015365-iqdi99pd	2512	4	Lungenbiopsie	Lungenbiopsie	NNP
cord-015365-iqdi99pd	2512	5	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	2512	6	,	,	,
cord-015365-iqdi99pd	2512	7	welche	welche	NNP
cord-015365-iqdi99pd	2512	8	das	das	NNP
cord-015365-iqdi99pd	2512	9	Vorliegen	Vorliegen	NNP
cord-015365-iqdi99pd	2512	10	einer	einer	NNP
cord-015365-iqdi99pd	2512	11	Lungenfibrose	Lungenfibrose	NNP
cord-015365-iqdi99pd	2512	12	vom	vom	VBP
cord-015365-iqdi99pd	2512	13	UIP	UIP	NNP
cord-015365-iqdi99pd	2512	14	-	-	HYPH
cord-015365-iqdi99pd	2512	15	Typ	Typ	NNP
cord-015365-iqdi99pd	2512	16	ergab	ergab	NN
cord-015365-iqdi99pd	2512	17	.	.	.
cord-015365-iqdi99pd	2513	1	Die	die	VB
cord-015365-iqdi99pd	2514	1	Kontroll	Kontroll	NNP
cord-015365-iqdi99pd	2514	2	-	-	HYPH
cord-015365-iqdi99pd	2514	3	Echokardiographien	Echokardiographien	NNP
cord-015365-iqdi99pd	2514	4	zeigten	zeigten	NNP
cord-015365-iqdi99pd	2514	5	durchwegs	durchwegs	NNP
cord-015365-iqdi99pd	2514	6	eine	eine	NNP
cord-015365-iqdi99pd	2514	7	gute	gute	NNP
cord-015365-iqdi99pd	2514	8	rechtsund	rechtsund	NNP
cord-015365-iqdi99pd	2514	9	linksventrikuläre	linksventrikuläre	NNP
cord-015365-iqdi99pd	2514	10	Funktion	Funktion	NNP
cord-015365-iqdi99pd	2514	11	,	,	,
cord-015365-iqdi99pd	2514	12	allerdings	allerdings	NNP
cord-015365-iqdi99pd	2514	13	verschlechterte	verschlechterte	NNP
cord-015365-iqdi99pd	2514	14	sich	sich	NNP
cord-015365-iqdi99pd	2514	15	der	der	NNP
cord-015365-iqdi99pd	2514	16	respiratorische	respiratorische	NNP
cord-015365-iqdi99pd	2514	17	Zustand	Zustand	NNP
cord-015365-iqdi99pd	2514	18	des	des	NNP
cord-015365-iqdi99pd	2514	19	Patienten	Patienten	NNP
cord-015365-iqdi99pd	2514	20	zunehmend	zunehmend	NNP
cord-015365-iqdi99pd	2514	21	,	,	,
cord-015365-iqdi99pd	2514	22	sodass	sodass	NNP
cord-015365-iqdi99pd	2514	23	er	er	UH
cord-015365-iqdi99pd	2514	24	"	"	''
cord-015365-iqdi99pd	2514	25	high	high	JJ
cord-015365-iqdi99pd	2514	26	urgent	urgent	JJ
cord-015365-iqdi99pd	2514	27	"	"	''
cord-015365-iqdi99pd	2514	28	zur	zur	NNP
cord-015365-iqdi99pd	2514	29	Lungentransplantation	Lungentransplantation	NNP
cord-015365-iqdi99pd	2514	30	gelistet	gelistet	NN
cord-015365-iqdi99pd	2514	31	werden	werden	NNP
cord-015365-iqdi99pd	2514	32	musste	musste	NNP
cord-015365-iqdi99pd	2514	33	.	.	.
cord-015365-iqdi99pd	2515	1	Ein	Ein	NNP
cord-015365-iqdi99pd	2515	2	größen	größen	NNP
cord-015365-iqdi99pd	2515	3	-	-	HYPH
cord-015365-iqdi99pd	2515	4	und	und	NNP
cord-015365-iqdi99pd	2515	5	blutgruppenkompatibles	blutgruppenkompatible	NNS
cord-015365-iqdi99pd	2516	1	Spenderorgan	Spenderorgan	NNP
cord-015365-iqdi99pd	2516	2	wurde	wurde	NN
cord-015365-iqdi99pd	2516	3	verfügbar	verfügbar	NNP
cord-015365-iqdi99pd	2516	4	und	und	NNP
cord-015365-iqdi99pd	2516	5	eine	eine	NNP
cord-015365-iqdi99pd	2516	6	bilaterale	bilaterale	NNP
cord-015365-iqdi99pd	2516	7	Lungentransplantation	Lungentransplantation	NNP
cord-015365-iqdi99pd	2516	8	mit	mit	NNP
cord-015365-iqdi99pd	2516	9	veno	veno	NNP
cord-015365-iqdi99pd	2516	10	-	-	HYPH
cord-015365-iqdi99pd	2516	11	arterieller	arterieller	NN
cord-015365-iqdi99pd	2516	12	ECMO	ECMO	NNP
cord-015365-iqdi99pd	2516	13	Unterstützung	Unterstützung	NNP
cord-015365-iqdi99pd	2516	14	durchgeführt	durchgeführt	NN
cord-015365-iqdi99pd	2516	15	.	.	.
cord-015365-iqdi99pd	2517	1	Die	die	VB
cord-015365-iqdi99pd	2517	2	ECMO	ECMO	NNP
cord-015365-iqdi99pd	2517	3	konnte	konnte	NNP
cord-015365-iqdi99pd	2517	4	am	be	VBP
cord-015365-iqdi99pd	2517	5	Ende	Ende	NNP
cord-015365-iqdi99pd	2517	6	der	der	NNP
cord-015365-iqdi99pd	2517	7	Operation	Operation	NNP
cord-015365-iqdi99pd	2517	8	bei	bei	NNP
cord-015365-iqdi99pd	2517	9	hämodynamisch	hämodynamisch	NNP
cord-015365-iqdi99pd	2518	1	und	und	NNP
cord-015365-iqdi99pd	2519	1	respiratorisch	respiratorisch	NNP
cord-015365-iqdi99pd	2519	2	stabilen	stabilen	NNP
cord-015365-iqdi99pd	2519	3	Verhältnissen	Verhältnissen	NNP
cord-015365-iqdi99pd	2519	4	wieder	wieder	NNP
cord-015365-iqdi99pd	2519	5	explantiert	explantiert	NNP
cord-015365-iqdi99pd	2520	1	werden	werden	NNP
cord-015365-iqdi99pd	2520	2	.	.	.
cord-015365-iqdi99pd	2521	1	Die	die	VB
cord-015365-iqdi99pd	2521	2	Ischämiezeit	Ischämiezeit	NNP
cord-015365-iqdi99pd	2521	3	der	der	NNP
cord-015365-iqdi99pd	2521	4	rechten	rechten	NNP
cord-015365-iqdi99pd	2521	5	Lunge	Lunge	NNP
cord-015365-iqdi99pd	2521	6	betrug	betrug	NNP
cord-015365-iqdi99pd	2521	7	340	340	CD
cord-015365-iqdi99pd	2522	1	Minuten	Minuten	NNP
cord-015365-iqdi99pd	2523	1	und	und	IN
cord-015365-iqdi99pd	2523	2	links	link	VBZ
cord-015365-iqdi99pd	2523	3	460	460	CD
cord-015365-iqdi99pd	2523	4	Minuten	Minuten	NNP
cord-015365-iqdi99pd	2523	5	.	.	.
cord-015365-iqdi99pd	2524	1	Am	be	VBP
cord-015365-iqdi99pd	2524	2	19	19	CD
cord-015365-iqdi99pd	2524	3	.	.	.
cord-015365-iqdi99pd	2525	1	postoperativen	postoperativen	NNP
cord-015365-iqdi99pd	2525	2	Tag	Tag	NNP
cord-015365-iqdi99pd	2525	3	konnte	konnte	NNP
cord-015365-iqdi99pd	2525	4	der	der	NNP
cord-015365-iqdi99pd	2526	1	Patient	Patient	NNP
cord-015365-iqdi99pd	2526	2	auf	auf	NNP
cord-015365-iqdi99pd	2526	3	die	die	VBP
cord-015365-iqdi99pd	2526	4	Normalstation	normalstation	NN
cord-015365-iqdi99pd	2526	5	verlegt	verlegt	NN
cord-015365-iqdi99pd	2527	1	und	und	IN
cord-015365-iqdi99pd	2527	2	nach	nach	NNP
cord-015365-iqdi99pd	2527	3	weiteren	weiteren	NNP
cord-015365-iqdi99pd	2528	1	23	23	CD
cord-015365-iqdi99pd	2528	2	Tagen	Tagen	NNP
cord-015365-iqdi99pd	2528	3	aus	aus	NNP
cord-015365-iqdi99pd	2528	4	dem	dem	NNP
cord-015365-iqdi99pd	2528	5	Krankenhaus	Krankenhaus	NNP
cord-015365-iqdi99pd	2528	6	entlassen	entlassen	NNP
cord-015365-iqdi99pd	2528	7	werden	werden	NNP
cord-015365-iqdi99pd	2528	8	.	.	.
cord-015365-iqdi99pd	2529	1	Schlussfolgerungen	Schlussfolgerungen	NNP
cord-015365-iqdi99pd	2529	2	.	.	.
cord-015365-iqdi99pd	2530	1	Entgegen	Entgegen	NNP
cord-015365-iqdi99pd	2530	2	der	der	NNP
cord-015365-iqdi99pd	2530	3	allgemeinen	allgemeinen	NNP
cord-015365-iqdi99pd	2530	4	Erwartung	Erwartung	NNP
cord-015365-iqdi99pd	2530	5	,	,	,
cord-015365-iqdi99pd	2530	6	dass	dass	NNP
cord-015365-iqdi99pd	2530	7	eine	eine	NNP
cord-015365-iqdi99pd	2530	8	Fibrose	Fibrose	NNP
cord-015365-iqdi99pd	2530	9	unter	unter	NNP
cord-015365-iqdi99pd	2530	10	immunsuppressiver	immunsuppressiver	NNP
cord-015365-iqdi99pd	2531	1	Therapie	Therapie	NNP
cord-015365-iqdi99pd	2531	2	ein	ein	NNP
cord-015365-iqdi99pd	2531	3	geringes	geringes	NNP
cord-015365-iqdi99pd	2531	4	Risiko	Risiko	NNP
cord-015365-iqdi99pd	2531	5	fü	fü	IN
cord-015365-iqdi99pd	2531	6	r	r	NNP
cord-015365-iqdi99pd	2531	7	Progression	progression	NN
cord-015365-iqdi99pd	2531	8	hat	hat	NN
cord-015365-iqdi99pd	2531	9	,	,	,
cord-015365-iqdi99pd	2531	10	zeigte	zeigte	NNP
cord-015365-iqdi99pd	2531	11	sich	sich	NNP
cord-015365-iqdi99pd	2531	12	in	in	IN
cord-015365-iqdi99pd	2531	13	diesem	diesem	NNP
cord-015365-iqdi99pd	2531	14	Fall	Fall	NNP
cord-015365-iqdi99pd	2531	15	eine	eine	NNP
cord-015365-iqdi99pd	2532	1	dramatische	dramatische	NNP
cord-015365-iqdi99pd	2532	2	Entwicklung	Entwicklung	NNP
cord-015365-iqdi99pd	2532	3	nach	nach	NNP
cord-015365-iqdi99pd	2532	4	der	der	NNP
cord-015365-iqdi99pd	2532	5	Herztransplantation	Herztransplantation	NNP
cord-015365-iqdi99pd	2532	6	.	.	.
cord-015365-iqdi99pd	2533	1	Deshalb	Deshalb	NNP
cord-015365-iqdi99pd	2533	2	sollte	sollte	NNP
cord-015365-iqdi99pd	2533	3	eine	eine	NNP
cord-015365-iqdi99pd	2534	1	Lungenfibrose	lungenfibrose	NN
cord-015365-iqdi99pd	2534	2	vor	vor	NN
cord-015365-iqdi99pd	2534	3	einer	einer	NNP
cord-015365-iqdi99pd	2535	1	HTX	HTX	NNP
cord-015365-iqdi99pd	2535	2	genau	genau	NNP
cord-015365-iqdi99pd	2535	3	abgeklärt	abgeklärt	NNP
cord-015365-iqdi99pd	2536	1	und	und	IN
cord-015365-iqdi99pd	2536	2	engmaschige	engmaschige	NNP
cord-015365-iqdi99pd	2536	3	postoperative	postoperative	JJ
cord-015365-iqdi99pd	2536	4	Kontrollen	Kontrollen	NNP
cord-015365-iqdi99pd	2536	5	durchgefü	durchgefü	NNP
cord-015365-iqdi99pd	2536	6	hrt	hrt	NNP
cord-015365-iqdi99pd	2536	7	werden	werden	NNP
cord-015365-iqdi99pd	2536	8	.	.	.
cord-015365-iqdi99pd	2537	1	Invasive	invasive	JJ
cord-015365-iqdi99pd	2537	2	mycoses	mycose	NNS
cord-015365-iqdi99pd	2537	3	after	after	IN
cord-015365-iqdi99pd	2537	4	heart	heart	NN
cord-015365-iqdi99pd	2537	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	2537	6	:	:	:
cord-015365-iqdi99pd	2538	1	outcome	outcome	NN
cord-015365-iqdi99pd	2538	2	and	and	CC
cord-015365-iqdi99pd	2538	3	long	long	JJ
cord-015365-iqdi99pd	2538	4	-	-	HYPH
cord-015365-iqdi99pd	2538	5	term	term	NN
cord-015365-iqdi99pd	2538	6	prognosis	prognosis	NN
cord-015365-iqdi99pd	2539	1	T.	T.	NNP
cord-015365-iqdi99pd	2539	2	Haberl	Haberl	NNP
cord-015365-iqdi99pd	2539	3	1	1	CD
cord-015365-iqdi99pd	2539	4	,	,	,
cord-015365-iqdi99pd	2539	5	D.	D.	NNP
cord-015365-iqdi99pd	2539	6	Hutschala	Hutschala	NNP
cord-015365-iqdi99pd	2539	7	2	2	CD
cord-015365-iqdi99pd	2539	8	,	,	,
cord-015365-iqdi99pd	2539	9	C.	C.	NNP
cord-015365-iqdi99pd	2539	10	Pelanek	Pelanek	NNP
cord-015365-iqdi99pd	2539	11	1	1	CD
cord-015365-iqdi99pd	2539	12	,	,	,
cord-015365-iqdi99pd	2539	13	A.	A.	NNP
cord-015365-iqdi99pd	2539	14	Aliabadi	Aliabadi	NNP
cord-015365-iqdi99pd	2539	15	1	1	CD
cord-015365-iqdi99pd	2539	16	,	,	,
cord-015365-iqdi99pd	2539	17	G.	G.	NNP
cord-015365-iqdi99pd	2539	18	Laufer	Laufer	NNP
cord-015365-iqdi99pd	2539	19	1	1	CD
cord-015365-iqdi99pd	2539	20	,	,	,
cord-015365-iqdi99pd	2539	21	A.	a.	NN
cord-015365-iqdi99pd	2539	22	Zuckermann	Zuckermann	NNP
cord-015365-iqdi99pd	2540	1	1Background	1background	LS
cord-015365-iqdi99pd	2540	2	.	.	.
cord-015365-iqdi99pd	2541	1	Although	although	IN
cord-015365-iqdi99pd	2541	2	orthotopic	orthotopic	JJ
cord-015365-iqdi99pd	2541	3	heart	heart	NN
cord-015365-iqdi99pd	2541	4	transplantation	transplantation	NN
cord-015365-iqdi99pd	2541	5	has	have	VBZ
cord-015365-iqdi99pd	2541	6	become	become	VBN
cord-015365-iqdi99pd	2541	7	a	a	DT
cord-015365-iqdi99pd	2541	8	routine	routine	JJ
cord-015365-iqdi99pd	2541	9	procedure	procedure	NN
cord-015365-iqdi99pd	2541	10	in	in	IN
cord-015365-iqdi99pd	2541	11	treatment	treatment	NN
cord-015365-iqdi99pd	2541	12	of	of	IN
cord-015365-iqdi99pd	2541	13	end	end	NN
cord-015365-iqdi99pd	2541	14	-	-	HYPH
cord-015365-iqdi99pd	2541	15	stage	stage	NN
cord-015365-iqdi99pd	2541	16	cardiac	cardiac	JJ
cord-015365-iqdi99pd	2541	17	failure	failure	NN
cord-015365-iqdi99pd	2541	18	,	,	,
cord-015365-iqdi99pd	2541	19	postoperative	postoperative	JJ
cord-015365-iqdi99pd	2541	20	mycosal	mycosal	NN
cord-015365-iqdi99pd	2541	21	infections	infection	NNS
cord-015365-iqdi99pd	2541	22	are	be	VBP
cord-015365-iqdi99pd	2541	23	still	still	RB
cord-015365-iqdi99pd	2541	24	a	a	DT
cord-015365-iqdi99pd	2541	25	serious	serious	JJ
cord-015365-iqdi99pd	2541	26	risk	risk	NN
cord-015365-iqdi99pd	2541	27	for	for	IN
cord-015365-iqdi99pd	2541	28	the	the	DT
cord-015365-iqdi99pd	2541	29	patients	patient	NNS
cord-015365-iqdi99pd	2541	30	.	.	.
cord-015365-iqdi99pd	2542	1	Objective	objective	NN
cord-015365-iqdi99pd	2542	2	of	of	IN
cord-015365-iqdi99pd	2542	3	the	the	DT
cord-015365-iqdi99pd	2542	4	current	current	JJ
cord-015365-iqdi99pd	2542	5	study	study	NN
cord-015365-iqdi99pd	2542	6	is	be	VBZ
cord-015365-iqdi99pd	2542	7	to	to	TO
cord-015365-iqdi99pd	2542	8	show	show	VB
cord-015365-iqdi99pd	2542	9	the	the	DT
cord-015365-iqdi99pd	2542	10	influence	influence	NN
cord-015365-iqdi99pd	2542	11	of	of	IN
cord-015365-iqdi99pd	2542	12	various	various	JJ
cord-015365-iqdi99pd	2542	13	parameters	parameter	NNS
cord-015365-iqdi99pd	2542	14	on	on	IN
cord-015365-iqdi99pd	2542	15	the	the	DT
cord-015365-iqdi99pd	2542	16	severity	severity	NN
cord-015365-iqdi99pd	2542	17	of	of	IN
cord-015365-iqdi99pd	2542	18	infection	infection	NN
cord-015365-iqdi99pd	2542	19	and	and	CC
cord-015365-iqdi99pd	2542	20	the	the	DT
cord-015365-iqdi99pd	2542	21	outcome	outcome	NN
cord-015365-iqdi99pd	2542	22	for	for	IN
cord-015365-iqdi99pd	2542	23	patients	patient	NNS
cord-015365-iqdi99pd	2542	24	.	.	.
cord-015365-iqdi99pd	2543	1	Methods	method	NNS
cord-015365-iqdi99pd	2543	2	.	.	.
cord-015365-iqdi99pd	2544	1	This	this	DT
cord-015365-iqdi99pd	2544	2	is	be	VBZ
cord-015365-iqdi99pd	2544	3	a	a	DT
cord-015365-iqdi99pd	2544	4	single	single	JJ
cord-015365-iqdi99pd	2544	5	-	-	HYPH
cord-015365-iqdi99pd	2544	6	center	center	NN
cord-015365-iqdi99pd	2544	7	retrospective	retrospective	JJ
cord-015365-iqdi99pd	2544	8	study	study	NN
cord-015365-iqdi99pd	2544	9	including	include	VBG
cord-015365-iqdi99pd	2544	10	338	338	CD
cord-015365-iqdi99pd	2544	11	patients	patient	NNS
cord-015365-iqdi99pd	2544	12	who	who	WP
cord-015365-iqdi99pd	2544	13	underwent	undergo	VBD
cord-015365-iqdi99pd	2544	14	heart	heart	NN
cord-015365-iqdi99pd	2544	15	transplantation	transplantation	NN
cord-015365-iqdi99pd	2544	16	from	from	IN
cord-015365-iqdi99pd	2544	17	2000	2000	CD
cord-015365-iqdi99pd	2544	18	-	-	SYM
cord-015365-iqdi99pd	2544	19	2008	2008	CD
cord-015365-iqdi99pd	2544	20	at	at	IN
cord-015365-iqdi99pd	2544	21	our	-PRON-	PRP$
cord-015365-iqdi99pd	2544	22	center	center	NN
cord-015365-iqdi99pd	2544	23	in	in	IN
cord-015365-iqdi99pd	2544	24	Vienna	Vienna	NNP
cord-015365-iqdi99pd	2544	25	.	.	.
cord-015365-iqdi99pd	2545	1	The	the	DT
cord-015365-iqdi99pd	2545	2	analyzed	analyze	VBN
cord-015365-iqdi99pd	2545	3	data	datum	NNS
cord-015365-iqdi99pd	2545	4	were	be	VBD
cord-015365-iqdi99pd	2545	5	collected	collect	VBN
cord-015365-iqdi99pd	2545	6	during	during	IN
cord-015365-iqdi99pd	2545	7	the	the	DT
cord-015365-iqdi99pd	2545	8	post	post	NN
cord-015365-iqdi99pd	2545	9	transplant	transplant	NN
cord-015365-iqdi99pd	2545	10	course	course	NN
cord-015365-iqdi99pd	2545	11	in	in	IN
cord-015365-iqdi99pd	2545	12	the	the	DT
cord-015365-iqdi99pd	2545	13	intensive	intensive	JJ
cord-015365-iqdi99pd	2545	14	care	care	NN
cord-015365-iqdi99pd	2545	15	unit	unit	NN
cord-015365-iqdi99pd	2545	16	(	(	-LRB-
cord-015365-iqdi99pd	2545	17	ICU	ICU	NNP
cord-015365-iqdi99pd	2545	18	)	)	-RRB-
cord-015365-iqdi99pd	2545	19	.	.	.
cord-015365-iqdi99pd	2546	1	Mycoses	Mycoses	NNP
cord-015365-iqdi99pd	2546	2	were	be	VBD
cord-015365-iqdi99pd	2546	3	diagnosed	diagnose	VBN
cord-015365-iqdi99pd	2546	4	by	by	IN
cord-015365-iqdi99pd	2546	5	cultures	culture	NNS
cord-015365-iqdi99pd	2546	6	of	of	IN
cord-015365-iqdi99pd	2546	7	blood	blood	NN
cord-015365-iqdi99pd	2546	8	,	,	,
cord-015365-iqdi99pd	2546	9	bronchoalveolar	bronchoalveolar	NNP
cord-015365-iqdi99pd	2546	10	lavages	lavages	NNP
cord-015365-iqdi99pd	2546	11	(	(	-LRB-
cord-015365-iqdi99pd	2546	12	BAL	BAL	NNP
cord-015365-iqdi99pd	2546	13	)	)	-RRB-
cord-015365-iqdi99pd	2546	14	and	and	CC
cord-015365-iqdi99pd	2546	15	smear	smear	VB
cord-015365-iqdi99pd	2546	16	tests	test	NNS
cord-015365-iqdi99pd	2546	17	of	of	IN
cord-015365-iqdi99pd	2546	18	central	central	JJ
cord-015365-iqdi99pd	2546	19	arterial	arterial	JJ
cord-015365-iqdi99pd	2546	20	and	and	CC
cord-015365-iqdi99pd	2546	21	venous	venous	JJ
cord-015365-iqdi99pd	2546	22	catheters	catheter	NNS
cord-015365-iqdi99pd	2546	23	,	,	,
cord-015365-iqdi99pd	2546	24	wounds	wound	NNS
cord-015365-iqdi99pd	2546	25	and	and	CC
cord-015365-iqdi99pd	2546	26	drainages	drainage	NNS
cord-015365-iqdi99pd	2546	27	.	.	.
cord-015365-iqdi99pd	2547	1	Results	result	NNS
cord-015365-iqdi99pd	2547	2	.	.	.
cord-015365-iqdi99pd	2548	1	Mean	mean	JJ
cord-015365-iqdi99pd	2548	2	age	age	NN
cord-015365-iqdi99pd	2548	3	at	at	IN
cord-015365-iqdi99pd	2548	4	time	time	NN
cord-015365-iqdi99pd	2548	5	of	of	IN
cord-015365-iqdi99pd	2548	6	transplantation	transplantation	NN
cord-015365-iqdi99pd	2548	7	was	be	VBD
cord-015365-iqdi99pd	2548	8	49	49	CD
cord-015365-iqdi99pd	2548	9	years	year	NNS
cord-015365-iqdi99pd	2548	10	,	,	,
cord-015365-iqdi99pd	2548	11	260	260	CD
cord-015365-iqdi99pd	2548	12	patients	patient	NNS
cord-015365-iqdi99pd	2548	13	(	(	-LRB-
cord-015365-iqdi99pd	2548	14	76.9	76.9	CD
cord-015365-iqdi99pd	2548	15	%	%	NN
cord-015365-iqdi99pd	2548	16	)	)	-RRB-
cord-015365-iqdi99pd	2548	17	were	be	VBD
cord-015365-iqdi99pd	2548	18	male	male	JJ
cord-015365-iqdi99pd	2548	19	(	(	-LRB-
cord-015365-iqdi99pd	2548	20	age	age	NN
cord-015365-iqdi99pd	2548	21	5	5	CD
cord-015365-iqdi99pd	2548	22	-	-	SYM
cord-015365-iqdi99pd	2548	23	71	71	CD
cord-015365-iqdi99pd	2548	24	years	year	NNS
cord-015365-iqdi99pd	2548	25	)	)	-RRB-
cord-015365-iqdi99pd	2548	26	and	and	CC
cord-015365-iqdi99pd	2548	27	78	78	CD
cord-015365-iqdi99pd	2548	28	patients	patient	NNS
cord-015365-iqdi99pd	2548	29	(	(	-LRB-
cord-015365-iqdi99pd	2548	30	23.1	23.1	CD
cord-015365-iqdi99pd	2548	31	%	%	NN
cord-015365-iqdi99pd	2548	32	)	)	-RRB-
cord-015365-iqdi99pd	2548	33	were	be	VBD
cord-015365-iqdi99pd	2548	34	female	female	JJ
cord-015365-iqdi99pd	2548	35	(	(	-LRB-
cord-015365-iqdi99pd	2548	36	age	age	NN
cord-015365-iqdi99pd	2548	37	3	3	CD
cord-015365-iqdi99pd	2548	38	weeks-76	weeks-76	NNS
cord-015365-iqdi99pd	2548	39	years	year	NNS
cord-015365-iqdi99pd	2548	40	)	)	-RRB-
cord-015365-iqdi99pd	2548	41	.	.	.
cord-015365-iqdi99pd	2549	1	90	90	CD
cord-015365-iqdi99pd	2549	2	patients	patient	NNS
cord-015365-iqdi99pd	2549	3	(	(	-LRB-
cord-015365-iqdi99pd	2549	4	34	34	CD
cord-015365-iqdi99pd	2549	5	%	%	NN
cord-015365-iqdi99pd	2549	6	)	)	-RRB-
cord-015365-iqdi99pd	2549	7	acquired	acquire	VBD
cord-015365-iqdi99pd	2549	8	an	an	DT
cord-015365-iqdi99pd	2549	9	invasive	invasive	JJ
cord-015365-iqdi99pd	2549	10	mycosal	mycosal	NN
cord-015365-iqdi99pd	2549	11	infection	infection	NN
cord-015365-iqdi99pd	2549	12	with	with	IN
cord-015365-iqdi99pd	2549	13	candida	candida	NN
cord-015365-iqdi99pd	2549	14	species	specie	NNS
cord-015365-iqdi99pd	2549	15	(	(	-LRB-
cord-015365-iqdi99pd	2549	16	94.3	94.3	CD
cord-015365-iqdi99pd	2549	17	%	%	NN
cord-015365-iqdi99pd	2549	18	)	)	-RRB-
cord-015365-iqdi99pd	2549	19	,	,	,
cord-015365-iqdi99pd	2549	20	aspergillus	aspergillus	NN
cord-015365-iqdi99pd	2549	21	(	(	-LRB-
cord-015365-iqdi99pd	2549	22	3.8	3.8	CD
cord-015365-iqdi99pd	2549	23	%	%	NN
cord-015365-iqdi99pd	2549	24	)	)	-RRB-
cord-015365-iqdi99pd	2549	25	and	and	CC
cord-015365-iqdi99pd	2549	26	pneumocystis	pneumocystis	NNP
cord-015365-iqdi99pd	2549	27	carinii	carinii	FW
cord-015365-iqdi99pd	2549	28	(	(	-LRB-
cord-015365-iqdi99pd	2549	29	1.9	1.9	CD
cord-015365-iqdi99pd	2549	30	%	%	NN
cord-015365-iqdi99pd	2549	31	)	)	-RRB-
cord-015365-iqdi99pd	2549	32	.	.	.
cord-015365-iqdi99pd	2550	1	Diagnosis	diagnosis	NN
cord-015365-iqdi99pd	2550	2	was	be	VBD
cord-015365-iqdi99pd	2550	3	performed	perform	VBN
cord-015365-iqdi99pd	2550	4	in	in	IN
cord-015365-iqdi99pd	2550	5	24.1	24.1	CD
cord-015365-iqdi99pd	2550	6	%	%	NN
cord-015365-iqdi99pd	2550	7	by	by	IN
cord-015365-iqdi99pd	2550	8	cultures	culture	NNS
cord-015365-iqdi99pd	2550	9	of	of	IN
cord-015365-iqdi99pd	2550	10	blood	blood	NN
cord-015365-iqdi99pd	2550	11	,	,	,
cord-015365-iqdi99pd	2550	12	in	in	IN
cord-015365-iqdi99pd	2550	13	23.5	23.5	CD
cord-015365-iqdi99pd	2550	14	%	%	NN
cord-015365-iqdi99pd	2550	15	by	by	IN
cord-015365-iqdi99pd	2550	16	BAL	BAL	NNP
cord-015365-iqdi99pd	2550	17	,	,	,
cord-015365-iqdi99pd	2550	18	18.8	18.8	CD
cord-015365-iqdi99pd	2550	19	%	%	NN
cord-015365-iqdi99pd	2550	20	by	by	IN
cord-015365-iqdi99pd	2550	21	smear	smear	NN
cord-015365-iqdi99pd	2550	22	tests	test	NNS
cord-015365-iqdi99pd	2550	23	of	of	IN
cord-015365-iqdi99pd	2550	24	vena	vena	NNP
cord-015365-iqdi99pd	2550	25	-	-	HYPH
cord-015365-iqdi99pd	2550	26	cava	cava	NNP
cord-015365-iqdi99pd	2550	27	catheters	catheter	NNS
cord-015365-iqdi99pd	2550	28	and	and	CC
cord-015365-iqdi99pd	2550	29	in	in	IN
cord-015365-iqdi99pd	2550	30	11.1	11.1	CD
cord-015365-iqdi99pd	2550	31	%	%	NN
cord-015365-iqdi99pd	2550	32	from	from	IN
cord-015365-iqdi99pd	2550	33	pulmonal	pulmonal	JJ
cord-015365-iqdi99pd	2550	34	artery	artery	NN
cord-015365-iqdi99pd	2550	35	catheters	catheter	NNS
cord-015365-iqdi99pd	2550	36	.	.	.
cord-015365-iqdi99pd	2551	1	In	in	IN
cord-015365-iqdi99pd	2551	2	77.6	77.6	CD
cord-015365-iqdi99pd	2551	3	%	%	NN
cord-015365-iqdi99pd	2551	4	treatment	treatment	NN
cord-015365-iqdi99pd	2551	5	with	with	IN
cord-015365-iqdi99pd	2551	6	a	a	DT
cord-015365-iqdi99pd	2551	7	single	single	JJ
cord-015365-iqdi99pd	2551	8	antimycosal	antimycosal	NN
cord-015365-iqdi99pd	2551	9	therapy	therapy	NN
cord-015365-iqdi99pd	2551	10	was	be	VBD
cord-015365-iqdi99pd	2551	11	sufficient	sufficient	JJ
cord-015365-iqdi99pd	2551	12	.	.	.
cord-015365-iqdi99pd	2552	1	20.9	20.9	CD
cord-015365-iqdi99pd	2552	2	%	%	NN
cord-015365-iqdi99pd	2552	3	of	of	IN
cord-015365-iqdi99pd	2552	4	patients	patient	NNS
cord-015365-iqdi99pd	2552	5	were	be	VBD
cord-015365-iqdi99pd	2552	6	in	in	IN
cord-015365-iqdi99pd	2552	7	need	need	NN
cord-015365-iqdi99pd	2552	8	of	of	IN
cord-015365-iqdi99pd	2552	9	a	a	DT
cord-015365-iqdi99pd	2552	10	double	double	JJ
cord-015365-iqdi99pd	2552	11	-	-	HYPH
cord-015365-iqdi99pd	2552	12	drug	drug	NN
cord-015365-iqdi99pd	2552	13	therapy	therapy	NN
cord-015365-iqdi99pd	2552	14	and	and	CC
cord-015365-iqdi99pd	2552	15	1.5	1.5	CD
cord-015365-iqdi99pd	2552	16	%	%	NN
cord-015365-iqdi99pd	2552	17	needed	need	VBD
cord-015365-iqdi99pd	2552	18	a	a	DT
cord-015365-iqdi99pd	2552	19	triple	triple	JJ
cord-015365-iqdi99pd	2552	20	-	-	HYPH
cord-015365-iqdi99pd	2552	21	drug	drug	NN
cord-015365-iqdi99pd	2552	22	-	-	HYPH
cord-015365-iqdi99pd	2552	23	therapy	therapy	NN
cord-015365-iqdi99pd	2552	24	.	.	.
cord-015365-iqdi99pd	2553	1	Patients	patient	NNS
cord-015365-iqdi99pd	2553	2	with	with	IN
cord-015365-iqdi99pd	2553	3	mycosal	mycosal	NN
cord-015365-iqdi99pd	2553	4	infection	infection	NN
cord-015365-iqdi99pd	2553	5	had	have	VBD
cord-015365-iqdi99pd	2553	6	an	an	DT
cord-015365-iqdi99pd	2553	7	median	median	NN
cord-015365-iqdi99pd	2553	8	stay	stay	NN
cord-015365-iqdi99pd	2553	9	in	in	IN
cord-015365-iqdi99pd	2553	10	the	the	DT
cord-015365-iqdi99pd	2553	11	ICU	ICU	NNP
cord-015365-iqdi99pd	2553	12	of	of	IN
cord-015365-iqdi99pd	2553	13	16	16	CD
cord-015365-iqdi99pd	2553	14	days	day	NNS
cord-015365-iqdi99pd	2554	1	(	(	-LRB-
cord-015365-iqdi99pd	2554	2	1st	1st	NNP
cord-015365-iqdi99pd	2554	3	Quartile	Quartile	NNP
cord-015365-iqdi99pd	2554	4	:	:	:
cord-015365-iqdi99pd	2554	5	7.25	7.25	CD
cord-015365-iqdi99pd	2554	6	,	,	,
cord-015365-iqdi99pd	2554	7	3rd	3rd	NNP
cord-015365-iqdi99pd	2554	8	Quartile	Quartile	NNP
cord-015365-iqdi99pd	2554	9	:	:	:
cord-015365-iqdi99pd	2554	10	24.75	24.75	CD
cord-015365-iqdi99pd	2554	11	)	)	-RRB-
cord-015365-iqdi99pd	2554	12	with	with	IN
cord-015365-iqdi99pd	2554	13	a	a	DT
cord-015365-iqdi99pd	2554	14	median	median	NN
cord-015365-iqdi99pd	2554	15	of	of	IN
cord-015365-iqdi99pd	2554	16	4.5	4.5	CD
cord-015365-iqdi99pd	2554	17	(	(	-LRB-
cord-015365-iqdi99pd	2554	18	Q1	q1	NN
cord-015365-iqdi99pd	2554	19	:	:	:
cord-015365-iqdi99pd	2554	20	0	0	NFP
cord-015365-iqdi99pd	2554	21	,	,	,
cord-015365-iqdi99pd	2554	22	Q3	q3	NN
cord-015365-iqdi99pd	2554	23	:	:	:
cord-015365-iqdi99pd	2554	24	7	7	CD
cord-015365-iqdi99pd	2554	25	)	)	-RRB-
cord-015365-iqdi99pd	2554	26	respirator	respirator	NN
cord-015365-iqdi99pd	2554	27	-	-	HYPH
cord-015365-iqdi99pd	2554	28	days	day	NNS
cord-015365-iqdi99pd	2554	29	compared	compare	VBN
cord-015365-iqdi99pd	2554	30	with	with	IN
cord-015365-iqdi99pd	2554	31	patient	patient	NN
cord-015365-iqdi99pd	2554	32	without	without	IN
cord-015365-iqdi99pd	2554	33	infection	infection	NN
cord-015365-iqdi99pd	2554	34	who	who	WP
cord-015365-iqdi99pd	2554	35	had	have	VBD
cord-015365-iqdi99pd	2554	36	median	median	JJ
cord-015365-iqdi99pd	2554	37	9	9	CD
cord-015365-iqdi99pd	2554	38	(	(	-LRB-
cord-015365-iqdi99pd	2554	39	Q1	Q1	NNP
cord-015365-iqdi99pd	2554	40	:	:	:
cord-015365-iqdi99pd	2554	41	4	4	CD
cord-015365-iqdi99pd	2554	42	,	,	,
cord-015365-iqdi99pd	2554	43	Q3	Q3	NNP
cord-015365-iqdi99pd	2554	44	:	:	:
cord-015365-iqdi99pd	2554	45	16	16	CD
cord-015365-iqdi99pd	2554	46	)	)	-RRB-
cord-015365-iqdi99pd	2554	47	days	day	NNS
cord-015365-iqdi99pd	2554	48	in	in	IN
cord-015365-iqdi99pd	2554	49	ICU	ICU	NNP
cord-015365-iqdi99pd	2554	50	with	with	IN
cord-015365-iqdi99pd	2554	51	1	1	CD
cord-015365-iqdi99pd	2555	1	(	(	-LRB-
cord-015365-iqdi99pd	2555	2	Q1	Q1	NNP
cord-015365-iqdi99pd	2555	3	:	:	:
cord-015365-iqdi99pd	2555	4	0	0	NFP
cord-015365-iqdi99pd	2555	5	,	,	,
cord-015365-iqdi99pd	2555	6	Q3	q3	NN
cord-015365-iqdi99pd	2555	7	:	:	:
cord-015365-iqdi99pd	2555	8	2	2	LS
cord-015365-iqdi99pd	2555	9	)	)	-RRB-
cord-015365-iqdi99pd	2555	10	respirator	respirator	NN
cord-015365-iqdi99pd	2555	11	-	-	HYPH
cord-015365-iqdi99pd	2555	12	days	day	NNS
cord-015365-iqdi99pd	2555	13	.	.	.
cord-015365-iqdi99pd	2556	1	100	100	CD
cord-015365-iqdi99pd	2556	2	%	%	NN
cord-015365-iqdi99pd	2556	3	of	of	IN
cord-015365-iqdi99pd	2556	4	the	the	DT
cord-015365-iqdi99pd	2556	5	patients	patient	NNS
cord-015365-iqdi99pd	2556	6	with	with	IN
cord-015365-iqdi99pd	2556	7	mycosis	mycosi	NNS
cord-015365-iqdi99pd	2556	8	compared	compare	VBN
cord-015365-iqdi99pd	2556	9	to	to	IN
cord-015365-iqdi99pd	2556	10	49	49	CD
cord-015365-iqdi99pd	2556	11	%	%	NN
cord-015365-iqdi99pd	2556	12	of	of	IN
cord-015365-iqdi99pd	2556	13	the	the	DT
cord-015365-iqdi99pd	2556	14	patients	patient	NNS
cord-015365-iqdi99pd	2556	15	without	without	IN
cord-015365-iqdi99pd	2556	16	mycosis	mycosis	NNP
cord-015365-iqdi99pd	2556	17	developed	develop	VBD
cord-015365-iqdi99pd	2556	18	or	or	CC
cord-015365-iqdi99pd	2556	19	already	already	RB
cord-015365-iqdi99pd	2556	20	had	have	VBN
cord-015365-iqdi99pd	2556	21	bacterial	bacterial	JJ
cord-015365-iqdi99pd	2556	22	co	co	NN
cord-015365-iqdi99pd	2556	23	-	-	NN
cord-015365-iqdi99pd	2556	24	infection	infection	NN
cord-015365-iqdi99pd	2557	1	(	(	-LRB-
cord-015365-iqdi99pd	2557	2	p	p	NN
cord-015365-iqdi99pd	2557	3	<	<	XX
cord-015365-iqdi99pd	2557	4	0.001	0.001	CD
cord-015365-iqdi99pd	2557	5	)	)	-RRB-
cord-015365-iqdi99pd	2557	6	.	.	.
cord-015365-iqdi99pd	2558	1	The	the	DT
cord-015365-iqdi99pd	2558	2	1-year	1-year	CD
cord-015365-iqdi99pd	2558	3	survival	survival	NN
cord-015365-iqdi99pd	2558	4	of	of	IN
cord-015365-iqdi99pd	2558	5	patients	patient	NNS
cord-015365-iqdi99pd	2558	6	with	with	IN
cord-015365-iqdi99pd	2558	7	mycosis	mycosis	NNP
cord-015365-iqdi99pd	2558	8	was	be	VBD
cord-015365-iqdi99pd	2558	9	63.3	63.3	CD
cord-015365-iqdi99pd	2558	10	%	%	NN
cord-015365-iqdi99pd	2558	11	compared	compare	VBN
cord-015365-iqdi99pd	2558	12	to	to	IN
cord-015365-iqdi99pd	2558	13	248	248	CD
cord-015365-iqdi99pd	2558	14	patients	patient	NNS
cord-015365-iqdi99pd	2558	15	without	without	IN
cord-015365-iqdi99pd	2558	16	infection	infection	NN
cord-015365-iqdi99pd	2558	17	where	where	WRB
cord-015365-iqdi99pd	2558	18	1-year	1-year	CD
cord-015365-iqdi99pd	2558	19	survival	survival	NN
cord-015365-iqdi99pd	2558	20	was	be	VBD
cord-015365-iqdi99pd	2558	21	83.3	83.3	CD
cord-015365-iqdi99pd	2558	22	%	%	NN
cord-015365-iqdi99pd	2558	23	(	(	-LRB-
cord-015365-iqdi99pd	2558	24	p	p	NN
cord-015365-iqdi99pd	2558	25	<	<	XX
cord-015365-iqdi99pd	2558	26	0.001	0.001	CD
cord-015365-iqdi99pd	2558	27	)	)	-RRB-
cord-015365-iqdi99pd	2558	28	.	.	.
cord-015365-iqdi99pd	2559	1	Average	average	JJ
cord-015365-iqdi99pd	2559	2	time	time	NN
cord-015365-iqdi99pd	2559	3	to	to	IN
cord-015365-iqdi99pd	2559	4	first	first	JJ
cord-015365-iqdi99pd	2559	5	fungal	fungal	JJ
cord-015365-iqdi99pd	2559	6	infection	infection	NN
cord-015365-iqdi99pd	2559	7	was	be	VBD
cord-015365-iqdi99pd	2559	8	7.6	7.6	CD
cord-015365-iqdi99pd	2559	9	AE	AE	NNP
cord-015365-iqdi99pd	2559	10	5.3	5.3	CD
cord-015365-iqdi99pd	2559	11	days	day	NNS
cord-015365-iqdi99pd	2559	12	.	.	.
cord-015365-iqdi99pd	2560	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2560	2	.	.	.
cord-015365-iqdi99pd	2561	1	Invasive	invasive	JJ
cord-015365-iqdi99pd	2561	2	mycosal	mycosal	NN
cord-015365-iqdi99pd	2561	3	infection	infection	NN
cord-015365-iqdi99pd	2561	4	acquired	acquire	VBN
cord-015365-iqdi99pd	2561	5	by	by	IN
cord-015365-iqdi99pd	2561	6	immune	immune	JJ
cord-015365-iqdi99pd	2561	7	suppressed	suppress	VBN
cord-015365-iqdi99pd	2561	8	patients	patient	NNS
cord-015365-iqdi99pd	2561	9	after	after	IN
cord-015365-iqdi99pd	2561	10	heart	heart	NN
cord-015365-iqdi99pd	2561	11	transplantation	transplantation	NN
cord-015365-iqdi99pd	2561	12	is	be	VBZ
cord-015365-iqdi99pd	2561	13	associated	associate	VBN
cord-015365-iqdi99pd	2561	14	with	with	IN
cord-015365-iqdi99pd	2561	15	prolonged	prolonged	JJ
cord-015365-iqdi99pd	2561	16	time	time	NN
cord-015365-iqdi99pd	2561	17	of	of	IN
cord-015365-iqdi99pd	2561	18	stay	stay	NN
cord-015365-iqdi99pd	2561	19	on	on	IN
cord-015365-iqdi99pd	2561	20	the	the	DT
cord-015365-iqdi99pd	2561	21	ICU	ICU	NNP
cord-015365-iqdi99pd	2561	22	as	as	RB
cord-015365-iqdi99pd	2561	23	well	well	RB
cord-015365-iqdi99pd	2561	24	as	as	IN
cord-015365-iqdi99pd	2561	25	higher	high	JJR
cord-015365-iqdi99pd	2561	26	rates	rate	NNS
cord-015365-iqdi99pd	2561	27	of	of	IN
cord-015365-iqdi99pd	2561	28	co	co	NNS
cord-015365-iqdi99pd	2561	29	-	-	NNS
cord-015365-iqdi99pd	2561	30	infections	infection	NNS
cord-015365-iqdi99pd	2561	31	and	and	CC
cord-015365-iqdi99pd	2561	32	a	a	DT
cord-015365-iqdi99pd	2561	33	significant	significant	JJ
cord-015365-iqdi99pd	2561	34	increase	increase	NN
cord-015365-iqdi99pd	2561	35	of	of	IN
cord-015365-iqdi99pd	2561	36	mortality	mortality	NN
cord-015365-iqdi99pd	2561	37	post	post	NN
cord-015365-iqdi99pd	2561	38	transplant	transplant	NN
cord-015365-iqdi99pd	2561	39	.	.	.
cord-015365-iqdi99pd	2562	1	Background	background	NN
cord-015365-iqdi99pd	2562	2	.	.	.
cord-015365-iqdi99pd	2563	1	Xenotransplantation	xenotransplantation	NN
cord-015365-iqdi99pd	2563	2	is	be	VBZ
cord-015365-iqdi99pd	2563	3	a	a	DT
cord-015365-iqdi99pd	2563	4	potential	potential	JJ
cord-015365-iqdi99pd	2563	5	strategy	strategy	NN
cord-015365-iqdi99pd	2563	6	to	to	TO
cord-015365-iqdi99pd	2563	7	overcome	overcome	VB
cord-015365-iqdi99pd	2563	8	the	the	DT
cord-015365-iqdi99pd	2563	9	shortage	shortage	NN
cord-015365-iqdi99pd	2563	10	of	of	IN
cord-015365-iqdi99pd	2563	11	human	human	JJ
cord-015365-iqdi99pd	2563	12	donor	donor	NN
cord-015365-iqdi99pd	2563	13	organs	organ	NNS
cord-015365-iqdi99pd	2563	14	.	.	.
cord-015365-iqdi99pd	2564	1	Since	since	IN
cord-015365-iqdi99pd	2564	2	this	this	DT
cord-015365-iqdi99pd	2564	3	technique	technique	NN
cord-015365-iqdi99pd	2564	4	has	have	VBZ
cord-015365-iqdi99pd	2564	5	a	a	DT
cord-015365-iqdi99pd	2564	6	major	major	JJ
cord-015365-iqdi99pd	2564	7	medical	medical	JJ
cord-015365-iqdi99pd	2564	8	and	and	CC
cord-015365-iqdi99pd	2564	9	psychological	psychological	JJ
cord-015365-iqdi99pd	2564	10	impact	impact	NN
cord-015365-iqdi99pd	2564	11	on	on	IN
cord-015365-iqdi99pd	2564	12	patients	patient	NNS
cord-015365-iqdi99pd	2564	13	and	and	CC
cord-015365-iqdi99pd	2564	14	their	-PRON-	PRP$
cord-015365-iqdi99pd	2564	15	family	family	NN
cord-015365-iqdi99pd	2564	16	and	and	CC
cord-015365-iqdi99pd	2564	17	friends	friend	NNS
cord-015365-iqdi99pd	2564	18	,	,	,
cord-015365-iqdi99pd	2564	19	the	the	DT
cord-015365-iqdi99pd	2564	20	attitude	attitude	NN
cord-015365-iqdi99pd	2564	21	of	of	IN
cord-015365-iqdi99pd	2564	22	patients	patient	NNS
cord-015365-iqdi99pd	2564	23	currently	currently	RB
cord-015365-iqdi99pd	2564	24	waiting	wait	VBG
cord-015365-iqdi99pd	2564	25	for	for	IN
cord-015365-iqdi99pd	2564	26	organ	organ	NN
cord-015365-iqdi99pd	2564	27	transplantation	transplantation	NN
cord-015365-iqdi99pd	2564	28	is	be	VBZ
cord-015365-iqdi99pd	2564	29	important	important	JJ
cord-015365-iqdi99pd	2564	30	.	.	.
cord-015365-iqdi99pd	2565	1	Medhods	Medhods	NNP
cord-015365-iqdi99pd	2565	2	.	.	.
cord-015365-iqdi99pd	2566	1	Therefore	therefore	RB
cord-015365-iqdi99pd	2566	2	we	-PRON-	PRP
cord-015365-iqdi99pd	2566	3	conducted	conduct	VBD
cord-015365-iqdi99pd	2566	4	a	a	DT
cord-015365-iqdi99pd	2566	5	survey	survey	NN
cord-015365-iqdi99pd	2566	6	on	on	IN
cord-015365-iqdi99pd	2566	7	the	the	DT
cord-015365-iqdi99pd	2566	8	attitude	attitude	NN
cord-015365-iqdi99pd	2566	9	towards	towards	IN
cord-015365-iqdi99pd	2566	10	xenotransplantation	xenotransplantation	NN
cord-015365-iqdi99pd	2566	11	of	of	IN
cord-015365-iqdi99pd	2566	12	patients	patient	NNS
cord-015365-iqdi99pd	2566	13	on	on	IN
cord-015365-iqdi99pd	2566	14	the	the	DT
cord-015365-iqdi99pd	2566	15	waiting	waiting	NN
cord-015365-iqdi99pd	2566	16	list	list	NN
cord-015365-iqdi99pd	2566	17	and	and	CC
cord-015365-iqdi99pd	2566	18	already	already	RB
cord-015365-iqdi99pd	2566	19	transplanted	transplant	VBN
cord-015365-iqdi99pd	2566	20	patients	patient	NNS
cord-015365-iqdi99pd	2566	21	.	.	.
cord-015365-iqdi99pd	2567	1	Patients	patient	NNS
cord-015365-iqdi99pd	2567	2	received	receive	VBD
cord-015365-iqdi99pd	2567	3	detailed	detailed	JJ
cord-015365-iqdi99pd	2567	4	information	information	NN
cord-015365-iqdi99pd	2567	5	before	before	IN
cord-015365-iqdi99pd	2567	6	being	be	VBG
cord-015365-iqdi99pd	2567	7	asked	ask	VBN
cord-015365-iqdi99pd	2567	8	to	to	TO
cord-015365-iqdi99pd	2567	9	fill	fill	VB
cord-015365-iqdi99pd	2567	10	in	in	RP
cord-015365-iqdi99pd	2567	11	the	the	DT
cord-015365-iqdi99pd	2567	12	questionnaire	questionnaire	NN
cord-015365-iqdi99pd	2567	13	.	.	.
cord-015365-iqdi99pd	2568	1	Results	result	NNS
cord-015365-iqdi99pd	2568	2	.	.	.
cord-015365-iqdi99pd	2569	1	We	-PRON-	PRP
cord-015365-iqdi99pd	2569	2	found	find	VBD
cord-015365-iqdi99pd	2569	3	that	that	IN
cord-015365-iqdi99pd	2569	4	65	65	CD
cord-015365-iqdi99pd	2569	5	%	%	NN
cord-015365-iqdi99pd	2569	6	would	would	MD
cord-015365-iqdi99pd	2569	7	accept	accept	VB
cord-015365-iqdi99pd	2569	8	xenotransplantation	xenotransplantation	NN
cord-015365-iqdi99pd	2569	9	,	,	,
cord-015365-iqdi99pd	2569	10	irrespective	irrespective	RB
cord-015365-iqdi99pd	2569	11	of	of	IN
cord-015365-iqdi99pd	2569	12	gender	gender	NN
cord-015365-iqdi99pd	2569	13	,	,	,
cord-015365-iqdi99pd	2569	14	education	education	NN
cord-015365-iqdi99pd	2569	15	level	level	NN
cord-015365-iqdi99pd	2569	16	or	or	CC
cord-015365-iqdi99pd	2569	17	if	if	IN
cord-015365-iqdi99pd	2569	18	the	the	DT
cord-015365-iqdi99pd	2569	19	patients	patient	NNS
cord-015365-iqdi99pd	2569	20	were	be	VBD
cord-015365-iqdi99pd	2569	21	on	on	IN
cord-015365-iqdi99pd	2569	22	the	the	DT
cord-015365-iqdi99pd	2569	23	waiting	waiting	NN
cord-015365-iqdi99pd	2569	24	list	list	NN
cord-015365-iqdi99pd	2569	25	or	or	CC
cord-015365-iqdi99pd	2569	26	already	already	RB
cord-015365-iqdi99pd	2569	27	transplanted	transplant	VBN
cord-015365-iqdi99pd	2569	28	.	.	.
cord-015365-iqdi99pd	2570	1	The	the	DT
cord-015365-iqdi99pd	2570	2	most	most	RBS
cord-015365-iqdi99pd	2570	3	common	common	JJ
cord-015365-iqdi99pd	2570	4	concern	concern	NN
cord-015365-iqdi99pd	2570	5	was	be	VBD
cord-015365-iqdi99pd	2570	6	transmission	transmission	NN
cord-015365-iqdi99pd	2570	7	of	of	IN
cord-015365-iqdi99pd	2570	8	diseases	disease	NNS
cord-015365-iqdi99pd	2570	9	or	or	CC
cord-015365-iqdi99pd	2570	10	genetic	genetic	JJ
cord-015365-iqdi99pd	2570	11	material	material	NN
cord-015365-iqdi99pd	2570	12	,	,	,
cord-015365-iqdi99pd	2570	13	followed	follow	VBN
cord-015365-iqdi99pd	2570	14	by	by	IN
cord-015365-iqdi99pd	2570	15	psychological	psychological	JJ
cord-015365-iqdi99pd	2570	16	concerns	concern	NNS
cord-015365-iqdi99pd	2570	17	and	and	CC
cord-015365-iqdi99pd	2570	18	ethical	ethical	JJ
cord-015365-iqdi99pd	2570	19	issues	issue	NNS
cord-015365-iqdi99pd	2570	20	.	.	.
cord-015365-iqdi99pd	2571	1	More	More	JJR
cord-015365-iqdi99pd	2571	2	patients	patient	NNS
cord-015365-iqdi99pd	2571	3	had	have	VBD
cord-015365-iqdi99pd	2571	4	a	a	DT
cord-015365-iqdi99pd	2571	5	positive	positive	JJ
cord-015365-iqdi99pd	2571	6	attitude	attitude	NN
cord-015365-iqdi99pd	2571	7	towards	towards	IN
cord-015365-iqdi99pd	2571	8	accepting	accept	VBG
cord-015365-iqdi99pd	2571	9	cell	cell	NN
cord-015365-iqdi99pd	2571	10	or	or	CC
cord-015365-iqdi99pd	2571	11	tissue	tissue	NN
cord-015365-iqdi99pd	2571	12	transplantation	transplantation	NN
cord-015365-iqdi99pd	2571	13	as	as	IN
cord-015365-iqdi99pd	2571	14	compared	compare	VBN
cord-015365-iqdi99pd	2571	15	to	to	IN
cord-015365-iqdi99pd	2571	16	whole	whole	JJ
cord-015365-iqdi99pd	2571	17	organs	organ	NNS
cord-015365-iqdi99pd	2571	18	.	.	.
cord-015365-iqdi99pd	2572	1	Pig	pig	NN
cord-015365-iqdi99pd	2572	2	pancreas	pancrea	VBZ
cord-015365-iqdi99pd	2572	3	islet	islet	NN
cord-015365-iqdi99pd	2572	4	cell	cell	NN
cord-015365-iqdi99pd	2572	5	transplantation	transplantation	NN
cord-015365-iqdi99pd	2572	6	is	be	VBZ
cord-015365-iqdi99pd	2572	7	generally	generally	RB
cord-015365-iqdi99pd	2572	8	well	well	RB
cord-015365-iqdi99pd	2572	9	accepted	accept	VBN
cord-015365-iqdi99pd	2572	10	,	,	,
cord-015365-iqdi99pd	2572	11	patients	patient	NNS
cord-015365-iqdi99pd	2572	12	with	with	IN
cord-015365-iqdi99pd	2572	13	diabetes	diabetes	NN
cord-015365-iqdi99pd	2572	14	mellitus	mellitus	NN
cord-015365-iqdi99pd	2572	15	show	show	VBP
cord-015365-iqdi99pd	2572	16	even	even	RB
cord-015365-iqdi99pd	2572	17	higher	high	JJR
cord-015365-iqdi99pd	2572	18	acceptance	acceptance	NN
cord-015365-iqdi99pd	2572	19	rates	rate	NNS
cord-015365-iqdi99pd	2572	20	than	than	IN
cord-015365-iqdi99pd	2572	21	patients	patient	NNS
cord-015365-iqdi99pd	2572	22	without	without	IN
cord-015365-iqdi99pd	2572	23	diabetes	diabetes	NN
cord-015365-iqdi99pd	2572	24	.	.	.
cord-015365-iqdi99pd	2573	1	Conclusions	conclusion	NNS
cord-015365-iqdi99pd	2573	2	.	.	.
cord-015365-iqdi99pd	2574	1	Xenotransplantation	Xenotransplantation	NNP
cord-015365-iqdi99pd	2574	2	seems	seem	VBZ
cord-015365-iqdi99pd	2574	3	to	to	TO
cord-015365-iqdi99pd	2574	4	be	be	VB
cord-015365-iqdi99pd	2574	5	well	well	RB
cord-015365-iqdi99pd	2574	6	accepted	accept	VBN
cord-015365-iqdi99pd	2574	7	in	in	IN
cord-015365-iqdi99pd	2574	8	patients	patient	NNS
cord-015365-iqdi99pd	2574	9	who	who	WP
cord-015365-iqdi99pd	2574	10	are	be	VBP
cord-015365-iqdi99pd	2574	11	potential	potential	JJ
cord-015365-iqdi99pd	2574	12	future	future	JJ
cord-015365-iqdi99pd	2574	13	candidates	candidate	NNS
cord-015365-iqdi99pd	2574	14	for	for	IN
cord-015365-iqdi99pd	2574	15	organ	organ	NN
cord-015365-iqdi99pd	2574	16	transplantation	transplantation	NN
cord-015365-iqdi99pd	2574	17	.	.	.
cord-015365-iqdi99pd	2575	1	Informing	inform	VBG
cord-015365-iqdi99pd	2575	2	patients	patient	NNS
cord-015365-iqdi99pd	2575	3	about	about	IN
cord-015365-iqdi99pd	2575	4	the	the	DT
cord-015365-iqdi99pd	2575	5	current	current	JJ
cord-015365-iqdi99pd	2575	6	status	status	NN
cord-015365-iqdi99pd	2575	7	of	of	IN
cord-015365-iqdi99pd	2575	8	research	research	NN
cord-015365-iqdi99pd	2575	9	tended	tend	VBD
cord-015365-iqdi99pd	2575	10	to	to	TO
cord-015365-iqdi99pd	2575	11	decrease	decrease	VB
cord-015365-iqdi99pd	2575	12	acceptance	acceptance	NN
cord-015365-iqdi99pd	2575	13	rates	rate	NNS
cord-015365-iqdi99pd	2575	14	slightly	slightly	RB
cord-015365-iqdi99pd	2575	15	.	.	.